PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gordon, DJ; Motwani, M; Pellman, D				Gordon, D. J.; Motwani, M.; Pellman, D.			Modeling the initiation of Ewing sarcoma tumorigenesis in differentiating human embryonic stem cells	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; ENRICHMENT ANALYSIS; GENOMIC LANDSCAPE; GENE; EXPRESSION; CANCER; GROWTH; FAMILY; EWS/FLI; PHENOTYPE	Oncogenic transformation in Ewing sarcoma tumors is driven by the fusion oncogene EWS-FLI1. However, despite the well-established role of EWS-FLI1 in tumor initiation, the development of models of Ewing sarcoma in human cells with defined genetic elements has been challenging. Here, we report a novel approach to model the initiation of Ewing sarcoma tumorigenesis that exploits the developmental and pluripotent potential of human embryonic stem cells. The inducible expression of EWS-FLI1 in embryoid bodies, or collections of differentiating stem cells, generates cells with properties of Ewing sarcoma tumors, including characteristics of transformation. These cell lines exhibit anchorage-independent growth, a lack of contact inhibition and a strong Ewing sarcoma gene expression signature. Furthermore, these cells also demonstrate a requirement for the persistent expression of EWS-FLI1 for cell survival and growth, which is a hallmark of Ewing sarcoma tumors.	[Gordon, D. J.; Motwani, M.; Pellman, D.] Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave, Boston, MA 02115 USA; [Pellman, D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Pellman, D.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Gordon, D. J.] Univ Iowa, Div Pediat Hematol Oncol, Dept Pediat, 25S Grand Ave, Iowa City, IA 52242 USA; [Motwani, M.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA 01655 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Iowa; University of Massachusetts System; University of Massachusetts Worcester	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave, Boston, MA 02115 USA.; Gordon, DJ (corresponding author), Univ Iowa, Div Pediat Hematol Oncol, Dept Pediat, 25S Grand Ave, Iowa City, IA 52242 USA.	david-j-gordon@uiowa.edu; david_pellman@dfci.harvard.edu	Motwani, Mona/AAV-8162-2020	Motwani, Mona/0000-0003-0912-5478; Gordon, David/0000-0003-1830-4371	NCI K08 award [5K08 CA160346-03]; CureSearch Award; Sarcoma Foundation of America Award; NIH [GM083299]; NATIONAL CANCER INSTITUTE [K08CA160346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083299] Funding Source: NIH RePORTER	NCI K08 award; CureSearch Award; Sarcoma Foundation of America Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Hubo Li for helpful discussions and Kelli Goss for assistance with the drug dose-response experiments. DJG is supported by a NCI K08 award (5K08 CA160346-03), a CureSearch Award and a Sarcoma Foundation of America Award. DP is a HHMI investigator and supported by NIH grant GM083299.	Amaral AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083645; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Benini S, 2004, INT J CANCER, V108, P358, DOI 10.1002/ijc.11576; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Chansky HA, 2004, J ORTHOPAED RES, V22, P910, DOI 10.1016/j.orthres.2003.12.008; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; De Vito C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023592; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; Grunewald TGP, 2012, MOL CANCER RES, V10, P52, DOI 10.1158/1541-7786.MCR-11-0524; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kobayashi E, 2010, MOL CANCER THER, V9, P535, DOI 10.1158/1535-7163.MCT-09-0774; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; Kowalewski Ashley A., 2011, Sarcoma, V2011, P598704, DOI 10.1155/2011/598704; KOWALVERN A, 1992, MODERN PATHOL, V5, P56; Ladanyi M, 2002, CANCER BIOL THER, V1, P330; Lawlor ER, 1998, CANCER RES, V58, P2469; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leacock SW, 2012, DIS MODEL MECH, V5, P95, DOI 10.1242/dmm.007401; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Maire G, 2008, CANCER GENET CYTOGEN, V181, P81, DOI 10.1016/j.cancergencyto.2007.11.002; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Navarro S, 2007, ANTICANCER RES, V27, P2457; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Potikyan G, 2008, LAB INVEST, V88, P1291, DOI 10.1038/labinvest.2008.99; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2014, CANCER CELL, V26, P1; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Roberts P, 2008, GENE CHROMOSOME CANC, V47, P207, DOI 10.1002/gcc.20523; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Sanchez G, 2008, P NATL ACAD SCI USA, V105, P6004, DOI 10.1073/pnas.0710748105; Scotlandi K, 2003, J CLIN ONCOL, V21, P1952, DOI 10.1200/JCO.2003.11.111; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tilan JU, 2013, ONCOTARGET, V4, P2487, DOI 10.18632/oncotarget.1604; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wiles ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059369; Williams SA, 2013, LAB INVEST, V93, P970, DOI 10.1038/labinvest.2013.92; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	59	14	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 16	2016	35	24					3092	3102		10.1038/onc.2015.368	http://dx.doi.org/10.1038/onc.2015.368			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO9GI	26455317	Green Submitted, Green Accepted			2022-12-26	WOS:000378092700002
J	Huang, F; Ramakrishnan, S; Pokhrel, S; Pflueger, C; Parnell, TJ; Kasten, MM; Currie, SL; Bhachech, N; Horikoshi, M; Graves, BJ; Cairns, BR; Bhaskara, S; Chandrasekharan, MB				Huang, Fu; Ramakrishnan, Saravanan; Pokhrel, Srijana; Pflueger, Christian; Parnell, Timothy J.; Kasten, Margaret M.; Currie, Simon L.; Bhachech, Niraja; Horikoshi, Masami; Graves, Barbara J.; Cairns, Bradley R.; Bhaskara, Srividya; Chandrasekharan, Mahesh B.			Interaction of the Jhd2 Histone H3 Lys-4 Demethylase with Chromatin Is Controlled by Histone H2A Surfaces and Restricted by H2B Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; histone; histone demethylase; histone methylation; histone modification; epigenetics; nucleosome; PHD finger; protein-protein interaction; transcription; H3K4 methylation	RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; PHD FINGER; LYSINE-4 METHYLATION; GENE REPRESSION; GENOME-WIDE; TRANSCRIPTION ELONGATION; DEACETYLASE COMPLEX; DI-METHYLATION; ACTIVE GENES	Histone H3 lysine 4 (H3K4) methylation is a dynamic modification. In budding yeast, H3K4 methylation is catalyzed by the Set1-COMPASS methyltransferase complex and is removed by Jhd2, a JMJC domain family demethylase. The catalytic JmjC and JmjN domains of Jhd2 have the ability to remove all three degrees (mono-, di-, and tri-) of H3K4 methylation. Jhd2 also contains a plant homeodomain (PHD) finger required for its chromatin association and H3K4 demethylase functions. The Jhd2 PHD finger associates with chromatin independent of H3K4 methylation and the H3 N-terminal tail. Therefore, how Jhd2 associates with chromatin to perform H3K4 demethylation has remained unknown. We report a novel interaction between the Jhd2 PHD finger and histone H2A. Two residues in H2A (Phe-26 and Glu-57) serve as a binding site for Jhd2 in vitro and mediate its chromatin association and H3K4 demethylase functions in vivo. Using RNA sequencing, we have identified the functional target genes for Jhd2 and the H2A Phe-26 and Glu-57 residues. We demonstrate that H2A Phe-26 and Glu-57 residues control chromatin association and H3K4 demethylase functions of Jhd2 during positive or negative regulation of transcription at target genes. Importantly, we show that H2B Lys-123 ubiquitination blocks Jhd2 from accessing its binding site on chromatin, and thereby, we have uncovered a second mechanism by which H2B ubiquitination contributes to the trans-histone regulation of H3K4 methylation. Overall, our study provides novel insights into the chromatin binding dynamics and H3K4 demethylase functions of Jhd2.	[Ramakrishnan, Saravanan; Pokhrel, Srijana; Bhaskara, Srividya; Chandrasekharan, Mahesh B.] Univ Utah, Dept Radiat Oncol, Salt Lake City, UT 84112 USA; [Pflueger, Christian; Kasten, Margaret M.; Currie, Simon L.; Bhachech, Niraja; Graves, Barbara J.; Cairns, Bradley R.; Bhaskara, Srividya] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Ramakrishnan, Saravanan; Pokhrel, Srijana; Pflueger, Christian; Parnell, Timothy J.; Kasten, Margaret M.; Currie, Simon L.; Bhachech, Niraja; Graves, Barbara J.; Cairns, Bradley R.; Bhaskara, Srividya; Chandrasekharan, Mahesh B.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Huang, Fu] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Horikoshi, Masami] Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Bunkyo Ku, Tokyo 1130032, Japan	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Stowers Institute for Medical Research; University of Tokyo	Chandrasekharan, MB (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	mahesh.chandrasekharan@hci.utah.edu	Pflueger, Christian/AAD-9877-2020; Chandrasekharan, Mahesh/AAF-4793-2020	Huang, Fu/0000-0001-9549-8937; Parnell, Timothy/0000-0002-3632-3691; Pflueger, Christian/0000-0002-5039-2714; Chandrasekharan, Mahesh/0000-0002-9956-8354; Bhaskara, Srividya/0000-0002-2182-9585; Currie, Simon/0000-0001-5083-1484	Huntsman Cancer Institute; Department of Radiation Oncology; Cancer Center Support Grant (Nuclear Control of Cell Growth and Differentiation program); NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038663] Funding Source: NIH RePORTER	Huntsman Cancer Institute; Department of Radiation Oncology; Cancer Center Support Grant (Nuclear Control of Cell Growth and Differentiation program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds provided by the Huntsman Cancer Institute, the Department of Radiation Oncology, and the Cancer Center Support Grant (Nuclear Control of Cell Growth and Differentiation program) (to M. B. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Chandrasekharan MB, 2011, METHODS, V54, P304, DOI 10.1016/j.ymeth.2011.02.010; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2012, BBA-GENE REGUL MECH, V1819, P733, DOI 10.1016/j.bbagrm.2012.01.019; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Faucher D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001082; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gadaleta MC, 2013, BIOTECHNIQUES, V55, P259, DOI 10.2144/000114100; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Huang F, 2010, J BIOL CHEM, V285, P24548, DOI 10.1074/jbc.M110.117333; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Maltby VE, 2012, P NATL ACAD SCI USA, V109, P18505, DOI 10.1073/pnas.1202070109; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Parra MA, 2007, MOL CELL BIOL, V27, P7641, DOI 10.1128/MCB.00742-07; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rizzardi LF, 2012, GENETICS, V192, P371, DOI 10.1534/genetics.112.142349; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Thornton JL, 2014, GENE DEV, V28, P115, DOI 10.1101/gad.232215.113; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Walter D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004095; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xu MS, 2012, DEV CELL, V23, P1059, DOI 10.1016/j.devcel.2012.10.005; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zheng ST, 2010, MOL CELL BIOL, V30, P3635, DOI 10.1128/MCB.00324-10	76	9	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28760	28777		10.1074/jbc.M115.693085	http://dx.doi.org/10.1074/jbc.M115.693085			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26451043	Green Published, hybrid			2022-12-26	WOS:000365762300019
J	Cai, YY; Leck, H; Lim, TP; Teo, J; Lee, W; Hsu, LY; Koh, TH; Tan, TT; Tan, TY; Kwa, ALH				Cai, Yiying; Leck, Hui; Lim, Tze Peng; Teo, Jocelyn; Lee, Winnie; Hsu, Li Yang; Koh, Tse Hsien; Tan, Thuan Tong; Tan, Thean-Yen; Kwa, Andrea Lay-Hoon			Using an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 Hours	PLOS ONE			English	Article							ATP-BIOLUMINESCENCE; KLEBSIELLA-PNEUMONIAE; SUSCEPTIBILITY; TIGECYCLINE; PHARMACOKINETICS; ADULTS	Background Current in vitro combination testing methods involve enumeration by bacterial plating, which is labor-intensive and time-consuming. Measurement of bioluminescence, released when bacterial adenosine triphosphate binds to firefly luciferin-luciferase, has been proposed as a surrogate for bacterial counts. We developed an ATP bioluminescent combination testing assay with a rapid turnaround time of 24h to determine effective antibiotic combinations. Methods 100 strains of carbapenem-resistant (CR) GNB [30 Acinetobacter baumannii (AB), 30 Pseudomonas aeruginosa (PA) and 40 Klebsiella pneumoniae (KP)] were used. Bacterial suspensions (10(5) CFU/ml) were added to 96-well plates containing clinically achievable concentrations of multiple single and two-antibiotic combinations. At 24h, the luminescence intensity of each well was measured. Receiver operator characteristic curves were plotted to determine optimal luminescence threshold (T-RLU) to discriminate between inhibitory/non-inhibitory combinations when compared to viable plating. The unweighted accuracy (UA) [(sensitivity + specificity)/2] of T-RLU values was determined. External validation was further done using 50 additional CR-GNB. Results Predictive accuracies of T-RLU were high for when all antibiotic combinations and species were collectively analyzed (T-RLU = 0.81, UA = 89%). When individual thresholds for each species were determined, UA remained high. Predictive accuracy was highest for KP (T-RLU = 0.81, UA = 91%), and lowest for AB (T-RLU = 0.83, UA = 87%). Upon external validation, high overall accuracy (91%) was observed. The assay distinguished inhibitory/non-inhibitory combinations with UA of 80%, 94% and 93% for AB, PA and KP respectively. Conclusion We developed an assay that is robust at identifying useful combinations with a rapid turnaround time of 24h, and may be employed to guide the timely selection of effective antibiotic combinations.	[Cai, Yiying; Leck, Hui; Lim, Tze Peng; Teo, Jocelyn; Lee, Winnie; Kwa, Andrea Lay-Hoon] Singapore Gen Hosp, Dept Pharm, Singapore, Singapore; [Hsu, Li Yang] Natl Univ Hlth Syst, Dept Infect Dis, Singapore, Singapore; [Koh, Tse Hsien] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Tan, Thuan Tong] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Tan, Thean-Yen] Changi Gen Hosp, Dept Lab Med, Singapore, Singapore; [Kwa, Andrea Lay-Hoon] Duke NUS Grad Med Sch, Emerging Infect Dis, Singapore, Singapore; [Kwa, Andrea Lay-Hoon] Natl Univ Singapore, Fac Sci, Pharm, Singapore 117548, Singapore	Singapore General Hospital; National University of Singapore; Singapore General Hospital; Singapore General Hospital; Changi General Hospital; National University of Singapore; National University of Singapore	Kwa, ALH (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore, Singapore.	andrea.kwa.l.h@sgh.com.sg	Teo, Jocelyn/ABA-1755-2021	Tan, Thean Yen/0000-0003-4358-1098; Teo, Jocelyn Qi-Min/0000-0003-2508-3941	National Medical Research Council Exploratory and Developmental Grant [EDG11may068]; Singapore General Hospital Research Grants [15/2011, SRG/C4/04/2014]	National Medical Research Council Exploratory and Developmental Grant; Singapore General Hospital Research Grants	This work was supported by the National Medical Research Council Exploratory and Developmental Grant (EDG11may068) and the Singapore General Hospital Research Grants (SRG#15/2011) and (SRG/C4/04/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Amodio E, 2014, J INFECT PUBLIC HEAL, V7, P92, DOI 10.1016/j.jiph.2013.09.005; Balm MND, 2012, J CLIN MICROBIOL, V50, P475, DOI 10.1128/JCM.05914-11; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; CHAPPELLE E W, 1968, Biochemical Medicine, V2, P41, DOI 10.1016/0006-2944(68)90006-9; Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT SUSC; Funke G, 1998, J CLIN MICROBIOL, V36, P1948, DOI 10.1128/JCM.36.7.1948-1952.1998; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; HANBERGER H, 1993, J ANTIMICROB CHEMOTH, V31, P245, DOI 10.1093/jac/31.2.245; Hattori N, 1998, ANTIMICROB AGENTS CH, V42, P1406, DOI 10.1128/AAC.42.6.1406; Ivancic V, 2008, J CLIN MICROBIOL, V46, P1213, DOI 10.1128/JCM.02036-07; Jaruratanasirikul S, 2005, ANTIMICROB AGENTS CH, V49, P1337, DOI 10.1128/AAC.49.4.1337-1339.2005; Kapoor R, 2010, J CLIN MICROBIOL, V48, P3725, DOI 10.1128/JCM.01482-10; Kitchel B, 2010, ANTIMICROB AGENTS CH, V54, P4201, DOI 10.1128/AAC.00008-10; Lafond M, 2010, J PHARMACOL TOX MET, V61, P16, DOI 10.1016/j.vascn.2009.10.004; Lee DH, 2013, ANN LAB MED, V33, P406, DOI 10.3343/alm.2013.33.6.406; Li J, 2006, ANTIMICROB AGENTS CH, V50, P2946, DOI 10.1128/AAC.00103-06; Lim TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028177; Lim TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018485; Magiorakos AP, 2011, CLIN MICROBIOL INFEC; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Pankey GA, 2005, J ANTIMICROB CHEMOTH, V56, P470, DOI 10.1093/jac/dki248; Pournaras S, 2011, INT J ANTIMICROB AG, V37, P244, DOI 10.1016/j.ijantimicag.2010.10.031; Rebuck JA, 2002, PHARMACOTHERAPY, V22, P1216, DOI 10.1592/phco.22.15.1216.33484; Rodvold KA, 2006, J ANTIMICROB CHEMOTH, V58, P1221, DOI 10.1093/jac/dkl403; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Shama G, 2013, INT J HYG ENVIR HEAL, V216, P115, DOI 10.1016/j.ijheh.2012.03.009; Teo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034254; Tod M, 1998, ANTIMICROB AGENTS CH, V42, P849, DOI 10.1128/AAC.42.4.849; van Belkum A, 2013, ANN LAB MED, V33, P14, DOI 10.3343/alm.2013.33.1.14; Vouillamoz J, 2008, J ANTIMICROB CHEMOTH, V61, P371, DOI 10.1093/jac/dkm459; Wadhwani T., 2008, INTERNET J MICROBIOL, V7; Zavascki AP, 2008, CLIN INFECT DIS, V47, P1298, DOI 10.1086/592577; Zavascki AP, 2013, EXPERT REV ANTI-INFE, V11, P1333, DOI 10.1586/14787210.2013.845523	34	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140446	10.1371/journal.pone.0140446	http://dx.doi.org/10.1371/journal.pone.0140446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460891	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300096
J	Delacretaz, A; Preisig, M; Vandenberghe, F; Morgui, NS; Quteineh, L; Choong, E; Gholam-Rezaee, M; Kutalik, Z; Magistretti, P; Aubry, JM; von Gunten, A; Castelao, E; Vollenweider, P; Waeber, G; Conus, P; Eap, CB				Delacretaz, Aurelie; Preisig, Martin; Vandenberghe, Frederik; Morgui, Nuria Saigi; Quteineh, Lina; Choong, Eva; Gholam-Rezaee, Mehdi; Kutalik, Zoltan; Magistretti, Pierre; Aubry, Jean-Michel; von Gunten, Armin; Castelao, Enrique; Vollenweider, Peter; Waeber, Gerard; Conus, Philippe; Eap, Chin B.			Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; ENERGY-BALANCE; ANTIPSYCHOTICS; RECEPTOR; OBESITY; ASSOCIATION; WEIGHT; IDENTIFICATION; EPIDEMIOLOGY; CHILDHOOD	Obesity development during psychotropic treatments represents a major health issue in psychiatry. Melanin-concentrating hormone receptor 2 (MCHR2) is a central receptor involved in energy homeostasis. MCHR2 shares its promoter region with MCHR2-AS1, a long antisense non-coding RNA. The aim of this study was to determine whether tagging single nucleotide polymorphisms (tSNPs) of MCHR2 and MCHR2-AS1 are associated with the body mass index (BMI) in the psychiatric and in the general population. The influence of MCHR2 and MCHR2-AS1 tSNPs on BMI was firstly investigated in a discovery psychiatric sample (n(1) = 474). Positive results were tested for replication in two other psychiatric samples (n(2) = 164, n(3) = 178) and in two population-based samples (CoLaus, n(4) = 5409; GIANT, n(5) = 113809). In the discovery sample, TT carriers of rs7754794C>T had 1.08 kg/m(2) (p = 0.04) lower BMI as compared to C-allele carriers. This observation was replicated in an independent psychiatric sample (-2.18 kg/m(2); p = 0.009). The association of rs7754794C>T and BMI seemed stronger in subjects younger than 45 years (median of age). In the population-based sample, a moderate association was observed (-0.17 kg/m(2); p = 0.02) among younger individuals (<45y). Interestingly, this association was totally driven by patients meeting lifetime criteria for atypical depression, i.e. major depressive episodes characterized by symptoms such as an increased appetite. Indeed, patients with atypical depression carrying rs7754794-TT had 1.17 kg/m(2) (p = 0.04) lower BMI values as compared to C-allele carriers, the effect being stronger in younger individuals (-2.50 kg/m(2); p = 0.03; interaction between rs7754794 and age: p-value = 0.08). This study provides new insights on the possible influence of MCHR2 and/or MCHR2-AS1 on obesity in psychiatric patients and on the pathophysiology of atypical depression.	[Delacretaz, Aurelie; Vandenberghe, Frederik; Morgui, Nuria Saigi; Quteineh, Lina; Choong, Eva; Eap, Chin B.] Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Unit Pharmacogenet & Clin Psychopharmacol, Prilly, Switzerland; [Preisig, Martin; Gholam-Rezaee, Mehdi; Castelao, Enrique] Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Epidemiol & Psychopathol, Prilly, Switzerland; [Kutalik, Zoltan] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Kutalik, Zoltan] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Magistretti, Pierre] Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Prilly, Switzerland; [Magistretti, Pierre] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Neuroenerget & Cellular Dynam, Lausanne, Switzerland; [Aubry, Jean-Michel] Univ Hosp Geneva, Div Psychiat Specialties, Geneva, Switzerland; [von Gunten, Armin] Univ Lausanne Hosp, Dept Psychiat, Serv Old Age Psychiat, Prilly, Switzerland; [Vollenweider, Peter; Waeber, Gerard] Univ Lausanne Hosp, Dept Med, Lausanne, Switzerland; [Conus, Philippe] Univ Lausanne Hosp, Dept Psychiat, Serv Gen Psychiat, Prilly, Switzerland; [Eap, Chin B.] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne	Eap, CB (corresponding author), Univ Lausanne Hosp, Dept Psychiat, Ctr Psychiat Neurosci, Unit Pharmacogenet & Clin Psychopharmacol, Prilly, Switzerland.	chin.eap@chuv.ch	Choong, Eva/F-1570-2019; Colaus, PsyColaus/K-6607-2013; Kutalik, Zoltan/HHZ-5697-2022	Choong, Eva/0000-0001-6776-4978; Kutalik, Zoltan/0000-0001-8285-7523; Waeber, Gerard/0000-0003-4193-788X; Conus, Philippe/0000-0002-5832-1910; Preisig, Martin/0000-0001-5689-4259; Eap, Chin/0000-0002-5439-0230; Saigi, Nuria/0000-0003-2503-1818; von Gunten, Armin/0000-0001-7852-3803; Castelao, Enrique/0000-0003-1966-3683; Vandenberghe, Frederik/0000-0002-8964-2047	Swiss National Research Foundation [320030120686, 324730-144064]; National Center of Competence in Research "SYNAPSY-The Synaptic Bases of Mental Diseases" - Swiss National Science Foundation [51AU40_125759]; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, 33CS30-148401, 31003A-143914]; Leenaards Foundation	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); National Center of Competence in Research "SYNAPSY-The Synaptic Bases of Mental Diseases" - Swiss National Science Foundation; GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation	This work has been funded in part by the Swiss National Research Foundation grants 320030120686 and 324730-144064 (CBE and PC) and by the National Center of Competence in Research "SYNAPSY-The Synaptic Bases of Mental Diseases" financed by the Swiss National Science Foundation grant 51AU40_125759. The CoLaus vertical bar PsyCoLaus study was and is supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (grants 3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468 and 33CS30-148401). ZK received support from the Leenaards Foundation and the Swiss National Science Foundation (31003A-143914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2003, ENDOCRINOLOGY, V144, P3943, DOI 10.1210/en.2003-0149; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; American Diabetes Association, 2004, Obes Res, V12, P362; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barson JR, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/983964; Blouin AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2461; Bornstein SR, 2006, MOL PSYCHIATR, V11, P892, DOI 10.1038/sj.mp.4001873; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Casey DE, 2004, J CLIN PSYCHIAT, V65, P4; Chagnon YC, 2004, MOL PSYCHIATR, V9, P1067, DOI 10.1038/sj.mp.4001537; Chee MJS, 2014, ENDOCRINOLOGY, V155, P81, DOI 10.1210/en.2013-1738; Choong E, 2013, JAMA PSYCHIAT, V70, P1011, DOI 10.1001/jamapsychiatry.2013.187; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Congrains A, 2013, INT J MOL SCI, V14, P1278, DOI 10.3390/ijms14011278; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Donini LM, 2003, INT PSYCHOGERIATR, V15, P73, DOI 10.1017/S1041610203008779; Esen-Danac A, 2008, PROG NEURO-PSYCHOPH, V32, P1434, DOI 10.1016/j.pnpbp.2008.03.015; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Ghoussaini M, 2007, J CLIN ENDOCR METAB, V92, P4403, DOI 10.1210/jc.2006-2316; Guesdon B, 2010, BEHAV BRAIN RES, V207, P14, DOI 10.1016/j.bbr.2009.09.032; Halley P, 2014, CELL REP, V6, P222, DOI 10.1016/j.celrep.2013.12.015; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Kishi T, 2005, MOL PSYCHIATR, V10, P132, DOI 10.1038/sj.mp.4001638; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; Lasserre AM, 2014, JAMA PSYCHIAT, V71, P880, DOI 10.1001/jamapsychiatry.2014.411; MacIntosh CG, 1999, AM J CLIN NUTR, V69, P999; Malhotra AK, 2012, ARCH GEN PSYCHIAT, V69, P904, DOI 10.1001/archgenpsychiatry.2012.191; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Perez-Iglesias R, 2008, J CLIN PSYCHOPHARM, V28, P289, DOI 10.1097/JCP.0b013e318172b8e6; Pissios P, 2006, ENDOCR REV, V27, P606, DOI 10.1210/er.2006-0021; Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9; Rodriguez M, 2001, MOL PHARMACOL, V60, P632; Sailer AW, 2001, P NATL ACAD SCI USA, V98, P7564, DOI 10.1073/pnas.121170598; Sentissi O, 2008, SCHIZOPHRENIA BULL, V34, P1189, DOI 10.1093/schbul/sbm141; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793	41	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139155	10.1371/journal.pone.0139155	http://dx.doi.org/10.1371/journal.pone.0139155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461262	Green Published, gold			2022-12-26	WOS:000362962300011
J	Fox, JT; Alexander, KA				Fox, J. Tyler; Alexander, Kathleen A.			Spatiotemporal Variation and the Role of Wildlife in Seasonal Water Quality Declines in the Chobe River, Botswana	PLOS ONE			English	Article							ESCHERICHIA-COLI; NATIONAL-PARK; SPATIAL AUTOCORRELATION; VARIABILITY; SOIL; DIARRHEA; HABITAT; GROWTH	Sustainable management of dryland river systems is often complicated by extreme variability of precipitation in time and space, especially across large catchment areas. Understanding regional water quality changes in southern African dryland rivers and wetland systems is especially important because of their high subsistence value and provision of ecosystem services essential to both public and animal health. We quantified seasonal variation of Escherichia coli (E. coli) and Total Suspended Solids (TSS) in the Chobe River using spatiotemporal and geostatisticalmodeling of water quality time series data collected along a transect spanning a mosaic of protected, urban, and developing urban land use. We found significant relationships in the dry season between E. coli concentrations and protected land use (p = 0.0009), floodplain habitat (p = 0.016), and fecal counts fromelephant (p = 0.017) and other wildlife (p = 0.001). Dry season fecal loading by both elephant (p = 0.029) and other wildlife (p = 0.006) was also an important predictor of early wet season E. coli concentrations. Locations of high E. coli concentrations likewise showed close spatial agreement with estimates of wildlife biomass derived from aerial survey data. In contrast to the dry season, wet season bacterial water quality patterns were associated only with TSS (p<0.0001), suggesting storm water and sediment runoff significantly influence E. coli loads. Our data suggest that wildlife populations, and elephants in particular, can significantly modify river water quality patterns. Loss of habitat and limitation of wildlife access to perennial rivers and floodplains in water-restricted regions may increase the impact of species on surface water resources. Our findings have important implications to land use planning in southern Africa's dryland river ecosystems.	[Fox, J. Tyler; Alexander, Kathleen A.] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Alexander, Kathleen A.] CARACAL Ctr Conservat African Resources, Kasane, Botswana	Virginia Polytechnic Institute & State University	Alexander, KA (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	kathyalx@vt.edu		Fox, John Tyler/0000-0003-4590-6036	National Science Foundation through the Dynamics of Coupled Natural and Human Systems Program [1114953]; Virginia Tech Open Access Subvention Fund	National Science Foundation through the Dynamics of Coupled Natural and Human Systems Program; Virginia Tech Open Access Subvention Fund	Funding was provided by the National Science Foundation through the Dynamics of Coupled Natural and Human Systems Program (award#1114953) and by the Virginia Tech Open Access Subvention Fund (KAA, JTF).	Akpan E. R., 1993, NIGERIAN REV HYDROLO, V26, P95; Alexander K, 2013, BMC PUBLIC HEALTH, V13, P1; Alexander KA, 2012, ADV INFECT DIS, V2, P143, DOI [DOI 10.4236/aid.2012.24023, DOI 10.4236/AID.2012.24023]; Alexander KA, 2013, INT J ENV RES PUB HE, V10, P1202, DOI 10.3390/ijerph10041202; Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x; Anselin L., 2003, INTRO SPATIAL REGRES; Bivand R, 2005, COMPREHENSIVE R ARCH; Bjornstad ON, 2008, NCF PACKAGE SPATIAL; BLUM D, 1987, EPIDEMIOL INFECT, V99, P429, DOI 10.1017/S0950268800067923; Boshoff A. F., 2002, African Journal of Range and Forage Science, V19, P29, DOI 10.2989/10220110209485772; Brabec E, 2002, J PLAN LIT, V16, P499, DOI 10.1177/088541202400903563; [BSCO Office BCS], 2011, POP HOUS CENS 2011 A, P506; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; CALEF GW, 1988, AFR J ECOL, V26, P323, DOI 10.1111/j.1365-2028.1988.tb00984.x; Chapman CA, 2006, AM J PRIMATOL, V68, P397, DOI 10.1002/ajp.20233; Cleveland R.B., 1990, J OFF STAT, V6, P3; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; Desmarais TR, 2002, APPL ENVIRON MICROB, V68, P1165, DOI 10.1128/AEM.68.3.1165-1172.2002; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; DWNP, 2014, AER CENS WILDL SOM D; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fujioka R, 1999, J APPL MICROBIOL, V85, p83S, DOI 10.1111/j.1365-2672.1998.tb05286.x; Gaughan AE, 2012, J ARID ENVIRON, V82, P19, DOI 10.1016/j.jaridenv.2012.02.007; Haining R, 2003, SPATIAL DATA ANAL; HARDINA CM, 1991, ENVIRON TOXIC WATER, V6, P185, DOI 10.1002/tox.2530060208; Jackson TP, 2008, ORYX, V42; Jamieson R, 2005, WATER RES, V39, P2665, DOI 10.1016/j.watres.2005.04.040; Jobbins SE, 2015, J WILDL DIS; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; JONES C, 1996, ECOSYSTEM MANAGEMENT, V14, P130; Jonnalagadda SB, 2001, WATER RES, V35, P2371, DOI 10.1016/S0043-1354(00)00533-9; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Levick L.R., 2008, ECOLOGICAL HYDROLOGI; Levy K, 2009, ENVIRON SCI TECHNOL, V43, P1788, DOI 10.1021/es8022545; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Lorntz B, 2006, PEDIATR INFECT DIS J, V25, P513, DOI 10.1097/01.inf.0000219524.64448.90; Mackay AW, 2011, WETLANDS, V31, P815, DOI 10.1007/s13157-011-0196-1; Magole L.I., 2005, BOTSW NOTES REC, V37, P80; Makhabu SW, 2005, J TROP ECOL, V21, P641, DOI 10.1017/S0266467405002701; Middleton N., 1997, WORLD ATLAS DESERTIF; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Mondal D, 2009, AM J TROP MED HYG, V80, P824, DOI 10.4269/ajtmh.2009.80.824; MUSCUTT AD, 1993, AGR ECOSYST ENVIRON, V45, P59, DOI 10.1016/0167-8809(93)90059-X; Mutembwa A, 1998, INITIATIVE GSF WATER; Nagels JW, 2002, WATER SCI TECHNOL, V45, P45, DOI 10.2166/wst.2002.0408; Naiman RJ, 1997, BIOSCIENCE, V47, P521, DOI 10.2307/1313120; O'Reilly CE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001256; Omphile UJ, 2002, J RANGE MANAGE, V55, P341, DOI 10.2307/4003470; Oshiro R, 2002, 1604 US EPA; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Pricope NG, 2013, ENVIRON MONIT ASSESS, V185, P1883, DOI 10.1007/s10661-012-2675-0; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; SADC, 2006, REG WAT POL; Schuyt KD, 2005, ECOL ECON, V53, P177, DOI 10.1016/j.ecolecon.2004.08.003; SEIDLER RJ, 1981, J AM WATER WORKS ASS, V73, P538; Skarpe C., 2014, ELEPHANTS SAVANNA WO; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Steiner TS, 1998, J INFECT DIS, V177, P88, DOI 10.1086/513809; Tooth S, 2000, EARTH-SCI REV, V51, P67, DOI 10.1016/S0012-8252(00)00014-3; Tooth S, 2013, TREATISE GEOMORPHOLO, V9; Tooth S, 2007, PROG PHYS GEOG, V31, P3, DOI 10.1177/0309133307073879; USEPA, 2000, 1604 US EPA, P53; USEPA, 1983, EPA600479020; Vandewalle M, 2003, P C ORG BOTSW NORW I; WALKER KF, 1995, REGUL RIVER, V11, P85, DOI 10.1002/rrr.3450110108; WHO, 2002, HLTH ENV SUST DEV; WILKINSON J, 1995, WATER RES, V29, P847, DOI 10.1016/0043-1354(94)00211-O; WRIGHT RC, 1986, J HYG-CAMBRIDGE, V96, P75, DOI 10.1017/S0022172400062550	74	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139936	10.1371/journal.pone.0139936	http://dx.doi.org/10.1371/journal.pone.0139936			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460613	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300039
J	Woodworth, D; Mayer, E; Leu, K; Ashe-McNalley, C; Naliboff, BD; Labus, JS; Tillisch, K; Kutch, JJ; Farmer, MA; Apkarian, AV; Johnson, KA; Mackey, SC; Ness, TJ; Landis, JR; Deutsch, G; Harris, RE; Clauw, DJ; Mullins, C; Ellingson, BM				Woodworth, Davis; Mayer, Emeran; Leu, Kevin; Ashe-McNalley, Cody; Naliboff, Bruce D.; Labus, Jennifer S.; Tillisch, Kirsten; Kutch, Jason J.; Farmer, Melissa A.; Apkarian, A. Vania; Johnson, Kevin A.; Mackey, Sean C.; Ness, Timothy J.; Landis, J. Richard; Deutsch, Georg; Harris, Richard E.; Clauw, Daniel J.; Mullins, Chris; Ellingson, Benjamin M.		MAPP Res Network	Unique Microstructural Changes in the Brain Associated with Urological Chronic Pelvic Pain Syndrome (UCPPS) Revealed by Diffusion Tensor MRI, Super-Resolution Track Density Imaging, and Statistical Parameter Mapping: A MAPP Network Neuroimaging Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CHRONIC BACK-PAIN; CYSTITIS/PAINFUL BLADDER SYNDROME; WHITE-MATTER ABNORMALITIES; MULTIPLE-SCLEROSIS; BASAL GANGLIA; GRAY-MATTER; WEIGHTED MRI; COEFFICIENTS; CORTEX	Studies have suggested chronic pain syndromes are associated with neural reorganization in specific regions associated with perception, processing, and integration of pain. Urological chronic pelvic pain syndrome (UCPPS) represents a collection of pain syndromes characterized by pelvic pain, namely Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) and Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS), that are both poorly understood in their pathophysiology, and treated ineffectively. We hypothesized patients with UCPPS may have microstructural differences in the brain compared with healthy control subjects (HCs), as well as patients with irritable bowel syndrome (IBS), a common gastrointestinal pain disorder. In the current study we performed population-based voxel-wise DTI and super-resolution track density imaging (TDI) in a large, two-center sample of phenotyped patients from the multicenter cohort with UCPPS (N = 45), IBS (N = 39), and HCs (N = 56) as part of the MAPP Research Network. Compared with HCs, UCPPS patients had lower fractional anisotropy (FA), lower generalized anisotropy (GA), lower track density, and higher mean diffusivity (MD) in brain regions commonly associated with perception and integration of pain information. Results also showed significant differences in specific anatomical regions in UCPPS patients when compared with IBS patients, consistent with microstructural alterations specific to UCPPS. While IBS patients showed clear sex related differences in FA, MD, GA, and track density consistent with previous reports, few such differences were observed in UCPPS patients. Heat maps illustrating the correlation between specific regions of interest and various pain and urinary symptom scores showed clustering of significant associations along the cortico-basal ganglia-thalamic-cortical loop associated with pain integration, modulation, and perception. Together, results suggest patients with UCPPS have extensive microstructural differences within the brain, many specific to syndrome UCPPS versus IBS, that appear to be localized to regions associated with perception and integration of sensory information and pain modulation, and seem to be a consequence of longstanding pain.	[Woodworth, Davis; Leu, Kevin; Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Woodworth, Davis; Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomed Phys, Los Angeles, CA 90095 USA; [Woodworth, Davis; Mayer, Emeran; Ashe-McNalley, Cody; Labus, Jennifer S.; Tillisch, Kirsten; Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Ctr Neurobiol Stress & PAIN, Los Angeles, CA 90095 USA; [Mayer, Emeran; Ashe-McNalley, Cody; Labus, Jennifer S.; Tillisch, Kirsten] Univ Calif Los Angeles, David Geffen Sch Med, Dept Digest Dis & Gastroenterol, Los Angeles, CA 90095 USA; [Mayer, Emeran; Naliboff, Bruce D.; Labus, Jennifer S.; Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Leu, Kevin; Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Bioengn, Los Angeles, CA 90095 USA; [Farmer, Melissa A.; Apkarian, A. Vania] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Johnson, Kevin A.; Mackey, Sean C.] Stanford Univ, Dept Neurol, Palo Alto, CA 94304 USA; [Ness, Timothy J.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Landis, J. Richard] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Deutsch, Georg] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Harris, Richard E.; Clauw, Daniel J.] Univ Michigan, Dept Anestesiol, Ann Arbor, MI 48109 USA; [Mullins, Chris] NIDDK, Div Kidney Urol & Hematol Dis, NIH, Bethesda, MD 20892 USA; [Kutch, Jason J.] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Stanford University; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Southern California	Ellingson, BM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA.	bellingson@mednet.ucla.edu	Woodworth, Davis/L-9364-2019; Tillisch, Kirsten/ABE-2174-2020; Kutch, Jason/B-3243-2018; Labus, Jennifer S/M-4567-2017; Mackey, Sean/AAF-3314-2019	Woodworth, Davis/0000-0002-6256-857X; Labus, Jennifer S/0000-0002-6634-2551; Landis, J Richard/0000-0001-8099-0988; Apkarian, A. Vania/0000-0002-9788-7458; Ness, Timothy/0000-0002-7908-4459; Mackey, Sean/0000-0001-7744-5348	National Institute of Diabetes and Digestive and Kidney Dis-eases (NIDDK), National Institutes of Health (NIH) [DK82370, DK82342, DK82315, DK82344, DK82325, DK82345, DK82333, DK82316]; NIH/NIDDK [DK 058351 (EAM), DK 064539 (EAM)]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK082315, U01DK082325, U01DK082345, U01DK082342, U01DK082316, P50DK064539, U01DK082333, U01DK082370, U01DK082344] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Dis-eases (NIDDK), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for the MAPP Research Network was obtained under coopera-tive agreements from the National Institute of Diabetes and Digestive and Kidney Dis-eases (NIDDK), National Institutes of Health (NIH) grants DK82370, DK82342, DK82315, DK82344, DK82325, DK82345, DK82333, and DK82316. In addition, this work was supported in part by NIH/NIDDK grants DK 058351 (EAM) and DK 064539 (EAM).	Allsop SA, 2011, NAT REV UROL, V8, P107, DOI 10.1038/nrurol.2010.227; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; Bagarinao E, 2014, PAIN, V155, P2502, DOI 10.1016/j.pain.2014.09.002; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Barajas RF, 2013, AM J NEURORADIOL, V34, P1319, DOI 10.3174/ajnr.A3400; Barmpoutis A, 2007, IEEE T MED IMAGING, V26, P1537, DOI 10.1109/TMI.2007.903195; Barmpoutis A, 2007, LECT NOTES COMPUT SC, V4584, P308; Barmpoutis A, 2009, NEUROIMAGE, V45, pS153, DOI 10.1016/j.neuroimage.2008.10.056; Basser PJ, 2007, SIGNAL PROCESS, V87, P220, DOI 10.1016/j.sigpro.2006.02.050; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Calamante F, 2013, HUM BRAIN MAPP, V34, P2538, DOI 10.1002/hbm.22083; Calamante F, 2012, NEUROIMAGE, V59, P2494, DOI 10.1016/j.neuroimage.2011.08.099; Calamante F, 2012, NEUROIMAGE, V59, P286, DOI 10.1016/j.neuroimage.2011.07.014; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Chang L, 2002, GASTROENTEROLOGY, V123, P1686, DOI 10.1053/gast.2002.36603; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Clemens JQ, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-57; Dimitrakov J, 2009, J UROLOGY, V181, P1550, DOI 10.1016/j.juro.2008.11.119; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Ellingson BM, 2013, PAIN, V154, P1528, DOI 10.1016/j.pain.2013.04.010; Ellingson BM, 2011, ACAD RADIOL, V18, P947, DOI 10.1016/j.acra.2011.02.020; Farmer MA, 2015, J UROLOGY IN PRESS; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; FORD JC, 1994, MAGNET RESON MED, V31, P488, DOI 10.1002/mrm.1910310504; Ford JC, 1998, JMRI-J MAGN RESON IM, V8, P775, DOI 10.1002/jmri.1880080405; Frokjaer JB, 2011, GUT, V60, P1554, DOI 10.1136/gut.2010.236620; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Grachev ID, 2000, PAIN, V89, P7, DOI 10.1016/S0304-3959(00)00340-7; Hanno P, 2012, NEUROUROL URODYNAM, V31, P375, DOI 10.1002/nau.22202; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hong JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084564; Horsfield MA, 1998, J NEUROL NEUROSUR PS, V64, pS80; Jayachandra MR, 2008, MAGN RESON MED, V60, P1207, DOI 10.1002/mrm.21775; Jiang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073932; Kairys AE, 2015, J UROLOGY, V193, P131, DOI 10.1016/j.juro.2014.08.042; Kilpatrick LA, 2014, J UROLOGY, V192, P947, DOI 10.1016/j.juro.2014.03.093; Kurniawan ND, 2014, NEUROIMAGE, V87, P465, DOI 10.1016/j.neuroimage.2013.09.030; Lai HH, 2012, J UROLOGY, V187, P2106, DOI 10.1016/j.juro.2012.01.081; Landis JR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-58; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mayer EA, PAIN IN PRESS; Nicke J Curtis, 2010, Rev Urol, V12, P67; Schwartz ED, 2005, NEUROREPORT, V16, P73, DOI 10.1097/00001756-200501190-00017; Shoskes DA, 2009, PROSTATE CANCER P D, V12, P177, DOI 10.1038/pcan.2008.42; Tournier J-D., 2010, P INT SOC MAGNETIC R, V1670; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Ullmann JFP, 2015, BRAIN STRUCT FUNCT, V220, P457, DOI 10.1007/s00429-013-0667-7; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626	54	52	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140250	10.1371/journal.pone.0140250	http://dx.doi.org/10.1371/journal.pone.0140250			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460744	Green Published, gold			2022-12-26	WOS:000362962300073
J	Fokkink, WJR; Falck, D; Santbergen, TCM; Huizinga, R; Wuhrer, M; Jacobs, BC				Fokkink, Willem Jan R.; Falck, David; Santbergen, Tom C. M.; Huizinga, Ruth; Wuhrer, Manfred; Jacobs, Bart C.			Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITY; SIALYLATION CHALLENGES; IVIG PLURIPOTENCY; IGG SUBCLASSES; ASSOCIATION; FORMULATIONS; IGIV	Intravenous immunoglobulin (IVIg) products from different pharmaceutical companies vary in composition, in part because of the selected blood donors and production process. N-glycosylation of the Fc-portion of IgG varies between blood donors and may influence both the side-effects and therapeutic effectiveness of IVIg. At present, the variation in Fc N-glycosylation between IVIg products has not been defined. Utilizing mass spectrometry, we performed relative quantitation of the Fc N-glycosylation of IgG, assessing a total of 154 unique lot numbers of IVIg. Seven products showed comparable Fc N-glycosylation, with only one product differing from the others in all glycosylation features ( galactosylation, sialylation, fucosylation and bisecting N-acetylglucosamine). However, the mean difference did not exceed 3%. Within product variation was present to a minor degree, but largely indistinguishable from analytical variation. In conclusion, we expect that the minor variation in Fc N-glycosylation between IVIg products has a small effect, if any, on the biological activity.	[Fokkink, Willem Jan R.; Santbergen, Tom C. M.; Huizinga, Ruth; Jacobs, Bart C.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [Fokkink, Willem Jan R.; Jacobs, Bart C.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [Falck, David; Wuhrer, Manfred] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands; [Wuhrer, Manfred] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Div BioAnalyt Chem, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Jacobs, BC (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands.	b.jacobs@erasmusmc.nl	Jacobs, Bart/ABE-2210-2021; Wuhrer, Manfred/ABE-9168-2020; Falck, David/J-6437-2019	Wuhrer, Manfred/0000-0002-0814-4995; Falck, David/0000-0003-3908-2376	Prinses Beatrix Spierfonds [W.OR11-27]; European Union Seventh Framework Programme HighGlycan [278535]; Netherlands Genomic Initiative Horizon Programme Zenith project [93511033]; Hoffmann la Roche	Prinses Beatrix Spierfonds; European Union Seventh Framework Programme HighGlycan; Netherlands Genomic Initiative Horizon Programme Zenith project; Hoffmann la Roche(Hoffmann-La Roche)	This work was supported by grants from the Prinses Beatrix Spierfonds (https://www.prinsesbeatrixspierfonds.nl/, grant number W.OR11-27), the European Union Seventh Framework Programme HighGlycan (http://www.highglycan.eu/, grant number 278535), as well as by the Netherlands Genomic Initiative Horizon Programme Zenith project (http://www.zonmw.nl/en/, grant number 93511033). Additional financial support was provided by Hoffmann la Roche (http://www.roche.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakovic MP, 2013, J PROTEOME RES, V12, P821, DOI 10.1021/pr300887z; BECK OE, 1981, VOX SANG, V41, P79, DOI 10.1111/j.1423-0410.1981.tb01018.x; Bonilla FA, 2008, IMMUNOL ALLERGY CLIN, V28, P803, DOI 10.1016/j.iac.2008.06.006; Buehler AM, 2015, EUR J PHARMACOL, V747, P96, DOI 10.1016/j.ejphar.2014.11.033; Darba J, 2012, J CLIN PHARMACOL, V52, P566, DOI 10.1177/0091270011399575; Einarsdottir HK, 2013, GLYCOCONJUGATE J, V30, P147, DOI 10.1007/s10719-012-9381-6; Farooq M, 1997, GLYCOCONJUGATE J, V14, P489, DOI 10.1023/A:1018555619519; Feldmeyer L, 2010, ACTA DERM-VENEREOL, V90, P494, DOI 10.2340/00015555-0900; Fokkink WJR, 2014, J PROTEOME RES, V13, P1722, DOI 10.1021/pr401213z; Gelfand EW, 2006, INT IMMUNOPHARMACOL, V6, P592, DOI 10.1016/j.intimp.2005.11.003; Hooper JA, 2008, IMMUNOL ALLERGY CLIN, V28, P765, DOI 10.1016/j.iac.2008.06.002; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Lattimore S, 2015, TRANSFUSION, V55, P91, DOI 10.1111/trf.12835; Leong H, 2008, AM J HEALTH-SYST PH, V65, P1815, DOI 10.2146/ajhp070582; Lin MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063399; Manlhiot C, 2010, PEDIAT ALLERG IMM-UK, V21, P515, DOI 10.1111/j.1399-3038.2010.00987.x; MARK SM, 2011, HOSP PHARM, V46, P668, DOI DOI 10.1310/hpj4609-668; Martin TD, 2006, INT IMMUNOPHARMACOL, V6, P517, DOI 10.1016/j.intimp.2005.11.005; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Schiestl M, 2011, NAT BIOTECHNOL, V29, P310, DOI 10.1038/nbt.1839; Schwab I, 2014, NAT REV IMMUNOL, V14, DOI 10.1038/nri3401-c2; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; SELIGMANN M, 1983, CLIN EXP IMMUNOL, V52, P417; Selman MHJ, 2012, J PROTEOMICS, V75, P1318, DOI 10.1016/j.jprot.2011.11.003; Selman MHJ, 2010, ANAL CHEM, V82, P1073, DOI 10.1021/ac9024413; Sewell WAC, 2014, EUR J IMMUNOL, V44, P2207, DOI 10.1002/eji.201444700; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Siegel J, 2005, PHARMACOTHERAPY, V25, p78S, DOI 10.1592/phco.2005.25.11part2.78S; Sudo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107772; Tjon ASW, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00197; Veldhuizen IJT, 2009, VOX SANG, V97, P129, DOI 10.1111/j.1423-0410.2009.01201.x; von Gunten S, 2014, NAT REV IMMUNOL, V14, P349, DOI 10.1038/nri3401-c1; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Zauner G, 2013, MOL CELL PROTEOMICS, V12, P856, DOI 10.1074/mcp.R112.026005	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0139828	10.1371/journal.pone.0139828	http://dx.doi.org/10.1371/journal.pone.0139828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457892	Green Published, gold, Green Submitted			2022-12-26	WOS:000362961100015
J	Ye, L; Hu, ZP; Wang, H; Zhu, HB; Dong, ZJ; Jiang, WL; Zhao, HJ; Li, N; Mi, W; Wang, WY; Hu, XH				Ye, Liang; Hu, Zhengping; Wang, Hui; Zhu, Haibo; Dong, Zhaoju; Jiang, Wanglin; Zhao, Huijuan; Li, Ning; Mi, Wei; Wang, Wenyan; Hu, Xihou			Tris-(2,3-Dibromopropyl) Isocyanurate, a New Emerging Pollutant, Impairs Cognition and Provokes Depression-Like Behaviors in Adult Rats	PLOS ONE			English	Article							BROMINATED FLAME-RETARDANT; POLYBROMINATED DIPHENYL ETHERS; PITUITARY-ADRENAL AXIS; TRIS(2,3-DIBROMOPROPYL) ISOCYANURATE; NEUROTROPHIC FACTOR; CHRONIC EXPOSURE; HIPPOCAMPUS; STRESS; MEMORY; MICE	Tris-(2,3-dibromopropyl) isocyanurate (TDBP-TAZTO), an emerging brominated flame retardant, possesses the characteristics of candidate persistent organic pollutants and has displayed toxicity to fish and rodents. TDBP-TAZTO can pass through the blood brain barrier and accumulate in brain. However, the neurotoxicity of TDBP-TAZTO has not yet studied in rodents. We hypothesize that TDBP-TAZTO could induce the neurotoxicity in rat hippocampal neurons. The male adult rats were exposed to TDBP-TAZTO of 5 and 50 mg/kg by gavage, daily for 6 months. TDBP-TAZTO resulted in cognitive impairment and depression-like behaviors, which may be related with TDBP-TAZTO-induced hypothalamicpituitary-adrenal axis hyperactivation, upregulation of inflammatory and oxidative stress markers, overexpression of pro-apoptotic proteins, downexpression of neurogenesis related proteins in hippocampus, and hippocampal neurons damage in DG, CA1 and CA3 areas. Our findings suggested that TDBP-TAZTO induces significant hippocampal neurotoxicity, which provokes cognitive impairment and depression-like behaviors in adult rats. Therefore, this research will contribute to evaluate the neurotoxic effects of TDBP-TAZTO in human.	[Ye, Liang; Zhu, Haibo; Dong, Zhaoju; Zhao, Huijuan; Li, Ning; Mi, Wei; Hu, Xihou] Binzhou Med Univ, Sch Publ Hlth & Management, Yantai, Shandong, Peoples R China; [Ye, Liang; Zhu, Haibo] Binzhou Med Univ, Inst Toxicol, Yantai, Shandong, Peoples R China; [Hu, Zhengping] Binzhou Med Univ, Med & Pharm Res Ctr, Yantai, Shandong, Peoples R China; [Wang, Hui; Wang, Wenyan] Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China; [Jiang, Wanglin] Binzhou Med Univ, Sch Pharm, Yantai, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University; Binzhou Medical University; Yantai University; Binzhou Medical University	Hu, XH (corresponding author), Binzhou Med Univ, Sch Publ Hlth & Management, Yantai, Shandong, Peoples R China.	pharmtoxi@hotmail.com			Natural Science Foundation of Shandong Province, China [ZR2014HM091]; Scientific Research Foundation of Binzhou Medical College, Shandong Province, China [BY2013KYQD21]; Outstanding Young Scientist Research Award Foundation of Shandong Province [BS2014YY008]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Scientific Research Foundation of Binzhou Medical College, Shandong Province, China; Outstanding Young Scientist Research Award Foundation of Shandong Province	This work was supported by the Natural Science Foundation of Shandong Province, China (No. ZR2014HM091), the Scientific Research Foundation of Binzhou Medical College, Shandong Province, China (No. BY2013KYQD21) and the Outstanding Young Scientist Research Award Foundation of Shandong Province (No. BS2014YY008).	Bakunina N, 2015, IMMUNOLOGY; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Choy KHC, 2008, HIPPOCAMPUS, V18, P655, DOI 10.1002/hipo.20425; Dingemans MML, 2011, ENVIRON HEALTH PERSP, V119, P900, DOI 10.1289/ehp.1003035; Diniz BS, 2014, J PSYCHIATR RES, V49, P96, DOI 10.1016/j.jpsychires.2013.11.004; Feng JY, 2010, TALANTA, V82, P1929, DOI 10.1016/j.talanta.2010.08.014; Frank MG, 2014, PSYCHONEUROENDOCRINO, V40, P191, DOI 10.1016/j.psyneuen.2013.11.006; Fujii T, 2014, HIPPOCAMPUS, V24, P214, DOI 10.1002/hipo.22216; Galdino PM, 2009, J ETHNOPHARMACOL, V124, P581, DOI 10.1016/j.jep.2009.05.001; Hueston CM, 2014, PHYSIOL BEHAV, V124, P77, DOI 10.1016/j.physbeh.2013.10.035; Hurley LL, 2013, NEUROTOX RES, V23, P131, DOI 10.1007/s12640-012-9348-1; Inoue K, 2006, ENVIRON HEALTH PERSP, V114, P1179, DOI 10.1289/ehp.9032; Jozuka H, 2003, J INT MED RES, V31, P36, DOI 10.1177/147323000303100106; Kelly KA, 2012, J NEUROCHEM, V122, P995, DOI 10.1111/j.1471-4159.2012.07864.x; Kesner RP, 2015, NEUROSCI BIOBEHAV R, V48, P92, DOI 10.1016/j.neubiorev.2014.11.009; Kunugi H, 2010, PSYCHIAT CLIN NEUROS, V64, P447, DOI 10.1111/j.1440-1819.2010.02135.x; Lanoix D, 2013, OA EVIDENCE BASED ME, V1, P1; Li J Y, 2011, THESIS HUAZHONG AGR; Li J, 2015, J APPL TOXICOL, V35, P375, DOI 10.1002/jat.3026; Li J, 2011, ENVIRON SCI TECHNOL, V45, P9750, DOI 10.1021/es202420g; Martisova E, 2013, CURR ALZHEIMER RES, V10, P420, DOI 10.2174/1567205011310040007; Nakajima A, 2009, TOXICOL LETT, V189, P78, DOI 10.1016/j.toxlet.2009.05.003; Neto FL, 2011, CURR NEUROPHARMACOL, V9, P530, DOI 10.2174/157015911798376262; Palta P, 2014, PSYCHOSOM MED, V76, P12, DOI 10.1097/PSY.0000000000000009; Petreas M, 2003, ENVIRON HEALTH PERSP, V111, P1175, DOI 10.1289/ehp.6220; Qu GB, 2011, SCI CHINA CHEM, V54, P1651, DOI 10.1007/s11426-011-4371-2; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Ruan T, 2009, ENVIRON SCI TECHNOL, V43, P3080, DOI 10.1021/es803397x; Wang T, 2013, CHEMOSPHERE, V90, P182, DOI 10.1016/j.chemosphere.2012.06.027; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Wang S, 2015, ANNU REV CLIN PSYCHO, V11, P331, DOI 10.1146/annurev-clinpsy-032814-112828; Ye L, 2013, PAK J PHARM SCI, V26, P315; Ye L, 2012, J ETHNOPHARMACOL, V144, P683, DOI [10.1016/j.jep.2012.10.013, 10.1016/j.jep.2012.10.011]; Zhang X, 2011, CHINESE SCI BULL, V56, P1548, DOI 10.1007/s11434-011-4471-6; Zhou D, 2010, PHARMACOL BIOCHEM BE, V94, P488, DOI 10.1016/j.pbb.2009.11.003; Zhu NL, 2012, ENVIRON SCI TECHNOL, V46, P7174, DOI 10.1021/es300776f	40	13	14	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140281	10.1371/journal.pone.0140281	http://dx.doi.org/10.1371/journal.pone.0140281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458255	Green Submitted, gold, Green Published			2022-12-26	WOS:000362961100029
J	Aguera, A; Collard, M; Jossart, Q; Moreau, C; Danis, B				Aguera, Antonio; Collard, Marie; Jossart, Quentin; Moreau, Camille; Danis, Bruno			Parameter Estimations of Dynamic Energy Budget (DEB) Model over the Life History of a Key Antarctic Species: The Antarctic Sea Star Odontaster validus Koehler, 1906	PLOS ONE			English	Article							PHOTOPERIODIC REGULATION; REPRODUCTIVE OUTPUT; COVARIATION METHOD; MCMURDO SOUND; GROWTH; GAMETOGENESIS; TEMPERATURE; BENTHOS; METABOLISM; ALLOCATION	Marine organisms in Antarctica are adapted to an extreme ecosystem including extremely stable temperatures and strong seasonality due to changes in day length. It is now largely accepted that Southern Ocean organisms are particularly vulnerable to global warming with some regions already being challenged by a rapid increase of temperature. Climate change affects both the physical and biotic components of marine ecosystems and will have an impact on the distribution and population dynamics of Antarctic marine organisms. To predict and assess the effect of climate change on marine ecosystems a more comprehensive knowledge of the life history and physiology of key species is urgently needed. In this study we estimate the Dynamic Energy Budget (DEB) model parameters for key benthic Antarctic species the sea star Odontaster validus using available information from literature and experiments. The DEB theory is unique in capturing the metabolic processes of an organism through its entire life cycle as a function of temperature and food availability. The DEB model allows for the inclusion of the different life history stages, and thus, becomes a tool that can be used to model lifetime feeding, growth, reproduction, and their responses to changes in biotic and abiotic conditions. The DEB model presented here includes the estimation of reproduction handling rules for the development of simultaneous oocyte cohorts within the gonad. Additionally it links the DEB model reserves to the pyloric caeca an organ whose function has long been ascribed to energy storage. Model parameters described a slowed down metabolism of long living animals that mature slowly. O. validus has a large reserve that-matching low maintenance costs-allow withstanding long periods of starvation. Gonad development is continuous and individual cohorts developed within the gonads grow in biomass following a power function of the age of the cohort. The DEB model developed here for O. validus allowed us to increase our knowledge on the ecophysiology of this species, providing new insights on the role of food availability and temperature on its life cycle and reproduction strategy.	[Aguera, Antonio; Collard, Marie; Jossart, Quentin; Moreau, Camille; Danis, Bruno] Univ Libre Bruxelles, Lab Biol Marine CP160 15, B-1050 Brussels, Belgium	Universite Libre de Bruxelles	Aguera, A (corresponding author), Univ Libre Bruxelles, Lab Biol Marine CP160 15, FD Roosevelt 50, B-1050 Brussels, Belgium.	antonio.aguera@gmail.com	Agüera, Antonio/O-5498-2017; Danis, Bruno/AAS-8444-2021	Agüera, Antonio/0000-0003-0076-1849; Danis, Bruno/0000-0002-9037-7623; Moreau, Camille/0000-0002-0981-7442; Collard, Marie/0000-0003-3919-6250; Jossart, Quentin/0000-0002-2280-243X	vERSO project; Belgian Science Policy Office (BELSPO) [BR/132/A1/vERSO]	vERSO project; Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office)	This work was funded by vERSO project (www.versoproject.be), funded by the Belgian Science Policy Office (BELSPO, contract no BR/132/A1/vERSO).	Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Barnes DKA, 2011, CURR BIOL, V21, pR451, DOI 10.1016/j.cub.2011.04.012; Barros VR, 2014, CIMATE CHANGE 2014 I; BOSCH I, 1990, MAR BIOL, V104, P41, DOI 10.1007/BF01313155; Bosch I., 1989, REPROD DEV SHALLOW W; Brockington S, 2007, MAR ECOL PROG SER, V330, P139, DOI 10.3354/meps330139; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Elzhov T V, 2013, R INTERFACE LEVENBER; FALKPETERSEN IB, 1982, SARSIA, V67, P215, DOI 10.1080/00364827.1982.10421336; FEDER H M, 1970, Ophelia, V8, P161; Gonzalez-Bernat MJ, 2013, POLAR BIOL, V36, P235, DOI 10.1007/s00300-012-1255-7; Grange LJ, 2007, MAR BIOL, V153, P15, DOI 10.1007/s00227-007-0776-z; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Gutt J, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.11091; HARROLD C, 1980, J EXP MAR BIOL ECOL, V48, P169, DOI 10.1016/0022-0981(80)90015-5; Hoegh-Guldberg O, 1991, ANTARCT J US, V26, P163; Hunt BM, 2003, ANTARCT SCI, V15, P333, DOI 10.1017/S0954102003001342; JANGOUX M, 1977, J EXP MAR BIOL ECOL, V30, P165, DOI 10.1016/0022-0981(77)90010-7; JANGOUX M, 1973, Netherlands Journal of Sea Research, V6, P389, DOI 10.1016/0077-7579(73)90024-0; Joly-Turquin G, 2013, J MAR BIOL ASSOC UK, V93, P1073, DOI 10.1017/S0025315412000124; Jusup M, 2014, J SEA RES, V94, P144, DOI 10.1016/j.seares.2014.09.002; Jusup M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021903; Kaiser S, 2013, MAR BIOL, V160, P2295, DOI 10.1007/s00227-013-2232-6; Kearney M, 2012, FUNCT ECOL, V26, P167, DOI 10.1111/j.1365-2435.2011.01917.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Klok C, 2014, J SEA RES, V94, P111, DOI 10.1016/j.seares.2014.01.011; Kooijman SALM, 2014, J SEA RES, V94, P128, DOI 10.1016/j.seares.2014.06.005; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; KOOIJMAN SALM, 1986, J THEOR BIOL, V121, P269, DOI 10.1016/S0022-5193(86)80107-2; Lawrence JM, 2000, ZOOL STUD, V39, P151; Lika K, 2011, J SEA RES, V66, P270, DOI 10.1016/j.seares.2011.07.010; Lika K, 2011, J SEA RES, V66, P278, DOI 10.1016/j.seares.2011.09.004; Maar M, 2015, J MARINE SYST, V148, P48, DOI 10.1016/j.jmarsys.2015.02.003; Matzelle A, 2014, J SEA RES, V94, P105, DOI 10.1016/j.seares.2014.01.009; McClintock JB, 2008, MAR BIOL, V154, P1077, DOI 10.1007/s00227-008-1001-4; MCCLINTOCK JB, 1989, POLAR BIOL, V9, P147, DOI 10.1007/BF00297169; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; MCCLINTOCK JB, 1988, MAR BIOL, V99, P235, DOI 10.1007/BF00391986; Micaletto G, 2003, POLAR BIOL, V26, P327, DOI 10.1007/s00300-003-0482-3; Monaco CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104658; PEARSE J S, 1969, Australian Natural History, V16, P234; Pearse J. S., 1965, Antarctic Research Series, V5, P39; Pearse John S., 2013, P120; Pearse JS, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P181, DOI 10.5479/si.097884601X.13; PEARSE JS, 1982, MAR BIOL, V67, P121, DOI 10.1007/BF00401277; Pearse JS, 2002, INVERTEBR REPROD DEV, V41, P73, DOI 10.1080/07924259.2002.9652737; PEARSE JS, 1991, AM ZOOL, V31, P65; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Peck LS, 2002, POLAR BIOL, V25, P31, DOI 10.1007/s003000100308; Peck LS, 2002, MAR BIOL, V141, P271, DOI 10.1007/s00227-002-0834-5; Pecquerie L, 2009, J SEA RES, V62, P93, DOI 10.1016/j.seares.2009.06.002; R Core Team, 2021, R LANGUAGE ENV STAT; Sanford E, 2002, J EXP MAR BIOL ECOL, V273, P199, DOI 10.1016/S0022-0981(02)00164-8; Sanford E, 2007, MAR ECOL PROG SER, V349, P1, DOI 10.3354/meps07166; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero GN, 2012, ANNU REV MAR SCI, V4, P39, DOI 10.1146/annurev-marine-120710-100935; Stanwell-Smith D, 1998, MAR BIOL, V131, P479, DOI 10.1007/s002270050339; Turner J, 2009, INT J CLIMATOLOGY; Turner J, 2014, POLAR REC, V50, P237, DOI 10.1017/S0032247413000296; van der Meer J, 2006, J SEA RES, V56, P85, DOI 10.1016/j.seares.2006.03.001; van der Meer J, 2014, J SEA RES, V94, P138, DOI 10.1016/j.seares.2014.07.007; van der Veer HW, 2006, J SEA RES, V56, P107, DOI 10.1016/j.seares.2006.03.005	63	21	21	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140078	10.1371/journal.pone.0140078	http://dx.doi.org/10.1371/journal.pone.0140078			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451918	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200033
J	Sammarco, MC; Simkin, J; Cammack, AJ; Fassler, D; Gossmann, A; Marrero, L; Lacey, M; Van Meter, K; Muneoka, K				Sammarco, Mimi C.; Simkin, Jennifer; Cammack, Alexander J.; Fassler, Danielle; Gossmann, Alexej; Marrero, Luis; Lacey, Michelle; Van Meter, Keith; Muneoka, Ken			Hyperbaric Oxygen Promotes Proximal Bone Regeneration and Organized Collagen Composition during Digit Regeneration	PLOS ONE			English	Article							LIMB REGENERATION; TIP REGENERATION; FINGER; ANGIOGENESIS; MOBILIZATION; REPLACEMENT; OSTEOCLASTS; EXPRESSION; EPITHELIUM; AMPUTATION	Oxygen is critical for optimal bone regeneration. While axolotls and salamanders have retained the ability to regenerate whole limbs, mammalian regeneration is restricted to the distal tip of the digit (P3) in mice, primates, and humans. Our previous study revealed the oxygen microenvironment during regeneration is dynamic and temporally influential in building and degrading bone. Given that regeneration is dependent on a dynamic and changing oxygen environment, a better understanding of the effects of oxygen during wounding, scarring, and regeneration, and better ways to artificially generate both hypoxic and oxygen replete microenvironments are essential to promote regeneration beyond wounding or scarring. To explore the influence of increased oxygen on digit regeneration in vivo daily treatments of hyperbaric oxygen were administered to mice during all phases of the entire regenerative process. Micro-Computed Tomography (mu CT) and histological analysis showed that the daily application of hyperbaric oxygen elicited the same enhanced bone degradation response as two individual pulses of oxygen applied during the blastema phase. We expand past these findings to show histologically that the continuous application of hyperbaric oxygen during digit regeneration results in delayed blastema formation at a much more proximal location after amputation, and the deposition of better organized collagen fibers during bone formation. The application of sustained hyperbaric oxygen also delays wound closure and enhances bone degradation after digit amputation. Thus, hyperbaric oxygen shows the potential for positive influential control on the various phases of an epimorphic regenerative response.	[Sammarco, Mimi C.; Simkin, Jennifer; Cammack, Alexander J.; Fassler, Danielle] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Gossmann, Alexej; Lacey, Michelle] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Marrero, Luis; Van Meter, Keith] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA; [Muneoka, Ken] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA	Tulane University; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Texas A&M University System; Texas A&M University College Station	Sammarco, MC (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	msammarc@tulane.edu		Simkin, Jennifer/0000-0002-6122-4222; Sammarco, Mimi/0000-0001-9491-5735; Gossmann, Alexej/0000-0001-9068-3877	Eunice Kennedy Shriver National Institute of Child Health and Human Development [NIH-F32HD071763-02]; Defense Advanced Research Projects Agency (DARPA) [DARPA-W911NF-06-1-0161]; US Army Research Center [ARO-W911NF0910305]; John L. and Mary Wright Ebaugh Endowment Fund at Tulane University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071763] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US Army Research Center; John L. and Mary Wright Ebaugh Endowment Fund at Tulane University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by a research grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development NIH-F32HD071763-02 (MS), Defense Advanced Research Projects Agency (DARPA) DARPA-W911NF-06-1-0161 (KM), US Army Research Center ARO-W911NF0910305 (KM), and John L. and Mary Wright Ebaugh Endowment Fund at Tulane University (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Agrawal V, 2011, TISSUE ENG PT A, V17, P3033, DOI [10.1089/ten.tea.2011.0257, 10.1089/ten.TEA.2011.0257]; Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Bryant SV, 2002, INT J DEV BIOL, V46, P887; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; DOUGLAS BS, 1972, AUST PAEDIATR J, V8, P86; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Ferris DR, 2010, DEV GROWTH DIFFER, V52, P715, DOI 10.1111/j.1440-169X.2010.01208.x; GOSS RJ, 1992, J EXP ZOOL, V264, P429, DOI 10.1002/jez.1402640408; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4; JAIN KK, 2004, TXB HYPERBARIC MED; JOHNELL O, 1977, CALC TISS RES, V23, P241, DOI 10.1007/BF02012792; Ke C, 2002, ASSIST SUITE S PLUS; Khanna S, 2006, FREE RADICAL BIO MED, V40, P2147, DOI 10.1016/j.freeradbiomed.2006.02.010; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Lee JW, 2013, DEV BIOL, V382, P98, DOI 10.1016/j.ydbio.2013.07.020; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Lowe J. S., 2015, STEVENS LOWES HUMAN; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Mu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059105; NEUFELD DA, 1993, PROG CLIN BIOL RES, V383, P243; Neufeld Daniel A., 1995, Wound Repair and Regeneration, V3, P461, DOI 10.1046/j.1524-475X.1995.30410.x; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Richmond KN, 1997, AM J PHYSIOL-CELL PH, V273, pC1613, DOI 10.1152/ajpcell.1997.273.5.C1613; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rollins MD, 2006, UNDERSEA HYPERBAR M, V33, P17; Said S, 2004, ANAT REC PART A, V278A, P443, DOI 10.1002/ar.a.20034; Sammarco MC, 2014, J BONE MINER RES, V29, P2336, DOI 10.1002/jbmr.2261; Sander AL, 2009, WOUND REPAIR REGEN, V17, P179, DOI 10.1111/j.1524-475X.2009.00455.x; Santosh N, 2011, DEV DYNAM, V240, P1127, DOI 10.1002/dvdy.22503; Siddiqui A, 1997, PLAST RECONSTR SURG, V99, P148, DOI 10.1097/00006534-199701000-00023; Simkin J, 2015, REGENERATION, V2, P93, DOI 10.1002/reg2.36; Simkin J, 2015, REGENERATION, V2, P106, DOI 10.1002/reg2.34; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; SINGER M, 1987, ANAT EMBRYOL, V177, P29, DOI 10.1007/BF00325287; Stevenson TJ, 2006, DEV DYNAM, V235, P606, DOI 10.1002/dvdy.20654; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068; Wang Y, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/621414; Wang YD, 1998, J ROY STAT SOC B, V60, P159, DOI 10.1111/1467-9868.00115; Yang EV, 1999, DEV DYNAM, V216, P2, DOI 10.1002/(SICI)1097-0177(199909)216:1<2::AID-DVDY2>3.3.CO;2-G; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; ZHAO WG, 1995, J EXP ZOOL, V271, P155, DOI 10.1002/jez.1402710212	47	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140156	10.1371/journal.pone.0140156	http://dx.doi.org/10.1371/journal.pone.0140156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452224	Green Submitted, gold, Green Published			2022-12-26	WOS:000362511200044
J	Asghari, G; Yuzbashian, E; Mirmiran, P; Mahmoodi, B; Azizi, F				Asghari, Golaleh; Yuzbashian, Emad; Mirmiran, Parvin; Mahmoodi, Behnaz; Azizi, Fereidoun			Fast Food Intake Increases the Incidence of Metabolic Syndrome in Children and Adolescents: Tehran Lipid and Glucose Study	PLOS ONE			English	Article							TRANS-FATTY-ACIDS; HEART HEALTH-PROMOTION; DIETARY PATTERNS; NONCOMMUNICABLE DISEASES; CARDIOVASCULAR EVENTS; IRANIAN ADOLESCENTS; SYNDROME PHENOTYPE; RELATIVE VALIDITY; CONSUMPTION; ADULTS	The aim of the study was to evaluate the association between fast food consumption and incidence of metabolic syndrome (MetS) and its components among children and adolescents over a 3.6 year follow-up. Dietary data of 424 healthy subjects, aged 6-18 years, was collected using a valid and reliable food frequency questionnaire. Metabolic syndrome was defined according to the Cook et al criteria. Consumption of fast foods including hamburgers, sausages, bologna (beef), and fried potatoes was calculated and further categorized to quartiles. Multiple logistic regression models were used to estimate the incidence of MetS and its components in each quartile of fast food intake. The incidence of MetS was 11.3% after a 3.6 year follow up. In the fully adjusted model, compared to the lowest quartile of fast food intake, individuals in the highest had odds ratios of 2.96 (95% CI: 1.02-8.63; P for trend<0.001), 2.82 (95% CI: 1.01-7.87; P for trend = 0.037), and 2.58 (95% CI: 1.01-6.61; P for trend = 0.009) for incidence of MetS, hypertriglyceridemia, and abdominal obesity, respectively. No significant association was found between fast food intakes and other components of MetS. Fast food consumption is associated with the incidence of MetS, abdominal obesity, and hypertriglyceridemia in Tehranian children and adolescents.	[Asghari, Golaleh; Yuzbashian, Emad; Mahmoodi, Behnaz] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran; [Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Mirmiran, P (corresponding author), Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran.	mirmiran@endocrine.ac.ir	asghari, golaleh/N-4521-2013; Yuzbashian, Emad/AAL-8268-2021; Azizi, Fereidoun/ABD-4136-2021; Mirmiran, Parvin/V-1433-2019	asghari, golaleh/0000-0002-7925-5158; Azizi, Fereidoun/0000-0002-6470-2517; Yuzbashian, Emad/0000-0002-1748-5978; Mirmiran, Parvin/0000-0003-2391-4924	Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran	Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran	This work was funded by a grant from the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami-Ardekani M, 2010, DIABETES CARE, V33, P2110, DOI 10.2337/dc09-0023; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2004, PEDIATRICS S, V114, P555; Asgary S, 2009, ASIA PAC J CLIN NUTR, V18, P187; Asghari G, 2012, BRIT J NUTR, V108, P1109, DOI 10.1017/S0007114511006313; Azadbakht L, 2009, J NUTR, V139, P335, DOI 10.3945/jn.108.096297; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Bammann K, 2007, MED KLIN, V102, P230, DOI 10.1007/s00063-007-1027-2; Batis C, 2014, BRIT J NUTR, V111, P1441, DOI 10.1017/S0007114513003917; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Braithwaite I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005813; Cheng TO, 2006, AM J CARDIOL, V97, P1676, DOI 10.1016/j.amjcard.2005.12.019; Cohen DA, 2012, OBES REV, V13, P618, DOI 10.1111/j.1467-789X.2012.00983.x; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Delshad M, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.151433; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Fulkerson JA, 2011, J AM DIET ASSOC, V111, P1892, DOI 10.1016/j.jada.2011.09.035; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Genuth S, 2003, DIABETES CARE, V26, P3160; Golzarand M, 2012, PUBLIC HEALTH NUTR, V15, P1835, DOI DOI 10.1017/S1368980011003673; Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120; Hosking DE, 2014, BRIT J NUTR, V112, P228, DOI 10.1017/S0007114514000646; Hosseinpanah F, 2013, INT J CARDIOL, V168, P369, DOI 10.1016/j.ijcard.2012.09.037; Hsieh S, 2014, AM J PREV MED, V46, P378, DOI 10.1016/j.amepre.2013.12.007; Kelishadi R, 2004, PREV MED, V39, P760, DOI 10.1016/j.ypmed.2004.02.047; Kelishadi R, 2003, PEDIATR INT, V45, P435, DOI 10.1046/j.1442-200X.2003.01738.x; Kelishadi R, 2007, J TROP PEDIATRICS, V53, P158, DOI 10.1093/tropej/fml090; Kirkpatrick SI, 2013, PUBLIC HEALTH NUTR, V15, P1, DOI DOI 10.1017/S1368980012005563; Kochan Z, 2010, POSTEP HIG MED DOSW, V64, P650; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; PETERKIN BB, 1990, J AM DIET ASSOC, V90, P1725; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Seubsman SA, 2009, INT J CONSUM STUD, V33, P669, DOI 10.1111/j.1470-6431.2009.00795.x; Stender S, 2007, INT J OBESITY, V31, P887, DOI 10.1038/sj.ijo.0803616; Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571; Young LR, 2003, J AM DIET ASSOC, V103, P231, DOI 10.1053/jada.2003.50027	42	27	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139641	10.1371/journal.pone.0139641	http://dx.doi.org/10.1371/journal.pone.0139641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447855	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000042
J	Bertucco, M; Bhanpuri, NH; Sanger, TD				Bertucco, Matteo; Bhanpuri, Nasir H.; Sanger, Terence D.			Perceived Cost and Intrinsic Motor Variability Modulate the Speed-Accuracy Trade-Off	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; INFORMATION CAPACITY; REACHING MOVEMENTS; CHILDREN; CLASSIFICATION; DEFINITION; DISORDERS; CHILDHOOD; DISEASE; MODEL	Fitts' Law describes the speed-accuracy trade-off of human movements, and it is an elegant strategy that compensates for random and uncontrollable noise in the motor system. The control strategy during targeted movements may also take into account the rewards or costs of any outcomes that may occur. The aim of this study was to test the hypothesis that movement time in Fitts' Law emerges not only from the accuracy constraints of the task, but also depends on the perceived cost of error for missing the targets. Subjects were asked to touch targets on an iPad (R) screen with different costs for missed targets. We manipulated the probability of error by comparing children with dystonia (who are characterized by increased intrinsic motor variability) to typically developing children. The results show a strong effect of the cost of error on the Fitts' Law relationship characterized by an increase in movement time as cost increased. In addition, we observed a greater sensitivity to increased cost for children with dystonia, and this behavior appears to minimize the average cost. The findings support a proposed mathematical model that explains how movement time in a Fitts-like task is related to perceived risk.	[Bertucco, Matteo; Bhanpuri, Nasir H.; Sanger, Terence D.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Sanger, Terence D.] Univ So Calif, Dept Child Neurol, Los Angeles, CA 90089 USA; [Sanger, Terence D.] Univ So Calif, Dept Biokinesiol, Los Angeles, CA 90089 USA; [Sanger, Terence D.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Sanger, TD (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	terry@sangerlab.net			National Institutes of Health [NS064046]; TDS; Don; Linda Carter Foundation; Crowley-Carter Foundation; University of Southern California Department of Biomedical Engineering, TDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TDS; Don; Linda Carter Foundation; Crowley-Carter Foundation; University of Southern California Department of Biomedical Engineering, TDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health #NS064046, TDS, Don and Linda Carter Foundation, TDS, Crowley-Carter Foundation, TDS and University of Southern California Department of Biomedical Engineering, TDS.	Barry MJ, 1999, DEV MED CHILD NEUROL, V41, P404, DOI 10.1017/S0012162299000870; Bertucco M, 2014, J CHILD NEUROL, V29, P1460, DOI 10.1177/0883073813494265; Bhanpuri NH, 2014, BRAIN, V137, P1931, DOI 10.1093/brain/awu115; Chu VWT, 2013, J NEUROPHYSIOL, V109, P2169, DOI 10.1152/jn.00908.2012; Cohen J., 2003, APPL MULTIPLE REGRES; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Dunning A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125461; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; McCrea P, 2005, EXP BRAIN RES, V162, P70, DOI 10.1007/s00221-004-2106-8; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Missenard O, 2008, NEUROSCI LETT, V437, P154, DOI 10.1016/j.neulet.2008.03.090; Nagengast AJ, 2011, J NEUROPHYSIOL, V105, P2668, DOI 10.1152/jn.00804.2010; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; SANES JN, 1985, NEUROPSYCHOLOGIA, V23, P381, DOI 10.1016/0028-3932(85)90024-7; Sanger TD, 2005, J CHILD NEUROL, V20, P489, DOI 10.1177/08830738050200060401; Sanger TD, 2003, J CHILD NEUROL, V18, pS9, DOI 10.1177/0883073803018001S0401; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89; Sanger TD, 2007, IEEE T NEUR SYS REH, V15, P458, DOI 10.1109/TNSRE.2007.903969; Sanger TD, 2014, NEURAL COMPUT, V26, P2669, DOI 10.1162/NECO_a_00662; Sanger TD, 2010, MOVEMENT DISORD, V25, P1538, DOI 10.1002/mds.23088; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Smits-Engelsman BCM, 2007, EXP BRAIN RES, V177, P431, DOI 10.1007/s00221-006-0698-x; Soukoreff RW, 2004, INT J HUM-COMPUT ST, V61, P751, DOI 10.1016/j.ijhcs.2004.09.001; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; Trommershauser J, 2003, SPATIAL VISION, V16, P255, DOI 10.1163/156856803322467527; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Wolpert DM, 2012, CURR OPIN NEUROBIOL, V22, P996, DOI 10.1016/j.conb.2012.05.003; Wu SW, 2006, J VISION, V6, P53, DOI 10.1167/6.1.5; Zhai SM, 2004, INT J HUM-COMPUT ST, V61, P791, DOI 10.1016/j.ijhcs.2004.09.006	42	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139988	10.1371/journal.pone.0139988	http://dx.doi.org/10.1371/journal.pone.0139988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TW	26447874	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000075
J	Liu, QB; Ma, Y; Zhou, X; Furuyashiki, T				Liu, Qingbin; Ma, Yan; Zhou, Xin; Furuyashiki, Tomoyuki			Constitutive Tor2 Activity Promotes Retention of the Amino Acid Transporter Agp3 at Trans-Golgi/Endosomes in Fission Yeast	PLOS ONE			English	Article							REGULATES ENDOCYTOSIS; DISTINCT PHENOTYPES; NITROGEN STARVATION; PATHWAY; MTORC1; LOCALIZATION; DELETION; COMPLEX; LIGASE; GROWTH	Amino acid transporters are located at specific subcellular compartments, and their localizations are regulated by the extracellular availability of amino acids. In yeast, target of rapamycin (TOR) activation induces the internalization of amino acid transporters located at the plasma membrane. However, whether and how TOR signaling regulates other amino acid transporters located at intracellular compartments remains unknown. Here, we demonstrate that in the fission yeast, the TOR inhibitor Torin-1 induces the transfer of several yellow fluorescent protein (YFP)-fused intracellular amino acid transporters, including Agp3, Isp5, Aat1, and Put4, from trans-Golgi/endosomes into the vacuoles. By contrast, the localizations of YFP-fused Can1, Fnx1, and Fnx2 transporter proteins were unaffected upon Torin-1 treatment. There are two TOR isoforms in fission yeast, Tor1 and Tor2. Whereas tor1 deletion did not affect the Torin-1-induced transfer of Agp3-YFP, Tor2 inhibition using a temperature-sensitive mutant induced the transfer of Agp3-YFP to the vacuolar lumen, similar to the effects of Torin-1 treatment. Tor2 inhibition also induced the transfer of the YFP-fused Isp5, Aat1, and Put4 transporter proteins to the vacuoles, although only partial transfer of the latter two transporters was observed. Under nitrogen depletion accompanied by reduced Tor2 activity, Agp3-YFP was transferred from the trans-Golgi/endosomes to the plasma membrane and then to the vacuoles, where it was degraded by the vacuolar proteases Isp6 and Psp3. Mutants with constitutively active Tor2 showed delayed transfer of Agp3-YFP to the plasma membrane upon nitrogen depletion. Cells lacking Tsc2, a negative regulator of Tor2, also showed a delay in this process in a Tor2-dependent manner. Taken together, these findings suggest that constitutive Tor2 activity is critical for the retention of amino acid transporters at trans-Golgi/endosomes. Moreover, nitrogen depletion suppresses Tor2 activity through Tsc2, thereby promoting the surface expression of these transporters.	[Liu, Qingbin; Ma, Yan; Furuyashiki, Tomoyuki] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan; [Zhou, Xin] Liaoning Med Univ, Affiliated Hosp 1, Dept Oncol, Jinzhou, Peoples R China	Kobe University; Jinzhou Medical University	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp	Furuyashiki, Tomoyuki/B-8760-2014; Furuyashiki, Tomoyuki/AAG-5283-2019	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399	Japan Society for the Promotion of Science [26460339]; Grants-in-Aid for Scientific Research [24689015, 15H01289] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by Grant-in-Aid for Scientific Research (C) to YM (No. 26460339) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspuria PJ, 2008, MOL GENET GENOMICS, V279, P441, DOI 10.1007/s00438-008-0320-y; Atkin J, 2014, J CELL SCI, V127, P1346, DOI 10.1242/jcs.146373; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Chardwiriyapreecha S, 2008, FEBS LETT, V582, P2225, DOI 10.1016/j.febslet.2008.05.017; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ma N, 2013, GENETICS, V195, P457, DOI 10.1534/genetics.113.154674; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mukaiyama H, 2011, APPL MICROBIOL BIOT, V90, P203, DOI 10.1007/s00253-010-3031-3; Nakase Y, 2013, J CELL SCI, V126, P3972, DOI 10.1242/jcs.128355; Nakashima A, 2014, BIOL OPEN, V3, P542, DOI 10.1242/bio.20148367; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sartagul W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111936; Thomas JD, 2014, CANCER CELL, V26, P754, DOI 10.1016/j.ccell.2014.09.008; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toda T, 1996, MOL CELL BIOL, V16, P6752; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Valbuena N, 2012, J CELL SCI, V125, P1920, DOI 10.1242/jcs.094219; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170	30	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139045	10.1371/journal.pone.0139045	http://dx.doi.org/10.1371/journal.pone.0139045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447710	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000018
J	Mongraw-Chaffin, M; Golden, SH; Allison, MA; Ding, JZ; Ouyang, P; Schreiner, PJ; Szklo, M; Woodward, M; Young, JH; Anderson, CAM				Mongraw-Chaffin, Morgana; Golden, Sherita Hill; Allison, Matthew A.; Ding, Jingzhong; Ouyang, Pamela; Schreiner, Pamela J.; Szklo, Moyses; Woodward, Mark; Young, Jeffery Hunter; Anderson, Cheryl A. M.			The Sex and Race Specific Relationship between Anthropometry and Body Fat Composition Determined from Computed Tomography: Evidence from the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; ABDOMINAL ADIPOSITY; RISK-FACTORS; MASS INDEX; BMI; DIMORPHISM; OBESITY; DISEASE; TISSUE	Background Few studies have investigated the relationship of anthropometric measurements with computed tomography (CT) body fat composition, and even fewer determined if these relationships differ by sex and race. Methods CT scans from 1,851 participants in the population based Multi-Ethnic Study of Atherosclerosis were assessed for visceral and subcutaneous fat areas by semi-automated segmentation of body compartments. Regression models were used to investigate relationships for anthropometry with visceral and subcutaneous fat separately by sex and race/ethnicity. Results Participants were 50% female, 41% Caucasian, 13% Asian, 21% African American, and 25% Hispanic. For visceral fat, the positive relationship with weight (p = 0.028), waist circumference (p<0.001), waist to hip ratio (p<0.001), and waist to height ratio (p = 0.05) differed by sex, with a steeper slope for men. That is, across the range of these anthropometric measures the rise in visceral fat is faster for men than for women. Additionally, there were differences by race/ethnicity in the relationship with height (p<0.001), weight (p<0.001), waist circumference (p<0.001), hip circumference (p = 0.006), and waist to hip ratio (p = 0.001) with the Hispanic group having shallower slopes. For subcutaneous fat, interaction by sex was found for all anthropometric indices at p<0.05, but not for race/ethnicity. Conclusion The relationship between anthropometry and underlying adiposity differs by sex and race/ethnicity. When anthropometry is used as a proxy for visceral fat in research, sex-specific models should be used.	[Mongraw-Chaffin, Morgana; Allison, Matthew A.; Anderson, Cheryl A. M.] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Mongraw-Chaffin, Morgana; Golden, Sherita Hill; Szklo, Moyses; Woodward, Mark; Young, Jeffery Hunter; Anderson, Cheryl A. M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Golden, Sherita Hill; Ouyang, Pamela; Young, Jeffery Hunter] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Ding, Jingzhong] Wake Forest Sch Med, Geriatr & Gerontol, Winston Salem, NC USA; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Woodward, Mark] Univ Oxford, Nuffield Dept Populat Hlth, George Inst Global Hlth, Oxford, England	University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; George Institute for Global Health; University of Sydney; University of Oxford	Mongraw-Chaffin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	mmongrawchaffin@ucsd.edu	Woodward, Mark/L-6817-2017; Woodward, Mark/D-8492-2015	Allison, Matthew/0000-0003-0777-8272; Mongraw-Chaffin, Morgana/0000-0001-6541-7198; Szklo, Moyses/0000-0001-9433-6266; Schreiner, Pamela/0000-0002-9920-6257; Woodward, Mark/0000-0001-9800-5296	National Heart Lung and Blood Institute [T32 HL007024, T32HL079891]; National Institute of Diabetes and Digestive and Kidney Diseases [T32DK062707]; NIH/NHLBI [R01 HL088451]; National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169]; NCRR [UL1-TR-000040, UL1-RR-025005]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095169, N01HC095164, N01HC095168, N01HC095167, N01HC095163, N01HC095165, N01HC095162, N01HC095160, N01HC095161, N01HC095166] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024, R01HL088451, T32HL079891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062707] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	MMC was supported by the following grants: National Heart Lung and Blood Institute T32 HL007024 and T32HL079891, and National Institute of Diabetes and Digestive and Kidney Diseases T32DK062707. The MESA Abdominal Body Composition, Inflammation and Cardiovascular Disease ancillary study is supported by NIH/NHLBI grant R01 HL088451. This research was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute and by grants UL1-TR-000040 and UL1-RR-025005 from NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Center for Information Technology National Institutes of Health, MIPAV MED IM PROC AN; Demerath EW, 2007, OBESITY, V15, P2984, DOI 10.1038/oby.2007.356; Fonseca V, 2003, AM J MED, V115, P42, DOI 10.1016/j.amjmed.2003.09.005; Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Lear SA, 2007, OBESITY, V15, P2817, DOI 10.1038/oby.2007.334; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; MATSUZAWA Y, 1995, OBES RES, V3, pS187, DOI 10.1002/j.1550-8528.1995.tb00462.x; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Nedungadi TP, 2009, J CARDIOVASC TRANSL, V2, P321, DOI 10.1007/s12265-009-9101-1; Ness-Abramof R, 2008, NUTR CLIN PRACT, V23, P397, DOI 10.1177/0884533608321700; Oka R, 2009, DIABETES RES CLIN PR, V83, P100, DOI 10.1016/j.diabres.2008.10.001; Onat A, 2010, NUTRITION, V26, P382, DOI 10.1016/j.nut.2009.05.019; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Schreiner PJ, 1996, AM J EPIDEMIOL, V144, P335, DOI 10.1093/oxfordjournals.aje.a008934; Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17; WHO, 2004, LANCET, V363, P902	23	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139559	10.1371/journal.pone.0139559	http://dx.doi.org/10.1371/journal.pone.0139559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448048	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000032
J	Caldwell, M; Moroz, T; Hapuarachchi, T; Bainbridge, A; Robertson, NJ; Cooper, CE; Tachtsidis, I				Caldwell, Matthew; Moroz, Tracy; Hapuarachchi, Tharindi; Bainbridge, Alan; Robertson, Nicola J.; Cooper, Chris E.; Tachtsidis, Ilias			Modelling Blood Flow and Metabolism in the Preclinical Neonatal Brain during and Following Hypoxic-Ischaemia	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; MAGNETIC-RESONANCE-SPECTROSCOPY; CEREBRAL ENERGY FAILURE; CYTOCHROME-OXIDASE; NEWBORN PIGLETS; MATHEMATICAL-MODEL; OXYGEN DEPENDENCY; INTRACELLULAR PH; HEALTHY-ADULTS; REDOX STATE	Hypoxia-ischaemia (HI) is a major cause of neonatal brain injury, often leading to long-term damage or death. In order to improve understanding and test new treatments, piglets are used as preclinical models for human neonates. We have extended an earlier computational model of piglet cerebral physiology for application to multimodal experimental data recorded during episodes of induced HI. The data include monitoring with near-infrared spectroscopy (NIRS) and magnetic resonance spectroscopy (MRS), and the model simulates the circulatory and metabolic processes that give rise to the measured signals. Model extensions include simulation of the carotid arterial occlusion used to induce HI, inclusion of cytoplasmic pH, and loss of metabolic function due to cell death. Model behaviour is compared to data from two piglets, one of which recovered following HI while the other did not. Behaviourally-important model parameters are identified via sensitivity analysis, and these are optimised to simulate the experimental data. For the non-recovering piglet, we investigate several state changes that might explain why some MRS and NIRS signals do not return to their baseline values following the HI insult. We discover that the model can explain this failure better when we include, among other factors such as mitochondrial uncoupling and poor cerebral blood flow restoration, the death of around 40% of the brain tissue.	[Caldwell, Matthew; Moroz, Tracy; Hapuarachchi, Tharindi; Tachtsidis, Ilias] UCL, Med Phys & Biomed Engn, London, England; [Moroz, Tracy; Hapuarachchi, Tharindi] UCL, CoMPLEX, London, England; [Bainbridge, Alan] UCLH NHS Fdn Trust, Med Phys & Bioengn, London, England; [Robertson, Nicola J.] UCL, Insititute Womens Hlth, London, England; [Cooper, Chris E.] Univ Essex, Biol Sci, Colchester CO4 3SQ, Essex, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Essex	Tachtsidis, I (corresponding author), UCL, Med Phys & Biomed Engn, London, England.	i.tachtsidis@ucl.ac.uk	Robertson, Nicola/GWR-2021-2022; Cooper, Chris/AAK-9729-2020; Tachtsidis, Ilias/N-2747-2018	Cooper, Chris/0000-0003-0381-3990; Tachtsidis, Ilias/0000-0002-8125-0313; Caldwell, Matthew/0000-0002-9578-1676	Wellcome Trust [088429/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by the Wellcome Trust, grant number 088429/Z/09/Z www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert A, 2001, ACTA BIOTHEOR, V49, P301, DOI 10.1023/A:1014286728421; Aubert A, 2007, P NATL ACAD SCI USA, V104, P4188, DOI 10.1073/pnas.0605864104; Bainbridge A, 2014, NEUROIMAGE, V102, P173, DOI 10.1016/j.neuroimage.2013.08.016; Banaji M, 2005, MATH BIOSCI, V194, P125, DOI 10.1016/j.mbs.2004.10.005; Banaji M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000212; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Boyd S, 2013, CONVEX OPTIMIZATION, P1; CADY EB, 1983, LANCET, V1, P1059; Cady EB, 2008, J NEUROCHEM, V107, P1027, DOI 10.1111/j.1471-4159.2008.05662.x; Cloutier M, 2009, J COMPUT NEUROSCI, V27, P391, DOI 10.1007/s10827-009-0152-8; COBELLI C, 1980, AM J PHYSIOL, V239, pR7, DOI 10.1152/ajpregu.1980.239.1.R7; Cooper CE, 1997, PHILOS T R SOC B, V352, P669, DOI 10.1098/rstb.1997.0048; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; Domoki F, 2014, J PHYSIOL PHARMACOL, V65, P551; Edvinsson L, 1992, CEREBRAL BLOOD FLOW; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Faulkner S, 2011, ANN NEUROL, V70, P133, DOI 10.1002/ana.22387; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hapuarachchi T, 2014, ADV EXP MED BIOL, V812, P187, DOI 10.1007/978-1-4939-0620-8_25; Hoshi Y, 1997, J APPL PHYSIOL, V83, P1842, DOI 10.1152/jappl.1997.83.6.1842; Jelfs B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038297; Jung A, 2005, J MATH BIOL, V51, P491, DOI 10.1007/s00285-005-0343-5; Kohl P, 2010, CLIN PHARMACOL THER, V88, P25, DOI 10.1038/clpt.2010.92; Kolyva C, 2012, BIOMED OPT EXPRESS, V3, P2550, DOI 10.1364/BOE.3.002550; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Levene MI, 2010, ARCH DIS CHILD-FETAL, V95, pF154, DOI 10.1136/adc.2009.165738; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; MATCHER SJ, 1995, P SOC PHOTO-OPT INS, V2359, P486; Moroz T, 2012, J R SOC INTERFACE, V9, P1499, DOI 10.1098/rsif.2011.0766; Moroz T, 2012, ADV EXP MED BIOL, V737, P293, DOI 10.1007/978-1-4614-1566-4_43; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; ORIOT D, 1995, ACTA PAEDIATR, V84, P621, DOI 10.1111/j.1651-2227.1995.tb13712.x; Orlowski P, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0079; Penrice J, 1997, PEDIATR RES, V41, P795, DOI 10.1203/00006450-199706000-00001; Pujol G, 2014, R PACKAGE SENSITIVIT, P1; Qiao M, 2004, PEDIATR RES, V55, P101, DOI 10.1203/01.PDR.0000100477.59081.FE; Robertson NJ, 2002, ANN NEUROL, V52, P732, DOI 10.1002/ana.10365; SALTELLI A, 2004, SENSITIVITY ANAL; Shah PS, 2007, ARCH PEDIAT ADOL MED, V161, P951, DOI 10.1001/archpedi.161.10.951; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Springett R, 2000, AM J PHYSIOL-HEART C, V279, pH2202, DOI 10.1152/ajpheart.2000.279.5.H2202; Springett R, 1999, ADV EXP MED BIOL, V471, P181; Tichauer KM, 2006, J APPL PHYSIOL, V100, P850, DOI 10.1152/japplphysiol.00830.2005; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Transtrum MK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036701; TSUJI M, 1995, DEV BRAIN RES, V85, P192, DOI 10.1016/0165-3806(94)00213-J; Uria-Avellanal C, 2014, TRANSL STROKE RES, V5, P79, DOI 10.1007/s12975-013-0322-x; Ursino M, 1998, AM J PHYSIOL-HEART C, V274, pH1715, DOI 10.1152/ajpheart.1998.274.5.H1715; VANNUCCI RC, 1990, PEDIATR RES, V27, P317, DOI 10.1203/00006450-199004000-00001; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vaz AIF, 2009, OPTIM METHOD SOFTW, V24, P669, DOI 10.1080/10556780902909948; Williamson DH, 1967, THE BIOCHEMICAL JOUR, V103, P514, DOI 10.1042/bj1030514	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140171	10.1371/journal.pone.0140171	http://dx.doi.org/10.1371/journal.pone.0140171			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445281	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000362510600147
J	Dessing, MC; Kers, J; Damman, J; Leuvenink, HGD; van Goor, H; Hillebrands, JL; Hepkema, BG; Snieder, H; van den Born, J; de Borst, MH; Bakker, SJL; Navis, GJ; Ploeg, RJ; Florquin, S; Seelen, M; Leemans, JC				Dessing, Mark C.; Kers, Jesper; Damman, Jeffrey; Leuvenink, Henri G. D.; van Goor, Harry; Hillebrands, Jan-Luuk; Hepkema, Bouke G.; Snieder, Harold; van den Born, Jacob; de Borst, Martin H.; Bakker, Stephan J. L.; Navis, Gerjan J.; Ploeg, Rutger J.; Florquin, Sandrine; Seelen, Marc; Leemans, Jaklien C.			Toll-Like Receptor Family Polymorphisms Are Associated with Primary Renal Diseases but Not with Renal Outcomes Following Kidney Transplantation	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; STOP CODON POLYMORPHISM; GENE POLYMORPHISMS; ISCHEMIA/REPERFUSION INJURY; COMMON POLYMORPHISM; ALLOGRAFT SURVIVAL; REPERFUSION INJURY; IMMUNE-RESPONSES; ACUTE REJECTION; URINARY-TRACT	Toll-like receptors (TLRs) play a crucial role in innate-and adaptive immunity. The TLR pathways were shown to play key functional roles in experimental acute and chronic kidney injury, including the allo-immune response after experimental renal transplantation. Data about the precise impact of TLRs and their negative regulators on human renal transplant outcomes however are limited and contradictory. We studied twelve non-synonymous single nucleotide polymorphisms (SNPs) of which eleven in TLR1-8 and one in SIGIRR in a final cohort comprising 1116 matching donors and recipients. TLR3 p.Leu412Phe and SIGIRR p.Gln312Arg significantly deviated from Hardy-Weinberg equilibrium and were excluded. The frequency distribution of the minor alleles of the remaining 10 TLR variants were compared between patients with end-stage renal disease (recipients) and controls (kidney donors) in a case-control study. Secondly, the associations between the minor allele frequency of the TLR variants and delayed graft function, biopsy-proven acute rejection and death-censored graft failure after transplantation were investigated with Cox regression. Carrier frequencies of the minor alleles of TLR1 p.His305Leu (OR = 4.79, 95% CI = 2.35-9.75, P = 0.0002), TLR1 p.Asn248Ser (OR = 1.26, 95% CI = 1.07-1.47, P = 0.04) and TLR8 p.Met1Val (OR = 1.37, 95% CI = 1.14-1.64, P = 0.008) were significantly higher in patients with ESRD, with little specificity for the underlying renal disease entity (adjusted for age, gender and donor-recipient relatedness). The minor allele frequency of none of the TLR variants significantly associated with the surrogate and definite outcomes, even when multivariable models were created that could account for TLR gene redundancy. In conclusion, genetic variants in TLR genes were associated with the prevalence of ESRD but not renal transplant outcomes. Therefore, our data suggests that specific TLR signaling routes might play a role in the final common pathway of primary renal injury. A role for TLR signaling in the context of renal transplantation is probably limited.	[Dessing, Mark C.; Kers, Jesper; Damman, Jeffrey; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Dessing, Mark C.] Univ So Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90033 USA; [Leuvenink, Henri G. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Hepkema, Bouke G.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [van den Born, Jacob; de Borst, Martin H.; Bakker, Stephan J. L.; Navis, Gerjan J.; Seelen, Marc] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Ploeg, Rutger J.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Florquin, Sandrine] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Southern California; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Oxford; Radboud University Nijmegen	Kers, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	j.kers@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020; van+Goor, Harry/AAS-7712-2020; Kers, Jesper/F-1995-2010	Florquin, Sandrine/0000-0002-9676-1722; van Goor, Harry/0000-0002-6670-1577; Leuvenink, Henri/0000-0001-5036-2999; De Borst, Martin/0000-0002-4127-8733; Hillebrands, Jan-Luuk/0000-0003-3135-3274	Dutch Kidney Foundation [C06.6023]; European Union [EU_FP-6 037697]	Dutch Kidney Foundation; European Union(European Commission)	This work was supported by the Dutch Kidney Foundation (www.nierstichting.nl), grant no. C06.6023. The funder had no role in study design, data collection, analysis, preparation of the manuscript or decision to publish. European Union FP6 program me grant no. EU_FP-6 037697. The funder had no role in study design, data collection, analysis, preparation of the manuscript or decision to publish.	Akil I, 2012, INT J IMMUNOGENET, V39, P303, DOI 10.1111/j.1744-313X.2012.01090.x; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Askar E, 2010, J MED VIROL, V82, P1859, DOI 10.1002/jmv.21893; Bayram MT, 2013, PEDIATR NEPHROL, V28, P1827, DOI 10.1007/s00467-013-2478-8; Cervera C, 2007, TRANSPLANTATION, V83, P1493, DOI 10.1097/01.tp.0000264999.71318.2b; Chen L, 2006, AM J TRANSPLANT, V6, P2282, DOI 10.1111/j.1600-6143.2006.01489.x; Cheng CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058687; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Damman J, 2012, AM J TRANSPLANT, V12, P660, DOI 10.1111/j.1600-6143.2011.03880.x; Dhiman N, 2008, VACCINE, V26, P1731, DOI 10.1016/j.vaccine.2008.01.017; Ducloux D, 2005, KIDNEY INT, V67, P2454, DOI 10.1111/j.1523-1755.2005.00354.x; Eikmans M, 2012, TRANSPLANTATION, V94, P478, DOI 10.1097/TP.0b013e31825c5967; Farrar CA, 2012, FASEB J, V26, P799, DOI 10.1096/fj.11-195396; Fekete A, 2006, TRANSPL INT, V19, P190, DOI 10.1111/j.1432-2277.2006.00265.x; Gluba A, 2010, NAT REV NEPHROL, V6, P224, DOI 10.1038/nrneph.2010.16; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P10593, DOI 10.1073/pnas.0501165102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Israni A, 2010, TRANSPLANTATION, V90, P1401, DOI 10.1097/TP.0b013e3182000085; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kim TH, 2013, INT J IMMUNOGENET, V40, P502, DOI 10.1111/iji.12069; Klimosch SN, 2013, CANCER RES, V73, P7232, DOI 10.1158/0008-5472.CAN-13-1746; Krichen H, 2013, TRANSPL P, V45, P3472, DOI 10.1016/j.transproceed.2013.09.003; Kruger B, 2010, CLIN SCI, V119, P535, DOI 10.1042/CS20100190; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Lech M, 2009, J IMMUNOL, V183, P4109, DOI 10.4049/jimmunol.0900118; Lee JS, 2011, INT J IMMUNOGENET, V38, P133, DOI 10.1111/j.1744-313X.2010.00978.x; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Mutlubas F, 2009, TRANSPL P, V41, P1589, DOI 10.1016/j.transproceed.2009.02.079; Nogueira E, 2007, TRANSPL P, V39, P412, DOI 10.1016/j.transproceed.2007.01.026; Noris M, 2009, J IMMUNOL, V183, P4249, DOI 10.4049/jimmunol.0803549; Oh DY, 2008, J INFECT DIS, V198, P701, DOI 10.1086/590431; Oh DY, 2009, AIDS, V23, P297, DOI 10.1097/QAD.0b013e32831fb540; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Palmer SM, 2006, CLIN TRANSPLANT, V20, P30, DOI 10.1111/j.1399-0012.2005.00436.x; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Reznichenko A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036512; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Sheridan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061326; Shey MS, 2010, GENES IMMUN, V11, P561, DOI 10.1038/gene.2010.14; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Sironi M, 2012, J IMMUNOL, V188, P818, DOI 10.4049/jimmunol.1102179; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Skuginna V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019204; Soylu A, 2010, RHEUMATOL INT, V30, P667, DOI 10.1007/s00296-009-1052-y; Srivastava P, 2012, CLIN TRANSPLANT, V26, P581, DOI 10.1111/j.1399-0012.2011.01577.x; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073985; Wang SJ, 2010, DIS MODEL MECH, V3, P92, DOI 10.1242/dmm.003533; West TE, 2013, J IMMUNOL, V190, P3373, DOI 10.4049/jimmunol.1202974; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu JF, 2012, J INFECT DIS, V206, P662, DOI 10.1093/infdis/jis420; Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493	64	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139769	10.1371/journal.pone.0139769	http://dx.doi.org/10.1371/journal.pone.0139769			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445497	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600078
J	Zhao, WM; Lu, HY; Wang, XY; Ransohoff, RM; Zhou, L				Zhao, Wanming; Lu, Haiyan; Wang, Xingyu; Ransohoff, Richard M.; Zhou, Lan			CX(3)CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions	FASEB JOURNAL			English	Article						chemokine; phagocytosis; IGF-1; monocyte recruitment; muscle regeneration	FRACTALKINE RECEPTOR CX3CR1; FOCAL CEREBRAL-ISCHEMIA; CHEMOKINE RECEPTOR; PHARMACOLOGICAL INHIBITION; MICROGLIAL ACTIVATION; AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; MOUSE MODEL; MDX MICE; REGENERATION	Adequate inflammatory response predominated by macrophage infiltration is essential to acute skeletal muscle injury repair. The majority of intramuscular macrophages express the chemokine receptor CX(3)CR1. We studied the role of CX(3)CR1 in regulating intramuscular macrophage number and function in acute injury repair by using a loss-of-function approach. Muscle injury repair was delayed in CX(3)CR1(GFP/GFP) mice as compared with wild-type (WT) controls. CX(3)CR1 was predominantly expressed by macrophages but not by myogenic cells or capillary endothelia cells in injured muscles. Intramuscular macrophage number and subset composition were not altered by CX(3)CR1 deficiency. Intramuscular macrophage phagocytosis function was impaired by CX(3)CR1 deficiency as demonstrated by increased number of necrotic fibers (+115%) and percentage of necrotic area (+204%) at 7 d, increased number of intramuscular neutrophils at 3 (+89%) but not 1 d, reduced number of phagocytosing macrophages (-12%) and phagocytosed beads within macrophages (-15%) in CX(3)CR1(GFP/GFP) mice as compared with WT controls. The mRNA expression of CD36 (-50%), CD14 (-43%), IGF-1 (-53%), and IL-6 (-40%) was reduced in CX(3)CR1-deficient macrophages as compared with WT controls. We conclude that CX(3)CR1 is important to acute skeletal muscle injury repair by regulating macrophage phagocytosis function and trophic growth factor production.	[Zhao, Wanming; Wang, Xingyu; Zhou, Lan] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Lu, Haiyan; Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44106 USA	Icahn School of Medicine at Mount Sinai; Cleveland Clinic Foundation	Zhou, L (corresponding author), Mt Sinai Sch Med, Dept Neurol, 1468 Madison Ave,Box 1052, New York, NY 10029 USA.	lan.zhou@mssm.edu			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059702]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059702] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai for the technical support. This study is supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01AR059702 (to L.Z.). The authors declare no conflicts of interest.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Begue G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057141; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Blomster LV, 2011, MOL CELL NEUROSCI, V48, P236, DOI 10.1016/j.mcn.2011.08.004; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cho SH, 2011, J BIOL CHEM, V286, P32713, DOI 10.1074/jbc.M111.254268; Cipriani R, 2011, J NEUROSCI, V31, P16327, DOI 10.1523/JNEUROSCI.3611-11.2011; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Cybulsky MI, 2003, J CLIN INVEST, V111, P1118, DOI 10.1172/JCI200318237; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Devitt A, 2004, J CELL BIOL, V167, P1161, DOI 10.1083/jcb.200410057; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Ishida Y, 2008, J IMMUNOL, V181, P4208, DOI 10.4049/jimmunol.181.6.4208; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kostadinova FI, 2010, J LEUKOCYTE BIOL, V88, P133, DOI 10.1189/jlb.1109768; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Poupel L, 2013, ARTERIOSCL THROM VAS, V33, P2297, DOI 10.1161/ATVBAHA.112.300930; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Sato E, 2010, JARO-J ASSOC RES OTO, V11, P223, DOI 10.1007/s10162-009-0198-3; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Varga T, 2013, J IMMUNOL, V191, P5695, DOI 10.4049/jimmunol.1301445; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wollberg AR, 2014, P NATL ACAD SCI USA, V111, P5409, DOI 10.1073/pnas.1316510111; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	51	39	41	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					380	393		10.1096/fj.14-270090	http://dx.doi.org/10.1096/fj.14-270090			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443824	Green Published			2022-12-26	WOS:000367621000036
J	Wu, Y; Shyng, SL; Chen, PC				Wu, Yi; Shyng, Show-Ling; Chen, Pei-Chun			Concerted Trafficking Regulation of Kv2.1 and K-ATP Channels by Leptin in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; INSULIN-SECRETION; ELECTRICAL-ACTIVITY; PTEN INHIBITION; RAT CRI-G1; GLUCOSE; CALCIUM; ACTIVATION; EXPRESSION; AMPK	In pancreatic beta-cells, voltage-gated potassium 2.1 (Kv2.1) channels are the dominant delayed rectifier potassium channels responsible for action potential repolarization. Here, we report that leptin, a hormone secreted by adipocytes known to inhibit insulin secretion, causes a transient increase in surface expression of Kv2.1 channels in rodent and human beta-cells. The effect of leptin on Kv2.1 surface expression is mediated by the AMP-activated protein kinase (AMPK). Activation of AMPK mimics whereas inhibition of AMPK occludes the effect of leptin. Inhibition of Ca2+/calmodulin-dependent protein kinase kinase beta, a known upstream kinase of AMPK, also blocks the effect of leptin. In addition, the cAMP-dependent protein kinase (PKA) is involved in Kv2.1 channel trafficking regulation. Inhibition of PKA prevents leptin or AMPK activators from increasing Kv2.1 channel density, whereas stimulation of PKA is sufficient to promote Kv2.1 channel surface expression. The increased Kv2.1 surface expression by leptin is dependent on actin depolymerization, and pharmacologically induced actin depolymerization is sufficient to enhance Kv2.1 surface expression. The signaling and cellular mechanisms underlying Kv2.1 channel trafficking regulation by leptin mirror those reported recently for ATP-sensitive potassium (K-ATP) channels, which are critical for coupling glucose stimulation with membrane depolarization. We show that the leptin-induced increase in surface K-ATP channels results in more hyperpolarized membrane potentials than control cells at stimulating glucose concentrations, and the increase in Kv2.1 channels leads to a more rapid repolarization of membrane potential in cells firing action potentials. This study supports a model in which leptin exerts concerted trafficking regulation of K-ATP and Kv2.1 channels to coordinately inhibit insulin secretion.	[Wu, Yi; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Chen, Pei-Chun] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 701, Taiwan	Oregon Health & Science University; National Cheng Kung University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu; pcchen@mail.ncku.edu.tw	Regan, Clinton/E-6250-2012	Chen, Pei-Chun/0000-0002-2550-6556	National Institutes of Health [R01DK057699, 3R01DK057699-14S1]; Ministry of Science and Technology Grant [MOST 1032320B006005MY2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK057699 and 3R01DK057699-14S1 (to S.-L. S) and by Ministry of Science and Technology Grant MOST 1032320B006005MY2 (to P.-C. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Ashcroft FM, 2006, BIOCHEM SOC T, V34, P243, DOI 10.1042/BST0340243; ASHCROFT FM, 1990, PFLUG ARCH EUR J PHY, V415, P504, DOI 10.1007/BF00373633; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; ASHCROFT FM, 1989, ANN NY ACAD SCI, V560, P410, DOI 10.1111/j.1749-6632.1989.tb24123.x; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; BOKVIST K, 1990, J PHYSIOL-LONDON, V423, P311, DOI 10.1113/jphysiol.1990.sp018024; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Cases JA, 2001, DIABETES, V50, P348, DOI 10.2337/diabetes.50.2.348; Chen PC, 2013, J BIOL CHEM, V288, P34098, DOI 10.1074/jbc.M113.516880; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; Dhar M, 2014, J NEUROSCI, V34, P10022, DOI 10.1523/JNEUROSCI.2868-13.2014; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Harvey J, 1998, J PHYSIOL-LONDON, V510, P47, DOI 10.1111/j.1469-7793.1998.047bz.x; Harvey J, 1998, J PHYSIOL-LONDON, V511, P695, DOI 10.1111/j.1469-7793.1998.695bg.x; Harvey J, 2000, J PHYSIOL-LONDON, V527, P95, DOI 10.1111/j.1469-7793.2000.00095.x; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Herrington J, 2005, J PHYSIOL-LONDON, V567, P159, DOI 10.1113/jphysiol.2005.089375; Hohmeier HE, 1997, DIABETES, V46, P968, DOI 10.2337/diabetes.46.6.968; Holz GG, 2013, ISLETS, V5, P229, DOI 10.4161/isl.26958; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Houamed KM, 2010, J PHYSIOL-LONDON, V588, P3511, DOI 10.1113/jphysiol.2009.184341; Jacobson DA, 2007, DIABETES OBES METAB, V9, P89, DOI 10.1111/j.1463-1326.2007.00784.x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jacobson DA, 2010, J PHYSIOL-LONDON, V588, P3525, DOI 10.1113/jphysiol.2010.190207; Jensen MV, 2013, J BIOL CHEM, V288, P23128, DOI 10.1074/jbc.M113.491654; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Kim SJ, 2012, CELL DEATH DIFFER, V19, P333, DOI 10.1038/cdd.2011.102; Komatsu M, 2013, J DIABETES INVEST, V4, P511, DOI 10.1111/jdi.12094; Li XY, 2013, J PHARMACOL EXP THER, V344, P407, DOI 10.1124/jpet.112.199083; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Meda P, 2003, CELL COMMUN ADHES, V10, P431, DOI 10.1080/15419060390263263; Moult PR, 2010, J NEUROSCI, V30, P4088, DOI 10.1523/JNEUROSCI.3614-09.2010; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Park SH, 2013, BIOCHEM BIOPH RES CO, V440, P539, DOI 10.1016/j.bbrc.2013.09.099; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; RORSMAN P, 1986, J PHYSIOL-LONDON, V374, P531, DOI 10.1113/jphysiol.1986.sp016096; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; SATIN LS, 1988, PFLUG ARCH EUR J PHY, V411, P401, DOI 10.1007/BF00587719; Sher E, 2003, J BIOENERG BIOMEMBR, V35, P687, DOI 10.1023/B:JOBB.0000008032.49504.48; Silva JR, 2014, BIOPHYS J, V107, P2016, DOI 10.1016/j.bpj.2014.09.037; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Szkudelski T, 2007, PHYSIOL RES, V56, P503, DOI 10.33549/physiolres.931038; Tamarina NA, 2005, AM J PHYSIOL-ENDOC M, V289, pE578, DOI 10.1152/ajpendo.00054.2005; Varadi A, 2006, DIABETOLOGIA, V49, P1567, DOI 10.1007/s00125-006-0257-9; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002; Yang SN, 2014, CELL MOL LIFE SCI, V71, P4149, DOI 10.1007/s00018-014-1680-6	60	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29676	29690		10.1074/jbc.M115.670877	http://dx.doi.org/10.1074/jbc.M115.670877			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26453299	Green Published, hybrid			2022-12-26	WOS:000366614700001
J	Cui, JQ; Chen, W; Sun, JH; Guo, H; Madley, R; Xiong, Y; Pan, XY; Wang, HL; Tai, AW; Weiss, MA; Arvan, P; Liu, M				Cui, Jingqiu; Chen, Wei; Sun, Jinhong; Guo, Huan; Madley, Rachel; Xiong, Yi; Pan, Xingyi; Wang, Hongliang; Tai, Andrew W.; Weiss, Michael A.; Arvan, Peter; Liu, Ming			Competitive Inhibition of the Endoplasmic Reticulum Signal Peptidase by Non-cleavable Mutant Preprotein Cargos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; COLI LEADER PEPTIDASE; MEMBRANE TOPOLOGY; REM PROTEIN; SEQUENCE; GLYCOPROTEIN; TRANSLOCATION; MUTATIONS; MECHANISM; PRECURSOR	Upon translocation across the endoplasmic reticulum (ER) membrane, secretory proteins are proteolytically processed to remove their signal peptide by signal peptidase (SPase). This process is critical for subsequent folding, intracellular trafficking, and maturation of secretory proteins. Prokaryotic SPase has been shown to be a promising antibiotic target. In contrast, to date, no eukaryotic SPase inhibitors have been reported. Here we report that introducing a proline immediately following the natural signal peptide cleavage site not only blocks preprotein cleavage but also, in trans, impairs the processing and maturation of co-expressed preproteins in the ER. Specifically, we find that a variant preproinsulin, pPI-F25P, is translocated across the ER membrane, where it binds to the catalytic SPase subunit SEC11A, inhibiting SPase activity in a dose-dependent manner. Similar findings were obtained with an analogous variant of preproparathyroid hormone, demonstrating that inhibition of the SPase does not depend strictly on the sequence or structure of the downstream mature protein. We further show that inhibiting SPase in the ER impairs intracellular processing of viral polypeptides and their subsequent maturation. These observations suggest that eukaryotic SPases (including the human ortholog) are, in principle, suitable therapeutic targets for antiviral drug design.	[Cui, Jingqiu; Liu, Ming] Tianjin Med Univ, Gen Hosp, Dept Endocrinol & Metab, Tianjin 300052, Peoples R China; [Cui, Jingqiu; Chen, Wei; Sun, Jinhong; Guo, Huan; Madley, Rachel; Xiong, Yi; Pan, Xingyi; Arvan, Peter; Liu, Ming] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Chen, Wei] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Wang, Hongliang; Tai, Andrew W.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Tianjin Medical University; University of Michigan System; University of Michigan; Academy of Military Medical Sciences - China; University of Michigan System; University of Michigan; Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu; parvan@umich.edu; mingli@umich.edu	Regan, Clinton/E-6250-2012; Wang, Hongliang/J-1941-2012; Tai, Andrew W./M-8380-2017	Wang, Hongliang/0000-0002-3304-2683; Tai, Andrew W./0000-0002-6877-450X; Liu, Ming/0000-0003-2665-4072	National Institutes of Health [P60-DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK040949, P60DK020572, R01DK069764, R01DK048280, R01DK088856, R01DK097374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Molecular Biology and DNA Sequencing Core of the University of Michigan Diabetes Research and Training Center funded by the National Institutes of Health (Grant P60-DK20572),	Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757; BARKOCYGALLAGHER GA, 1992, J BIOL CHEM, V267, P1231; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Byun H, 2010, P NATL ACAD SCI USA, V107, P12287, DOI 10.1073/pnas.1004303107; Choo KH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S15; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dalbey RE, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3493, DOI 10.1016/B978-0-12-382219-2.00774-2; Datta R, 2007, P NATL ACAD SCI USA, V104, P19989, DOI 10.1073/pnas.0708725104; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; ITO M, 1993, J CLIN INVEST, V91, P2565, DOI 10.1172/JCI116494; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Kalies KU, 1996, J BIOL CHEM, V271, P3925; KOSHLAND D, 1982, CELL, V30, P903, DOI 10.1016/0092-8674(82)90295-1; KUO D, 1994, BIOCHEMISTRY-US, V33, P8347, DOI 10.1021/bi00193a023; KUO DW, 1993, ARCH BIOCHEM BIOPHYS, V303, P274, DOI 10.1006/abbi.1993.1283; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; Law LMJ, 2001, J VIROL, V75, P1978, DOI 10.1128/JVI.75.4.1978-1983.2001; Li Y, 2000, VIROLOGY, V272, P417, DOI 10.1006/viro.2000.0357; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159; Mullins C, 1996, J BIOL CHEM, V271, P29094, DOI 10.1074/jbc.271.46.29094; NILSSON I, 1992, FEBS LETT, V299, P243, DOI 10.1016/0014-5793(92)80124-Y; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 2014, BBA-MOL CELL RES, V1843, P1497, DOI 10.1016/j.bbamcr.2013.12.003; Pekosz A, 1998, P NATL ACAD SCI USA, V95, P13233, DOI 10.1073/pnas.95.22.13233; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; RACCHI M, 1993, J BIOL CHEM, V268, P5735; Rao CVS, 2014, BBA-MOL CELL RES, V1843, P1762, DOI 10.1016/j.bbamcr.2014.02.004; RUSSEL M, 1981, P NATL ACAD SCI-BIOL, V78, P1717, DOI 10.1073/pnas.78.3.1717; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; SHEN LM, 1991, BIOCHEMISTRY-US, V30, P11775, DOI 10.1021/bi00115a006; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Suzuki R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003589; VanValkenburgh C, 1999, J BIOL CHEM, V274, P11519, DOI 10.1074/jbc.274.17.11519; von Heijne G, 1998, NATURE, V396, P111, DOI 10.1038/24036; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Walker SJ, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3512, DOI 10.1016/B978-0-12-382219-2.00778-X; WALTER P, 1979, P NATL ACAD SCI USA, V76, P1795, DOI 10.1073/pnas.76.4.1795; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889; ZWIZINSKI C, 1981, J BIOL CHEM, V256, P3593	48	17	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28131	28140		10.1074/jbc.M115.692350	http://dx.doi.org/10.1074/jbc.M115.692350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446786	Green Published, hybrid			2022-12-26	WOS:000365761900009
J	Putman, SB; Brown, JL; Franklin, AD; Schneider, EC; Boisseau, NP; Asa, CS; Pukazhenthi, BS				Putman, Sarah B.; Brown, Janine L.; Franklin, Ashley D.; Schneider, Emily C.; Boisseau, Nicole P.; Asa, Cheryl S.; Pukazhenthi, Budhan S.			Characterization of Ovarian Steroid Patterns in Female African Lions (Panthera leo), and the Effects of Contraception on Reproductive Function	PLOS ONE			English	Article							GNRH ANALOG DESLORELIN; MELENGESTROL ACETATE; SEXUAL-BEHAVIOR; ESTROUS-CYCLE; ESTRUS; FELIDS; WILD; CAT; PROGESTERONE; SUPPRESSION	Because of poor reproduction after the lifting of an 8-year breeding moratorium, a biomedical survey of female lions in U.S. zoos was initiated in 2007. Fecal estrogen (FEM), progestagen (FPM) and glucocorticoid (FGM) metabolites were analyzed in samples collected 3-4 times per wk from 28 lions at 17 facilities (0.9-13.8 yr of age) for 4 mo-3.5 yr and body weights were obtained similar to monthly from 17 animals at eight facilities (0.0-3.0 yr of age). Based on FEM, estrous cycle length averaged 17.5 +/- 0.4 d in duration, with estrus lasting 4.4 +/- 0.2 d. All but one female exhibited waves of estrogenic activity indicative of follicular activity; however, not all females expressed estrous behaviors (73%), suggesting silent estrus was common. Female lions experienced puberty earlier than expected; waves of estrogenic activity were observed as young as 1.1 yr of age, which may be related to a faster growth rate of captive vs. wild lions. Mean gestation length was 109.5 +/- 1.0 d, whereas the non-pregnant luteal phase was less than half (46.0 +/- 1.2 d). Non-mating induced increases in FPM were observed in 33% of females housed without a male, consistent with spontaneous ovulation. A number of study animals had been contracepted, and the return to cyclicity after treatment withdrawal, while variable, was similar to 4.0 yr and longer than the 1-yr expected efficacy, especially for those implanted with Suprelorin. For FGM, there were no differences in overall, baseline or peak mean concentrations among the age groups or across seasons, nor were there any relationships between reproductive parameters and FGM concentrations. Overall, results suggest that poor reproduction in lions after the breeding moratorium was not related to altered adrenal or ovarian steroid activity, but for some females may have been a consequence of individual institutions' management decisions.	[Putman, Sarah B.; Brown, Janine L.; Franklin, Ashley D.; Schneider, Emily C.; Boisseau, Nicole P.; Pukazhenthi, Budhan S.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Putman, Sarah B.] George Mason Univ, Fairfax, VA 22030 USA; [Franklin, Ashley D.] Point Defiance Zoo & Aquarium, Tacoma, WA USA; [Schneider, Emily C.] Shady Grove Fertil, Rockville, MD USA; [Asa, Cheryl S.] AZA Wildlife Contracept Ctr, St Louis, MO USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University	Pukazhenthi, BS (corresponding author), Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.	pukazhenthib@si.edu	Franklin, Ashley D/J-3069-2015	Franklin, Ashley D/0000-0002-0818-5156; Pukazhenthi, Budhan/0000-0003-4657-2023	ASLAN Fund National Zoo; Ritz Carlton	ASLAN Fund National Zoo; Ritz Carlton	This work was supported by ASLAN Fund National Zoo and Ritz Carlton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann CL, 2012, THERIOGENOLOGY, V78, P817, DOI 10.1016/j.theriogenology.2012.03.030; ANDERSON LH, 1994, J ANIM SCI, V72, P2955, DOI 10.2527/1994.72112955x; Asa C, 2012, REPROD DOMEST ANIM, V47, P377, DOI 10.1111/rda.12004; Asa C.S., 2005, WILDLIFE CONTRACEPTI; Asa Cheryl S., 2005, P29; Asa Cheryl S., 2005, P83; Awasthi MK, 2007, ANIM REPROD SCI, V99, P258, DOI 10.1016/j.anireprosci.2006.05.014; Axner E, 2008, THERIOGENOLOGY, V70, P186, DOI 10.1016/j.theriogenology.2008.03.003; AZA Lion Species Survival Plan, 2012, AZA LION SPEC SURV P; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bauer H, 2003, CR BIOL, V326, pS112, DOI 10.1016/S1631-0691(03)00047-7; Beijerink NJ, 2007, DOMEST ANIM ENDOCRIN, V32, P63, DOI 10.1016/j.domaniend.2005.12.008; BERTRAM BCR, 1975, J ZOOL, V177, P463; Bertschinger HJ, 2008, WILDLIFE RES, V35, P525, DOI 10.1071/WR07141; BONNEY RC, 1981, J REPROD FERTIL, V63, P523; BOULANOUAR B, 1995, ANIM REPROD SCI, V40, P229, DOI 10.1016/0378-4320(95)01420-5; Briggs MB, 1990, ENDOCRINE PROFILES E; Brown JL, 2011, ANIM REPROD SCI, V124, P155, DOI 10.1016/j.anireprosci.2010.08.024; Brown JL, 1996, J REPROD FERTIL, V106, P337, DOI 10.1530/jrf.0.1060337; BROWN JL, 1995, BIOL REPROD, V53, P93, DOI 10.1095/biolreprod53.1.93; BROWN JL, 1993, J REPROD FERTIL, V97, P107; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Cetin Y, 2013, REPROD DOMEST ANIM, V48, P195, DOI 10.1111/j.1439-0531.2012.02128.x; Chardonnet P., 2002, CONSERVATION AFRICAN; CHASTAIN CB, 1981, AM J VET RES, V42, P2029; Connell EB, 1998, ENCY REPROD, V3, P574; Cooper J., 1942, COMPAR PSYCHO MONOG, V17, P1; Crosier AE, 2011, BIOL REPROD, V85, P243, DOI 10.1095/biolreprod.110.089417; Daigle C. L., 2015, International Zoo Yearbook, V49, P198, DOI 10.1111/izy.12073; DICZFALUSY E, 1968, AM J OBSTET GYNECOL, V100, P136, DOI 10.1016/S0002-9378(15)33651-6; Eaton R. L., 1971, INT ZOO YB, V11, P198; Fazio J., 2010, BEHAV ASSESSMENT CLO; GERALL AA, 1973, PHYSIOL BEHAV, V10, P225, DOI 10.1016/0031-9384(73)90302-8; Goericke-Pesch S, 2013, THERIOGENOLOGY, V79, P640, DOI 10.1016/j.theriogenology.2012.11.018; Graham LH, 2006, GEN COMP ENDOCR, V147, P362, DOI 10.1016/j.ygcen.2006.02.008; GRAHAM LH, 1995, ZOO BIOL, V14, P223, DOI 10.1002/zoo.1430140304; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Herne B., 1999, LLC; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Kinoshita K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019314; Klein TA, 1998, ENCY REPROD, V4, P127; Lagendijk DDG, 2008, ENVIRON MANAGE, V42, P971, DOI 10.1007/s00267-008-9204-5; Lehmann MB, 2008, AFR ZOOL, V43, P230, DOI 10.3377/1562-7020-43.2.230; Levasseur M., 1980, REPROD LIFE CYCLES, P130; Macdonald KA, 2005, J DAIRY SCI, V88, P3363, DOI 10.3168/jds.S0022-0302(05)73020-4; Magni P, 2003, ENCY HORMONES, V2, P572; Mann M, 1997, ARCH INTERN MED, V157, P1651, DOI 10.1001/archinte.157.15.1651; MARKERKRAUS L, 1993, ZOO BIOL, V12, P5, DOI 10.1002/zoo.1430120104; MCCLINTOCK MK, 1971, NATURE, V229, P244, DOI 10.1038/229244a0; MELLEN JD, 1991, ZOO BIOL, V10, P95, DOI 10.1002/zoo.1430100202; Monfort SL, 2003, REPROD SCI INTEGRATE; Moreira N, 2001, ZOO BIOL, V20, P103, DOI 10.1002/zoo.1010; Mostl E, 1993, J Reprod Fertil Suppl, V47, P540; MUELLER CC, 1979, BIOL REPROD, V21, P1099, DOI 10.1095/biolreprod21.5.1099; Munson L, 2002, VET PATHOL, V39, P419, DOI 10.1354/vp.39-4-419; Munson L, 2001, J REP FER S, P269; Munson L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002545; Naing KK, 1999, CANCER, V86, P1044, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1044::AID-CNCR21>3.0.CO;2-C; Norris DO., 2007, VERTEBRATE ENDOCRINO, V4; ORFORD HJL, 1988, J ZOOL, V216, P717, DOI 10.1111/j.1469-7998.1988.tb02467.x; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; PACKER C, 1983, ANIM BEHAV, V31, P334, DOI 10.1016/S0003-3472(83)80051-7; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Panthera Inc., 2013, LIONS PANTHERA LEADE; Pavlik EJ, 2000, GYNECOL ONCOL, V77, P410, DOI 10.1006/gyno.2000.5783; Pfaff SE, 2014, N AM REGIONAL AFRICA; Pope CE, 2006, THERIOGENOLOGY, V66, P59, DOI 10.1016/j.theriogenology.2006.03.014; Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076; Ricklefs RE, 2007, ECOL LETT, V10, P867, DOI 10.1111/j.1461-0248.2007.01085.x; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Roelofs JB, 2005, THERIOGENOLOGY, V64, P1690, DOI 10.1016/j.theriogenology.2005.04.004; Rudnai J, 1973, E AFR WILDL J, V11, P214; SADLEIR RMF, 1966, J REPROD FERTIL, V12, P411; Saltzman W, 2006, GEN COMP ENDOCR, V149, P90, DOI 10.1016/j.ygcen.2006.05.007; Sankhala K. S., 1967, International Zoo Yearbook, V7, P133, DOI 10.1111/j.1748-1090.1967.tb00354.x; Santymire RM, 2011, ANIM REPROD SCI, V128, P60, DOI 10.1016/j.anireprosci.2011.09.001; Scarlata CD, 2011, GEN COMP ENDOCR, V171, P373, DOI 10.1016/j.ygcen.2011.03.002; Schaller G. B., 1972, SERENGETI LION; SCHMIDT AM, 1979, J REPROD FERTIL, V57, P267, DOI 10.1530/jrf.0.0570267; SCHMIDT PM, 1983, BIOL REPROD, V28, P657, DOI 10.1095/biolreprod28.3.657; Schook MW, 2013, BIOL REPROD, DOI [10.1095/biolreprod.113.110122, DOI 10.1095/BI0LREPR0D.113.110122]; SCHRAMM RD, 1994, ZOO BIOL, V13, P301, DOI 10.1002/zoo.1430130403; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; SEAL US, 1976, J ZOO ANIM MED, V7, P12, DOI 10.2307/20094382; SELMAN PJ, 1994, EUR J ENDOCRINOL, V131, P422, DOI 10.1530/eje.0.1310422; Shoemaker Alan H., 1997, International Zoo Yearbook, V35, P120, DOI 10.1111/j.1748-1090.1997.tb01200.x; Smuts G. L., 1982, LION; SMUTS GL, 1978, CARNIVORE, V1, P17; SMUTS GL, 1980, J ZOOL, V190, P365; Stabenfeldt G. H., 1991, Feline husbandry: diseases and management in the multiple-cat environment., P129; Staley AM, 2007, J COMP PHYSIOL B, V177, P609, DOI 10.1007/s00360-007-0159-2; Steinman KJ, 2012, GEN COMP ENDOCR, V175, P389, DOI 10.1016/j.ygcen.2011.11.008; Stewart RA, 2010, GEN COMP ENDOCR, V166, P409, DOI 10.1016/j.ygcen.2009.12.016; Steyn TJ, 1951, FAUNA FLORA, V2, P37; Toydemir TSF, 2012, THERIOGENOLOGY, V77, P662, DOI 10.1016/j.theriogenology.2011.07.046; Tummers B., 2006, DATA THIEF; van Dorsser FJD, 2007, REPROD FERT DEVELOP, V19, P822, DOI 10.1071/RD07053; VERHAGE HG, 1976, BIOL REPROD, V14, P579, DOI 10.1095/biolreprod14.5.579; Wielebnowski N, 1998, ZOO BIOL, V17, P193, DOI 10.1002/(SICI)1098-2361(1998)17:3<193::AID-ZOO4>3.0.CO;2-4; Wildt D., 2010, BIOL CONSERVATION WI, P217; Wildt David E., 1997, International Zoo Yearbook, V35, P164, DOI 10.1111/j.1748-1090.1997.tb01207.x; WILDT DE, 1981, BIOL REPROD, V24, P217, DOI 10.1095/biolreprod24.1.217; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; ZIMBELMAN RG, 1966, J REPROD FERTIL, V11, P193, DOI 10.1530/jrf.0.0110193	106	20	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140373	10.1371/journal.pone.0140373	http://dx.doi.org/10.1371/journal.pone.0140373			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460849	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300085
J	Wu, YJ; Shi, ZY; Wang, MJ; Zhu, YB; Li, C; Li, GD; Marcantonio, ER; Xie, ZC; Shen, Y				Wu, Yujie; Shi, Zhongyong; Wang, Meijuan; Zhu, Yingbo; Li, Cheng; Li, Guodong; Marcantonio, Edward R.; Xie, Zhongcong; Shen, Yuan			Different MMSE Score Is Associated with Postoperative Delirium in Young-Old and Old-Old Adults	PLOS ONE			English	Article							CARDIAC-SURGERY; RISK-FACTORS; ELDERLY-PATIENTS; ASSESSMENT SCALE; PREDICTION RULE; CHINESE VERSION; HIP-SURGERY; DEMENTIA; VALIDATION; SHANGHAI	Background Postoperative delirium is one of the most common postoperative complications in geriatric patients. Mini-mental state examination (MMSE) assesses cognitive function in patients and is associated with postoperative delirium. However, whether there is an age-dependent relationship between preoperative MMSE score and postoperative delirium remains unknown. Methods We therefore set out to investigate the association between preoperative MMSE score and postoperative delirium in young-old (<= 80 year-old, 75.46 +/- 4.69 years, 27.0% male, n = 63) and old-old (>80 year-old, 84.51 +/- 3.46 years, 20.9% male, n = 67) participants, who had repairs of hip fractures under general anesthesia. The Confusion Assessment Method and Memorial Delirium Assessment Scale were administrated before surgery, and on the first, second and fourth days after surgery, to assess the incidence and severity of the delirium, respectively. A receiver operating characteristic curve analysis was used to calculate the optimal cutoff score of MMSE in predicting postoperative delirium. Results Thirty-four (26.2%) of 130 patients (80.12 +/- 6.12 years, 23.8% male) developed postoperative delirium. Preoperative MMSE scores were negatively associated with higher incidences and greater severity of postoperative delirium. The optimal cutoff scores of MMSE associated with postoperative delirium for young-old and old-old participants were 18.4 and 21.4, with a sensitivity of 60% and 83.8%, and a specificity of 92.5% and 62.8%, respectively. Conclusion The data demonstrated the optimal cutoff score of MMSE associated with postoperative delirium in young-old adults might be lower than that in old-old adults. Pending further investigation, these findings suggest that the association between preoperative MMSE score and postoperative delirium is age-dependent.	[Wu, Yujie; Shi, Zhongyong; Wang, Meijuan; Zhu, Yingbo; Shen, Yuan] Tongji Univ, Peoples Hosp 10, Dept Psychiat, Shanghai 200072, Peoples R China; [Li, Cheng] Tongji Univ, Peoples Hosp 10, Dept Anesthesiol, Shanghai 200072, Peoples R China; [Li, Guodong] Tongji Univ, Peoples Hosp 10, Dept Orthoped Surg, Shanghai 200072, Peoples R China; [Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med, Boston, MA 02215 USA; [Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Primary Care & Gerontol, Boston, MA 02215 USA; [Marcantonio, Edward R.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Xie, Zhongcong] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Charlestown, MA 02129 USA; [Xie, Zhongcong] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Tongji University; Tongji University; Tongji University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University	Xie, ZC (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Charlestown, MA 02129 USA.	zxie@mgh.harvard.edu; kmshy@sina.com	Marcantonio, Edward R/U-3929-2017	Marcantonio, Edward R/0000-0002-2911-4250	National Natural Science Foundation of China [81200833, 81571034]; Shanghai Natural Science Foundation [12ZR1428600]; National Institutes of Health, Bethesda, Maryland [R21AG038994]; Alzheimer's Association, Chicago, Illinois; Mid-Career Investigator Award from the National Institute on Aging [K24AG035075]; NATIONAL INSTITUTE ON AGING [K24AG035075] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association, Chicago, Illinois(Alzheimer's Association); Mid-Career Investigator Award from the National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by research grants 81200833 and 81571034 from the National Natural Science Foundation of China and 12ZR1428600 from the Shanghai Natural Science Foundation to Dr. Yuan Shen; and also supported by R21AG038994 from National Institutes of Health, Bethesda, Maryland and Investigator-initiated Research grant from Alzheimer's Association, Chicago, Illinois to Zhongcong Xie; Dr. Marcantonio was funded in part by a Mid-Career Investigator Award (K24AG035075) from the National Institute on Aging.	American Psychiatric Association, 1997, DIAGN STAT MAN MENT; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Bantis LE, 2005, BIOMETRICAL J, V47, P458; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; de Castro SMM, 2014, AM J SURG, V208, P26, DOI 10.1016/j.amjsurg.2013.12.029; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Gao M, 2012, J DIS MONITOR CONTRO, V6, P506; Guenther U, 2013, ANN SURG, V257, P1160, DOI 10.1097/SLA.0b013e318281b01c; Hempenius L, 2015, EJSO-EUR J SURG ONC, V41, P28, DOI 10.1016/j.ejso.2014.04.006; Hosmer DW L, 2000, APPL LOGISTIC REGRES, P91; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jankowski CJ, 2011, ANESTH ANALG, V112, P1186, DOI 10.1213/ANE.0b013e318211501b; Kalisvaart KJ, 2006, J AM GERIATR SOC, V54, P817, DOI 10.1111/j.1532-5415.2006.00704.x; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kazmierski J, 2010, J PSYCHOSOM RES, V69, P179, DOI 10.1016/j.jpsychores.2010.02.009; Liu LL, 2000, J AM GERIATR SOC, V48, P405, DOI 10.1111/j.1532-5415.2000.tb04698.x; Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Robinson TN, 2011, ARCH SURG-CHICAGO, V146, P295, DOI 10.1001/archsurg.2011.14; Rudolph JL, 2009, CIRCULATION, V119, P229, DOI 10.1161/CIRCULATIONAHA.108.795260; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Shi ZY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00297; Stoltzfus JC, 2011, ACAD EMERG MED, V18, P1099, DOI 10.1111/j.1553-2712.2011.01185.x; Vasilevskis EE, 2012, BEST PRACT RES-CLIN, V26, P277, DOI 10.1016/j.bpa.2012.07.003; Veliz-Reissmuller G, 2007, AGING CLIN EXP RES, V19, P172, DOI 10.1007/BF03324686; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2014, ANN CLIN TRANSL NEUR, V1, P319, DOI 10.1002/acn3.58; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412; Zhang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027019	31	22	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139879	10.1371/journal.pone.0139879	http://dx.doi.org/10.1371/journal.pone.0139879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460750	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300029
J	Zhao, Y; Li, L; Zhang, PF; Shen, W; Liu, J; Yang, FF; Liu, HB; Hao, ZH				Zhao, Yong; Li, Lan; Zhang, Peng-Fei; Shen, Wei; Liu, Jing; Yang, Fen-Fang; Liu, Hong-Bo; Hao, Zhi-Hui			Differential Regulation of Gene and Protein Expression by Zinc Oxide Nanoparticles in Hen's Ovarian Granulosa Cells: Specific Roles of Nanoparticles	PLOS ONE			English	Article							RNA-SEQ; CHICKEN; ZNO; GROWTH	Annually, tons and tons of zinc oxide nanoparticles (ZnO NPs) are produced in the world. And they are applied in almost all aspects of our life. Their release from the products into environment may pose issue for human health. Although many studies have reported the adverse effects of ZnO NPs on organisms, little is known about the effects on female reproductive systems or the related mechanisms. Quantitative proteomics have not been applied although quantitative transcriptomics have been used in zinc oxide nanoparticles (ZnO NPs) research. Genes are very important players however proteins are the real actors in the biological systems. By using hen's ovarian granulosa cells, it was found that ZnO-NP-5 mu g/ml and ZnSO4-10 mu g/ml treatments produced the same amount of intracellular Zn and resulted in similar cell growth inhibition. And NPs were found in the treated cells. However, ZnO-NP-5 mu g/ml specifically regulated the expression of genes and proteins compared with that in ZnSO4-10 mu g/ml treatment. For the first time, this investigation reports that intact NPs produce different impacts on the expression of genes and proteins involved in specific pathways compared to that by Zn2+. The findings enrich our knowledge for the molecular insights of zinc oxide nanoparticles effects on the female reproductive systems. This also may raise the health concern that ZnO NPs may adversely affect the female reproductive systems through regulation of specific signaling pathways.	[Zhao, Yong; Zhang, Peng-Fei; Yang, Fen-Fang; Liu, Hong-Bo; Hao, Zhi-Hui] Qingdao Agr Univ, Coll Chem & Pharmaceut Sci, Qingdao 266109, Peoples R China; [Zhao, Yong; Li, Lan; Zhang, Peng-Fei; Shen, Wei] Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao 266109, Peoples R China; [Liu, Jing] Qingdao Agr Univ, Core Labs, Qingdao 266109, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University	Hao, ZH (corresponding author), Qingdao Agr Univ, Coll Chem & Pharmaceut Sci, Qingdao 266109, Peoples R China.	zHao6276@hotmail.com	Hao, Zhihui/Y-2167-2019		National Natural Science Foundation of China [31402256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31402256).	Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; BAHR J, 1990, J EXP ZOOL, P192, DOI 10.1002/jez.1402560441; Baumhoer D, 2011, ONCOTARGET, V2, P970; Brun NR, 2014, SCI TOTAL ENVIRON, V476, P657, DOI 10.1016/j.scitotenv.2014.01.053; Chang DF, 2007, P NATL ACAD SCI USA, V104, P157, DOI 10.1073/pnas.0605635103; Chen TH, 2014, J HAZARD MATER, V277, P134, DOI 10.1016/j.jhazmat.2013.12.030; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Gan C, J PROTEOME RES, V6, P821; He LL, 2011, MICROBIOL RES, V166, P207, DOI 10.1016/j.micres.2010.03.003; Hermann M, 1998, FASEB J, V12, P897, DOI 10.1096/fasebj.12.10.897; Hickford DE, 2011, BIOL REPROD, V85, P733, DOI 10.1095/biolreprod.111.091629; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HUANG ESR, 1979, BIOL REPROD, V20, P454, DOI 10.1095/biolreprod20.3.454; Jo E, 2013, J TOXICOL SCI, V38, P525, DOI 10.2131/jts.38.525; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kim AR, 2013, J BIOMED NANOTECHNOL, V9, P926, DOI 10.1166/jbn.2013.1495; Kitowska A, 2010, ACTA BIOCHIM POL, V57, P15; Kocbek P, 2010, SMALL, V6, P1908, DOI 10.1002/smll.201000032; Li CH, 2012, NANOTOXICOLOGY, V6, P746, DOI 10.3109/17435390.2011.620717; Lopes S, 2014, ENVIRON TOXICOL CHEM, V33, P190, DOI 10.1002/etc.2413; Ma HB, 2013, ENVIRON POLLUT, V172, P76, DOI 10.1016/j.envpol.2012.08.011; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Osmond-McLeod MJ, 2014, NANOTOXICOLOGY, V8, P72, DOI 10.3109/17435390.2013.855832; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Petushkova NA, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0072-7; Poynton HC, 2011, ENVIRON SCI TECHNOL, V45, P762, DOI 10.1021/es102501z; Reeves Mark E, 2012, BMC Res Notes, V5, P239, DOI 10.1186/1756-0500-5-239; Roduner E, 2006, CHEM SOC REV, V35, P583, DOI 10.1039/b502142c; Schmierer B, 2003, BIOL REPROD, V68, P620, DOI 10.1095/biolreprod.102.008714; Schneider WJ, 1998, BIOL CHEM, V379, P965; Talebi AR, 2013, J ASSIST REPROD GEN, V30, P1203, DOI 10.1007/s10815-013-0078-y; Tuomela S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068415; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yamashita K, 2011, NAT NANOTECHNOL, V6, P321, DOI [10.1038/nnano.2011.41, 10.1038/NNANO.2011.41]; Zhao CY, 2014, BIOL TRACE ELEM RES, V160, P361, DOI 10.1007/s12011-014-0052-2; Zhao Y, 2009, FREE RADICAL BIO MED, V47, P176, DOI 10.1016/j.freeradbiomed.2009.04.022	37	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140499	10.1371/journal.pone.0140499	http://dx.doi.org/10.1371/journal.pone.0140499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460738	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300106
J	Aust, S; Knogler, T; Pils, D; Obermayr, E; Reinthaller, A; Zahn, L; Radlgruber, I; Mayerhoefer, ME; Grimm, C; Polterauer, S				Aust, Stefanie; Knogler, Thomas; Pils, Dietmar; Obermayr, Eva; Reinthaller, Alexander; Zahn, Lisa; Radlgruber, Ilja; Mayerhoefer, Marius Erik; Grimm, Christoph; Polterauer, Stephan			Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer	PLOS ONE			English	Article							SERUM-ALBUMIN; SARCOPENIA; PLASMA; PATHOPHYSIOLOGY; INTERLEUKIN-10; PATHOGENESIS; INFLAMMATION; CYTOKINES; OBESITY; BETA	Objective Tumor cachexia is an important prognostic parameter in epithelial ovarian cancer (EOC). Tumor cachexia is characterized by metabolic and inflammatory disturbances. These conditions might be reflected by body composition measurements (BCMs) ascertained by pre-operative computed tomography (CT). Thus, we aimed to identify the prognostically most relevant BCMs assessed by pre-operative CT in EOC patients. Methods We evaluated muscle BCMs and well established markers of nutritional and inflammatory status, as well as clinical-pathological parameters in 140 consecutive patients with EOC. Furthermore, a multiplexed inflammatory marker panel of 25 cytokines was used to determine the relationship of BCMs with inflammatory markers and patient's outcome. All relevant parameters were evaluated in uni- and multivariate survival analysis. Results Muscle attenuation (MA)-a well established BCM parameter-is an independent prognostic factor for survival in multivariate analysis (HR 2.25; p = 0.028). Low MA-reflecting a state of cachexia-is also associated with residual tumor after cytoreductive surgery (p = 0.046) and with an unfavorable performance status (p = 0.015). Moreover, MA is associated with Eotaxin and IL-10 out of the 25 cytokine multiplex marker panel in multivariate linear regression analysis (p = 0.021 and p = 0.047, respectively). Conclusion MA-ascertained by routine pre-operative CT-is an independent prognostic parameter in EOC patients. Low MA is associated with the inflammatory, as well as the nutritional component of cachexia. Therefore, the clinical value of pre-operative CT could be enhanced by the assessment of MA.	[Aust, Stefanie; Pils, Dietmar; Obermayr, Eva; Reinthaller, Alexander; Zahn, Lisa; Grimm, Christoph; Polterauer, Stephan] Med Univ Vienna, Ctr Comprehens Canc, Gynecol Canc Unit, Dept Gynaecol & Gynaecol Oncol, A-1090 Vienna, Austria; [Knogler, Thomas; Radlgruber, Ilja; Mayerhoefer, Marius Erik] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Polterauer, S (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Gynecol Canc Unit, Dept Gynaecol & Gynaecol Oncol, A-1090 Vienna, Austria.	stephan.polterauer@meduniwien.ac.at	Polterauer, Stephan/AAG-1331-2021; Grimm, Christoph/GSJ-3020-2022; Mayerhoefer, Marius/AAD-2156-2021; Obermayr, Eva/E-7720-2011	Polterauer, Stephan/0000-0002-9649-4505; Grimm, Christoph/0000-0003-2948-8129; Mayerhoefer, Marius/0000-0001-8786-8686; Obermayr, Eva/0000-0001-6324-2961; Aust, stefanie/0000-0002-6760-949X; Pils, Dietmar/0000-0002-8355-0977	"Margaretha-Hehberger-Stiftung", embedded in the "Medizinisch-Wissenschaftlicher Fonds des Burgermeisters", Vienna, Austria	"Margaretha-Hehberger-Stiftung", embedded in the "Medizinisch-Wissenschaftlicher Fonds des Burgermeisters", Vienna, Austria	This work was supported by the "Margaretha-Hehberger-Stiftung", embedded in the "Medizinisch-Wissenschaftlicher Fonds des Burgermeisters", Vienna, Austria. http://www.wien.gv.at/gesundheit/einrichtungen/med-wiss-fonds/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuner-Ozbabacan ES, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S2; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Argiles JM, 2003, INT J BIOCHEM CELL B, V35, P405, DOI 10.1016/S1357-2725(02)00251-0; Argiles JM, 2005, NUTRITION, V21, P977, DOI 10.1016/j.nut.2005.02.003; Argiles JM, 2003, CURR OPIN CLIN NUTR, V6, P401, DOI 10.1097/01.mco.0000078983.18774.cc; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Asher V, 2012, MED ONCOL, V29, P2005, DOI 10.1007/s12032-011-0019-5; Aubrey J, 2014, ACTA PHYSIOL, V210, P489, DOI 10.1111/apha.12224; Aust S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-115; Bachmann J, 2008, J GASTROINTEST SURG, V12, P1193, DOI 10.1007/s11605-008-0505-z; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Block MS, 2015, CYTOKINE, V73, P108, DOI 10.1016/j.cyto.2015.01.035; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Faber J, 2009, ONCOL REP, V22, P1403, DOI 10.3892/or_00000581; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Goodpaster BH, 2000, ANN NY ACAD SCI, V904, P18; Harrell FE, 2001, REGRESSION MODELING; Koc U, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/274515; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Levina V, 2009, CLIN CANCER RES, V15, P2647, DOI 10.1158/1078-0432.CCR-08-2024; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; MCNAMARA MJ, 1992, JPEN-PARENTER ENTER, V16, pS50, DOI 10.1177/014860719201600603; Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299; Neven B, 2013, BLOOD, V122, P3713, DOI 10.1182/blood-2013-06-508267; Nick AM, 2015, NAT REV CLIN ONCOL, V12, P239, DOI 10.1038/nrclinonc.2015.26; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Rankin SM, 2000, MOL MED TODAY, V6, P20, DOI 10.1016/S1357-4310(99)01635-4; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Santin AD, 2001, BRIT J OBSTET GYNAEC, V108, P804, DOI 10.1111/j.1471-0528.2001.00206.x; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Stehle G, 1997, CRIT REV ONCOL HEMAT, V26, P77, DOI 10.1016/S1040-8428(97)00015-2; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Suzuki H, 2013, J GASTROENTEROL, V48, P574, DOI 10.1007/s00535-013-0787-0; Tempfer C, 1997, GYNECOL ONCOL, V66, P27, DOI 10.1006/gyno.1997.4726; Tsai-Turton M, 2009, GYNECOL ONCOL, V114, P12, DOI 10.1016/j.ygyno.2009.03.028; WEISSMAN AD, 1990, J CHEM NEUROANAT, V3, P347	39	80	80	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140403	10.1371/journal.pone.0140403	http://dx.doi.org/10.1371/journal.pone.0140403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457674	Green Published, Green Submitted, gold			2022-12-26	WOS:000362961100033
J	An, N; Fan, MS; Zhang, FS; Christie, P; Yang, JC; Huang, JL; Guo, SW; Shi, XJ; Tang, QY; Peng, JW; Zhong, XH; Sun, YX; Lv, SH; Jiang, RF; Dobermann, A				An, Ning; Fan, Mingsheng; Zhang, Fusuo; Christie, Peter; Yang, Jianchang; Huang, Jianliang; Guo, Shiwei; Shi, Xiaojun; Tang, Qiyuan; Peng, Jianwei; Zhong, Xuhua; Sun, Yixiang; Lv, Shihua; Jiang, Rongfeng; Dobermann, Achim			Exploiting Co-Benefits of Increased Rice Production and Reduced Greenhouse Gas Emission through Optimized Crop and Soil Management	PLOS ONE			English	Article							NITROGEN-FERTILIZER APPLICATION; IRRIGATED RICE; NUTRIENT MANAGEMENT; USE EFFICIENCY; ENVIRONMENTAL-QUALITY; METHANE EMISSION; FOOD SECURITY; PADDY FIELDS; YIELD GAPS; GRAIN	Meeting the future food security challenge without further sacrificing environmental integrity requires transformative changes in managing the key biophysical determinants of increasing agronomic productivity and reducing the environmental footprint. Here, we focus on Chinese rice production and quantitatively address this concern by conducting 403 on-farm trials across diverse rice farming systems. Inherent soil productivity, management practices and rice farming type resulted in confounded and interactive effects on yield, yield gaps and greenhouse gas (GHG) emissions (N2O, CH4 and CO2-equivalent) with both trade-offs and compensating effects. Advances in nitrogen, water and crop management (Best Management Practices-BMPs) helped closing existing yield gaps and resulted in a substantial reduction in CO2-equivalent emission of rice farming despite a tradeoff of increase N2O emission. However, inherent soil properties limited rice yields to a larger extent than previously known. Cultivating inherently better soil also led to lower GHG intensity (GHG emissions per unit yield). Neither adopting BMPs only nor improving soils with low or moderate productivity alone can adequately address the challenge of substantially increasing rice production while reducing the environmental footprint. A combination of both represents the most efficient strategy to harness the combined-benefits of enhanced production and mitigating climate change. Extrapolating from our farm data, this strategy could increase rice production in China by 18%, which would meet the demand for direct human consumption of rice by 2030. It would also reduce fertilizer nitrogen consumption by 22% and decrease CO2-equivalent emissions during the rice growing period by 7% compared with current farming practice continues. Benefits vary by rice-based cropping systems. Single rice systems have the largest food provision benefits due to its wider yield gap and total cultivated area, whereas double-rice system (especially late rice) contributes primarily to reducing GHG emissions. The study therefore provides farm-based evidence for feasible, practical approaches towards achieving realistic food security and environmental quality targets at a national scale.	[An, Ning; Fan, Mingsheng; Zhang, Fusuo; Christie, Peter; Jiang, Rongfeng] China Agr Univ, Ctr Resources Environm & Food Secur, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Yang, Jianchang] Yangzhou Univ, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou 225009, Jiangsu, Peoples R China; [Huang, Jianliang] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Guo, Shiwei] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Shi, Xiaojun] Southwest Univ, Resource & Environm Coll, Chongqing, Peoples R China; [Tang, Qiyuan; Peng, Jianwei] Hunan Agr Univ, Crop Physiol Ecol & Prod Ctr, Changsha, Hunan, Peoples R China; [Zhong, Xuhua] Guangdong Acad Agr Sci, Rice Res Inst, Guangzhou, Guangdong, Peoples R China; [Sun, Yixiang] Anhui Acad Agr Sci, Soil & Fertilizer Res Inst, Hefei, Peoples R China; [Lv, Shihua] Sichuan Acad Agr Sci, Inst Soils & Fertilizers, Chengdu, Peoples R China; [Dobermann, Achim] Rothamsted Res, Harpenden, Herts, England	China Agricultural University; Yangzhou University; Huazhong Agricultural University; Nanjing Agricultural University; Southwest University - China; Hunan Agricultural University; Guangdong Academy of Agricultural Sciences; Anhui Academy of Agricultural Sciences; Sichuan Academy of Agricultural Sciences (SAAS); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Fan, MS (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	fanms@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021; Christie, Peter/B-7919-2008	Christie, Peter/0000-0002-1939-7277; Dobermann, Achim/0000-0001-5728-5594	National Basic Research Program of China (973, Program) [2015CB150403]; Special Fund for the Agriculture Profession [201103003]; Innovative Group Grant of the National Science Foundation of China [31121062]; National Natural Science Foundation of China [41171195]	National Basic Research Program of China (973, Program)(National Basic Research Program of China); Special Fund for the Agriculture Profession; Innovative Group Grant of the National Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work has been funded by the National Basic Research Program of China (973, Program: 2015CB150403) (http://www.973.gov.cn/AreaAppl.aspx), the Special Fund for the Agriculture Profession (201103003) (http://www.hymof.net.cn/webapp/login.asp), the Innovative Group Grant of the National Science Foundation of China (31121062), and the National Natural Science Foundation of China (41171195). The funders had no role in study design, data collection and analysis, decision to publish.	An N, 2015, PLANT NUTR FERT SCI, V21, P846; [Anonymous], 2013, FAO STAT YB, P160; [Anonymous], 2012, IFA DAT; Bai ZG, 2008, GLOBAL ASSESSMENT LA; Bouman BAM, 2007, ADV AGRON, V92, P187, DOI 10.1016/S0065-2113(04)92004-4; Bouman BAM, 2007, AGR SYST, V93, P43, DOI 10.1016/j.agsy.2006.04.004; Buresh RJ, 2010, PLANT SOIL, V335, P35, DOI 10.1007/s11104-010-0441-z; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Cai ZC, 1997, PLANT SOIL, V196, P7, DOI 10.1023/A:1004263405020; Cassman KG, 1998, FIELD CROP RES, V56, P7, DOI 10.1016/S0378-4290(97)00140-8; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Chen HZ, 2004, CHINA RICE, V4, P9; Chen Jie, 2002, Journal of Geographical Sciences, V12, P243; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Dobermann A, 2005, SCI CHINA SER C, V48, P745, DOI 10.1360/062005-268; Dobermann A, 2003, AGRON J, V95, P913, DOI 10.2134/agronj2003.0913; Dobermann A, 2002, FIELD CROP RES, V74, P37, DOI 10.1016/S0378-4290(01)00197-6; Dobermann A., 2013, SOLUTIONS SUSTAINABL; Dobermann A., 2000, RICE NUTR DISORDERS; Fan MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074617; Fan MS, 2012, J EXP BOT, V63, P13, DOI 10.1093/jxb/err248; Fan MS, 2009, AGRON J, V101, P1421, DOI 10.2134/agronj2009.0009; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gao LZ, 1984, SCI AGR SIN, V1, P17; George T, 2014, GLOB FOOD SECUR-AGR, V3, P49, DOI 10.1016/j.gfs.2013.10.002; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Heffer P., 2009, ASSESSMENT FERTILIZE; Hettel G., 2002, RICE ALMANAC, V3th; HOLZAPFELPSCHORN A, 1986, J GEOPHYS RES-ATMOS, V91, P1803, DOI 10.1029/JD091iD11p11803; Laborte AG, 2012, EUR J AGRON, V36, P9, DOI 10.1016/j.eja.2011.08.005; Li CS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002341; Lindert P. H., 2000, SHIFTING GROUND CHAN; Ma YC, 2013, AGR ECOSYST ENVIRON, V164, P209, DOI 10.1016/j.agee.2012.11.003; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; National Bureau of Statistics of China, 2011, CHIN STAT YB; Neue H. U., 1994, CLIMATE BIOSPHERE IN, P65; Pampolino MF, 2007, AGR SYST, V93, P1, DOI 10.1016/j.agsy.2006.04.002; Pandey S., 2010, RICE GLOBAL EC STRAT; Patzel N, 2000, J PLANT NUTR SOIL SC, V163, P129, DOI 10.1002/(SICI)1522-2624(200004)163:2<129::AID-JPLN129>3.0.CO;2-D; Peng SB, 2010, AGRON SUSTAIN DEV, V30, P649, DOI 10.1051/agro/2010002; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Peng SQ, 2006, CHINA AGR TECH EXTEN, V22, P280; Perez CM, 1996, CEREAL CHEM, V73, P556; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pittelkow CM, 2014, GLOBAL CHANGE BIOL, V20, P1382, DOI 10.1111/gcb.12413; Pittelkow CM, 2013, AGR ECOSYST ENVIRON, V177, P10, DOI 10.1016/j.agee.2013.05.011; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Tian J, 2013, PLANT SOIL, V372, P53, DOI 10.1007/s11104-013-1715-z; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; van Wart J, 2013, FIELD CROP RES, V143, P34, DOI 10.1016/j.fcr.2012.11.018; Wang GH, 2001, AGRON J, V93, P869, DOI 10.2134/agronj2001.934869x; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107; Wu LQ, 2013, CHINA AGR TECH EXTEN, V29, P35; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Zhang FS, 2012, ADV AGRON, V116, P1, DOI 10.1016/B978-0-12-394277-7.00001-4; Zhang H, 2008, AGRON J, V100, P726, DOI 10.2134/agronj2007.0169; Zhang H, 2010, J EXP BOT, V61, P3719, DOI 10.1093/jxb/erq198; Zou JW, 2009, GLOBAL CHANGE BIOL, V15, P229, DOI 10.1111/j.1365-2486.2008.01775.x; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	61	12	12	6	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140023	10.1371/journal.pone.0140023	http://dx.doi.org/10.1371/journal.pone.0140023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452155	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200027
J	Godwin, A; Sharma, A; Yang, WL; Wang, ZM; Nicastro, J; Coppa, GF; Wang, P				Godwin, Andrew; Sharma, Archna; Yang, Weng-Lang; Wang, Zhimin; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping			Receptor-Interacting Protein Kinase 3 Deficiency Delays Cutaneous Wound Healing	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR EXPRESSION; NECROSIS; RIP3; APOPTOSIS; REPAIR; CELL; NECROPTOSIS; INHIBITOR; DISEASE	Wound healing consists of a complex, dynamic and overlapping process involving inflammation, proliferation and tissue remodeling. A better understanding of wound healing process at the molecular level is needed for the development of novel therapeutic strategies. Receptor-interacting protein kinase 3 (RIPK3) controls programmed necrosis in response to TNF-alpha during inflammation and has been shown to be highly induced during cutaneous wound repair. However, its role in wound healing remains to be demonstrated. To study this, we created dorsal cutaneous wounds on male wild-type (WT) and RIPK3-deficient (Ripk3(-/-)) mice. Wound area was measured daily until day 14 post-wound and skin tissues were collected from wound sites at various days for analysis. The wound healing rate in Ripk3(-/-) mice was slower than the WT mice over the 14-day course; especially, at day 7, the wound size in Ripk3(-/-) mice was 53% larger than that of WT mice. H&E and Masson-Trichrome staining analysis showed impaired quality of wound closure in Ripk3(-/-) wounds with delayed re-epithelialization and angiogenesis and defected granulation tissue formation and collagen deposition compared to WT. The neutrophil infiltration pattern was altered in Ripk3(-/-) wounds with less neutrophils at day 1 and more neutrophils at day 3. This altered pattern was also reflected in the differential expression of IL-6, KC, IL-1 beta and TNF-alpha between WT and Ripk3(-/-) wounds. MMP-9 protein expression was decreased with increased Timp-1 mRNA in the Ripk3(-/-) wounds compared to WT. The microvascular density along with the intensity and timing of induction of proangiogenic growth factors VEGF and TGF-beta 1 were also decreased or delayed in the Ripk3(-/-) wounds. Furthermore, mouse embryonic fibroblasts (MEFs) from Ripk3(-/-) mice migrated less towards chemoattractants TGF-beta 1 and PDGF than MEFs from WT mice. These results clearly demonstrate that RIPK3 is an essential molecule to maintain the temporal manner of the normal progression of wound closure.	[Godwin, Andrew; Yang, Weng-Lang; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping] Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY 11030 USA; [Sharma, Archna; Yang, Weng-Lang; Wang, Zhimin; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA	Hofstra University; Northwell Health; Northwell Health	Wang, P (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY 11030 USA.	pwang@nshs.edu	Sharma, Archna/R-9377-2016	Sharma, Archna/0000-0003-4745-0220; Wang, Ping/0000-0002-1557-0394	US National Institute of Health [R01 HL07619]	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grants from the US National Institute of Health (R01 HL07619) to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2007, J INVEST DERMATOL, V127, P538, DOI 10.1038/sj.jid.5700588; Adams S, 2010, EXP CELL RES, V316, P126, DOI 10.1016/j.yexcr.2009.10.006; Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Chan FK, 2012, COLD SPRING HARB PER, V4; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Gottrup F, 2000, WOUND REPAIR REGEN, V8, P83, DOI 10.1046/j.1524-475x.2000.00083.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; Linkermann A, 2012, MOL MED, V18, P577, DOI 10.2119/molmed.2011.00423; Markova A, 2012, DERMATOL CLIN, V30, P107, DOI 10.1016/j.det.2011.08.005; Medina A, 2005, J BURN CARE REHABIL, V26, P306, DOI 10.1097/01.BCR.0000169887.04973.3A; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Nissen NN, 1998, AM J PATHOL, V152, P1445; Pazdernik NJ, 1999, MOL CELL BIOL, V19, P6500; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sharma A, 2014, CRIT CARE, V18, DOI 10.1186/cc13970; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wall SJ, 2002, J INVEST DERMATOL, V119, P91, DOI 10.1046/j.1523-1747.2002.01779.x; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WERNER S, 1994, J INVEST DERMATOL, V103, P469, DOI 10.1111/1523-1747.ep12395564; Xu FX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/754802; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang DW, 2010, CELL MOL IMMUNOL, V7, P243, DOI 10.1038/cmi.2010.10	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140514	10.1371/journal.pone.0140514	http://dx.doi.org/10.1371/journal.pone.0140514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451737	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200071
J	Ou, HT; Wu, MH; Lin, CY; Chen, PC				Ou, Huang-tz; Wu, Meng-Hsing; Lin, Chung-Ying; Chen, Pei-Chi			Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ)	PLOS ONE			English	Article							ASIAN WOMEN; EMOTIONAL DISTRESS; DIABETES-MELLITUS; PREVALENCE	Objectives To develop the Chinese version of the Polycystic Ovary Syndrome Health-related Quality of Life Questionnaire (Chi-PCOSQ). Research Design and Method This cross-sectional study was conducted in a medical center in Taiwan. Eighty women who met the criteria were enrolled: female, age range of 18-45 years, competent in the Chinese language, had been diagnosed with polycystic ovary syndrome (PCOS), and were regularly followed at outpatient clinics (defined as at least two outpatient visits before enrollment). The PCOSQ was translated and culturally adapted according to standard procedures. A semi-structured interview was applied to assess face validity. Exploratory factor analysis (EFA) was applied to determine scale constructs. Measurements of internal consistency via Cronbach's a, test-retest reliability via intraclass correlation coefficient (ICC), construct validity, and discriminative validity were performed. Results Five additional items, representing the issues of acne, hair loss, and fear of getting diabetes, were incorporated into the original scale. A six-factor structure emerged as a result of the EFA, explaining 71.9% of the variance observed. The reliability analyses demonstrated satisfactory results for Cronbach's a ranging from 0.78-0.96, and for ICC ranging from 0.73-0.86. Construct validity was confirmed by significant correlation between the domains of the Chi-PCOSQ and generic health-related quality of life (HRQoL) measures (WHOQOL-BREF, EQ-5D) and clinical parameters (body mass index, waist-hip ratio, blood pressure). The known-group analysis indicated that the Chi-PCOSQ is a discriminative tool that differentiates patients according to their HRQoL. Conclusion The Chi-PCOSQ seems internally consistent, culturally acceptable, and our preliminary evidence suggests that it may be reliable and valid. The Chi-PCOSQ is a promising assessment tool to address the HRQoL of women affected by PCOS in Chinese-speaking countries and to further identify ethnic/cultural differences in the HRQoL of women with PCOS.	[Ou, Huang-tz; Chen, Pei-Chi] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan 7010, Taiwan; [Wu, Meng-Hsing] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Obstet & Gynecol, Tainan 7010, Taiwan; [Lin, Chung-Ying] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 7010, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Ou, HT (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, 1 Univ Rd, Tainan 7010, Taiwan.	huangtz@mail.ncku.edu.tw	Wu, Meng-Hsing/AAU-1985-2020; Lin, Chung-Ying/I-5434-2016	Wu, Meng-Hsing/0000-0001-7542-5554; Lin, Chung-Ying/0000-0002-2129-4242	Medical Science and Technology Research Grant, National Cheng Kung University Hospital, Tainan, Taiwan [NCKUH-10407023]	Medical Science and Technology Research Grant, National Cheng Kung University Hospital, Tainan, Taiwan	The work was supported by grants to Meng-Hsing Wu and Huang-tz Ou from Medical Science and Technology Research Grant, National Cheng Kung University Hospital (NCKUH-10407023), Tainan, Taiwan.	Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Barnard L, 2007, HUM REPROD, V22, P2279, DOI 10.1093/humrep/dem108; Bazarganipour F, 2014, J SEX MED, V11, P1023, DOI 10.1111/jsm.12405; Bazarganipour F, 2012, HUM REPROD, V27, P2729, DOI 10.1093/humrep/des199; Chang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098767; Chen XL, 2008, EUR J OBSTET GYN R B, V139, P59, DOI 10.1016/j.ejogrb.2007.12.018; Ching HL, 2007, CLIN ENDOCRINOL, V66, P373, DOI 10.1111/j.1365-2265.2007.02742.x; Coffey S, 2006, GYNECOL ENDOCRINOL, V22, P80, DOI 10.1080/09513590600604541; Colwell HH, 1998, AM J OBSTET GYNECOL, V179, P47, DOI 10.1016/S0002-9378(98)70250-9; Cronin L, 1998, J CLIN ENDOCR METAB, V83, P1976, DOI 10.1210/jc.83.6.1976; Elsenbruch S, 2003, J CLIN ENDOCR METAB, V88, P5801, DOI 10.1210/jc.2003-030562; Elsenbruch S, 2006, HUM REPROD, V21, P1092, DOI 10.1093/humrep/dei409; Guyatt G, 2004, J CLIN EPIDEMIOL, V57, P1279, DOI 10.1016/j.jclinepi.2003.10.018; Hahn S, 2005, EUR J ENDOCRINOL, V153, P853, DOI 10.1530/eje.1.02024; Hahn S, 2006, HUM REPROD, V21, P1925, DOI 10.1093/humrep/del069; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hashimoto D M, 2003, Anthropol Anz, V61, P297; Jones GL, 2008, HUM REPROD UPDATE, V14, P15; Jones GL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-149; Jones GL, 2004, HUM REPROD, V19, P371, DOI 10.1093/humrep/deh048; Jones GL, 2002, AM J OBSTET GYNECOL, V187, P501, DOI 10.1067/mob.2002.124940; Kitzinger C, 2002, SOC SCI MED, V54, P349, DOI 10.1016/S0277-9536(01)00034-X; Kline P, 2000, PSYCHOMETRICS PRIMER; Lam PM, 2009, FERTIL STERIL, V91, P1493, DOI 10.1016/j.fertnstert.2008.07.1764; Lee HY, 2013, J FORMOS MED ASSOC, V112, P699, DOI 10.1016/j.jfma.2012.12.015; Lin YS, 2011, AM J REPROD IMMUNOL, V66, P527, DOI 10.1111/j.1600-0897.2011.01059.x; Lipton MG, 2006, J PSYCHOSOM RES, V61, P161, DOI 10.1016/j.jpsychores.2006.01.016; McCook JG, 2005, JOGNN-J OBST GYN NEO, V34, P12, DOI 10.1177/0884217504272945; McDowell I., 1996, MEASURING HLTH GUIDE; Moran L, 2004, BEST PRACT RES CL OB, V18, P719, DOI 10.1016/j.bpobgyn.2004.05.003; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Schmid J, 2004, HUM REPROD, V19, P2251, DOI 10.1093/humrep/deh432; SONINO N, 1993, POSTGRAD MED J, V69, P186, DOI 10.1136/pgmj.69.809.186; Trent Maria E, 2003, J Pediatr Adolesc Gynecol, V16, P33, DOI 10.1016/S1083-3188(02)00205-X; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weerakiet S, 2004, GYNECOL ENDOCRINOL, V19, P134, DOI 10.1080/09513590400007242; Weerakiet S, 2001, INT J GYNECOL OBSTET, V75, P177, DOI 10.1016/S0020-7292(01)00477-5; Weerakiet S, 2007, GYNECOL ENDOCRINOL, V23, P153, DOI 10.1080/09513590701214158; Wong E, 2001, J CLIN EPIDEMIOL, V54, P1081, DOI 10.1016/S0895-4356(01)00393-6; Yao G, 2002, J FORMOS MED ASSOC, V101, P342; Zhao XM, 2011, FERTIL STERIL, V96, P792, DOI 10.1016/j.fertnstert.2011.06.040; Zhao XM, 2010, INT J GYNECOL OBSTET, V108, P148, DOI 10.1016/j.ijgo.2009.09.021; Zhao Y, 2013, STEROIDS, V78, P755, DOI 10.1016/j.steroids.2013.04.006	43	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0137772	10.1371/journal.pone.0137772	http://dx.doi.org/10.1371/journal.pone.0137772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TY	26452153	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511200003
J	Engdahl, C; Knutsson, S; Fredriksson, SA; Linusson, A; Bucht, G; Ekstrom, F				Engdahl, Cecilia; Knutsson, Sofie; Fredriksson, Sten-Ake; Linusson, Anna; Bucht, Goran; Ekstrom, Fredrik			Acetylcholinesterases from the Disease Vectors Aedes aegypti and Anopheles gambiae: Functional Characterization and Comparisons with Vertebrate Orthologues	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; MALARIA MOSQUITO; TARGET SITE; IDENTIFICATION; EXPRESSION; INHIBITORS; DIPTERA; BINDING; GENE; SELECTIVITY	Mosquitoes of the Anopheles (An.) and Aedes (Ae.) genus are principal vectors of human diseases including malaria, dengue and yellow fever. Insecticide-based vector control is an established and important way of preventing transmission of such infections. Currently used insecticides can efficiently control mosquito populations, but there are growing concerns about emerging resistance, off-target toxicity and their ability to alter ecosystems. A potential target for the development of insecticides with reduced off-target toxicity is the cholinergic enzyme acetylcholinesterase (AChE). Herein, we report cloning, baculoviral expression and functional characterization of the wild-type AChE genes (ace-1) from An. gambiae and Ae. aegypti, including a naturally occurring insecticide-resistant (G119S) mutant of An. gambiae. Using enzymatic digestion and liquid chromatography-tandem mass spectrometry we found that the secreted proteins were post-translationally modified. The Michaelis-Menten constants and turnover numbers of the mosquito enzymes were lower than those of the orthologous AChEs from Mus musculus and Homo sapiens. We also found that the G119S substitution reduced the turnover rate of substrates and the potency of selected covalent inhibitors. Furthermore, non-covalent inhibitors were less sensitive to the G119S substitution and differentiate the mosquito enzymes from corresponding vertebrate enzymes. Our findings indicate that it may be possible to develop selective non-covalent inhibitors that effectively target both the wild-type and insecticide resistant mutants of mosquito AChE.	[Engdahl, Cecilia; Knutsson, Sofie; Linusson, Anna] Umea Univ, Dept Chem, Umea, Sweden; [Fredriksson, Sten-Ake; Bucht, Goran; Ekstrom, Fredrik] Swedish Def Res Agcy, CBRN Def & Secur, Umea, Sweden	Umea University; Saab Group	Bucht, G (corresponding author), Swedish Def Res Agcy, CBRN Def & Secur, Umea, Sweden.	goran.bucht@foi.se; fredrik.ekstrom@foi.se		Bucht, Goran/0000-0002-8851-8298; Bucht, Goran/0000-0003-1442-0543	Centrum for Miljovetenskaplig Forskning (CMF); Vetenskapsradet (VR)	Centrum for Miljovetenskaplig Forskning (CMF); Vetenskapsradet (VR)(Swedish Research Council)	This work was supported by Centrum for Miljovetenskaplig Forskning (CMF), http://www8.umu.se/cmf/index_eng.htm, AL; and Vetenskapsradet (VR), http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html, AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alout H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047125; ANTHONY N, 1995, FEBS LETT, V368, P461, DOI 10.1016/0014-5793(95)00711-H; Artursson E, 2009, TOXICOLOGY, V265, P108, DOI 10.1016/j.tox.2009.09.002; AUGUSTINSSON KB, 1949, SCIENCE, V110, P98, DOI 10.1126/science.110.2847.98; Bateman KP, 1998, J CHROMATOGR A, V794, P327, DOI 10.1016/S0021-9673(97)00937-0; Berg L, 2012, ANGEW CHEM INT EDIT, V51, P12716, DOI 10.1002/anie.201205113; Berg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026039; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Casida JE, 1998, ANNU REV ENTOMOL, V43, P1, DOI 10.1146/annurev.ento.43.1.1; Cha DJ, 2015, EVOL DEV, V17, P109, DOI 10.1111/ede.12111; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Dou DF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01068; Ekstrom F, 2006, BIOCHEMISTRY-US, V45, P74, DOI 10.1021/bi051286t; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Fredriksson SA, 2005, ANAL CHEM, V77, P1545, DOI 10.1021/ac048756u; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Hartsel JA, 2012, BIOORG MED CHEM LETT, V22, P4593, DOI 10.1016/j.bmcl.2012.05.103; HOFFMANN F, 1992, J MOL BIOL, V223, P17, DOI 10.1016/0022-2836(92)90710-2; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; Hsiao YM, 2004, J AGR FOOD CHEM, V52, P5340, DOI 10.1021/jf0494377; Huchard E, 2006, P R SOC B, V273, P2595, DOI 10.1098/rspb.2006.3621; Jiang HB, 2009, INSECT BIOCHEM MOLEC, V39, P646, DOI 10.1016/j.ibmb.2009.07.002; Jiang Y, 2013, PESTIC BIOCHEM PHYS, V106, P156, DOI 10.1016/j.pestbp.2013.03.006; Kim YH, 2013, INSECT BIOCHEM MOLEC, V43, P47, DOI 10.1016/j.ibmb.2012.11.004; Kryger G, 1998, J PHYSIOLOGY-PARIS, V92, P191, DOI 10.1016/S0928-4257(98)80008-9; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Ledermann JP, 2004, J ECON ENTOMOL, V97, P1828, DOI 10.1603/0022-0493-97.6.1828; Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735; Mongin E, 2004, TRENDS PARASITOL, V20, P49, DOI 10.1016/j.pt.2003.11.003; Mori A, 2007, INSECT BIOCHEM MOLEC, V37, P667, DOI 10.1016/j.ibmb.2007.03.014; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; Organization WH, 2015, WHO PEST EV SCHEM WH; Pang YP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000058; Pang YP, 2007, BIOORG MED CHEM LETT, V17, P197, DOI 10.1016/j.bmcl.2006.09.073; Pang YP, 2012, CURR DRUG TARGETS, V13, P471, DOI 10.2174/138945012799499703; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Pezzementi Leo, 2006, Invertebrate Neuroscience, V6, P47, DOI 10.1007/s10158-006-0017-z; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Ranson H., 2010, TROPIKA, V1, P1; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saxena A, 1999, CHEM-BIOL INTERACT, V119, P61, DOI 10.1016/S0009-2797(99)00014-9; Saxena A, 1997, BIOCHEMISTRY-US, V36, P7481, DOI 10.1021/bi963156d; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Sugimoto H, 2000, CURR MED CHEM, V7, P303, DOI 10.2174/0929867003375191; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Temeyer KB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-31; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Weill M, 2004, CURR BIOL, V14, pR552, DOI 10.1016/j.cub.2004.07.008; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Wong DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046712; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607	61	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138598	10.1371/journal.pone.0138598	http://dx.doi.org/10.1371/journal.pone.0138598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447952	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000010
J	Nguyen, MVH; Jenny-Avital, ER; Burger, S; Leibert, EM; Achkar, JM				Nguyen, Minh-Vu H.; Jenny-Avital, Elizabeth R.; Burger, Susanne; Leibert, Eric M.; Achkar, Jacqueline M.			Clinical and Radiographic Manifestations of Sputum Culture-Negative Pulmonary Tuberculosis	PLOS ONE			English	Article							UNDIAGNOSED TUBERCULOSIS; HOSPITALIZED-PATIENTS; UNTIL NECROPSY; AUTOPSY; STATES	Intervention at the earliest possible stage of pulmonary tuberculosis (PTB) reduces morbidity for the individual and transmission for the community. We characterize the clinical and radiographic manifestations of sputum culture-negative (Cx-) PTB in order to facilitate awareness of this under recognized and likely early disease state. In this cross-sectional sub-study, we reviewed the medical records of HIV-uninfected PTB patients enrolled from 2006-2014 within the context of a TB biomarker study in New York City. Cx-PTB was defined as clinical and/or radiographic presentation consistent with PTB, three initial mycobacterial sputum cultures negative, and no evidence of other respiratory disease. Diagnosis was confirmed by clinical and radiographic improvement on antituberculous treatment and/or culture, nucleic acid, or histological confirmation from a specimen other than the initial three sputa. Cx+ PTB was defined as above but with M. tuberculosis growth in at least one of the first three sputum cultures. Demographics, symptoms, and radiographic findings on initial presentation were compared between the two groups. Of 99 subjects diagnosed with PTB, 21 met the criteria of Cx-PTB. Cx-compared to Cx+ subjects presented with a significantly lower frequency of cough (70% vs. 91%, P = 0.02), sputum production (30% vs. 64%, P < 0.01), weight loss (25% vs. 54%, P = 0.02), and frequency of cavitation on chest CT (12% vs. 68%, P < 0.01). Our findings should raise awareness that neither a positive culture nor the hallmark symptoms are invariably associated with early TB disease.	[Nguyen, Minh-Vu H.; Jenny-Avital, Elizabeth R.; Achkar, Jacqueline M.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA; [Leibert, Eric M.] NYU, Sch Med, Dept Med, Div Pulm & Crit Care Med, New York, NY USA; [Burger, Susanne] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Achkar, Jacqueline M.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Achkar, JM (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA.	jacqueline.achkar@einstein.yu.edu		Achkar, Jacqueline M./0000-0002-5227-7293	National Institutes of Health/National Center for Advancing Translational Science Einstein-Montefiore Clinical and Translational Science Awards [UL1TR001073]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI096213]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105684, R01AI096213] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Advancing Translational Science Einstein-Montefiore Clinical and Translational Science Awards; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health/National Center for Advancing Translational Science Einstein-Montefiore Clinical and Translational Science Awards [UL1TR001073], and in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI096213 to J.M.A.].	Achkar JM, 2011, J INFECT DIS, V204, pS1179, DOI 10.1093/infdis/jir451; Achkar JM, 2010, CLIN VACCINE IMMUNOL, V17, P384, DOI 10.1128/CVI.00503-09; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 2010, WHOHTMTB2009420; [Anonymous], 2013, 2013 ANN TB SUMM; ASHBA JK, 1972, CHEST, V61, P447, DOI 10.1378/chest.61.5.447; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; Cardona PJ, 2010, ARCH IMMUNOL THER EX, V58, P7, DOI 10.1007/s00005-009-0062-5; Centers for Disease Control and Prevention, 2013, REP TUB US 2013; Centers for Disease Control and Prevention, 2013, CORE CURRICULUM TUBE; COWIE RL, 1985, S AFR MED J, V68, P878; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; DUTT AK, 1989, AM REV RESPIR DIS, V139, P867, DOI 10.1164/ajrccm/139.4.867; EDLIN GP, 1978, LANCET, V1, P650; Hong Kong Chest Service/Tuberculosis Research Centre MBMRC, 1981, TUBERCLE, V62, P155; Jeong YJ, 2008, AM J ROENTGENOL, V191, P834, DOI 10.2214/AJR.07.3896; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; KATZ I, 1985, CHEST, V87, P770, DOI 10.1378/chest.87.6.770; LEE JKM, 1990, J ROY SOC HEALTH, V110, P141, DOI 10.1177/146642409011000411; LINELL F, 1966, SCAND J RESPIR DIS, V47, P200; Pavic I, 2012, CROAT MED J, V53, P48, DOI 10.3325/cmj.2012.53.48; Van Dyck P, 2003, EUR RADIOL, V13, P1771, DOI 10.1007/s00330-002-1612-y; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2007, RED NUMB SMEARS DIAG; 2009, MMWR MORB MORTAL WKL, V58, P7	26	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140003	10.1371/journal.pone.0140003	http://dx.doi.org/10.1371/journal.pone.0140003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448182	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000077
J	Cadotte, A; Cadotte, DW; Livne, M; Cohen-Adad, J; Fleet, D; Mikulis, D; Fehlings, MG				Cadotte, Adam; Cadotte, David W.; Livne, Micha; Cohen-Adad, Julien; Fleet, David; Mikulis, David; Fehlings, Michael G.			Spinal Cord Segmentation by One Dimensional Normalized Template Matching: A Novel, Quantitative Technique to Analyze Advanced Magnetic Resonance Imaging Data	PLOS ONE			English	Article							AUTOMATIC SEGMENTATION; IMAGES; ATROPHY	Spinal cord segmentation is a developing area of research intended to aid the processing and interpretation of advanced magnetic resonance imaging (MRI). For example, high resolution three-dimensional volumes can be segmented to provide a measurement of spinal cord atrophy. Spinal cord segmentation is difficult due to the variety of MRI contrasts and the variation in human anatomy. In this study we propose a new method of spinal cord segmentation based on one-dimensional template matching and provide several metrics that can be used to compare with other segmentation methods. A set of ground-truth data from 10 subjects was manually-segmented by two different raters. These ground truth data formed the basis of the segmentation algorithm. A user was required to manually initialize the spinal cord center-line on new images, taking less than one minute. Template matching was used to segment the new cord and a refined center line was calculated based on multiple centroids within the segmentation. Arc distances down the spinal cord and cross-sectional areas were calculated. Inter-rater validation was performed by comparing two manual raters (n = 10). Semi-automatic validation was performed by comparing the two manual raters to the semi-automatic method (n = 10). Comparing the semi-automatic method to one of the raters yielded a Dice coefficient of 0.91 +/- 0.02 for ten subjects, a mean distance between spinal cord center lines of 0.32 +/- 0.08 mm, and a Hausdorff distance of 1.82 +/- 0.33 mm. The absolute variation in cross-sectional area was comparable for the semi-automatic method versus manual segmentation when compared to inter-rater manual segmentation. The results demonstrate that this novel segmentation method performs as well as a manual rater for most segmentation metrics. It offers a new approach to study spinal cord disease and to quantitatively track changes within the spinal cord in an individual case and across cohorts of subjects.	[Cadotte, Adam; Cadotte, David W.; Fehlings, Michael G.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Cadotte, David W.; Mikulis, David; Fehlings, Michael G.] Toronto Western Hosp, Univ Hlth Network, Toronto, ON M5T 2S8, Canada; [Livne, Micha; Fleet, David] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Cohen-Adad, Julien] Ecole Polytech, Inst Biomed Engn, Montreal, PQ H3C 3A7, Canada; [Cohen-Adad, Julien] Univ Montreal, Funct Neuroimaging Unit, CRIUGM, Montreal, PQ, Canada; [Mikulis, David] Univ Toronto, Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Spine Program, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Universite de Montreal; Polytechnique Montreal; Universite de Montreal; University of Toronto; University of Toronto	Fehlings, MG (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada.	michael.fehlings@uhn.ca	Mikulis, David J/H-5167-2019	/0000-0003-0734-7114; Fehlings, Michael/0000-0002-5722-6364; Mikulis, David/0000-0003-3956-0892	Craig H. Neilsen Foundation; Gerald and Tootsie Halbert Chair in Neural Repair and Regeneration; Phillip and Peggy DeZwirek	Craig H. Neilsen Foundation; Gerald and Tootsie Halbert Chair in Neural Repair and Regeneration; Phillip and Peggy DeZwirek	The authors are grateful to the Craig H. Neilsen Foundation (http://chnfoundation.org/mDefault.aspx?Section=home) for funding for this research. MGF is supported by the Gerald and Tootsie Halbert Chair in Neural Repair and Regeneration and by funding from Phillip and Peggy DeZwirek. The funders had no role in the design, data collection, data analysis, decision to publish or preparation of the manuscript.	Asman AJ, 2014, MED IMAGE ANAL, V18, P460, DOI 10.1016/j.media.2014.01.003; Aspert N, 2002, IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I AND II, PROCEEDINGS, P705, DOI 10.1109/ICME.2002.1035879; Cadotte DW, 2014, AM J NEURORADIOLOGY; Chen M, 2013, NEUROIMAGE, V83, P1051, DOI 10.1016/j.neuroimage.2013.07.060; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Coulon O, 2002, MAGN RESON MED, V47, P1176, DOI 10.1002/mrm.10162; De Leener B, 2014, NEUROIMAGE, V98, P528, DOI 10.1016/j.neuroimage.2014.04.051; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Koh J, 2011, I S BIOMED IMAGING, P1467, DOI 10.1109/ISBI.2011.5872677; Koh J, 2010, IEEE ENG MED BIO, P3117, DOI 10.1109/IEMBS.2010.5626097; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; McIntosh C, 2006, LECT NOTES COMPUT SC, V4190, P808; Mukherjee DP, 2010, IEEE T INF TECHNOL B, V14, P1275, DOI 10.1109/TITB.2010.2052060	14	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139323	10.1371/journal.pone.0139323	http://dx.doi.org/10.1371/journal.pone.0139323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445367	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000362510600052
J	Hoskovcova, M; Dusek, P; Sieger, T; Brozova, H; Zarubova, K; Bezdicek, O; Sprdlik, O; Jech, R; Stochl, J; Roth, J; Ruzicka, E				Hoskovcova, Martina; Dusek, Petr; Sieger, Tomas; Brozova, Hana; Zarubova, Katerina; Bezdicek, Ondrej; Sprdlik, Otakar; Jech, Robert; Stochl, Jan; Roth, Jan; Ruzicka, Evzen			Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?	PLOS ONE			English	Article							RISK-FACTORS; GAIT; BALANCE; PEOPLE; SCALE; RHYTHMICITY; SYMPTOMS	Background Falls are a common complication of advancing Parkinson's disease (PD). Although numerous risk factors are known, reliable predictors of future falls are still lacking. The objective of this prospective study was to investigate clinical and instrumented tests of balance and gait in both OFF and ON medication states and to verify their utility in the prediction of future falls in PD patients. Methods Forty-five patients with idiopathic PD were examined in defined OFF and ON medication states within one examination day including PD-specific clinical tests, instrumented Timed Up and Go test (iTUG) and computerized dynamic posturography. The same gait and balance tests were performed in 22 control subjects of comparable age and sex. Participants were then followed-up for 6 months using monthly fall diaries and phone calls. Results During the follow-up period, 27/45 PD patients and 4/22 control subjects fell one or more times. Previous falls, fear of falling, more severe motor impairment in the OFF state, higher PD stage, more pronounced depressive symptoms, higher daily levodopa dose and stride time variability in the OFF state were significant risk factors for future falls in PD patients. Increased stride time variability in the OFF state in combination with faster walking cadence appears to be the most significant predictor of future falls, superior to clinical predictors. Conclusion Incorporating instrumented gait measures into the baseline assessment battery as well as accounting for both OFF and ON medication states might improve future fall prediction in PD patients. However, instrumented testing in the OFF state is not routinely performed in clinical practice and has not been used in the development of fall prevention programs in PD. New assessment methods for daylong monitoring of gait, balance and falls are thus required to more effectively address the risk of falling in PD patients.	[Hoskovcova, Martina; Dusek, Petr; Sieger, Tomas; Brozova, Hana; Zarubova, Katerina; Bezdicek, Ondrej; Jech, Robert; Roth, Jan; Ruzicka, Evzen] Charles Univ Prague, Dept Neurol, Prague, Czech Republic; [Hoskovcova, Martina; Dusek, Petr; Sieger, Tomas; Brozova, Hana; Zarubova, Katerina; Bezdicek, Ondrej; Jech, Robert; Roth, Jan; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Hoskovcova, Martina; Dusek, Petr; Sieger, Tomas; Brozova, Hana; Zarubova, Katerina; Bezdicek, Ondrej; Jech, Robert; Roth, Jan; Ruzicka, Evzen] Charles Univ Prague, Gen Univ Hosp Prague, Prague, Czech Republic; [Sieger, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Sprdlik, Otakar] Czech Tech Univ, Fac Elect Engn, Dept Control Engn, CR-16635 Prague, Czech Republic; [Stochl, Jan] Charles Univ Prague, Dept Kinanthropol, Prague, Czech Republic; [Dusek, Petr] Univ Med Goettingen, Inst Neuroradiol, Gottingen, Germany; [Stochl, Jan] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	Charles University Prague; Charles University Prague; Charles University Prague; General University Hospital Prague; Czech Technical University Prague; Czech Technical University Prague; Charles University Prague; University of York - UK	Ruzicka, E (corresponding author), Charles Univ Prague, Dept Neurol, Prague, Czech Republic.	eruzi@lf1.cuni.cz	Růžička, Evžen/F-9299-2017; Hoskovcová, Martina/AAK-4642-2020; Dusek, Petr/F-9084-2017; Stochl, Jan/AAF-1379-2020; Roth, Jan/O-1817-2017; Hoskovcová, Martina/K-1207-2017; Stochl, Jan/D-2284-2018; Jech, Robert/HHY-7342-2022; Bezdicek, Ondrej/AAK-4730-2020; Sieger, Tomas/AAD-9342-2019; Bezdicek, Ondrej/C-2101-2015; Brozova, Hana/AAM-9717-2021	Růžička, Evžen/0000-0002-4893-9661; Hoskovcová, Martina/0000-0001-5798-8740; Dusek, Petr/0000-0003-4877-9642; Stochl, Jan/0000-0002-9693-9930; Roth, Jan/0000-0002-5247-7746; Hoskovcová, Martina/0000-0001-5798-8740; Stochl, Jan/0000-0002-9693-9930; Jech, Robert/0000-0002-9732-8947; Bezdicek, Ondrej/0000-0002-5108-0181; Bezdicek, Ondrej/0000-0002-5108-0181; Brozova, Hana/0000-0003-3383-7117; Sieger, Tomas/0000-0003-4960-1934	Czech Ministry of Health [NS10336-3/2009, NS11190-6/2010, NT14181-3/2013]; Charles University in Prague [PRVOUK P26/LF1/4]; European social fund at the Czech Technical University in Prague [CZ.1.07/2.3.00/30.0034]	Czech Ministry of Health(Ministry of Health, Czech Republic); Charles University in Prague; European social fund at the Czech Technical University in Prague	This study was supported by the Czech Ministry of Health, NS10336-3/2009, http://iga.mzcr.cz/publicWeb/, MH; Czech Ministry of Health, NS11190-6/2010, http://iga.mzcr.cz/publicWeb/, HB; Czech Ministry of Health, NT14181-3/2013, http://iga.mzcr.cz/publicWeb/, ER; Charles University in Prague, PRVOUK P26/LF1/4, http://is.cuni.cz/webapps/whois2/org/1365292082243020/, ER; European social fund realized at the Czech Technical University in Prague, CZ.1.07/2.3.00/30.0034, TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock LM, 2009, PARKINSONISM RELAT D, V15, P110, DOI 10.1016/j.parkreldis.2008.03.010; Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Ashburn A, 2001, AGE AGEING, V30, P47, DOI 10.1093/ageing/30.1.47; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Brandler TC, 2012, AM J GERIAT PSYCHIAT, V20, P425, DOI 10.1097/JGP.0b013e31821181c6; Bronte-Stewart HM, 2002, BRAIN, V125, P2100, DOI 10.1093/brain/awf207; Bryant MS, 2011, NEUROREHABILITATION, V29, P247, DOI 10.3233/NRE-2011-0700; Canning CG, 2014, NEURODEGENER DIS MAN, V4, P203, DOI [10.2217/nmt.14.22, 10.2217/NMT.14.22]; Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596; Cole MH, 2010, MOVEMENT DISORD, V25, P2369, DOI 10.1002/mds.23292; Contreras A, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/362572; Dennison AC, 2007, AM J PHYS MED REHAB, V86, P621, DOI 10.1097/PHM.0b013e311611583; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Duncan RP, 2013, PHYS THER, V93, P542, DOI 10.2522/ptj.20120302; Duncan RP, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/237673; Foreman KB, 2011, PARKINSONISM RELAT D, V17, P166, DOI 10.1016/j.parkreldis.2010.12.007; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Kopecek M, 2015, APPL NEUROPSYCHOLOGY; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Lindholm B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117018; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Mak MKY, 2010, J NEUROL, V257, P1543, DOI 10.1007/s00415-010-5573-9; Mak MKY, 2009, J NEUROL, V256, P1689, DOI 10.1007/s00415-009-5184-5; Mak MKY, 2009, J NEUROL, V256, P742, DOI 10.1007/s00415-009-5007-8; Matinolli M, 2011, ACTA NEUROL SCAND, V123, P193, DOI 10.1111/j.1600-0404.2010.01386.x; McNeely ME, 2012, GAIT POSTURE, V36, P144, DOI 10.1016/j.gaitpost.2012.02.009; Paul SS, 2014, NEUROREHAB NEURAL RE, V28, P282, DOI 10.1177/1545968313508470; Paul SS, 2013, MOVEMENT DISORD, V28, P655, DOI 10.1002/mds.25404; Pickering RM, 2007, MOVEMENT DISORD, V22, P1892, DOI 10.1002/mds.21598; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Robinson K, 2005, NEUROREHABILITATION, V20, P169; Rochester L, 2011, MOVEMENT DISORD, V26, P430, DOI 10.1002/mds.23450; Scanaill CN, 2011, AGEING INT, V36, P217, DOI 10.1007/s12126-010-9087-7; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Spielberger C., 1983, STAI MANUAL; Team RDC, 2010, R LANG ENV STAT COMP; Thomas M, 2004, J NEUROL SCI, V217, P89, DOI 10.1016/j.jns.2003.09.005; Valkovic P, 2008, MOVEMENT DISORD, V23, P1453, DOI 10.1002/mds.22131; Voss TS, 2012, PARKINSONISM RELAT D, V18, P837, DOI 10.1016/j.parkreldis.2012.04.004; Yang YQ, 2014, PHYS THER, V94, P392, DOI 10.2522/ptj.20130019; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	48	25	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139849	10.1371/journal.pone.0139849	http://dx.doi.org/10.1371/journal.pone.0139849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26443998	gold, Green Published			2022-12-26	WOS:000362510600091
J	Koops, K; Furuichi, T; Hashimoto, C; van Schaik, CP				Koops, Kathelijne; Furuichi, Takeshi; Hashimoto, Chie; van Schaik, Carel P.			Sex Differences in Object Manipulation in Wild Immature Chimpanzees (Pan troglodytes schweinfurthii) and Bonobos (Pan paniscus): Preparation for Tool Use?	PLOS ONE			English	Article							EARLY SOCIAL-DEVELOPMENT; KALINZU FOREST; TESTOSTERONE; ACQUISITION; AGGRESSION; BEHAVIORS; SELECTION; HABITAT; CENSUS; VERUS	Sex differences in immatures predict behavioural differences in adulthood in many mammal species. Because most studies have focused on sex differences in social interactions, little is known about possible sex differences in 'preparation' for adult life with regards to tool use skills. We investigated sex and age differences in object manipulation in immature apes. Chimpanzees use a variety of tools across numerous contexts, whereas bonobos use few tools and none in foraging. In both species, a female bias in adult tool use has been reported. We studied object manipulation in immature chimpanzees at Kalinzu (Uganda) and bonobos at Wamba (Democratic Republic of Congo). We tested predictions of the 'preparation for tool use' hypothesis. We confirmed that chimpanzees showed higher rates and more diverse types of object manipulation than bonobos. Against expectation, male chimpanzees showed higher object manipulation rates than females, whereas in bonobos no sex difference was found. However, object manipulation by male chimpanzees was play-dominated, whereas manipulation types of female chimpanzees were more diverse (e.g., bite, break, carry). Manipulation by young immatures of both species was similarly dominated by play, but only in chimpanzees did it become more diverse with age. Moreover, in chimpanzees, object types became more tool-like (i.e., sticks) with age, further suggesting preparation for tool use in adulthood. The male bias in object manipulation in immature chimpanzees, along with the late onset of tool-like object manipulation, indicates that not all (early) object manipulation (i.e., object play) in immatures prepares for subsistence tool use. Instead, given the similarity with gender differences in human children, object play may also function in motor skill practice for male-specific behaviours (e.g., dominance displays). In conclusion, even though immature behaviours almost certainly reflect preparation for adult roles, more detailed future work is needed to disentangle possible functions of object manipulation during development.	[Koops, Kathelijne; van Schaik, Carel P.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Koops, Kathelijne] Univ Cambridge, Div Biol Anthropol, Dept Archaeol & Anthropol, Cambridge, England; [Furuichi, Takeshi; Hashimoto, Chie] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	University of Zurich; University of Cambridge; Kyoto University	Koops, K (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.	kathelijne.koops@uzh.ch			Lucie Burgers Foundation for Comparative Behaviour Research (Netherlands); Homerton College (Cambridge); McDonald Institute for Archaeological Research (Cambridge); MEXT [20002001, 24000001];  [JSPS-U04-PWS]	Lucie Burgers Foundation for Comparative Behaviour Research (Netherlands); Homerton College (Cambridge); McDonald Institute for Archaeological Research (Cambridge); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by Lucie Burgers Foundation for Comparative Behaviour Research (Netherlands), KK; Homerton College (Cambridge), KK; McDonald Institute for Archaeological Research (Cambridge), KK; MEXT (#20002001, #24000001) and JSPS-U04-PWS grants to Tetsuro Matsuzawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Biro D, 2011, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P476; BOESCH C, 1984, J HUM EVOL, V13, P415, DOI 10.1016/S0047-2484(84)80055-X; BOESCH C, 1991, BEHAVIOUR, V117, P221, DOI 10.1163/156853991X00544; Boose KJ, 2013, AM J PRIMATOL, V75, P917, DOI 10.1002/ajp.22155; Coelho CG, 2015, ANIM COGN, V18, P911, DOI 10.1007/s10071-015-0861-5; COLLAER ML, 1995, PSYCHOL BULL, V118, P55, DOI 10.1037/0033-2909.118.1.55; Dennett D, 1995, DARWINS DANERGOUS ID; Field A, 2013, DISCOVERING STAT USI; Furuichi T, 2015, BEHAVIOUR, V152, P425, DOI 10.1163/1568539X-00003226; Furuichi T, 2004, INT J PRIMATOL, V25, P755, DOI 10.1023/B:IJOP.0000029121.25284.7f; Furuichi T, 2001, INT J PRIMATOL, V22, P913, DOI 10.1023/A:1012057403512; Gibson QA, 2008, ANIM BEHAV, V76, P375, DOI 10.1016/j.anbehav.2008.01.021; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gredlein JM, 2005, HUM NATURE-INT BIOS, V16, P211, DOI 10.1007/s12110-005-1004-5; Gruber T, 2010, ANIM BEHAV, V80, P1023, DOI 10.1016/j.anbehav.2010.09.005; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; HASHIMOTO C, 1995, PRIMATES, V36, P477, DOI 10.1007/BF02382870; Hashimoto C, 2000, PRIMATES, V41, P103, DOI 10.1007/BF02557466; Hashimoto C, 1998, INT J PRIMATOL, V19, P1045, DOI 10.1023/A:1020378320913; Hassett JM, 2008, HORM BEHAV, V54, P359, DOI 10.1016/j.yhbeh.2008.03.008; Hayashi M, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P395, DOI 10.1007/4-431-30248-4_24; Hiraiwa-Hasegawa M., 1989, P104; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Holekamp KE, 1998, BIOSCIENCE, V48, P997, DOI 10.2307/1313456; Howard P. C., 1991, NATURE CONSERVATION; Humle T, 2009, ANIM COGN, V12, pS37, DOI 10.1007/s10071-009-0272-6; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; Kahlenberg SM, 2010, CURR BIOL, V20, pR1067, DOI 10.1016/j.cub.2010.11.024; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Koops K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11356; Kortlandt A., 1967, P208; Kortlandt A., 1964, YB AM PHILOS SOC, P327; KURODA S, 1980, Primates, V21, P181, DOI 10.1007/BF02374032; LEE PC, 1986, NATL GEOGR RES, V2, P388; Lonsdorf EV, 2014, ANIM BEHAV, V88, P79, DOI 10.1016/j.anbehav.2013.11.015; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Lonsdorf EV, 2005, ANIM BEHAV, V70, P673, DOI 10.1016/j.anbehav.2004.12.014; Lonsdorf EV, 2006, ANIM COGN, V9, P36, DOI 10.1007/s10071-005-0002-7; LOVEJOY J, 1988, PSYCHOBIOLOGY, V16, P348; Mann Janet, 2006, P107; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; McGrew W. C., 1977, P261; McGrew W. C., 1979, GREAT APES, P441; McGrew William, 2004, CULTURED CHIMPANZEE; Meulman EJM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0050; Mulavwa MN, 2010, AM J PRIMATOL, V72, P575, DOI 10.1002/ajp.20810; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Myowa-Yamakoshi M, 2011, PRIMATOL MONOGR, P231, DOI 10.1007/978-4-431-53921-6_25; Osvath M, 2009, CURR BIOL, V19, pR190, DOI 10.1016/j.cub.2009.01.010; Pellegrini AD, 2004, HUM NATURE-INT BIOS, V15, P23, DOI 10.1007/s12110-004-1002-z; PRATT DM, 1979, Z TIERPSYCHOL, V51, P233; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Pruetz JD, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140507; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; PUSEY AE, 1983, ANIM BEHAV, V31, P363, DOI 10.1016/S0003-3472(83)80055-4; Ramsey Jacklyn K., 2005, P89; Resende B., 2008, DEVELOPMENTAL SCI, V11, P828, DOI DOI 10.1111/J.1467-7687.2008.00731.X; Tebbich S, 2001, P ROY SOC B-BIOL SCI, V268, P2189, DOI 10.1098/rspb.2001.1738; van Noordwijk Maria A., 1993, P77; Watts David P., 1993, P148; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070	64	21	21	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139909	10.1371/journal.pone.0139909	http://dx.doi.org/10.1371/journal.pone.0139909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444011	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000362510600103
J	Perez-Sepulveda, A; Monteiro, LJ; Dobierzewska, A; Espana-Perrot, PP; Venegas-Araneda, P; Guzman-Rojas, AM; Gonzalez, MI; Palominos-Rivera, M; Irarrazabal, CE; Figueroa-Diesel, H; Varas-Godoy, M; Illanes, SE				Perez-Sepulveda, Alejandra; Monteiro, Lara J.; Dobierzewska, Aneta; Espana-Perrot, Pedro P.; Venegas-Araneda, Pia; Guzman-Rojas, Alejandra M.; Gonzalez, Maria I.; Palominos-Rivera, Macarena; Irarrazabal, Carlos E.; Figueroa-Diesel, Horacio; Varas-Godoy, Manuel; Illanes, Sebastian E.			Placental Aromatase Is Deficient in Placental Ischemia and Preeclampsia	PLOS ONE			English	Article							INDUCIBLE TRANSCRIPTION FACTOR; CATECHOL-O-METHYLTRANSFERASE; EARLY-ONSET PREECLAMPSIA; BREAST-CANCER PATIENTS; 1ST TRIMESTER; HYPOXIA; GENE; EXPRESSION; POLYMORPHISMS; INHIBITORS	Introduction Preeclampsia is a maternal hypertensive disorder with uncertain etiology and a leading cause of maternal and fetal mortality worldwide, causing nearly 40% of premature births delivered before 35 weeks of gestation. The first stage of preeclampsia is characterized by reduction of utero-placental blood flow which is reflected in high blood pressure and proteinuria during the second half of pregnancy. In human placenta androgens derived from the maternal and fetal adrenal glands are converted into estrogens by the enzymatic action of placental aromatase. This implies that alterations in placental steroidogenesis and, subsequently, in the functionality or bioavailability of placental aromatase may be mechanistically involved in the pathophysiology of PE. Methods Serum samples were collected at 32-36 weeks of gestation and placenta biopsies were collected at time of delivery from PE patients (n = 16) and pregnant controls (n = 32). The effect of oxygen tension on placental cells was assessed by incubation JEG-3 cells under 1% and 8% O-2 for different time periods, Timed-mated, pregnant New Zealand white rabbits (n = 6) were used to establish an in vivo model of placental ischemia (achieved by ligature of uteroplacental vessels). Aromatase content and estrogens and androgens concentrations were measured. Results The protein and mRNA content of placental aromatase significantly diminished in placentae obtained from preeclamptic patients compared to controls. Similarly, the circulating concentrations of 17-beta-estradiol/testosterone and estrone/androstenedione were reduced in preeclamptic patients vs. controls. These data are consistent with a concomitant decrease in aromatase activity. Aromatase content was reduced in response to low oxygen tension in the choriocarcinoma JEG-3 cell line and in rabbit placentae in response to partial ligation of uterine spiral arteries, suggesting that reduced placental aromatase activity in preeclamptic patients may be associated with chronic placental ischemia and hypoxia later in gestation. Conclusions Placental aromatase expression and functionality are diminished in pregnancies complicated by preeclampsia in comparison with healthy pregnant controls.	[Perez-Sepulveda, Alejandra; Monteiro, Lara J.; Dobierzewska, Aneta; Espana-Perrot, Pedro P.; Venegas-Araneda, Pia; Guzman-Rojas, Alejandra M.; Gonzalez, Maria I.; Palominos-Rivera, Macarena; Figueroa-Diesel, Horacio; Varas-Godoy, Manuel; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Dept Obstet & Gynecol, Reprod Biol Lab, Santiago, Chile; [Irarrazabal, Carlos E.] Univ Los Andes, Fac Med, Lab Mol Physiol, Santiago, Chile; [Figueroa-Diesel, Horacio; Illanes, Sebastian E.] Clin Davila, Perinatal Unit, Santiago, Chile	Universidad de los Andes - Chile; Universidad de los Andes - Chile; Clinica Davila	Illanes, SE (corresponding author), Univ Los Andes, Fac Med, Dept Obstet & Gynecol, Reprod Biol Lab, Santiago, Chile.	sillanes@uandes.cl	Monteiro, Lara J/AAU-8518-2020	Irarrazabal, Carlos Ernesto/0000-0002-6538-5314; Illanes, Sebastian/0000-0001-5433-9315; Varas-Godoy, Manuel/0000-0001-5857-4793	Comision Nacional de Investigacion Cientifica y Tecnologica, Fondo Nacional de Desarrollo Cientifico y Tecnologico/POSTDOCTORADO [3140038]; Comision Nacional de Investigacion Cientifica y Tecnologica, Fondo Nacional de Desarrollo Cientifico y Tecnologico/REGULAR [1110883]	Comision Nacional de Investigacion Cientifica y Tecnologica, Fondo Nacional de Desarrollo Cientifico y Tecnologico/POSTDOCTORADO; Comision Nacional de Investigacion Cientifica y Tecnologica, Fondo Nacional de Desarrollo Cientifico y Tecnologico/REGULAR	This study was supported by grants from Comision Nacional de Investigacion Cientifica y Tecnologica, Fondo Nacional de Desarrollo Cientifico y Tecnologico/POSTDOCTORADO N. 3140038 (LJM); and Comision Nacional de Investigacion Cientifica y Tecnologica, Fondo Nacional de Desarrollo Cientifico y Tecnologico/REGULAR N. 1110883 (SEI) (http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Caniggia I, 2002, PLACENTA, V23, pS47, DOI 10.1053/plac.2002.0815; Caradeux J, 2013, PRENATAL DIAG, V33, P732, DOI 10.1002/pd.4113; Carlsen SM, 2005, ACTA OBSTET GYN SCAN, V84, P117, DOI 10.1111/j.0001-6349.2005.00493.x; Cheng MH, 2009, EXPERT REV MOL DIAGN, V9, P37, DOI 10.1586/14737159.9.1.37; Czajka-Oraniec I, 2010, ENDOKRYNOL POL, V61, P126; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Figueroa H, 2012, EARLY HUM DEV, V88, P899, DOI 10.1016/j.earlhumdev.2012.07.010; Garcia-Casado Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-36; Ghorashi Valentina, 2008, Endokrynol Pol, V59, P390; Grill S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-70; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Harada N, 1998, BRIT J CANCER, V77, P567, DOI 10.1038/bjc.1998.92; Harada N, 1999, ENDOCR-RELAT CANCER, V6, P211, DOI 10.1677/erc.0.0060211; Hertig A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.011; Hong YY, 2009, ANN NY ACAD SCI, V1155, P112, DOI 10.1111/j.1749-6632.2009.03703.x; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jiang B, 2000, MOL ENDOCRINOL, V14, P1661, DOI 10.1210/me.14.10.1661; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kanasaki K, 2009, KIDNEY INT, V76, P831, DOI 10.1038/ki.2009.284; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Lee SB, 2010, AM J PATHOL, V176, P710, DOI 10.2353/ajpath.2010.090513; Ma CX, 2005, CANCER RES, V65, P11071, DOI 10.1158/0008-5472.CAN-05-1218; Myatt L, 2014, HYPERTENSION, V63, P1293, DOI 10.1161/HYPERTENSIONAHA.113.02664; Palmer K, 2011, AM J PATHOL, V178, P2484, DOI 10.1016/j.ajpath.2011.02.029; Perez-Sepulveda A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/731962; Perez-Sepulveda A, 2013, REPROD SCI, V20, P1020, DOI 10.1177/1933719113477483; Perez-Sepulveda A, 2012, PRENATAL DIAG, V32, P1053, DOI 10.1002/pd.3954; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Rajakumar A, 2001, BIOL REPROD, V64, P499, DOI 10.1093/biolreprod/64.2.499; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Tao MH, 2007, CANCER EPIDEM BIOMAR, V16, P943, DOI 10.1158/1055-9965.EPI-06-1012; Troisi R, 2003, INT J EPIDEMIOL, V32, P455, DOI 10.1093/ije/dyg094; Wang LW, 2010, CANCER RES, V70, P319, DOI 10.1158/0008-5472.CAN-09-3224; Wolfe LM, 2014, PLACENTA, V35, P645, DOI 10.1016/j.placenta.2014.05.005; Zamudio S, 2007, AM J PATHOL, V170, P2171, DOI 10.2353/ajpath.2007.061185	45	45	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139682	10.1371/journal.pone.0139682	http://dx.doi.org/10.1371/journal.pone.0139682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444006	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600067
J	Zarybnicka, M; Riegert, J; Brejskova, L; Sindelar, J; Kouba, M; Hanel, J; Popelkova, A; Menclova, P; Tomasek, V; St'astny, K				Zarybnicka, Marketa; Riegert, Jan; Brejskova, Lucie; Sindelar, Jiri; Kouba, Marek; Hanel, Jan; Popelkova, Alena; Menclova, Petra; Tomasek, Vaclav; St'astny, Karel			Factors Affecting Growth of Tengmalm's Owl (Aegolius funereus) Nestlings: Prey Abundance, Sex and Hatching Order	PLOS ONE			English	Article							BROOD SIZE MANIPULATIONS; SIBLING COMPETITION; PARENTAL INVESTMENT; OFFSPRING GROWTH; FOOD LIMITATION; SURVIVAL; DIMORPHISM; BEHAVIOR; SUCCESS; KESTREL	In altricial birds, energy supply during growth is a major predictor of the physical condition and survival prospects of fledglings. A number of experimental studies have shown that nestling body mass and wing length can vary with particular extrinsic factors, but between-year observational data on this topic are scarce. Based on a seven-year observational study in a central European Tengmalm's owl population we examine the effect of year, brood size, hatching order, and sex on nestling body mass and wing length, as well as the effect of prey abundance on parameters of growth curve. We found that nestling body mass varied among years, and parameters of growth curve, i.e. growth rate and inflection point in particular, increased with increasing abundance of the owl's main prey (Apodemus mice, Microtus voles), and pooled prey abundance (Apodemus mice, Microtus voles, and Sorex shrews). Furthermore, nestling body mass varied with hatching order and between sexes being larger for females and for the first-hatched brood mates. Brood size had no effect on nestling body mass. Simultaneously, we found no effect of year, brood size, hatching order, or sex on the wing length of nestlings. Our findings suggest that in this temperate owl population, nestling body mass is more sensitive to prey abundance than is wing length. The latter is probably more limited by the physiology of the species.	[Zarybnicka, Marketa; Brejskova, Lucie; Sindelar, Jiri; Kouba, Marek; Hanel, Jan; Popelkova, Alena; Menclova, Petra; Tomasek, Vaclav; St'astny, Karel] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Riegert, Jan] Univ South Bohemia Ceske Budejovice, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic	Czech University of Life Sciences Prague; University of South Bohemia Ceske Budejovice	Zarybnicka, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	zarybnicka.marketa@seznam.cz	Riegert, Jan/AAQ-5136-2021; Kouba, Marek/A-1350-2019; Riegert, Jan/D-9070-2016; ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020	Riegert, Jan/0000-0003-4195-1278; Kouba, Marek/0000-0003-2262-5733; Riegert, Jan/0000-0003-4195-1278; Zarybnicka, Marketa/0000-0001-5883-0988	Czech University of Life Sciences Prague (CIGA Grant) [20144203]	Czech University of Life Sciences Prague (CIGA Grant)	This study was supported by the Czech University of Life Sciences Prague (CIGA Grant No. 20144203). http://ga.czu.cz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DJ, 1993, CAN J ZOOL, V71, P2541, DOI 10.1139/z93-347; Apanius V., 1998, AVIAN GROWTH DEV EVO; Arroyo BE, 2002, ANIM BEHAV, V63, P235, DOI 10.1006/anbe.2001.1899; Berthold P., 1976, Vogelwarte, V28, P257; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; Eldegard K, 2010, BEHAV ECOL SOCIOBIOL, V64, P815, DOI 10.1007/s00265-009-0898-z; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; FUJIOKA M, 1985, ANIM BEHAV, V33, P1228, DOI 10.1016/S0003-3472(85)80183-4; GOTTLANDER K, 1987, ORNIS SCAND, V18, P269, DOI 10.2307/3676895; Granbom M, 2006, AUK, V123, P97, DOI 10.1642/0004-8038(2006)123[0097:FLDBIA]2.0.CO;2; Haley KL, 2013, J RAPTOR RES, V47, P365, DOI 10.3356/JRR-12-00022.1; Hipkiss T, 2004, POPUL ECOL, V46, P263, DOI 10.1007/s10144-004-0195-7; Hipkiss T, 2002, J ZOOL, V257, P281, DOI 10.1017/S0952836902000870; Hipkiss T, 2002, J ANIM ECOL, V71, P693, DOI 10.1046/j.1365-2656.2002.t01-1-00635.x; Hornfeldt B, 2000, MOL ECOL, V9, P187, DOI 10.1046/j.1365-294x.2000.00847.x; Karell P, 2009, CAN J ZOOL, V87, P8, DOI 10.1139/Z08-133; KORPIMAKI E, 1988, J ANIM ECOL, V57, P1027, DOI 10.2307/5109; KORPIMAKI E, 1991, OECOLOGIA, V85, P543, DOI 10.1007/BF00323767; KORPIMAKI E, 1988, ORNIS FENNICA, V65, P21; KORPIMAKI E, 1990, ORNIS SCAND, V21, P169, DOI 10.2307/3676776; Korpimaki E, 1996, ECOSCIENCE, V3, P264, DOI 10.1080/11956860.1996.11682341; Kouba M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121641; Kouba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095594; Kouba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067034; Krijgsveld KL, 1998, PHYSIOL ZOOL, V71, P693, DOI 10.1086/515983; Lack D., 1954, P343; Lok T, 2014, ARDEA, V102, P181, DOI 10.5253/arde.v102i2.a8; Maddox JD, 2012, J FIELD ORNITHOL, V83, P17, DOI 10.1111/j.1557-9263.2011.00351.x; Massemin S, 2002, J AVIAN BIOL, V33, P235, DOI 10.1034/j.1600-048X.2002.330305.x; Mikkola H., 2020, OWLS, P97; Musgrove AB, 2014, AUK, V131, P571, DOI 10.1642/AUK-14-51.1; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Naef-Daenzer B, 2008, ARDEA, V96, P181, DOI 10.5253/078.096.0204; Newton I., 1979, POPULATION ECOLOGY R; Perrig M, 2014, IBIS, V156, P755, DOI 10.1111/ibi.12171; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roulin A, 1999, ARDEA, V87, P91; Roulin A, 2002, ARDEA, V90, P259; Santangeli A, 2012, ANIM BEHAV, V83, P1115, DOI 10.1016/j.anbehav.2012.02.002; StatSoft I, 2013, STAT DATA ANAL SOFTW; Townsend HM, 2007, CAN J ZOOL, V85, P686, DOI 10.1139/Z07-047; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Valkama J, 2002, OECOLOGIA, V133, P334, DOI 10.1007/s00442-002-1033-2; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wiebe KL, 1998, J ANIM ECOL, V67, P908, DOI 10.1046/j.1365-2656.1998.6760908.x; Zarybnicka M, 2015, IBIS, V157, P459, DOI 10.1111/ibi.12265; Zarybnicka M, 2015, IBIS, V157, P369, DOI 10.1111/ibi.12244; Zarybnicka M, 2015, J ORNITHOL, V156, P457, DOI 10.1007/s10336-014-1145-6; Zarybnicka M, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-36; Zarybnicka M, 2013, POPUL ECOL, V55, P353, DOI 10.1007/s10144-013-0367-4; Zarybnicka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036932; Zarybnicka M, 2011, ORNIS FENNICA, V88, P147; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911; Zarybnicka M, 2009, FOLIA ZOOL, V58, P104; Zarybnicka M, 2009, J ORNITHOL, V150, P231, DOI 10.1007/s10336-008-0342-6	56	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138177	10.1371/journal.pone.0138177	http://dx.doi.org/10.1371/journal.pone.0138177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444564	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600022
J	Killian, ML; Thomopoulos, S				Killian, Megan L.; Thomopoulos, Stavros			Scleraxis is required for the development of a functional tendon enthesis	FASEB JOURNAL			English	Article						attachment; musculoskeletal; postnatal; supraspinatus	TO-BONE INSERTION; ROTATOR CUFF; BRACHIAL-PLEXUS; EXPRESSION; ATTACHMENT; MATRIX; PROGENITORS; INTEGRITY; SITES; CELLS	The attachment of dissimilar materials is a major engineering challenge, yet this challenge is seemingly overcome in biology. This study aimed to determine how the transcription factor Scleraxis (Scx) influences the development and maturation of the tendon-to-bone attachment (enthesis). Mice with conditional knockout (cKO) for Scx (Scx(flx/-), Prx1Cre(+)) and wild-type [(WT) Scx(flx/+) or Scx(flx/flx/)] littermates were killed at postnatal days 7-56 (P7-P56). Enthesis morphometry, histology, and collagen alignment were investigated throughout postnatal growth. Enthesis tensile mechanical properties were also assessed. Laser microdissection of distinct musculoskeletal tissues was performed at P7 for WT, cKO, and muscle-unloaded (botulinum toxin A treated) attachments for quantitative PCR. cKO mice were smaller, with altered bone shape and impaired enthesis morphology, morphometry, and organization. Structural alterations led to altered mechanical properties; cKO entheses demonstrated reduced strength and stiffness. In P7 attachments, cKOmice had reduced expression of transforming growth factor (TGF) superfamily genes in fibrocartilage compared with WT mice. In conclusion, deletion of Scx led to impairments in enthesis structure, which translated into impairedfunctional (i.e., mechanical) outcomes. These changes may be driven by transient signaling cues from mechanical loading and growth factors.	[Killian, Megan L.; Thomopoulos, Stavros] Washington Univ, Dept Orthoped Surg, St Louis, MO USA	Washington University (WUSTL)	Thomopoulos, S (corresponding author), Columbia Univ, Dept Orthoped Surg, Black Bldg,Room 1408,650 W 168 St, New York, NY 10032 USA.	sat2@columbia.edu	Killian, Megan L./K-2442-2015	Killian, Megan L./0000-0001-6868-5550	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR055580, F32AR064652]; NIH [UL1-TR000448, P30-AR057235]; Children's Discovery Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR064652, P30AR057235, R01AR055580] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R01-AR055580 and F32AR064652, NIH Training Grant UL1-TR000448 to the Washington University Institute of Clinical and Translational Sciences, NIH Grant P30-AR057235 to the Washington University Musculoskeletal Research Center, and the Children's Discovery Institute. Scx<SUP>flx</SUP> mice were provided by Dr. Ronen Schweitzer. Histology was performed by Crystal Idleburg (Washington University Musculoskeletal Research Center, St. Louis, MO, USA). The authors declare no conflicts of interest.	Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Biewener AA, 1996, BONE, V19, P1, DOI 10.1016/8756-3282(96)00116-0; Birman V., 2013, ADV MAT MODELLING ST, V19, P65; Blitz E, 2013, DEVELOPMENT, V140, P2680, DOI 10.1242/dev.093906; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Breidenbach AP, 2015, J ORTHOP RES, V33, P1142, DOI 10.1002/jor.22899; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; Galatz L, 2007, J ORTHOP RES, V25, P1621, DOI 10.1002/jor.20441; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Habernek H, 1999, BRIT J SPORT MED, V33, P430, DOI 10.1136/bjsm.33.6.430; HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982, DOI 10.2106/00004623-199173070-00004; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Jost B, 2006, J BONE JOINT SURG AM, V88A, P472, DOI 10.2106/JBJS.E.00003; Killian ML, 2013, J ORTHOP RES, V31, P1240, DOI 10.1002/jor.22345; Kim HM, 2010, J ORTHOP RES, V28, P1391, DOI 10.1002/jor.21128; Kim HM, 2009, J BONE JOINT SURG AM, V91A, P879, DOI 10.2106/JBJS.H.00088; Liu YX, 2012, MECH MATER, V44, P83, DOI 10.1016/j.mechmat.2011.08.005; Liu YX, 2011, J ENG MATER-T ASME, V133, DOI 10.1115/1.4002641; Liu YX, 2014, BIOMECH MODEL MECHAN, V13, P973, DOI 10.1007/s10237-013-0548-2; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mendias CL, 2012, J ORTHOP RES, V30, P606, DOI 10.1002/jor.21550; Milz S, 2002, J ANAT, V200, P145, DOI 10.1046/j.0021-8782.2001.00016.x; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nakagaki WR, 2011, BONE, V48, P372, DOI 10.1016/j.bone.2010.09.011; Neri BR, 2009, J SHOULDER ELB SURG, V18, P808, DOI 10.1016/j.jse.2009.03.013; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; Schwartz AG, 2015, DEVELOPMENT, V142, P196, DOI 10.1242/dev.112714; Schwartz AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048630; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Tatara AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097375; Thomopoulos S, 2003, J ORTHOP RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418; Thomopoulos S, 2011, TISSUE ENG PT A, V17, P1039, DOI [10.1089/ten.tea.2009.0499, 10.1089/ten.TEA.2009.0499]; Waggett AD, 1998, MATRIX BIOL, V16, P457, DOI 10.1016/S0945-053X(98)90017-8; Wang MN, 2013, J BONE MINER RES, V28, P598, DOI 10.1002/jbmr.1801; Zelzer E, 2014, BIRTH DEFECTS RES C, V102, P101, DOI 10.1002/bdrc.21056	45	43	44	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					301	311		10.1096/fj.14-258236	http://dx.doi.org/10.1096/fj.14-258236			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443819	Green Published			2022-12-26	WOS:000367621000029
J	Larsen, FJ; Schiffer, TA; Ortenblad, N; Zinner, C; Morales-Alamo, D; Willis, SJ; Calbet, JA; Holmberg, HC; Boushel, R				Larsen, Filip J.; Schiffer, Tomas A.; Ortenblad, Niels; Zinner, Christoph; Morales-Alamo, David; Willis, Sarah J.; Calbet, Jose A.; Holmberg, Hans-Christer; Boushel, Robert			High-intensity sprint training inhibits mitochondrial respiration through aconitase inactivation	FASEB JOURNAL			English	Article						exercise; mitochondrial dysfunction; reactive oxygen species; citrate	HUMAN SKELETAL-MUSCLE; OXYGEN-UPTAKE; REDOX REGULATION; VITAMIN-C; EXERCISE; HUMANS; METABOLISM; INCREASES; DEHYDROGENASE; CONTRACTION	Intense exercise training is a powerful stimulus that activates mitochondrial biogenesis pathways and thus increases mitochondrial density and oxidative capacity. Moderate levels of reactive oxygen species (ROS) during exercise are considered vital in the adaptive response, but high ROS production is a serious threat to cellular homeostasis. Although biochemical markers of the transition from adaptive to maladaptive ROS stress are lacking, it is likely mediated by redox sensitive enzymes involved in oxidative metabolism. One potential enzyme mediating such redox sensitivity is the citric acid cycle enzyme aconitase. In this study, we examined biopsy specimens of vastus lateralis and triceps brachii in healthy volunteers, together with primary human myotubes. An intense exercise regimen inactivated aconitase by 55-72%, resulting in inhibition of mitochondrial respiration by 50-65%. In the vastus, the mitochondrial dysfunction was compensated for by a 15-72% increase in mitochondrial proteins, whereas H2O2 emission was unchanged. In parallel with the inactivation of aconitase, the intermediary metabolite citrate accumulated and played an integral part in cellular protection against oxidative stress. In contrast, the triceps failed to increase mitochondrial density, and citrate did not accumulate. Instead, mitochondrial H2O2 emission was decreased to 40% of the pretraining levels, together with a 6-fold increase in protein abundance of catalase. In this study, a novel mitochondrial stress response was highlighted where accumulation of citrate acted to preserve the redox status of the cell during periods of intense exercise.	[Larsen, Filip J.; Schiffer, Tomas A.] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Larsen, Filip J.; Boushel, Robert] Swedish Sch Sport & Hlth Sci, Stockholm, Sweden; [Ortenblad, Niels] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Muscle Res Cluster, Odense, Denmark; [Zinner, Christoph; Willis, Sarah J.; Holmberg, Hans-Christer] Mid Sweden Univ, Swedish Winter Sports Res Ctr, Dept Hlth Sci, Ostersund, Sweden; [Zinner, Christoph] Univ Wurzburg, Dept Sport Sci, D-97070 Wurzburg, Germany; [Morales-Alamo, David; Calbet, Jose A.] Res Inst Biomed & Hlth Sci IUIBS, Las Palmas Gran Canaria, Canary Islands, Spain; [Boushel, Robert] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada	Karolinska Institutet; Swedish School of Sport & Health Sciences; University of Southern Denmark; Mid-Sweden University; University of Wurzburg; University of British Columbia	Larsen, FJ (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Nanna Svartzvag 2, SE-17177 Stockholm, Sweden.	filip.larsen@ki.se	Ortenblad, Niels/AAN-8713-2021; Morales-Alamo, David/D-2683-2009; Schiffer, Tomas/X-1343-2018; Boushel, Robert/ABD-7840-2021; Calbet, Jose A L/H-6693-2015	Ortenblad, Niels/0000-0001-9060-4139; Morales-Alamo, David/0000-0001-8463-397X; Schiffer, Tomas/0000-0002-9077-2682; Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885; Willis, Sarah/0000-0002-0150-3182; Holmberg, Hans-Christer/0000-0002-3814-6246	Swedish National Centre for Research in Sports	Swedish National Centre for Research in Sports	This study was funded by Swedish National Centre for Research in Sports. D.M.-A. is a fellow of the Dr. Manuel Morales Foundation. The authors declare no conflicts of interest.	Andersson U, 1998, BIOCHEM BIOPH RES CO, V249, P512, DOI 10.1006/bbrc.1998.9171; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Blomstrand E, 1997, J PHYSIOL-LONDON, V501, P455, DOI 10.1111/j.1469-7793.1997.455bn.x; Boushel R, 2014, ACTA PHYSIOL, V211, P122, DOI 10.1111/apha.12258; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Brink-Elfegoun T, 2007, J APPL PHYSIOL, V102, P781, DOI 10.1152/japplphysiol.00566.2006; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cobley JN, 2015, FREE RADICAL BIO MED, V84, P65, DOI 10.1016/j.freeradbiomed.2015.03.018; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Ho KP, 2001, BIOCHEM BIOPH RES CO, V282, P264, DOI 10.1006/bbrc.2001.4536; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; Hyzewicz J, 2015, FREE RADICAL BIO MED, V82, P122, DOI 10.1016/j.freeradbiomed.2015.01.023; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; JANSSON E, 1984, ACTA PHYSIOL SCAND, V122, P145, DOI 10.1111/j.1748-1716.1984.tb07492.x; Larsen FJ, 2011, FASEB J, V25, P2843, DOI 10.1096/fj.11-182139; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Narahari J, 2000, J BIOL CHEM, V275, P16227, DOI 10.1074/jbc.M910450199; Paulsen G, 2014, J PHYSIOL-LONDON, V592, P1887, DOI 10.1113/jphysiol.2013.267419; Pearson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096378; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Poole DC, 2008, MED SCI SPORT EXER, V40, P462, DOI [10.1249/mss.0b013e31815ef29b, 10.1249/MSS.0b013e31815ef29b]; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Sahlin K, 2010, J APPL PHYSIOL, V108, P780, DOI 10.1152/japplphysiol.00966.2009; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Skenderi KP, 2008, EUR J CLIN INVEST, V38, P159, DOI 10.1111/j.1365-2362.2007.01917.x; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P435, DOI 10.1046/j.1365-201X.1997.00233.x; Vina J, 2000, IUBMB LIFE, V49, P539; Westerblad H, 2011, ANTIOXID REDOX SIGN, V15, P2487, DOI 10.1089/ars.2011.3909; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1154, DOI 10.1152/ajpcell.00110.2007	35	48	49	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					417	427		10.1096/fj.15-276857	http://dx.doi.org/10.1096/fj.15-276857			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26452378	Green Submitted			2022-12-26	WOS:000367621000039
J	Singh, BK; Sinha, RA; Zhou, J; Tripathi, M; Ohba, K; Wang, ME; Astapova, I; Ghosh, S; Hollenberg, AN; Gauthier, K; Yen, PM				Singh, Brijesh K.; Sinha, Rohit A.; Zhou, Jin; Tripathi, Madhulika; Ohba, Kenji; Wang, Mu-En; Astapova, Inna; Ghosh, Sujoy; Hollenberg, Anthony N.; Gauthier, Karine; Yen, Paul M.			Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; gene regulation; gluconeogenesis; thyroid hormone; transcription coregulator; AKT; MTORC2; RICTOR; insulin signaling	RAPAMYCIN COMPLEX 2; TRANSCRIPTION FACTORS; MAMMALIAN TARGET; TR-BETA; EXPRESSION PROFILES; NEGATIVE REGULATION; MOLECULAR-BASIS; SIRTUIN 1; METABOLISM; RECEPTOR	Background: Thyroid hormone (TH) and FOXO1 share similar transcriptional networks. However, TH regulation of FOXO1 activity is not well understood. Results: TH decreased RICTOR acetylation and MTORC2/AKT activity by SIRT1 activation and reduced FOXO1 phosphorylation. Conclusion: TH co-regulated transcription of FOXO1 target genes via RICTOR deacetylation. Significance: Downstream metabolic effects by TH can post-translationally activate other transcription factors. MTORC2-AKT is a key regulator of carbohydrate metabolism and insulin signaling due to its effects on FOXO1 phosphorylation. Interestingly, both FOXO1 and thyroid hormone (TH) have similar effects on carbohydrate and energy metabolism as well as overlapping transcriptional regulation of many target genes. Currently, little is known about the regulation of MTORC2-AKT or FOXO1 by TH. Accordingly, we performed hepatic transcriptome profiling in mice after FOXO1 knockdown in the absence or presence of TH, and we compared these results with hepatic FOXO1 and THRB1 (TR1) ChIP-Seq data. We identified a subset of TH-stimulated FOXO1 target genes that required co-regulation by FOXO1 and TH. TH activation of FOXO1 was directly linked to an increase in SIRT1-MTORC2 interaction and RICTOR deacetylation. This, in turn, led to decreased AKT and FOXO1 phosphorylation. Moreover, TH increased FOXO1 nuclear localization, DNA binding, and target gene transcription by reducing AKT-dependent FOXO1 phosphorylation in a THRB1-dependent manner. These events were associated with TH-mediated oxidative phosphorylation and NAD(+) production and suggested that downstream metabolic effects by TH can post-translationally activate other transcription factors. Our results showed that RICTOR/MTORC2-AKT can integrate convergent hormonal and metabolic signals to provide coordinated and sensitive regulation of hepatic FOXO1-target gene expression.	[Singh, Brijesh K.; Sinha, Rohit A.; Zhou, Jin; Tripathi, Madhulika; Ohba, Kenji; Wang, Mu-En; Ghosh, Sujoy; Yen, Paul M.] Duke Natl Univ Singapore, Grad Sch Med, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, Singapore 169857, Singapore; [Ghosh, Sujoy] Duke Natl Univ Singapore, Grad Sch Med, Ctr Computat Biol, Singapore 169857, Singapore; [Tripathi, Madhulika] Natl Inst Neurosci, Stroke Trial Unit, Singapore 308433, Singapore; [Wang, Mu-En] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan; [Astapova, Inna; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Astapova, Inna; Hollenberg, Anthony N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gauthier, Karine] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon, F-69364 Lyon 07, France	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); National Taiwan University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Yen, PM (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, 8 Coll Rd, Singapore 169857, Singapore.	paul.yen@duke-nus.edu.sg	Sinha, Rohit/GXV-2427-2022; Ohba, Kenji/AAU-5180-2021; Ghosh, Sujoy/I-3729-2017; Yen, Paul M/V-9857-2019; Singh, Brijesh K/C-1093-2009	Ohba, Kenji/0000-0001-8538-8742; Ghosh, Sujoy/0000-0002-7601-165X; Singh, Brijesh K/0000-0003-4615-3988; Yen, Paul/0000-0002-3790-8114; Wang, Mu-En/0000-0002-5953-3499	Duke-NUS Graduate Medical School Faculty Funds; National Medical Research Council/Early Development Grant [1044/2011]; National Medical Research Council/Clinical Investigator Research Grant [1340/2012]; National Medical Research Council/Clinician Scientist Award [MH95:03/1-8]; Ministry of Health; Ministry of Education; Ministry of Trade, Singapore; A*StaR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056123, T32DK007516] Funding Source: NIH RePORTER	Duke-NUS Graduate Medical School Faculty Funds; National Medical Research Council/Early Development Grant; National Medical Research Council/Clinical Investigator Research Grant; National Medical Research Council/Clinician Scientist Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Health; Ministry of Education; Ministry of Trade, Singapore; A*StaR(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Duke-NUS Graduate Medical School Faculty Funds (to P. M. Y.), National Medical Research Council/Early Development Grant 1044/2011, National Medical Research Council/Clinical Investigator Research Grant 1340/2012, and National Medical Research Council/Clinician Scientist Award Grant MH95:03/1-8, Ministry of Health, Ministry of Education, and Ministry of Trade, Singapore, and A*StaR. The authors declare that they have no conflicts of interest with the contents of this article.	Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Billon C, 2014, ENDOCRINOLOGY, V155, P2735, DOI 10.1210/en.2014-1098; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Contreras-Jurado C, 2011, J BIOL CHEM, V286, P24079, DOI 10.1074/jbc.M111.218487; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Farah BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098155; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Gauthier K, 2010, J BIOL CHEM, V285, P28156, DOI 10.1074/jbc.M110.146241; Glidden EJ, 2012, J BIOL CHEM, V287, P581, DOI 10.1074/jbc.M111.304337; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kalyanaraman H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004911; Kocalis HE, 2014, MOL METAB, V3, P394, DOI 10.1016/j.molmet.2014.01.014; Liberzon A, 2014, METHODS MOL BIOL, V1150, P153, DOI 10.1007/978-1-4939-0512-6_9; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; McAninch EA, 2014, ANN NY ACAD SCI, V1311, P77, DOI 10.1111/nyas.12374; MOURADIAN M, 1983, DIABETES CARE, V6, P512, DOI 10.2337/diacare.6.5.512; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; OPPENHEIMER JH, 1985, ANN INTERN MED, V102, P374, DOI 10.7326/0003-4819-102-3-374; Ortiga-Carvalho TM, 2014, NAT REV ENDOCRINOL, V10, P582, DOI 10.1038/nrendo.2014.143; Ramadoss P, 2014, J BIOL CHEM, V289, P1313, DOI 10.1074/jbc.M113.521450; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rehan L, 2014, LIFE SCI, V105, P1, DOI 10.1016/j.lfs.2014.03.015; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Selmi-Ruby S, 2014, ENDOCRINOLOGY, V155, P635, DOI 10.1210/en.2013-1435; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Singh BK, 2013, J BIOL CHEM, V288, P30365, DOI 10.1074/jbc.M113.504845; Sinha RA, 2014, TRENDS ENDOCRIN MET, V25, P538, DOI 10.1016/j.tem.2014.07.001; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070097; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Thakran S, 2013, J BIOL CHEM, V288, P807, DOI 10.1074/jbc.M112.437970; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, TRENDS ENDOCRIN MET, V14, P327, DOI 10.1016/S1043-2760(03)00114-0; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zhu XG, 2010, ONCOGENE, V29, P1909, DOI 10.1038/onc.2009.476	57	29	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					198	214		10.1074/jbc.M115.668673	http://dx.doi.org/10.1074/jbc.M115.668673			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26453307	hybrid, Green Published			2022-12-26	WOS:000367589500016
J	Ma, JF; Liu, T; Wei, AC; Banerjee, P; O'Rourke, B; Hart, GW				Ma, Junfeng; Liu, Ting; Wei, An-Chi; Banerjee, Partha; O'Rourke, Brian; Hart, Gerald W.			O-GlcNAcomic Profiling Identifies Widespread O-Linked beta-N-Acetylglucosamine Modification (O-GlcNAcylation) in Oxidative Phosphorylation System Regulating Cardiac Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; LINKAGE; CARDIOPROTECTION; LOCALIZATION; TRANSFERASE; EXPRESSION; GLCNACASE; TAU	Dynamic cycling of O-linked beta-N-acetylglucosamine (O-GlcNAc) on nucleocytoplasmic proteins serves as a nutrient sensor to regulate numerous biological processes. However, mitochondrial protein O-GlcNAcylation and its effects on function are largely unexplored. In this study, we performed a comparative analysis of the proteome and O-GlcNAcome of cardiac mitochondria from rats acutely (12 h) treated without or with thiamet-G (TMG), a potent and specific inhibitor of O-GlcNAcase. We then determined the functional consequences in mitochondria isolated from the two groups. O-GlcNAcomic profiling finds that over 88 mitochondrial proteins are O-GlcNAcylated, with the oxidative phosphorylation system as a major target. Moreover, in comparison with controls, cardiac mitochondria from TMG-treated rats did not exhibit altered protein abundance but showed overall elevated O-GlcNAcylation of many proteins. However, O-GlcNAc was unexpectedly down-regulated at certain sites of specific proteins. Concomitantly, TMG treatment resulted in significantly increased mitochondrial oxygen consumption rates, ATP production rates, and enhanced threshold for permeability transition pore opening by Ca2+. Our data reveal widespread and dynamic mitochondrial protein O-GlcNAcylation, serving as a regulator to their function.	[Ma, Junfeng; Banerjee, Partha; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Liu, Ting; Wei, An-Chi; O'Rourke, Brian] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 North Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Regan, Clinton/E-6250-2012	Liu, Ting/0000-0002-8304-5751; Hart, Gerald/0000-0001-7812-4351; Banerjee, Partha/0000-0002-2602-1681; Wei, An-Chi/0000-0001-7927-1636; O'Rourke, Brian/0000-0002-5548-4853	National Institutes of Health [N01-HV-00240, P01HL107153, R01DK61671]; NCRR [S10RR26474]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026474] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK061671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants N01-HV-00240, P01HL107153, and R01DK61671 and Award S10RR26474 from the NCRR (for sharing the Seahorse instrument). Dr. Hart receives a share of royalty received by the university on sales of the CTD 110.6 antibody, which are managed by the Johns Hopkins University.	Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Baycin-Hizal D, 2012, J PROTEOME RES, V11, P5265, DOI 10.1021/pr300476w; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Cao WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076399; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Duncan JG, 2011, BBA-MOL CELL RES, V1813, P1351, DOI 10.1016/j.bbamcr.2011.01.014; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Foster DB, 2008, BIOCHEM BIOPH RES CO, V366, P649, DOI 10.1016/j.bbrc.2007.11.154; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Johnsen VL, 2013, PHYSIOL GENOMICS, V45, P17, DOI 10.1152/physiolgenomics.00111.2012; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Marsh SA, 2014, J BIOL CHEM, V289, P34449, DOI 10.1074/jbc.R114.585984; Nicholls DG, 2013, BIOENERGETICS 4, P89; Ramirez-Corream G. A., 2015, DIABETES, DOI [10.2337/db14-1107, DOI 10.2337/DB14-1107]; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shin SH, 2011, AMINO ACIDS, V40, P885, DOI 10.1007/s00726-010-0719-8; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vaidyanathan K, 2014, J BIOL CHEM, V289, P34466, DOI 10.1074/jbc.R114.591560; Vosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Wei AC, 2011, BBA-MOL CELL RES, V1813, P1373, DOI 10.1016/j.bbamcr.2011.02.012; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wu TJ, 2009, EUR J PHARMACOL, V613, P93, DOI 10.1016/j.ejphar.2009.04.012; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2014, CHEM SOC REV, V43, P6839, DOI 10.1039/c4cs00038b; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]	51	64	67	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29141	29153		10.1074/jbc.M115.691741	http://dx.doi.org/10.1074/jbc.M115.691741			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26446791	Green Published, hybrid			2022-12-26	WOS:000366613400003
J	Liu, WS; Liu, YD; Liu, HO; Zhang, WJ; Fu, Q; Xu, JJ; Gu, JX				Liu, Weisi; Liu, Yidong; Liu, Haiou; Zhang, Weijuan; Fu, Qiang; Xu, Jiejie; Gu, Jianxin			Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; ZESTE HOMOLOG 2; PROSTATE-CANCER; ANDROGEN RECEPTOR; HEPATOMA-CELLS; PAK6; GROWTH; IDENTIFICATION; EXPRESSION; ANOIKIS	Our previous studies identified the oncogenic role of p21-activated kinase 1 (PAK1) in hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). Contrarily, PAK6 was found to predict a favorable prognosis in RCC patients. Nevertheless, the ambiguous tumor suppressive function of PAK6 in hepatocarcinogenesis remains obscure. Herein, decreased PAK6 expression was found to be associated with tumor node metastasis stage progression and unfavorable overall survival inHCCpatients. Additionally, overexpression and silence of PAK6 experiments showed that PAK6 inhibited xenografted tumor growth in vivo, and restricted cell proliferation, colony formation, migration, and invasion and promoted cell apoptosis and anoikis in vitro. Moreover, overexpression of kinase dead and nuclear localization signal deletion mutants of PAK6 experiments indicated the tumor suppressive function of PAK6 was partially dependent on its kinase activity and nuclear translocation. Furthermore, gain or loss of function in polycomb repressive complex 2 (PRC2) components, including EZH2, SUZ12, and EED, elucidated epigenetic control of H3K27me3-arbitrated PAK6 down-regulation in hepatoma cells. More importantly, negative correlation between PAK6 and EZH2 expression was observed in hepatoma tissues from HCC patients. These data identified the tumor suppressive role and potential underlying mechanism of PAK6 in hepatocarcinogenesis.	[Liu, Weisi; Liu, Yidong; Fu, Qiang; Xu, Jiejie; Gu, Jianxin] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Zhang, Weijuan] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China; [Liu, Haiou] Fudan Univ, Hosp Obstet & Gynecol, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, JJ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China.	jjxufdu@fudan.edu.cn; jxgu@shmu.edu.cn	Liu, Haiou/AFS-2886-2022; Zhang, Weijuan/Q-1645-2019	Liu, Haiou/0000-0003-0200-8981; Zhang, Weijuan/0000-0003-3494-3114; liu, weisi/0000-0002-4730-5448	National Basic Research Program of China [2012CB822104]; National Key Projects for Infectious Diseases of China [2012ZX10002-012]; National Natural Science Foundation of China [31100629, 31270863, 31300671, 81372755, 31470794, 81401988, 81402082, 81402085, 81471621, 81472227, 81472376, 31570803, 81572352]; Program for New Century Excellent Talents in University [NCET-13-0146]; Shanghai Rising-Star Program [13QA1400300]	National Basic Research Program of China(National Basic Research Program of China); National Key Projects for Infectious Diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Program	This work was supported by National Basic Research Program of China Grant 2012CB822104, National Key Projects for Infectious Diseases of China Grant 2012ZX10002-012, National Natural Science Foundation of China Grants 31100629, 31270863, 31300671, 81372755, 31470794, 81401988, 81402082, 81402085, 81471621, 81472227, 81472376, 31570803, and 81572352, Program for New Century Excellent Talents in University Grant NCET-13-0146, and Shanghai Rising-Star Program Grant 13QA1400300. All study sponsors have no roles in the study design, collection, analysis, and interpretation of data.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Cai SW, 2015, ONCOTARGET, V6, P3904, DOI 10.18632/oncotarget.2880; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen HW, 2014, J SURG RES, V189, P81, DOI 10.1016/j.jss.2014.01.049; Chen J, 2015, ONCOTARGET, V6, P355, DOI 10.18632/oncotarget.2803; Cheng CC, 2015, IN VIVO, V29, P237; Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hayashi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091330; Henrici A, 2015, MOL CARCINOGEN, V54, P585, DOI 10.1002/mc.22122; Hodgson MC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0061-y; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Kamarajan P, 2012, CANCER-AM CANCER SOC, V118, P5800, DOI 10.1002/cncr.27655; Kaur R, 2008, PROSTATE, V68, P1510, DOI 10.1002/pros.20787; Lee EJ, 2010, ONCOL RES, V18, P401; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Liu T, 2013, J BIOL CHEM, V288, P3359, DOI 10.1074/jbc.M112.384289; Liu WS, 2014, ANN SURG ONCOL, V21, pS575, DOI 10.1245/s10434-014-3680-z; Lu GD, 2015, HEPATOLOGY, V61, P965, DOI 10.1002/hep.27593; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; Ma WL, 2008, GASTROENTEROLOGY, V135, P1805; Mann DA, 2014, HEPATOLOGY, V60, P1418, DOI 10.1002/hep.27131; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Tian XC, 2010, J VIROL, V84, P3373, DOI 10.1128/JVI.02555-09; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; van de Wijngaart DJ, 2006, J BIOL CHEM, V281, P19407, DOI 10.1074/jbc.M602567200; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wang SS, 2013, CANCER SCI, V104, P750, DOI 10.1111/cas.12132; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wu J, 2013, DIGEST DIS SCI, V58, P3545, DOI 10.1007/s10620-013-2867-7; Xiao QY, 2013, GUT, V62, P440, DOI 10.1136/gutjnl-2011-300781; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhu Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.2; Zhu Y, 2013, CANCER SCI, V104, P1052, DOI 10.1111/cas.12176	49	16	18	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28489	28501		10.1074/jbc.M115.658237	http://dx.doi.org/10.1074/jbc.M115.658237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26442588	hybrid, Green Published			2022-12-26	WOS:000365761900042
J	Abraham, A; Alabdali, M; Qrimli, M; Albulaihe, H; Breiner, A; Barnett, C; Katzberg, HD; Lovblom, LE; Perkins, BA; Bril, V				Abraham, Alon; Alabdali, Majed; Qrimli, Mohammad; Albulaihe, Hana; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Lovblom, Leif E.; Perkins, Bruce A.; Bril, Vera			Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination	PLOS ONE			English	Article							CRITERIA; POLYRADICULONEUROPATHY; POLYNEUROPATHY; VALIDATION; DIAGNOSIS; SOCIETY; SYSTEM	Introduction Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is one of several chronic treatable acquired demyelinating neuropathies. Objectives To explore the association between the degree of demyelination in CIDP, and treatment responsiveness. Methods A retrospective chart review of CIDP subjects assessed between 1997 and 2013 was performed to compare treatment responsiveness using different sets of criteria. Results 99 CIDP patients were included, 34 with diabetes mellitus (DM). Treatment responsiveness was higher in CIDP-DM fulfilling 1 or more EFNS/PNS criteria, (63% vs. 31%, p = 0.03), and in CIDP+DM fulfilling 2 or more criteria (89% vs. 36%, p = 0.01). Nonetheless, treatment responsiveness in CIDP+DM had the highest odds ratio (3.73, p = 0.01). Similar results were also shown in simplified uniform study criteria, with 10% cut off values for CIDP-DM, compared to 30% for CIDP+DM. Conclusion In CIDP+DM, higher degrees of demyelination are associated with treatment responsiveness, implying the need to adjust current criteria in these patients.	[Abraham, Alon; Qrimli, Mohammad; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Bril, Vera] Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Div Neurol,Dept Med, Toronto, ON, Canada; [Alabdali, Majed] Univ Dammam, King Fahad Hosp Univ, Dept Neurol, Dammam, Saudi Arabia; [Albulaihe, Hana] King Saud Univ, King Khalid Univ Hosp, Dept Neurol, Riyadh, Saudi Arabia; [Lovblom, Leif E.; Perkins, Bruce A.] Mt Sinai Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON M5G 1X5, Canada; [Lovblom, Leif E.; Perkins, Bruce A.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Imam Abdulrahman Bin Faisal University; King Saud University; King Khalid University Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bril, V (corresponding author), Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Div Neurol,Dept Med, Toronto, ON, Canada.	vera.bril@utoronto.ca	Perkins, Bruce A/L-3726-2017; Barnett, Carolina/AFM-9470-2022; BRIL, vera/ABA-6509-2020; Abraham, Alon/H-9343-2019	Abraham, Alon/0000-0002-9020-2399; Barnett, Carolina/0000-0001-5546-0221; Lovblom, Leif Erik/0000-0002-6774-8924				Abraham A, 2015, EXPERT REV CLIN IMMU, V11, P537, DOI 10.1586/1744666X.2015.1018891; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2011, PAINLESS DIABETIC MO; Bolton CF, 2000, CAN J NEUROL SCI, V27, P288, DOI 10.1017/S0317167100001013; Bosboom WMJ, 2001, BRAIN, V124, P2427, DOI 10.1093/brain/124.12.2427; Breiner A, 2014, MUSCLE NERVE, V50, P40, DOI 10.1002/mus.24088; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Chan YC, 2006, J NEUROL NEUROSUR PS, V77, P114, DOI 10.1136/jnnp.2004.056515; Cocito D, 2006, EUR J NEUROL, V13, P669, DOI 10.1111/j.1468-1331.2006.01259.x; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; Dunnigan SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089344; Dunnigan SK, 2013, DIABETES CARE, V36, P3684, DOI 10.2337/dc13-0746; DYCK PJ, 1986, ANN NEUROL, V19, P425, DOI 10.1002/ana.410190503; Gorson KC, 2000, MUSCLE NERVE, V23, P37, DOI 10.1002/(SICI)1097-4598(200001)23:1<37::AID-MUS5>3.0.CO;2-9; Herrmann DN, 2002, MUSCLE NERVE, V26, P232, DOI 10.1002/mus.10204; Hughes RAC, 2006, EUR J NEUROL, V13, P326, DOI 10.1111/j.1468-1331.2006.01278.x; Iijima M, 2005, NEUROLOGY, V64, P1471, DOI 10.1212/01.WNL.0000158680.89323.F8; Joint Task Force of the EFNS and the PNS, 2010, EUR FED NEUR SOC PER, P1, DOI [10.1111/j.1529-8027.2010.00245.x, DOI 10.1111/J.1529-8027.2010.00245.X]; Katz JS, 2000, NEUROLOGY, V54, P615, DOI 10.1212/WNL.54.3.615; Koller H, 2005, NEW ENGL J MED, V352, P1343, DOI 10.1056/nejmra041347; Koski CL, 2009, J NEUROL SCI, V277, P1, DOI 10.1016/j.jns.2008.11.015; Kuwabara S, 2002, J NEUROL NEUROSUR PS, V72, P37, DOI 10.1136/jnnp.72.1.37; Latov N, 2002, NEUROLOGY, V59, pS2, DOI 10.1212/WNL.59.12_suppl_6.S2; Laughlin RS, 2009, NEUROLOGY, V73, P39, DOI 10.1212/WNL.0b013e3181aaea47; Magda P, 2003, ARCH NEUROL-CHICAGO, V60, P1755, DOI 10.1001/archneur.60.12.1755; PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203; Rajabally YA, 2015, MUSCLE NERVE, V51, P932, DOI 10.1002/mus.24496; Rotta FT, 2000, J NEUROL SCI, V173, P129, DOI 10.1016/S0022-510X(99)00317-2; SIMMONS Z, 1993, NEUROLOGY, V43, P2202, DOI 10.1212/WNL.43.11.2202; Stewart JD, 1996, J NEUROL SCI, V142, P59, DOI 10.1016/0022-510X(96)00126-8; Uncini A, 1999, CLIN NEUROPHYSIOL, V110, P705, DOI 10.1016/S1388-2457(98)00028-5; Weisman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058783; Wilson JR, 1998, MUSCLE NERVE, V21, P1228, DOI 10.1002/(SICI)1097-4598(199809)21:9<1228::AID-MUS20>3.0.CO;2-M	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139674	10.1371/journal.pone.0139674	http://dx.doi.org/10.1371/journal.pone.0139674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461125	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300021
J	Li, HC; Holroyd, E; Lau, J				Li, Haochu; Holroyd, Eleanor; Lau, Joseph			Exploring Unprotected Anal Intercourse among Newly Diagnosed HIV Positive Men Who Have Sex with Men in China: An Ethnographic Study	PLOS ONE			English	Article							RISK BEHAVIOR; CONDOM USE; METAANALYSIS; CONNECTIONS; DISCLOSURE; GUANGZHOU; MSM	Background Unprotected anal intercourse (UAI) is a major pathway towards secondary HIV transmission among men who have sex with men (MSM). We explored the socio-cultural environment and individual beliefs and experiences conducive to UAI in the context of Southern China. Methods We employed an ethnographic approach utilizing a socio-ecological framework to conduct repeated in-depth interviews with thirty one newly diagnosed HIV positive MSM as well as participant observations in Shenzhen based healthcare settings, MSM venues and NGO offices. Results Some men (6/31) reported continuing to practice UAI after an initial diagnosis of being HIV positive. For MSM who had existing lovers or stable partners, the fear of losing partners in a context of non-serostatus disclosure was testified to be a major concern. MSM with casual partners reported that anonymous sexual encounters and moral judgments played a significant role in their sexual risk behaviors. Simultaneously, self-reported negative emotional and psychological status, perception and idiosyncratic risk interpretation, as well as substance abuse informed the intrapersonal context for UAI. Conclusion UAI among these HIV positive MSM was embedded in an intrapersonal context, related to partner type, shaped by anonymous sexual encounters, psychological status, and moral judgments. It is important that prevention and intervention for secondary HIV transmission among newly diagnosed HIV positive MSM in China take into account these contextual factors.	[Li, Haochu] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China; [Li, Haochu] Univ N Carolina, Inst Global Hlth & Infect Dis, UNC Project China, Chapel Hill, NC USA; [Holroyd, Eleanor] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Holroyd, Eleanor] Univ Melbourne, Ctr Womens Hlth Gender & Soc, Melbourne, Vic, Australia; [Lau, Joseph] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Shandong University; University of North Carolina; University of North Carolina Chapel Hill; Royal Melbourne Institute of Technology (RMIT); University of Melbourne; Chinese University of Hong Kong	Li, HC (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China.	haochuli@med.unc.edu		Holroyd, Eleanor/0000-0002-2993-8823	Center for Health Behaviors Research of the Jockey Club School of Public Health and Primary Care (JCSPHPC); Chinese University of Hong Kong (CUHK); postgraduate study grant in JCSPHPC; Global Scholarship Programme for Research Excellence - CNOOC Grants in CUHK	Center for Health Behaviors Research of the Jockey Club School of Public Health and Primary Care (JCSPHPC); Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); postgraduate study grant in JCSPHPC; Global Scholarship Programme for Research Excellence - CNOOC Grants in CUHK	This research obtained funding from the Center for Health Behaviors Research of the Jockey Club School of Public Health and Primary Care (JCSPHPC), The Chinese University of Hong Kong (CUHK), a postgraduate study grant in JCSPHPC, and the Global Scholarship Programme for Research Excellence - CNOOC Grants 2010-11 in CUHK.	[Anonymous], AIDS BEHAV, DOI DOI 10.1023/A:1011348828325; Behringer K, 2003, THESIS UCHC; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Boone MR, 2013, AIDS BEHAV, V17, P1883, DOI 10.1007/s10461-012-0167-4; Brennan DJ, 2010, AIDS EDUC PREV, V22, P126, DOI 10.1521/aeap.2010.22.2.126; *CHIN MIN HLTH, 2003, JOINT ASS HIV AIDS P; China Ministry of Health UNAIDS World Health Organization (WHO), 2010, 2009 EST HIV AIDS EP; Chinese Ministry of Health, 2012, 2012 CHIN AIDS RESP; Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P923, DOI 10.1037/0022-3514.73.5.923; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Ciccarone DH, 2003, AM J PUBLIC HEALTH, V93, P949, DOI 10.2105/AJPH.93.6.949; Finkel N., 2001, DISCOURSE STUDIES, V3, P5, DOI DOI 10.1177/1461445601003001001; Gorbach PM, 2004, SEX TRANSM INFECT, V80, P512, DOI 10.1136/sti.2004.010918; Green J, 2009, QUALITATIVE METHODS; Guy RJ, 2011, SEX HEALTH, V8, P319, DOI 10.1071/SH10095; Hatfield E, 1980, PERS RELATIONSHIP, P165; Jin FY, 2012, SEX TRANSM DIS, V39, P191, DOI 10.1097/OLQ.0b013e3182401a2f; Li HC, 2010, AIDS CARE, V22, P1481, DOI 10.1080/09540121.2010.482121; Li HC, 2010, CULT HEALTH SEX, V12, P401, DOI 10.1080/13691050903551721; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Martin JI, 2010, AM J ORTHOPSYCHIAT, V80, P293, DOI 10.1111/j.1939-0025.2010.01032.x; Mou J, 2011, J COMMUNITY PSYCHOL, V39, P212, DOI 10.1002/jcop.20428; O'Cleirigh C, 2013, AIDS BEHAV, V17, P1764, DOI 10.1007/s10461-013-0462-8; Rofel Lisa, 2007, DESIRING CHINA EXPER; Rosser BRS, 2010, J BEHAV MED, V33, P147, DOI 10.1007/s10865-009-9244-1; Safren SA, 2010, HEALTH PSYCHOL, V29, P215, DOI 10.1037/a0017859; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Schutz M, 2011, INT J STD AIDS, V22, P391, DOI 10.1258/ijsa.2011.010205; Shenzhen City Government General Office, 2011, SHENZH SHI RENK FAZH; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; van Kesteren NMC, 2005, QUAL HEALTH RES, V15, P145, DOI 10.1177/1049732304270817; Vanable PA, 2012, AIDS BEHAV, V16, P554, DOI 10.1007/s10461-011-0047-3; Xie W, 2010, CHIN J AIDS STD, V17, P414	33	7	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140555	10.1371/journal.pone.0140555	http://dx.doi.org/10.1371/journal.pone.0140555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT6ZJ	26461258	Green Published, gold			2022-12-26	WOS:000362962300110
J	Tseng, CW; Lai, KL; Chen, DY; Lin, CH; Chen, HH				Tseng, Chih-Wei; Lai, Kuo-Lung; Chen, Der-Yuan; Lin, Ching-Heng; Chen, Hsin-Hua			The Incidence and Prevalence of Common Variable Immunodeficiency Disease in Taiwan, A Population-Based Study	PLOS ONE			English	Article							IMMUNE-DEFICIENCY; NATIONAL REGISTRY; UPDATE; HYPOGAMMAGLOBULINEMIA; DISORDERS; FEATURES; DATABASE; RISK; IRAN	Common variable immunodeficiency (CVID) is one of the primary immunodeficiency diseases that occur in both children and adults. We present here a nationwide, population-based epidemiological study of CVID across all ages in Taiwan during 2002-2011. Using the International Classification of Diseases, Ninth Revision code 279.06, cases of CVID were identified from Taiwan's National Health Insurance Research Database from January 2002 to December 2011. Age-and sex-specific incidence and prevalence rates were calculated. A total of 47 new cases of CVID during 2002-2011 were identified. Total prevalence rose from 0.13 per 100,000 in 2002 to 0.28 per 100,000 in 2011. The annual incidence rate during 2002-2011 was 0.019 per 100,000. Cases were equally distributed between males and females and males mostly occurred in younger patients. This nationwide population-based study showed that the incidence and prevalence of CVID in Taiwan were lower than that in Western countries.	[Tseng, Chih-Wei; Lai, Kuo-Lung; Chen, Der-Yuan; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taichung, Taiwan; [Lai, Kuo-Lung; Chen, Der-Yuan; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Lin, Ching-Heng; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.	epid@ms39.hinet.net; shc5555@hotmail.com		Tseng, Chih-Wei/0000-0002-5948-7306				Aghamohammadi A, 2014, J CLIN IMMUNOL, V34, P478, DOI 10.1007/s10875-014-0001-z; Ardeniz O, 2009, CLIN IMMUNOL, V133, P198, DOI 10.1016/j.clim.2009.05.001; Chan HY, 2014, J FORMOS MED ASSOC, V113, P340, DOI 10.1016/j.jfma.2012.07.005; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Edgar JDM, 2014, CLIN EXP IMMUNOL, V175, P68, DOI 10.1111/cei.12172; Eijkhout HW, 2001, ANN INTERN MED, V135, P165, DOI 10.7326/0003-4819-135-3-200108070-00008; Gathmann B, 2013, CLIN EXP IMMUNOL, V173, P372, DOI 10.1111/cei.12105; Gathmann B, 2009, CLIN EXP IMMUNOL, V157, P3, DOI 10.1111/j.1365-2249.2009.03954.x; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; HAYAKAWA H, 1981, J CLIN IMMUNOL, V1, P31, DOI 10.1007/BF00915474; Haymore BR, 2008, AUTOIMMUN REV, V7, P309, DOI 10.1016/j.autrev.2007.11.024; Lee WI, 2011, IMMUNOBIOLOGY, V216, P1286, DOI 10.1016/j.imbio.2011.06.002; Lee WI, 2005, J CLIN IMMUNOL, V25, P162, DOI 10.1007/s10875-005-2822-2; Lehman HK, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0553-x; Liang Fang-Chen, 2008, Acta Paediatrica Taiwanica, V49, P3; Lin Li-Hsin, 2005, Journal of Microbiology Immunology and Infection, V38, P358; Mellemkjaer L, 2002, CLIN EXP IMMUNOL, V130, P495, DOI 10.1046/j.1365-2249.2002.02004.x; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Rensing-Ehl A, 2010, CLIN IMMUNOL, V137, P357, DOI 10.1016/j.clim.2010.08.008; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Rezaei N, 2006, J CLIN IMMUNOL, V26, P519, DOI 10.1007/s10875-006-9047-x; Rhim JW, 2012, J KOREAN MED SCI, V27, P788, DOI 10.3346/jkms.2012.27.7.788; Schatorje EJH, 2014, CLIN EXP IMMUNOL, V176, P387, DOI 10.1111/cei.12281; Wang J, 2005, J AUTOIMMUN, V25, P57, DOI 10.1016/j.jaut.2005.04.006; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Xiao X, 2014, AUTOIMMUN REV, V13, P858, DOI 10.1016/j.autrev.2014.04.006	27	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140473	10.1371/journal.pone.0140473	http://dx.doi.org/10.1371/journal.pone.0140473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461272	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300099
J	Zheng, HR; Wen, SS; Zhang, Y; Sun, ZL				Zheng, Hengrui; Wen, Songsong; Zhang, Yang; Sun, Zhenliang			Organosilane and Polyethylene Glycol Functionalized Magnetic Mesoporous Silica Nanoparticles as Carriers for CpG Immunotherapy In Vitro and In Vivo	PLOS ONE			English	Article							DRUG-DELIVERY; DEGRADATION BEHAVIOR; BACTERIAL-DNA; GENE; BIODISTRIBUTION; DISSOLUTION; ADSORPTION; ADJUVANT; CPG-7909; SEQUENCE	Cytosine-guanine (CpG) containing oligodeoxynucleotides (ODN) have significant clinical potential as immunotherapeutics. However, limitations exist due to their transient biological stability in vivo, lack of specificity for target cells, and poor cellular uptake. To address these issues, we prepared amine magnetic mesoporous silica nanoparticles (M-MSN-A) then further modified with polyethylene glycol (PEG) for use as CpG delivery vectors. The PEG modified M-MSN-A (M-MSN-P) had notable CpG ODN loading capacity, negligible cytotoxicity, and were easily internalized into cells where they released the loaded CpG into the cytoplasm. As a result, such complexes were effective in activating macrophages and inhibiting tumor cells when combined with chemotherapeutics in vitro. Furthermore, these complexes had excellent immuno-stimulating activity in vivo, compared to the free CpG therapeutics. We report here a highly effective MSNs-based delivery system with great potential as a therapeutic CpG formulation in cancer immunotherapy.	[Zheng, Hengrui] Qingdao Univ, Affiliated Hosp, Med Res Ctr, Qingdao 266003, Peoples R China; [Sun, Zhenliang] So Med Univ, Fengxian Hosp, Shanghai 201499, Peoples R China; [Wen, Songsong] Qilu Pharmaceut Co Ltd, Jinan 250101, Peoples R China; [Zhang, Yang] Shanghai Jiao Tong Univ, Tong Ren Hosp, Sch Med, Shanghai 200336, Peoples R China	Qingdao University; Southern Medical University - China; Shanghai Jiao Tong University	Sun, ZL (corresponding author), So Med Univ, Fengxian Hosp, 6600 NanFeng Rd, Shanghai 201499, Peoples R China.	hope1126@hotmail.com			Qilu Pharmaceutical Co. Ltd.	Qilu Pharmaceutical Co. Ltd.	The authors received no specific funding for this work. Qilu Pharmaceutical Co. Ltd. provided support in the form of salary for author S. Wen, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Chen KH, 2012, J MATER CHEM, V22, P22005, DOI 10.1039/c2jm34364a; Cooper CL, 2005, AIDS, V19, P1473, DOI 10.1097/01.aids.0000183514.37513.d2; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Faneca H, 2002, BBA-BIOMEMBRANES, V1567, P23, DOI 10.1016/S0005-2736(02)00545-X; Hafeli UO, 2004, INT J PHARMACEUT, V277, P19, DOI 10.1016/S0378-5173(04)00127-9; Hartono SB, 2012, ACS NANO, V6, P2104, DOI 10.1021/nn2039643; He QJ, 2010, MICROPOR MESOPOR MAT, V131, P314, DOI 10.1016/j.micromeso.2010.01.009; Hwang SJ, 2001, CURR OPIN MOL THER, V3, P183; Kim J, 2008, ANGEW CHEM INT EDIT, V47, P8438, DOI 10.1002/anie.200802469; Kim N, 2012, INT J PHARMACEUT, V427, P123, DOI 10.1016/j.ijpharm.2011.08.014; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kunzmann A, 2011, BBA-GEN SUBJECTS, V1810, P361, DOI 10.1016/j.bbagen.2010.04.007; Lang N, 2004, CHEM MATER, V16, P1961, DOI 10.1021/cm030633n; Li X, 2013, BIOMATERIALS, V34, P1391, DOI 10.1016/j.biomaterials.2012.10.072; Li X, 2012, LANGMUIR, V28, P2827, DOI 10.1021/la204443j; Li X, 2011, BIOMATERIALS, V32, P9546, DOI 10.1016/j.biomaterials.2011.08.068; Li X, 2011, LANGMUIR, V27, P6099, DOI 10.1021/la104653s; Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t; Liu J, 2012, BIOMATERIALS, V33, P970, DOI 10.1016/j.biomaterials.2011.10.001; Lu J, 2010, SMALL, V6, P1794, DOI 10.1002/smll.201000538; Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030; Mahato RI, 1998, HUM GENE THER, V9, P2083, DOI 10.1089/hum.1998.9.14-2083; Meyer O, 1998, J BIOL CHEM, V273, P15621, DOI 10.1074/jbc.273.25.15621; Mizuno Y, 2010, J CONTROL RELEASE, V141, P252, DOI 10.1016/j.jconrel.2009.09.014; Mutwiri GK, 2004, J CONTROL RELEASE, V97, P1, DOI 10.1016/j.jcornel.2004.02.022; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Pontarollo RA, 2002, VET IMMUNOL IMMUNOP, V84, P43, DOI 10.1016/S0165-2427(01)00379-8; Rankin R, 2001, ANTISENSE NUCLEIC A, V11, P333, DOI 10.1089/108729001753231713; Ravikovitch PI, 1997, J PHYS CHEM B, V101, P3671, DOI 10.1021/jp9625321; Rosenholm JM, 2010, NANOSCALE, V2, P1870, DOI 10.1039/c0nr00156b; Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tu J, 2012, BIOMATERIALS, V33, P7903, DOI 10.1016/j.biomaterials.2012.07.025; Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488; Verthelyi D, 2003, J IMMUNOL, V170, P4717, DOI 10.4049/jimmunol.170.9.4717; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Wilson KD, 2009, ADV DRUG DELIVER REV, V61, P233, DOI 10.1016/j.addr.2008.12.014; Xia T, 2008, ACS NANO, V2, P85, DOI 10.1021/nn700256c; Xu H, 2006, J AM CHEM SOC, V128, P15582, DOI 10.1021/ja066165a; YAMAMOTO T, 1994, MICROBIOL IMMUNOL, V38, P831, DOI 10.1111/j.1348-0421.1994.tb01867.x; Zhang JX, 2011, J COLLOID INTERF SCI, V361, P16, DOI 10.1016/j.jcis.2011.05.038; Zhu YF, 2011, J PHYS CHEM C, V115, P13630, DOI 10.1021/jp203454g; Zhu YF, 2011, J PHYS CHEM C, V115, P447, DOI 10.1021/jp109535d; Zhu YF, 2011, MICROPOR MESOPOR MAT, V141, P199, DOI 10.1016/j.micromeso.2010.11.013	49	15	17	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140265	10.1371/journal.pone.0140265	http://dx.doi.org/10.1371/journal.pone.0140265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451735	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200055
J	Guo, L; Xu, CY; Li, D; Zheng, XL; Tang, JB; Bu, JY; Sun, H; Yang, ZK; Sun, WJ; Yu, XG				Guo, Liang; Xu, Chunyan; Li, Dong; Zheng, Xiulan; Tang, Jiebing; Bu, Jingyi; Sun, Hui; Yang, Zhengkai; Sun, Wenjing; Yu, Xiaoguang			Calcium Ion Flow Permeates Cells through SOCs to Promote Cathode-Directed Galvanotaxis	PLOS ONE			English	Article							CURRENT ELECTRIC-FIELD; EPITHELIAL-CELLS; NERVE GROWTH; RECEPTORS; RESPONSES; CA2+; MOVEMENT; MOTILITY; ACTIN; ELECTROPHORESIS	Sensing and responding to endogenous electrical fields are important abilities for cells engaged in processes such as embryogenesis, regeneration and wound healing. Many types of cultured cells have been induced to migrate directionally within electrical fields in vitro using a process known as galvanotaxis. The underlying mechanism by which cells sense electrical fields is unknown. In this study, we assembled a polydimethylsiloxane (PDMS) galvanotaxis system and found that mouse fibroblasts and human prostate cancer PC3 cells migrated to the cathode. By comparing the effects of a pulsed direct current, a constant direct current and an anion-exchange membrane on the directed migration of mouse fibroblasts, we found that these cells responded to the ionic flow in the electrical fields. Taken together, the observed effects of the calcium content of the medium, the function of the store-operated calcium channels (SOCs) and the intracellular calcium content on galvanotaxis indicated that calcium ionic flow from the anode to the cathode within the culture medium permeated the cells through SOCs at the drift velocity, promoting migration toward the cathode. The RTK-PI3K pathway was involved in this process, but the ROCK and MAPK pathways were not. PC3 cells and mouse fibroblasts utilized the same mechanism of galvanotaxis. Together, these results indicated that the signaling pathway responsible for cathode-directed cellular galvanotaxis involved calcium ionic flow from the anode to the cathode within the culture medium, which permeated the cells through SOCs, causing cytoskeletal reorganization via PI3K signaling.	[Guo, Liang; Xu, Chunyan; Li, Dong; Bu, Jingyi; Sun, Hui; Yang, Zhengkai; Sun, Wenjing; Yu, Xiaoguang] Harbin Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Harbin 150081, Heilongjiang, Peoples R China; [Guo, Liang] Harbin Engn Univ, Inst Biomed Engn, Coll Automat, Harbin 150001, Heilongjiang, Peoples R China; [Guo, Liang] Harbin Engn Univ, Coll Automat, Bioinformat Res Ctr, Harbin 150001, Heilongjiang, Peoples R China; [Zheng, Xiulan] Harbin Med Univ, Canc Hosp, Dept Ultrasonog, Harbin 150081, Heilongjiang, Peoples R China; [Tang, Jiebing] Harbin Med Univ, Canc Hosp, Dept Clin Oncol, Harbin 150081, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Engineering University; Harbin Engineering University; Harbin Medical University; Harbin Medical University	Yu, XG (corresponding author), Harbin Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Harbin 150081, Heilongjiang, Peoples R China.	Xiaoguang_yu@hotmail.com			National Natural Science Foundation of China [61301007, 61471139]; Fundamental Research Funds for the Central Universities [HEUCFT1302, HEUCFX41303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by National Natural Science Foundation of China (No. 61301007 and 61471139) and Fundamental Research Funds for the Central Universities (HEUCFT1302, HEUCFX41303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GM, 2013, CURR BIOL, V23, P560, DOI 10.1016/j.cub.2013.02.047; Arocena M, 2010, J NEUROSCI RES, V88, P3267, DOI 10.1002/jnr.22502; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Chang PCT, 1996, J FORMOS MED ASSOC, V95, P623; COOPER MS, 1985, J NEUROSCI RES, V13, P223, DOI 10.1002/jnr.490130116; Cuzick J, 1998, LANCET, V352, P359, DOI 10.1016/S0140-6736(97)10002-2; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Han J, 2009, CURR EYE RES, V34, P438, DOI 10.1080/02713680902879033; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang L, 2009, J CELL PHYSIOL, V219, P162, DOI 10.1002/jcp.21660; Keizer-Gunnink I, 2007, J CELL BIOL, V177, P579, DOI 10.1083/jcb.200611046; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; MCCLOSKEY MA, 1984, J CELL BIOL, V99, P778, DOI 10.1083/jcb.99.3.778; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Ozkucur N, 2014, CELL MOL LIFE SCI, V71, P4653, DOI 10.1007/s00018-014-1632-1; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; ONUMA EK, 1988, J CELL BIOL, V106, P2067, DOI 10.1083/jcb.106.6.2067; ORIDA N, 1978, NATURE, V275, P31, DOI 10.1038/275031a0; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2003, J PHYSIOL-LONDON, V547, P333, DOI 10.1113/jphysiol.2002.034140; Perike S, 2014, EXP CELL RES, V324, P13, DOI 10.1016/j.yexcr.2014.03.005; POO MM, 1977, NATURE, V265, P602, DOI 10.1038/265602a0; Putney JW, 2004, TRENDS CELL BIOL, V14, P282, DOI 10.1016/j.tcb.2004.04.002; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248; Siwy Z, 2003, EUR BIOPHYS J BIOPHY, V32, P12, DOI 10.1007/s00249-002-0267-6; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Trollinger DR, 2002, J CELL PHYSIOL, V193, P1, DOI 10.1002/jcp.10144; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152; WITKE W, 1993, J CELL BIOL, V121, P599, DOI 10.1083/jcb.121.3.599; YAMAMOTO K, 1982, J CELL BIOL, V95, P711, DOI 10.1083/jcb.95.3.711; Yao L, 2009, HIPPOCAMPUS, V19, P855, DOI 10.1002/hipo.20569; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2012, PROG RETIN EYE RES, V31, P65, DOI 10.1016/j.preteyeres.2011.10.001; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	43	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139865	10.1371/journal.pone.0139865	http://dx.doi.org/10.1371/journal.pone.0139865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447479	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000061
J	Hua, N; Baik, F; Pham, T; Phinikaridou, A; Giordano, N; Friedman, B; Whitney, M; Nguyen, QT; Tsien, RY; Hamilton, JA				Hua, Ning; Baik, Fred; Pham, Tuan; Phinikaridou, Alkystis; Giordano, Nick; Friedman, Beth; Whitney, Michael; Nguyen, Quyen T.; Tsien, Roger Y.; Hamilton, James A.			Identification of High-Risk Plaques by MRI and Fluorescence Imaging in a Rabbit Model of Atherothrombosis	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; IN-VIVO; MATRIX METALLOPROTEINASES; ATHEROSCLEROTIC PLAQUE; INCREASED EXPRESSION; EX-VIVO; THROMBIN; ATHEROGENESIS; INFLAMMATION; ACTIVATION	Introduction The detection of atherosclerotic plaques at risk for disruption will be greatly enhanced by molecular probes that target vessel wall biomarkers. Here, we test if fluorescently-labeled Activatable Cell Penetrating Peptides (ACPPs) could differentiate stable plaques from vulnerable plaques that disrupt, forming a luminal thrombus. Additionally, we test the efficacy of a combined ACPP and MRI technique for identifying plaques at high risk of rupture. Methods and Results In an atherothrombotic rabbit model, disrupted plaques were identified with in vivo MRI and co-registered in the same rabbit aorta with the in vivo uptake of ACPPs, cleaved by matrix metalloproteinases (MMPs) or thrombin. ACPP uptake, mapped ex vivo in whole aortas, was higher in disrupted compared to non-disrupted plaques. Specifically, disrupted plaques demonstrated a 4.5 similar to 5.0 fold increase in fluorescence enhancement, while non-disrupted plaques showed only a 2.2 similar to 2.5 fold signal increase. Receiver operating characteristic (ROC) analysis indicates that both ACPPs (MMP and thrombin) show high specificity (84.2% and 83.2%) and sensitivity (80.0% and 85.7%) in detecting disrupted plaques. The detection power of ACPPs was improved when combined with the MRI derived measure, outward remodeling ratio. Conclusions Our targeted fluorescence ACPP probes distinguished disrupted plaques from stable plaques with high sensitivity and specificity. The combination of anatomic, MRI-derived predictors for disruption and ACPP uptake can further improve the power for identification of high-risk plaques and suggests future development of ACPPs with molecular MRI as a readout.	[Hua, Ning; Giordano, Nick; Hamilton, James A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Baik, Fred; Nguyen, Quyen T.] Univ Calif San Diego, Div Head & Neck Surg, La Jolla, CA 92093 USA; [Pham, Tuan] Boston Univ, Dept Biomed Engn, Boston, MA 02118 USA; [Phinikaridou, Alkystis] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Friedman, Beth; Whitney, Michael; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Boston University; University of California System; University of California San Diego; Boston University; University of London; King's College London; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Hamilton, JA (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	jhamilt@bu.edu	Phinikaridou, Alkystis/AAA-9607-2020	Phinikaridou, Alkystis/0000-0002-5687-8504; Baik, Fred/0000-0001-8949-4577; Hamilton, James/0000-0002-4747-7071	Boston University Nanomedicine grant; Howard Hughes Medical Institute; NIH [CA158448]; NATIONAL CANCER INSTITUTE [R01CA158448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846] Funding Source: NIH RePORTER	Boston University Nanomedicine grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partly funded by a Boston University Nanomedicine grant to JAH. Work in the Tsien group was funded by the Howard Hughes Medical Institute and by NIH CA158448, (https://grants.nih.gov/grants/oer.htm) to RYT.	Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Byrne CD, 2011, METABOLIC SYNDROME, 2ND EDITION, P1, DOI 10.1002/9781444347319; Cai K, 2010, JACC-CARDIOVASC IMAG, V3, P824, DOI 10.1016/j.jcmg.2010.03.012; Chatzizisis YS, 2011, CIRCULATION, V123, P621, DOI 10.1161/CIRCULATIONAHA.110.970038; Choudhary S, 2006, ARTERIOSCL THROM VAS, V26, P2351, DOI 10.1161/01.ATV.0000239461.87113.0b; Choudhury RP, 2002, ARTERIOSCL THROM VAS, V22, P1065, DOI 10.1161/01.ATV.0000019735.54479.2F; Fayad ZA, 2001, CIRC RES, V89, P305, DOI 10.1161/hh1601.095596; Galis ZS, 1997, ARTERIOSCL THROM VAS, V17, P483, DOI 10.1161/01.ATV.17.3.483; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; Koo BH, 2010, J BIOL CHEM; Lancelot E, 2008, ARTERIOSCL THROM VAS, V28, P425, DOI 10.1161/ATVBAHA.107.149666; Li ZH, 1996, AM J PATHOL, V148, P121; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Makowski MR, 2011, NAT MED, V17, P383, DOI 10.1038/nm.2310; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Olson ES, 2012, INTEGR BIOL-UK, V4, P595, DOI 10.1039/c2ib00161f; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; PASTERKAMP G, 1995, J AM COLL CARDIOL, V26, P422, DOI 10.1016/0735-1097(95)80017-B; Phinikaridou A, 2013, CIRC CARDIOVASC IMAG; Phinikaridou A, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-45; Phinikaridou A, 2010, CIRC-CARDIOVASC IMAG, V3, P323, DOI 10.1161/CIRCIMAGING.109.918524; Phinikaridou A, 2009, J LIPID RES, V50, P787, DOI 10.1194/jlr.M800460-JLR200; PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183; Razavian M, 2011, J NUCL MED, V52, P1795, DOI 10.2967/jnumed.111.092379; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saam T, 2008, J AM COLL CARDIOL, V51, P1014, DOI 10.1016/j.jacc.2007.10.054; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Scholtes VPW, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001040; Tarkin JM, 2014, NAT REV CARDIOL, V11, P443, DOI 10.1038/nrcardio.2014.80; Temma T, 2010, J NUCL MED, V51, P1979, DOI 10.2967/jnumed.110.081216; Whitney M, 2013, ANGEW CHEM INT EDIT, V52, P325, DOI 10.1002/anie.201205721; Whitney M, 2010, J BIOL CHEM, V285, P22532, DOI 10.1074/jbc.M110.138297; Yamashita A, 2013, CIRC J, V77, P2626, DOI 10.1253/circj.CJ-12-1463; Yamashita A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/424929; Yeon SB, 2007, J AM COLL CARDIOL, V50, P441, DOI 10.1016/j.jacc.2007.03.052; Yoo H, 2011, NAT MED, V17, P1680, DOI 10.1038/nm.2555; Yuan C, 2001, J INVEST MED, V49, P491, DOI 10.2310/6650.2001.33625	44	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139833	10.1371/journal.pone.0139833	http://dx.doi.org/10.1371/journal.pone.0139833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448434	gold, Green Published			2022-12-26	WOS:000362511000057
J	Klar, AS; Gopinadh, J; Kleber, S; Wadle, A; Renner, C				Klar, Agnes S.; Gopinadh, Jakka; Kleber, Sascha; Wadle, Andreas; Renner, Christoph			Treatment with 5-Aza-2 '-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing	PLOS ONE			English	Article							CLASS-I ANTIGENS; CANCER-TESTIS ANTIGENS; CANCER/TESTIS ANTIGENS; CUTANEOUS MELANOMA; BREAST-CARCINOMA; GENE-EXPRESSION; DNA METHYLATION; UP-REGULATION; RESPONSES; HETEROGENEITY	Background NY-ESO-1 belongs to the cancer/testis antigen (CTA) family and represents an attractive target for cancer immunotherapy. Its expression is induced in a variety of solid tumors via DNA demethylation of the promoter of CpG islands. However, NY-ESO-1 expression is usually very low or absent in some tumors such as breast cancer or multiple myeloma. Therefore, we established an optimized in vitro treatment protocol for up-regulation of NY-ESO-1 expression by tumor cells using the hypomethylating agent 5-aza-2'-deoxycytidine (DAC). Methodology/Principal Findings We demonstrated de novo induction of NY-ESO-1 in MCF7 breast cancer cells and significantly increased expression in U266 multiple myeloma cells. This effect was time-and dose-dependent with the highest expression of NY-ESO-1 mRNA achieved by the incubation of 10 mu M DAC for 72 hours. NY-ESO-1 activation was also confirmed at the protein level as shown by Western blot, flow cytometry, and immunofluorescence staining. The detection and quantification of single NY-ESO-1 peptides presented at the tumor cell surface in the context of HLA-A*0201 molecules revealed an increase of 100% and 50% for MCF7 and U266 cells, respectively. Moreover, the enhanced expression of NY-ESO-1 derived peptides at the cell surface was accompanied by an increased specific lysis of MCF7 and U266 cells by HLA-A*0201/NY-ESO-1(157-165) peptide specific chimeric antigen receptor (CAR) CD8(+) T cells. In addition, the killing activity of CAR T cells correlated with the secretion of higher IFN-gamma levels. Conclusions/Significance These results indicate that NY-ESO-1 directed immunotherapy with specific CAR T cells might benefit from concomitant DAC treatment.	[Klar, Agnes S.] Univ Childrens Hosp Zurich, Dept Surg, Tissue Biol Res Unit, Zurich, Switzerland; [Klar, Agnes S.] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Gopinadh, Jakka; Kleber, Sascha; Wadle, Andreas] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland; [Renner, Christoph] Univ Basel Hosp, Dept Oncol, CH-4031 Basel, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; University of Basel	Klar, AS (corresponding author), Univ Childrens Hosp Zurich, Dept Surg, Tissue Biol Res Unit, Zurich, Switzerland.	Agnes.Klar@kispi.uzh.ch; Christoph.Renner@hirslanden.ch		Klar, Agnes S./0000-0003-3521-8010	"Forschungskredit" University ofnZurich; Cancer Research Institute; Ludwig Institute of Cancer Research; Pablo Frohlich Stiftung; "Hoch spezialisierte Medizin" of the Canton Zurich, Switzerland; Krebsliga Zurich	"Forschungskredit" University ofnZurich; Cancer Research Institute; Ludwig Institute of Cancer Research; Pablo Frohlich Stiftung; "Hoch spezialisierte Medizin" of the Canton Zurich, Switzerland; Krebsliga Zurich	This study was funded by the "Forschungskredit" University ofnZurich, Cancer Research Institute, Ludwig Institute of Cancer Research, Pablo Frohlich Stiftung, and the funding initiative "Hoch spezialisierte Medizin" of the Canton Zurich, Switzerland, and Krebsliga Zurich (all CR).	Adair SJ, 2009, CANCER IMMUNOL IMMUN, V58, P589, DOI 10.1007/s00262-008-0582-6; Algarra I, 1997, INT J CLIN LAB RES, V27, P95, DOI 10.1007/BF02912442; Almunia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067645; Bao L, 2011, CANCER IMMUNOL IMMUN, V60, P1299, DOI 10.1007/s00262-011-1037-z; Baxevanis CN, 2009, CANCER IMMUNOL IMMUN, V58, P317, DOI 10.1007/s00262-008-0576-4; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Coral S, 1999, J IMMUNOTHER, V22, P16, DOI 10.1097/00002371-199901000-00003; Coral S, 2002, CLIN CANCER RES, V8, P2690; De Smet C, 1999, MOL CELL BIOL, V19, P7327; dos Santos NR, 2000, CANCER RES, V60, P1654; ENGEL LW, 1978, CANCER RES, V38, P4327; Eshhar Z, 2001, J IMMUNOL METHODS, V248, P67, DOI 10.1016/S0022-1759(00)00343-4; Fiszer D, 1998, AM J REPROD IMMUNOL, V40, P172; Fonsatti E, 2007, CLIN CANCER RES, V13, P3333, DOI 10.1158/1078-0432.CCR-06-3091; Frumento G, 2000, TISSUE ANTIGENS, V56, P30, DOI 10.1034/j.1399-0039.2000.560104.x; Fujie T, 1997, ANN ONCOL, V8, P369, DOI 10.1023/A:1008255630202; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Held G, 2004, EUR J IMMUNOL, V34, P2919, DOI 10.1002/eji.200425297; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jakka G, 2013, ANTICANCER RES, V33, P4189; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Juretic A, 2003, LANCET ONCOL, V4, P104, DOI 10.1016/S1470-2045(03)00982-3; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Natsume A, 2008, INT J CANCER, V122, P2542, DOI 10.1002/ijc.23407; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; PEREZ M, 1986, J IMMUNOGENET, V13, P247; Perez SA, 2008, ADV EXP MED BIOL, V622, P235, DOI 10.1007/978-0-387-68969-2_19; Purbhoo MA, 2006, J IMMUNOL, V176, P7308, DOI 10.4049/jimmunol.176.12.7308; Sarti MSMV, 2004, BRAZ J MED BIOL RES, V37, P901, DOI 10.1590/S0100-879X2004000600016; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Schirrmann TaP G, 2007, HDB THERAPEUTIC ANTI; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Schuberth PC, 2013, GENE THER, V20, P386, DOI 10.1038/gt.2012.48; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Sigalotti L, 2004, CANCER RES, V64, P9167, DOI 10.1158/0008-5472.CAN-04-1442; Sigalotti L, 2002, BRIT J CANCER, V86, P979, DOI 10.1038/sj.bjc.6600174; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P10872, DOI 10.1073/pnas.0905399106; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Xin H, 2000, BBA-MOL BASIS DIS, V1501, P125, DOI 10.1016/S0925-4439(00)00014-4	45	29	36	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139221	10.1371/journal.pone.0139221	http://dx.doi.org/10.1371/journal.pone.0139221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447882	Green Submitted, gold, Green Published			2022-12-26	WOS:000362511000020
J	Kyrtsos, CR; Baras, JS				Kyrtsos, Christina Rose; Baras, John S.			Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis	PLOS ONE			English	Article							HIPPOCAMPAL NEURON NUMBER; BRAIN INTERSTITIAL FLUID; AMYLOID-BETA-PEPTIDE; CEREBROVASCULAR DYSFUNCTION; CLEARANCE; BARRIER; PROTEIN; MICROGLIA; EXERCISE; MICRODIALYSIS	Alzheimer's disease (AD) is the most common cause of dementia in the elderly, affecting over 10% population over the age of 65 years. Clinically, AD is described by the symptom set of short term memory loss and cognitive decline, changes in mentation and behavior, and eventually long-term memory deficit as the disease progresses. On imaging studies, significant atrophy with subsequent increase in ventricular volume have been observed. Pathology on post-mortem brain specimens demonstrates the classic findings of increased beta amyloid (A beta) deposition and the presence of neurofibrillary tangles (NFTs) within affected neurons. Neuroinflammation, dysregulation of blood-brain barrier transport and clearance, deposition of A beta in cerebral blood vessels, vascular risk factors such as atherosclerosis and diabetes, and the presence of the apolipoprotein E4 allele have all been identified as playing possible roles in AD pathogenesis. Recent research has demonstrated the importance of the glymphatic system in the clearance of A beta from the brain via the perivascular space surrounding cerebral blood vessels. Given the variety of hypotheses that have been proposed for AD pathogenesis, an interconnected, multilayer model offers a unique opportunity to combine these ideas into a single unifying model. Results of this model demonstrate the importance of vessel stiffness and heart rate in maintaining adequate clearance of A beta from the brain.	[Kyrtsos, Christina Rose] Univ Pittsburgh, Dept Neurol, Med Ctr, Pittsburgh, PA 15260 USA; [Kyrtsos, Christina Rose; Baras, John S.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Baras, John S.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Baras, JS (corresponding author), Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA.	baras@umd.edu			Institute for Systems Research, University of Maryland; University of Maryland Foundation	Institute for Systems Research, University of Maryland; University of Maryland Foundation	CRK and JBS were funded by (1) Institute for Systems Research, University of Maryland. www.isr.umd.edu; and (2) University of Maryland Foundation, www.umd.edu (no grant #). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Bachmeier C, 2013, NEURODEGENER DIS, V11, P13, DOI 10.1159/000337231; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dang SY, 2015, P NATL ACAD SCI USA, V112, P3344, DOI 10.1073/pnas.1502150112; Deane R, 2008, CURR PHARM DESIGN, V14, P1601, DOI 10.2174/138161208784705487; Dorr A, 2012, BRAIN, V135, P3039, DOI 10.1093/brain/aws243; Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9; Filippov AV, 2010, MAGN RESON CHEM, V48, P427, DOI 10.1002/mrc.2596; Flanagan TRJ, 1994, PROVIDING PHARM ACCE; Fritschi SK, 2014, BRAIN, V137, P2909, DOI 10.1093/brain/awu255; Garipcan B, 2011, ADV ENG MATER, V13, pB54, DOI 10.1002/adem.201080076; Gomis M, 2009, STROKE, V40, P3197, DOI 10.1161/STROKEAHA.109.559641; Grimmer T, 2014, NEUROIMAGE-CLIN, V4, P411, DOI 10.1016/j.nicl.2014.01.016; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harding AJ, 1998, CEREB CORTEX, V8, P710, DOI 10.1093/cercor/8.8.710; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; HELLIWELL T, 1982, J PATHOL, V136, P227, DOI 10.1002/path.1711360306; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ito S, 2013, J CEREBR BLOOD F MET, V33, P1770, DOI 10.1038/jcbfm.2013.125; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Krouwer VJD, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-12; Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277; Lange-Asschenfeldt C, 2008, EXP GERONTOL, V43, P499, DOI 10.1016/j.exger.2008.04.002; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luca M, 2003, B MATH BIOL, V65, P693, DOI 10.1016/S0092-8240(03)00030-2; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Morris AWJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00251; Mura E, 2010, CURR PHARM DESIGN, V16, P672, DOI 10.2174/138161210790883723; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Op den Buijs J, 2004, AM J PHYSIOL-HEART C, V287, pH2651, DOI 10.1152/ajpheart.00332.2004; Ottesen JT, 2004, APPL MATH MODELS HUM, P18; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Puri IK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015176; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rodrigue KM, 2009, NEUROPSYCHOL REV, V19, P436, DOI 10.1007/s11065-009-9118-x; Sane DC, 2004, BLOOD, V104, P2615, DOI 10.1182/blood-2004-08-3026; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Tetreault NA, 2012, J AUTISM DEV DISORD, V42, P2569, DOI 10.1007/s10803-012-1513-0; Vasileyko V, 2010, ANN NY ACAD SCI, V1207, P58, DOI 10.1111/j.1749-6632.2010.05786.x; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Weller RO, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt6; Wildsmith KR, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt187; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Ye M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04681; Yoon SS, 2012, BIOMOL THER, V20, P245, DOI 10.4062/biomolther.2012.20.3.245; Zarow C, 2005, ANN NEUROL, V57, P896, DOI 10.1002/ana.20503	66	55	58	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139574	10.1371/journal.pone.0139574	http://dx.doi.org/10.1371/journal.pone.0139574			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448331	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000362511000034
J	Stalder, C; Vertino, A; Rosso, A; Ruggeberg, A; Pirkenseer, C; Spangenberg, JE; Spezzaferri, S; Camozzi, O; Rappo, S; Hajdas, I				Stalder, Claudio; Vertino, Agostina; Rosso, Antonietta; Rueggeberg, Andres; Pirkenseer, Claudius; Spangenberg, Jorge E.; Spezzaferri, Silvia; Camozzi, Osvaldo; Rappo, Sacha; Hajdas, Irka			Microfossils, a Key to Unravel Cold-Water Carbonate Mound Evolution through Time: Evidence from the Eastern Alboran Sea	PLOS ONE			English	Article							BENTHIC FORAMINIFERAL FAUNAS; LEVANTINE INTERMEDIATE WATER; ROCK-EVAL PYROLYSIS; MEDITERRANEAN SEA; LATE PLEISTOCENE; CORAL PROVINCE; NE ATLANTIC; COMMUNITY STRUCTURE; CONTINENTAL-MARGIN; NORTHEAST ATLANTIC	Cold-water coral (CWC) ecosystems occur worldwide and play a major role in the ocean's carbonate budget and atmospheric CO2 balance since the Danian (similar to 65m.y.ago). However their temporal and spatial evolution against climatic and oceanographic variability is still unclear. For the first time, we combine the main macrofaunal components of a sediment core from a CWC mound of the Melilla Mounds Field in the Eastern Alboran Sea with the associated microfauna and we highlight the importance of foraminifera and ostracods as indicators ofCWC mound evolution in the paleorecord. Abundances of macrofauna along the core reveal alternating periods dominated by distinct CWC taxa (mostly Lophelia pertusa, Madrepora oculata) that correspond to major shifts in foraminiferal and ostracod assemblages. The period dominated byM. oculata coincides with a period characterized by increased export of refractory organic matter to the seafloor and rather unstable oceanographic conditions at the benthic boundary layer with periodically decreased water energy and oxygenation, variable bottom water temperature/density and increased sediment flow. The microfaunal and geochemical data strongly suggest thatM. oculata and in particular Dendrophylliidae show a higher tolerance to environmental changes than L. pertusa. Finally, we show evidence for sustained CWC growth during the Allered-Younger-Dryas in the Eastern Alboran Sea and that this period corresponds to stable benthic conditions with cold/dense and well oxygenated bottom waters, high fluxes of labile organic matter and relatively strong bottom current	[Stalder, Claudio; Rueggeberg, Andres; Pirkenseer, Claudius; Spezzaferri, Silvia; Camozzi, Osvaldo; Rappo, Sacha] Univ Fribourg, Dept Geosci, CH-1700 Fribourg, Switzerland; [Vertino, Agostina] Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy; [Rosso, Antonietta] Univ Catania, Dept Biol Geol & Environm Sci, Catania, Italy; [Spangenberg, Jorge E.] Univ Lausanne, Inst Earth Surface Dynam, Lausanne, Switzerland; [Hajdas, Irka] ETH, Eidgenoss Tech Hsch, Ion Beam Phys, Zurich, Switzerland	University of Fribourg; University of Milano-Bicocca; University of Catania; University of Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich	Stalder, C (corresponding author), Univ Fribourg, Dept Geosci, CH-1700 Fribourg, Switzerland.	claudio.stalder@unifr.ch	Rüggeberg, Andres/ABE-9057-2021; Rosso, Antonietta/E-5660-2017; Hajdas, Irka/C-6696-2011	Rüggeberg, Andres/0000-0003-2393-0625; Rosso, Antonietta/0000-0001-5565-9513; Hajdas, Irka/0000-0003-2373-2725; Spangenberg, Jorge E./0000-0001-8636-6414	Swiss National Science Foundation [200020_153125, 200020_131829]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation with grants 200020_153125 and 200020_131829 for CS (http://www.snf.ch/fr/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zied RH, 2008, MAR MICROPALEONTOL, V67, P46, DOI 10.1016/j.marmicro.2007.08.006; Adkins J, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001200; Ariztegui D, 2001, J PALEOLIMNOL, V26, P283, DOI 10.1023/A:1017585808433; Ausiin B, 2015, PALAEOGEOGR PALAEOCL, V418, P126, DOI 10.1016/j.palaeo.2014.11.011; Baldacci A, 2001, J MARINE SYST, V29, P293, DOI 10.1016/S0924-7963(01)00021-5; Barcena MA, 2001, PALAEOGEOGR PALAEOCL, V167, P337, DOI 10.1016/S0031-0182(00)00246-7; Barras C, 2014, ECOL INDIC, V36, P719, DOI 10.1016/j.ecolind.2013.09.028; Bassetti MA, 2010, MAR MICROPALEONTOL, V77, P1, DOI 10.1016/j.marmicro.2010.06.004; Behar F, 2001, OIL GAS SCI TECHNOL, V56, P111, DOI 10.2516/ogst:2001013; Blanc-Vernet L., 1969, RECL TRAV STN MAR EN, V64, P1; BLANCVERNET L, 1982, B SOC GEOL FR, V24, P203; Cacho I, 2001, PALEOCEANOGRAPHY, V16, P40, DOI 10.1029/2000PA000502; CARALP MH, 1988, MAR MICROPALEONTOL, V13, P265, DOI 10.1016/0377-8398(88)90006-0; Casford JSL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000601; Casford JSL, 2003, PALAEOGEOGR PALAEOCL, V190, P103, DOI 10.1016/S0031-0182(02)00601-6; CEDHAGEN T, 1994, SARSIA, V79, P65, DOI 10.1080/00364827.1994.10413549; Ciampo G, 2003, GEOBIOS-LYON, V36, P1, DOI 10.1016/S0016-6995(02)00104-3; CITA MB, 1977, QUATERNARY RES, V8, P205, DOI 10.1016/0033-5894(77)90046-1; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clifford H.T., 1975, INTRO NUMERICAL CLAS; COLES GP, 1994, PALAEONTOLOGY, V37, P71; Colmenero-Hidalgo E, 2004, PALAEOGEOGR PALAEOCL, V205, P317, DOI 10.1016/j.palaeo.2003.12.014; COMAS M. C., 1999, P OCEAN DRILL PROGRA, V161, P555, DOI [DOI 10.2973/ODP.PROC.SR.161.262.1999, DOI 10.2973/ODP.PROC]; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; De Lange GJ, 2008, NAT GEOSCI, V1, P606, DOI 10.1038/ngeo283; De Mol L, 2011, MAR GEOL, V282, P40, DOI 10.1016/j.margeo.2010.04.011; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; de Stigter HC, 1998, J FORAMIN RES, V28, P40; Dewey J.F., 1989, ALPINE TECTONICS, V45, P265, DOI DOI 10.1144/GSL.SP.1989.045.01.15; DINGLE RV, 1995, MAR GEOL, V122, P207, DOI 10.1016/0025-3227(94)00098-6; Dorschel B, 2007, MAR GEOL, V244, P184, DOI 10.1016/j.margeo.2007.06.010; Dorschel B, 2005, EARTH PLANET SC LETT, V233, P33, DOI 10.1016/j.epsl.2005.01.035; Drinia H, 2014, QUATERN INT, V345, P18, DOI 10.1016/j.quaint.2014.04.011; Duineveld GCA, 2007, B MAR SCI, V81, P449; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; El Hmaidi Abdellah, 2010, Revue de Micropaleontologie, V53, P17, DOI 10.1016/j.revmic.2008.05.001; Emeis KC, 2000, PALAEOGEOGR PALAEOCL, V158, P259, DOI 10.1016/S0031-0182(00)00053-5; ESPITALIE J, 1986, REV I FR PETROL, V41, P73, DOI 10.2516/ogst:1986003; ESPITALIE J, 1977, REV I FR PETROL, V32, P23, DOI 10.2516/ogst:1977002; Fabres J, 2002, J MARINE SYST, V33, P431, DOI 10.1016/S0924-7963(02)00070-2; FAUGERES JC, 1986, B SOC GEOL FR, V2, P423; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Fink HG, 2013, MAR GEOL, V339, P71, DOI 10.1016/j.margeo.2013.04.009; Fletcher WJ, 2010, CLIM PAST, V6, P245, DOI 10.5194/cp-6-245-2010; Fontanier C, 2002, DEEP-SEA RES PT I, V49, P751, DOI 10.1016/S0967-0637(01)00078-4; Fontanier C, 2008, J FORAMIN RES, V38, P137, DOI 10.2113/gsjfr.38.2.137; Freiwald A, 1996, MAR MICROPALEONTOL, V28, P199, DOI 10.1016/0377-8398(96)00002-3; Freiwald A., 2004, COLD WATER CORAL REE; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Frigola J, 2008, QUATERN INT, V181, P88, DOI 10.1016/j.quaint.2007.06.016; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Goineau A, 2012, BIOGEOSCIENCES, V9, P1367, DOI 10.5194/bg-9-1367-2012; Grelaud M, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002288; Hajdas I, 2004, RADIOCARBON, V46, P189, DOI 10.1017/S0033822200039515; Hajdas I, 2004, NUCL INSTRUM METH B, V223, P267, DOI 10.1016/j.nimb.2004.04.054; Hawkes AD, COLDWATER CORALS ECO, P881; Hebbeln D, 2009, BERICHTE FACHBEREICH; HEBURN GW, 1990, J GEOPHYS RES-OCEANS, V95, P1599, DOI 10.1029/JC095iC02p01599; Heinz P, 2001, J FORAMIN RES, V31, P210, DOI 10.2113/31.3.210; Hull SL, 1999, J MAR BIOL ASSOC UK, V79, P1045, DOI 10.1017/S0025315499001289; Husum K, 2004, J FORAMIN RES, V34, P34, DOI 10.2113/0340034; Huvenne VAI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028755; Ivanov MK, 2010, IOC TECHNICAL SERIES, V94, P1; Jimenez-Espejo FJ, 2008, GEOCHEMISTRY GEOPHYS, V9; Jimenez-Espejo FJ, 2007, QUATERNARY SCI REV, V26, P836, DOI 10.1016/j.quascirev.2006.12.013; JORISSEN FJ, 1987, MAR MICROPALEONTOL, V12, P21, DOI 10.1016/0377-8398(87)90012-0; Jorissen FJ, 1998, DEEP-SEA RES PT I, V45, P2157, DOI 10.1016/S0967-0637(98)00056-9; JORISSEN FJ, 1992, MAR MICROPALEONTOL, V19, P131, DOI 10.1016/0377-8398(92)90025-F; Kano A, 2007, GEOLOGY, V35, P1051, DOI 10.1130/G23917A.1; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lambeck K, 2011, QUATERN INT, V232, P250, DOI 10.1016/j.quaint.2010.04.026; LANGFORD FF, 1990, AAPG BULL, V74, P799; Lascaratos A, 1999, PROG OCEANOGR, V44, P5, DOI 10.1016/S0079-6611(99)00019-1; Lindberg B, 2005, GEOLOGY, V33, P537, DOI 10.1130/G21577.1; Liu QS, 2012, PALAEOGEOGR PALAEOCL, V333, P1, DOI 10.1016/j.palaeo.2012.02.036; Lo Iacono C, 2014, DEEP-SEA RES PT II, V99, P316, DOI 10.1016/j.dsr2.2013.07.006; Lopez Correa M, 2012, QUATERNARY SCI REV, V34, P24, DOI 10.1016/j.quascirev.2011.12.005; Lotter AF, 2012, QUATERNARY SCI REV, V36, P103, DOI 10.1016/j.quascirev.2010.06.022; LUTZE GF, 1984, MAR MICROPALEONTOL, V8, P361, DOI 10.1016/0377-8398(84)90002-1; Magny M, 2007, QUATERNARY SCI REV, V26, P1951, DOI 10.1016/j.quascirev.2006.04.013; Magny M, 2006, J QUATERNARY SCI, V21, P311, DOI 10.1002/jqs.999; Majoran S, 1995, J MICROPALAEONTOL, V14, P96, DOI 10.1144/jm.14.2.96; Malinverno E, 2010, DEEP-SEA RES PT II, V57, P345, DOI 10.1016/j.dsr2.2009.08.025; Margreth S, 2011, MAR GEOL, V282, P26, DOI 10.1016/j.margeo.2011.02.006; Margreth S, 2009, DEEP-SEA RES PT I, V56, P2216, DOI 10.1016/j.dsr.2009.07.009; Martinez-Garcia P, 2011, GEO-MAR LETT, V31, P19, DOI 10.1007/s00367-010-0212-0; Martinez-Ruiz E, 2015, QUATERNARY SCI REV, V107, P25, DOI 10.1016/j.quascirev.2014.09.018; McCulloch M, 2010, EARTH PLANET SC LETT, V298, P143, DOI 10.1016/j.epsl.2010.07.036; MCKENZIE KG, 1989, PALAEOGEOGR PALAEOCL, V74, P343, DOI 10.1016/0031-0182(89)90069-2; Milker Y, 2012, PALAEONTOL ELECTRON, V15; Milker Y, 2009, MAR MICROPALEONTOL, V73, P207, DOI 10.1016/j.marmicro.2009.10.003; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Minto'o CMA, 2015, QUATERN INT, V357, P295, DOI 10.1016/j.quaint.2014.11.038; Morel JL, 1996, GEOLOGY, V24, P755, DOI 10.1130/0091-7613(1996)024<0755:GATTZA>2.3.CO;2; Morigi C, 2005, MAR MICROPALEONTOL, V57, P25, DOI 10.1016/j.marmicro.2005.06.001; Morigi C, 2012, DEEP-SEA RES PT I, V59, P54, DOI 10.1016/j.dsr.2011.10.004; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Mueller CE, 2014, BIOGEOSCIENCES, V11, P123, DOI 10.5194/bg-11-123-2014; Murray J. W., 2003, PALAEONTOL ELECTRON, V5, P1; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Nebout NC, 2009, CLIM PAST, V5, P503, DOI 10.5194/cp-5-503-2009; PERKINS H, 1990, J PHYS OCEANOGR, V20, P242, DOI 10.1175/1520-0485(1990)020<0242:TAIITW>2.0.CO;2; Raddatz J, 2011, MAR GEOL, V282, P79, DOI 10.1016/j.margeo.2010.10.019; Ramsey CB, 2013, RADIOCARBON, V55, P2021; RATHBURN AE, 1994, PALEOCEANOGRAPHY, V9, P87, DOI 10.1029/93PA02327; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Remia A, 2005, FACIES, V50, P419, DOI 10.1007/s10347-004-0029-2; Renault L, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007659; Revel M, 2014, REG ENVIRON CHANGE, V14, P1685, DOI 10.1007/s10113-014-0588-x; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; ROBINSON AR, 1992, EARTH-SCI REV, V32, P285, DOI 10.1016/0012-8252(92)90002-B; Robinson AR, 2001, ENCY OCEAN SCI, DOI [10.1006/rwos.2001.0376,2001, DOI 10.1006/RWOS.2001.0376,2001]; Rodrigo-Gamiz M, 2011, QUATERNARY SCI REV, V30, P2018, DOI 10.1016/j.quascirev.2011.05.011; Rogerson M, 2008, GEOCHEMISTRY GEOPHYS, V9; ROHLING EJ, 1994, MAR GEOL, V122, P1, DOI 10.1016/0025-3227(94)90202-X; Rohling EJ, 1997, J MICROPALAEONTOL, V16, P97, DOI 10.1144/jm.16.2.97; ROHLING EJ, 1995, DEEP-SEA RES PT I, V42, P1609, DOI 10.1016/0967-0637(95)00069-I; ROSS CR, 1984, J FORAMIN RES, V14, P134, DOI 10.2113/gsjfr.14.2.134; Rosso A, 2010, DEEP-SEA RES PT II, V57, P360, DOI 10.1016/j.dsr2.2009.08.024; Ruggeberg A, 2007, INT J EARTH SCI, V96, P57, DOI 10.1007/s00531-005-0504-1; Sarhan T, 2000, J MARINE SYST, V23, P317, DOI 10.1016/S0924-7963(99)00068-8; Schmiedl G, 2003, PALAEOGEOGR PALAEOCL, V190, P139, DOI 10.1016/S0031-0182(02)00603-X; Schmiedl G, 2000, MAR MICROPALEONTOL, V40, P167, DOI 10.1016/S0377-8398(00)00038-4; Schmiedl G, 1998, PALEOCEANOGRAPHY, V13, P447, DOI 10.1029/98PA01864; Schnfeld J, 1997, MAR MICROPALEONTOL, V29, P211; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; Schonfeld J, 2011, FACIES, V57, P187, DOI 10.1007/s10347-010-0234-0; Schonfeld J, 2000, PALAEOGEOGR PALAEOCL, V159, P85, DOI 10.1016/S0031-0182(00)00035-3; Schonfeld J, 2002, DEEP-SEA RES PT I, V49, P1853, DOI 10.1016/S0967-0637(02)00088-2; Schroder-Ritzrau A, 2005, ERLANGEN EARTH C SER, P157, DOI 10.1007/3-540-27673-4_8; Send U, 1999, PROG OCEANOGR, V44, P37, DOI 10.1016/S0079-6611(99)00020-8; Sherwood OA, 2008, DEEP-SEA RES PT I, V55, P1392, DOI 10.1016/j.dsr.2008.05.013; Slomp CP, 2002, GEOCHIM COSMOCHIM AC, V66, P1171, DOI 10.1016/S0016-7037(01)00848-1; Smeulders GGB, 2014, DEEP-SEA RES PT II, V99, P270, DOI 10.1016/j.dsr2.2013.10.001; Spezzaferri S, 2001, GEOL CARPATH, V52, P361; Spezzaferri S, ATLAS BENTH IN PRESS; Spezzaferri S, 2013, J FORAMIN RES, V43, P21, DOI 10.2113/gsjfr.43.1.21; Stalder C, J FORAMINIF IN PRESS; Stalder C, 2014, DEEP-SEA RES PT II, V99, P249, DOI 10.1016/j.dsr2.2013.07.009; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; Tissot B.P., 1984, PETROLEUM FORMATION, DOI 10.1007/978-3-642-96446-6; Titschack J, 2015, SEDIMENTOLOGY, V62, P1873, DOI 10.1111/sed.12206; Toucanne S, CONTOURITES GULF CAD; van der Zwaan G.J., 1991, Geological Society Special Publication, V58, P65, DOI 10.1144/GSL.SP.1991.058.01.05; Van Wambeke F, 2004, MAR ECOL PROG SER, V269, P1, DOI 10.3354/meps269001; Vanicek Vlatka, 2000, Geologia Croatica, V53, P269; Vargas-Yanez M, 2002, J MARINE SYST, V35, P229, DOI 10.1016/S0924-7963(02)00128-8; VENECPEYRE MT, 1984, ECOLOGIE MICROORGANI, P60; VERGNAUD-GRAZZINI C., 1992, RAPPORTS COMMISSION, V33, P327; VERGNAUDGRAZZINI C, 1989, OCEANOL ACTA, V12, P305; Vertino A, 2010, DEEP-SEA RES PT II, V57, P380, DOI 10.1016/j.dsr2.2009.08.023; Vertino A, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P257, DOI 10.1007/978-94-007-6704-1_14; Viudez A, 1996, J PHYS OCEANOGR, V26, P684, DOI 10.1175/1520-0485(1996)026<0684:CITASA>2.0.CO;2; Voelker AHL, 2006, EARTH PLANET SC LETT, V245, P39, DOI 10.1016/j.epsl.2006.03.014; WHATLEY R C, 1975, Bulletins of American Paleontology, V65, P173; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25; Wienberg C, 2009, DEEP-SEA RES PT I, V56, P1873, DOI 10.1016/j.dsr.2009.05.016; Wisshak M, 2006, FACIES, V52, P1, DOI 10.1007/s10347-005-0033-1; Wu PL, 1996, J GEOPHYS RES-OCEANS, V101, P6591, DOI 10.1029/95JC03555	160	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140223	10.1371/journal.pone.0140223	http://dx.doi.org/10.1371/journal.pone.0140223			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447699	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000106
J	Brinkmann, J; Koudelka, T; Keppler, JK; Tholey, A; Schwarz, K; Thaller, G; Tetens, J				Brinkmann, Julia; Koudelka, Tomas; Keppler, Julia K.; Tholey, Andreas; Schwarz, Karin; Thaller, Georg; Tetens, Jens			Characterization of an Equine alpha-S2-Casein Variant Due to a 1.3 kb Deletion Spanning Two Coding Exons	PLOS ONE			English	Article							MARES MILK; GENETIC-VARIANTS; COWS MILK; IDENTIFICATION; BOVINE; CASEINS; PROTEIN; ALLERGENICITY; ISOFORMS; HORSE	The production and consumption of mare's milk in Europe has gained importance, mainly based on positive health effects and a lower allergenic potential as compared to cows' milk. The allergenicity of milk is to a certain extent affected by different genetic variants. In classical dairy species, much research has been conducted into the genetic variability of milk proteins, but the knowledge in horses is scarce. Here, we characterize two major forms of equine alpha(S2)-casein arising from genomic 1.3 kb in-frame deletion involving two coding exons, one of which represents an equid specific duplication. Findings at the DNA-level have been verified by cDNA sequencing from horse milk of mares with different genotypes. At the protein-level, we were able to show by SDS-page and in-gel digestion with subsequent LC-MS analysis that both proteins are actually expressed. The comparison with published sequences of other equids revealed that the deletion has probably occurred before the ancestor of present-day asses and zebras diverged from the horse lineage.	[Brinkmann, Julia; Thaller, Georg; Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Systemat Prote & Bioanalyt, Kiel, Germany; [Keppler, Julia K.; Schwarz, Karin] Univ Kiel, Inst Human Nutr & Food Sci, Div Food Technol, Kiel, Germany	University of Kiel; University of Kiel; University of Kiel	Tetens, J (corresponding author), Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany.	jtetens@tierzucht.uni-kiel.de	Schwarz, Karin/AAO-2819-2020; Tholey, Andreas/B-3407-2010; Keppler, Julia/L-6060-2017	Tholey, Andreas/0000-0002-8687-6817; Keppler, Julia/0000-0003-4183-1794; Tetens, Jens/0000-0001-5352-464X	German Federal Ministry of Education and Research (Bonn, Germany) within the competence network "Food Chain Plus" (FoCus) [0315539A]	German Federal Ministry of Education and Research (Bonn, Germany) within the competence network "Food Chain Plus" (FoCus)	This project was funded by the German Federal Ministry of Education and Research (Bonn, Germany) within the competence network "Food Chain Plus" (FoCus, grant no. 0315539A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Businco L, 2000, J ALLERGY CLIN IMMUN, V105, P1031, DOI 10.1067/mai.2000.106377; Caroli AM, 2009, J DAIRY SCI, V92, P5335, DOI 10.3168/jds.2009-2461; Chen Y, 2010, J DAIRY SCI, V93, P884, DOI 10.3168/jds.2009-2672; Chianese L, 2010, J CHROMATOGR A, V1217, P4834, DOI 10.1016/j.chroma.2010.05.017; Curadi M.C., 2001, USE MARE MILK PEDIAT; Foekel C, 2009, INT J FOOD SCI NUTR, V60, P41, DOI 10.1080/09637480802249082; Fox P. F., 2010, 61 ANN M EUR ASS AN, P39; Gallinat JL, 2013, J DAIRY SCI, V96, P699, DOI 10.3168/jds.2012-5908; Hinz K, 2012, J DAIRY RES, V79, P185, DOI 10.1017/S0022029912000015; Ikonen T, 2001, J DAIRY SCI, V84, P507, DOI 10.3168/jds.S0022-0302(01)74501-8; Jonsson H, 2014, P NATL ACAD SCI USA, V111, P18655, DOI 10.1073/pnas.1412627111; Lara-Villoslada F, 2005, J DAIRY SCI, V88, P1654, DOI 10.3168/jds.S0022-0302(05)72837-X; Lisson M, 2014, J DAIRY SCI, V97, P1939, DOI 10.3168/jds.2013-7355; Lisson M, 2013, J DAIRY SCI, V96, P5532, DOI 10.3168/jds.2013-6684; Malacarne M, 2002, INT DAIRY J, V12, P869, DOI 10.1016/S0958-6946(02)00120-6; Martuzzi F, 2010, 61 ANN M EUR ASS AN, P40; Mateos A, 2010, RAPID COMMUN MASS SP, V24, P1533, DOI 10.1002/rcm.4552; MCLEAN DM, 1984, J DAIRY RES, V51, P531, DOI 10.1017/S0022029900032854; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ochirkhuyag B, 2000, LAIT, V80, P223, DOI 10.1051/lait:2000121; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Rozen S, 2000, Methods Mol Biol, V132, P365; Saletti R, 2012, J MASS SPECTROM, V47, P1150, DOI 10.1002/jms.3031; Schubert M, 2014, P NATL ACAD SCI USA, V111, pE5661, DOI 10.1073/pnas.1416991111; Schubert R., 2009, Ernahrung, V33, P314; Uniacke-Lowe T, 2013, J AGR FOOD CHEM, V61, P2839, DOI 10.1021/jf3045846; Uniacke-Lowe T, 2010, INT DAIRY J, V20, P609, DOI 10.1016/j.idairyj.2010.02.007	27	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139700	10.1371/journal.pone.0139700	http://dx.doi.org/10.1371/journal.pone.0139700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444874	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600072
J	Le Bel, M; Gosselin, J				Le Bel, Manon; Gosselin, Jean			Leukotriene B-4 Enhances NOD2-Dependent Innate Response against Influenza Virus Infection	PLOS ONE			English	Article							NF-KAPPA-B; RIG-I; STRANDED-RNA; ANTIVIRAL RESPONSES; RECOGNITION; TAK1; ACTIVATION; NLRP3; NOD2; MEDIATORS	Leukotriene B-4 (LTB4), a central mediator of inflammation, is well known for its chemoattractant properties on effectors cells of the immune system. LTB4 also has the ability to control microbial infection by improving host innate defenses through the release of antimicrobial peptides and modulation of intracellular Toll-like receptors (TLRs) expression in response to agonist challenge. In this report, we provide evidences that LTB4 acts on nucleotide-binging oligomerization domain 2 (NOD2) pathway to enhance immune response against influenza A infection. Infected mice receiving LTB4 show improved survival, lung architecture and reduced lung viral loads as compared to placebo-treated animals. NOD2 and its downstream adaptor protein IPS-1 have been found to be essential for LTB4-mediated effects against IAV infection, as absence of NOD2 or IPS-1 diminished its capacity to control viral infection. Treatment of IAV-infected mice with LTB4 induces an increased activation of IPS-1-IRF3 axis leading to an enhanced production of IFN beta in lungs of infected mice. LTB4 also has the ability to act on the RICK-NF-kappa B axis since administration of LTB4 to mice challenged with MDP markedly increases the secretion of IL-6 and TNF alpha in lungs of mice. TAK1 appears to be essential to the action of LTB4 on NOD2 pathway since pretreatment of MEFs with TAK1 inhibitor prior stimulation with IAV or MDP strongly abrogated the potentiating effects of LTB4 on both IFN beta and cytokine secretion. Together, our results demonstrate that LTB4, through its ability to activate TAK1, potentiates both IPS-1 and RICK axis of the NOD2 pathway to improve host innate responses.	[Le Bel, Manon; Gosselin, Jean] Univ Laval, Res Ctr, CHU Quebec, Lab Innate Immunol, Quebec City, PQ, Canada; [Gosselin, Jean] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Gosselin, J (corresponding author), Univ Laval, Res Ctr, CHU Quebec, Lab Innate Immunol, Quebec City, PQ, Canada.	jean.gosselin@crchudequebec.ulaval.ca			Canadian Institutes of Health Research [MOP-115078, MOP-123440]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from The Canadian Institutes of Health Research to JG (MOP-115078 and MOP-123440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Coulombe F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036734; Flamand L, 2004, J INFECT DIS, V189, P2001, DOI 10.1086/386374; Garfield AS, 2010, METHODS MOL BIOL, V633, P19, DOI 10.1007/978-1-59745-019-5_2; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Gaudreault E, 2012, INT IMMUNOL, V24, P693, DOI 10.1093/intimm/dxs074; Gaudreault E, 2009, J IMMUNOL, V183, P2650, DOI 10.4049/jimmunol.0804135; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gosselin J, 2005, J IMMUNOL, V174, P1587, DOI 10.4049/jimmunol.174.3.1587; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Inohara N, 2000, J BIOL CHEM, V275, P27823; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Le Bel M, 2014, J INNATE IMMUN, V6, P159, DOI 10.1159/000353694; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matthias KA, 2008, J IMMUNOL, V180, P6246, DOI 10.4049/jimmunol.180.9.6246; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Okada M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579961; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shin EH, 2006, BIOCHEM BIOPH RES CO, V348, P606, DOI 10.1016/j.bbrc.2006.07.084; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Widegren H, 2011, RESP MED, V105, P997, DOI 10.1016/j.rmed.2010.12.021; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8	40	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139856	10.1371/journal.pone.0139856	http://dx.doi.org/10.1371/journal.pone.0139856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444420	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600093
J	Zhang, LT; Huang, XF; Xue, B; Peng, QH; Wang, ZS; Yan, TH; Wang, LZ				Zhang, Litai; Huang, Xiaofeng; Xue, Bai; Peng, Quanhui; Wang, Zhisheng; Yan, Tianhai; Wang, Lizhi			Immunization against Rumen Methanogenesis by Vaccination with a New Recombinant Protein	PLOS ONE			English	Article							METHANE MITIGATION; REVERSE VACCINOLOGY; NITROUS-OXIDE; ANTIBODIES; EMISSIONS; CATTLE; SHEEP	Vaccination through recombinant proteins against rumen methanogenesis provides a mitigation approach to reduce enteric methane (CH4) emissions in ruminants. The objective of present study was to evaluate the in vivo efficacy of a new vaccine candidate protein (EhaF) on methanogenesis and microbial population in the rumen of goats. We amplified the gene mru 1407 encoding protein EhaF using fresh rumen fluid samples of mature goats and successfully expressed recombinant protein (EhaF) in Escherichia coli Rosetta. This product was evaluated using 12 mature goats with half for control and other half injected with 400ug/goat the purified recombinant protein in day 1 and two subsequent booster immunizations in day 35 and 49. All measurements were undertaken from 63 to 68 days after the initial vaccination, with CH4 emissions determined using respiration calorimeter chambers. The results showed that the vaccination caused intensive immune responses in serum and saliva, although it had no significant effect on total enteric CH4 emissions and methanogen population in the rumen, when compared with the control goats. However, the vaccination altered the composition of rumen bacteria, especially the abundance of main phylum Firmicutes and genus Prevotella. The results indicate that protein EhaF might not be an effective vaccine to reduce enteric CH4 emissions but our vaccine have potential to influence the rumen ecosystem of goats.	[Zhang, Litai; Huang, Xiaofeng; Xue, Bai; Peng, Quanhui; Wang, Zhisheng; Wang, Lizhi] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [Yan, Tianhai] Agrifood & Biosci Inst, Hillsborough, North Ireland	Sichuan Agricultural University; Agri-Food & Biosciences Institute	Wang, LZ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	wanglizhi08@aliyun.com			International Cooperation Project of Ministry of Science and Technology of China [2014DFA32860]	International Cooperation Project of Ministry of Science and Technology of China	The financial support was provided by the International Cooperation Project of Ministry of Science and Technology of China (2014DFA32860) to LZW, http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buddle BM, 2011, VET J, V188, P11, DOI 10.1016/j.tvjl.2010.02.019; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cook SR, 2008, AUST J EXP AGR, V48, P260, DOI 10.1071/EA07249; DEMACARIO EC, 1984, J IMMUNOL, V132, P883; DEMACARIO EC, 1982, J BACTERIOL, V152, P762; Eckard RJ, 2010, LIVEST SCI, V130, P47, DOI 10.1016/j.livsci.2010.02.010; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gan WJ, 2010, PARASITOL RES, V106, P873, DOI 10.1007/s00436-010-1729-x; Ge XC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011666; Hristov AN, 2013, J ANIM SCI, V91, P5045, DOI 10.2527/jas.2013-6583; Huang XD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-237; Key N, 2012, CLIMATIC CHANGE, V112, P387, DOI 10.1007/s10584-011-0206-6; Kumar S, 2014, APPL MICROBIOL BIOT, V98, P31, DOI 10.1007/s00253-013-5365-0; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Li Y, 2013, P 5 GREENH GAS AN AG, P309; Lie TJ, 2012, P NATL ACAD SCI USA, V109, P15473, DOI 10.1073/pnas.1208779109; Liu JH, 2013, AM J PHYSIOL-REG I, V305, pR232, DOI 10.1152/ajpregu.00068.2013; Liu XK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057959; Patra AK, 2012, ENVIRON MONIT ASSESS, V184, P1929, DOI 10.1007/s10661-011-2090-y; Qiu LM, 2010, MOL BIOL REP, V37, P1725, DOI 10.1007/s11033-009-9594-3; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; Subharat S, 2015, VET IMMUNOL IMMUNOP, V164, P201, DOI 10.1016/j.vetimm.2015.02.008; Thorpe A, 2009, CLIMATIC CHANGE, V93, P407, DOI 10.1007/s10584-008-9506-x; Wedlock DN, 2013, ANIMAL, V7, P244, DOI 10.1017/S1751731113000682; Wedlock DN, 2010, NEW ZEAL VET J, V58, P29, DOI 10.1080/00480169.2010.65058; Williams YJ, 2008, BRIT J NUTR, V99, P100, DOI 10.1017/S0007114507801553; Williams YJ, 2009, APPL ENVIRON MICROB, V75, P1860, DOI 10.1128/AEM.02453-08	31	11	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140086	10.1371/journal.pone.0140086	http://dx.doi.org/10.1371/journal.pone.0140086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445479	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600137
J	Joshi, R; Liu, S; Brown, MD; Young, SM; Batie, M; Kofron, JM; Xu, Y; Weaver, TE; Apsley, K; Varisco, BM				Joshi, Rashika; Liu, Sheng; Brown, Montell D.; Young, Sarah M.; Batie, Matthew; Kofron, J. Matthew; Xu, Yan; Weaver, Timmothy E.; Apsley, Karen; Varisco, Brian M.			Stretch regulates expression and binding of chymotrypsin-like elastase 1 in the postnatal lung	FASEB JOURNAL			English	Article						matrix remodeling; lung development; lung regeneration; elastin; mechanical strain	GROWTH; MICE; DIFFERENTIATION; DEFICIENCY; INHIBITOR; ELASTIN; MOUSE	Lung stretch is critical for normal lung development and for compensatory lung growth after pneumonectomy (PNX), but the mechanisms by which strain induces matrix remodeling are unclear. Our prior work demonstrated an association of chymotrypsin-like elastase 1 (Cela1) with lung elastin remodeling, and that strain triggered a near-instantaneous elastin-remodeling response. We sought to determine whether stretch regulates Cela1 expression and Cela1 binding to lung elastin. In C57BL/6J mice, Cela1 protein increased 176-fold during lung morphogenesis. Cela1 was covalently bound to serpin peptidase inhibitor, clade A, member 1, resulting in a higher molecular mass in lung homogenate compared to pancreas homogenate. Post-PNX, Cela1mRNA increased 6-fold, protein 3-fold, and Cela1-positive cells 2-fold. Cela1 was expressed predominantly in alveolar type II cells in the embryonic lung and predominantly in CD90-positive lungfibroblasts postnatally. During compensatory lung growth, Cela1 expression was induced in non-proliferative mesenchymal cells. In ex vivo mouse lung sections, stretch increased Cela1 binding to lung tissue by 46%. Competitive inhibition with soluble elastin completely abrogated this increase. Areas of stretch-induced elastase activity and Cela1 binding colocalized. The stretch-dependent expression and binding kinetics of Cela1 indicate an important role in stretch-dependent remodeling of the peripheral lung during development and regeneration.	[Joshi, Rashika; Liu, Sheng; Varisco, Brian M.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Kofron, J. Matthew] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Xu, Yan; Weaver, Timmothy E.; Apsley, Karen] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Batie, Matthew] Cincinnati Childrens Hosp Med Ctr, Dept Clin Engn, Cincinnati, OH 45229 USA; [Brown, Montell D.] Cincinnati Childrens Hosp Med Ctr, Biomed Res Internship Minor Students Program, Cincinnati, OH 45229 USA; [Young, Sarah M.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; Ohio State University	Varisco, BM (corresponding author), 3333 Burnet Ave,MLC 2005, Cincinnati, OH 45229 USA.	brian.varisco@cchmc.org		, Yan/0000-0003-2025-027X; Kofron, Matthew/0000-0001-6427-4148; Varisco, Brian/0000-0003-0180-2577	Proctor Scholar Program at Cincinnati Children's Hospital; Parker B. Francis Family Foundation; Biomedical Research Internship Program for Minority Students at Cincinnati Children's Hospital Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028827] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL131261] Funding Source: NIH RePORTER	Proctor Scholar Program at Cincinnati Children's Hospital; Parker B. Francis Family Foundation; Biomedical Research Internship Program for Minority Students at Cincinnati Children's Hospital Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Proctor Scholar Program at Cincinnati Children's Hospital, the Parker B. Francis Family Foundation, and Biomedical Research Internship Program for Minority Students at Cincinnati Children's Hospital Medical Center. Monica de Lay (Flow Cytometry Core, Cincinnati Children's Hospital Medical Center) and Anna K. Perl (Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center) provided advice with cytometry experiments. The Cincinnati Children's Hospital Medical Center confocal imaging facility provided technical support for imaging and image analysis. Ken Greis and the University of Cincinnati Proteomics Core (Cincinnati, OH, USA) provided proteomic support. Basillia Zingargelli (Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center) provided aged mouse lung homogenate samples. R.J. and S.L. are cofirst authors.	Ambalavanan N, 2008, PEDIATR RES, V63, P26, DOI 10.1203/PDR.0b013e31815b690d; Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983; Chen LL, 2012, AM J RESP CELL MOL, V47, P517, DOI 10.1165/rcmb.2012-0030OC; Dane DM, 2013, J APPL PHYSIOL, V114, P99, DOI 10.1152/japplphysiol.01213.2012; De Paepe ME, 2014, PEDIATR PULM, V49, P60, DOI 10.1002/ppul.22818; Du Y., 2015, THORAX, DOI [10.1136/thoraxjnl-2015-207035, DOI 10.1136/THORAXJNL-2015-207035]; Getie M, 2005, PROTEINS, V61, P649, DOI 10.1002/prot.20643; Gill SE, 2009, DEV GROWTH DIFFER, V51, P17, DOI 10.1111/j.1440-169X.2008.01075.x; Hilgendorff A, 2012, AM J PHYSIOL-LUNG C, V303, pL215, DOI 10.1152/ajplung.00405.2011; Hoffman AM, 2010, AM J PHYSIOL-LUNG C, V298, pL158, DOI 10.1152/ajplung.90594.2008; Jesudason R, 2010, BIOPHYS J, V99, P3076, DOI 10.1016/j.bpj.2010.09.018; Kho AT, 2013, AM J PHYSIOL-LUNG C, V305, pL542, DOI 10.1152/ajplung.00403.2012; Liu S., 2014, JOVE-J VIS EXP, V1, P1; Liu S, 2014, AM J PHYSIOL-LUNG C, V306, pL1104, DOI 10.1152/ajplung.00126.2013; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009; Senior R M, 1977, Adv Exp Med Biol, V79, P249; Sharoni E, 1998, J PEDIATR SURG, V33, P1578, DOI 10.1016/S0022-3468(98)90505-X; Snowise S, 2014, AM J PERINAT, V31, P605, DOI 10.1055/s-0034-1373842; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Tang T, 2014, J MOL CELL CARDIOL, V75, P174, DOI 10.1016/j.yjmcc.2014.07.014; Varisco BM, 2012, AM J RESP CELL MOL, V46, P765, DOI 10.1165/rcmb.2011-0316OC; Wang W, 2013, AM J RESP CELL MOL, V49, P697, DOI 10.1165/rcmb.2012-0332MA; Young SM, 2015, J APPL PHYSIOL, V118, P921, DOI 10.1152/japplphysiol.00954.2014; Ysasi AB, 2013, AM J PHYSIOL-LUNG C, V305, pL439, DOI 10.1152/ajplung.00134.2013	27	7	7	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					590	600		10.1096/fj.15-277350	http://dx.doi.org/10.1096/fj.15-277350			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443822	Green Published			2022-12-26	WOS:000369391900012
J	Losdyck, E; Hornakova, T; Springuel, L; Degryse, S; Gielen, O; Cools, J; Constantinescu, SN; Flex, E; Tartaglia, M; Renauld, JC; Knoops, L				Losdyck, Elisabeth; Hornakova, Tekla; Springuel, Lorraine; Degryse, Sandrine; Gielen, Olga; Cools, Jan; Constantinescu, Stefan N.; Flex, Elisabetta; Tartaglia, Marco; Renauld, Jean-Christophe; Knoops, Laurent			Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Janus kinase (JAK); leukemia; oncogene; signal transduction; tyrosine-protein kinase (tyrosine kinase); JAK inhibitor	ACUTE MEGAKARYOBLASTIC LEUKEMIA; SIGNAL-TRANSDUCTION; FERM DOMAIN; N-TERMINUS; MUTATIONS; ACTIVATION; CELLS; GAMMA; TRANSFORMATION; SELECTIVITY	JAK1 and JAK3 are recurrently mutated in acute lymphoblastic leukemia. These tyrosine kinases associate with heterodimeric cytokine receptors such as IL-7 receptor or IL-9 receptor, in which JAK1 is appended to the specific chain, and JAK3 is appended to the common gamma chain. Here, we studied the role of these receptor complexes in mediating the oncogenic activity of JAK3 mutants. Although JAK3(V674A) and the majority of other JAK3 mutants needed to bind to a functional cytokine receptor complex to constitutively activate STAT5, JAK3(L857P) was unexpectedly found to not depend on such receptor complexes for its activity, which was induced without receptor or JAK1 co-expression. Introducing a mutation in the FERM domain that abolished JAK-receptor interaction did not affect JAK3(L857P) activity, whereas it inhibited the other receptor-dependent mutants. The same cytokine receptor independence as for JAK3(L857P) was observed for homologous Leu(857) mutations of JAK1 and JAK2 and for JAK3(L875H). This different cytokine receptor requirement correlated with different functional properties in vivo and with distinct sensitivity to JAK inhibitors. Transduction of murine hematopoietic cells with JAK3(V674A) led homogenously to lymphoblastic leukemias in BALB/c mice. In contrast, transduction with JAK3(L857P) induced various types of lymphoid and myeloid leukemias. Moreover, ruxolitinib, which preferentially blocks JAK1 and JAK2, abolished the proliferation of cells transformed by the receptor-dependent JAK3(V674A), yet proved much less potent on cells expressing JAK3(L857P). These particular cells were, in contrast, more sensitive to JAK3-specific inhibitors. Altogether, our results showed that different JAK3 mutations induce constitutive activation through distinct mechanisms, pointing to specific therapeutic perspectives.	[Losdyck, Elisabeth; Hornakova, Tekla; Springuel, Lorraine; Constantinescu, Stefan N.; Renauld, Jean-Christophe; Knoops, Laurent] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Losdyck, Elisabeth; Hornakova, Tekla; Springuel, Lorraine; Constantinescu, Stefan N.; Renauld, Jean-Christophe; Knoops, Laurent] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Degryse, Sandrine; Gielen, Olga; Cools, Jan] Katholieke Univ Leuven, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Degryse, Sandrine; Gielen, Olga; Cools, Jan] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Flex, Elisabetta] Ist Super Sanita, I-00161 Rome, Italy; [Knoops, Laurent] Clin Univ St Luc, Hematol Unit, B-1200 Brussels, Belgium; [Tartaglia, Marco] Osped Pediat Bambino Gesu, IRCCS, Genet Disorders & Rare Dis Res Div, I-00146 Rome, Italy	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Istituto Superiore di Sanita (ISS); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; IRCCS Bambino Gesu	Knoops, L (corresponding author), Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 74, B-1200 Brussels, Belgium.	laurent.knoops@uclouvain.be	Tartaglia, Marco/K-2955-2018; Degryse, Sandrine/M-8722-2015; Flex, Elisabetta/A-5958-2017; Renauld, Jean-Christophe/B-7268-2012	Tartaglia, Marco/0000-0001-7736-9672; Degryse, Sandrine/0000-0003-2815-3634; Flex, Elisabetta/0000-0002-6802-1356; Constantinescu, Stefan N./0000-0002-8599-2699; Cools, Jan/0000-0001-6626-5843; Renauld, Jean-Christophe/0000-0003-1736-2131	Belgian Program on Interuniversity Poles of Attraction [IAP-P7/43]; Belgian State, Prime Minister's Office, Science Policy Programming; Actions de Recherche Concertees of the Communaute Francaise de Belgique Grant [ARC10/15-027]; Fondation contre le Cancer, Belgium; Foundation Salus Sanguinis, Belgium; Operation Televie, Belgium; Associazione Italiana per la Ricerca sul Cancro [IG2009-8803, IG2012-3360]; Fund for Medical Scientific Research, Belgium; Atlantic Philanthropies New York; Fonds National de la Recherche Scientifique Belgium-Televie grant	Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Belgian State, Prime Minister's Office, Science Policy Programming; Actions de Recherche Concertees of the Communaute Francaise de Belgique Grant; Fondation contre le Cancer, Belgium; Foundation Salus Sanguinis, Belgium; Operation Televie, Belgium; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fund for Medical Scientific Research, Belgium(Fonds de la Recherche Scientifique - FNRS); Atlantic Philanthropies New York; Fonds National de la Recherche Scientifique Belgium-Televie grant(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by Grant IAP-P7/43 from the Belgian Program on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming (to S. N. C.); Actions de Recherche Concertees of the Communaute Francaise de Belgique Grant ARC10/15-027 (to S. N. C.); the Fondation contre le Cancer, Belgium (to S. N. C.); the Foundation Salus Sanguinis, Belgium; the Operation Televie, Belgium; Associazione Italiana per la Ricerca sul Cancro Grants IG2009-8803 and IG2012-3360 (to M. T.); the Fund for Medical Scientific Research, Belgium (to S. N. C.); and the Atlantic Philanthropies New York (to S. N. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Fonds National de la Recherche Scientifique Belgium-Televie grant.	[Anonymous], 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x; Bains T, 2012, LEUKEMIA, V26, P2144, DOI 10.1038/leu.2012.74; Bellanger D, 2014, LEUKEMIA, V28, P417, DOI 10.1038/leu.2013.271; Cacalano NA, 1999, EMBO J, V18, P1549, DOI 10.1093/emboj/18.6.1549; Degryse S, 2014, BLOOD, V124, P3092, DOI 10.1182/blood-2014-04-566687; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Gerland K, 2000, MOL CELL ENDOCRINOL, V168, P1, DOI 10.1016/S0303-7207(00)00314-2; Gordon GM, 2010, BIOCHEM J, V432, P255, DOI 10.1042/BJ20100774; Haan C, 2001, J BIOL CHEM, V276, P37451, DOI 10.1074/jbc.M106135200; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; He M, 2012, CLIN CANCER RES, V18, P1790, DOI 10.1158/1078-0432.CCR-11-2361; Hornakova T, 2011, HAEMATOL-HEMATOL J, V96, P845, DOI 10.3324/haematol.2010.036350; Hornakova T, 2009, J BIOL CHEM, V284, P6773, DOI 10.1074/jbc.M807531200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lupardus PJ, 2014, P NATL ACAD SCI USA, V111, P8025, DOI 10.1073/pnas.1401180111; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; Malka Y, 2008, J BIOL CHEM, V283, P33569, DOI 10.1074/jbc.M803125200; Riera L, 2011, LEUKEMIA LYMPHOMA, V52, P1742, DOI 10.3109/10428194.2011.574757; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; Springuel L, 2014, BLOOD, V124, P3924, DOI 10.1182/blood-2014-05-576652; Tang W, 2001, BIOCHEM BIOPH RES CO, V283, P598, DOI 10.1006/bbrc.2001.4824; Thoma G, 2011, J MED CHEM, V54, P284, DOI 10.1021/jm101157q; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Yamaguchi F, 2014, ONCOL LETT, V7, P357, DOI 10.3892/ol.2013.1705; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yi CA, 2015, FUTURE ONCOL, V11, P719, DOI [10.2217/fon.14.272, 10.2217/FON.14.272]; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	33	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29022	29034		10.1074/jbc.M115.670224	http://dx.doi.org/10.1074/jbc.M115.670224			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26446793	Green Published, hybrid			2022-12-26	WOS:000365762300040
J	Kopecna, J; de Vaca, IC; Adams, NBP; Davison, PA; Brindley, AA; Hunter, CN; Guallar, V; Sobotka, R				Kopecna, Jana; Cabeza de Vaca, Israel; Adams, Nathan B. P.; Davison, Paul A.; Brindley, Amanda A.; Hunter, C. Neil; Guallar, Victor; Sobotka, Roman			Porphyrin Binding to Gun4 Protein, Facilitated by a Flexible Loop, Controls Metabolite Flow through the Chlorophyll Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM CHELATASE; TETRAPYRROLE BIOSYNTHESIS; MG-CHELATASE; SUBUNIT; EXPRESSION; FERROCHELATASE; REGULATOR; PROMOTE; MUTANT; LEVEL	In oxygenic phototrophs, chlorophylls, hemes, and bilins are synthesized by a common branched pathway. Given the phototoxic nature of tetrapyrroles, this pathway must be tightly regulated, and an important regulatory role is attributed to magnesium chelatase enzyme at the branching between the heme and chlorophyll pathway. Gun4 is a porphyrin-binding protein known to stimulate in vitro the magnesium chelatase activity, but how the Gun4-porphyrin complex acts in the cell was unknown. To address this issue, we first performed simulations to determine the porphyrin-docking mechanism to the cyanobacterial Gun4 structure. After correcting crystallographic loop contacts, we determined the binding site for magnesium protoporphyrin IX. Molecular modeling revealed that the orientation of alpha 6/alpha 7 loop is critical for the binding, and the magnesium ion held within the porphyrin is coordinated by Asn-211 residue. We also identified the basis for stronger binding in the Gun4-1 variant and for weaker binding in the W192A mutant. The W192A-Gun4 was further characterized in magnesium chelatase assay showing that tight porphyrin binding in Gun4 facilitates its interaction with the magnesium chelatase ChlH subunit. Finally, we introduced the W192A mutation into cells and show that the Gun4-porphyrin complex is important for the accumulation of ChlH and for channeling metabolites into the chlorophyll biosynthetic pathway.	[Kopecna, Jana; Sobotka, Roman] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic; [Sobotka, Roman] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Cabeza de Vaca, Israel; Guallar, Victor] Inst Res Biomed Res Program, Ctr Genom Regulat, Joint Barcelona Supercomp Ctr, Barcelona 08034, Spain; [Adams, Nathan B. P.; Davison, Paul A.; Brindley, Amanda A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Guallar, Victor] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Sheffield; ICREA	Guallar, V (corresponding author), Inst Microbiol Opatovicky Mlyn, Trebon 37981, Czech Republic.	victor.guallar@bsc.es; sobotka@alga.cz	Guallar, Victor/B-1579-2013; Sobotka, Roman/J-3077-2014	Guallar, Victor/0000-0002-4580-1114; Sobotka, Roman/0000-0001-5909-3879; Adams, Nathan/0000-0003-3080-3448	Czech Science Foundation [P501/12/G055]; National Programme of Sustainability I Grant [LO1416]; ERC [2009-Adg25027-PELE]; Project Algain [EE2.3.30.0059]; Biotechnology and Biological Sciences Research Council [BB/G021546/1, BB/M000265/1]; European Research Council [338895]; ICREA Funding Source: Custom; BBSRC [BB/G021546/1, BB/M000265/1] Funding Source: UKRI	Czech Science Foundation(Grant Agency of the Czech Republic); National Programme of Sustainability I Grant; ERC(European Research Council (ERC)European Commission); Project Algain; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Project P501/12/G055 of the Czech Science Foundation, by National Programme of Sustainability I Grant LO1416, by ERC Grant 2009-Adg25027-PELE (to V. G.). This work was also supported by Project Algain Grant EE2.3.30.0059 (to J. K.), Awards BB/G021546/1 and BB/M000265/1 from the Biotechnology and Biological Sciences Research Council (to N. B. P. A., P. A. D., A. A. B., and C. N. H.), and Advanced Award 338895 from the European Research Council (to C. N. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams NBP, 2014, BIOCHEM J, V464, P315, DOI 10.1042/BJ20140463; Adams NBP, 2014, BIOCHEM J, V457, P163, DOI 10.1042/BJ20130834; Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Adhikari ND, 2009, J BIOL CHEM, V284, P24783, DOI 10.1074/jbc.M109.025205; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; Brzezowski P, 2014, PLANT J, V79, P285, DOI 10.1111/tpj.12560; Case D.A., 2022, AMBER 2020; Chen XM, 2015, MOL PLANT, V8, P1125, DOI 10.1016/j.molp.2015.04.013; Czarnecki O, 2012, J EXP BOT, V63, P1675, DOI 10.1093/jxb/err437; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Formighieri C, 2012, MOL PLANT, V5, P1242, DOI 10.1093/mp/sss051; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Gravenstein P. B., 2013, F1000RES, V2, P142; Guallar V, 2004, J MOL BIOL, V337, P227, DOI 10.1016/j.jmb.2003.11.016; Hernandez-Ortega A, 2011, BIOCHEM J, V436, P341, DOI 10.1042/BJ20102090; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kopecna J, 2015, PLANT PHYSIOL, V169, P1307, DOI 10.1104/pp.15.01150; Kopecna J, 2012, PLANT PHYSIOL, V160, P2239, DOI 10.1104/pp.112.207274; Kotev M, 2015, BIOPHYS J, V108, P116, DOI 10.1016/j.bpj.2014.11.3453; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Luo T, 2012, PLANT PHYSIOL, V159, P118, DOI 10.1104/pp.112.195446; Madadkar-Sobhani A, 2013, NUCLEIC ACIDS RES, V41, pW322, DOI 10.1093/nar/gkt454; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Papenbrock J, 1999, PLANTA, V208, P264, DOI 10.1007/s004250050558; Papenbrock J, 2001, PLANT J, V28, P41, DOI 10.1046/j.1365-313X.2001.01126.x; Papenbrock J, 2000, PLANT PHYSIOL, V122, P1161, DOI 10.1104/pp.122.4.1161; Papenbrock J, 2000, PLANT J, V22, P155, DOI 10.1046/j.1365-313x.2000.00724.x; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Pilny J, 2015, BIOPROTOCOL, V5, pe1390, DOI DOI 10.21769/BI0PR0T0C.1390; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2014, PHOTOSYNTH RES, V119, P223, DOI 10.1007/s11120-013-9797-2; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Tabrizi ST, 2015, ACTA CRYSTALLOGR F, V71, P1094, DOI 10.1107/S2053230X15012248; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151	43	22	23	8	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28477	28488		10.1074/jbc.M115.664987	http://dx.doi.org/10.1074/jbc.M115.664987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446792	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-26	WOS:000365761900041
J	Shoji, M; Arakaki, Y; Esumi, T; Kohnomi, S; Yamamoto, C; Suzuki, Y; Takahashi, E; Konishi, S; Kido, H; Kuzuhara, T				Shoji, Masaki; Arakaki, Yumie; Esumi, Tomoyuki; Kohnomi, Shuntaro; Yamamoto, Chihiro; Suzuki, Yutaka; Takahashi, Etsuhisa; Konishi, Shiro; Kido, Hiroshi; Kuzuhara, Takashi			Bakuchiol Is a Phenolic Isoprenoid with Novel Enantiomer-selective Anti-influenza A Virus Activity Involving Nrf2 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; PSORALEA-CORYLIFOLIA; IN-VITRO; VIRAL REPLICATION; GENE-EXPRESSION; CELL-LINE; OSELTAMIVIR; NEURAMINIDASE; HEMAGGLUTININ; INDUCTION	Influenza represents a substantial threat to human health and requires novel therapeutic approaches. Bakuchiol is a phenolic isoprenoid compound present in Babchi (Psoralea corylifolia L.) seeds. We examined the anti-influenza viral activity of synthetic bakuchiol using Madin-Darby canine kidney cells. We found that the naturally occurring form, (+)-(S)-bakuchiol, and its enantiomer, (-)-(R)-bakuchiol, inhibited influenza A viral infection and growth and reduced the expression of viral mRNAs and proteins in these cells. Furthermore, these compounds markedly reduced the mRNA expression of the host cell influenza A virus-induced immune response genes, interferon-beta and myxovirus-resistant protein 1. Interestingly, (+)-(S)bakuchiol had greater efficacy than (-)-(R)-bakuchiol, indicating that chirality influenced anti-influenza virus activity. In vitro studies indicated that bakuchiol did not strongly inhibit the activities of influenza surface proteins or the M2 ion channel, expressed in Chinese hamster ovary cells. Analysis of luciferase reporter assay data unexpectedly indicated that bakuchiol may induce some host cell factor(s) that inhibited firefly and Renilla luciferases. Next generation sequencing and KeyMolnet analysis of influenza A virus-infected and non-infected cells exposed to bakuchiol revealed activation of transcriptional regulation by nuclear factor erythroid 2-related factor (Nrf), and an Nrf2 reporter assay showed that (+)-(S)-bakuchiol activated Nrf2. Additionally, (+)-(S)-bakuchiol up-regulated the mRNA levels of two Nrf2-induced genes, NAD(P)H quinone oxidoreductase 1 and glutathione S-transferase A3. These findings demonstrated that bakuchiol had enantiomer-selective anti-influenza viral activity involving a novel effect on the host cell oxidative stress response.	[Shoji, Masaki; Arakaki, Yumie; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan; [Esumi, Tomoyuki; Yamamoto, Chihiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Inst Pharmacognosy, Tokushima 7708514, Japan; [Kohnomi, Shuntaro; Konishi, Shiro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Dept Neurophysiol, Kagawa 7692193, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778568, Japan; [Takahashi, Etsuhisa; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 7708503, Japan	Tokushima Bunri University; Tokushima Bunri University; Tokushima Bunri University; University of Tokyo; Tokushima University	Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan.	kuzuhara@ph.bunri-u.ac.jp	Konishi, Shiro/ABA-5905-2020	Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science (JSPS) [25460574]; Tokushima Bunri University for Educational Reform and Collaborative Research Grant [TBU2013-2-1]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED;  [26860083]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima Bunri University for Educational Reform and Collaborative Research Grant; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); 	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) 25460574 (to T. K.), Grant-in-Aid for Young Scientists (B) 26860083 (to M. S.), Tokushima Bunri University for Educational Reform and Collaborative Research Grant TBU2013-2-1 (to M. S.), and the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari S, 2003, CHEM RES TOXICOL, V16, P1062, DOI 10.1021/tx034082r; Balannik V, 2009, BIOCHEMISTRY-US, V48, P11872, DOI 10.1021/bi9014488; Chen Hong-li, 2010, Yaoxue Xuebao, V45, P467; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chen Z, 2010, EUR J PHARMACOL, V643, P170, DOI 10.1016/j.ejphar.2010.06.025; Chung S, 2010, PSYCHIAT INVEST, V7, P302, DOI 10.4306/pi.2010.7.4.302; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Esumi T, 2013, SYNLETT, V24, P1845, DOI 10.1055/s-0033-1338968; Furuse Y, 2009, ANTIMICROB AGENTS CH, V53, P4457, DOI 10.1128/AAC.00650-09; Haraguchi H, 2000, PLANTA MED, V66, P569, DOI 10.1055/s-2000-8605; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hiasa M, 2013, BRIT J PHARMACOL, V169, P115, DOI 10.1111/bph.12102; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Johnson J, 2009, INVEST OPHTH VIS SCI, V50, P2398, DOI 10.1167/iovs.08-2088; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Katsura H, 2001, ANTIMICROB AGENTS CH, V45, P3009, DOI 10.1128/AAC.45.11.3009-3013.2001; Kensler TW, 1999, CHEM RES TOXICOL, V12, P113, DOI 10.1021/tx980185b; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; Kim KA, 2013, TOXICOL APPL PHARM, V269, P109, DOI 10.1016/j.taap.2013.03.017; Kitching A, 2009, EUROSURVEILLANCE, V14, P2; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; L'Huillier AG, 2011, PHARMACOGENOMICS, V12, P1493, DOI [10.2217/PGS.11.91, 10.2217/pgs.11.91]; Lee SW, 2012, PLANTA MED, V78, P903, DOI 10.1055/s-0031-1298482; Lim SH, 2009, BRIT J NUTR, V101, P1031, DOI 10.1017/S0007114508066750; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; MEHTA G, 1966, TETRAHEDRON LETT, P4561; Merrell MD, 2008, DRUG METAB DISPOS, V36, P1716, DOI 10.1124/dmd.108.020867; Murakami S, 2008, J VIROL, V82, P1605, DOI 10.1128/JVI.01876-07; Muto NA, 2012, JPN J VET RES, V60, P71; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Pae HO, 2001, INT IMMUNOPHARMACOL, V1, P1849, DOI 10.1016/S1567-5769(01)00110-2; Polakova K, 2015, CLIN COSMET INVESTI, V8, P187, DOI 10.2147/CCID.S81691; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Sato Hiromi, 2005, Curr Drug Discov Technol, V2, P89, DOI 10.2174/1570163054064701; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sun NJ, 1998, J NAT PROD, V61, P362, DOI 10.1021/np970488q; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Tsvetkov P, 2010, CELL DEATH DIFFER, V17, P103, DOI 10.1038/cdd.2009.67; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; Wu ZLL, 2009, BIOCHEM BIOPH RES CO, V379, P749, DOI 10.1016/j.bbrc.2008.12.139; Zhao G, 2008, BIOCHEM PHARMACOL, V75, P1835, DOI 10.1016/j.bcp.2008.01.014; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029120	62	32	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					28001	28017		10.1074/jbc.M115.669465	http://dx.doi.org/10.1074/jbc.M115.669465			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26446794	Green Published, hybrid			2022-12-26	WOS:000365757500046
J	Finnerty, JJ; Peyser, A; Carloni, P				Finnerty, Justin John; Peyser, Alexander; Carloni, Paolo			Cation Selectivity in Biological Cation Channels Using Experimental Structural Information and Statistical Mechanical Simulation	PLOS ONE			English	Article							FREE-ENERGY; POTASSIUM CHANNELS; CALCIUM-CHANNELS; IONIC CHANNELS; K+ CHANNELS; SODIUM; PERMEATION; HYDRATION; CONDUCTION; BINDING	Cation selective channels constitute the gate for ion currents through the cell membrane. Here we present an improved statistical mechanical model based on atomistic structural information, cation hydration state and without tuned parameters that reproduces the selectivity of biological Na+ and Ca2+ ion channels. The importance of the inclusion of step-wise cation hydration in these results confirms the essential role partial dehydration plays in the bacterial Na+ channels. The model, proven reliable against experimental data, could be straightforwardly used for designing Na+ and Ca2+ selective nanopores.	[Finnerty, Justin John; Peyser, Alexander; Carloni, Paolo] German Res Sch Simulat Sci, Computat Biophys, D-52425 Julich, Germany; [Peyser, Alexander] Forschungszentrum Julich, Julich Aachen Res Alliance, Inst Adv Simulat, Simulat Lab Neurosci,Bernstein Facil Simulat & Da, D-52425 Julich, Germany; [Carloni, Paolo] Forschungszentrum Julich, Inst Neurosci & Med INM 9, Computat Biomed, D-52425 Julich, Germany; [Carloni, Paolo] Forschungszentrum Julich, Inst Adv Simulat IAS 5, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Finnerty, JJ (corresponding author), German Res Sch Simulat Sci, Computat Biophys, D-52425 Julich, Germany.	j.finnerty@grs-sim.de; a.peyser@fz-juelich.de	Peyser, Alexander/M-4063-2016	Peyser, Alexander/0000-0002-3453-310X; Carloni, Paolo/0000-0002-9010-0149; Finnerty, Justin/0000-0002-3262-7663	Deutsche Forschungsgemeinschaft [CA 973/17-1]; Helmholtz Association through the Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain" [36]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association through the Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain"(Helmholtz Association)	J. J. Finnerty and P. Carloni thank the Deutsche Forschungsgemeinschaft (www.dfg.de) for the ERA 364 Chemistry Grant CA 973/17-1. A. Peyser thanks the Helmholtz Association (www.helmholtz.de) for partial funding through 369 the Helmholtz Portfolio Theme "Supercomputing and Modeling for the Human Brain."	Allen R, 2001, PHYS CHEM CHEM PHYS, V3, P4177, DOI 10.1039/b105176h; AQVIST J, 1992, J PHYS CHEM-US, V96, P10019, DOI 10.1021/j100203a079; Azam SS, 2009, J PHYS CHEM A, V113, P1827, DOI 10.1021/jp8093462; BARCILON V, 1993, J CHEM PHYS, V98, P1193, DOI 10.1063/1.464342; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Bernstein J, 1902, ARCH GESAMTE PHYSIOL, V92, P521, DOI 10.1007/BF01790181; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; BLATZ AL, 1984, BIOPHYS J, V45, pA306; Boda D, 2002, PHYS CHEM CHEM PHYS, V4, P5154, DOI 10.1039/b203686j; Boda D, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046702; Boda D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.168102; Boda D, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212423; Bostick DL, 2007, P NATL ACAD SCI USA, V104, P9260, DOI 10.1073/pnas.0700554104; Bucher D, 2006, BIOPHYS CHEM, V124, P292, DOI 10.1016/j.bpc.2006.04.008; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; CHEN DP, 1993, BIOPHYS J, V65, P727, DOI 10.1016/S0006-3495(93)81099-3; CHEN DP, 1993, BIOPHYS J, V64, P1405, DOI 10.1016/S0006-3495(93)81507-8; Chen Duanpin, 1992, Journal of General Physiology, V100, p9A; Cole KS, 1939, J GEN PHYSIOL, V22, P649, DOI 10.1085/jgp.22.5.649; COLLINS KD, 1995, P NATL ACAD SCI USA, V92, P5553, DOI 10.1073/pnas.92.12.5553; Ding Y, 2014, P NATL ACAD SCI USA, V111, P3310, DOI 10.1073/pnas.1400675111; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENBERG RS, 1993, BIOPHYS J, V64, pA22; Eisenberg RS, 2013, NEW DEVELOPMENTS AND, V7, P269; EISENMAN G, 1962, Biophys J, V2, P259; Eisenman G., 1961, S MEMBRANE TRANSPORT, P163; Finnerty JJ, 2013, J CHEM THEORY COMPUT, V9, P766, DOI 10.1021/ct300768j; Finol-Urdaneta RK, 2014, J GEN PHYSIOL, V143, P157, DOI 10.1085/jgp.201311037; Gillespie D, 2008, BIOPHYS J, V95, P2658, DOI 10.1529/biophysj.107.127977; Giri J, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026004; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hille B., 1992, IONIC CHANNELS OF EX; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hofer TS, 2005, J COMPUT CHEM, V26, P949, DOI 10.1002/jcc.20232; Kamerlin SCL, 2011, ANNU REV PHYS CHEM, V62, P41, DOI 10.1146/annurev-physchem-032210-103335; KEBARLE P, 1977, ANNU REV PHYS CHEM, V28, P445, DOI 10.1146/annurev.pc.28.100177.002305; KHAN AA, 1972, ACTA CRYSTALL B-STRU, VB 28, P683, DOI 10.1107/S0567740872003024; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Li H, 2015, P NATL ACAD SCI US; Mahler J, 2012, INORG CHEM, V51, P425, DOI 10.1021/ic2018693; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; MARCUS Y, 1991, J CHEM SOC FARADAY T, V87, P2995, DOI 10.1039/ft9918702995; Marcus Y, 2010, PURE APPL CHEM, V82, P1889, DOI 10.1351/PAC-CON-09-07-02; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Nadler B, 2004, J PHYS-CONDENS MAT, V16, pS2153, DOI 10.1088/0953-8984/16/22/015; Nonner W, 2000, BIOPHYS J, V79, P1976, DOI 10.1016/S0006-3495(00)76446-0; Nonner W, 2004, BIOPHYS J, V87, P3716, DOI 10.1529/biophysj.104.047548; Nonner W, 1998, BIOPHYS J, V75, P1287, DOI 10.1016/S0006-3495(98)74048-2; Nonner W, 1998, BIOPHYS J, V74, P2327, DOI 10.1016/S0006-3495(98)77942-1; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peyser A, 2012, EUR BIOPHYS J BIOPHY, V41, P705, DOI 10.1007/s00249-012-0847-z; Peyser A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011910; ROSSEINSKY DR, 1965, CHEM REV, V65, P467, DOI 10.1021/cr60236a004; Rossi M, 2013, P NATL ACAD SCI USA, V110, P12978, DOI 10.1073/pnas.1302757110; Roux B, 2012, J PHYS CHEM B, V116, P6966, DOI 10.1021/jp3007365; Schuss Z, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.036116; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Stock L, 2013, J PHYS CHEM B, V117, P3782, DOI 10.1021/jp401403b; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Varma S, 2011, J GEN PHYSIOL, V138, P279, DOI 10.1085/jgp.2010105791382c; Vchirawongkwin V, 2007, J COMPUT CHEM, V28, P1006, DOI 10.1002/jcc.20583; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15	66	1	1	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0138679	10.1371/journal.pone.0138679	http://dx.doi.org/10.1371/journal.pone.0138679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460827	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300008
J	Arponent, O; Sudah, M; Masarwah, A; Taina, M; Rautiainen, S; Kononen, M; Sironen, R; Kosma, VM; Sutela, A; Hakumaki, J; Vanninen, R				Arponent, Otso; Sudah, Mazen; Masarwah, Amro; Taina, Mikko; Rautiainen, Suvi; Kononen, Mervi; Sironen, Reijo; Kosma, Veli-Matti; Sutela, Anna; Hakumaki, Juhana; Vanninen, Ritva			Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest	PLOS ONE			English	Article							INVASIVE DUCTAL CARCINOMA; PROGNOSTIC-FACTORS; COEFFICIENT VALUE; RADIOGENOMIC ANALYSIS; CANCER; CONTRAST; LESIONS; ADC; ACCURACY; VALUES	Introduction Apparent diffusion coefficient (ADC) values are increasingly reported in breast MRI. As there is no standardized method for ADC measurements, we evaluated the effect of the size of region of interest (ROI) to diagnostic utility and correlation to prognostic markers of breast cancer. Methods This prospective study was approved by the Institutional Ethics Board; the need for written informed consent for the retrospective analyses of the breast MRIs was waived by the Chair of the Hospital District. We compared diagnostic accuracy of ADC measurements from whole-lesion ROIs (WL-ROIs) to small subregions (S-ROIs) showing the most restricted diffusion and evaluated correlations with prognostic factors in 112 consecutive patients (mean age 56.2 +/- 11.6 years, 137 lesions) who underwent 3.0-T breast MRI. Results Intra- and interobserver reproducibility were substantial (k= 0.616-0.784; Intra-Class Correlation 0.589-0.831). In receiver operating characteristics analysis, differentiation between malignant and benign lesions was excellent (area under curve 0.957-0.962, cut-off ADC values for WL-ROIs: 0.87x10(-3) mm(2)s(-1); S-ROIs: 0.69x10(-3) mm(2)s(-1), P<0.001). WL-ROIs/S-ROIs achieved sensitivities of 95.7%/91.3%, specificities of 89.5%/94.7%, and overall accuracies of 89.8%/94.2%. In S-ROIs, lower ADC values correlated with presence of axillary metastases (P = 0.03), high histological grade (P = 0.006), and worsened Nottingham Prognostic Index Score (P<0.05). In both ROIs, ADC values correlated with progesterone receptors and advanced stage (P<0.01), but not with HER2, estrogen receptors, or Ki-67. Conclusions ADC values assist in breast tumor characterization. Small ROIs were more accurate than whole-lesion ROIs and more frequently associated with prognostic factors. Cut-off values differed significantly depending on measurement procedure, which should be recognized when comparing results from the literature. Instead of using a whole lesion covering ROI, a small ROI could be advocated in diffusion-weighted imaging.	[Arponent, Otso; Sudah, Mazen; Masarwah, Amro; Taina, Mikko; Rautiainen, Suvi; Kononen, Mervi; Sutela, Anna; Hakumaki, Juhana; Vanninen, Ritva] Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Sironen, Reijo; Kosma, Veli-Matti] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland; [Arponent, Otso; Masarwah, Amro; Taina, Mikko; Rautiainen, Suvi; Vanninen, Ritva] Univ Eastern Finland, Kuopio Univ Hosp, Inst Clin Med, Sch Med,Dept Clin Radiol, Kuopio, Finland; [Sironen, Reijo; Kosma, Veli-Matti] Univ Eastern Finland, Kuopio Univ Hosp, Inst Clin Med, Sch Med,Dept Clin Pathol & Forens Med, Kuopio, Finland; [Sironen, Reijo; Kosma, Veli-Matti; Vanninen, Ritva] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Arponent, O (corresponding author), Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Otso.Arponen@kuh.fi	Hakumäki, Juhana/AAH-1058-2021	Hakumaki, Juhana/0000-0001-7341-5440; Kononen, Mervi/0000-0002-9622-2796	Kuopio University Hospital; University of Eastern Finland (UEF); Cancer Society of Finland	Kuopio University Hospital; University of Eastern Finland (UEF); Cancer Society of Finland	Otso Arponen received an EVO grant from Kuopio University Hospital (https://www.psshp.fi/), strategic funding for the Cancer Center of Eastern Finland from the University of Eastern Finland (UEF) (https://www.uef.fi/en), and a grant from the Cancer Society of Finland (http://www.cancer.fi/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Bogner W, 2009, RADIOLOGY, V253, P341, DOI 10.1148/radiol.2532081718; Cakir O, 2013, EUR J RADIOL, V82, pE801, DOI 10.1016/j.ejrad.2013.09.001; Cheng LQ, 2013, TUMOR BIOL, V34, P1537, DOI 10.1007/s13277-013-0682-6; Choi SY, 2014, BRIT J RADIOL, V85, pe474; Costantini M, 2010, CLIN RADIOL, V65, P1005, DOI 10.1016/j.crad.2010.07.008; Dong HB, 2014, CLIN BREAST CANCER, V14, P265, DOI 10.1016/j.clbc.2013.12.001; Dorrius MD, 2014, EUR RADIOL, V24, P2835, DOI 10.1007/s00330-014-3338-z; Edge SB, 2010, AJCC CANC STAGING MA; Gevaert O, 2014, RADIOLOGY, V273, P168, DOI 10.1148/radiol.14131731; Imamura T, 2010, MAGN RESON MED SCI, V9, P217, DOI 10.2463/mrms.9.217; Janka R, 2014, ROFO-FORTSCHR RONTG, V186, P130, DOI 10.1055/s-0033-1350298; Jeh SK, 2011, J MAGN RESON IMAGING, V33, P102, DOI 10.1002/jmri.22400; Kamitani T, 2013, MAGN RESON MED SCI, V12, P193, DOI 10.2463/mrms.2012-0095; Kim SH, 2009, J MAGN RESON IMAGING, V30, P615, DOI 10.1002/jmri.21884; Koskela AK, 2005, RADIOLOGY, V236, P801, DOI 10.1148/radiol.2363040782; Kuhl CK, 2006, RADIOLOGY, V239, P666, DOI 10.1148/radiol.2392050509; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lambregts DMJ, 2011, EUR RADIOL, V21, P2567, DOI 10.1007/s00330-011-2220-5; Mazurowski MA, 2014, RADIOLOGY, V273, P365, DOI 10.1148/radiol.14132641; Morris EA, 2013, ACR BIRADS ATL BREAS; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; Nguyen VL, 2014, J MAGN RESON IMAGING, V39, P1449, DOI 10.1002/jmri.24302; Nogueira L, 2014, CLIN RADIOL, V69, P378, DOI 10.1016/j.crad.2013.11.005; OREL SG, 1994, RADIOLOGY, V190, P485, DOI 10.1148/radiology.190.2.8284404; Oshida K, 2005, EUR RADIOL, V15, P1353, DOI 10.1007/s00330-005-2661-9; Park SH, 2015, J MAGN RESON IMAGING, V41, P175, DOI 10.1002/jmri.24519; Partridge SC, 2009, AM J ROENTGENOL, V193, P1716, DOI 10.2214/AJR.08.2139; Ramadan S, 2010, J MAGN RESON IMAGING, V31, P262, DOI 10.1002/jmri.21972; Rautiainen S, 2013, RADIOLOGY, V269, P54, DOI 10.1148/radiol.13122637; Razek AAKA, 2010, NMR BIOMED, V23, P619, DOI 10.1002/nbm.1503; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Scaranelo AM, 2012, RADIOLOGY, V262, P425, DOI 10.1148/radiol.11110639; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma U, 2009, NMR BIOMED, V22, P104, DOI 10.1002/nbm.1245; Siegmann KC, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781403; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Tan SLL, 2014, CLIN RADIOL, V69, P63, DOI 10.1016/j.crad.2013.08.007; TODD JH, 1987, BRIT J CANCER, V56, P489, DOI 10.1038/bjc.1987.230; Yuen S, 2009, J MAGN RESON IMAGING, V29, P1080, DOI 10.1002/jmri.21743	41	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0138702	10.1371/journal.pone.0138702	http://dx.doi.org/10.1371/journal.pone.0138702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458106	Green Published, gold, Green Submitted			2022-12-26	WOS:000362961100007
J	Sampath, PV; Liao, HS; Curtis, ZK; Doran, PJ; Herbert, ME; May, CA; Li, SG				Sampath, Prasanna Venkatesh; Liao, Hua-Sheng; Curtis, Zachary Kristopher; Doran, Patrick J.; Herbert, Matthew E.; May, Christopher A.; Li, Shu-Guang			Understanding the Groundwater Hydrology of a Geographically-Isolated Prairie Fen: Implications for Conservation	PLOS ONE			English	Article							ALLUVIAL AQUIFER; EAST-ANGLIA; WATER; WETLAND; FLOW; MICHIGAN; MEADOWS; SCALE	The sources of water and corresponding delivery mechanisms to groundwater-fed fens are not well understood due to the multi-scale geo-morphologic variability of the glacial landscape in which they occur. This lack of understanding limits the ability to effectively conserve these systems and the ecosystem services they provide, including biodiversity and water provisioning. While fens tend to occur in clusters around regional groundwater mounds, Ives Road Fen in southern Michigan is an example of a geographically-isolated fen. In this paper, we apply a multi-scale groundwater modeling approach to understand the groundwater sources for Ives Road fen. We apply Transition Probability geo-statistics on more than 3000 well logs from a state-wide water well database to characterize the complex geology using conditional simulations. We subsequently implement a 3-dimensional reverse particle tracking to delineate groundwater contribution areas to the fen. The fen receives water from multiple sources: local recharge, regional recharge from an extensive till plain, a regional groundwater mound, and a nearby pond. The regional sources deliver water through a tortuous, 3-dimensional "pipeline" consisting of a confined aquifer lying beneath an extensive clay layer. Water in this pipeline reaches the fen by upwelling through openings in the clay layer. The pipeline connects the geographically-isolated fen to the same regional mound that provides water to other fen clusters in southern Michigan. The major implication of these findings is that fen conservation efforts must be expanded from focusing on individual fens and their immediate surroundings, to studying the much larger and inter-connected hydrologic network that sustains multiple fens.	[Sampath, Prasanna Venkatesh; Liao, Hua-Sheng; Curtis, Zachary Kristopher; Li, Shu-Guang] Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA; [Doran, Patrick J.; Herbert, Matthew E.; May, Christopher A.] Nature Conservancy, Lansing, MI USA	Michigan State University; Nature Conservancy	Li, SG (corresponding author), Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA.	lishug@egr.msu.edu	Sampath, Prasanna V/E-4896-2016; Sampath, Prasanna Venkatesh/ABG-3634-2021; Herbert, Matt/S-2403-2019	Sampath, Prasanna Venkatesh/0000-0002-7429-6866; 				Abbas H, 2011, THESIS MICHIGAN STAT; Afshari S, 2008, J HYDROL ENG, V13, P894, DOI 10.1061/(ASCE)1084-0699(2008)13:9(894); Alexander RB, 2007, J AM WATER RESOUR AS, V43, P41, DOI 10.1111/j.1752-1688.2007.00005.x; Alley W.M., 1998, US GEOLOGICAL SURVEY, V1139; Almendinger JE, 1998, WETLANDS, V18, P184, DOI 10.1007/BF03161655; Amon JP, 2002, WETLANDS, V22, P301, DOI 10.1672/0277-5212(2002)022[0301:TZFOTG]2.0.CO;2; Batelaan O, 2003, J HYDROL, V275, P86, DOI 10.1016/S0022-1694(03)00018-0; Bedekar V, 2012, GROUND WATER, V50, P187, DOI 10.1111/j.1745-6584.2011.00829.x; Bedford BL, 2003, WETLANDS, V23, P608, DOI 10.1672/0277-5212(2003)023[0608:FOTUSD]2.0.CO;2; Bedford BL, 1996, ECOL APPL, V6, P57, DOI 10.2307/2269552; Brunner P, 2010, GROUND WATER, V48, P174, DOI 10.1111/j.1745-6584.2009.00644.x; Carle S.F., 1999, T PROGS TRANSITION P; Carle SF, 1998, SEPM SPECIAL PUBLICA, P147; Cobb MK, 2008, 200804 U WISC WISC G; Dekker SC, 2005, HYDROL PROCESS, V19, P3973, DOI 10.1002/hyp.5864; Doherty J, 2001, GROUND WATER, V39, P863, DOI 10.1111/j.1745-6584.2001.tb02474.x; Drexler JZ, 2013, J HYDROL, V481, P22, DOI 10.1016/j.jhydrol.2012.11.056; Drexler JZ, 1999, HYDROL PROCESS, V13, P1341, DOI 10.1002/(SICI)1099-1085(19990630)13:9&lt;1341::AID-HYP810&gt;3.0.CO;2-5; Fogg GE, 2000, GEOL S AM S, P25; GILVEAR DJ, 1993, J HYDROL, V144, P311, DOI 10.1016/0022-1694(93)90178-C; GILVEAR DJ, 1994, AQUAT CONSERV, V4, P105, DOI 10.1002/aqc.3270040203; Grootjans A., 2005, STAPFIA, V85, P97; Grootjans AP, 2006, APPL VEG SCI, V9, P175, DOI 10.1658/1402-2001(2006)9[175:HLSOBF]2.0.CO;2; Haitjema HM, 2005, GROUND WATER, V43, P781, DOI 10.1111/j.1745-6584.2005.00090.x; Heath RC, 1983, BAS GROUND WAT HYDR, V2220; Herbert ME, 2010, CONSERV BIOL, V24, P1002, DOI 10.1111/j.1523-1739.2010.01460.x; Hunt RJ, 1996, WATER RESOUR RES, V32, P495, DOI 10.1029/95WR03724; Jansen AJM, 2000, APPL VEG SCI, V3, P51, DOI 10.2307/1478918; Jansen AJ, 2001, ECOL ENG, V17, P3, DOI 10.1016/S0925-8574(00)00129-4; Kehew AE, 1998, GROUND WATER, V36, P849, DOI 10.1111/j.1745-6584.1998.tb02204.x; Landis DA, 2012, J INSECT CONSERV, V16, P131, DOI 10.1007/s10841-011-9398-3; Li SG, 2004, COMPUT APPL ENG EDUC, V11, P179, DOI 10.1002/cae.10052; Li SG, 2006, ENVIRON MODELL SOFTW, V21, P601; Li SG, 2006, GROUND WATER, V44, P758, DOI 10.1111/j.1745-6584.2006.00225.x; Li ShuGuang, 2009, Modelling of pollutants in complex environmental systems, Volume 1, P177; Liao HS, 2015, J HYDROLOGIC ENG; Liao HS, 2015, J HYDROLOGY; MDEQ (Michigan Department of Environmental Quality), 2006, WELL SYST; NED USGS, 2006, NAT EL DAT; NHD USGS, 2010, USGS NAT HYDR DAT; Rains MC, 2002, GROUND WATER, V40, P552, DOI 10.1111/j.1745-6584.2002.tb02540.x; SHEDLOCK RJ, 1993, J HYDROL, V141, P127, DOI 10.1016/0022-1694(93)90047-D; SIEGEL DI, 1988, ENVIRON MANAGE, V12, P621, DOI 10.1007/BF01867540; Stuyfzand P.J., 1993, HYDROCHEMISTRY HYDRO; Tiedeman CR, 1997, US GEOLOGICAL SURVEY; TOTH J, 1963, J GEOPHYS RES, V68, P4795, DOI 10.1029/JZ068i008p02354; van der Kamp G, 2009, HYDROGEOL J, V17, P203, DOI 10.1007/s10040-008-0367-1; WASSEN MJ, 1990, LANDSCAPE ECOL, V5, P21, DOI 10.1007/BF00153801; Winter, 1992, PHYSIOGRAPHIC CLIMAT, P127; Winter TC, 2001, WETLANDS, V21, P462, DOI 10.1672/0277-5212(2001)021[0462:WSTFUS]2.0.CO;2; WINTER TC, 1988, ENVIRON MANAGE, V12, P605, DOI 10.1007/BF01867539	51	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140430	10.1371/journal.pone.0140430	http://dx.doi.org/10.1371/journal.pone.0140430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452279	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200069
J	Haavik, LJ; Dodds, KJ; Allison, JD				Haavik, Laurel J.; Dodds, Kevin J.; Allison, Jeremy D.			Do Native Insects and Associated Fungi Limit Non-Native Woodwasp, Sirex noctilio, Survival in a Newly Invaded Environment?	PLOS ONE			English	Article							BORER COLEOPTERA BUPRESTIDAE; TWOLINED CHESTNUT BORER; ASIAN LONGHORNED BEETLE; GOLDSPOTTED OAK BORER; HYMENOPTERA-SIRICIDAE; PINUS-SYLVESTRIS; SPATIAL-DISTRIBUTION; IBALIA-LEUCOSPOIDES; BIOLOGICAL-CONTROL; MORTALITY FACTORS	Sirex noctilio F. (Hymenoptera: Siricidae) is an introduced pest of pines (Pinus spp.) in several countries in the Southern Hemisphere. Although S. noctilio is established in North America (first discovered in 2004), it has not been a destructive pest there so far, where forest communities more closely resemble those in its native Eurasian range-where it is not a pest. To investigate the influence of the existing community of associated insects (competitors + natural enemies) and fungi (vectored by insects) on S. noctilio survival in North America, we examined stage-specific mortality factors and their relative importance, generating life tables drawn from experimentally-manipulated and natural cohorts of Sirex spp. (mostly S. noctilio, but some native S. nigricornis F.). For both natural and experimentally-manipulated cohorts, factors which acted during the earliest Sirex life stages, most likely tree resistance and/or competition among fungal associates, were paramount in dictating woodwasp survival. Experimentally-manipulated life tables revealed that protection from the community of associates resulted in a significantly, and substantially larger (>15x) S. noctilio F1 generation than exposure to it. Seventy percent of generation mortality in the exposed cohort was due to tree resistance or unknown causes early in larval development, which could have included competition among other bark-or wood-inhabiting insects and/or their fungal associates. Only 46% of generation mortality in the protected cohort was due to tree resistance and/or unknown causes. Parasitoids, particularly endoparasitoids (Ibalia spp.), showed limited ability to control S. noctilio, and reduced the experimentally-established cohort by only 11%, and natural cohorts an average of 3.4%. The relative importance of tree resistance vs. competition with bark- and wood-borers in reducing S. noctilio survival remains unclear. Tree resistance and/or competition likely contribute more than natural enemies in maintaining the S. noctilio population in North America below damaging levels.	[Haavik, Laurel J.; Allison, Jeremy D.] Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada; [Dodds, Kevin J.] US Forest Serv, USDA, Forest Hlth Protect, Durham, NH USA	Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre; United States Department of Agriculture (USDA); United States Forest Service	Haavik, LJ (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	ljhaavik@gmail.com	Allison, Jeremy/AAQ-1461-2020	Haavik, Laurel/0000-0002-7749-9095; Allison, Jeremy/0000-0002-0765-3149	Natural Resources Canada; Ontario Ministry of Natural Resources; USDA Forest Service-Forest Health Protection	Natural Resources Canada(Natural Resources CanadaCanadian Forest Service); Ontario Ministry of Natural Resources; USDA Forest Service-Forest Health Protection(United States Department of Agriculture (USDA)United States Forest Service)	This collaborative work was funded in part by Natural Resources Canada, The Ontario Ministry of Natural Resources, and the USDA Forest Service-Forest Health Protection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R A LANGUAGE AND ENV; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Ayres MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090321; Bordeaux JM, 2014, J ECON ENTOMOL, V107, P1931, DOI 10.1603/EC14151; Chase KD, 2014, J ECON ENTOMOL, V107, P1142, DOI 10.1603/EC14023; Coleman TW, 2014, ENVIRON ENTOMOL, V43, P729, DOI 10.1603/EN13162; Coleman TW, 2008, PAN-PAC ENTOMOL, V84, P288, DOI 10.3956/2008-18.1; Corley JC, 2014, J PEST SCI, V87, P551, DOI 10.1007/s10340-014-0613-3; Corley JC, 2010, J INSECT BEHAV, V23, P431, DOI 10.1007/s10905-010-9226-8; Corley JC, 2009, BIOL CONTROL, V51, P471, DOI 10.1016/j.biocontrol.2009.08.010; CORNELL HV, 1995, AM NAT, V145, P563, DOI 10.1086/285756; COUTTS MP, 1969, AUST J BIOL SCI, V22, P1153, DOI 10.1071/BI9691153; COUTTS MP, 1969, FOREST SCI, V15, P412; Coutts MP, 1966, LEAFLET, V101, P14; Coutts MP., 1965, BULLETIN, V41, P80; Coyle DR, 2012, ENVIRON ENTOMOL, V41, P731, DOI 10.1603/EN11280; de Groot Peter, 2006, Great Lakes Entomologist, V39, P49; Dodds KJ, 2014, FORESTS, V5, P2810, DOI 10.3390/f5112810; Dodds KJ, 2012, ENVIRON ENTOMOL, V41, P1350, DOI 10.1603/EN12180; Dodds KJ, 2011, CAN J FOREST RES, V41, P1729, DOI [10.1139/X11-097, 10.1139/x11-097]; Dodds KJ, 2010, CAN J FOREST RES, V40, P212, DOI 10.1139/X09-181; Dodds KJ, 2000, ENTOMOL EXP APPL, V97, P331, DOI 10.1023/A:1004183904479; Duan JJ, 2010, ENVIRON ENTOMOL, V39, P1513, DOI 10.1603/EN10023; DUNN JP, 1986, OECOLOGIA, V70, P596, DOI 10.1007/BF00379911; Eager PT, 2011, ENVIRON ENTOMOL, V40, P1266, DOI 10.1603/EN10322; Favaro R, 2015, ENTOMOL EXP APPL, V155, P95, DOI 10.1111/eea.12292; Fernandez-Arhex V, 2005, BIOCONTROL SCI TECHN, V15, P207, DOI 10.1080/09583150400016084; Fischbein D, 2015, B ENTOMOL RES, V105, P1, DOI 10.1017/S0007485314000418; Fischbein D, 2013, EVOL ECOL, V27, P619, DOI 10.1007/s10682-012-9608-9; Fischbein D, 2012, ECOL ENTOMOL, V37, P161, DOI 10.1111/j.1365-2311.2012.01350.x; GAUT IPC, 1969, AUST J BIOL SCI, V22, P905; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; HAACK RA, 1981, GREAT LAKES ENTOMOL, V14, P113; Haavik LJ, 2012, ENVIRON ENTOMOL, V41, P1311, DOI 10.1603/EN12212; Herms DA, 2014, ANNU REV ENTOMOL, V59, P13, DOI 10.1146/annurev-ento-011613-162051; HILLIS WE, 1968, PHYTOCHEMISTRY, V7, P13, DOI 10.1016/S0031-9422(00)88199-6; Hoebeke E. R., 2005, Newsletter of the Michigan Entomological Society, V50, P24; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hurley BP, 2007, AGR FOREST ENTOMOL, V9, P159, DOI 10.1111/j.1461-9563.2007.00340.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Long SJ, 2009, CAN ENTOMOL, V141, P153, DOI 10.4039/n08-068; MADDEN JL, 1968, NATURE, V218, P189, DOI 10.1038/218189a0; MADDEN JL, 1974, AUST J ZOOL, V22, P341, DOI 10.1071/ZO9740341; MADDEN JL, 1981, AUST J ZOOL, V29, P493, DOI 10.1071/ZO9810493; MADDEN JL, 1971, B ENTOMOL RES, V60, P467, DOI 10.1017/S0007485300040414; MORGAN FD, 1968, ANNU REV ENTOMOL, V13, P239, DOI 10.1146/annurev.en.13.010168.001323; MORGAN FD, 1966, T ROY SOC NZ ZOOL, V7, P195; Muilenburg VL, 2012, ENVIRON ENTOMOL, V41, P1372, DOI 10.1603/EN12238; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; POWELL W, 1982, B ENTOMOL RES, V72, P645, DOI 10.1017/S000748530000866X; Rawlings G. B., 1948, New Zealand Journal of Forestry, V5, P411; REID R. W., 1963, CANADIAN ENTOMOL, V95, P225; Rhainds M, 2010, ENVIRON ENTOMOL, V39, P1794, DOI 10.1603/EN10164; Ryan K, 2012, ENVIRON ENTOMOL, V41, P289, DOI 10.1603/EN11275; Ryan K, 2013, CAN ENTOMOL, V145, P117, DOI 10.4039/tce.2012.96; Ryan K, 2012, AGR FOREST ENTOMOL, V14, P187, DOI 10.1111/j.1461-9563.2011.00558.x; Ryan K, 2011, CAN ENTOMOL, V143, P224, DOI 10.4039/n11-001; SHIBATA E, 1987, RES POPUL ECOL, V29, P347, DOI 10.1007/BF02538893; Smith G, 2000, COLEOPTS BULL, V54, P540, DOI 10.1649/0010-065X(2000)054[0540:FNAROT]2.0.CO;2; Southwood TRE, 2000, ECOLOGICAL METHODS, P356; SPRADBERY JP, 1978, B ENTOMOL RES, V68, P341, DOI 10.1017/S0007485300009330; Sun JH, 2013, ANNU REV ENTOMOL, V58, P293, DOI 10.1146/annurev-ento-120811-153624; TAYLOR KL, 1978, OECOLOGIA, V32, P1, DOI 10.1007/BF00344686; Thompson BM, 2014, ANN ENTOMOL SOC AM, V107, P453, DOI 10.1603/AN13128; TITZE J. F., 1965, Australian Forest Research, V1, P14; Wermelinger B, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P65, DOI 10.1007/978-94-007-1960-6_5; Yu Q., 2009, International Journal of Nematology, V19, P23; Zylstra KE, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.8301	69	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138516	10.1371/journal.pone.0138516	http://dx.doi.org/10.1371/journal.pone.0138516			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447845	Green Submitted, gold, Green Published			2022-12-26	WOS:000362511000009
J	Meyer, SU; Krebs, S; Thirion, C; Blum, H; Krause, S; Pfaffl, MW				Meyer, Swanhild U.; Krebs, Stefan; Thirion, Christian; Blum, Helmut; Krause, Sabine; Pfaffl, Michael W.			Tumor Necrosis Factor Alpha and Insulin-Like Growth Factor 1 Induced Modifications of the Gene Expression Kinetics of Differentiating Skeletal Muscle Cells	PLOS ONE			English	Review							MYOGENIC REGULATORY FACTORS; MESSENGER-RNA; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; PLASMINOGEN-ACTIVATOR; INTEGRATIVE ANALYSIS; SATELLITE CELLS; C2C12 MYOBLASTS; TNF-ALPHA; B-MYB	Introduction TNF-alpha levels are increased during muscle wasting and chronic muscle degeneration and regeneration processes, which are characteristic for primary muscle disorders. Pathologically increased TNF-alpha levels have a negative effect on muscle cell differentiation efficiency, while IGF1 can have a positive effect; therefore, we intended to elucidate the impact of TNF-alpha and IGF1 on gene expression during the early stages of skeletal muscle cell differentiation. Methodology/Principal Findings This study presents gene expression data of the murine skeletal muscle cells PMI28 during myogenic differentiation or differentiation with TNF-alpha or IGF1 exposure at 0 h, 4 h, 12 h, 24 h, and 72 h after induction. Our study detected significant coregulation of gene sets involved in myoblast differentiation or in the response to TNF-alpha. Gene expression data revealed a time-and treatment-dependent regulation of signaling pathways, which are prominent in myogenic differentiation. We identified enrichment of pathways, which have not been specifically linked to myoblast differentiation such as doublecortin-like kinase pathway associations as well as enrichment of specific semaphorin isoforms. Moreover to the best of our knowledge, this is the first description of a specific inverse regulation of the following genes in myoblast differentiation and response to TNF-alpha: Aknad1, Cmbl, Sepp1, Ndst4, Tecrl, Unc13c, Spats2l, Lix1, Csdc2, Cpa1, Parm1, Serpinb2, Aspn, Fibin, Slc40a1, Nrk, and Mybpc1. We identified a gene subset (Nfkbia, Nfkb2, Mmp9, Mef2c, Gpx, and Pgam2), which is robustly regulated by TNF-alpha across independent myogenic differentiation studies. Conclusions This is the largest dataset revealing the impact of TNF-alpha or IGF1 treatment on gene expression kinetics of early in vitro skeletal myoblast differentiation. We identified novel mRNAs, which have not yet been associated with skeletal muscle differentiation or response to TNF-alpha. Results of this study may facilitate the understanding of transcriptomic networks underlying inhibited muscle differentiation in inflammatory diseases.	[Meyer, Swanhild U.; Pfaffl, Michael W.] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Physiol Weihenstephan, Freising Weihenstephan, Germany; [Krebs, Stefan; Blum, Helmut] Univ Munich, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Thirion, Christian] SIRION Biotech GmbH, Martinsried, Germany; [Krause, Sabine] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany	Technical University of Munich; University of Munich; University of Munich	Meyer, SU (corresponding author), Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Physiol Weihenstephan, Freising Weihenstephan, Germany.	meyers@wzw.tum.de	Pfaffl, Michael/G-6622-2013; Krause, Sabine/AAJ-1163-2020	Pfaffl, Michael/0000-0002-3192-1019; Krause, Sabine/0000-0002-3141-886X	German Ministry of Education and Research (BMBF, Bonn, Germany) [S1, 01GM0601]; German Federal Ministry of Education and Research [01GM0887]; SIRION Biotech GmbH	German Ministry of Education and Research (BMBF, Bonn, Germany)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); SIRION Biotech GmbH	The "Muscle Tissue Culture Collection" is part of the German network on muscular dystrophies (MD-NET, service structure S1, 01GM0601) funded by the German Ministry of Education and Research (BMBF, Bonn, Germany, http://www.bmbf.de/). The Muscle Tissue Culture Collection is a partner of EuroBioBank (www.eurobiobank.org) and TREAT-NMD (EC, 6th FP, proposal #036825). This work was an individual research project within the MD-NET and was supported by a grant from the German Federal Ministry of Education and Research [01GM0887] which was granted to CT. SIRION Biotech GmbH provided support in the form of salary for author CT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Ackermann MA, 2013, FASEB J, V27, P3217, DOI 10.1096/fj.13-228882; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Al-Sawaf O, 2014, SCI REP-UK, V4, DOI 10.1038/srep03625; Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; Barallobre-Barreiro J, 2012, CIRCULATION, V125, P789, DOI 10.1161/CIRCULATIONAHA.111.056952; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Budasz-Rwiderska M, 2005, J Physiol Pharmacol, V56 Suppl 3, P195; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Canatan H, 2008, CELL BIOCHEM FUNCT, V26, P179, DOI 10.1002/cbf.1425; Cassano M, 2009, J MUSCLE RES CELL M, V30, P243, DOI 10.1007/s10974-010-9204-y; Chandrasekar B, 2005, J BIOL CHEM, V280, P26263, DOI 10.1074/jbc.M502586200; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Chen Z, 2011, BIOCHEM J, V436, P437, DOI 10.1042/BJ20102007; Chen ZX, 2013, J NEUROSCI, V33, P8336, DOI 10.1523/JNEUROSCI.5128-12.2013; Dahlman JM, 2009, J CELL BIOCHEM, V106, P42, DOI 10.1002/jcb.21976; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Ding Y, 2008, AM J PATHOL, V172, P1529, DOI 10.2353/ajpath.2008.070429; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Droguett R, 2010, EXP CELL RES, V316, P2487, DOI 10.1016/j.yexcr.2010.04.031; Duan Q, 2012, ANIM GENET, V43, P115, DOI 10.1111/j.1365-2052.2011.02224.x; Fareed MU, 2006, AM J PHYSIOL-REG I, V290, pR1589, DOI 10.1152/ajpregu.00668.2005; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013; Gardner S, 2011, MOL ENDOCRINOL, V25, P128, DOI 10.1210/me.2010-0292; Grabiec K, 2013, POL J VET SCI, V16, P255, DOI 10.2478/pjvs-2013-0036; Grossi A, 2008, CELL BIOL INT, V32, P615, DOI 10.1016/j.cellbi.2008.01.005; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Ha K, 2013, HUM MOL GENET, V22, P4967, DOI 10.1093/hmg/ddt344; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Himes BE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002824; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jang WG, 2004, PROTEOMICS, V4, P3383, DOI 10.1002/pmic.200400972; Johnson LR, 2002, J BIOL CHEM, V277, P4088, DOI 10.1074/jbc.M105112200; Johnston IA, 2009, J EXP BIOL, V212, P1781, DOI 10.1242/jeb.029918; Kanai-Azuma M, 1999, MECH DEVELOP, V89, P155, DOI 10.1016/S0925-4773(99)00193-8; Ko JA, 2005, FEBS LETT, V579, P2236, DOI 10.1016/j.febslet.2005.03.022; Krueger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015511; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Kubista M, 2013, 6TH INTERNATIONAL QP; Kurokawa S, 2012, J BIOL CHEM, V287, P28717, DOI 10.1074/jbc.M112.383521; Lakner J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-26; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LAUG WE, 1993, CANCER RES, V53, P6051; Layne MD, 1999, EXP CELL RES, V249, P177, DOI 10.1006/excr.1999.4465; Lei HQ, 2013, AM J PHYSIOL-CELL PH, V305, pC529, DOI 10.1152/ajpcell.00051.2013; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu H, 2012, J CELL SCI, V123, P2914; Liu YL, 2011, CELL SIGNAL, V23, P827, DOI 10.1016/j.cellsig.2011.01.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundberg I, 1995, J NEUROIMMUNOL, V63, P9, DOI 10.1016/0165-5728(95)00122-0; Marotta M, 2009, PHYSIOL GENOMICS, V37, P119, DOI 10.1152/physiolgenomics.90370.2008; Marshall AD, 2011, CANCER RES, V71, P7471, DOI 10.1158/0008-5472.CAN-11-0924; Martinez I, 2011, CANCER RES, V71, P5370, DOI 10.1158/0008-5472.CAN-11-1044; Marty I, 2000, J BIOL CHEM, V275, P8206, DOI 10.1074/jbc.275.11.8206; Mazzaro G, 1999, ONCOGENE, V18, P5831, DOI 10.1038/sj.onc.1202962; Merritt EK, 2013, J APPL PHYSIOL, V115, P937, DOI 10.1152/japplphysiol.00019.2013; Meyer SU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135284; Meyer SU, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0083-0; Meyer SU, 2014, METHODS MOL BIOL, V1160, P165, DOI 10.1007/978-1-4939-0733-5_15; Murray J, 2011, AM J PHYSIOL-CELL PH, V301, pC630, DOI 10.1152/ajpcell.00033.2011; Nakano K, 2003, EXP CELL RES, V287, P219, DOI 10.1016/S0014-4827(03)00136-8; NAKASHIMA J, 1995, CANCER RES, V55, P4881; Neuhaus P, 2003, MOL CELL BIOL, V23, P6037, DOI 10.1128/MCB.23.17.6037-6048.2003; Ohsawa Y, 2012, LAB INVEST, V92, P1100, DOI 10.1038/labinvest.2012.78; Omoteyama K, 2009, J CELL BIOCHEM, V106, P546, DOI 10.1002/jcb.22012; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Park MY, 1998, MOL CELLS, V8, P513; Pisaniello A, 2003, J CELL SCI, V116, P1589, DOI 10.1242/jcs.00358; Podbregar M, 2013, SCI WORLD J, DOI 10.1155/2013/617170; Porrello A, 2000, J CELL BIOL, V151, P1295, DOI 10.1083/jcb.151.6.1295; Prelovsek O, 2006, AM J PHYSIOL-REG I, V291, pR1651, DOI 10.1152/ajpregu.00020.2006; Reddy VS, 2010, AM J PHYSIOL-HEART C, V299, pH1242, DOI 10.1152/ajpheart.00451.2010; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Saab R, 2006, MOL CANCER THER, V5, P1299, DOI 10.1158/1535-7163.MCT-05-0383; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; Sakakima H, 2006, ACTA HISTOCHEM, V108, P357, DOI 10.1016/j.acthis.2006.04.003; Sato Y, 2013, ANIM SCI J, V84, P185, DOI 10.1111/asj.12014; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Sheppard BL, 1999, SEMIN THROMB HEMOST, V25, P443, DOI 10.1055/s-2007-994947; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storz P, 1998, FEBS LETT, V440, P41, DOI 10.1016/S0014-5793(98)01421-5; Stupka N, 2006, NEUROMUSCULAR DISORD, V16, P337, DOI 10.1016/j.nmd.2006.03.003; Stupka N, 2013, J BIOL CHEM, V288, P1907, DOI 10.1074/jbc.M112.429647; Szalay K, 1997, EUR J CELL BIOL, V74, P391; Tamir Y, 1998, ONCOGENE, V17, P347, DOI 10.1038/sj.onc.1201929; Tanaka H, 2000, J MUSCLE RES CELL M, V21, P507, DOI 10.1023/A:1026561120566; Tatsumi R, 2009, AM J PHYSIOL-CELL PH, V297, pC238, DOI 10.1152/ajpcell.00161.2009; Tonami K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003668; Tzeng ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067040; Ullah Z, 2011, MOL CELL BIOL, V31, P4129, DOI 10.1128/MCB.05723-11; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Vallejo G, 2010, J CELL PHYSIOL, V222, P127, DOI 10.1002/jcp.21929; Van den Plas D, 2004, CELL BIOL INT, V28, P199, DOI 10.1016/j.cellbi.2003.11.019; Varoqueaux F, 2005, MOL CELL BIOL, V25, P5973, DOI 10.1128/MCB.25.14.5973-5984.2005; Vega AV, 2011, J PHYSIOL-LONDON, V589, P4649, DOI 10.1113/jphysiol.2011.210765; Wagatsuma A, 2011, MOL CELL BIOCHEM, V347, P145, DOI 10.1007/s11010-010-0622-3; Wakeling EN, 2012, J COMP NEUROL, V520, P1737, DOI 10.1002/cne.23010; Wang W, 2009, AM J PATHOL, V174, P541, DOI 10.2353/ajpath.2009.080509; Weyman CM, 1998, ENDOCRINOLOGY, V139, P1794, DOI 10.1210/en.139.4.1794; Wittler L, 2012, GENE, V506, P392, DOI 10.1016/j.gene.2012.06.082; Wu H, 2007, EUR J CELL BIOL, V86, P331, DOI 10.1016/j.ejcb.2007.03.002; Xu J, 2013, ONCOGENE, V32, P976, DOI 10.1038/onc.2012.121; Yang YB, 2012, IN VITRO CELL DEV-AN, V48, P359, DOI 10.1007/s11626-012-9513-0; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yim SY, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S2-S10; Yin LD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S19; Yu YH, 2008, J ANIM SCI, V86, P64, DOI 10.2527/jas.2007-0399; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zavizion B, 1998, BBA-MOL CELL RES, V1403, P141, DOI 10.1016/S0167-4889(98)00035-4; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhang LX, 2008, DEVELOPMENT, V135, P2065, DOI 10.1242/dev.022673; Zhao L, 2003, MOL CANCER RES, V1, P195; Zhao SP, 1997, INT J CARDIOL, V58, P257, DOI 10.1016/S0167-5273(96)02873-2; Zhao YH, 2013, HUM PATHOL, V44, P365, DOI 10.1016/j.humpath.2012.03.030; Zhou HY, 2006, AM J HUM GENET, V79, P859, DOI 10.1086/508500; Zhou HY, 2013, HUM MUTAT, V34, P986, DOI 10.1002/humu.22326; Zhu XJ, 2007, CARDIOVASC RES, V76, P141, DOI 10.1016/j.cardiores.2007.06.015; Zimowska M, 2009, Int J Cell Biol, V2009, P659372, DOI 10.1155/2009/659372	136	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139520	10.1371/journal.pone.0139520	http://dx.doi.org/10.1371/journal.pone.0139520			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447881	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000031
J	Okop, KJ; Levitt, N; Puoane, T				Okop, Kufre Joseph; Levitt, Naomi; Puoane, Thandi			Factors Associated with Excessive Body Fat in Men and Women: Cross-Sectional Data from Black South Africans Living in a Rural Community and an Urban Township	PLOS ONE			English	Article							NUTRITION TRANSITION; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; MASS INDEX; CARDIOMETABOLIC RISK; NORMAL-WEIGHT; OBESITY; PERCENTAGE; HEALTH; DETERMINANTS	Objective To determine the factors associated with excessive body fat among black African men and women living in rural and urban communities of South Africa. Methods This is a cross-sectional analysis of data from the Prospective Urban and Rural Epidemiology (PURE) study, Cape Town, South Africa conducted in 2009/2010. The study sample included 1220 participants (77.2% women) aged 35-70 years, for whom anthropometric measurements were obtained and risk factors documented through face-to-face interviews using validated international PURE study protocols. Sex-specific logistic regression models were used to evaluate socio-demographic, lifestyle and psychological factors associated with three excessive body fat indicators, namely body mass index (BMI), waist circumference (WC) and body fat percent (BF%). Results The prevalence of excessive body fat based on BF%, WC and BMI cut-offs were 96.0%, 86.1%, and 81.6% for women respectively, and 62.2%, 25.9%, and 36.0% for men respectively. The significant odds of excessive body fat among the currently married compared to unmarried were 4.1 (95% CI: 1.3-12.5) for BF% and 1.9 (95% CI: 1.3-2.9) for BMI among women; and 4.9 (95% CI: 2.6-9.6), 3.2 (95% CI: 1.6-6.4) and 3.6 (95% CI: 1.9-6.8) for BF%, WC and BMI respectively among men. Age <= 50 years (compared to age >50 years) was inversely associated with excessive BF% in men and women, and less-than-a-college education was inversely associated with excessive BMI and WC in men. Tobacco smoking was inversely associated with all three excessive adiposity indicators in women but not in men. Unemployment, depression, and stress did not predict excessive body fat in men or women. Conclusion The sex-differences in the socio-demographic and lifestyle factors associated with the high levels of excessive body fat in urban and rural women and men should be considered in packaging interventions to reduce obesity in these communities.	[Okop, Kufre Joseph; Puoane, Thandi] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Okop, Kufre Joseph; Levitt, Naomi; Puoane, Thandi] Univ Cape Town, Dept Med, Chron Dis Initiat Africa, ZA-7925 Cape Town, South Africa; [Levitt, Naomi] Univ Cape Town, Dept Med, Div Endocrinol & Diabet, ZA-7925 Cape Town, South Africa	University of the Western Cape; University of Cape Town; University of Cape Town	Okop, KJ (corresponding author), Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa.	kufreokop@gmail.com	Okop, Kufre Joseph/J-1752-2019	Okop, Kufre Joseph/0000-0002-0841-4588; Levitt, Naomi/0000-0001-6480-8066	South African Medical Research Council; Population Health Research Institute of McMaster University, Canada; National Research Foundation of South Africa	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Population Health Research Institute of McMaster University, Canada; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by the South African Medical Research Council (http://www.mrc.ac.za/), to TP; the Population Health Research Institute of McMaster University, Canada (http://www.phri.ca/), to TP; and the National Research Foundation of South Africa (http://www.nrf.ac.za/), to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeboye B, 2012, CARDIOVASC J AFR, V23, P512, DOI 10.5830/CVJA-2012-040; Akarolo-Anthony SN, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-455, 10.1186/1471-2458-14-529]; [Anonymous], 2003, POP CENS CENS BRIEF; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Chatkin R, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-61; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Faber M, 2005, ETHNIC DIS, V15, P238; FORBES GB, 1987, NUTR REV, V45, P225; Gaziano TA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-170; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Heo M, 2012, AM J CLIN NUTR, V95, P594, DOI 10.3945/ajcn.111.025171; Igumbor EU, 2012, PLOS MED, P9; Joubert J, 2007, SAMJ S AFR MED J, V97, P683; Julia Goedecke, 2006, OBESITY S AFRICA CHR; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim JY, 2013, OBESITY, V21, P1571, DOI 10.1002/oby.20020; Kones RRU, 1995, HOSP PRACT, V42, P92; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Malhotra R, 2008, S AFR J CLIN NUTR, V21, P315; Micklesfield LK, 2013, CARDIOVASC J AFR, V24, P369, DOI 10.5830/CVJA-2013-069; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Peer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107471; Phillips CM, 2013, OBESITY, V21, pE154, DOI 10.1002/oby.20263; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Puoane T, 2010, ETHNIC DIS, V20, P29; Rheeder P, 2002, SAMJ S AFR MED J, V92, P637; Ricciardi R, 2009, APPL NURS RES, V22, P2, DOI 10.1016/j.apnr.2007.01.011; Seidell JC, 2010, EUR J CLIN NUTR, V64, P35, DOI 10.1038/ejcn.2009.71; Shen W, 2006, OBESITY, V14, P727, DOI 10.1038/oby.2006.83; Shisana O, 2013, S AFRICAN NATL HLTH; Steyn NP, 2014, ANN NY ACAD SCI, V1311, P88, DOI 10.1111/nyas.12433; Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008; Teo K, 2009, AM HEART J, P158; Vorster HH, 2011, NUTRIENTS, V3, P429, DOI 10.3390/nu3040429; Vorster HH, 2005, PUBLIC HEALTH NUTR, V8, P480, DOI 10.1079/PHN2005784; Winstanley M., 2012, TOBACCO AUSTR FACTS; World Health Organization, 2000, WHO TECHN REP SER, V894; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	45	19	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140153	10.1371/journal.pone.0140153	http://dx.doi.org/10.1371/journal.pone.0140153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447880	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000097
J	Rooney, SI; Tobias, JW; Bhatt, PR; Kuntz, AF; Soslowsky, LJ				Rooney, Sarah Ilkhanipour; Tobias, John W.; Bhatt, Pankti R.; Kuntz, Andrew F.; Soslowsky, Louis J.			Genetic Response of Rat Supraspinatus Tendon and Muscle to Exercise	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; PROSTAGLANDIN E-2; MATRIX; FIBROBLASTS; OVERUSE; MODEL; MICRODIALYSIS; TENDINOPATHY; INCREASES; HUMANS	Inflammation is a complex, biologic event that aims to protect and repair tissue. Previous studies suggest that inflammation is critical to induce a healing response following acute injury; however, whether similar inflammatory responses occur as a result of beneficial, non-injurious loading is unknown. The objective of this study was to screen for alterations in a subset of inflammatory and extracellular matrix genes to identify the responses of rat supraspinatus tendon and muscle to a known, non-injurious loading condition. We sought to define how a subset of genes representative of specific inflammation and matrix turnover pathways is altered in supraspinatus tendon and muscle 1) acutely following a single loading bout and 2) chronically following repeated loading bouts. In this study, Sprague-Dawley rats in the acute group ran a single bout of non-injurious exercise on a flat treadmill (10 m/min, 1 hour) and were sacrificed 12 or 24 hours after. Rats in the chronic group ran 5 days/wk for 1 or 8 weeks. A control group maintained normal cage activity. Supraspinatus muscle and tendon were harvested for RNA extractions, and a custom Panomics QuantiGene 2.0 multiplex assay was used to detect 48 target and 3 housekeeping genes. Muscle/tendon and acute/chronic groups had distinct gene expression. Components of the arachidonic acid cascade and matrix metalloproteinases and their inhibitors were altered with acute and chronic exercise. Collagen expression increased. Using a previously validated model of non-injurious exercise, we have shown that supraspinatus tendon and muscle respond to acute and chronic exercise by regulating inflammatory-and matrix turnover-related genes, suggesting that these pathways are involved in the beneficial adaptations to exercise.	[Rooney, Sarah Ilkhanipour; Bhatt, Pankti R.; Kuntz, Andrew F.; Soslowsky, Louis J.] Univ Penn, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA; [Tobias, John W.] Univ Penn, Perelman Sch Med, Mol Profiling Core, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Soslowsky, LJ (corresponding author), Univ Penn, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA.	soslowsk@upenn.edu		Kuntz, Andrew/0000-0003-3053-5500; Rooney, Sarah/0000-0002-9850-771X	Penn Center for Musculoskeletal Disorders (National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P30 AR050950]; U.S. Department of Veterans Affairs [VISN 4 CPPF]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER	Penn Center for Musculoskeletal Disorders (National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by the Penn Center for Musculoskeletal Disorders (National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases P30 AR050950, http://www.niams.nih.gov/) and the U.S. Department of Veterans Affairs (VISN 4 CPPF, http://www.research.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SPRAGUE DAWLEY RAT; Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Connizzo BK, 2014, CLIN ORTHOP RELAT R, V472, P2433, DOI 10.1007/s11999-013-3258-2; Devkota AC, 2010, CONNECT TISSUE RES, V51, P306, DOI 10.3109/03008200903318261; Ferry Scott T, 2012, Sports Med Arthrosc Rehabil Ther Technol, V4, P2, DOI 10.1186/1758-2555-4-2; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kjaer M, 2013, J APPL PHYSIOL, V115, P879, DOI 10.1152/japplphysiol.00120.2013; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680; Millar NL, 2008, CLIN ORTHOP RELAT R, V466, P1569, DOI 10.1007/s11999-008-0265-9; Pasternak B, 2009, ACTA ORTHOP, V80, P693, DOI 10.3109/17453670903448257; PERRY AK, 1988, J EXP BIOL, V137, P207; Perry SM, 2005, J SHOULDER ELB SURG, V14, p79S, DOI 10.1016/j.jse.2004.09.020; Rooney SI, 2015, MUSCLES LIGAMENTS TE, V4, P413; Rullman E, 2007, J APPL PHYSIOL, V102, P2346, DOI 10.1152/japplphysiol.00822.2006; Rullman E, 2009, J APPL PHYSIOL, V106, P804, DOI 10.1152/japplphysiol.90872.2008; Soslowsky L J, 1996, J Shoulder Elbow Surg, V5, P383; SULLIVAN TE, 1978, J APPL PHYSIOL, V44, P358, DOI 10.1152/jappl.1978.44.3.358; Szomor ZL, 2006, J ORTHOP RES, V24, P80, DOI 10.1002/jor.20009; Thampatty BP, 2006, GENE, V372, P103, DOI 10.1016/j.gene.2005.12.013; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962	25	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139880	10.1371/journal.pone.0139880	http://dx.doi.org/10.1371/journal.pone.0139880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447778	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000063
J	Schaafsma, T; Wakefield, J; Hanisch, R; Bray, F; Schuz, J; Joy, EJM; Watts, MJ; McCormack, V				Schaafsma, Torin; Wakefield, Jon; Hanisch, Rachel; Bray, Freddie; Schuez, Joachim; Joy, Edward J. M.; Watts, Michael J.; McCormack, Valerie			Africa's Oesophageal Cancer Corridor: Geographic Variations in Incidence Correlate with Certain Micronutrient Deficiencies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SOUTH-AFRICA; RISK-FACTORS; MAIZE GRAIN; SELENIUM; POPULATION; ZINC; PREVALENCE; WIDESPREAD; DISEASE	Background The aetiology of Africa's easterly-lying corridor of squamous cell oesophageal cancer is poorly understood. Micronutrient deficiencies have been implicated in this cancer in other areas of the world, but their role in Africa is unclear. Without prospective cohorts, timely insights can instead be gained through ecological studies. Methods Across Africa we assessed associations between a country's oesophageal cancer incidence rate and food balance sheet-derived estimates of mean national dietary supplies of 7 nutrients: calcium (Ca), copper (Cu), iron (Fe), iodine (I), magnesium (Mg), selenium (Se) and zinc (Zn). We included 32 countries which had estimates of dietary nutrient supplies and of better-quality GLOBCAN 2012 cancer incidence rates. Bayesian hierarchical Poisson lognormal models were used to estimate incidence rate ratios for oesophageal cancer associated with each nutrient, adjusted for age, gender, energy intake, phytate, smoking and alcohol consumption, as well as their 95% posterior credible intervals (CI). Adult dietary deficiencies were quantified using an estimated average requirements (EAR) cut-point approach. Results Adjusted incidence rate ratios for oesophageal cancer associated with a doubling of mean nutrient supply were: for Fe 0.49 (95% CI: 0.29-0.82); Mg 0.58 (0.31-1.08); Se 0.40 (0.18-0.90); and Zn 0.29 (0.11-0.74). There were no associations with Ca, Cu and I. Mean national nutrient supplies exceeded adult EARs for Mg and Fe in most countries. For Se, mean supplies were less than EARs (both sexes) in 7 of the 10 highest oesophageal cancer ranking countries, compared to 23% of remaining countries. For Zn, mean supplies were less than the male EARs in 8 of these 10 highest ranking countries compared to in 36% of other countries. Conclusions Ecological associations are consistent with the potential role of Se and/or Zn deficiencies in squamous cell oesophageal cancer in Africa. Individual-level analytical studies are needed to elucidate their causal role in this setting.	[Schaafsma, Torin] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wakefield, Jon] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Hanisch, Rachel; Schuez, Joachim; McCormack, Valerie] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon, France; [Bray, Freddie] Int Agcy Res Canc, Sect Canc Surveillance, F-69372 Lyon, France; [Joy, Edward J. M.; Watts, Michael J.] British Geol Survey, Inorgan Geochem, Ctr Environm Geochem, Nottingham NG12 5GG, England; [Joy, Edward J. M.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham	McCormack, V (corresponding author), Int Agcy Res Canc, Sect Environm & Radiat, 150 Cours Albert Thomas, F-69372 Lyon, France.	mccormackv@iarc.fr		Bray, Freddie/0000-0002-3248-7787; Watts, Michael/0000-0003-0379-8401; Joy, Edward/0000-0002-0106-866X; McCormack, Valerie/0000-0001-7397-3442	International Agency for Research on Cancer (IARC); NATIONAL CANCER INSTITUTE [R21CA191965] Funding Source: NIH RePORTER	International Agency for Research on Cancer (IARC)(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the International Agency for Research on Cancer (IARC). There was no external funding.	Abnet CC, 2005, JNCI-J NATL CANCER I, V97, P301, DOI 10.1093/jnci/dji042; Abnet CC, 2015, GASTROENTEROLOGY, V148, P1234, DOI 10.1053/j.gastro.2015.02.007; Arnold M, 2014, GUT; Banda LT, 2001, TROP MED INT HEALTH, V6, P296, DOI 10.1046/j.1365-3156.2001.00707.x; Chilimba ADC, 2012, FIELD CROP RES, V125, P118, DOI 10.1016/j.fcr.2011.08.014; Chilimba ADC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00072; Chokunonga E, 2013, INT J CANCER, V133, P721, DOI 10.1002/ijc.28063; Courtman C, 2012, S AFR J ANIM SCI, V42, P454, DOI 10.4314/sajas.v42i5.2; Dawsey SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014080; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fong LYY, 1999, CANCER LETT, V143, P63, DOI 10.1016/S0304-3835(99)00191-3; Geographic Information System on Alcohol and Health (GISAH), 2014, GLOB HLTH OBS DAT RE; Gyedu A, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.327.4806; Hashemian Maryam, 2014, Middle East J Dig Dis, V6, P177; HIZA PR, 1976, E AFR MED J, V53, P82; Hurst R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01425; Institute of Medicine (IOM), 2000, DIET REF INT VIT A V; IOM - Institute of Medicine, 2002, DIET REF INT VIT C V; JASKIEWICZ K, 1988, CANCER, V62, P2635, DOI 10.1002/1097-0142(19881215)62:12<2635::AID-CNCR2820621232>3.0.CO;2-5; Joy EJM, 2015, SCI TOTAL ENVIRON, V505, P587, DOI 10.1016/j.scitotenv.2014.10.038; Joy EJM, 2014, PHYSIOL PLANTARUM, V151, P208, DOI 10.1111/ppl.12144; Joy EJM, 2015, BMC NUTR IN PRESS; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Kayamba V, 2015, CANCER MED-US, V4, P588, DOI 10.1002/cam4.434; Liu J, 2013, INT J CANCER, V133, P473, DOI 10.1002/ijc.28024; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; MCGLASHAN ND, 1969, GUT, V10, P643, DOI 10.1136/gut.10.8.643; Mohammed Moawia Elbalal, 2012, Arab J Gastroenterol, V13, P174, DOI 10.1016/j.ajg.2012.06.012; Munishi MO, 2015, CANCER CAUSE CONTROL, V26, P1477, DOI 10.1007/s10552-015-0646-9; Ocama P, 2008, AFR HEALTH SCI, V8, P80; Pacella-Norman R, 2002, BRIT J CANCER, V86, P1751, DOI 10.1038/sj.bjc.6600338; Parkin DM, 2014, CANCER EPIDEM BIOMAR, V23, P953, DOI 10.1158/1055-9965.EPI-14-0281; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; SEGAL I, 1988, BRIT J CANCER, V58, P681, DOI 10.1038/bjc.1988.286; Siyame EWP, 2013, INT J VITAM NUTR RES, V83, P176, DOI 10.1024/0300-9831/a000158; Somdyala NI, 2014, INT J CANC; Steevens J, 2010, GASTROENTEROLOGY, V138, P1704, DOI 10.1053/j.gastro.2009.12.004; Sumba PO, 2010, BRIT J CANCER, V103, P1736, DOI 10.1038/sj.bjc.6605947; VANRENSBURG SJ, 1985, BRIT J CANCER, V51, P399, DOI 10.1038/bjc.1985.54; VANRENSBURG SJ, 1981, J NATL CANCER I, V67, P243; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Wakhisi Johnston, 2005, Afr Health Sci, V5, P157; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Wolf LL, 2012, WORLD J SURG, V36, P1074, DOI 10.1007/s00268-012-1490-7	45	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140107	10.1371/journal.pone.0140107	http://dx.doi.org/10.1371/journal.pone.0140107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448405	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000362511000090
J	de Cobelli, O; Terracciano, D; Tagliabue, E; Raimondi, S; Bottero, D; Cioffi, A; Jereczek-Fossa, B; Petralia, G; Cordima, G; Almeida, GL; Lucarelli, G; Buonerba, C; Matei, DV; Renne, G; Di Lorenzo, G; Ferro, M				de Cobelli, Ottavio; Terracciano, Daniela; Tagliabue, Elena; Raimondi, Sara; Bottero, Danilo; Cioffi, Antonio; Jereczek-Fossa, Barbara; Petralia, Giuseppe; Cordima, Giovanni; Almeida, Gilberto Laurino; Lucarelli, Giuseppe; Buonerba, Carlo; Matei, Deliu Victor; Renne, Giuseppe; Di Lorenzo, Giuseppe; Ferro, Matteo			Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging	PLOS ONE			English	Article							RECLASSIFICATION; ASSOCIATION; OUTCOMES; SOCIETY; TUMOR; MEN	Purpose The aim of this study was to investigate the prognostic performance of multiparametric magnetic resonance imaging (mpMRI) and Prostate Imaging Reporting and Data System (PIR-ADS) score in predicting pathologic features in a cohort of patients eligible for active surveillance who underwent radical prostatectomy. Methods A total of 223 patients who fulfilled the criteria for "Prostate Cancer Research International: Active Surveillance", were included. Mp-1.5 Tesla MRI examination staging with endorectal coil was performed at least 6-8 weeks after TRUS-guided biopsy. In all patients, the likelihood of the presence of cancer was assigned using PIRADS score between 1 and 5. Outcomes of interest were: Gleason score upgrading, extra capsular extension (ECE), unfavorable prognosis (occurrence of both upgrading and ECE), large tumor volume (>= 0.5ml), and seminal vesicle invasion (SVI). Receiver Operating Characteristic (ROC) curves and Decision Curve Analyses (DCA) were performed for models with and without inclusion of PIRADS score. Results Multivariate analysis demonstrated the association of PIRADS score with upgrading (P<0.0001), ECE (P<0.0001), unfavorable prognosis (P<0.0001), and large tumor volume (P = 0.002). ROC curves and DCA showed that models including PIRADS score resulted in greater net benefit for almost all the outcomes of interest, with the only exception of SVI. Conclusions mpMRI and PIRADS scoring are feasible tools in clinical setting and could be used as decision-support systems for a more accurate selection of patients eligible for AS.	[de Cobelli, Ottavio; Bottero, Danilo; Cioffi, Antonio; Cordima, Giovanni; Matei, Deliu Victor; Ferro, Matteo] European Inst Oncol, Div Urol, Milan, Italy; [Terracciano, Daniela] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Tagliabue, Elena; Raimondi, Sara] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Jereczek-Fossa, Barbara] European Inst Oncol, Dept Radiotherapy, Milan, Italy; [Petralia, Giuseppe] European Inst Oncol, Dept Radiol, Milan, Italy; [Almeida, Gilberto Laurino] Univ Vale Itajai, Catarinense Inst Urol, Div Laparoscopy, Itajai, Brazil; [Lucarelli, Giuseppe] Univ Bari, Urol & Kidney Transplantat Unit, Dept Emergency & Organ Transplantat, Bari, Italy; [Buonerba, Carlo] CROB IRCCS, Div Med Oncol, Rionero In Vulture, Italy; [Renne, Giuseppe] European Inst Oncol, Div Pathol, Milan, Italy; [Di Lorenzo, Giuseppe] Univ Naples Federico II, Dept Clin Med, Med Oncol Unit, Naples, Italy	IRCCS European Institute of Oncology (IEO); University of Naples Federico II; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); Universidade do Vale do Itajai; Universita degli Studi di Bari Aldo Moro; IRCCS CROB; IRCCS European Institute of Oncology (IEO); University of Naples Federico II	Ferro, M (corresponding author), European Inst Oncol, Div Urol, Milan, Italy.	matteo.ferro@ieo.it	Matei, Deliu V/A-1899-2013; Ferro, Matteo/K-3705-2018; Buonerba, Carlo/J-6095-2018; Bottero, Danilo/AAM-7289-2020; Cioffi, Antonio/AAM-9160-2020; Terracciano, Daniela/AAB-9521-2022; LUCARELLI, GIUSEPPE/AAX-4148-2020; renne, giuseppe/AAQ-9380-2020; Raimondi, Sara/J-5236-2016; DE COBELLI, OTTAVIO/O-2315-2017; Cordima, Giovanni/AAQ-7064-2020; Di Lorenzo, Giuseppe/AAR-9799-2020	Matei, Deliu V/0000-0003-4715-5432; Buonerba, Carlo/0000-0002-1806-442X; Terracciano, Daniela/0000-0003-4296-429X; LUCARELLI, GIUSEPPE/0000-0001-7807-1229; Raimondi, Sara/0000-0003-4673-9049; DE COBELLI, OTTAVIO/0000-0002-0699-8620; Di Lorenzo, Giuseppe/0000-0001-7414-1568; PETRALIA, Giuseppe/0000-0003-3502-3643; PETRALIA, GIUSEPPE/0000-0001-8483-3816; bottero, Danilo/0000-0002-2657-4438; Ferro, Matteo/0000-0002-9250-7858; Tagliabue, Elena/0000-0002-8153-2599; Cioffi, Antonio/0000-0002-6661-9848				Abdi H, 2015, UROLOGY, V85, P423, DOI 10.1016/j.urology.2014.09.060; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Bangma CH, 2012, CURR OPIN UROL, V22, P216, DOI 10.1097/MOU.0b013e328351dcc7; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Cantiello F, 2015, UROL ONCOL; Feng TS, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.11.007; Ferro M, 2015, ANTICANCER RES, V35, P1017; Guzzo TJ, 2012, UROL ONCOL-SEMIN ORI, V30, P301, DOI 10.1016/j.urolonc.2010.08.023; Isharwal S, 2011, UROL, V77, P763, DOI DOI 10.1016/J; Kayat Bittencourt L, 2015, RADIOLOGY; Kuru TH, 2013, BJU INT, V112, P1080, DOI 10.1111/bju.12259; Lee DH, 2013, J UROLOGY, V190, P1213, DOI 10.1016/j.juro.2013.03.127; Loeb S, 2015, EUR UROL, V67, P619, DOI 10.1016/j.eururo.2014.10.010; Mcvey GP, 2010, BJU INT, V106, P1161, DOI 10.1111/j.1464-410X.2010.09288.x; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Mullins JK, 2013, BJU INT, V111, P1037, DOI 10.1111/j.1464-410X.2012.11641.x; Ploussard G, 2013, UROL ONCOL-SEMIN ORI, V31, P1060, DOI 10.1016/j.urolonc.2011.12.018; Ploussard G, 2011, BJU INT, V108, P513, DOI 10.1111/j.1464-410X.2010.09974.x; Ploussard G, 2009, EUR UROL, V56, P891, DOI 10.1016/j.eururo.2009.07.053; Portalez D, 2012, EUR UROL, V62, P986, DOI 10.1016/j.eururo.2012.06.044; Selvadurai ED, 2013, EUR UROL, V64, P981, DOI 10.1016/j.eururo.2013.02.020; Shukla-Dave A, 2012, BJU INT, V109, P1315, DOI 10.1111/j.1464-410X.2011.10612.x; Siddiqui MM, 2015, J UROL; Tosoian JJ, 2012, J UROLOGY, V188, P1131, DOI 10.1016/j.juro.2012.06.009; Turkbey B, 2013, RADIOLOGY, V268, P144, DOI 10.1148/radiol.13121325; van den Bergh RCN, 2014, EUR UROL, V65, P1023, DOI 10.1016/j.eururo.2014.01.027; van der Kwast TH, 2011, MODERN PATHOL, V24, P16, DOI 10.1038/modpathol.2010.156; Vargas HA, 2012, J UROLOGY, V188, P1732, DOI 10.1016/j.juro.2012.07.024; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2009, EUR UROL, V56, P753, DOI 10.1016/j.eururo.2009.07.047; Walton Diaz A, 2015, UROL ONCOL; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	32	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139696	10.1371/journal.pone.0139696	http://dx.doi.org/10.1371/journal.pone.0139696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444548	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600070
J	Li, L; Walsh, RM; Wagh, V; James, MF; Beauchamp, RL; Chang, YS; Gusella, JF; Hochedlinger, K; Ramesh, V				Li, Lin; Walsh, Ryan M.; Wagh, Vilas; James, Marianne F.; Beauchamp, Roberta L.; Chang, Yuh-Shin; Gusella, James F.; Hochedlinger, Konrad; Ramesh, Vijaya			Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency	PLOS ONE			English	Article							PRIMITIVE ENDODERM FORMATION; GENE-EXPRESSION; STEM-CELLS; TRANSCRIPTION; DIFFERENTIATION; MAGICIN; COMPLEX; CANCER; NANOG; MED12	The multi-subunit mammalian Mediator complex acts as an integrator of transcriptional regulation by RNA Polymerase II, and has emerged as a master coordinator of development and cell fate determination. We previously identified the Mediator subunit, MED28, as a cytosolic binding partner of merlin, the Neurofibromatosis 2 (NF2) tumor suppressor, and thus MED28 is distinct in having a cytosolic role as an NF2 interacting protein as well as a nuclear role as a Mediator complex subunit. Although limited in vitro studies have been performed on MED28, its in vivo function remains unknown. Employing a knockout mouse model, we describe for the first time the requirement for Med28 in the developing mouse embryo. Med28-deficiency causes peri-implantation lethality resulting from the loss of pluripotency of the inner cell mass accompanied by reduced expression of key pluripotency transcription factors Oct4 and Nanog. Further, overexpression of Med28 in mouse embryonic fibroblasts enhances the efficiency of their reprogramming to pluripotency. Cre-mediated inactivation of Med28 in induced pluripotent stem cells shows that Med28 is required for their survival. Intriguingly, heterozygous loss of Med28 results in differentiation of induced pluripotent stem cells into extraembryonic trophectoderm and primitive endoderm lineages. Our findings document the essential role of Med28 in the developing embryo as well as in acquisition and maintenance of pluripotency during reprogramming.	[Li, Lin; Wagh, Vilas; James, Marianne F.; Beauchamp, Roberta L.; Gusella, James F.; Ramesh, Vijaya] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Walsh, Ryan M.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Chang, Yuh-Shin] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Gusella, James F.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Ramesh, V (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	ramesh@helix.mgh.harvard.edu	Wagh, Vilas/B-3267-2009		U.S. Army Medical Research and Material Command [W81XWH-11-1-0264]; NIH [NS082482, P30 HD018655]; NCI Cancer Center Support Grant, NIH [5 P30 CA06516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS082482] Funding Source: NIH RePORTER	U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by U.S. Army Medical Research and Material Command contract W81XWH-11-1-0264, NIH NS082482. NIH P30 HD018655 supported the IDDRC gene manipulation core at Children's Hospital, Boston. Dana-Farber/Harvard Cancer Center is supported in part by an NCI Cancer Center Support Grant, NIH 5 P30 CA06516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beyer KS, 2007, J BIOL CHEM, V282, P32152, DOI 10.1074/jbc.M706592200; Cai KQ, 2008, DEV DYNAM, V237, P2820, DOI 10.1002/dvdy.21703; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Hashimoto S, 2011, SCIENCE, V333, P1161, DOI 10.1126/science.1206638; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kuuselo R, 2011, INT J CANCER, V129, P2553, DOI 10.1002/ijc.25924; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lee MF, 2006, BIOCHEM BIOPH RES CO, V348, P826, DOI 10.1016/j.bbrc.2006.07.126; Lu M, 2007, CANCER BIOL THER, V6, P936, DOI 10.4161/cbt.6.6.4189; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muncke N, 2003, CIRCULATION, V108, P2843, DOI 10.1161/01.CIR.0000103684.77636.CD; Napoli C, 2012, BIOCHIMIE, V94, P579, DOI 10.1016/j.biochi.2011.09.016; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tudor M, 1999, GENE DEV, V13, P2365, DOI 10.1101/gad.13.18.2365; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wiederhold T, 2004, ONCOGENE, V23, P8815, DOI 10.1038/sj.onc.1208110; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Yin JW, 2014, DEVELOPMENT, V141, P977, DOI 10.1242/dev.098392; Yoon NK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-335; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang LP, 2004, CLIN CANCER RES, V10, P3504, DOI 10.1158/1078-0432.CCR-03-0467	37	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140192	10.1371/journal.pone.0140192	http://dx.doi.org/10.1371/journal.pone.0140192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445504	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600150
J	Lootvoet, AC; Philippon, J; Bessa-Gomes, C				Lootvoet, Amelie Christelle; Philippon, Justine; Bessa-Gomes, Carmen			Behavioral Correlates of Primates Conservation Status: Intrinsic Vulnerability to Anthropogenic Threats	PLOS ONE			English	Article							6TH MASS EXTINCTION; SEXUAL SELECTION; DEMOGRAPHIC STOCHASTICITY; MATING SYSTEM; HABITAT LOSS; BODY-SIZE; RISK; BIRDS; POPULATIONS; PATTERNS	Behavioral traits are likely to influence species vulnerability to anthropogenic threats and in consequence, their risk of extinction. Several studies have addressed this question and have highlighted a correlation between reproductive strategies and different viability proxies, such as introduction success and local extinction risk. Yet, very few studies have investigated the effective impact of social behaviour, and evidence regarding global extinction risk remains scant. Here we examined the effects of three main behavioral factors: the group size, the social and reproductive system, and the strength of sexual selection on global extinction risk. Using Primates as biological model, we performed comparative analysis on 93 species. The conservation status as described by the IUCN Red List was considered as a proxy for extinction risk. In addition, we added previously identified intrinsic factors of vulnerability to extinction, and a measure of the strength of the human impact for each species, described by the human footprint. Our analysis highlighted a significant effect of two of the three studied behavioral traits, group size and social and reproductive system. Extinction risk is negatively correlated with mean group size, which may be due to an Allee effect resulting from the difficulties for solitary and monogamous species to find a partner at low densities. Our results also indicate that species with a flexible mating system are less vulnerable. Taking into account these behavioral variables is thus of high importance when establishing conservation plans, particularly when assessing species relative vulnerability.	[Lootvoet, Amelie Christelle; Philippon, Justine; Bessa-Gomes, Carmen] Univ Paris 11, UMR 8079, Ecol Lab, Systemat,Evolut, Orsay, France; [Lootvoet, Amelie Christelle; Philippon, Justine; Bessa-Gomes, Carmen] CNRS, UMR 8079, Ecol Lab, Systemat,Evolut, F-91405 Orsay, France; [Lootvoet, Amelie Christelle; Philippon, Justine; Bessa-Gomes, Carmen] AgroParisTech, UMR 8079, Ecol Lab, Systemat,Evolut, Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Bessa-Gomes, C (corresponding author), Univ Paris 11, UMR 8079, Ecol Lab, Systemat,Evolut, Batiment 362, Orsay, France.	carmen.bessa-gomes@u-psud.fr		Bessa Gomes, Carmen/0000-0002-3476-0767	"Agence Nationale pour la Reherche" (ANR) [2009PEXT01001]; ANR-RARE	"Agence Nationale pour la Reherche" (ANR)(French National Research Agency (ANR)); ANR-RARE(French National Research Agency (ANR))	The authors were supported by a grant from the "Agence Nationale pour la Reherche" (ANR), for the project "Research on Allee and Rarity Effects" (RARE; 2009PEXT01001). AL's salary was funded by ANR-RARE. http://www.agence-nationalerecherche.fr/.	Allee W.C, 1931, ANIMAL AGGREGATION S; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bertram B.C.R., 1978, P64; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Bessa-Gomes C, 2003, ANN ZOOL FENN, V40, P231; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Candolin U, 2008, TRENDS ECOL EVOL; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; Caro TM, 1998, BEHAVIORAL ECOLOGY A; CHEVERUD JM, 1985, EVOLUTION, V39, P1335, DOI 10.1111/j.1558-5646.1985.tb05699.x; Cortes Y, 1998, BIOL CONSERV, V86, P179, DOI 10.1016/S0006-3207(98)00009-3; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cowlishaw G., 2000, PRIMATE CONSERVATION; Cowlishaw G, 2009, P R SOC B, V276, P63, DOI 10.1098/rspb.2008.0767; Danchin E., 2008, BEHAV ECOLOGY; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Doherty PF, 2003, P NATL ACAD SCI USA, V100, P5858, DOI 10.1073/pnas.0836953100; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; EISENBER.JF, 1972, SCIENCE, V176, P863, DOI 10.1126/science.176.4037.863; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Estes R.D., 1974, IUCN Publs (New Series), VNo. 24, P166; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foufopoulos J, 1999, AM NAT, V153, P1, DOI 10.1086/303149; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; GITTLEMAN JL, 1993, SYM ZOOL S, P65; Gosling L, 2000, BEHAVIOUR AND CONSER; GOTELLI NJ, 1990, J BIOGEOGR, V17, P315, DOI 10.2307/2845127; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2012, IUCN REDLIST THREANT; Jager HI, 2006, ECOL MODEL, V191, P416, DOI 10.1016/j.ecolmodel.2005.05.025; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; KATTAN GH, 1992, CONSERV BIOL, V6, P64, DOI 10.1046/j.1523-1739.1992.610064.x; Kokko H, 2003, ANN ZOOL FENN, V40, P207; LECK CF, 1979, AUK, V96, P343; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Legendre S, 1999, AM NAT, V153, P449, DOI 10.1086/303195; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Loyola RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006807; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Moller AP, 1999, ECOL LETT, V2, P149; Morrow EH, 2004, P ROY SOC B-BIOL SCI, V271, P2395, DOI 10.1098/rspb.2004.2888; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Peh KSH, 2005, BIOL CONSERV, V123, P489, DOI 10.1016/j.biocon.2005.01.010; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; PULLIAM HR, 1982, J THEOR BIOL, V95, P89, DOI 10.1016/0022-5193(82)90289-2; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Putland D, 2005, SCIENCE, V310, P1277; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; Rowe N, ALL THE WORLDS PRIMA; Rowe N, 1996, THE PICTORIAL GUIDE; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Snaith TV, 2008, BEHAV ECOL, V19, P1289, DOI 10.1093/beheco/arn076; Sodhi NS, 2006, CONSERV BIOL, V20, P772, DOI 10.1111/j.1523-1739.2006.00363.x; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Urquiza-Haas T, 2009, BIOL CONSERV, V142, P134, DOI 10.1016/j.biocon.2008.10.007; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williams SE, 1998, P ROY SOC B-BIOL SCI, V265, P597, DOI 10.1098/rspb.1998.0336; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x	75	7	7	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0135585	10.1371/journal.pone.0135585	http://dx.doi.org/10.1371/journal.pone.0135585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444966	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600002
J	Steglich, M; Nitsche, A; von Muller, L; Herrmann, M; Kohl, TA; Niemann, S; Nubel, U				Steglich, Matthias; Nitsche, Andreas; von Mueller, Lutz; Herrmann, Mathias; Kohl, Thomas A.; Niemann, Stefan; Nuebel, Ulrich			Tracing the Spread of Clostridium difficile Ribotype 027 in Germany Based on Bacterial Genome Sequences	PLOS ONE			English	Article							POINT-PREVALENCE; GLOBAL SPREAD; INFECTION; EVOLUTION; EMERGENCE; EPIDEMIC; STRAINS; DISEASE; RESISTANCE	We applied whole-genome sequencing to reconstruct the spatial and temporal dynamics underpinning the expansion of Clostridium difficile ribotype 027 in Germany. Based on resequencing of genomes from 57 clinical C. difficile isolates, which had been collected from hospitalized patients at 36 locations throughout Germany between 1990 and 2012, we demonstrate that C. difficile genomes have accumulated sequence variation sufficiently fast to document the pathogen's spread at a regional scale. We detected both previously described lineages of fluoroquinolone-resistant C. difficile ribotype 027, FQR1 and FQR2. Using Bayesian phylogeographic analyses, we show that fluoroquinolone-resistant C. difficile 027 was imported into Germany at least four times, that it had been widely disseminated across multiple federal states even before the first outbreak was noted in 2007, and that it has continued to spread since.	[Steglich, Matthias] Robert Koch Inst, Dept Infect Dis, Div Nosocomial Pathogens & Antibiot Resistances, Wernigerode, Germany; [Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, ZBS Highly Pathogen Viruses 1, Berlin, Germany; [von Mueller, Lutz; Herrmann, Mathias] Univ Saarland, Med Ctr, Inst Med Microbiol & Hyg, Natl Consultant Lab Clostridium Difficile, Homburg, Germany; [Kohl, Thomas A.; Niemann, Stefan] Res Ctr Borstel, Mol Mycobacteriol, Borstel, Germany; [Niemann, Stefan] German Ctr Infect Res DZIF, Borstel, Germany; [Nuebel, Ulrich] Leibniz Inst DSMZ, Dept Microbial Genome Res, Braunschweig, Germany; [Nuebel, Ulrich] German Ctr Infect Res DZIF, Braunschweig, Germany	Robert Koch Institute; Robert Koch Institute; Saarland University; Forschungszentrum Borstel; German Center for Infection Research; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); German Center for Infection Research	Nubel, U (corresponding author), Leibniz Inst DSMZ, Dept Microbial Genome Res, Braunschweig, Germany.	ulrich.nuebel@dsmz.de	Herrmann, Mathias/B-6475-2013; Kohl, Thomas Andreas/AAB-9782-2020; Niemann, Stefan/C-9327-2011	Herrmann, Mathias/0000-0003-2638-2257; Kohl, Thomas Andreas/0000-0002-1126-6803; von Muller, Lutz/0000-0001-9013-4245; Niemann, Stefan/0000-0002-6604-0684; Nitsche, Andreas/0000-0001-8185-3176	Robert Koch Institute; European Union, project PathNgenTrace [FP7-278864-2]	Robert Koch Institute; European Union, project PathNgenTrace	The National Consultant Laboratory for Clostridium difficile at the University of Saarland Medical Centre in Homburg was partially funded by a grant from the Robert Koch Institute (to MH). The work of MS was funded through a PhD stipend from the Robert Koch Institute (to UN). This work was partially funded by the European Union, project PathNgenTrace (FP7-278864-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, EPIDEMIOLOGISCHES B, P233; [Anonymous], 2013, POINT PREVALENCE SUR; Arvand M, 2014, EURO SURVEILLANCE B, V19; Bassetti M, 2012, EXPERT REV ANTI-INFE, V10, P1405, DOI [10.1586/ERI.12.135, 10.1586/eri.12.135]; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Davies KA, 2014, LANCET INFECT DIS, V14, P1208, DOI 10.1016/S1473-3099(14)70991-0; Eaton J.W., 2021, GNU OCTAVE VERSION 6; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Geffers C, 2011, DTSCH ARZTEBL INT, V108, P87, DOI 10.3238/arztebl.2011.0087; Gerding DN, 2013, CLIN INFECT DIS, V56, P1601, DOI 10.1093/cid/cit133; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Hunt JJ, 2013, MICROBIOL MOL BIOL R, V77, P567, DOI 10.1128/MMBR.00017-13; Joost I, 2009, INT J ANTIMICROB AG, V33, pS13, DOI 10.1016/S0924-8579(09)70010-X; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kleinkauf N, 2007, EUROSURVEILLANCE, V12; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Pacheco SM, 2013, CURR OPIN GASTROEN, V29, P42, DOI 10.1097/MOG.0b013e32835a68d4; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; von Muller L, 2012, BUNDESGESUNDHEITSBLA, V55, P1410, DOI 10.1007/s00103-012-1556-6; Zaiss NH, 2007, EUROSURVEILLANCE, V12; Zaiss NH, 2010, EMERG INFECT DIS, V16, P675, DOI 10.3201/eid1604.090859; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	42	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139811	10.1371/journal.pone.0139811	http://dx.doi.org/10.1371/journal.pone.0139811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444881	gold, Green Published			2022-12-26	WOS:000362510600084
J	Zhang, L; Wang, XM; Liu, T; Wang, HY; Wang, GL; Chi, S; Liu, C				Zhang, Lei; Wang, Xumin; Liu, Tao; Wang, Haiyang; Wang, Guoliang; Chi, Shan; Liu, Cui			Complete Plastid Genome of the Brown Alga Costaria costata (Laminariales, Phaeophyceae)	PLOS ONE			English	Article							RNA GENES; SEQUENCE; MITOCHONDRIAL; CHLOROPLAST; RATES; POLYSACCHARIDES; GENERATION; PHYLOGENY	Costaria costata is a commercially and industrially important brown alga. In this study, we used next-generation sequencing to determine the complete plastid genome of C. costata. The genome consists of a 129,947 bp circular DNA molecule with an A+T content of 69.13% encoding a standard set of six ribosomal RNA genes, 27 transfer RNA genes, and 137 protein-coding genes with two conserved open reading frames (ORFs). The overall genome structure of C. costata is nearly the same as those of Saccharina japonica and Undaria pinnatifida. The plastid genomes of these three algal species retain a strong conservation of the GTG start codon while infrequently using TGA as a stop codon. In this regard, they differ substantially from the plastid genomes of Ectocarpus siliculosus and Fucus vesiculosus. Analysis of the nucleic acid substitution rates of the Laminariales plastid genes revealed that the petF gene has the highest substitution rate and the petN gene contains no substitution over its complete length. The variation in plastid genes between C. costata and S. japonica is lower than that between C. costata and U. pinnatifida as well as that between U. pinnatifida and S. japonica. Phylogenetic analyses demonstrated that C. costata and U. pinnatifida have a closer genetic relationship. We also identified two gene length mutations caused by the insertion or deletion of repeated sequences, which suggest a mechanism of gene length mutation that may be one of the key explanations for the genetic variation in plastid genomes.	[Zhang, Lei; Liu, Tao; Wang, Haiyang; Chi, Shan; Liu, Cui] Ocean Univ China, Coll Marine Life Sci, Lab Genet & Breeding Marine Organism, Qingdao, Peoples R China; [Wang, Xumin; Wang, Guoliang] Chinese Acad Sci, Beijing Inst Genom, Beijing Key Lab Genome & Precis Med Technol, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Liu, T (corresponding author), Ocean Univ China, Coll Marine Life Sci, Lab Genet & Breeding Marine Organism, Qingdao, Peoples R China.	liutao@ouc.edu.cn	wang, xumin/HII-8627-2022		Special Fund for Agro-scientific Research in the Public Interest [201203063]; Project of Shandong Province Science and Technology Development Program [2014GGE29091]; Fundamental Research Funds for the Central Universities [201362040]	Special Fund for Agro-scientific Research in the Public Interest; Project of Shandong Province Science and Technology Development Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201203063), Project of Shandong Province Science and Technology Development Program (Grant No. 2014GGE29091) and the Fundamental Research Funds for the Central Universities (Grant No. 201362040).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Archibald JM, 2012, ADV BOT RES, V64, P87, DOI 10.1016/B978-0-12-391499-6.00003-7; Boo Sung Min, 1999, Phycological Research, V47, P109, DOI 10.1111/j.1440-1835.1999.tb00291.x; BOYEN C, 1994, NUCLEIC ACIDS RES, V22, P1400, DOI 10.1093/nar/22.8.1400; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Druehl LD, 1997, PLANT SYST EVOL, V11, P35; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; [付慧 Fu Hui], 2012, [大连海洋大学学报, Journal of Dalian Ocean University], V27, P200; Imbs TI, 2011, CHEM NAT COMPD+, V47, P96, DOI 10.1007/s10600-011-9839-y; Imbs TI, 2009, CHEM NAT COMPD+, V45, P786, DOI 10.1007/s10600-010-9507-7; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li TY, 2014, MITOCHONDR DNA, P1; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Luo XM, 2012, BIOCHEM SYST ECOL, V44, P61, DOI 10.1016/j.bse.2012.04.004; Moon HJ, 2009, J NAT PROD, V72, P1731, DOI 10.1021/np800797v; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qu JQ, 2014, MITOCHONDR DNA, P1; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAUNDERS GW, 1992, J PHYCOL, V28, P544, DOI 10.1111/j.0022-3646.1992.00544.x; Selivanova ON, 2007, RUSS J MAR BIOL +, V33, P278, DOI 10.1134/S1063074007050021; Smith DR, 2015, GENOME BIOL EVOL, V7, P1227, DOI 10.1093/gbe/evv069; Sohn CH, 2003, J PHYCOL, P53; Tajima N, 2014, J PLANT RES, V127, P389, DOI 10.1007/s10265-014-0627-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065902; Wang XL, 2013, MAR GENOM, V10, P1, DOI 10.1016/j.margen.2012.12.002; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yoon HS, 2001, MOL PHYLOGENET EVOL, V21, P231, DOI 10.1006/mpev.2001.1009; Zhang Jing, 2011, Journal of Ocean University of China, V10, P351, DOI 10.1007/s11802-011-1856-8; Zhang ZY, 1992, J DALIAN FISHERIES U, V7, P40	37	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140144	10.1371/journal.pone.0140144	http://dx.doi.org/10.1371/journal.pone.0140144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444909	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600144
J	Zhang, YN; Zhu, XY; Fang, LP; He, P; Wang, ZQ; Chen, G; Sun, L; Ye, ZF; Deng, DG; Li, JB				Zhang, Ya-Nan; Zhu, Xiu-Yun; Fang, Li-Ping; He, Peng; Wang, Zhi-Qiang; Chen, Geng; Sun, Liang; Ye, Zhan-Feng; Deng, Dao-Gui; Li, Jin-Bu			Identification and Expression Profiles of Sex Pheromone Biosynthesis and Transport Related Genes in Spodoptera litura	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; FATTY-ACYL REDUCTASE; CHEMOSENSORY PROTEINS; FUNCTIONAL-CHARACTERIZATION; SESAMIA-INFERENS; BOMBYX-MORI; Z-ISOMER; MOTH; DESATURASE; GLAND	Although the general pathway of sex pheromone synthesis in moth species has been established, the molecular mechanisms remain poorly understood. The common cutworm Spodoptera litura is an important agricultural pest worldwide and causes huge economic losses annually. The female sex pheromone of S. litura comprises Z9, E11-14: OAc, Z9, E12-14: OAc, Z9-14: OAc, and E11-14: OAc. By sequencing and analyzing the transcriptomic data of the sex pheromone glands, we identified 94 candidate genes related to pheromone biosynthesis (55 genes) or chemoreception (39 genes). Gene expression patterns and phylogenetic analysis revealed that two desaturase genes (SlitDes5 and SlitDes11) and one fatty acyl reductase gene (SlitFAR3) showed pheromone gland (PG) biased or specific expression, and clustered with genes known to be involved in pheromone synthesis in other moth species. Furthermore, 4 chemoreception related genes (SlitOBP6, SlitOBP11, SlitCSP3, and SlitCSP14) also showed higher expression in the PG, and could be additional candidate genes involved in sex pheromone transport. This study provides the first solid background information that should facilitate further elucidation of sex pheromone biosynthesis and transport, and indicates potential targets to disrupt sexual communication in S. litura for a novel pest management strategy.	[Zhang, Ya-Nan; Zhu, Xiu-Yun; Fang, Li-Ping; Wang, Zhi-Qiang; Chen, Geng; Deng, Dao-Gui; Li, Jin-Bu] Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China; [He, Peng] Guizhou Univ, Key Lab Green Pesticide & Agr Bioengn, State Key Lab Breeding Base Green Pesticide & Agr, Minist Educ, Guiyang 550003, Peoples R China; [Sun, Liang] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China; [Ye, Zhan-Feng] Nanjing Agr Univ, Coll Plant Protect, Key Lab Integrated Management Crop Dis & Pests, Educ Minist, Nanjing, Jiangsu, Peoples R China	Huaibei Normal University; Guizhou University; Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Nanjing Agricultural University	Zhang, YN (corresponding author), Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China.	ynzhang_insect@163.com; lijinbu0991@163.com	He, Peng/H-1098-2013; He, Peng/ABF-9928-2020	He, Peng/0000-0003-2934-0044	Natura Science Fund of Education Department of Anhui province, China [KJ2013A234]; National Natural Science Foundation of China [31501647]; Doctoral Scientific Research Foundation of Huaibei Normal University, China [1500969]	Natura Science Fund of Education Department of Anhui province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Research Foundation of Huaibei Normal University, China	This work was supported by grants from Natura Science Fund of Education Department of Anhui province, China (No.: KJ2013A234), the National Natural Science Foundation of China (No.: 31501647) and Doctoral Scientific Research Foundation of Huaibei Normal University, China (No.: 1500969).	ANDERSON P, 1990, INT J INSECT MORPHOL, V19, P13, DOI 10.1016/0020-7322(90)90027-M; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; [Anonymous], 2014, PHEROMONES ANIMAL BE; Antony B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1710-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; FAUCHEUX MJ, 1988, INT J INSECT MORPHOL, V17, P473, DOI 10.1016/0020-7322(88)90026-8; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foster SP, 1996, ARCH INSECT BIOCHEM, V33, P135, DOI 10.1002/(SICI)1520-6327(1996)33:2&lt;135::AID-ARCH4&gt;3.0.CO;2-X; Fujii T, 2011, P NATL ACAD SCI USA, V108, P7102, DOI 10.1073/pnas.1019519108; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Hagstrom AK, 2014, J CHEM ECOL, V40, P63, DOI 10.1007/s10886-013-0373-1; Hagstrom AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037230; Hao Guixia, 2002, J Insect Sci, V2, P26; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jeong SE, 2003, INSECT BIOCHEM MOLEC, V33, P609, DOI 10.1016/S0965-1748(03)00043-2; Jurenka R, 2004, TOP CURR CHEM, V239, P97, DOI 10.1007/b95450; JURENKA RA, 1989, INSECT BIOCHEM, V19, P639, DOI 10.1016/0020-1790(89)90098-X; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Li ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09324; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Liu NY, 2013, COMP BIOCHEM PHYS A, V165, P254, DOI 10.1016/j.cbpa.2013.03.016; Liu NY, 2012, COMP BIOCHEM PHYS B, V161, P295, DOI 10.1016/j.cbpb.2011.11.007; Liu W, 1999, INSECT BIOCHEM MOLEC, V29, P435, DOI 10.1016/S0965-1748(99)00020-X; Liu WT, 2002, INSECT BIOCHEM MOLEC, V32, P1489, DOI 10.1016/S0965-1748(02)00069-3; Liu WT, 2002, P NATL ACAD SCI USA, V99, P620, DOI 10.1073/pnas.221601498; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; MORSE D, 1987, PHEROMONE BIOCH, P212; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Ohnishi A, 2009, J BIOL CHEM, V284, P5128, DOI 10.1074/jbc.M806072200; Park HY, 2008, INSECT BIOCHEM MOLEC, V38, P581, DOI 10.1016/j.ibmb.2008.02.001; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Qian SG, 2011, INSECT BIOCHEM MOLEC, V41, P22, DOI 10.1016/j.ibmb.2010.09.008; Raina AK, 2000, ARTHROPOD STRUCT DEV, V29, P343, DOI 10.1016/S1467-8039(01)00014-7; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Sun Fan, 2002, Acta Entomologica Sinica, V45, P404; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEAL PEA, 1987, ARCH INSECT BIOCHEM, V4, P261, DOI 10.1002/arch.940040404; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Wang HL, 2010, INSECT BIOCHEM MOLEC, V40, P742, DOI 10.1016/j.ibmb.2010.07.009; Wu WQ, 1998, INSECT BIOCHEM MOLEC, V28, P895, DOI 10.1016/S0965-1748(98)00063-0; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; Xia YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep07888; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117054; Zhang J, 2015, CHEM SENSES, V40, P7, DOI 10.1093/chemse/bju052; Zhang YN, 2014, J CHEM ECOL, V40, P439, DOI 10.1007/s10886-014-0433-1; Zhang YN, 2014, GENE, V536, P279, DOI 10.1016/j.gene.2013.12.011; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08	70	36	36	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140019	10.1371/journal.pone.0140019	http://dx.doi.org/10.1371/journal.pone.0140019			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445454	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600125
J	Godin-Heymann, N; Brabetz, S; Murillo, MM; Saponaro, M; Santos, CR; Lobley, A; East, P; Chakravarty, P; Matthews, N; Kelly, G; Jordan, S; Castellano, E; Downward, J				Godin-Heymann, N.; Brabetz, S.; Murillo, M. M.; Saponaro, M.; Santos, C. R.; Lobley, A.; East, P.; Chakravarty, P.; Matthews, N.; Kelly, G.; Jordan, S.; Castellano, E.; Downward, J.			Tumour-suppression function of KLF12 through regulation of anoikis	ONCOGENE			English	Article							INTESTINAL EPITHELIAL-CELLS; KRUPPEL-LIKE-FACTORS; MESENCHYMAL TRANSITION; CANCER-CELLS; EXTRACELLULAR-MATRIX; DOWN-REGULATION; BREAST-CANCER; UP-REGULATION; CYCLE ARREST; RAS	Suppression of detachment-induced cell death, known as anoikis, is an essential step for cancer metastasis to occur. We report here that expression of KLF12, a member of the Kruppel-like family of transcription factors, is downregulated in lung cancer cell lines that have been selected to grow in the absence of cell adhesion. Knockdown of KLF12 in parental cells results in decreased apoptosis following cell detachment from matrix. KLF12 regulates anoikis by promoting the cell cycle transition through S phase and therefore cell proliferation. Reduced expression levels of KLF12 results in increased ability of lung cancer cells to form tumours in vivo and is associated with poorer survival in lung cancer patients. We therefore identify KLF12 as a novel metastasis-suppressor gene whose loss of function is associated with anoikis resistance through control of the cell cycle.	[Godin-Heymann, N.; Brabetz, S.; Murillo, M. M.; Jordan, S.; Castellano, E.; Downward, J.] Canc Res UK London Res Inst, Signal Transduct, London WC2A 3PX, England; [Murillo, M. M.; Downward, J.] Inst Canc Res, London SW3 6JB, England; [Saponaro, M.] Canc Res UK London Res Inst, Clare Hall Labs, Mechanisms Gene Transcript Lab, London WC2A 3PX, England; [Santos, C. R.] Canc Res UK London Res Inst, Translat Canc Therapeut, London WC2A 3PX, England; [Lobley, A.; East, P.; Chakravarty, P.; Kelly, G.] Canc Res UK London Res Inst, Bioinformat & Biostat Labs, London WC2A 3PX, England; [Matthews, N.] Canc Res UK London Res Inst, Adv Sequencing Facil, London WC2A 3PX, England; [Castellano, E.] Univ London, Ctr Canc & Inflammat, Barts Canc Inst, Charterhouse Sq, London EC1M 6BP, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; University of London; Queen Mary University London	Downward, J (corresponding author), Signal Transduct Lab Canc Res UK, 44 Lincolns Inn Fields, London WC2A 3LY, England.	downward@cancer.org.uk	Sánchez, Esther Castellano/AAA-8087-2020; Saponaro, Marco/M-1854-2015; Kelly, Gavin/ABG-2715-2021	Sánchez, Esther Castellano/0000-0002-8449-4081; Saponaro, Marco/0000-0002-9302-2553; Kelly, Gavin/0000-0001-7219-560X; chakravarty, probir/0000-0003-1146-8824; Downward, Julian/0000-0002-2331-4729	Cancer Research UK, from the European Commission [259770]; European Research Council Advanced Grant RASTARGET; Cancer Research UK [15680] Funding Source: researchfish; The Francis Crick Institute [10071, 10002, 10070, 10074] Funding Source: researchfish	Cancer Research UK, from the European Commission; European Research Council Advanced Grant RASTARGET; Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank Elza de Bruin and Clare Sheridan for advice. We also thank Mike Howell and LRI Core Technology Facilities, including Equipment Park, FACS lab and Cell Services. This work was funded by Cancer Research UK, funding from the European Commission's Seventh Framework Programme (FP7/2007-2013) under the grant agreement LUNGTARGET (project 259770) and from the European Research Council Advanced Grant RASTARGET.	Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boudreau N, 1996, P NATL ACAD SCI USA, V93, P3509, DOI 10.1073/pnas.93.8.3509; Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x; Buchheit CL, 2012, SEMIN CELL DEV BIOL, V23, P402, DOI 10.1016/j.semcdb.2012.04.007; Bureau C, 2009, CURR GENOMICS, V10, P353, DOI 10.2174/138920209788921010; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chen CS, 2001, GENE CHROMOSOME CANC, V31, P333, DOI 10.1002/gcc.1152; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Giefing M, 2008, NEOPLASMA, V55, P55; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imhof A, 1999, MOL CELL BIOL, V19, P194; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HRC, 1999, CANCER RES, V59, P4148; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lahiri SK, 2012, AM J TRANSL RES, V4, P357; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Nakamura Y, 2009, INT J CANCER, V125, P1859, DOI 10.1002/ijc.24538; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Rabien A, 2012, CANCER SCI, V103, P169, DOI 10.1111/j.1349-7006.2011.02140.x; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Wei L, 2004, ONCOGENE, V23, P9052, DOI 10.1038/sj.onc.1208091; Yang YZ, 2012, CELL CYCLE, V11, P4033, DOI 10.4161/cc.22265; Yoo BH, 2011, J BIOL CHEM, V286, P38894, DOI 10.1074/jbc.M111.290692; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005	48	25	26	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3324	3334		10.1038/onc.2015.394	http://dx.doi.org/10.1038/onc.2015.394			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26455320	hybrid, Green Published			2022-12-26	WOS:000378306400011
J	Wei, C; He, WJ; Wei, L; Li, CY; Ma, J				Wei, Chao; He, Wenjie; Wei, Li; Li, Chunying; Ma, Jun			The Analysis of a Microbial Community in the UV/O-3-Anaerobic/Aerobic Integrated Process for Petrochemical Nanofiltration Concentrate (NFC) Treatment by 454-Pyrosequencing	PLOS ONE			English	Article							WASTE-WATER RECLAMATION; OXIDATION; PERFORMANCE; REDUCTION; REUSE; UV	In this study, high-throughput pyrosequencing was applied on the analysis of the microbial community of activated sludge and biofilm in a lab-scale UV/O-3-anaerobic/aerobic (A/O) integrated process for the treatment of petrochemical nanofiltration concentrate (NFC) wastewater. NFC is a type of saline wastewater with low biodegradability. From the anaerobic activated sludge (Sample A) and aerobic biofilm (Sample O), 59,748 and 51,231 valid sequence reads were obtained, respectively. The dominant phylotypes related to the metabolism of organic compounds, polycyclic aromatic hydrocarbon (PAH) biodegradation, assimilation of carbon from benzene, and the biodegradation of nitrogenous organic compounds were detected as genus Clostridium, genera Pseudomonas and Stenotrophomonas, class Betaproteobacteria, and genus Hyphomicrobium. Furthermore, the nitrite-oxidising bacteria Nitrospira, nitrite-reducing and sulphate-oxidising bacteria (NR-SRB) Thioalkalivibrio were also detected. In the last twenty operational days, the total Chemical Oxygen Demand (COD) and Total Organic Carbon (TOC) removal efficiencies on average were 64.93% and 62.06%, respectively. The removal efficiencies of ammonia nitrogen and Total Nitrogen (TN) on average were 90.51% and 75.11% during the entire treatment process.	[Wei, Chao; He, Wenjie; Wei, Li; Ma, Jun] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Heilongjiang, Peoples R China; [He, Wenjie] Tianjin Waterworks Grp Co Ltd, Tianjin, Peoples R China; [Li, Chunying] Harbin Univ Commerce, Sch Energy & Civil Engn, Harbin, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin University of Commerce	Wei, L (corresponding author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Heilongjiang, Peoples R China.	weilihit@126.com	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022; Ma, Jun/A-7253-2011; yan, linxia/K-7044-2017		Funds for Creative Research Groups of China [51121062]; State Key Laboratory of Urban Water Resource and Environment (Harbin Institute of Technology) [2015TS07]	Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); State Key Laboratory of Urban Water Resource and Environment (Harbin Institute of Technology)(Harbin Institute of Technology)	The Project is supported by the Funds for Creative Research Groups of China (Grant No. 51121062) (http://waterlab.hit.edu.cn/news/sub_xm.asp?c_id=A00030003) and State Key Laboratory of Urban Water Resource and Environment (Harbin Institute of Technology) (Grant No. 2015TS07) (http://waterlab.hit.edu.cn/news/sub_xm.asp?c_id=A00030008). The funders didn't play role in study design, decision to publish, and preparation of the manuscript. Tianjin Waterworks Group Co., Ltd., served as the author Wenjie He affiliation and didn't provide any financial support and experiment facilities for our research.	Andreozzi R, 1999, CATAL TODAY, V53, P51, DOI 10.1016/S0920-5861(99)00102-9; APHA, 2005, STAND METH WAT WAST; Chan YJ, 2009, CHEM ENG J, V155, P1, DOI 10.1016/j.cej.2009.06.041; Comstock SEH, 2011, WATER RES, V45, P4855, DOI 10.1016/j.watres.2011.06.035; Dialynas E, 2008, WATER RES, V42, P4603, DOI 10.1016/j.watres.2008.08.008; FROSTELL B, 1983, STARKE, V35, P185, DOI 10.1002/star.19830350602; Jechalke S, 2013, FEMS MICROBIOL ECOL, V85, P14, DOI 10.1111/1574-6941.12090; Kappel C, 2013, SEP PURIF TECHNOL, V120, P437, DOI 10.1016/j.seppur.2013.10.022; LETTINGA G, 1981, WATER RES, V15, P171, DOI 10.1016/0043-1354(81)90109-3; Li XW, 2015, BIORESOURCE TECHNOL, V175, P245, DOI 10.1016/j.biortech.2014.10.078; Liao XB, 2015, ENVIRON SCI POLLUT R, V22, P546, DOI 10.1007/s11356-014-3393-7; Lin CH, 2012, J HAZARD MATER, V209, P348, DOI 10.1016/j.jhazmat.2012.01.029; Lu XY, 2011, INT BIODETER BIODEGR, V65, P204, DOI 10.1016/j.ibiod.2010.11.004; Nederlof MM, 2005, DESALINATION, V178, P303, DOI 10.1016/j.desal.2004.11.041; Ning XQ, 2014, CAN J MICROBIOL, V60, P799, DOI 10.1139/cjm-2014-0263; Nowka B, 2015, APPL ENVIRON MICROB, V81, P745, DOI 10.1128/AEM.02734-14; Oller I, 2011, SCI TOTAL ENVIRON, V409, P4141, DOI 10.1016/j.scitotenv.2010.08.061; Perez G, 2010, WATER RES, V44, P2763, DOI 10.1016/j.watres.2010.02.017; Shu HY, 2005, J HAZARD MATER, V121, P127, DOI 10.1016/j.jhazmat.2005.01.020; Tam LS, 2007, DESALINATION, V202, P106, DOI 10.1016/j.desal.2005.12.045; Top S, 2011, DESALINATION, V268, P158, DOI 10.1016/j.desal.2010.10.012; Van der Bruggen B, 2008, SEP PURIF TECHNOL, V63, P251, DOI 10.1016/j.seppur.2008.05.010; Van der Bruggen B, 2003, ENVIRON SCI TECHNOL, V37, P3733, DOI 10.1021/es0201754; Van Geluwe S, 2011, J MEMBRANE SCI, V378, P128, DOI 10.1016/j.memsci.2011.04.059; Wang GS, 2001, SCI TOTAL ENVIRON, V277, P87, DOI 10.1016/S0048-9697(00)00865-2; Wang J, 2011, APPL MICROBIOL BIOT, V90, P2015, DOI 10.1007/s00253-011-3217-3; Wang YJ, 2012, J HAZARD MATER, V229, P115, DOI 10.1016/j.jhazmat.2012.05.108; Xu XJ, 2014, J HAZARD MATER, V278, P250, DOI 10.1016/j.jhazmat.2014.06.006; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S; Yang Sienhung, 2012, Evid Based Complement Alternat Med, V2012, P521780, DOI 10.1155/2012/521780; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zangeneh H, 2014, J IND ENG CHEM, V20, P1453, DOI 10.1016/j.jiec.2013.07.031; Zhou FL, 2013, BIORESOURCE TECHNOL, V131, P349, DOI 10.1016/j.biortech.2012.12.145	34	5	5	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139991	10.1371/journal.pone.0139991	http://dx.doi.org/10.1371/journal.pone.0139991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461260	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300044
J	Desin, TS; Townsend, HG; Potter, AA				Desin, Taseen S.; Townsend, Hugh G.; Potter, Andrew A.			Antibodies Directed against Shiga-Toxin Producing Escherichia coli Serotype O103 Type III Secreted Proteins Block Adherence of Heterologous STEC Serotypes to HEp-2 Cells	PLOS ONE			English	Article							EFFACING LESIONS; TERMINAL RECTUM; 2-DOSE REGIMEN; VACCINE; CATTLE; O157H7; COLONIZATION; O157-H7; EFFICACY; INTIMIN	Shiga toxin-producing Escherichia coli (STEC) serotype O103 is a zoonotic pathogen that is capable of causing hemorrhagic colitis and hemolytic uremic syndrome (HUS) in humans. The main animal reservoir for STEC is ruminants and hence reducing the levels of this pathogen in cattle could ultimately lower the risk of STEC infection in humans. During the process of infection, STECO103 uses a Type III Secretion System (T3SS) to secrete effector proteins (T3SPs) that result in the formation of attaching and effacing (A/E) lesions. Vaccination of cattle with STEC serotype O157 T3SPs has previously been shown to be effective in reducing shedding of STECO157 in a serotype-specific manner. In this study, we tested the ability of rabbit polyclonal sera against individual STECO103 T3SPs to block adherence of the organism to HEp-2 cells. Our results demonstrate that pooled sera against EspA, EspB, EspF, NleA and Tir significantly lowered the adherence of STECO103 relative to pre-immune sera. Likewise, pooled anti-STECO103 sera were also able to block adherence by STECO157. Vaccination of mice with STECO103 recombinant proteins induced strong IgG antibody responses against EspA, EspB, NleA and Tir but not against EspF. However, the vaccine did not affect fecal shedding of STECO103 compared to the PBS vaccinated group over the duration of the experiment. Cross reactivity studies using sera against STECO103 recombinant proteins revealed a high degree of cross reactivity with STECO26 and STECO111 proteins implying that sera against STECO103 proteins could potentially provide neutralization of attachment to epithelial cells by heterologous STEC serotypes.	[Desin, Taseen S.; Townsend, Hugh G.; Potter, Andrew A.] Univ Saskatchewan, Int Vaccine Ctr, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	University of Saskatchewan	Desin, TS (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Coll Sci & Hlth Profess, Dept Basic Sci, Riyadh, Saudi Arabia.	desint@ksau-hs.edu.sa			Saskatchewan Health Research Foundation	Saskatchewan Health Research Foundation	This project was funded by the Saskatchewan Health Research Foundation.	Abe A, 1999, MOL MICROBIOL, V33, P1162, DOI 10.1046/j.1365-2958.1999.01558.x; Allen KJ, 2011, CAN J VET RES, V75, P98; Amani J, 2010, VACCINE, V28, P6923, DOI 10.1016/j.vaccine.2010.07.061; Asper DJ, 2007, VACCINE, V25, P8262, DOI 10.1016/j.vaccine.2007.09.054; Asper DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1052, DOI 10.1128/CVI.00068-11; Babiuk S, 2008, MICROB PATHOGENESIS, V45, P7, DOI 10.1016/j.micpath.2008.01.005; Beutin L, 2005, J CLIN MICROBIOL, V43, P1552, DOI 10.1128/JCM.43.4.1552-1563.2005; Boland KG, 2013, CLIN VACCINE IMMUNOL, V20, P562, DOI 10.1128/CVI.00743-12; Cai K, 2011, VACCINE, V29, P946, DOI 10.1016/j.vaccine.2010.11.035; Cernicchiaro N, 2014, J FOOD PROTECT, V77, P732, DOI 10.4315/0362-028X.JFP-13-358; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Fox JT, 2009, FOODBORNE PATHOG DIS, V6, P893, DOI 10.1089/fpd.2009.0336; Gao X, 2011, VACCINE, V29, P6656, DOI 10.1016/j.vaccine.2011.06.106; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gill A, 2010, CAN J VET RES, V74, P161; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Ho NK, 2013, CAN J GASTROENTEROL, V27, P281, DOI 10.1155/2013/138673; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; La Ragione RM, 2006, MICROBES INFECT, V8, P426, DOI 10.1016/j.micinf.2005.07.009; Matthews L, 2013, P NATL ACAD SCI USA, V110, P16265, DOI 10.1073/pnas.1304978110; McNeilly TN, 2010, VACCINE, V28, P1422, DOI 10.1016/j.vaccine.2009.10.076; Mohawk KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/258185; Moxley RA, 2009, FOODBORNE PATHOG DIS, V6, P879, DOI 10.1089/fpd.2009.0297; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Paddock ZD, 2014, FOODBORNE PATHOG DIS, V11, P186, DOI 10.1089/fpd.2013.1659; Peterson RE, 2007, J FOOD PROTECT, V70, P2568, DOI 10.4315/0362-028X-70.11.2568; Peterson RE, 2007, J FOOD PROTECT, V70, P2561, DOI 10.4315/0362-028X-70.11.2561; Potter AA, 2004, VACCINE, V22, P362, DOI 10.1016/j.vaccine.2003.08.007; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; Sharma VK, 2012, INFECT IMMUN, V80, P1333, DOI 10.1128/IAI.05869-11; Smith DR, 2008, FOODBORNE PATHOG DIS, V5, P589, DOI 10.1089/fpd.2008.0080; Smith DR, 2009, FOODBORNE PATHOG DIS, V6, P885, DOI 10.1089/fpd.2009.0299; Smith DR, 2009, FOODBORNE PATHOG DIS, V6, P155, DOI 10.1089/fpd.2008.0136; Smith JL, 2014, ADV APPL MICROBIOL, V86, P145, DOI 10.1016/B978-0-12-800262-9.00003-2; TARR PI, 1989, J INFECT DIS, V159, P344, DOI 10.1093/infdis/159.2.344; Thomson DU, 2009, FOODBORNE PATHOG DIS, V6, P871, DOI 10.1089/fpd.2009.0290; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Van Donkersgoed J, 2005, CAN VET J, V46, P724; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Vogstad AR, 2014, ZOONOSES PUBLIC HLTH, V61, P283, DOI 10.1111/zph.12069; Vogstad AR, 2013, FOODBORNE PATHOG DIS, V10, P678, DOI 10.1089/fpd.2012.1374; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P2438, DOI 10.1128/IAI.58.8.2438-2445.1990; Walle KV, 2013, VET IMMUNOL IMMUNOP, V152, P109, DOI 10.1016/j.vetimm.2012.09.028; Zhang XH, 2011, VACCINE, V29, P3923, DOI 10.1016/j.vaccine.2011.02.007	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139803	10.1371/journal.pone.0139803	http://dx.doi.org/10.1371/journal.pone.0139803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451946	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200017
J	Iorio, F; Shrestha, RL; Levin, N; Boilot, V; Garnett, MJ; Saez-Rodriguez, J; Draviam, VM				Iorio, Francesco; Shrestha, Roshan L.; Levin, Nicolas; Boilot, Viviane; Garnett, Mathew J.; Saez-Rodriguez, Julio; Draviam, Viji M.			A Semi-Supervised Approach for Refining Transcriptional Signatures of Drug Response and Repositioning Predictions	PLOS ONE			English	Article							EXPRESSION SIGNATURES; CONNECTIVITY MAP; MITOTIC SPINDLE; CANCER; SIRT2; IDENTIFICATION; MICROTUBULES; SENSITIVITY; INHIBITION; DISCOVERY	We present a novel strategy to identify drug-repositioning opportunities. The starting point of our method is the generation of a signature summarising the consensual transcriptional response of multiple human cell lines to a compound of interest (namely the seed compound). This signature can be derived from data in existing databases, such as the connectivity-map, and it is used at first instance to query a network interlinking all the connectivitymap compounds, based on the similarity of their transcriptional responses. This provides a drug neighbourhood, composed of compounds predicted to share some effects with the seed one. The original signature is then refined by systematically reducing its overlap with the transcriptional responses induced by drugs in this neighbourhood that are known to share a secondary effect with the seed compound. Finally, the drug network is queried again with the resulting refined signatures and the whole process is carried on for a number of iterations. Drugs in the final refined neighbourhood are then predicted to exert the principal mode of action of the seed compound. We illustrate our approach using paclitaxel (a microtubule stabilising agent) as seed compound. Our method predicts that glipizide and splitomicin perturb microtubule function in human cells: a result that could not be obtained through standard signature matching methods. In agreement, we find that glipizide and splitomicin reduce interphase microtubule growth rates and transiently increase the percentage of mitotic cells-consistent with our prediction. Finally, we validated the refined signatures of paclitaxel response by mining a large drug screening dataset, showing that human cancer cell lines whose basal transcriptional profile is anti-correlated to them are significantly more sensitive to paclitaxel and docetaxel.	[Iorio, Francesco; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Shrestha, Roshan L.; Levin, Nicolas; Boilot, Viviane; Draviam, Viji M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Garnett, Mathew J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SD, England; [Saez-Rodriguez, Julio] RWTH Aachen Univ Hosp, D-52062 Aachen, Germany	European Molecular Biology Laboratory (EMBL); University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; RWTH Aachen University; RWTH Aachen University Hospital	Saez-Rodriguez, J (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	saezrodriguez@ebi.ac.uk; viji.draviam@gen.cam.ac.uk	Iorio, Francesco/H-3282-2019; Saez-Rodriguez, Julio/H-7114-2019; Iorio, Francesco/H-3284-2019	Saez-Rodriguez, Julio/0000-0002-8552-8976; Iorio, Francesco/0000-0001-7063-8913; Draviam, Viji/0000-0001-8295-3689	EBI-SANGER post-doctoral fellowship; Centre for Therapeutic Target Validation [CTTV015]; CRUK Career Development Grant [C28598/A9787]; Cancer Research UK [9787] Funding Source: researchfish	EBI-SANGER post-doctoral fellowship; Centre for Therapeutic Target Validation; CRUK Career Development Grant; Cancer Research UK(Cancer Research UK)	This work was partially funded by an EBI-SANGER post-doctoral fellowship to FI, by the Centre for Therapeutic Target Validation (proj.CTTV015) and by a CRUK Career Development Grant to VJD (C28598/A9787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton G, 2007, NAT REV CANCER, V7, P159, DOI 10.1038/nrc2095; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Bianchi M, 2009, SYNAPSE, V63, P359, DOI 10.1002/syn.20614; Bonezzi K, 2012, NEOPLASIA, V14, P846, DOI 10.1593/neo.12728; Bulinski JC, 1998, PROG NEUROBIOL, V55, P641, DOI 10.1016/S0301-0082(98)00023-9; Chen MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027186; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corrigan AM, 2013, CELL CYCLE, V12, P2643, DOI 10.4161/cc.25671; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Fryknas M, 2013, BMC CANCER, V13, P1; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Iorio F, 2010, AUTOPHAGY; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iorio F, 2009, LECT N BIOINFORMAT, V5488, P56; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lussier YA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001512; Makowski P, 1997, FEBS LETT, V409, P292, DOI 10.1016/S0014-5793(97)00524-3; Nagai T, 2013, J CELL SCI, V126, P4369, DOI 10.1242/jcs.127209; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Park SM, 2004, FEBS LETT, V570, P143, DOI 10.1016/j.febslet.2004.06.037; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; PETERSON CM, 1982, DIABETES CARE, V5, P497, DOI 10.2337/diacare.5.5.497; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Serrano L, 2013, GENE DEV, V27, P639, DOI 10.1101/gad.211342.112; Shigemizu D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002347; Shrestha RL, 2013, CURR BIOL, P1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terkeltaub RA, 2011, ARTHRITIS RHEUM-US, V63, P2226, DOI 10.1002/art.30389; Thadani-Mulero M, 2012, CANCER RES, V72, P4611, DOI 10.1158/0008-5472.CAN-12-0783; WEBSTER DR, 1989, J CELL SCI, V92, P57; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zhang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-236; Zhang ZX, 2010, INVEST NEW DRUG, V28, P715, DOI 10.1007/s10637-009-9303-z	47	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139446	10.1371/journal.pone.0139446	http://dx.doi.org/10.1371/journal.pone.0139446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452147	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200011
J	Marlier, M; Van Dyck, D; Cardon, G; De Bourdeaudhuij, I; Babiak, K; Willem, A				Marlier, Mathieu; Van Dyck, Delfien; Cardon, Greet; De Bourdeaudhuij, Ilse; Babiak, Kathy; Willem, Annick			Interrelation of Sport Participation, Physical Activity, Social Capital and Mental Health in Disadvantaged Communities: A SEM-Analysis	PLOS ONE			English	Article							LEISURE-TIME; ACTIVITY QUESTIONNAIRE; MULTILEVEL ANALYSIS; POPULATION; DETERMINANTS; ADULTS; STRATIFICATION; ASSOCIATIONS; INACTIVITY; EXERCISE	Background The Health through Sport conceptual model links sport participation with physical, social and psychological outcomes and stresses the need for more understanding between these outcomes. The present study aims to uncover how sport participation, physical activity, social capital and mental health are interrelated by examining these outcomes in one model. Methods A cross-sectional survey was conducted in nine disadvantaged communities in Antwerp (Belgium). Two hundred adults (aged 18-56) per community were randomly selected and visited at home to fill out a questionnaire on socio-demographics, sport participation, physical activity, social capital and mental health. A sample of 414 adults participated in the study. Results Structural Equation Modeling analysis showed that sport participation (beta = .095) and not total physical activity (beta = .027) was associated with better mental health. No association was found between sport participation and community social capital (beta = .009) or individual social capital (beta = .045). Furthermore, only community social capital was linked with physical activity (beta = .114), individual social capital was not (beta = -.013). In contrast, only individual social capital was directly associated with mental health (beta = .152), community social capital was not (beta = .070). Conclusion This study emphasizes the importance of sport participation and individual social capital to improve mental health in disadvantaged communities. It further gives a unique insight into the functionalities of how sport participation, physical activity, social capital and mental health are interrelated. Implications for policy are that cross-sector initiatives between the sport, social and health sector need to be supported as their outcomes are directly linked to one another.	[Marlier, Mathieu; Van Dyck, Delfien; Cardon, Greet; De Bourdeaudhuij, Ilse; Willem, Annick] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Babiak, Kathy] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	Ghent University; University of Michigan System; University of Michigan	Marlier, M (corresponding author), Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium.	Mathieu.Marlier@UGent.be	Marlier, Mathieu/AAX-6359-2020; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Van Dyck, Delfien/AAO-8981-2020; Willem, Annick/A-7311-2017	Marlier, Mathieu/0000-0001-5351-9824; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Cardon, Greet/0000-0003-4983-6557; Willem, Annick/0000-0003-3753-2919; Van Dyck, Delfien/0000-0003-1783-9075	Flemish Policy Research Centre on Sports	Flemish Policy Research Centre on Sports	Marlier is funded by the Flemish Policy Research Centre on Sports. No grant number was allocated to this project. The URL of its website is: http://www.steunpuntsport.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Omar K, 2004, SOZ PRAVENTIV MED, V49, P301, DOI 10.1007/s00038-004-3109-8; Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Asztalos M, 2009, J SCI MED SPORT, V12, P468, DOI 10.1016/j.jsams.2008.06.009; Baum FE, 2003, J EPIDEMIOL COMMUN H, V57, P320, DOI 10.1136/jech.57.5.320; Bentler PM., 2003, STRUCTURAL EQUATION; Bertotti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080127; Bourdieu P, 2001, SOCIOLOGY OF ECONOMIC LIFE, SECOND EDITION, P96; Carpiano RM, 2007, HEALTH PLACE, V13, P639, DOI 10.1016/j.healthplace.2006.09.001; Coakley J, 2015, INT REV SOCIOL SPORT, V50, P402, DOI 10.1177/1012690214538864; Coalter F, 2007, SPORT SOC, V10, P537, DOI 10.1080/17430430701388723; Collins M, 2004, J SPORT SCI, V22, P727, DOI 10.1080/02640410410001712430; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crespo CJ, 2000, AM J PREV MED, V18, P46, DOI 10.1016/S0749-3797(99)00105-1; De Clercq B, 2012, SOC SCI MED, V74, P202, DOI 10.1016/j.socscimed.2011.10.025; De Silva M., 2006, SYSTEMATIC REV METHO; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Eime R, 2013, J PHYS ACT HLTH; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Fox KR, 1999, PUBLIC HEALTH NUTR, V2, P411, DOI 10.1017/S1368980099000567; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Greiner KA, 2004, SOC SCI MED, V59, P2303, DOI 10.1016/j.socscimed.2004.03.023; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Harpham T, 2008, SOCIAL CAPITAL AND H; IPAQ, 2013, GUIDELINES FOR DATA; Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kesteloot C, 2007, ATLAS OF DISADVANTAG; Kilpatrick M, 2005, J AM COLL HEALTH, V54, P87, DOI 10.3200/JACH.54.2.87-94; Kim D, 2006, SOC SCI MED, V63, P1045, DOI 10.1016/j.socscimed.2006.02.017; Koeter M, 1992, GENERAL HEALTH QUEST; Kull M, 2012, HEALTH CARE WOMEN IN, V33, P457, DOI 10.1080/07399332.2011.645968; Letki N, 2008, POLIT STUD-LONDON, V56, P99, DOI 10.1111/j.1467-9248.2007.00692.x; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lindstrom M, 2011, PUBLIC HEALTH, V125, P442, DOI 10.1016/j.puhe.2011.01.015; Lindstrom M, 2002, SOC SCI MED, V54, P1779, DOI 10.1016/S0277-9536(01)00147-2; Lyras A, 2011, SPORT MANAG REV, V14, P311, DOI 10.1016/j.smr.2011.05.006; Marmot M, 2010, FAIR SOCIETY HEALTHY; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; McMillan DW, 1996, J COMMUNITY PSYCHOL, V24, P315, DOI 10.1002/(SICI)1520-6629(199610)24:4<315::AID-JCOP2>3.0.CO;2-T; Muthen LK, 1998, STATISTICAL ANALYSES; Okayasu I, 2010, INT REV SOCIOL SPORT, V45, P163, DOI 10.1177/1012690210362027; Osterlund K, 2013, J CIV SOC, V9, P391, DOI 10.1080/17448689.2013.847548; Perks T, 2007, SOCIOL SPORT J, V24, P378, DOI 10.1123/ssj.24.4.378; Philippaerts RM, 2006, INT J SPORTS MED, V27, P131, DOI 10.1055/s-2005-837619; Physical Activity Guidelines for Americans, 2008, ADVISORY COMMITTEE R; Poortinga W, 2006, SOC SCI MED, V62, P292, DOI 10.1016/j.socscimed.2005.06.008; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Putnam R., 2000, BOWLING ALONE COLLAP; Putnam Robert D., 1993, MAKING DEMOCRACY WOR; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Saxena S, 2006, WORLD PSYCHIATRY, V5, P179; Scheerder J., 2005, International Review for the Sociology of Sport, V40, P139, DOI 10.1177/1012690205057191; Schmitz N, 1999, ACTA PSYCHIAT SCAND, V100, P462; Schulenkorf N, 2012, SPORT MANAG REV, V15, P1, DOI 10.1016/j.smr.2011.06.001; Seippel O, 2006, ACTA SOCIOL, V49, P169, DOI 10.1177/0001699306064771; Silveira H, 2013, NEUROPSYCHOBIOLOGY, V67, P61, DOI [10.1159/000345160, 10.1159/0]; Skinner J., 2008, SPORT MANAGEMENT REV, V11, P253, DOI [DOI 10.1016/S1441-3523(08)70112-8, 10.1016/S1441-3523(08)70112-8]; Subramanian SV, 2002, J URBAN HEALTH, V79, pS21, DOI 10.1093/jurban/79.suppl_1.S21; Sugiyama T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.064287; Survey ES, 2010, ESS ROUND 5 SOURCE Q; Tonts M, 2005, J RURAL STUD, V21, P137, DOI 10.1016/j.jrurstud.2005.03.001; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Ueshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012135; Van Dyck D, 2011, INT J BEHAV MED, V18, P235, DOI 10.1007/s12529-010-9127-4; Van Dyck D, 2011, J URBAN HEALTH, V88, P154, DOI 10.1007/s11524-010-9536-3; Van Tuyckom C, 2010, SCI SPORT, V25, P304, DOI 10.1016/j.scispo.2010.04.003; Van Tuyckom C, 2010, SPORT EDUC SOC, V15, P495, DOI 10.1080/13573322.2010.514746; Wacquant L. J. D., 1992, INVITATION REFLEXIVE; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Wijndaele K, 2007, PSYCHOL SPORT EXERC, V8, P425, DOI 10.1016/j.psychsport.2006.08.001; Wipfli B, 2011, SCAND J MED SCI SPOR, V21, P474, DOI 10.1111/j.1600-0838.2009.01049.x; Ziersch AM, 2004, J EPIDEMIOL COMMUN H, V58, P493, DOI 10.1136/jech.2003.009084	78	34	34	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140196	10.1371/journal.pone.0140196	http://dx.doi.org/10.1371/journal.pone.0140196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TY	26451731	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200047
J	Uchiyama, T; Tomono, S; Sato, K; Nakamura, T; Kurabayashi, M; Okajima, F				Uchiyama, Tsuyoshi; Tomono, Shoichi; Sato, Koichi; Nakamura, Tetsuya; Kurabayashi, Masahiko; Okajima, Fumikazu			Angiotensin II Reduces Lipoprotein Lipase Expression in Visceral Adipose Tissue via Phospholipase C beta 4 Depending on Feeding but Increases Lipoprotein Lipase Expression in Subcutaneous Adipose Tissue via c-Src	PLOS ONE			English	Article							BINDING; MASS; MEN	Metabolic syndrome is characterized by visceral adiposity, insulin resistance, high triglyceride (TG)-and low high-density lipoprotein cholesterol-levels, hypertension, and diabetesall of which often cause cardiovascular and cerebrovascular diseases. It remains unclear, however, why visceral adiposity but not subcutaneous adiposity causes insulin resistance and other pathological situations. Lipoprotein lipase (LPL) catalyzes hydrolysis of TG in plasma lipoproteins. In the present study, we investigated whether the effects of angiotensin II (AngII) on TG metabolism are mediated through an effect on LPL expression. Adipose tissues were divided into visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) for comparison. AngII accelerated LPL expression in SAT but, on the contrary, suppressed its expression in VAT. In both SAT and VAT, AngII signaled through the same type 1 receptor. In SAT, AngII increased LPL expression via c-Src and p38 MAPK signaling. In VAT, however, AngII reduced LPL expression via the G(q) class of G proteins and the subsequent phospholipase C beta 4 (PLC beta 4), protein kinase C beta 1, nuclear factor kappa B, and inducible nitric oxide synthase signaling pathways. PLC beta 4 small interfering RNA experiments showed that PLC beta 4 expression is important for the AngII-induced LPL reduction in VAT, in which PLC beta 4 expression increases in the evening and falls at night. Interestingly, PLC beta 4 expression in VAT decreased with fasting, while AngII did not decrease LPL expression in VAT in a fasting state. In conclusion, AngII reduces LPL expression through PLC beta 4, the expression of which is regulated by feeding in VAT, whereas AngII increases LPL expression in SAT. The different effects of AngII on LPL expression and, hence, TG metabolism in VAT and SAT may partly explain their different contributions to the development of metabolic syndrome.	[Uchiyama, Tsuyoshi; Sato, Koichi; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma, Japan; [Tomono, Shoichi] Gunma Univ, Sch Hlth Sci, Maebashi, Gunma, Japan; [Nakamura, Tetsuya] Gunma Univ, Clin Invest Unit, Maebashi, Gunma, Japan; [Kurabayashi, Masahiko] Gunma Univ, Dept Med & Biol Sci, Maebashi, Gunma, Japan	Gunma University; Gunma University; Gunma University; Gunma University	Uchiyama, T (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma, Japan.	uchiyat@gunma-u.ac.jp			JSPS KAKENHI [24659125]; Sanofi Grant (GDC) [130706, 141060]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sanofi Grant (GDC)	This work was supported by a JSPS KAKENHI Grant-in-Aid for Exploratory Research (24659125) and a Sanofi Grant (GDC 130706, 141060, to TU and ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier M, 2006, J BIOL CHEM, V281, P2551, DOI 10.1074/jbc.M511878200; Engeli S, 2003, INT J BIOCHEM CELL B, V35, P807, DOI 10.1016/S1357-2725(02)00311-4; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Jenkins TC, 2007, BRAIN RES, V1178, P83, DOI 10.1016/j.brainres.2007.07.098; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Kim MJ, 1998, J BIOL CHEM, V273, P3618, DOI 10.1074/jbc.273.6.3618; Klein Brittany M, 2008, Comp Hepatol, V7, P8, DOI 10.1186/1476-5926-7-8; Massiera F, 2001, ENDOCRINOLOGY, V142, P5220, DOI 10.1210/en.142.12.5220; Otaegui D, 2010, MOL CELL BIOCHEM, V337, P167, DOI 10.1007/s11010-009-0296-x; Park D, 2003, NAT NEUROSCI, V6, P337, DOI 10.1038/nn1033; Ryo M, 2014, INTERNAL MED, V53, P299, DOI 10.2169/internalmedicine.53.9476; Safar ME, 2013, J AM COLL CARDIOL, V61, P12, DOI 10.1016/j.jacc.2012.01.088; Saiki A, 2008, METABOLISM, V57, P1093, DOI 10.1016/j.metabol.2008.03.014; Saiki A, 2006, DIABETES RES CLIN PR, V74, P242, DOI 10.1016/j.diabres.2006.04.004; Salki A, 2009, METABOLISM, V58, P708, DOI 10.1016/j.metabol.2009.01.013; Sato K, 2014, NEUROCHEM INT, V68, P38, DOI 10.1016/j.neuint.2014.02.005; Shah Ravi V, 2014, JACC Cardiovasc Imaging, V7, P1221, DOI 10.1016/j.jcmg.2014.07.017; Susan K, 2001, METHOD MOL BIOL, V155, P197; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang F, 2014, HYPERTENSION, V63, P281, DOI 10.1161/HYPERTENSIONAHA.113.02303; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072146; Welty FK, 2016, TRANSL RES, V167, P257, DOI 10.1016/j.trsl.2015.06.017; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139638	10.1371/journal.pone.0139638	http://dx.doi.org/10.1371/journal.pone.0139638			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447765	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000041
J	Chakarov, N; Pauli, M; Mueller, AK; Potiek, A; Grunkorn, T; Dijkstra, C; Kruger, O				Chakarov, Nayden; Pauli, Martina; Mueller, Anna-Katharina; Potiek, Astrid; Gruenkorn, Thomas; Dijkstra, Cor; Krueger, Oliver			Territory Quality and Plumage Morph Predict Offspring Sex Ratio Variation in a Raptor	PLOS ONE			English	Article							BUZZARD BUTEO-BUTEO; LIFETIME REPRODUCTIVE SUCCESS; SPARROWHAWK ACCIPITER-NISUS; COMMON BUZZARD; HETEROZYGOTE ADVANTAGE; HABITAT HETEROGENEITY; EUROPEAN SPARROWHAWK; ENERGY-REQUIREMENTS; SIZE DIMORPHISM; FOOD CONDITIONS	Parents may adapt their offspring sex ratio in response to their own phenotype and environmental conditions. The most significant causes for adaptive sex-ratio variation might express themselves as different distributions of fitness components between sexes along a given variable. Several causes for differential sex allocation in raptors with reversed sexual size dimorphism have been suggested. We search for correlates of fledgling sex in an extensive dataset on common buzzards Buteo buteo, a long-lived bird of prey. Larger female offspring could be more resource-demanding and starvation-prone and thus the costly sex. Prominent factors such as brood size and laying date did not predict nestling sex. Nonetheless, lifetime sex ratio (LSR, potentially indicative of individual sex allocation constraints) and overall nestling sex were explained by territory quality with more females being produced in better territories. Additionally, parental plumage morphs and the interaction of morph and prey abundance tended to explain LSR and nestling sex, indicating local adaptation of sex allocation However, in a limited census of nestling mortality, not females but males tended to die more frequently in prey-rich years. Also, although females could have potentially longer reproductive careers, a subset of our data encompassing full individual life histories showed that longevity and lifetime reproductive success were similarly distributed between the sexes. Thus, a basis for adaptive sex allocation in this population remains elusive. Overall, in common buzzards most major determinants of reproductive success appeared to have no effect on sex ratio but sex allocation may be adapted to local conditions in morph-specific patterns.	[Chakarov, Nayden; Pauli, Martina; Mueller, Anna-Katharina; Potiek, Astrid; Krueger, Oliver] Univ Bielefeld, Dept Anim Behav, D-33501 Bielefeld, Germany; [Gruenkorn, Thomas] BioConsult SH, D-25813 Husum, Germany; [Dijkstra, Cor] Univ Groningen, Behav Biol, NL-9700 CC Groningen, Netherlands	University of Bielefeld; University of Groningen	Chakarov, N (corresponding author), Univ Bielefeld, Dept Anim Behav, POB 10 01 31, D-33501 Bielefeld, Germany.	az.nayden@gmail.com	Dijkstra, Cor/D-5876-2011	Dijkstra, Cor/0000-0002-7042-8083	Volkswagen Foundation within its Evolutionary Biology initiative [I/84 196]; Young Researcher Fund of Bielefeld University; Deutsche Bundesstiftung Umwelt; BMWi [0325300D]; BioConsult SH	Volkswagen Foundation within its Evolutionary Biology initiative; Young Researcher Fund of Bielefeld University; Deutsche Bundesstiftung Umwelt; BMWi(Federal Ministry for Economic Affairs and Energy (BMWi)); BioConsult SH	N. C. was supported by the Volkswagen Foundation within its Evolutionary Biology initiative, grant I/84 196, and the Young Researcher Fund of Bielefeld University. A. K. M. was funded by the Deutsche Bundesstiftung Umwelt. A. P. was funded by the BMWi (0325300D). O. K. holds a Heisenberg Professorship of the German Science Foundation (DFG, KR 2089/3-1). BioConsult SH provided support in the form of salary for author T. G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2014, LANG ENV STAT COMP; Aparicio JM, 2001, EVOLUTION, V55, P1188; Benito MM, 2007, J EVOLUTION BIOL, V20, P1522, DOI 10.1111/j.1420-9101.2007.01327.x; Bijlsma, 1997, HANDLEIDING VELDONDE; Boerner M, 2013, J EVOLUTION BIOL, V26, P2233, DOI 10.1111/jeb.12221; Boerner M, 2009, BEHAV ECOL, V20, P180, DOI 10.1093/beheco/arn132; Brommer JE, 2003, OECOLOGIA, V137, P140, DOI 10.1007/s00442-003-1317-1; Burnham K. P., 2002, MODEL SELECTION AND; Byholm P, 2005, ANN ZOOL FENN, V42, P81; Byholm P, 2002, J ANIM ECOL, V71, P994, DOI 10.1046/j.1365-2656.2002.00663.x; Byholm P, 2008, ECOLOGY, V89, P1696, DOI 10.1890/07-0675.1; Carranza J, 2004, BEHAV ECOL, V15, P223, DOI 10.1093/beheco/arh004; Chakarov N, 2008, FUNCT ECOL, V22, P1062, DOI 10.1111/j.1365-2435.2008.01460.x; Chakarov N, 2015, MOL ECOL, V24, P1355, DOI 10.1111/mec.13115; Chakarov N, 2013, MOL ECOL, V22, P5430, DOI 10.1111/mec.12493; Chakarov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015229; Cramp S, 1980, HANDBOOK OF THE BIRD; Daan S, 1996, BEHAV ECOL, V7, P426, DOI 10.1093/beheco/7.4.426; Desfor KB, 2007, IBIS, V149, P98; Dreiss AN, 2012, J EVOLUTION BIOL, V25, P103, DOI 10.1111/j.1420-9101.2011.02407.x; Fisher RA, 1930, THE GENETICAL THEORY; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Heg D, 2000, AUK, V117, P980, DOI 10.1642/0004-8038(2000)117[0980:PCOOSR]2.0.CO;2; Heise S., 1991, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V43, P30; Jacquin L, 2012, BEHAV ECOL, V23, P907, DOI 10.1093/beheco/ars055; Janssen K, 2006, BEHAV ECOL, V17, P236, DOI 10.1093/beheco/arj015; Jonker RM, 2014, IBIS, V156, P97, DOI 10.1111/ibi.12124; Krijgsveld KL, 1998, PHYSIOL ZOOL, V71, P693, DOI 10.1086/515983; Kruger O, 2012, J ANIM ECOL, V81, P330, DOI 10.1111/j.1365-2656.2011.01904.x; Kruger O, 2005, P ROY SOC B-BIOL SCI, V272, P375, DOI 10.1098/rspb.2004.2943; Kruger O, 2004, BIRD STUDY, V51, P125; Kruger O, 2002, OECOLOGIA, V133, P474, DOI 10.1007/s00442-002-1053-y; Kruger O, 2002, OIKOS, V96, P441, DOI 10.1034/j.1600-0706.2002.960306.x; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; Kruger O, 2001, EVOLUTION, V55, P1207; Neuhauser M, 2004, ENVIRON ECOL STAT, V11, P295, DOI 10.1023/B:EEST.0000038017.58293.c0; NEWTON I, 1979, AM NAT, V113, P309, DOI 10.1086/283390; Newton I., 1979, POPULATION ECOLOGY O; NEWTON I, 1989, LIFETIME REPRODUCTIO; Nicolaus M, 2009, J ANIM ECOL, V78, P414, DOI 10.1111/j.1365-2656.2008.01505.x; Reif V, 2004, ANN ZOOL FENN, V41, P599; Riedstra B, 1998, AUK, V115, P635, DOI 10.2307/4089412; Roulin A, 2010, ECOL LETT, V13, P616, DOI 10.1111/j.1461-0248.2010.01459.x; Rubenstein DR, 2007, AM NAT, V170, P155, DOI 10.1086/518671; Rutz C, 2012, BIOL J LINN SOC, V105, P937, DOI 10.1111/j.1095-8312.2011.01818.x; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vedder O, 2005, ARDEA, V93, P179; Vedder O, 2005, BEHAV ECOL SOCIOBIOL, V58, P429, DOI 10.1007/s00265-005-0926-6; WALLS SS, 1995, IBIS, V137, P177, DOI 10.1111/j.1474-919X.1995.tb03237.x; Weimerskirch H, 2005, J ANIM ECOL, V74, P285, DOI 10.1111/j.1365-2656.2005.00922.x; West SA, 2005, EVOLUTION, V59, P1211; West SA, 2009, PRINCETON	54	8	8	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138295	10.1371/journal.pone.0138295	http://dx.doi.org/10.1371/journal.pone.0138295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445010	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600025
J	Muchhala, N; Serrano, D				Muchhala, Nathan; Serrano, Diana			The Complexity of Background Clutter Affects Nectar Bat Use of Flower Odor and Shape Cues	PLOS ONE			English	Article							FRUIT-EATING BATS; POLLINATED PLANTS; ECHOLOCATION; OLFACTION; BEHAVIOR; DISCRIMINATION; CAMPANULACEAE; ORIENTATION; EVOLUTION; STRATEGY	Given their small size and high metabolism, nectar bats need to be able to quickly locate flowers during foraging bouts. Chiropterophilous plants depend on these bats for their reproduction, thus they also benefit if their flowers can be easily located, and we would expect that floral traits such as odor and shape have evolved to maximize detection by bats. However, relatively little is known about the importance of different floral cues during foraging bouts. In the present study, we undertook a set of flight cage experiments with two species of nectar bats (Anoura caudifer and A. geoffroyi) and artificial flowers to compare the importance of shape and scent cues in locating flowers. In a training phase, a bat was presented an artificial flower with a given shape and scent, whose position was constantly shifted to prevent reliance on spatial memory. In the experimental phase, two flowers were presented, one with the training-flower scent and one with the training-flower shape. For each experimental repetition, we recorded which flower was located first, and then shifted flower positions. Additionally, experiments were repeated in a simple environment, without background clutter, or a complex environment, with a background of leaves and branches. Results demonstrate that bats visit either flower indiscriminately with simple backgrounds, with no significant difference in terms of whether they visit the training-flower odor or training- flower shape first. However, in a complex background olfaction was the most important cue; scented flowers were consistently located first. This suggests that for well-exposed flowers, without obstruction from clutter, vision and/or echolocation are sufficient in locating them. In more complex backgrounds, nectar bats depend more heavily on olfaction during foraging bouts.	[Muchhala, Nathan] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Serrano, Diana] Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Quito, Ecuador	University of Missouri System; University of Missouri Saint Louis; Pontificia Universidad Catolica del Ecuador	Muchhala, N (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	muchhalan@umsl.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014		National Geographic Society [8722-09]	National Geographic Society(National Geographic Society)	This work was supported by the National Geographic Society (Research Grant # 8722-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Bestmann HJ, 1997, PHYTOCHEMISTRY, V46, P1169, DOI 10.1016/S0031-9422(97)00428-7; BHATNAGAR KP, 1974, J MORPHOL, V142, P71, DOI 10.1002/jmor.1051420104; Carter GG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010808; CHASE J, 1983, ANIM BEHAV, V31, P526, DOI 10.1016/S0003-3472(83)80075-X; Eklof J, 2002, OIKOS, V99, P347, DOI 10.1034/j.1600-0706.2002.990216.x; Fleming TH, 1998, OECOLOGIA, V114, P368, DOI 10.1007/s004420050459; Forrest J, 2009, NATURWISSENSCHAFTEN, V96, P921, DOI 10.1007/s00114-009-0549-2; GENTRY AH, 1974, ANN MO BOT GARD, V61, P728, DOI 10.2307/2395026; Gutierrez EdA, 2014, BEHAV PROCESSES; Helversen D., 1999, NATURE, V398, P759; Helversen OV., 1993, ANIMAL PLANT INTERAC, P41; Holderied MW, 2006, J EXP BIOL, V209, P3457, DOI 10.1242/jeb.02386; Johnson SD, 2006, ECOLOGY, V87, P2709, DOI 10.1890/0012-9658(2006)87[2709:DBNFAA]2.0.CO;2; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Kalko EKV, 1998, FUNCT ECOL, V12, P364, DOI 10.1046/j.1365-2435.1998.00198.x; KNUDSEN JT, 1995, BOT J LINN SOC, V119, P45, DOI 10.1111/j.1095-8339.1995.tb00728.x; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Muchhala N, 2003, OECOLOGIA, V134, P373, DOI 10.1007/s00442-002-1132-0; Muchhala N, 2002, BIOTROPICA, V34, P387, DOI 10.1111/j.1744-7429.2002.tb00552.x; Muchhala N, 2006, AM J BOT, V93, P1081, DOI 10.3732/ajb.93.8.1081; Sazima M, 1999, ANN BOT-LONDON, V83, P705, DOI 10.1006/anbo.1999.0876; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Simon R, 2011, SCIENCE, V333, P631, DOI 10.1126/science.1204210; Singaravelan N, 2004, J MAMMAL, V85, P1, DOI 10.1644/1545-1542(2004)085<0001:NFAPCF>2.0.CO;2; Stephan H, 1970, J ZOOL SYST EVOL RES, V8, P200; SUTHERS R, 1969, BIOL BULL, V137, P535, DOI 10.2307/1540174; Swift SM, 2002, BEHAV ECOL SOCIOBIOL, V52, P408, DOI 10.1007/s00265-002-0531-x; O'Mara MT, 2014, BEHAV ECOL, V25, P1233, DOI 10.1093/beheco/aru120; Temeles EJ, 2009, ECOLOGY, V90, P1147, DOI 10.1890/08-0695.1; Thiele J, 2005, ANIM BEHAV, V69, P315, DOI 10.1016/j.anbehav.2004.05.012; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Toelch U, 2008, ANIM BEHAV, V75, P913, DOI 10.1016/j.anbehav.2007.07.011; VANDERPIJL L, 1961, EVOLUTION, V15, P44, DOI 10.2307/2405842; Von Helversen D, 2003, J EXP BIOL, V206, P1025, DOI 10.1242/jeb.00203; von Helversen O, 2003, BAT ECOLOGY, P346; von Helversen O, 2000, J COMP PHYSIOL A, V186, P143, DOI 10.1007/s003590050014; Whitfield M, 2014, BEHAV ECOL, V25, P328, DOI 10.1093/beheco/art115; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Winter Y, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P148, DOI 10.1017/CBO9780511542268.009; Zhang W, 2014, BEHAV PROCESS, V103, P23, DOI 10.1016/j.beproc.2013.10.004; Zortéa M., 2003, Braz. J. Biol., V63, P159, DOI 10.1590/S1519-69842003000100020	43	17	17	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0136657	10.1371/journal.pone.0136657	http://dx.doi.org/10.1371/journal.pone.0136657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445216	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600004
J	Neri, A; Pezzotti, P; Fazio, C; Vacca, P; D'Ancona, FP; Caporali, MG; Stefanelli, P				Neri, Arianna; Pezzotti, Patrizio; Fazio, Cecilia; Vacca, Paola; D'Ancona, Fortunato Paolo; Caporali, Maria Grazia; Stefanelli, Paola			Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13	PLOS ONE			English	Article							BACTERIAL-MENINGITIS; VACCINATION; EUROPE	Background Following the introduction of meningococcal serogroup C conjugate vaccine in Italy in 2005, changes in the epidemiology of Invasive Meningococcal Disease (IMD) were expected. The study aims were to describe the epidemiological trend and to characterize the isolates collected during the period 2008/09-2012/13 by multilocus sequence typing (MLST). Data on laboratory confirmed meningococcal diseases from National Surveillance System of IMD were reported. Methods Poisson regression models were used to estimate the incidence rate over time. Serogrouping and MLST were performed following published methods. Results The incidence rate of laboratory confirmed meningococcal disease decreased from 0.33 per 100,000 population in 2008/09 to 0.25 per 100,000 population in 2012/13. The serogroup B incidence rate was significantly higher (p<0.01) than that of other serogroups, among all age groups. The significant decrease of the IMD incidence rate (p = 0.01) reflects the decrease of serogroup B and C, in particular among individuals aged 15-24 years old (p< 0.01). On the other hand, serogroup Y incidence increased during the period (from 0.01/100,000 in 2008/09 to 0.02/100,000 in 2012/13, p = 0.05). Molecular characterizations revealed that ST-41/44 cc and ST-11 cc were the main clonal complexes identified among serogroup B and C isolates, respectively. In particular, ST-41/44 cc was predominant in all age groups, whereas ST-11 cc was not identified in infants less than 1 year of age. Conclusions IMD incidence declined in Italy and serogroup B caused most of the IMD cases, with infants having the highest risk of disease. Continued surveillance is needed to provide information concerning further changes in circulating meningococci with special regard to serogroup distribution. Moreover, knowledge of meningococcal genotypes is essential to detect hyper-invasive strains.	[Neri, Arianna; Pezzotti, Patrizio; Fazio, Cecilia; Vacca, Paola; Stefanelli, Paola] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [D'Ancona, Fortunato Paolo; Caporali, Maria Grazia] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Stefanelli, P (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	paola.stefanelli@iss.it	D'Ancona, Fortunato/B-2139-2013; FAZIO, CECILIA/ABA-8534-2021; PEZZOTTI, PATRIZIO/C-6480-2016; STEFANELLI, PAOLA/B-8729-2016; NERI, ARIANNA/B-8726-2016; Vacca, Paola/I-4796-2018; CAPORALI, MARIA GRAZIA/N-7960-2017	D'Ancona, Fortunato/0000-0002-9855-2924; PEZZOTTI, PATRIZIO/0000-0002-0805-2927; STEFANELLI, PAOLA/0000-0003-1620-4385; Vacca, Paola/0000-0003-3076-1604; Neri, Arianna/0000-0001-5748-880X; CAPORALI, MARIA GRAZIA/0000-0002-8806-0416	Ministry of Health [4M01]	Ministry of Health	This work was supported by Ministry of Health-CCM Project 4M01, Sorveglianza delle malattie invasive da Neisseria meningitidis, Streptococcus pneumoniae ed Haemophilus influenzae, 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo CI, 2008, EMERG INFECT DIS, V14, P990, DOI 10.3201/eid1406.071357; [Anonymous], 2012, INVASIVE MENINGOCOCC; Broker M, 2015, HUM VACC IMMUNOTHER; Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en; D'Ancona F, 2008, 24 ECCMID BARC SPAIN; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; Deghmane AE, 2010, J INFECT DIS, V202, P247, DOI 10.1086/653583; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; European Centre for Disease Prevention and Control E, 2013, ANN EP REP; Fazio C, 2009, EUROSURVEILLANCE, V14; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Istituto Superiore di Sanita Gruppo di lavoro ICONA, 2009, 0929 ISTISAN I SUP S, V8, P118; Kinlin LM, 2009, AM J EPIDEMIOL, V169, P588, DOI 10.1093/aje/kwn383; Ladhani SN, 2015, CLIN INFECT DIS, V60, P578, DOI 10.1093/cid/ciu881; Lahra MM, 2011, COMMUN DIS INTELL, V35, P257; Maiden MCJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0147; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mastrantonio P, 2007, CLIN MICROBIOL INFEC, V13, P100, DOI 10.1111/j.1469-0691.2006.01570.x; Mastrantonio P, 2003, CLIN INFECT DIS, V36, P422, DOI 10.1086/346154; Memish Ziad A, 2010, J Infect Public Health, V3, P143, DOI 10.1016/j.jiph.2010.09.008; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Skoczynska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071943; Stefanelli P, 2015, VACCINE, V33, P3678, DOI 10.1016/j.vaccine.2015.06.032; Stefanelli P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-135; Trotter CL, 2006, EPIDEMIOL INFECT, V134, P556, DOI 10.1017/S0950268805005339; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111/j.1574-6976.2006.00053.x; Vescio F, 2015, EPIDEMIOL INFECT, V143, P1742, DOI 10.1017/S0950268814002659; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139376	10.1371/journal.pone.0139376	http://dx.doi.org/10.1371/journal.pone.0139376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445461	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600053
J	Bi, FG; Shi, ZL; Zhou, CH; Liu, A; Shen, Y; Yan, SG				Bi, Fanggang; Shi, Zhongli; Zhou, Chenhe; Liu, An; Shen, Yue; Yan, Shigui			Intermittent Administration of Parathyroid Hormone [1-34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model	PLOS ONE			English	Article							DEBRIS-INDUCED OSTEOLYSIS; INDUCED BONE-RESORPTION; OVARIECTOMIZED RATS; POLYETHYLENE PARTICLES; POSTMENOPAUSAL WOMEN; CANCELLOUS BONE; OSTEOPENIC RATS; DEFICIENT MICE; CORTICAL BONE; MURINE MODEL	We examined whether intermittent administration of parathyroid hormone [1-34] (PTH[1-34]; 60 mu g/kg/day) can prevent the negative effects of titanium (Ti) particles on implant fixation and periprosthetic osteolysis in a rat model. Eighteen adult male rats (12 weeks old, bones still growing) received intramedullary Ti implants in their bilateral femurs; 6 rats from the blank group received vehicle injections, and 12 rats from the control group and PTH treatment group received Ti particle injections at the time of operation and intra-articular injections 2 and 4 weeks postoperatively. Six of the rats that received Ti particles from the PTH group also received PTH[1-34] treatment. Six weeks postoperatively, all specimens were collected for assessment by X-ray, micro-CT, biomechanical, scanning electron microscopy (SEM), and dynamic histomorphometry. A lower BMD, BV/TV, Tb.N, maximal fixation strength, and mineral apposition rate were observed in the control group compared to the blank group, demonstrating that a periprosthetic osteolysis model had been successfully established. Administration of PTH[1-34] significantly increased the bone mineral density of the distal femur, BV/TV, Tb. N, Tb.Th, Tb.Sp, Con.D, SMI, and maximal fixation strength in the PTH group compared to that in the control group. SEM revealed higher bone-implant contact, thicker lamellar bone, and larger trabecular bone area in the PTH group than in the control group. A higher mineral apposition rate was observed in the PTH group compared to both the blank and control groups. These findings imply that intermittent administration of PTH[1-34] prevents periprosthetic osteolysis by promoting bone formation. The effects of PTH[1-34] were evaluated at a suprapharmacological dosage to the human equivalent in rats; therefore, additional studies are required to demonstrate its therapeutic potential in periprosthetic osteolysis.	[Bi, Fanggang; Shi, Zhongli; Zhou, Chenhe; Liu, An; Shen, Yue; Yan, Shigui] Zhejiang Univ, Dept Orthoped Surg, Affiliated Hosp 2, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yan, SG (corresponding author), Zhejiang Univ, Dept Orthoped Surg, Affiliated Hosp 2, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	zrjwsj@zju.edu.cn	Zhou, Chenhe/AAI-9226-2020	Yan, Shigui/0000-0001-9096-2868	National Natural Science Foundation of China [81101377, 81171687, 81371954, 81201414]; Zhejiang Provincial Natural Science Foundation of China [Y2100161, Y2090283]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201018936]; Fund of Health Department of Zhejiang Province [2012RCA032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Scientific Research Fund of Zhejiang Provincial Education Department; Fund of Health Department of Zhejiang Province	This work is supported by the National Natural Science Foundation of China (81101377, 81171687, 81371954, 81201414), the Zhejiang Provincial Natural Science Foundation of China (Y2100161, Y2090283) and the Scientific Research Fund of Zhejiang Provincial Education Department (Y201018936), and the Fund of Health Department of Zhejiang Province (2012RCA032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 1996, J BONE JOINT SURG BR, V78B, P32, DOI 10.1302/0301-620X.78B1.0780032; Andreassen TT, 2000, J BONE MINER RES, V15, P2266, DOI 10.1359/jbmr.2000.15.11.2266; Andrews EB, 2012, J BONE MINER RES, V27, P2429, DOI 10.1002/jbmr.1768; Bellido M, 2011, OSTEOARTHR CARTILAGE, V19, P1228, DOI 10.1016/j.joca.2011.07.003; Bi FG, 2014, INT J MOL SCI, V15, P17366, DOI 10.3390/ijms151017366; Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082; Brouwers JEM, 2009, OSTEOPOROSIS INT, V20, P1823, DOI 10.1007/s00198-009-0882-5; Bruel A, 2013, BONE, V53, P51, DOI 10.1016/j.bone.2012.11.037; Carmody EE, 2002, ARTHRITIS RHEUM-US, V46, P1298, DOI 10.1002/art.10227; Chandra A, 2014, BONE, V67, P33, DOI 10.1016/j.bone.2014.06.030; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Childs LM, 2001, J BONE JOINT SURG AM, V83A, P1789, DOI 10.2106/00004623-200112000-00004; Darowish M, 2009, BONE, V45, P661, DOI 10.1016/j.bone.2009.06.004; Daugaard H, 2012, ACTA ORTHOP, V83, P411, DOI 10.3109/17453674.2012.702388; Dempster DW, 2001, J BONE MINER RES, V16, P1846, DOI 10.1359/jbmr.2001.16.10.1846; Dong L, 2008, J ORTHOP RES, V26, P1114, DOI 10.1002/jor.20607; Ejersted C, 1995, BONE, V17, P507, DOI 10.1016/8756-3282(95)00371-1; Ellegaard M, 2010, CALCIFIED TISSUE INT, V87, P1, DOI 10.1007/s00223-010-9360-5; Epstein NJ, 2005, J ORTHOP RES, V23, P501, DOI 10.1016/j.orthres.2004.10.004; Gabet Y, 2005, OSTEOPOROSIS INT, V16, P1436, DOI 10.1007/s00198-005-1876-6; Gabet Y, 2006, BONE, V39, P276, DOI 10.1016/j.bone.2006.02.004; Gittens SA, 2004, J PHARM PHARM SCI, V7, P27; GLANT TT, 1993, J BONE MINER RES, V8, P1071; GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001; Grosso MJ, 2015, J ORTHOP RES, V33, P163, DOI 10.1002/jor.22748; Hall MJ, 2010, NATL HLTH STAT REPOR, V29, p:; Harris WH, 2001, CLIN ORTHOP RELAT R, P66; Hirano T, 1999, J BONE MINER RES, V14, P536, DOI 10.1359/jbmr.1999.14.4.536; HOCK JM, 1992, J BONE MINER RES, V7, P65, DOI 10.1002/jbmr.5650070110; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Iwase M, 2002, J ORTHOPAED RES, V20, P499, DOI 10.1016/S0736-0266(01)00155-3; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jimenez C, 2005, J BONE MINER RES, V20, P1562, DOI 10.1359/JBMR.050507; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; KIMMEL DB, 1993, ENDOCRINOLOGY, V132, P1577, DOI 10.1210/en.132.4.1577; Kreibich DN, 1996, J BONE JOINT SURG BR, V78B, P18, DOI 10.1302/0301-620X.78B1.0780018; Landgraeber S, 2009, APOPTOSIS, V14, P173, DOI 10.1007/s10495-008-0297-3; Liu S, 2012, ARTHRITIS RHEUM-US, V64, P4012, DOI 10.1002/art.37697; Ma T, 2006, J BIOMED MATER RES A, V79A, P740, DOI 10.1002/jbm.a.30949; Markel DC, 2009, INFLAMM RES, V58, P413, DOI 10.1007/s00011-009-0007-9; Millett PJ, 2002, J BONE JOINT SURG AM, V84A, P236, DOI 10.2106/00004623-200202000-00011; Ming N, 2012, SPINE, V37, P1275, DOI 10.1097/BRS.0b013e31824ac089; MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988, DOI 10.1302/0301-620X.72B6.2246303; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; OHLIN A, 1990, CLIN ORTHOP RELAT R, P287; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Sacomen D, 1998, J BIOMED MATER RES, V43, P123, DOI 10.1002/(SICI)1097-4636(199822)43:2<123::AID-JBM6>3.0.CO;2-Q; Savarino L, 2002, J BIOMED MATER RES, V63, P467, DOI 10.1002/jbm.10299; SHEN V, 1992, CALCIFIED TISSUE INT, V50, P214, DOI 10.1007/BF00296285; Shirota T, 2003, J ORAL MAXIL SURG, V61, P471, DOI 10.1053/joms.2003.50093; Subbiah V, 2010, OSTEOPOROSIS INT, V21, P1041, DOI 10.1007/s00198-009-1004-0; TADA K, 1990, BONE, V11, P163, DOI 10.1016/8756-3282(90)90210-P; Takano Y, 1996, J BONE MINER RES, V11, P169; Tashjian AH, 2002, J BONE MINER RES, V17, P1151, DOI 10.1359/jbmr.2002.17.7.1151; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Vahle JL, 2004, TOXICOL PATHOL, V32, P426, DOI 10.1080/01926230490462138; Vermes C, 2000, J BONE MINER RES, V15, P1756, DOI 10.1359/jbmr.2000.15.9.1756; von Knoch F, 2005, J BIOMED MATER RES A, V75A, P288, DOI 10.1002/jbm.a.30441; von Knoch F, 2005, BIOMATERIALS, V26, P5783, DOI 10.1016/j.biomaterials.2005.02.008; Wedemeyer C, 2007, CALCIFIED TISSUE INT, V80, P268, DOI 10.1007/s00223-007-9005-5; Wedemeyer C, 2007, J BONE MINER RES, V22, P1011, DOI 10.1359/JBMR.070408; Weisser A, 2002, EXP CELL RES, V279, P1, DOI 10.1006/excr.2002.5580; Wilkinson JM, 2011, BONE, V49, P95, DOI 10.1016/j.bone.2011.01.009; WRONSKI TJ, 1993, ENDOCRINOLOGY, V132, P823, DOI 10.1210/en.132.2.823; Yang SY, 2004, GENE THER, V11, P483, DOI 10.1038/sj.gt.3302192; Zhang T, 2009, BIOMATERIALS, V30, P6102, DOI 10.1016/j.biomaterials.2009.07.032; Zhu FB, 2010, J ORTHOP RES, V28, P893, DOI 10.1002/jor.21062; Zhu HX, 2015, CLIN ORTHOP RELAT R, V473, P1830, DOI 10.1007/s11999-015-4154-8	70	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139793	10.1371/journal.pone.0139793	http://dx.doi.org/10.1371/journal.pone.0139793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441073	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510300056
J	Cohen, C; Naidoo, N; Meiring, S; de Gouveia, L; von Mollendorf, C; Walaza, S; Naicker, P; Madhi, SA; Feldman, C; Klugman, KP; Dawood, H; von Gottberg, A				Cohen, Cheryl; Naidoo, Nireshni; Meiring, Susan; de Gouveia, Linda; von Mollendorf, Claire; Walaza, Sibongile; Naicker, Preneshni; Madhi, Shabir A.; Feldman, Charles; Klugman, Keith P.; Dawood, Halima; von Gottberg, Anne		GERMS-SA	Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National Surveillance Data, 2003-2008	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; COMMUNITY-ACQUIRED PNEUMONIA; ANTIBIOTIC-RESISTANCE; CONJUGATE VACCINE; CLINICAL PRESENTATION; TERM SURVIVAL; BACTEREMIA; HIV; INFECTION; THERAPY	Background An association between pneumococcal serotypes and mortality has been suggested. We aimed to investigate this among individuals aged >= 15 years with invasive pneumococcal disease (IPD) in South Africa. Methods IPD cases were identified through national laboratory-based surveillance at 25 sites, prepneumococcal conjugate vaccine (PCV) introduction, from 2003-2008. We assessed the association between the 20 commonest serotypes and in-hospital mortality using logistic regression with serotype 4 (the third commonest serotype with intermediate case-fatality ratio (CFR)) as referent. Results Among 3953 IPD cases, CFR was 55% (641/1166) for meningitis and 23% (576/2484) for bacteremia (p<0.001). Serotype 19F had the highest CFR (48%, 100/207), followed by serotype 23F (39%, 99/252) and serotype 1 (38%, 246/651). On multivariable analysis, factors independently associated with mortality included serotype 1 (OR 1.9, 95% CI 1.1-3.5) and 19F (OR 2.9, 95% CI 1.4-6.1) vs. serotype 4; increasing age (25-44 years, OR 1.8, 95% CI 1.0-3.0; 45-64 years, OR 3.6, 95% CI 2.0-6.4; >= 65 years, OR 5.2, 95% CI 1.9-14.1; vs. 15-24 years); meningitis (OR 4.1, 95% CI 3.0-5.6) vs. bacteremic pneumonia; and HIV infection (OR1.7, 95% CI 1.0-2.8). On stratified multivariate analysis, serotype 19F was associated with increased mortality amongst bacteremic pneumococcal pneumonia cases, while no serotype was associated with increased mortality in meningitis cases. Conclusion Mortality was increased in HIV-infected individuals, which may be reduced by increased antiretroviral therapy availability. Serotypes associated with increased mortality are included in the 10-and-13-valent PCV and may become less common in adults due to indirect effects following routine infant immunization.	[Cohen, Cheryl; Naidoo, Nireshni; Meiring, Susan; de Gouveia, Linda; von Mollendorf, Claire; Walaza, Sibongile; Madhi, Shabir A.; von Gottberg, Anne] NHLS, Ctr Resp Dis & Meningitis, NICD, Johannesburg, South Africa; [Cohen, Cheryl; Naidoo, Nireshni; von Mollendorf, Claire; Walaza, Sibongile] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Naicker, Preneshni] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Feldman, Charles] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa; [Klugman, Keith P.] Emory Univ, Hubert Sch Publ Hlth, Atlanta, GA 30322 USA; [Dawood, Halima] Univ KwaZulu Natal, Fac Hlth Sci, Dept Internal Med, Pietermaritzburg, South Africa; [von Gottberg, Anne] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Cape Town; University of Witwatersrand; Emory University; University of Kwazulu Natal; University of Witwatersrand	Cohen, C (corresponding author), NHLS, Ctr Resp Dis & Meningitis, NICD, Johannesburg, South Africa.	cherylc@nicd.ac.za	Meiring, Susan/M-1463-2019; Feldman, Charles/ABF-3315-2020; Dawood, Halima/AAF-6045-2020; Dawood, Halima/AAO-6963-2020	Meiring, Susan/0000-0003-4508-5469; Feldman, Charles/0000-0002-6881-8314; Dawood, Halima/0000-0001-8180-6791; Cohen, Cheryl/0000-0003-0376-2302; von Gottberg, Anne/0000-0002-0243-7455	National Institute for Communicable Diseases, a division of the National health Laboratory Service; United States Agency for International Development's Antimicrobial Resistance Initiativefrom the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [U60/CCU022088]; CDC [U62/CCU022901]	National Institute for Communicable Diseases, a division of the National health Laboratory Service; United States Agency for International Development's Antimicrobial Resistance Initiativefrom the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia(United States Agency for International Development (USAID)); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by funding from the National Institute for Communicable Diseases, a division of the National health Laboratory Service, and was supported in part by funds from the United States Agency for International Development's Antimicrobial Resistance Initiative, transferred via a cooperative agreement (number U60/CCU022088) from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia; and cooperative agreement U62/CCU022901 from the CDC. (The contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.)	Baddour LM, 2004, AM J RESP CRIT CARE, V170, P440, DOI 10.1164/rccm.200311-1578OC; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Black Steven, 2003, J Pediatr, V143, P688; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Buie KA, 2004, J INFECT DIS, V189, P1996, DOI 10.1086/386548; Cheyip M, 2007, GERMS COLLECTION RAT; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; CLSI, 2012, PERF STAND ANT SUS S; Cohen C, 2014, PEDIAT INFECT DIS J; Dohoo I, 2003, VET EPIDEMIOLOGIC RE, P378; du Plessis M, 2008, INT J ANTIMICROB AG, V32, pS66, DOI 10.1016/j.ijantimicag.2008.06.002; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Feldman C, 2007, J INFECTION, V55, P125, DOI 10.1016/j.jinf.2007.04.001; Frankel RE, 1996, CLIN INFECT DIS, V23, P577, DOI 10.1093/clinids/23.3.577; Gilbert K, 1994, Semin Respir Infect, V9, P140; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Henriques B, 2000, J INFECT DIS, V182, P833, DOI 10.1086/315761; Huebner RE, 1999, S AFR MED J, V89, P924; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Kothe H, 2008, EUR RESPIR J, V32, P139, DOI 10.1183/09031936.00092507; Martens P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-21; Moroney JF, 2001, CLIN INFECT DIS, V33, P797, DOI 10.1086/322623; National Department of Health South Africa, 2021, 2019 NAT ANT HIV SEN; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Nunes MC, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18432; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Nyasulu P, 2011, PEDIATR INFECT DIS J, V30, P1075, DOI 10.1097/INF.0b013e31822cca05; Ostergaard C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-93; Paterson DL, 2004, CLIN INFECT DIS, V39, P31, DOI 10.1086/420816; Rodgers Gail L, 2011, Vaccine, V29 Suppl 3, pC43, DOI 10.1016/j.vaccine.2011.07.047; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Satistics South Africa, 2009, SUBJ POV S AFR FIND; Shisana O, 2012, S AFRICAN NATL HIV P; South Africa Department of Health.., 2006, STAND TREATM GUID ES; Statistics South Africa, 2012, CENS 2011 STAT REL P; van Hoek AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039150; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	46	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140185	10.1371/journal.pone.0140185	http://dx.doi.org/10.1371/journal.pone.0140185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460800	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300062
J	Johnson-Kerner, BL; Diaz, AG; Ekins, S; Wichterle, H				Johnson-Kerner, Bethany L.; Diaz, Alejandro Garcia; Ekins, Sean; Wichterle, Hynek			Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy	PLOS ONE			English	Article							INDEPENDENT PATHWAY; DEGRADATION; DISEASE; PROTEASOME; CELLS; ORGANIZATION	Patients with giant axonal neuropathy (GAN) show progressive loss of motor and sensory function starting in childhood and typically live for less than 30 years. GAN is caused by autosomal recessive mutations leading to low levels of gigaxonin (GIG), a ubiquitously-expressed BTB/Kelch cytoplasmic protein believed to be an E3 ligase substrate adaptor. GAN pathology is characterized by aggregates of intermediate filaments (IFs) in multiple tissues. To delineate the molecular pathway between GIG deficiency and IF pathology, we undertook a proteomic screen to identify the normal binding partners of GIG. Prominent among them were several classes of IFs, including the neurofilament subunits whose accumulation leads to the axonal swellings for which GAN is named. We showed these interactions were dependent on the Kelch domain of GIG. Furthermore, we identified the E3 ligase MYCBP2 and the heat shock proteins HSP90AA1/AB1 as interactors with the BTB domain that may result in the ubiquitination and subsequent degradation of intermediate filaments. Our open-ended proteomic screen provides support to GIG's role as an adaptor protein, linking IF proteins through its Kelch domain to the ubiquitin pathway proteins via its BTB domain, and points to future approaches for reversing the phenotype in human patients.	[Johnson-Kerner, Bethany L.; Diaz, Alejandro Garcia; Wichterle, Hynek] Jenifer Estess Lab Stem Cell Res, Project ALS, New York, NY 10032 USA; [Johnson-Kerner, Bethany L.; Diaz, Alejandro Garcia; Wichterle, Hynek] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, New York, NY USA; [Johnson-Kerner, Bethany L.; Wichterle, Hynek] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA; [Johnson-Kerner, Bethany L.; Wichterle, Hynek] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Johnson-Kerner, Bethany L.; Wichterle, Hynek] Columbia Univ, Dept Neurosci, Med Ctr, New York, NY USA; [Johnson-Kerner, Bethany L.; Wichterle, Hynek] Columbia Univ, Columbia Stem Cell Initiat, Med Ctr, New York, NY USA; [Ekins, Sean] Collaborat Chem, Fuquay Varina, NC USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Wichterle, H (corresponding author), Jenifer Estess Lab Stem Cell Res, Project ALS, New York, NY 10032 USA.	hw350@cumc.columbia.edu		Wichterle, Hynek/0000-0002-7817-0080	Hannah's Hope Fund; Project A.L.S; New York Stem Cell Foundation NYSTEM [CO24415]; National Institute of Neurological Disorders and Stroke NINDS [F31, NS077544-01A1]; Hearst Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077544] Funding Source: NIH RePORTER	Hannah's Hope Fund; Project A.L.S; New York Stem Cell Foundation NYSTEM; National Institute of Neurological Disorders and Stroke NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hearst Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Hannah's Hope Fund, Project A.L.S, and New York Stem Cell Foundation NYSTEM (CO24415). B.J.K. is supported by an F31 grant from National Institute of Neurological Disorders and Stroke NINDS (NS077544-01A1) and a Hearst Scholarship.	Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; ASBURY AK, 1972, ACTA NEUROPATHOL, V20, P237, DOI 10.1007/BF00686905; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; BERG BO, 1972, PEDIATRICS, V49, P894; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Bomont P, 2003, HUM MOL GENET, V12, P813, DOI 10.1093/hmg/ddg092; Cleveland DW, 2009, HUM MOL GENET, V18, P1384, DOI 10.1093/hmg/ddp044; Cullen VC, 2004, NEUROREPORT, V15, P873, DOI 10.1097/00001756-200404090-00028; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding JQ, 2006, HUM MOL GENET, V15, P1451, DOI 10.1093/hmg/ddl069; Ding JQ, 2002, J CELL BIOL, V158, P427, DOI 10.1083/jcb.200202055; ESCURAT M, 1990, J NEUROSCI, V10, P764; Gordon N, 2004, DEV MED CHILD NEUROL, V46, P717, DOI 10.1017/S0012162204001215; Huang L, 2007, FEBS LETT, V581, P4955, DOI 10.1016/j.febslet.2007.09.031; Johnson-Kerner BL, 2014, MUSCLE NERVE, V50, P467, DOI 10.1002/mus.24321; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Mahammad S, 2013, J CLIN INVEST, V123, P1964, DOI 10.1172/JCI66387; McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mussche S, 2012, MUSCLE NERVE, V46, P246, DOI 10.1002/mus.23306; PEIFFER J, 1977, ACTA NEUROPATHOL, V40, P213, DOI 10.1007/BF00691956; PENA SDJ, 1982, MUSCLE NERVE, V5, P166, DOI 10.1002/mus.880050215; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Wang W, 2005, CURR BIOL, V15, P2050, DOI 10.1016/j.cub.2005.10.052; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200	29	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140157	10.1371/journal.pone.0140157	http://dx.doi.org/10.1371/journal.pone.0140157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460568	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300060
J	Du, J; Emilio, D; Pang, Y; Ma, Y; Mi, FL; Liu, YH; Li, L				Du, Jian; Emilio, Dirlikov; Pang, Yu; Ma, Yan; Mi, Fengling; Liu, Yuhong; Li, Liang			Tuberculosis Hospitalization Fees and Bed Utilization in China from 1999 to 2009: The Results of a National Survey of Tuberculosis Specialized Hospitals	PLOS ONE			English	Article							SHANDONG PROVINCE; TB SERVICES; HEALTH	Background China is transitioning towards concentrating tuberculosis (TB) diagnostic and treatment services in hospitals, while the Centers of Disease Control and Prevention (CDC) system will retain important public health functions. Patient expenditure incurred through hospitalization may lead to barriers to TB care or interruption of treatment. Methodology/Principal Findings We conducted a national survey of TB specialized hospitals to determine hospitalization fees and hospital bed utilization in 1999, 2004, and 2009. Hospitalization of TB patients increased 185.3% from 1999 to 2009. While the average hospitalization fees also increased, the proportion of those fees in relation to GDP per capita decreased. Hospitalization fees differed across the three regions (eastern, central, and western). Using a least standard difference (LSD) paired analysis, in 2004, the difference in hospitalization fees was significant when comparing eastern and central provinces (p<0.001) as well as to western provinces (p<0.001). In 2009, the difference remained statistically significant when comparing eastern province hospitalization fees with central provinces (p<0.001) and western provinces (p = 0.008). In 2004 and 2009, the cost associated with hospitalization as a proportion of GDP per capita was highest in the western region. The average in-patient stay decreased from 33 days in 1999 to 26 and 27 days in 2004 and 2009 respectively. Finally, hospital bed utilization in all three regions increased over this period. Conclusions/Significance Our findings show that both the total number of in-patients and hospitalization fees increased from 1999 to 2009, though the proportion of hospitalization fees to GDP per capita decreased. As diagnostic services move to hospitals, regulatory and monitoring mechanisms should be established, and hospitals should make use of the experience garnered by the CDC system through continued strong collaborations. Infrastructure and social protection mechanisms in high burden areas, such as in the western region, should be strengthened.	[Du, Jian; Ma, Yan; Mi, Fengling; Liu, Yuhong; Li, Liang] Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China; [Du, Jian; Ma, Yan; Mi, Fengling; Liu, Yuhong; Li, Liang] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Du, Jian; Ma, Yan; Mi, Fengling; Liu, Yuhong; Li, Liang] China CDC, Clin Ctr TB Control, Adm Off, Beijing, Peoples R China; [Emilio, Dirlikov] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Pang, Yu] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China	Capital Medical University; Chinese Center for Disease Control & Prevention; McGill University; Chinese Center for Disease Control & Prevention	Liu, YH (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China.	liuyuhong0516@126.com; liliang69@tb123.org		Dirlikov, Emilio/0000-0003-4631-2643	Ministry of Health of China	Ministry of Health of China	This study was supported by Ministry of Health of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CEINET STAT DAT; Barber SL, 2011, INT J HEALTH PLAN M, V26, P339, DOI 10.1002/hpm.1109; Chai SJ, 2013, HEALTH POLICY PLANN, V28, P100, DOI 10.1093/heapol/czs029; Du J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111945; Fan CC, 1997, INT J URBAN REGIONAL, V21, P620, DOI 10.1111/1468-2427.00105; He GX, 2012, INT J TUBERC LUNG D, V16, P1485, DOI 10.5588/ijtld.12.0193; Hipgrave David, 2011, J Glob Health, V1, P224; Lienhardt C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001135; Liu J, 2005, CHINESE J HOSP STAT, V12, P227; MOH of the PRC, 2011, CHIN NAT TUB CONTR P; MOH of the PRC, 2002, 4 NAT SURV EP TUB 20; MOH of the PRC, 2011, 5 NAT SURV EP TUB 20; Oxlade O, 2009, INT J TUBERC LUNG D, V13, P1238; Qiu SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126770; Wang WB, 2014, INT J TUBERC LUNG D, V18, P939, DOI 10.5588/ijtld.13.0131; Wei X, 2011, BMC PUBLIC HEALTH, V11, P1; Wei XL, 2009, INT J TUBERC LUNG D, V13, P514; Wei XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090596; Wei XL, 2011, TROP MED INT HEALTH, V16, P847, DOI 10.1111/j.1365-3156.2011.02769.x; World Bank, 2014, CHIN DAT; World Health Organization, 2014, WHOHTMTB201408; Xu L, 2010, INT J TUBERC LUNG D, V14, P440; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Zhan SK, 2004, INT J HEALTH PLAN M, V19, pS63, DOI 10.1002/hpm.778; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zou GY, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-21	28	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0139901	10.1371/journal.pone.0139901	http://dx.doi.org/10.1371/journal.pone.0139901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457980	Green Submitted, gold, Green Published			2022-12-26	WOS:000362961100016
J	Edge, R; Heath, J; Rowlingson, B; Keegan, TJ; Isba, R				Edge, Rhiannon; Heath, Joseph; Rowlingson, Barry; Keegan, Thomas J.; Isba, Rachel			Seasonal Influenza Vaccination amongst Medical Students: A Social Network Analysis Based on a Cross-Sectional Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; LONG-TERM-CARE; HOME STAFF; MORTALITY; OUTBREAK; RESIDENTS; IMPACT	Introduction The Chief Medical Officer for England recommends that healthcare workers have a seasonal influenza vaccination in an attempt to protect both patients and NHS staff. Despite this, many healthcare workers do not have a seasonal influenza vaccination. Social network analysis is a well-established research approach that looks at individuals in the context of their social connections. We examine the effects of social networks on influenza vaccination decision and disease dynamics. Methods We used a social network analysis approach to look at vaccination distribution within the network of the Lancaster Medical School students and combined these data with the students' beliefs about vaccination behaviours. We then developed a model which simulated influenza outbreaks to study the effects of preferentially vaccinating individuals within this network. Results Of the 253 eligible students, 217 (86%) provided relational data, and 65% of responders had received a seasonal influenza vaccination. Students who were vaccinated were more likely to think other medical students were vaccinated. However, there was no clustering of vaccinated individuals within the medical student social network. The influenza simulation model demonstrated that vaccination of well-connected individuals may have a disproportional effect on disease dynamics. Conclusions This medical student population exhibited vaccination coverage levels similar to those seen in other healthcare groups but below recommendations. However, in this population, a lack of vaccination clustering might provide natural protection from influenza outbreaks. An individual student's perception of the vaccination coverage amongst their peers appears to correlate with their own decision to vaccinate, but the directionality of this relationship is not clear. When looking at the spread of disease within a population it is important to include social structures alongside vaccination data. Social networks influence disease epidemiology and vaccination campaigns designed with information from social networks could be a future target for policy makers.	[Edge, Rhiannon; Heath, Joseph; Rowlingson, Barry; Keegan, Thomas J.; Isba, Rachel] Univ Lancaster, Dept Hlth & Med, Lancaster, Lancs, England	Lancaster University	Edge, R (corresponding author), Univ Lancaster, Dept Hlth & Med, Lancaster, Lancs, England.	r.edge@lancaster.ac.uk		Keegan, Thomas/0000-0003-3691-953X; Edge, Rhiannon/0000-0001-5349-783X; Isba, Rachel/0000-0002-2896-4309; Rowlingson, Barry/0000-0002-8586-6625	Colt Foundation; University Hospitals of Morecombe Bay NHS Foundation Trust	Colt Foundation; University Hospitals of Morecombe Bay NHS Foundation Trust	RE is funded by the Colt Foundation for this work as part of her PhD [http://www.coltfoundation.org.uk/]. Funding for the data collection was provided for JH by University Hospitals of Morecombe Bay NHS Foundation Trust [http://www.uhmb.nhs.uk/about-us/the-trust-board/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EURO SURVEILL; Barclay VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087042; Baron G, 2001, CAN FAM PHYSICIAN, V47, P2261; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Brunson EK, 2013, PEDIATRICS, V131, pE1397, DOI 10.1542/peds.2012-2452; Calatayud L, 2010, EPIDEMIOL INFECT, V138, P183, DOI 10.1017/S0950268809991191; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Huisman M., 2009, J SOC STRUCT, V10, P1, DOI DOI 10.21307/joss-2019-051; Lam PP, 2010, CAN MED ASSOC J, V182, pE542, DOI 10.1503/cmaj.091304; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Loulergue P, 2009, VACCINE, V27, P4240, DOI 10.1016/j.vaccine.2009.03.039; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Majumder MS, 2015, JAMA PEDIATR, V169, P494, DOI 10.1001/jamapediatrics.2015.0384; Mbah MLN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002469; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nichol KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009548; Ofstead CL, 2008, INFECT CONT HOSP EP, V29, P99, DOI 10.1086/526431; Poland GA, 2005, VACCINE, V23, P2251, DOI 10.1016/j.vaccine.2005.01.043; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Public Health England, SEAS INFL VACC UPT A; R Development Core Team, 2014, R LANG ENV STAT COMP; Smedley J, 2007, OCCUP ENVIRON MED, V64, P223, DOI 10.1136/oem.2005.023564; STORK D, 1992, GROUP ORGAN MANAGE, V17, P193, DOI 10.1177/1059601192172006; *WHO, INFL FACT SHEET	30	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140085	10.1371/journal.pone.0140085	http://dx.doi.org/10.1371/journal.pone.0140085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TY	26452223	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511200036
J	Todd, H; Galea, GL; Meakin, LB; Delisser, PJ; Lanyon, LE; Windahl, SH; Price, JS				Todd, Henry; Galea, Gabriel L.; Meakin, Lee B.; Delisser, Peter J.; Lanyon, Lance E.; Windahl, Sara H.; Price, Joanna S.			Wnt16 Is Associated with Age-Related Bone Loss and Estrogen Withdrawal in Murine Bone	PLOS ONE			English	Article							RECEPTOR-ALPHA; MINERAL DENSITY; OSTEOGENIC RESPONSE; GENE-EXPRESSION; LOAD-BEARING; GENOME-WIDE; GROWTH; BETA; OSTEOCYTES; MUTATIONS	Genome Wide Association Studies suggest that Wnt16 is an important contributor to the mechanisms controlling bone mineral density, cortical thickness, bone strength and ultimately fracture risk. Wnt16 acts on osteoblasts and osteoclasts and, in cortical bone, is predominantly derived from osteoblasts. This led us to hypothesize that low bone mass would be associated with low levels of Wnt16 expression and that Wnt16 expression would be increased by anabolic factors, including mechanical loading. We therefore investigated Wnt16 expression in the context of ageing, mechanical loading and unloading, estrogen deficiency and replacement, and estrogen receptor alpha (ER alpha) depletion. Quantitative real time PCR showed that Wnt16 mRNA expression was lower in cortical bone and marrow of aged compared to young female mice. Neither increased nor decreased (by disuse) mechanical loading altered Wnt16 expression in young female mice, although Wnt16 expression was decreased following ovariectomy. Both 17 beta-estradiol and the Selective Estrogen Receptor Modulator Tamoxifen increased Wnt16 expression relative to ovariectomy. Wnt16 and ER beta expression were increased in female ER alpha(-/-) mice when compared to Wild Type. We also addressed potential effects of gender on Wnt16 expression and while the expression was lower in the cortical bone of aged males as in females, it was higher in male bone marrow of aged mice compared to young. In the kidney, which we used as a non-bone reference tissue, Wnt16 expression was unaffected by age in either males or females. In summary, age, and its associated bone loss, is associated with low levels of Wnt16 expression whereas bone loss associated with disuse has no effect on Wnt16 expression. In the artificially loaded mouse tibia we observed no loading-related up-regulation of Wnt16 expression but provide evidence that its expression is influenced by estrogen receptor signaling. These findings suggest that while Wnt16 is not an obligatory contributor to regulation of bone mass per se, it potentially plays a role in influencing pathways associated with regulation of bone mass during ageing and estrogen withdrawal.	[Todd, Henry; Galea, Gabriel L.; Meakin, Lee B.; Delisser, Peter J.; Lanyon, Lance E.; Windahl, Sara H.; Price, Joanna S.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Windahl, Sara H.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden	University of Bristol; University of Gothenburg	Windahl, SH (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	sara.windahl@bristol.ac.uk	Delisser, Peter James/AAT-3022-2021; Galea, Gabriel/I-9374-2019; Meakin, Lee/H-7726-2019	Galea, Gabriel/0000-0003-2515-1342; Meakin, Lee/0000-0002-2161-9414; Delisser, Peter/0000-0002-2742-2532; Windahl, Sara/0000-0002-6611-6001	European Union [657178]	European Union(European Commission)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 657178.	Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Borjesson AE, 2013, CELL MOL LIFE SCI, V70, P4023, DOI 10.1007/s00018-013-1317-1; Borjesson AE, 2011, P NATL ACAD SCI USA, V108, P6288, DOI 10.1073/pnas.1100454108; Callewaert F, 2010, J BONE MINER RES, V25, P124, DOI 10.1359/jbmr.091001; Chen Jia-Shing, 2014, BMC Res Notes, V7, P15, DOI 10.1186/1756-0500-7-15; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Galea GL, 2015, J BONE MINER RES, V30, P411, DOI 10.1002/jbmr.2377; Galea GL, 2014, J BIOL CHEM, V289, P25509, DOI 10.1074/jbc.M114.580365; Galea GL, 2013, J BIOL CHEM, V288, P9035, DOI 10.1074/jbc.M112.405456; Garcia-Ibarbia C, 2013, OSTEOPOROSIS INT, V24, P2449, DOI 10.1007/s00198-013-2302-0; Hendrickx G, 2014, BONE, V59, P57, DOI 10.1016/j.bone.2013.10.022; Kan A, 2013, GENE DEV, V27, P514, DOI 10.1101/gad.209239.112; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Kobayashi Y, 2015, BIOCHEM BIOPH RES CO, V463, P1278, DOI 10.1016/j.bbrc.2015.06.102; Koller DL, 2013, J BONE MINER RES, V28, P547, DOI 10.1002/jbmr.1796; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lindberg MK, 2001, J ENDOCRINOL, V171, P425, DOI 10.1677/joe.0.1710425; Lindberg MK, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740167; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Medina-Gomez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002718; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Moverare-Skrtic S, 2014, NAT MED, V20, P1279, DOI 10.1038/nm.3654; Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009; Saxon LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE484, DOI 10.1152/ajpendo.00189.2007; Saxon LK, 2012, ENDOCRINOLOGY, V153, P2254, DOI 10.1210/en.2011-1977; Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9; Shen LX, 2009, J CELL BIOCHEM, V106, P337, DOI 10.1002/jcb.22010; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sugiyama T, 2011, BONE, V49, P133, DOI 10.1016/j.bone.2011.03.775; Sugiyama T, 2010, ENDOCRINOLOGY, V151, P5582, DOI 10.1210/en.2010-0645; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Vidal O, 1999, BIOCHEM BIOPH RES CO, V265, P569, DOI 10.1006/bbrc.1999.1711; Wergedal JE, 2015, ENDOCRINOLOGY, V156, P1023, DOI 10.1210/en.2014-1702; Windahl SH, 2013, P NATL ACAD SCI USA, V110, P2294, DOI 10.1073/pnas.1220811110; Windahl SH, 2013, J BONE MINER RES, V28, P291, DOI 10.1002/jbmr.1754; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Windahl SH, 2001, J BONE MINER RES, V16, P1388, DOI 10.1359/jbmr.2001.16.8.1388; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504; Zaman G, 2012, J BIOL CHEM, V287, P3946, DOI 10.1074/jbc.M111.252742; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745	48	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140260	10.1371/journal.pone.0140260	http://dx.doi.org/10.1371/journal.pone.0140260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451596	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200054
J	Houvenaghel, JF; Le Jeune, F; Dondaine, T; Esquevin, A; Robert, GH; Peron, J; Haegelen, C; Drapier, S; Jannin, P; Lozachmeur, C; Argaud, S; Duprez, J; Drapier, D; Verin, M; Sauleau, P				Houvenaghel, Jean-Francois; Le Jeune, Florence; Dondaine, Thibaut; Esquevin, Aurore; Robert, Gabriel Hadrien; Peron, Julie; Haegelen, Claire; Drapier, Sophie; Jannin, Pierre; Lozachmeur, Clement; Argaud, Soizic; Duprez, Joan; Drapier, Dominique; Verin, Marc; Sauleau, Paul			Reduced Verbal Fluency following Subthalamic Deep Brain Stimulation: A Frontal-Related Cognitive Deficit?	PLOS ONE			English	Article							PARKINSONS-DISEASE; NUCLEUS STIMULATION; NEUROPSYCHOLOGICAL CHANGES; STN-DBS; PET; APATHY; PERFORMANCE; DECLINE; TRIAL; SCALE	Objective The decrease in verbal fluency in patients with Parkinson's disease (PD) undergoing subthalamic nucleus deep brain stimulation (STN-DBS) is usually assumed to reflect a frontal lobe-related cognitive dysfunction, although evidence for this is lacking. Methods To explore its underlying mechanisms, we combined neuropsychological, psychiatric and motor assessments with an examination of brain metabolism using F-18 fluorodeoxyglucose positron emission tomography, in 26 patients with PD, 3 months before and after surgery. We divided these patients into two groups, depending on whether or not they exhibited a postoperative deterioration in either phonemic (10 patients) or semantic (8 patients) fluency. We then compared the STN-DBS groups with and without verbal deterioration on changes in clinical measures and brain metabolism. Results We did not find any neuropsychological change supporting the presence of an executive dysfunction in patients with a deficit in either phonemic or semantic fluency. Similarly, a comparison of patients with or without impaired fluency on brain metabolism failed to highlight any frontal areas involved in cognitive functions. However, greater changes in cognitive slowdown and apathy were observed in patients with a postoperative decrease in verbal fluency. Conclusions These results suggest that frontal lobe-related cognitive dysfunction could play only a minor role in the postoperative impairment of phonemic or semantic fluency, and that cognitive slowdown and apathy could have a more decisive influence. Furthermore, the phonemic and semantic impairments appeared to result from the disturbance of distinct mechanisms.	[Houvenaghel, Jean-Francois; Le Jeune, Florence; Dondaine, Thibaut; Robert, Gabriel Hadrien; Peron, Julie; Drapier, Sophie; Lozachmeur, Clement; Argaud, Soizic; Duprez, Joan; Drapier, Dominique; Verin, Marc; Sauleau, Paul] Univ Rennes, Behav & Basal Ganglia Res Unit, EA 4712, Rennes, France; [Houvenaghel, Jean-Francois; Drapier, Sophie; Verin, Marc] Rennes Univ Hosp, Dept Neurol, Rennes, France; [Le Jeune, Florence] Eugene Marquis Hosp, Dept Nucl Med, Rennes, France; [Esquevin, Aurore] Rennes Univ Hosp, Dept Neuroradiol, Rennes, France; [Robert, Gabriel Hadrien; Lozachmeur, Clement; Drapier, Dominique] Rennes Univ Hosp, Dept Psychiat, Rennes, France; [Peron, Julie; Argaud, Soizic] Univ Geneva, Dept Psychol, Neurosci Emot & Affect Dynam Lab, Geneva, Switzerland; [Peron, Julie; Argaud, Soizic] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Haegelen, Claire] Rennes Univ Hosp, Dept Neurosurg, Rennes, France; [Haegelen, Claire; Jannin, Pierre] Univ Rennes, INSERM, MediCIS Lab, UMR 1099,LTSI, Rennes, France; [Sauleau, Paul] Rennes Univ Hosp, Dept Neurophysiol, Rennes, France	Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; University of Geneva; University of Geneva; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes	Houvenaghel, JF (corresponding author), Univ Rennes, Behav & Basal Ganglia Res Unit, EA 4712, Rennes, France.	Jeanfrancois.Houvenaghel@chu-rennes.fr	Le Jeune, Florence/ABC-6983-2020; Duprez, Joan/X-8320-2019; Verin, Marc/ABC-6924-2020; Péron, Julie/C-5658-2013; Jannin, Pierre/P-9958-2019; Sauleau, Paul/ABC-4459-2020; Haegelen, Claire CH/J-5332-2016; Jannin, Pierre/F-5538-2010	Duprez, Joan/0000-0002-8176-5114; Péron, Julie/0000-0002-6579-4011; Jannin, Pierre/0000-0002-7415-071X; Jannin, Pierre/0000-0002-7415-071X; Houvenaghel, Jean-Francois/0000-0001-5424-2759; Dondaine, Thibaut/0000-0002-8778-5079	University of Rennes 1	University of Rennes 1	The study was funded by University of Rennes 1.	Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO;2-Z; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Castner JE, 2007, BRAIN, V130, P1395, DOI 10.1093/brain/awm059; Cilia R, 2007, PARKINSONISM RELAT D, V13, P290, DOI 10.1016/j.parkreldis.2006.11.011; Cogan GB, 2014, NATURE, V507, P94, DOI 10.1038/nature12935; Drapier D, 2006, J NEUROL, V253, P1083, DOI 10.1007/s00415-006-0177-0; Ehlen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079247; Frerichs RJ, 2005, ARCH CLIN NEUROPSYCH, V20, P321, DOI 10.1016/j.acn.2004.08.002; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803; Gironell A, 2003, J NEUROL, V250, P917, DOI 10.1007/s00415-003-1109-x; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Kalbe E, 2009, NEUROLOGY, V72, P42, DOI 10.1212/01.wnl.0000338536.31388.f0; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Le Jeune F, 2009, NEUROLOGY, V73, P1746, DOI 10.1212/WNL.0b013e3181c34b34; Le Jeune F, 2010, EUR J NUCL MED MOL I, V37, P1512, DOI 10.1007/s00259-010-1436-y; Lefaucheur R, 2012, J NEUROL SCI, V321, P96, DOI 10.1016/j.jns.2012.07.033; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marshall DF, 2012, EUR J NEUROL, V19, P1525, DOI 10.1111/j.1468-1331.2012.03759.x; Massano Joao, 2012, Front Neurol, V3, P66, DOI 10.3389/fneur.2012.00066; Mattis S, 1988, DEMENTIA RATING SCAL; McDonald C, 1996, J CLIN EXP NEUROPSYC, V18, P793, DOI 10.1080/01688639608408303; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Pillon B, 2000, NEUROLOGY, V55, P411, DOI 10.1212/WNL.55.3.411; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rothlind JC, 2015, J NEUROL NEUROSUR PS, V86, P622, DOI 10.1136/jnnp-2014-308119; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Schroeder U, 2003, ANN NEUROL, V54, P445, DOI 10.1002/ana.10683; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Welter ML, 2002, BRAIN, V125, P575, DOI 10.1093/brain/awf050; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; Witt K, 2013, BRAIN, V136, P2109, DOI 10.1093/brain/awt151; Zec RF, 1999, ARCH CLIN NEUROPSYCH, V14, P255, DOI 10.1016/S0887-6177(98)00008-0	38	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140083	10.1371/journal.pone.0140083	http://dx.doi.org/10.1371/journal.pone.0140083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448131	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000088
J	Kang, CK; Park, HJ; Choy, EJ; Choi, KS; Hwang, K; Kim, JB				Kang, Chang-Keun; Park, Hyun Je; Choy, Eun Jung; Choi, Kwang-Sik; Hwang, Kangseok; Kim, Jong-Bin			Linking Intertidal and Subtidal Food Webs: Consumer-Mediated Transport of Intertidal Benthic Microalgal Carbon	PLOS ONE			English	Article							REED PHRAGMITES-AUSTRALIS; CORDGRASS SPARTINA-ALTERNIFLORA; STABLE-ISOTOPES; CONTINENTAL-SHELF; TROPHIC POSITION; TIDAL FLAT; MICROPHYTOBENTHOS; BAY; RESUSPENSION; DELTA-C-13	We examined stable carbon and nitrogen isotope ratios for a large variety of consumers in intertidal and subtidal habitats, and their potential primary food sources [i. e., microphytobenthos (MPB), phytoplankton, and Phragmites australis] in a coastal bay system, Yeoja Bay of Korea, to test the hypothesis that the transfer of intertidal MPB-derived organic carbon to the subtidal food web can be mediated by motile consumers. Compared to a narrow delta C-13 range (-18 to -16 parts per thousand) of offshore consumers, a broad delta C-13 range (-18 to -12 parts per thousand) of both intertidal and subtidal consumers indicated that C-13-enriched sources of organic matter are an important trophic source to coastal consumers. In the intertidal areas, delta C-13 of most consumers overlapped with or was C-13-enriched relative to MPB. Despite the scarcity of MPB in the subtidal, highly motile consumers in subtidal habitat had nearly identical delta C-13 range with many intertidal foragers (including crustaceans and fish), overlapping with the range of MPB. In contrast, delta C-13 values of many sedentary benthic invertebrates in the subtidal areas were similar to those of offshore consumers and more C-13-depleted than motile foragers, indicating high dependence on phytoplankton-derived carbon. The isotopic mixing model calculation confirms that the majority of motile consumers and also some of subtidal sedentary ones depend on intertidal MPB for more than a half of their tissue carbon. Finally, although further quantitative estimates are needed, these results suggest that direct foraging by motile consumers on intertidal areas, and thereby biological transport of MPB-derived organic carbon to the subtidal areas, may provide important trophic connection between intertidal production and the nearshore shallow subtidal food webs.	[Kang, Chang-Keun] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Gwangju, South Korea; [Park, Hyun Je] Gangneung Wonju Natt Univ, Dept Marine Biosci, Kangnung, South Korea; [Choy, Eun Jung] Korea Inst Ocean Sci & Technol, Korea Polar Res Inst, Inchon, South Korea; [Choi, Kwang-Sik] Jeju Natl Univ, Fac Marine Biomed Sci, Jeju, South Korea; [Hwang, Kangseok] Natl Fisheries Res & Dev Inst NFRDI, Fisheries Resources Management Div, Busan, South Korea; [Kim, Jong-Bin] NFRDI, Subtrop Fisheries Res Ctr, Jeju, South Korea	Gwangju Institute of Science & Technology (GIST); Kangnung Wonju National University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Jeju National University	Kang, CK (corresponding author), Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Gwangju, South Korea.	ckkang@gist.ac.kr	Kang, Chang-Keun/GLR-8512-2022; Choi, Kwang-Sik Albert/B-5367-2011		project titled "Long-term change of structure and function in marine ecosystems of Korea" - Ministry of Oceans and Fisheries, Korea; National Fisheries Research & Development Institute [RP-2014-FR-064]	project titled "Long-term change of structure and function in marine ecosystems of Korea" - Ministry of Oceans and Fisheries, Korea; National Fisheries Research & Development Institute	This research was partly supported by the project titled "Long-term change of structure and function in marine ecosystems of Korea", funded by the Ministry of Oceans and Fisheries, Korea. This work was partially supported by National Fisheries Research & Development Institute (Project No. RP-2014-FR-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, INVERTEBRATE ZOOLOGY; Blanchard GF, 1997, MAR ECOL PROG SER, V151, P17, DOI 10.3354/meps151017; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carlier A, 2007, ESTUAR COAST SHELF S, V72, P1, DOI 10.1016/j.ecss.2006.10.001; Chiba T, 2012, J MOLLUS STUD, V78, P205, DOI 10.1093/mollus/eys002; Choy EJ, 2008, ESTUAR COAST SHELF S, V78, P215, DOI 10.1016/j.ecss.2007.11.024; Choy EJ, 2009, J EXP MAR BIOL ECOL, V382, P18, DOI 10.1016/j.jembe.2009.10.002; Currin CA, 2003, ESTUARIES, V26, P495, DOI 10.1007/BF02823726; DAME R, 1986, MAR ECOL PROG SER, V33, P217, DOI 10.3354/meps033217; Deegan LA, 1997, MAR ECOL PROG SER, V147, P31, DOI 10.3354/meps147031; DEJONGE VN, 1992, NETH J SEA RES, V30, P91, DOI 10.1016/0077-7579(92)90049-K; DEJONGE VN, 1987, ESTUAR COAST SHELF S, V24, P725, DOI 10.1016/0272-7714(87)90148-X; DELGADO M, 1991, MAR BIOL, V108, P321, DOI 10.1007/BF01344347; Dubois S, 2007, J EXP MAR BIOL ECOL, V351, P121, DOI 10.1016/j.jembe.2007.06.020; Fanelli E, 2011, DEEP-SEA RES PT I, V58, P98, DOI 10.1016/j.dsr.2010.12.005; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Focken U, 1998, OECOLOGIA, V115, P337, DOI 10.1007/s004420050525; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Grall J, 2006, J EXP MAR BIOL ECOL, V338, P1, DOI 10.1016/j.jembe.2006.06.013; Grippo MA, 2011, LIMNOL OCEANOGR, V56, P841, DOI 10.4319/lo.2011.56.3.0841; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; 서인수, 2010, [Korean Journal of Fisheries and Aquatic Sciences, 한국수산과학회지], V43, P510; Hong SY., 2006, MARINE INVERTEBRATES; Hwang Sun Wan, 2003, Journal of the Korean Fisheries Society, V36, P676; Hyndes GA, 2005, ESTUAR COAST SHELF S, V63, P633, DOI 10.1016/j.ecss.2005.01.008; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Islam R., 2009, BANGLADESH J PROGR S, V7, P273; Kang CK, 2008, MAR BIOL, V153, P1181, DOI 10.1007/s00227-007-0890-y; Kang CK, 2009, AQUAT BIOL, V6, P289, DOI 10.3354/ab00126; Kang CK, 2003, MAR ECOL PROG SER, V259, P79, DOI 10.3354/meps259079; Kim Dongseon, 2006, Ocean Science Journal, V41, P125; Knox G. A., 1986, ESTUARINE ECOSYSTEMS, VII; Le Loc'h F, 2008, J MARINE SYST, V72, P17, DOI 10.1016/j.jmarsys.2007.05.011; Lucas CH, 2000, MAR ECOL PROG SER, V196, P59, DOI 10.3354/meps196059; Lucas CH, 1999, MAR ECOL PROG SER, V180, P51, DOI 10.3354/meps180051; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Michener R.H., 1994, P138; Miller RJ, 2012, MAR BIOL, V159, P1391, DOI 10.1007/s00227-012-1929-2; Ministry of Land Transport & Maritime Affairs Korea Marine Environment Management Corporation., 2011, ANN MON REP KOR MAR, V16; Ministry of Oceans and Fisheries, 2013, ANN REP MAR ENV MON, V18; Morton B, 1999, J EXP MAR BIOL ECOL, V240, P213, DOI 10.1016/S0022-0981(99)00060-X; Nadon MO, 2006, LIMNOL OCEANOGR, V51, P2828, DOI 10.4319/lo.2006.51.6.2828; National Fisheries Research and Development Institute (NFRDI), 2002, FIN REP ASS ENV COAS; National Fisheries Research and Development Institute (NFRDI), 2010, ANN REPORT; NFRDI, 2009, CHEM COMP MAR PROD K, V2nd Edn; Nixon S.W., 1980, ESTUAR WETL PROCESS, P437; Odum EP., 1980, ESTUARINE PERSPECTIV, P485; Orvain F, 2004, MAR ECOL PROG SER, V278, P205, DOI 10.3354/meps278205; Orvain F, 2014, J SEA RES, V92, P46, DOI 10.1016/j.seares.2014.03.004; Park HJ, 2015, ESTUAR COAST, V38, P599, DOI 10.1007/s12237-014-9834-1; Park HJ, 2013, WETLANDS, V33, P737, DOI 10.1007/s13157-013-0433-x; Park HJ, 2011, AQUACULTURE, V322, P149, DOI 10.1016/j.aquaculture.2011.10.015; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Raffaelli D, 2001, ECOLOGICAL COMP SEDI, P338; Reise K., 1985, TIDAL FLAT ECOLOGY E; Riera P, 1996, ESTUAR COAST SHELF S, V42, P347, DOI 10.1006/ecss.1996.0023; Ross DJ, 2002, MAR ECOL PROG SER, V241, P99, DOI 10.3354/meps241099; Seo In-Soo, 2010, Korean Journal of Fisheries and Aquatic Sciences, V43, P521; Seo In-Soo, 2006, Journal of the Korean Fisheries Society, V39, P165; Seo IS., 2003, THESIS INHA U; Sherwood GD, 2005, ESTUAR COAST SHELF S, V63, P537, DOI 10.1016/j.ecss.2004.12.010; Son SeungHyun, 2006, Ocean Science Journal, V41, P181; SULLIVAN BK, 1994, MAR BIOL, V121, P335, DOI 10.1007/BF00346742; Takai N, 2002, LIMNOL OCEANOGR, V47, P730, DOI 10.4319/lo.2002.47.3.0730; Ubertini M, 2015, J EXP MAR BIOL ECOL, V467, P52, DOI 10.1016/j.jembe.2015.02.007; Ubertini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044155; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Wainright SC, 2000, MAR ECOL PROG SER, V200, P77, DOI 10.3354/meps200077; Yang KY, 2003, MAR BIOL, V143, P245, DOI 10.1007/s00227-003-1067-y; Yokoyama H, 2007, MAR ECOL PROG SER, V346, P127, DOI 10.3354/meps07010; Yokoyama H, 2009, ESTUAR COAST SHELF S, V82, P243, DOI 10.1016/j.ecss.2009.01.010; Yoshino K, 2012, ESTUAR COAST SHELF S, V109, P138, DOI 10.1016/j.ecss.2012.05.021; You K, 2004, ACTA ECOLOGIA SINICA, V24, P1004	75	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139802	10.1371/journal.pone.0139802	http://dx.doi.org/10.1371/journal.pone.0139802			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448137	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000055
J	Li, A; Xu, XY; Zhang, H; Wang, MH				Li, Ao; Xu, Xiaoyi; Zhang, He; Wang, Minghui			Kinase Identification with Supervised Laplacian Regularized Least Squares	PLOS ONE			English	Article							PHOSPHORYLATION SITES; IMAGE CLASSIFICATION; PREDICTION; INACTIVATION; FRAMEWORK; SEQUENCE; COMPLEX	Phosphorylation is catalyzed by protein kinases and is irreplaceable in regulating biological processes. Identification of phosphorylation sites with their corresponding kinases contributes to the understanding of molecular mechanisms. Mass spectrometry analysis of phosphor-proteomes generates a large number of phosphorylated sites. However, experimental methods are costly and time-consuming, and most phosphorylation sites determined by experimental methods lack kinase information. Therefore, computational methods are urgently needed to address the kinase identification problem. To this end, we propose a new kernel-based machine learning method called Supervised Laplacian Regularized Least Squares (SLapRLS), which adopts a new method to construct kernels based on the similarity matrix and minimizes both structure risk and overall inconsistency between labels and similarities. The results predicted using both Phospho. ELM and an additional independent test dataset indicate that SLapRLS can more effectively identify kinases compared to other existing algorithms.	[Li, Ao; Xu, Xiaoyi; Zhang, He; Wang, Minghui] Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230027, Anhui, Peoples R China; [Li, Ao; Wang, Minghui] Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, MH (corresponding author), Univ Sci & Technol China, Sch Informat Sci & Technol, 443 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	mhwang@ustc.edu.cn			National Natural Science Foundation of China [61471331, 61101061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (61471331, 61101061).	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belkin M, 2006, J MACH LEARN RES, V7, P2399; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Fan WW, 2014, AMINO ACIDS, V46, P1069, DOI 10.1007/s00726-014-1669-3; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Gomez-Chova L, 2008, IEEE GEOSCI REMOTE S, V5, P336, DOI 10.1109/LGRS.2008.916070; Kadri H., 2013, ARXIV13012655; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Lu F, 2005, P NATL ACAD SCI USA, V102, P12332, DOI 10.1073/pnas.0505411102; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mallapragada PK, 2009, IEEE T PATTERN ANAL, V31, P2000, DOI 10.1109/TPAMI.2008.235; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin Sewell, 2008, STRUCTURAL RISK MINI; Miettinen K, 2008, LECT NOTES COMPUT SC, V5252, P27, DOI 10.1007/978-3-540-88908-3_2; Newman RH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.12; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Singh CR, 2005, MOL CELL BIOL, V25, P5480, DOI 10.1128/MCB.25.13.5480-5491.2005; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Wood CD, 2009, INT J BIOL SCI, V5, P428; Wu JS, 2013, IEEE ACM T COMPUT BI, V10, P752, DOI 10.1109/TCBB.2013.75; Xu XY, 2014, MOL BIOSYST, V10, P694, DOI 10.1039/c3mb70462a; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Yang LX, 2014, IEEE GEOSCI REMOTE S, V11, P651, DOI 10.1109/LGRS.2013.2273792; Zhang P, 2004, INT C PATT RECOG, P176, DOI 10.1109/ICPR.2004.1334050	32	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139676	10.1371/journal.pone.0139676	http://dx.doi.org/10.1371/journal.pone.0139676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448296	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000045
J	Rico, Y; Morris-Pocock, J; Zigouris, J; Nocera, JJ; Kyle, CJ				Rico, Yessica; Morris-Pocock, James; Zigouris, Joanna; Nocera, Joseph J.; Kyle, Christopher J.			Lack of Spatial Immunogenetic Structure among Wolverine (Gulo gulo) Populations Suggestive of Broad Scale Balancing Selection	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-I; COPY NUMBER VARIATION; GENETIC DIVERSITY; NATURAL-SELECTION; CLIMATE-CHANGE; MICROSATELLITE LOCI; CODING DNA; DRB LOCI; VARIABILITY	Elucidating the adaptive genetic potential of wildlife populations to environmental selective pressures is fundamental for species conservation. Genes of the major histocompatibility complex (MHC) are highly polymorphic, and play a key role in the adaptive immune response against pathogens. MHC polymorphism has been linked to balancing selection or heterogeneous selection promoting local adaptation. However, spatial patterns of MHC polymorphism are also influenced by gene flow and drift. Wolverines are highly vagile, inhabiting varied ecoregions that include boreal forest, taiga, tundra, and high alpine ecosystems. Here, we investigated the immunogenetic variation of wolverines in Canada as a surrogate for identifying local adaptation by contrasting the genetic structure at MHC relative to the structure at 11 neutral microsatellites to account for gene flow and drift. Evidence of historical positive selection was detected at MHC using maximum likelihood codonbased methods. Bayesian and multivariate cluster analyses revealed weaker population genetic differentiation at MHC relative to the increasing microsatellite genetic structure towards the eastern wolverine distribution. Mantel correlations of MHC against geographical distances showed no pattern of isolation by distance (IBD: r = -0.03, p = 0.9), whereas for microsatellites we found a relatively strong and significant IBD (r = 0.54, p = 0.01). Moreover, we found a significant correlation between microsatellite allelic richness and the mean number of MHC alleles, but we did not observe low MHC diversity in small populations. Overall these results suggest that MHC polymorphism has been influenced primarily by balancing selection and to a lesser extent by neutral processes such as genetic drift, with no clear evidence for local adaptation. This study contributes to our understanding of how vulnerable populations of wolverines may respond to selective pressures across their range.	[Rico, Yessica; Morris-Pocock, James; Kyle, Christopher J.] Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada; [Rico, Yessica; Morris-Pocock, James; Kyle, Christopher J.] Trent Univ, Nat Resources DNA Profiling & Forens Ctr, Peterborough, ON K9J 7B8, Canada; [Zigouris, Joanna] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada; [Nocera, Joseph J.] Minist Nat Resources, Wildlife Res Dev Sect, Appl Res Dev Branch, Peterborough, ON, Canada	Trent University; Trent University; Trent University; Ministry of Natural Resources & Forestry; Natural Resources Canada	Rico, Y (corresponding author), Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada.	yessica.ricom@gmail.com	Rico, Yessica/S-1541-2017	Rico, Yessica/0000-0002-0468-8928; Nocera, Joseph/0000-0002-5913-8851	Ontario Ministry of Natural Resources, Species at Risk Research for Ontario [SARRFO40-13]; Natural Sciences and Engineering Research Council of Canada; Consejo Nacional de Ciencia y Tecnologia of Mexico [232411]	Ontario Ministry of Natural Resources, Species at Risk Research for Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was funded by the Ontario Ministry of Natural Resources, Species at Risk Research for Ontario (SARRFO40-13 TRENTU6; http://wwf.panda.org/who_we_are/wwf_offices/canada/index.cfm?uProjectID=CA0091) and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to C.J.K, and Consejo Nacional de Ciencia y Tecnologia of Mexico (232411; http://www.conacyt.gob.mx) to Y.R. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; ADDISON EM, 1978, CAN J ZOOL, V56, P2241, DOI 10.1139/z78-304; Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Aitken SN, 2013, ANN REV; Babik W, 2008, MOL ECOL, V17, P2339, DOI 10.1111/j.1365-294X.2008.03757.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Bourne EC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2795; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; BRYANT HN, 1987, CAN J EARTH SCI, V24, P654, DOI 10.1139/e87-063; Cegelski CC, 2006, CONSERV GENET, V7, P197, DOI 10.1007/s10592-006-9126-9; Cegelski CC, 2003, MOL ECOL, V12, P2907, DOI 10.1046/j.1365-294X.2003.01969.x; Charles A Janeway J, 2001, GARLAND SCI; Dalerum F, 2006, J ZOOL, V269, P527, DOI 10.1111/j.1469-7998.2006.00116.x; Dallas JF, 1998, MOL ECOL, V7, P1248; Davis CS, 1998, MOL ECOL, V7, P1776, DOI 10.1046/j.1365-294x.1998.00515.x; De Assuncao-Franco M, 2012, SCI REPORTS; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dubey JP, 2010, J PARASITOL, V96, P972, DOI 10.1645/GE-2412.1; Duffy AJ, 1998, ANIM GENET, V29, P63; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Ejsmond MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1662; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fleming MA, 1999, MOL ECOL, V8, P1352, DOI 10.1046/j.1365-294X.1999.00701_2.x; Flies AS, 2012, VET IMMUNOL IMMUNOP, V145, P110, DOI 10.1016/j.vetimm.2011.10.016; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hall JP, 2001, ENVIRON MONIT ASSESS, V67, P109, DOI 10.1023/A:1006433132539; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Herdegen M, 2014, J EVOLUTION BIOL, V27, P2347, DOI 10.1111/jeb.12476; Huchard E, 2013, MOL ECOL, V22, P4071, DOI 10.1111/mec.12349; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Intergovernmental Panel on Climate Change, 2014, ORG ENV, V24, P1; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamath PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050971; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kennedy LJ, 2011, INT J IMMUNOGENET, V38, P109, DOI 10.1111/j.1744-313X.2010.00973.x; Kiemnec-Tyburczy KM, 2012, HEREDITY, V109, P146, DOI 10.1038/hdy.2012.22; Kutz SJ, 2009, VET PARASITOL, V163, P217, DOI 10.1016/j.vetpar.2009.06.008; Kyle CJ, 2014, MOL ECOL, V23, P2287, DOI 10.1111/mec.12726; Kyle CJ, 2002, J MAMMAL, V83, P1141, DOI 10.1644/1545-1542(2002)083<1141:COPACP>2.0.CO;2; Kyle CJ, 2001, MOL ECOL, V10, P337, DOI 10.1046/j.1365-294x.2001.01222.x; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Lamaze FC, 2014, MOL ECOL, V23, P1730, DOI 10.1111/mec.12684; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Lighten J, 2014, MOL ECOL RESOUR, V14, P753, DOI 10.1111/1755-0998.12225; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Mikko S, 1999, IMMUNOL REV, V167, P169, DOI 10.1111/j.1600-065X.1999.tb01390.x; Mikko S, 1997, J HERED, V88, P499, DOI 10.1093/oxfordjournals.jhered.a023144; Miller HC, 2007, J HERED, V98, P666, DOI 10.1093/jhered/esm095; Miller HC, 2010, MOL ECOL, V19, P3894, DOI 10.1111/j.1365-294X.2010.04771.x; Mona S, 2008, MOL ECOL, V17, P4053, DOI 10.1111/j.1365-294X.2008.03892.x; Murray BW, 1998, IMMUNOGENETICS, V48, P242, DOI 10.1007/s002510050428; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nadachowska-Brzyska K, 2012, MOL ECOL, V21, P887, DOI 10.1111/j.1365-294X.2011.05347.x; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Niskanen AK, 2014, MOL ECOL, V23, P875, DOI 10.1111/mec.12647; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Oomen RA, 2013, MOL ECOL RESOUR, V13, P103, DOI 10.1111/1755-0998.12027; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pritchard JK, 2000, GENETICS, V155, P945; Reichard MV, 2008, PARASITOL RES, V103, P657, DOI 10.1007/s00436-008-1028-y; Rico Y, 2014, MOL ECOL, V23, P832, DOI 10.1111/mec.12639; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; Schiffers K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0083; Sepil I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-68; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Slough BG, 2007, WILDLIFE BIOL, V13, P76, DOI 10.2981/0909-6396(2007)13[76:SOTWGG]2.0.CO;2; Sommer S, 2003, MOL ECOL, V12, P2845, DOI 10.1046/j.1365-294X.2003.01906.x; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Srithayakumar V, 2014, J GEN VIROL, V95, P16, DOI 10.1099/vir.0.053942-0; Strand TM, 2012, ECOL EVOL, V2, P341, DOI 10.1002/ece3.86; Stuglik MT, 2011, MOL ECOL RESOUR, V11, P739, DOI 10.1111/j.1755-0998.2011.02997.x; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JN, 2005, CURRENT BIOL; Thoss M, 2011, MOL ECOL, V20, P1546, DOI 10.1111/j.1365-294X.2011.05009.x; Tobler M, 2014, J EVOLUTION BIOL, V27, P960, DOI 10.1111/jeb.12370; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; Version O, 2010, INTERFACE, P1; Weber DS, 2013, ANIM CONSERV, V16, P671, DOI 10.1111/acv.12045; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GM, 2000, J MAMMAL, V81, P186, DOI 10.1644/1545-1542(2000)081<0186:GVOWGG>2.0.CO;2; Worley K, 2010, MOL ECOL, V19, P3064, DOI 10.1111/j.1365-294X.2010.04724.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395; Zhao MA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-113; Zigouris J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083837; Zigouris J, 2012, CONSERV GENET, V13, P1543, DOI 10.1007/s10592-012-0399-x	110	23	23	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140170	10.1371/journal.pone.0140170	http://dx.doi.org/10.1371/journal.pone.0140170			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448462	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000101
J	Rose, E; Flanagan, SP; Jones, AG				Rose, Emily; Flanagan, Sarah P.; Jones, Adam G.			The Effects of Synthetic Estrogen Exposure on the Sexually Dimorphic Liver Transcriptome of the Sex-Role-Reversed Gulf Pipefish	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; SPOTTED SANDPIPER; SEASONAL-CHANGES; TERM EXPOSURE; WATER; MANIPULATION; EVOLUTION; SELECTION; DYNAMICS; BEHAVIOR	Species exhibiting sex-role reversal provide an unusual perspective on the evolution of sex roles and sex differences. However, the proximate effects of sex-role reversal are largely unknown. Endocrine disruptors provide an experimental mechanism to address hormonal regulation of sexually dimorphic gene expression in sex-role-reversed taxa. Here, we investigate gene expression patterns in the liver of the sex-role-reversed Gulf pipefish, because the liver is known to be sexually dimorphic and estrogen-regulated in species with conventional sex roles. Using next-generation RNA-sequencing technology (RNA-seq), we detected sexually dimorphic hepatic gene expression patterns, with a total of 482 differentially expressed genes between the sexes in Gulf pipefish. Two-thirds of these genes were over-expressed in females, and the sex-specific transcriptomes of this sex-role-reversed pipefish's liver were superficially similar to those of fishes with conventional sex-roles. We exposed females, pregnant males, and non-pregnant males to 17 alpha-ethinylestradiol (EE2) at ecologically relevant concentrations of 5ng/L and compared gene expression patterns in the livers of exposed fish to control fish. Several genes that were up-regulated in EE2exposed males relative to control males were also found to be female-biased in control animals. These genes included several of the classic estrogen biomarkers, such as vitellogenin, choriogenin, and zona pellucida. Thus, estrogen exposure induced feminization of the male liver transcriptome in a sex-role-reversed pipefish. These results suggest that the ancestral state of estrogen-regulated female reproductive physiology has been retained in all sex-role-reversed vertebrates thus far studied, despite substantial evolution of the hormonal regulation of ornamentation and mating behavior in these interesting taxa.	[Rose, Emily; Flanagan, Sarah P.; Jones, Adam G.] Texas A&M Univ, Dept Biol, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station	Rose, E (corresponding author), Texas A&M Univ, Dept Biol, 3258 TAMU, College Stn, TX 77845 USA.	erose@bio.tamu.edu	Rose, Emily/C-9116-2016; Flanagan, Sarah/I-9844-2017	Flanagan, Sarah/0000-0002-2226-4213; Rose, Emily/0000-0002-8794-1887; Jones, Adam/0000-0003-0228-7124	National Science Foundation [DEB-1119261]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation grant (DEB-1119261) awarded to Adam G. Jones.	Adkins-Regan E, 2012, GEN COMP ENDOCR, V176, P279, DOI 10.1016/j.ygcen.2011.12.040; BERGLUND A, 1993, BEHAV ECOL SOCIOBIOL, V32, P331; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; Colli-Dula RC, 2014, AQUAT TOXICOL, V156, P148, DOI 10.1016/j.aquatox.2014.08.008; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COVENS M, 1987, COMP BIOCHEM PHYS B, V88, P75, DOI 10.1016/0305-0491(87)90082-4; Dawson C.E., 1985, INDOPACIFIC PIPEFISH; Eens M, 2000, HORM BEHAV, V37, P126, DOI 10.1006/hbeh.1999.1569; Eens M, 2000, BEHAV PROCESS, V51, P135, DOI 10.1016/S0376-6357(00)00124-8; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FIVIZZANI AJ, 1986, BIOL REPROD, V35, P1195, DOI 10.1095/biolreprod35.5.1195; FIVIZZANI AJ, 1986, GEN COMP ENDOCR, V62, P137, DOI 10.1016/0016-6480(86)90102-4; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Goetz FW, 2009, PHYSIOL GENOMICS, V38, P261, DOI 10.1152/physiolgenomics.00069.2009; Goncalves D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3070; Goymann W, 2008, P ROY SOC B-BIOL SCI, V275, P1053, DOI 10.1098/rspb.2007.1707; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRATTOTREVOR CL, 1990, GEN COMP ENDOCR, V80, P407, DOI 10.1016/0016-6480(90)90190-W; Hirao J, 2011, J TOXICOL SCI, V36, P9, DOI 10.2131/jts.36.9; Hoffmann JL, 2006, AQUAT TOXICOL, V79, P233, DOI 10.1016/j.aquatox.2006.06.009; JOHNS JERRY E., 1964, CONDOR, V66, P449, DOI 10.2307/1365222; Jones AG, 2001, P ROY SOC B-BIOL SCI, V268, P2531, DOI 10.1098/rspb.2001.1841; Ketterson ED, 1999, AM NAT, V154, pS4, DOI 10.1086/303280; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Leung YF, 2005, ZEBRAFISH, V2, P269, DOI 10.1089/zeb.2005.2.269; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Muck C, 2011, BEHAV ECOL, V22, P1312, DOI 10.1093/beheco/arr133; Murata K, 1997, P NATL ACAD SCI USA, V94, P2050, DOI 10.1073/pnas.94.5.2050; Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209; Norris D. O., 1997, VERTEBRATE ENDOCRINO; ORING LW, 1988, GEN COMP ENDOCR, V72, P247, DOI 10.1016/0016-6480(88)90207-9; ORING LW, 1986, GEN COMP ENDOCR, V62, P394, DOI 10.1016/0016-6480(86)90049-3; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Partridge C, 2013, ETHOLOGY, V119, P692, DOI 10.1111/eth.12110; Partridge C, 2010, HORM BEHAV, V58, P800, DOI 10.1016/j.yhbeh.2010.08.002; Pojana G, 2007, ENVIRON INT, V33, P929, DOI 10.1016/j.envint.2007.05.003; R Core Team, 2013, R LANG ENV STAT COMP; Robison BD, 2008, COMP BIOCHEM PHYS D, V3, P141, DOI 10.1016/j.cbd.2008.01.001; Rose E, 2013, EVOL APPL, V6, P1160, DOI 10.1111/eva.12093; ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345; Sarria MP, 2013, J HAZARD MATER, V88, P75; Scobell SK, 2011, J FISH BIOL, V78, P1662, DOI 10.1111/j.1095-8649.2011.02994.x; Skold HN, 2008, HORM BEHAV, V54, P549, DOI 10.1016/j.yhbeh.2008.05.018; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Taboada X, 2012, GENE, V492, P250, DOI 10.1016/j.gene.2011.10.020; TATA JR, 1976, CELL, V9, P1, DOI 10.1016/0092-8674(76)90047-7; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Ueda N, 2005, B ENVIRON CONTAM TOX, V74, P1207, DOI 10.1007/s00128-005-0709-9; VINCENT A, 1992, TRENDS ECOL EVOL, V7, P237, DOI 10.1016/0169-5347(92)90052-D; Voigt C, 2007, DEV NEUROBIOL, V67, P1560, DOI 10.1002/dneu.20528; Warnes GR, 2015, GPLOTS VARIOUS R PRO; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; Zheng WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053562	62	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139401	10.1371/journal.pone.0139401	http://dx.doi.org/10.1371/journal.pone.0139401			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448558	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000025
J	Setkowicz, Z; Gazdzinska, A; Osoba, JJ; Karwowska, K; Majka, P; Orzel, J; Kossowski, B; Bogorodzki, P; Janeczko, K; Wylezol, M; Gazdzinski, SP				Setkowicz, Zuzanna; Gazdzinska, Agata; Osoba, Joanna J.; Karwowska, Karolina; Majka, Piotr; Orzel, Jaroslaw; Kossowski, Bartosz; Bogorodzki, Piotr; Janeczko, Krzysztof; Wylezol, Mariusz; Gazdzinski, Stefan P.			Does Long-Term High Fat Diet Always Lead to Smaller Hippocampi Volumes, Metabolite Concentrations, and Worse Learning and Memory? A Magnetic Resonance and Behavioral Study in Wistar Rats	PLOS ONE			English	Article							BODY-MASS INDEX; PROTEIN-INTAKE; KETOGENIC DIET; BRAIN; OBESITY; COGNITION; HEALTHY; GLUCOSE; IMPAIRS; CARBOHYDRATE	Background Obesity is a worldwide epidemic with more than 600 million affected individuals. Human studies have demonstrated some alterations in brains of otherwise healthy obese individuals and elevated risk of neurodegenerative disease of old age; these studies have also pointed to slightly diminished memory and executive functions among healthy obese individuals. Similar findings were obtained in animal models of obesity induced by high fat diet. On the other hand, low carbohydrate high fat diets are currently promoted for losing weight (e.g., Atkin's style diets). However, the long-term effects of such diets are not known. Additionally, high fat diets leading to (mild) ketonemia were shown to improve brain function in elderly humans and in some animal models. Aim To evaluate the hypothesis that long-term use of a high fat diet was associated with decreases in spatial memory, smaller hippocampi and hippocampi metabolite concentrations in Wistar rats. Methods Twenty five male Wistar rats were put on high fat diet (HFD; 60% calories from fat, 30% from carbohydrates) on their 55th day of life, while 25 control male rats (CONs) remained on chow. Adequate levels of essential nutrients were provided. Both groups underwent memory tests in 8-arm radial maze at 3rd, 6th, 9th, and 12th month. H-1 magnetic resonance spectroscopy was employed to measure concentrations of tNAA (marker of neuronal integrity) at one month and one year, whereas MRI was used to evaluate hippocampal volumes. Results Obese rats (OBRs) consumed similar amount of calories as CONs, but less proteins. However, their protein intake was within recommended amounts. Throughout the experiment OBRs had statistically higher concentrations of blood ketone bodies than CONs, but still within normal values. At post-mortem assessment, OBRs had 38% larger fat deposits than CONs (p<0.05), as evaluated by volume of epididymis fat, an acknowledged marker of fat deposits in rats. Contrary to our expectations, OBRs had better scores of memory behavioral tasks than CONs throughout the experiment. At one year, their hippocampi were by 2.6% larger than in CONs (p = 0.05), whereas concentration of tNAA was 9.8% higher (p = 0.014). Conclusion Long-term HFD in our study resulted in better memory, larger hippocampal volumes, as well as higher hippocampal metabolite concentrations, possibly due to increased levels of blood ketone bodies. The results should be interpreted with caution, as results from animal models do not necessarily directly translate in human condition.	[Setkowicz, Zuzanna; Osoba, Joanna J.; Karwowska, Karolina; Janeczko, Krzysztof] Jagiellonian Univ, Dept Neuroanat, Krakow, Poland; [Majka, Piotr] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Orzel, Jaroslaw; Kossowski, Bartosz; Bogorodzki, Piotr] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland; [Orzel, Jaroslaw; Kossowski, Bartosz; Bogorodzki, Piotr] Warsaw Univ Technol, Fac Elect & Informat Technol, Warsaw, Poland; [Gazdzinska, Agata; Wylezol, Mariusz; Gazdzinski, Stefan P.] Mil Inst Aviat Med, Warsaw, Poland	Jagiellonian University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Warsaw University of Technology; Military Institute of Aviation Medicine	Gazdzinski, SP (corresponding author), Mil Inst Aviat Med, Warsaw, Poland.	sgazdzin@wiml.waw.pl	Majka, Piotr/P-9741-2016; Gaździńska, Agata/GZM-2291-2022	Majka, Piotr/0000-0002-9055-8686; Gaździńska, Agata/0000-0001-9910-3445; Setkowicz, Zuzanna/0000-0002-7213-8194; Kossowski, Bartosz/0000-0002-4240-3452; Gazdzinski, Stefan/0000-0003-0740-8765; Bogorodzki, Piotr/0000-0001-6596-5274; Janeczko, Krzysztof/0000-0002-9544-918X	Polish National Science Centre [2011/03/B/NZ4/03771]	Polish National Science Centre	The study was funded by the Polish National Science Centre under grant no 2011/03/B/NZ4/03771 to Stefan P. Gazdzinski.	Auer MK, 2015, J CEREBR BLOOD F MET, V35, P554, DOI 10.1038/jcbfm.2014.231; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bauer L, 2010, AM J ADDICTION, V19, P391, DOI 10.1111/j.1521-0391.2010.00069.x; Beilharz JE, 2014, BRAIN BEHAV IMMUN, V37, P134, DOI 10.1016/j.bbi.2013.11.016; Bielohuby M, 2011, AM J PHYSIOL-ENDOC M, V300, pE65, DOI 10.1152/ajpendo.00478.2010; Courchesne-Loyer A, 2013, NUTRITION, V29, P635, DOI 10.1016/j.nut.2012.09.009; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; DYERBERG J, 1977, DAN MED BULL, V24, P52; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Freeman LR, 2014, NUTR NEUROSCI, V17, P241, DOI 10.1179/1476830513Y.0000000092; Gazdzinski S, 2008, ANN NEUROL, V63, P652, DOI 10.1002/ana.21377; Gazdzinski S, 2010, OBESITY, V18, P743, DOI 10.1038/oby.2009.325; Gillette-Guyonnet S, 2013, BRIT J CLIN PHARMACO, V75, P738, DOI 10.1111/bcp.12058; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Greenwood CE, 2001, NEUROBIOL LEARN MEM, V75, P179, DOI 10.1006/nlme.2000.3964; Grieb P, 2008, NUTR RES, V28, P825, DOI 10.1016/j.nutres.2008.09.011; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742; Gzielo-Jurek K, 2014, 12 INT S MOL BAS PAT, P332, DOI [10.5114/fn.2014.45656, DOI 10.5114/FN.2014.45656]; Hallbook T, 2012, EPILEPSY RES, V100, P304, DOI 10.1016/j.eplepsyres.2011.04.017; Hayes AW., 2007, PRINCIPLES METHODS T, V5th, DOI DOI 10.1093/nar/gkw124; Imai E, 2014, J AM GERIATR SOC, V62, P426, DOI 10.1111/jgs.12690; Iritani N, 1996, J BIOCHEM, V120, P242, DOI 10.1093/oxfordjournals.jbchem.a021405; Jeppesen C, 2014, PUBLIC HEALTH NUTR, V17, P462, DOI 10.1017/S136898001300013X; Jurdak N, 2009, PHYSIOL BEHAV, V96, P1, DOI 10.1016/j.physbeh.2008.07.023; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Merchant AT, 2005, J NUTR, V135, P1196; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morris MC, 2014, NEUROBIOL AGING, V35, pS59, DOI 10.1016/j.neurobiolaging.2014.03.038; Morten Scheibye-Knudsen SJM, 2014, CELL METAB, V20, P16; Munch-Andersen T, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.17342; Pancani T, 2013, NEUROBIOL AGING, V34, P1977, DOI 10.1016/j.neurobiolaging.2013.02.019; Patten AR, 2013, NEUROSCIENCE, V254, P173, DOI 10.1016/j.neuroscience.2013.09.024; Pecoraro N, 2006, PHYSIOL BEHAV, V89, P598, DOI 10.1016/j.physbeh.2006.07.019; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Ross B, 2011, CURR TOP MED CHEM, V11, P93, DOI 10.2174/156802611793611850; Roy M, 2012, BRAIN RES, V1488, P14, DOI 10.1016/j.brainres.2012.10.008; Sabia S, 2009, AM J CLIN NUTR, V89, P601, DOI 10.3945/ajcn.2008.26482; Stanek KM, 2013, NEUROPSYCHOLOGY, V27, P141, DOI 10.1037/a0031988; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Valdes-Hernandez Pedro Antonio, 2011, Front Neuroinform, V5, P26, DOI 10.3389/fninf.2011.00026; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Westerterp-Plantenga MS, 2008, REGUL PEPTIDES, V149, P67, DOI 10.1016/j.regpep.2007.08.026; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Wijtenburg SA, 2013, J MAGN RESON IMAGING, V38, P460, DOI 10.1002/jmri.23997; Winocur G, 2005, NEUROBIOL AGING, V26, pS46, DOI 10.1016/j.neurobiolaging.2005.09.003; Winocur G, 1999, BEHAV BRAIN RES, V101, P153, DOI 10.1016/S0166-4328(98)00147-8; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	54	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139987	10.1371/journal.pone.0139987	http://dx.doi.org/10.1371/journal.pone.0139987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447788	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000074
J	da Rocha, AL; Pereira, BC; Pauli, JR; Cintra, DE; de Souza, CT; Ropelle, ER; da Silva, ASR				da Rocha, Alisson L.; Pereira, Bruno C.; Pauli, Jose R.; Cintra, Dennys E.; de Souza, Claudio T.; Ropelle, Eduardo R.; da Silva, Adelino S. R.			Downhill Running-Based Overtraining Protocol Improves Hepatic Insulin Signaling Pathway without Concomitant Decrease of Inflammatory Proteins	PLOS ONE			English	Article							MUSCLE GLYCOGEN-SYNTHASE; ECCENTRIC EXERCISE LEADS; INDUCED OBESE MICE; BRAIN IL-1-BETA; KINASE-ACTIVITY; LIVER; PERFORMANCE; RESISTANCE; RATS; GLUCONEOGENESIS	The purpose of this study was to verify the effects of overtraining (OT) on insulin, inflammatory and gluconeogenesis signaling pathways in the livers of mice. Rodents were divided into control (CT), overtrained by downhill running (OTR/down), overtrained by uphill running (OTR/up) and overtrained by running without inclination (OTR). Rotarod, incremental load, exhaustive and grip force tests were used to evaluate performance. Thirty-six hours after a grip force test, the livers were extracted for subsequent protein analyses. The phosphorylation of insulin receptor beta (pIRbeta), glycogen synthase kinase 3 beta (pGSK3beta) and forkhead box O1 (pFoxo1) increased in OTR/down versus CT. pGSK3beta was higher in OTR/up versus CT, and pFoxo1 was higher in OTR/up and OTR versus CT. Phosphorylation of protein kinase B (pAkt) and insulin receptor substrate 1 (pIRS-1) were higher in OTR/up versus CT and OTR/down. The phosphorylation of I kappa B kinase alpha and beta (pIK-Kalpha/beta) was higher in all OT protocols versus CT, and the phosphorylation of stress-activated protein kinases/Jun amino-terminal kinases (pSAPK-JNK) was higher in OTR/ down versus CT. Protein levels of peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) and hepatocyte nuclear factor 4alpha (HNF-4alpha) were higher in OTR versus CT. In summary, OTR/down improved the major proteins of insulin signaling pathway but up-regulated TRB3, an Akt inhibitor, and its association with Akt.	[da Rocha, Alisson L.; Pereira, Bruno C.; da Silva, Adelino S. R.] Univ Sao Paulo, RibeiraoPreto Med Sch, Postgrad Program Rehabil & Funct Performance, BR-09500900 Sao Paulo, Brazil; [Pauli, Jose R.; Cintra, Dennys E.; Ropelle, Eduardo R.] Univ Estadual Campinas, Fac Sci Appl, Sport Sci Course, Sao Paulo, Brazil; [de Souza, Claudio T.] Univ Far Southern Santa Catarina, Hlth Sci Unit, Postgrad Program Hlth Sci, Exercise Biochem & Physiol Lab, Criciuma, SC, Brazil; [da Silva, Adelino S. R.] Univ Sao Paulo, Sch Phys Educ & Sport RibeiraoPreto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	da Silva, ASR (corresponding author), Univ Sao Paulo, RibeiraoPreto Med Sch, Postgrad Program Rehabil & Funct Performance, BR-09500900 Sao Paulo, Brazil.	adelinosanchez@usp.br	Pauli, José Rdrigo/AAD-2763-2021; Silva, Adelino/P-3400-2019; da Rocha, Alisson Luiz/P-6901-2017; Silva, Adelino/J-7379-2013; Ropelle, Eduardo R/C-3977-2012	Pauli, José Rdrigo/0000-0002-6129-1521; Silva, Adelino/0000-0002-9679-8357; da Rocha, Alisson Luiz/0000-0002-4133-8353; Silva, Adelino/0000-0002-9679-8357; Ropelle, Eduardo R/0000-0003-1655-9557; Pereira, Bruno/0000-0001-6102-4530	Sao Paulo Research Foundation [2013/20591-3, 2014/25459-9, 2013/22737-5, 2013/19985-7]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation: 2013/20591-3, ASRS; Sao Paulo Research Foundation: 2014/25459-9 and 2013/22737-5, ALR; and Sao Paulo Research Foundation: 2013/19985-7, BCP.	Anderson KD, 2004, EXP NEUROL, V190, P184, DOI 10.1016/j.expneurol.2004.06.029; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Brun JF, 2001, DIABETES METAB, V27, P92; Carmichael MD, 2006, AM J PHYSIOL-REG I, V291, pR1344, DOI 10.1152/ajpregu.00141.2006; Carmichael MD, 2005, BRAIN BEHAV IMMUN, V19, P445, DOI 10.1016/j.bbi.2005.03.012; CASTON J, 1995, NEUROBIOL LEARN MEM, V64, P195, DOI 10.1006/nlme.1995.0002; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Cornachione A, 2011, ACTA HISTOCHEM, V113, P277, DOI 10.1016/j.acthis.2009.10.009; DONOVAN CM, 1990, AM J PHYSIOL, V258, pR770, DOI 10.1152/ajpregu.1990.258.3.R770; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Dubois M GK, 1956, ANAL CHEM, V28, P6; Garcia-Valles Rebeca, 2013, Longev Healthspan, V2, P14, DOI 10.1186/2046-2395-2-14; Haase TN, 2011, AM J PHYSIOL-REG I, V301, pR1501, DOI 10.1152/ajpregu.00775.2010; Halson SL, 2004, SPORTS MED, V34, P967, DOI 10.2165/00007256-200434140-00003; Hody S, 2013, MED SCI SPORT EXER, V45, P1460, DOI 10.1249/MSS.0b013e3182894a33; Hohl R, 2009, MED SCI SPORT EXER, V41, P1155, DOI 10.1249/MSS.0b013e318191259c; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huang TY, 2012, J APPL PHYSIOL, V113, P889, DOI 10.1152/japplphysiol.01363.2011; Kiraly MA, 2010, AM J PHYSIOL-ENDOC M, V298, pE671, DOI 10.1152/ajpendo.90575.2008; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lalli CA, 2008, METABOLISM, V57, P57, DOI 10.1016/j.metabol.2007.07.021; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Marinho R, 2012, J CELL PHYSIOL, V227, P2917, DOI 10.1002/jcp.23037; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pereira BC, 2015, INT J SPORTS MED, V36, P378, DOI 10.1055/s-0034-1395589; Pereira BC, 2014, INT J SPORTS MED, V35, P139, DOI 10.1055/s-0033-1349077; Pereira BC, 2014, MED SCI SPORT EXER, V46, P686, DOI 10.1249/MSS.0000000000000149; Pereira BC, 2012, CLIN EXP PHARMACOL P, V39, P793, DOI 10.1111/j.1440-1681.2012.05728.x; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Radziuk J, 2001, DIABETES-METAB RES, V17, P250, DOI 10.1002/dmrr.217; Rajan MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059725; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Pauli LSS, 2014, J PHYSIOL-LONDON, V592, P1325, DOI 10.1113/jphysiol.2013.264002; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	41	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140020	10.1371/journal.pone.0140020	http://dx.doi.org/10.1371/journal.pone.0140020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445495	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600126
J	Khurana, T; Dobrovolskaia, E; Shartouny, JR; Slater, JE				Khurana, Taruna; Dobrovolskaia, Ekaterina; Shartouny, Jessica R.; Slater, Jay E.			Multiplex Assay for Protein Profiling and Potency Measurement of German Cockroach Allergen Extracts	PLOS ONE			English	Article							DIAGNOSIS; CHILDREN; SYSTEM; ASTHMA	Background German cockroach (GCr) allergens induce IgE responses and may cause asthma. Commercial GCr allergen extracts are variable and existing assays may not be appropriate for determining extract composition and potency. Objective Our aim was to develop a multiplex antibody/bead-based assay for assessment of GCr allergen extracts. Methods Single chain fragment variable (scFv) antibodies against GCr were obtained by screening libraries derived from naive human lymphocytes and hyperimmunized chicken splenocytes and bone marrow. Selected clones were sequenced and characterized by immunoblotting. Eighteen scFv antibodies (17 chicken, 1 human) coupled to polystyrene beads were used in this suspension assay; binding of targeted GCr allergens to antibody-coated beads was detected using rabbit antisera against GCr, and against specific allergens rBla g 1, rBla g 2, and rBla g 4. The assay was tested for specificity, accuracy, and precision. Extracts were also compared by IgE competition ELISA. Results Chicken scFv's generated eight different binding patterns to GCr proteins from 14 to 150 kDa molecular weight. Human scFv's recognized a 100 kDa GCr protein. The multiplex assay was found to be specific and reproducible with intra-assay coefficient of variation (CV) of 2.64% and inter-assay CV of 10.0%. Overall potencies of various GCr extracts were calculated using mean logEC50s for eight selected scFvs. Overall potency measures were also analyzed by assessing the contributions to potency of each target. Conclusions An scFv antibody-based multiplex assay has been developed capable of simultaneously measuring different proteins in a complex mixture, and to determine the potencies and compositions of allergen extracts.	[Khurana, Taruna; Dobrovolskaia, Ekaterina; Shartouny, Jessica R.; Slater, Jay E.] US FDA, Lab Immunobiochem, Div Bacterial Parasit & Allergen Prod, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Slater, JE (corresponding author), US FDA, Lab Immunobiochem, Div Bacterial Parasit & Allergen Prod, Silver Spring, MD 20993 USA.	jay.slater@fda.hhs.gov			intramural FDA	intramural FDA	All work was funded by intramural FDA research support.	Chuang JG, 2010, PROTEOMICS, V10, P3854, DOI 10.1002/pmic.201000348; deVore NC, 2010, ANN ALLERG ASTHMA IM, V105, P351, DOI 10.1016/j.anai.2010.09.026; Dobrovolskaia E, 2006, CLIN EXP ALLERGY, V36, P525, DOI 10.1111/j.1365-2222.2006.02466.x; Finlay WJJ, 2005, CLIN EXP ALLERGY, V35, P1040, DOI 10.1111/j.1365-2222.2005.02307.x; Jeong KY, 2013, INT ARCH ALLERGY IMM, V161, P315, DOI 10.1159/000347034; Khurana T, 2011, ARB P EHRLICH I BUND, V97, P37; Khurana T, 2014, ANN ALLERG ASTHMA IM, V112, P140, DOI 10.1016/j.anai.2013.11.007; Londres MI, 2011, CLIN LAB, V57, P969; Lorenz AR, 2008, INT ARCH ALLERGY IMM, V147, P263, DOI 10.1159/000146074; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Morrow KS, 2001, CLIN REV ALLERG IMMU, V21, P141, DOI 10.1385/CRIAI:21:2-3:141; Patterson ML, 2002, CLIN EXP ALLERGY, V32, P721, DOI 10.1046/j.1365-2222.2002.01397.x; Pomes A, 2014, METHODS, V66, P75, DOI 10.1016/j.ymeth.2013.07.036; Rabin RL, 2014, ALLERGENS AND ALLERGEN IMMUNOTHERAPY: SUBCUTANEOUS, SUBLINGUAL,AND ORAL, 5TH EDITION, P281; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Slater JE, 2007, CLIN EXP ALLERGY, V37, P1033, DOI 10.1111/j.1365-2222.2007.02751.x; Slater JE, 2005, DEV BIOLOGICALS, V122, P145; Soldatova LN, 2000, J ALLERGY CLIN IMMUN, V105, P482, DOI 10.1067/mai.2000.104549; Wood RA, 2014, J ALLERGY CLIN IMMUN, V133, P846, DOI 10.1016/j.jaci.2013.08.047	19	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140225	10.1371/journal.pone.0140225	http://dx.doi.org/10.1371/journal.pone.0140225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444288	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600152
J	McBrayer, ZL; Dimova, J; Pisansky, MT; Sun, M; Beppu, H; Gewirtz, JC; O'Connor, MB				McBrayer, Zofeyah L.; Dimova, Jiva; Pisansky, Marc T.; Sun, Mu; Beppu, Hideyuki; Gewirtz, Jonathan C.; O'Connor, Michael B.			Forebrain-Specific Loss of BMPRII in Mice Reduces Anxiety and Increases Object Exploration	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; HIPPOCAMPAL DENTATE GYRUS; ELEVATED PLUS-MAZE; MORRIS WATER MAZE; NERVOUS-SYSTEM; II RECEPTOR; EXPRESSION; ACTIVIN; SMAD4/DPC4; PATTERNS	To investigate the role of Bone Morphogenic Protein Receptor Type II (BMPRII) in learning, memory, and exploratory behavior in mice, a tissue-specific knockout of BMPRII in the post-natal hippocampus and forebrain was generated. We found that BMPRII mutant mice had normal spatial learning and memory in the Morris water maze, but showed significantly reduced swimming speeds with increased floating behavior. Further analysis using the Porsolt Swim Test to investigate behavioral despair did not reveal any differences in immobility between mutants and controls. In the Elevated Plus Maze, BMPRII mutants and Smad4 mutants showed reduced anxiety, while in exploratory tests, BMPRII mutants showed more interest in object exploration. These results suggest that loss of BMPRII in the mouse hippocampus and forebrain does not disrupt spatial learning and memory encoding, but instead impacts exploratory and anxiety-related behaviors.	[McBrayer, Zofeyah L.; Sun, Mu; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Dimova, Jiva; Pisansky, Marc T.; Gewirtz, Jonathan C.] Univ Minnesota, Dept Psychol & Neurosci, Minneapolis, MN USA; [Beppu, Hideyuki] Toyama Univ, Dept Clin & Mol Pathol, Toyama 930, Japan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Toyama	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@umn.edu	O'Connor, Michael B/C-9977-2014	O'Connor, Michael B/0000-0002-3067-5506	National Institute of General Medicine [GM095746]; National Institute of Neurological Disorders and Stroke [P30NS062158]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008471, R01GM095746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062158] Funding Source: NIH RePORTER	National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of General Medicine (GM095746; MBO) and the National Institute of Neurological Disorders and Stroke (P30NS062158).	Ageta H, 2010, LEARN MEMORY, V17, P176, DOI 10.1101/lm.16659010; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Bailey KR, 2009, FRONT NEUROSCI, P77; Bast T, 2009, PLOS BIOL, V7, P730, DOI 10.1371/journal.pbio.1000089; Bengtsson H, 1995, NEUROREPORT, V7, P113, DOI 10.1097/00001756-199512000-00027; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; Bond AM, 2014, STEM CELLS, V32, P2201, DOI 10.1002/stem.1688; Caronia G, 2010, J NEUROSCI, V30, P6291, DOI 10.1523/JNEUROSCI.0550-10.2010; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Ebendal T, 1998, J NEUROSCI RES, V51, P139, DOI 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E; Fan XT, 2003, DEV BRAIN RES, V146, P51, DOI 10.1016/j.devbrainres.2003.09.007; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Gorski JA, 2002, J NEUROSCI, V22, P6309; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Mikawa S, 2011, NEUROSCIENCE, V184, P38, DOI 10.1016/j.neuroscience.2011.03.036; Mikawa S, 2006, J COMP NEUROL, V499, P613, DOI 10.1002/cne.21125; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miyagi M, 2011, NEUROSCIENCE, V176, P93, DOI 10.1016/j.neuroscience.2010.12.027; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Powell Susan B, 2012, Curr Top Behav Neurosci, V12, P251, DOI 10.1007/7854_2011_195; Sato T, 2010, J COMP NEUROL, V518, P4513, DOI 10.1002/cne.22469; Scott IC, 2000, DEV DYNAM, V217, P449, DOI 10.1002/(SICI)1097-0177(200004)217:4<449::AID-DVDY12>3.0.CO;2-8; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Zhang DM, 1998, J NEUROSCI, V18, P3314; Zheng F, 2009, MOL PSYCHIATR, V14, P332, DOI 10.1038/sj.mp.4002131; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	50	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139860	10.1371/journal.pone.0139860	http://dx.doi.org/10.1371/journal.pone.0139860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444546	gold, Green Submitted, Green Published			2022-12-26	WOS:000362510600094
J	Mokadem, M; Zechner, JF; Uchida, A; Aguirre, V				Mokadem, Mohamad; Zechner, Juliet F.; Uchida, Aki; Aguirre, Vincent			Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice	PLOS ONE			English	Article							INTRACEREBROVENTRICULAR BOLUS INJECTION; REVERSES INSULIN-RESISTANCE; NERVOUS-SYSTEM CONTROL; ENERGY-EXPENDITURE; BARIATRIC SURGERY; SKELETAL-MUSCLE; BODY-WEIGHT; FOOD-INTAKE; MELANOCORTIN SYSTEM; MEDICAL THERAPY	Background & Aims Leptin, the protein product of the ob gene, increases energy expenditure and reduces food intake, thereby promoting weight reduction. Leptin also regulates glucose homeostasis and hepatic insulin sensitivity via hypothalamic proopiomelanocortin neurons in mice. Roux-en-Y gastric bypass (RYGB) induces weight loss that is substantial and sustained despite reducing plasma leptin levels. In addition, patients who fail to undergo diabetes remission after RYGB are hypoletinemic compared to those who do and to lean controls. We have previously demonstrated that the beneficial effects of RYGB in mice require the melanocortin-4 receptor, a downstream effector of leptin action. Based on these observations, we hypothesized that leptin is required for sustained weight reduction and improved glucose homeostasis observed after RYGB. Methods To investigate this hypothesis, we performed RYGB or sham operations on leptin-deficient ob/ob mice maintained on regular chow. To investigate whether leptin is involved in post-RYGB weight maintenance, we challenged post-surgical mice with high fat diet. Results RYGB reduced total body weight, fat and lean mass and caused reduction in calorie intake in ob/ob mice. However, it failed to improve glucose tolerance, glucose-stimulated plasma insulin, insulin tolerance, and fasting plasma insulin. High fat diet eliminated the reduction in calorie intake observed after RYGB in ob/ob mice and promoted weight regain, although not to the same extent as in sham-operated mice. We conclude that leptin is required for the effects of RYGB on glucose homeostasis but not body weight or composition in mice. Our data also suggest that leptin may play a role in post-RYGB weight maintenance.	[Mokadem, Mohamad] Univ Iowa, Roy J & Lucille A Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Mokadem, Mohamad] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, Iowa City, IA 52242 USA; [Zechner, Juliet F.; Uchida, Aki; Aguirre, Vincent] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Zechner, Juliet F.; Aguirre, Vincent] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Digest & Liver Dis, Dallas, TX 75390 USA	University of Iowa; University of Iowa; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mokadem, M (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA.	mohamad-mokadem@uiowa.edu		Mokadem, Mohamad/0000-0003-1402-580X	NIH T32 training grant [DK007745]; University of Iowa Department of Internal Medicine for research development; NIH F32 grant [DK100085, DK0073077]; UT Southwestern Department of Internal Medicine; NIH K08 award [DK091511]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007745, K08DK091511, F32DK100085] Funding Source: NIH RePORTER	NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Department of Internal Medicine for research development; NIH F32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Southwestern Department of Internal Medicine; NIH K08 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from NIH T32 training grant DK007745 (M.M.), University of Iowa Department of Internal Medicine for research development (M.M.), NIH F32 grant DK100085 and DK0073077 (A.U.), UT Southwestern Department of Internal Medicine (V.A.), and NIH K08 award DK091511 (V.A.).	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Almeida NG, 1996, AM J PHYSIOL-REG I, V271, pR1380, DOI 10.1152/ajpregu.1996.271.5.R1380; Beckman LM, 2010, J AM DIET ASSOC, V110, P571, DOI 10.1016/j.jada.2009.12.023; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Burcelin R, 1999, DIABETES, V48, P1264, DOI 10.2337/diabetes.48.6.1264; Chua SC, 1996, DIABETES, V45, P1141, DOI 10.2337/diabetes.45.8.1141; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cusin I, 1996, DIABETES, V45, P1446, DOI 10.2337/diabetes.45.10.1446; da Silva AA, 2004, HYPERTENSION, V43, P1312, DOI 10.1161/01.HYP.0000128421.23499.b9; da Silva AA, 2009, DIABETES, V58, P1749, DOI 10.2337/db08-1221; Doucet E, 2003, CLIN SCI, V105, P89, DOI 10.1042/CS20020252; Dryden S, 1999, CLIN SCI, V96, P307, DOI [10.1042/CS19980226, 10.1042/cs0960307]; Eggert DL, 2006, J ANIM SCI, V84, P276, DOI 10.2527/2006.842276x; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Faraj M, 2001, J LIPID RES, V42, P571; Fox AS, 2000, HORM BEHAV, V37, P377, DOI 10.1006/hbeh.2000.1580; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Fujikawa T, 2013, CELL METAB, V18, P431, DOI 10.1016/j.cmet.2013.08.004; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; German J, 2009, ENDOCRINOLOGY, V150, P4502, DOI 10.1210/en.2009-0445; German JP, 2011, ENDOCRINOLOGY, V152, P394, DOI 10.1210/en.2010-0890; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hao Z, 2015, INT J OBESITY, V39, P798, DOI 10.1038/ijo.2014.189; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Hirsch FF, 2012, OBES SURG, V22, P910, DOI 10.1007/s11695-012-0589-0; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Karra E, 2010, TRENDS ENDOCRIN MET, V21, P337, DOI 10.1016/j.tem.2010.01.006; Kask A, 1998, EUR J PHARMACOL, V360, P15, DOI 10.1016/S0014-2999(98)00699-2; Korner J, 2005, J CLIN ENDOCR METAB, V90, P359, DOI 10.1210/jc.2004-1076; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Meirelles K, 2009, ANN SURG, V249, P277, DOI 10.1097/SLA.0b013e3181904af0; MERCER SW, 1987, J NUTR, V117, P2147; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mokadem M, 2014, MOL METAB, V3, P191, DOI 10.1016/j.molmet.2013.11.010; Montez JM, 2005, P NATL ACAD SCI USA, V102, P2537, DOI 10.1073/pnas.0409530102; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Muzzin P, 2000, REGUL PEPTIDES, V92, P57, DOI 10.1016/S0167-0115(00)00150-6; Nguyen NT, 2011, J AM COLL SURGEONS, V213, P261, DOI 10.1016/j.jamcollsurg.2011.04.030; Odstrcil EA, 2010, AM J CLIN NUTR, V92, P704, DOI 10.3945/ajcn.2010.29870; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; PULLAR JD, 1977, BRIT J NUTR, V37, P355, DOI 10.1079/BJN19770039; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Rosenbaum M, 2003, AM J PHYSIOL-REG I, V285, pR183, DOI 10.1152/ajpregu.00474.2002; Rosenbaum M, 2002, J CLIN ENDOCR METAB, V87, P2391, DOI 10.1210/jc.87.5.2391; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Sarwer DB, 2008, SURG OBES RELAT DIS, V4, P640, DOI 10.1016/j.soard.2008.04.013; Satoh N, 1998, NEUROSCI LETT, V249, P107, DOI 10.1016/S0304-3940(98)00401-7; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shimizu H, 2014, SURG OBES RELAT DIS, V10, P29, DOI 10.1016/j.soard.2013.01.021; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P1705, DOI 10.1210/en.2008-1316; Toda C, 2009, DIABETES, V58, P2757, DOI 10.2337/db09-0638; Wang TL, 1998, PHYSIOL BEHAV, V65, P333, DOI 10.1016/S0031-9384(98)00173-5; Wolff BS, 2009, AM J PHYSIOL-GASTR L, V297, pG594, DOI 10.1152/ajpgi.00104.2009; Xu Y, 2002, J SURG RES, V107, P56, DOI [10.1006/jsre.2002.6508, 10.1016/S0022-4804(02)96508-X]; Yura S, 2008, OBESITY, V16, P1289, DOI 10.1038/oby.2008.57; Zechner JF, 2013, GASTROENTEROLOGY, V144, P580, DOI 10.1053/j.gastro.2012.11.022	66	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139960	10.1371/journal.pone.0139960	http://dx.doi.org/10.1371/journal.pone.0139960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445459	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600113
J	Resnyk, CW; Chen, CM; Huang, HZ; Wu, CH; Simon, J; Le Bihan-Duval, E; Duclos, MJ; Cogburn, LA				Resnyk, Christopher W.; Chen, Chuming; Huang, Hongzhan; Wu, Cathy H.; Simon, Jean; Le Bihan-Duval, Elisabeth; Duclos, Michel J.; Cogburn, Larry A.			RNA-Seq Analysis of Abdominal Fat in Genetically Fat and Lean Chickens Highlights a Divergence in Expression of Genes Controlling Adiposity, Hemostasis, and Lipid Metabolism	PLOS ONE			English	Article							LOCI AFFECTING FATNESS; ENDOTHELIAL GROWTH-FACTOR; RENIN-ANGIOTENSIN SYSTEM; ACTIVATED RECEPTOR-GAMMA; BINDING-PROTEIN 4; CELLS IN-VITRO; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; NITRIC-OXIDE; MELANOCORTIN RECEPTORS	Genetic selection for enhanced growth rate in meat-type chickens (Gallus domesticus) is usually accompanied by excessive adiposity, which has negative impacts on both feed efficiency and carcass quality. Enhanced visceral fatness and several unique features of avian metabolism (i.e., fasting hyperglycemia and insulin insensitivity) mimic overt symptoms of obesity and related metabolic disorders in humans. Elucidation of the genetic and endocrine factors that contribute to excessive visceral fatness in chickens could also advance our understanding of human metabolic diseases. Here, RNA sequencing was used to examine differential gene expression in abdominal fat of genetically fat and lean chickens, which exhibit a 2.8-fold divergence in visceral fatness at 7 wk. Ingenuity Pathway Analysis revealed that many of 1687 differentially expressed genes are associated with hemostasis, endocrine function and metabolic syndrome in mammals. Among the highest expressed genes in abdominal fat, across both genotypes, were 25 differentially expressed genes associated with de novo synthesis and metabolism of lipids. Over-expression of numerous adipogenic and lipogenic genes in the FL chickens suggests that in situ lipogenesis in chickens could make a more substantial contribution to expansion of visceral fat mass than previously recognized. Distinguishing features of the abdominal fat transcriptome in lean chickens were high abundance of multiple hemostatic and vasoactive factors, transporters, and ectopic expression of several hormones/receptors, which could control local vasomotor tone and proteolytic processing of adipokines, hemostatic factors and novel endocrine factors. Over-expression of several thrombogenic genes in abdominal fat of lean chickens is quite opposite to the pro-thrombotic state found in obese humans. Clearly, divergent genetic selection for an extreme (2.5-2.8-fold) difference in visceral fatness provokes a number of novel regulatory responses that govern growth and metabolism of visceral fat in this unique avian model of juvenile-onset obesity and glucose-insulin imbalance.	[Resnyk, Christopher W.; Cogburn, Larry A.] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19717 USA; [Chen, Chuming; Huang, Hongzhan; Wu, Cathy H.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE USA; [Simon, Jean; Le Bihan-Duval, Elisabeth; Duclos, Michel J.] INRA, Rech Avicoles UR83, F-37380 Nouzilly, France	University of Delaware; University of Delaware; INRAE	Cogburn, LA (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19717 USA.	cogburn@udel.edu	DUCLOS, Michel/AAQ-3957-2021; Chen, Chuming/A-7585-2009	DUCLOS, Michel/0000-0002-9305-3982; Chen, Chuming/0000-0002-7287-9013; Cogburn, Larry/0000-0003-0977-7580; Wu, Cathy/0000-0001-6379-8601	United States Department of Agriculture, Initiative for Future Agricultural and Food Systems [00-52100-9614]; Avian Biosciences Center; Core Fee Wavier from an Institutional Development Award, Network of Biomedical Research Excellence at the University of Delaware; National Science Foundation, Experimental Program to Stimulate Competitive Research/Institutional Development Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	United States Department of Agriculture, Initiative for Future Agricultural and Food Systems(United States Department of Agriculture (USDA)); Avian Biosciences Center; Core Fee Wavier from an Institutional Development Award, Network of Biomedical Research Excellence at the University of Delaware; National Science Foundation, Experimental Program to Stimulate Competitive Research/Institutional Development Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the United States Department of Agriculture, Initiative for Future Agricultural and Food Systems (http://www.csrees.usda.gov/about/offices/compprogs_ifafs.html) Animal Genome Program (Award # 00-52100-9614) to LAC and JS. Additional funding was obtained from the Avian Biosciences Center (http://ag.udel.edu/abc/index.html) and a Core Fee Wavier (to LAC) from an Institutional Development Award, Network of Biomedical Research Excellence at the University of Delaware (http://bioinformatics.udel.edu/node/107). A portion of this work was supported by the National Science Foundation, Experimental Program to Stimulate Competitive Research/Institutional Development Award (http://www.nsf.gov/od/iia/programs/epscor/nsf_oiia_epscor_index.jsp) to CHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2006, GENET SEL EVOL, V38, P297, DOI 10.1051/gse:2006005; Alemany M, 2012, FREE RADICAL BIO MED, V52, P2108, DOI 10.1016/j.freeradbiomed.2012.03.003; Allman-Farinelli MA, 2011, SEMIN THROMB HEMOST, V37, P902, DOI 10.1055/s-0031-1297369; An JJ, 2007, J BIOL CHEM, V282, P2862, DOI 10.1074/jbc.M603454200; Arciniegas E, 2004, DNA CELL BIOL, V23, P815, DOI 10.1089/1044549042729603; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Assaf S, 2004, COMP BIOCHEM PHYS B, V137, P433, DOI 10.1016/j.cbpc.2004.02.005; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Baeza E, 2015, J ANIM SCI, V93, P107, DOI 10.2527/jas.2014-8482; Baeza E, 2013, ANIMAL, V7, P965, DOI 10.1017/S1751731113000153; Baeza E, 2015, ANIMAL, P1; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Beiroa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054591; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bourneuf E, 2006, GENE, V372, P162, DOI 10.1016/j.gene.2005.12.028; BOYD TA, 1975, GEN COMP ENDOCR, V26, P243, DOI 10.1016/0016-6480(75)90141-0; Bramswig NC, 2011, DIABETES OBES METAB, V13, P13, DOI 10.1111/j.1463-1326.2011.01440.x; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Busby MA, 2013, BIOINFORMATICS, V29, P656, DOI 10.1093/bioinformatics/btt015; Byerly MS, 2010, PHYSIOL GENOMICS, V42, P157, DOI 10.1152/physiolgenomics.00029.2010; Byerly MS, 2009, AM J PHYSIOL-REG I, V296, pR1180, DOI 10.1152/ajpregu.90813.2008; Carre W, 2002, GENE, V299, P235, DOI 10.1016/S0378-1119(02)01077-6; Carre W, 2001, ANIM GENET, V32, P289, DOI 10.1046/j.1365-2052.2001.00792.x; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; Chen MH, 2013, J GASTROENTEROL, V48, P101, DOI 10.1007/s00535-012-0614-z; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cogburn LA, 2007, POULTRY SCI, V86, P2059, DOI 10.1093/ps/86.10.2059; Cogburn LA, 2003, POULTRY SCI, V82, P939, DOI 10.1093/ps/82.6.939; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Dakovic N, 2014, MOL BIOL EVOL, V31, P2637, DOI 10.1093/molbev/msu208; Daval S, 2000, GENET SEL EVOL, V32, P521, DOI 10.1051/gse:2000134; de Kreutzenberg SV, 2003, EUR HEART J, V24, P1210, DOI 10.1016/S0195-668X(03)00206-9; Dijkers PF, 2009, MOL BIOL CELL, V20, P4083, DOI 10.1091/mbc.E09-05-0362; Dodgson JB, 2007, POULTRY SCI, V86, P1453, DOI 10.1093/ps/86.7.1453; Duan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059636; Faber DR, 2009, OBES REV, V10, P554, DOI 10.1111/j.1467-789X.2009.00593.x; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Friedman-Einat M, 2014, ENDOCRINOLOGY, V155, P3376, DOI 10.1210/en.2014-1273; GERAERT PA, 1987, REPROD NUTR DEV, V27, P1041, DOI 10.1051/rnd:19870807; GERAERT PA, 1988, J NUTR, V118, P1232, DOI 10.1093/jn/118.10.1232; Gondret F, 2001, J LIPID RES, V42, P106; GOODRIDGE AG, 1967, AM J PHYSIOL, V213, P245, DOI 10.1152/ajplegacy.1967.213.1.245; GRIFFIN HD, 1992, J NUTR, V122, P363, DOI 10.1093/jn/122.2.363; HAZELWOOD RL, 1959, AM J PHYSIOL, V197, P47, DOI 10.1152/ajplegacy.1959.197.1.47; HERMIER D, 1991, REPROD NUTR DEV, V31, P419, DOI 10.1051/rnd:19910408; HERMIER D, 1989, J NUTR, V119, P1369, DOI 10.1093/jn/119.10.1369; HERMIER D, 1984, J NUTR, V114, P1112, DOI 10.1093/jn/114.6.1112; Huang HZ, 2011, BIOINFORMATICS, V27, P1190, DOI 10.1093/bioinformatics/btr101; Ikeobi CON, 2002, ANIM GENET, V33, P428, DOI 10.1046/j.1365-2052.2002.00911.x; Insenser M, 2012, MOL CELL ENDOCRINOL, V363, P10, DOI 10.1016/j.mce.2012.07.001; Jennen DGJ, 2004, POULTRY SCI, V83, P295, DOI 10.1093/ps/83.3.295; Ji B, 2014, PHYSIOL GENOMICS, V46, P315, DOI 10.1152/physiolgenomics.00163.2013; Ji B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-441; Johnsen IK, 2009, CANCER RES, V69, P5784, DOI 10.1158/0008-5472.CAN-08-4428; Kajimoto K, 2012, ENDOCRINOLOGY, V153, P5629, DOI 10.1210/en.2012-1456; Kalupahana NS, 2012, CRIT REV BIOCHEM MOL, V47, P379, DOI 10.3109/10409238.2012.694843; Kim K, 2008, INT J OBESITY, V32, P1395, DOI 10.1038/ijo.2008.106; Kim S, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/27012; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Kukreja RC, 2012, J AM COLL CARDIOL, V59, P1921, DOI 10.1016/j.jacc.2011.09.086; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Le Mignon G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-575; LECLERCQ B, 1980, BRIT POULTRY SCI, V21, P107, DOI 10.1080/00071668008416644; LECLERCQ B, 1984, REPROD NUTR DEV, V24, P53, DOI 10.1051/rnd:19840106; LECLERCQ B, 1989, GENET SEL EVOL, V21, P69, DOI 10.1051/gse:19890106; LEVEILLE GA, 1968, P SOC EXP BIOL MED, V128, P398; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li Y, 2012, TOXICOLOGY, V297, P68, DOI 10.1016/j.tox.2012.04.004; Liu H, 2012, PROTEOMICS, V12, P269, DOI 10.1002/pmic.201100127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzet R, 2012, THROMB RES, V129, P285, DOI 10.1016/j.thromres.2011.10.021; Lugnier C, 2011, CURR OPIN PHARMACOL, V11, P698, DOI 10.1016/j.coph.2011.09.012; Matias I, 2006, PROSTAG LEUKOTR ESS, V75, P413, DOI 10.1016/j.plefa.2006.08.002; Matsumoto Y, 2006, LEARN MEMORY, V13, P35, DOI 10.1101/lm.130506; MCCUMBEE WD, 1977, GEN COMP ENDOCR, V33, P518, DOI 10.1016/0016-6480(77)90111-3; McInnes KJ, 2012, DIABETES, V61, P1072, DOI 10.2337/db11-1136; Mignon GL, 2008, ANIM GENET, V40, P157; Mitra MS, 2013, P NATL ACAD SCI USA, V110, P642, DOI 10.1073/pnas.1213493110; Mutryn MF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1623-0; Naukkarinen J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000976; OHEA EK, 1968, COMP BIOCHEM PHYSIOL, V26, P111, DOI 10.1016/0010-406X(68)90317-4; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Page CP, 2012, CURR OPIN PHARMACOL, V12, P275, DOI 10.1016/j.coph.2012.02.016; Park WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028186; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Pitel F, 2010, GEN COMP ENDOCR, V167, P1, DOI 10.1016/j.ygcen.2009.10.006; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rao LVM, 2014, BLOOD, V124, P1553, DOI 10.1182/blood-2014-05-578328; RASTOGI KS, 1990, ENDOCRINOLOGY, V126, P1096, DOI 10.1210/endo-126-2-1096; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Resnyk CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-557; Richards MP, 2008, GEN COMP ENDOCR, V156, P323, DOI 10.1016/j.ygcen.2008.01.014; Richards MP, 2009, GEN COMP ENDOCR, V163, P39, DOI 10.1016/j.ygcen.2008.09.010; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Roux PF, 2015, G3 GENES GENOMES GEN; Roux PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111299; SAADOUN A, 1987, J NUTR, V117, P428, DOI 10.1093/jn/117.3.428; SAADOUN A, 1987, BRIT POULTRY SCI, V28, P519, DOI 10.1080/00071668708416985; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Sanchez E, 2009, J EXP BIOL, V212, P3901, DOI 10.1242/jeb.035121; Schafer K, 2011, CLIN EXP PHARMACOL P, V38, P864, DOI 10.1111/j.1440-1681.2011.05589.x; Schioth HB, 2003, GENOMICS, V81, P504, DOI 10.1016/S0888-7543(03)00028-4; SIMON J, 1982, J NUTR, V112, P1961, DOI 10.1093/jn/112.10.1961; SIMON J, 1989, Critical Reviews in Poultry Biology, V2, P121; Souza SC, 2011, BIOCHEM BIOPH RES CO, V410, P398, DOI 10.1016/j.bbrc.2011.05.143; Stelmanska E, 2012, J STEROID BIOCHEM, V132, P160, DOI 10.1016/j.jsbmb.2012.05.005; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Strande JL, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-4; STROSSER MT, 1983, BIOCHIM BIOPHYS ACTA, V763, P191, DOI 10.1016/0167-4889(83)90044-7; Sun B, 2012, CYTOKINE, V59, P131, DOI 10.1016/j.cyto.2012.03.030; Thatcher S, 2009, MOL CELL ENDOCRINOL, V302, P111, DOI 10.1016/j.mce.2009.01.019; Touchburn S, 1981, J NUTR, V325, P335; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waddleton D, 2008, BIOCHEM PHARMACOL, V76, P884, DOI 10.1016/j.bcp.2008.07.025; Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193; Wang HB, 2006, J BIOSCIENCES, V31, P565, DOI 10.1007/BF02708408; Wang XK, 2012, ANIMAL, V6, P1897, DOI 10.1017/S1751731112001358; Yue JTY, 2012, DIABETES, V61, P197, DOI 10.2337/db11-0690; Zhang PX, 2012, J BIOL CHEM, V287, P3485, DOI 10.1074/jbc.M111.296681; Zhang W, 2015, COMP BIOCHEM PHYS A, V181, P62, DOI 10.1016/j.cbpa.2014.11.012; Zhang W, 2013, PHYSIOL GENOMICS, V45, P1084, DOI 10.1152/physiolgenomics.00102.2013; Zhang ZW, 2014, J ANIM SCI, V92, P4797, DOI 10.2527/jas.2014-7997; Zhou SL, 2012, GENET MOL RES, V11, P1254, DOI 10.4238/2012.May.9.4; Ziche M, 2000, J NEURO-ONCOL, V50, P139, DOI 10.1023/A:1006431309841	127	38	40	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139549	10.1371/journal.pone.0139549	http://dx.doi.org/10.1371/journal.pone.0139549			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445145	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600062
J	Lin, KY; Ye, H; Han, BW; Wang, WT; Wei, PP; He, B; Li, XJ; Chen, YQ				Lin, K-Y; Ye, H.; Han, B-W; Wang, W-T; Wei, P-P; He, B.; Li, X-J; Chen, Y-Q			Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NECROSIS-FACTOR-ALPHA; CELL-DIFFERENTIATION; SIGNAL TRANSDUCER; IN-VITRO; CANCER; STAT3; GROWTH; EXPRESSION; INTERLEUKIN-6	Cholangiocarcinoma (CCA), which is a poor prognosis malignancy that arises from the malignant transformation of cholangiocytes, is associated with chronic inflammation of the biliary epithelium. Thus far, the molecular mechanisms of the origin and neoplastic processes of CCA that are promoted by inflammation are still unclear and need to be fully elucidated. Here using small RNA sequencing to determine the microRNA (miRNA) expression profiles in CCA, we found that let-7c, miR-99a and miR-125b, which are three miRNAs of the same cluster, were downregulated in CCA and targeted interleukin 6 (IL-6), IL-6R and type 1 insulin-like growth factor, which are important cytokines and receptors of the IL-6/signal transducer and activator 3 (STAT3) pathway and have key roles in inflammation and CCA initiation. We also found that enforced expression of let-7c, miR-99a or miR-125b could reduce the activity of STAT3 and further suppress CCA tumorigenicity in vivo and inhibit the migration and invasion of CCA cells in vitro. Surprisingly, let-7c/miR-99a/miR-125b cluster also significantly decreased the ability of CCA cells for cancer stem cell-like mammosphere generation by downregulating CD133 and CD44, which suggests the pivotal roles of let-7c, miR-99a and miR-125b in CCA by regulating both inflammation and stem-like properties. Our findings showed potential links between miRNAs and inflammation, and provide a potential treatment strategy for developing an miRNA-based therapy via IL-6/STAT3 targeting for CCA.	[Lin, K-Y; Han, B-W; Wang, W-T; Wei, P-P; Li, X-J; Chen, Y-Q] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Key Lab Gene Engn,Minist Engn, Guangzhou, Guangdong, Peoples R China; [Ye, H.; He, B.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary, Guangzhou, Guangdong, Peoples R China; [Ye, H.; He, B.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, YQ (corresponding author), Sun Yat Sen Univ, Biotechnol Res Ctr, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.	lsscyq@mail.sysu.edu.cn	Lin, Kangyu/I-8050-2016	Lin, Kangyu/0000-0003-0140-2557; Wang, Wen-Tao/0000-0003-3913-4455	National Science and Technology Department [973, 2011CB8113015, 2011CBA0110]; National Science Foundation of China [81270629]; Guangdong Province Key Laboratory of Computational Science; Guangdong Province Computational Science Innovative Research Team; National Science Foundation of Guangdong [2014A020212135]	National Science and Technology Department; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Key Laboratory of Computational Science; Guangdong Province Computational Science Innovative Research Team; National Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by the funds from National Science and Technology Department (973, 2011CB8113015 and 2011CBA0110), National Science Foundation of China (no. 81270629) and Guangdong (2014A020212135). This work is also supported in part by the Guangdong Province Key Laboratory of Computational Science and the Guangdong Province Computational Science Innovative Research Team.	Akiyama T, 1998, HEPATO-GASTROENTEROL, V45, P665; Alvaro D, 2006, AM J PATHOL, V169, P877, DOI 10.2353/ajpath.2006.050464; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barton BE, 2004, MOL CANCER THER, V3, P1183; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Benckert C, 2003, CANCER RES, V63, P1083; Boonyanugomol W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077358; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Falamarzian A, 2014, J BIOMED MATER RES A, V102, P3216, DOI 10.1002/jbm.a.34992; Fava G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/630543; Furqan M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-90; Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Isomoto H, 2009, DIGESTION, V79, P2, DOI 10.1159/000167859; Johnson Christopher, 2012, Transl Gastrointest Cancer, V1, P58; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Kimura F, 1999, HEPATO-GASTROENTEROL, V46, P1613; Kokuryo T, 2012, J HEPATO-BIL-PAN SCI, V19, P606, DOI 10.1007/s00534-012-0542-6; Landi S, 2003, CANCER RES, V63, P3560; Lazaridis KN, 2005, GASTROENTEROLOGY, V128, P1655, DOI 10.1053/j.gastro.2005.03.040; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; Li S, 2012, CANCER RES, V72, P865, DOI 10.1158/0008-5472.CAN-11-1357; Li XJ, 2013, BRIT J CANCER, V109, P2189, DOI 10.1038/bjc.2013.562; Li Z, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-17; Lin KY, 2011, J BIOL CHEM, V286, P38253, DOI 10.1074/jbc.M111.269670; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Maione D, 1998, EMBO J, V17, P5588, DOI 10.1093/emboj/17.19.5588; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Munoz-Garrido P, 2012, WORLD J GASTROENTERO, V18, P6189, DOI 10.3748/wjg.v18.i43.6189; Park J, 1999, HEPATOLOGY, V29, P1037, DOI 10.1002/hep.510290423; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Rosen HR, 1997, DIGEST DIS SCI, V42, P1290, DOI 10.1023/A:1018822628096; Scotte M, 1991, Eur Cytokine Netw, V2, P177; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Smith AD, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0070-8; Sun D, 2014, ONCOGENE, V33, P1448, DOI 10.1038/onc.2013.77; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Sun Z, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-14; Thanan R, 2013, FREE RADICAL BIO MED, V65, P1464, DOI 10.1016/j.freeradbiomed.2013.07.034; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0086-0; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-6; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yazumi S, 2000, INT J CANCER, V86, P782; Zen Y, 2005, LAB INVEST, V85, P572, DOI 10.1038/labinvest.3700236; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006849; Zhang KZ, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-28; Zheng TS, 2014, HEPATOLOGY, V59, P935, DOI 10.1002/hep.26705; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	57	52	52	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3376	3386		10.1038/onc.2015.396	http://dx.doi.org/10.1038/onc.2015.396			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26455324	Green Published, hybrid			2022-12-26	WOS:000379270100003
J	Raddaoui, A; Simoes, AS; Baaboura, R; Felix, S; Achour, W; Ben Othman, T; Bejaoui, M; Sa-Leao, R; Ben Hassen, A				Raddaoui, Anis; Simoes, Alexandra S.; Baaboura, Rekaya; Felix, Sofia; Achour, Wafa; Ben Othman, Tarek; Bejaoui, Mohamed; Sa-Leao, Raquel; Ben Hassen, Assia			Serotype Distribution, Antibiotic Resistance and Clonality of Streptococcus pneumoniae Isolated from Immunocompromised Patients in Tunisia	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; CHILDREN; SUSCEPTIBILITY; DISEASE; CLONES; EPIDEMIOLOGY; POPULATION; EUROPE; TRENDS; 19A	Background Pneumococcal disease, a major cause of morbidity and mortality globally, has higher incidence among young children, the elderly and the immunocompromised of all ages. In Tunisia, pneumococcal conjugate vaccines (PCVs) are not included in the national immunization program. Also, few studies have described the epidemiology of S. pneumoniae in this country and, in particular, no molecular typing studies have been performed. The aim of this study was to evaluate serotype distribution, antimicrobial resistance and clonality of Streptococcus pneumoniae isolated from neutropenic patients in Tunisia. Methods Fifty-nine S. pneumoniae were isolated from infection (n = 31) and colonization (n = 28) sites of patients (children and adults) attending the National Centre of Bone Marrow Transplantation in Tunis between 2005-2011. All isolates were characterized by serotype, antimicrobial resistance pattern and multilocus sequence typing (MLST). Results The majority (66.1%) of the isolates belonged to five serotypes all included in PCVs: 6B, 9V, 14, 19F and 23F. The potential coverage of the 10-valent and 13-valent PCV was of 71.2% and 76.3% respectively. Resistance rates were very high and 69.5% of the isolates were multidrug resistant: non-susceptibility rates to penicillin, amoxicillin and cefotaxime were 66.1%, 40.7% and 27.1%, respectively; resistance rates to erythromycin, clindamycin, tetracycline, chloramphenicol and trimethoprim-sulfamethoxazole, were 69.5%, 61.0%, 37.3%, 22.0% and 67.8%, respectively. The most frequent serotypes had STs characteristic of multidrug resistant international clones known to be highly successful and important causes of pneumococcal infection: Spain 23F-ST81, France 9V/14-ST156, Spain 6B-ST90, 19F-ST320, and Portugal 19F-ST177. Conclusions The majority of S. pneumoniae strains recovered from immunocompromised patients in Tunisia are representatives of multidrug resistant pandemic clones that express serotypes targeted by PCVs. To contain the burden of pneumococcal disease and improve treatment choices among Tunisian immunocompromised patients PCVs should be offered to all of them.	[Raddaoui, Anis; Baaboura, Rekaya; Achour, Wafa; Ben Hassen, Assia] Lab Natl Bone Marrow Transplantat Ctr, Tunis, Tunisia; [Simoes, Alexandra S.; Felix, Sofia; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Mol Microbiol Human Pathogens, P-2780156 Oeiras, Portugal; [Raddaoui, Anis] Univ Carthage, Fac Sci Bizerte, Tunis, Tunisia; [Baaboura, Rekaya; Achour, Wafa; Ben Hassen, Assia] Univ Tunis El Manar, Microbiol Greffe Moelle Osseuse, UR12ES02, Tunis 2092, Tunisia; [Ben Othman, Tarek] Natl Bone Marrow Transplantat Ctr, Hematol Ward, Tunis, Tunisia; [Bejaoui, Mohamed] Natl Bone Marrow Transplantat Ctr, Pediat Immunohematol Ward, Tunis, Tunisia	Universite de Tunis-El-Manar; Centre Nationale de Greffe de la Moelle Osseuse; Universidade Nova de Lisboa; Universite de Carthage; Universite de Tunis-El-Manar; Universite de Tunis-El-Manar; Centre Nationale de Greffe de la Moelle Osseuse; Universite de Tunis-El-Manar; Centre Nationale de Greffe de la Moelle Osseuse	Sa-Leao, R (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Mol Microbiol Human Pathogens, P-2780156 Oeiras, Portugal.	rsaleao@itqb.unl.pt; assiabenhassen28@gmail.com	Simões, Alexandra S/G-4884-2013; bejaoui, mohamed/K-2679-2016; Sá-Leão, Raquel/A-9341-2011	Simões, Alexandra S/0000-0002-3234-7522; Sá-Leão, Raquel/0000-0001-9804-827X; Felix, Sofia/0000-0003-1581-6793	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/BIABEC/098289/2008, Pest-OE/EQB/LA0004/2011]; FCT [SFRH/BD/40706/2007, PD/BD/105732/2014]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by PTDC/BIABEC/098289/2008, and Pest-OE/EQB/LA0004/2011, from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. ASS and SF were supported by grants SFRH/BD/40706/2007 and PD/BD/105732/2014, respectively, from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; CASFM, 2013, REC 2013 COM ANT SOC; Charfi F, 2012, VACCINE, V30, pG18, DOI 10.1016/j.vaccine.2012.07.017; Cunha G, 2014, CLIN BIOMED RES, V34, P97; Dagan R, 2004, PNEUMOCCOCUS, P283; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; EARS, 2009, ANN REP EUR ANT RES; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Henriques-Normark B, 2008, NAT REV MICROBIOL, V6, P827, DOI 10.1038/nrmicro2011; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Klugman KP, 2002, J ANTIMICROB CHEMOTH, V50, P1, DOI 10.1093/jac/dkf500; Kumar D, 2008, BONE MARROW TRANSPL, V41, P743, DOI 10.1038/sj.bmt.1705964; Marzouk M, 2015, MICROB DRUG RESIST, V21, P85, DOI 10.1089/mdr.2014.0084; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Morrison KE, 2000, J CLIN MICROBIOL, V38, P434; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Riedel S, 2007, EUR J CLIN MICROBIOL, V26, P485, DOI 10.1007/s10096-007-0321-5; Sa-Leao R, 2000, J INFECT DIS, V182, P1153, DOI 10.1086/315813; Smaoui H, 2009, ARCH PEDIATRIE, V16, P220, DOI 10.1016/j.arcped.2008.12.015; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; STIKO, 2014, REC STAND COMM VACC; Tali-Maamar H, 2012, MED MALADIES INFECT, V42, P59, DOI 10.1016/j.medmal.2011.12.001; Varon E, 2012, MED MALADIES INFECT, V42, P361, DOI 10.1016/j.medmal.2012.04.002; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7	27	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140390	10.1371/journal.pone.0140390	http://dx.doi.org/10.1371/journal.pone.0140390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461259	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300088
J	Downing, LE; Heidker, RM; Caiozzi, GC; Wong, BS; Rodriguez, K; Del Rey, F; Ricketts, ML				Downing, Laura E.; Heidker, Rebecca M.; Caiozzi, Gianella C.; Wong, Brian S.; Rodriguez, Kelvin; Del Rey, Fernando; Ricketts, Marie-Louise			A Grape Seed Procyanidin Extract Ameliorates Fructose-Induced Hypertriglyceridemia in Rats via Enhanced Fecal Bile Acid and Cholesterol Excretion and Inhibition of Hepatic Lipogenesis	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; FARNESOID-X-RECEPTOR; LOWER TRIGLYCERIDE LEVELS; METABOLIC SYNDROME; PPAR-ALPHA; DIETARY PROANTHOCYANIDINS; TARGETED DISRUPTION; SWEETENED BEVERAGES; IN-VIVO; EXPRESSION	The objective of this study was to determine whether a grape seed procyanidin extract (GSPE) exerts a triglyceride-lowering effect in a hyperlipidemic state using the fructose-fed rat model and to elucidate the underlying molecular mechanisms. Rats were fed either a starch control diet or a diet containing 65% fructose for 8 weeks to induce hypertriglyceridemia. During the 9th week of the study, rats were maintained on their respective diet and administered vehicle or GSPE via oral gavage for 7 days. Fructose increased serum triglyceride levels by 171% after 9 weeks, compared to control, while GSPE administration attenuated this effect, resulting in a 41% decrease. GSPE inhibited hepatic lipogenesis via downregulation of sterol regulatory element binding protein 1c and stearoyl-CoA desaturase 1 in the fructose-fed animals. GSPE increased fecal bile acid and total lipid excretion, decreased serum bile acid levels and increased the expression of genes involved in cholesterol synthesis. However, bile acid biosynthetic gene expression was not increased in the presence of GSPE and fructose. Serum cholesterol levels remained constant, while hepatic cholesterol levels decreased. GSPE did not modulate expression of genes responsible for esterification or biliary export of the newly synthesized cholesterol, but did increase fecal cholesterol excretion, suggesting that in the presence of GSPE and fructose, the liver may secrete more free cholesterol into the plasma which may then be shunted to the proximal small intestine for direct basolateral to apical secretion and subsequent fecal excretion. Our results demonstrate that GSPE effectively lowers serum triglyceride levels in fructose-fed rats after one week administration. This study provides novel insight into the mechanistic actions of GSPE in treating hypertriglyceridemia and demonstrates that it targets hepatic de novo lipogenesis, bile acid homeostasis and non-biliary cholesterol excretion as important mechanisms for reducing hypertriglyceridemia and hepatic lipid accumulation in the presence of fructose.	[Downing, Laura E.; Heidker, Rebecca M.; Caiozzi, Gianella C.; Wong, Brian S.; Rodriguez, Kelvin; Del Rey, Fernando; Ricketts, Marie-Louise] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Ricketts, ML (corresponding author), Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA.	mricketts@cabnr.unr.edu		Ricketts, Marie-Louise/0000-0002-8306-7563; Heidker, Rebecca/0000-0002-8323-988X	University of Nevada Reno; USDA Hatch/Multi-State project: Beneficial and Adverse Effects of Natural Chemicals on Human Health and Food Safety [NEV 0738, W-3122]; CONICYT Bicentennial Becas-Chile Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554] Funding Source: NIH RePORTER	University of Nevada Reno; USDA Hatch/Multi-State project: Beneficial and Adverse Effects of Natural Chemicals on Human Health and Food Safety; CONICYT Bicentennial Becas-Chile Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by start-up funding from the University of Nevada Reno and USDA Hatch (NEV 0738)/Multi-State project W-3122: Beneficial and Adverse Effects of Natural Chemicals on Human Health and Food Safety (http://nimss.umd.edu/lgu_v2/homepages/home.cfm?trackID=14436) to MLR. GCC was the recipient of a CONICYT Bicentennial Becas-Chile Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila M, 2003, LIVER INT, V23, P363, DOI 10.1034/j.1478-3231.2003.00858.x; Auger C, 2004, J AGR FOOD CHEM, V52, P5297, DOI 10.1021/jf040125d; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Birjmohun RS, 2005, J AM COLL CARDIOL, V45, P185, DOI 10.1016/j.jacc.2004.10.031; Caimari A, 2013, INT J OBESITY, V37, P576, DOI 10.1038/ijo.2012.75; Chan TF, 2014, NUTRIENTS, V6, P2088, DOI 10.3390/nu6052088; Chong MFF, 2007, AM J CLIN NUTR, V85, P1511, DOI 10.1093/ajcn/85.6.1511; Clifton PM, 2004, J BIOMED BIOTECHNOL, P272, DOI 10.1155/S1110724304403088; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Del Bas JM, 2005, FASEB J, V19, P479, DOI 10.1096/fj.04-3095fje; Del Bas JM, 2008, MOL NUTR FOOD RES, V52, P1172, DOI 10.1002/mnfr.200800054; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; Enjoji M, 2010, WORLD J GASTROENTERO, V16, P800, DOI 10.3748/wjg.v16.i7.800; Fernandez A, 2008, J GASTROEN HEPATOL, V23, pS9, DOI 10.1111/j.1440-1746.2007.05280.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Houten SM, 2007, MOL ENDOCRINOL, V21, P1312, DOI 10.1210/me.2007-0113; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Kelley Glen L, 2005, Nutr Metab (Lond), V2, P18, DOI 10.1186/1743-7075-2-18; Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Del Bas JM, 2009, MOL NUTR FOOD RES, V53, P805, DOI 10.1002/mnfr.200800364; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Masterjohn C, 2013, NUTRIENTS, V5, P3311, DOI 10.3390/nu5083311; Modica Salvatore, 2011, Curr Protoc Mouse Biol, V1, P289, DOI 10.1002/9780470942390.mo100226; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; Moutzouri E, 2010, VASC HEALTH RISK MAN, V6, P525; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Osakabe N, 2013, J CLIN BIOCHEM NUTR, V52, P186, DOI 10.3164/jcbn.12-130; Quesada H, 2009, INT J OBESITY, V33, P1007, DOI 10.1038/ijo.2009.136; Quesada H, 2012, BRIT J NUTR, V108, P208, DOI 10.1017/S0007114511005472; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; REAVEN GM, 1991, AM J HYPERTENS, V4, P610, DOI 10.1093/ajh/4.7.610; Roglans N, 2002, J PHARMACOL EXP THER, V302, P232, DOI 10.1124/jpet.302.1.232; Rucker R, 2002, J NUTR, V132, P2999, DOI 10.1093/jn/131.10.2999; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stanhope KL, 2013, CURR OPIN LIPIDOL, V24, P198, DOI 10.1097/MOL.0b013e3283613bca; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; van der Velde AE, 2010, CURR OPIN LIPIDOL, V21, P167, DOI 10.1097/MOL.0b013e3283395e45; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yamakoshi J, 2002, FOOD CHEM TOXICOL, V40, P599, DOI 10.1016/S0278-6915(02)00006-6; Zern TL, 2005, J NUTR, V135, P1911, DOI 10.1093/jn/135.8.1911	58	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140267	10.1371/journal.pone.0140267	http://dx.doi.org/10.1371/journal.pone.0140267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458107	Green Published, gold, Green Submitted			2022-12-26	WOS:000362961100027
J	Lipper, CH; Paddock, ML; Onuchic, JN; Mittler, R; Nechushtai, R; Jennings, PA				Lipper, Colin H.; Paddock, Mark L.; Onuchic, Jose N.; Mittler, Ron; Nechushtai, Rachel; Jennings, Patricia A.			Cancer-Related NEET Proteins Transfer 2Fe-2S Clusters to Anamorsin, a Protein Required for Cytosolic Iron-Sulfur Cluster Biogenesis	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; DRUG TARGET MITONEET; FE-S CLUSTER; BREAST-CANCER; ENDOPLASMIC-RETICULUM; KINETIC-ANALYSIS; NAF-1; BIOSYNTHESIS; MUTATION; APOFERREDOXIN	Iron-sulfur cluster biogenesis is executed by distinct protein assembly systems. Mammals have two systems, the mitochondrial Fe-S cluster assembly system (ISC) and the cytosolic assembly system (CIA), that are connected by an unknown mechanism. The human members of the NEET family of 2Fe-2S proteins, nutrient-deprivation autophagy factor-1 (NAF-1) and mitoNEET (mNT), are located at the interface between the mitochondria and the cytosol. These proteins have been implicated in cancer cell proliferation, and they can transfer their 2Fe-2S clusters to a standard apo-acceptor protein. Here we report the first physiological 2Fe-2S cluster acceptor for both NEET proteins as human Anamorsin (also known as cytokine induced apoptosis inhibitor-1; CIAPIN-1). Anamorsin is an electron transfer protein containing two iron-sulfur cluster-binding sites that is required for cytosolic Fe-S cluster assembly. We show, using UV-Vis spectroscopy, that both NAF-1 and mNT can transfer their 2Fe-2S clusters to apo-Anamorsin with second order rate constants similar to those of other known human 2Fe-2S transfer proteins. A direct protein-protein interaction of the NEET proteins with apo-Anamorsin was detected using biolayer interferometry. Furthermore, electrospray mass spectrometry of holo-Anamorsin prepared by cluster transfer shows that it receives both of its 2Fe-2S clusters from the NEETs. We propose that mNT and NAF-1 can provide parallel routes connecting the mitochondrial ISC system and the CIA. 2Fe-2S clusters assembled in the mitochondria are received by NEET proteins and when needed transferred to Anamorsin, activating the CIA.	[Lipper, Colin H.; Paddock, Mark L.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Lipper, Colin H.; Paddock, Mark L.; Jennings, Patricia A.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; [Onuchic, Jose N.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Onuchic, Jose N.] Rice Univ, Dept Phys, Houston, TX 77005 USA; [Mittler, Ron] Univ N Texas, Dept Biol, Denton, TX 76203 USA; [Nechushtai, Rachel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	University of California System; University of California San Diego; University of California System; University of California San Diego; Rice University; Rice University; University of North Texas System; University of North Texas Denton; Hebrew University of Jerusalem	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA.	pajennings@ucsd.edu	Mittler, Ron/ABE-6496-2020		NIH [GM101467]; Israel Science Foundation [ISF 865/13]; University of North Texas College of Arts and Sciences; National Science Foundation [PHY-1427654, MCB-1214457]; Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101467] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1427654] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); University of North Texas College of Arts and Sciences; National Science Foundation(National Science Foundation (NSF)); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by NIH GM101467 awarded to PAJ, the Israel Science Foundation - ISF 865/13 awarded to RN, and funds from the University of North Texas College of Arts and Sciences awarded to RM. Work at the Center for Theoretical Biological Physics was sponsored by the National Science Foundation (Grants PHY-1427654 and MCB-1214457) and by the Cancer Prevention and Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bai F, 2015, P NATL ACAD SCI USA, V112, P3698, DOI 10.1073/pnas.1502960112; Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Chang NC, 2012, HUM MOL GENET, V21, P2277, DOI 10.1093/hmg/dds048; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2011, ACTA CRYSTALLOGR D, V67, P516, DOI 10.1107/S0907444911011577; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Fuss JO, 2015, BBA-MOL CELL RES, V1853, P1253, DOI 10.1016/j.bbamcr.2015.01.018; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; Landry AP, 2014, J BIOL CHEM, V289, P4307, DOI 10.1074/jbc.M113.542050; Li XH, 2008, CARCINOGENESIS, V29, P1587, DOI 10.1093/carcin/bgn052; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu LX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0183-5; Lu D, 2012, MOLECULES, V17, P7595, DOI 10.3390/molecules17067595; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Nechushtai R, 2012, PLANT CELL, V24, P2139, DOI 10.1105/tpc.112.097634; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Qi WB, 2011, COORDIN CHEM REV, V255, P688, DOI 10.1016/j.ccr.2010.10.016; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Taminelli GL, 2008, BIOCHEM BIOPH RES CO, V365, P856, DOI 10.1016/j.bbrc.2007.11.076; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Tamir S, 2014, ACTA CRYSTALLOGR D, V70, P1572, DOI 10.1107/S1399004714005458; Tamir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061202; Vranish JN, 2015, J AM CHEM SOC, V137, P390, DOI 10.1021/ja510998s; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429; Wu SP, 2003, BIOCHEMISTRY-US, V42, P5784, DOI 10.1021/bi026939+; Wu SP, 2002, BIOCHEMISTRY-US, V41, P8876, DOI 10.1021/bi0256781; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang Y, 2014, P NATL ACAD SCI USA, V111, pE1695, DOI 10.1073/pnas.1405204111; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	43	47	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139699	10.1371/journal.pone.0139699	http://dx.doi.org/10.1371/journal.pone.0139699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448442	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000046
J	Ayuso, JM; Basheer, HA; Monge, R; Sanchez-Alvarez, P; Doblare, M; Shnyder, SD; Vinader, V; Afarinkia, K; Fernandez, LJ; Ochoa, I				Ayuso, Jose M.; Basheer, Haneen A.; Monge, Rosa; Sanchez-Alvarez, Pablo; Doblare, Manuel; Shnyder, Steven D.; Vinader, Victoria; Afarinkia, Kamyar; Fernandez, Luis J.; Ochoa, Ignacio			Study of the Chemotactic Response of Multicellular Spheroids in a Microfluidic Device	PLOS ONE			English	Article							SU-8 BASED MICROPROBES; NEUTROPHIL RECRUITMENT; CELL-MIGRATION; CANCER; TUMOR; MECHANISMS; GRADIENTS; INVASION; CULTURE; ANGIOGENESIS	We report the first application of a microfluidic device to observe chemotactic migration in multicellular spheroids. A microfluidic device was designed comprising a central microchamber and two lateral channels through which reagents can be introduced. Multicellular spheroids were embedded in collagen and introduced to the microchamber. A gradient of fetal bovine serum (FBS) was established across the central chamber by addition of growth media containing serum into one of the lateral channels. We observe that spheroids of oral squamous carcinoma cells OSC-19 invade collectively in the direction of the gradient of FBS. This invasion is more directional and aggressive than that observed for individual cells in the same experimental setup. In contrast to spheroids of OSC-19, U87-MG multicellular spheroids migrate as individual cells. A study of the exposure of spheroids to the chemoattractant shows that the rate of diffusion into the spheroid is slow and thus, the chemoattractant wave engulfs the spheroid before diffusing through it.	[Ayuso, Jose M.; Monge, Rosa; Sanchez-Alvarez, Pablo; Doblare, Manuel; Fernandez, Luis J.; Ochoa, Ignacio] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Grp Struct Mech & Mat Modeling GEMM, Zaragoza, Spain; [Ayuso, Jose M.; Monge, Rosa; Sanchez-Alvarez, Pablo; Doblare, Manuel; Fernandez, Luis J.; Ochoa, Ignacio] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Ayuso, Jose M.; Monge, Rosa; Sanchez-Alvarez, Pablo; Doblare, Manuel; Fernandez, Luis J.; Ochoa, Ignacio] Inst Salud Carlos III, Aragon Inst Biomed Res, Madrid, Spain; [Basheer, Haneen A.; Shnyder, Steven D.; Vinader, Victoria; Afarinkia, Kamyar] Univ Bradford, Inst Canc Therapeut, Fac Life Sci, Bradford BD7 1DP, W Yorkshire, England	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Zaragoza; Instituto de Salud Carlos III; University of Bradford	Fernandez, LJ (corresponding author), Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Grp Struct Mech & Mat Modeling GEMM, Zaragoza, Spain.	luisf@unizar.es	Ochoa, Ignacio/G-8776-2015; Ayuso, Jose/AAB-2437-2020; Afarinkia, Kamyar/B-7965-2010; Fernandez Ledesma, Luis Jose/K-9090-2014	Ochoa, Ignacio/0000-0003-2410-5678; Afarinkia, Kamyar/0000-0003-2819-4364; Shnyder, Steven/0000-0002-4647-2340; Vinader, Victoria/0000-0002-7706-8586; Fernandez Ledesma, Luis Jose/0000-0001-5376-4440	National Research Program of Spain [DPI2011-28262-c04-01]; project "MICROANGIOTHECAN" (CIBER-BBN); project "MICROANGIOTHECAN" (IMIBIC); project "MICROANGIOTHECAN" (SEOM)	National Research Program of Spain; project "MICROANGIOTHECAN" (CIBER-BBN); project "MICROANGIOTHECAN" (IMIBIC); project "MICROANGIOTHECAN" (SEOM)	This work has been supported by National Research Program of Spain (DPI2011-28262-c04-01) and by the project "MICROANGIOTHECAN" (CIBER-BBN, IMIBIC and SEOM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuna A, 2013, LAB CHIP, V13, P1422, DOI 10.1039/c3lc41364k; Altuna A, 2012, BIOSENS BIOELECTRON, V37, P1, DOI 10.1016/j.bios.2012.03.039; Armour AD, 2008, TISSUE ENG PT C-METH, V14, P89, DOI 10.1089/tec.2007.0228; Ayuso JM, 2015, FRONT MATER, V2, DOI 10.3389/fmats.2015.00037; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Blanco FJ, 2004, J MICROMECH MICROENG, V14, P1047, DOI 10.1088/0960-1317/14/7/027; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Cooper Carlton R, 2004, Cancer Treat Res, V118, P291; Czirok A, 2012, BIRTH DEFECTS RES C, V96, P153, DOI 10.1002/bdrc.21010; Etienne-Manneville S, 2014, CURR OPIN CELL BIOL, V30, P51, DOI 10.1016/j.ceb.2014.06.004; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jeong GS, 2011, ANAL CHEM, V83, P8454, DOI 10.1021/ac202170e; Keenan TM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345914; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Kim C, 2015, LAB CHIP, V15, P301, DOI 10.1039/c4lc00866a; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]; Kunz-Schughart LA, 1999, CELL BIOL INT, V23, P157, DOI 10.1006/cbir.1999.0384; Li HY, 2015, TISSUE CELL, V47, P39, DOI 10.1016/j.tice.2014.10.008; Li L, 2012, CELL MOL LIFE SCI, V69, P2779, DOI 10.1007/s00018-012-0951-3; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Vinader V, 2011, J PHARMACOL TOX MET, V64, P213, DOI 10.1016/j.vascn.2011.01.004; Williams MR, 2011, TRENDS IMMUNOL, V32, P461, DOI 10.1016/j.it.2011.06.009; Wu JD, 2013, LAB CHIP, V13, P2484, DOI [10.1039/c3lc50415h, 10.1039/c31c50415h]; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; YOKOI T, 1988, Tumor Research, V23, P43; Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o; ZICHA D, 1991, J CELL SCI, V99, P769; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	44	23	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139515	10.1371/journal.pone.0139515	http://dx.doi.org/10.1371/journal.pone.0139515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444904	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600060
J	Lanzilao, L; Stefanetti, G; Saul, A; MacLennan, CA; Micoli, F; Rondini, S				Lanzilao, Luisa; Stefanetti, Giuseppe; Saul, Allan; MacLennan, Calman A.; Micoli, Francesca; Rondini, Simona			Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CHAIN-LENGTH; IMMUNOLOGICAL-PROPERTIES; SERUM RESISTANCE; LIPOPOLYSACCHARIDE; POLYSACCHARIDE; MICE; ENTERITIDIS; PROTECTION; PROTEIN	Nontyphoidal Salmonellae, principally S. Typhimurium and S. Enteritidis, are a major cause of invasive bloodstream infections in sub-Saharan Africa with no vaccine currently available. Conjugation of lipopolysaccharide O-antigen to a carrier protein constitutes a promising vaccination strategy. Here we describe a rational process to select the most appropriate isolates of Salmonella as source of O-antigen for developing a bivalent glycoconjugate vaccine. We screened a library of 30 S. Typhimurium and 21 S. Enteritidis in order to identify the most suitable strains for large scale O-antigen production and generation of conjugate vaccines. Initial screening was based on growth characteristics, safety profile of the isolates, O-antigen production, and O-antigen characteristics in terms of molecular size, O-acetylation and glucosylation level and position, as determined by phenol sulfuric assay, NMR, HPLC-SEC and HPAEC-PAD. Three animal isolates for each serovar were identified and used to synthesize candidate glycoconjugate vaccines, using CRM197 as carrier protein. The immunogenicity of these conjugates and the functional activity of the induced antibodies was investigated by ELISA, serum bactericidal assay and flow cytometry. S. Typhimurium O-antigen showed high structural diversity, including O-acetylation of rhamnose in a Malawian invasive strain generating a specific immunodominant epitope. S. Typhimurium conjugates provoked an anti-O-antigen response primarily against the O:5 determinant. O-antigen from S. Enteritidis was structurally more homogeneous than from S. Typhimurium, and no idiosyncratic antibody responses were detected for the S. Enteritidis conjugates. Of the three initially selected isolates, two S. Typhimurium (1418 and 2189) and two S. Enteritidis (502 and 618) strains generated glycoconjugates able to induce high specific antibody levels with high breadth of serovar-specific strain coverage, and were selected for use in vaccine production. The strain selection approach described is potentially applicable to the development of glycoconjugate vaccines against other bacterial pathogens.	[Lanzilao, Luisa; Stefanetti, Giuseppe; Saul, Allan; Micoli, Francesca; Rondini, Simona] Sclavo Behring Vaccines Inst Global Hlth Srl, I-53100 Siena, Italy; [MacLennan, Calman A.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford OX3 7DQ, England; [MacLennan, Calman A.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Oxford; Jenner Institute; Wellcome Trust Sanger Institute	Rondini, S (corresponding author), Sclavo Behring Vaccines Inst Global Hlth Srl, Via Fiorentina 1, I-53100 Siena, Italy.	simona.x.rondini@gsk.com	Rondini, Simona/GLN-4357-2022; MacLennan, Calman A/L-9343-2014; Saul, Allan J/I-6968-2013; Stefanetti, Giuseppe/AFD-5536-2022; Saul, Allan/ABH-2091-2020	MacLennan, Calman A/0000-0001-9694-0846; Saul, Allan J/0000-0003-0665-4091; Stefanetti, Giuseppe/0000-0002-2796-4817; Saul, Allan/0000-0003-0665-4091	European Community [251522 GENDRIVAX]; Novartis	European Community(European Commission); Novartis(Novartis)	The research leading to these results was supported in part by the European Community's Seventh Framework Programme [FP7/2007-2013] under Grant Agreement No: 251522 GENDRIVAX. During the course of the study, Luisa Lanzilao, Giuseppe Stefanetti, Allan Saul, Calman A. MacLennan, Francesca Micoli and Simona Rondini were employees of Novartis Vaccines Institute for Global Health S.r.l. at the time the study was conducted; all of the preceding listed authors, except Giuseppe Stefanetti and Calman A. MacLennan, are now employees of Sclavo Behring Vaccines Institute For Global Health S.r.l., a GSK Company, Siena, Italy. Novartis provided support in the form of salaries for the authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; Berger CN, 2011, ENVIRON MICROBIOL, V13, P1299, DOI 10.1111/j.1462-2920.2011.02429.x; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; COLWELL DE, 1984, J IMMUNOL, V133, P950; de Jong A, 2013, INT J ANTIMICROB AG, V41, P403, DOI 10.1016/j.ijantimicag.2012.11.004; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Guard-Petter J, 1999, APPL ENVIRON MICROB, V65, P2195; HELANDER IM, 1992, MOL MICROBIOL, V6, P2857, DOI 10.1111/j.1365-2958.1992.tb01465.x; HELLERQV.CG, 1969, CARBOHYD RES, V9, P237, DOI 10.1016/S0008-6215(00)82139-4; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hormaeche CE, 1996, VACCINE, V14, P251, DOI 10.1016/0264-410X(95)00249-Z; Jang H, 2008, J BIOTECHNOL, V135, P71, DOI 10.1016/j.jbiotec.2008.02.017; JOINER KA, 1986, J IMMUNOL, V136, P710; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Konadu E, 1996, INFECT IMMUN, V64, P2709, DOI 10.1128/IAI.64.7.2709-2715.1996; Konadu EY, 2000, INFECT IMMUN, V68, P1529, DOI 10.1128/IAI.68.3.1529-1534.2000; LIANGTAKASAKI CJ, 1983, INFECT IMMUN, V41, P563, DOI 10.1128/IAI.41.2.563-569.1983; Lilleengen K, 1948, ACTA PATHOL MICROB S, V77, P11, DOI DOI 10.1111/J.1699-0463.1952.TB00174.X; MacLennan CA, 2014, HUM VACC IMMUNOTHER, V10, P1478, DOI 10.4161/hv.29054; MacLennan CA, 2013, EXPERT REV ANTI-INFE, V11, P443, DOI [10.1586/ERI.13.27, 10.1586/eri.13.27]; Micoli F, 2013, ANAL BIOCHEM, V434, P136, DOI 10.1016/j.ab.2012.10.038; Micoli F, 2014, CARBOHYD RES, V385, P1, DOI 10.1016/j.carres.2013.12.003; Micoli F, 2013, P NATL ACAD SCI USA, V110, P19077, DOI 10.1073/pnas.1314476110; Micoli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047039; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nagy G, 2008, BIOL CHEM, V389, P513, DOI 10.1515/BC.2008.056; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Onsare RS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003573; Parker CT, 2001, ENVIRON MICROBIOL, V3, P332, DOI 10.1046/j.1462-2920.2001.00200.x; Ravenscroft N, 2015, CARBOHYD RES, V404, P108, DOI 10.1016/j.carres.2014.12.002; Rondini S, 2015, INFECT IMMUN, V83, P996, DOI 10.1128/IAI.03079-14; Rondini S, 2013, MICROB PATHOGENESIS, V63, P19, DOI 10.1016/j.micpath.2013.05.014; Rondini S, 2012, J INFECT DEV COUNTR, V6, P763, DOI 10.3855/jidc.2495; Rondini S, 2011, CLIN VACCINE IMMUNOL, V18, P460, DOI 10.1128/CVI.00387-10; Simon R, 2012, HUM VACC IMMUNOTHER, V8, P494, DOI 10.4161/hv.19158; Simon R, 2011, INFECT IMMUN, V79, P4240, DOI 10.1128/IAI.05484-11; SLAUCH JM, 1995, INFECT IMMUN, V63, P437, DOI 10.1128/IAI.63.2.437-441.1995; Stefanetti G, 2014, VACCINE, V32, P6122, DOI 10.1016/j.vaccine.2014.08.056; SVENSON SB, 1981, INFECT IMMUN, V32, P490, DOI 10.1128/IAI.32.2.490-496.1981; SVENSON SB, 1979, INFECT IMMUN, V25, P863, DOI 10.1128/IAI.25.3.863-872.1979; WATSON DC, 1992, INFECT IMMUN, V60, P4679, DOI 10.1128/IAI.60.11.4679-4686.1992; WOLLIN R, 1987, J BACTERIOL, V169, P1003, DOI 10.1128/jb.169.3.1003-1009.1987; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1	50	29	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139847	10.1371/journal.pone.0139847	http://dx.doi.org/10.1371/journal.pone.0139847			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445460	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600089
J	Richardson, ET; Shukla, S; Nagy, N; Boom, WH; Beck, RC; Zhou, L; Landreth, GE; Harding, CV				Richardson, Edward T.; Shukla, Supriya; Nagy, Nancy; Boom, W. Henry; Beck, Rose C.; Zhou, Lan; Landreth, Gary E.; Harding, Clifford V.			ERK Signaling Is Essential for Macrophage Development	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR-1; MOUSE BONE-MARROW; MYCOBACTERIUM-TUBERCULOSIS; IN-VIVO; PROTEIN; CELLS; MICE; PHOSPHORYLATION; DIFFERENTIATION; IDENTIFICATION	Macrophages depend on colony stimulating factor 1 (also known as M-CSF) for their growth and differentiation, but the requirements for intracellular signals that lead to macrophage differentiation and function remain unclear. M-CSF is known to activate ERK1 and ERK2, but the importance of this signaling pathway in macrophage development is unknown. In these studies, we characterized a novel model of Erk1(-/-) Erk2(flox/flox) Lyz2(Cre/Cre) mice in which the ERK2 isoform is deleted from macrophages in the background of global ERK1 deficiency. Cultures of M-CSF-stimulated bone marrow precursors from these mice yielded reduced numbers of macrophages. Whereas macrophages developing from M-CSF-stimulated bone marrow of Erk2(flox/flox) Lyz2(Cre/Cre) mice showed essentially complete loss of ERK2 expression, the reduced number of macrophages that develop from Erk1(-/-) Erk2(flox/flox) Lyz2(Cre/Cre) bone marrow show retention of ERK2 expression, indicating selective outgrowth of a small proportion of precursors in which Cre-mediated deletion failed to occur. The bone marrow of Erk1(-/-) Erk2(flox/flox) Lyz2(Cre/Cre) mice was enriched for CD11b(+) myeloid cells, CD11b(hi) Gr-1(hi) neutrophils, Lin-c-Kit(+) Sca-1(+) hematopoietic stem cells, and Lin(-) c-Kit(+) CD34(+) CD16/32(+) granulocyte-macrophage progenitors. Culture of bone marrow Lin(-) cells under myeloid-stimulating conditions yielded reduced numbers of monocytes. Collectively, these data indicate that the defect in production of macrophages is not due to a reduced number of progenitors, but rather due to reduced ability of progenitors to proliferate and produce macrophages in response to M-CSF-triggered ERK signaling. Macrophages from Erk1(-/-) Erk2(flox/flox) Lyz2(Cre/Cre) bone marrow showed reduced induction of M-CSF-regulated genes that depend on the ERK pathway for their expression. These data demonstrate that ERK1/ERK2 play a critical role in driving M-CSF-dependent proliferation of bone marrow progenitors for production of macrophages.	[Richardson, Edward T.; Shukla, Supriya; Nagy, Nancy; Beck, Rose C.; Zhou, Lan; Harding, Clifford V.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Richardson, Edward T.; Shukla, Supriya; Nagy, Nancy; Boom, W. Henry; Beck, Rose C.; Zhou, Lan; Harding, Clifford V.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Richardson, Edward T.] Case Western Reserve Univ, Med Scientist Training Program, Cleveland, OH 44106 USA; [Boom, W. Henry; Harding, Clifford V.] Case Western Reserve Univ, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Boom, W. Henry; Harding, Clifford V.] Case Western Reserve Univ, Ctr AIDS Res, Cleveland, OH 44106 USA; [Landreth, Gary E.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Harding, CV (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	cvh3@cwru.edu		Richardson, Edward/0000-0002-7576-2603; Shukla, Supriya/0000-0001-7441-6306	NIH [R01 AI034343, T32 GM007250, T32 AI089474, R01 AI027243, R01 HL103827]; Case Comprehensive Cancer Center [P30 CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474, R01AI034343, R01AI027243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 AI034343 (to CVH), T32 GM007250 (to ETR), T32 AI089474 (to ETR), R01 AI027243 (to WHB), R01 HL103827 (to LZ) and P30 CA043703 (Case Comprehensive Cancer Center). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P466, DOI 10.1016/j.imbio.2009.08.002; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Faust N, 2000, BLOOD, V96, P719; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Jack GD, 2009, BLOOD, V114, P2172, DOI 10.1182/blood-2008-11-191536; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; Nekrasova T, 2005, J IMMUNOL, V175, P2374, DOI 10.4049/jimmunol.175.4.2374; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Pfaffl MW., 2006, REAL TIME PCR, P63; Richardson ET, 2015, INFECT IMMUN, V83, P2242, DOI 10.1128/IAI.00135-15; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SKLAR MD, 1985, J CELL PHYSIOL, V125, P403, DOI 10.1002/jcp.1041250307; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100	33	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140064	10.1371/journal.pone.0140064	http://dx.doi.org/10.1371/journal.pone.0140064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445168	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600134
J	Sponaas, AM; Moharrami, NN; Feyzi, E; Standal, T; Rustad, EH; Waage, A; Sundan, A				Sponaas, Anne-Marit; Moharrami, Neda Nejati; Feyzi, Emadoldin; Standal, Therese; Rustad, Even Holth; Waage, Anders; Sundan, Anders			PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy	PLOS ONE			English	Article							MULTIPLE-MYELOMA; TLR LIGANDS; PD-L1; SUBSETS	In this study we set out to investigate whether anti PDL1 or PD-1 treatment targeting the immune system could be used against multiple myeloma. DCs are important in regulating T cell responses against tumors. We therefore determined PDL1 and PDL2 expression on DC populations in bone marrow of patients with plasma cell disorders using multicolour Flow Cytometry. We specifically looked at CD141(+) and CD141(-) myeloid and CD303(+) plasmacytoid DC. The majority of plasma cells (PC) and DC subpopulations expressed PDL1, but the proportion of positive PDL1(+) cells varied among patients. A correlation between the proportion of PDL1(+) PC and CD141(+) mDC was found, suggesting both cell types could down-regulate the anti-tumor T cell response.	[Sponaas, Anne-Marit; Moharrami, Neda Nejati; Feyzi, Emadoldin; Standal, Therese; Rustad, Even Holth; Waage, Anders; Sundan, Anders] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, KG Jebsen Ctr Myeloma Res, N-7034 Trondheim, Norway; [Moharrami, Neda Nejati; Standal, Therese; Sundan, Anders] Norwegian Univ Sci & Technol, Ctr Mol Immune Regulat, CEMIR, N-7034 Trondheim, Norway; [Feyzi, Emadoldin; Rustad, Even Holth; Waage, Anders] St Olavs Univ Hosp, Dept Hematol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Sponaas, AM (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, KG Jebsen Ctr Myeloma Res, N-7034 Trondheim, Norway.	anne-marit.sponaas@ntnu.no	Rustad, Even/T-3535-2019; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Standal, Therese/0000-0003-3314-8522; Nejati Moharrami, Neda/0000-0001-9355-0383; Rustad, Even/0000-0002-9320-4963	K.G. Jebsen Foundation for Medical Research; Cancer Society of Norway; Regional Health Research Foundation; Research Council of Norway [223255/F50]	K.G. Jebsen Foundation for Medical Research; Cancer Society of Norway; Regional Health Research Foundation; Research Council of Norway(Research Council of Norway)	The work was supported by K.G. Jebsen Foundation for Medical Research, The Cancer Society of Norway, The Regional Health Research Foundation, and The Research Council of Norway (Grant no. 223255/F50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lesokhin AM, 2014, PAT REL REFR LYMPH M; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Paiva B, 2015, LEUKEMIA, V29, P2110, DOI 10.1038/leu.2015.79; Quezada SA, 2013, BRIT J CANCER, V108, P1560, DOI 10.1038/bjc.2013.117; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Ray A, 2015, LEUKEMIA, V29, P1441, DOI 10.1038/leu.2015.11; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Tamura H, 2013, LEUKEMIA, V27, P464, DOI 10.1038/leu.2012.213; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	17	59	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139867	10.1371/journal.pone.0139867	http://dx.doi.org/10.1371/journal.pone.0139867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444869	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600096
J	Winkel, AF; Engel, CK; Margerie, D; Kannt, A; Szillat, H; Glombik, H; Kallus, C; Ruf, S; Gussregen, S; Riedel, J; Herling, AW; von Knethen, A; Weigert, A; Brune, B; Schmoll, D				Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard; Schmoll, Dieter			Characterization of RA839, a Noncovalent Small Molecule Binder to Keapl and Selective Activator of Nrf2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTION; OXIDATIVE STRESS; SYNTHETIC OLEANANE; BARDOXOLONE METHYL; RECOGNITION MODEL; KEAP1-NRF2 SYSTEM; KIDNEY-DISEASE; DLG MOTIFS; TRITERPENOIDS; INHIBITOR	The activation of the transcription factor NE-E2-related factor 2 (Nrf2) maintains cellular homeostasis in response to oxidative stress by the regulation of multiple cytoprotective genes. Without stressors, the activity of Nrf2 is inhibited by its interaction with the Keapl (kelch-like ECH-associated protein 1). Here, we describe (3S)-1-[4-[(2,3,5,6-tetramethylphenyl) sulfonylamino]-1-naphthyl] pyrrolidine-3-carboxylic acid (RA839), a small molecule that binds noncovalently to the Nrf2-interacting kelch domain of Keapl with a K-d of similar to 6 mu M, as demonstrated by x-ray co-crystallization and isothermal titration calorimetry. Whole genome DNA arrays showed that at 10 mu M RA839 significantly regulated 105 probe sets in bone marrow-derived macrophages. Canonical pathway mapping of these probe sets revealed an activation of pathways linked with Nrf2 signaling. These pathways were also activated after the activation of Nrf2 by the silencing of Keap1 expression. RA839 regulated only two genes in Nrf2 knock-out macrophages. Similar to the activation of Nrf2 by either silencing of Keap1 expression or by the reactive compound 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid methyl ester (CDDO-Me), RA839 prevented the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages. In mice, RA839 acutely induced Nrf2 target gene expression in liver. RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compound to study the biology of Nrf2.	[Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; Schmoll, Dieter] Sanofi, R&D, D-65926 Frankfurt, Germany; [Kannt, Aimo] Heidelberg Univ, Med Fac Mannheim, D-69120 Mannheim, Germany; [von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Biochem 1, D-60590 Frankfurt, Germany	Sanofi-Aventis; Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Schmoll, D (corresponding author), Sanofi, R&D, Diabet Div, Ind Pk Hoechst, D-65926 Frankfurt, Germany.	dieter.schmoll@sanofi.com	Kannt, Aimo/AAZ-6898-2020; Weigert, Andreas/E-6540-2010	Weigert, Andreas/0000-0002-7529-1952; Schmoll, Dieter/0000-0003-2578-3366; Kannt, Aimo/0000-0002-5197-2286				Anderka O, 2008, J BIOL CHEM, V283, P31333, DOI 10.1074/jbc.M805434200; Baird L, 2014, BIOTECHNOL ADV, V32, P1133, DOI 10.1016/j.biotechadv.2014.03.004; Chen H, 2014, J CLIN INVEST, V124, P2188, DOI 10.1172/JCI72151; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Gao B, 2014, CLIN PHARMACOL-ADV A, V6, P19, DOI 10.2147/CPAA.S35078; Gjyshi O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004460; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Hall ET, 2014, DIABETES, V63, P2904, DOI 10.2337/db14-0829; Halland N, 2015, J MED CHEM, V58, P4839, DOI 10.1021/jm501840b; Harris RC, 2013, AM J PHYSIOL-RENAL, V304, pF1086, DOI 10.1152/ajprenal.00693.2012; Haxaire C, 2012, AGING CELL, V11, P336, DOI 10.1111/j.1474-9726.2012.00792.x; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hu LQ, 2013, BIOORG MED CHEM LETT, V23, P3039, DOI 10.1016/j.bmcl.2013.03.013; Jiang ZY, 2014, J MED CHEM, V57, P2736, DOI 10.1021/jm5000529; Kim SW, 2013, FREE RADICAL BIO MED, V65, P468, DOI 10.1016/j.freeradbiomed.2013.07.028; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuchler L, 2014, ANTIOXID REDOX SIGN, V21, P2483, DOI 10.1089/ars.2013.5760; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Marcotte D, 2013, BIOORGAN MED CHEM, V21, P4011, DOI 10.1016/j.bmc.2013.04.019; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Qiu SL, 2014, J BIOL CHEM, V289, P9449, DOI 10.1074/jbc.M113.543447; Richter M, 2014, J TOXICOL SCI, V39, P353, DOI 10.2131/jts.39.353; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; To C, 2010, J BIOL CHEM, V285, P27944, DOI 10.1074/jbc.M110.103036; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tran QT, 2009, CARCINOGENESIS, V30, P480, DOI 10.1093/carcin/bgn292; Weerachayaphorn J, 2014, J HEPATOL, V60, P160, DOI 10.1016/j.jhep.2013.08.015; Yates MS, 2007, ACTA PHARMACOL SIN, V28, P1331, DOI 10.1111/j.1745-7254.2007.00688.x; Zhang DD, 2013, ANTIOXID REDOX SIGN, V19, P517, DOI 10.1089/ars.2012.5118; Zoja C, 2014, NEPHROL DIAL TRANSPL, V29, pI19, DOI 10.1093/ndt/gft224; Zong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053427	39	65	67	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28446	28455		10.1074/jbc.M115.678136	http://dx.doi.org/10.1074/jbc.M115.678136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26459563	Green Published, hybrid			2022-12-26	WOS:000365761900038
J	Rogowska, ME; Iskander, DR				Rogowska, Marta E.; Iskander, D. Robert			Age-Related Changes in Corneal Deformation Dynamics Utilizing Scheimpflug Imaging	PLOS ONE			English	Article							GOLDMANN APPLANATION TONOMETRY; BIOMECHANICAL PROPERTIES; INTRAOCULAR-PRESSURE; THICKNESS; MODEL; ELASTICITY; NONCONTACT; EYES	Purpose To study age-related changes in corneal deformation response to air-puff applanation tonometry. Methods Fifty healthy subjects were recruited for a prospective study and divided into two equal age groups (<= 28 and >= 50 years old). Up to three measurements by a corneal deformation analyser based on the Scheimpflug principle were performed on the left eye of each subject. Raw Scheimpflug images were used to extract changes in anterior and posterior corneal profiles, which were further modelled by an orthogonal series of Chebyshev polynomial functions. Time series of the polynomial coefficients of even order exhibited a dynamic behavior in which three distinct stages were recognized. A bilinear function was used to model the first and the third stage of corneal dynamics. Slope parameters of the bilinear fit were then tested between the two age groups using Wilcoxon rank sum test and two-way non-parametric ANOVA (Friedman) test. Results Statistically significant changes (Wilcoxon test, rho<0.05) between the age groups were observed in the phase of the second applanation dynamics for the posterior corneal profile. In a two-way comparison, in which the corneal profile was used as a dependent variable, statistically significant changes (ANOVA/Friedman test, rho = 0.017) between the groups were also observed for that phase. Conclusion Corneal biomechanics depend on age. The changes in corneal deformation dynamics, which correspond to mostly free return of the cornea to its original shape after the air pulse, indicate that the age related differences in corneal biomechanics are subtle but observable with high speed imaging.	[Rogowska, Marta E.; Iskander, D. Robert] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland	Wroclaw University of Science & Technology	Rogowska, ME (corresponding author), Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland.	marta.rogowska@pwr.edu.pl	Iskander, D Robert/E-3576-2017	Iskander, D Robert/0000-0002-5962-6206				Abitbol O, 2010, ACTA OPHTHALMOL, V88, P116, DOI 10.1111/j.1755-3768.2009.01554.x; Abramowitz M., 1972, HDB MATH FUNCTIONS, P773; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318; ALSBIRK PH, 1978, ACTA OPHTHALMOL, V56, P95; Ambrosio R, 2013, REV BRAS OFTALMOL, V72, P99, DOI 10.1590/S0034-72802013000200005; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Bryant MR, 1996, J BIOMECH ENG-T ASME, V118, P473, DOI 10.1115/1.2796033; Cartwright NEK, 2011, INVEST OPHTH VIS SCI, V52, P4324, DOI 10.1167/iovs.09-4798; Chen XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109577; Danielewska ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102814; Danielewska ME, 2014, OPTOMETRY VISION SCI, V91, P54, DOI 10.1097/OPX.0000000000000113; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Dua HS, 2013, OPHTHALMOLOGY, V120, P1778, DOI 10.1016/j.ophtha.2013.01.018; Durkin SR, 2007, CLIN EXP OPHTHALMOL, V35, P728, DOI 10.1111/j.1442-9071.2007.01574.x; Elsheikh A, 2007, J REFRACT SURG, V23, P808, DOI 10.3928/1081-597X-20071001-11; Elsheikh A, 2010, J R SOC INTERFACE, V7, P1475, DOI 10.1098/rsif.2010.0108; Hachol A, 1996, SENSOR ACTUAT A-PHYS, V57, P29, DOI 10.1016/S0924-4247(97)80091-X; Han ZL, 2014, J REFRACT SURG, V30, P208, DOI 10.3928/1081597X-20140212-02; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Iyamu E, 2012, J OPTOM, V5, P87, DOI [10.1016/j.optom.2012.02.001, DOI 10.1016/J.OPTOM.2012.02.001]; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Kobayashi AS, 1974, EXPT MECH, V13, P497; Kotecha A, 2005, BRIT J OPHTHALMOL, V89, P1572, DOI 10.1136/bjo.2005.075580; Kotecha A, 2006, INVEST OPHTH VIS SCI, V47, P5337, DOI 10.1167/iovs.06-0557; Krag S, 1997, INVEST OPHTH VIS SCI, V38, P357; Lombardo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112169; Murgatroyd H, 2008, BJA EDUC, V8, P100, DOI 10.1093/bjaceaccp/mkn015; Otsu N, 1975, AUTOMATICA, V11, P285; Pandolfi A, 2006, BIOMECH MODEL MECHAN, V5, P237, DOI 10.1007/s10237-005-0014-x; Pourjavan Sayeh, 2007, International Ophthalmology, V27, P357, DOI 10.1007/s10792-007-9161-7; Rogowska M., 2014, P 7 EUR WORLD M VIS, P276; Swarbrick HA, 2006, CLIN EXP OPTOM, V89, P124, DOI 10.1111/j.1444-0938.2006.00044.x; Szczesna DH, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3431103; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Uchio E, 1999, BRIT J OPHTHALMOL, V83, P1106, DOI 10.1136/bjo.83.10.1106; Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0; Zhang L., 2013, J CLIN EXP OPHTHALMO, V4	38	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140093	10.1371/journal.pone.0140093	http://dx.doi.org/10.1371/journal.pone.0140093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460972	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300053
J	Vanden Broeck, A; Van der Heiden, E; Sauvage, E; Dauvin, M; Joris, B; Duez, C				Vanden Broeck, Arnaud; Van der Heiden, Edwige; Sauvage, Eric; Dauvin, Marjorie; Joris, Bernard; Duez, Colette			A Lysine Cluster in Domain II of Bacillus subtilis PBP4a Plays a Role in the Membrane Attachment of This C1-PBP	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; CRYSTAL-STRUCTURE; TRANSPEPTIDASE; CARBOXYPEPTIDASE; IDENTIFICATION; PEPTIDOGLYCAN; DACC; R39	In PBP4a, a Bacillus subtilis class-C1 penicillin-binding protein (PBP), four clustered lysine (K) residues, K86, K114, K119, and K265, protrude from domain II. Replacement of these amino acids with glutamine (Q) residues by site-directed mutagenesis yielded Mut4KQ PBP4a. When produced in Escherichia coli without its predicted Sec-signal peptide, wildtype (WT) PBP4a was found mainly associated with the host cytoplasmic membrane, whereas Mut4KQ PBP4a remained largely unbound. After purification, the capacities of the two proteins to bind to B. subtilis membranes were compared. The results were similar to those obtained in E. coli: in vitro, a much higher percentage of WT PBP4a than of Mut4KQ PBP4a was found to interact with B. subtilis membranes. Immunodetection of PBP4a in B. subtilis membrane extracts revealed that a processed form of this PBP (as indicated by its size) associates with the B. subtilis cytoplasmic membrane. In the absence of any amphiphilic peptide in PBP4a, the crown of positive charges on the surface of domain II is likely responsible for the cellular localization of this PBP and its attachment to the cytoplasmic membrane.	[Vanden Broeck, Arnaud; Van der Heiden, Edwige; Dauvin, Marjorie; Joris, Bernard; Duez, Colette] Univ Liege, Inst Chim B6a, Ctr Prot Engn, Sart Tilman Par Liege, Belgium; [Sauvage, Eric] Univ Liege, Inst Phys B5a, Ctr Prot Engn, Sart Tilman Par Liege, Belgium	University of Liege; University of Liege	Duez, C (corresponding author), Univ Liege, Inst Chim B6a, Ctr Prot Engn, Sart Tilman Par Liege, Belgium.	cduez@ulg.ac.be		Vanden Broeck, Arnaud/0000-0003-0930-4249; Dauvin, Marjorie/0000-0001-7447-6368	Belgian Program on Interuniversity Poles of Attraction by the Prime Minister's Office, Science Policy Programming (IAP) [P6/19, P7/44]	Belgian Program on Interuniversity Poles of Attraction by the Prime Minister's Office, Science Policy Programming (IAP)	This work was supported by the Belgian Program on Interuniversity Poles of Attraction by the Prime Minister's Office, Science Policy Programming (IAP noP6/19 and P7/44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duez C, 2001, J BACTERIOL, V183, P1595, DOI 10.1128/JB.183.5.1595-1599.2001; Duez C, 2009, FEMS MICROBIOL LETT, V300, P42, DOI 10.1111/j.1574-6968.2009.01761.x; DUSART J, 1973, ANTIMICROB AGENTS CH, V3, P181, DOI 10.1128/AAC.3.2.181; Fonze E, 1999, J BIOL CHEM, V274, P21853, DOI 10.1074/jbc.274.31.21853; Frere J M, 1976, Methods Enzymol, V45, P610; JACKSON ME, 1987, MOL MICROBIOL, V1, P23, DOI 10.1111/j.1365-2958.1987.tb00522.x; JUDD RC, 1991, MOL MICROBIOL, V5, P1091, DOI 10.1111/j.1365-2958.1991.tb01881.x; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; NGUYENDISTECHE M, 1982, BIOCHEM J, V207, P109, DOI 10.1042/bj2070109; Otto A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1137; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pedersen LB, 1998, J BACTERIOL, V180, P4967, DOI 10.1128/JB.180.18.4967-4973.1998; Sauvage E, 2005, J BIOL CHEM, V280, P31249, DOI 10.1074/jbc.M503271200; Sauvage E, 2007, J MOL BIOL, V371, P528, DOI 10.1016/j.jmb.2007.05.071; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Siligardi G, 1997, BBA-BIOMEMBRANES, V1329, P278, DOI 10.1016/S0005-2736(97)00117-X; VANDERLINDEN MPG, 1992, J BACTERIOL, V174, P7572, DOI 10.1128/JB.174.23.7572-7578.1992; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yasukawa H, 2003, BIOL PHARM BULL, V26, P1018	19	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140082	10.1371/journal.pone.0140082	http://dx.doi.org/10.1371/journal.pone.0140082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460848	Green Published, gold			2022-12-26	WOS:000362962300052
J	Lopez-Vidal, J; Gomez-Sebastian, S; Barcena, J; Nunez, MD; Martinez-Alonso, D; Dudognon, B; Guijarro, E; Escribano, JM				Lopez-Vidal, Javier; Gomez-Sebastian, Silvia; Barcena, Juan; del Carmen Nunez, Maria; Martinez-Alonso, Diego; Dudognon, Benoit; Guijarro, Eva; Escribano, Jose M.			Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System	PLOS ONE			English	Article							RABBIT-HEMORRHAGIC-DISEASE; PORCINE CIRCOVIRUS TYPE-2; MAJOR CAPSID PROTEIN; INSECT CELLS; RECOMBINANT PROTEINS; VACCINE DESIGN; CALICIVIRUS; LARVAE; PIGS; VP60	Vaccines based on virus-like particles (VLPs) have proven effective in humans and animals. In this regard, the baculovirus expression vector system (BEVS) is one of the technologies of choice to generate such highly immunogenic vaccines. The extended use of these vaccines for human and animal populations is constrained because of high production costs, therefore a significant improvement in productivity is crucial to ensure their commercial viability. Here we describe the use of the previously described baculovirus expression cassette, called TB, to model the production of two VLP-forming vaccine antigens in insect cells. Capsid proteins from porcine circovirus type 2 (PCV2 Cap) and from the calicivirus that causes rabbit hemorrhagic disease (RHDV VP60) were expressed in insect cells using baculoviruses genetically engineered with the TB expression cassette. Productivity was compared to that obtained using standard counterpart vectors expressing the same proteins under the control of the polyhedrin promoter. Our results demonstrate that the use of the TB expression cassette increased the production yields of these vaccine antigens by around 300% with respect to the standard vectors. The recombinant proteins produced by TB-modified vectors were fully functional, forming VLPs identical in size and shape to those generated by the standard baculoviruses, as determined by electron microscopy analysis. The use of the TB expression cassette implies a simple modification of the baculovirus vectors that significantly improves the cost efficiency of VLP-based vaccine production, thereby facilitating the commercial viability and broad application of these vaccines for human and animal health.	[Lopez-Vidal, Javier; Gomez-Sebastian, Silvia; del Carmen Nunez, Maria; Martinez-Alonso, Diego; Dudognon, Benoit] Univ Politecn Madrid, Alternat Gene Express SL ALGENEX, Madrid, Spain; [Barcena, Juan] INIA, CISA, Madrid, Spain; [Guijarro, Eva; Escribano, Jose M.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain	Universidad Politecnica de Madrid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Escribano, JM (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Autovia A6 Km 7, Madrid, Spain.	escriban@inia.es	Barcena, Juan/B-8855-2013; Gómez-Sebastián, Silvia/ABC-5878-2020; Gomez-Sebastian, Silvia/AAA-4441-2019	Barcena, Juan/0000-0001-6050-0654; Gómez-Sebastián, Silvia/0000-0002-7326-3181; Martinez Alonso, Diego/0000-0003-0521-5134	Spanish Ministry of Economy and Competitiveness [AGL2013-48550-C2-2-R]; Alternative Gene Expression S.L. Collaborative project; INIA	Spanish Ministry of Economy and Competitiveness(Spanish Government); Alternative Gene Expression S.L. Collaborative project; INIA(Instituto de Investigacion Agropecuaria (INIA))	This work was supported by the Spanish Ministry of Economy and Competitiveness, grant number AGL2013-48550-C2-2-R, http://www.mineco.gob.es, to JB, EG, and JME and the Alternative Gene Expression S.L. Collaborative project with INIA, www.algenex.com, to JLV, SGS, MCN, DMA, and BD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Barcena J, 2004, VIROLOGY, V322, P118, DOI 10.1016/j.virol.2004.01.021; Barcena Juan, 2013, Subcell Biochem, V68, P631, DOI 10.1007/978-94-007-6552-8_21; Beyer Thomas, 2001, Current Drug Targets - Infectious Disorders, V1, P287, DOI 10.2174/1568005014605973; Boga JA, 1997, J GEN VIROL, V78, P2315, DOI 10.1099/0022-1317-78-9-2315; Buckland BC, 2005, NAT MED, V11, pS16, DOI 10.1038/nm1218; Cox MMJ, 2012, VACCINE, V30, P1759, DOI 10.1016/j.vaccine.2012.01.016; Crisci E, 2012, VACCINE, V30, P2427, DOI 10.1016/j.vaccine.2012.01.069; Crisci E, 2009, VIROLOGY, V387, P303, DOI 10.1016/j.virol.2009.02.045; Crisci E, 2012, VET IMMUNOL IMMUNOP, V148, P211, DOI 10.1016/j.vetimm.2012.04.026; Dalton KP, 2015, ARCH VIROL, V160, P877, DOI 10.1007/s00705-014-2329-3; Fachinger V, 2008, VACCINE, V26, P1488, DOI 10.1016/j.vaccine.2007.11.053; Fan H, 2007, VET RES COMMUN, V31, P487, DOI 10.1007/s11259-007-3469-7; Fort M, 2008, VACCINE, V26, P1063, DOI 10.1016/j.vaccine.2007.12.019; Gomez-Casado E, 2011, PROTEIN EXPRES PURIF, V79, P35, DOI 10.1016/j.pep.2011.03.007; Gomez-Sebastian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096562; Gotoh T, 2001, J BIOSCI BIOENG, V92, P248, DOI 10.1263/jbb.92.248; Gromadzka B, 2006, ACTA BIOCHIM POL, V53, P371; Hitchman RB, 2010, BIOTECHNOL APPL BIOC, V56, P85, DOI 10.1042/BA20090130; Hitchman Richard B, 2009, Recent Pat Biotechnol, V3, P46; Hom LG, 2000, VIROLOGY, V277, P178, DOI 10.1006/viro.2000.0586; Ikonomou L, 2003, APPL MICROBIOL BIOT, V62, P1, DOI 10.1007/s00253-003-1223-9; Kaba SA, 2004, J VIROL METHODS, V122, P113, DOI 10.1016/j.jviromet.2004.07.006; Le Gall-Recule G, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-81; Liu FX, 2013, PROTEIN EXPRES PURIF, V90, P104, DOI 10.1016/j.pep.2013.05.009; Liu FX, 2013, COMP IMMUNOL MICROB, V36, P343, DOI 10.1016/j.cimid.2013.02.002; Liu L, 2008, PROTEIN EXPRES PURIF, V62, P21, DOI 10.1016/j.pep.2008.07.010; Marin MS, 1995, VIRUS RES, V39, P119, DOI 10.1016/0168-1702(95)00074-7; NAGESHA HS, 1995, ARCH VIROL, V140, P1095, DOI 10.1007/BF01315418; Naggie S, 1998, BIOTECHNOL PROGR, V14, P227, DOI 10.1021/bp980002b; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; OHLINGER VF, 1990, J VIROL, V64, P3331, DOI 10.1128/JVI.64.7.3331-3336.1990; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; PATTERSON RM, 1995, ENVIRON HEALTH PERSP, V103, P756, DOI 10.2307/3432869; Perez-Filgueira DM, 2007, VIROLOGY, V364, P422, DOI 10.1016/j.virol.2007.03.016; Perez-Martin E, 2010, VACCINE, V28, P2340, DOI 10.1016/j.vaccine.2009.12.061; PlanaDuran J, 1996, ARCH VIROL, V141, P1423, DOI 10.1007/BF01718245; Plummer EM, 2011, WIRES NANOMED NANOBI, V3, P174, DOI 10.1002/wnan.119; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Romier C, 2006, ACTA CRYSTALLOGR D, V62, P1232, DOI 10.1107/S0907444906031003; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Thomas CJ, 1998, J VIROL, V72, P10207, DOI 10.1128/JVI.72.12.10207-10212.1998; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Vicente T, 2011, J INVERTEBR PATHOL, V107, pS42, DOI 10.1016/j.jip.2011.05.004; Wang JW, 2013, EXPERT REV VACCINES, V12, P129, DOI [10.1586/erv.12.151, 10.1586/ERV.12.151]	49	24	28	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140039	10.1371/journal.pone.0140039	http://dx.doi.org/10.1371/journal.pone.0140039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458221	gold, Green Published, Green Submitted			2022-12-26	WOS:000362961100019
J	Pan, JC; Liu, CM; Hwu, HG; Huang, GH				Pan, Jia-Chiun; Liu, Chih-Min; Hwu, Hai-Gwo; Huang, Guan-Hua			Allocation Variable-Based Probabilistic Algorithm to Deal with Label Switching Problem in Bayesian Mixture Models	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; UNKNOWN NUMBER; SCHIZOPHRENIA; DISTRIBUTIONS; COMPONENTS	The label switching problem occurs as a result of the nonidentifiability of posterior distribution over various permutations of component labels when using Bayesian approach to estimate parameters in mixture models. In the cases where the number of components is fixed and known, we propose a relabelling algorithm, an allocation variable-based (denoted by AVP) probabilistic relabelling approach, to deal with label switching problem. We establish a model for the posterior distribution of allocation variables with label switching phenomenon. The AVP algorithm stochastically relabel the posterior samples according to the posterior probabilities of the established model. Some existing deterministic and other probabilistic algorithms are compared with AVP algorithm in simulation studies, and the success of the proposed approach is demonstrated in simulation studies and a real dataset.	[Pan, Jia-Chiun] Natl Chung Cheng Univ, Dept Math, Chiayi 621, Taiwan; [Liu, Chih-Min; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, Chih-Min; Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Huang, Guan-Hua] Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan	National Chung Cheng University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University	Huang, GH (corresponding author), Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan.	ghuang@stat.nctu.edu.tw		HWU, HAI-GWO/0000-0002-2582-2807; LIU, CHIH-MIN/0000-0001-7016-8990	National Health Research Institutes, Taiwan [DOH 83-HR-306, DOH 84-HR-306, DOH 85-HR-306, DOH 86-HR-306, DOH 87-HR-306, DOH 88-HR-825, NHRI-GT-EX89-P825P, NHRI-EX90-8825PP]; National Science Council, Taiwan [NSC 95-3112-B-001-018-Y, NSC 97-3112-B-001-020, NSC 98-3112-B-001-027]; Ministry of Science and Technology, Taiwan [MOST 103-2118-M-009 -002 -MY2]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was partially supported by grants from the National Health Research Institutes, Taiwan (DOH 83, 84, 85, 86, and 87-HR-306; DOH 88-HR-825; NHRI-GT-EX89-P825P; NHRI-EX90-8825PP); National Science Council, Taiwan (NSC 95-3112-B-001-018-Y, NSC 97-3112-B-001-020, NSC 98-3112-B-001-027); and the Ministry of Science and Technology, Taiwan (MOST 103-2118-M-009 -002 -MY2).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2001, ARTIFICIAL INTELLIGE; Bishop C. M, 2006, PATTERN RECOGNITION; Celeux G, 2000, J AM STAT ASSOC, V95, P957, DOI 10.2307/2669477; Chang CJ, 2002, SCHIZOPHRENIA BULL, V28, P379, DOI 10.1093/oxfordjournals.schbul.a006947; Chen WJ, 1998, SCHIZOPHRENIA BULL, V24, P163, DOI 10.1093/oxfordjournals.schbul.a033308; Cheng J.J., 1996, CHIN PSYCHIAT, V10, P251; Dellaportas P, 2006, STAT COMPUT, V16, P57, DOI 10.1007/s11222-006-5338-6; DIEBOLT J, 1994, J ROY STAT SOC B MET, V56, P363; Fruhwirth-Schnatter S, 2001, J AM STAT ASS, V96; Grun B, 2009, J MULTIVARIATE ANAL, V100, P851, DOI 10.1016/j.jmva.2008.09.006; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Huang GH, 2004, PSYCHOMETRIKA, V69, P5, DOI 10.1007/BF02295837; Huang GH, 2011, COMPR PSYCHIAT, V52, P469, DOI 10.1016/j.comppsych.2010.10.012; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Liu SK, 2006, J FORMOS MED ASSOC, V105, P978, DOI 10.1016/S0929-6646(09)60282-5; McCullagh P, 1989, GEN LINEAR MODELS; McLachlan GJ, 2004, FINITE MIXTURE MODEL, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Pan JC, 2014, PSYCHOMETRIKA, V79, P621, DOI [10.1007/s11336-013-9368-7, 10.1007/S11336-013-9368-7]; Papastamoulis P, 2015, ARXIV150302271; Papastamoulis P, 2013, METHODOL COMPUT APPL, V15, P293, DOI 10.1007/s11009-011-9238-7; Papastamoulis P, 2010, J COMPUT GRAPH STAT, V19, P313, DOI 10.1198/jcgs.2010.09008; Richardson S, 1997, J ROY STAT SOC B MET, V59, P731, DOI 10.1111/1467-9868.00095; Rodriguez CE, 2014, J COMPUT GRAPH STAT, V23, P25, DOI 10.1080/10618600.2012.735624; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Sperrin M, 2009, SERBSKOE ZHITIE LITO, P1; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; Stephens M, 1997, BAYESIAN METHODS MIX; Titterington DM, 1985, STAT ANAL FINITE MIX, V7; ZEGER SL, 1991, J AM STAT ASSOC, V86, P79, DOI 10.2307/2289717	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0138899	10.1371/journal.pone.0138899	http://dx.doi.org/10.1371/journal.pone.0138899			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458185	gold, Green Submitted, Green Published			2022-12-26	WOS:000362961100008
J	Ramnarine, S; Zhang, J; Chen, LS; Culverhouse, R; Duan, WM; Hancock, DB; Hartz, SM; Johnson, EO; Olfson, E; Schwantes-An, TH; Saccone, NL				Ramnarine, Shelina; Zhang, Juan; Chen, Li-Shiun; Culverhouse, Robert; Duan, Weimin; Hancock, Dana B.; Hartz, Sarah M.; Johnson, Eric O.; Olfson, Emily; Schwantes-An, Tae-Hwi; Saccone, Nancy L.			When Does Choice of Accuracy Measure Alter Imputation Accuracy Assessments?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; NICOTINE DEPENDENCE; AFRICAN-AMERICANS; ADMIXED POPULATIONS; SMOKING-BEHAVIOR; QUALITY-CONTROL; METAANALYSES; HAPLOTYPES; VARIANTS	Imputation, the process of inferring genotypes for untyped variants, is used to identify and refine genetic association findings. Inaccuracies in imputed data can distort the observed association between variants and a disease. Many statistics are used to assess accuracy; some compare imputed to genotyped data and others are calculated without reference to true genotypes. Prior work has shown that the Imputation Quality Score (IQS), which is based on Cohen's kappa statistic and compares imputed genotype probabilities to true genotypes, appropriately adjusts for chance agreement; however, it is not commonly used. To identify differences in accuracy assessment, we compared IQS with concordance rate, squared correlation, and accuracy measures built into imputation programs. Genotypes from the 1000 Genomes reference populations (AFR N = 246 and EUR N = 379) were masked to match the typed single nucleotide polymorphism (SNP) coverage of several SNP arrays and were imputed with BEAGLE 3.3.2 and IMPUTE2 in regions associated with smoking behaviors. Additional masking and imputation was conducted for sequenced subjects from the Collaborative Genetic Study of Nicotine Dependence and the Genetic Study of Nicotine Dependence in African Americans (N = 1,481 African Americans and N = 1,480 European Americans). Our results offer further evidence that concordance rate inflates accuracy estimates, particularly for rare and low frequency variants. For common variants, squared correlation, BEAGLE R-2, IMPUTE2 INFO, and IQS produce similar assessments of imputation accuracy. However, for rare and low frequency variants, compared to IQS, the other statistics tend to be more liberal in their assessment of accuracy. IQS is important to consider when evaluating imputation accuracy, particularly for rare and low frequency variants.	[Ramnarine, Shelina; Duan, Weimin; Saccone, Nancy L.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Zhang, Juan] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China; [Chen, Li-Shiun; Hartz, Sarah M.; Olfson, Emily] Washington Univ, Dept Psychiat, St Louis, MO USA; [Culverhouse, Robert] Washington Univ, Dept Med, St Louis, MO USA; [Hancock, Dana B.] RTI Int, Behav Hlth & Criminal Justice Div, Behav & Urban Hlth Program, Res Triangle Pk, NC USA; [Johnson, Eric O.] RTI Int, Fellow Program, Res Triangle Pk, NC USA; [Johnson, Eric O.] RTI Int, Behav Hlth & Criminal Justice Div, Res Triangle Pk, NC USA; [Schwantes-An, Tae-Hwi] NHGRI, Genometr Sect, Computat & Stat Genom Branch, NIH, Baltimore, MD USA	Washington University (WUSTL); Chinese Academy of Sciences; University of Science & Technology of China, CAS; Washington University (WUSTL); Washington University (WUSTL); Research Triangle Institute; Research Triangle Institute; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA)	Saccone, NL (corresponding author), Washington Univ, Dept Genet, St Louis, MO 63110 USA.	nlims@genetics.wustl.edu	Hartz, Sarah/AAD-4073-2019; Hartz, Sarah M/AAD-7662-2020	Hartz, Sarah/0000-0002-5429-3799; Hancock, Dana/0000-0003-2240-3604; Johnson, Eric Otto/0000-0002-8870-1949	National Institute on Drug Abuse (NIDA) [R01DA026911]; NIDA [R21DA033827, P01DA035825, R01DA035825, R01DA025888, K08DA032680]; National Institutes of Health [T32GM07200, UL1TR000448, F30AA023685, TL1TR000449]; NCI [P01CA089392]; NIH [HHSN268201100011I, K08DA030398]; Division of Intramural Research at National Human Genome Research Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA023685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA033827, R01DA035825, R01DA026911, R01DA025888, K08DA032680] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research at National Human Genome Research Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NLS, WD, JZ, SR, and RC were supported by R01DA026911 from the National Institute on Drug Abuse (NIDA). RC was also supported by R21DA033827 from NIDA. NLS, WD, and RC were also supported by P01DA035825 from NIDA. DBH and EOJ were supported by R01DA035825 from NIDA. EOJ was also supported by R01DA025888 from NIDA. EO was supported by T32GM07200, UL1TR000448, F30AA023685, and TL1TR000449 from the National Institutes of Health. This work was also supported by P01CA089392 from NCI and HHSN268201100011I from NIH. LC was supported by K08DA030398 from NIH. SMH was supported by K08DA032680 from NIDA. TSA was supported by the Division of Intramural Research at National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Chanda P, 2012, J HUM GENET, V57, P411, DOI 10.1038/jhg.2012.43; Duan Q, 2013, BIOINFORMATICS, V29, P528, DOI 10.1093/bioinformatics/bts724; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Hancock DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050610; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johnson EO, 2013, HUM GENET, V132, P509, DOI 10.1007/s00439-013-1266-7; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009697; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Luo ZH, 2008, NICOTINE TOB RES, V10, P1223, DOI 10.1080/14622200802163266; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Nelson SC, 2013, G3-GENES GENOM GENET, V3, P1795, DOI 10.1534/g3.113.007161; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogers Ally, 2014, BMC Proc, V8, pS22, DOI 10.1186/1753-6561-8-S1-S22; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Shriner D, 2013, HUM GENET, V132, P1073, DOI 10.1007/s00439-013-1336-x; Shriner D, 2010, GENET EPIDEMIOL, V34, P258, DOI 10.1002/gepi.20457; Sung YJ, 2012, GENET EPIDEMIOL, V36, P508, DOI 10.1002/gepi.21647; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Truong L, 2015, OPEN J EPIDEMIOLOGY, P41; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Zheng HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116487; Zheng HF, 2012, J GENET GENOMICS, V39, P545, DOI 10.1016/j.jgg.2012.07.002; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	35	70	72	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0137601	10.1371/journal.pone.0137601	http://dx.doi.org/10.1371/journal.pone.0137601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458263	gold, Green Published, Green Submitted			2022-12-26	WOS:000362961100001
J	Frei, R; Haile, SR; Mutsch, M; Rohrmann, S				Frei, Regina; Haile, Sarah R.; Mutsch, Margot; Rohrmann, Sabine			Relationship of Serum Vitamin D Concentrations and Allostatic Load as a Measure of Cumulative Biological Risk among the US Population: A Cross-Sectional Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SELF-RATED HEALTH; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; CHRONIC STRESS; ADULTS; METAANALYSIS; BLACKS; UPDATE; WHITES	Introduction The allostatic load (AL) index is a multi-systemic measure of physiologic dysregulation known to be associated with chronic exposure to stress and adverse health outcomes. We examined the relationship between AL and serum 25-hydroxyvitamin D (25(OH) D) concentration in non-institutionalized US adults. Methods Data from the Third National Health and Nutrition Examination Survey (NHANES III, 198894) were used to calculate two versions of AL including 9 biomarkers and another two with 14 biomarkers (systolic and diastolic blood pressure, pulse rate, serum cholesterol, serum HDL-cholesterol, glycated hemoglobin, sex-specific waist-to-hip ratio, serum albumin, and serum C-reactive protein for AL1, and, additionally body mass index, serum triglyceride, serum creatinine, and serum herpes I & II antibodies for AL2), each set defined by predefined cut-offs or by quartiles. Serum vitamin D concentration was ranked into quartiles. Logistic regression, Poisson regression and linear regression were used to examine the association of serum 25(OH) D concentrations on AL, after adjusting for biological, physiological, socioeconomic, lifestyle, and health variables. Results Odds Ratios (OR) for high AL of the lowest 25(OH) D serum quartile were between 1.45 (95% CI: 1.28, 1.67) and 1.79 (95% CI: 1.39, 2.32) for the fully adjusted model, depending on AL version. Inverse relationships between vitamin D serum concentrations were observed for all AL versions and every adjustment. This relationship was consistent after stratification by sex, age or ethnic background. Sensitivity to low 25(OH) D concentrations was highest among the youngest group (20-39 years) with an OR of 2.11 (95% CI: 1.63, 2.73) for the lowest vitamin D quartile Q1. Conclusions Vitamin D had a consistent and statistically significant inverse association with all tested models of high AL, which remained consistent after adjusting for biological, socioeconomic, lifestyle and health variables. Our study adds evidence linking low 25(OH) D concentrations with poorer health, further-reaching than bone health.	[Frei, Regina; Haile, Sarah R.; Mutsch, Margot; Rohrmann, Sabine] Univ Zurich, Div Chron Dis Epidemiol, EBPI, Zurich, Switzerland	University of Zurich	Mutsch, M (corresponding author), Univ Zurich, Div Chron Dis Epidemiol, EBPI, Zurich, Switzerland.	margot.muetsch@uzh.ch	Haile, Sarah R/C-2330-2011; Rohrmann, Sabine/D-2113-2012	Haile, Sarah R/0000-0002-4704-6570; Rohrmann, Sabine/0000-0002-2215-1200; Mutsch, Margot/0000-0003-0620-5376				[Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1988, ANAL REPORTING GUIDE; [Anonymous], 2000, 3 NATL HLTH NUTR EXA; Au N, 2014, SOC SCI MED, V121, P21, DOI 10.1016/j.socscimed.2014.10.007; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bendik I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00248; Bird CE, 2010, J EPIDEMIOL COMMUN H, V64, P860, DOI 10.1136/jech.2008.084814; Borrell LN, 2010, PUBLIC HEALTH REP, V125, P810, DOI 10.1177/003335491012500608; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; Bouillon R, 2014, NAT REV ENDOCRINOL, V10, P79, DOI 10.1038/nrendo.2013.226; Chen N, 2014, NUTRIENTS, V6, P2206, DOI 10.3390/nu6062206; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crimmins EM, 2003, EXP GERONTOL, V38, P731, DOI 10.1016/S0531-5565(03)00099-8; Dong JY, 2013, NUTRIENTS, V5, P3551, DOI 10.3390/nu5093551; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Gruenewald TL, 2006, P NATL ACAD SCI USA, V103, P14158, DOI 10.1073/pnas.0606215103; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Hilger J, 2014, BRIT J NUTR, V111, P23, DOI 10.1017/S0007114513001840; Hwang AC, 2014, J AM MED DIR ASSOC, V15, P490, DOI 10.1016/j.jamda.2014.02.001; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Juster RP, 2012, GENDER MED, V9, P511, DOI 10.1016/j.genm.2012.10.008; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Levine ME, 2014, AM J HUM BIOL, V26, P768, DOI 10.1002/ajhb.22595; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Low CA, 2009, PSYCHOSOM MED, V71, P927, DOI 10.1097/PSY.0b013e3181ba18ed; Mangin M, 2014, INFLAMM RES, V63, P803, DOI 10.1007/s00011-014-0755-z; Marin MF, 2011, NEUROBIOL LEARN MEM, V96, P583, DOI 10.1016/j.nlm.2011.02.016; Mauss D., 2014, IND HLTH; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Merkin SS, 2009, ANN EPIDEMIOL, V19, P194, DOI 10.1016/j.annepidem.2008.12.006; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Peek MK, 2010, AM J PUBLIC HEALTH, V100, P940, DOI 10.2105/AJPH.2007.129312; Pilz S, 2013, ARCH TOXICOL, V87, P2083, DOI 10.1007/s00204-013-1152-z; Rosenberg N, 2015, PUBLIC HEALTH NUTR, V18, P313, DOI 10.1017/S1368980014000056; Sabbah W, 2008, J EPIDEMIOL COMMUN H, V62, P415, DOI 10.1136/jech.2007.064188; Schottker B, 2013, AGEING RES REV, V12, P708, DOI 10.1016/j.arr.2012.02.004; Seeman T, 2004, SOC SCI MED, V59, P2245, DOI 10.1016/j.socscimed.2004.03.027; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Sterling Peter, 2003, ALLOSTASIS HOMEOSTAS, P17; Tak YJ, 2014, J REN NUTR; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Tamez H, 2012, CURR OPIN NEPHROL HY, V21, P492, DOI 10.1097/MNH.0b013e3283557bf0; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Troesch B, 2012, BRIT J NUTR, V108, P692, DOI 10.1017/S0007114512001808; Van Belle TL, 2013, TRENDS ENDOCRIN MET, V24, P561, DOI 10.1016/j.tem.2013.07.002; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Vie TL, 2014, SOC SCI MED, V117, P1, DOI 10.1016/j.socscimed.2014.07.019; Weyland PG, 2014, NUTRIENTS, V6, P3403, DOI 10.3390/nu6093403; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S; Zhang MC, 2014, MED SCI MONITOR, V20, P1274, DOI 10.12659/MSM.890930; Zhao JY, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-860	58	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139217	10.1371/journal.pone.0139217	http://dx.doi.org/10.1371/journal.pone.0139217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451600	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200006
J	Azabou, E; Magalhaes, E; Braconnier, A; Yahiaoui, L; Moneger, G; Heming, N; Annane, D; Mantz, J; Chretien, F; Durand, MC; Lofaso, F; Porcher, R; Sharshar, T				Azabou, Eric; Magalhaes, Eric; Braconnier, Antoine; Yahiaoui, Lyria; Moneger, Guy; Heming, Nicholas; Annane, Djillali; Mantz, Jean; Chretien, Fabrice; Durand, Marie-Christine; Lofaso, Frederic; Porcher, Raphael; Sharshar, Tarek		GENER	Early Standard Electroencephalogram Abnormalities Predict Mortality in Septic Intensive Care Unit Patients	PLOS ONE			English	Article							PERIODIC EPILEPTIFORM DISCHARGES; MECHANICALLY VENTILATED PATIENTS; CRITICALLY-ILL CHILDREN; ELECTROGRAPHIC SEIZURES; ACUTE PHYSIOLOGY; BRAIN-INJURY; EEG; DELIRIUM; ENCEPHALOPATHY; DEFINITIONS	Introduction Sepsis is associated with increased mortality, delirium and long-term cognitive impairment in intensive care unit (ICU) patients. Electroencephalogram (EEG) abnormalities occurring at the acute stage of sepsis may correlate with severity of brain dysfunction. Predictive value of early standard EEG abnormalities for mortality in ICU septic patients remains to be assessed. Methods In this prospective, single center, observational study, standard EEG was performed, analyzed and classified according to both Synek and Young EEG scales, in consecutive patients acutely admitted in ICU for sepsis. Delirium, coma and the level of sedation were assessed at the time of EEG recording; and duration of sedation, occurrence of in-ICU delirium or death were assessed during follow-up. Adjusted analyses were carried out using multiple logistic regression. Results One hundred ten patients were included, mean age 63.8 (+/- 18.1) years, median SAPS-II score 38 (29-55). At the time of EEG recording, 46 patients (42%) were sedated and 22 (20%) suffered from delirium. Overall, 54 patients (49%) developed delirium, of which 32 29%) in the days after EEG recording. 23 (21%) patients died in the ICU. Absence of EEG reactivity was observed in 27 patients (25%), periodic discharges (PDs) in 21 (19%) and electrographic seizures (ESZ) in 17 (15%). ICU mortality was independently associated with a delta-predominant background (OR: 3.36; 95% CI [1.08 to 10.4]), absence of EEG reactivity (OR: 4.44; 95% CI [1.37-14.3], PDs (OR: 3.24; 95% CI [1.03 to 10.2]), Synek grade >= 3 (OR: 5.35; 95% CI [1.66-17.2]) and Young grade > 1 (OR: 3.44; 95% CI [1.09-10.8]) after adjustment to Simplified Acute Physiology Score (SAPS-II) at admission and level of sedation. Delirium at the time of EEG was associated with ESZ in non-sedated patients (32% vs 10%, p = 0.037); with Synek grade >= 3 (36% vs 7%, p< 0.05) and Young grade > 1 (36% vs 17%, p< 0.001). Occurrence of delirium in the days after EEG was associated with a delta-predominant background (48% vs 15%, p = 0.001); absence of reactivity (39% vs 10%, p = 0.003), Synek grade >= 3 (42% vs 17%, p = 0.001) and Young grade > 1 (58% vs 17%, p = 0.0001). Conclusions In this prospective cohort of 110 septic ICU patients, early standard EEG was significantly disturbed. Absence of EEG reactivity, a delta-predominant background, PDs, Synek grade >= 3 and Young grade > 1 at day 1 to 3 following admission were independent predictors of ICU mortality and were associated with occurence of delirium. ESZ and PDs, found in about 20% of our patients. Their prevalence could have been higher, with a still higher predictive value, if they had been diagnosed more thoroughly using continuous EEG.	[Azabou, Eric; Durand, Marie-Christine; Lofaso, Frederic] Univ Versailles St Quentin En Yvelines Garches, Dept Physiol, Assistance Publ Hop Paris, Raymond Poincare Hosp,U1179,INSERM, Versailles, France; [Azabou, Eric; Magalhaes, Eric; Braconnier, Antoine; Yahiaoui, Lyria; Moneger, Guy; Heming, Nicholas; Annane, Djillali; Sharshar, Tarek] Univ Versailles St Quentin En Yvelines Garches, Gen Intens Care Med, Assistance Publ Hop Paris, Raymond Poincare Hosp,U1173,INSERM, Versailles, France; [Mantz, Jean] Paris Descartes Univ, Dept Anesthesiol & Intens Care Med, European Hosp Georges Pompidou, Paris, France; [Chretien, Fabrice] Inst Pasteur, Lab Human Histopathol & Anim Models, Paris, France; [Porcher, Raphael] Univ Paris 05, Hotel Dieu Hosp, Assistance Publ Hop Paris, Dept Stat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Sharshar, T (corresponding author), Univ Versailles St Quentin En Yvelines Garches, Gen Intens Care Med, Assistance Publ Hop Paris, Raymond Poincare Hosp,U1173,INSERM, Versailles, France.	tarek.sharshar@rpc.aphp.fr	Rohaut, Benjamin/O-9250-2017; Verdonk, Franck/AAG-8997-2021; Chretien, fabrice B/D-4035-2018; Annane, Djillali/R-7947-2019; Weiss, Nicolas/E-7345-2011; Sharshar, Tarek/ABF-4117-2021; Lofaso, Frédéric/R-6100-2018; Sonneville, Romain/AAE-7039-2020; Gaillard, Raphael/J-6527-2015	Rohaut, Benjamin/0000-0001-6752-8756; Verdonk, Franck/0000-0001-7061-5594; Chretien, fabrice B/0000-0002-2794-1383; Weiss, Nicolas/0000-0001-5155-196X; Sonneville, Romain/0000-0003-0245-309X; Navarro, Vincent/0000-0003-0077-8114; Gaillard, Raphael/0000-0002-1297-4369; Porcher, Raphael/0000-0002-5277-4679; naccache, lionel/0000-0002-2874-1009; Adam, Nicolas/0000-0002-0933-7705				Adam N, 2013, EXPERT REV ANTI-INFE, V11, P211, DOI [10.1586/ERI.12.159, 10.1586/eri.12.159]; Akman CI, 2013, EPILEPSY RES, V106, P378, DOI 10.1016/j.eplepsyres.2013.06.019; Akman CI, 2011, J CLIN NEUROPHYSIOL, V28, P366, DOI 10.1097/WNP.0b013e3182273486; ANDERSEN P, 1967, J PHYSIOL-LONDON, V192, P283, DOI 10.1113/jphysiol.1967.sp008300; Andre-Obadia N, 2014, NEUROPHYSIOL CLIN, V44, P515, DOI 10.1016/j.neucli.2014.10.001; Andresen JM, 2014, CRIT CARE MED, V42, P2244, DOI 10.1097/CCM.0000000000000522; Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Coulon P, 2009, CELL CALCIUM, V46, P333, DOI 10.1016/j.ceca.2009.09.005; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Foreman B, 2012, NEUROLOGY, V79, P1951, DOI 10.1212/WNL.0b013e3182735cd7; Formisano R, 2007, BRAIN INJURY, V21, P499, DOI 10.1080/02699050701310994; Gigout S, 2013, BRAIN RES, V1525, P39, DOI 10.1016/j.brainres.2013.05.044; Guerit J M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P117; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; JACKSON GG, 1962, ARCH INTERN MED, V110, P663, DOI 10.1001/archinte.1962.03620230109016; JENNETT B, 1975, LANCET, V1, P480; Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kurtz P, 2014, INTENS CARE MED, V40, P228, DOI 10.1007/s00134-013-3149-8; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; OLDENHOF H, 1988, CLIN PHARMACOL THER, V43, P263, DOI 10.1038/clpt.1988.31; Polito A, 2013, CRIT CARE, V17, DOI 10.1186/cc12899; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sharshar T, 2014, LANCET NEUROL, V13, P534, DOI 10.1016/S1474-4422(14)70064-X; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Sutter R, 2014, EUR J NEUROL, V21, P1268, DOI 10.1111/ene.12436; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; WIJDICKS EFM, 1993, NEUROLOGY, V43, P1042, DOI 10.1212/WNL.43.5.1042; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016; Zauner C, 2002, CRIT CARE MED, V30, P1136, DOI 10.1097/00003246-200205000-00030; [No title captured]; [No title captured]	46	62	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139969	10.1371/journal.pone.0139969	http://dx.doi.org/10.1371/journal.pone.0139969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447697	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511000073
J	Gardner, J; Rudd, PA; Prow, NA; Belarbi, E; Roques, P; Larcher, T; Gresh, L; Balmaseda, A; Harris, E; Schroder, WA; Suhrbier, A				Gardner, Joy; Rudd, Penny A.; Prow, Natalie A.; Belarbi, Essia; Roques, Pierre; Larcher, Thibaut; Gresh, Lionel; Balmaseda, Angel; Harris, Eva; Schroder, Wayne A.; Suhrbier, Andreas			Infectious Chikungunya Virus in the Saliva of Mice, Monkeys and Humans	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; DENGUE VIRUS; TRANSMISSION; INTERFERON; EPIDEMIC; DISEASE; ANTIBODIES; MANAGEMENT; DIAGNOSIS; OUTBREAK	Chikungunya virus (CHIKV) is a reemerging, ordinarily mosquito-transmitted, alphavirus that occasionally produces hemorrhagic manifestations, such as nose bleed and bleeding gums, in human patients. Interferon response factor 3 and 7 deficient (IRF3/7(-/-)) mice, which are deficient for interferon a/a responses, reliably develop hemorrhagic manifestations after CHIKV infection. Here we show that infectious virus was present in the oral cavity of CHIKV infected IRF3/7(-/-)mice, likely due to hemorrhagic lesions in the olfactory epithelium that allow egress of infected blood into the nasal, and subsequently, oral cavities. In addition, IRF3/7(-/-) mice were more susceptible to infection with CHIKV via intranasal and oral routes, with IRF3/7(-/-) mice also able to transmit virus mouse-to-mouse without an arthropod vector. Cynomolgus macaques often show bleeding gums after CHIKV infection, and analysis of saliva from several infected monkeys also revealed the presence of viral RNA and infectious virus. Furthermore, saliva samples collected from several acute CHIKV patients with hemorrhagic manifestations were found to contain viral RNA and infectious virus. Oral fluids can therefore be infectious during acute CHIKV infections, likely due to hemorrhagic manifestations in the oral/nasal cavities.	[Gardner, Joy; Prow, Natalie A.; Schroder, Wayne A.; Suhrbier, Andreas] Australian Infect Dis Res Ctr, QIMR Berghofer Med Res Inst, Inflammat Biol Lab, Brisbane, Qld, Australia; [Rudd, Penny A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Belarbi, Essia; Roques, Pierre] Univ Paris 11, CEA, IMETI, Div Immunovirol, Fontenay Aux Roses, France; [Belarbi, Essia; Roques, Pierre] INSERM, UMR 1184, Ctr Immunol Viral Infect & Autoimmune Dis, Fontenay Aux Roses, France; [Larcher, Thibaut] INRA, Nantes, France; [Gresh, Lionel] Sustainable Sci Inst, Managua, Nicaragua; [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua; [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	QIMR Berghofer Medical Research Institute; University of Queensland; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; University of California System; University of California Berkeley	Suhrbier, A (corresponding author), Australian Infect Dis Res Ctr, QIMR Berghofer Med Res Inst, Inflammat Biol Lab, Brisbane, Qld, Australia.	Andreas.Suhrbier@qimrberghofer.edu.au	Larcher, Thibaut/X-8500-2019; Larcher, Thibaut/M-9160-2013	Suhrbier, Andreas/0000-0001-8986-9025; Gresh, Lionel/0000-0002-2333-1748; Larcher, Thibaut/0000-0002-0396-3190	National Health and Medical Research Council (NHMRC), Australia [APP613622]; Queensland Tropical Health Alliance; Integrated Chikungunya Research (ICRES) project of the European Union; DIM-Malinf program from Region Ile de France; National Institute Of Allergy and Infectious Diseases of the National Institutes of Health (USA) [R01AI099631]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099631] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Tropical Health Alliance; Integrated Chikungunya Research (ICRES) project of the European Union; DIM-Malinf program from Region Ile de France(Region Ile-de-France); National Institute Of Allergy and Infectious Diseases of the National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The mouse work was funded by the National Health and Medical Research Council (NHMRC), Australia (grant APP613622) (www.nhmrc.gov.au). A.S. is a principal research fellow with the NHMRC. P.A.R. was a postdoctoral fellow with the Canadian Institutes of Health Research. BSL3 equipment was funded by the Queensland Tropical Health Alliance (www.qtha.org.au), and a donation from Prof Ed Westaway, Royal Australian Air Force Association. The monkey work was funded by the Integrated Chikungunya Research (ICRES) project of the European Union (www.icres.eu), and a PhD scholarship awarded to Essia Belarbi from the DIM-Malinf program from Region Ile de France (www.dimmalinf.org). Human studies were supported by the National Institute Of Allergy and Infectious Diseases of the National Institutes of Health (USA) under Award Number R01AI099631 (to A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003; Balmaseda A, 1999, AM J TROP MED HYG, V61, P893, DOI 10.4269/ajtmh.1999.61.893; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Canaday DH, 2010, J CLIN IMMUNOL, V30, P373, DOI 10.1007/s10875-010-9374-9; Chan Yi-Hao, 2015, Med Sci (Basel), V3, P64, DOI 10.3390/medsci3030064; Colbert JA, 2007, PEDIATR INFECT DIS J, V26, P850, DOI 10.1097/INF.0b013e3180619692; Cox KH, 2011, GENES BRAIN BEHAV, V10, P465, DOI 10.1111/j.1601-183X.2011.00688.x; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; DELLER JJ, 1968, AM J TROP MED HYG, V17, P107; Dietz JA, 2012, NEONATOLOGY, V101, P55, DOI 10.1159/000328026; FERNANDEZ RJ, 1990, MEM I OSWALDO CRUZ, V85, P347, DOI 10.1590/S0074-02761990000300012; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Hardy GAD, 2009, BLOOD, V113, P5497, DOI 10.1182/blood-2008-11-190231; Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5; Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13; Horwood PF, 2013, EMERG INFECT DIS, V19, P1535, DOI 10.3201/eid1909.130130; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kam YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095647; Katti Roopa, 2011, Indian J Dent Res, V22, P613, DOI 10.4103/0970-9290.90325; Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092; Kuehn BM, 2014, JAMA-J AM MED ASSOC, V312, P776, DOI 10.1001/jama.2014.9916; Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072; Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044682; Kuno G, 2001, ACTA VIROL, V45, P139; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; LALINN M, 1995, J VIROL METHODS, V52, P51; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; MING CK, 1974, B WORLD HEALTH ORGAN, V51, P227; NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; PADBIDRI VS, 1979, J HYG EPID MICROB IM, V23, P445; Pellot A S, 2012, Med Trop (Mars), V72 Spec No, P88; Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354; Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151; Rocha C, 2009, AM J TROP MED HYG, V81, P287, DOI 10.4269/ajtmh.2009.81.287; Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12; SARKAR JK, 1965, INDIAN J MED RES, V53, P921; SCHERER WF, 1980, AM J TROP MED HYG, V29, P1359; Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121; Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; TOMORI O, 1981, AM J TROP MED HYG, V30, P855, DOI 10.4269/ajtmh.1981.30.855; Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759; Vogel P, 1996, ARCH PATHOL LAB MED, V120, P164; Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035	54	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139481	10.1371/journal.pone.0139481	http://dx.doi.org/10.1371/journal.pone.0139481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447467	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000028
J	Kalus, I; Rohn, S; Puvirajesinghe, TM; Guimond, SE; Eyckerman-Kolln, PJ; ten Dam, G; van Kuppevelt, TH; Turnbull, JE; Dierks, T				Kalus, Ina; Rohn, Susanne; Puvirajesinghe, Tania M.; Guimond, Scott E.; Eyckerman-Koelln, Pieter J.; ten Dam, Gerdy; van Kuppevelt, Toin H.; Turnbull, Jeremy E.; Dierks, Thomas			Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; VENTRAL SPINAL-CORD; SONIC HEDGEHOG; CELL-LINE; NERVOUS-SYSTEM; NEUROGENESIS; APOPTOSIS; 6-O-ENDOSULFATASES; 6-O-SULFATION; EXPRESSION	Introduction Sulf1 and Sulf2 are cell surface sulfatases, which remove specific 6-O-sulfate groups from heparan sulfate (HS) proteoglycans, resulting in modulation of various HS-dependent signaling pathways. Both Sulf1 and Sulf2 knockout mice show impairments in brain development and neurite outgrowth deficits in neurons. Methodology and Main Findings To analyze the molecular mechanisms behind these impairments we focused on the postnatal cerebellum, whose development is mainly characterized by proliferation, migration, and neurite outgrowth processes of precursor neurons. Primary cerebellar granule cells isolated from Sulf1 or Sulf2 deficient newborns are characterized by a reduction in neurite length and cell survival. Furthermore, Sulf1 deficiency leads to a reduced migration capacity. The observed impairments in cell survival and neurite outgrowth could be correlated to Sulf-specific interference with signaling pathways, as shown for FGF2, GDNF and NGF. In contrast, signaling of Shh, which determines the laminar organization of the cerebellar cortex, was not influenced in either Sulf1 or Sulf2 knockouts. Biochemical analysis of cerebellar HS demonstrated, for the first time in vivo, Sulf-specific changes of 6-O-, 2-O-and N-sulfation in the knockouts. Changes of a particular HS epitope were found on the surface of Sulf2-deficient cerebellar neurons. This epitope showed a restricted localization to the inner half of the external granular layer of the postnatal cerebellum, where precursor cells undergo final maturation to form synaptic contacts. Conclusion Sulfs introduce dynamic changes in HS proteoglycan sulfation patterns of the postnatal cerebellum, thereby orchestrating fundamental mechanisms underlying brain development.	[Kalus, Ina; Rohn, Susanne; Eyckerman-Koelln, Pieter J.; Dierks, Thomas] Univ Bielefeld, Fak Chem, Biochem 1, D-33615 Bielefeld, Germany; [Puvirajesinghe, Tania M.; Guimond, Scott E.; Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Ctr Glycobiol, Liverpool L69 3BX, Merseyside, England; [ten Dam, Gerdy; van Kuppevelt, Toin H.] Univ Nijmegen, Dept Biochem, Nijmegen, Netherlands; [ten Dam, Gerdy; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol Life Sci, Nijmegen, Netherlands	University of Bielefeld; University of Liverpool; Radboud University Nijmegen; Radboud University Nijmegen	Turnbull, JE (corresponding author), Univ Liverpool, Sch Biol Sci, Ctr Glycobiol, Liverpool L69 3BX, Merseyside, England.	j.turnbull@liverpool.ac.uk; thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012; Puvirajesinghe, Tania/AAD-9137-2020	Dierks, Thomas/0000-0001-6426-1339; Guimond, Scott/0000-0002-5903-418X; Puvirajesinghe, Tania/0000-0002-8304-9824	Deutsche Forschungsgemeinschaft [DI575/6]; Fonds der Chemischen Industrie [Forschungskonto] [164517]; Medical Research Council UK; joint Medical Research Council UK/Engineering & Physical Sciences Research Council UK PhD studentship; A*MIDEX project - Investissements d'Avenir French Government program [ANR-11-IDEX-0001-02]; Aix Marseille Universite [A_M-AAP-ID-14-15-140314-09.45-GUENNEAU-PUVIRAJESINGHE-HLS_SAT]; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University; BBSRC [BB/I004343/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie [Forschungskonto](Fonds der Chemischen Industrie); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); joint Medical Research Council UK/Engineering & Physical Sciences Research Council UK PhD studentship; A*MIDEX project - Investissements d'Avenir French Government program(French National Research Agency (ANR)); Aix Marseille Universite; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Deutsche Forschungsgemeinschaft [DI575/6], the Fonds der Chemischen Industrie [Forschungskonto 164517], a Senior Research Fellowship to J.E.T. from the Medical Research Council UK, and a joint Medical Research Council UK/Engineering & Physical Sciences Research Council UK PhD studentship to T.M.P. and J.E.T. T.M.P was also supported by an A*MIDEX project (no ANR-11-IDEX-0001-02) funded by the Investissements d'Avenir French Government program, managed by the French National Research Agency (ANR) with Aix Marseille Universite (T.M.P., A_M-AAP-ID-14-15-140314-09.45-GUENNEAU-PUVIRAJESINGHE-HLS_SAT). We acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Al Oustah A, 2014, DEVELOPMENT, V141, P1392, DOI 10.1242/dev.101717; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Brickman YG, 1998, GLYCOBIOLOGY, V8, P463, DOI 10.1093/glycob/8.5.463; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Carletti B, 2008, NEUROSCIENTIST, V14, P91, DOI 10.1177/1073858407304629; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dou CL, 1995, J NEUROSCI, V15, P8053; Ford-Perriss M, 2002, GLYCOBIOLOGY, V12, P721, DOI 10.1093/glycob/cwf072; Guimond SE, 2009, J BIOL CHEM, V284, P25714, DOI 10.1074/jbc.M109.032755; Joy MT, 2015, EXP NEUROL, V263, P150, DOI 10.1016/j.expneurol.2014.10.011; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Lossi L, 2002, NEUROSCIENCE, V112, P509, DOI 10.1016/S0306-4522(02)00112-4; Lossi L, 2008, HISTOL HISTOPATHOL, V23, P367, DOI 10.14670/HH-23.367; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Porcionatto MA, 2006, BRAZ J MED BIOL RES, V39, P313, DOI 10.1590/S0100-879X2006000300001; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Ramsbottom SA, 2014, DEV BIOL, V391, P207, DOI 10.1016/j.ydbio.2014.04.010; RIOPELLE RJ, 1990, BRAIN RES, V525, P92, DOI 10.1016/0006-8993(90)91324-A; Rudd TR, 2008, CARBOHYD RES, V343, P2184, DOI 10.1016/j.carres.2007.12.019; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Skidmore MA, 2006, J CHROMATOGR A, V1135, P52, DOI 10.1016/j.chroma.2006.09.064; Skidmore MA, 2010, NAT PROTOC, V5, P1983, DOI 10.1038/nprot.2010.145; Smits NC, 2004, AM J RESP CELL MOL, V30, P166, DOI 10.1165/rcmb.2003-0198OC; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; Tao Y, 1997, J NEUROBIOL, V33, P289, DOI 10.1002/(SICI)1097-4695(199709)33:3<289::AID-NEU7>3.0.CO;2-Y; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; Thuret G, 2003, BRIT J OPHTHALMOL, V87, P346, DOI 10.1136/bjo.87.3.346; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WERZ W, 1985, J NEUROCHEM, V44, P907, DOI 10.1111/j.1471-4159.1985.tb12902.x; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Wijnhoven TJ, 2008, GLYCOCONJUGATE J, V25, P177, DOI 10.1007/s10719-007-9070-z	52	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139853	10.1371/journal.pone.0139853	http://dx.doi.org/10.1371/journal.pone.0139853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448642	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000060
J	van Oss, R; Abbo, S; Eshed, R; Sherman, A; Coyne, CJ; Vandemark, GJ; Zhang, HB; Peleg, Z				van Oss, Ruth; Abbo, Shahal; Eshed, Ravit; Sherman, Amir; Coyne, Clarice J.; Vandemark, George J.; Zhang, Hong-Bin; Peleg, Zvi			Genetic Relationship in Cicer Sp Expose Evidence for Geneflow between the Cultigen and Its Wild Progenitor	PLOS ONE			English	Article							CORE AREA HYPOTHESIS; SINGLE DOMESTICATION; WHEAT DOMESTICATION; POPULATION-STRUCTURE; MOLECULAR DIVERSITY; PULSE DOMESTICATION; PLANT DOMESTICATION; CROP EVOLUTION; NEAR-EAST; AFLP DATA	There is a debate concerning mono-or poly-phyletic origins of the Near Eastern crops. In parallel, some authors claim that domestication was not possible within the natural range of the wild progenitors due to wild alleles flow into the nascent crops. Here we address both, the mono-or poly-phyletic origins and the domestications within or without the natural range of the progenitor, debates in order to understand the relationship between domesticated chickpea (Cicer arietinum L.) and its wild progenitor (C. reticulatum Ladizinsky) with special emphasis on its domestication centre in southeastern Turkey. A set of 103 chickpea cultivars and landraces from the major growing regions alongside wild accessions (C. reticulatum, C. echinospermum P. H Davis and C. bijugum K. H. Rech) sampled across the natural distribution range in eastern Turkey were genotyped with 194 SNPs markers. The genetic affinities between and within the studied taxa were assessed. The analysis suggests a mono-phyletic origin of the cultigen, with several wild accession as likely members of the wild stock of the cultigen. Clear separation between the wild and domesticated germplasm was apparent, with negligible level of admixture. A single C. reticulatum accession shows morphological and allelic signatures of admixture, a likely result of introgression. No evidence of geneflow from the wild into domesticated germplasm was found. The traditional farming systems of southeaster Turkey are characterized by occurrence of sympatric wild progenitor-domesticated forms of chickpea (and likewise cereals and other grain legumes). Therefore, both the authentic crop landraces and the wild populations native to the area are a unique genetic resource. Our results grant support to the notion of domestication within the natural distribution range of the wild progenitor, suggesting that the Neolithic domesticators were fully capable of selecting the desired phenotypes even when facing rare wild-domesticated introgression events.	[van Oss, Ruth; Abbo, Shahal; Peleg, Zvi] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Levi Eshkol Sch Agr, IL-76100 Rehovot, Israel; [Eshed, Ravit; Sherman, Amir] Agr Res Org, Volcani Ctr, Inst Plant Sci, Genom Unit, IL-50250 Bet Dagan, Israel; [Coyne, Clarice J.; Vandemark, George J.] Washington State Univ, ARS, USDA, Western Reg Plant Intro Stn, Pullman, WA 99164 USA; [Zhang, Hong-Bin] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Zhang, Hong-Bin] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA	Hebrew University of Jerusalem; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; United States Department of Agriculture (USDA); Washington State University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Abbo, S (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, Levi Eshkol Sch Agr, IL-76100 Rehovot, Israel.	shahal.abbo@mail.huji.ac.il; zvi.peleg@mail.huji.ac.il	Peleg, Zvi/P-3695-2019	Peleg, Zvi/0000-0001-8063-1619	BARD, The United States-Israel Binational Agricultural Research and Development Fund [IS-4427-11C]; Hebrew University of Jerusalem; ARS [ARS-0424494] Funding Source: Federal RePORTER	BARD, The United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Hebrew University of Jerusalem; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported in part by Research Grant No. IS-4427-11C from BARD, The United States-Israel Binational Agricultural Research and Development Fund. http://www.bardisus.com". Stipend support to the senior author (RvO) during her PhD studies was provided by the Hebrew University of Jerusalem. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2003, Q REV BIOL, V78, P435, DOI 10.1086/378927; Abbo S, 2003, FUNCT PLANT BIOL, V30, P1081, DOI 10.1071/FP03084; Abbo S, 2002, NEW PHYTOL, V154, P695, DOI 10.1046/j.1469-8137.2002.00405.x; Abbo S, 2001, GENOME, V44, P309, DOI 10.1139/gen-44-3-309; Abbo S., 2008, P243; Abbo S, 2014, TRENDS PLANT SCI, V19, P351, DOI 10.1016/j.tplants.2013.12.002; Abbo S, 2014, J EXP BOT, V65, P1917, DOI 10.1093/jxb/eru068; Abbo S, 2013, J EXP BOT, V64, P815, DOI 10.1093/jxb/ers373; Abbo S, 2012, CRIT REV PLANT SCI, V31, P241, DOI 10.1080/07352689.2011.645428; Abbo S, 2011, GENET RESOUR CROP EV, V58, P175, DOI 10.1007/s10722-010-9630-0; Abbo S, 2010, CRIT REV PLANT SCI, V29, P317, DOI 10.1080/07352689.2010.502823; Allaby RG, 2005, THEOR APPL GENET, V112, P58, DOI 10.1007/s00122-005-0103-3; Allaby RG, 2004, GENOME, V47, P621, DOI 10.1139/G04-012; Allaby RG, 2003, GENOME, V46, P448, DOI [10.1139/g03-025, 10.1139/G03-025]; Allaby R, 2010, J EXP BOT, V61, P935, DOI 10.1093/jxb/erp382; Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Alo F, 2011, J HERED, V102, P315, DOI 10.1093/jhered/esr015; Asouti E, 2012, VEG HIST ARCHAEOBOT, V21, P149, DOI 10.1007/s00334-011-0332-0; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Bajaj D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12468; Berger J, 2003, CROP SCI, V43, P1076, DOI 10.2135/cropsci2003.1076; Blackman BK, 2011, P NATL ACAD SCI USA, V108, P14360, DOI 10.1073/pnas.1104853108; Chapman MA, 2010, AM J BOT, V97, P831, DOI 10.3732/ajb.0900137; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fuller DQ, 2012, VEG HIST ARCHAEOBOT, V21, P131, DOI 10.1007/s00334-011-0329-8; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Fuller DQ, 2012, J EXP BOT, V63, P617, DOI 10.1093/jxb/err307; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Heun M, 2012, J EXP BOT, V63, P4333, DOI 10.1093/jxb/ers162; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Kawakami SI, 2007, GENOME, V50, P180, DOI 10.1139/G06-139; Kilian B, 2007, MOL BIOL EVOL, V24, P2657, DOI 10.1093/molbev/msm192; LADIZINSKY G, 1985, ECON BOT, V39, P191, DOI 10.1007/BF02907844; LADIZINSKY G, 1987, ECON BOT, V41, P60, DOI 10.1007/BF02859349; LADIZINSKY G, 1976, THEOR APPL GENET, V48, P197, DOI 10.1007/BF00527371; LADIZINSKY G, 1993, ECON BOT, V47, P60, DOI 10.1007/BF02862206; Ladizinsky G, 1999, GENET RESOUR CROP EV, V46, P115, DOI 10.1023/A:1008626128871; LADIZINSKY G, 1976, EUPHYTICA, V25, P211, DOI 10.1007/BF00041547; Ladizinsky G., 1995, EVOLUTION CROP PLANT, P258; Ladizinsky G, 2015, SPRINGERBR PLANT SCI, P1, DOI 10.1007/978-3-319-14505-1_1; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Misra G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0315-2; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Nguyen TT, 2004, PLANT BREEDING, V123, P173, DOI 10.1046/j.1439-0523.2003.00942.x; Ozkan H, 2005, THEOR APPL GENET, V110, P1052, DOI 10.1007/s00122-005-1925-8; Ozkan H, 2002, MOL BIOL EVOL, V19, P1797, DOI 10.1093/oxfordjournals.molbev.a004002; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Parween S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12806; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Pritchard JK, 2000, GENETICS, V155, P945; Pundir R.P.S., 1988, ICRISAT CHICKPEA GER; Roorkiwal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102016; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; TAKAHASHI R, 1955, ADV GENET, V7, P227, DOI 10.1016/S0065-2660(08)60097-8; Tzarfati R, 2013, ANN BOT-LONDON, V112, P829, DOI 10.1093/aob/mct148; van der Maesen LJG, 2007, CHICKPEA BREEDING AND MANAGEMENT, P14, DOI 10.1079/9781845932138.002; Van der Maesen L.J.G., 1972, MONOGRAPH GENUS SPEZ, P72; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Vaughan DA, 2008, RICE, V1, P16, DOI 10.1007/s12284-008-9000-0; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; WILKES HG, 1977, ECON BOT, V31, P254, DOI 10.1007/BF02866877; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Wills DM, 2006, J HERED, V97, P403, DOI 10.1093/jhered/esl001; Zizumbo-Villarreal D, 2005, CROP SCI, V45, P1073, DOI 10.2135/cropsci2004.0340; Zohary D, 1999, GENET RESOUR CROP EV, V46, P133, DOI 10.1023/A:1008692912820; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary D, 1996, ORIGINS SPREAD AGR P, P142	76	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139789	10.1371/journal.pone.0139789	http://dx.doi.org/10.1371/journal.pone.0139789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447951	Green Submitted, gold, Green Published			2022-12-26	WOS:000362511000054
J	Akintola, AA; Noordam, R; Jansen, SW; de Craen, AJ; Ballieux, BE; Cobbaert, CM; Mooijaart, SP; Pijl, H; Westendorp, RG; van Heemst, D				Akintola, Abimbola A.; Noordam, Raymond; Jansen, Steffy W.; de Craen, Anton J.; Ballieux, Bart E.; Cobbaert, Christa M.; Mooijaart, Simon P.; Pijl, Hanno; Westendorp, Rudi G.; van Heemst, Diana			Accuracy of Continuous Glucose Monitoring Measurements in Normo-Glycemic Individuals	PLOS ONE			English	Article							VARIABILITY; SYSTEM; PERFORMANCE; VALIDATION; SENSOR; RISK	Background The validity of continuous glucose monitoring (CGM) is well established in diabetic patients. CGM is also increasingly used for research purposes in normo-glycemic individuals, but the CGM validity in such individuals is unknown. We studied the accuracy of CGM measurements in normo-glycemic individuals by comparing CGM-derived versus venous blood-derived glucose levels and measures of glycemia and glycemic variability. Methods In 34 healthy participants (mean age 65.7 years), glucose was simultaneously measured every 10 minutes, via both an Enlite (R) CGM sensor, and in venous blood sampled over a 24-hour period. Validity of CGM-derived individual glucose measurements, calculated measures of glycemia over daytime (09:00h-23:00h) and nighttime (23:00h-09:00h), and calculated measures of glycemic variability (e.g. 24h standard deviation [SD]) were assessed by Pearson correlation coefficients, mean absolute relative difference (MARD) and paired t-tests. Results The median correlation coefficient between CGM and venous glucose measurements per participant was 0.68 (interquartile range: 0.40-0.78), and the MARD was 17.6% (SD = 17%). Compared with venous sampling, the calculated measure of glycemia during daytime was 0.22 mmol/L higher when derived from CGM, but no difference was observed during nighttime. Most measures of glycemic variability were lower with CGM than with venous blood sampling (e.g., 24h SD:1.07 with CGM and 1.26 with venous blood; p-value = 0.004). Conclusion In normo-glycemic individuals, CGM-derived glucose measurements had good agreement with venous glucose levels. However, the measure of glycemia was higher during the day and most measures of glycemic variability were lower when derived from CGM.	[Akintola, Abimbola A.; Noordam, Raymond; Jansen, Steffy W.; de Craen, Anton J.; Mooijaart, Simon P.; Westendorp, Rudi G.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Ballieux, Bart E.; Cobbaert, Christa M.] Leiden Univ, Med Ctr, Dept Clin Chem, Leiden, Netherlands; [Pijl, Hanno] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [Westendorp, Rudi G.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen	van Heemst, D (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	D.van_Heemst@lumc.nl	Akintola, Abi/T-5361-2019; Mooijaart, Simon P./A-5306-2008; Pijl, Hanno/W-8719-2018	Mooijaart, Simon P./0000-0003-3106-3568; Pijl, Hanno/0000-0002-3076-1551; Noordam, Raymond/0000-0001-7801-809X; Cobbaert, Christa/0000-0003-3565-1404	European Commission project Switchbox (FP7) [Health-F2-2010-259772]; European Commission project HUMAN (FP7) [Health-2013-INNOVIATION-1-602757]	European Commission project Switchbox (FP7); European Commission project HUMAN (FP7)	This study was funded by the European Commission projects Switchbox (FP7, Health-F2-2010-259772) and HUMAN (FP7, Health-2013-INNOVIATION-1-602757). The funders had no role in the design of the study, collection of the data, analyses, decision to publish, or preparation of the manuscript.	Akintola AA, 2015, METHODSX, V2, P33, DOI 10.1016/j.mex.2014.12.003; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bailey TS, 2014, DIABETES TECHNOL THE, V16, P277, DOI 10.1089/dia.2013.0222; Bay C, 2013, DIABETES TECHNOL THE, V15, P371, DOI 10.1089/dia.2013.0004; Beardsall K, 2013, ARCH DIS CHILD-FETAL, V98, pF136, DOI 10.1136/archdischild-2012-301661; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Damiano ER, 2013, DIABETES CARE, V36, P251, DOI 10.2337/dc12-0070; Damiano ER, 2014, J DIABETES SCI TECHN, V8, P699; Davison LJ, 2003, J SMALL ANIM PRACT, V44, P435, DOI 10.1111/j.1748-5827.2003.tb00102.x; Dobson L, 2003, DIABETES CARE, V26, P1940, DOI 10.2337/diacare.26.6.1940-a; Fabricatore AN, 2011, AM J CLIN NUTR, V94, P1519, DOI 10.3945/ajcn.111.020354; Fabris C, 2014, DIABETES TECHNOL THE, V16, P644, DOI 10.1089/dia.2013.0252; Facchinetti A, 2015, MED BIOL ENG COMPUT, V53, P1259, DOI 10.1007/s11517-014-1226-y; Facchinetti A, 2014, IEEE T BIO-MED ENG, V61, P620, DOI 10.1109/TBME.2013.2284023; Gross T M, 2000, Diabetes Technol Ther, V2, P49, DOI 10.1089/152091500316737; Harrison Bern, 2011, J Diabetes Sci Technol, V5, P1009; Jansen SW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11525; Klueh Ulrike, 2013, J Diabetes Sci Technol, V7, P452; Kohnert KD, 2013, DIABETES TECHNOL THE, V15, P448, DOI 10.1089/dia.2012.0303; Lunn DJ, 2011, STAT MED, V30, P2234, DOI 10.1002/sim.4254; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; Medtronic, CGM SENS CAL; Pearce KL, 2012, DIABETES TECHNOL THE, V14, P1126, DOI 10.1089/dia.2012.0143; Rodbard D, 2009, DIABETES TECHNOL THE, V11, P551, DOI 10.1089/dia.2009.0015; Rodbard D, 2009, DIABETES TECHNOL THE, V11, pS55, DOI 10.1089/dia.2008.0132; Sachedina N, 2003, DIABETIC MED, V20, P1012, DOI 10.1046/j.1464-5491.2003.01037.x; SONKSEN PH, 1978, LANCET, V1, P729; Tsang MW, 2001, J TELEMED TELECARE, V7, P47, DOI 10.1258/1357633011936138; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2013, AGING CELL, V12, P207, DOI 10.1111/acel.12042; WU JT, 1993, J CLIN LAB ANAL, V7, P293, DOI 10.1002/jcla.1860070510	31	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139973	10.1371/journal.pone.0139973	http://dx.doi.org/10.1371/journal.pone.0139973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445499	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600114
J	Zanin, FHC; da Silva, CAM; Bonomo, E; Teixeira, RA; Pereira, CAD; dos Santos, KB; Fausto, MA; Negrao-Correa, DA; Lamounier, JA; Carneiro, M				Calheiros Zanin, Francisca Helena; Mariano da Silva, Camilo Adalton; Bonomo, Elido; Teixeira, Romero Alves; de Jesus Pereira, Cintia Aparecida; dos Santos, Karina Benatti; Fausto, Maria Arlene; Negrao-Correa, Deborah Aparecida; Lamounier, Joel Alves; Carneiro, Mariangela			Determinants of Iron Deficiency Anemia in a Cohort of Children Aged 6-71 Months Living in the Northeast of Minas Gerais, Brazil	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HEALTH; INFECTIONS; DIAGNOSIS; INFANTS; STATE	Iron deficiency anemia is one of the most common nutritional disorders worldwide. The aim was to identify the prevalence and incidence of anemia in children and to identify predictors of this condition, including intestinal parasites, social, nutritional and environmental factors, and comorbidities. A population-based cohort study was conducted in a sample of 414 children aged 6-71 months living in Novo Cruzeiro in the Minas Gerais State. Data were collected in 2008 and 2009 by interview and included socio-economic and demographic information about the children and their families. Blood samples were collected for testing of hemoglobin, ferritin and C-reactive protein. Anthropometric measurements and parasitological analyses of fecal samples were performed. To identify risk factors associated with anemia multivariate analyses were performed using the generalized estimating equations (GEE). In 2008 and 2009, respectively, the prevalence rates of anemia were 35.9% (95% CI 31.2-40.8) and 9.8% (95% CI 7.2-12.9), the prevalence rates of iron deficiency were 18.4% (95% CI 14.7-22.6) and 21.8%(95% CI 17.8-26.2), and the incidence rates of anemia and iron deficiency were 3.2% and 21.8%. The following risk factors associated with anemia were: iron deficiency (OR = 3.2; 95% CI 2.0-. 5.3), parasitic infections (OR = 1.9; 95% CI 1.2-2.8), being of risk of or being a low length/height-for-age (OR = 2.1; 95% CI 1.4-3.2), and lower retinol intake (OR = 1.7; 95% CI 1.1-2.7), adjusted over time. Nutritional factors, parasitic infections and chronic malnutrition were identified as risk factors for anemia. These factors can be verified in a chronic process and have been classically described as risk factors for these conditions.	[Calheiros Zanin, Francisca Helena; de Jesus Pereira, Cintia Aparecida; dos Santos, Karina Benatti; Negrao-Correa, Deborah Aparecida; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-31270901 Belo Horizonte, MG, Brazil; [Mariano da Silva, Camilo Adalton; Bonomo, Elido] Univ Fed Ouro Preto, Dept Nutr Clin & Social, Escola Nutr, BR-35400000 Ouro Preto, MG, Brazil; [Teixeira, Romero Alves] Univ Fed Vales Jequitinhonha & Mucuri, Fac Ciencias Biol & Saude, BR-39100000 Diamantina, MG, Brazil; [Fausto, Maria Arlene] Univ Fed Ouro Preto, Escola Nutr, Dept Alimentos, BR-35400000 Ouro Preto, MG, Brazil; [Lamounier, Joel Alves] Univ Fed Sao Joao Del Rei, Campus Ctr Oeste, BR-36307352 Divinopolis, MG, Brazil; [Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Posgrad Infectol & Med Trop, BR-31270901 Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Ouro Preto; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Minas Gerais	Carneiro, M (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.	mcarneir@icb.ufmg.br	Teixeira, Romero A/B-1582-2017	Teixeira, Romero A/0000-0001-6623-8239; Silva, Camilo Adalton Mariano/0000-0002-5683-9556	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG [CDS-1897/2006]; FAPEMIG/Pesquisador Mineiro	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG/Pesquisador Mineiro	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG - Grant Number CDS-1897/2006 and FAPEMIG/Pesquisador Mineiro, 2008, MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUQUERQUE Maria de Fátima Machado de, 2002, Rev. Nutr., V15, P291; [Anonymous], 2001, WHO TECHN REP SER; Azeredo CM, 2010, REV SAUDE PUBL, V44, P1; Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576; Bates I, 2007, PLOS MED, V4, P1285, DOI 10.1371/journal.pmed.0040231; Boeke CE, 2010, J TROP PEDIATRICS, V56, P299, DOI 10.1093/tropej/fmp136; Brasil Minist?rio da Sa?de, 2009, PESQ NAC DEM SAUD CR; Brasil Ministerio da Saude/SAS/Departamento de Atencao Basica, 2008, TET CRED IMPL ESTR A; Brasil. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Atencao Basica, 2013, MAN COND GER PROGR N; Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1; de Oliveira TDC, 2014, CIENC SAUDE COLETIVA, V19, P59, DOI 10.1590/1413-81232014191.1927; Carvalho AGC, 2010, REV SAUDE PUBL, V44, P513, DOI 10.1590/S0034-89102010000300015; Silla LMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068805; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Diggle PJ, 2002, ANAL LONGITUDINAL DA; ENDEF, 1999, I BRAS GEOGR EST IBG; Assuncao MCF, 2007, REV SAUDE PUBL, V41, P539, DOI 10.1590/S0034-89102006005000031; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Galeazzi MAM, 1997, ESTUDO MULTICENTRICO; Grotto Helena Z. W., 2010, Rev. Bras. Hematol. Hemoter., V32, P22; Hoffman W. A., 1934, Puerto Rico Journal of Public Health & Tropical Medicine, V9, P283; Instituto Brasileiro de Geografia e Estatistica, CENS DEM 2010 RES GE; Janus J, 2010, AM FAM PHYSICIAN, V81, P1462; JOHNS WL, 1989, B WORLD HEALTH ORGAN, V67, P627; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Katz N, 1972, REV INST MED TROP SP, V14, P394; Macedo MD, 2012, CAD SAUDE PUBLICA, V28, P346, DOI 10.1590/S0102-311X2012000200013; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Cotta RMM, 2011, CAD SAUDE PUBLICA, V27, pS309, DOI 10.1590/S0102-311X2011001400017; Morris LD, 2007, VOX SANG, V93, P64, DOI 10.1111/j.1423-0410.2007.00919.x; Muniz PT, 2007, CAD SAUDE PUBLICA, V23, P1283, DOI 10.1590/S0102-311X2007000600004; Mwanri L, 2000, J NUTR, V130, P2691, DOI 10.1093/jn/130.11.2691; Nguyen CK, 2010, PUBLIC HEALTH NUTR, V13, P1863, DOI 10.1017/S1368980010000571; Rocha Daniela da Silva, 2012, Rev. bras. epidemiol., V15, P675, DOI 10.1590/S1415-790X2012000300020; Gondim SSR, 2012, REV SAUDE PUBL, V46, P649, DOI 10.1590/S0034-89102012005000055; Sari M, 2001, B WORLD HEALTH ORGAN, V79, P506; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320; Sigulem DM., 2000, J PEDIAT, V76, pS275, DOI [10.2223/JPED.164, DOI 10.1590/S0103-05822009000200004]; Silva RR, 2009, T ROY SOC TROP MED H, V103, P512, DOI 10.1016/j.trstmh.2008.10.019; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; TACO, 2006, NUCL EST PESQ AL U E; Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44; United Nations Development Program, 2009, REL DES HUM ULTR BAR; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2001, IR DEF AN ASS PREV C; Zabotto CB, 1996, REGISTRO FOTOGRAFICO	47	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139555	10.1371/journal.pone.0139555	http://dx.doi.org/10.1371/journal.pone.0139555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445270	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600063
J	Inagaki, S; Henry, IM; Lieberman, MC; Comai, L				Inagaki, Soichi; Henry, Isabelle M.; Lieberman, Meric C.; Comai, Luca			High-Throughput Analysis of T-DNA Location and Structure Using Sequence Capture	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; BINARY VECTOR; GENOME; PLANTS; INTEGRATION; INSERTIONS; CHROMOSOME; GENERATION	Agrobacterium-mediated transformation of plants with T-DNA is used both to introduce transgenes and for mutagenesis. Conventional approaches used to identify the genomic location and the structure of the inserted T-DNA are laborious and high-throughput methods using next-generation sequencing are being developed to address these problems. Here, we present a cost-effective approach that uses sequence capture targeted to the T-DNA borders to select genomic DNA fragments containing T-DNA-genome junctions, followed by Illumina sequencing to determine the location and junction structure of T-DNA insertions. Multiple probes can be mixed so that transgenic lines transformed with different T-DNA types can be processed simultaneously, using a simple, index-based pooling approach. We also developed a simple bioinformatic tool to find sequence read pairs that span the junction between the genome and T-DNA or any foreign DNA. We analyzed 29 transgenic lines of Arabidopsis thaliana, each containing inserts from 4 different T-DNA vectors. We determined the location of T-DNA insertions in 22 lines, 4 of which carried multiple insertion sites. Additionally, our analysis uncovered a high frequency of unconventional and complex TDNA insertions, highlighting the needs for high-throughput methods for T-DNA localization and structural characterization. Transgene insertion events have to be fully characterized prior to use as commercial products. Our method greatly facilitates the first step of this characterization of transgenic plants by providing an efficient screen for the selection of promising lines.	[Inagaki, Soichi; Henry, Isabelle M.; Lieberman, Meric C.; Comai, Luca] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Inagaki, Soichi; Henry, Isabelle M.; Lieberman, Meric C.; Comai, Luca] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Inagaki, Soichi] Natl Inst Genet, Dept Integrat Genet, Mishima, Shizuoka 411, Japan	University of California System; University of California Davis; University of California System; University of California Davis; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Comai, L (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	lcomai@ucdavis.edu	Comai, Luca/F-4279-2010	Comai, Luca/0000-0003-2642-6619	DOE Office of Science, Office of Biological and Environmental Research (BER) [DE-SC0007183]	DOE Office of Science, Office of Biological and Environmental Research (BER)(United States Department of Energy (DOE))	This work was supported in part by a Grant-in-aid from the Japan Society for the Promotion of Science (JSPS) fellows (to S.I.) and by the DOE Office of Science, Office of Biological and Environmental Research (BER), grants no. DE-SC0007183 (to L.C. and I.M.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2014, SCIENCE, V346, P646, DOI 10.1126/science.1257225; De Buck S, 2000, MOL BREEDING, V6, P459, DOI 10.1023/A:1026575524345; De Buck S, 2009, PLANT J, V60, P134, DOI 10.1111/j.1365-313X.2009.03942.x; De Rybel B, 2011, PLANT PHYSIOL, V156, P1292, DOI 10.1104/pp.111.177337; DEROLES SC, 1988, PLANT MOL BIOL, V11, P365, DOI 10.1007/BF00027393; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Ji JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010577; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lepage E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070912; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; OCHMAN H, 1988, GENETICS, V120, P621; Oltmanns H, 2010, PLANT PHYSIOL, V152, P1158, DOI 10.1104/pp.109.148585; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009; Urbanski DF, 2012, PLANT J, V69, P731, DOI 10.1111/j.1365-313X.2011.04827.x; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	22	20	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139672	10.1371/journal.pone.0139672	http://dx.doi.org/10.1371/journal.pone.0139672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445462	gold, Green Submitted, Green Published			2022-12-26	WOS:000362510600065
J	Jiang, N; Gonzalez, M; Ling, PM; Glantz, SA				Jiang, Nan; Gonzalez, MariaElena; Ling, Pamela M.; Glantz, Stanton A.			Relationship of Smokefree Laws and Alcohol Use with Light and Intermittent Smoking and Quit Attempts among US Adults and Alcohol Users	PLOS ONE			English	Article							CIGARETTE-SMOKING; UNITED-STATES; YOUNG-ADULTS; SMOKERS; DRINKING; COLLEGE; ASSOCIATION; CONSUMPTION; PATTERNS; IMPACT	Introduction Light and intermittent smoking (LITS) has become increasingly common. Alcohol drinkers are more likely to smoke. We examined the association of smokefree law and bar law coverage and alcohol use with current smoking, LITS, and smoking quit attempts among US adults and alcohol drinkers. Methods Cross-sectional analyses among a population-based sample of US adults (n = 27,731) using restricted data from 2009 National Health Interview Survey and 2009 American Nonsmokers' Rights Foundation United States Tobacco Control Database. Multivariate logistic regression models examined the relationship of smokefree law coverage and drinking frequency (1) with current smoking among all adults; (2) with 4 LITS patterns among current smokers; and (3) with smoking quit attempts among 6 smoking subgroups. Same multivariate analyses were conducted but substituted smokefree bar law coverage for smokefree law coverage to investigate the association between smokefree bar laws and the outcomes. Finally we ran the above analyses among alcohol drinkers (n = 16,961) to examine the relationship of smokefree law (and bar law) coverage and binge drinking with the outcomes. All models controlled for demographics and average cigarette price per pack. The interactions of smokefree law (and bar law) coverage and drinking status was examined. Results Stronger smokefree law (and bar law) coverage was associated with lower odds of current smoking among all adults and among drinkers, and had the same effect across all drinking and binge drinking subgroups. Increased drinking frequency and binge drinking wererelated to higher odds of current smoking. Smokefree law (and bar law) coverage and drinking status were not associated with any LITS measures or smoking quit attempts. Conclusions Stronger smokefree laws and bar laws are associated with lower smoking rates across all drinking subgroups, which provides further support for these policies. More strict tobacco control measures might help reduce cigarette consumption and increase quit attempts.	[Jiang, Nan; Ling, Pamela M.; Glantz, Stanton A.] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Jiang, Nan] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Gonzalez, MariaElena] Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA USA	University of California System; University of California San Francisco; University of Hong Kong; University of California System; University of California Merced	Glantz, SA (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu	Jiang, Nan/O-4202-2019	Jiang, Nan/0000-0003-0714-750X; Ling, Pamela/0000-0001-6166-9347	National Cancer Institute Grant [CA-061021]; NATIONAL CANCER INSTITUTE [R01CA061021] Funding Source: NIH RePORTER	National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute Grant CA-061021. The funding agency played no role in the selection of the question, conduct of the research, preparation of the manuscript, or decision to submit this paper for publication. (http://projectreporter.nih.gov/project_info_description.cfm?aid=8688747&icde=23104330&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs= ASC).	Agaku IT, 2014, MMWR-MORBID MORTAL W, V63, P29; Albers AB, 2007, TOB CONTROL, V16, P101, DOI 10.1136/tc.2006.017426; [Anonymous], 2011, TAX BURDEN TOBACCO H; [Anonymous], 1992, TOB CONTROL; Bobo JK, 2000, ALCOHOL RES HEALTH, V24, P225; BORLAND R, 1990, AM J PUBLIC HEALTH, V80, P178, DOI 10.2105/AJPH.80.2.178; Brauer LH, 1996, ADDICT BEHAV, V21, P233, DOI 10.1016/0306-4603(95)00054-2; Breslau N, 1996, AM J PUBLIC HEALTH, V86, P985, DOI 10.2105/AJPH.86.7.985; Centers for Disease Control and Prevention, 2010, 2009 NAT HLTH INT SU; DeNavas-Walt C., 2009, INCOME POVERTY HLTH; Dinno A, 2009, SOC SCI MED, V68, P1439, DOI 10.1016/j.socscimed.2009.02.003; Farkas AJ, 1999, TOB CONTROL, V8, P261, DOI 10.1136/tc.8.3.261; Glasgow R E, 1997, Tob Control, V6 Suppl 2, pS44, DOI 10.1136/tc.6.suppl_2.S44; Gonzalez M, 2014, AM J PUBLIC HEALTH, V104, pE88, DOI 10.2105/AJPH.2013.301714; Halperin AC, 2010, NICOTINE TOB RES, V12, P96, DOI 10.1093/ntr/ntp182; Harrison ELR, 2008, ADDICT BEHAV, V33, P668, DOI 10.1016/j.addbeh.2007.11.012; Harrison ELR, 2008, ALCOHOL CLIN EXP RES, V32, P2081, DOI 10.1111/j.1530-0277.2008.00796.x; Hennrikus DJ, 1996, AM J PUBLIC HEALTH, V86, P1260, DOI 10.2105/AJPH.86.9.1260; Hymowitz N, 1997, Tob Control, V6 Suppl 2, pS57, DOI 10.1136/tc.6.suppl_2.S57; Jemal A, 2011, BMC PUBLIC HEALTH, V11, P1; Jiang N, 2013, AM J PUBLIC HEALTH, V103, pE53, DOI 10.2105/AJPH.2012.301014; Jiang NM, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-50; Levy DE, 2009, NICOTINE TOB RES, V11, P156, DOI 10.1093/ntr/ntp011; McKee SA, 2004, NICOTINE TOB RES, V6, P111, DOI 10.1080/14622200310001656939; Moskowitz JM, 2000, AM J PUBLIC HEALTH, V90, P757, DOI 10.2105/AJPH.90.5.757; National Institute on Alcohol Abuse and Alcoholism, 2007, ALCOHOL ALERT; Okuyemi KS, 2004, ETHNIC DIS, V14, P127; OKUYEMI KS, 2002, NICOTINE TOB RES S2, V4, P167; Pierce JP, 2009, NICOTINE TOB RES, V11, P171, DOI 10.1093/ntr/ntp014; Reed MB, 2007, ADDICT BEHAV, V32, P449, DOI 10.1016/j.addbeh.2006.05.016; Rose JE, 2004, NICOTINE TOB RES, V6, P133, DOI 10.1080/14622200310001656957; Sanders-Jackson A, 2013, AM J PUBLIC HEALTH, V103, pE44, DOI 10.2105/AJPH.2013.301449; Schane RE, 2009, ARCH INTERN MED, V169, P1742, DOI 10.1001/archinternmed.2009.315; Shiffman S, 1994, J Subst Abuse, V6, P21, DOI 10.1016/S0899-3289(94)90052-3; Smith PH, 2014, NICOTINE TOB RES, V16, P846, DOI 10.1093/ntr/ntu014; Trinidad DR, 2009, NICOTINE TOB RES, V11, P203, DOI 10.1093/ntr/ntn018; U.S. Department of Health and Human Services, 2010, HLTH US 2009 SPEC FE; Weitzman ER, 2005, DRUG ALCOHOL DEPEN, V80, P377, DOI 10.1016/j.drugalcdep.2005.05.008; WOODRUFF TJ, 1993, ARCH INTERN MED, V153, P1485, DOI 10.1001/archinte.153.12.1485	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137023	10.1371/journal.pone.0137023	http://dx.doi.org/10.1371/journal.pone.0137023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26445314	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600005
J	Pettersson, BMF; Das, S; Behra, PRK; Jordan, HR; Ramesh, M; Mallick, A; Root, KM; Cheramie, MN; Melara, ID; Small, PLC; Dasgupta, S; Ennis, DG; Kirsebom, LA				Pettersson, B. M. Fredrik; Das, Sarbashis; Behra, Phani Rama Krishna; Jordan, Heather R.; Ramesh, Malavika; Mallick, Amrita; Root, Kate M.; Cheramie, Martin N.; Melara, Irma de la Cruz; Small, Pamela L. C.; Dasgupta, Santanu; Ennis, Don G.; Kirsebom, Leif A.			Comparative Sigma Factor-mRNA Levels in Mycobacterium marinum under Stress Conditions and during Host Infection	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; GLOBAL GENE-EXPRESSION; COLD-SHOCK; POSTTRANSCRIPTIONAL CONTROL; DIFFERENTIAL EXPRESSION; CELL-DIVISION; IN-VIVO; TUBERCULOSIS; SMEGMATIS; BACTERIAL	We have used RNASeq and qRT-PCR to study mRNA levels for all s-factors in different Mycobacterium marinum strains under various growth and stress conditions. We also studied their levels in M. marinum from infected fish and mosquito larvae. The annotated s-factors were expressed and transcripts varied in relation to growth and stress conditions. Some were highly abundant such as sigA, sigB, sigC, sigD, sigE and sigH while others were not. The s-factor mRNA profiles were similar after heat stress, during infection of fish and mosquito larvae. The similarity also applies to some of the known heat shock genes such as the a-crystallin gene. Therefore, it seems probable that the physiological state of M. marinum is similar when exposed to these different conditions. Moreover, the mosquito larvae data suggest that this is the state that the fish encounter when infected, at least with respect to s-factor mRNA levels. Comparative genomic analysis of s-factor gene localizations in three M. marinum strains and Mycobacterium tuberculosis H37Rv revealed chromosomal rearrangements that changed the localization of especially sigA, sigB, sigD, sigE, sigF and sigJ after the divergence of these two species. This may explain the variation in species-specific expression upon exposure to different growth conditions.	[Pettersson, B. M. Fredrik; Das, Sarbashis; Behra, Phani Rama Krishna; Ramesh, Malavika; Melara, Irma de la Cruz; Dasgupta, Santanu; Kirsebom, Leif A.] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Jordan, Heather R.; Small, Pamela L. C.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Mallick, Amrita; Root, Kate M.; Cheramie, Martin N.; Ennis, Don G.] Univ Louisiana, Dept Biol, Lafayette, LA USA	Uppsala University; University of Tennessee System; University of Tennessee Knoxville; University of Louisiana Lafayette	Kirsebom, LA (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	Leif.Kirsebom@icm.uu.se	Behra, Phani Rama Krishna/F-2307-2016; Ramesh, Malavika/I-5970-2017	Behra, Phani Rama Krishna/0000-0002-8810-6066; Ramesh, Malavika/0000-0002-2353-0237; Das, Sarbashis/0000-0001-8799-691X; Pettersson, Fredrik/0000-0003-4177-8145	Swedish Research Council; Swedish Research Council-SIDA; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS); Uppsala RNA Research Center (Swedish Research Council Linneus support); Louisiana Board of Regents Research and Development Grant [RD01-A-38]; NIH [5R21AI055964-01]; NIEHS grant through Oregon State [P30 ES03850]; University of Louisiana Graduate Student Organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003850] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council-SIDA(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS)(Swedish Research Council Formas); Uppsala RNA Research Center (Swedish Research Council Linneus support); Louisiana Board of Regents Research and Development Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS grant through Oregon State; University of Louisiana Graduate Student Organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Swedish Research Council (M), the Swedish Research Council-SIDA, the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS), and Uppsala RNA Research Center (Swedish Research Council Linneus support) to L. A. Kirsebom. D. G. Ennis acknowledges support by the Louisiana Board of Regents Research and Development Grant (RD01-A-38) and NIH grant (5R21AI055964-01), NIEHS grant (P30 ES03850) through Oregon State as well as by AM student travel awards to Wind River Conferences, Louisiana Graduate Fellowship award and funds for supplies and travel by the University of Louisiana Graduate Student Organization to KMR and MNC. Pamela L. C. Small acknowledges the UBS Optimus Foundation Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackleh AS, 2014, J BIOL SYST, V22, P29, DOI 10.1142/S0218339014500028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barker LP, 1997, INFECT IMMUN, V65, P1497, DOI 10.1128/IAI.65.4.1497-1504.1997; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Broussard GW, 2007, COMP BIOCHEM PHYS C, V145, P45, DOI 10.1016/j.cbpc.2006.07.012; Cappelli G, 2006, RES MICROBIOL, V157, P445, DOI 10.1016/j.resmic.2005.10.007; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cronan MR, 2014, DIS MODEL MECH, V7, P777, DOI 10.1242/dmm.016089; DeMaio J, 1997, TUBERCLE LUNG DIS, V78, P3, DOI 10.1016/S0962-8479(97)90010-1; DeMaio J, 1996, P NATL ACAD SCI USA, V93, P2790, DOI 10.1073/pnas.93.7.2790; Dona V, 2008, J BACTERIOL, V190, P5963, DOI 10.1128/JB.00622-08; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Fouts DE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks757; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Gaudion A, 2013, TUBERCULOSIS, V93, P482, DOI 10.1016/j.tube.2013.05.005; Gomez M, 1998, MOL MICROBIOL, V29, P617, DOI 10.1046/j.1365-2958.1998.00960.x; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; Hu JM, 1999, J BACTERIOL, V181, P469, DOI 10.1128/JB.181.2.469-476.1999; Hu YM, 2001, FEMS MICROBIOL LETT, V202, P59, DOI 10.1016/S0378-1097(01)00280-4; Hulten K, 2000, VET MICROBIOL, V77, P513, DOI 10.1016/S0378-1135(00)00336-9; Kaps I, 2001, GENE, V278, P115, DOI 10.1016/S0378-1119(01)00712-0; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kiran M, 2009, TUBERCULOSIS, V89, pS70, DOI 10.1016/S1472-9792(09)70016-2; Landini P, 2014, ENV MICROBIOL REP, V6, P1, DOI 10.1111/1758-2229.12112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2008, J BACTERIOL, V190, P1128, DOI 10.1128/JB.00511-07; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mukherjee R, 2005, BIOCHEM BIOPH RES CO, V338, P964, DOI 10.1016/j.bbrc.2005.10.038; Mutoji KN, 2012, COMP BIOCHEM PHYS C, V155, P39, DOI 10.1016/j.cbpc.2011.05.011; Newton-Foot M, 2013, TUBERCULOSIS, V93, P60, DOI 10.1016/j.tube.2012.08.003; Nogueira T, 2000, CURR OPIN MICROBIOL, V3, P154, DOI 10.1016/S1369-5274(00)00068-0; Pagan-Ramos E, 2006, J BACTERIOL, V188, P2674, DOI 10.1128/JB.188.7.2674-2680.2006; Peterson TS, 2013, DIS AQUAT ORGAN, V106, P229, DOI 10.3354/dao02649; Pettersson BMF, 2013, FEMS MICROBIOL LETT, V342, P98, DOI 10.1111/1574-6968.12118; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pozos TC, 2004, CURR OPIN IMMUNOL, V16, P499, DOI 10.1016/j.coi.2004.05.011; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Roltgen K, 2012, INFECT GENET EVOL, V12, P522, DOI 10.1016/j.meegid.2012.01.018; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sechi LA, 2007, INFECT GENET EVOL, V7, P424, DOI 10.1016/j.meegid.2007.01.001; Shires K, 2001, MOL MICROBIOL, V39, P994, DOI 10.1046/j.1365-2958.2001.02291.x; Singh B, 2010, ANTON LEEUW INT J G, V98, P165, DOI 10.1007/s10482-010-9446-0; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Smollett KL, 2011, J BACTERIOL, V193, P1007, DOI 10.1128/JB.01241-10; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Thieringer HA, 1998, BIOESSAYS, V20, P49; Triccas J A, 2001, BMC Microbiol, V1, P3, DOI 10.1186/1471-2180-1-3; Waagmeester A, 2005, TRENDS MICROBIOL, V13, P505, DOI 10.1016/j.tim.2005.08.009; WALLACE RJ, 1986, J CLIN MICROBIOL, V24, P976, DOI 10.1128/JCM.24.6.976-981.1986; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075828; Winn RN, 2000, P NATL ACAD SCI USA, V97, P12655, DOI 10.1073/pnas.220428097; Wu SP, 2004, MOL MICROBIOL, V51, P1551, DOI 10.1111/j.1365-2958.2003.03922.x	71	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139823	10.1371/journal.pone.0139823	http://dx.doi.org/10.1371/journal.pone.0139823			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445268	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600087
J	Poppinga, S; Haushahn, T; Warnke, M; Masselter, T; Speck, T				Poppinga, Simon; Haushahn, Tobias; Warnke, Markus; Masselter, Tom; Speck, Thomas			Sporangium Exposure and Spore Release in the Peruvian Maidenhair Fern (Adiantum peruvianum, Pteridaceae)	PLOS ONE			English	Article							PHYSICAL WORLD; PLANT; DISPERSAL; EVOLUTION; MOVEMENT; INSIGHTS; DISTANCE; WALL	We investigated the different processes involved in spore liberation in the polypod fern Adiantum peruvianum (Pteridaceae). Sporangia are being produced on the undersides of so-called false indusia, which are situated at the abaxial surface of the pinnule margins, and become exposed by a desiccation-induced movement of these pinnule flaps. The complex folding kinematics and functional morphology of false indusia are being described, and we discuss scenarios of movement initiation and passive hydraulic actuation of these structures. High-speed cinematography allowed for analyses of fast sporangium motion and for tracking ejected spores. Separation and liberation of spores from the sporangia are induced by relaxation of the annulus (the 'throwing arm' of the sporangium catapult) and conservation of momentum generated during this process, which leads to sporangium bouncing. The ultra-lightweight spores travel through air with a maximum velocity of similar to 5 m s(-1), and a launch acceleration of similar to 6300g is measured. In some cases, the whole sporangium, or parts of it, together with contained spores break away from the false indusium and are shed as a whole. Also, spores can stick together and form spore clumps. Both findings are discussed in the context of wind dispersal.	[Poppinga, Simon; Haushahn, Tobias; Warnke, Markus; Masselter, Tom; Speck, Thomas] Univ Freiburg, Plant Biomech Grp, Bot Garden, Fac Biol, D-79106 Freiburg, Germany; [Poppinga, Simon; Speck, Thomas] Univ Freiburg, Freiburg Mat Res Ctr FMF, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Poppinga, S (corresponding author), Univ Freiburg, Plant Biomech Grp, Bot Garden, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	simon.poppinga@biologie.uni-freiburg.de	Poppinga, Simon/B-7260-2012; Haushahn, Tobias/D-8516-2012	Poppinga, Simon/0000-0001-5341-9188; Masselter, Tom/0000-0001-5465-8252; Haushahn, Tobias/0000-0003-0136-4108	German Federal Ministry of Education and Research (BMBF) [01RB0806]; German Research Foundation (DFG) within the Collaborative Research Centre (CRC) [TRR 141]; Albert-Ludwigs-University Freiburg; German Research Foundation (DFG)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) within the Collaborative Research Centre (CRC); Albert-Ludwigs-University Freiburg; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank the German Federal Ministry of Education and Research (BMBF) (funding directive BIONA, 01RB0806) for long-lasting financial support. The current work is funded by the German Research Foundation (DFG) within the Collaborative Research Centre (CRC) TRR 141 Biological Design and Integrative Structures-Analysis, Simulation and Implementation in Architecture. The article processing charge was funded by the German Research Foundation (DFG) and the Albert-Ludwigs-University Freiburg in the funding programme Open Access Publishing.	Arosa ML, 2009, AM FERN J, V99, P260, DOI 10.1640/0002-8444-99.4.260; Atkinson GF, 1894, STUDY BIOL FERNS COL; AYLOR DE, 1991, PHYTOPATHOLOGY, V81, P548, DOI 10.1094/Phyto-81-548; Bianchini M, 1996, INT J PLANT SCI, V157, P739, DOI 10.1086/297397; Buller AHR, 1909, RES FUNGI, VI; BURROWS FM, 1988, PROC R SOC SER B-BIO, V233, P477, DOI 10.1098/rspb.1988.0034; Elbaum R, 2014, PLANT SCI, V223, P124, DOI 10.1016/j.plantsci.2014.03.014; FilippiniDeGiorgi A, 1997, AM FERN J, V87, P93; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gregory P. H., 1945, TRANS BRIT MYCOL SOC, V28, P26; GREGORY PH, 1978, PURE APPL GEOPHYS, V116, P309, DOI 10.1007/BF01636888; HAIDER K, 1954, PLANTA, V44, P370, DOI 10.1007/BF01940087; Hovenkamp PH, 2009, GRANA, V48, P122, DOI 10.1080/00173130902804331; Ingold C. T., 1965, SPORE LIBERATION; Kessler M., 2010, FERN ECOLOGY, P22, DOI DOI 10.1017/CBO9780511844898.003; King AL, 1944, P NATL ACAD SCI USA, V30, P155, DOI 10.1073/pnas.30.7.155; KLOTZSCH JF, 1844, LINNAEA, V18, P525; LARGE MF, 1993, NEW ZEAL J BOT, V31, P403, DOI 10.1080/0028825X.1993.10419518; Li X, 2013, J SYST EVOL, V51, P499, DOI 10.1111/jse.12034; Lyon FM., 1887, B TORREY BOT CLUB, V14, P180, DOI [10.2307/2476668, DOI 10.2307/2476668]; Marmottant P, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1465; Martone PT, 2010, INTEGR COMP BIOL, V50, P888, DOI 10.1093/icb/icq122; Noblin X, 2012, SCIENCE, V335, P1322, DOI 10.1126/science.1215985; Noblin X, 2009, P 6 PLANT BIOM C CAY, P179; Page CN, 2002, REV PALAEOBOT PALYNO, V119, P1, DOI 10.1016/S0034-6667(01)00127-0; PECK JH, 1990, AM FERN J, V80, P126, DOI 10.2307/1547200; Poppinga S, 2013, BIOESSAYS, V35, P649, DOI 10.1002/bies.201200175; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Pryer KM, 2009, TIMETREE LIFE, P153; Razghandi K, 2014, NONLINEAR ELASTICITY, DOI [10.1002/9783527665068.ch8, DOI 10.1002/9783527665068.CH8]; RITMAN KT, 1990, J EXP BOT, V41, P1157, DOI 10.1093/jxb/41.9.1157; Roper M, 2010, PNAS, V105, P20583; Roper M, 2010, P NATL ACAD SCI USA, V107, P17474, DOI 10.1073/pnas.1003577107; ROY RP, 1961, CARYOLOGIA, V14, P413, DOI 10.1080/00087114.1961.10796044; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider H, 2009, SYST BOT, V34, P455, DOI 10.1600/036364409789271209; Schneller JJ, 1995, BOT HELV, V105, P187; Simpson MG, 2010, PLANT SYSTEMATICS, 2ND EDITION, P1; Singh S, 2013, REV BRAS FARMACOGN, V23, P207, DOI 10.1590/S0102-695X2013005000023; Sitte P., 1963, BER NAT MED VEREIN I, V53, P193; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Steinbrinck C, 1897, BER DEUT BOT GES, V15, P86; Straka H., 1962, HDB PFLANZENPHYSIO 2, VXVII, P749; TRYON AF, 1975, CAN J BOT, V53, P2260, DOI 10.1139/b75-250; TRYON R, 1970, Biotropica, V2, P76, DOI 10.2307/2989765; TRYON ROLLA, 1960, AMER FERN JOUR, V50, P46, DOI 10.2307/1545242; Tyree M. T., 2002, SPR S WOOD; Ursprung A., 1915, BERICHTE DTSCH BOT G, V33, P152; Vaknin Y, 2001, NEW PHYTOL, V152, P301, DOI 10.1046/j.0028-646X.2001.00263.x; Vogel S, 2005, J BIOSCIENCES, V30, P303, DOI 10.1007/BF02703667; Vogel S, 2005, J BIOSCIENCES, V30, P167, DOI 10.1007/BF02703696; Wang L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-158; WERTH CR, 1990, AM FERN J, V80, P183, DOI 10.2307/1547207; Whitaker DL, 2010, SCIENCE, V329, P406, DOI 10.1126/science.1190179; ZURAKOWSKI KA, 1988, AM J BOT, V75, P1559, DOI 10.2307/2444706	56	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138495	10.1371/journal.pone.0138495	http://dx.doi.org/10.1371/journal.pone.0138495			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444002	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600031
J	Wang, H; Liu, B; Al-Aidaroos, AQO; Shi, H; Li, L; Guo, K; Li, J; Tan, BCP; Loo, JM; Tang, JP; Thura, M; Zeng, Q				Wang, H.; Liu, B.; Al-Aidaroos, A. Q. O.; Shi, H.; Li, L.; Guo, K.; Li, J.; Tan, B. C. P.; Loo, J. M.; Tang, J. P.; Thura, M.; Zeng, Q.			Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans	ONCOGENE			English	Article							C-SRC; PROTEIN; CANCER; KINASES; FAMILY; IDENTIFICATION; METASTASIS; TARGETS; FAK; ACTIVATION	Despite abundant data supporting c-Src as a metastasis-promoting oncogene, activating mutations of c-Src are rare. This suggests that trans-interacting proteins may have a critical role in regulating c-Src activation. Here, we first report the discovery of Src homology 3 (SH3) domain-binding glutamic acid-rich-like protein (SH3BGRL), a novel c-Src activator in mice. Ectopic expression of murine SH3BGRL (mSH3BGRL) strongly promoted both tumor cell invasion and lung metastasis. Molecularly, mSH3BGRL specifically bound the inactive form of c-Src phosphorylated at Tyr527, promoting Tyr416 phosphorylation of c-Src and subsequent FAK-mediated activation of ERK and AKT signaling pathways. Targeting endogenous c-Src alone was sufficient to abolish mSH3BGRL-induced cancer metastasis in vivo. Unexpectedly, human SH3BGRL (hSH3BGRL) in turn suppressed tumorigenesis and metastasis in nature. We attempted site-specific reversion of hSH3BGRL amino-acid sequence to mSH3BGRL and found V108A substitution sufficient to restore SH3BGRL function as a c-Src activator and metastasis promoter. Notably, the somatic mutation R76C of hSH3BGRL can similarly act as hSH3BGRL-V108A and mSH3BGRL in tumorigenesis and metastasis. Our results uncover an evolutionarily controversial role of SH3BGRL in driving tumor metastasis through c-Src activation, and suggests that hSH3BGRL mutation status could be relevant to cancer diagnosis and therapy.	[Wang, H.; Liu, B.; Shi, H.; Li, L.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, 74 Second Zhonshan Rd, Guangzhou 510080, Guangdong, Peoples R China; [Wang, H.; Liu, B.; Shi, H.; Li, L.] Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Guangzhou 510275, Guangdong, Peoples R China; [Al-Aidaroos, A. Q. O.; Guo, K.; Li, J.; Tan, B. C. P.; Tang, J. P.; Thura, M.; Zeng, Q.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Loo, J. M.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Zeng, Q.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore	Sun Yat Sen University; Sun Yat Sen University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Rockefeller University; National University of Singapore	Wang, H (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, 74 Second Zhonshan Rd, Guangzhou 510080, Guangdong, Peoples R China.; Zeng, Q (corresponding author), 61 Biopolis Dr,Room 3-02, Singapore 138673, Singapore.	wanghaih@mail.sysu.edu.cn; mcbzengq@imcb.astar.edu.sg	Haihe, Wang/AAD-4036-2021	Loo, Jia Min/0000-0002-6605-4031; LIU, BIN/0000-0003-0467-3678	National Natural Science Foundation of China [81171947]; Project of International Collaboration in Science and Technology, Guangdong Province [2014A050503030]; Agency of Science, Technology and Research (A* STAR), Singapore	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of International Collaboration in Science and Technology, Guangdong Province; Agency of Science, Technology and Research (A* STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by research grants from the National Natural Science Foundation of China (WH; No. 81171947), Project of International Collaboration in Science and Technology, Guangdong Province (WH; No. 2014A050503030) and The Agency of Science, Technology and Research (A* STAR), Singapore. We are also thankful to Professor Wanjin Hong, Professor Shulan Yang and Mr Mingming Zhang in our group for critical reading of the manuscript.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Berleth ES, 2000, INT J IMMUNOPHARMACO, V22, P1137, DOI 10.1016/S0192-0561(00)00071-0; Berleth ES, 1999, CANCER RES, V59, P5497; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; BRATTAIN MG, 1980, CANCER RES, V40, P2142; Egeo A, 1998, BIOCHEM BIOPH RES CO, V247, P302, DOI 10.1006/bbrc.1998.8763; Elkin Michael, 2001, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1902s12; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Garritano S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.15; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Henn AD, 2001, FASEB J, V15, P1315, DOI 10.1096/fj.00-0543fje; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Johnson FM, 2007, ANTI-CANCER AGENT ME, V7, P651, DOI 10.2174/187152007784111278; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Majid SM, 2006, ONCOGENE, V25, P756, DOI 10.1038/sj.onc.1209107; Mazzocco M, 2002, GENE, V291, P233, DOI 10.1016/S0378-1119(02)00602-9; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nilbert M, 2000, CANCER GENET CYTOGEN, V121, P94, DOI 10.1016/S0165-4608(00)00226-0; Piguet AC, 2011, J HEPATOL, V54, P1317, DOI 10.1016/j.jhep.2010.12.013; Rao S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117215; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Sigal A, 2000, CANCER RES, V60, P6788; Tan YX, 2005, WORLD J GASTROENTERO, V11, P2351, DOI 10.3748/wjg.v11.i15.2351; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zeng Q, 2003, CANCER RES, V63, P2716	35	15	15	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3303	3313		10.1038/onc.2015.391	http://dx.doi.org/10.1038/onc.2015.391			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26455318	Green Published, hybrid			2022-12-26	WOS:000378306400009
J	Rajkovic, J; Poreba, M; Caglic, D; Vidmar, R; Wilk, A; Borowik, A; Salvesen, G; Turk, V; Drag, M; Turk, B				Rajkovic, Jelena; Poreba, Marcin; Caglic, Dejan; Vidmar, Robert; Wilk, Aleksandra; Borowik, Agata; Salvesen, Guy; Turk, Vito; Drag, Marcin; Turk, Boris			Biochemical Characterization and Substrate Specificity of Autophagin-2 from the Parasite Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL; UNEXPECTED SPECIFICITY; CYSTEINE PROTEINASES; SECONDARY STRUCTURE; ACTIVATION; DIFFERENTIATION; CATHEPSINS; LYSOSOMES; PROTEASES; MECHANISM	The genome of the parasite Trypanosoma cruzi encodes two copies of autophagy-related cysteine proteases, Atg4.1 and Atg4.2. T. cruzi autophagin-2 (TcAtg4.2) carries the majority of proteolytic activity and is responsible for processing Atg8 proteins near the carboxyl terminus, exposing a conserved glycine. This enables progression of autophagy and differentiation of the parasite, which is required for successful colonization of humans. The mechanism of substrate hydrolysis by Atg4 was found to be highly conserved among the species as critical mutations in the TcAtg4.2, including mutation of the conserved Gly-244 residue in the hinge region enabling flexibility of the regulatory loop, and deletion of the regulatory loop, completely abolished processing capacity of the mutants. Using the positional scanning-substrate combinatorial library (PS-SCL) we determined that TcAtg4.2 tolerates a broad spectrum of amino acids in the P4 and P3 positions, similar to the human orthologue autophagin-1 (HsAtg4B). In contrast, both human and trypanosome Atg4 orthologues exhibited exclusive preference for aromatic amino acid residues in the P2 position, and for Gly in the P1 position, which is absolutely conserved in the natural Atg8 substrates. Using an extended P2 substrate library, which also included the unnatural amino acid cyclohexylalanine (Cha) derivative of Phe, we generated highly selective tetrapeptide substrates acetyl- Lys-Lys-Cha-Gly-AEC (Ac-KKChaG-AFC) and acetyl-Lys-Thr-Cha-Gly-AFC (Ac-KTChaG-AF(.). Although these substrates were cleaved by cathepsins, making them unsuitable for analysis of complex cellular systems, they were recognized exclusively by TcAtg4.2, but not by HsAtg4B nor by the structurally related human proteases SENP1, SENP2, and UCH-L3.	[Rajkovic, Jelena; Caglic, Dejan; Vidmar, Robert; Turk, Vito; Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Rajkovic, Jelena; Vidmar, Robert] Jozef Stefan Int Postgrad Sch, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Ctr Excellence Integrated Approaches Chem & Biol, SI-1000 Ljubljana, Slovenia; [Caglic, Dejan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Salvesen, Guy] Scripps Res Inst, Sanford Burnham Med Res Inst, Program Cell Death & Survival Networks, La Jolla, CA 92037 USA; [Poreba, Marcin; Wilk, Aleksandra; Borowik, Agata; Drag, Marcin] Wroclaw Univ Technol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; Wroclaw University of Science & Technology; University of Ljubljana	Turk, B (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova Cesta 39, SI-1000 Ljubljana, Slovenia.	boris.turk@ijs.si	Regan, Clinton/E-6250-2012; Caglic, Dejan/A-1868-2009; Vidmar, Robert/O-9075-2017	Turk, Boris/0000-0002-9007-5764; Vidmar, Robert/0000-0001-5068-3119	Slovene Research Agency [P1-0140]; Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology; National Institutes of Health [R01GM09040]; NATIONAL CANCER INSTITUTE [R01CA163743] Funding Source: NIH RePORTER	Slovene Research Agency(Slovenian Research Agency - Slovenia); Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Slovene Research Agency Grant P1-0140 (to B. T.), a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology, and National Institutes of Health Grant R01GM09040. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez VE, 2008, AUTOPHAGY, V4, P361, DOI 10.4161/auto.5592; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; Chen JL, 2008, J BIOL CHEM, V283, P34432, DOI 10.1074/jbc.M804239200; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Fernandez AF, 2015, J CLIN INVEST, V125, P33, DOI 10.1172/JCI73940; GRIERSON AW, 1994, J GEN VIROL, V75, P2761, DOI 10.1099/0022-1317-75-10-2761; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Herman M, 2006, AUTOPHAGY, V2, P107, DOI 10.4161/auto.2.2.2369; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kosec G, 2006, BIOCELL, V30, P479; KUHELJ R, 1995, EUR J BIOCHEM, V229, P533, DOI 10.1111/j.1432-1033.1995.0533k.x; Lecaille F, 2001, EUR J BIOCHEM, V268, P2733, DOI 10.1046/j.1432-1327.2001.02172.x; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Lv XH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06010; Ma JZ, 2013, BIOINFORMATICS, V29, P257, DOI 10.1093/bioinformatics/btt210; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mihelic M, 2008, J BIOL CHEM, V283, P14453, DOI 10.1074/jbc.M801283200; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Noda NN, 2009, CHEM REV, V109, P1587, DOI 10.1021/cr800459r; Papandreou I, 2008, CELL DEATH DIFFER, V15, P1572, DOI 10.1038/cdd.2008.84; Polajnar M, 2013, BIOL CHEM, V394, P783, DOI 10.1515/hsz-2012-0278; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Poreba M, 2014, AMINO ACIDS, V46, P931, DOI 10.1007/s00726-013-1654-2; RANCOURT C, 1994, P NATL ACAD SCI USA, V91, P844, DOI 10.1073/pnas.91.3.844; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shapiro IM, 2014, AUTOPHAGY, V10, P7, DOI 10.4161/auto.26679; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Wada Y, 2014, CURR OPIN GENET DEV, V27, P60, DOI 10.1016/j.gde.2014.03.010; Wang SK, 2014, EMBO REP, V15, P1053, DOI 10.15252/embr.201338343; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WHO, 2010, 63 WHO WORLD HLTH AS; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	69	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28231	28244		10.1074/jbc.M115.687764	http://dx.doi.org/10.1074/jbc.M115.687764			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446788	hybrid, Green Published			2022-12-26	WOS:000365761900017
J	Sun, LL; Zhao, ZZ; Liu, S; Liu, X; Sun, ZF; Luo, B				Sun, Lingling; Zhao, Zhenzhen; Liu, Song; Liu, Xia; Sun, Zhifu; Luo, Bing			Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China	PLOS ONE			English	Article							ENHANCED TRANSCRIPTIONAL ACTIVITY; V-VAL SUBTYPE; NASOPHARYNGEAL CARCINOMA; AMERICAN PATIENTS; EBNA-1 GENE; DISEASE; CELLS; TUMOR; MALIGNANCIES; POLYMORPHISM	Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is the only viral protein expressed in all EBV-positive tumors as it is essential for the maintenance, replication and transcription of the virus genome. According to the polymorphism of residue 487 in EBNA1 gene, EBV isolates can be classified into five subtypes: P-ala, P-thr, V-val, V-leu and V-pro. Whether these EBNA1 subtypes contribute to different tissue tropism of EBV and are consequently associated with certain malignancies remain to be determined. To elucidate the relationship, one hundred and ten EBV-positive lymphoma tissues of different types from Northern China, a non-NPC endemic area, were tested for the five subtypes by nested-PCR and DNA sequencing. In addition, EBV type 1 and type 2 classification was typed by using standard PCR assays across type-specific regions of the EBNA3C genes. Four EBNA1 subtypes were identified: V-val (68.2%, 75/110), P-thrV (15.5%, 17/110), V-leuV (3.6%, 4/110) and P-ala (10.9%, 12/110). The distribution of the EBNA1 subtypes in the four lymphoma groups was not significantly different (p = 0.075), neither was that of the EBV type 1/type 2 (p = 0.089). Compared with the previous data of gastric carcinoma (GC), nasopharyngeal carcinoma (NPC) and throat washing (TW) from healthy donors, the distribution of EBNA1 subtypes in lymphoma differed significantly (p = 0.016), with a little higher frequency of Pala subtype. The EBV type distribution between lymphoma and the other three groups was significantly different (p = 0.000, p = 0.000, p = 0.001, respectively). The proportion of type 1 and type 2 mixed infections was higher in lymphoma than that in GC, NPC and TW. In lymphomas, the distribution of EBNA1 subtypes in the three EBV types was not significantly different (p = 0.546). These data suggested that the variation patterns of EBNA1 gene may be geographic-associated rather than tumor-specific and the role of EBNA1 gene variations in tumorigenesis needs more extensive and deep explorations.	[Sun, Lingling] Qingdao Univ, Affiliated Hosp, Dept Pathol, Qingdao 266071, Peoples R China; [Sun, Lingling; Zhao, Zhenzhen; Liu, Song; Liu, Xia; Luo, Bing] Qingdao Univ, Coll Med, Dept Med Microbiol, Qingdao 266071, Peoples R China; [Sun, Zhifu] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Qingdao University; Qingdao University; Mayo Clinic	Luo, B (corresponding author), Qingdao Univ, Coll Med, Dept Med Microbiol, Qingdao 266071, Peoples R China.	qdluobing@163.com			Specialized Research Fund for the Doctoral Program of Higher Education [20133706110001]; Natural Science Foundation of Shandong Province [ZR2011CM016]; Science and Technology of Qingdao City, China [13-1-3-50-jch]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science and Technology of Qingdao City, China	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (http://www.cutech.edu.cn), Grant: 20133706110001 to BL, the Natural Science Foundation of Shandong Province (http://www.sdnsf.gov.cn), Grant: ZR2011CM016 to BL and the Science and Technology of Qingdao City, China (http://www.qdstc.gov.cn), Grant 13-1-3-50-jch to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Junhong, 2012, Virol J, V9, P13, DOI 10.1186/1743-422X-9-13; Lorenzetti MA, 2010, J MED VIROL, V82, P1730, DOI 10.1002/jmv.21871; AMBINDER RF, 1991, J VIROL, V65, P1466, DOI 10.1128/JVI.65.3.1466-1478.1991; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bhatia K, 1996, ONCOGENE, V13, P177; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Chang KL, 1999, BLOOD, V94, P244, DOI 10.1182/blood.V94.1.244.413a33_244_250; Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170; CHEN MR, 1993, J VIROL, V67, P4875, DOI 10.1128/JVI.67.8.4875-4885.1993; Chen YY, 1998, LAB INVEST, V78, P877; Do NV, 2008, VIRUS RES, V132, P15, DOI 10.1016/j.virusres.2007.10.020; Frappier L, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/438204; Gorzer I, 2006, VIRUS RES, V118, P105, DOI 10.1016/j.virusres.2005.11.020; Gratama JW, 1995, ADV CANCER RES, V67, P197, DOI 10.1016/S0065-230X(08)60714-9; Gutierrez MI, 1998, BLOOD, V92, P600, DOI 10.1182/blood.V92.2.600.414k33_600_606; Gutierrez MI, 1997, J GEN VIROL, V78, P1663, DOI 10.1099/0022-1317-78-7-1663; Habeshaw G, 1999, J VIROL, V73, P965, DOI 10.1128/JVI.73.2.965-975.1999; Hsu JL, 2000, CRIT REV ONCOL HEMAT, V34, P27, DOI 10.1016/S1040-8428(00)00046-9; Kang MS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.84; KHAN G, 1992, J CLIN PATHOL, V45, P616, DOI 10.1136/jcp.45.7.616; MacKenzie J, 1999, J GEN VIROL, V80, P2741, DOI 10.1099/0022-1317-80-10-2741; Mai SJ, 2010, ONCOL REP, V23, P1417, DOI 10.3892/or_00000779; RICKINSON AB, 1987, J VIROL, V61, P1310, DOI 10.1128/JVI.61.5.1310-1317.1987; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Sandvej K, 2000, J PATHOL, V191, P127, DOI 10.1002/(SICI)1096-9896(200006)191:2<127::AID-PATH614>3.0.CO;2-E; Tsao SW, 2015, J PATHOL, V235, P323, DOI 10.1002/path.4448; Tzellos S, 2012, PATHOGENS, V1, P156, DOI 10.3390/pathogens1020156; Vockerodt M, 2015, J PATHOL, V235, P312, DOI 10.1002/path.4459; Wang JT, 2003, J MED VIROL, V69, P417, DOI 10.1002/jmv.10305; Wang WY, 2002, CLIN CANCER RES, V8, P2586; Wang Y, 2010, VIRUS RES, V147, P258, DOI 10.1016/j.virusres.2009.11.010; Yao QY, 1996, J VIROL, V70, P4884, DOI 10.1128/JVI.70.8.4884-4894.1996; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Zhang XS, 2004, CANCER LETT, V211, P11, DOI 10.1016/j.canlet.2004.01.035	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140529	10.1371/journal.pone.0140529	http://dx.doi.org/10.1371/journal.pone.0140529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460969	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300108
J	Wolffhechel, K; Hahn, AC; Jarmer, H; Fisher, CI; Jones, BC; DeBruine, LM				Wolffhechel, Karin; Hahn, Amanda C.; Jarmer, Hanne; Fisher, Claire I.; Jones, Benedict C.; DeBruine, Lisa M.			Testing the Utility of a Data-Driven Approach for Assessing BMI from Face Images	PLOS ONE			English	Article							VISUAL CUES; PERCEPTION; ADIPOSITY; HEALTH	Several lines of evidence suggest that facial cues of adiposity may be important for human social interaction. However, tests for quantifiable cues of body mass index (BMI) in the face have examined only a small number of facial proportions and these proportions were found to have relatively low predictive power. Here we employed a data-driven approach in which statistical models were built using principal components (PCs) derived from objectively defined shape and color characteristics in face images. The predictive power of these models was then compared with models based on previously studied facial proportions (perimeter-to-area ratio, width-to-height ratio, and cheek-to-jaw width). Models based on 2D shape-only PCs, color-only PCs, and 2D shape and color PCs combined each performed significantly and substantially better than models based on one or more of the previously studied facial proportions. A non-linear PC model considering both 2D shape and color PCs was the best predictor of BMI. These results highlight the utility of a "bottom-up", data-driven approach for assessing BMI from face images.	[Wolffhechel, Karin; Jarmer, Hanne] Tech Univ Denmark, Ctr Biol Sequence Anal, DTU Syst Biol, DK-2800 Lyngby, Denmark; [Hahn, Amanda C.; Fisher, Claire I.; Jones, Benedict C.; DeBruine, Lisa M.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Technical University of Denmark; University of Glasgow	Wolffhechel, K (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DTU Syst Biol, DK-2800 Lyngby, Denmark.	karinw@cbs.dtu.dk	Hahn, Amanda C/AAH-1106-2021; DeBruine, Lisa M/A-6990-2008; Jones, Benedict C/A-7850-2008	Hahn, Amanda C/0000-0002-4555-7924; DeBruine, Lisa M/0000-0002-7523-5539; Jones, Benedict C/0000-0001-7777-0220	European Research Council [282655, 647910]; Economic and Social Research Council [ES/I031022/1]; Economic and Social Research Council [ES/I031022/2] Funding Source: researchfish; ESRC [ES/I031022/2, ES/I031022/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by European Research Council Grant 282655 (OCMATE), http://erc.europa.eu (BCJ); European Research Council Grant 647910 (KINSHIP), http://erc.europa.eu (LMD); and Economic and Social Research Council Grant ES/I031022/1, http://www.esrc.ac.uk, (LMD, BCJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2005, VIOPLOT VIOLIN PLOT; [Anonymous], 2014, R LANG ENV STAT COMP; Calder AJ, 2001, VISION RES, V41, P1179, DOI 10.1016/S0042-6989(01)00002-5; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Dryden IL, 2013, SHAPES STAT SHAPE AN; Fisher CI, 2014, BRIT J PSYCHOL, V105, P474, DOI 10.1111/bjop.12055; Fisher CI, 2014, PERCEPTION, V43, P499, DOI 10.1068/p7728; Geniole SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132726; Goeman J, 2014, L1 LASSO FUSED LASSO; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Huang WL, 2012, IMAGE VISION COMPUT, V30, P355, DOI 10.1016/j.imavis.2012.03.004; Jones BC, 2015, PSYCHONEUROENDOCRINO, V56, P29, DOI 10.1016/j.psyneuen.2015.02.021; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Krstajic D, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-10; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Mayew WJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0538; Rantala MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0255; Rantala MJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2495; Reither EN, 2009, DEMOGRAPHY, V46, P27, DOI 10.1353/dem.0.0037; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Teh YW, 2001, ADV NEUR IN, V13, P908; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tinlin RM, 2013, BRIT J PSYCHOL, V104, P235, DOI 10.1111/j.2044-8295.2012.02117.x; Todorov A, 2011, IEEE SIGNAL PROC MAG, V28, P117, DOI 10.1109/MSP.2010.940006; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Whitehead RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032988; Wolffhechel K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107721; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	34	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140347	10.1371/journal.pone.0140347	http://dx.doi.org/10.1371/journal.pone.0140347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460526	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300082
J	Yost, AD; Joshi, SG				Yost, Adam D.; Joshi, Suresh G.			Atmospheric Nonthermal Plasma-Treated PBS Inactivates Escherichia coli by Oxidative DNA Damage	PLOS ONE			English	Article							BARRIER DISCHARGE PLASMA; HYDROGEN-PEROXIDE; LIPID-PEROXIDATION; TRANSCRIPTIONAL ACTIVATION; BACTERICIDAL ANTIBIOTICS; STRESS; OXYR; MECHANISMS; INVOLVEMENT; ENZYMES	We recently reported that phosphate-buffered saline (PBS) treated with nonthermal dielectric- barrier discharge plasma (plasma) acquires strong antimicrobial properties, but the mechanisms underlying bacterial inactivation were not known. The goal of this study is to understand the cellular responses of Escherichia coli and to investigate the properties of plasma-activated PBS. The plasma-activated PBS induces severe oxidative stress in E. coli cells and reactive-oxygen species scavengers, a-tocopherol and catalase, protect E. coli from cell death. Here we show that the response of E. coli to plasma-activated PBS is regulated by OxyR and SoxyRS regulons, and mediated predominantly through the expression of katG that deactivates plasma-generated oxidants. During compensation of E. coli in the absence of both katG and katE, sodA and sodB are significantly overexpressed in samples exposed to plasma-treated PBS. Microarray analysis found that up-regulation of genes involved in DNA repair, and E. coli expressing recA:: lux fusion was extremely sensitive to the SOS response upon exposure to plasma-treated PBS. The cellular changes include rapid loss of E. coli membrane potential and membrane integrity, lipid peroxidation, accumulation of 8-hydroxy-deoxyguinosine (8OHdG), and severe oxidative DNA damage; reveal ultimate DNA disintegration, and cell death. Together, these data suggest that plasma-treated PBS contains hydrogen peroxide and superoxide like reactive species or/ and their products which lead to oxidative changes to cell components, and are eventually responsible for cell death.	[Yost, Adam D.; Joshi, Suresh G.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Surg Infect & Biofilms, Philadelphia, PA 19104 USA; [Yost, Adam D.; Joshi, Suresh G.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Joshi, SG (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Surg Infect & Biofilms, Philadelphia, PA 19104 USA.	suresh.joshi@drexelmed.edu	Joshi, Suresh G./AAT-1354-2021	Joshi, Suresh G./0000-0002-7838-4898				Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Asad NR, 2004, GENET MOL BIOL, V27, P291, DOI 10.1590/S1415-47572004000200026; BEYER WF, 1987, BIOCHEMISTRY-US, V26, P1251, DOI 10.1021/bi00379a008; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bouhafs RKL, 1999, LUNG, V177, P101, DOI 10.1007/PL00007629; Bruno-Barcena JM, 2010, APPL ENVIRON MICROB, V76, P2747, DOI 10.1128/AEM.02718-09; Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x; DEMPLE B, 1991, ANNU REV GENET, V25, P315, DOI 10.1146/annurev.ge.25.120191.001531; Ercan UK, 2013, PLASMA PROCESS POLYM, V10, P544, DOI 10.1002/ppap.201200104; FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gonzalez-Flecha B, 1999, J BACTERIOL, V181, P3833; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; Hidalgo E, 1996, J BIOL CHEM, P271; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Joshi S.G., 2015, ADV BIOSCI BIOTECHNO, V6, P49, DOI [10.4236/abb.2015.62006, DOI 10.4236/ABB.2015.62006, DOI 10.4236/ABB.2015.62006)]; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; Kamgang-Youbi G, 2007, APPL ENVIRON MICROB, V73, P4791, DOI 10.1128/AEM.00120-07; Ko KC, 2012, ANTIMICROB AGENTS CH, V56, P1725, DOI 10.1128/AAC.05874-11; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KONO Y, 1994, ARCH BIOCHEM BIOPHYS, V311, P153, DOI 10.1006/abbi.1994.1220; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Lan J, 2000, J NEUROCHEM, V74, P302, DOI 10.1046/j.1471-4159.2000.0740302.x; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Lee PE, 2009, P NATL ACAD SCI USA, V106, P13164, DOI 10.1073/pnas.0906429106; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Sharma A, 2009, J APPL MICROBIOL, V107, P1440, DOI 10.1111/j.1365-2672.2009.04323.x; Stephani K, 2003, MOL MICROBIOL, V49, P1605, DOI 10.1046/j.1365-2958.2003.03644.x; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Storz G., 1990, ANTON LEEUW INT J G, V1990, P157, DOI DOI 10.1007/BF00548927; Traylor MJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/47/472001; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Vollmer AC, 1997, APPL ENVIRON MICROB, V63, P2566, DOI 10.1128/AEM.63.7.2566-2571.1997; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wu HY, 2012, PLASMA PROCESS POLYM, V9, P417, DOI 10.1002/ppap.201100065; Yoon SJ, 2002, J BIOCHEM MOL BIOL, V35, P297; Zavilgelsky GB, 2007, MUTAT RES-GEN TOX EN, V634, P172, DOI 10.1016/j.mrgentox.2007.07.012; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zheng S, 2008, VACUUM, V83, P238, DOI 10.1016/j.vacuum.2008.04.002	51	37	38	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139903	10.1371/journal.pone.0139903	http://dx.doi.org/10.1371/journal.pone.0139903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461113	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300032
J	Cohen, Y				Cohen, Yigal			The Novel Oomycide Oxathiapiprolin Inhibits All Stages in the Asexual Life Cycle of Pseudoperonospora cubensis - Causal Agent of Cucurbit Downy Mildew	PLOS ONE			English	Article							ACID AMIDE FUNGICIDES; METALAXYL-RESISTANT; POWDERY MILDEW; MANAGEMENT; EFFICACY; CUCUMBER; ULTRASTRUCTURE; CYMOXANIL; FUNGUS	Oxathiapiprolin is a new oomycide (piperidinyl thiazole isoxazoline class) discovered by DuPont which controls diseases caused by oomycete plant pathogens. It binds in the oxysterol- binding protein domain of Oomycetes. Growth chambers studies with detached leaves and potted plants showed remarkable activity of oxathiapiprolin against Pseudoperonospora cubensis in cucurbits. The compound affected all stages in the asexual life cycle of the pathogen. It inhibited zoospore release, cystospore germination, lesion formation, lesion expansion, sporangiophore development and sporangial production. When applied to the foliage as a preventive spray no lesions developed due to inhibition of zoospore release and cystospore germination, and when applied curatively, at one or two days after inoculation, small restricted lesions developed but no sporulation occurred. When applied later to mature lesions, sporulation was strongly inhibited. Oxathiapiprolin suppressed sporulation of P. cubensis in naturally-infected leaves. It exhibited trans-laminar activity, translocated acropetaly from older to younger leaves, and moved from the root system to the foliage. Seed coating was highly effective in protecting the developed cucumber plants against downy mildew. UV microscopy observations made with cucumber leaves infected with P. cubensis revealed that inhibition of mycelium growth and sporulation induced by oxathiapiprolin was associated with callose encasement of the haustoria.	Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel	Bar Ilan University	Cohen, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	yigal.cohen1@gmail.com			DuPont de Numerous	DuPont de Numerous	This research was supported by a grant from DuPont de Numerous.	Adams M.L., 2014, PLANT DIS MANAG REP, V8, pV240; Bittner R, 2014, PHYTOPATHOLOGY, V104, P15; Blum M, 2011, PEST MANAG SCI, V67, P1211, DOI 10.1002/ps.2238; COHEN Y, 1993, CROP PROT, V12, P284, DOI 10.1016/0261-2194(93)90048-N; COHEN Y, 1990, PHYSIOL MOL PLANT P, V36, P191, DOI 10.1016/0885-5765(90)90025-S; COHEN Y, 1986, ANNU REV PHYTOPATHOL, V24, P311, DOI 10.1146/annurev.py.24.090186.001523; COHEN Y, 1989, PHYSIOL MOL PLANT P, V34, P27, DOI 10.1016/0885-5765(89)90014-3; COHEN Y, 1983, PHYTOPATHOLOGY, V73, P1516, DOI 10.1094/Phyto-73-1516; Cohen Y, 2003, PHYTOPARASITICA, V31, P458, DOI 10.1007/BF02979739; COHEN Y, 1979, PHYTOPATHOLOGY, V69, P645, DOI 10.1094/Phyto-69-645; Cohen Y, 2015, OXATHIAPIPROLIN NEW; Cohen Y, 2015, PHYTOPATHOLOGY, V105, P1; Cohen Y, 2014, FUNGICIDE RESISTANCE, V9, DOI 10.1371/ journal. pone. 0109766; Cohen Y, 2007, PHYTOPATHOLOGY, V97, P1274, DOI 10.1094/PHYTO-97-10-1274; Cohen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109766; Cohen Y, 2012, EUR J PLANT PATHOL, V132, P577, DOI 10.1007/s10658-011-9902-3; Cohen Y, 2010, EUR J PLANT PATHOL, V126, P553, DOI 10.1007/s10658-009-9564-6; Fehr M, 2016, PEST MANAG SCI, V72, P591, DOI 10.1002/ps.4031; Gisi U, 2014, FUNGICIDE RESISTANCE; Gold RE, 2011, MODERN FUNGICIDES AN, P55; Hausbeck M.K., 2014, PLANT DIS MANAGE REP, V8, pV304, DOI [10.1094/PDMR08, DOI 10.1094/PDMR08]; Hermann D, 2016, FUNGICIDE RESISTANCE; Holmes GJ, 2006, OLD ENEMY RE EMERGES; Humann R, 2014, PHYTOPATHOLOGY, V104, P52; Ishii H, 2001, PHYTOPATHOLOGY, V91, P1166, DOI 10.1094/PHYTO.2001.91.12.1166; Ji P, 2015, ANN APPL BIOL, V166, P229, DOI 10.1111/aab.12176; Ji PS, 2014, PLANT DIS, V98, P1551, DOI 10.1094/PDIS-02-14-0172-RE; Lebeda A, 2011, FUNGICIDE RESISTANCE IN CROP PROTECTION: RISK AND MANAGEMENT, P44, DOI 10.1079/9781845939052.0044; Lebeda A, 2011, EUR J PLANT PATHOL, V129, P157, DOI 10.1007/s10658-010-9658-1; Matheron ME, 2014, PHYTOPATHOLOGY, V104, P75; Ojiambo PS, 2010, PHYTOPATHOLOGY, V100, P1066, DOI 10.1094/PHYTO-12-09-0348; Ojiambo PS, 2015, ANNU REV PHYTOPATHOL, V53; PALTI J, 1980, PHYTOPARASITICA, V8, P109, DOI 10.1007/BF02994506; Patel JS, 2014, PHYTOPATHOLOGY, V104, P90; PATEL JS, 2013, PHYTOPATHOLOGY S2, V103, P111; Pavelkova J, 2014, CROP PROT, V60, P9, DOI 10.1016/j.cropro.2014.02.006; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; REUVENI M, 1980, Plant Disease, V64, P1108, DOI 10.1094/PD-64-1108; SAMOUCHA Y, 1985, Bulletin OEPP, V15, P419; SAMOUCHA Y, 1984, PHYTOPATHOLOGY, V74, P1437, DOI 10.1094/Phyto-74-1437; Sierotzki H, 2011, MODERN FUNGICIDES AN; Sweigard JA, 2014, 13 IUPAC C PEST CHEM; Thornton A.C., 2005, FUNGIC NEMATIC TESTS, V60, pV059, DOI DOI 10.1094/FN60; Zhu SS, 2007, PLANT PATHOL, V56, P967, DOI 10.1111/j.1365-3059.2007.01649.x; Zhu XL, 2015, J AGR FOOD CHEM, V63, P3377, DOI 10.1021/acs.jafc.5b00228	45	44	47	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140015	10.1371/journal.pone.0140015	http://dx.doi.org/10.1371/journal.pone.0140015			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452052	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511200026
J	Barr-Beare, E; Saxena, V; Hilt, EE; Thomas-White, K; Schober, M; Li, BR; Becknell, B; Hains, DS; Wolfe, AJ; Schwaderer, AL				Barr-Beare, Evan; Saxena, Vijay; Hilt, Evann E.; Thomas-White, Krystal; Schober, Megan; Li, Birong; Becknell, Brian; Hains, David S.; Wolfe, Alan J.; Schwaderer, Andrew L.			The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; IDIOPATHIC HYPERCALCIURIA; OCHROBACTRUM-ANTHROPI; STONE FORMERS; BACTERIA; KIDNEY; INFLAMMATION; CHILDREN; RISK	Background The role of calcium oxalate crystals and deposits in UTI pathogenesis has not been established. The objectives of this study were to identify bacteria present in pediatric urolithiasis and, using in vitro and in vivo models, to determine the relevance of calcium oxalate deposits during experimental pyelonephritis. Methods Pediatric kidney stones and urine were collected and both cultured and sequenced for bacteria. Bacterial adhesion to calcium oxalate was compared. Murine kidney calcium oxalate deposits were induced by intraperitoneal glyoxalate injection and kidneys were transurethrally inoculated with uropathogenic Escherichia coli to induce pyelonephritis Results E. coli of the family Enterobacteriaceae was identified in patients by calcium oxalate stone culture. Additionally Enterobacteriaceae DNA was sequenced from multiple calcium oxalate kidney stones. E. coli selectively aggregated on and around calcium oxalate monohydrate crystals. Mice inoculated with glyoxalate and uropathogenic E. coli had higher bacterial burdens, increased kidney calcium oxalate deposits and an increased kidney innate immune response compared to mice with only calcium oxalate deposits or only pyelonephritis. Conclusions In a murine model, the presence of calcium oxalate deposits increases pyelonephritis risk, likely due to preferential aggregation of bacteria on and around calcium oxalate crystals. When both calcium oxalate deposits and uropathogenic bacteria were present, calcium oxalate deposit number increased along with renal gene transcription of inner stone core matrix proteins increased. Therefore renal calcium oxalate deposits may be a modifiable risk factor for infections of the kidney and urinary tract. Furthermore, bacteria may be present in calcium oxalate deposits and potentially contribute to calcium oxalate renal disease.	[Barr-Beare, Evan; Saxena, Vijay; Li, Birong; Becknell, Brian] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH USA; [Hilt, Evann E.; Thomas-White, Krystal; Wolfe, Alan J.; Schwaderer, Andrew L.] Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Schober, Megan] Nationwide Childrens Hosp, Div Urol, Columbus, OH USA; [Becknell, Brian; Schwaderer, Andrew L.] Nationwide Childrens Hosp, Div Nephrol, Columbus, OH USA; [Hains, David S.] Lebonheur Childrens Hosp, Div Nephrol, Memphis, TN USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Loyola University Chicago; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Schwaderer, AL (corresponding author), Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA.	Andrew.schwaderer@nationwidechildrens.org	Hains, David/AAR-1112-2020; Hilt, Evann/AGY-7111-2022; Schwaderer, Andrew/E-4049-2011; Saxena, Vijay/GRJ-1960-2022	Hains, David/0000-0001-6511-9561; Thomas-White, Krystal/0000-0002-4635-1426; Saxena, Vijay/0000-0002-6696-0472	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1-RC4-DK-090937-01A]; Falk Foundation [LU202567]; NIH [R21DK097435-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK097435, RC4DK090937] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Falk Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.L. Schwaderer and D.S. Hains were supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant 1-RC4-DK-090937-01A. A.J. Wolfe was supported by the Falk Foundation (LU202567) and by NIH grant R21DK097435-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestracci A, 2014, ARCH ARGENT PEDIATR, V112, P428, DOI [10.5546/aap.2014.428, 10.5546/aap.2014.eng.428]; Brubaker L, 2015, AM J OBSTET GYNECOL, V213, P644, DOI 10.1016/j.ajog.2015.05.032; Cameron MA, 2005, PEDIATR NEPHROL, V20, P1587, DOI 10.1007/s00467-005-1883-z; Canales BK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.05.005; Chutipongtanate S, 2013, J BIOL INORG CHEM, V18, P299, DOI 10.1007/s00775-012-0974-0; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Elisabetta M, 1996, NEPHROL DIAL TRANSPL, V11, P1185; Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2; Flannigan R, 2014, NAT REV UROL, V11, P333, DOI 10.1038/nrurol.2014.99; Flythe JE, 2009, AM J KIDNEY DIS, V54, P127, DOI 10.1053/j.ajkd.2008.10.042; Ghazali A, 1997, J CLIN ENDOCR METAB, V82, P32, DOI 10.1210/jc.82.1.32; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; GRASES F, 1990, UROL RES, V18, P17, DOI 10.1007/BF00294575; Grover RK, 2012, P NATL ACAD SCI USA, V109, P6036, DOI 10.1073/pnas.1202214109; Hains DS, 2014, AM J PHYSIOL-RENAL, V307, pF869, DOI 10.1152/ajprenal.00344.2014; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; HOLMGREN K, 1989, SCAND J UROL NEPHROL, V23, P131, DOI 10.3109/00365598909180827; Huang HS, 2003, UROLOGY, V62, P1123, DOI 10.1016/S0090-4295(03)00764-7; HUGOSSON J, 1989, SCAND J UROL NEPHROL, V23, P61, DOI 10.1080/00365599.1989.11690432; KAIJSER B, 1977, LANCET, V1, P663; Lanter BB, 2014, MBIO, V5, DOI 10.1128/mBio.01206-14; Lieske JC, 2006, KIDNEY INT, V69, P760, DOI 10.1038/sj.ki.5000150; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Mushtaq S, 2007, CLIN CHIM ACTA, V384, P41, DOI 10.1016/j.cca.2007.05.015; Nacaroglu HT, 2013, RENAL FAILURE, V35, P327, DOI 10.3109/0886022X.2013.764254; NILEKANI S, 1983, BIOCHEMISTRY-US, V22, P4657, DOI 10.1021/bi00289a008; Okada A, 2007, UROL RES, V35, P89, DOI 10.1007/s00240-007-0082-8; Osborne CA, 1999, VET CLIN N AM-SMALL, V29, P213, DOI 10.1016/S0195-5616(99)50012-0; Pak CYC, 1998, LANCET, V351, P1797, DOI 10.1016/S0140-6736(98)01295-1; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Qasimyar H, 2014, J PERINATOL, V34, P489, DOI 10.1038/jp.2014.31; Rhee E, 1998, J UROLOGY, V160, P2284, DOI 10.1016/S0022-5347(01)62311-5; Shoag J, 2014, J UROLOGY, V191, pE272; Silva TMA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/518323; Srivastava T, 2009, PEDIATR RES, V66, P85, DOI 10.1203/PDR.0b013e3181a2939e; Suen JL, 2010, UROL RES, V38, P81, DOI 10.1007/s00240-010-0260-y; Tavichakorntrakool R, 2012, NEPHROL DIAL TRANSPL, V27, P4125, DOI 10.1093/ndt/gfs057; Tittel AP, 2011, J AM SOC NEPHROL, V22, P1435, DOI 10.1681/ASN.2010101072; Velasco J, 1998, INT J SYST BACTERIOL, V48, P759, DOI 10.1099/00207713-48-3-759; Wang XL, 2014, CLIN J AM SOC NEPHRO, V9, P1757, DOI 10.2215/CJN.01490214; Whiteside SA, 2015, NAT REV UROL, V12, P81, DOI 10.1038/nrurol.2014.361; WIESSNER JH, 1988, AM REV RESPIR DIS, V138, P445, DOI 10.1164/ajrccm/138.2.445; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11	45	66	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139575	10.1371/journal.pone.0139575	http://dx.doi.org/10.1371/journal.pone.0139575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448465	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000035
J	Camp, EF; Krause, SL; Santos, LMF; Naumann, MS; Kikuchi, RKP; Smith, DJ; Wild, C; Suggett, DJ				Camp, Emma F.; Krause, Sophie-Louise; Santos, Lourianne M. F.; Naumann, Malik S.; Kikuchi, Ruy K. P.; Smith, David J.; Wild, Christian; Suggett, David J.			The "Flexi-Chamber": A Novel Cost-Effective In Situ Respirometry Chamber for Coral Physiological Measurements	PLOS ONE			English	Article							COMMUNITY METABOLISM; OCEAN ACIDIFICATION; CARBON-DIOXIDE; WATER-FLOW; PHOTOSYNTHESIS; RESPIRATION; CALCIFICATION; PRODUCTIVITY; TEMPERATURE; STRESS	Coral reefs are threatened worldwide, with environmental stressors increasingly affecting the ability of reef-building corals to sustain growth from calcification (G), photosynthesis (P) and respiration (R). These processes support the foundation of coral reefs by directly influencing biogeochemical nutrient cycles and complex ecological interactions and therefore represent key knowledge required for effective reef management. However, metabolic rates are not trivial to quantify and typically rely on the use of cumbersome in situ respirometry chambers and/or the need to remove material and examine ex situ, thereby fundamentally limiting the scale, resolution and possibly the accuracy of the rate data. Here we describe a novel low-cost in situ respirometry bag that mitigates many constraints of traditional glass and plexi-glass incubation chambers. We subsequently demonstrate the effectiveness of our novel "Flexi-Chamber" approach via two case studies: 1) the Flexi-Chamber provides values of P, R and G for the reef-building coral Siderastrea cf. stellata collected from reefs close to Salvador, Brazil, which were statistically similar to values collected from a traditional glass respirometry vessel; and 2) wide-scale application of obtaining P, R and G rates for different species across different habitats to obtain inter- and intra-species differences. Our novel cost-effective design allows us to increase sampling scale of metabolic rate measurements in situ without the need for destructive sampling and thus significantly expands on existing research potential, not only for corals as we have demonstrated here, but also other important benthic groups.	[Camp, Emma F.; Smith, David J.; Suggett, David J.] Univ Essex, Sch Biol Sci, Coral Reef Res Unit, Colchester CO4 3SQ, Essex, England; [Krause, Sophie-Louise; Naumann, Malik S.; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, D-28359 Bremen, Germany; [Krause, Sophie-Louise; Wild, Christian] Univ Bremen, Fac Biol & Chem FB 2, D-28359 Bremen, Germany; [Santos, Lourianne M. F.; Kikuchi, Ruy K. P.] Univ Fed Bahia, Coral Reef & Global Changes Res Grp RECOR, Inst Geosci, Salvador, BA, Brazil; [Suggett, David J.] Univ Technol Sydney, Funct Plant Biol & Climate Change Cluster C3, Broadway, NSW, Australia	University of Essex; Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; Universidade Federal da Bahia; University of Technology Sydney	Camp, EF (corresponding author), Univ Essex, Sch Biol Sci, Coral Reef Res Unit, Colchester CO4 3SQ, Essex, England.	efcamp@essex.ac.uk	Camp, Emma/W-3335-2017; Naumann, Malik/A-3607-2011; Suggett, David J/G-9212-2017; /AAL-3738-2021; Kikuchi, Ruy K P/I-4884-2013	Camp, Emma/0000-0003-1962-1336; Naumann, Malik/0000-0002-6870-291X; Suggett, David J/0000-0001-5326-2520; Kikuchi, Ruy K P/0000-0002-6271-7491; Smith, David/0000-0003-1886-8193	Program Marie Curie Actions-People Grant "SymbioCoRe" (Synergies Through Merging Biological and Biogeochemical Expertise in Coral Research) [PIRSES-GA-2011-295191]; Australian Research Council Future Fellowship [FT130100202]	Program Marie Curie Actions-People Grant "SymbioCoRe" (Synergies Through Merging Biological and Biogeochemical Expertise in Coral Research); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported through the Program Marie Curie Actions-People Grant PIRSES-GA-2011-295191 "SymbioCoRe" (Synergies Through Merging Biological and Biogeochemical Expertise in Coral Research) to CW, DJSug, MN and DJSm. The contribution of DJSug was additionally supported through an Australian Research Council Future Fellowship FT130100202.	Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Andersson AJ, 2009, BIOGEOSCIENCES, V6, P1811, DOI 10.5194/bg-6-1811-2009; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2013, BIOGEOSCIENCES, V10, P4897, DOI 10.5194/bg-10-4897-2013; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; ATKINSON MJ, 1992, LIMNOL OCEANOGR, V37, P273, DOI 10.4319/lo.1992.37.2.0273; Baird ME, 1997, LIMNOL OCEANOGR, V42, P1685, DOI 10.4319/lo.1997.42.8.1685; BARNES DJ, 1983, J EXP MAR BIOL ECOL, V66, P149, DOI 10.1016/0022-0981(83)90036-9; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Burke L., 2011, REEFS RISK REVISITED; Camp E, 2015, PERSONAL OBSER UNPUB; Camp EF, 2014, PERSONAL OBSERVATION; Cirano M., 2007, REVIS BRASILEIRA GEO, V25, P363, DOI DOI 10.1590/S0102-261X2007000400002; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Coles SL, 1992, P 7 INT COR REEF S, V1, P223; Connell JH, 1973, BIOL GEOL CORAL REEF, VII; Crawley M.J., 2007, R BOOK; DAVIES PS, 1980, BIOL BULL, V158, P187, DOI 10.2307/1540930; de Beer D, 2000, MAR ECOL PROG SER, V194, P75, DOI 10.3354/meps194075; Dickson A.G., 2007, GUIDE BEST PRACTICES; Dove SG, 2013, P NATL ACAD SCI USA, V110, P15342, DOI 10.1073/pnas.1302701110; DYKENS JA, 1992, J EXP BIOL, V168, P219; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Falter JL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007268; Foote C.S, 1976, FREE RADICALS BIOL, P85, DOI DOI 10.1016/B978-0-12-566502-5.50010-X; GATTUSO JP, 1993, MAR ECOL PROG SER, V96, P259, DOI 10.3354/meps096259; Hennige SJ, 2010, J EXP MAR BIOL ECOL, V391, P143, DOI 10.1016/j.jembe.2010.06.019; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Kays W., 1980, CONVECTIVE HEAT MASS, V2, P355; Kinsey DW, 1983, PERSPECTIVES CORAL R, V200; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; Marsh J.A. Jr, 1978, Monographs on Oceanographic Methodology, P361; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McCloskey L.R., 1978, Monographs on Oceanographic Methodology, P379; McCloskey LR, 1978, MONOGRAPHS OCEANOGRA; McCloskey R, 1978, CORAL REEFS RES METH, P361; MUTHIGA NA, 1987, BIOL BULL-US, V173, P539, DOI 10.2307/1541699; Nakamura T, 2005, MAR POLLUT BULL, V50, P1115, DOI 10.1016/j.marpolbul.2005.06.025; Nakamura T, 2009, CORAL REEFS, V28, P229, DOI 10.1007/s00338-008-0454-8; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Naumann MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082923; Nystrom M, 2001, MAR BIOL, V138, P1225; Okazaki RR, 2013, CORAL REEFS, V32, P671, DOI 10.1007/s00338-013-1015-3; OnSet, 2012, HOBO PEND G DAT LOGG; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; PATTERSON MR, 1991, LIMNOL OCEANOGR, V36, P936, DOI 10.4319/lo.1991.36.5.0936; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REX A, 1995, J EXP MAR BIOL ECOL, V186, P33, DOI 10.1016/0022-0981(95)00150-P; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Schutter M, 2011, MAR BIOL, V158, P769, DOI 10.1007/s00227-010-1605-3; Shapiro OH, 2014, P NATL ACAD SCI USA, V111, P13391, DOI 10.1073/pnas.1323094111; Shashar N, 1996, J EXP MAR BIOL ECOL, V199, P17, DOI 10.1016/0022-0981(95)00156-5; SMITH SV, 1975, LIMNOL OCEANOGR, V20, P493, DOI 10.4319/lo.1975.20.3.0493; Suggett DJ, 2013, CORAL REEFS, V32, P327, DOI 10.1007/s00338-012-0996-7; Vollmer SV, 2000, BIOL BULL-US, V199, P21, DOI 10.2307/1542703; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilkinson C, 2008, STATUS CORAL REEFS W; Yates KK, 2003, CORAL REEFS, V22, P247, DOI 10.1007/s00338-003-0314-5; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	71	19	19	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138800	10.1371/journal.pone.0138800	http://dx.doi.org/10.1371/journal.pone.0138800			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448294	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000362511000012
J	Cheng, J; Huang, W; Cao, SL; Yang, R; Yang, W; Yun, ZQ; Wang, ZJ; Feng, QJ				Cheng, Jun; Huang, Wei; Cao, Shuangliang; Yang, Ru; Yang, Wei; Yun, Zhaoqiang; Wang, Zhijian; Feng, Qianjin			Enhanced Performance of Brain Tumor Classification via Tumor Region Augmentation and Partition	PLOS ONE			English	Article							CONTENT-BASED RETRIEVAL; MR-IMAGES; SEGMENTATION; POPULATION	Automatic classification of tissue types of region of interest (ROI) plays an important role in computer-aided diagnosis. In the current study, we focus on the classification of three types of brain tumors (i.e., meningioma, glioma, and pituitary tumor) in T1-weighted contrastenhanced MRI (CE-MRI) images. Spatial pyramid matching (SPM), which splits the image into increasingly fine rectangular subregions and computes histograms of local features from each subregion, exhibits excellent results for natural scene classification. However, this approach is not applicable for brain tumors, because of the great variations in tumor shape and size. In this paper, we propose a method to enhance the classification performance. First, the augmented tumor region via image dilation is used as the ROI instead of the original tumor region because tumor surrounding tissues can also offer important clues for tumor types. Second, the augmented tumor region is split into increasingly fine ring-form subregions. We evaluate the efficacy of the proposed method on a large dataset with three feature extraction methods, namely, intensity histogram, gray level co-occurrence matrix (GLCM), and bag-of-words (BoW) model. Compared with using tumor region as ROI, using augmented tumor region as ROI improves the accuracies to 82.31% from 71.39%, 84.75% from 78.18%, and 88.19% from 83.54% for intensity histogram, GLCM, and BoW model, respectively. In addition to region augmentation, ring-form partition can further improve the accuracies up to 87.54%, 89.72%, and 91.28%. These experimental results demonstrate that the proposed method is feasible and effective for the classification of brain tumors in T1-weighted CE-MRI.	[Cheng, Jun; Huang, Wei; Cao, Shuangliang; Yang, Ru; Yang, Wei; Yun, Zhaoqiang; Feng, Qianjin] Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Wang, Zhijian] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Feng, QJ (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.	qianjinfeng08@gmail.com	WANG, JINGYI/GSJ-1241-2022; Feng, Qianjin/Y-5438-2019; feng, qianjin/GNM-7856-2022; wang, jie/GRS-0942-2022	feng, qianjin/0000-0002-3830-5120; 	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAI14B02]; National Natural Science Foundation of China [81101109, 31371009]; National High Technology Research and Development Program of China (863 Program) [2012AA02A616]; Program of Pearl River Young Talents of Science and Technology in Guangzhou [2013J2200065, 2012J2200041]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program of Pearl River Young Talents of Science and Technology in Guangzhou	This work was supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (http://kjzc.jhgl.org/) under grant (No. 2012BAI14B02), the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under grant (No. 81101109 and No. 31371009), the National High Technology Research and Development Program of China (863 Program) (http://www.863.gov.cn/) under grant (No. 2012AA02A616), Program of Pearl River Young Talents of Science and Technology in Guangzhou (http://www.gzsi.gov.cn/) under grant (No. 2013J2200065), and Program of Pearl River Young Talents of Science and Technology in Guangzhou (http://www.gzsi.gov.cn/) under grant (No. 2012J2200041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Avni U, 2011, IEEE T MED IMAGING, V30, P733, DOI 10.1109/TMI.2010.2095026; Bagci U, 2010, PATTERN RECOGN LETT, V31, P315, DOI 10.1016/j.patrec.2009.09.010; Bernhard S., 2007, ADV NEURAL INFORM PR, P801; Bosch A., 2006, IEEE COMPUT SOC C CO, V2, P1552, DOI DOI 10.1109/CVPR.2006.188; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Gordillo N, 2013, MAGN RESON IMAGING, V31, P1426, DOI 10.1016/j.mri.2013.05.002; Harada T, 2011, PROC CVPR IEEE, P1617, DOI 10.1109/CVPR.2011.5995691; Javed Umer, 2013, Progress In Electromagnetics Research B, V53, P73; Jiang J, 2013, COMPUT MED IMAG GRAP, V37, P512, DOI 10.1016/j.compmedimag.2013.05.007; Jiang YN, 2012, LECT NOTES COMPUT SC, V7573, P730, DOI 10.1007/978-3-642-33709-3_52; John P, 2012, INT J SCI ENG RES, V3, P85; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Lazebnik S, 2009, IEEE T PATTERN ANAL, V31, P1294, DOI 10.1109/TPAMI.2008.138; Liu LQ, 2011, IEEE I CONF COMP VIS, P2486, DOI 10.1109/ICCV.2011.6126534; Liu W., 2010, P 27 INT C MACH LEAR, P679; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Matas J., 2002, Electronic Proceedings of the 13th British Machine Vision Conference, P384; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Patil S., 2013, INT J COMPUTER SCI E, V3, P61; Selvaraj H., 2007, INT J INTELLIGENT CO, V1, P21, DOI DOI 10.1080/1931308X.2007.10644134; Sharma G, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.6; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Torheim T, 2014, IEEE T MED IMAGING, V33, P1648, DOI 10.1109/TMI.2014.2321024; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Varma M, 2009, IEEE T PATTERN ANAL, V31, P2032, DOI 10.1109/TPAMI.2008.182; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wu Y, 2013, J DIGIT IMAGING, V26, P786, DOI 10.1007/s10278-012-9568-1; Yang JC, 2009, PROC CVPR IEEE, P1794, DOI 10.1109/CVPRW.2009.5206757; Yang L, 2008, P IEEE COMP SOC C CO; Yang W, 2012, J DIGIT IMAGING, V25, P708, DOI 10.1007/s10278-012-9495-1; Yang W, 2012, MED PHYS, V39, P6929, DOI 10.1118/1.4754305; Zulpe N., 2012, INT J COMPUT SCI ISS, V9, P354	35	130	131	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140381	10.1371/journal.pone.0140381	http://dx.doi.org/10.1371/journal.pone.0140381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447861	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000119
J	Jakobsson, ME; Moen, A; Davidson, B; Falnes, PO				Jakobsson, Magnus E.; Moen, Anders; Davidson, Ben; Falnes, Pal O.			Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma	PLOS ONE			English	Article							OVARIAN-CARCINOMA; SET DOMAIN; CANCER; FAMILY; METHYLTRANSFERASES; IDENTIFICATION; PROTEINS; TUMORS; CELLS	Cellular proteins are subject to frequent methylation on lysine residues, introduced by specific methyltransferases, and each lysine residue can receive up to three methyl groups. Histone methylations, which are key determinants of chromatin state and transcriptional status, have been subject to particularly intense studies, but methylations on non-histone protein substrates are also abundant and biologically significant. Numerous studies have addressed lysine methylation in the realm of cancer biology. A recent study used an antibody-based approach to investigate the methylation of Lys-561 of the stress-inducible Hsp70 protein HSPA1, focusing exclusively on dimethylated HSPA1, concluding that it was elevated in cancer [Cho et al. (2012), Nat. Commun., 3, 1072]. In the present study, we have performed a more extensive analysis of HSPA1 methylation status in cancer samples, using protein mass spectrometry. We found that the four methylation states of Lys561 on HSPA1 (un-, mono-, di- and trimethylated) could be measured accurately and reproducibly in samples from carcinomas. We investigated HSPA1 methylation in 70 effusions, representing 53 high-grade serous ovarian carcinomas and 17 breast carcinomas. Notably, we found the trimethylated form of HSPA1 to be predominant in the cancer samples. HSPA1 methylation was studied for association with clinicopathologic parameters, including chemotherapy response and survival. The trimethylated form was more prevalent in breast carcinoma effusions (p = 0.014), whereas the dimethylated (p = 0.025), monomethylated (p = 0.004) and unmethylated (p = 0.021) forms were overrepresented in the ovarian carcinomas. For the ovarian carcinomas, the monomethylated (p = 0.028) and unmethylated (p = 0.007) forms were significantly related to the presence of higher residual disease volume, while the unmethylated form was significantly associated with poor overall (p = 0.015) and progression-free (p = 0.012) survival. In conclusion, lysine methylation of HSPA1 differs between metastatic breast and ovarian carcinoma, and unmethylated HSPA1 shows potential as a prognostic marker in high-grade serous carcinoma.	[Jakobsson, Magnus E.; Moen, Anders; Falnes, Pal O.] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Davidson, Ben] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, N-0424 Oslo, Norway; [Davidson, Ben] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Davidson, B (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, N-0424 Oslo, Norway.	bend@medisin.uio.no; pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Falnes, Pal/0000-0001-8114-6025	Norwegian Cancer Society [107744-PR-2007-0132]; Inger and John Fredriksen Foundation for Ovarian Cancer	Norwegian Cancer Society(Norwegian Cancer Society); Inger and John Fredriksen Foundation for Ovarian Cancer	This work was supported by grants from the Norwegian Cancer Society (grant #107744-PR-2007-0132 to POF) and and the Inger and John Fredriksen Foundation for Ovarian Cancer (to BD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Miyako, 2004, Clin Prostate Cancer, V3, P49, DOI 10.3816/CGC.2004.n.013; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Carr SM, 2011, EMBO J, V30, P317, DOI 10.1038/emboj.2010.311; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Copeland RA, 2013, ONCOGENE, V32, P939, DOI 10.1038/onc.2012.552; Davidson B, 2001, AM J SURG PATHOL, V25, P1405, DOI 10.1097/00000478-200111000-00008; Davidson B, 2011, CYTOPATHOLOGY, V22, P5, DOI 10.1111/j.1365-2303.2010.00829.x; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; Dutta SK, 2012, PANCREAS, V41, P530, DOI 10.1097/MPA.0b013e3182374ace; Elstrand MB, 2009, INT J GYNECOL PATHOL, V28, P211, DOI 10.1097/PGP.0b013e31818b0f5e; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THIGPEN JT, 1994, J CLIN ONCOL, V12, P1748, DOI 10.1200/JCO.1994.12.9.1748; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zimmermann M, 2012, CLIN CHIM ACTA, V413, P1115, DOI 10.1016/j.cca.2012.03.008	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140168	10.1371/journal.pone.0140168	http://dx.doi.org/10.1371/journal.pone.0140168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448330	Green Published, gold			2022-12-26	WOS:000362511000100
J	Kotani, T; Takeuchi, T; Ishida, T; Masutani, R; Isoda, K; Hata, K; Yoshida, S; Makino, S; Hanafusa, T				Kotani, Takuya; Takeuchi, Tohru; Ishida, Takaaki; Masutani, Ryota; Isoda, Kentaro; Hata, Kenichiro; Yoshida, Shuzo; Makino, Shigeki; Hanafusa, Toshiaki			Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study	PLOS ONE			English	Article							CLINICALLY AMYOPATHIC DERMATOMYOSITIS; LUNG-DISEASE; T-CELLS; ENTRY MEDIATOR; CYCLOSPORINE-A; POLYMYOSITIS; PROGNOSIS; ACTIVATION; EXPRESSION; CT	Background Activated CD8+ T cells play an important role in the pathogenesis of dermatomyositis (DM) with interstitial pneumonia (IP). Serum CD8+ T-cell activator, LIGHT, and Th1/Th2/Th17 cytokines were measured in DM-IP patients and compared with clinical parameters to investigate their usefulness. Methods The correlations between the clinical findings and serum LIGHT and Th1/Th2/Th17 cytokine levels were investigated in 21 patients with DM-IP (14 with rapidly progressive IP [RPIP] and 7 with chronic IP [CIP], including 4 fatal cases of IP). Results The median serum LIGHT level was 119 (16-335.4) pg/ml, which was higher than that in healthy control subjects and DM patients without IP. The median serum IL-6 level was 14.7 (2.4-154.5) pg/ml (n = 13). The other cytokines were detected in only a few patients. The median serum LIGHT level in DM-RPIP patients (156 [49.6-335.4] pg/ml) was significantly higher than that in DM-CIP patients (94.3 [16-164.2] pg/ml) (P = 0.02). The serum IL-6 level did not correlate with either progression or outcome of DM-IP. ROC curve analysis determined a serum LIGHT level of >= 120 mu g/ml to be the cut-off value for the rapid progression of DM-IP. Serum LIGHT levels correlated significantly with % DLco (R = 0.55, P = 0.04) and total ground-glass opacity scores (R = 0.72, P = 0.0002). The serum LIGHT level significantly decreased to 100.5 (12.4-259.3) pg/ml 4 weeks after treatment initiation (P = 0.04). Conclusions The serum LIGHT level may be a promising marker of disease progression and severity in patients with DM-IP.	[Kotani, Takuya; Takeuchi, Tohru; Ishida, Takaaki; Isoda, Kentaro; Hata, Kenichiro; Yoshida, Shuzo; Makino, Shigeki; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 569, Japan; [Masutani, Ryota] Osaka Med Coll, Dept Cent Lab, Takatsuki, Osaka 569, Japan	Osaka Medical College; Osaka Medical College	Kotani, T (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 569, Japan.	in1242@poh.osaka-med.ac.jp						Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Arai S, 2013, MOD RHEUMATOL, V23, P872, DOI [10.3109/s10165-012-0756-0, 10.1007/s10165-012-0756-0]; Arakawa H, 2003, CHEST, V123, P1096, DOI 10.1378/chest.123.4.1096; BENBASSAT J, 1985, ARTHRITIS RHEUM-US, V28, P249, DOI 10.1002/art.1780280303; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Chen F, 2012, RHEUMATOL INT, V32, P3909, DOI 10.1007/s00296-011-2323-y; Clark JG, 1998, J IMMUNOL, V161, P1913; Cohavy O, 2004, J IMMUNOL, V173, P251, DOI 10.4049/jimmunol.173.1.251; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; Enelow RI, 1998, J CLIN INVEST, V102, P1653, DOI 10.1172/JCI4174; Gerami P, 2006, J AM ACAD DERMATOL, V54, P597, DOI 10.1016/j.jaad.2005.10.041; Gono T, 2014, RHEUMATOLOGY, V53, P2196, DOI 10.1093/rheumatology/keu258; Gono T, 2012, RHEUMATOLOGY, V51, P1336, DOI 10.1093/rheumatology/kes012; Gono T, 2010, RHEUMATOLOGY, V49, P1354, DOI 10.1093/rheumatology/keq073; Granger SW, 2003, CYTOKINE GROWTH F R, V14, P289, DOI 10.1016/S1359-6101(03)00031-5; Haroon N, 2010, ANN RHEUM DIS, V69, P297, DOI 10.1136/ard.2008.102277; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; Isoda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089610; Kameda H, 2005, J RHEUMATOL, V32, P1719; Kameda Hideto, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P409; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kim WJ, 2005, IMMUNOLOGY, V114, P272, DOI 10.1111/j.1365-2567.2004.02004.x; Kotani H, 2012, CLIN EXP IMMUNOL, V168, P318, DOI 10.1111/j.1365-2249.2012.04576.x; Kotani T, 2008, J RHEUMATOL, V35, P254; Kurasawa K, 2002, CLIN EXP IMMUNOL, V129, P541, DOI 10.1046/j.1365-2249.2002.01933.x; Maugars YM, 1996, CLIN EXP RHEUMATOL, V14, P263; Morel Y, 2000, J IMMUNOL, V165, P4397, DOI 10.4049/jimmunol.165.8.4397; Nagai K, 2011, MOD RHEUMATOL, V21, P32, DOI 10.1007/s10165-010-0342-2; Nara M, 2014, MOD RHEUMATOL, V24, P633, DOI 10.3109/14397595.2013.844390; Otterdal K, 2006, BLOOD, V108, P928, DOI 10.1182/blood-2005-09-010629; REMYJARDIN M, 1993, RADIOLOGY, V189, P693, DOI 10.1148/radiology.189.3.8234692; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2013, MOD RHEUMATOL, V23, P496, DOI 10.1007/s10165-012-0663-4; Sontheimer RD, 2002, DERMATOL CLIN, V20, P387, DOI 10.1016/S0733-8635(02)00021-9; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tamada K, 2002, J IMMUNOL, V168, P4832, DOI 10.4049/jimmunol.168.10.4832; TAZELAAR HD, 1990, AM REV RESPIR DIS, V141, P727, DOI 10.1164/ajrccm/141.3.727	38	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140117	10.1371/journal.pone.0140117	http://dx.doi.org/10.1371/journal.pone.0140117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448572	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000092
J	Nelson, JA; Bugbee, B				Nelson, Jacob A.; Bugbee, Bruce			Analysis of Environmental Effects on Leaf Temperature under Sunlight, High Pressure Sodium and Light Emitting Diodes	PLOS ONE			English	Article							STOMATAL CONDUCTANCE; TRANSPIRATION; PHOTOSYNTHESIS; MICROCLIMATE; CROP; CO2	The use of LED technology is commonly assumed to result in significantly cooler leaf temperatures than high pressure sodium technology. To evaluate the magnitude of this effect, we measured radiation incident to and absorbed by a leaf under four radiation sources: clear sky sunlight in the field, sunlight in a glass greenhouse, and indoor plants under either high pressure sodium or light emitting diodes. We then applied a common mechanistic energy-balance model to compare leaf to air temperature difference among the radiation sources and environments. At equal photosynthetic photon flux, our results indicate that the effect of plant water status and leaf evaporative cooling is much larger than the effect of radiation source. If plants are not water stressed, leaves in all four radiation sources were typically within 2 degrees C of air temperature. Under clear sky conditions, cool sky temperatures mean that leaves in the field are always cooler than greenhouse or indoor plants-when photosynthetic photon flux, stomatal conductance, wind speed, vapor pressure deficit, and leaf size are equivalent. As water stress increases and cooling via transpiration decreases, leaf temperatures can increase well above air temperature. In a near-worst case scenario of water stress and low wind, our model indicates that leaves would increase 6 degrees, 8 degrees, 10 degrees, and 12 degrees C above air temperature under field, LED, greenhouse, and HPS scenarios, respectively. Because LED fixtures emit much of their heat through convection rather than radiative cooling, they result in slightly cooler leaf temperatures than leaves in greenhouses and under HPS fixtures, but the effect of LED technology on leaf temperature is smaller than is often assumed. Quantifying the thermodynamic outputs of these lamps, and their physiological consequences, will allow both researchers and the horticulture industry to make informed decisions when employing these technologies.	[Nelson, Jacob A.; Bugbee, Bruce] Utah State Univ, Dept Plant Soils & Climate, Crop Physiol Lab, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Bugbee, B (corresponding author), Utah State Univ, Dept Plant Soils & Climate, Crop Physiol Lab, Logan, UT 84322 USA.	bruce.bugbee@usu.edu		Nelson, Jacob/0000-0002-4663-2420				Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; BAILLE M, 1994, AGR FOREST METEOROL, V71, P83, DOI 10.1016/0168-1923(94)90101-5; Blanchard MG, 2010, T ASABE, V53, P939; Blonquist JM, 2009, AGR FOREST METEOROL, V149, P1931, DOI [10.1016/j.agrformet.2009.10.003, 10.1016/j.agrformet.2009.06.021]; Camp CR, 1998, T ASAE, V41, P1353, DOI 10.13031/2013.17309; Campbell Gaylon S., 1998; Faust JE, 1998, J AM SOC HORTIC SCI, V123, P208, DOI 10.21273/JASHS.123.2.208; FAUST JE, 1993, J AM SOC HORTIC SCI, V118, P747, DOI 10.21273/JASHS.118.6.747; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; Kichah A, 2012, BIOSYST ENG, V112, P22, DOI 10.1016/j.biosystemseng.2012.01.012; MCCREE KJ, 1972, AGR METEOROL, V9, P191, DOI 10.1016/0002-1571(71)90022-7; Monteith J., 1990, PRINCIPLES ENV PHYS, Vsecond; Nelson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099010; Noda HM, 2014, ECOL RES, V29, P111, DOI 10.1007/s11284-013-1096-z; SEGINER I, 1984, AGR METEOROL, V30, P257, DOI 10.1016/0002-1571(84)90002-5; Shimizu H, 2004, J AM SOC HORTIC SCI, V129, P303, DOI 10.21273/JASHS.129.3.0303; Wheeler RM, 1999, ANN BOT-LONDON, V83, P243, DOI 10.1006/anbo.1998.0813; Widmoser P, 2009, AGR WATER MANAGE, V96, P711, DOI 10.1016/j.agwat.2008.10.003	18	52	57	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138930	10.1371/journal.pone.0138930	http://dx.doi.org/10.1371/journal.pone.0138930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448613	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000015
J	Neuner, B; Lenfers, A; Kelsch, R; Jager, K; Bruggmann, N; van der Harst, P; Walter, M				Neuner, Bruno; Lenfers, Anna; Kelsch, Reinhard; Jaeger, Kathrin; Brueggmann, Nina; van der Harst, Pim; Walter, Michael			Telomere Length Is Not Related to Established Cardiovascular Risk Factors but Does Correlate with Red and White Blood Cell Counts in a German Blood Donor Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; DISEASE; SHORTER; ASSOCIATION; ATHEROSCLEROSIS; MORTALITY; GENDER; AGE	Telomere length (TL) is considered a marker of biological aging and has been associated with the presence of various coronary risk factors in patients. Much less is known about the relationships between TL and classic coronary risk factors in other populations. We measured TL in peripheral blood leukocytes of 343 middle-aged blood donors (mean age 40.2 +/- 12.4 years; 201 men, 142 women) using quantitative polymerase chain reaction. Median TL was 0.86 (range: 0.48-1.85) relative TL units. In linear regression analyses with natural log-transformed T to S ratio as the dependent variable, there was a significant association with age (per year: beta = -0.007, p<0.001) and sex (males vs. females: beta = 0.075, p = 0.007) with longer telomeres in men. After adjusting for these two variables, we observed no association of TL with classic coronary risk factors including cholesterol (p = 0.36), triglyceride (p = 0.09), HDL-cholesterol (p = 0.26), LDL-cholesterol (p = 0.36), smoking (p = 0.97), and personal (p = 0.46) or family history (p = 0.63) of cardiovascular disease. However, we did find a significant positive association with white (p = 0.011) and red blood cell count (p = 0.031), hemoglobin (p = 0.014) and hematocrit (p = 0.013); we also found a borderline positive association with thrombocytes (p = 0.074). Positive associations remained significant for hemoglobin (p = 0.017), hematocrit (p = 0.023), and leukocytes (p = 0.009) in a subgroup with no reported vascular disease; associations were of borderline significance for erythrocytes (p = 0.053) and thrombocytes (p = 0.088) in this subgroup. The data do not support the concept that classic coronary risk factors contribute to telomere attrition in a blood donor population. However, telomere attrition may be a marker for reduced proliferation reserve in hematopoietic progenitor cells.	[Neuner, Bruno] Charite, Campus Virchow Klinikum, Dept Anaesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Neuner, Bruno] Charite, Dept Anaesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Lenfers, Anna] Univ Hosp Munster, Dept Gynecol & Obstet, Munster, Germany; [Kelsch, Reinhard] Univ Hosp Munster, Inst Transfus Med, Munster, Germany; [Jaeger, Kathrin; Brueggmann, Nina; Walter, Michael] Charite, Campus Virchow Klinikum, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; [Jaeger, Kathrin; Walter, Michael] Charite Vivantes Serv GmbH, Lab Berlin, Berlin, Germany; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Labor Berlin - Charite Vivantes GmbH; University of Groningen	Walter, M (corresponding author), Charite, Campus Virchow Klinikum, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany.	m.walter@charite.de						Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Aulinas A, 2014, EUR J ENDOCRINOL, V171, P21, DOI 10.1530/EJE-14-0098; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; Brouilette SW, 2008, HEART, V94, P422, DOI 10.1136/hrt.2007.139675; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; De Meyer T, 2008, AGING CELL, V7, P700, DOI 10.1111/j.1474-9726.2008.00419.x; De Meyer T, 2012, ARTERIOSCL THROM VAS, V32, P3076, DOI 10.1161/ATVBAHA.112.300341; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Goldeck D, 2015, BIOGERONTOLOGY; Gutmajster E, 2013, SCI WORLD J, DOI 10.1155/2013/153608; Huzen J, 2011, ARTERIOSCL THROM VAS, V31, P1219, DOI 10.1161/ATVBAHA.110.217158; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Kozlitina J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051046; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Needham BL, 2014, BIODEMOGR SOC BIOL, V60, P156, DOI 10.1080/19485565.2014.947471; Ogami M, 2004, ARTERIOSCL THROM VAS, V24, P546, DOI 10.1161/01.ATV.0000117200.46938.e7; Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7; Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Satoh H, 1996, JPN J HUM GENET, V41, P413, DOI 10.1007/BF01876332; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Walter M, 2009, ARTERIOSCL THROM VAS, V29, P1244, DOI 10.1161/ATVBAHA.108.181438; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; Wong LSM, 2010, EUR J HEART FAIL, V12, P348, DOI 10.1093/eurjhf/hfq007	36	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139308	10.1371/journal.pone.0139308	http://dx.doi.org/10.1371/journal.pone.0139308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445269	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600051
J	Pinto-Almeida, A; Mendes, T; Armada, A; Belo, S; Carrilho, E; Viveiros, M; Afonso, A				Pinto-Almeida, Antonio; Mendes, Tiago; Armada, Ana; Belo, Silvana; Carrilho, Emanuel; Viveiros, Miguel; Afonso, Ana			The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype	PLOS ONE			English	Article							P-GLYCOPROTEIN; COLLATERAL SENSITIVITY; MULTIDRUG-RESISTANCE; IN-VIVO; INHIBITION; INFECTION; SUSCEPTIBILITY; TRANSPORTERS; METAANALYSIS; PARAMETERS	Background Schistosomiasis is a neglected disease caused by a trematode of the genus Schistosoma that is second only to malaria in public health significance in Africa, South America, and Asia. Praziquantel (PZQ) is the drug of choice to treat this disease due to its high cure rates and no significant side effects. However, in the last years increasingly cases of tolerance to PZQ have been reported, which has caused growing concerns regarding the emergency of resistance to this drug. Methodology/Principal Findings Here we describe the selection of a parasitic strain that has a stable resistance phenotype to PZQ. It has been reported that drug resistance in helminths might involve efflux pumps such as members of ATP-binding cassette transport proteins, including P-glycoprotein and multidrug resistance-associated protein families. Here we evaluate the role of efflux pumps in Schistosoma mansoni resistance to PZQ, by comparing the efflux pumps activity in susceptible and resistant strains. The evaluation of the efflux activity was performed by an ethidium bromide accumulation assay in presence and absence of Verapamil. The role of efflux pumps in resistance to PZQ was further investigated comparing the response of susceptible and resistant parasites in the absence and presence of different doses of Verapamil, in an ex vivo assay, and these results were further reinforced through the comparison of the expression levels of SmMDR2 RNA by RT-PCR. Conclusions/Significance This work strongly suggests the involvement of Pgp-like transporters SMDR2 in Praziquantel drug resistance in S. mansoni. Low doses of Verapamil successfully reverted drug resistance. Our results might give an indication that a combination therapy with PZQ and natural or synthetic Pgp modulators can be an effective strategy for the treatment of confirmed cases of resistance to PZQ in S. mansoni.	[Pinto-Almeida, Antonio] Univ Porto, Inst Ciencias Biomed Abel Salazar, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal; [Pinto-Almeida, Antonio; Mendes, Tiago; Belo, Silvana; Afonso, Ana] Univ Nova Lisboa, Inst Higiene Med Trop, Med Parasitol Unit, Global Hlth & Trop Med, P-1200 Lisbon, Portugal; [Pinto-Almeida, Antonio; Carrilho, Emanuel; Afonso, Ana] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Mendes, Tiago] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Armada, Ana; Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene Med Trop, Med Microbiol Unit, Global Hlth & Trop Med, P-1200 Lisbon, Portugal; [Afonso, Ana] Univ Fed Sao Carlos, Dept Morfol & Patol, Parasitol Lab, BR-13560 Sao Carlos, SP, Brazil	Universidade do Porto; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Federal de Sao Carlos	Afonso, A (corresponding author), Univ Nova Lisboa, Inst Higiene Med Trop, Med Parasitol Unit, Global Hlth & Trop Med, P-1200 Lisbon, Portugal.	anaafonso74@hotmail.com	Mendes, Tiago M F/F-7281-2016; Armada, Ana/I-2113-2012; Viveiros, Miguel/A-7326-2008; Belo, Silvana/J-8555-2012; Carrilho, E./A-5845-2009; Afonso, Ana/K-1023-2015	Mendes, Tiago M F/0000-0002-3630-9099; Armada, Ana/0000-0001-5066-9982; Viveiros, Miguel/0000-0001-9676-6251; Belo, Silvana/0000-0001-8701-8657; Carrilho, E./0000-0001-7351-8220; Pinto Almeida, Antonio/0000-0001-8695-8129; Afonso, Ana/0000-0002-8476-1346	Fundacao para a Ciencia e a Tecnologia de Portugal (FCT) [PEst- OE/SAU/UI0074/2014]; Instituto de Ciencias Biomedicas Abel Salazar, Universidade; FCT [SFRH/BD/51697/2011, PTDC/BIAMIC/121859/2010]; CAPES PhD program; CNPq [400168/2013-8, 375781/2013-7]	Fundacao para a Ciencia e a Tecnologia de Portugal (FCT)(Portuguese Foundation for Science and Technology); Instituto de Ciencias Biomedicas Abel Salazar, Universidade; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); CAPES PhD program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Antonio Pinto-Almeida, Tiago Mendes, Silvana Belo and Ana Afonso were supported by Fundacao para a Ciencia e a Tecnologia de Portugal (FCT) (PEst- OE/SAU/UI0074/2014). Antonio Pinto-Almeida would like to thank Graduate Program in Areas of Basic and Applied Biology (GABBA) program from the Instituto de Ciencias Biomedicas Abel Salazar, Universidade and FCT for funding (SFRH/BD/51697/2011). Tiago Mendes would like to thank CAPES PhD program for funding. Emanuel Carrilho and Ana Afonso are supported by CNPq no 400168/2013-8 and CNPq no 375781/2013-7. Miguel Viveiros and Ana Armada were partially supported by project PTDC/BIAMIC/121859/2010 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly IRB, 2010, MEM I OSWALDO CRUZ, V105, P729, DOI 10.1590/S0074-02762010000600001; Anderson PJ, 2006, J BIOL CHEM, V281, P850, DOI 10.1074/jbc.M504540200; [Anonymous], 2013, SCHIST PROGR REP 200; Ardelli BF, 2013, VET PARASITOL, V191, P264, DOI 10.1016/j.vetpar.2012.09.021; Bin Dajem SM, 2008, PARASITOL RES, V103, P1059, DOI 10.1007/s00436-008-1092-3; Blanton RE, 2011, INT J PARASITOL, V41, P1093, DOI 10.1016/j.ijpara.2011.06.002; BOSCH IB, 1994, MOL BIOCHEM PARASIT, V65, P351, DOI 10.1016/0166-6851(94)90085-X; Cioli D, 2004, INT J PARASITOL, V34, P979, DOI 10.1016/j.ijpara.2004.05.001; Crompton DWT, 1999, J PARASITOL, V85, P397, DOI 10.2307/3285768; Davis A, 2014, MANSONS TROPICAL DIS, P1431; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Doenhoff MJ, 2002, T ROY SOC TROP MED H, V96, P465, DOI 10.1016/S0035-9203(02)90405-0; FALLON PG, 1994, AM J TROP MED HYG, V51, P83, DOI 10.4269/ajtmh.1994.51.83; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Gracio AM, 2003, INT J ANTIMICROB AG, V22, P347, DOI 10.1016/S0924-8579(03)00204-8; Greenberg RM, 2013, PARASITOL INT, V62, P647, DOI 10.1016/j.parint.2013.02.006; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hall MD, 2014, J BIOL CHEM, V289, P21473, DOI 10.1074/jbc.M114.581702; Hall MD, 2009, TRENDS PHARMACOL SCI, V30, P546, DOI 10.1016/j.tips.2009.07.003; Ismail M, 1999, AM J TROP MED HYG, V60, P932, DOI 10.4269/ajtmh.1999.60.932; Ismail M, 1996, AM J TROP MED HYG, V55, P214, DOI 10.4269/ajtmh.1996.55.214; James CE, 2009, TRENDS PARASITOL, V25, P538, DOI 10.1016/j.pt.2009.09.007; Kamel EG, 2011, PARASITOL INT, V60, P388, DOI 10.1016/j.parint.2011.06.016; Kasinathan RS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001425; Kasinathan RS, 2012, EXP PARASITOL, V132, P2, DOI 10.1016/j.exppara.2011.03.004; Kasinathan RS, 2010, MOL BIOCHEM PARASIT, V173, P25, DOI 10.1016/j.molbiopara.2010.05.003; Kasinathan RS, 2010, FASEB J, V24, P128, DOI 10.1096/fj.09-137091; Katz N, 2008, ACTA TROP, V108, P72, DOI 10.1016/j.actatropica.2008.05.006; Kerboeuf D, 2002, PARASITOL RES, V88, P816, DOI 10.1007/s00436-002-0654-z; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Lamberton PHL, 2010, AM J TROP MED HYG, V83, P1340, DOI 10.4269/ajtmh.2010.10-0413; Lewis FA, 1998, CURRENT PROTOCOLS IM; Liang YS, 2010, J HELMINTHOL, V84, P202, DOI 10.1017/S0022149X0999054X; Liang You-Sheng, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P605; Liang YS, 2001, INT J PARASITOL, V31, P1227, DOI 10.1016/S0020-7519(01)00246-6; Manson P, 1902, BRIT MED J, V1902, P1894, DOI 10.1136/bmj.2.2190.1894; Martins A, 2011, INT J ANTIMICROB AG, V37, P410, DOI 10.1016/j.ijantimicag.2011.01.010; Meister I, 2014, ANTIMICROB AGENTS CH, V58, P5466, DOI 10.1128/AAC.02741-14; Messerli SM, 2009, MOL BIOCHEM PARASIT, V167, P54, DOI 10.1016/j.molbiopara.2009.04.007; Pica-Mattoccia L, 2004, INT J PARASITOL, V34, P527, DOI 10.1016/j.ijpara.2003.12.003; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Rodrigues L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-35; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Spengler G, 2009, ANTICANCER RES, V29, P2173; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Sulova Z, 2009, GEN PHYSIOL BIOPHYS, V28, pF89; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Viveiros M, 2010, METHODS MOL BIOL, V642, P159, DOI 10.1007/978-1-60327-279-7_12; Wu W, 2011, PARASITOL RES, V109, P1501, DOI 10.1007/s00436-011-2670-3	49	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140147	10.1371/journal.pone.0140147	http://dx.doi.org/10.1371/journal.pone.0140147			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445012	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600145
J	Borthakur, G; Duvvuri, S; Ruvolo, V; Tripathi, DN; Piya, S; Burks, J; Jacamo, R; Kojima, K; Ruvolo, P; Fueyo-Margareto, J; Konopleva, M; Andreeff, M				Borthakur, Gautam; Duvvuri, Seshagiri; Ruvolo, Vivian; Tripathi, Durga Nand; Piya, Sujan; Burks, Jared; Jacamo, Rodrigo; Kojima, Kensuke; Ruvolo, Peter; Fueyo-Margareto, Juan; Konopleva, Marina; Andreeff, Michael			MDM2 Inhibitor, Nutlin 3a, Induces p53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation	PLOS ONE			English	Article							PROTEIN-KINASE; NONCATALYTIC BETA; INDUCED APOPTOSIS; INDUCTION; SENSITIVITY; ANTAGONISTS; PATHWAYS; ASSAYS; ULK1	MDM2 (mouse double minute 2) inhibitors that activate p53 and induce apoptosis in a nongenotoxic manner are in clinical development for treatment of leukemias. P53 can modulate other programmed cell death pathways including autophagy both transcriptionally and nontranscriptionally. We investigated autophagy induction in acute leukemia by Nutlin 3a, a first-in-class MDM2 inhibitor. Nutlin 3a induced autophagy in a p53 dependent manner and transcriptional activation of AMP kinase (AMPK) is critical, as this effect is abrogated in AMPK -/-mouse embryonic fibroblasts. Nutlin 3a induced autophagy appears to be proapoptotic as pharmacological (bafilomycin) or genetic inhibition (BECLIN1 knockdown) of autophagy impairs apoptosis induced by Nutlin 3a.	[Borthakur, Gautam; Duvvuri, Seshagiri; Ruvolo, Vivian; Piya, Sujan; Burks, Jared; Jacamo, Rodrigo; Kojima, Kensuke; Ruvolo, Peter; Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Borthakur, Gautam; Duvvuri, Seshagiri; Ruvolo, Vivian; Piya, Sujan; Burks, Jared; Jacamo, Rodrigo; Kojima, Kensuke; Ruvolo, Peter; Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Tripathi, Durga Nand] Texas A&M Hlth Sci Ctr, Ctr Translat Canc Res, Inst Biosci & Technol, Houston, TX USA; [Fueyo-Margareto, Juan] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center	Andreeff, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA.	mandreef@mdanderson.org	Tripathi, Durga Nand/H-3247-2019; Borthakur, Gautam/AAQ-4490-2021	Tripathi, Durga Nand/0000-0001-8736-4808; Fueyo, Juan/0000-0001-6941-2335	American Society of Clinical Oncology; National Institutes of Health Lymphoma SPORE [CA136411]; National Institutes of Health Leukemia SPORE [CA100632]; National Institutes of Health Cancer Center Support Grant [CA16672]; National Institutes of Health Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672] Funding Source: NIH RePORTER	American Society of Clinical Oncology; National Institutes of Health Lymphoma SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Leukemia SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Paul and Mary Haas Chair in Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported in part by a Career Development Grant from the American Society of Clinical Oncology (GB) and the National Institutes of Health Lymphoma SPORE (CA136411), Leukemia SPORE (CA100632), Cancer Center Support Grant (CA16672), the Paul and Mary Haas Chair in Genetics (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich H, 2007, AUTOPHAGY, V3, P275, DOI 10.4161/auto.3915; Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Andreeff M, 2010, ASH ANN M, V116, P657; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; DAVIES SP, 1994, EUR J BIOCHEM, V223, P351, DOI 10.1111/j.1432-1033.1994.tb19001.x; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gao G, 1996, J BIOL CHEM, V271, P8675, DOI 10.1074/jbc.271.15.8675; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kojima K, 2008, LEUKEMIA, V22, P1728, DOI 10.1038/leu.2008.158; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Komatsu S, 2013, BIOCHEM BIOPH RES CO, V437, P41, DOI 10.1016/j.bbrc.2013.06.032; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Lozano G, 1998, BBA-REV CANCER, V1377, pM55, DOI 10.1016/S0304-419X(97)00037-1; LUNA RMD, 1995, NATURE, V378, P203; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Marvaso G, 2014, CANCER BIOL THER, V15, P797, DOI 10.4161/cbt.28556; Nyfeler B, 2012, METHODS MOL BIOL, V821, P239, DOI 10.1007/978-1-61779-430-8_14; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Suman S, 2014, BRIT J CANCER, V111, P309, DOI 10.1038/bjc.2014.203; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295; YANG GS, 1993, LEUKEMIA, V7, P1012; Zhou Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05382	33	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139254	10.1371/journal.pone.0139254	http://dx.doi.org/10.1371/journal.pone.0139254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440941	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510300017
J	Wang, YS; Zheng, ZF; Zhang, JY; Wang, Y; Kong, RR; Liu, JY; Zhang, Y; Deng, HK; Du, XJ; Ke, Y				Wang, Yingshuang; Zheng, Zongfang; Zhang, Jingyi; Wang, You; Kong, Ruirui; Liu, Jiangying; Zhang, Ying; Deng, Hongkui; Du, Xiaojuan; Ke, Yang			A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSCEPTIBILITY GENE-PRODUCT; CELL-CYCLE CONTROL; BREAST-CANCER; TUMOR-SUPPRESSOR; THERAPEUTIC RESPONSE; PROTEASOME PATHWAY; DEPENDENT DEGRADATION; ONCOPROTEIN MDM2; FAMILY PROTEINS; E7	Retinoblastoma protein (RB) plays critical roles in tumor suppression and is degraded through the proteasomal pathway. However, E3 ubiquitin ligases responsible for proteasome-mediated degradation of RB are largely unknown. Here we characterize a novel RB E3 ubiquitin ligase (NRBE3) that binds RB and promotes RB degradation. NRBE3 contains an LXCXE motif and bound RB in vitro. NRBE3 interacted with RB in cells when proteasome activity was inhibited. NRBE3 promoted RB ubiquitination and degradation via the ubiquitin-proteasome pathway. Importantly, purified NRBE3 ubiquitinated recombinant RB in vitro, and a U-box was identified as essential for its E3 activity. Surprisingly, NRBE3 was transcriptionally activated by E2F1/DP1. Consequently, NRBE3 affected the cell cycle by promoting G1/S transition. Moreover, NRBE3 was up-regulated in breast cancer tissues. Taken together, we identified NRBE3 as a novel ubiquitin E3 ligase for RB that might play a role as a potential oncoprotein in human cancers.	[Wang, Yingshuang; Zheng, Zongfang; Zhang, Jingyi; Wang, You; Kong, Ruirui; Liu, Jiangying; Zhang, Ying; Deng, Hongkui; Du, Xiaojuan; Ke, Yang] Peking Univ, Beijing Canc Hosp & Inst, Sch Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China; [Wang, Yingshuang; Zheng, Zongfang; Wang, You; Kong, Ruirui; Liu, Jiangying; Zhang, Ying; Ke, Yang] Peking Univ, Beijing Canc Hosp & Inst, Sch Oncol, Genet Lab, Beijing 100142, Peoples R China; [Deng, Hongkui; Du, Xiaojuan] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Cell Biol, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University	Du, XJ (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Cell Biol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	duxiaojuan100@bjmu.edu.cn; keyang@hsc.pku.edu.cn	Du, Xiaojuan/AAY-1186-2021		National Natural Science Foundation of China [30571038, 81372222]; Innovation team of the Ministry of Education [IRT13001]; Beijing Municipal Natural Science Foundation [7122032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation team of the Ministry of Education; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 30571038 and 81372222, the Innovation team of the Ministry of Education (Grant IRT13001), and Beijing Municipal Natural Science Foundation Grant 7122032. The authors declare that they have no conflict of interest with the contents of this article.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams PD, 1999, MOL CELL BIOL, V19, P1068; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Boyer SN, 1996, CANCER RES, V56, P4620; Brown DR, 1998, EMBO J, V17, P2513, DOI 10.1093/emboj/17.9.2513; Casimiro Mathew C, 2012, Genes Cancer, V3, P649, DOI 10.1177/1947601913479022; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Deshpande A, 2006, CURR MOL MED, V6, P809; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dublin EA, 1998, INT J CANCER, V79, P71, DOI 10.1002/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K; DYSON N, 1992, J VIROL, V66, P4606, DOI 10.1128/JVI.66.7.4606-4611.1992; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu LL, 2011, J BIOL CHEM, V286, P3119, DOI 10.1074/jbc.M110.157842; HU NP, 1994, ONCOGENE, V9, P1021; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Hui R, 2000, CLIN CANCER RES, V6, P2777; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; JONES RE, 1990, J BIOL CHEM, V265, P12782; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; Marine JC, 2012, NAT REV CANCER, V12, P455, DOI 10.1038/nrc3271; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nordquist KA, 2010, BIOCHEMISTRY-US, V49, P347, DOI 10.1021/bi901620v; Oh KJ, 2010, VIROLOGY, V396, P118, DOI 10.1016/j.virol.2009.10.018; Pan WJ, 2001, CANCER RES, V61, P2885; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Wu JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031692; Yang L, 2005, BIOCHEM BIOPH RES CO, V334, P884, DOI 10.1016/j.bbrc.2005.06.179; Zheng Zong-fang, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P613	79	12	12	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28200	28213		10.1074/jbc.M115.655597	http://dx.doi.org/10.1074/jbc.M115.655597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26442585	Green Published, hybrid			2022-12-26	WOS:000365761900015
J	Li, XM; Jiang, L; Liu, ZJ; Liu, XG; Zhang, H; Zhou, H; Wei, F; Yu, M; Wu, FL				Li, Xiumao; Jiang, Liang; Liu, Zhongjun; Liu, Xiaoguang; Zhang, Hua; Zhou, Hua; Wei, Feng; Yu, Miao; Wu, Fengliang			Different Approaches for Treating Multilevel Cervical Spondylotic Myelopathy: A Retrospective Study of 153 Cases from a Single Spinal Center	PLOS ONE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; SURGICAL-TREATMENT; ANTERIOR; DECOMPRESSION; LAMINOPLASTY; COMPRESSION; OUTCOMES; FUSION; RATIO; CORD	Objective The optimal surgical treatment for multilevel cervical spondylotic myelopathy (MCSM) remains controversial. This study compared the outcomes of three surgical approaches for MSCM treatment, focusing on the efficacy and safety of a combined approach. Methods This retrospective study included 153 consecutive MCSM patients (100 men, 53 women; mean age +/- standard deviation, 55.7 +/- 9.4 years) undergoing operations involving >= 3 intervertebral segments. The patients were divided into three groups according to surgical approach: anterior (n = 19), posterior (n = 76), and combined (n = 58). We assessed demographic variables, perioperative parameters, and clinical outcomes >= 12 months after surgery (20.5 +/- 7.6 months), including Japanese Orthopaedic Association (JOA) score, improvement, recovery rate, and complications. Results The anterior group had the most favorable preoperative conditions, including the highest preoperative JOA score (12.95 +/- 1.86, rho = 0.046). In contrast, the combined group had the highest occupancy ratio (48.0% +/- 11.6%, rho = 0.002). All groups showed significant neurological improvement at final follow-ups, with JOA recovery rates of 59.7%, 54.6%, and 68.9% in the anterior, posterior, and combined groups, respectively (rho = 0.163). After multi-variable adjustments, the groups did not have significantly different clinical outcomes (postoperative JOA score, rho = 0.424; improvement, rho = 0.424; recovery rate, rho = 0.080). Further, subgroup analyses of patients with occupancy ratios >= 50% showed similar functional outcomes following the posterior and combined approaches. Overall complication rates did not differ significantly among the three approaches (rho = 0.600). Occupancy ratios did not have a significant negative influence on postoperative recovery following the posterior approach. Conclusions If applied appropriately, all three approaches are effective for treating MCSM. All three approaches had equivalent neurological outcomes, even in subgroups with high occupancy ratios. Further investigations of surgical approaches to MCSM are needed, particularly prospective multicenter studies with long-term follow-up.	[Li, Xiumao; Jiang, Liang; Liu, Zhongjun; Liu, Xiaoguang; Zhou, Hua; Wei, Feng; Yu, Miao; Wu, Fengliang] Peking Univ, Hosp 3, Dept Orthopaed, Beijing 100191, Peoples R China; [Zhang, Hua] Peking Univ, Hosp 3, Res Ctr Clin Epidemiol, Beijing 100191, Peoples R China	Peking University; Peking University	Jiang, L (corresponding author), Peking Univ, Hosp 3, Dept Orthopaed, Beijing 100191, Peoples R China.	puh371508@bjmu.edu.cn	Zhou, Hua/HGC-9504-2022; , 姜亮/AAH-4981-2020	Zhou, hua/0000-0002-2718-4108	AOSpine China Research Grant Project [AOSCN (R) 2013-07]	AOSpine China Research Grant Project	The work described here was supported by the AOSpine China Research Grant Project (AOSCN (R) 2013-07) (URL: https://aospine.aofoundation.org/Structure/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumi K, 2015, EUR SPINE J, V24, pS186, DOI 10.1007/s00586-015-3838-9; Aebli N, 2013, SPINE J, V13, P605, DOI 10.1016/j.spinee.2012.10.039; Aryan HE, 2007, EUR SPINE J, V16, P1401, DOI 10.1007/s00586-006-0291-9; Fehlings MG, 2013, SPINE, V38, P2247, DOI 10.1097/BRS.0000000000000047; Fehlings MG, 2012, J NEUROSURG-SPINE, V16, P425, DOI 10.3171/2012.1.SPINE11467; Fujimori T, 2014, SPINE, V39, P58, DOI 10.1097/BRS.0000000000000054; Furlan JC, 2011, J NEUROSURG-SPINE, V14, P348, DOI 10.3171/2010.10.SPINE091029; Gok B, 2008, J NEUROSURG-SPINE, V9, P152, DOI 10.3171/SPI/2008/9/8/152; Harry NH, 2011, ROTHMAN SIMEONE SPIN, P762, DOI 10.1016/b978-1-4160-6726-9.00046-8; Kalb S, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10265; Kalsi-Ryan S, 2013, NEUROSCIENTIST, V19, P409, DOI 10.1177/1073858412467377; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Karpova A, 2013, SPINE, V38, P392, DOI 10.1097/BRS.0b013e3182715bc3; Kato S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123022; Kim HJ, 2013, SPINE, V38, pS78, DOI 10.1097/BRS.0b013e3182a7eb06; Koakutsu T, 2010, J ORTHOP SCI, V15, P71, DOI 10.1007/s00776-009-1429-4; Konig SA, 2014, ACTA NEUROCHIR WIEN, V2, P253; Konya D, 2009, J CLIN NEUROSCI, V16, P404, DOI 10.1016/j.jocn.2008.07.070; Lawrence BD, 2013, SPINE, V38, pS171, DOI 10.1097/BRS.0b013e3182a7f4ff; Morio Y, 2001, SPINE, V26, P1238, DOI 10.1097/00007632-200106010-00012; Sembrano JN, 2009, J SPINAL DISORD TECH, V22, P162, DOI 10.1097/BSD.0b013e318175d821; Shamji MF, 2013, SPINE, V38, pS195, DOI 10.1097/BRS.0b013e3182a7eb27; Suda K, 2003, SPINE, V28, P1258, DOI 10.1097/00007632-200306150-00008; Takeshita K, 2001, J Orthop Sci, V6, P223, DOI 10.1007/s007760100038; Wen SF, 2012, SPINE, V37, P1463, DOI 10.1097/BRS.0b013e31824ff9bc; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Yoon ST, 2013, SPINE, V38, pS232, DOI 10.1097/BRS.0b013e3182a7eb55	27	9	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140031	10.1371/journal.pone.0140031	http://dx.doi.org/10.1371/journal.pone.0140031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460488	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300049
J	Edison, L; Beaudoin, A; Goh, L; Introcaso, CE; Martin, D; Dubray, C; Marrone, J; Van Beneden, C				Edison, Laura; Beaudoin, Amanda; Goh, Lucy; Introcaso, Camille E.; Martin, Diana; Dubray, Christine; Marrone, James; Van Beneden, Chris			Scabies and Bacterial Superinfection among American Samoan Children, 2011-2012	PLOS ONE			English	Article							PARASITIC SKIN DISEASES; SARCOPTES-SCABIEI; RURAL-COMMUNITY; GLOBAL CONTROL; MANAGEMENT; MORBIDITY; EPIDEMIOLOGY; IVERMECTIN; SURVIVAL; BRAZIL	Background Scabies, a highly pruritic and contagious mite infestation of the skin, is endemic among tropical regions and causes a substantial proportion of skin disease among lower-income countries. Delayed treatment can lead to bacterial superinfection, and treatment of close contacts is necessary to prevent reinfestation. We describe scabies incidence and superinfection among children in American Samoa (AS) to support scabies control recommendations. Methodology/Principal Findings We reviewed 2011-2012 pharmacy records from the only AS pharmacy to identify children aged <= 14 years with filled prescriptions for permethrin, the only scabicide available in AS. Medical records of identified children were reviewed for physician-diagnosed scabies during January 1, 2011-December 31, 2012. We calculated scabies incidence, bacterial superinfection prevalence, and reinfestation prevalence during 14-365 days after first diagnosis. We used log binomial regression to calculate incidence ratios for scabies by age, sex, and county. Medical record review identified 1,139 children with scabies (incidence 29.3/1,000 children aged <= 14 years); 604 (53%) had a bacterial superinfection. Of 613 children who received a scabies diagnosis during 2011, 94 (15.3%) had one or more reinfestation. Scabies incidence varied significantly among the nine counties (range 14.8-48.9/1,000 children). Children aged < 1 year had the highest incidence (99.9/1,000 children). Children aged 0-4 years were 4.9 times more likely and those aged 5-9 years were 2.2 times more likely to have received a scabies diagnosis than children aged 10-14 years. Conclusions/Significance Scabies and its sequelae cause substantial morbidity among AS children. Bacterial superinfection prevalence and frequent reinfestations highlight the importance of diagnosing scabies and early treatment of patients and close contacts. Investigating why certain AS counties have a lower scabies incidence might help guide recommendations for improving scabies control among counties with a higher incidence. We recommend interventions targeting infants and young children who have frequent close family contact.	[Edison, Laura; Beaudoin, Amanda] Ctr Dis Control & Prevent, Epidemiol Workforce Branch, Atlanta, GA USA; [Goh, Lucy; Marrone, James] Lyndon B Johnson Trop Med Ctr, Dept Pediat, Pago Pago, GA USA; [Introcaso, Camille E.] Penn Ctr Dermatol, Philadelphia, PA USA; [Martin, Diana; Dubray, Christine] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Van Beneden, Chris] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Edison, L (corresponding author), Georgia Dept Publ Hlth, Epidemiol, 2 Peachtree St NW,Suite 14-232, Atlanta, GA 30303 USA.	kgq2@cdc.gov						Andrews Ross M, 2009, Pediatr Clin North Am, V56, P1421, DOI 10.1016/j.pcl.2009.09.002; Ariza L, 2013, EUR J CLIN MICROBIOL, V32, P373, DOI 10.1007/s10096-012-1752-1; ARLIAN LG, 1984, J AM ACAD DERMATOL, V11, P210, DOI 10.1016/S0190-9622(84)70151-4; BROOK I, 1995, J CLIN MICROBIOL, V33, P2139, DOI 10.1128/JCM.33.8.2139-2140.1995; Carapetis JR, 1997, PEDIATR INFECT DIS J, V16, P494, DOI 10.1097/00006454-199705000-00008; Central Intelligence Agency, 2013, CENTR INT AG WORLD F; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Engelman D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002167; ESTES SA, 1981, J AM ACAD DERMATOL, V5, P343, DOI 10.1016/S0190-9622(81)80151-X; Feldmeier H, 2005, TROP MED INT HEALTH, V10, P713, DOI 10.1111/j.1365-3156.2005.01457.x; Feldmeier H, 2009, B WORLD HEALTH ORGAN, V87, P152, DOI 10.2471/BLT.07.047308; Feldmeier H, 2009, J AM ACAD DERMATOL, V60, P436, DOI 10.1016/j.jaad.2008.11.005; Hay RJ, 2012, CLIN MICROBIOL INFEC, V18, P313, DOI 10.1111/j.1469-0691.2012.03798.x; Hay RJ, 2013, CURR OPIN INFECT DIS, V26, P107, DOI 10.1097/QCO.0b013e32835e085b; Hegazy AA, 1999, INT J DERMATOL, V38, P291, DOI 10.1046/j.1365-4362.1999.00630.x; Hengge UR, 2006, LANCET INFECT DIS, V6, P769, DOI 10.1016/S1473-3099(06)70654-5; Heukelbach J, 2005, BRIT J DERMATOL, V153, P150, DOI 10.1111/j.1365-2133.2005.06591.x; Heukelbach J, 2006, LANCET, V367, P1767, DOI 10.1016/S0140-6736(06)68772-2; Jackson A, 2007, BRAZ J INFECT DIS, V11, P386, DOI 10.1590/S1413-86702007000400001; Jackson A, 2007, TROP MED INT HEALTH, V12, P493, DOI 10.1111/j.1365-3156.2006.01809.x; Karthikeyan K, 2007, ARCH DIS CHILDHOOD-E, V92, pEP65, DOI 10.1136/adc.2005.073825; La Vincente S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000444; Landwehr D, 1998, INT J DERMATOL, V37, P588, DOI 10.1046/j.1365-4362.1998.00367.x; Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467; Steer AC, 2009, B WORLD HEALTH ORGAN, V87, P173, DOI 10.2471/BLT.08.052712; TAPLIN D, 1991, LANCET, V337, P1016, DOI 10.1016/0140-6736(91)92669-S; US Department of Commerce, 2010, AM FACT FIND US CENS; Walter B, 2011, ARCH DERMATOL, V147, P468, DOI 10.1001/archdermatol.2011.51; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; WHO, 2005, WHOFCHCAH0512; Worth C, 2012, PEDIATR DERMATOL, V29, P430, DOI 10.1111/j.1525-1470.2011.01680.x	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0139336	10.1371/journal.pone.0139336	http://dx.doi.org/10.1371/journal.pone.0139336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458270	Green Published, Green Submitted, gold			2022-12-26	WOS:000362961100010
J	Travaglione, S; Ballan, G; Fortuna, A; Ferri, A; Guidotti, M; Campana, G; Fiorentini, C; Loizzo, S				Travaglione, Sara; Ballan, Giulia; Fortuna, Andrea; Ferri, Alberto; Guidotti, Marco; Campana, Gabriele; Fiorentini, Carla; Loizzo, Stefano			CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; RHO-GTPASES; DENDRITIC SPINES; ABSENCE EPILEPSY; BINDING-PROTEIN; WAVE-DISCHARGES; SEIZURE; MODEL; MITOCHONDRIA; ACTIVATION	Epilepsy, one of the most common conditions affecting the brain, is characterized by neuroplasticity and brain cell energy defects. In this work, we demonstrate the ability of the Escherichia coli protein toxin cytotoxic necrotizing factor 1 (CNF1) to counteract epileptiform phenomena in inbred DBA/2J mice, an animal model displaying genetic background with an high susceptibility to induced-and spontaneous seizures. Via modulation of the Rho GTPases, CNF1 regulates actin dynamics with a consequent increase in spine density and length in pyramidal neurons of rat visual cortex, and influences the mitochondrial homeostasis with remarkable changes in the mitochondrial network architecture. In addition, CNF1 improves cognitive performances and increases ATP brain content in mouse models of Rett syndrome and Alzheimer's disease. The results herein reported show that a single dose of CNF1 induces a remarkable amelioration of the seizure phenotype, with a significant augmentation in neuroplasticity markers and in cortex mitochondrial ATP content. This latter effect is accompanied by a decrease in the expression of mitochondrial fission proteins, suggesting a role of mitochondrial dynamics in the CNF1-induced beneficial effects on this epileptiform phenotype. Our results strongly support the crucial role of brain energy homeostasis in the pathogenesis of certain neurological diseases, and suggest that CNF1 could represent a putative new therapeutic tool for epilepsy.	[Travaglione, Sara; Ballan, Giulia; Fortuna, Andrea; Fiorentini, Carla; Loizzo, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Ferri, Alberto] CNR, Inst Cellular Biol & Neurobiol, I-00143 Rome, Italy; [Guidotti, Marco] Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Campana, Gabriele] Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); University of Bologna	Loizzo, S (corresponding author), Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	stefano.loizzo@iss.it	Campana, Gabriele/A-8285-2010; Fiorentini, Carla/Q-2088-2015; FERRI, ALBERTO/B-7660-2015; FIORENTINI, CARLA/AAG-8005-2019; Ballan, Giulia/J-5891-2016; Travaglione, Sara/AAJ-2516-2021	Campana, Gabriele/0000-0001-8978-0530; Fiorentini, Carla/0000-0003-1707-6282; FERRI, ALBERTO/0000-0002-4097-0605; FIORENTINI, CARLA/0000-0003-1707-6282; Loizzo, Stefano/0000-0001-6344-2613; Travaglione, Sara/0000-0002-2816-0490				Akiyama T, 2005, CLIN NEUROPHYSIOL, V116, P2819, DOI 10.1016/j.clinph.2005.08.029; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Arciello M, 2010, J NEUROCHEM, V112, P183, DOI 10.1111/j.1471-4159.2009.06441.x; BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231; Capasso A, 2003, J PHARM PHARMACOL, V55, P1115, DOI 10.1211/002235703322277140; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cerri C, 2011, J NEUROSCI, V31, P15163, DOI 10.1523/JNEUROSCI.2617-11.2011; Chang CR, 2007, EMBO REP, V8, P1088, DOI 10.1038/sj.embor.7401118; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Chevallier JA, 2014, EPILEPSIA, V55, P707, DOI 10.1111/epi.12570; De Filippis B, 2015, EUR NEUROPSYCHOPHARM, V25, P889, DOI 10.1016/j.euroneuro.2015.03.012; De Filippis B, 2012, NEUROPSYCHOPHARMACOL, V37, P1152, DOI 10.1038/npp.2011.301; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Demarest ST, 2014, J CHILD NEUROL, V29, P1249, DOI 10.1177/0883073814538511; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; FALZANO L, 1993, MOL MICROBIOL, V9, P1247, DOI 10.1111/j.1365-2958.1993.tb01254.x; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Ferraro TN, 2002, BRAIN RES, V936, P82, DOI 10.1016/S0006-8993(02)02565-9; Ferraro TN, 2001, GENOMICS, V75, P35, DOI 10.1006/geno.2001.6577; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; FOLBERGROVA J, 1981, J NEUROCHEM, V37, P1228, DOI 10.1111/j.1471-4159.1981.tb04673.x; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Galanopoulou AS, 2008, CURR NEUROPHARMACOL, V6, P1, DOI 10.2174/157015908783769653; Galella G, 1983, J Neurosurg Sci, V27, P69; Galietta G, 2005, J ETHNOPHARMACOL, V97, P415, DOI 10.1016/j.jep.2004.12.003; Gobbele R, 2007, J CLIN NEUROPHYSIOL, V24, P27, DOI 10.1097/01.wnp.0000240871.37986.63; Guarino Irene, 2004, Neural Plasticity, V11, P241, DOI 10.1155/NP.2004.241; Halboni P, 2000, CLIN NEUROPHYSIOL, V111, P2277, DOI 10.1016/S1388-2457(00)00473-9; Howell GR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-76; HOYER S, 1985, ARCH GERONTOL GERIAT, V4, P193, DOI 10.1016/0167-4943(85)90001-9; ISOKAWA M, 1991, NEUROSCI LETT, V132, P212, DOI 10.1016/0304-3940(91)90304-C; Isokawa M, 1998, NEUROSCI LETT, V258, P73, DOI 10.1016/S0304-3940(98)00848-9; Jackson HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125897; Jiang MH, 1998, J NEUROSCI, V18, P8356; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kovac S, 2013, NEUROPHARMACOLOGY, V69, P96, DOI 10.1016/j.neuropharm.2012.05.012; Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014; Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009; Letts VA, 2014, GENES BRAIN BEHAV, V13, P519, DOI 10.1111/gbb.12142; Loizzo A, 2012, J ENDOCRINOL, V215, P413, DOI 10.1530/JOE-12-0369; Loizzo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065898; Marrosu F, 2006, EPILEPSIA, V47, P489, DOI 10.1111/j.1528-1167.2006.00456.x; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Miao AL, 2014, NEUROSCI LETT, V566, P21, DOI 10.1016/j.neulet.2014.02.038; MULTANI P, 1994, EPILEPSIA, V35, P728, DOI 10.1111/j.1528-1157.1994.tb02503.x; Ryan LJ, BRAIN RES B; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Seidenbecher T, 2001, EUR J NEUROSCI, V13, P1537, DOI 10.1046/j.0953-816x.2001.01537.x; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Sun QJ, 2009, BEHAV BRAIN RES, V201, P292, DOI 10.1016/j.bbr.2009.02.027; Tan HO, 2008, EPILEPSIA, V49, P921, DOI 10.1111/j.1528-1167.2008.01536.x; Travaglione S, 2014, FEBS J, V281, P3473, DOI 10.1111/febs.12874; Turner JG, 1998, HEARING RES, V118, P101, DOI 10.1016/S0378-5955(98)00024-0; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Urrestarazu E, 2006, EPILEPSIA, V47, P1465, DOI 10.1111/j.1528-1167.2006.00618.x; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Vancova O, 2010, J CELL MOL MED, V14, P2667, DOI 10.1111/j.1582-4934.2009.00879.x; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070; Wang S, 2013, EPILEPSIA, V54, P370, DOI 10.1111/j.1528-1167.2012.03721.x; Wasterlain CG, 2010, NEUROCHEM RES, V35, P2193, DOI 10.1007/s11064-010-0339-4; Wong AA, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00052; Worrell G, 2011, BIOMARK MED, V5, P557, DOI [10.2217/BMM.11.74, 10.2217/bmm.11.74]; Yang H, 2013, NEURAL REGEN RES, V8, P1316, DOI 10.3969/j.issn.1673-5374.2013.14.008; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zheng TW, 2012, EPILEPSIA, V53, P1948, DOI 10.1111/j.1528-1167.2012.03720.x	72	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140495	10.1371/journal.pone.0140495	http://dx.doi.org/10.1371/journal.pone.0140495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457896	Green Published, gold, Green Submitted			2022-12-26	WOS:000362961100035
J	Chisti, MJ; Salam, MA; Bardhan, PK; Faruque, AG; Shahid, AMSB; Shahunja, KM; Das, SK; Hossain, MI; Ahmed, T				Chisti, Mohammod Jobayer; Salam, Mohammed Abdus; Bardhan, Pradip Kumar; Faruque, Abu S. G.; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Hossain, Md Iqbal; Ahmed, Tahmeed			Treatment Failure and Mortality amongst Children with Severe Acute Malnutrition Presenting with Cough or Respiratory Difficulty and Radiological Pneumonia	PLOS ONE			English	Article							MALNOURISHED CHILDREN; CHILDHOOD PNEUMONIA; ETIOLOGY; CHLORAMPHENICOL; GENTAMICIN; BANGLADESH; DIARRHEA; RISK	Background Appropriate intervention is critical in reducing deaths among under-five, severe acutely malnourished (SAM) children with danger signs of severe pneumonia; however, there is paucity of data on outcome of World Health Organisation (WHO) recommended interventions of SAM children with severe pneumonia. We sought to evaluate outcome of the interventions in such children. Methods We prospectively enrolled SAM children aged 0-59 months, admitted to the Intensive Care Unit (ICU) or Acute Respiratory Infection (ARI) ward of the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b), between April 2011 and June 2012 with cough or respiratory difficulty and radiological pneumonia. All the enrolled children were treated with ampicillin and gentamicin, and micronutrients as recommended by the WHO. Comparison was made among pneumonic children with (n = 111) and without WHO defined danger signs of severe pneumonia (n = 296). The outcomes of interest were treatment failure (if a child required changing of antibiotics) and deaths during hospitalization. Further comparison was also made among those who developed treatment failure and who did not and among the survivors and deaths. Results SAM children with danger signs of severe pneumonia more often experienced treatment failure (58% vs. 20%; p < 0.001) and fatal outcome (21% vs. 4%; p < 0.001) compared to those without danger signs. Only 6/111 (5.4%) SAM children with danger signs of severe pneumonia and 12/296 (4.0%) without danger signs had bacterial isolates from blood. In log-linear binomial regression analysis, after adjusting for potential confounders, danger signs of severe pneumonia, dehydration, hypocalcaemia, and bacteraemia were independently associated both with treatment failure and deaths in SAM children presenting with cough or respiratory difficulty and radiological pneumonia (p < 0.01). Conclusion and Significance The result suggests that SAM children with cough or respiratory difficulty and radiologic pneumonia who had WHO-defined danger signs of severe pneumonia more often had treatment failure and fatal outcome compared to those without the danger signs. In addition to danger signs of severe pneumonia, other common causes of both treatment failure and deaths were dehydration, hypocalcaemia, and bacteraemia on admission. The result underscores the importance for further research especially a randomized, controlled clinical trial to validate standard WHO therapy in SAM children with pneumonia especially with danger signs of severe pneumonia to reduce treatment failures and deaths.	[Chisti, Mohammod Jobayer; Bardhan, Pradip Kumar; Faruque, Abu S. G.; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Hossain, Md Iqbal; Ahmed, Tahmeed] Int Ctr Diarhoeal Dis Res Bangladesh Icddr B, Ctr Nutr & Food Secur CNFS, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Bardhan, Pradip Kumar; Hossain, Md Iqbal] Icddr B, Dhaka Hosp, Dhaka, Bangladesh; [Salam, Mohammed Abdus] Icddr B, Res & Clin Adm & Strategy RCAS, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Int Ctr Diarhoeal Dis Res Bangladesh Icddr B, Ctr Nutr & Food Secur CNFS, Dhaka, Bangladesh.	chisti@icddrb.org	Chisti, Mohammod J/A-7216-2018; Das, Sumon Kumar/T-6384-2019; Das, Sumon Kumar/AAD-1551-2019; Shahunja, K M/AAR-6229-2020	Shahunja, K M/0000-0002-9345-206X	International Centre for Diarrhoeal Disease Research, Bangladesh [Gr- 00233]; Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	International Centre for Diarrhoeal Disease Research, Bangladesh; Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b; grant no Gr- 00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include the following: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Asghar R, 2008, BMJ-BRIT MED J, V336, P80, DOI 10.1136/bmj.39421.435949.BE; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Carrol ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021042; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chisti MJ, 2015, EPIDEMIOL INFECT, V143, P799, DOI 10.1017/S0950268814001368; Chisti MJ, 2011, ANN TROP PAEDIATR, V31, P311, DOI 10.1179/1465328111Y.0000000033; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Chisti MJ, 2014, J HEALTH POPUL NUTR, V32, P270; Chisti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039164; Chisti MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073728; Chisti MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071911; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; FAGBULE DO, 1993, TROP GEOGR MED, V45, P294; Ginsburg AS, 2013, INT J ANTIMICROB AG, V42, P482, DOI 10.1016/j.ijantimicag.2013.08.012; Golden MHN, 1998, BRIT MED BULL, V54, P433, DOI 10.1093/oxfordjournals.bmb.a011699; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Lassi ZS, 2014, ARCH DIS CHILD, V99, P687, DOI 10.1136/archdischild-2013-304023; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Sarmin M, 2014, ACTA PAEDIATR, V103, pe306, DOI 10.1111/apa.12640; SHIMELES D, 1994, E AFR MED J, V71, P264; SUSKIND D, 1990, NESTLE NUTR WORKS SE, V19, P1; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2013, POCK BOOK HOSP CAR C	30	18	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140327	10.1371/journal.pone.0140327	http://dx.doi.org/10.1371/journal.pone.0140327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451603	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200062
J	Hou, Y; Nowak, MD; Mirre, V; Bjora, CS; Brochmann, C; Popp, M				Hou, Yan; Nowak, Michael D.; Mirre, Virginia; Bjora, Charlotte S.; Brochmann, Christian; Popp, Magnus			Thousands of RAD-seq Loci Fully Resolve the Phylogeny of the Highly Disjunct Arctic-Alpine Genus Diapensia (Diapensiaceae)	PLOS ONE			English	Article							SNP DISCOVERY; DE-NOVO; GENOME; MARKERS; INFERENCE; SEQUENCE; INTROGRESSION; EVOLUTIONARY; CONCORDANCE; RADIATION	Restriction-site associated DNA sequencing (RAD-seq) has recently become an important method to generate genome-widemolecular data for species delimitation, phylogeography, and population genetic studies. However, very few empirical studies have so far tested its applicability in phylogenetic reconstruction. The alpine-arctic genus Diapensia was selected to study the origin of the disjunction between the Arctic and the Himalayan-Hengduan Mountains (HHM). However, a previous phylogenetic analysis based on one nuclear and four plastid DNA regions failed to resolve the oldest divergences in Diapensia as well as the relationship between the two HHM species. Here we reconstruct a fully resolved phylogeny of Diapensia and address the conflict between the currently accepted taxonomy and the gene trees in the HHM species using RAD-seq. Based on a data set containing 2,650 loci selected to maximize the number of parsimony informative sites and allowing for a high level of missing data (51%), the phylogeny of Diapensia was fully resolved and each of the four species was reciprocally monophyletic. Whereas the arctic D. lapponica was inferred as sister to the HHM clade in the previous study, the RAD-seq data resolved the two arctic species as sisters to the HHM clade. Similar relationships were inferred from a differently filtered data set with far fewer loci (114) and lessmissing data (21%), but with lower support and with one of the two HHM species as non-monophyletic. Bayesian concordance analysis and Patterson's D-statistic tests suggested that admixture has occurred between the two HHM species.	[Hou, Yan; Nowak, Michael D.; Mirre, Virginia; Bjora, Charlotte S.; Brochmann, Christian; Popp, Magnus] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Nowak, Michael D.] Stockholm Univ, Sci Life Lab, Solna, Sweden	University of Oslo; Stockholm University	Hou, Y (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	yan.hou@nhm.uio.no	Popp, Magnus/A-7481-2010; Brochmann, Christian/A-4105-2009; Nowak, Michael/M-3747-2017	Nowak, Michael/0000-0001-8924-6506	Natural History Museum, University of Oslo; Research School in Biosystematics (ForBio), Norway; China Scholarship Council (CSC)	Natural History Museum, University of Oslo; Research School in Biosystematics (ForBio), Norway; China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the Natural History Museum, University of Oslo (www.nhm.uio.no) for the study design, data collection and analysis, and preparation of the manuscript, by Research School in Biosystematics (ForBio), Norway (www.forbio.uio.no) for material collection, and by the China Scholarship Council (CSC; www.en.csc.edu.cn) for living expenses in Oslo. Each funding above has no specific grant number, and YH is the receiver of all of the three grants.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Ane C, 2007, MOL BIOL EVOL, V24, P412; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Cariou M, 2013, ECOL EVOL, V3, P846, DOI 10.1002/ece3.512; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Elven R., 2011, ANNOTATED CHECKLIST; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hipp AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093975; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hou Y, N HIMALAYAN HE UNPUB; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Malyschev L., 1997, FLORA OF SIBERIA, V11; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Qin H. N., 2005, FLORA CHINA, P235; Rambaut A., 2004, TRACER; Rheindt FE, 2014, SYST BIOL, V63, P134, DOI 10.1093/sysbio/syt070; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scaglione D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-3; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang N, 2013, MOL ECOL, V22, P3098, DOI 10.1111/mec.12131; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; Zimmer EA, 2013, MOL PHYLOGENET EVOL, V66, P539, DOI 10.1016/j.ympev.2013.01.005	44	24	24	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140175	10.1371/journal.pone.0140175	http://dx.doi.org/10.1371/journal.pone.0140175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448557	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511000102
J	Liu, XJ; Zhang, L; Chen, SC				Liu, Xuejun; Zhang, Li; Chen, Songcan			Modeling Exon-Specific Bias Distribution Improves the Analysis of RNA-Seq Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; ISOFORM EXPRESSION; NORMALIZATION; INFERENCE; ARRAYS; TOOL	RNA-seq technology has become an important tool for quantifying the gene and transcript expression in transcriptome study. The two major difficulties for the gene and transcript expression quantification are the read mapping ambiguity and the overdispersion of the read distribution along reference sequence. Many approaches have been proposed to deal with these difficulties. A number of existing methods use Poisson distribution to model the read counts and this easily splits the counts into the contributions from multiple transcripts. Meanwhile, various solutions were put forward to account for the overdispersion in the Poisson models. By checking the similarities among the variation patterns of read counts for individual genes, we found that the count variation is exon-specific and has the conserved pattern across the samples for each individual gene. We introduce Gamma-distributed latent variables to model the read sequencing preference for each exon. These variables are embedded to the rate parameter of a Poisson model to account for the overdispersion of read distribution. The model is tractable since the Gamma priors can be integrated out in the maximum likelihood estimation. We evaluate the proposed approach, PGseq, using four real datasets and one simulated dataset, and compare its performance with other popular methods. Results show that PGseq presents competitive performance compared to other alternatives in terms of accuracy in the gene and transcript expression calculation and in the downstream differential expression analysis. Especially, we show the advantage of our method in the analysis of low expression.	[Liu, Xuejun; Zhang, Li; Chen, Songcan] Nanjing Univ Aeronaut & Astronaut, Coll Comp Sci & Technol, Nanjing 210016, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics	Liu, XJ (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Comp Sci & Technol, Nanjing 210016, Jiangsu, Peoples R China.	xuejun.liu@nuaa.edu.cn			National Science Foundation of China [61170152]; Fundamental Research Funds for the Central University [CXZZ11_0217]; Qing Lan project	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University; Qing Lan project(Jiangsu Polytech Institute)	XL is supported by the National Science Foundation of China (61170152), LZ is supported by the Fundamental Research Funds for the Central University (CXZZ11_0217), and SC is supported by Qing Lan project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Busby MA, 2013, BIOINFORMATICS, V29, P656, DOI 10.1093/bioinformatics/btt015; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hein AMK, 2005, BIOSTATISTICS, V6, P349, DOI 10.1093/biostatistics/kxi016; Hein AMK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-353; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Jones DC, 2012, BIOINFORMATICS, V28, P921, DOI 10.1093/bioinformatics/bts055; Kaminuma E, 2011, NUCLEIC ACIDS RES, V39, pD22, DOI 10.1093/nar/gkq1041; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-305; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r50; Li W, 2012, BIOINFORMATICS, V28, P2914, DOI 10.1093/bioinformatics/bts559; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Liu XJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-98; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Spellucci P, 1998, MATH PROGRAM, V82, P413, DOI 10.1007/BF01580078; Srivastava S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq670; Suo C, 2014, BIOINFORMATICS, V30, P506, DOI 10.1093/bioinformatics/btt704; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Turro E., 2013, BIOINFORMATICS; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ZP, 2011, BIOINFORMATICS, V27, P502, DOI 10.1093/bioinformatics/btq696; Yu DN, 2013, BIOINFORMATICS, V29, P1275, DOI 10.1093/bioinformatics/btt143	44	2	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140032	10.1371/journal.pone.0140032	http://dx.doi.org/10.1371/journal.pone.0140032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448625	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000081
J	Luo, JL; Tang, SH; Peng, XJ; Yan, XH; Zeng, XH; Li, J; Li, XF; Wu, G				Luo, Junling; Tang, Shaohua; Peng, Xiaojue; Yan, Xiaohong; Zeng, Xinhua; Li, Jun; Li, Xiaofei; Wu, Gang			Elucidation of Cross-Talk and Specificity of Early Response Mechanisms to Salt and PEG-Simulated Drought Stresses in Brassica napus Using Comparative Proteomic Analysis	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; SIGNAL-TRANSDUCTION; REGULATORY NETWORKS; ARABIDOPSIS; PLANTS; REVEALS; PDZ; TOLERANCE; SALINITY; TARGETS	To understand the cross-talk and specificity of the early responses of plants to salt and drought, we performed physiological and proteome analyses of Brassica napus seedlings pretreated with 245 mM NaCl or 25% polyethylene glycol (PEG) 6000 under identical osmotic pressure (-1.0 MPa). Significant decreases in water content and photosynthetic rate and excessive accumulation of compatible osmolytes and oxidative damage were observed in response to both stresses. Unexpectedly, the drought response was more severe than the salt response. We further identified 45 common differentially expressed proteins (DEPs), 143 salt-specific DEPs and 160 drought-specific DEPs by isobaric tags for relative and absolute quantitation (iTRAQ) analysis. The proteome quantitative data were then confirmed by multiple reaction monitoring (MRM). The differences in the proteomic profiles between drought-treated and salt-treated seedlings exceeded the similarities in the early stress responses. Signal perception and transduction, transport and membrane trafficking, and photosynthesis-related proteins were enriched as part of the molecular cross-talk and specificity mechanism in the early responses to the two abiotic stresses. The Ca2+ signaling, G protein-related signaling, 14-3-3 signaling pathway and phosphorylation cascades were the common signal transduction pathways shared by both salt and drought stress responses; however, the proteins with executive functions varied. These results indicate functional specialization of family proteins in response to different stresses, i.e., CDPK21, TPR, and CTR1 specific to phosphorylation cascades under early salt stress, whereas STN7 and BSL were specific to phosphorylation cascades under early drought stress. Only the calcium-binding EF-hand family protein and ZKT were clearly identified as signaling proteins that acted as cross-talk nodes for salt and drought signaling pathways. Our study provides new clues and insights for developing strategies to improve the tolerance of crops to complex, multiple environmental stresses.	[Luo, Junling; Tang, Shaohua; Yan, Xiaohong; Zeng, Xinhua; Li, Jun; Li, Xiaofei; Wu, Gang] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr Peoples Republ China, Oil Crops Res Inst, Wuhan, Peoples R China; [Peng, Xiaojue] Nanchang Univ, Coll Life Sci, Key Lab Mol Biol & Gene Engn Jiangxi Prov, Nanchang, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanchang University	Wu, G (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr Peoples Republ China, Oil Crops Res Inst, Wuhan, Peoples R China.	wugang@caas.cn	Peng, xiaojue/AGY-1853-2022; Li, xiaofei/GXF-7187-2022		National Natural Science Foundation of China [31201152, 31160019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant numbers 31201152) to JLL and the National Natural Science Foundation of China (grant numbers 31160019) to XJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Bandehagh A, 2011, PROTEOMICS, V11, P1965, DOI 10.1002/pmic.201000564; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; Denison FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028306; Ellouzi H, 2014, PLANTA, V240, P1299, DOI 10.1007/s00425-014-2154-7; Elmore JM, 2011, MOL PLANT, V4, P416, DOI 10.1093/mp/ssq083; Fernandez-Calvino L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018880; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Ghosh D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00006; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hormozdiari F, 2010, J COMPUT BIOL, V17, P669, DOI 10.1089/cmb.2009.0032; Houslay MD, 2009, BRIT J PHARMACOL, V158, P483, DOI 10.1111/j.1476-5381.2009.00359.x; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Huang WH, 2013, MOL PLANT, V6, P1673, DOI 10.1093/mp/sst069; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Ishikawa A, 2005, BIOSCI BIOTECH BIOCH, V69, P972, DOI 10.1271/bbb.69.972; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Koh J, 2015, J PROTEOME RES; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qiao JJ, 2012, J PROTEOME RES, V11, P5286, DOI 10.1021/pr300504w; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Shi HT, 2013, J PROTEOME RES, V12, P4951, DOI 10.1021/pr400479k; Shi HT, 2013, PLANT PHYSIOL BIOCH, V67, P209, DOI 10.1016/j.plaphy.2013.03.016; Shi HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053422; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tester M, 2005, PLANT PHYSIOL, V137, P791, DOI 10.1104/pp.104.900138; Vemuri GN, 2005, MICROBIOL MOL BIOL R, V69, P197, DOI 10.1128/MMBR.69.2.197-216.2005; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang SY, 2013, J PROTEOME RES, V12, P2022, DOI 10.1021/pr301153z; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JH, 2007, MOL CELL BIOL, V27, P5214, DOI 10.1128/MCB.01989-06; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	47	50	56	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138974	10.1371/journal.pone.0138974	http://dx.doi.org/10.1371/journal.pone.0138974			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448643	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000016
J	Ota, K; Nouda, S; Takeuchi, T; Iguchi, M; Kojima, Y; Kuramoto, T; Inoue, T; Shindo, Y; Uesugi, K; Fujito, Y; Nishihara, H; Ohtsuka, N; Higuchi, K				Ota, Kazuhiro; Nouda, Sadaharu; Takeuchi, Toshihisa; Iguchi, Munetaka; Kojima, Yuichi; Kuramoto, Takanori; Inoue, Takuya; Shindo, Yasunori; Uesugi, Kenshiro; Fujito, Yoshiaki; Nishihara, Hironori; Ohtsuka, Naotake; Higuchi, Kazuhide		Team Mermaid	What Kind of Capsule Endoscope Is Suitable for a Controllable Self-Propelling Capsule Endoscope? Experimental Study Using a Porcine Stomach Model for Clinical Application (with Videos)	PLOS ONE			English	Article							PILLCAM COLON CAPSULE; MULTICENTER; ACCURACY; TRIAL	Background We have been developing the Self-Propelling Capsule Endoscope (SPCE) that allows for controllability from outside of the body and real-time observation. What kind of capsule endoscope (CE) is suitable for a controllable SPCE is unclear and a very critical point for clinical application. We compared observing ability of three kinds of SPCEs with different viewing angles and frame rates. Methods Eleven buttons were sewed in an excised porcine stomach. Four examiners controlled the SPCE using PillCamSB2, -ESO2, and -COLON2 (Given Imaging Ltd., Israel), for 10 minutes each with the aim of detecting as many buttons and examining them as closely as possible. The ability to find lesions was assessed based on the number of detected buttons. The SPCE-performance score (SPS) was used to evaluate the ability to examine the lesions in detail. Results The SPCE-ESO2, -COLON2, and -SB2 detected 11 [interquartile range (IQR): 0], 10.5 (IQR, 0.5), and 8 (IQR, 1.0) buttons, respectively. The SPCE-ESO2 and -COLON2 had a significantly better ability to detect lesions than the -SB2 (p < 0.05). The SPCE-ESO2, -COLON2, and -SB2 had significantly different SPS values of 22 (IQR, 0), 16.5 (IQR, 1.5), and 14 (IQR, 1.0), respectively (p < 0.05 for all comparisons; SPCE-SB2 vs. -ESO2, -SB2 vs. -COLON2, and -ESO2 vs. -COLON2). Conclusions PillCamESO2 is most suitable in different three CEs for SPCE for examining lesions in detail of the stomach.	[Ota, Kazuhiro; Nouda, Sadaharu; Takeuchi, Toshihisa; Iguchi, Munetaka; Kojima, Yuichi; Kuramoto, Takanori; Inoue, Takuya; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 569, Japan; [Shindo, Yasunori] Ryukoku Univ, Fac Sci & Technol, Seta, Shiga, Japan; [Uesugi, Kenshiro; Fujito, Yoshiaki; Nishihara, Hironori; Ohtsuka, Naotake] Mu Ltd, Seta, Shiga, Japan	Osaka Medical College; Ryukoku University	Ota, K (corresponding author), Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 569, Japan.	clash_kaz@yahoo.co.jp			Mu Ltd.	Mu Ltd.	The authors received no specific funding for this work. Mu Ltd. provided support in the form of salaries for authors KU, YF, HN and NO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Eliakim R, 2006, ENDOSCOPY, V38, P963, DOI 10.1055/s-2006-944832; Eliakim R, 2005, J CLIN GASTROENTEROL, V39, P572, DOI 10.1097/01.mcg.0000170764.29202.24; Fukumoto A, 2009, GASTROINTEST ENDOSC, V69, P857, DOI 10.1016/j.gie.2008.06.007; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Kakugawa Yasuo, 2014, Nihon Rinsho, V72, P168; Kakugawa Y, 2012, WORLD J GASTROENTERO, V18, P2092, DOI 10.3748/wjg.v18.i17.2092; Kurokawa S, 2014, J GASTROENTEROL, V49, P239, DOI 10.1007/s00535-013-0805-2; Matsushita Y, 2013, J GASTROENTEROL, V48, P633, DOI 10.1007/s00535-012-0660-6; Metzger Y., 2009, MEDICAL IMAGING, V2, P7, DOI DOI 10.2147/RMI.S4227; Morita E, 2010, GASTROINTEST ENDOSC, V72, P836, DOI 10.1016/j.gie.2010.06.016; Ohtsuka N, 2012, GASTROINTEST ENDOSC, V75, P126; Rey JF, 2010, ENDOSCOPY, V42, P541, DOI 10.1055/s-0030-1255521; Rey JF, 2012, GASTROINTEST ENDOSC, V75, P373, DOI 10.1016/j.gie.2011.09.030; Selby WS, 2011, EUR J GASTROEN HEPAT, V23, P101, DOI 10.1097/MEG.0b013e3283410210; Spada C, 2012, THER ADV GASTROENTER, V5, P173, DOI 10.1177/1756283X12438054; Valdastri P, 2012, ANNU REV BIOMED ENG, V14, P397, DOI 10.1146/annurev-bioeng-071811-150006	16	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139878	10.1371/journal.pone.0139878	http://dx.doi.org/10.1371/journal.pone.0139878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447694	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000062
J	Zhu, QL; Sui, SZ; Lei, XH; Yang, ZF; Lu, K; Liu, GD; Liu, YG; Li, MY				Zhu, Qinlong; Sui, Shunzhao; Lei, Xinghua; Yang, Zhongfang; Lu, Kun; Liu, Guangde; Liu, Yao-Guang; Li, Mingyang			Ectopic Expression of the Coleus R2R3 MYB-Type Proanthocyanidin Regulator Gene SsMYB3 Alters the Flower Color in Transgenic Tobacco	PLOS ONE			English	Article							ANTHOCYANIDIN-REDUCTASE GENE; TRANSCRIPTION FACTOR; LEUCOANTHOCYANIDIN REDUCTASE; FUNCTIONAL-CHARACTERIZATION; FLAVONOID BIOSYNTHESIS; CABERNET-SAUVIGNON; YOUNG BERRIES; SEED COAT; ENCODES; L.	Proanthocyanidins (PAs) play an important role in plant disease defense and have beneficial effects on human health. We isolated and characterized a novel R2R3 MYB-type PA-regulator SsMYB3 from a well-known ornamental plant, coleus (Solenostemon scutellarioides), to study the molecular regulation of PAs and to engineer PAs biosynthesis. The expression level of SsMYB3 was correlated with condensed tannins contents in various coleus tissues and was induced by wounding and light. A complementation test in the Arabidopsis tt2 mutant showed that SsMYB3 could restore the PA-deficient seed coat phenotype and activated expression of the PA-specific gene ANR and two related genes, DFR and ANS. In yeast twohybrid assays, SsMYB3 interacted with the Arabidopsis AtTT8 and AtTTG1 to reform the ternary transcriptional complex, and also interacted with two tobacco bHLH proteins (NtAn1a and NtJAF13-1) and aWD40 protein, NtAn11-1. Ectopic overexpression of SsMYB3 in transgenic tobacco led to almost-white flowers by greatly reducing anthocyanin levels and enhancing accumulation of condensed tannins. This overexpression of SsMYB3 upregulated the key PA genes (NtLAR and NtANR) and late anthocyanin structural genes (NtDFR and NtANS), but downregulated the expression of the final anthocyanin gene NtUFGT. The formative SsMYB3-complex represses anthocyanin accumulation by directly suppressing the expression of the final anthocyanin structural gene NtUFGT, through competitive inhibition or destabilization of the endogenous NtAn2-complex formation. These results suggested that SsMYB3 may forma transcription activation complex to regulate PA biosynthesis in the Arabidopsis tt2 mutant and transgenic tobacco. Our findings suggest that SsMYB3 is involved in the regulation of PA biosynthesis in coleus and has the potential as a molecular tool for manipulating biosynthesis of PAs in fruits and other crops using metabolic engineering.	[Zhu, Qinlong; Yang, Zhongfang; Liu, Yao-Guang] South China Agr Univ, Coll Life Sci, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China; [Sui, Shunzhao; Li, Mingyang] Southwest Univ, Coll Hort & Landscape, Chongqing Engn Res Ctr Floriculture, Chongqing 400716, Peoples R China; [Lei, Xinghua] Chongqing Agr Sch, Dept Bot, Chongqing 401329, Peoples R China; [Lu, Kun] Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Chongqing 400716, Peoples R China; [Liu, Guangde] ChongqingAgr Broadcasting & Televis Sch, Chongqing 401121, Peoples R China	South China Agricultural University; Southwest University - China; Southwest University - China	Zhu, QL (corresponding author), South China Agr Univ, Coll Life Sci, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China.	zhuql@scau.edu.cn; limy@swu.edu.cn	Lu, Kun/C-2597-2008	Lu, Kun/0000-0003-1370-8633	China Postdoctoral Science Foundation [20070420787]; National High Technology Research and Development Program ('863' Program) of China [2007AA10Z184]; National Natural Science Foundation of China [31000698]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National High Technology Research and Development Program ('863' Program) of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the China Postdoctoral Science Foundation (20070420787), the National High Technology Research and Development Program ('863' Program) of China (2007AA10Z184), and the National Natural Science Foundation of China (31000698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2011, CURR OPIN BIOTECH, V22, P239, DOI 10.1016/j.copbio.2010.11.004; Akagi T, 2010, PLANTA, V232, P1045, DOI 10.1007/s00425-010-1241-7; Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Bai YH, 2011, PLANTA, V234, P363, DOI 10.1007/s00425-011-1407-y; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bauer N, 2002, FOOD TECHNOL BIOTECH, V40, P163; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; BROADHURST RB, 1978, J SCI FOOD AGR, V29, P788, DOI 10.1002/jsfa.2740290908; Carrier G, 2013, PLANT PHYSIOL BIOCH, V72, P87, DOI 10.1016/j.plaphy.2013.04.014; Chavan UD, 2001, FOOD CHEM, V75, P509, DOI 10.1016/S0308-8146(01)00234-5; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czemmel S, 2012, PROTOPLASMA, V249, P109, DOI 10.1007/s00709-012-0380-z; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Gagne S, 2009, PLANT PHYSIOL BIOCH, V47, P282, DOI 10.1016/j.plaphy.2008.12.004; Gerats T, 2009, PETUNIA EVOLUTIONARY, P269; Gesell A, 2014, PLANTA, V240, P497, DOI 10.1007/s00425-014-2098-y; Han YP, 2012, J EXP BOT, V63, P2437, DOI 10.1093/jxb/err415; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Kovinich N, 2012, J AGR FOOD CHEM, V60, P574, DOI 10.1021/jf2033939; Kovinich N, 2010, PHYTOCHEMISTRY, V71, P1253, DOI 10.1016/j.phytochem.2010.05.009; Koyama K, 2012, PHYTOCHEMISTRY, V78, P54, DOI 10.1016/j.phytochem.2012.02.026; Kubo H, 2007, J PLANT RES, V120, P445, DOI 10.1007/s10265-006-0067-7; Lebowitz R. J., 1985, Plant Breeding Reviews, V3, P343; Liao L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00243; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; NAGEL CW, 1991, AM J ENOL VITICULT, V42, P364; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Patra B, 2013, BBA-GENE REGUL MECH, V1829, P1236, DOI 10.1016/j.bbagrm.2013.09.006; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; PETERSEN M, 1993, PLANTA, V189, P10, DOI 10.1007/BF00201337; Petersen M, 2009, PHYTOCHEMISTRY, V70, P1663, DOI 10.1016/j.phytochem.2009.05.010; RABINO I, 1986, PLANT PHYSIOL, V81, P922, DOI 10.1104/pp.81.3.922; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Shih CH, 2008, PLANTA, V228, P1043, DOI 10.1007/s00425-008-0806-1; Singh K, 2009, TREE PHYSIOL, V29, P837, DOI 10.1093/treephys/tpp022; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; Verdier J, 2012, P NATL ACAD SCI USA, V109, P1766, DOI 10.1073/pnas.1120916109; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; Yoshida K, 2008, PLANT CELL PHYSIOL, V49, P157, DOI 10.1093/pcp/pcn009; Zhu QL, 2014, GENE, V548, P39, DOI 10.1016/j.gene.2014.07.004	49	15	21	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139392	10.1371/journal.pone.0139392	http://dx.doi.org/10.1371/journal.pone.0139392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448466	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000024
J	Chang, DH; Shimizu, T; Haraguchi, Y; Gao, S; Sakaguchi, K; Umezu, M; Yamato, M; Liu, ZM; Okano, T				Chang, Dehua; Shimizu, Tatsuya; Haraguchi, Yuji; Gao, Shuai; Sakaguchi, Katsuhisa; Umezu, Mitsuo; Yamato, Masayuki; Liu, Zhongmin; Okano, Teruo			Time Course of Cell Sheet Adhesion to Porcine Heart Tissue after Transplantation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RESPONSIVE CULTURE SURFACES; ENDOSCOPIC SUBMUCOSAL DISSECTION; CARDIOMYOCYTE SHEETS; ADIPOSE-TISSUE; RAT MODEL; TEMPERATURE; GRAFTS; FIBRONECTIN; MATRIX	Multilayered cell sheets have been produced from bone marrow-derived mesenchymal stem cells (MSCs) for investigating their adhesion properties onto native porcine heart tissue. Once MSCs reached confluence after a 7-day culture on a temperature-responsive culture dish, a MSCs monolayer spontaneously detached itself from the dish, when the culture temperature was reduced from 37 to 20 degrees C. The basal extracellular matrix (ECM) proteins of the single cell sheet are preserved, because this technique requires no proteolytic enzymes for harvesting cell sheet, which become a basic building block for assembling a multilayer cell sheet. The thickness of multilayered cell sheets made from three MSC sheets was found to be approximately 60 mu m. For investigating the adhesion properties of the basal and apical sides, the multilayered cell sheets were transplanted onto the surface of the heart's left ventricle. Multilayered cell sheets were histological investigated at 15, 30, 45 and 60 minutes after transplantation by hematoxylin eosin (HE) and azan dyes to determine required time for the adhesion of the multilayered sheets following cell-sheet transplantation. The results showed that only the basal side of multilayered cell sheets significantly enhanced the sheets adhesion onto the surface of heart 30 minutes after transplantation. This study concluded that (1) cell sheets had to be transplanted with its basal side onto the surface of heart tissue and (2) at least 30 minutes were necessary for obtaining the histological adhesion of the sheets to the heart tissue. This study provided clinical evidence and parameters for the successful application of MSC sheets to the myocardium and allowed cell sheet technology to be adapted clinical cell-therapy for myocardial diseases.	[Chang, Dehua; Shimizu, Tatsuya; Haraguchi, Yuji; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, TWIns, Shinjuku Ku, Tokyo 1628666, Japan; [Chang, Dehua; Gao, Shuai; Liu, Zhongmin] Tongji Univ, Sch Med, Shanghai East Hosp, Translat Med Ctr Stem Cell Therapy, Shanghai 200120, Peoples R China; [Sakaguchi, Katsuhisa; Umezu, Mitsuo] Waseda Univ, Res Inst Sci & Engn, TWIns, Shinjuku Ku, Tokyo 1628480, Japan	Tokyo Women's Medical University; Tongji University; Waseda University	Okano, T (corresponding author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, TWIns, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tokano@twmu.ac.jp	Tatsuya, Shimizu/AAN-5675-2021; Sakaguchi, Katsuhisa/P-7252-2018	Sakaguchi, Katsuhisa/0000-0002-8610-8455; Okano, Teruo/0000-0002-4470-9842	Special Coordination Found for Promoting Science and Technology of Japan; Formation of Innovation Center for Fusion	Special Coordination Found for Promoting Science and Technology of Japan; Formation of Innovation Center for Fusion	This work was supported by the Special Coordination Found for Promoting Science and Technology of Japan and the Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology Cell Sheet Tissue Engineering Center (CSTEC) from the Ministry of Education, Culture, Sports Science, and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canavan HE, 2006, PLASMA PROCESS POLYM, V3, P516, DOI 10.1002/ppap.200600017; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Haraguchi Y, 2006, BIOMATERIALS, V27, P4765, DOI 10.1016/j.biomaterials.2006.04.034; Harimoto M, 2003, MACROMOL SYMP, V195, P231, DOI 10.1002/masy.200390127; Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Kushida A, 2001, J BIOMED MATER RES, V54, P37, DOI 10.1002/1097-4636(200101)54:1<37::AID-JBM5>3.0.CO;2-7; Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Ogata T, 2007, GASTROINTEST ENDOSC, V65, pAB152, DOI 10.1016/j.gie.2007.03.218; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Ohki T, 2006, TISSUE ENG, V12, P1058; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Gomes JAP, 2010, INVEST OPHTH VIS SCI, V51, P1408, DOI 10.1167/iovs.09-4029; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reinlib L, 2000, CIRCULATION, V101, pE182; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Sekine H, 2006, CIRCULATION, V114, pI87, DOI 10.1161/CIRCULATIONAHA.105.000273; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Sherman W, 2003, J AM COLL CARDIOL, V41, p176A; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; Shiroyanagi Y, 2003, TISSUE ENG, V9, P1005, DOI 10.1089/107632703322495646; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002; Yamato M, 2000, BIOMATERIALS, V21, P981, DOI 10.1016/S0142-9612(99)00239-2; Yamato M, 1999, J BIOMED MATER RES, V44, P44, DOI 10.1002/(SICI)1097-4636(199901)44:1<44::AID-JBM5>3.3.CO;2-O; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	40	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137494	10.1371/journal.pone.0137494	http://dx.doi.org/10.1371/journal.pone.0137494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444683	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600011
J	Isoda, Y; Yagi, H; Satoh, T; Shibata-Koyama, M; Masuda, K; Satoh, M; Kato, K; Iida, S				Isoda, Yuya; Yagi, Hirokazu; Satoh, Tadashi; Shibata-Koyama, Mami; Masuda, Kazuhiro; Satoh, Mitsuo; Kato, Koichi; Iida, Shigeru			Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with Fc gamma RIIIa and Other Fc gamma Receptors	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; N-LINKED OLIGOSACCHARIDE; THERAPEUTIC ANTIBODIES; IMMUNOGLOBULIN-G; BINDING-AFFINITY; STRUCTURAL BASIS; HUMAN-IGG; FUCOSE; POLYMORPHISMS; RITUXIMAB	Antibody-dependent cellular cytotoxicity (ADCC) is an important effector function determining the clinical efficacy of therapeutic antibodies. Core fucose removal from N-glycans on the Fc portion of immunoglobulin G (IgG) improves the binding affinity for Fc gamma receptor IIIa (Fc gamma RIIIa) and dramatically enhances ADCC. Our previous structural analyses revealed that Tyr-296 of IgG1-Fc plays a critical role in the interaction with Fc gamma RIIIa, particularly in the enhanced Fc gamma RIIIa binding of nonfucosylated IgG1. However, the importance of the Tyr-296 residue in the antibody in the interaction with various Fc gamma receptors has not yet been elucidated. To further clarify the biological importance of this residue, we established comprehensive Tyr-296 mutants as fucosylated and nonfucosylated anti-CD20 IgG1s rituximab variants and examined their binding to recombinant soluble human Fc gamma receptors: shFc gamma RI, shFc gamma RIIa, shFc gamma RIIIa, and shFc gamma RIIIb. Some of the mutations affected the binding of antibody to not only shFc gamma RIIIa but also shFc gamma RIIa and shFc gamma RIIIb, suggesting that the Tyr-296 residue in the antibody was also involved in interactions with Fc gamma RIIa and Fc gamma RIIIb. For Fc gamma RIIIa binding, almost all Tyr-296 variants showed lower binding affinities than the wild-type antibody, irrespective of their core fucosylation, particularly in Y296K and Y296P. Notably, only the Y296W mutant showed improved binding to Fc gamma RIIIa. The 3.00 A reoslution crystal structure of the nonfucosylated296W mutant in complex with shFc gamma RIIIa harboring two N-glycans revealed that the Tyr-to-Trp substitution increased the number of potential contact atoms in the complex, thus improving the binding of the antibody to shFc gamma RIIIa. The nonfucosylated Y296W mutant retained high ADCC activity, relative to the nonfucosylated wild-type IgG1, and showed greater binding affinity for Fc gamma RIIa. Our data may improve our understanding of the biological importance of human IgG1-Fc Tyr-296 in interactions with various Fc gamma receptors, and have applications in the modulation of the IgG1-Fc function of therapeutic antibodies.	[Isoda, Yuya; Masuda, Kazuhiro; Iida, Shigeru] Kyowa Hakko Kirin Co Ltd, R&D Div, Res Funct Unit, Machida, Tokyo, Japan; [Yagi, Hirokazu; Satoh, Tadashi; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Satoh, Tadashi] JST, PRESTO, Mizuho Ku, Nagoya, Aichi, Japan; [Shibata-Koyama, Mami; Satoh, Mitsuo] Kyowa Hakko Kirin Co Ltd, Immunol & Allergy R&D Unit, R&D Div, Machida, Tokyo, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Higashiyama Ku, Okazaki, Aichi 4448585, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Higashiyama Ku, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] GLYENCE Co Ltd, Chikusa Ku, Nagoya, Aichi, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 112, Japan	Kyowa Kirin Ltd; Nagoya City University; Japan Science & Technology Agency (JST); Kyowa Kirin Ltd; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Ochanomizu University	Iida, S (corresponding author), Kyowa Hakko Kirin Co Ltd, R&D Div, Res Funct Unit, Asahi Machi, Machida, Tokyo, Japan.	shigeru.iida@kyowa-kirin.co.jp	Yagi, Hirokazu/ABH-6151-2020; Satoh, Tadashi/M-5157-2017	Kato, Koichi/0000-0001-7187-9612; Yagi, Hirokazu/0000-0001-9296-0225; Satoh, Tadashi/0000-0002-4493-4978	JSPS KAKENHI [25102008, 24249002]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Okazaki ORION project; Grants-in-Aid for Scientific Research [25102008] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Okazaki ORION project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI (Grant Numbers 25102008, 24249002 to K.K.), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) (to K.K.), and the Okazaki ORION project. Yuya Isoda, Mami Shibata-Koyama, Kazuhiro Masuda, Mitsuo Satoh, and Shigeru Iida are from Kyowa Hakko Kirin Co., Ltd. Koichi Kato is a scientific advisor of Medical & Biological Laboratories Co. Ltd. These funders provided support in the form of salaries for authors (Y.I., M.S., K.M., M.S., S.I., K.K.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Beck A, 2012, MABS-AUSTIN, V4, P419, DOI 10.4161/mabs.20996; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Edberg JC, 1997, J IMMUNOL, V159, P3849; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Hatjiharissi E, 2007, BLOOD, V110, P2561, DOI 10.1182/blood-2007-01-070656; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Iida S, 2006, CLIN CANCER RES, V12, P2879, DOI 10.1158/1078-0432.CCR-05-2619; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; KAWASAKI N, 2014, J GLYCOMICS LIPIDOMI, V4, P2; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu JH, 2011, J BIOL CHEM, V286, P40608, DOI 10.1074/jbc.M111.257550; Masuda K, 2007, MOL IMMUNOL, V44, P3122, DOI 10.1016/j.molimm.2007.02.005; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Niwa R, 2005, J IMMUNOL METHODS, V306, P151, DOI 10.1016/j.jim.2005.08.009; Niwa R, 2004, CLIN CANCER RES, V10, P6248, DOI 10.1158/1078-0432.CCR-04-0850; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467; Rath T, 2013, J CLIN IMMUNOL, V33, pS9, DOI 10.1007/s10875-012-9768-y; SARMAY G, 1992, MOL IMMUNOL, V29, P633, DOI 10.1016/0161-5890(92)90200-H; Sheridan C, 2014, NAT BIOTECHNOL, V32, P205, DOI 10.1038/nbt0314-205; Shibata-Koyama M, 2009, GLYCOBIOLOGY, V19, P126, DOI 10.1093/glycob/cwn110; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; TAO MH, 1989, J IMMUNOL, V143, P2595; URLAUB G, 1986, SOMAT CELL MOLEC GEN, V12, P555, DOI 10.1007/BF01671941; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Webster R, 2014, NAT REV DRUG DISCOV, V13, P883, DOI 10.1038/nrd4476; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Wright A, 1997, TRENDS BIOTECHNOL, V15, P26, DOI 10.1016/S0167-7799(96)10062-7; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Yamaguchi Y, 2007, COMPREHENSIVE GLYCOS, V3, P745; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yamane-Ohnuki N, 2009, MABS-AUSTIN, V1, P230, DOI 10.4161/mabs.1.3.8328; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021	47	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140120	10.1371/journal.pone.0140120	http://dx.doi.org/10.1371/journal.pone.0140120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444434	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600141
J	Kurze, C; Le Conte, Y; Dussaubat, C; Erler, S; Kryger, P; Lewkowski, O; Muller, T; Widder, M; Moritz, RFA				Kurze, Christoph; Le Conte, Yves; Dussaubat, Claudia; Erler, Silvio; Kryger, Per; Lewkowski, Oleg; Mueller, Thomas; Widder, Miriam; Moritz, Robin F. A.			Nosema Tolerant Honeybees (Apis mellifera) Escape Parasitic Manipulation of Apoptosis	PLOS ONE			English	Article							CELL-DEATH; CERANAE MICROSPORIDIA; IMMUNE-RESPONSE; EXPRESSION; INFECTION; GENES; INHIBITION; EPITHELIUM; CASPASES; SURVIVAL	Apoptosis is not only pivotal for development, but also for pathogen defence in multicellular organisms. Although numerous intracellular pathogens are known to interfere with the host's apoptotic machinery to overcome this defence, its importance for host-parasite coevolution has been neglected. We conducted three inoculation experiments to investigate in the apoptotic respond during infection with the intracellular gut pathogen Nosema ceranae, which is considered as potential global threat to the honeybee (Apis mellifera) and other bee pollinators, in sensitive and tolerant honeybees. To explore apoptotic processes in the gut epithelium, we visualised apoptotic cells using TUNEL assays and measured the relative expression levels of subset of candidate genes involved in the apoptotic machinery using qPCR. Our results suggest that N. ceranae reduces apoptosis in sensitive honeybees by enhancing inhibitor of apoptosis protein-(iap)-2 gene transcription. Interestingly, this seems not be the case in Nosema tolerant honeybees. We propose that these tolerant honeybees are able to escape the manipulation of apoptosis by N. ceranae, which may have evolved a mechanism to regulate an anti-apoptotic gene as key adaptation for improved host invasion.	[Kurze, Christoph; Erler, Silvio; Lewkowski, Oleg; Moritz, Robin F. A.] Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Saale, Germany; [Le Conte, Yves; Dussaubat, Claudia] INRA, UR Abeilles & Environm 406, Avignon, France; [Kryger, Per] Aarhus Univ, Dept Agroecol, Flakkebjerg, Denmark; [Mueller, Thomas; Widder, Miriam] Univ Halle Wittenberg, Dept Internal Med 4, D-06108 Halle, Saale, Germany; [Moritz, Robin F. A.] German Inst Integrat Biodivers Res iDiv, Leipzig, Germany; [Moritz, Robin F. A.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	Martin Luther University Halle Wittenberg; INRAE; Aarhus University; Martin Luther University Halle Wittenberg; University of Pretoria	Kurze, C (corresponding author), Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Saale, Germany.	christoph.kurze@zoologie.uni-halle.de	Le Conte, Yves M/B-3246-2016; Erler, Silvio/B-4162-2012; Lewkowski, Oleg/AAG-1443-2019; Kryger, Per/H-4600-2019; Le Conte, Yves/M-4442-2018; Kryger, Per/C-1773-2013; Le Conte, Yves/AAP-2379-2021; Mueller, Thomas/ABE-4197-2020; Lewkowski, Oleg/AAQ-8796-2020; Moritz, Robin FA/K-6053-2012	Le Conte, Yves M/0000-0002-8466-5370; Erler, Silvio/0000-0002-9425-8103; Kryger, Per/0000-0001-5306-3230; Le Conte, Yves/0000-0002-8466-5370; Kryger, Per/0000-0001-5306-3230; Le Conte, Yves/0000-0002-8466-5370; Lewkowski, Oleg/0000-0001-8435-9202; Moritz, Robin FA/0000-0003-0791-887X	Deutsche Forschungsgemeinschaft through the priority programme "Host-Parasite Coevolution - Rapid Reciprocal Adaptation and its Genetic Basis" (SPP 1399) [MO373/26-2]; Foundation for the Preservation of Honey Bees, Inc.	Deutsche Forschungsgemeinschaft through the priority programme "Host-Parasite Coevolution - Rapid Reciprocal Adaptation and its Genetic Basis" (SPP 1399); Foundation for the Preservation of Honey Bees, Inc.	This study was funded by the Deutsche Forschungsgemeinschaft through the priority programme "Host-Parasite Coevolution - Rapid Reciprocal Adaptation and its Genetic Basis" (SPP 1399, Grant number MO373/26-2) to RFAM and a scholarship from The Foundation for the Preservation of Honey Bees, Inc. to CK.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, R FOUNDATION FOR STA; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Binnicker MJ, 2003, CELL MICROBIOL, V5, P549, DOI 10.1046/j.1462-5822.2003.00300.x; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; del Aguila C, 2006, INT J PARASITOL, V36, P869, DOI 10.1016/j.ijpara.2006.04.002; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gisder S, 2011, ENVIRON MICROBIOL, V13, P404, DOI 10.1111/j.1462-2920.2010.02346.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hatjina F, 2014, J APICULT RES, V53, P337, DOI 10.3896/IBRA.1.53.3.02; Hay BA, 2004, NAT REV GENET, V5, P911, DOI 10.1038/nrg1491; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Higes M, 2013, ENV MICROBIOL REP, V5, P530, DOI 10.1111/1758-2229.12059; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Holt HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-799; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Huh JR, 2007, J BIOL CHEM, V282, P2056, DOI 10.1074/jbc.M608051200; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Kanda H, 2004, J BIOCHEM, V136, P1, DOI 10.1093/jb/mvh098; Keeling P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000489; Liu J, 2008, INFECT IMMUN, V76, P3784, DOI 10.1128/IAI.00308-08; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Molestina RE, 2003, J CELL SCI, V116, P4359, DOI 10.1242/jcs.00683; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PIPAN N, 1980, ZOOMORPHOLOGIE, V94, P217, DOI 10.1007/BF01081936; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Scanlon M, 1999, J EUKARYOT MICROBIOL, V46, p34S; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seeley TD, 1985, YELLOW RAIN SCI AM, V253, P122; Smart MD, 2012, J INVERTEBR PATHOL, V109, P148, DOI 10.1016/j.jip.2011.09.009; Steller H, 2000, NAT CELL BIOL, V2, pE100, DOI 10.1038/35014093; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vidau C, 2014, J INVERTEBR PATHOL, V121, P89, DOI 10.1016/j.jip.2014.07.002; Zuur Alain F., 2009, P1	43	44	46	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140174	10.1371/journal.pone.0140174	http://dx.doi.org/10.1371/journal.pone.0140174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445372	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600148
J	Lee, D; Cho, ES; Kim, DJ; Kim, JH; Yu, JS; Chung, JJ				Lee, Dahye; Cho, Eun-Suk; Kim, Dae Jung; Kim, Joo Hee; Yu, Jeong-Sik; Chung, Jae-Joon			Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30 degrees Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastasis	PLOS ONE			English	Article							GD-EOB-DTPA; HEPATOCELLULAR-CARCINOMA; IMPROVE CONSPICUOUSNESS; PREOPERATIVE EVALUATION; DIAGNOSTIC PERFORMANCE; THERAPEUTIC STRATEGY; HEPATOBILIARY PHASE; CLINICAL-EVALUATION; MULTICENTER TRIAL; CONTRAST AGENT	Objectives To compare 10-minute delayed hepatocyte phase imaging using a 30 degrees flip angle (10min-FA30) and 20-minute hepatocyte phase imaging using a 10 degrees FA (20min-FA10) in gadoxetic acid-enhanced MRI of patients with possible liver metastases, regarding lesion-to-liver contrast-to-noise ratio (CNR) and focal hepatic lesion (FHL) detection to evaluate whether 10min-FA30 would be superior to 20min-FA10. Materials and Methods Eighty-three patients with 248 liver metastases and 78 benign FHLs who underwent gadoxetic acid-enhanced MRI with 10min-FA30 and 20min-FA10 were enrolled. Lesion-to-liver CNRs were compared between the two image groups. Two radiologists independently assessed the presence of FHLs using a four-point scale and detection sensitivity was calculated. Results The mean CNR for liver metastases on the 10min-FA30 (248.5 +/- 101.6) were significantly higher than that of the 20min-FA10 (187.4 +/- 77.4) (p < 0.001). The mean CNR difference between the two image groups was 61.2 +/- 56.8. There was no significant difference in detection sensitivity of FHLs for two readers between 10min-FA30 (mean 97.7%) and 20min-FA10 (mean 97.9%), irrespective of the lesion size or malignancy. Conclusion 10min-FA30 yielded higher CNR with similar sensitivity compared to 20min-FA10. This finding indicates that 10min-FA30 can potentially replace 20min-FA10 with higher diagnostic performance and save 10 minutes of time.	[Lee, Dahye; Cho, Eun-Suk; Kim, Joo Hee; Yu, Jeong-Sik; Chung, Jae-Joon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea; [Kim, Dae Jung] CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University	Cho, ES (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.	jjondol@yuhs.ac		Yu, Jeong-Sik/0000-0002-8171-5838				Ahn SS, 2010, RADIOLOGY, V255, P459, DOI 10.1148/radiol.10091388; Bashir MR, 2012, J MAGN RESON IMAGING, V35, P611, DOI 10.1002/jmri.22850; Bashir MR, 2011, EUR RADIOL, V21, P291, DOI 10.1007/s00330-010-1917-1; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Brody JM, 2005, J MAGN RESON IMAGING, V21, P391, DOI 10.1002/jmri.20289; Cho ES, 2015, AM J ROENTGENOL, V204, P69, DOI 10.2214/AJR.13.11903; Filippone A, 2010, J MAGN RESON IMAGING, V31, P356, DOI 10.1002/jmri.22054; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Halavaara J, 2006, J COMPUT ASSIST TOMO, V30, P345, DOI 10.1097/00004728-200605000-00001; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Haradome H, 2012, J MAGN RESON IMAGING, V35, P132, DOI 10.1002/jmri.22805; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Jeong HT, 2012, J MAGN RESON IMAGING, V35, P635, DOI 10.1002/jmri.22880; Kim HJ, 2015, RADIOLOGY, V274, P712, DOI 10.1148/radiol.14140390; Kim YK, 2010, EUR J RADIOL, V73, P131, DOI 10.1016/j.ejrad.2008.09.027; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Motosugi U, 2009, EUR RADIOL, V19, P2623, DOI 10.1007/s00330-009-1467-6; Nagle SK, 2012, J MAGN RESON IMAGING, V36, P890, DOI 10.1002/jmri.23713; Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061; Reimer P, 1997, EUR RADIOL, V7, P275, DOI 10.1007/s003300050150; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; Ringe KI, 2010, AM J ROENTGENOL, V195, P13, DOI 10.2214/AJR.10.4392; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Scharitzer M, 2013, EUR RADIOL, V23, P2187, DOI 10.1007/s00330-013-2824-z; Sofue K, 2014, EUR RADIOL, V24, P2532, DOI 10.1007/s00330-014-3233-7; Sofue K, 2011, EUR RADIOL, V21, P2336, DOI 10.1007/s00330-011-2197-0; Tamada T, 2013, J MAGN RESON IMAGING, V37, P1093, DOI 10.1002/jmri.23903; van Kessel CS, 2012, EUR RADIOL, V22, P2153, DOI 10.1007/s00330-012-2486-2; Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946; Zech CJ, 2008, INVEST RADIOL, V43, P504, DOI 10.1097/RLI.0b013e3181705cd1	31	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139863	10.1371/journal.pone.0139863	http://dx.doi.org/10.1371/journal.pone.0139863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444677	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600095
J	Li, CF; Yao, MZ; Ma, CL; Ma, JQ; Jin, JQ; Chen, L				Li, Chun-Fang; Yao, Ming-Zhe; Ma, Chun-Lei; Ma, Jian-Qiang; Jin, Ji-Qiang; Chen, Liang			Differential Metabolic Profiles during the Albescent Stages of 'Anji Baicha' (Camellia sinensis)	PLOS ONE			English	Article							GENE-EXPRESSION; YOUNG LEAVES; GREEN TEA; BIOSYNTHESIS; PLANTS	'Anji Baicha' is an albino tea cultivar with white shoots at low air temperature and green shoots at high air temperature in early spring. The metabolite contents in the shoots dynamically vary with the color changes and with shoot development. To investigate the metabolomic variation during the albescent and re-greening stages, gas chromatography-mass spectrometry combined with multivariate analysis were applied to analyze the metabolite profiles in the different color stages during the development of 'Anji Baicha' leaves. The metabolite profiles of three albescent stages, including the yellow-green stage, the early albescent stage, and the late albescent stage, as well as the re-greening stage were distinguished using principal component analysis, revealing that the distinct developmental stages were likely responsible for the observed metabolic differences. Furthermore, a group classification and pairwise discrimination was revealed among the three albescent stages and re-greening stage by partial least squares discriminant analysis. A total of 65 differential metabolites were identified with a variable influence on projection greater than 1. The main differential metabolic pathways of the albescent stages compared with the re-greening stage included carbon fixation in photosynthetic organisms and the phenylpropanoid and flavonoid biosynthesis pathways. Compared with the regreening stage, the carbohydrate and amino acid metabolic pathways were disturbed during the albescent stages. During the albescent stages, the sugar (fructofuranose), sugar derivative (glucose-1-phosphate) and epicatechin concentrations decreased, whereas the amino acid (mainly glycine, serine, tryptophan, citrulline, glutamine, proline, and valine) concentrations increased. These results reveal the changes in metabolic profiling that occur during the color changes associated with the development of the albino tea plant leaves.	[Li, Chun-Fang; Yao, Ming-Zhe; Ma, Chun-Lei; Ma, Jian-Qiang; Jin, Ji-Qiang; Chen, Liang] Chinese Acad Agr Sci, Minist Agr, Tea Res Inst, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Chen, L (corresponding author), Chinese Acad Agr Sci, Minist Agr, Tea Res Inst, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China.	liangchen@tricaas.com	MINGZHE, YAO/AAH-7748-2021; Chen, Liang/R-4438-2019	Chen, Liang/0000-0002-7507-3947	Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System [CARS-023]; Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2014-TRICAAS]; National Natural Science Foundation of China [31400581, 31170624, 31100504]	Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System; Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System (CARS-023) received by LC, by the Chinese Academy of Agricultural Sciences through the Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2014-TRICAAS) received by LC, and by the National Natural Science Foundation of China (Nos. 31400581 received by CFL, 31170624 received by MZY and 31100504 received by CLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Deng WW, 2012, PLANT PHYSIOL BIOCH, V56, P35, DOI 10.1016/j.plaphy.2012.04.003; Dethloff F, 2014, METHODS MOL BIOL, V1166, P171, DOI 10.1007/978-1-4939-0844-8_14; Du Y, 2010, AFRI J BIOTECHNOL, V7, P1881; Du YY, 2006, J HORTIC SCI BIOTECH, V81, P809, DOI 10.1080/14620316.2006.11512142; Feng L, 2014, FOOD CHEM, V155, P98, DOI 10.1016/j.foodchem.2014.01.044; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fujimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023426; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Jang ZH, 2012, MOL BIOSYST, V8, P2001, DOI 10.1039/c2mb25073j; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Ku KM, 2010, J AGR FOOD CHEM, V58, P418, DOI 10.1021/jf902929h; Lastdrager J, 2014, J EXP BOT, V65, P799, DOI 10.1093/jxb/ert474; Lee JE, 2011, J AGR FOOD CHEM, V59, P10579, DOI 10.1021/jf202304z; Lee JE, 2010, J AGR FOOD CHEM, V58, P10582, DOI 10.1021/jf102415m; Li Q, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-44; Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b; Ma CL, 2012, SCI HORTIC-AMSTERDAM, V148, P246, DOI 10.1016/j.scienta.2012.09.033; MaedaYamamoto M, 1996, J JPN SOC FOOD SCI, V43, P1309; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Seetohul LN, 2006, J SCI FOOD AGR, V86, P2092, DOI 10.1002/jsfa.2578; Smeekens S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00113; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Wang L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0352-x; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wei K, 2012, FOOD CHEM, V130, P720, DOI 10.1016/j.foodchem.2011.07.092; Xiong LG, 2013, PLANT PHYSIOL BIOCH, V71, P132, DOI 10.1016/j.plaphy.2013.06.019; Zhang QF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112572	36	20	27	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139996	10.1371/journal.pone.0139996	http://dx.doi.org/10.1371/journal.pone.0139996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444680	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600119
J	Pizarro-Delgado, J; Deeney, JT; Martin-del-Rio, R; Corkey, BE; Tamarit-Rodriguez, J				Pizarro-Delgado, Javier; Deeney, Jude T.; Martin-del-Rio, Rafael; Corkey, Barbara E.; Tamarit-Rodriguez, Jorge			KCl -Permeabilized Pancreatic Islets: An Experimental Model to Explore the Messenger Role of ATP in the Mechanism of Insulin Secretion	PLOS ONE			English	Article							HEMICHANNELS; STIMULATION; CONTRIBUTES; METABOLISM; CELLS	Our previous work has demonstrated that islet depolarization with KCl opens connexin36 hemichannels in beta-cells of mouse pancreatic islets allowing the exchange of small metabolites with the extracellular medium. In this study, the opening of these hemichannels has been further characterized in rat islets and INS-1 cells. Taking advantage of hemicannels'opening, the uptake of extracellular ATP and its effect on insulin release were investigated. 70 mM KCl stimulated light emission by luciferin in dispersed rat islets cells transduced with the fire-fly luciferase gene: it was suppressed by 20 mM glucose and 50 mu M mefloquine, a specific connexin36 inhibitor. Extracellular ATP was taken up or released by islets depolarized with 70 mM KCl at 5 mM glucose, depending on the external ATP concentration. 1 mM ATP restored the loss of ATP induced by the depolarization itself. ATP concentrations above 5 mM increased islet ATP content and the ATP/ADP ratio. No ATP uptake occurred in non-depolarized or KCl-depolarized islets simultaneously incubated with 50 mu M mefloquine or 20 mM glucose. Extracellular ATP potentiated the secretory response induced by 70 mM KCl at 5 mM glucose in perifused rat islets: 5 mM ATP triggered a second phase of insulin release after the initial peak triggered by KCl-depolarization itself; at 10 mM, it increased both the initial, KCl-dependent, peak and stimulated a greater second phase of secretion than at 5 mM. These stimulatory effects of extracellular ATP were almost completely suppressed by 50 mu M mefloquine. The magnitude of the second phase of insulin release due to 5 mM extracellular ATP was decreased by addition of 5 mM ADP (extracellular ATP/ADP ratio = 1). ATP acts independently of K-ATP channels closure and its intracellular concentration and its ATP/ADP ratio seems to regulate the magnitude of both the first (triggering) and second (amplifying) phases of glucose-induced insulin secretion.	[Pizarro-Delgado, Javier; Tamarit-Rodriguez, Jorge] Univ Complutense, Sch Med, Dept Biochem, E-28040 Madrid, Spain; [Martin-del-Rio, Rafael] Ramon y Cajal Hosp IRYCIS, Res Dept, Madrid, Spain; [Deeney, Jude T.; Corkey, Barbara E.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA	Complutense University of Madrid; Boston University	Tamarit-Rodriguez, J (corresponding author), Univ Complutense, Sch Med, Dept Biochem, E-28040 Madrid, Spain.	tamarit@med.ucm.es	PIZARRO-DELGADO, JAVIER/E-7268-2012	Deeney, Jude/0000-0003-0988-9419; PIZARRO-DELGADO, JAVIER/0000-0002-3735-844X	National Institutes of Health [RO-1-DK35914]; Ministerio de Economia y Competitividad [SAF2009/1267]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad(Spanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by RO-1-DK35914, National Institutes of Health (www.nih.gov) and SAF2009/1267: Ministerio de Economia y Competitividad (www.mineco.gob.es).	Bavamian S, 2007, DIABETES OBES METAB, V9, P118, DOI 10.1111/j.1463-1326.2007.00780.x; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Eliasson E, 1997, J PHYSL, V503, P399; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; JONES BN, 1981, J LIQ CHROMATOGR, V4, P565, DOI 10.1080/01483918108059956; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Pizarro-Delgado J, 2014, AM J PHYSIOL-ENDOC M, V306, pE1354, DOI 10.1152/ajpendo.00358.2013; Pizarro-Delgado J, 2010, BIOCHEM J, V431, P381, DOI 10.1042/BJ20100714; Pizarro-Delgado J, 2009, BIOCHEM J, V419, P359, DOI 10.1042/BJ20081731; Scemes E, 2012, BBA-BIOMEMBRANES, V1818, P1880, DOI 10.1016/j.bbamem.2011.06.005; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760; Verspohl EJ, 2002, CAN J PHYSIOL PHARM, V80, P562, DOI 10.1139/Y02-079; VYTASEK R, 1982, ANAL BIOCHEM, V120, P243, DOI 10.1016/0003-2697(82)90342-6; Wellershaus K, 2008, EXP CELL RES, V314, P997, DOI 10.1016/j.yexcr.2007.12.024	19	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140096	10.1371/journal.pone.0140096	http://dx.doi.org/10.1371/journal.pone.0140096			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444014	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600139
J	Rosen, PN; Boer, ER; Gracitelli, CPB; Abe, RY; Diniz, A; Marvasti, AH; Medeiros, FA				Rosen, Peter N.; Boer, Erwin R.; Gracitelli, Carolina P. B.; Abe, Ricardo Y.; Diniz-Filho, Alberto; Marvasti, Amir H.; Medeiros, Felipe A.			A Portable Platform for Evaluation of Visual Performance in Glaucoma Patients	PLOS ONE			English	Article							VEHICLE COLLISION INVOLVEMENT; FIELD-OF-VIEW; CONTRAST SENSITIVITY; DRIVING PERFORMANCE; OLDER-ADULTS; IMPAIRMENT; RISK; ABILITY; VISION; DAMAGE	Purpose To propose a new tablet-enabled test for evaluation of visual performance in glaucoma, the PERformance CEntered Portable Test (PERCEPT), and to evaluate its ability to predict history of falls and motor vehicle crashes. Design Cross-sectional study. Methods The study involved 71 patients with glaucomatous visual field defects on standard automated perimetry (SAP) and 59 control subjects. The PERCEPT was based on the concept of increasing visual task difficulty to improve detection of central visual field losses in glaucoma patients. Subjects had to perform a foveal 8-alternative-forced-choice orientation discrimination task, while detecting a simultaneously presented peripheral stimulus within a limited presentation time. Subjects also underwent testing with the Useful Field of View (UFOV) divided attention test. The ability to predict history of motor vehicle crashes and falls was investigated by odds ratios and incident-rate ratios, respectively. Results When adjusted for age, only the PERCEPT processing speed parameter showed significantly larger values in glaucoma compared to controls (difference: 243ms; P<0.001). PERCEPT results had a stronger association with history of motor vehicle crashes and falls than UFOV. Each 1 standard deviation increase in PERCEPT processing speed was associated with an odds ratio of 2.69 (P = 0.003) for predicting history of motor vehicle crashes and with an incident-rate ratio of 1.95 (P = 0.003) for predicting history of falls. Conclusion A portable platform for testing visual function was able to detect functional deficits in glaucoma, and its results were significantly associated with history of involvement in motor vehicle crashes and history of falls.	[Rosen, Peter N.; Boer, Erwin R.; Gracitelli, Carolina P. B.; Abe, Ricardo Y.; Diniz-Filho, Alberto; Marvasti, Amir H.; Medeiros, Felipe A.] Univ Calif San Diego, Dept Ophthalmol, Visual Performance Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Medeiros, FA (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Visual Performance Lab, La Jolla, CA 92093 USA.	fmedeiros@ucsd.edu	Gracitelli, Carolina/ABI-5387-2020; Filho, Alberto Diniz/C-8564-2015; Abe, Ricardo Y/L-1965-2018	Gracitelli, Carolina/0000-0001-5086-9060; Filho, Alberto Diniz/0000-0002-0371-2359; Abe, Ricardo Y/0000-0002-7023-2144	National Institutes of Health/National Eye Institute (Bethesda, Maryland) [EY021818, P30EY022589]; Research to Prevent Blindness (New York, USA); Brazilian National Research Council CAPES (Sao Paulo, Brazil) [12309-13-3]; NATIONAL EYE INSTITUTE [R01EY021818, P30EY022589] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (New York, USA)(Research to Prevent Blindness (RPB)); Brazilian National Research Council CAPES (Sao Paulo, Brazil); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health/National Eye Institute (Bethesda, Maryland) grants EY021818 (FAM) and core grant P30EY022589, an unrestricted grant from Research to Prevent Blindness (New York, USA), and Brazilian National Research Council CAPES (Sao Paulo, Brazil) grant 12309-13-3 (CPBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball K, 1993, J Am Optom Assoc, V64, P71; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Cwikel JG, 1998, DISABIL REHABIL, V20, P161, DOI 10.3109/09638289809166077; Friedman C, 2013, INVEST OPHTH VIS SCI, V54, P778, DOI 10.1167/iovs.12-11249; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Lajunen T, 2004, ACCIDENT ANAL PREV, V36, P231, DOI 10.1016/S0001-4575(02)00152-5; LEIBOWITZ HW, 1969, HUM FACTORS, V11, P387, DOI 10.1177/001872086901100409; MACKEAN JM, 1982, BRIT MED J, V285, P777, DOI 10.1136/bmj.285.6344.777-a; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; Medeiros FA, 2006, INVEST OPHTH VIS SCI, V47, P2520, DOI 10.1167/iovs.05-1441; Medeiros FA, 2012, J GLAUCOMA, V21, P221, DOI 10.1097/IJG.0b013e3182071832; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Ramulu PY, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.037; Richman J, 2015, BRIT J OPHTHALMOL, V99, P16, DOI 10.1136/bjophthalmol-2014-305223; Richman J, 2010, OPHTHAL EPIDEMIOL, V17, P144, DOI 10.3109/09286581003734878; SANDERS A F, 1970, Ergonomics, V13, P101, DOI 10.1080/00140137008931124; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; van Landingham SW, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-4; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wood JM, 2002, HUM FACTORS, V44, P482, DOI 10.1518/0018720024497664; WOOD JM, 1994, HUM FACTORS, V36, P476, DOI 10.1177/001872089403600305; Wood JM, 2014, GERONTOLOGY, V60, P315, DOI 10.1159/000356753; Zhang CW, 2014, OPHTHALMOLOGY, V121, P2371, DOI 10.1016/j.ophtha.2014.06.047	37	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139426	10.1371/journal.pone.0139426	http://dx.doi.org/10.1371/journal.pone.0139426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26445501	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600054
J	Zhu, JJ; Liu, SS; Ye, FQ; Shen, Y; Tie, Y; Zhu, J; Wei, LX; Jin, YH; Fu, HJ; Wu, YG; Zheng, XF				Zhu, Juanjuan; Liu, Shanshan; Ye, Fuqiang; Shen, Yuan; Tie, Yi; Zhu, Jie; Wei, Lixin; Jin, Yinghua; Fu, Hanjiang; Wu, Yongge; Zheng, Xiaofei			Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ELEMENT DATABASE; TUMOR-GROWTH; EXPRESSION; CANCER; PROLIFERATION; TRANSCRIPTION; ANGIOGENESIS; CHROMATIN; PROMOTER	Maternally Expressed Gene 3 (MEG3) encodes a lncRNA which is suggested to function as a tumor suppressor. Previous studies suggested that MEG3 functioned through activation of p53, however, the functional properties of MEG3 remain obscure and their relevance to human diseases is under continuous investigation. Here, we try to illuminate the relationship of MEG3 and p53, and the consequence in hepatoma cells. We find that transfection of expression construct of MEG3 enhances stability and transcriptional activity of p53. Deletion analysis of MEG3 confirms that full length and intact structure of MEG3 are critical for it to activate p53-mediated transactivation. Interestingly, our results demonstrate for the first time that MEG3 can interact with p53 DNA binding domain and various p53 target genes are deregulated after overexpression of MEG3 in hepatoma cells. Furthermore, results of qRT-PCR have shown that MEG3 RNA is lost or reduced in the majority of HCC samples compared with adjacent non-tumorous samples. Ectopic expression of MEG3 in hepatoma cells significantly inhibits proliferation and induces apoptosis. In conclusion, our data demonstrates that MEG3 functions as a tumor suppressor in hepatoma cells through interacting with p53 protein to activate p53-mediated transcriptional activity and influence the expression of partial p53 target genes.	[Zhu, Juanjuan; Liu, Shanshan; Ye, Fuqiang; Shen, Yuan; Tie, Yi; Zhu, Jie; Fu, Hanjiang; Zheng, Xiaofei] Beijing Inst Radiat Med, Beijing, Peoples R China; [Zhu, Juanjuan; Liu, Shanshan; Jin, Yinghua; Wu, Yongge] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Zhu, Juanjuan] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Wei, Lixin] Gen Hosp PLA, Dept Pathol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Jilin University; China Pharmaceutical University; Chinese People's Liberation Army General Hospital	Fu, HJ (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	fuhj75@126.com; ygwu@jlu.edu.cn; xfzheng100@126.com		Fu, Hanjiang/0000-0002-4352-1178	Chinese State Key Projects for Basic Research [2013CB910801]; National 863 plans projects [2012AA022501]; Chinese National Natural Science Foundation projects [31170713, 31270836, 31370760]	Chinese State Key Projects for Basic Research; National 863 plans projects(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation projects(National Natural Science Foundation of China (NSFC))	This work was supported partially by Chinese State Key Projects for Basic Research (2013CB910801), National 863 plans projects (2012AA022501), and Chinese National Natural Science Foundation projects (31170713, 31270836, 31370760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; Croteau S, 2003, MAMM GENOME, V14, P231, DOI 10.1007/s00335-002-2244-x; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Gabizon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038060; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ishigaki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00529; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; SHIN TH, 1995, MOL CELL BIOL, V15, P4694; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; St Clair S, 2004, MOL CELL, V16, P725; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Vizoso M, 2012, CELL RES, V22, P1413, DOI 10.1038/cr.2012.93; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yuan SX, 2012, HEPATOLOGY, V56, P2231, DOI 10.1002/hep.25895; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhang X, 2010, ENDOCRINOLOGY, V151, P939, DOI 10.1210/en.2009-0657; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	41	92	100	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139790	10.1371/journal.pone.0139790	http://dx.doi.org/10.1371/journal.pone.0139790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444285	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600080
J	Olshina, MA; Baumann, H; Willison, KR; Baum, J				Olshina, Maya A.; Baumann, Hella; Willison, Keith R.; Baum, Jake			Plasmodium actin is incompletely folded by heterologous protein-folding machinery and likely requires the native Plasmodium chaperonin complex to enter a mature functional state	FASEB JOURNAL			English	Article						malaria; apicomplexa; gliding motility; in vitro translation; rabbit reticulocyte lysate	PARASITE TOXOPLASMA-GONDII; MALARIA PARASITE; BETA-ACTIN; EUKARYOTIC CHAPERONIN; CYTOSOLIC CHAPERONIN; FILAMENT STRUCTURE; BINDING-SITES; C-TERMINUS; FALCIPARUM; GENE	Actin filament turnover underpins several processes in the life cycle of the malaria parasite, Plasmodium falciparum. Polymerization and depolymerization are especially important for gliding motility, a substrate-dependent form of cell movement that underpins the protozoan parasite's ability to disseminate and invade host cells. To date, given difficulties in extraction of native actins directly from parasites, much of our biochemical understanding of malarial actin has instead relied on recombinant protein extracted and purified from heterologous protein expression systems. Here, using in vitro transcription-translation methodologies and quantitative protein-binding assays, we explored the folding state of heterologously expressed P. falciparum actin 1 (PfACTI) with the aim of assessing the reliability of current recombinant-protein-based data. We demonstrate that PfACTI, when expressed in non-native systems, is capable of binding to and release from bacterial, yeast, and mammalian chaperonin complexes but appears to be incompletely folded. Characterization of the native Plasmodium folding machinery in silico, the chaperonin containing t-complex protein-1 complex, highlights key divergences between the different chaperonin systems that likely underpins this incomplete folded state. These results highlight the importance of characterizing actin's folded state and raise concerns about the interpretation of actin polymerization kinetics based solely on protein derived from heterologous expression systems.	[Olshina, Maya A.] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Olshina, Maya A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Baumann, Hella; Baum, Jake] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Willison, Keith R.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Imperial College London; Imperial College London	Baum, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Alexander Fleming Bldg Level 6, London SW7 2AZ, England.	jake.baum@imperial.ac.uk		Baum, Jake/0000-0002-0275-352X	Human Frontier Science Program Young Investigator Program [RGY0071/2011]; Australia National Health and Medical Research Council Dora Lush Scholarship [APP1018002]; Australian Society for Biochemistry and Molecular Biology; Wellcome Trust [100993/Z/13/Z]	Human Frontier Science Program Young Investigator Program(Human Frontier Science Program); Australia National Health and Medical Research Council Dora Lush Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Australian Society for Biochemistry and Molecular Biology; Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Jacqui Gulbis for ongoing support and advice throughout the project's duration. Supported by Human Frontier Science Program Young Investigator Program Grant RGY0071/2011 (to J.B.). M.A.O. is supported through Australia National Health and Medical Research Council Dora Lush Scholarship APP1018002 and was supported in the United Kingdom with a travel award from the Australian Society for Biochemistry and Molecular Biology. J.B. is supported by the Wellcome Trust, through New Investigator Award 100993/Z/13/Z. The authors declare no conflicts of interest.	Altschuler GM, 2009, FEBS LETT, V583, P782, DOI 10.1016/j.febslet.2009.01.031; Amit M, 2010, J MOL BIOL, V401, P532, DOI 10.1016/j.jmb.2010.06.037; Angrisano F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032188; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; Das A, 1997, MOL BIOCHEM PARASIT, V88, P95, DOI 10.1016/S0166-6851(97)00081-9; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Deligianni E, 2011, CELL MICROBIOL, V13, P1714, DOI 10.1111/j.1462-5822.2011.01652.x; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; DREWES G, 1993, EUR J BIOCHEM, V212, P247, DOI 10.1111/j.1432-1033.1993.tb17656.x; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; FIELD SJ, 1993, CELL MOTIL CYTOSKEL, V25, P43, DOI 10.1002/cm.970250106; Grantham J, 2000, J BIOL CHEM, V275, P4587, DOI 10.1074/jbc.275.7.4587; Hliscs M, 2015, CELL MICROBIOL, V17, P207, DOI 10.1111/cmi.12359; HOLLOWAY SP, 1994, MOL BIOCHEM PARASIT, V64, P25, DOI 10.1016/0166-6851(94)90131-7; Hynes GM, 2000, J BIOL CHEM, V275, P18985, DOI 10.1074/jbc.M910297199; JOHANNES FJ, 1991, EMBO J, V10, P3951, DOI 10.1002/j.1460-2075.1991.tb04965.x; Kudryashev Mikhail, 2010, PMC Biophys, V3, P6, DOI 10.1186/1757-5036-3-6; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150; Lee JY, 2012, J PHYS CHEM B, V116, P1677, DOI 10.1021/jp209340y; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Mizuno Y, 2002, PARASITOL RES, V88, P844, DOI 10.1007/s00436-002-0666-8; Neirynck K, 2006, J MOL BIOL, V355, P124, DOI 10.1016/j.jmb.2005.10.051; ODONOGHUE SI, 1992, ARCH BIOCHEM BIOPHYS, V293, P110, DOI 10.1016/0003-9861(92)90372-4; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Rommelaere H, 1999, BIOCHEMISTRY-US, V38, P3246, DOI 10.1021/bi9815905; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schmitz S, 2010, J BIOL CHEM, V285, P36577, DOI 10.1074/jbc.M110.142638; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Skillman KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3285; Skillman KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002280; Smythe WA, 2008, CELL MICROBIOL, V10, P452, DOI 10.1111/j.1462-5822.2007.01058.x; STOURNARAS C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P86, DOI 10.1016/0167-4838(90)90105-O; STOURNARAS C, 1988, BIOCHEM BIOPH RES CO, V155, P962, DOI 10.1016/S0006-291X(88)80590-4; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; Stuart SF, 2011, J BIOL CHEM, V286, P178, DOI 10.1074/jbc.M110.166256; TIAN GL, 1995, NATURE, V375, P250, DOI 10.1038/375250a0; Tsapara A, 1999, FEBS LETT, V455, P117, DOI 10.1016/S0014-5793(99)00848-0; Vahokoski J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004091; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; WESSELING JG, 1988, MOL BIOCHEM PARASIT, V30, P143, DOI 10.1016/0166-6851(88)90107-7; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; XIA D, 1995, CELL MOTIL CYTOSKEL, V32, P163, DOI 10.1002/cm.970320302; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	57	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					405	416		10.1096/fj.15-276618	http://dx.doi.org/10.1096/fj.15-276618			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443825	hybrid, Green Published			2022-12-26	WOS:000367621000038
J	Mello, AA; Leal, MF; Rey, JA; Pinto, GR; Lamarao, LM; Montenegro, RC; Alves, APNN; Assumpcao, PP; Borges, BD; Smith, MC; Burbano, RR				Mello, Adriano Azevedo; Leal, Mariana Ferreira; Rey, Juan Antonio; Pinto, Giovanny Reboucas; Lamarao, Leticia Martins; Montenegro, Raquel Carvalho; Negreiros Nunes Alves, Ana Paula; Assumpcao, Paulo Pimentel; Borges, Barbara do Nascimento; Smith, Marilia Cardoso; Burbano, Rommel Rodriguez			Deregulated Expression of SRC, LYN and CKB Kinases by DNA Methylation and Its Potential Role in Gastric Cancer Invasiveness and Metastasis	PLOS ONE			English	Article							CONVENTIONAL CYTOGENETIC CHARACTERIZATION; C-MYC AMPLIFICATION; CREATINE-KINASE; NORTHERN BRAZIL; CLINICOPATHOLOGICAL CHARACTERISTICS; NUMERICAL ABERRATIONS; OVARIAN-CANCER; E-CADHERIN; INDIVIDUALS; ACTIVATION	Kinases are downstream modulators and effectors of several cellular signaling cascades and play key roles in the development of neoplastic disease. In this study, we aimed to evaluate SRC, LYN and CKB protein and mRNA expression, as well as their promoter methylation, in gastric cancer. We found elevated expression of SRC and LYN kinase mRNA and protein but decreased levels of CKB kinase, alterations that may have a role in the invasiveness and metastasis of gastric tumors. Expression of the three studied kinases was also associated with MYC oncogene expression, a possible biomarker for gastric cancer. To understand the mechanisms that regulate the expression of these genes, we evaluated the DNA promoter methylation of the three kinases. We found that reduced SRC and LYN methylation and increased CKB methylation was associated with gastric cancer. The reduced SRC and LYN methylation was associated with increased levels of mRNA and protein expression, suggesting that DNA methylation is involved in regulating the expression of these kinases. Conversely, reduced CKB methylation was observed in samples with reduced mRNA and protein expression, suggesting CKB expression was found to be only partly regulated by DNA methylation. Additionally, we found that alterations in the DNA methylation pattern of the three studied kinases were also associated with the gastric cancer onset, advanced gastric cancer, deeper tumor invasion and the presence of metastasis. Therefore, SRC, LYN and CKB expression or DNA methylation could be useful markers for predicting tumor progression and targeting in anti-cancer strategies.	[Mello, Adriano Azevedo] Univ Fed Campina Grande, Ctr Ciencias Biol & Saude, Campina Grande, PB, Brazil; [Leal, Mariana Ferreira; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, SP, Brazil; [Leal, Mariana Ferreira] Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil; [Rey, Juan Antonio] Hosp Univ La Paz, Lab Oncogenet Mol, Madrid, Spain; [Pinto, Giovanny Reboucas] Univ Fed Piaui, Dept Biomed, Parnaiba, PI, Brazil; [Lamarao, Leticia Martins] Fundacao Ctr Hemoterapia & Hematol Para, Lab Testes Acidos Nucleicos, Belem, Para, Brazil; [Lamarao, Leticia Martins; Montenegro, Raquel Carvalho; Borges, Barbara do Nascimento; Burbano, Rommel Rodriguez] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Negreiros Nunes Alves, Ana Paula] Univ Fed Ceara, Fac Odontol, Dept Patol Oral, Fortaleza, Ceara, Brazil; [Assumpcao, Paulo Pimentel; Burbano, Rommel Rodriguez] Fed Univ Para, Hosp Univ Joao de Barros Barreto, Nucleo Pesquisa Oncol, BR-66059 Belem, Para, Brazil; [Borges, Barbara do Nascimento] Univ Fed Rural Amazonia, Inst Socioambiental & Recursos Hidr, Ctr Tecnol Agr, Belem, Para, Brazil	Universidade Federal de Campina Grande; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Hospital Universitario La Paz; Universidade Federal do Piaui; Universidade Federal do Para; Universidade Federal do Ceara; Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, SP, Brazil.	mariana.morf@epm.br	Pinto, Giovanny R/G-9852-2012; Burbano, Rommel R/C-4149-2012; Leal, Mariana/C-4010-2012; de A. C. Smith, Marilia/C-4397-2012; Chen, Elizabeth/G-1598-2012; Montenegro, Raquel/I-1260-2013; Borges, Barbara N/G-1355-2012; Pinto, Giovanny Rebouças/AAB-9308-2020	Pinto, Giovanny R/0000-0001-9110-1840; Burbano, Rommel R/0000-0002-4872-234X; Leal, Mariana/0000-0003-4375-2563; de A. C. Smith, Marilia/0000-0002-1441-1033; Chen, Elizabeth/0000-0002-3573-0164; Montenegro, Raquel/0000-0002-3861-293X; Borges, Barbara N/0000-0002-5989-8287; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471072/2012-5, 402283/2013-9]; Fundacao de Amparo a Pesquisa do Para (FAPESPA) [ICAAF 123/2014]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/07145-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grants #471072/2012-5 and 402283/2013-9; fellowship to MCS and RRB), Fundacao de Amparo a Pesquisa do Para (FAPESPA; grant #ICAAF 123/2014 to RRB) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant #2009/07145-9; fellowship to MFL) as grants and fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Assumpcao PP, 2006, CANCER GENET CYTOGEN, V169, P45, DOI 10.1016/j.cancergencyto.2006.03.019; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Borges BD, 2010, ANTICANCER RES, V30, P2225; Buffart TE, 2007, J PATHOL, V211, P45, DOI 10.1002/path.2085; Bundela S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102610; Burbano RR, 2006, ANTICANCER RES, V26, P2909; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calcagno DQ, 2006, WORLD J GASTROENTERO, V12, P6207, DOI 10.3748/wjg.v12.i38.6207; Calcagno DQ, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-141; Calcagno DQ, 2010, CANCER GENET CYTOGEN, V202, P63, DOI 10.1016/j.cancergencyto.2010.05.020; Calcagno DQ, 2005, ANTICANCER RES, V25, P4069; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Dalhoff C, 2010, CHEMBIOCHEM, V11, P256, DOI 10.1002/cbic.200900349; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Eftang LL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-586; Elsberger B, 2010, BRIT J CANCER, V103, P899, DOI 10.1038/sj.bjc.6605829; da Costa JDFB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021988; Leal MF, 2007, WORLD J GASTROENTERO, V13, P2568, DOI 10.3748/wjg.v13.i18.2568; Gigek CO, 2011, CANCER INVEST, V29, P162, DOI 10.3109/07357907.2010.543365; Gigek CO, 2010, GROWTH HORM IGF RES, V20, P234, DOI 10.1016/j.ghir.2010.02.005; Gigek CO, 2009, BIOMARKERS, V14, P630, DOI 10.3109/13547500903225912; Guan H, 2008, MOL CANCER THER, V7, P1807, DOI 10.1158/1535-7163.MCT-08-0058; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hoshino K, 2007, LEUKEMIA, V21, P906, DOI 10.1038/sj.leu.2404615; Huddleston HG, 2005, GYNECOL ONCOL, V96, P77, DOI 10.1016/j.ygyno.2004.08.047; Humar B, 2007, CANCER RES, V67, P2480, DOI 10.1158/0008-5472.CAN-06-3021; Ishikawa J, 2005, CLIN CHIM ACTA, V361, P135, DOI 10.1016/j.cccn.2005.05.028; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Kitamura K, 1996, BRIT J CANCER, V73, P798, DOI 10.1038/bjc.1996.139; Koster H, 2007, ASSAY DRUG DEV TECHN, V5, P381, DOI 10.1089/adt.2006.039; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leal MF, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-9; Leal MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042255; Leal MF, 2012, WORLD J GASTROENTERO, V18, P1531, DOI 10.3748/wjg.v18.i13.1531; Leal MF, 2009, CANCER GENET CYTOGEN, V195, P85, DOI 10.1016/j.cancergencyto.2009.04.020; Li XH, 2013, INT J BIOCHEM CELL B, V45, P979, DOI 10.1016/j.biocel.2013.02.003; Lima EM, 2008, BRAZ J MED BIOL RES, V41, P539, DOI 10.1590/S0100-879X2008000600017; Lima EM, 2008, BIOCELL, V32, P237; Lima EM, 2004, BRAZ J MED BIOL RES, V37, P1831, DOI 10.1590/S0100-879X2004001200008; Lima EM, 2008, INT J MORPHOL, V25, P8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehara Y, 1996, CANCER-AM CANCER SOC, V77, P1774, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1774::AID-CNCR3>3.0.CO;2-C; Masaki T, 2000, AM J GASTROENTEROL, V95, P837; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Mooney SM, 2011, J CELL BIOCHEM, V112, P1066, DOI 10.1002/jcb.23020; Nair NG, 2014, RES J RECENT SCI, V3, P7; Okamoto W, 2010, MOL CANCER THER, V9, P1188, DOI 10.1158/1535-7163.MCT-10-0002; Panani AD, 2008, CANCER LETT, V266, P99, DOI 10.1016/j.canlet.2008.02.053; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Patel Nikul, 2012, Sarcoma, V2012, P498472, DOI 10.1155/2012/498472; Prabhu JS, 2009, INT J BIOL MARKER, V24, P57, DOI 10.1177/172460080902400109; Qayyum T, 2012, BRIT J CANCER, V107, P856, DOI 10.1038/bjc.2012.314; Raiol LCC, 2008, CANCER GENET CYTOGEN, V181, P31, DOI 10.1016/j.cancergencyto.2007.10.011; Silva TCR, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-85; Rask-Andersen M, 2014, TRENDS PHARMACOL SCI, V35, P60, DOI 10.1016/j.tips.2014.09.007; Su N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-43; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Szyf M, 2012, GENOME MED, V4, DOI 10.1186/gm325; TAKEKURA N, 1990, INT J CANCER, V45, P847, DOI 10.1002/ijc.2910450510; Tavares A, 2013, PATHOL ONCOL RES, V19, P111, DOI 10.1007/s12253-012-9530-z; de Souza CRT, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-179; de Souza CRT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064420; Waki T, 2002, AM J PATHOL, V161, P399, DOI 10.1016/S0002-9440(10)64195-8; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Yang Y, 2014, ONCOL REP, V32, P45, DOI 10.3892/or.2014.3188; Zardan A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.30; Zarghami N, 1996, BRIT J CANCER, V73, P386, DOI 10.1038/bjc.1996.66	74	33	35	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140492	10.1371/journal.pone.0140492	http://dx.doi.org/10.1371/journal.pone.0140492			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460485	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300104
J	Montalbano, A; Corradetti, R; Mlinar, B				Montalbano, Alberto; Corradetti, Renato; Mlinar, Boris			Pharmacological Characterization of 5-HT1A Autoreceptor-Coupled GIRK Channels in Rat Dorsal Raphe 5-HT Neurons	PLOS ONE			English	Article							POTASSIUM CHANNELS; K+ CHANNEL; RECEPTOR ANTAGONIST; SEROTONIN; INHIBITION; SUBUNITS; CURRENTS; RECORDINGS; ACTIVATION; EXPRESSION	G protein-activated inwardly rectifying potassium (GIRK) channels in 5-HT neurons are assumed to be principal effectors of 5-hydroxytryptamine 1A (5-HT1A) autoreceptors, but their pharmacology, subunit composition and the role in regulation of 5-HT neuron activity have not been fully elucidated. We sought for a pharmacological tool for assessing the functional role of GIRK channels in 5-HT neurons by characterizing the effects of drugs known to block GIRK channels in the submicromolar range of concentrations. Whole-cell voltageclamp recording in brainstem slices were used to determine concentration-response relationships for the selected GIRK channel blockers on 5-HT1A autoreceptor-activated inwardly rectifying K+ conductance in rat dorsal raphe 5-HT neurons. 5-HT1A autoreceptoractivated GIRK conductance was completely blocked by the nonselective inwardly rectifying potassium channels blocker Ba2+ (EC50 = 9.4 mu M, full block with 100 mu M) and by SCH23390 (EC50 = 1.95 mu M, full block with 30 mu M). GIRK-specific blocker tertiapin-Q blocked 5-HT1A autoreceptor-activated GIRK conductance with high potency (EC50 = 33.6 nM), but incompletely, i.e. similar to 16% of total conductance resulted to be tertiapin-Q-resistant. U73343 and SCH28080, reported to block GIRK channels with submicromolar EC(50)s, were essentially ineffective in 5-HT neurons. Our data show that inwardly rectifying K+ channels coupled to 5-HT1A autoreceptors display pharmacological properties generally expected for neuronal GIRK channels, but different from GIRK1-GIRK2 heteromers, the predominant form of brain GIRK channels. Distinct pharmacological properties of GIRK channels in 5-HT neurons should be explored for the development of new therapeutic agents for mood disorders.	[Montalbano, Alberto; Corradetti, Renato; Mlinar, Boris] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy	University of Florence	Mlinar, B (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy.	bmlinar@unifi.it	Corradetti, Renato/A-1604-2008; Mlinar, Boris/A-7034-2008	Corradetti, Renato/0000-0002-2588-0484; Mlinar, Boris/0000-0001-9082-0827	University of Florence; Regione Toscana; Aziende Chimiche Riunite Angelini Francesco A.C.R. A.F. SpA (POR CRO FSE)	University of Florence; Regione Toscana(Regione Toscana); Aziende Chimiche Riunite Angelini Francesco A.C.R. A.F. SpA (POR CRO FSE)	Funding for this study was provided by the University of Florence. A. Montalbano was recipient of a fellowship from the Regione Toscana and Aziende Chimiche Riunite Angelini Francesco A.C.R. A.F. SpA (POR CRO FSE 2007-2013: 5-HT@DRUGeMOOD).	AGHAJANIAN GK, 1984, BRAIN RES, V305, P181, DOI 10.1016/0006-8993(84)91137-5; AGHAJANIAN GK, 1982, BRAIN RES, V238, P463, DOI 10.1016/0006-8993(82)90124-X; Aguado C, 2008, J NEUROCHEM, V105, P497, DOI 10.1111/j.1471-4159.2007.05153.x; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Audero E, 2013, J NEUROSCI, V33, P8678, DOI 10.1523/JNEUROSCI.2067-12.2013; Bayliss DA, 1997, J NEUROPHYSIOL, V77, P1362, DOI 10.1152/jn.1997.77.3.1362; Bayliss DA, 1997, J NEUROPHYSIOL, V77, P1349, DOI 10.1152/jn.1997.77.3.1349; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Del Burgo LS, 2008, J COMP NEUROL, V510, P581, DOI 10.1002/cne.21810; Fairchild G, 2003, NEUROPHARMACOLOGY, V45, P925, DOI 10.1016/S0028-3908(03)00269-7; Inanobe A, 1999, J NEUROSCI, V19, P1006; Ishihara K, 2009, BIOCHEM BIOPH RES CO, V380, P832, DOI 10.1016/j.bbrc.2009.01.179; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; Karschin C, 1996, J NEUROSCI, V16, P3559; Kuzhikandathil EV, 2002, MOL PHARMACOL, V62, P119, DOI 10.1124/mol.62.1.119; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Liao YJ, 1996, J NEUROSCI, V16, P7137; Llamosas N, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv051; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lujan R, 2014, TRENDS NEUROSCI, V37, P20, DOI 10.1016/j.tins.2013.10.006; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Millan MJ, 2001, PSYCHOPHARMACOLOGY, V156, P58, DOI 10.1007/s002130100742; Mlinar B, 2015, J GEN PHYSIOL, V145, P225, DOI 10.1085/jgp.201411330; Murer G, 1997, NEUROSCIENCE, V80, P345, DOI 10.1016/S0306-4522(97)00001-8; PENINGTON NJ, 1993, J PHYSIOL-LONDON, V469, P407, DOI 10.1113/jphysiol.1993.sp019820; PENINGTON NJ, 1990, NEURON, V4, P751, DOI 10.1016/0896-6273(90)90201-P; PENINGTON NJ, 1993, J PHYSIOL-LONDON, V469, P387, DOI 10.1113/jphysiol.1993.sp019819; PENINGTON NJ, 1991, J NEUROSCI, V11, P3594, DOI 10.1523/jneurosci.11-11-03594.1991; Ramu Y, 2004, BIOCHEMISTRY-US, V43, P10701, DOI 10.1021/bi049125x; Sickmann T, 2008, NEUROSCI LETT, V436, P102, DOI 10.1016/j.neulet.2008.02.067; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; Walsh KB, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00064; WILLIAMS JT, 1988, J NEUROSCI, V8, P3499	36	31	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140369	10.1371/journal.pone.0140369	http://dx.doi.org/10.1371/journal.pone.0140369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460748	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300084
J	Yu, SM; Ki, SH; Baek, HM				Yu, Seung-Man; Ki, Sung Hwan; Baek, Hyeon-Man			Nonalcoholic Fatty Liver Disease: Correlation of the Liver Parenchyma Fatty Acid with Intravoxel Incoherent Motion MR Imaging-An Experimental Study in a Rat Model	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; TERM-FOLLOW-UP; ADIPOSE-TISSUE; STEATOHEPATITIS; QUANTIFICATION; FIBROSIS; MICE; PROGRESSION; H-1-NMR; DIXON	Purpose To prospectively evaluate the changes in fatty acid concentration after administrating a 60% high-fat diet to a non-alcoholic fatty liver disease rat model and to perform a correlation analysis between fatty acid with molecular diffusion (D-true), perfusion-related diffusion (D-fast), and perfusion fraction (P-fraction). Material and Methods This prospective study was approved by the appropriate ethics committee. Ten male Sprague-Dawley rats were fed a 60% high-fat diet until the study was finished. Point-resolved spectroscopy sequence H-1-MRS with TR = 1,500 msec, TE = 35 msec, NEX = 64, and 8x8x8 mm(3) voxel was used to acquire magnetic resonance spectroscopy (MRS) data. Diffusion-weighted imaging was performed on a two-dimensional multi-b value spin echo planar image with the following parameters: repetition time msec/echo time msec, 4500 /63; field of view, 120x120 msec(2); matrix, 128x128; section thickness, 3 mm; number of repetition, 8; and multiple b value, 0, 25, 50, 75, 100, 200, 500, 1000 sec/mm(2). Baseline magnetic resonance imaging and magnetic resonance spectroscopy data (control) were acquired. H-1 proton MRS and diffusion-weighted imaging were obtained every 2 weeks for 8 weeks. The individual contributions of the true molecular diffusion and the incoherent motions of water molecules in the capillary network to the apparent diffusion changes were estimated using a least-square nonlinear fitting in MatLab. A Wilcoxon signed-rank test with the Kruskal-Wallis test was used to compare each week's fatty acid mean quantification. Spearman's correlation coefficient was used to evaluate the correlation between each fatty acid (e.g., total lipid (TL), total saturated fatty acid (TSFA), total unsaturated fatty acid (TUSFA), total unsaturated bond (TUSB), and polyunsaturated bond (PUSB)) and intravoxel incoherent motion (IVIM) mapping images (e.g., D-true, D-fast, and P-fraction). Results The highest mean TL value was at week 8 (0.278 +/- 0.10) after the administration of the 60% high- fat diet, followed by weeks 6, 4, 2, and 0. The concentration level (16.99 +/- 2.29) of TSFA at week 4 was the highest. No significant differences in the concentrations of TUSFA, TUSB, or PUSB were observed in different weeks. Conclusion After the administration of the 60% high-fat diet in nonalcoholic fatty liver disease model, TL and TSFA depositions had significant changes. The mean concentrations of TUSFA, TUSB, PUSB did not significantly change. Total unsaturated fatty acid and polyunsaturated bond showed positive correlations with D-true and P-fraction.	[Yu, Seung-Man] Catholic Univ Korea, Coll Med, Res Inst Biomed Engn, Dept Biomed Engn, Seoul, South Korea; [Yu, Seung-Man] Gimcheon Univ, Dept Radiol Sci, Gimcheon, Gyeongsangbuk D, South Korea; [Ki, Sung Hwan] Chosun Univ, Coll Pharm, Dept Toxicol, Gwangju, South Korea; [Baek, Hyeon-Man] Korea Basic Sci Inst, Chungbuk, South Korea	Catholic University of Korea; Chosun University; Korea Basic Science Institute (KBSI)	Baek, HM (corresponding author), Korea Basic Sci Inst, Chungbuk, South Korea.	hmbaek@kbsi.re.kr	Yu, Sungman/AAH-6164-2020	Yu, Seung-Man/0000-0003-4145-4511	Korea Basic Science Institute (KBSI) [E35436, E35600]; Basic Science Research program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A1A02036988]	Korea Basic Science Institute (KBSI); Basic Science Research program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This paper was supported in part by the Korea Basic Science Institute (KBSI) Grant No. E35436 and E35600 and the Basic Science Research program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A02036988).	Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Anderson SW, 2011, J MAGN RESON IMAGING, V33, P882, DOI 10.1002/jmri.22481; Bataller R, 2011, BEST PRACT RES CL GA, V25, P231, DOI 10.1016/j.bpg.2011.02.010; Bonekamp S, 2011, J CLIN GASTROENTEROL, V45, P885, DOI 10.1097/MCG.0b013e318223bd2c; Brunt EM, 2009, HEPATOLOGY, V49, P809, DOI 10.1002/hep.22724; Bulow R, 2013, EUR RADIOL, V23, P1281, DOI 10.1007/s00330-012-2700-2; Cassidy FH, 2009, RADIOGRAPHICS, V29, P231, DOI 10.1148/rg.291075123; Cheung JS, 2008, MAGN RESON MED, V59, P1170, DOI 10.1002/mrm.21506; Cheung JS, 2011, ACAD RADIOL, V18, P377, DOI 10.1016/j.acra.2010.10.012; Corbin IR, 2009, BBA-MOL CELL BIOL L, V1791, P757, DOI 10.1016/j.bbalip.2009.02.014; Day C P, 2005, Gastroenterology, V129, P375, DOI 10.1053/j.gastro.2005.05.041; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fassio E, 2004, HEPATOLOGY, V40, P820, DOI 10.1002/hep.20410; Guiu B, 2012, RADIOLOGY, V265, P96, DOI 10.1148/radiol.12112478; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; Hope TA, 2014, RADIOL CLIN N AM, V52, P709, DOI 10.1016/j.rcl.2014.02.016; Hwang JH, 2003, NMR BIOMED, V16, P160, DOI 10.1002/nbm.824; Joo I, 2014, RADIOLOGY, V270, P131, DOI 10.1148/radiol.13122506; Kessoku T, 2014, WORLD J GASTROENTERO, V20, P10108, DOI 10.3748/wjg.v20.i29.10108; Kuhn JP, 2014, J MAGN RESON IMAGING, V39, P1494, DOI 10.1002/jmri.24289; Lee SS, 2011, J MAGN RESON IMAGING, V33, P1390, DOI 10.1002/jmri.22583; Lee SJ, 2014, APPL MAGN RESON, V45, P1333, DOI 10.1007/s00723-014-0563-1; Meisamy S, 2011, RADIOLOGY, V258, P767, DOI 10.1148/radiol.10100708; Mikolasevic I, 2014, CLIN INTERV AGING, V9, P1295, DOI 10.2147/CIA.S65382; Monteiro J, 2014, FOOD FUNCT, V5, P426, DOI 10.1039/c3fo60551e; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Pacifico L, 2014, MINI-REV MED CHEM, V14, P791; Povero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113651; Prescot AP, 2014, NMR BIOMED, V27, P863, DOI 10.1002/nbm.3115; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Ren JM, 2008, J LIPID RES, V49, P2055, DOI 10.1194/jlr.D800010-JLR200; Runge JH, 2014, ACAD RADIOL, V21, P1446, DOI 10.1016/j.acra.2014.06.009; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Scorletti E, 2014, CONTEMP CLIN TRIALS, V37, P301, DOI 10.1016/j.cct.2014.02.002; Shpyleva S, 2014, J NUTR BIOCHEM, V25, P1235, DOI 10.1016/j.jnutbio.2014.06.012; Strobel K, 2008, J LIPID RES, V49, P473, DOI 10.1194/jlr.D700024-JLR200; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Targher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Venkatesh BA, 2012, J MAGN RESON IMAGING, V36, P1222, DOI 10.1002/jmri.23761; Wierzbicki AS, 2012, CURR OPIN LIPIDOL, V23, P345, DOI 10.1097/MOL.0b013e3283541cfc; Yokoo T, 2011, RADIOLOGY, V258, P749, DOI 10.1148/radiol.10100659; Yu SM, 2013, APPL MAGN RESON, V44, P791, DOI 10.1007/s00723-013-0443-0; ZANCANARO C, 1994, J LIPID RES, V35, P2191; Zhou IY, 2014, MAGN RESON MED, V72, P1389, DOI 10.1002/mrm.25035	45	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139874	10.1371/journal.pone.0139874	http://dx.doi.org/10.1371/journal.pone.0139874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460614	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300028
J	Lin, JY; Brewer, G; Li, ML				Lin, Jing-Yi; Brewer, Gary; Li, Mei-Ling			HuR and Ago2 Bind the Internal Ribosome Entry Site of Enterovirus 71 and Promote Virus Translation and Replication	PLOS ONE			English	Article							MOUTH-DISEASE; RNA; INTERACTS; PROTEIN; INFECTIONS; OUTBREAK; SEQUENCE; REGION; AUF1; HAND	EV71 (enterovirus 71) RNA contains an internal ribosomal entry site (IRES) that directs cap-independent initiation of translation. IRES-dependent translation requires the host's translation initiation factors and IRES-associated trans-acting factors (ITAFs). We reported recently that mRNA decay factor AUF1 is a negative-acting ITAF that binds IRES stem-loop II. We also reported that the small RNA-processing enzyme Dicer produces at least four small RNAs (vsRNAs) from the EV71 IRES. One of these, vsRNA1, derived from IRES stem-loop II, reduces IRES activity and virus replication. Since its mechanism of action is unknown, we hypothesized that it might control association of ITAFs with the IRES. Here, we identified the mRNA stability factor HuR and the RISC subunit Argonaute 2 (Ago2) as two ITAFs that bind stem-loop II. In contrast to AUF1, HuR and Ago2 promote EV71 IRES activity and virus replication. In vitro RNA-binding assays revealed that vsRNA1 can alter association of Ago2, HuR, and AUF1 with stem-loop II. This presents a possible mechanism by which vsRNA1 could control viral translation and replication.	[Lin, Jing-Yi] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Coll Med Sci & Technol, Taipei, Taiwan; [Brewer, Gary; Li, Mei-Ling] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08901 USA	Taipei Medical University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Li, ML (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08901 USA.	lime@rwjms.rutgers.edu		Lin, Jing-Yi/0000-0002-5692-5657	National Institutes of Health [R01 CA052443]; Taiwan NCS grant [102-2320-B-038-055-MY3]; NATIONAL CANCER INSTITUTE [R01CA052443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan NCS grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health R01 CA052443 (G.B.) and Taiwan NCS grant 102-2320-B-038-055-MY3 (J-Y.L.).	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garcia-Ruiz H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004755; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang HI, 2012, FUTURE MICROBIOL, V7, P467, DOI [10.2217/FMB.12.22, 10.2217/fmb.12.22]; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Koffa MD, 2000, P NATL ACAD SCI USA, V97, P4677, DOI 10.1073/pnas.070049097; Lemay J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-47; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103827; Lin JY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-103; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901; Liu XH, 2012, MOL CELL, V46, P507, DOI 10.1016/j.molcel.2012.03.010; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; Shih SR, 2011, J VIROLOGY; Shimakami T, 2012, J VIROL, V86, P7372, DOI 10.1128/JVI.00513-12; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; Spangberg K, 2000, VIROLOGY, V274, P378, DOI 10.1006/viro.2000.0461; Thibault PA, 2015, J VIROL, V89, P6294, DOI 10.1128/JVI.03631-14; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Weng KF, 2014, NUCLEIC ACIDS RES, V42, P12789, DOI 10.1093/nar/gku952; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yasumura Y., 1963, NIPPON RINSHO, V21, P9	37	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140291	10.1371/journal.pone.0140291	http://dx.doi.org/10.1371/journal.pone.0140291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451954	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200057
J	Ayral, F; Zilber, AL; Bicout, DJ; Kodjo, A; Artois, M; Djelouadji, Z				Ayral, Florence; Zilber, Anne-Laure; Bicout, Dominique J.; Kodjo, Angeli; Artois, Marc; Djelouadji, Zoheira			Distribution of Leptospira interrogans by Multispacer Sequence Typing in Urban Norway Rats (Rattus norvegicus): A Survey in France in 2011-2013	PLOS ONE			English	Article							RODENTS; IDENTIFICATION; EPIDEMIOLOGY; GENETICS	Background Urban leptospirosis has increasingly been reported in both developing and developed countries. The control of the disease is limited because our understanding of basic aspects of the epidemiology, including the transmission routes of leptospires among rat populations, remains incomplete. Through the ability to distinguish among Leptospira strains in rats, multispacer sequence typing (MST) could provide a modern understanding of Leptospira epidemiology; however, to our knowledge, the distribution of Leptospira strains among urban rat colonies has not been investigated using MST. Aims and Methodology The objective of this study was to identify the Leptospira strains present in rats (Rattus norvegicus) in Lyon (France) using MST and to characterize their spatial distribution. Kidneys and urine were collected from rats trapped live in seven locations in the city and in one suburban location. Each location was considered to represent a rat colony. Bacterial cultures and quantitative polymerase chain reaction (qPCR) assays were performed, and the L. interrogans DNA identified was then genotyped using MST. The distributions of Leptospira strains were spatially described. Key Results Among 84 wild rats, MST profiles were obtained in 35 of 37 rats that had a positive result for L. interrogans by bacterial culture and/or qPCR analyses. All of the MST profiles were related to reference strains previously isolated from human patients that belong to the serogroup Icterohaemorrhagiae and the serovars [strain(s)] Copenhageni [Wijinberg or M20] (n = 26), Icterohaemorrhagiae [CHU Rrunion] (n = 7), Icterohaemorrhagiae [R1] (n = 1) and Copenhageni [Shibaura 9] (n = 1). Each colony was infected with leptospires having the same MST profile. Major Conclusions This study demonstrated that MST could be used for the purpose of field studies, either on culture isolates or on DNA extracted from kidneys and urine, to distinguish among L. interrogans isolates in rats. MST could thus be used to monitor their distributions in urban rats from the same city, thereby providing new knowledge that could be applied to explore the circulation of L. interrogans infection in rat colonies. Because the strains are related to those previously found in humans, this application of MST could aid in the source tracking of human leptospirosis, and the findings would be relevant for public health purposes according to the One Health principle.	[Ayral, Florence; Artois, Marc] Univ Lyon VetAgro Sup, WildTech, USC 1233, Marcy Letoile, France; [Zilber, Anne-Laure] Univ Lyon VetAgro Sup, USC 1233, Marcy Letoile, France; [Kodjo, Angeli; Djelouadji, Zoheira] Univ Lyon VetAgro Sup, USC 1233, Lab Leptospires, Marcy Letoile, France; [Bicout, Dominique J.] Univ Grenoble Alpes, VetAgro Sup, Biomatemat & Epidemiol, EPSP TIMC,CNRS,UMR 5525, Marcy Letoile, France	VetAgro Sup; VetAgro Sup; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); VetAgro Sup	Ayral, F (corresponding author), Univ Lyon VetAgro Sup, WildTech, USC 1233, Marcy Letoile, France.	florence.ayral@vetagro-sup.fr	Ayral, Florence/A-8568-2019	Ayral, Florence/0000-0002-7119-3765; Kodjo, Angeli/0000-0002-7247-9765	USC [1233]; WildTech Project [WP6]; European Commission under the Food, Agriculture and Fisheries; Biotechnology theme of the Seventh Framework Programme for Research and Technological Development [222633]	USC; WildTech Project; European Commission under the Food, Agriculture and Fisheries; Biotechnology theme of the Seventh Framework Programme for Research and Technological Development	This project was supported by USC 1233 and by WildTech Project WP6, Epidemiology and Risk Assessment, which is supported by the European Commission under the Food, Agriculture and Fisheries and Biotechnology theme of the Seventh Framework Programme for Research and Technological Development (grant number 222633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Ridder B, 2010, INT J ANTIMICROB AG, V36, pS5, DOI 10.1016/j.ijantimicag.2010.06.012; Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3502; Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012; Aviat F, 2009, COMP IMMUNOL MICROB, V32, P463, DOI 10.1016/j.cimid.2008.05.004; Ayral F, 2015, EPIDEMIOL INFECT, V143, P586, DOI 10.1017/S0950268814001137; Barnett S. A., 1963, RAT STUDY BEHAV; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bourhy P, 2014, INT J SYST EVOL MICR, V64, P4061, DOI 10.1099/ijs.0.066597-0; Bourhy P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002114; Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902; DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387; Djelouadji Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002433; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x; Guerra MA, 2009, JAVMA-J AM VET MED A, V234, P472, DOI 10.2460/javma.234.4.472; Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x; Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455; Kmety E., 1993, CLASSIFICATION SPECI; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Li SJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-75; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Pereira C, 2014, INT J ENV RES PUB HE, V11, P4140, DOI 10.3390/ijerph110404140; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Socolovschi C, 2011, INT J INFECT DIS, V15, pE710, DOI 10.1016/j.ijid.2011.05.017; Viana M, 2014, TRENDS ECOL EVOL, V29, P270, DOI 10.1016/j.tree.2014.03.002; Villanueva SYAM, 2014, MICROBES INFECT, V16, P902, DOI 10.1016/j.micinf.2014.07.001; Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; Zilber AL, 2014, J CLIN MICROBIOL, V52, P564, DOI 10.1128/JCM.02482-13; ZUERNER RL, 2005, CURR PROTOC MICR OCT, V12, P1, DOI DOI 10.1002/9780471729259.MC12E01S00	36	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139604	10.1371/journal.pone.0139604	http://dx.doi.org/10.1371/journal.pone.0139604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447693	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000040
J	Beyene, MB; Beyene, HB				Beyene, Melkamu Bedimo; Beyene, Habtamu Bedimo			Predictors of Late HIV Diagnosis among Adult People Living with HIV/AIDS Who Undertake an Initial CD4 T Cell Evaluation, Northern Ethiopia: A Case-Control Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RISK-FACTORS; TESTING POLICY; INFECTION; AIDS; CARE; DETERMINANTS; PREVALENCE; ERA; CONSEQUENCES	Introduction Early HIV testing and timely initiation of ART is critical for the improved quality of life of PLWHIV. Having identified a higher rates of Late HIV diagnosis, this study was aimed to determine Determinants of late diagnosis of HIV among adult HIV patients in Bahir Dar, Northern Ethiopia. Methods A case control study was conducted between January 2010 to December 2011 at Bahir Dar Felege Hiwot Referral Hospital. The study subjects consisted of 267 cases and 267 controls. Cases were adult people living with HIV/AIDS whose initial CD4 T cell count was <200/mu l of blood. Controls were those with a CD4 T cell count of greater than 200/mu l. Trained staff nurses were involved in data collection using a semi-structured questionnaire. Data was entered and analyzed using SPSS version 20. Descriptive statistics and Binary logistic regression were performed. Results Subjects who hold a certificate and above (AOR = 0.26; 95% CI = 0.13. 0.54), being initiated by friends, families and other socials to undertake HIV testing (AOR = 0.65; 95% CI = 0.29, 1.48), who reported a medium and high knowledge score about HIV/AIDS and who undertake HIV testing while visiting a clinic for ANC (AOR = 0.40; 95% CI = 0.19, 0.83) were less likely to be diagnosed late. Subjects who undertake HIV testing due to providers' initiation (AOR = 1.70; 95% CI = 1.08, 2.68), who reported a medium internalized stigma (AOR = 4.94; 95% CI = 3.13, 7.80) and who reported a high internalized stigma score towards HIV/AIDS (AOR = 16.64; 95% CI = 8.29, 33.4) had a high odds of being diagnosed late compared to their counterparts. Conclusion Internalized stigma, low knowledge level about HIV/AIDS, not to have attended formal education and failure to undertake HIV testing by own initiation were significant determinant factors associated with Late HIV diagnosis. Education about HIV/AIDS, promotion of general education, and encouraging people to motivate their social mates to undertake HIV testing are highly recommended.	[Beyene, Melkamu Bedimo] Bahir Dar Univ, Dept Publ Hlth, Coll Hlth Sci, Bahir Dar, Ethiopia; [Beyene, Habtamu Bedimo] Univ Addis Ababa, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia	Bahir Dar University; Addis Ababa University	Beyene, HB (corresponding author), Univ Addis Ababa, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia.	habtish1976@gmail.com	beyene, habtamu/AAN-2485-2021	Beyene, Melkamu Bedimo/0000-0003-4349-9887	Bahir Dar University	Bahir Dar University	This work was supported by Bahir Dar University that provided a partial fund for this study. Additional costs were covered by the authors own source/pocket money. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Adamu B.T., 2013, PUBLIC HLTH RES, V3, P98, DOI DOI 10.5923/J.PHR.20130304.03; Agaba PA, 2014, HIV MED, V15, P396, DOI 10.1111/hiv.12125; Alvarez-Uria G, 2012, FACTORS ASS LATE PRE; Bareta JC, 2002, INT C AIDS, V14; Bedimo M., 2011, SURVIVAL DIAGN UNPUB; Bonjour Maeva A, 2008, AIDS Res Ther, V5, P6, DOI 10.1186/1742-6405-5-6; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Carrizosa CM, 2010, AIDS PATIENT CARE ST, V24, P333, DOI 10.1089/apc.2009.0138; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Castilla Jesús, 2006, Gac Sanit, V20, P442, DOI 10.1157/13096525; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Ddamulira J B M, 2009, East Afr Med J, V86, P411; Delpierre C, 2007, INT J STD AIDS, V18, P312, DOI 10.1258/095646207780749709; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Federal Ministry of Health (FMOH), 2005, GUID IMPL ANT THER E; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Kirschner D, 2000, J ACQ IMMUN DEF SYND, V24, P352; Kivela PS, 2010, HIV MED, V11, P360, DOI 10.1111/j.1468-1293.2009.00783.x; LANG W, 1989, J ACQ IMMUN DEF SYND, V2, P63; Lanoy E, 2007, ANTIVIR THER, V12, P89; Lee JH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-411; Longo B, 2005, AIDS CARE, V17, P834, DOI 10.1080/09540120500038397; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mayben JK, 2007, AIDS PATIENT CARE ST, V21, P195, DOI 10.1089/apc.2006.0097; Mohammed Y, 2015, INT J CURRENT RES LI, V4, P187; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Mugavero MJ, 2007, AM J MED, V120, P370, DOI 10.1016/j.amjmed.2006.05.050; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Samet JH, 2001, AIDS, V15, P77, DOI 10.1097/00002030-200101050-00012; Santos J, 2004, INT J STD AIDS, V15, P594, DOI 10.1258/0956462041724253; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Schwarcz S, 2006, JAIDS-J ACQ IMM DEF, V43, P491, DOI 10.1097/01.qai.0000243114.37035.de; Sobrino-Vegas P, 2009, CURR HIV RES, V7, P224, DOI 10.2174/157016209787581535; Teira Cobo R, 2007, GAC SANIT, V21, P66; Tey J, 1996, ANN ACAD MED SINGAP, V41, P194; USAID/ETHIOPIA, 2010, HIV AIDS HLTH PROF	39	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140004	10.1371/journal.pone.0140004	http://dx.doi.org/10.1371/journal.pone.0140004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448332	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000078
J	Fiebach, JB; Stief, JD; Ganeshan, R; Hotter, B; Ostwaldt, AC; Nolte, CH; Villringer, K				Fiebach, Jochen B.; Stief, Jonas D.; Ganeshan, Ramanan; Hotter, Benjamin; Ostwaldt, Ann-Christin; Nolte, Christian H.; Villringer, Kersten			Reliability of Two Diameters Method in Determining Acute Infarct Size. Validation as New Imaging Biomarker	PLOS ONE			English	Article							ISCHEMIC-STROKE; THROMBOLYSIS; CT	Background In order to select patients most likely to benefit for thrombolysis and to predict patient outcome in acute ischemic stroke, the volumetric assessment of the infarcted tissue is used. However, infarct volume estimation on Diffusion weighted imaging (DWI) has moderate interrater variability despite the excellent contrast between ischemic lesion and healthy tissue. In this study, we compared volumetric measurements of DWI hyperintensity to a simple maximum orthogonal diameter approach to identify thresholds indicating infarct size >70 ml and >100 ml. Methods Patients presenting with ischemic stroke with an NIHSS of >= 8 were examined with stroke MRI within 24 h after symptom onset. For assessment of the orthogonal DWI lesion diameters (od-values) the image with the largest lesion appearance was chosen. The maximal diameter of the lesion was determined and a second diameter was measured perpendicular. Both diameters were multiplied. Od-values were compared to volumetric measurement and od-value thresholds identifying a lesion size of >70 ml and >100 ml were determined. In a selected dataset with an even distribution of lesion sizes we compared the results of the od value thresholds with results of the ABC/2 and estimations of lesion volumes made by two resident physicians. Results For 108 included patients (53 female, mean age 71.36 years) with a median infarct volume of 13.4 ml we found an excellent correlation between volumetric measures and od-values (r2 = 0.951). Infarct volume >100 ml corresponds to an od-value cut off of 42; >70 ml corresponds to an od-value of 32. In the compiled dataset (n = 50) od-value thresholds identified infarcts > 100 ml/>70 ml with a sensitivity of 90%/93% and with a specificity of 98%/89%. The od-value offered a higher accuracy in identifying large infarctions compared to both visual estimations and the ABC/2 method. Conclusion The simple od-value enables identification of large DWI lesions in acute stroke. The cutoff of 42 is useful to identify large infarctions with volume larger than 100 ml. Further studies can analyze the therapeutic utility of this new method.	[Fiebach, Jochen B.; Stief, Jonas D.; Ganeshan, Ramanan; Hotter, Benjamin; Ostwaldt, Ann-Christin; Nolte, Christian H.; Villringer, Kersten] Charite, Dept Neurol, Ctr Stroke Res Berlin CSB, D-12200 Berlin, Germany; [Stief, Jonas D.] Charite, Dept Radiol, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Ostwaldt, Ann-Christin] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Massachusetts General Hospital	Fiebach, JB (corresponding author), Charite, Dept Neurol, Ctr Stroke Res Berlin CSB, Hindenburgdamm 30, D-12200 Berlin, Germany.	jochen.fiebach@charite.de	Nolte, Christian/AAA-2651-2022; Hotter, Benjamin/ABD-9099-2020; Ostwaldt, Ann-Christin/X-9523-2019	Nolte, Christian/0000-0001-5577-1775; Ostwaldt, Ann-Christin/0000-0002-3210-8513; Stief, Jonas/0000-0002-8586-1250; Hotter, Benjamin/0000-0002-5272-9181; Fiebach, Jochen B./0000-0002-7936-6958; Ganeshan, Ramanan/0000-0003-4043-1115	Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin [01EO0801, 01EO1301]	Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin	The research leading to these results received funding from the Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin (01EO0801 and 01EO1301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hotter B, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-60; Kufner A, 2015, STROKE, V46, P1368, DOI 10.1161/STROKEAHA.114.008115; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Pedraza S, 2012, J NEUROIMAGING, V22, P155, DOI 10.1111/j.1552-6569.2011.00588.x; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Singer OC, 2009, STROKE, V40, P2743, DOI 10.1161/STROKEAHA.109.550111; von Kummer R, 2001, RADIOLOGY, V219, P95, DOI 10.1148/radiology.219.1.r01ap0695	9	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140065	10.1371/journal.pone.0140065	http://dx.doi.org/10.1371/journal.pone.0140065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447761	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000085
J	Correia, AS; Patel, P; Dutta, K; Julien, JP				Correia, Ana Sofia; Patel, Priyanka; Dutta, Kallol; Julien, Jean-Pierre			Inflammation Induces TDP-43 Mislocalization and Aggregation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; TRANSGENIC MICE; TARDBP MUTATIONS; INCLUSIONS; ALS; ACTIVATION; REGULATOR; PATHOLOGY	TAR DNA-binding protein 43 (TDP-43) is a major component in aggregates of ubiquitinated proteins in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Here we report that lipopolysaccharide (LPS)-induced inflammation can promote TDP-43 mislocalization and aggregation. In culture, microglia and astrocytes exhibited TDP-43 mislocalization after exposure to LPS. Likewise, treatment of the motoneuron-like NSC-34 cells with TNF-alpha (TNF-alpha) increased the cytoplasmic levels of TDP-43. In addition, the chronic intraperitoneal injection of LPS at a dose of 1mg/kg in TDP-43(A315T) transgenic mice exacerbated the pathological TDP-43 accumulation in the cytoplasm of spinal motor neurons and it enhanced the levels of TDP-43 aggregation. These results suggest that inflammation may contribute to development or exacerbation of TDP-43 proteinopathies in neurodegenerative disorders.	[Correia, Ana Sofia] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; [Patel, Priyanka; Dutta, Kallol; Julien, Jean-Pierre] Univ Laval, Dept Psychiat & Neurosci, Inst Univ Sante Mentale Quebec, Res Ctr, Quebec City, PQ, Canada	Laval University; Laval University	Julien, JP (corresponding author), Univ Laval, Dept Psychiat & Neurosci, Inst Univ Sante Mentale Quebec, Res Ctr, Quebec City, PQ, Canada.	jean-pierre.julien@fmed.ulaval.ca	Dutta, Kallol/J-5827-2019	Dutta, Kallol/0000-0001-6402-1300	Canadian Institutes of Health Research (CIHR); Fondation Andre-Delambre	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fondation Andre-Delambre	This work was supported by the Canadian Institutes of Health Research (CIHR) and the Fondation Andre-Delambre.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Devon R. M., 2001, PROTOCOLS NEURAL CEL, P325; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hart MP, 2012, J NEUROSCI, V32, P9133, DOI 10.1523/JNEUROSCI.0996-12.2012; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Morris HR, 2012, CURR NEUROL NEUROSCI, V12, P243, DOI 10.1007/s11910-012-0268-5; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Swarup V, 2012, J NEUROSCI, V32, P18186, DOI 10.1523/JNEUROSCI.2267-12.2012; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Walker AK, 2015, ACTA NEUROPATHOL; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang RZ, 2011, J NEUROIMMUNOL, V230, P114, DOI 10.1016/j.jneuroim.2010.08.012; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017	37	59	59	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140248	10.1371/journal.pone.0140248	http://dx.doi.org/10.1371/journal.pone.0140248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444430	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600153
J	Flies, AS; Mansfield, LS; Grant, CK; Weldele, ML; Holekamp, KE				Flies, Andrew S.; Mansfield, Linda S.; Grant, Chris K.; Weldele, Mary L.; Holekamp, Kay E.			Markedly Elevated Antibody Responses in Wild versus Captive Spotted Hyenas Show that Environmental and Ecological Factors Are Important Modulators of Immunity	PLOS ONE			English	Article							NATURAL ANTIBODIES; CROCUTA-CROCUTA; MASAI-MARA; IMMUNOGLOBULIN LEVELS; COMPLEMENT; HYGIENE; VIRUS; MICE; PARASITES; DEFENSE	Evolutionary processes have shaped the vertebrate immune system over time, but proximal mechanisms control the onset, duration, and intensity of immune responses. Based on testing of the hygiene hypothesis, it is now well known that microbial exposure is important for proper development and regulation of the immune system. However, few studies have examined the differences between wild animals in their natural environments, in which they are typically exposed to a wide array of potential pathogens, and their conspecifics living in captivity. Wild spotted hyenas (Crocuta crocuta) are regularly exposed to myriad pathogens, but there is little evidence of disease-induced mortality in wild hyena populations, suggesting that immune defenses are robust in this species. Here we assessed differences in immune defenses between wild spotted hyenas that inhabit their natural savanna environment and captive hyenas that inhabit a captive environment where pathogen control programs are implemented. Importantly, the captive population of spotted hyenas was derived directly from the wild population and has been in captivity for less than four generations. Our results show that wild hyenas have significantly higher serum antibody concentrations, including total IgG and IgM, natural antibodies, and autoantibodies than do captive hyenas; there was no difference in the bacterial killing capacity of sera collected from captive and wild hyenas. The striking differences in serum antibody concentrations observed here suggest that complementing traditional immunology studies, with comparative studies of wild animals in their natural environment may help to uncover links between environment and immune function, and facilitate progress towards answering immunological questions associated with the hygiene hypothesis.	[Flies, Andrew S.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Flies, Andrew S.; Holekamp, Kay E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Flies, Andrew S.; Holekamp, Kay E.] Michigan State Univ, Interdisciplinary Program Ecol Evolutionary Biol, E Lansing, MI 48824 USA; [Flies, Andrew S.] Univ S Australia, Dept Pharm & Med Sci, Adelaide, SA 5001, Australia; [Mansfield, Linda S.] Michigan State Univ, Dept Microbiol & Mol Genet, Natl Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA; [Grant, Chris K.] Custom Monoclonals Int Corp, West Sacramento, CA USA; [Weldele, Mary L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of Tasmania; Michigan State University; Michigan State University; University of South Australia; Michigan State University; University of California System; University of California Berkeley	Flies, AS (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	andyflies@gmail.com	Flies, Andrew S/L-3482-2019; Flies, Andrew S/Q-7535-2018; Flies, Andrew/B-3122-2008	Flies, Andrew S/0000-0002-4550-1859; Flies, Andrew S/0000-0002-4550-1859; Flies, Andrew/0000-0002-4550-1859; Mansfield, Linda S./0000-0002-7523-7577	Army Research Office [W911NF-08-1-0310]; National Institutes of Health [1R01GM105042, K26RR023080, U10 AI090872]; National Science Foundation [IOS1121474, DEB1353110, IOS0809914]; Sigma Xi; American Society of Mammalogists; Morris Animal Foundation [D12Z0-604]; NSF Graduate Research Fellowship	Army Research Office; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Sigma Xi; American Society of Mammalogists; Morris Animal Foundation; NSF Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by Award No. W911NF-08-1-0310 from the Army Research Office, National Institutes of Health grant 1R01GM105042, and National Science Foundation grants IOS1121474 and DEB1353110 to KEH, National Science Foundation Grant IOS0809914 to Stephen Glickman, National Institutes of Health grants K26RR023080 and U10 AI090872 to LSM, Grants-in-Aid-of research from Sigma Xi, Grants-in-Aid of Research from the American Society of Mammalogists, Veterinary Student Scholars grant D12Z0-604 from the Morris Animal Foundation, and an NSF Graduate Research Fellowship to ASF. Custom Monoclonals International Corp contributed antibodies used in this study. Author CKG, president of Custom Monoclonals International Corp, provided advice on experimental design, assay optimization, and assisted in writing the Materials and Methods section of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abolins SR, 2011, MOL ECOL, V20, P881, DOI 10.1111/j.1365-294X.2010.04910.x; Alexander KA, 1995, J ZOO WILDLIFE MED, V26, P201; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Attanasio R, 2001, CLIN EXP IMMUNOL, V123, P361, DOI 10.1046/j.1365-2249.2001.01454.x; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Boots M, 2004, P ROY SOC B-BIOL SCI, V271, P715, DOI 10.1098/rspb.2003.2655; BOS NA, 1989, EUR J IMMUNOL, V19, P2335, DOI 10.1002/eji.1830191223; Boysen P, 2011, MOL ECOL, V20, P5103, DOI 10.1111/j.1365-294X.2011.05269.x; Buehler DM, 2008, J AVIAN BIOL, V39, P560, DOI 10.1111/j.0908-8857.2008.04408.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; Clinical and Laboratory Standards Institute (CLSI), 2009, METH DIL ANT SUSC TE; Cole RA, 1999, FIELD MANUAL WILDLIF, P48; Cooper SM, 1999, AFR J ECOL, V37, P149, DOI 10.1046/j.1365-2028.1999.00161.x; COUTINHO A, 1989, IMMUNOL REV, V110, P63, DOI 10.1111/j.1600-065X.1989.tb00027.x; Devalapalli AP, 2006, SCAND J IMMUNOL, V64, P125, DOI 10.1111/j.1365-3083.2006.01785.x; Dishaw LJ, 2014, DEV COMP IMMUNOL, V47, P36, DOI 10.1016/j.dci.2014.06.011; East ML, 2008, J WILDLIFE DIS, V44, P45, DOI 10.7589/0090-3558-44.1.45; East ML, 2004, VET MICROBIOL, V102, P1, DOI 10.1016/j.vetmic.2004.04.012; East ML, 2001, P NATL ACAD SCI USA, V98, P15026, DOI 10.1073/pnas.261411898; Engh AL, 2003, J WILDLIFE DIS, V39, P224, DOI 10.7589/0090-3558-39.1.224; Flies AS, 2014, VET RES COMMUN, V38, P165, DOI 10.1007/s11259-014-9592-3; Flies AS, 2012, VET IMMUNOL IMMUNOP, V145, P110, DOI 10.1016/j.vetimm.2011.10.016; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; GLICKMAN SE, 1992, ANN NY ACAD SCI, V662, P135, DOI 10.1111/j.1749-6632.1992.tb22858.x; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Harrison TM, 2006, J ZOO WILDLIFE MED, V37, P102, DOI 10.1638/05-022.1; Harrison TM, 2004, J WILDLIFE DIS, V40, P1, DOI 10.7589/0090-3558-40.1.1; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Holekamp KE, 2015, ANIM BEHAV, V103, P237, DOI 10.1016/j.anbehav.2015.01.023; Holekamp KE, 2003, HORM BEHAV, V44, P385, DOI 10.1016/j.yhbeh.2003.06.003; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; Horrocks NPC, 2011, INTEGR COMP BIOL, V51, P563, DOI 10.1093/icb/icr011; Joop G, 2004, EVOL ECOL RES, V6, P1051; KORVER K, 1984, J IMMUNOL METHODS, V74, P241, DOI 10.1016/0022-1759(84)90291-6; LACROIXDESMAZES S, 1995, EUR J IMMUNOL, V25, P2598, DOI 10.1002/eji.1830250929; Lee SMY, 2014, P NATL ACAD SCI USA, V111, P3793, DOI 10.1073/pnas.1324266111; Lembo T, 2011, EMERG INFECT DIS, V17, P387, DOI 10.3201/eid1703.101290; Liebl AL, 2009, FUNCT ECOL, V23, P1091, DOI 10.1111/j.1365-2435.2009.01592.x; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Miko A, 2009, APPL ENVIRON MICROB, V75, P6462, DOI 10.1128/AEM.00904-09; Moore SM, 2012, ECOLOGY, V93, P1095, DOI 10.1890/11-0086.1; Nagele EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060726; Parmentier HK, 2004, DEV COMP IMMUNOL, V28, P39, DOI 10.1016/S0145-305X(03)00087-9; Pi C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120255; R Development Core Team, 2014, R LANG ENV STAT COMP; Reeves WH, 2004, ORIGINS ANTINUCLEAR; RELLER LB, 1977, J INFECT DIS, V136, P196, DOI 10.1093/infdis/136.2.196; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rifkin JL, 2012, AM NAT, V180, P70, DOI 10.1086/666081; ROWE D. S., 1968, CLIN EXP IMMUNOL, V3, P63; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; THORNTON BP, 1994, J IMMUNOL, V152, P1727; TURNER MW, 1966, J TROP MED HYG, V69, P99; Ujvari B, 2011, FUNCT ECOL, V25, P813, DOI 10.1111/j.1365-2435.2011.01860.x; Viney M, 2015, PARASITE IMMUNOL, V37, P267, DOI 10.1111/pim.12150; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Waitz J.A, 1990, METH DIL ANT SUSC TE; Wander K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037406; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5382, DOI 10.1073/pnas.1121631109; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	75	18	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137679	10.1371/journal.pone.0137679	http://dx.doi.org/10.1371/journal.pone.0137679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444876	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000362510600012
J	Kurihara, T; Arimochi, H; Bhuyan, ZA; Ishifune, C; Tsumura, H; Ito, M; Ito, Y; Kitamura, A; Maekawa, Y; Yasutomo, K				Kurihara, Takeshi; Arimochi, Hideki; Bhuyan, Zaied Ahmed; Ishifune, Chieko; Tsumura, Hideki; Ito, Morihiro; Ito, Yasuhiko; Kitamura, Akiko; Maekawa, Yoichi; Yasutomo, Koji			CD98 Heavy Chain Is a Potent Positive Regulator of CD4(+) T Cell Proliferation and Interferon-gamma Production In Vivo	PLOS ONE			English	Article							IMMUNE-RESPONSES; DIFFERENTIATION; ACTIVATION; TOLERANCE; TH1	Upon their recognition of antigens presented by the MHC, T cell proliferation is vital for clonal expansion and the acquisition of effector functions, which are essential for mounting adaptive immune responses. The CD98 heavy chain (CD98hc, Slc3a2) plays a crucial role in the proliferation of both CD4(+) and CD8(+) T cells, although it is unclear if CD98hc directly regulates the T cell effector functions that are not linked with T cell proliferation in vivo. Here, we demonstrate that CD98hc is required for both CD4(+) T cell proliferation and Th1 functional differentiation. T cell-specific deletion of CD98hc did not affect T cell development in the thymus. CD98hc-deficient CD4(+) T cells proliferated in vivo more slowly as compared with control T cells. C57BL/6 mice lacking CD98hc in their CD4(+) T cells could not control Leishmania major infections due to lowered IFN-gamma production, even with massive CD4(+) T cell proliferation. CD98hc-deficient CD4(+) T cells exhibited lower IFN-gamma production compared with wild-type T cells, even when comparing IFN-gamma expression in cells that underwent the same number of cell divisions. Therefore, these data indicate that CD98hc is required for CD4(+) T cell expansion and functional Th1 differentiation in vivo, and suggest that CD98hc might be a good target for treating Th1-mediated immune disorders.	[Kurihara, Takeshi; Arimochi, Hideki; Bhuyan, Zaied Ahmed; Ishifune, Chieko; Kitamura, Akiko; Maekawa, Yoichi; Yasutomo, Koji] Univ Tokushima, Grad Sch Med, Dept Immunol & Parasitol, Tokushima 770, Japan; [Tsumura, Hideki] Natl Res Inst Child Hlth & Dev, Div Lab Anim Resources, Tokyo, Japan; [Ito, Morihiro; Ito, Yasuhiko] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan	Tokushima University; National Center for Child Health & Development - Japan; Chubu University	Yasutomo, K (corresponding author), Univ Tokushima, Grad Sch Med, Dept Immunol & Parasitol, Tokushima 770, Japan.	yasutomo@tokushima-u.ac.jp		Maekawa, Yoichi/0000-0002-3879-5713	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [15H04724] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Knowledge Cluster programs from The Ministry of Education, Culture, Sports, Science, and Technology.	Cantor J, 2011, J IMMUNOL, V187, P851, DOI 10.4049/jimmunol.1100002; Cantor JM, 2008, IMMUNOL REV, V223, P236, DOI 10.1111/j.1600-065X.2008.00640.x; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Komada H, 2006, BIOMED RES-TOKYO, V27, P61, DOI 10.2220/biomedres.27.61; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kudo Y, 2004, FEBS LETT, V577, P473, DOI 10.1016/j.febslet.2004.10.047; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lian G, 2012, J IMMUNOL; Liu Z, 2012, TRANSPLANTATION, V93, P1116, DOI 10.1097/TP.0b013e31824fd7cd; Maekawa Y, 1998, J IMMUNOL, V161, P2120; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tsumura H, 2003, BIOCHEM BIOPH RES CO, V308, P847, DOI 10.1016/S0006-291X(03)01473-6; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	22	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139692	10.1371/journal.pone.0139692	http://dx.doi.org/10.1371/journal.pone.0139692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444422	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600069
J	Lee, E; Stafford, WF				Lee, Eunhee; Stafford, Walter F., III			Interaction of Myosin Phosphatase Target Subunit (MYPT1) with Myosin Phosphatase-RhoA Interacting Protein (MRIP): A Role of Glutamic Acids in the Interaction	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHATASE; SEDIMENTATION-VELOCITY; BOUNDARY ANALYSIS; P116(RIP)	Scaffold proteins bind to and functionally link protein members of signaling pathways. Interaction of the scaffold proteins, myosin phosphatase target subunit (MYPT1) and myosin phosphatase-RhoA interacting protein (MRIP), causes co-localization of myosin phosphatase and RhoA to actomyosin. To examine biophysical properties of interaction of MYPT1 with MRIP, we employed analytical ultracentrifugation and surface plasmon resonance. In regard to MRIP, its residues 724-837 are sufficient for the MYPT1/MRIP interaction. Moreover, MRIP binds to MYPT1 as either a monomer or a dimer. With respect to MYPT1, its leucine repeat region, LR (residues 991-1030) is sufficient to account for the MYPT1/MRIP interaction. Furthermore, point mutations that replace glutamic acids 998-1000 within LR reduced the binding affinity toward MRIP. This suggests that the glutamic acids of MYPT1 play an important role in the interaction.	[Lee, Eunhee] Boston Biomed Res Inst, Cardiovasc Biol Program, Watertown, MA 02472 USA; Boston Biomed Res Inst, AUC Res Lab, Watertown, MA 02472 USA	Boston Biomedical Research Institute; Boston Biomedical Research Institute	Lee, E (corresponding author), Boston Biomed Res Inst, Cardiovasc Biol Program, 64 Grove St, Watertown, MA 02472 USA.	eunhee.lee.ext@boehringer-ingelheim.com	Stafford, Walter/ABC-6553-2020					Andre G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000852; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Koga Y, 2005, J BIOL CHEM, V280, P4983, DOI 10.1074/jbc.M410909200; Laszlo B, 2010, FEBS J, V277, P4348, DOI 10.1111/j.1742-4658.2010.07864.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Lee JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1371, DOI 10.1152/ajpcell.00254.2011; LIU S, 1995, ANAL BIOCHEM, V224, P199, DOI 10.1006/abio.1995.1030; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Mulder J, 2005, FEBS LETT, V579, P6121, DOI 10.1016/j.febslet.2005.09.083; Mulder J, 2004, MOL BIOL CELL, V15, P5516, DOI 10.1091/mbc.E04-04-0275; Okamoto R, 2005, TRANSGENIC RES, V14, P337, DOI 10.1007/s11248-005-3453-3; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; STAFFORD WF, 1994, METHOD ENZYMOL, V240, P478; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007	19	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139875	10.1371/journal.pone.0139875	http://dx.doi.org/10.1371/journal.pone.0139875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445108	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600098
J	Lee, Y; Kim, KH; Kim, DG; Cho, HJ; Kim, Y; Rheey, J; Shin, K; Seo, YJ; Choi, YS; Lee, JI; Lee, J; Joo, KM; Nam, DH				Lee, Yeri; Kim, Kang Ho; Kim, Dong Geon; Cho, Hee Jin; Kim, Yeonghwan; Rheey, Jinguen; Shin, Kayoung; Seo, Yun Jee; Choi, Yeon-Sook; Lee, Jung-Il; Lee, Jeongwu; Joo, Kyeung Min; Nam, Do-Hyun			FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; HUMAN BREAST-CANCER; TRANSCRIPTION FACTOR; SELF-RENEWAL; MESENCHYMAL TRANSITION; GENE-EXPRESSION; GLIOMA-CELLS; HETEROGENEITY; TUMORIGENICITY; PROLIFERATION	Glioblastoma (GBM) is the most aggressive and most lethal brain tumor. As current standard therapy consisting of surgery and chemo-irradiation provides limited benefit for GBM patients, novel therapeutic options are urgently required. Forkhead box M1 (FoxM1) transcription factor is an oncogenic regulator that promotes the proliferation, survival, and treatment resistance of various human cancers. The roles of FoxM1 in GBM remain incompletely understood, due in part to pleotropic nature of the FoxM1 pathway. Here, we show the roles of FoxM1 in GBM stem cell maintenance and radioresistance. ShRNA-mediated FoxM1 inhibition significantly impeded clonogenic growth and survival of patient-derived primary GBM cells with marked downregulation of Sox2, a master regulator of stem cell phenotype. Ectopic expression of Sox2 partially rescued FoxM1 inhibition-mediated effects. Conversely, FoxM1 overexpression upregulated Sox2 expression and promoted clonogenic growth of GBM cells. These data, with a direct binding of FoxM1 in the Sox2 promoter region in GBM cells, suggest that FoxM1 regulates stemness of primary GBM cells via Sox2. We also found significant increases in FoxM1 and Sox2 expression in GBM cells after irradiation both in vitro and in vivo orthotopic tumor models. Notably, genetic or a small-molecule FoxM1 inhibitor-mediated FoxM1 targeting significantly sensitized GBM cells to irradiation, accompanying with Sox2 downregulation. Finally, FoxM1 inhibition combined with irradiation in a patient GBM-derived orthotopic model significantly impeded tumor growth and prolonged the survival of tumor bearing mice. Taken together, these results indicate that the FoxM1-Sox2 signaling axis promotes clonogenic growth and radiation resistance of GBM, and suggest that FoxM1 targeting combined with irradiation is a potentially effective therapeutic approach for GBM.	[Lee, Yeri; Kim, Dong Geon; Cho, Hee Jin; Shin, Kayoung; Nam, Do-Hyun] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Kim, Kang Ho; Rheey, Jinguen; Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Seo, Yun Jee; Choi, Yeon-Sook; Lee, Jung-Il; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Suwon, South Korea; [Kim, Yeonghwan; Lee, Jeongwu] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44106 USA	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Cleveland Clinic Foundation	Joo, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea.	kmjoo@skku.edu; nsnam@skku.edu			Korea Health Technology R&D Project, through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C3418]	Korea Health Technology R&D Project, through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project, through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3418).	Abla AA, 2012, WORLD NEUROSURG, V77, P594, DOI 10.1016/j.wneu.2012.03.001; Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Balli D, 2013, EMBO J, V32, P231, DOI 10.1038/emboj.2012.336; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Guan P, 2011, CLIN INVEST MED, V34, pE1; Halasi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031761; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Joo KM, 2012, CANCER RES, V72, P3828, DOI 10.1158/0008-5472.CAN-11-3760; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Nakamura S, 2010, CARCINOGENESIS, V31, P2012, DOI 10.1093/carcin/bgq185; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; REMMELE W, 1987, PATHOLOGE, V8, P138; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sullivan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051277; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Wang Y, 2013, LUNG CANCER, V79, P173, DOI 10.1016/j.lungcan.2012.10.019; Wang ZB, 2011, CANCER RES, V71, P4292, DOI 10.1158/0008-5472.CAN-10-4087; Xie YP, 2014, INT J MOL SCI, V15, P23345, DOI 10.3390/ijms151223345; Xu N, 2012, ACTA PHARMACOL SIN, V33, P675, DOI 10.1038/aps.2011.188; Yang C, 2013, CANCER LETT, V340, P104, DOI 10.1016/j.canlet.2013.07.004; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	43	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137703	10.1371/journal.pone.0137703	http://dx.doi.org/10.1371/journal.pone.0137703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444992	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600013
J	Loturco, I; Nakamura, FY; Tricoli, V; Kobal, R; Abad, CCC; Kitamura, K; Ugrinowitsch, C; Gil, S; Pereira, LA; Gonzalez-Badillo, JJ				Loturco, Irineu; Nakamura, Fabio Yuzo; Tricoli, Valmor; Kobal, Ronaldo; Abad, Cesar Cavinato Cal; Kitamura, Katia; Ugrinowitsch, Carlos; Gil, Saulo; Pereira, Lucas Adriano; Gonzalez-Badillo, Juan Jose			Determining the Optimum Power Load in Jump Squat Using the Mean Propulsive Velocity	PLOS ONE			English	Article							ATHLETIC PERFORMANCE; VERTICAL JUMP; PEAK POWER; STRENGTH; SPRINT; SPEED; VARIABLES; ABILITY; FORCE; TESTS	The jump squat is one of the exercises most frequently used to improve lower body power production, which influences sports performance. However, the traditional determination of the specific workload at which power production is maximized (i.e., optimum power load) is time-consuming and requires one-repetition maximum tests. Therefore, the aim of this study was to verify whether elite athletes from different sports would produce maximum mean propulsive power values at a narrow range of mean propulsive velocities, resulting in similar jump heights. One hundred and nine elite athletes from several individual/ team sport disciplines underwent repetitions at maximal velocity with progressive loads, starting at 40% of their body mass with increments of 10% to determine the individual optimum power zone. Results indicated that regardless of sport discipline, the athletes' optimum mean propulsive power was achieved at a mean propulsive velocity close to 1.0 m.s(-1) (1.01 +/- 0.07 m.s(-1)) and at a jump height close to 20 cm (20.47 +/- 1.42 cm). Data were narrowly scattered around these values. Therefore, jump squat optimum power load can be determined simply by means of mean propulsive velocity or jump height determination in training/testing settings, allowing it to be implemented quickly in strength/power training.	[Loturco, Irineu; Nakamura, Fabio Yuzo; Kobal, Ronaldo; Abad, Cesar Cavinato Cal; Kitamura, Katia; Gil, Saulo; Pereira, Lucas Adriano] NAR Nucleus High Performance Sport, Sao Paulo, SP, Brazil; [Loturco, Irineu; Gonzalez-Badillo, Juan Jose] Pablo de Olavide Univ, Fac Sport, Seville, Spain; [Nakamura, Fabio Yuzo] Univ Estadual Londrina, Londrina, PR, Brazil; [Tricoli, Valmor; Ugrinowitsch, Carlos] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil	Universidad Pablo de Olavide; Universidade Estadual de Londrina; Universidade de Sao Paulo	Loturco, I (corresponding author), NAR Nucleus High Performance Sport, Sao Paulo, SP, Brazil.	irineu.loturco@terra.com.br	Pereira, Lucas/S-3110-2019; Tricoli, Valmor/E-3747-2012; Ugrinowitsch, Carlos/A-3925-2010; Gil, Saulo/I-4100-2017; PEREIRA, LUCAS/HHZ-5877-2022; Loturco, Irineu/AAH-4916-2019; Kobal, Ronaldo/AAU-8415-2021; Nakamura, Fábio Yuzo/AAC-3069-2020; Gil, Saulo/AAO-7196-2020	Pereira, Lucas/0000-0003-1079-2446; Tricoli, Valmor/0000-0002-9014-087X; Ugrinowitsch, Carlos/0000-0001-8547-419X; Gil, Saulo/0000-0001-9050-0073; Loturco, Irineu/0000-0003-1309-2568; Kobal, Ronaldo/0000-0003-0243-2133; Nakamura, Fábio Yuzo/0000-0002-5336-3652; Gil, Saulo/0000-0001-9050-0073				Alcaraz PE, 2011, J STRENGTH COND RES, V25, P3045, DOI 10.1519/JSC.0b013e318212e1fa; Baker D, 1999, J STRENGTH COND RES, V13, P230; Baker D, 2001, J STRENGTH COND RES, V15, P92; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Bret C, 2002, J SPORT MED PHYS FIT, V42, P274; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cormie P, 2007, J STRENGTH COND RES, V21, P1042; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; Cormie P, 2010, MED SCI SPORT EXER, V42, P1582, DOI 10.1249/MSS.0b013e3181d2013a; Coutts AJ, 2014, INT J SPORT PHYSIOL, V9, P741, DOI 10.1123/IJSPP.2014-0353; Garnacho-Castano MV, 2015, J SPORT SCI MED, V14, P128; Haff GG, 2012, STRENGTH COND J, V34, P2, DOI 10.1519/SSC.0b013e31826db467; Hansen KT, 2011, J STRENGTH COND RES, V25, P867, DOI 10.1519/JSC.0b013e3181c69f0a; Harris NK, 2008, J STRENGTH COND RES, V22, P691, DOI 10.1519/JSC.0b013e31816d8d80; Hennessy L, 2001, J STRENGTH COND RES, V15, P326; Hori N, 2005, STRENGTH COND J, V27, P50, DOI 10.1519/1533-4295(2005)27[50:WEEAPT]2.0.CO;2; Izquierdo M, 2002, EUR J APPL PHYSIOL, V87, P264, DOI 10.1007/s00421-002-0628-y; Kawamori N, 2004, J STRENGTH COND RES, V18, P675; KOMI PV, 1978, MED SCI SPORT EXER, V10, P261; Loturco I, 2015, J STRENGTH COND RES, V29, P1966, DOI 10.1519/JSC.0000000000000849; Loturco I, 2015, J SPORT SCI, V33, P1283, DOI 10.1080/02640414.2015.1022574; Loturco I, 2015, J STRENGTH COND RES, V29, P758, DOI 10.1519/JSC.0000000000000660; Loturco I, 2014, J STRENGTH COND RES, V28, P1826, DOI 10.1519/JSC.0000000000000329; Loturco I, 2013, J SPORT SCI MED, V12, P109; Markovic G, 2011, INT J SPORTS MED, V32, P365, DOI 10.1055/s-0031-1271678; Marques MC, 2007, INTJ SPORT PHYSIOL, V2, P414, DOI 10.1123/ijspp.2.4.414; McBride JM, 2011, J SPORT SCI, V29, P1215, DOI 10.1080/02640414.2011.587444; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; McMaster DT, 2014, SPORTS MED, V44, P603, DOI 10.1007/s40279-014-0145-2; Newton RU, 2006, J STRENGTH COND RES, V20, P955; Newton RU, 2002, MED SCI SPORT EXER, V34, P1367, DOI 10.1097/00005768-200208000-00020; Newton RU, 1999, MED SCI SPORT EXER, V31, P323, DOI 10.1097/00005768-199902000-00017; Pereira G, 2011, J SPORT SCI, V29, P927, DOI 10.1080/02640414.2011.571272; Samozino P, 2010, J THEOR BIOL, V264, P11, DOI 10.1016/j.jtbi.2010.01.021; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Sapega A A, 1983, J Orthop Sports Phys Ther, V5, P7; Swinton PA, 2014, J STRENGTH COND RES, V28, P1839, DOI 10.1519/JSC.0000000000000348; Turner AP, 2012, J STRENGTH COND RES, V26, P1594, DOI 10.1519/JSC.0b013e318234ebe5; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; Wilson JM, 2013, J STRENGTH COND RES, V27, P854, DOI 10.1519/JSC.0b013e31825c2bdb	42	70	71	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140102	10.1371/journal.pone.0140102	http://dx.doi.org/10.1371/journal.pone.0140102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444293	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600140
J	van Geldermalsen, M; Wang, Q; Nagarajah, R; Marshall, AD; Thoeng, A; Gao, D; Ritchie, W; Feng, Y; Bailey, CG; Deng, N; Harvey, K; Beith, JM; Selinger, CI; O'Toole, SA; Rasko, JEJ; Holst, J				van Geldermalsen, M.; Wang, Q.; Nagarajah, R.; Marshall, A. D.; Thoeng, A.; Gao, D.; Ritchie, W.; Feng, Y.; Bailey, C. G.; Deng, N.; Harvey, K.; Beith, J. M.; Selinger, C. I.; O'Toole, S. A.; Rasko, J. E. J.; Holst, J.			ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; AMINO-ACID-TRANSPORT; HUMAN HEPATOMA-CELLS; MOLECULAR SUBTYPE; LUNG-CANCER; METABOLISM; EXPRESSION; TARGET; PROGRESSION; SENSITIVITY	Alanine, serine, cysteine-preferring transporter 2 (ASCT2; SLC1A5) mediates uptake of glutamine, a conditionally essential amino acid in rapidly proliferating tumour cells. Uptake of glutamine and subsequent glutaminolysis is critical for activation of the mTORC1 nutrient-sensing pathway, which regulates cell growth and protein translation in cancer cells. This is of particular interest in breast cancer, as glutamine dependence is increased in high-risk breast cancer subtypes. Pharmacological inhibitors of ASCT2-mediated transport significantly reduced glutamine uptake in human breast cancer cell lines, leading to the suppression of mTORC1 signalling, cell growth and cell cycle progression. Notably, these effects were subtype-dependent, with ASCT2 transport critical only for triple-negative (TN) basal-like breast cancer cell growth compared with minimal effects in luminal breast cancer cells. Both stable and inducible shRNA-mediated ASCT2 knockdown confirmed that inhibiting ASCT2 function was sufficient to prevent cellular proliferation and induce rapid cell death in TN basal-like breast cancer cells, but not in luminal cells. Using a bioluminescent orthotopic xenograft mouse model, ASCT2 expression was then shown to be necessary for both successful engraftment and growth of HCC1806 TN breast cancer cells in vivo. Lower tumoral expression of ASCT2 conferred a significant survival advantage in xenografted mice. These responses remained intact in primary breast cancers, where gene expression analysis showed high expression of ASCT2 and glutamine metabolism-related genes, including GLUL and GLS, in a cohort of 90 TN breast cancer patients, as well as correlations with the transcriptional regulators, MYC and ATF4. This study provides preclinical evidence for the feasibility of novel therapies exploiting ASCT2 transporter activity in breast cancer, particularly in the high-risk basal-like subgroup of TN breast cancer where there is not only high expression of ASCT2, but also a marked reliance on its activity for sustained cellular proliferation.	[van Geldermalsen, M.; Wang, Q.; Nagarajah, R.; Holst, J.] Centenary Inst, Origins Canc Program, Camperdown, NSW, Australia; [van Geldermalsen, M.; Wang, Q.; Nagarajah, R.; Marshall, A. D.; Thoeng, A.; Gao, D.; Ritchie, W.; Feng, Y.; Bailey, C. G.; Rasko, J. E. J.; Holst, J.] Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia; [van Geldermalsen, M.; Wang, Q.; Nagarajah, R.; Marshall, A. D.; Thoeng, A.; Gao, D.; Ritchie, W.; Feng, Y.; Bailey, C. G.; Beith, J. M.; O'Toole, S. A.; Rasko, J. E. J.; Holst, J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Gao, D.; Ritchie, W.] Centenary Inst, Bioinformat Lab, Camperdown, NSW, Australia; [Deng, N.; Harvey, K.; O'Toole, S. A.] St Vincents Hosp, Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia; [Deng, N.; Harvey, K.; O'Toole, S. A.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Deng, N.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Harvey, K.; Selinger, C. I.; O'Toole, S. A.] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW 2050, Australia; [Beith, J. M.] Chris OBrien Lifehouse, Dept Med Oncol, Camperdown, NSW, Australia; [Rasko, J. E. J.] Royal Prince Alfred Hosp, Cell & Mol Therapies, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Centenary Institute; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney	Holst, J (corresponding author), Centenary Inst, Origins Canc Program, Locked Bag 6, Newtown, NSW 2042, Australia.	j.holst@centenary.org.au	Holst, Jeff/H-7634-2012; Gao, Dadi/AAW-4359-2020	Holst, Jeff/0000-0002-0377-9318; Gao, Dadi/0000-0002-3638-8479; Bailey, Charles/0000-0002-4725-7829; Marshall, Amy/0000-0001-5803-3815; Wang, Qian (Kevin)/0000-0002-6514-3470; Deng, Niantao/0000-0001-9717-2236; rasko, John/0000-0003-2975-807X	National Breast Cancer Foundation [ECF-12-05]; Movember through the Prostate Cancer Foundation of Australia [YI0813, YI0707]; Cancer Institute NSW; Cancer Council NSW [APP1080503]; University of Sydney; Tour de Cure Fellowship; Sydney Breast Cancer Foundation; RT Hall Foundation; Cure the Future and an anonymous foundation; National Breast Cancer Foundation [PRAC-16-006] Funding Source: researchfish	National Breast Cancer Foundation; Movember through the Prostate Cancer Foundation of Australia; Cancer Institute NSW; Cancer Council NSW(Cancer Council New South Wales); University of Sydney(University of Sydney); Tour de Cure Fellowship; Sydney Breast Cancer Foundation; RT Hall Foundation; Cure the Future and an anonymous foundation; National Breast Cancer Foundation	This work was supported by grants from the National Breast Cancer Foundation (ECF-12-05 to JH); Movember through the Prostate Cancer Foundation of Australia (YI0813 to QW; YI0707 to JH); Cancer Institute NSW (WR and MvG); Cancer Council NSW (APP1080503 to JH); University of Sydney (AM); Cure the Future and an anonymous foundation (JEJR); Tour de Cure Fellowship (CGB); Sydney Breast Cancer Foundation and the RT Hall Foundation (SO'T). We thank Michael P Kuligowski from Centenary Imaging Facility for assistance with Volocity image analysis and staff at the Advanced Cytometry Facility, Sydney for FACS assistance.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Chen XS, 2010, TUMORI J, V96, P103, DOI 10.1177/030089161009600117; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fuchs BC, 2004, AM J PHYSIOL-GASTR L, V286, pG467, DOI 10.1152/ajpgi.00344.2003; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hassanein M, 2015, INT J CANCER, V137, P1587, DOI 10.1002/ijc.29535; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Jacque N, 2015, BLOOD, V126, P1346, DOI 10.1182/blood-2015-01-621870; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; Kekuda R, 1996, J BIOL CHEM, V271, P18657, DOI 10.1074/jbc.271.31.18657; Kim S, 2013, ENDOCR-RELAT CANCER, V20, P339, DOI 10.1530/ERC-12-0398; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Perou CM, 2010, ONCOLOGIST, V15, P39, DOI 10.1634/theoncologist.2010-S5-39; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Ren P, 2015, J PATHOL, V235, P90, DOI 10.1002/path.4429; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Tiffen JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-299; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Wang Q, 2014, INT J CANCER, V135, P1060, DOI 10.1002/ijc.28749; Wang Q, 2013, JNCI-J NATL CANCER I, V105, P1463, DOI 10.1093/jnci/djt241; Wang Q, 2011, CANCER RES, V71, P7525, DOI 10.1158/0008-5472.CAN-11-1821; Willems L, 2013, BLOOD, V122, P3521, DOI 10.1182/blood-2013-03-493163; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28	47	309	318	9	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 16	2016	35	24					3201	3208		10.1038/onc.2015.381	http://dx.doi.org/10.1038/onc.2015.381			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO9GI	26455325	Green Published, hybrid			2022-12-26	WOS:000378092700011
J	Diogo, R; Esteve-Altava, B; Smith, C; Boughner, JC; Rasskin-Gutman, D				Diogo, Rui; Esteve-Altava, Borja; Smith, Christopher; Boughner, Julia C.; Rasskin-Gutman, Diego			Anatomical Network Comparison of Human Upper and Lower, Newborn and Adult, and Normal and Abnormal Limbs, with Notes on Development, Pathology and Limb Serial Homology vs. Homoplasy	PLOS ONE			English	Article							MORPHOLOGICAL INTEGRATION; MAMMALIAN SKULL; PHENOTYPIC VARIATION; HINDLIMB MUSCLES; EVO-DEVO; EVOLUTION; MODULARITY; PHYLOGENY; EVOLVABILITY; COVARIATION	How do the various anatomical parts (modules) of the animal body evolve into very different integrated forms (integration) yet still function properly without decreasing the individual's survival? This long-standing question remains unanswered for multiple reasons, including lack of consensus about conceptual definitions and approaches, as well as a reasonable bias toward the study of hard tissues over soft tissues. A major difficulty concerns the nontrivial technical hurdles of addressing this problem, specifically the lack of quantitative tools to quantify and compare variation across multiple disparate anatomical parts and tissue types. In this paper we apply for the first time a powerful new quantitative tool, Anatomical Network Analysis (AnNA), to examine and compare in detail the musculoskeletal modularity and integration of normal and abnormal human upper and lower limbs. In contrast to other morphological methods, the strength of AnNA is that it allows efficient and direct empirical comparisons among body parts with even vastly different architectures (e.g. upper and lower limbs) and diverse or complex tissue composition (e.g. bones, cartilages and muscles), by quantifying the spatial organization of these parts-their topological patterns relative to each other-using tools borrowed from network theory. Our results reveal similarities between the skeletal networks of the normal newborn/adult upper limb vs. lower limb, with exception to the shoulder vs. pelvis. However, when muscles are included, the overall musculoskeletal network organization of the upper limb is strikingly different from that of the lower limb, particularly that of the more proximal structures of each limb. Importantly, the obtained data provide further evidence to be added to the vast amount of paleontological, gross anatomical, developmental, molecular and embryological data recently obtained that contradicts the long-standing dogma that the upper and lower limbs are serial homologues. In addition, the AnNA of the limbs of a trisomy 18 human fetus strongly supports Pere Alberch's ill-named "logic of monsters" hypothesis, and contradicts the commonly accepted idea that birth defects often lead to lower integration (i.e. more parcellation) of anatomical structures.	[Diogo, Rui] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; [Diogo, Rui; Esteve-Altava, Borja; Smith, Christopher] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; [Esteve-Altava, Borja] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, Struct & Mot Lab, London, England; [Esteve-Altava, Borja; Rasskin-Gutman, Diego] Univ Valencia, Theoret Biol Res Grp, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Boughner, Julia C.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada	Howard University; Howard University; University of London; University of London Royal Veterinary College; University of Valencia; University of Saskatchewan	Diogo, R (corresponding author), Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA.	rui.diogo@howard.edu; boresal@uv.es; csmith55333@gmail.com; diego.rasskin@uv.es	Smith, Christopher M/AAH-1958-2021; Esteve-Altava, Borja/S-3092-2016	Smith, Christopher M/0000-0001-9259-1079; Esteve-Altava, Borja/0000-0002-6645-4684				Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Ackermann RR, 2002, J HUM EVOL, V43, P167, DOI 10.1006/jhev.2002.0569; Alberch P., 1989, Geobios Memoire Special (Villeurbanne), P21; [Anonymous], 2015, PREDICTABILITY DOES, V20, P260; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Barash B A, 1970, Birth Defects Orig Artic Ser, V6, P3; Bardeen CR, 1910, MANUAL HUMAN EMBRYOL, V1, P438; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Bastir M, 2013, AM J PHYS ANTHROPOL, V152, P287, DOI 10.1002/ajpa.22359; Bateson W., 1894, MAT STUDY VARIATION; Bello-Hellegouarch G, 2013, J MORPHOL, V274, P275, DOI 10.1002/jmor.20090; Buchanan M., 2003, NEXUS SMALL WORLDS G; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; Clack J. A., 2012, GAINING GROUND ORIGI; Coates Michael I., 2007, P15; Cornette R, 2013, J ANAT, V223, P329, DOI 10.1111/joa.12086; Crider KS, 2008, AM J MED GENET A, V146A, P820, DOI 10.1002/ajmg.a.32200; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Daston Lorraine, 2001, WONDERS ORDER NATURE; Diogo R, 2011, J ANAT, V219, P273, DOI 10.1111/j.1469-7580.2011.01403.x; Diogo R., 2012, COMP ANATOMY PHYLOGE; Diogo R, 2015, DEV DYNAM, V244, P1357, DOI 10.1002/dvdy.24336; Diogo R, 2014, J EXP ZOOL PART B, V322, P106, DOI 10.1002/jez.b.22552; Diogo R, 2014, J EXP ZOOL PART B, V322, P86, DOI 10.1002/jez.b.22549; Diogo R, 2013, BIOL REV, V88, P988, DOI 10.1111/brv.12039; Diogo R, 2013, BIOL REV, V88, P196, DOI 10.1111/j.1469-185X.2012.00247.x; Diogo R, 2012, EVOLUTION, V66, P3267, DOI 10.1111/j.1558-5646.2012.01621.x; Esteve-Altava B, 2015, ANATOMICAL NETWORK A, V18; Esteve-Altava B, 2015, J ANTHROPOL SCI, V93, P103, DOI 10.4436/JASS.93001; Esteve-Altava B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127653; Esteve-Altava B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08298; Fabrezi M, 2007, ANAT REC, V290, P900, DOI 10.1002/ar.20522; Gondre-Lewis MC, 2015, J ANAT, V227, P255, DOI 10.1111/joa.12343; Goswami A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000995; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Hallgrimsson B, 2002, YEARB PHYS ANTHROPOL, V45, P131, DOI 10.1002/ajpa.10182; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Hodin J, 2000, J EXP ZOOL, V288, P1; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Leroi A. M., 2005, MUTANTS GENETIC VARI; Lewton KL, 2012, EVOL BIOL, V39, P126, DOI 10.1007/s11692-011-9143-6; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Margulies EH, 2001, GENOME RES, V11, P1686, DOI 10.1101/gr.192601; Marroig G, 2001, EVOLUTION, V55, P2576; Marroig G, 2005, EVOLUTION, V59, P1128; Marroig G, 2009, EVOL BIOL, V36, P136, DOI 10.1007/s11692-009-9051-1; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Monteiro LR, 2005, EVOL DEV, V7, P429, DOI 10.1111/j.1525-142X.2005.05047.x; MOSS ML, 1969, AMER J ORTHODONTICS, V55, P566, DOI 10.1016/0002-9416(69)90034-7; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Pont SJ, 2006, AM J MED GENET A, V140A, P1749, DOI 10.1002/ajmg.a.31382; Porto A, 2013, EVOLUTION, V67, P3305, DOI 10.1111/evo.12177; Porto A, 2009, EVOL BIOL, V36, P118, DOI 10.1007/s11692-008-9038-3; Raff R. A., 1996, SHAPE LIFE GENES DEV; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; Rasskin-Gutman D, 2005, MODULARITY UNDERSTAN; Rasskin-Gutman Diego, 2014, Biological Theory, V9, P178, DOI 10.1007/s13752-014-0175-x; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reid SN, 2015, J ANAT, V227, P21, DOI 10.1111/joa.12326; Reno PL, 2013, J EXP ZOOL PART B, V320B, P276, DOI 10.1002/jez.b.22506; Rolian C, 2010, EVOLUTION, V64, P1558, DOI 10.1111/j.1558-5646.2010.00944.x; Rolian C, 2009, EVOL BIOL, V36, P100, DOI 10.1007/s11692-009-9049-8; Rolian C, 2009, J EXP BIOL, V212, P713, DOI 10.1242/jeb.019885; Ross CF, 2013, J HUM EVOL, V64, P56, DOI 10.1016/j.jhevol.2012.08.010; Roth VL, 1994, ORGANISMS REPLICATOR, P301; Rui DG, 2014, ANAT REC, V297, P1047, DOI 10.1002/ar.22919; Sears KE, 2015, EVOLUTION, V69, P2543, DOI 10.1111/evo.12773; SHAPIRO BL, 1983, AM J MED GENET, V14, P241, DOI 10.1002/ajmg.1320140206; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Smith C. M, 2015, MUSCULAR SKELETAL AN; Villmoare B, 2011, EVOL BIOL, V38, P88, DOI 10.1007/s11692-011-9108-9; Villmoare BA, 2014, J HUM EVOL, V77, P143, DOI 10.1016/j.jhevol.2014.06.014; Villmoare BA, 2011, P NATL ACAD SCI USA, V108, P16200, DOI 10.1073/pnas.1105844108; Wagner G, 2001, NATURAL SELECTION OR; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wagner Gunter P., 2007, P49; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Young NM, 2010, P NATL ACAD SCI USA, V107, P3400, DOI 10.1073/pnas.0911856107; Young NM, 2005, EVOLUTION, V59, P2691; Zelditch ML, 2008, EVOL DEV, V10, P756, DOI 10.1111/j.1525-142X.2008.00290.x; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	85	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140030	10.1371/journal.pone.0140030	http://dx.doi.org/10.1371/journal.pone.0140030			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452269	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200029
J	Song, N; Kim, N; Xiao, R; Choi, H; Chun, HI; Kang, MH; Kim, JH; Seo, K; Soundrarajan, N; Do, JT; Song, H; Ge, ZJ; Park, C				Song, Ning; Kim, Nameun; Xiao, Rui; Choi, Hojun; Chun, Hyo-Im; Kang, Min-Hee; Kim, Jin-Hoi; Seo, Kunho; Soundrarajan, Nagasundarapandian; Do, Jeong-Tae; Song, Hyuk; Ge, Zhao-Jia; Park, Chankyu			Lack of Cytosolic Carboxypeptidase 1 Leads to Subfertility due to the Reduced Number of Antral Follicles in pcd3J(-/-) Females	PLOS ONE			English	Article							PURKINJE-CELL-DEGENERATION; CEREBELLAR MUTANT MOUSE; NEUROLOGICAL MUTATION; RETINAL DEGENERATION; THALAMIC NEURONS; OVARIAN RESERVE; ALPHA-TUBULIN; MICE REVEALS; POLYGLUTAMYLATION; GENE	Females homozygous for the Purkinje cell degeneration mutation (pcd) are fertile, although the success rate is much lower than in the wild type. We performed detailed analysis of reproductive abnormalities of pcd females. The number of oocytes produced following exogenous gonadotropin treatment was much lower in pcd(3J-/-) females than in pcd(3J+/+) females. Furthermore, the estrous cyclicity of pcd3(J-/-) females according to the appearance of the vagina was almost undetectable comparing to that of the wild type. Histological analyses and follicle counting of 4- and 8-week-old pcd3(J-/-) ovaries showed an increase in the number of secondary follicles and a decrease in the number of antral follicles, indicating that AGTPBP1/CCP1 plays an important role in the development of secondary follicles into antral follicles. Consistent with a previous analysis of the pcd cerebellum, pcd(3J-/-) ovaries also showed a clear increase in the level of polyglutamylation. Gene expression analysis showed that both oocytes and cumulus cells express CCP1. However, Ccp4 and CCP6, which can compensate the function of CCP1, were not expressed in mouse ovaries. Failure of microtubule deglutamylation did not affect the structure and function of the meiotic spindle in properly aligning chromosomes in the center of the nucleus during meiosis in pcd3(J-/-) females. We also showed that the pituitary-derived growth and reproduction-related endocrine system functions normally in pcd(3J-/-) mice. The results of this study provide insight into additional functions of CCP1, which cannot be fully explained by the side chain deglutamylation of microtubules alone.	[Song, Ning; Kim, Nameun; Xiao, Rui; Choi, Hojun; Chun, Hyo-Im; Kang, Min-Hee; Kim, Jin-Hoi; Soundrarajan, Nagasundarapandian; Do, Jeong-Tae; Song, Hyuk; Park, Chankyu] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea; [Seo, Kunho] Konkuk Univ, Coll Vet Med, Seoul, South Korea; [Ge, Zhao-Jia] Qingdao Agr Univ, Coll Anim Sci & Vet Med, Qingdao, Peoples R China	Konkuk University; Konkuk University; Qingdao Agricultural University	Park, C (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea.	chankyu@konkuk.ac.kr	Kang, Min-hee/AAW-8491-2020; Park, Chankyu/D-8775-2011; Seo, Kun-Ho/AAQ-2666-2020	Do, Jeong Tae/0000-0001-6721-1441; kim, jin-hoi/0000-0003-1232-5307; Park, Chankyu/0000-0003-4855-2210	Cooperative Research Program for Agriculture Science & Technology Development [PJ009103]; Next-Generation BioGreen 21, Rural Development Administration, Republic of Korea [PJ01113003]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A1009701]; KU Brain Pool of Konkuk University [2014KUBP]	Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Next-Generation BioGreen 21, Rural Development Administration, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; KU Brain Pool of Konkuk University	This work was supported by grants from the Cooperative Research Program for Agriculture Science & Technology Development (No. PJ009103) and the Next-Generation BioGreen 21 (No. PJ01113003), Rural Development Administration, Republic of Korea, and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2015R1A5A1009701). Nagasundarapandian Soundrarajan was supported by the 2014 KU Brain Pool of Konkuk University (2014KUBP).	Baltanas FC, 2011, J BIOL CHEM, V286, P28287, DOI 10.1074/jbc.M111.246041; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; Berezniuk I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060981; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Brown C, 2010, BIOL REPROD, V82, P246, DOI 10.1095/biolreprod.109.077925; Campbell PK, 2002, GENETICS, V162, P307; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Otazo MRD, 2013, FASEB J, V27, P424, DOI 10.1096/fj.12-209080; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; HANDEL MA, 1981, GAMETE RES, V4, P185, DOI 10.1002/mrd.1120040303; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kann ML, 2003, CELL MOTIL CYTOSKEL, V55, P14, DOI 10.1002/cm.10107; Kim N, 2011, MOL CELLS, V31, P39, DOI 10.1007/s10059-011-0002-1; KRULEWSKI TF, 1989, P NATL ACAD SCI USA, V86, P3709, DOI 10.1073/pnas.86.10.3709; Kyuhou S, 2006, NEUROSCI LETT, V396, P91, DOI 10.1016/j.neulet.2005.11.023; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Monget P, 2012, MOL CELL ENDOCRINOL, V356, P2, DOI 10.1016/j.mce.2011.07.046; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; OGORMAN S, 1985, J COMP NEUROL, V234, P277, DOI 10.1002/cne.902340302; OGORMAN S, 1985, J COMP NEUROL, V234, P298, DOI 10.1002/cne.902340303; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Shang YH, 2002, J CELL BIOL, V158, P1195, DOI 10.1083/jcb.200205101; Tanco S, 2015, MOL CELL PROTEOMICS, V14, P177, DOI 10.1074/mcp.M114.040360; Valero J, 2006, MOL CELL NEUROSCI, V33, P283, DOI 10.1016/j.mcn.2006.08.002; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wu HY, 2012, FASEB J, V26, P4468, DOI 10.1096/fj.12-205047; Xiao R, 2005, MOL CELLS, V20, P219	45	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139557	10.1371/journal.pone.0139557	http://dx.doi.org/10.1371/journal.pone.0139557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452267	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200013
J	Jatho, A; Hartmann, S; Kittana, N; Mugge, F; Wuertz, CM; Tiburcy, M; Zimmermann, WH; Katschinski, DM; Lutz, S				Jatho, Aline; Hartmann, Svenja; Kittana, Naim; Muegge, Felicitas; Wuertz, Christina M.; Tiburcy, Malte; Zimmermann, Wolfram-Hubertus; Katschinski, Doerthe M.; Lutz, Susanne			RhoA Ambivalently Controls Prominent Myofibroblast Characteritics by Involving Distinct Signaling Routes	PLOS ONE			English	Article							GENE-EXPRESSION; CARDIAC FIBROBLASTS; ALPHA-TUBULIN; GROWTH; TISSUE; PROTEIN; ACETYLATION; ACTIVATION; INHIBITION; CELLS	Introduction RhoA has been shown to be beneficial in cardiac disease models when overexpressed in cardiomyocytes, whereas its role in cardiac fibroblasts (CF) is still poorly understood. During cardiac remodeling CF undergo a transition towards a myofibroblast phenotype thereby showing an increased proliferation and migration rate. Both processes involve the remodeling of the cytoskeleton. Since RhoA is known to be a major regulator of the cytoskeleton, we analyzed its role in CF and its effect on myofibroblast characteristics in 2 D and 3D models. Results Downregulation of RhoA was shown to strongly affect the actin cytoskeleton. It decreased the myofibroblast marker alpha-sm-actin, but increased certain fibrosis-associated factors like TGF-beta and collagens. Also, the detailed analysis of CTGF expression demonstrated that the outcome of RhoA signaling strongly depends on the involved stimulus. Furthermore, we show that proliferation of myofibroblasts rely on RhoA and tubulin acetylation. In assays accessing three different types of migration, we demonstrate that RhoA/ROCK/Dia1 are important for 2D migration and the repression of RhoA and Dia1 signaling accelerates 3D migration. Finally, we show that a downregulation of RhoA in CF impacts the viscoelastic and contractile properties of engineered tissues. Conclusion RhoA positively and negatively influences myofibroblast characteristics by differential signaling cascades and depending on environmental conditions. These include gene expression, migration and proliferation. Reduction of RhoA leads to an increased viscoelasticity and a decrease in contractile force in engineered cardiac tissue.	[Jatho, Aline; Hartmann, Svenja; Kittana, Naim; Muegge, Felicitas; Wuertz, Christina M.; Tiburcy, Malte; Zimmermann, Wolfram-Hubertus; Lutz, Susanne] Univ Gottingen, Univ Med Ctr Gottingen, Inst Pharmacol, Gottingen, Germany; [Jatho, Aline; Katschinski, Doerthe M.] Univ Gottingen, Univ Med Ctr Gottingen, Dept Cardiovasc Physiol, Gottingen, Germany; [Jatho, Aline; Hartmann, Svenja; Wuertz, Christina M.; Tiburcy, Malte; Zimmermann, Wolfram-Hubertus; Katschinski, Doerthe M.; Lutz, Susanne] DZHK German Ctr Cardiovasc Res, Munich, Germany; [Hartmann, Svenja] Kings Coll London, Div Cell & Mol Biophys, London WC2R 2LS, England	University of Gottingen; University of Gottingen; German Centre for Cardiovascular Research; University of London; King's College London	Lutz, S (corresponding author), Univ Gottingen, Univ Med Ctr Gottingen, Inst Pharmacol, Gottingen, Germany.	Susanne.Lutz@med.uni-goettingen.de	Zimmermann, Wolfram-Hubertus H/I-6838-2012; Kittana, Naim/AID-6786-2022	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; Kittana, Naim/0000-0003-2758-271X	Deutsche Forschungsgemeinschaft [Lu1486/1-1, SFB 1002, IRTG 1816]; German Research Council (DFG) [ZE 708/7-1, ZE 708/8-1, ZE 708/10-1, SFB 937A18]; German Federal Ministry for Science and Education [DZHK 13GW0007A]; National Institute of Health [U01 HL099997]; German Academic Exchange Service (DAAD); German Research Foundation; Open Access Publication Funds of the Gottingen University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099997] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Council (DFG)(German Research Foundation (DFG)); German Federal Ministry for Science and Education; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was financially supported by the Deutsche Forschungsgemeinschaft grants Lu1486/1-1 (to SL), SFB 1002 (to AJ, SL and WHZ), IRTG 1816 (to SH and FM), German Research Council (DFG ZE 708/7-1, 8-1, 10-1) (to WHZ), SFB 937A18 (to WHZ), German Federal Ministry for Science and Education (DZHK 13GW0007A) (to WHZ), National Institute of Health (U01 HL099997) (to WHZ). NK was funded by the German Academic Exchange Service (DAAD). The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Aguilar A, 2014, MOL BIOL CELL, V25, P1854, DOI 10.1091/mbc.E13-10-0609; Bei Y, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.105; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Cavin S, 2014, BBA-MOL CELL RES, V1843, P335, DOI 10.1016/j.bbamcr.2013.11.008; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cheng JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126532; Copaja M, 2011, TOXICOL APPL PHARM, V255, P57, DOI 10.1016/j.taap.2011.05.016; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Gradilone SA, 2013, CANCER RES, V73, P2259, DOI 10.1158/0008-5472.CAN-12-2938; Hayata N, 2008, BIOCHEM BIOPH RES CO, V370, P274, DOI 10.1016/j.bbrc.2008.03.100; He JC, 2008, INVEST OPHTH VIS SCI, V49, P2936, DOI 10.1167/iovs.07-0900; Heegaard AM, 2004, J CELL BIOCHEM, V93, P463, DOI 10.1002/jcb.20189; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; Hirabayashi T, 2000, EUR J BIOCHEM, V267, P2525, DOI 10.1046/j.1432-1327.2000.01258.x; Huang ZH, 2006, AM J PHYSIOL-LUNG C, V290, pL1291, DOI 10.1152/ajplung.00443.2005; Koch G, 1997, J PHARMACOL EXP THER, V283, P901; Lavall D, 2014, J BIOL CHEM, V289, P6656, DOI 10.1074/jbc.M113.519256; Leask A, 2008, J CELL COMMUN SIGNAL, V2, P47, DOI 10.1007/s12079-008-0027-1; Lu D, 2014, AM J PHYSIOL-CELL PH, V306, pC779, DOI 10.1152/ajpcell.00381.2013; Miyasato SK, 2011, MATRIX BIOL, V30, P318, DOI 10.1016/j.matbio.2011.05.003; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, P10; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Mun JH, 2014, WOUND REPAIR REGEN, V22, P125, DOI 10.1111/wrr.12136; Nakakura T, 2015, MED MOL MORPHOL, V48, P44, DOI 10.1007/s00795-014-0076-x; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, P1; Porter KE, 2004, CARDIOVASC RES, V61, P745, DOI 10.1016/j.cardiores.2003.11.032; Schram K, 2011, ENDOCRINOLOGY, V152, P2037, DOI 10.1210/en.2010-1166; Sixt M, 2012, J CELL BIOL, V197, P346, DOI 10.1083/jcb.201204039; Skrbic B, 2015, CARDIOVASC RES, V106, P32, DOI 10.1093/cvr/cvv041; Sun Y, 2000, J LAB CLIN MED, V135, P316, DOI 10.1067/mlc.2000.105971; Taglieri DM, 2014, J MOL CELL CARDIOL, V66, P27, DOI 10.1016/j.yjmcc.2013.10.010; Tsoutsman T, 2013, J MOL CELL CARDIOL, V62, P164, DOI 10.1016/j.yjmcc.2013.05.019; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; WEBSTER KA, 1993, J BIOL CHEM, V268, P16852; Woan KV, 2015, MOL ONCOL, V24; Xiang SY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004405; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Zilberman Y, 2011, MOL BIOL CELL, V22, P2900, DOI 10.1091/mbc.E11-01-0007	44	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0137519	10.1371/journal.pone.0137519	http://dx.doi.org/10.1371/journal.pone.0137519			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448568	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000003
J	de Vries, ST; de Vries, FM; Dekker, T; Haaijer-Ruskamp, FM; de Zeeuw, D; Ranchor, AV; Denig, P				de Vries, Sieta T.; de Vries, Folgerdiena M.; Dekker, Thijs; Haaijer-Ruskamp, Flora M.; de Zeeuw, Dick; Ranchor, Adelita V.; Denig, Petra			The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes	PLOS ONE			English	Article							HEALTH OUTCOME PRIORITIZATION; WILLINGNESS-TO-PAY; OLDER PERSONS; DECISION-MAKING; ANTIHYPERTENSIVE DRUGS; CONJOINT-ANALYSIS; MEDICATION; CARE; ADHERENCE; PHYSICIANS	Objectives To assess whether patients' willingness to add a blood pressure-lowering drug and the importance they attach to specific treatment characteristics differ among age groups in patients with type 2 diabetes. Materials and Methods Patients being prescribed at least an oral glucose-lowering and a blood pressure-lowering drug completed a questionnaire including a discrete choice experiment. This experiment contained choice sets with hypothetical blood pressure-lowering drugs and a no additional drug alternative, which differed in their characteristics (i.e. effects and intake moments). Differences in willingness to add a drug were compared between patients <75 years (non-aged) and >= 75 years (aged) using Pearson chi(2)-tests. Multinomial logit models were used to assess and compare the importance attached to the characteristics. Results Of the 161 patients who completed the questionnaire, 151 (72%) could be included in the analyses (mean age 68 years; 42% female). Aged patients were less willing to add a drug than non-aged patients (67% versus 84% respectively; P = 0.017). In both age groups, the effect on blood pressure was most important for choosing a drug, followed by the risk of adverse drug events and the risk of death. The effect on limitations due to stroke was only significant in the non-aged group. The effect on blood pressure was slightly more important in the non-aged than the aged group (P = 0.043). Conclusions Aged patients appear less willing to add a preventive drug than non-aged patients. The importance attached to various treatment characteristics does not seem to differ much among age groups.	[de Vries, Sieta T.; de Vries, Folgerdiena M.; Haaijer-Ruskamp, Flora M.; de Zeeuw, Dick; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Dekker, Thijs] Univ Leeds, Inst Transport Studies, Leeds LS2 9JT, W Yorkshire, England; [Ranchor, Adelita V.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands	University of Groningen; University of Leeds; University of Groningen	Denig, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	p.denig@umcg.nl	Ranchor, Adelita/X-5725-2019; Dekker, Thijs/M-7763-2013; de Zeeuw, Dick/E-9080-2014; Denig, Petra/L-9865-2014	Ranchor, Adelita/0000-0001-7048-3771; Dekker, Thijs/0000-0003-2313-8419; de Zeeuw, Dick/0000-0003-3434-7777; Denig, Petra/0000-0002-7929-4739; de Vries, Sieta/0000-0001-6090-2434	Research Institute SHARE, University Medical Center Groningen, Groningen, The Netherlands	Research Institute SHARE, University Medical Center Groningen, Groningen, The Netherlands	The study was funded by the Research Institute SHARE, University Medical Center Groningen, Groningen, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ADV PSYHIATRIC TREAT, DOI DOI 10.1192/APT.BP.106.003194; [Anonymous], 2014, STERFT KERNC NAAR DI; Aristides M, 2004, VALUE HEALTH, V7, P442, DOI 10.1111/j.1524-4733.2004.74007.x; Benson J, 2002, BRIT MED J, V325, P873, DOI 10.1136/bmj.325.7369.873; Brown TM, 2011, HAEMOPHILIA, V17, P476, DOI 10.1111/j.1365-2516.2010.02401.x; Cantril H., 1965, PATTERN HUMAN CONCER; Carter BL, 2014, J CLIN HYPERTENS, V16, P115, DOI 10.1111/jch.12238; Chan DC, 2012, ARCH GERONTOL GERIAT, V54, P168, DOI 10.1016/j.archger.2011.02.005; Chin MH, 2008, MED CARE, V46, P275, DOI 10.1097/MLR.0b013e318158af40; Darba J, 2011, OSTEOPOROSIS INT, V22, P1947, DOI 10.1007/s00198-010-1382-3; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; de Vries ST, 2014, J PSYCHOSOM RES, V76, P134, DOI 10.1016/j.jpsychores.2013.11.003; DiBonaventura MD, 2010, PATIENT PREFER ADHER, V4, P397, DOI 10.2147/PPA.S14477; Fried TR, 2007, J GEN INTERN MED, V22, P495, DOI 10.1007/s11606-007-0104-9; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Fried TR, 2011, ARCH INTERN MED, V171, P923, DOI 10.1001/archinternmed.2011.32; Fried TR, 2011, PATIENT EDUC COUNS, V83, P278, DOI 10.1016/j.pec.2010.04.032; Gascon JJ, 2004, FAM PRACT, V21, P125, DOI 10.1093/fampra/cmh202; Hauber AB, 2009, DIABETIC MED, V26, P416, DOI 10.1111/j.1464-5491.2009.02696.x; Hauber AB, 2014, PROSTATE, V74, P1488, DOI 10.1002/pros.22865; Hauber AB, 2013, PATIENT PREFER ADHER, V7, P937, DOI 10.2147/PPA.S43465; Herbild L, 2009, VALUE HEALTH, V12, P560, DOI 10.1111/j.1524-4733.2008.00465.x; Hiligsmann M, 2013, PATIENT PREFER ADHER, V7, P133, DOI 10.2147/PPA.S38408; Hoyos D, 2010, ECOL ECON, V69, P1595, DOI 10.1016/j.ecolecon.2010.04.011; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Johnson MD, 2013, GEN HOSP PSYCHIAT, V35, P59, DOI 10.1016/j.genhosppsych.2012.08.003; Kauf TL, 2012, PATIENT, V5, P265, DOI 10.2165/11633580-000000000-00000; Kellett N, 2006, BRIT J DERMATOL, V154, P524, DOI 10.1111/j.1365-2133.2005.07047.x; Kimman ML, 2010, ACTA ONCOL, V49, P328, DOI 10.3109/02841860903536002; Laba TL, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4501; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Lewanczuk R, 2007, CAN J CARDIOL, V23, P573, DOI 10.1016/S0828-282X(07)70803-6; Milte R, 2014, VALUE HEALTH, V17, P655, DOI 10.1016/j.jval.2014.05.005; NICE National Institute for Health and Care Excellence, HYPERTENSION; Polster Michael, 2010, J Med Econ, V13, P655, DOI 10.3111/13696998.2010.529377; Porzsolt F, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-125; Proeftuin farmacie Groningen, HYPERTENSIE; Ryan M, 2004, BMJ-BRIT MED J, V328, P360, DOI 10.1136/bmj.328.7436.360; Ryan M, 2009, HEALTH ECON, V18, P321, DOI 10.1002/hec.1369; Sarkisian CA, 2002, J AM GERIATR SOC, V50, P1837, DOI 10.1046/j.1532-5415.2002.50513.x; Scalone L, 2011, SEX TRANSM DIS, V38, P802, DOI 10.1097/OLQ.0b013e318218702c; Shafey M, 2011, BONE MARROW TRANSPL, V46, P962, DOI 10.1038/bmt.2010.225; Sherbourne CD, 1999, GERONTOLOGIST, V39, P271, DOI 10.1093/geront/39.3.271; Stack RJ, 2011, DIABETES METAB SYNDR, V4, P127, DOI 10.2147/DMSO.S17444; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steel N, 2000, BRIT MED J, V320, P1446, DOI 10.1136/bmj.320.7247.1446; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Tsevat J, 1998, JAMA-J AM MED ASSOC, V279, P371, DOI 10.1001/jama.279.5.371; van Hateren KJJ, 2012, INT J CLIN PRACT, V66, P125, DOI 10.1111/j.1742-1241.2011.02841.x; van Hateren KJJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001387; Verenso, 2011, MULT RICHTL DIAB VER; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Viney Rosalie, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P319, DOI 10.1586/14737167.2.4.319; Zanchetti A, 2002, J HYPERTENS, V20, P2099, DOI 10.1097/00004872-200211000-00001	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139755	10.1371/journal.pone.0139755	http://dx.doi.org/10.1371/journal.pone.0139755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26445349	gold, Green Published			2022-12-26	WOS:000362510600076
J	Lin, KL; Lin, JJ; Hsia, SH; Chou, ML; Hung, PC; Wang, HS				Lin, Kuang-Lin; Lin, Jainn-Jim; Hsia, Shao-Hsuan; Chou, Min-Liang; Hung, Po-Cheng; Wang, Huei-Shyong		CHEESE Study Grp	Effect of Antiepileptic Drugs for Acute and Chronic Seizures in Children with Encephalitis	PLOS ONE			English	Article							CONVULSIVE STATUS EPILEPTICUS; REFRACTORY STATUS EPILEPTICUS; REPETITIVE PARTIAL SEIZURES; POSTENCEPHALITIC EPILEPSY; DEFINITION; MANAGEMENT; CHILDHOOD; THERAPIES; EFFICACY; TAIWAN	Background Encephalitis presents with seizures in the acute phase and increases the risk of late unprovoked seizures and epilepsy. This study aimed to evaluate the effect of antiepileptic drugs in pediatric patients with acute seizures due to encephalitis and epilepsy. Patients and Methods Cases of acute pediatric encephalitis between January 2000 and December 2010 were reviewed. Clinical data, including onset at age, seizure type, seizure frequency, effects of antiepileptic drugs, and prognosis were analyzed. Results During the study period, 1038 patients (450 girls, 588 boys) were enrolled. Among them, 44.6% (463) had seizures in the acute phase, 33% had status epilepticus, and 26% (251) developed postencephalitic epilepsy. At one year of follow-up, 205 of the 251 patients with postencephalitic epilepsy were receiving antiepileptic drugs while 18% were seizure free even after discontinuing the antiepileptic drugs. Among those with postencephalitic epilepsy, 67% had favorable outcomes and were using <2 anti-epileptic drugs while 15% had intractable seizures and were using >= 2 antiepileptic drugs. After benzodiazepines, intravenous phenobarbital was preferred over phenytoin as treatment of postencephalitic seizures in the acute phase. For refractory status epilepticus, high-dose topiramate combined with intravenous high-dose phenobarbital or high-dose lidocaine had less side effects. Conclusions Children with encephalitis have a high rate of postencephalitic epilepsy. Phenobarbital and clonazepam are the most common drugs used, alone or in combination, for postencephalitic epilepsy.	[Lin, Kuang-Lin; Lin, Jainn-Jim; Chou, Min-Liang; Hung, Po-Cheng; Wang, Huei-Shyong] Chang Gung Childrens Hosp, Div Pediat Neurol, Taoyuan, Taiwan; [Lin, Kuang-Lin; Lin, Jainn-Jim; Hsia, Shao-Hsuan; Chou, Min-Liang; Hung, Po-Cheng; Wang, Huei-Shyong] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Taoyuan, Taiwan; [Lin, Kuang-Lin; Lin, Jainn-Jim; Hsia, Shao-Hsuan; Chou, Min-Liang; Hung, Po-Cheng; Wang, Huei-Shyong; CHEESE Study Grp] Chang Gung Childrens Hosp, Study Grp Children Encephalitis Encephalopathy Re, Taoyuan, Taiwan; [Lin, Jainn-Jim; Hsia, Shao-Hsuan] Chang Gung Childrens Hosp, Div Pediat Crit Care & Emergency Med, Taoyuan, Taiwan; [Lin, Jainn-Jim] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, KL (corresponding author), Chang Gung Childrens Hosp, Div Pediat Neurol, Taoyuan, Taiwan.	lincgh@cgmh.org.tw			Chang Gung Memorial Hospital, Taiwan [CMRPG4C0022]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The work was supported by grants from Chang Gung Memorial Hospital (grant: CMRPG4C0022), Taiwan(https://www.cgmh.org.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEGERS JF, 1988, NEUROLOGY, V38, P1407, DOI 10.1212/WNL.38.9.1407; AWAYA Y, 1982, Folia Psychiatrica et Neurologica Japonica, V36, P338; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fowler A, 2010, PEDIATRICS, V126, pE828, DOI 10.1542/peds.2009-3188; Getts DR, 2008, J NEUROCHEM, V104, P1167, DOI 10.1111/j.1471-4159.2007.05171.x; Ismail S, 2012, AM J EMERG MED, V30, P2000, DOI 10.1016/j.ajem.2011.11.007; Kramer U, 2011, EPILEPSIA, V52, P1956, DOI 10.1111/j.1528-1167.2011.03250.x; Lee WT, 2007, EUR J PAEDIATR NEURO, V11, P302, DOI 10.1016/j.ejpn.2007.02.011; Lin JJ, 2008, EUR J PAEDIATR NEURO, V12, P32, DOI 10.1016/j.ejpn.2007.05.007; Lin JJ, 2012, PEDIATR NEUROL, V47, P252, DOI 10.1016/j.pediatrneurol.2012.06.013; Lin JJ, 2011, EPILEPSIA, V52, P1979, DOI 10.1111/j.1528-1167.2011.03218.x; Lin JJ, 2010, PEDIATR NEUROL, V43, P41, DOI 10.1016/j.pediatrneurol.2010.02.017; Lin JJ, 2009, BRAIN DEV-JPN, V31, P605, DOI 10.1016/j.braindev.2008.09.010; Lin KL, 2009, PEDIATR NEUROL, V41, P413, DOI 10.1016/j.pediatrneurol.2009.06.004; Major P, 2007, PEDIATR REV, V28, P405, DOI 10.1542/pir.28-11-405; Michael BD, 2012, EPILEPSIA, V53, P63, DOI 10.1111/j.1528-1167.2012.03615.x; Misra UK, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01751.x; Moon SY, 2008, EUR J NEUROL, V15, P38, DOI [10.1111/j.1468-1331.2007.01997.x, 10.1111/j.1468-1331.2008.02269.x]; Nabbout R, 2010, EPILEPSIA, V51, P2033, DOI 10.1111/j.1528-1167.2010.02703.x; Rosman N P, 1985, Pediatr Neurol, V1, P278; Saito Y, 2007, BRAIN DEV-JPN, V29, P147, DOI 10.1016/j.braindev.2006.08.005; Sakuma Hiroshi, 2001, No To Hattatsu, V33, P385; Scott RC, 2007, LANCET, V370, P724, DOI 10.1016/S0140-6736(07)61357-9; Shorvon S, 2011, BRAIN, V134, P2802, DOI 10.1093/brain/awr215; Singh TD, 2015, EPILEPSIA, V56, P133, DOI 10.1111/epi.12879; Sugai K, 2007, ACTA NEUROL SCAND, V115, P62, DOI 10.1111/j.1600-0404.2007.00811.x; Tan RYL, 2010, EPILEPSY RES, V91, P111, DOI 10.1016/j.eplepsyres.2010.07.015; Wheless JW, 2010, SEMIN PEDIATR NEUROL, V17, P190, DOI 10.1016/j.spen.2010.06.007; YOSHIOKA M, 1989, Acta Paediatrica Japonica, V31, P480	31	6	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139974	10.1371/journal.pone.0139974	http://dx.doi.org/10.1371/journal.pone.0139974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444013	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600115
J	Nishina, K; Takagishi, H; Inoue-Murayama, M; Takahashi, H; Yamagishi, T				Nishina, Kuniyuki; Takagishi, Haruto; Inoue-Murayama, Miho; Takahashi, Hidehiko; Yamagishi, Toshio			Polymorphism of the Oxytocin Receptor Gene Modulates Behavioral and Attitudinal Trust among Men but Not Women	PLOS ONE			English	Article							INTERPERSONAL-TRUST; OXTR POLYMORPHISM; MATERNAL-BEHAVIOR; HUMANS; NEUROBIOLOGY; ATTACHMENT; INTERACT; AMYGDALA; STRESS	A relationship between the oxytocin receptor gene (OXTR) and behavioral and attitudinal trust has been suggested, but the nature of this relationship has not yet been established. We obtained behavioral trust data from 470 Japanese participants (242 women) aged 2059 years, together with their levels of general trust and personality traits (NEO-FFI). Saliva buccal swabs were collected from 411 of these 470 participants and used for genotyping of OXTR rs53576. Our participants were found to have more AA alleles (40%) than GG alleles (12%). The GG men were more trusting and also rated higher on attitudinal trust than AA men, and this difference did not diminish when personality traits were controlled for. However, this pattern was not observed among women. In addition, controlling for attitudinal trust reduced the difference in behavioral trust among men to a non-significant level, but the difference in attitudinal trust remained significant when behavioral trust was controlled. These results indicate that the OXTR genotype affects attitudinal trust as part of an individual's relatively stable disposition, and further affects behavioral trust through changes in attitudinal trust.	[Nishina, Kuniyuki] Tamagawa Univ, Grad Sch Brain Sci, Tokyo, Japan; [Takagishi, Haruto; Takahashi, Hidehiko; Yamagishi, Toshio] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Takahashi, Hidehiko] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Yamagishi, Toshio] Hitotsubashi Univ, Grad Sch Int Corp Strategy, Tokyo, Japan	Kyoto University; Kyoto University; Hitotsubashi University	Yamagishi, T (corresponding author), Tamagawa Univ, Brain Sci Inst, Tokyo, Japan.	yamagishitoshio@gmail.com	Takagishi, Haruto/AFR-1157-2022	NISHINA, Kuniyuki/0000-0002-1250-0147; Takahashi, Hidehiko/0000-0002-5102-1982	Japan Society for the Promotion of Scientific Grant [25118004, 23223003]; Grants-in-Aid for Scientific Research [15H05730] Funding Source: KAKEN	Japan Society for the Promotion of Scientific Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by Japan Society for the Promotion of Scientific Grant #25118004 and #23223003 https://www.jsps.go.jp/english/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Barber B, 1983, LOGIC LIMITS TRUST; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Chen FS, 2011, P NATL ACAD SCI USA, V108, P19937, DOI 10.1073/pnas.1113079108; Costa PT, 2007, REVISED NEO PERSONAL; Crockford C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00068; Domes G, 2007, BIOL PSYCHIAT, V62, P1187, DOI 10.1016/j.biopsych.2007.03.025; Hiraishi K, 2008, EVOL HUM BEHAV, V29, P79, DOI 10.1016/j.evolhumbehav.2007.07.004; INOUE T, 1994, J BIOL CHEM, V269, P32451; Insel TR, 1997, AM J PSYCHIAT, V154, P726; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; Koscik TR, 2011, NEUROPSYCHOLOGIA, V49, P602, DOI 10.1016/j.neuropsychologia.2010.09.023; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krueger F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00004; Mikolajczak M, 2010, PSYCHOL SCI, V21, P1072, DOI 10.1177/0956797610377343; Ohtsubo Y, 2014, PERS INDIV DIFFER, V69, P182, DOI 10.1016/j.paid.2014.05.033; Oskarsson S, 2012, TWIN RES HUM GENET, V15, P21, DOI 10.1375/twin.15.1.21; PEDERSEN CA, 1979, P NATL ACAD SCI USA, V76, P6661, DOI 10.1073/pnas.76.12.6661; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rothstein B, 2005, WORLD POLIT, V58, P41, DOI 10.1353/wp.2006.0022; ROTTER JB, 1980, AM PSYCHOL, V35, P1, DOI 10.1037/0003-066X.35.1.1; Sturgis P, 2010, POLIT BEHAV, V32, P205, DOI 10.1007/s11109-009-9101-5; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Van Lange PAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093880; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yamagishi T, 2011, WORLD POLITICS; Yamagishi T, 2014, PSYCHOL SCI, V25, P1699, DOI 10.1177/0956797614538065; Yao SX, 2014, INT J NEUROPSYCHOPH, V17, P1785, DOI 10.1017/S146114571400090X; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zhong SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051095	40	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137089	10.1371/journal.pone.0137089	http://dx.doi.org/10.1371/journal.pone.0137089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444016	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600007
J	Kumar, M; Govindan, S; Zhang, MJ; Khairallah, RJ; Martin, JL; Sadayappan, S; de Tombe, PP				Kumar, Mohit; Govindan, Suresh; Zhang, Mengjie; Khairallah, Ramzi J.; Martin, Jody L.; Sadayappan, Sakthivel; de Tombe, Pieter P.			Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAINS; KINASE-A; CALCIUM SENSITIVITY; STRIATED-MUSCLE; THIN-FILAMENTS; HYPERTROPHIC CARDIOMYOPATHY; FORCE; MUTATION; IMPACT; TITIN	beta-Adrenergic stimulation in heart leads to increased contractility and lusitropy via activation of protein kinase A (PKA). In the cardiac sarcomere, both cardiac myosin binding protein C (cMyBP-C) and troponin-I (cTnI) are prominent myofilament targets of PKA. Treatment of permeabilized myocardium with PKA induces enhanced myofilament length-dependent activation (LDA), the cellular basis of the Frank-Starling cardiac regulatory mechanism. It is not known, however, which of these targets mediates the altered LDA and to what extent. Here, we employed two genetic mouse models in which the three PKA sites in cMyBP-C were replaced with either phospho-mimic (DDD) or phospho-null (AAA) residues. AAA-or DDD-permeabilized myocytes (n = 12-17) were exchanged (similar to 93%) for recombinant cTnI in which the two PKA sites were mutated to either phosphomimic (DD) or phospho-null (AA) residues. Force-[Ca2+] relationships were determined at two sarcomere lengths (SL = 1.9 mu m and SL = 2.3 mu m). Data were fit to a modified Hill equation for each individual cell preparation at each SL. LDA was indexed as Delta EC50, the difference in [Ca2+] required to achieve 50% force activation at the two SLs. We found that PKA-mediated phosphorylation of cMyBP-C and cTnI each independently contribute to enhance myofilament length-dependent activation properties of the cardiac sarcomere, with relative contributions of similar to 67 and similar to 33% for cMyBP-C for cTnI, respectively. We conclude that beta-adrenergic stimulation enhances the Frank-Starling regulatory mechanism predominantly via cMyBP-C PKA-mediated phosphorylation. We speculate that this molecular mechanism enhances cross-bridge formation at long SL while accelerating cross-bridge detachment and relaxation at short SLs.	[Kumar, Mohit; Govindan, Suresh; Zhang, Mengjie; Khairallah, Ramzi J.; Martin, Jody L.; Sadayappan, Sakthivel; de Tombe, Pieter P.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL 60153 USA	Loyola University Chicago	de Tombe, PP (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, 2160 S First Ave, Maywood, IL 60153 USA.	pdetombe@luc.edu	Kumar, Mohit/AAM-6405-2021; Regan, Clinton/E-6250-2012	Kumar, Mohit/0000-0002-3554-0563; Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health [HL62426, HL101297, HL75494, HL105826, HL114749, HL120643]; American Hearth Association [13POST14720024, 14GRNT20490025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075494, P30HL101297, F32HL120643, K02HL114749, P01HL062426, R01HL105826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearth Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL62426, HL101297, and HL75494 (to P. P. d T), HL105826 and HL114749 (to S. S.), and HL120643 (to R. K.). This work was also supported by American Hearth Association Grants 13POST14720024 (to S. G.) and 14GRNT20490025 (to S. S). The authors declare that they have no conflicts of interest with the contents of this article.	Barefield D, 2015, J MOL CELL CARDIOL, V79, P234, DOI 10.1016/j.yjmcc.2014.11.018; Belin RJ, 2011, PFLUG ARCH EUR J PHY, V462, P795, DOI 10.1007/s00424-011-1024-4; Belknap B, 2014, BIOCHEMISTRY-US, V53, P6717, DOI 10.1021/bi500787f; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D; Burgoyne T, 2008, CARDIOVASC RES, V77, P707, DOI 10.1093/cvr/cvm117; Cazorla O, 2006, CARDIOVASC RES, V69, P370, DOI 10.1016/j.cardiores.2005.11.009; Cazorla O, 2001, CIRC RES, V88, P1028, DOI 10.1161/hh1001.090876; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Cheng YH, 2014, BIOPHYS J, V107, P1675, DOI 10.1016/j.bpj.2014.08.008; Cingolani HE, 2013, AM J PHYSIOL-HEART C, V304, pH175, DOI 10.1152/ajpheart.00508.2012; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; deTombe PP, 1996, AM J PHYSIOL-HEART C, V271, pH73, DOI 10.1152/ajpheart.1996.271.1.H73; Dobesh DP, 2002, AM J PHYSIOL-HEART C, V282, pH1055, DOI 10.1152/ajpheart.00667.2001; Fan DS, 1997, CIRCULATION, V95, P2312, DOI 10.1161/01.CIR.95.9.2312; Hanft LM, 2013, J PHYSIOL-LONDON, V591, P4535, DOI 10.1113/jphysiol.2013.258400; Hanft LM, 2009, AM J PHYSIOL-HEART C, V296, pH1524, DOI 10.1152/ajpheart.00864.2008; Hidalgo C, 2013, TRENDS CARDIOVAS MED, V23, P165, DOI 10.1016/j.tcm.2012.10.005; Hwang PM, 2014, P NATL ACAD SCI USA, V111, P14412, DOI 10.1073/pnas.1410775111; Kampourakis T, 2014, P NATL ACAD SCI USA, V111, P18763, DOI 10.1073/pnas.1413922112; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Konhilas JP, 2002, J PHYSIOL-LONDON, V544, P225, DOI 10.1113/jphysiol.2002.024505; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; Mamidi R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00461; Mateja RD, 2012, BIOPHYS J, V103, pL13, DOI 10.1016/j.bpj.2012.05.034; Methawasin M, 2014, CIRCULATION, V129, P1924, DOI 10.1161/CIRCULATIONAHA.113.005610; Moss RL, 2015, CIRC RES, V116, P183, DOI 10.1161/CIRCRESAHA.116.300561; Mun JY, 2014, P NATL ACAD SCI USA, V111, P2170, DOI 10.1073/pnas.1316001111; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Nixon BR, 2012, J BIOL CHEM, V287, P19136, DOI 10.1074/jbc.M111.323048; Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Rao VS, 2013, J PHYSIOL-LONDON, V591, P475, DOI 10.1113/jphysiol.2012.241604; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Reconditi M, 2014, J PHYSIOL-LONDON, V592, P1119, DOI 10.1113/jphysiol.2013.267849; Rosas PC, 2015, CIRC-HEART FAIL, V8, P582, DOI 10.1161/CIRCHEARTFAILURE.114.001550; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Tachampa K, 2007, CIRC RES, V101, P1081, DOI 10.1161/CIRCRESAHA.107.165258; Vikhorev PG, 2014, BIOPHYS J, V107, P2369, DOI 10.1016/j.bpj.2014.10.024; Wijnker PJM, 2013, AM J PHYSIOL-HEART C, V304, pH260, DOI 10.1152/ajpheart.00498.2012; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Zhang M., 2015, AM J PHYSL HEART CIR, DOI 0.1152/ajpheart.00598.2015	51	36	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29241	29249		10.1074/jbc.M115.686790	http://dx.doi.org/10.1074/jbc.M115.686790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26453301	hybrid, Green Published			2022-12-26	WOS:000366613400012
J	Athrey, G; Lance, RF; Leberg, PL				Athrey, Giridhar; Lance, Richard F.; Leberg, Paul L.			Using Genealogical Mapping and Genetic Neighborhood Sizes to Quantify Dispersal Distances in the Neotropical Passerine, the Black-Capped Vireo	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; PARENTAGE ANALYSIS; HABITAT FRAGMENTATION; COMPUTER-PROGRAM; LINKAGE DISEQUILIBRIUM; RESTRICTED DISPERSAL; ACADIAN FLYCATCHERS; NATURAL-POPULATIONS; BREEDING DISPERSAL; GENOTYPING ERRORS	Dispersal is a key demographic process, ultimately responsible for genetic connectivity among populations. Despite its importance, quantifying dispersal within and between populations has proven difficult for many taxa. Even in passerines, which are among the most intensely studied, individual movement and its relation to gene flow remains poorly understood. In this study we used two parallel genetic approaches to quantify natal dispersal distances in a Neotropical migratory passerine, the black-capped vireo. First, we employed a strategy of sampling evenly across the landscape coupled with parentage assignment to map the genealogical relationships of individuals across the landscape, and estimate dispersal distances; next, we calculated Wright's neighborhood size to estimate gene dispersal distances. We found that a high percentage of captured individuals were assigned at short distances within the natal population, and males were assigned to the natal population more often than females, confirming sex-biased dispersal. Parentage-based dispersal estimates averaged 2400m, whereas gene dispersal estimates indicated dispersal distances ranging from 1600-4200 m. Our study was successful in quantifying natal dispersal distances, linking individual movement to gene dispersal distances, while also providing a detailed look into the dispersal biology of Neotropical passerines. The high-resolution information was obtained with much reduced effort (sampling only 20% of breeding population) compared to mark-resight approaches, demonstrating the potential applicability of parentage-based approaches for quantifying dispersal in other vagile passerine species.	[Athrey, Giridhar] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA; [Athrey, Giridhar] Texas A&M Univ, Fac Ecol & Evolutionary Biol, College Stn, TX USA; [Athrey, Giridhar; Leberg, Paul L.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Lance, Richard F.] USACE, Environm Lab, Vicksburg, MS USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Louisiana Lafayette; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Athrey, G (corresponding author), Texas A&M Univ, Dept Poultry Sci, 2472 TAMU, College Stn, TX 77843 USA.	giri.athrey@tamu.edu			US Department of Defense under Section 6.1 Basic research program; U.S. Army 6.2 Threatened and Endangered Species program; National Geographic Society Committee for Research and Exploration grant	US Department of Defense under Section 6.1 Basic research program(United States Department of Defense); U.S. Army 6.2 Threatened and Endangered Species program; National Geographic Society Committee for Research and Exploration grant(National Geographic Society)	This study was partly funded by US Department of Defense under Section 6.1 Basic research program and U.S. Army 6.2 Threatened and Endangered Species program to RFL and PLL (http://www.acq.osd.mil/rd/basic_research/program_info/funding.html). Part of this study was also funded by a National Geographic Society Committee for Research and Exploration grant to GA. The funders had no role in study design, data collection, analysis, decision to publish or preparation of manuscript.	Arora N, 2012, MOL ECOL, V21, P3352, DOI 10.1111/j.1365-294X.2012.05608.x; Athrey G, 2011, CONSERV GENET, P13; Athrey G, 2012, MOL ECOL, V21, P4359, DOI 10.1111/j.1365-294X.2012.05694.x; Athrey G, 2012, EVOL APPL, V5, P540, DOI 10.1111/j.1752-4571.2011.00233.x; Barr KR, 2008, MOL ECOL, V17, P3628, DOI 10.1111/j.1365-294X.2008.03868.x; Barr KR, 2007, MOL ECOL NOTES, V7, P1067, DOI 10.1111/j.1471-8286.2007.01779.x; Belkhir K, 2004, 5000 CNRS UMR; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Burczyk J, 2002, MOL ECOL, V11, P2379, DOI 10.1046/j.1365-294X.2002.01603.x; Chapuis MP, 2011, P ROY SOC B-BIOL SCI, V278, P3152, DOI 10.1098/rspb.2010.2605; CHESSER RK, 1991, GENETICS, V129, P573; CHESSER RK, 1991, GENETICS, V127, P437; Corder G., 2014, NONPARAMETRIC STAT S, Vsecond; Coulon A, 2010, CONSERV BIOL, V24, P1080, DOI 10.1111/j.1523-1739.2009.01438.x; Dieckmann U, 1999, TRENDS ECOL EVOL, V14, P88, DOI 10.1016/S0169-5347(98)01571-7; Dubey S, 2010, MOL ECOL, V19, P886, DOI 10.1111/j.1365-294X.2010.04539.x; England PR, 2006, CONSERV GENET, V7, P303, DOI 10.1007/s10592-005-9103-8; Epperson BK, 2005, HEREDITY, V95, P7, DOI 10.1038/sj.hdy.6800680; Evans ML, 2009, J FIELD ORNITHOL, V80, P146, DOI 10.1111/j.1557-9263.2009.00216.x; Feldheim KA, 2004, EVOLUTION, V58, P2332, DOI 10.1111/j.0014-3820.2004.tb01607.x; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; GRABER JW, 1961, ECOL MONOGR, V31, P25; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; GRZYBOWSKI J. A., 1995, BIRDS N AM; Guerier AS, 2012, CONSERV GENET, V13, P811, DOI 10.1007/s10592-012-0331-4; Hansson B, 2002, OECOLOGIA, V130, P536, DOI 10.1007/s00442-001-0831-2; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hung S, 2009, CONDOR, V111, P653, DOI 10.1525/cond.2009.090082; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Kostecke RM, 2008, CONDOR, V110, P251, DOI 10.1525/cond.2008.8459; Leberg PL, 2009, MOL INSIGHTS NATURAL; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mendez M, 2011, BIOL CONSERV, V144, P2615, DOI 10.1016/j.biocon.2011.07.011; NEI M, 1981, GENETICS, V98, P625; Norris DR, 2001, CONSERV BIOL, V15, P729, DOI 10.1046/j.1523-1739.2001.015003729.x; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patrick SC, 2012, P ROY SOC B-BIOL SCI, V279, P1724, DOI 10.1098/rspb.2011.1820; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rossiter SJ, 2000, P ROY SOC B-BIOL SCI, V267, P545, DOI 10.1098/rspb.2000.1035; Shurtliff QR, 2005, J MAMMAL, V86, P531, DOI 10.1644/1545-1542(2005)86[531:PAOTCM]2.0.CO;2; SLATKIN M, 1995, GENETICS, V139, P457; Sterling K.S., 2013, CONSERV GENET, V13, P859; Sumner J, 2001, MOL ECOL, V10, P1917, DOI 10.1046/j.0962-1083.2001.01337.x; Telfer S, 2003, MOL ECOL, V12, P1939, DOI 10.1046/j.1365-294X.2003.01859.x; U. S. FISH AND WILDLIFE SERVICE (USFWS), 1991, BLACK CAPP VIR VIR A; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wagner AP, 2007, MOL ECOL, V16, P4356, DOI 10.1111/j.1365-294X.2007.03470.x; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waser PM, 2006, MOL ECOL, V15, P1929, DOI 10.1111/j.1365-294X.2006.02893.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Woltmann S, 2012, J AVIAN BIOL, V43, P33, DOI 10.1111/j.1600-048X.2011.05572.x; Wright S, 1943, GENETICS, V28, P114; Wright S, 1968, VARIABILITY NATURAL	71	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140115	10.1371/journal.pone.0140115	http://dx.doi.org/10.1371/journal.pone.0140115			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461257	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300055
J	Hammond, GRV; Takasuga, S; Sasaki, T; Balla, T				Hammond, Gerald R. V.; Takasuga, Shunsuke; Sasaki, Takehiko; Balla, Tamas			The ML1Nx2 Phosphatidylinositol 3,5-Bisphosphate Probe Shows Poor Selectivity in Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; LYSOSOMAL MEMBRANE; MAMMALIAN ORTHOLOG; ENDOCYTIC PATHWAY; 5-KINASE ACTIVITY; LIPID KINASE; IN-VIVO; PIKFYVE; 3-PHOSPHATE; FAB1P	Phosphatidylinositol (3,5)-bisphosphate (PtdIns(3,5)P-2) is a quantitatively minor phospholipid in eukaryotic cells that plays a fundamental role in regulating endocytic membrane traffic. Despite its clear importance for cellular function and organism physiology, mechanistic details of its biology have so far not been fully elucidated. In part, this is due to a lack of experimental tools that specifically probe for PtdIns(3,5)P-2 in cells to unambiguously identify its dynamics and site(s) of action. In this study, we have evaluated a recently reported PtdIns(3,5)P-2 biosensor, GFP-ML1Nx2, for its veracity as such a probe. We report that, in live cells, the localization of this biosensor to sub-cellular compartments is largely independent of PtdIns(3,5)P-2, as assessed after pharmacological, chemical genetic or genomic interventions that block the lipid's synthesis. We therefore conclude that it is unwise to interpret the localization of ML1Nx2 as a true and unbiased biosensor for PtdIns(3,5)P-2.	[Hammond, Gerald R. V.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Hammond, Gerald R. V.; Balla, Tamas] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA; [Takasuga, Shunsuke; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Sasaki, Takehiko] Akita Univ, Biosignal Res Ctr, Akita 0108543, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Akita University; Akita University	Hammond, GRV (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	ghammond@pitt.edu	Hammond, Gerald R/A-5759-2016	Hammond, Gerald R/0000-0002-6660-3272; Sasaki, Takehiko/0000-0003-1837-3748; Balla, Tamas/0000-0002-9077-3335	Department of Cell Biology University of Pittsburgh; intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; Core Research for Evolutional Science and Technology (CREST, JST); Funding Program for Next Generation World-Leading Researchers (NEXT, MEXT); JSPS KAKENHI [20790054, 22790055]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	Department of Cell Biology University of Pittsburgh; intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; Core Research for Evolutional Science and Technology (CREST, JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Funding Program for Next Generation World-Leading Researchers (NEXT, MEXT); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	GH was funded by funds from the Department of Cell Biology University of Pittsburgh. GH and TB were supported by the intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. ST and TS were funded in part by research grants from Core Research for Evolutional Science and Technology (CREST, JST), and Funding Program for Next Generation World-Leading Researchers (NEXT, MEXT), and also by research grants from JSPS KAKENHI Grant Number 20790054, 22790055.	ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carlton JG, 2005, J CELL SCI, V118, P4527, DOI 10.1242/jcs.02568; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Ikonomov OC, 2015, BBA-MOL CELL RES, P1; Ikonomov OC, 2013, AM J PHYSL ENDOCRINO; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jovic M, 2014, J CELL SCI, V127, P3745, DOI 10.1242/jcs.148809; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Li XR, 2013, P NATL ACAD SCI USA, V110, P21165, DOI 10.1073/pnas.1311864110; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shisheva A, 2015, BIOESSAYS; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; Takasuga S, 2013, P NATL ACAD SCI USA, V110, P1726, DOI 10.1073/pnas.1213212110; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	44	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139957	10.1371/journal.pone.0139957	http://dx.doi.org/10.1371/journal.pone.0139957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460749	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000362962300040
J	Reddy, MB; Yang, KH; Rao, GR; Rayner, CR; Nie, J; Pamulapati, C; Marathe, BM; Forrest, A; Govorkova, EA				Reddy, Micaela B.; Yang, Kuo-Hsiung; Rao, Gauri; Rayner, Craig R.; Nie, Jing; Pamulapati, Chandrasena; Marathe, Bindumadhav M.; Forrest, Alan; Govorkova, Elena A.			Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NEURAMINIDASE INHIBITOR OSELTAMIVIR; INFLUENZA-VIRUS; ORAL OSELTAMIVIR; RO 64-0802; GS 4071; EFFICACY; SAFETY; PATHOGENESIS; PROPHYLAXIS	The ferret is a suitable small animal model for preclinical evaluation of efficacy of antiviral drugs against various influenza strains, including highly pathogenic H5N1 viruses. Rigorous pharmacokinetics/pharmacodynamics (PK/PD) assessment of ferret data has not been conducted, perhaps due to insufficient information on oseltamivir PK. Here, based on PK data from several studies on both uninfected and influenza-infected groups (i.e., with influenza A viruses of H5N1 and H3N2 subtypes and an influenza B virus) and several types of anesthesia we developed a population PK model for the active compound oseltamivir carboxylate (OC) in the ferret. The ferret OC population PK model incorporated delayed first-order input, two-compartment distribution, and first-order elimination to successfully describe OC PK. Influenza infection did not affect model parameters, but anesthesia did. The conclusion that OC PK was not influenced by influenza infection must be viewed with caution because the influenza infections in the studies included here resulted in mild clinical symptoms in terms of temperature, body weight, and activity scores. Monte Carlo simulations were used to determine that administration of a 5.08 mg/kg dose of oseltamivir phosphate to ferret every 12 h for 5 days results in the same median OC area under the plasma concentration-time curve 0-12 h (i.e., 3220 mg h/mL) as that observed in humans during steady state at the approved dose of 75 mg twice daily for 5 days. Modeling indicated that PK variability for OC in the ferret model is high, and can be affected by anesthesia. Therefore, for proper interpretation of PK/PD data, sparse PK sampling to allow the OC PK determination in individual animals is important. Another consideration in appropriate design of PK/PD studies is achieving an influenza infection with pronounced clinical symptoms and efficient virus replication, which will allow adequate evaluation of drug effects.	[Reddy, Micaela B.; Yang, Kuo-Hsiung; Rayner, Craig R.; Nie, Jing; Pamulapati, Chandrasena] Hoffmann La Roche Inc, Dept Drug Metab & Pharmacokinet, Nutley, NJ 07110 USA; [Yang, Kuo-Hsiung; Rao, Gauri; Forrest, Alan] SUNY Buffalo, Dept Pharm Practice, Buffalo, NY 14260 USA; [Marathe, Bindumadhav M.; Govorkova, Elena A.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	Roche Holding; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; St Jude Children's Research Hospital	Reddy, MB (corresponding author), Array BioPharma, Dept Clin Pharmacol, Boulder, CO 80301 USA.	micaela.reddy@arraybiopharma.com; elena.govorkova@stjude.org		Govorkova, Elena/0000-0001-9067-5682	Hoffmann-La Roche Inc. (Nutley, NJ, USA); F. Hoffmann-La Roche Ltd.; Hoffmann-La Roche Inc.	Hoffmann-La Roche Inc. (Nutley, NJ, USA)(Hoffmann-La Roche); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Hoffmann-La Roche Inc.(Hoffmann-La Roche)	This work was funded by Hoffmann-La Roche Inc. (Nutley, NJ, USA). Support for third-party writing assistance for this manuscript was provided by F. Hoffmann-La Roche Ltd. Hoffmann-La Roche Inc. provided support in the form of salaries for authors MBR, K-HY, CRR, JN and CP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Boltz DA, 2008, J INFECT DIS, V197, P1315, DOI 10.1086/586711; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Canini L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003568; Canini L, 2011, J VIROL, V85, P2764, DOI 10.1128/JVI.01318-10; D'Argenio D, 2009, ADAPT 5 USERS GUIDE; Davies BE, 2010, J ANTIMICROB CHEMOTH, V65, pII5, DOI 10.1093/jac/dkq015; Dobrovolny HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057088; Dutkowski R, 2003, DRUG SAFETY, V26, P787, DOI 10.2165/00002018-200326110-00004; Dutkowski R, 2010, INT J ANTIMICROB AG, V35, P461, DOI 10.1016/j.ijantimicag.2009.12.023; Funk DJ, 2010, CRIT CARE MED, V38, pE30, DOI 10.1097/CCM.0b013e3181d10522; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2011, ANTIVIR RES, V91, P81, DOI 10.1016/j.antiviral.2011.05.008; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; Ison MG, 2012, ANTIVIR THER, V17, P955, DOI 10.3851/IMP2192; Johnston SL, 2005, PEDIATR INFECT DIS J, V24, P225, DOI 10.1097/01.inf.0000154322.38267.ce; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Li WX, 1998, ANTIMICROB AGENTS CH, V42, P647, DOI 10.1128/AAC.42.3.647; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Parrott N, 2011, CLIN PHARMACOKINET, V50, P613, DOI 10.2165/11592640-000000000-00000; Rath B, 2015, SAFETY VIROLOGY PHAR, DOI [10.3851/IMP2967, DOI 10.3851/IMP2967]; Rayner CR, 2008, J CLIN PHARMACOL, V48, P935, DOI 10.1177/0091270008320317; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Shargel L., 2012, APPL BIOPHARMACEUTIC; Smith JR, 2011, ADV THER, V28, P927, DOI 10.1007/s12325-011-0072-7; Smith JR, 2010, CRIT CARE MED, V38, pE43, DOI 10.1097/CCM.0b013e3181c85229; Smith JH, 2011, J VIROL, V85, P7572, DOI 10.1128/JVI.00512-11; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Wattanagoon Y, 2009, ANTIMICROB AGENTS CH, V53, P945, DOI 10.1128/AAC.00588-08; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Wiltshire H, 2000, J CHROMATOGR B, V745, P373, DOI 10.1016/S0378-4347(00)00300-5	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0138069	10.1371/journal.pone.0138069	http://dx.doi.org/10.1371/journal.pone.0138069			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460484	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300005
J	Elias, FTS; da Silva, EN; Belfort, R; Silva, MT; Atallah, AN				Silva Elias, Flavia Tavares; da Silva, Everton Nunes; Belfort, Rubens, Jr.; Silva, Marcus Tolentino; Atallah, Alvaro Nagib			Treatment Options for Age-Related Macular Degeneration: A Budget Impact Analysis from the Perspective of the Brazilian Public Health System	PLOS ONE			English	Article							BEVACIZUMAB; RANIBIZUMAB; DISEASES; AVASTIN; PEOPLE; RISK; EYE	Background Age-related macular degeneration (AMD) is a disease that causes reduced visual acuity and blindness. The new treatment options for AMD are not provided by the Brazilian public health system. Objective To conduct a budget impact analysis of three scenarios for the introduction of AMD treatments: all the medications (verteporfin, ranibizumab, and bevacizumab-the reference scenario), ranibizumab alone, and bevacizumab alone. Methods The basic assumption was that the Brazilian public health system would treat the entire target population with AMD aged >70 years between 2008 and 2011. The size of the population of interest was estimated from official population projections and the prevalence of the disease was obtained from a systematic review. Medication prices were estimated by weighting their market values with correction factors to take account of the public procurement policy. The possibility of aliquoting bevacizumab was also considered. A panel of experts was consulted to estimate the market share of the different medications for the reference scenario. The incremental costs of the ranibizumab-alone and bevacizumab-alone scenarios compared to the reference scenario were calculated. Univariate sensitivity analyses were run to check the robustness of the model. Results In four years, the Brazilian public health system would have treated 1,136,349 individuals with AMD. The annual costs of treating one patient would have been US$476.65 for bevacizumab, US$11,469.39 for ranibizumab, and US$4,376.28 for verteporfin. The incremental cost of the ranibizumab-alone scenario would have been US$1,878,318,056.00 in four years, while the incremental cost for the bevacizumab-alone scenario would have been a reduction of US$4,978,326,359.00 (i.e., a cost saving) in the same period. The bevacizumab-alone option was found to represent a cost saving across sensitivity analyses. Conclusion The introduction of bevacizumab for the treatment of AMD is recommended for the Brazilian Public Health System.	[Silva Elias, Flavia Tavares] Fundacao Oswaldo Cruz, Brasilia, DF, Brazil; [da Silva, Everton Nunes] Univ Brasilia, Brasilia, DF, Brazil; [Belfort, Rubens, Jr.; Atallah, Alvaro Nagib] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil; [Silva, Marcus Tolentino] Univ Fed Amazonas, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Universidade de Brasilia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Amazonas	Elias, FTS (corresponding author), Fundacao Oswaldo Cruz, Brasilia, DF, Brazil.	flavia.tselias@gmail.com	Atallah, Álvaro N/K-7182-2013; Silva, Marcus Tolentino/J-1791-2014	Silva, Marcus Tolentino/0000-0002-7186-9075; Silva, Everton/0000-0001-8747-4185				American Academy of Ophthalmology, 2008, PREF PRACT PATT AG R; Andriolo RB, 2009, SAO PAULO MED J, V127, P84, DOI 10.1590/S1516-31802009000200006; Antoniak Katarzyna, 2008, Klin Oczna, V110, P211; Bakri SJ, 2006, RETINA-J RET VIT DIS, V26, P519, DOI 10.1097/01.iae.0000225354.92444.7a; BRAZIL, 2012, BANC PREC SAUD BPS N, V2009, P2010; BRAZIL, 2008, BRATS B BRAS AV TECN, V6; BRAZIL. Ministerio da Saude. Secretaria de Atencao a Saude, 2012, MIN SAUD SECR AT SAU; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Ferreira-Da-Silva AL, 2012, CAD SAUDE PUBLICA, V28, P1223, DOI 10.1590/S0102-311X2012000700002; Fraser-Bell S, 2005, AM J OPHTHALMOL, V139, P30, DOI 10.1016/j.ajo.2004.08.029; Gonzalez S, 2012, AM J OPHTHALMOL, V153, P196, DOI 10.1016/j.ajo.2011.11.023; Gupta OP, 2010, OPHTHALMOLOGY, V117, P2134, DOI 10.1016/j.ophtha.2010.02.032; Hutton D, 2014, HEALTH AFFAIR, V33, P931, DOI 10.1377/hlthaff.2013.0832; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein BEK, 2001, AM J EPIDEMIOL, V154, P207, DOI 10.1093/aje/154.3.207; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Kodjikian L, 2013, OPHTHALMOLOGY, V120, P2300, DOI 10.1016/j.ophtha.2013.06.020; Leske MC, 2006, OPHTHALMOLOGY, V113, P29, DOI 10.1016/j.ophtha.2005.08.012; Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI 10.5123/S1679-49742011000400002; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2; National Institute of Health and Care Excellence, 2008, TECHN APPR GUID; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; World Health Organization, 2003, PRIOR EYE DIS; WORMALD R, 2003, COCHRANE DB SYST REV; Zimmermann I, 2012, VALUE HEALTH, V15, pA569, DOI 10.1016/j.jval.2012.08.2052	30	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0139556	10.1371/journal.pone.0139556	http://dx.doi.org/10.1371/journal.pone.0139556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457416	Green Published, gold, Green Submitted			2022-12-26	WOS:000362961100011
J	Gil, C; Dorca-Arevalo, J; Blasi, J				Gil, Carles; Dorca-Arevalo, Jonatan; Blasi, Juan			Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide	PLOS ONE			English	Article							HIGH-AFFINITY BINDING; MDCK CELLS; PROTEIN; PORE; PERMEABILITY; CHANNELS; RECEPTOR; KIDNEY; FORMS; ACTS	Epsilon toxin (Etx) is one of the major lethal toxins produced by Clostridium perfringens types B and D, being the causal agent of fatal enterotoxemia in animals, mainly sheep and goats. Etx is synthesized as a non-active prototoxin form (proEtx) that becomes active upon proteolytic activation. Etx exhibits a cytotoxic effect through the formation of a pore in the plasma membrane of selected cell targets where Etx specifically binds due to the presence of specific receptors. However, the identity and nature of host receptors of Etx remain a matter of controversy. In the present study, the interactions between Etx and membrane lipids from the synaptosome-enriched fraction from rat brain (P2 fraction) and MDCK cell plasma membrane preparations were analyzed. Our findings show that both Etx and proEtx bind to lipids extracted from lipid rafts from the two different models as assessed by protein-lipid overlay assay. Lipid rafts are membrane microdomains enriched in cholesterol and sphingolipids. Binding of proEtx to sulfatide, phosphatidylserine, phosphatidylinositol (3)-phosphate and phosphatidylinositol (5)-phosphate was detected. Removal of the sulphate groups via sulfatase treatment led to a dramatic decrease in Etx-induced cytotoxicity, but not in proEtx-GFP binding to MDCK cells or a significant shift in oligomer formation, pointing to a role of sulfatide in pore formation in rafts but not in toxin binding to the target cell membrane. These results show for the first time the interaction between Etx and membrane lipids from host tissue and point to a major role for sulfatides in C. perfringens epsilon toxin pathophysiology.	[Gil, Carles] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Catalunya, Spain; [Gil, Carles] Univ Autonoma Barcelona, Inst Neurociencies, Bellaterra, Catalunya, Spain; [Dorca-Arevalo, Jonatan; Blasi, Juan] Univ Barcelona, Sch Med, Dept Pathol & Expt Therapeut, Lab Cellular & Mol Neurosci, Barcelona, Spain; [Dorca-Arevalo, Jonatan; Blasi, Juan] IDIBELL Bellvitge Biomed Res Inst, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Gil, C (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Catalunya, Spain.	carles.gil@uab.cat; blasi@ub.edu	Gil, Carles/C-7016-2008; Dorca, Jonatan/C-9220-2018; Gil, Carles/AAI-9532-2020; Dorca-Arévalo, Jonatan/F-8984-2016	Dorca, Jonatan/0000-0001-7606-0462; Gil, Carles/0000-0003-2976-4146; 	Ministerio de Economia y Competitividad [SAF2011-27566, SAF2014-56811-R]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by grants SAF2011-27566 and SAF2014-56811-R from Ministerio de Economia y Competitividad (http://www.idi.mineco.gob.es/) to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bokori-Brown M, 2013, PROTEIN SCI, V22, P650, DOI 10.1002/pro.2250; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman RJ, 2008, ANAEROBE, V14, P102, DOI 10.1016/j.anaerobe.2008.01.003; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; Chen JM, 2013, MOL MICROBIOL, V89, P1154, DOI 10.1111/mmi.12336; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cubi R, 2013, BBA-BIOMEMBRANES, V1828, P2385, DOI 10.1016/j.bbamem.2013.06.022; Dolinsky S, 2014, INFECT IMMUN, V82, P4021, DOI 10.1128/IAI.01685-14; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; Dorca-Arevalo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102417; Dorca-Arevalo J, 2012, VET MICROBIOL, V157, P179, DOI 10.1016/j.vetmic.2011.12.020; DREYFUS LA, 1993, P NATL ACAD SCI USA, V90, P3202, DOI 10.1073/pnas.90.8.3202; Fennessey CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046866; Miyakawa MEF, 2011, HUM EXP TOXICOL, V30, P275, DOI 10.1177/0960327110371700; Finnie JW, 2004, ANAEROBE, V10, P145, DOI 10.1016/j.anaerobe.2003.08.003; Frank M, 2000, PROG NEUROBIOL, V60, P531, DOI 10.1016/S0301-0082(99)00039-8; FREDMAN P, 1988, BIOCHEM J, V251, P17, DOI 10.1042/bj2510017; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; GLEESONWHITE MH, 1955, LANCET, V1, P384; Hayashi Y, 2013, GUT, V62, P1536, DOI 10.1136/gutjnl-2011-301625; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Ivie SE, 2012, BIOCHEMISTRY-US, V51, P7588, DOI 10.1021/bi300690a; Ivie SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017787; Knapp O, 2009, BBA-BIOMEMBRANES, V1788, P2584, DOI 10.1016/j.bbamem.2009.09.020; KOHN J, 1955, LANCET, V1, P385; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Linden JR, 2015, MBIO, V6, DOI 10.1128/mBio.02513-14; Lonchamp E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013046; Manni MM, 2015, BBA-BIOMEMBRANES, V1848, P797, DOI 10.1016/j.bbamem.2014.11.028; Miller C, 2004, LIVER TRANSPLANT, V10, P1315, DOI 10.1002/lt.20227; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyamoto O, 1998, INFECT IMMUN, V66, P2501, DOI 10.1128/IAI.66.6.2501-2508.1998; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1111/j.1574-6968.2000.tb09215.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; MORINAGA G, 1965, J BACTERIOL, V90, P826, DOI 10.1128/JB.90.3.826-826.1965; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; MURRELL TGC, 1986, MED HYPOTHESES, V19, P27, DOI 10.1016/0306-9877(86)90134-9; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Nagahama M, 2011, FEBS J, V278, P3395, DOI 10.1111/j.1742-4658.2011.08263.x; Payne D., 1997, CLOSTRIDIUM PERFRING; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2003, CELL MICROBIOL, V5, P155, DOI 10.1046/j.1462-5822.2003.00262.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Piao H, 2011, NEUROCHEM RES, V36, P58, DOI 10.1007/s11064-010-0263-7; Pizarro-Cerda J, 2014, BIOCH BIOPHYSICA ACT; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; Rousset E, 1998, INFECT IMMUN, V66, P5650, DOI 10.1128/IAI.66.12.5650-5658.1998; Rumah KR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004896; Rumah KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076359; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Shortt SJ, 2000, HUM EXP TOXICOL, V19, P108, DOI 10.1191/096032700678815710; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; Stiles BG, 2013, TOXINS, V5, P2138, DOI 10.3390/toxins5112138; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Tamai E, 2003, INFECT IMMUN, V71, P5371, DOI 10.1128/IAI.71.9.5371-5375.2003; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; van Zyl R, 2010, J NEUROCHEM, V112, P282, DOI 10.1111/j.1471-4159.2009.06458.x; Weerheim AM, 2002, ANAL BIOCHEM, V302, P191, DOI 10.1006/abio.2001.5552; Wioland L, 2015, CELL MICROBIOL, V17, P369, DOI 10.1111/cmi.12373; Wioland L, 2013, TOXICON, V75, P122, DOI 10.1016/j.toxicon.2013.04.003; Zhu C, 2001, EXP NEUROL, V169, P72, DOI 10.1006/exnr.2001.7652	72	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140321	10.1371/journal.pone.0140321	http://dx.doi.org/10.1371/journal.pone.0140321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452234	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200060
J	Ha, M; Sabherwal, M; Duncan, E; Stevens, S; Stockwell, P; McConnell, M; Bekhit, AED; Carne, A				Ha, Minh; Sabherwal, Manya; Duncan, Elizabeth; Stevens, Stewart; Stockwell, Peter; McConnell, Michelle; Bekhit, Alaa El-Din; Carne, Alan			In-Depth Characterization of Sheep (Ovis aries) Milk Whey Proteome and Comparison with Cow (Bos taurus)	PLOS ONE			English	Article							LARGE GENE LISTS; BOVINE-MILK; BIOACTIVE COMPONENTS; MASS-SPECTROMETRY; CAMEL MILK; SKIM MILK; PROTEINS; GOAT; CAPRINE; IDENTIFICATION	An in-depth proteomic study of sheep milk whey is reported and compared to the data available in the literature for the cow whey proteome. A combinatorial peptide ligand library kit (ProteoMiner) was used to normalize protein abundance in the sheep whey proteome followed by an in-gel digest of a 1D-PAGE display and an in-solution digestion followed by OFFGEL isoelectric focusing fractionation. The peptide fractions obtained were then analyzed by LC-MS/MS. This enabled identification of 669 proteins in sheep whey that, to our knowledge, is the largest inventory of sheep whey proteins identified to date. A comprehensive list of cow whey proteins currently available in the literature (783 proteins from unique genes) was assembled and compared to the sheep whey proteome data obtained in this study (606 proteins from unique genes). This comparison revealed that while the 233 proteins shared by the two species were significantly enriched for immune and inflammatory responses in gene ontology analysis, proteins only found in sheep whey in this study were identified that take part in both cellular development and immune responses, whereas proteins only found in cow whey in this study were identified to be associated with metabolism and cellular growth.	[Ha, Minh; Stevens, Stewart; Stockwell, Peter; Carne, Alan] Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin, New Zealand; [Sabherwal, Manya] Univ Otago, Sch Dent, Dept Oral Sci, Dunedin, New Zealand; [Duncan, Elizabeth] Univ Otago, Lab Evolut & Dev Genet Otago & Gravida, Natl Ctr Growth & Dev, Dept Biochem, Dunedin, Aotearoa, New Zealand; [McConnell, Michelle] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand; [Bekhit, Alaa El-Din] Univ Otago, Dept Food Sci, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Otago	Ha, M (corresponding author), Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin, New Zealand.	minh.ha@otago.ac.nz	Carne, Alan/R-6260-2019; Bekhit, Alaa El-Din A./A-4241-2019	Bekhit, Alaa El-Din A./0000-0003-2569-8620; Ha, Minh/0000-0003-4394-0820; Duncan, Elizabeth/0000-0002-1841-504X; Carne, Alan/0000-0003-3665-1940	Otago School of Medical Sciences, University of Otago; University of Otago Special Health Research Scholarship	Otago School of Medical Sciences, University of Otago; University of Otago Special Health Research Scholarship	This project was funded by a Dean's Bequest Grant-in-Aid from the Otago School of Medical Sciences, University of Otago to AC. MH acknowledges receipt of the 2012 University of Otago Special Health Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan T, 2010, AM J CLIN NUTR, V91, P966, DOI 10.3945/ajcn.2009.28406; Ballabio C, 2011, J DAIRY SCI, V94, P998, DOI 10.3168/jds.2010-3545; Boyazoglu J, 2001, SMALL RUMINANT RES, V40, P1, DOI 10.1016/S0921-4488(00)00203-0; BULLEN JJ, 1972, BMJ-BRIT MED J, V1, P69, DOI 10.1136/bmj.1.5792.69; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casper JL, 1998, J DAIRY SCI, V81, P3117, DOI 10.3168/jds.S0022-0302(98)75876-X; Chatchatee P, 2001, CLIN EXP ALLERGY, V31, P1256, DOI 10.1046/j.1365-2222.2001.01167.x; Chiaradia E, 2013, J PROTEOMICS, V83, P144, DOI 10.1016/j.jprot.2013.03.017; D'Alessandro A, 2011, MOL BIOSYST, V7, P579, DOI 10.1039/c0mb00027b; D'Alessandro A, 2010, J PROTEOME RES, V9, P3339, DOI 10.1021/pr100123f; D'Amato A, 2012, J PROTEOMICS, V75, P914, DOI 10.1016/j.jprot.2011.10.009; D'Amato A, 2009, J PROTEOME RES, V8, P3925, DOI 10.1021/pr900221x; Guerrier L, 2008, NAT PROTOC, V3, P883, DOI 10.1038/nprot.2008.59; Ha M, 2014, SMALL RUMINANT RES, V120, P125, DOI 10.1016/j.smallrumres.2014.04.012; Hernandez-Ledesma B, 2011, SMALL RUMINANT RES, V101, P196, DOI 10.1016/j.smallrumres.2011.09.040; Hinz K, 2012, J DAIRY RES, V79, P185, DOI 10.1017/S0022029912000015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JENNESS R, 1979, J DAIRY RES, V46, P197, DOI 10.1017/S0022029900017040; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kawasaki K, 2011, MOL BIOL EVOL, V28, P2053, DOI 10.1093/molbev/msr020; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; Le A, 2011, J PROTEOME RES, V10, P692, DOI 10.1021/pr100884z; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Liao YL, 2011, J PROTEOME RES, V10, P1746, DOI 10.1021/pr101028k; Mange A, 2008, J CHROMATOGR B, V876, P252, DOI 10.1016/j.jchromb.2008.11.003; McGill HC, 1996, NUTR REV, V54, pS31; Mills S, 2011, INT DAIRY J, V21, P377, DOI 10.1016/j.idairyj.2010.12.011; Molinari CE, 2012, J PROTEOME RES, V11, P1696, DOI 10.1021/pr2008797; Nissen A, 2013, J DAIRY SCI, V96, P7854, DOI 10.3168/jds.2013-7106; Panchaud A, 2012, J PROTEOMICS, V75, P3546, DOI 10.1016/j.jprot.2011.12.022; Park YW, 2007, SMALL RUMINANT RES, V68, P88, DOI 10.1016/j.smallrumres.2006.09.013; PARRIS N, 1991, J AGR FOOD CHEM, V39, P2167, DOI 10.1021/jf00012a013; Pisanu S, 2011, J PROTEOMICS, V74, P350, DOI 10.1016/j.jprot.2010.11.011; RAINARD P, 1995, INFECT IMMUN, V63, P3422, DOI 10.1128/IAI.63.9.3422-3427.1995; Recio I, 2000, INT DAIRY J, V10, P597, DOI 10.1016/S0958-6946(00)00089-3; Recio I., 2009, BIOACTIVE COMPONENTS, P83, DOI 10.1002/9780813821504.ch4; Reinhardt TA, 2013, J PROTEOMICS, V82, P141, DOI 10.1016/j.jprot.2013.02.013; Roncada P, 2012, J PROTEOMICS, V75, P4259, DOI 10.1016/j.jprot.2012.05.028; Roy JP, 2009, VET MICROBIOL, V134, P136, DOI 10.1016/j.vetmic.2008.09.020; Sanchez-Rivera L, 2014, FOOD RES INT, V63, P170, DOI 10.1016/j.foodres.2014.01.069; Scholz-Ahrens KE, 2000, BRIT J NUTR, V84, pS147; Scumaci D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117433; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smolenski G, 2007, J PROTEOME RES, V6, P207, DOI 10.1021/pr0603405; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Walzem RL, 2002, CRIT REV FOOD SCI, V42, P353; Ward RE, 2004, J NUTR, V134, p962S, DOI 10.1093/jn/134.4.962S; Yang YX, 2013, J PROTEOME RES, V12, P1660, DOI 10.1021/pr301001m	50	39	40	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139774	10.1371/journal.pone.0139774	http://dx.doi.org/10.1371/journal.pone.0139774			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447763	gold, Green Published			2022-12-26	WOS:000362511000052
J	Praxenthaler, H; Smylla, TK; Nagel, AC; Preiss, A; Maier, D				Praxenthaler, Heiko; Smylla, Thomas K.; Nagel, Anja C.; Preiss, Anette; Maier, Dieter			Generation of New Hairless Alleles by Genomic Engineering at the Hairless Locus in Drosophila melanogaster	PLOS ONE			English	Article							NOTCH SIGNALING PATHWAY; SENSORY ORGAN DEVELOPMENT; QUANTITATIVE TRAIT LOCI; ALTERNATIVE CELL FATES; GENETIC INTERACTIONS; BRISTLE NUMBER; FUSHI-TARAZU; WING MARGIN; PROTEIN; SUPPRESSOR	Hairless (H) is the major antagonist within the Notch signalling pathway of Drosophila melanogaster. By binding to Suppressor of Hairless [Su(H)] and two co-repressors, H induces silencing of Notch target genes in the absence of Notch signals. We have applied genomic engineering to create several new H alleles. To this end the endogenous H locus was replaced with an attP site by homologous recombination, serving as a landing platform for subsequent site directed integration of different H constructs. This way we generated a complete H knock out allele H-attP, reintroduced a wild type H genomic and a cDNA-construct (H-gwt, H-cwt) as well as two constructs encoding H proteins defective of Su(H) binding (H-LD, H-lD). Phenotypes regarding viability, bristle and wing development were recorded, and the expression of Notch target genes wingless and cut was analysed in mutant wing discs or in mutant cell clones. Moreover, genetic interactions with Notch (N-5419) and Delta (Dl(B2)) mutants were addressed. Overall, phenotypes were largely as expected: both H-LD and H-lD were similar to the H-attP null allele, indicating that most of H activity requires the binding of Su(H). Both rescue constructs H-gwt and H-cwt were homozygous viable without phenotype. Unexpectedly, the hemizygous condition uncovered that they were not identical to the wild type allele: notably Hcwt showed a markedly reduced activity, suggesting the presence of as yet unidentified regulatory or stabilizing elements in untranslated regions of the H gene. Interestingly, H-gwt homozygous cells expressed higher levels of H protein, perhaps unravelling gene-by-environment interactions.	[Praxenthaler, Heiko; Smylla, Thomas K.; Nagel, Anja C.; Preiss, Anette; Maier, Dieter] Univ Hohenheim, Inst Genet 240, D-70599 Stuttgart, Germany	University Hohenheim	Maier, D (corresponding author), Univ Hohenheim, Inst Genet 240, Garbenstr 30, D-70599 Stuttgart, Germany.	dieter.maier@uni-hohenheim.de	Nagel, Anja/AAA-4254-2022	Smylla, Thomas/0000-0002-8343-7341; Nagel, Anja/0000-0002-2733-3249	DFG [MA 1328/10-1]; University of Hohenheim; National Institute of Child Health and Human Development; National Science Foundation	DFG(German Research Foundation (DFG)); University of Hohenheim; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF))	This work was funded by a DFG grant MA 1328/10-1 (http://www.dfg.de) to DM and by the University of Hohenheim. Some of the antisera used in this study were obtained from Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biology, Iowa City, Iowa 52242. Some Drosophila fly stocks were obtained from the Bloomington Drosophila Stock Center BDSC, funded by the National Science Foundation (http://flystocks.bio.indiana.edu/Inst/funding.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Auer JS, 2015, CELL SIGNAL, V27, P115, DOI 10.1016/j.cellsig.2014.10.007; BANG AG, 1991, DEVELOPMENT, V111, P89; BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752; Barolo S, 2002, GENE DEV, V16, P1964, DOI 10.1101/gad.987402; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bridges C. B., 1923, Carnegie Institution Publication, V327, P1; Bridges C.B., 1923, 3 CHROMOSOME GROUP M; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; Collins KJ, 2014, STRUCTURE, V22, P70, DOI 10.1016/j.str.2013.10.010; Contreras AN, 2015, PROTEIN SCI, V24, P812, DOI 10.1002/pro.2652; deCelis JF, 1996, DEVELOPMENT, V122, P2719; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Foronda D, 2014, GENE DEV, V28, P2421, DOI 10.1101/gad.241588.114; Go MJ, 1998, DEVELOPMENT, V125, P2031; Gowen JW, 1933, J EXP ZOOL, V65, P83, DOI 10.1002/jez.1400650106; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; House VL, 1969, ANAT REC, P581; Huang J, 2009, FLY, V3, P274, DOI 10.4161/fly.9978; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Johannes B, 2002, MECH DEVELOP, V115, P3, DOI 10.1016/S0925-4773(02)00083-7; JOST W, 1995, ROUX ARCH DEV BIOL, V205, P160, DOI 10.1007/BF00357762; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Lees AD, 1942, DROSOPH INF SERV, V16, P70; Lindsley D.L., 1968, GENETIC VARIATIONS D; Long AD, 1996, GENETICS, V144, P1497; LYMAN DF, 1995, GENETICS, V141, P1491; Lyman RF, 1998, GENETICS, V149, P983; Maggert Keith A., 2008, V420, P155, DOI 10.1007/978-1-59745-583-1_9; MAIER D, 1990, EMBO J, V9, P3957, DOI 10.1002/j.1460-2075.1990.tb07616.x; MAIER D, 1992, MECH DEVELOP, V38, P143, DOI 10.1016/0925-4773(92)90006-6; Maier D, 1999, MECH DEVELOP, V89, P195, DOI 10.1016/S0925-4773(99)00208-7; Maier D, 1997, MECH DEVELOP, V67, P97, DOI 10.1016/S0925-4773(97)00117-2; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Maier D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081578; Maier D, 2011, MOL BIOL CELL, V22, P3242, DOI 10.1091/mbc.E11-05-0420; Maier D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-175; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Mohler JD, 1956, DROS INFORM SERV, V30, P78; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Muller D, 2006, J CELL SCI, V119, P250, DOI 10.1242/jcs.02743; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nagel AC, 2011, HEREDITAS, V148, P77, DOI 10.1111/j.1601-5223.2011.02221.x; Nash D, 1969, DIS, P95; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Protzer CE, 2008, J CELL SCI, V121, P3167, DOI 10.1242/jcs.035014; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Schreiber SL, 2002, GENESIS, V33, P141, DOI 10.1002/gene.10102; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; Walrad PB, 2011, MOL BIOL CELL, V22, P1364, DOI 10.1091/mbc.E10-06-0483; Wang HD, 1997, MOL CELL BIOL, V17, P6838, DOI 10.1128/MCB.17.12.6838; XU T, 1993, DEVELOPMENT, V117, P1223; Xue ZY, 2014, G3-GENES GENOM GENET, V4, P2167, DOI 10.1534/g3.114.014159	68	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140007	10.1371/journal.pone.0140007	http://dx.doi.org/10.1371/journal.pone.0140007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448463	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000079
J	Straney, LD; Bray, JE; Beck, B; Finn, J; Bernard, S; Dyson, K; Lijovic, M; Smith, K				Straney, Lahn D.; Bray, Janet E.; Beck, Ben; Finn, Judith; Bernard, Stephen; Dyson, Kylie; Lijovic, Marijana; Smith, Karen			Regions of High Out-Of-Hospital Cardiac Arrest Incidence and Low Bystander CPR Rates in Victoria, Australia	PLOS ONE			English	Article							INITIATED CPR; CARDIOPULMONARY-RESUSCITATION; NEIGHBORHOOD CHARACTERISTICS; WESTERN-AUSTRALIA; SURVIVAL RATES; ASSOCIATION; CARE; INTERVENTION; OUTCOMES; VICTIMS	Background Out-of-hospital cardiac arrest (OHCA) remains a major public health issue and research has shown that large regional variation in outcomes exists. Of the interventions associated with survival, the provision of bystander CPR is one of the most important modifiable factors. The aim of this study is to identify census areas with high incidence of OHCA and low rates of bystander CPR in Victoria, Australia Methods We conducted an observational study using prospectively collected population-based OHCA data from the state of Victoria in Australia. Using ArcGIS (ArcMap 10.0), we linked the location of the arrest using the dispatch coordinates (longitude and latitude) to Victorian Local Government Areas (LGAs). We used Bayesian hierarchical models with random effects on each LGA to provide shrunken estimates of the rates of bystander CPR and the incidence rates. Results Over the study period there were 31,019 adult OHCA attended, of which 21,436 (69.1%) cases were of presumed cardiac etiology. Significant variation in the incidence of OHCA among LGAs was observed. There was a 3 fold difference in the incidence rate between the lowest and highest LGAs, ranging from 38.5 to 115.1 cases per 100,000 person-years. The overall rate of bystander CPR for bystander witnessed OHCAs was 62.4%, with the rate increasing from 56.4% in 2008-2010 to 68.6% in 2010-2013. There was a 25.1% absolute difference in bystander CPR rates between the highest and lowest LGAs. Conclusion Significant regional variation in OHCA incidence and bystander CPR rates exists throughout Victoria. Regions with high incidence and low bystander CPR participation can be identified and would make suitable targets for interventions to improve CPR participation rates.	[Straney, Lahn D.; Bray, Janet E.; Beck, Ben; Finn, Judith; Bernard, Stephen; Dyson, Kylie; Smith, Karen] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bray, Janet E.; Finn, Judith] Curtin Univ, Fac Hlth Sci, Perth, WA 6845, Australia; [Finn, Judith] St John Ambulance Western Australia, Perth, WA, Australia; [Bernard, Stephen] Alfred Hosp Melbourne, Intens Care Unit, Melbourne, Vic, Australia; [Dyson, Kylie; Lijovic, Marijana; Smith, Karen] Ambulance Victoria, Melbourne, Vic, Australia	Monash University; Curtin University	Straney, LD (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	lahn.straney@monash.edu	Finn, Judith C/B-2678-2010; Dyson, Kylie/AAA-5115-2019; Beck, Ben/ABD-5556-2020; Bray, Janet/H-7089-2014	Finn, Judith C/0000-0002-7307-7944; Dyson, Kylie/0000-0002-0037-3195; Beck, Ben/0000-0003-3262-5956; Smith, Karen/0000-0002-9057-0685; Bray, Janet/0000-0002-1559-5882	NHMRC Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research Excellence (CRE) [1029983]; National Health and Medical Research Council (NHMRC) Public Health Postgraduate Research Scholarship [1075456]; NHMRC Aus-ROC CRE; NHMRC; Heart Foundation; St John Ambulance Western Australia	NHMRC Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research Excellence (CRE)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Public Health Postgraduate Research Scholarship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Aus-ROC CRE(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation; St John Ambulance Western Australia	LS, BB, JB and JF receive salary support from the NHMRC Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research Excellence (CRE) (ID: 1029983, https://www.ausroc.org.au). KD is supported by a National Health and Medical Research Council (NHMRC) Public Health Postgraduate Research Scholarship (ID: 1075456) and a scholarship funded through the NHMRC Aus-ROC CRE. JB receives an early career researcher fellowship from the NHMRC and the Heart Foundation. JF receives salary support from St John Ambulance Western Australia.	[Anonymous], 1998, INTRO MULTILEVEL MOD; Australian Bureau of Statistics, POP PEOPL POP PEOPL; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bossaert L, 1989, RESUSCITATION S, V17, pS55; Bray JE, 2014, RESUSCITATION, V85, P757, DOI 10.1016/j.resuscitation.2014.02.017; Bray JE, 2011, RESUSCITATION, V82, P1393, DOI 10.1016/j.resuscitation.2011.06.018; Brooks SC, 2010, RESUSCITATION, V81, P175, DOI 10.1016/j.resuscitation.2009.10.021; Chiang WC, 2014, RESUSCITATION, V85, P53, DOI 10.1016/j.resuscitation.2013.07.033; COPLEY DP, 1977, CIRCULATION, V56, P901, DOI 10.1161/01.CIR.56.6.901; Department of Housing and Settlement Areas of Banyumas Regency, 2011, SPATIAL STRUCTURE MA; EISENBERG M, 1979, AM J PUBLIC HEALTH, V69, P30, DOI 10.2105/AJPH.69.1.30; Finn JC, 2001, RESUSCITATION, V51, P247, DOI 10.1016/S0300-9572(01)00408-7; Fosbol EL, 2014, RESUSCITATION, V85, P1512, DOI 10.1016/j.resuscitation.2014.08.013; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Heward A, 2004, EMERG MED J, V21, P115, DOI 10.1136/emj.2003.006940; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Jennings PA, 2006, MED J AUSTRALIA, V185, P135, DOI 10.5694/j.1326-5377.2006.tb00498.x; Lund-Kordahl I, 2010, RESUSCITATION, V81, P422, DOI 10.1016/j.resuscitation.2009.12.020; Nehme Z, 2014, MED J AUSTRALIA, P200; Nehme Z, 2015, CIRC-CARDIOVASC QUAL, V8, P56, DOI 10.1161/CIRCOUTCOMES.114.001185; Nolan J, 2006, RESUSCITATION, V71, P270, DOI 10.1016/j.resuscitation.2006.09.001; O'Keeffe C, 2011, EMERG MED J, V28, P703, DOI 10.1136/emj.2009.086363; Ornato JP, 2010, CIRCULATION, V122, P1876, DOI 10.1161/CIRCULATIONAHA.110.963991; Raun LH, 2013, AM J PREV MED, V45, P137, DOI 10.1016/j.amepre.2013.03.013; RITTER G, 1985, AM HEART J, V110, P932, DOI 10.1016/0002-8703(85)90187-5; ROTH R, 1984, ANN EMERG MED, V13, P237, DOI 10.1016/S0196-0644(84)80470-9; Sasson C, 2012, NEW ENGL J MED, V367, P1607, DOI 10.1056/NEJMoa1110700; Sasson C, 2012, ACAD EMERG MED, V19, P139, DOI 10.1111/j.1553-2712.2011.01284.x; Sasson C, 2010, ANN INTERN MED, V153, P19, DOI 10.7326/0003-4819-153-1-201007060-00255; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Semple HM, 2013, J COMMUN HEALTH, V38, P277, DOI 10.1007/s10900-012-9611-7; Srebotnjak T, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-26; Vaillancourt C, 2008, RESUSCITATION, V79, P417, DOI 10.1016/j.resuscitation.2008.07.012; Vaillancourt C, 2008, CAN J EMERG MED, V10, P51, DOI 10.1017/S1481803500010010	35	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139776	10.1371/journal.pone.0139776	http://dx.doi.org/10.1371/journal.pone.0139776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447844	Green Published, gold			2022-12-26	WOS:000362511000053
J	Carter, G; Leffer, L				Carter, Gerald; Leffer, Lauren			Social Grooming in Bats: Are Vampire Bats Exceptional?	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; FRUIT-EATING BAT; CAROLLIA-PERSPICILLATA; ARTIBEUS-JAMAICENSIS; FEMALE BABOONS; DESMODUS-ROTUNDUS; NEOTROPICAL BATS; SPOTTED HYAENAS; VERVET MONKEYS; NEOCORTEX SIZE	Evidence for long-term cooperative relationships comes from several social birds and mammals. Vampire bats demonstrate cooperative social bonds, and like primates, they maintain these bonds through social grooming. It is unclear, however, to what extent vampires are special among bats in this regard. We compared social grooming rates of common vampire bats Desmodus rotundus and four other group-living bats, Artibeus jamaicensis, Carollia perspicillata, Eidolon helvum and Rousettus aegyptiacus, under the same captive conditions of fixed association and no ectoparasites. We conducted 13 focal sampling sessions for each combination of sex and species, for a total of 1560 presence/absence observations per species. We observed evidence for social grooming in all species, but social grooming rates were on average 14 times higher in vampire bats than in other species. Self-grooming rates did not differ. Vampire bats spent 3.7% of their awake time social grooming (95% CI = 1.5-6.3%), whereas bats of the other species spent 0.1-0.5% of their awake time social grooming. Together with past data, this result supports the hypothesis that the elevated social grooming rate in the vampire bat is an adaptive trait, linked to their social bonding and unique regurgitated food sharing behavior.	[Carter, Gerald; Leffer, Lauren] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Carter, G (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	gcarter@umd.edu			Howard Hughes Medical Institute through the Science Education Program	Howard Hughes Medical Institute through the Science Education Program	This research was supported in part by a grant to the University of Maryland from the Howard Hughes Medical Institute through the Science Education Program.	Ancillotto L, 2012, ETHOLOGY, V118, P331, DOI 10.1111/j.1439-0310.2011.02016.x; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; August P.V., 1979, P151; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Baron G., 1996, COMP NEUROBIOLOGY CH; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Bhatnagar KP, 2008, BRAZ J BIOL, V68, P583, DOI 10.1590/S1519-69842008000300017; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Boeckle M, 2012, CURR BIOL, V22, P801, DOI 10.1016/j.cub.2012.03.023; Brent LJN, 2015, ANIM BEHAV, V103, P211, DOI 10.1016/j.anbehav.2015.01.020; Brent LJN, 2014, ANN NY ACAD SCI, V1316, P1, DOI 10.1111/nyas.12315; Byrne RW, 2004, P ROY SOC B-BIOL SCI, V271, P1693, DOI 10.1098/rspb.2004.2780; Canty A, 2015, BOOTSTRAP R S PLUS F; Carter GG, 2009, CAN J ZOOL, V87, P604, DOI 10.1139/Z09-051; Carter Gerald, 2013, Communicative & Integrative Biology, V6, pe25783, DOI 10.4161/cib.25783; Carter GG, 2008, ANIM BEHAV, V76, P1343, DOI 10.1016/j.anbehav.2008.04.023; Carter Gerald G., 2013, P225; Carter GG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2573; Carter GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038791; Connor RC, 2015, ANIM BEHAV, V103, P223, DOI 10.1016/j.anbehav.2015.02.019; de Waal FBM, 1997, J COMP PSYCHOL, V111, P370, DOI 10.1037/0735-7036.111.4.370; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fernandez AA, 2014, ANIM BEHAV, V98, P149, DOI 10.1016/j.anbehav.2014.10.011; FORAND KJ, 1989, AM MIDL NAT, V122, P357, DOI 10.2307/2425923; Fraser ON, 2012, ANIM BEHAV, V83, P171, DOI 10.1016/j.anbehav.2011.10.023; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; Fruteau C, 2011, ANIM BEHAV, V81, P1223, DOI 10.1016/j.anbehav.2011.03.008; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Gero S, 2015, ANIM BEHAV, V102, P15, DOI 10.1016/j.anbehav.2015.01.008; Gersick AS, 2015, ANIM BEHAV, V103, P107, DOI 10.1016/j.anbehav.2015.02.003; Gill SA, 2012, BEHAV ECOL SOCIOBIOL, V66, P757, DOI 10.1007/s00265-012-1323-6; Gomes CM, 2009, P ROY SOC B-BIOL SCI, V276, P699, DOI 10.1098/rspb.2008.1324; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; HEMELRIJK CK, 1991, ANIM BEHAV, V41, P923, DOI 10.1016/S0003-3472(05)80630-X; Hirsch BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037301; Holekamp KE, 2015, ANIM BEHAV, V103, P237, DOI 10.1016/j.anbehav.2015.01.023; Jaeggi AV, 2013, EVOL HUM BEHAV, V34, P69, DOI 10.1016/j.evolhumbehav.2012.09.005; Kerth Gerald, 2003, Acta Ethologica, V5, P107; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; Kimura R, 1998, APPL ANIM BEHAV SCI, V59, P265, DOI 10.1016/S0168-1591(97)00129-9; Knornschild M, 2014, BEHAVIOUR, V151, P781, DOI 10.1163/1568539X-00003171; Knornschild M, 2013, ANIM BEHAV, V86, P941, DOI 10.1016/j.anbehav.2013.08.011; Kudo H, 2001, ANIM BEHAV, V62, P711, DOI 10.1006/anbe.2001.1808; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; Kutsukake N, 2010, ANIM BEHAV, V79, P271, DOI 10.1016/j.anbehav.2009.10.014; Kwiecinski Gary G., 1999, Mammalian Species, V611, P1; Massen JJ, 2014, NATURE COMM, P5; Massen JJM, 2014, CURR BIOL, V24, P2733, DOI 10.1016/j.cub.2014.09.073; Matoba T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073044; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; MUROYAMA Y, 1994, BEHAVIOUR, V128, P103, DOI 10.1163/156853994X00064; Ophir AG, 2008, BRAIN BEHAV EVOLUT, V71, P32, DOI 10.1159/000108609; Ortega J, 2003, MOL ECOL, V12, P2409, DOI 10.1046/j.1365-294X.2003.01924.x; Ortega J, 2006, ACTA CHIROPTEROL, V8, P485, DOI 10.3161/1733-5329(2006)8[485:FIIHGO]2.0.CO;2; Ortega J, 2008, J MAMMAL, V89, P1372, DOI 10.1644/08-MAMM-S-056.1; Patterson BD, 2008, PARASITOL RES, V103, P1091, DOI 10.1007/s00436-008-1097-y; Prat Y, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500019; Radford AN, 2012, BIOL LETTERS, V8, P24, DOI 10.1098/rsbl.2011.0559; Roberts G, 1998, NATURE, V394, P175, DOI 10.1038/28160; RUSSELL EM, 1984, MAMMAL REV, V14, P101, DOI 10.1111/j.1365-2907.1984.tb00343.x; Russell J.K., 1983, P263; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Seyfarth RM, 2015, ANIM BEHAV, V103, P191, DOI 10.1016/j.anbehav.2015.01.030; Seyfarth RM, 2014, ANIM BEHAV, V87, P23, DOI 10.1016/j.anbehav.2013.10.008; Seyfarth RM, 2013, P NATL ACAD SCI USA, V110, P10349, DOI 10.1073/pnas.1301223110; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith JE, 2011, ANIM BEHAV, V81, P401, DOI 10.1016/j.anbehav.2010.11.007; Stopka P, 2001, BEHAV ECOL, V12, P584, DOI 10.1093/beheco/12.5.584; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; Tiddi B, 2011, BEHAV ECOL, V22, P663, DOI 10.1093/beheco/arr028; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; WILKINSON GS, 1986, ANIM BEHAV, V34, P1880, DOI 10.1016/S0003-3472(86)80274-3; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P111; WILLIAMS CF, 1986, ETHOLOGY, V71, P265; WOOD MT, 1977, ANIM BEHAV, V25, P635, DOI 10.1016/0003-3472(77)90114-2	85	48	49	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138430	10.1371/journal.pone.0138430	http://dx.doi.org/10.1371/journal.pone.0138430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445502	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600030
J	Chen, XGR; Fan, SA; Ware, RI; Etzkorn, FA				Chen, Xingguo R.; Fan, Shuang A.; Ware, Rachel I.; Etzkorn, Felicia A.			Stereochemical Control in the Still-Wittig Rearrangement Synthesis of Cyclohexyl (Z)-Alkene Inhibitors of Pin1	PLOS ONE			English	Article							PROLYL ISOMERASE PIN1; STEREOSELECTIVE-SYNTHESIS; CIS-PROLINE; REDUCTION; PROTEIN	Three stereoisomeric inhibitors of Pin1: (2R,5S)-, (2S,5R)-and (2S,5S)-Ac-pSer-Psi[(Z) CH = C]-pipecolyl(Pip)-2-(2-naphthyl) ethylamine 1, that mimic L-pSer-D-Pro, D-pSer-L-Pro, and D-pSer-D-Pro amides respectively, were synthesized by a 13-step route. The newly formed stereogenic centers in the pipecolyl ring were introduced by Luche reduction, followed by stereospecific [2,3]-Still-Wittig rearrangement. The (Z)-to (E)-alkene ratio in the rearrangements were consistently 5.5 to 1. The stereochemistry at the original Ser a-carbon controlled the stereochemistry of the Luche reduction, but it did not affect the stereochemical outcome of the rearrangement, which consistently gave the (Z)-alkene. The epimerized by-product, (2S,5S)-10, resulting from the work-up after Na/NH3 debenzylation of (2S,5R)-9, was carried on to the (2S,5S)-1 isomer. Compound (2S, 5S)-10 was resynthesized from the Luche reduction by-product, (2R, 3R)-3, and the stereochemistry was confirmed by comparison of the optical rotations. The IC50 values for (2R,5S)-1, (2S,5R)-1 and (2S,5S)-1 Pin1 inhibition were: 52, 85, and 140 mu M, respectively.	[Chen, Xingguo R.; Fan, Shuang A.; Ware, Rachel I.; Etzkorn, Felicia A.] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Etzkorn, FA (corresponding author), Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA.	fetzkorn@vt.edu		Etzkorn, Felicia A./0000-0001-5850-3661	NIH [R01 CA110940]; NSF LC-MS Grant [CHE0722638]; NATIONAL CANCER INSTITUTE [R01CA110940] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF LC-MS Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by NIH Grant No. R01 CA110940 (FAE) and the NSF LC-MS Grant No. CHE0722638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON DHR, 1983, TETRAHEDRON LETT, V24, P1605, DOI 10.1016/S0040-4039(00)81721-9; CHEREST M, 1968, TETRAHEDRON LETT, P2199; Esnault S, 2007, J ALLERGY CLIN IMMUN, V120, P1082, DOI 10.1016/j.jaci.2007.06.024; Hart SA, 2001, ORG LETT, V3, P1789, DOI 10.1021/ol015764d; Hart SA, 1998, J ORG CHEM, V63, P7580, DOI 10.1021/jo981387f; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; LUCHE JL, 1978, J CHEM SOC CHEM COMM, P601, DOI 10.1039/c39780000601; Ma SL, 2012, J BIOL CHEM, V287, P6969, DOI 10.1074/jbc.C111.298596; Misumi S, 2010, J BIOL CHEM, V285, P25185, DOI 10.1074/jbc.M110.114256; Moore JD, 2013, BIOORG MED CHEM LETT, V23, P4283, DOI 10.1016/j.bmcl.2013.05.088; NAHM S, 1981, TETRAHEDRON LETT, V22, P3815, DOI 10.1016/S0040-4039(01)91316-4; Namanja AT, 2011, P NATL ACAD SCI USA, V108, P12289, DOI 10.1073/pnas.1019382108; Namanja AT, 2010, J AM CHEM SOC, V132, P5607, DOI 10.1021/ja9096779; Niel G., 1994, J CHEM SOC P1, P1275; SEITZ DE, 1983, SYNTHETIC COMMUN, V13, P129, DOI 10.1080/00397918308061970; STILL WC, 1978, J AM CHEM SOC, V100, P1927, DOI 10.1021/ja00474a049; Wang XDJ, 2004, J AM CHEM SOC, V126, P15533, DOI 10.1021/ja046396m; Wang XDJ, 2003, J ORG CHEM, V68, P2343, DOI 10.1021/jo026663b; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Xu GYG, 2009, DRUG NEWS PERSPECT, V22, P399, DOI [10.1358/dnp.2009.22.7.1414594, 10.1358/dnp.2009.22.7.1381751]; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zhang MM, 2012, ACS CHEM BIOL, V7, P1462, DOI 10.1021/cb3000887; Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044; Zhao S, 2007, BIOORG MED CHEM LETT, V17, P6615, DOI 10.1016/j.bmcl.2007.09.073	26	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139543	10.1371/journal.pone.0139543	http://dx.doi.org/10.1371/journal.pone.0139543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445009	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600061
J	Legge, S; Garnett, S; Maute, K; Heathcote, J; Murphy, S; Woinarski, JCZ; Astheimer, L				Legge, Sarah; Garnett, Stephen; Maute, Kim; Heathcote, Joanne; Murphy, Steve; Woinarski, John C. Z.; Astheimer, Lee			A Landscape-Scale, Applied Fire Management Experiment Promotes Recovery of a Population of the Threatened Gouldian Finch, Erythrura gouldiae, in Australia's Tropical Savannas	PLOS ONE			English	Article							MONSOONAL NORTHERN AUSTRALIA; KAKADU NATIONAL-PARK; YINBERRIE HILLS AREA; WET-DRY TROPICS; BIODIVERSITY CONSERVATION; ECOSYSTEM MANAGEMENT; GRANIVOROUS BIRDS; SMALL MAMMALS; SOUTH-AFRICA; ARNHEM-LAND	Fire is an integral part of savanna ecology and changes in fire patterns are linked to biodiversity loss in savannas worldwide. In Australia, changed fire regimes are implicated in the contemporary declines of small mammals, riparian species, obligate-seeding plants and grass seed-eating birds. Translating this knowledge into management to recover threatened species has proved elusive. We report here on a landscape-scale experiment carried out by the Australian Wildlife Conservancy (AWC) on Mornington Wildlife Sanctuary in northwest Australia. The experiment was designed to understand the response of a key savanna bird guild to fire, and to use that information to manage fire with the aim of recovering a threatened species population. We compared condition indices among three seed-eating bird species-one endangered (Gouldian finch) and two non-threatened (long-tailed finch and double-barred finch)-from two large areas (> 2,830 km(2)) with initial contrasting fire regimes ('extreme': frequent, extensive, intense fire; versus 'benign': less frequent, smaller, lower intensity fires). Populations of all three species living with the extreme fire regime had condition indices that differed from their counterparts living with the benign fire regime, including higher haematocrit levels in some seasons (suggesting higher levels of activity required to find food), different seasonal haematocrit profiles, higher fat scores in the early wet season (suggesting greater food uncertainty), and then lower muscle scores later in the wet season (suggesting prolonged food deprivation). Gouldian finches also showed seasonally increasing stress hormone concentrations with the extreme fire regime. Cumulatively, these patterns indicated greater nutritional stress over many months for seed-eating birds exposed to extreme fire regimes. We tested these relationships by monitoring finch condition over the following years, as AWC implemented fire management to produce the 'benign' fire regime throughout the property. The condition indices of finch populations originally living with the extreme fire regime shifted to resemble those of their counterparts living with the benign fire regime. This research supports the hypothesis that fire regimes affect food resources for savanna seed-eating birds, with this impact mediated through a range of grass species utilised by the birds over different seasons, and that fire management can effectively moderate that impact. This work provides a rare example of applied research supporting the recovery of a population of a threatened species.	[Legge, Sarah; Maute, Kim; Heathcote, Joanne; Murphy, Steve] Australian Wildlife Conservancy, Subiaco East, WA 6008, Australia; [Garnett, Stephen; Woinarski, John C. Z.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Garnett, Stephen; Woinarski, John C. Z.] Charles Darwin Univ, Natl Environm Sci Programme, Threatened Species Recovery Hub, Darwin, NT 0909, Australia; [Maute, Kim] Univ Wollongong, Inst Conservat Biol & Environm Management, Wollongong, NSW 2522, Australia; [Murphy, Steve] Bush Heritage Australia, Melbourne, Vic, Australia; [Astheimer, Lee] Deakin Univ, DVC Res Off, Geelong, Vic 3220, Australia	Charles Darwin University; Charles Darwin University; University of Wollongong; Deakin University	Legge, S (corresponding author), Univ Queensland, Natl Environm Sci Programme, Threatened Species Recovery Hub, St Lucia, Qld, Australia.	SarahMariaLegge@gmail.com	Legge, Sarah/GYE-1554-2022; Maute, Kimberly L/D-4642-2017; Legge, Sarah/AAB-7229-2019	Maute, Kimberly L/0000-0003-4791-8743; Legge, Sarah/0000-0001-6968-2781	Australian Research Council Linkage grant; AWC; Rangelands NRM grant; Commonwealth Government's Caring For Our Country	Australian Research Council Linkage grant(Australian Research Council); AWC; Rangelands NRM grant; Commonwealth Government's Caring For Our Country	This research was funded by public donations to the Australian Wildlife Conservancy (AWC), an Australian Research Council Linkage grant (to SG, SL, JW, LA) and a Rangelands NRM grant (to SL, AWC). The fire management was funded by AWC supporters, Rangelands NRM, and the Commonwealth Government's Caring For Our Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x; Armstrong G, 2011, INT J WILDLAND FIRE, V20, P974, DOI 10.1071/WF10130; Astheimer LB, 2002, EMU, V102, P19, DOI 10.1071/MU01031; BACKEUS I, 1992, J VEG SCI, V3, P345, DOI 10.2307/3235759; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; BOWMAN DMJS, 1993, J BIOGEOGR, V20, P373, DOI 10.2307/2845586; Bradstock RA., 2002, FLAMMABLE AUSTR FIRE; Brazill-Boast J, 2011, EMU, V111, P304, DOI 10.1071/MU10064; Buchanan KL, 2000, TRENDS ECOL EVOL, V15, P156, DOI 10.1016/S0169-5347(99)01812-1; Burton CT, 2003, EMU, V103, P1, DOI 10.1071/MU02030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; COREY B, 2013, N KIMBERLEY LANDSCAP; Craig AB., 1992, ASPECTS POSTFIRE REG; Cresswell W, 2003, ANIM BEHAV, V65, P1035, DOI 10.1006/anbe.2003.2140; Crowley G, 1999, AUST J ECOL, V24, P208, DOI 10.1046/j.1442-9993.1999.00964.x; Crowley GM, 2001, AUST J BOT, V49, P735, DOI 10.1071/BT00090; Cuthill IC, 2000, BEHAV ECOL, V11, P189, DOI 10.1093/beheco/11.2.189; Dostine PL, 2002, EMU, V102, P159, DOI 10.1071/MU01034; Dostine PL, 2001, WILDLIFE RES, V28, P445, DOI 10.1071/WR00049; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; du Toit J.T., 2003, KRUGER EXPERIENCE EC; Dutson G, 2010, ACTION PLAN AUSTR BI; Ellis RD, 2012, LANDSCAPE ECOL, V27, P1, DOI 10.1007/s10980-011-9671-6; Fair J, 2007, IBIS, V149, P535, DOI 10.1111/j.1474-919X.2007.00680.x; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Franklin DC, 2005, WILDLIFE RES, V32, P399, DOI 10.1071/WR05052; Franklin DC, 1999, BIOL CONSERV, V90, P53, DOI 10.1016/S0006-3207(99)00010-5; Fraser Fiona, 2003, Ecological Management & Restoration, V4, P94, DOI 10.1046/j.1442-8903.2003.00142.x; GARNETT S, 1995, EMU, V95, P54, DOI 10.1071/MU9950054; Garnett ST, 2010, RANGELAND J, V32, P215, DOI 10.1071/RJ09083; Garnett S. T., 1994, AUSTR BIRD WATCHER, V5, P306; Garnett Stephen T., 2010, P191; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Gregory NC, 2010, CONSERV BIOL, V24, P1606, DOI 10.1111/j.1523-1739.2010.01533.x; Griffiths AD, 2014, INT J WILDLAND FIRE, V23, P1034, DOI 10.1071/WF14026; HIGGINS P. J., 2006, HDB AUSTR NZ ANTARCT; Kitaysky AS, 2010, FUNCT ECOL, V24, P625, DOI 10.1111/j.1365-2435.2009.01679.x; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Leahy L, 2013, RESPONSES SMALL MAMM; Legge S, 2015, ANIM CONSERV, V18, P113, DOI 10.1111/acv.12195; Legge S, 2012, BIODIVERSITY MONITORING IN AUSTRALIA, P127; Legge Sarah, 2011, Ecological Management & Restoration, V12, P84, DOI 10.1111/j.1442-8903.2011.00595.x; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Lewis M., 2007, TEMPORAL DIMENSIONS, P218, DOI [10.1007/978-0-387-45447-4_13, DOI 10.1007/978-0-387-45447-4_13]; Maute K, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov025; Maute KL, 2013, J COMP PHYSIOL B, V183, P1023, DOI 10.1007/s00360-013-0775-y; McGregor HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109097; Milenkaya O, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot020; Mott J, 1985, P ECOLOGICAL SOC AUS, V13; Murphy SA, 2010, WILDLIFE RES, V37, P145, DOI 10.1071/WR09007; O'Malley C, 2006, RECOVERY PLAN GOULDI; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; Parr CL, 2003, AUSTRAL ECOL, V28, P384, DOI 10.1046/j.1442-9993.2003.01296.x; PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003; PRICE O, 1994, J BIOGEOGR, V21, P573, DOI 10.2307/2846032; Price OF, 1999, BIOL CONSERV, V91, P169, DOI 10.1016/S0006-3207(99)00081-6; Prior LD, 2007, ECOL RES, V22, P228, DOI 10.1007/s11284-006-0011-2; Ritchie EG, 2013, CONSERV BIOL, V27, P1133, DOI 10.1111/cobi.12189; Rodrigues ASL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113934; Russell-Smith J, 1998, J APPL ECOL, V35, P829, DOI 10.1111/j.1365-2664.1998.tb00002.x; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Russell-Smith J, 2004, J BIOGEOGR, V31, P1293, DOI 10.1111/j.1365-2699.2004.01069.x; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, pV, DOI 10.1071/WF03074; Russell-Smith J, 2014, BIODIVERSITY ENV CHA, P335; Russell-Smith J., 2009, CULTURE ECOLOGY EC F; RussellSmith J, 1997, HUM ECOL, V25, P159, DOI 10.1023/A:1021970021670; RUSSELLSMITH J, 1992, BIOL CONSERV, V59, P51, DOI 10.1016/0006-3207(92)90713-W; Skroblin A, 2012, AUSTRAL ECOL, V37, P874, DOI 10.1111/j.1442-9993.2011.02331.x; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; TIDEMANN SC, 1994, EMU, V94, P46, DOI 10.1071/MU9940046; Tidemann SC, 1999, EMU, V99, P191, DOI 10.1071/MU99022; TIDEMANN SC, 1992, J TROP ECOL, V8, P373, DOI 10.1017/S0266467400006702; van Wilgen BW, 2011, BIOL CONSERV, V144, P1179, DOI 10.1016/j.biocon.2010.05.006; van Wilgen BW, 2007, INT J WILDLAND FIRE, V16, P519, DOI 10.1071/WF06115; Vigilante T., 2001, AUSTR GEOGRAPHICAL S, V39, P135, DOI [10.1111/1467-8470.00136, DOI 10.1111/1467-8470.00136]; WATKINSON AR, 1989, J ECOL, V77, P162, DOI 10.2307/2260923; Whelan R.J.., 1995, ECOLOGY FIRE; Williams R. J., 2003, FIRE TROPICAL SAVANN; Wingfield JC, 1997, BEHAV APPROACHES CON; Woinarski J, 2007, NATURE OF NORTHERN AUSTRALIA: NATURAL VALUES, ECOLOGICAL PROCESSES AND FUTURE PROSPECTS, P1; Woinarski J, 2014, 10 COMMITMENTS REVIS, P31; Woinarski JCZ, 2013, EMU, V113, P319, DOI 10.1071/MU12109; Woinarski JCZ, 2012, WILDLIFE RES, V39, P397, DOI 10.1071/WR11213; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; Woinarski JCZ, 2005, WILDLIFE RES, V32, P377, DOI 10.1071/WR03008; WOINARSKI JCZ, 1991, WILDLIFE RES, V18, P479, DOI 10.1071/WR9910479; WOINARSKI JCZ, 1990, AUST J ECOL, V15, P1, DOI 10.1111/j.1442-9993.1990.tb01016.x; WOINARSKI JCZ, 1992, EMU, V92, P33, DOI 10.1071/MU9920033; Woinarski JCZ, 2013, LAND, V2, P20, DOI 10.3390/land2010020; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Yibarbuk D, 2001, J BIOGEOGR, V28, P325, DOI 10.1046/j.1365-2699.2001.00555.x; Ziembicki Mark R., 2015, Therya, V6, P169, DOI 10.12933/therya-15-236	96	29	31	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137997	10.1371/journal.pone.0137997	http://dx.doi.org/10.1371/journal.pone.0137997			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445496	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600018
J	Molton, JS; Chee, YL; Hennedige, TP; Venkatesh, SK; Archuleta, S				Molton, James S.; Chee, Yen Lin; Hennedige, Tiffany P.; Venkatesh, Sudhakar K.; Archuleta, Sophia			Impact of Regional Vein Thrombosis in Patients with Klebsiella pneumoniae Liver Abscess	PLOS ONE			English	Article							TAIWAN	Klebsiella liver abscess (KLA) is an emerging infection in Asia caused by hypermucoviscous strains of Klebsiella pneumoniae. It is associated with thrombophlebitis of portal and hepatic veins. The natural history and role of anticoagulation for this regional thrombophlebitis is unclear. In a retrospective study of 169 subjects with KLA over 7 years, thrombophlebitis was identified in 53/169 (31.4%). Only 1 received therapeutic anticoagulation. Despite this 30/49 (73.2%) of those with follow up scan available showed improvement or recanalization (mean duration between scans 44 days). Abscess resolution was associated with improvement in thrombophlebitis.	[Molton, James S.; Archuleta, Sophia] Natl Univ Hlth Syst, Univ Med Cluster, Singapore, Singapore; [Molton, James S.; Chee, Yen Lin; Archuleta, Sophia] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Chee, Yen Lin] Natl Univ Hlth Syst, Dept Hematol Oncol, Singapore, Singapore; [Hennedige, Tiffany P.] Natl Univ Hlth Syst, Dept Diagnost Imaging, Singapore, Singapore; [Venkatesh, Sudhakar K.] Mayo Clin, Dept Radiol, Rochester, MN USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Mayo Clinic	Archuleta, S (corresponding author), Natl Univ Hlth Syst, Univ Med Cluster, Singapore, Singapore.	sophia@nus.edu.sg	Venkatesh, Sudhakar Kundapur/T-9385-2019; Molton, James S/M-3267-2016	Venkatesh, Sudhakar Kundapur/0000-0002-7514-1030; Molton, James S/0000-0002-2916-2818; Archuleta, Sophia/0000-0002-8414-6327				Alsaif HS, 2011, RADIOLOGY, V260, P129, DOI 10.1148/radiol.11101876; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Kim SB, 2007, J COMPUT ASSIST TOMO, V31, P59, DOI 10.1097/01.rct.0000224629.48068.69; Lee NK, 2011, BRIT J RADIOL, V84, P518, DOI 10.1259/bjr/23004588; Shin SU, 2013, ACTA RADIOL, V54, P557, DOI 10.1177/0284185113477400; Syed MA, 2007, EUR J RADIOL, V61, P513, DOI 10.1016/j.ejrad.2006.11.022; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Wang YF, 2013, INFECTION, V41, P1137, DOI 10.1007/s15010-013-0497-9	8	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140129	10.1371/journal.pone.0140129	http://dx.doi.org/10.1371/journal.pone.0140129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444702	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600143
J	Wolpert, F; Happold, C; Reifenberger, G; Florea, AM; Deenen, R; Roth, P; Neidert, MC; Lamszus, K; Westphal, M; Weller, M; Eisele, G				Wolpert, Fabian; Happold, Caroline; Reifenberger, Guido; Florea, Ana-Maria; Deenen, Rene; Roth, Patrick; Neidert, Marian Christoph; Lamszus, Katrin; Westphal, Manfred; Weller, Michael; Eisele, Guenter			Interferon-beta Modulates the Innate Immune Response against Glioblastoma Initiating Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; GLIOMA-CELLS; MALIGNANT GLIOMA; DOWN-REGULATION; STEM-CELLS; IFN-BETA; IN-VITRO; GENE; EXPRESSION; TUMOR	Immunotherapy targeting glioblastoma initiating cells (GIC) is considered a promising strategy. However, GIC are prone to evade immune response and there is a need for potent adjuvants. IFN-beta might enhance the immune response and here we define its net effect on the innate immunogenicity of GIC. The transcriptomes of GIC treated with IFN-beta and controls were assessed by microarray-based expression profiling for altered expression of immune regulatory genes. Several genes involved in adaptive and innate immune responses were regulated by IFN-beta. We validated these results using reverse transcription (RT)-PCR and flow cytometry for corresponding protein levels. The up-regulation of the NK cell inhibitory molecules HLA-E and MHC class I was balanced by immune stimulating effects including the up-regulation of nectin-2. In 3 out of 5 GIC lines tested we found a net immune stimulating effect of IFN-beta in cytotoxicity assays using NKL cells as effectors. IFN-beta therefore warrants further investigation as an adjuvant for immunotherapy targeting GIC.	[Wolpert, Fabian; Happold, Caroline; Roth, Patrick; Weller, Michael; Eisele, Guenter] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Reifenberger, Guido; Florea, Ana-Maria] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Reifenberger, Guido; Florea, Ana-Maria] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Deenen, Rene] Univ Dusseldorf, Ctr Biol & Med Res BMFZ, GTL, D-40225 Dusseldorf, Germany; [Neidert, Marian Christoph] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Lamszus, Katrin; Westphal, Manfred] Univ Hosp Hamburg Eppendorf, Dept Neurosurg, D-20246 Hamburg, Germany	University of Zurich; University Zurich Hospital; Heinrich Heine University Dusseldorf; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; University of Zurich; University Zurich Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wolpert, F (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	fabian.wolpert@usz.ch	Wolpert, Fabian/N-4191-2013; Roth, Patrick/R-6671-2018; Reifenberger, Guido/AAE-3599-2019	Roth, Patrick/0000-0003-3897-214X; Weller, Michael/0000-0002-1748-174X	Swiss National Science Foundation [SNF 31003A_130122]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (SNF 31003A_130122 to M. Weller), www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CZ, 2013, INT J PHARMACEUT, V445, P79, DOI 10.1016/j.ijpharm.2013.01.057; Balakrishnan R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat054; Bauvois B, 2009, BIOCHEM PHARMACOL, V78, P514, DOI 10.1016/j.bcp.2009.05.005; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Codo P, 2014, ONCOTARGET, V5, P7651, DOI 10.18632/oncotarget.2287; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Finocchiaro G, 2014, CURR OPIN ONCOL, V26, P608, DOI 10.1097/CCO.0000000000000135; Finocchiaro G, 2011, CURR OPIN NEUROL, V24, P641, DOI 10.1097/WCO.0b013e32834cbb17; Friese MA, 2004, ONKOLOGIE, V27, P487, DOI 10.1159/000080371; Friese MA, 2003, CANCER RES, V63, P8996; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Guo Y, 2012, ASIAN PAC J CANCER P, V13, P2837, DOI 10.7314/APJCP.2012.13.6.2837; Happold C, 2014, MOL CANCER THER, V13, P948, DOI 10.1158/1535-7163.MCT-13-0772; Heimberger AB, 2011, NEURO-ONCOLOGY, V13, P3, DOI 10.1093/neuonc/noq169; Huang H, 2013, J NEUROIMMUNOL, V258, P27, DOI 10.1016/j.jneuroim.2013.02.010; Johnson DR, 2012, CANCER-AM CANCER SOC, V118, P5608, DOI 10.1002/cncr.27590; Lee-MacAry AE, 2001, J IMMUNOL METHODS, V252, P83, DOI 10.1016/S0022-1759(01)00336-2; Li YB, 2013, MOL NEUROBIOL, V47, P1000, DOI 10.1007/s12035-013-8403-0; Mizuno M, 1998, CANCER IMMUNOL IMMUN, V47, P227, DOI 10.1007/s002620050525; Mohme M, 2014, CANCER TREAT REV, V40, P248, DOI 10.1016/j.ctrv.2013.08.008; Motomura K, 2011, CANCER-AM CANCER SOC, V117, P1721, DOI 10.1002/cncr.25637; Nakahara N, 2003, CANCER GENE THER, V10, P549, DOI 10.1038/sj.cgt.7700598; Nakajima H, 2012, VACCINE, V30, P722, DOI 10.1016/j.vaccine.2011.11.074; Natsume A, 2005, CANCER RES, V65, P7573, DOI 10.1158/0008-5472.CAN-05-0036; Natsume A, 2008, CANCER CHEMOTH PHARM, V61, P653, DOI 10.1007/s00280-007-0520-x; Odaka M, 2001, CANCER RES, V61, P6201; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Sin WX, 2012, IMMUNOL RES, V53, P25, DOI 10.1007/s12026-012-8293-7; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stegmann KA, 2012, J INFECT DIS, V205, P1351, DOI 10.1093/infdis/jis210; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tabatabai G, 2011, CELL TISSUE RES, V343, P459, DOI 10.1007/s00441-010-1123-0; VAN MEIR E, 1990, CANCER RES, V50, P6683; Wang BX, 2011, J INTERF CYTOK RES, V31, P545, DOI 10.1089/jir.2010.0158; Watanabe T, 2005, J NEURO-ONCOL, V72, P57, DOI 10.1007/s11060-004-2160-x; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Wiendl H, 2002, J IMMUNOL, V168, P4772, DOI 10.4049/jimmunol.168.9.4772; Williams RF, 2010, ANTICANCER RES, V30, P3301; Wischhusen J, 2005, J NEUROPATH EXP NEUR, V64, P523, DOI 10.1093/jnen/64.6.523; Wolpert F, 2014, NEURO-ONCOLOGY, V16, P382, DOI 10.1093/neuonc/not232; Wolpert F, 2012, J NEUROIMMUNOL, V250, P27, DOI 10.1016/j.jneuroim.2012.05.010; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004	45	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139603	10.1371/journal.pone.0139603	http://dx.doi.org/10.1371/journal.pone.0139603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441059	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000362510300037
J	Coghlan, R; Gardiner, E; Amanullah, F; Ihekweazu, C; Triasih, R; Grzemska, M; Sismanidis, C				Coghlan, Renia; Gardiner, Elizabeth; Amanullah, Farhana; Ihekweazu, Chikwe; Triasih, Rina; Grzemska, Malgorzata; Sismanidis, Charalambos			Understanding Market Size and Reporting Gaps for Paediatric TB in Indonesia, Nigeria and Pakistan: Supporting Improved Treatment of Childhood TB in the Advent of New Medicines	PLOS ONE			English	Article							TUBERCULOSIS; CHILDREN; EPIDEMIOLOGY; DIAGNOSIS; HOSPITALS	Objective of the Study We sought to understand gaps in reporting childhood TB cases among public and private sector health facilities (dubbed "non-NTP" facilities) outside the network of national TB control programmes, and the resulting impact of under-reporting on estimates of paediatric disease burden and market demand for new medicines. Methodology Exploratory assessments were carried out in Indonesia, Nigeria and Pakistan, reaching a range of facility types in two selected areas of each country. Record reviews and interviews of healthcare providers were carried out to assess numbers of unreported paediatric TB cases, diagnostic pathways followed and treatment regimens prescribed. Main Findings A total of 985 unreported diagnosed paediatric TB cases were identified over a three month period in 2013 in Indonesia from 64 facilities, 463 in Pakistan from 35 facilities and 24 in Nigeria from 20 facilities. These represent an absolute additional annualised yield to 2013 notifications reported to WHO of 15% for Indonesia, 2% for Nigeria and 7% for Pakistan. Only 12% of all facilities provided age and sex-disaggregated data. Findings highlight the challenges of confirming childhood TB. Diagnosis patterns in Nigeria highlight a very low suspicion for childhood TB. Providers note the need for paediatric medicines aligned to WHO recommendations. Conclusion: How Market Data Can Support Better Public Health Interventions This study emphasises the impact of incomplete reporting on the estimation of disease burden and potential market size of paediatric TB medicines. Further studies on "hubs" (facilities treating large numbers of childhood TB cases) will improve our understanding of the epidemic, support introduction efforts for new treatments and better measure markets for new paediatric medicines.	[Coghlan, Renia] TESS Dev Advisors, Geneva, Switzerland; [Amanullah, Farhana] Ind Hosp, Paediat TB Programme, Karachi, Pakistan; [Ihekweazu, Chikwe] EpiAfric, Abuja, Nigeria; [Triasih, Rina] Univ Gadjah Mada, Fac Med, Dr Sardjito Hosp, Dept Paediat, Yogyakarta, Indonesia; [Grzemska, Malgorzata; Sismanidis, Charalambos] WHO, Global TB Programme, CH-1211 Geneva, Switzerland	Central General Hospital Dr. Sardjito; Gadjah Mada University; World Health Organization	Coghlan, R (corresponding author), TESS Dev Advisors, Geneva, Switzerland.	renia@tessadvisors.org		Triasih, Rina/0000-0002-6907-3422	USAID; UNITAID; World Health Organization	USAID(United States Agency for International Development (USAID)); UNITAID; World Health Organization(World Health Organization)	The study was funded by a grant from USAID (www.usaid.gov) and UNITAID (www.unitaid.eu) to the Global Alliance for TB Drug Development and the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2013, STOP TB PARTN ROADM; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Brent AJ, 2008, T ROY SOC TROP MED H, V102, P217, DOI 10.1016/j.trstmh.2007.09.011; Chakraborty AK, 1999, IND J TUB, V46, P91; Cruz AT, 2007, PAEDIATR RESPIR REV, V8, P107, DOI 10.1016/j.prrv.2007.04.008; Datta M, 2001, Paediatr Respir Rev, V2, P91, DOI 10.1053/prrv.2000.0115; Detjen AK, 2012, PUBLIC HLTH ACTION; Dodd PJ, 2014, LANCET GLOBAL HLTH; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; Gie RP, 2009, INT J TUBERC LUNG D, V13, P277; Irawati SR, 2007, INT J TUBERC LUNG D, V11, P33; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Lestari T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-784; Lolekha R, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-94; Marais BJ, 2006, INT J TUBERC LUNG D, V10, P732; Marais BJ, 2007, ARCH DIS CHILD, V92, P446, DOI 10.1136/adc.2006.104976; Marais BJ, 2010, INFECT DIS CLIN N AM, V24, P727, DOI 10.1016/j.idc.2010.04.004; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278; Obimbo E, 2013, NIGERIA 2010 2015 NA; PREEZ KD, 2011, PUBLIC HLTH ACTION, V1, P19, DOI DOI 10.5588/PHA.11.0010; Schwalbe NR, INT J TUBERC LUNG DI, V12, P1173; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Starke JR, 2002, INT J TUBERC LUNG D, V6, P373; Stop TB Partnership World Health Organization Stop TB Department, 2012, NO MOR CRYING NO MOR; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; Teo SSS, 2009, EUR RESPIR J, V34, P176, DOI 10.1183/09031936.00031808; WHO, 2010, WHOHTMTB201013; World Health Organization, 2013, WHOHTMTB201315; World Health Organization, WHOHTMTB201403	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0138323	10.1371/journal.pone.0138323	http://dx.doi.org/10.1371/journal.pone.0138323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460607	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300006
J	Mester, B; Bauer, E; Wood, CE; Hermans, IF; Gasser, O				Mester, Brigitta; Bauer, Evelyn; Wood, Catherine E.; Hermans, Ian F.; Gasser, Olivier			Expression of CD1a and Type-1 Polarization Are Dissociated in Human Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							PPAR-GAMMA; NKT CELLS; T-CELL; ACTIVATION; MATURE; DIFFERENTIATION; EXPANSION; MELANOMA; PROFILE; PLASMA	Ex vivo generated monocyte-derived dendritic cell (moDC)-vaccines have long been touted as promising immunotherapeutic agents for cancer treatment, although the response rate generally remains low. The reasons for this are still unclear and confounded by the diversity in manufacturing protocols that may affect moDC function. Preclinical studies have shown that the stimulatory function of dendritic cells can be improved by engaging invariant NKT cells in vivo through the presentation of the glycolipid alpha-galactosylceramide via CD1d. However, expression of CD1d on moDC has been shown to be negatively correlated with expression of CD1a, which in turn has been suggested to be a surrogate marker for IL-12 secreting type-1 polarized moDC, the preferred functional characteristics for cancer vaccines. Here we challenge this notion by showing that plasma-derived lipids drive functional levels of CD1d expression, while CD1a expression can vary considerably in these cells without being correlated with a loss of polarization or immunogenicity.	[Mester, Brigitta; Bauer, Evelyn; Wood, Catherine E.; Hermans, Ian F.; Gasser, Olivier] Malaghan Inst Med Res, Wellington, New Zealand; [Wood, Catherine E.] Capital & Coast Dist Hlth Board, Wellington, New Zealand; [Hermans, Ian F.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Hermans, Ian F.] Maurice Wilkins Ctr, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; Victoria University Wellington	Gasser, O (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	ogasser@malaghan.org.nz	Hermans, Ian/I-3961-2013	Gasser, Olivier/0000-0002-8235-2274; Hermans, Ian/0000-0002-7584-887X	New Zealand Health Research Council [10/667]; New Zealand Lottery Health Research [341092]	New Zealand Health Research Council(Health Research Council of New Zealand); New Zealand Lottery Health Research	This work was supported by the New Zealand Health Research Council (IFH; http://www.hrc.govt.nz; Grant 10/667) and New Zealand Lottery Health Research (OG; http://www.communitymatters.govt.nz/Funding-and-grants-Lottery-grants-Lottery-Health-Research; Grant 341092).	Cernadas M, 2009, CLIN EXP IMMUNOL, V155, P523, DOI 10.1111/j.1365-2249.2008.03853.x; CHAM BE, 1976, J LIPID RES, V17, P176; Chang CCJ, 2000, J IMMUNOL, V165, P3584, DOI 10.4049/jimmunol.165.7.3584; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Dhodapkar MV, 2000, J CLIN INVEST, V105, pR9, DOI 10.1172/JCI9051; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Krasagakis K, 1998, BRIT J CANCER, V77, P1492, DOI 10.1038/bjc.1998.245; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nemunaitis J, 2001, CANCER INVEST, V19, P239, DOI 10.1081/CNV-100102550; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Paquin-Proulx D, 2013, BLOOD, V121, P4963, DOI 10.1182/blood-2013-04-499442; Petersen TR, 2010, IMMUNOL CELL BIOL, V88, P596, DOI 10.1038/icb.2010.9; Richter J, 2013, BLOOD, V121, P423, DOI 10.1182/blood-2012-06-435503; Seshadri C, 2013, J IMMUNOL, V191, P1586, DOI 10.4049/jimmunol.1300575; Smed-Sorensen A, 2008, BLOOD, V111, P5037, DOI 10.1182/blood-2007-07-099549; Szatmari I, 2004, IMMUNITY, V21, P95, DOI 10.1016/j.immuni.2004.06.003; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7	21	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140432	10.1371/journal.pone.0140432	http://dx.doi.org/10.1371/journal.pone.0140432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460687	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300094
J	Silwal-Pandit, L; Russnes, H; Borgen, E; Skarpeteig, V; Vollan, HKM; Schlichting, E; Karesen, R; Naume, B; Borresen-Dale, AL; Farnebo, M; Langerod, A				Silwal-Pandit, Laxmi; Russnes, Hege; Borgen, Elin; Skarpeteig, Veronica; Vollan, Hans Kristian Moen; Schlichting, Ellen; Karesen, Rolf; Naume, Bjorn; Borresen-Dale, Anne-Lise; Farnebo, Marianne; Langerod, Anita			The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer	PLOS ONE			English	Article							DNA-DAMAGE; DYSKERATOSIS-CONGENITA; TP53; SUSCEPTIBILITY; RADIOTHERAPY; EXPRESSION; SURVIVAL; THERAPY; REPAIR; GENES	WRAP53 protein controls intracellular trafficking of DNA repair proteins, the telomerase enzyme, and splicing factors. Functional loss of the protein has been linked to carcinogenesis, premature aging and neurodegeneration. The aim of this study was to investigate the prognostic significance of WRAP53 protein expression in breast cancer. A tissue microarray was constructed from primary breast tumors and immunostained by a polyclonal WRAP53 antibody to assess the protein expression pattern. Two different patient cohorts with long term follow-up were studied; a test-and a validation set of 154 and 668 breast tumor samples respectively. Breast cancer patients with tumor cells lacking the expression of WRAP53 in the nucleus had a significantly poorer outcome compared to patients with tumor cells expressing this protein in the nuclei (HR = 1.95, 95% CI = 1.09-3.51, rho = 0.025). Nuclear localization of WRAP53 was further shown to be an independent marker of prognosis in multivariate analysis (HR = 2.57, 95% CI = 1.27-5.19, rho = 0.008), and also significantly associated with better outcome in patients with TP53 mutation. Here we show that the subcellular localization of the WRAP53 protein has a significant impact on breast cancer survival, and thus has a potential as a clinical marker in diagnostics and treatment.	[Silwal-Pandit, Laxmi; Russnes, Hege; Skarpeteig, Veronica; Vollan, Hans Kristian Moen; Borresen-Dale, Anne-Lise; Langerod, Anita] Oslo Univ Hosp, Radiumhosp, Div Canc Med Surg & Transplantat, Dept Canc Genet,Inst Canc Res, N-0424 Oslo, Norway; [Russnes, Hege; Borgen, Elin] Oslo Univ Hosp, Dept Pathol, Div Diagnost & Intervent, N-0450 Oslo, Norway; [Vollan, Hans Kristian Moen; Naume, Bjorn] Oslo Univ Hosp, Dept Oncol, Div Canc Surg & Transplantat, N-0450 Oslo, Norway; [Silwal-Pandit, Laxmi; Russnes, Hege; Borgen, Elin; Vollan, Hans Kristian Moen; Karesen, Rolf; Naume, Bjorn; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0313 Oslo, Norway; [Schlichting, Ellen; Karesen, Rolf] Oslo Univ Hosp, Dept Breast & Endocrine Surg, Div Surg Canc & Transplantat, N-0450 Oslo, Norway; [Farnebo, Marianne] Karolinska Inst, CCK, Dept Oncol Pathol, SE-17176 Stockholm, Sweden	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet	Langerod, A (corresponding author), Oslo Univ Hosp, Radiumhosp, Div Canc Med Surg & Transplantat, Dept Canc Genet,Inst Canc Res, N-0424 Oslo, Norway.	Anita.Langerod@rr-research.no	Russnes, Hege Elisabeth Giercksky/N-6170-2015	Russnes, Hege Elisabeth Giercksky/0000-0001-8724-1891	EC FP6 [LSHC-CT-2004-502983]; Norwegian Cancer Society [0332]; Research Council of Norway [163027/V40]; South-Eastern Norway Regional Health Authority [2011079]; Radium Hospital Foundation	EC FP6(European CommissionEuropean Commission Joint Research Centre); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority; Radium Hospital Foundation	This work was supported by EC FP6 (LSHC-CT-2004-502983), Norwegian Cancer Society (0332), The Research Council of Norway (163027/V40), South-Eastern Norway Regional Health Authority (2011079), and The Radium Hospital Foundation.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Bug M, 2011, ONCOGENE, V30, P3612, DOI 10.1038/onc.2011.72; Frank Jr E.H., 2015, RMS REGRESSION MODEL, V5.1-4; Garcia-Closas M, 2007, INT J CANCER, V121, P2532, DOI 10.1002/ijc.22985; Garvin S, 2015, ORAL ONCOL, V51, P24, DOI 10.1016/j.oraloncology.2014.10.003; Hedstrom E, 2015, CELL DEATH IN PRESS; Henriksson S, 2014, GENE DEV, V28, P2726, DOI 10.1101/gad.246546.114; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Lan Q, 2009, CARCINOGENESIS, V30, P50, DOI 10.1093/carcin/bgn249; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Mahmoudi S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.90; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Medrek K, 2012, MOL BIOL REP; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pereboeva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076473; Rao XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091670; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wiedswang G, 2003, J CLIN ONCOL, V21, P3469, DOI 10.1200/JCO.2003.02.009; Zhang H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-294; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	25	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139965	10.1371/journal.pone.0139965	http://dx.doi.org/10.1371/journal.pone.0139965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460974	Green Submitted, gold, Green Published			2022-12-26	WOS:000362962300042
J	Zheng, M; Yang, Y; Liu, XQ; Liu, MY; Zhang, XF; Wang, X; Li, HP; Tan, JG				Zheng, Miao; Yang, Yang; Liu, Xiao-Qiang; Liu, Ming-Yue; Zhang, Xiao-Fei; Wang, Xin; Li, He-Ping; Tan, Jian-Guo			Enhanced Biological Behavior of In Vitro Human Gingival Fibroblasts on Cold Plasma-Treated Zirconia	PLOS ONE			English	Article							SOFT-TISSUE REACTIONS; INITIAL ATTACHMENT; SURFACE-TOPOGRAPHY; TITANIUM SURFACES; DENTAL IMPLANT; FLEXURAL STRENGTH; FUNCTIONAL-GROUPS; GENE-EXPRESSION; CELL-ADHESION; WETTABILITY	Objective To evaluate whether atmospheric-pressure dielectric-barrier-discharge plasma treatment of zirconia enhances its biocompatibility with human gingival fibroblasts. Materials and Methods The zirconia disks were divided into four groups and treated using helium atmospheric-pressure dielectric-barrier-discharge plasmas for 30, 60 or 90 s or left untreated. The surface morphology, wettability and chemical elements were analyzed. Fibroblasts density, morphology, morphometry and attachment-related genes expression were measured at different time points from 3 to 72 h. Results After plasma treatment, the surface morphology and roughness remained the same, while the contact angle decreased from 78.31 degrees to 43.71 degrees, and the surface C/O ratio decreased from 3.17 to 0.89. The surficial areas and perimeters of HGFs were increased two-fold in the treated groups at 3 h. Fibroblasts density increased on treated disks at all time points, especially the ones treated for 60 s. Attachment-related genes in the groups treated for 30 and 60 s were significantly higher at 3 and 24 h. Conclusion The helium atmospheric-pressure dielectric-barrier-discharge plasma treatment enhances the biological behavior of fibroblasts on zirconia by increasing the expression of attachment-related genes within 24 h and promoting the cell density during longer culture times. Wettability of zirconia, an important physicochemical property, has a vital influence on the cell behaviors.	[Zheng, Miao; Yang, Yang; Liu, Xiao-Qiang; Liu, Ming-Yue; Tan, Jian-Guo] Peking Univ, Dept Prosthodont, Sch Stomatol, Beijing 100081, Peoples R China; [Zhang, Xiao-Fei; Li, He-Ping] Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China; [Wang, Xin] North China Univ Sci & Technol, Coll Mech Engn, Tangshan 063009, Peoples R China	Peking University; Tsinghua University; North China University of Science & Technology	Li, HP (corresponding author), Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China.	liheping@tsinghua.edu.cn; kqtanjg@bjmu.edu.cn	Li, He-Ping/C-1109-2017	Li, He-Ping/0000-0002-3149-757X; Liu, Xiaoqiang/0000-0002-3427-2130	National Natural Science Foundation of China [81200807, 11475103]; Foundation of Peking University School of Stomatology [YS020212]; Research Fund for the Doctoral Program of Higher Education [20120001110044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Peking University School of Stomatology; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	Funding was provided by the National Natural Science Foundation of China (Grant Nos. 81200807 and 11475103), the Foundation of Peking University School of Stomatology (Grant No. YS020212), and the Research Fund for the Doctoral Program of Higher Education (Grant No. 20120001110044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson I, 1998, J CLIN PERIODONTOL, V25, P721, DOI 10.1111/j.1600-051X.1998.tb02513.x; Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; An N, 2012, DENT MATER, V28, P1207, DOI 10.1016/j.dental.2012.08.007; Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013; Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x; BUSER D, 1992, J PERIODONTOL, V63, P225, DOI 10.1902/jop.1992.63.3.225; Canullo L, 2013, INT J ORAL MAX IMPL, V28, P957, DOI 10.11607/jomi.2664; Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x; Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; Gomez-Florit M, 2014, J PERIODONTAL RES, V49, P425, DOI 10.1111/jre.12121; Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001; Han Y, 2009, J BIOMED MATER RES A, V88A, P117, DOI 10.1002/jbm.a.31859; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147; Hoffmann C, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-21; Holst S, 2005, J ORAL MAXIL SURG, V63, P89, DOI 10.1016/j.joms.2005.05.161; Ito A., 1993, Clinical Materials, V12, P203, DOI 10.1016/0267-6605(93)90074-H; Jin C, 2012, J BIOMED MATER RES B, V100B, P2167, DOI 10.1002/jbm.b.32784; Kenny FN, 2015, CELL TISSUE RES, V360, P571, DOI 10.1007/s00441-014-2064-9; Kim JH, 2014, ACTA ODONTOL SCAND, V72, P1, DOI 10.3109/00016357.2013.795660; Kobune K, 2014, DENT MATER J, V33, P696, DOI 10.4012/dmj.2014-087; Lai YZ, 2013, J DENT, V41, P1109, DOI 10.1016/j.jdent.2013.08.004; Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688; Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P56, DOI 10.1111/j.1600-0501.2008.01597.x; Li J., 1993, Clinical Materials, V12, P197, DOI 10.1016/0267-6605(93)90073-G; Lyapin A, 2005, ACTA MATER, V53, P2925, DOI 10.1016/j.actamat.2005.03.009; Marin-Pareja N, 2014, COLLOID SURFACE B, V122, P601, DOI 10.1016/j.colsurfb.2014.07.038; Moon IS, 1999, J CLIN PERIODONTOL, V26, P658, DOI 10.1034/j.1600-051X.1999.261005.x; Mustafa K, 1998, CLIN ORAL IMPLAN RES, V9, P195, DOI 10.1034/j.1600-0501.1998.090307.x; Mustafa K, 2008, CLIN ORAL IMPLAN RES, V19, P1178, DOI 10.1111/j.1600-0501.2008.01560.x; Noro A, 2013, J BIOMED MATER RES B, V101B, P355, DOI 10.1002/jbm.b.32846; Papanagiotou HP, 2006, J PROSTHET DENT, V96, P154, DOI 10.1016/j.prosdent.2006.08.004; Park JH, 2012, ACTA BIOMATER, V8, P1966, DOI 10.1016/j.actbio.2011.11.026; Pivodova V, 2011, BIOMED PAP, V155, P109, DOI 10.5507/bp.2011.021; QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801; Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045719; Shon WJ, 2014, CLIN ORAL IMPLAN RES, V25, P573, DOI 10.1111/clr.12115; Silva NRFA, 2011, J BIOMED MATER RES B, V99B, P199, DOI 10.1002/jbm.b.31887; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071; Watanabe H, 2012, DENT MATER J, V31, P806, DOI 10.4012/dmj.2012-069; Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K; Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002; Yamano S, 2011, INT J ORAL MAX IMPL, V26, P1247; Yang Y, 2015, J BIOMED MATER RES B, V103, P116, DOI 10.1002/jbm.b.33183; Zitzmann NU, 2002, J CLIN PERIODONTOL, V29, P456, DOI 10.1034/j.1600-051X.2002.290511.x	49	27	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140278	10.1371/journal.pone.0140278	http://dx.doi.org/10.1371/journal.pone.0140278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461253	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300077
J	Michiels, B; Appelen, L; Franck, B; den Heijer, CDJ; Bartholomeeusen, S; Coenen, S				Michiels, Barbara; Appelen, Lien; Franck, Barbara; den Heijer, Casper D. J.; Bartholomeeusen, Stefaan; Coenen, Samuel			Staphylococcus aureus, Including Meticillin-Resistant Staphylococcus aureus, among General Practitioners and Their Patients: A Cross-Sectional Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; NASAL CARRIAGE; TROMSO STAPHYLOCOCCUS; SPA TYPES; PREVALENCE; TRANSMISSION; POPULATION; COMMUNITY; CARRIERS; GPS	Background The role of general practitioners (GPs) as reservoir and potential source for Staphylococcus aureus (SA) transmission is unknown. Our primary objective was to evaluate the prevalence of SA and community-acquired methicillin resistant SA (CA-MRSA) carrier status (including spa typing) among GPs and their patients in Belgium. The secondary objective was to determine the association between SA/CA-MRSA carriage in patients and their characteristics, SA carriage in GPs, GP and practice characteristics. Methods The Belgian GPs, who swabbed their patients in the APRES study (which assessed the prevalence of SA nasal carriage in nine European countries; November 2010 - June 2011), were asked to swab themselves as well (May-June 2011). GPs and their patients had to complete a questionnaire on factors related to SA carriage and transmission. SA isolation including CA-MRSA and spa typing was performed on the swabs. Results In eighteen practices 34 GPs swabbed patients of which 25 GPs provided personal swabs. The analysis was performed on 3008 patient records. Among GPs SA carriage (28%) was more prevalent than among their patients (19.2%), but CA-MRSA carriage was not present. SA was more prevalent among younger patients and those living with cattle. Spa typing SA and MRSA strains did not suggest correlation within practices or between patients and GPs, but chronic skin conditions of GPs and always handshaking patients by SA positive GPs were associated with more SA among patients, and hand washing after every patient contact with less SA among patients in practices with high antibiotic prescribing rates. Conclusion No MRSA was found among GPs, although their SA carriership was higher compared to their patients'. Spa types did not cluster within practices, possibly due to difference in timing of swabbing. To minimise SA transmission to their patients GPs should consider taking appropriate care of their chronic skin diseases, antibiotic prescribing behaviour, handshaking and hand washing habits.	[Michiels, Barbara; Bartholomeeusen, Stefaan; Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Ctr Gen Practice, Dept Primary & Interdisciplinary Care Antwerp, B-2020 Antwerp, Belgium; [Appelen, Lien; Franck, Barbara] Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [den Heijer, Casper D. J.] Maastricht Univ, Med Ctr, CAPHRI, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands; [Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Lab Med Microbiol, Vaccine & Infect Dis Inst VAXINFECTIO, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; Maastricht University; Maastricht University Medical Centre (MUMC); University of Antwerp	Michiels, B (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Gen Practice, Dept Primary & Interdisciplinary Care Antwerp, B-2020 Antwerp, Belgium.	barbara.michiels@uantwerpen.be	Coenen, Samuel JA/A-6410-2011; Michiels, Barbara/J-4046-2016	Coenen, Samuel JA/0000-0002-1238-8052; Michiels, Barbara/0000-0001-6904-9919	European Commission Directorate-General for Research within its 7th Framework Programme [223083]	European Commission Directorate-General for Research within its 7th Framework Programme	The collection and laboratory analysis of data of patients was carried out as part of the APRES study which was funded by the European Commission Directorate-General for Research within its 7th Framework Programme (grant agreement 223083). The sponsor had no influence on the study design, collection, analysis, and interpretation of data; on the writing of the report or on the decision to submit the paper for publication. The researchers were independent from the funders. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Champion AE, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0033-5; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; den Heijer CDJ, 2013, LANCET INFECT DIS, V13, P409, DOI 10.1016/S1473-3099(13)70036-7; Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319; Halablab MA, 2010, EPIDEMIOL INFECT, V138, P702, DOI 10.1017/S0950268809991233; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lim KT, 2012, INDIAN J MICROBIOL, V52, P593, DOI 10.1007/s12088-012-0286-7; Lucet JC, 2010, CLIN INFECT DIS, V51, P585, DOI 10.1086/655695; Mulqueen J, 2007, BRIT J GEN PRACT, V57, P811; Olsen K, 2013, EPIDEMIOL INFECT, V141, P143, DOI 10.1017/S0950268812000465; Olsen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063716; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Rijnders MIA, 2010, BRIT J GEN PRACT, V60, P902, DOI 10.3399/bjgp10X544078; Ruppitsch W, 2006, J CLIN MICROBIOL, V44, P2442, DOI 10.1128/JCM.00113-06; Sangvik M, 2011, J CLIN MICROBIOL, V49, P4213, DOI 10.1128/JCM.05290-11; Thibaut S, 2010, CLIN MICROBIOL INFEC, V16, P915, DOI 10.1111/j.1469-0691.2009.02953.x; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; van Bijnen EME, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-293; Verkade E, 2013, CLIN INFECT DIS, V57, pE11, DOI 10.1093/cid/cit228; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	21	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140045	10.1371/journal.pone.0140045	http://dx.doi.org/10.1371/journal.pone.0140045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458264	gold, Green Submitted, Green Published			2022-12-26	WOS:000362961100020
J	Cho, ST; Chang, HH; Egamberdieva, D; Kamilova, F; Lugtenberg, B; Kuo, CH				Cho, Shu-Ting; Chang, Hsing-Hua; Egamberdieva, Dilfuza; Kamilova, Faina; Lugtenberg, Ben; Kuo, Chih-Horng			Genome Analysis of Pseudomonas fluorescens PCL1751: A Rhizobacterium that Controls Root Diseases and Alleviates Salt Stress for Its Plant Host	PLOS ONE			English	Article							SEQUENCE; DIVERSITY; GROWTH; COLONIZATION; RHIZOSPHERE; TOLERANCE; EVOLUTION; ALIGNMENT; GENES; KEGG	Pseudomonas fluorescens PCL1751 is a rod-shaped Gram-negative bacterium isolated from the rhizosphere of a greenhouse-grown tomato plant in Uzbekistan. It controls several plant root diseases caused by Fusarium fungi through the mechanism of competition for nutrients and niches (CNN). This mechanism does not rely on the production of antibiotics, so it avoids the concerns of resistance development and is environmentally safe. Additionally, this bacterium promotes plant growth by alleviating salt stress for its plant host. To investigate the genetic mechanisms that may explain these observations, we determined the complete genome sequence of this bacterium, examined its gene content, and performed comparative genomics analysis with other Pseudomonas strains. The genome of P. fluorescens PCL1751 consisted of one circular chromosome that is 6,143,950 basepairs (bp) in size; no plasmid was found. The annotation included 19 rRNA, 70 tRNA, and 5,534 protein-coding genes. The gene content analysis identified a large number of genes involved in chemotaxis and motility, colonization of the rhizosphere, siderophore biosynthesis, and osmoprotectant production. In contrast, the pathways involved in the biosynthesis of phytohormones or antibiotics were not found. Comparison with other Pseudomonas genomes revealed extensive variations in their genome size and gene content. The presence and absence of secretion system genes were highly variable. As expected, the synteny conservation among strains decreased as a function of phylogenetic divergence. The integration of prophages appeared to be an important driver for genome rearrangements. The whole-genome gene content analysis of this plant growth-promoting rhizobacterium (PGPR) provided some genetic explanations to its phenotypic characteristics. The extensive and versatile substrate utilization pathways, together with the presence of many genes involved in competitive root colonization, provided further support for the finding that this strain achieves biological control of pathogens through effective competition for nutrients and niches.	[Cho, Shu-Ting; Chang, Hsing-Hua; Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Egamberdieva, Dilfuza] Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany; [Kamilova, Faina] Koppert Biol Syst, NL-2651 BE Berkel, Netherlands; [Lugtenberg, Ben] Leiden Univ, Sylvius Lab, Inst Biol, Leiden, Netherlands; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei, Taiwan; [Kuo, Chih-Horng] Acad Sinica, Taipei 115, Taiwan; [Kuo, Chih-Horng] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Koppert Biological Systems; Leiden University; Leiden University - Excl LUMC; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University	Kuo, CH (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	chk@gate.sinica.edu.tw	Kuo, Chih-Horng/E-2045-2013; Egamberdieva, Dilfuza/A-1349-2014	Kuo, Chih-Horng/0000-0002-2857-0529; Egamberdieva, Dilfuza/0000-0001-9811-9277; Cho, Shu-Ting/0000-0003-2140-5165	Academia Sinica; World Academy of Sciences; Alexander von Humboldt Foundation; commercial company, Koppert Biological Systems	Academia Sinica(Academia Sinica - Taiwan); World Academy of Sciences; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); commercial company, Koppert Biological Systems	Funding for this work was provided by research grants from Academia Sinica to CHK. DE was supported by the World Academy of Sciences and Alexander von Humboldt Foundation. A commercial company, Koppert Biological Systems, provided support in the form of salary for FK. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barea J.M., 2015, PRINCIPLES PLANT MIC, P225, DOI 10.1007/978-3-319-08575-3_24; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Berg G., 2013, MOL MICROBIAL ECOLOG, P587, DOI [10.1002/9781118297674.ch55, DOI 10.1002/9781118297674.CH55]; Brandel J, 2012, DALTON T, V41, P2820, DOI 10.1039/c1dt11804h; Browne P, 2009, APPL SOIL ECOL, V43, P131, DOI 10.1016/j.apsoil.2009.06.010; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang JH, 2014, ANNU REV PHYTOPATHOL, V52, P317, DOI 10.1146/annurev-phyto-011014-015624; Chang TH, 2014, GENOME BIOL EVOL, V6, P500, DOI 10.1093/gbe/evu033; Cordero P, 2012, SYST APPL MICROBIOL, V35, P342, DOI 10.1016/j.syapm.2012.04.005; Cornelis P, 2009, ENV MICROBIOL REP, V1, P256, DOI 10.1111/j.1758-2229.2009.00041.x; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Dodd IC, 2010, ANN APPL BIOL, V157, P361, DOI 10.1111/j.1744-7348.2010.00439.x; Dorr J, 1998, MOL MICROBIOL, V30, P7, DOI 10.1046/j.1365-2958.1998.01010.x; Duan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058640; Dueholm MS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00898-14; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egamberdieva D, 2008, ENVIRON MICROBIOL, V10, P1, DOI 10.1111/j.1462-2920.2007.01424.x; Egamberdieva D, 2013, PLANT SOIL, V369, P453, DOI 10.1007/s11104-013-1586-3; Egamberdieva D, 2011, BIOL FERT SOILS, V47, P197, DOI 10.1007/s00374-010-0523-3; Egamberdieva D, 2009, BIOL FERT SOILS, V45, P563, DOI 10.1007/s00374-009-0366-y; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Girlanda M, 2001, APPL ENVIRON MICROB, V67, P1851, DOI 10.1128/AEM.67.4.1851-1864.2001; Gjermansen M, 2006, FEMS MICROBIOL LETT, V265, P215, DOI 10.1111/j.1574-6968.2006.00493.x; Glick B.R., 2015, PRINCIPLES PLANT MIC, P257, DOI DOI 10.1007/978-3-319-08575-3_27; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jousset A, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00322-14; Kamilova F, 2005, ENVIRON MICROBIOL, V7, P1809, DOI 10.1111/j.1462-2920.2005.00889.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ku CA, 2013, GENOME BIOL EVOL, V5, P1151, DOI 10.1093/gbe/evt084; Kuo CH, 2011, POPULATION GENETICS OF BACTERIA: A TRIBUTE TO THOMAS S. WHITTAM, P31; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Kuo CH, 2009, FEMS MICROBIOL REV, V33, P38, DOI 10.1111/j.1574-6976.2008.00140.x; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu YH, 2008, PHYTOPATHOLOGY, V98, P830, DOI 10.1094/PHYTO-98-7-0830; Lo WS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01005-14; Lo WS, 2013, GENOME BIOL EVOL, V5, P1512, DOI 10.1093/gbe/evt108; Lo WS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-22; Loewen PC, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00689-14; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lugtenberg BJJ, 2004, PSEUDOMONAS, VOL 1: GENOMICS, LIFE STYLE AND MOLECULAR ARCHITECTURE, P403; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Ma LS, 2014, CELL HOST MICROBE, V16, P94, DOI 10.1016/j.chom.2014.06.002; Miller SH, 2010, ENV MICROBIOL REP, V2, P403, DOI 10.1111/j.1758-2229.2009.00105.x; Nadeem SM, 2009, CAN J MICROBIOL, V55, P1302, DOI [10.1139/W09-092, 10.1139/w09-092]; Nowak-Thompson B, 1999, J BACTERIOL, V181, P2166, DOI 10.1128/JB.181.7.2166-2174.1999; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pieterse C.M.J., 2015, PRINCIPLES PLANT MIC, P123, DOI DOI 10.1007/978-3-319-08575-3_14; Pliego C, 2011, BACTERIA IN AGROBIOLOGY: CROP ECOSYSTEMS, P295, DOI 10.1007/978-3-642-18357-7_11; Rangarajan S, 2001, J APPL MICROBIOL, V91, P742, DOI 10.1046/j.1365-2672.2001.01442.x; Ravel J, 2003, TRENDS MICROBIOL, V11, P195, DOI 10.1016/S0966-842X(03)00076-3; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schnider-Keel U, 2001, APPL ENVIRON MICROB, V67, P5683, DOI 10.1128/AEM.67.12.5683-5693.2001; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Spaepen S., 2015, PRINCIPLES PLANT MIC, P247, DOI DOI 10.1007/978-3-319-08575-3_26; Thomashow L., 2015, PRINCIPLES PLANT MIC, P165, DOI DOI 10.1007/978-3-319-08575-3_18; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Weert S. de, 2007, Biological control of plant diseases, P103; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	74	31	33	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140231	10.1371/journal.pone.0140231	http://dx.doi.org/10.1371/journal.pone.0140231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452056	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200050
J	Wang, HY; Guo, MZ; Liu, FH; Wang, JL; Zhou, Z; Ji, J; Ye, YH; Song, WQ; Liu, SG; Sun, B				Wang, Haiyan; Guo, Mingzhen; Liu, Fenghua; Wang, Jingli; Zhou, Zheng; Ji, Jing; Ye, Yuanhua; Song, Weiqing; Liu, Shiguo; Sun, Bo			Role of IL-17 Variants in Preeclampsia in Chinese Han Women	PLOS ONE			English	Article							GENE POLYMORPHISMS; OXIDATIVE STRESS; T-CELLS; ASSOCIATION; RECEPTOR; INTERLEUKIN-17; SUSCEPTIBILITY; HYPERTENSION; RISK	Previous studies have suggested an important role for IL-17, mainly secreted by Th17 cells, in the development of systemic inflammation in preeclampsia (PE). This study therefore investigated the association between genetic variants in IL-17A, IL-17F, and IL-17RA and susceptibility to PE in Chinese Han women. We recruited 1,031 PE patients and 1,298 controls of later pregnant women, and used TaqMan allelic discrimination real-time PCR to genotype the polymorphisms of IL17A rs2275913, IL-17F rs763780, and IL-17RA rs4819554. No significant differences in genotypic or allelic frequencies were found at all three polymorphic sites between PE patients and controls (rs2275913: genotype chi(2) = 0.218, p = 0.897 and allele chi(2) = 0.157, p = 0.692, OR = 1.024, 95% CI 0.911-1.152; rs763780: genotype chi(2) = 1.948, p = 0.377 and allele chi(2) = 1.242, p = 0.265, OR = 0.897, 95% CI 0.741-1.086; rs4819554: genotype chi(2) = 0.633, p = 0.729 and allele chi(2) = 0.115, p = 0.735, OR = 1.020, 95% CI 0.908-1.146). There were also no significant differences in genetic distributions between mild/severe PE or early/late-onset PE and control subgroups. Our data indicate that the genetic variants of rs2275913 in IL-17A, rs763780 in IL-17F, and rs4819554 in IL-17RA may not play a role in the pathogenesis of PE in Chinese Han women. However, these findings should be confirmed in other ethnic populations.	[Wang, Haiyan; Guo, Mingzhen; Sun, Bo] Qingdao Univ, Affiliated Hosp, Dept Blood Transfus, Qingdao 266071, Peoples R China; [Liu, Fenghua] Harbin Med Univ, Affiliated Hosp 1, Dept Blood Transfus, Harbin, Peoples R China; [Wang, Jingli; Zhou, Zheng; Ye, Yuanhua; Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao 266071, Peoples R China; [Ji, Jing] Qingdao Univ, Coll Med, Dept Pathogen Microorganisms, Qingdao 266071, Peoples R China; [Song, Weiqing] Qingdao Municipal Hosp Grp, Dept Clin Lab, Qingdao, Peoples R China	Qingdao University; Harbin Medical University; Qingdao University; Qingdao University; Qingdao Municipal Hospital	Liu, SG (corresponding author), Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao 266071, Peoples R China.	qysunbo@163.com			National Natural Science Foundation of China [81371499, 30971586]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81371499 and 30971586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Alvarez-Fernandez I, 2014, CLIN CHEM LAB MED, V52, P1159, DOI 10.1515/cclm-2013-0901; Anvari F, 2015, IRAN J IMMUNOL, V12, P117, DOI IJIv12i2A4; Cheng DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078173; Cornelius D C, 2014, Minerva Ginecol, V66, P243; Cornelius DC, 2013, HYPERTENSION, V62, P1068, DOI 10.1161/HYPERTENSIONAHA.113.01514; Coto E, 2015, HUM IMMUNOL, V76, P75, DOI 10.1016/j.humimm.2015.01.027; Darmochwal-Kolarz Dorota, 2014, Dev Period Med, V18, P141; de Groot CJM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.047; Dhillion P, 2012, AM J PHYSIOL-REG I, V303, pR353, DOI 10.1152/ajpregu.00051.2012; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hansson SR, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00516; Hayashi R, 2013, CLIN EXP MED, V13, P239, DOI 10.1007/s10238-012-0206-5; Jeyabalan A, 2013, NUTR REV, V71, pS18, DOI 10.1111/nure.12055; Kawaguchi M, 2006, J ALLERGY CLIN IMMUN, V117, P795, DOI 10.1016/j.jaci.2005.12.1346; Kim YG, 2012, AM J NEPHROL, V36, P472, DOI 10.1159/000343571; Ferrer RL, 2013, MEDICC REV, V15, P22, DOI 10.37757/MR2013V15.N3.6; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Li J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05250; LIN H, 1993, J IMMUNOL, V151, P4562; Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200; Naderi M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.11195; Najafi S, 2014, J ASSIST REPROD GEN, V31, P1491, DOI 10.1007/s10815-014-0294-0; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; Perez-Sepulveda A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00244; Pontillo A, 2015, AM J REPROD IMMUNOL, V73, P577, DOI 10.1111/aji.12353; Procopciuc LM, 2014, J MATERN-FETAL NEO M, V27, P1754, DOI 10.3109/14767058.2014.942625; Rolfo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059403; Saito S, 2010, IMMUNOL CELL BIOL, V88, P615, DOI 10.1038/icb.2010.68; Sowmya S, 2014, INFLAMMATION, V37, P1022, DOI 10.1007/s10753-014-9824-2; Toldi G, 2011, AM J REPROD IMMUNOL, V66, P223, DOI 10.1111/j.1600-0897.2011.00987.x; Wang X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096299, 10.1371/journal.pone.0085760]; Zhang XP, 2011, PROTEIN CELL, V2, P26, DOI 10.1007/s13238-011-1006-5	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140118	10.1371/journal.pone.0140118	http://dx.doi.org/10.1371/journal.pone.0140118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451724	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200039
J	Perazzoli, G; Prados, J; Ortiz, R; Caba, O; Cabeza, L; Berdasco, M; Gonzalez, B; Melguizo, C				Perazzoli, Gloria; Prados, Jose; Ortiz, Raul; Caba, Octavio; Cabeza, Laura; Berdasco, Maria; Gonzalez, Beatriz; Melguizo, Consolacion			Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression	PLOS ONE			English	Article							MISMATCH REPAIR DEFICIENCY; MULTIDRUG-RESISTANCE; PROTEIN EXPRESSION; PROMOTER METHYLATION; APOPTOSIS; SURVIVAL; CANCER; MECHANISM; GENE; METHYLTRANSFERASE	Background The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme patients. However, TMZ resistance may be one of the main reasons why treatment fails. Although this resistance has frequently been linked to the expression of O6-methylguanine-DNA methyltransferase (MGMT) it seems that this enzyme is not the only molecular mechanism that may account for the appearance of drug resistance in glioblastoma multiforme patients as the mismatch repair (MMR) complex, P-glycoprotein, and/or the presence of cancer stem cells may also be implicated. Methods Four nervous system tumor cell lines were used to analyze the modulation of MGMT expression and MGMT promoter methylation by TMZ treatment. Furthermore, 5-aza-2'-deoxycytidine was used to demethylate the MGMT promoter and O(6)-benzylguanine to block GMT activity. In addition, MMR complex and P-glycoprotein expression were studied before and after TMZ exposure and correlated with MGMT expression. Finally, the effect of TMZ exposure on CD133 expression was analyzed. Results Our results showed two clearly differentiated groups of tumor cells characterized by low (A172 and LN229) and high (SF268 and SK-N-SH) basal MGMT expression. Interestingly, cell lines with no MGMT expression and low TMZ IC50 showed a high MMR complex expression, whereas cell lines with high MGMT expression and high TMZ IC50 did not express the MMR complex. In addition, modulation of MGMT expression in A172 and LN229 cell lines was accompanied by a significant increase in the TMZ IC50, whereas no differences were observed in SF268 and SK-N-SH cell lines. In contrast, P-glycoprotein and CD133 was found to be unrelated to TMZ resistance in these cell lines. Conclusions These results may be relevant in understanding the phenomenon of TMZ resistance, especially in glioblastoma multiforme patients laking MGMT expression, and may also aid in the design of new therapeutic strategies to improve the efficacy of TMZ in glioblastoma multiforme patients.	[Perazzoli, Gloria; Prados, Jose; Cabeza, Laura; Melguizo, Consolacion] Inst Biopathol & Regenerat Med IBIMER, Granada, Spain; [Prados, Jose; Melguizo, Consolacion] Univ Granada, SAS, Biosanitary Inst Granada Ibs GRANADA, Granada, Spain; [Ortiz, Raul; Caba, Octavio] Univ Jaen, Dept Hlth Sci, Jaen, Spain; [Berdasco, Maria] Bellvitge Biomed Res Inst, Canc Epigenet & Biol Program, Barcelona, Spain; [Gonzalez, Beatriz] San Cecilio Hosp, Med Oncol Serv, Granada, Spain	Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Universidad de Jaen; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Prados, J (corresponding author), Inst Biopathol & Regenerat Med IBIMER, Granada, Spain.	jcprados@ugr.es	Perazzoli, Gloria/AAI-7350-2020; Perazzoli, Gloria/F-9946-2018; Prados, Jose/J-7116-2017; Ortiz Quesada, Raúl/J-7256-2017; ORTIZ, RAUL/GOH-0599-2022; Melguizo, Consolación/E-9842-2016; Caba, Octavio/H-1918-2015	Prados, Jose/0000-0003-4303-7746; Ortiz Quesada, Raúl/0000-0001-8409-5235; Melguizo, Consolación/0000-0003-3990-806X; Caba, Octavio/0000-0003-3426-8294; Cabeza Montilla, Laura/0000-0001-9369-5945	Fundacio la Marato TV3 [111431]; Consejeria de Salud de la Junta de Andalucia [PI-0049]	Fundacio la Marato TV3; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia)	This study was supported by the Fundacio la Marato TV3 via project no. 111431, and by the Consejeria de Salud de la Junta de Andalucia through Project no. PI-0049.	Binkhathlan Z, 2013, CURR CANCER DRUG TAR, V13, P326, DOI 10.2174/15680096113139990076; Brandes AA, 2008, CRIT REV ONCOL HEMAT, V67, P139, DOI 10.1016/j.critrevonc.2008.02.005; Cabrini G, 2015, INT J ONCOL; Choy W, 2012, NEUROSURG CLIN N AM, V23, P391, DOI 10.1016/j.nec.2012.04.011; Fodale V, 2011, CANCER J, V17, P89, DOI 10.1097/PPO.0b013e318212dd3d; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Goellner EM, 2011, CANCER RES, V71, P2308, DOI 10.1158/0008-5472.CAN-10-3213; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Guo J, 2013, BIOCHEM CELL BIOL, V91, P209, DOI 10.1139/bcb-2012-0100; Happold C, 2012, J NEUROCHEM, V122, P444, DOI 10.1111/j.1471-4159.2012.07781.x; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hirose Y, 2001, CANCER RES, V61, P1957; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Jhaveri N, 2011, CANCER LETT, V312, P245, DOI 10.1016/j.canlet.2011.08.015; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kheirelseid EAH, 2013, J GASTROINTEST ONCOL, V4, P397, DOI 10.3978/j.issn.2078-6891.2013.021; Kim KJ, 2011, NEUROPATHOLOGY, V31, P494, DOI 10.1111/j.1440-1789.2010.01194.x; Koukourakis GV, 2009, MOLECULES, V14, P1561, DOI 10.3390/molecules14041561; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Marchesia F, 2007, PHARMACOL RES, V56, P275, DOI 10.1016/j.phrs.2007.08.003; Maxwell JA, 2008, CLIN CANCER RES, V14, P4859, DOI 10.1158/1078-0432.CCR-07-4807; Mazaris P, 2014, CLIN NEUROL NEUROSUR, V120, P103, DOI 10.1016/j.clineuro.2014.03.001; Melguizo C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-250; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nakagawa T, 2009, NEUROPATHOLOGY, V29, P379, DOI 10.1111/j.1440-1789.2008.00983.x; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Ramalho-Carvalho J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058206; Riganti C, 2014, CELL MOL LIFE SCI, V71, P499, DOI 10.1007/s00018-013-1397-y; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Sasaki A, 2013, HUM CELL, V26, P73, DOI 10.1007/s13577-013-0060-0; Sengupta S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831090; Shahar T, 2012, J CLIN NEUROSCI, V19, P1530, DOI 10.1016/j.jocn.2012.04.005; Shinsato Y, 2013, ONCOTARGET, V4, P2261, DOI 10.18632/oncotarget.1302; Spiegl-Kreinecker S, 2010, NEURO-ONCOLOGY, V12, P28, DOI 10.1093/neuonc/nop003; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Uno M, 2011, CLINICS, V66, P1747, DOI 10.1590/S1807-59322011001000013; Vangipuram SD, 2010, PEDIATR BLOOD CANCER, V54, P361, DOI 10.1002/pbc.22351; von Bueren AO, 2012, BRIT J CANCER, V107, P1399, DOI 10.1038/bjc.2012.403; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wick W, 2014, NAT REV NEUROL, V10, P372, DOI 10.1038/nrneurol.2014.100; Yin AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085102; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Yoshimoto K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00186; Yoshino A, 2010, INT J ONCOL, V36, P1367, DOI 10.3892/ijo_00000621; YUSA K, 1989, CANCER RES, V49, P5002; Zawadzki A, 2008, DIS COLON RECTUM, V51, P1696, DOI 10.1007/s10350-008-9372-7; Zhai J-H, 2014, TUMOR BIOL J INT SOC, V36, P701; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046	52	109	114	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140131	10.1371/journal.pone.0140131	http://dx.doi.org/10.1371/journal.pone.0140131			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447477	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000094
J	Schmidt, RE; Cullati, S; Mostofsky, E; Haller, G; Agoritsas, T; Mittleman, MA; Perneger, TV; Courvoisier, DS				Schmidt, Ralph E.; Cullati, Stephane; Mostofsky, Elizabeth; Haller, Guy; Agoritsas, Thomas; Mittleman, Murray A.; Perneger, Thomas V.; Courvoisier, Delphine S.			Healthcare-Related Regret among Nurses and Physicians Is Associated with Self-Rated Insomnia Severity: A Cross-Sectional Study	PLOS ONE			English	Article							SLEEP LOSS; COGNITIVE PERFORMANCE; HOSPITAL NURSES; MENTAL-HEALTH; VALIDATION; PROFESSIONALS; DEPRESSION; FATIGUE; ERRORS; INDEX	To examine the association between healthcare-related regrets and sleep difficulties among nurses and physicians, we surveyed 240 nurses and 220 physicians at the University Hospitals of Geneva. Regret intensity and regret coping were measured using validated scales. Sleep difficulties were measured using the Insomnia Severity Index (ISI), and an additional question assessed the frequency of sleeping pill use. After controlling for sex, profession, years of experience, rate of employment, and depression as well as for all other regret-related variables, the following variables remained significantly associated with selfrated severity of insomnia: regret intensity (slope = 1.32, p = 0.007, 95%CI: [0.36; 2.29], std. coefficient = 0.16) and maladaptive (e.g., rumination) emotion-focused coping (slope = 1.57, p = 0.002, 95%CI: [0.60; 2.55], std. coefficient = 0.17) remained significant predictors of self-rated insomnia severity. If these cross-sectional associations represent causal effects, the development of regret-management programs may represent a promising approach to mitigating sleep difficulties of healthcare professionals.	[Schmidt, Ralph E.] Univ Geneva, Dept Psychol, Geneva, Switzerland; [Cullati, Stephane; Courvoisier, Delphine S.] Univ Hosp Geneva, Qual Care Unit, Geneva, Switzerland; [Mostofsky, Elizabeth; Mittleman, Murray A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Epidemiol Res Unit,Dept Med, Boston, MA 02215 USA; [Mostofsky, Elizabeth; Mittleman, Murray A.; Courvoisier, Delphine S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Haller, Guy] Univ Hosp Geneva, Dept Anesthesiol, Pharmacol, Intens Care, Geneva, Switzerland; [Agoritsas, Thomas] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Perneger, Thomas V.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland	University of Geneva; University of Geneva; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Geneva; McMaster University; University of Geneva	Courvoisier, DS (corresponding author), Univ Hosp Geneva, Qual Care Unit, Geneva, Switzerland.	Delphine.courvoisier1@gmail.com	Cullati, Stephane/F-7991-2011; Agoritsas, Thomas/F-4321-2014	Cullati, Stephane/0000-0002-3881-446X; Agoritsas, Thomas/0000-0002-6182-9969; haller, guy/0000-0001-7367-7029; Mittleman, Murray/0000-0001-9788-7274	National Heart, Lung, and Blood Institute [F32-HL120505]; University Hospitals of Geneva [PRD-09-II-20]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL120505] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University Hospitals of Geneva; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung, and Blood Institute (F32-HL120505; http://www1.imperial.ac.uk/nhli/) to Dr. Mofstofsky, and from the University Hospitals of Geneva (PRD-09-II-20; www.hcuge.ch) to Dr. Courvoisier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arimura M, 2010, IND HEALTH, V48, P811, DOI 10.2486/indhealth.MS1093; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bjorvatn B, 2012, NURS CRIT CARE, V17, P180, DOI 10.1111/j.1478-5153.2012.00504.x; Carney CE, 2010, BEHAV RES THER, V48, P540, DOI 10.1016/j.brat.2010.03.004; Courvoisier D, 2013, LANCET, V382, P1553, DOI 10.1016/S0140-6736(13)62325-9; Courvoisier DS, 2013, MED CARE, V51, P285, DOI 10.1097/MLR.0b013e318280f02c; Courvoisier DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023138; Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; Courvoisier DS, 2014, J OCCUP HEALTH, V56, P430, DOI 10.1539/joh.14-0060-OA; Donchin Y, 2003, QUAL SAF HEALTH CARE, V12, P143, DOI 10.1136/qhc.12.2.143; Dorrian J, 2006, CHRONOBIOL INT, V23, P1149, DOI 10.1080/07420520601059615; Eriksen W, 2008, INT ARCH OCC ENV HEA, V81, P301, DOI 10.1007/s00420-007-0214-z; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Geiger-Brown J, 2012, CHRONOBIOL INT, V29, P211, DOI 10.3109/07420528.2011.645752; Geiger-Brown J, 2011, J OCCUP ENVIRON MED, V53, P303, DOI 10.1097/JOM.0b013e31820c3f87; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Hsieh ML, 2011, NURS HEALTH SCI, V13, P468, DOI 10.1111/j.1442-2018.2011.00641.x; Ingersoll-Dayton B, 2005, RES AGING, V27, P267, DOI 10.1177/0164027504274122; JACQUES CHM, 1990, J FAM PRACTICE, V30, P223; Johnson AL, 2010, AAOHN J, V58, P147, DOI [10.3928/08910162-20100329-05, 10.3928/08910162-20100316-02]; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kroning Luna C, 2014, OCCUP ENV MED S1, V71, pA80, DOI [10.1136/oemed-2014-102362.249, DOI 10.1136/OEMED-2014-102362.249]; Lin PC, 2012, INT ARCH OCC ENV HEA, V85, P877, DOI 10.1007/s00420-011-0730-8; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Niu SF, 2013, BIOL RES NURS, V15, P273, DOI 10.1177/1099800412439459; Owens JA, 2007, J PERINAT NEONAT NUR, V21, P92, DOI 10.1097/01.JPN.0000270624.64584.9d; Payette M, 2009, AM J SURG, V197, P820, DOI 10.1016/j.amjsurg.2008.05.013; Perneger TV, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-6; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Piers RD, 2011, JAMA-J AM MED ASSOC, V306, P2694, DOI 10.1001/jama.2011.1888; Roelofs J, 2008, BEHAV RES THER, V46, P1283, DOI 10.1016/j.brat.2008.10.002; Roese NJ, 2009, J SOC CLIN PSYCHOL, V28, P671, DOI 10.1521/jscp.2009.28.6.671; Ruggiero JS, 2003, RES NURS HEALTH, V26, P434, DOI 10.1002/nur.10106; Schmidt RE, 2013, COGNITIVE THER RES, V37, P872, DOI 10.1007/s10608-013-9532-5; Schmidt RE, 2011, INT J AGING HUM DEV, V73, P371, DOI 10.2190/AG.73.4.f; Schmidt RE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00349; Schmidt RE, 2010, J SLEEP RES, V19, P487, DOI 10.1111/j.1365-2869.2010.00834.x; Schmidt RE, 2009, EMOTION, V9, P549, DOI 10.1037/a0015856; Scott IA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1860; Thomas Frank, 2006, Air Med J, V25, P216, DOI 10.1016/j.amj.2006.06.005; Thorndike FP, 2011, BEHAV SLEEP MED, V9, P216, DOI 10.1080/15402002.2011.606766; Vela-Bueno A, 2008, J PSYCHOSOM RES, V64, P435, DOI 10.1016/j.jpsychores.2007.10.014; Walker MP, 2010, SLEEP MED REV, V14, P215, DOI 10.1016/j.smrv.2010.02.003; Wesnes KA, 1997, BRIT J SURG, V84, P493; Zeelenberg M, 2007, J CONSUM PSYCHOL, V17, P3, DOI 10.1207/s15327663jcp1701_3; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	47	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139770	10.1371/journal.pone.0139770	http://dx.doi.org/10.1371/journal.pone.0139770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TW	26447692	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000051
J	Jeon, YT; Na, H; Ryu, H; Chung, Y				Jeon, Young-Tae; Na, Hyeongjin; Ryu, Heeju; Chung, Yeonseok			Modulation of Dendritic Cell Activation and Subsequent Th1 Cell Polarization by Lidocaine	PLOS ONE			English	Article							FOLLICULAR HELPER-CELLS; KAPPA-B ACTIVATION; LOCAL-ANESTHETICS; INTRAVENOUS LIDOCAINE; IL-12 FAMILY; T-CELLS; CYTOKINES; EXPRESSION; SURGERY; PAIN	Dendritic cells play an essential role in bridging innate and adaptive immunity by recognizing cellular stress including pathogen- and damage-associated molecular patterns and by shaping the types of antigen-specific T cell immunity. Although lidocaine is widely used in clinical settings that trigger cellular stress, it remains unclear whether such treatment impacts the activation of innate immune cells and subsequent differentiation of T cells. Here we showed that lidocaine inhibited the production of IL-6, TNF alpha and IL-12 from dendritic cells in response to toll-like receptor ligands including lipopolysaccharide, poly(I:C) and R837 in a dose-dependent manner. Notably, the differentiation of Th1 cells was significantly suppressed by the addition of lidocaine while the same treatment had little effect on the differentiation of Th17, Th2 and regulatory T cells in vitro. Moreover, lidocaine suppressed the ovalbumin-specific Th1 cell responses in vivo induced by the adoptive transfer of ovalbumin- pulsed dendritic cells. These results demonstrate that lidocaine inhibits the activation of dendritic cells in response to toll-like receptor signals and subsequently suppresses the differentiation of Th1 cell responses.	[Jeon, Young-Tae] Seoul Natl Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Na, Hyeongjin; Ryu, Heeju; Chung, Yeonseok] Seoul Natl Univ, Coll Pharm, Inst Pharmaceut Sci, Lab Immune Regulat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Chung, Y (corresponding author), Seoul Natl Univ, Coll Pharm, Inst Pharmaceut Sci, Lab Immune Regulat, Seoul, South Korea.	yeonseok@snu.ac.kr		Chung, Yeonseok/0000-0001-5780-4841	Seoul National University Bundang Hospital Research Fund [02-2014-025]; National Research Foundation of Korea (NRF) - Korea government (MEST) [2014R1A2A1A11054364]	Seoul National University Bundang Hospital Research Fund; National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by grants 02-2014-025 from the Seoul National University Bundang Hospital Research Fund (YTJ) and 2014R1A2A1A11054364 from the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson SL, 2014, VET ANAESTH ANALG, V41, P553, DOI 10.1111/vaa.12191; Azuma Y, 2000, INT J IMMUNOPHARMACO, V22, P789, DOI 10.1016/S0192-0561(00)00040-0; Batinac T, 2013, J DERMATOL, V40, P522, DOI 10.1111/1346-8138.12168; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Chung YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003628; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Feng G, 2008, PHARMACOLOGY, V81, P32, DOI 10.1159/000107792; Fischer LG, 2001, ANESTH ANALG, V92, P1041; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Huang YH, 2006, ANESTH ANALG, V102, P1739, DOI 10.1213/01.ANE.0000219593.15109.DB; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawasaki T, 2001, ANESTH ANALG, V92, P1322; Kelbel I, 2001, Curr Opin Anaesthesiol, V14, P685, DOI 10.1097/00001503-200112000-00015; Kurosawa S, 2008, J ANESTH, V22, P263, DOI 10.1007/s00540-008-0626-2; Kurosawa S, 2012, CURR OPIN ANESTHESIO, V25, P376, DOI 10.1097/ACO.0b013e328352b4a8; Lahat A, 2008, CLIN EXP IMMUNOL, V152, P320, DOI 10.1111/j.1365-2249.2008.03636.x; Lan W, 2005, ANESTH ANALG, V100, P409, DOI 10.1213/01.ANE.0000142113.39092.87; Lan W, 2004, EUR J ANAESTH, V21, P967, DOI 10.1017/S0265021504000353; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; Lim H, 2015, INT IMMUNOPHARMACOL, V28, P846, DOI 10.1016/j.intimp.2015.03.051; Lim H, 2014, IMMUNITY, V40, P153, DOI 10.1016/j.immuni.2013.11.021; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; McCarthy GC, 2010, DRUGS, V70, P1149, DOI 10.2165/10898560-000000000-00000; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ogata M, 2000, CRIT CARE MED, V28, P3166, DOI 10.1097/00003246-200009000-00007; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Ploppa A, 2010, REGION ANESTH PAIN M, V35, P45, DOI 10.1097/AAP.0b013e3181c75199; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Shiga M, 2001, ANESTH ANALG, V92, P128; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Terkawi AS, 2015, PAIN PHYSICIAN, V18, pE139; To D, 2014, DERMATOL SURG, V40, P1367, DOI 10.1097/DSS.0000000000000190; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Yardeni IZ, 2009, ANESTH ANALG, V109, P1464, DOI 10.1213/ANE.0b013e3181bab1bd; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	49	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139845	10.1371/journal.pone.0139845	http://dx.doi.org/10.1371/journal.pone.0139845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445366	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600088
J	Liu, H; Wang, XY; Tan, GZ				Liu Heng; Wang Xingyuan; Tan Guozhen			Structure Identification of Uncertain Complex Networks Based on Anticipatory Projective Synchronization	PLOS ONE			English	Article							ADAPTIVE LAG SYNCHRONIZATION; DELAYED NEURAL-NETWORKS; TOPOLOGY IDENTIFICATION; DYNAMICAL NETWORK	This paper investigates a method to identify uncertain system parameters and unknown topological structure in general complex networks with or without time delay. A complex network, which has uncertain topology and unknown parameters, is designed as a drive network, and a known response complex network with an input controller is designed to identify the drive network. Under the proposed input controller, the drive network and the response network can achieve anticipatory projective synchronization when the system is steady. Lyapunov theorem and Barba. lat's lemma guarantee the stability of synchronization manifold between two networks. When the synchronization is achieved, the system parameters and topology in response network can be changed to equal with the parameters and topology in drive network. A numerical example is given to show the effectiveness of the proposed method.	[Liu Heng; Wang Xingyuan; Tan Guozhen] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China	Dalian University of Technology	Liu, H (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China.	liuheng@mail.dlut.edu.cn	Wang, Xing-yuan/I-6353-2015		National Natural Science Foundation of China [61370145, 61173183, 60973152]; Doctoral Program Foundation of Institution of Higher Education of China [20070141014]; Program for Liaoning Excellent Talents in University [LR2012003]; National Natural Science Foundation of Liaoning province [20082165]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program Foundation of Institution of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Liaoning Excellent Talents in University; National Natural Science Foundation of Liaoning province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (Nos: 61370145, 61173183, and 60973152), the Doctoral Program Foundation of Institution of Higher Education of China (No: 20070141014), Program for Liaoning Excellent Talents in University (No: LR2012003), the National Natural Science Foundation of Liaoning province (No: 20082165) and the Fundamental Research Funds for the Central Universities (No: DUT12JB06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Che Y, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20959-7; Che YQ, 2013, CHAOS, V23, DOI 10.1063/1.4793541; Chen L, 2009, IEEE T CIRCUITS-II, V56, P310, DOI 10.1109/TCSII.2009.2015381; Corron NJ, 2005, CHAOS, V15, DOI 10.1063/1.1898597; Ding JR, 2011, PLOS ONE, V10, P1371; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Guo WL, 2011, NONLINEAR ANAL-REAL, V12, P2579, DOI 10.1016/j.nonrwa.2011.03.007; Khalil H. K., 2002, NONLINEAR SYSTEMS 3, V3rd; Li CD, 2004, PHYSICA D, V194, P187, DOI 10.1016/j.physd.2004.02.005; Liu H, 2009, AUTOMATICA, V45, P1799, DOI 10.1016/j.automatica.2009.03.022; Lu JH, 2005, IEEE T AUTOMAT CONTR, V50, P841, DOI 10.1109/TAC.2005.849233; Perez T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019900; Petri G, 2013, PLOS ONE, V10, P1371; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; Shahverdiev EM, 2002, PHYS LETT A, V292, P320, DOI 10.1016/S0375-9601(01)00824-6; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sun YH, 2007, PHYS LETT A, V364, P277, DOI 10.1016/j.physleta.2006.12.019; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu L, 2003, PHYS LETT A, V315, P101, DOI 10.1016/S0375-9601(03)01004-1; Wu XQ, 2008, PHYSICA A, V387, P997, DOI 10.1016/j.physa.2007.10.030; Wu XQ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046106; Xia WG, 2009, CHAOS, V19, DOI 10.1063/1.3071933; Xiao Fan Wang, 2003, IEEE Circuits and Systems Magazine, V3, P6, DOI 10.1109/MCAS.2003.1228503; Zhao JC, 2010, CHAOS, V20, DOI 10.1063/1.3421947; Zhou J, 2005, CIRC SYST SIGNAL PR, V24, P599, DOI 10.1007/s00034-005-2410-y	33	1	2	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139804	10.1371/journal.pone.0139804	http://dx.doi.org/10.1371/journal.pone.0139804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444690	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600083
J	Quinn, EM; Coleman, C; Molloy, B; Castro, PD; Cormican, P; Trimble, V; Mahmud, N; McManus, R				Quinn, Emma M.; Coleman, Ciara; Molloy, Ben; Castro, Patricia Dominguez; Cormican, Paul; Trimble, Valerie; Mahmud, Nasir; McManus, Ross			Transcriptome Analysis of CD4+T Cells in Coeliac Disease Reveals Imprint of BACH2 and IFN gamma Regulation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; T-CELLS; RNA-SEQ; INTERFERON-GAMMA; GENE-EXPRESSION; ENRICHMENT ANALYSIS; PREDICTS PROGNOSIS; MULTIPLE COMMON; TYPE-1; METAANALYSIS	Genetic studies have to date identified 43 genome wide significant coeliac disease susceptibility (CD) loci comprising over 70 candidate genes. However, how altered regulation of such disease associated genes contributes to CD pathogenesis remains to be elucidated. Recently there has been considerable emphasis on characterising cell type specific and stimulus dependent genetic variants. Therefore in this study we used RNA sequencing to profile over 70 transcriptomes of CD4+ T cells, a cell type crucial for CD pathogenesis, in both stimulated and resting samples from individuals with CD and unaffected controls. We identified extensive transcriptional changes across all conditions, with the previously established CD gene IFN gamma the most strongly up-regulated gene (log2 fold change 4.6; P-adjusted = 2.40x10(-11)) in CD4+ T cells from CD patients compared to controls. We show a significant correlation of differentially expressed genes with genetic studies of the disease to date (P-adjusted = 0.002), and 21 CD candidate susceptibility genes are differentially expressed under one or more of the conditions used in this study. Pathway analysis revealed significant enrichment of immune related processes. Co-expression network analysis identified several modules of coordinately expressed CD genes. Two modules were particularly highly enriched for differentially expressed genes (P<2.2x10(-16)) and highlighted IFN gamma and the genetically associated transcription factor BACH2 which showed significantly reduced expression in coeliac samples (log2FC - 1.75; P-adjusted = 3.6x10(-3)) as key regulatory genes in CD. Genes regulated by BACH2 were very significantly over-represented among our differentially expressed genes (P<2.2x10(-16)) indicating that reduced expression of this master regulator of T cell differentiation promotes a pro-inflammatory response and strongly corroborates genetic evidence that BACH2 plays an important role in CD pathogenesis.	[Quinn, Emma M.; Coleman, Ciara; Molloy, Ben; Castro, Patricia Dominguez; Trimble, Valerie; Mahmud, Nasir; McManus, Ross] Univ Dublin Trinity Coll, St Jamess Hosp, Trin Ctr, Dept Clin Med, Dublin 8, Ireland; [Cormican, Paul] TEAGASC, Grange Res Ctr, Anim & Biosci Res Dept, Dunsany, Meath, Ireland	Trinity College Dublin; Teagasc	McManus, R (corresponding author), Univ Dublin Trinity Coll, St Jamess Hosp, Trin Ctr, Dept Clin Med, Dublin 8, Ireland.	rmcmanus@tcd.ie	McManus, Ross/AAE-9236-2020	McManus, Ross/0000-0002-0529-9617; Dominguez Castro, Patricia/0000-0002-2871-9573	Science Foundation Ireland [09/IN.1/B2640]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This project was funded by Science Foundation Ireland Grant number 09/IN.1/B2640 to RM.	Akhabir L, 2014, J ALLERGY CLIN IMMUN, V134, P729, DOI 10.1016/j.jaci.2014.02.039; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anderson RP, 2006, GUT, V55, P485, DOI 10.1136/gut.2005.064550; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Bracken S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-377; Cesaro A, 2010, AM J PHYSIOL-GASTR L, V299, pG32, DOI 10.1152/ajpgi.00282.2009; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Coleman C., 2015, EUR J HUM GENET; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; Dubois PC, 2008, CLIN EXP IMMUNOL, V153, P162, DOI 10.1111/j.1365-2249.2008.03704.x; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Floyel T, 2014, P NATL ACAD SCI USA, V111, P10305, DOI 10.1073/pnas.1402571111; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Garner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101428; Granzotto M, 2009, DIGEST DIS SCI, V54, P1513, DOI 10.1007/s10620-008-0501-x; Guo H, 2015, HUM MOL GENET, V24, P3305, DOI 10.1093/hmg/ddv077; Hart SN, 2013, J COMPUT BIOL, V20, P970, DOI 10.1089/cmb.2012.0283; Hmida NB, 2012, AM J GASTROENTEROL, V107, P604, DOI 10.1038/ajg.2011.397; Hrdlickova B, 2011, CLIN GENET, V80, P203, DOI 10.1111/j.1399-0004.2011.01707.x; Hrdlickova B, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0088-0; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Juuti-Uusitalo K, 2004, J AUTOIMMUN, V22, P249, DOI 10.1016/j.jaut.2003.12.001; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Koskinen LLE, 2009, HUM MOL GENET, V18, P1148, DOI 10.1093/hmg/ddn438; Kumar V, 2015, HUM MOL GENET, V24, P397, DOI 10.1093/hmg/ddu453; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Meresse B, 2012, IMMUNITY, V36, P907, DOI 10.1016/j.immuni.2012.06.006; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Olaussen RW, 2002, SCAND J IMMUNOL, V56, P652, DOI 10.1046/j.1365-3083.2002.01195.x; Plaza-Izurieta L, 2014, EUR J HUM GENET; Plaza-Izurieta L, 2011, J MED GENET, V48, P493, DOI 10.1136/jmg.2011.089714; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Subramaniam S, 2012, NAT NEUROSCI, V15, P191, DOI 10.1038/nn.2994; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wapenaar MC, 2004, J AUTOIMMUN, V23, P183, DOI 10.1016/j.jaut.2004.05.004; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zanzi D, 2011, AM J GASTROENTEROL, V106, P1308, DOI 10.1038/ajg.2011.80	71	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140049	10.1371/journal.pone.0140049	http://dx.doi.org/10.1371/journal.pone.0140049			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444573	gold, Green Submitted, Green Published			2022-12-26	WOS:000362510600130
J	Wereszczuk, A; Zalewski, A				Wereszczuk, Anna; Zalewski, Andrzej			Spatial Niche Segregation of Sympatric Stone Marten and Pine Marten - Avoidance of Competition or Selection of Optimal Habitat?	PLOS ONE			English	Article							BIALOWIEZA-NATIONAL-PARK; AMERICAN MINK; INTERFERENCE COMPETITION; ANTHROPOGENIC FOOD; DNA ANALYSIS; PATTERNS; DIET; COEXISTENCE; FOINA; SIZE	Coexistence of ecologically similar species relies on differences in one or more dimensions of their ecological niches, such as space, time and resources in diel and/or seasonal scales. However, niche differentiation may result from other mechanisms such as avoidance of high predation pressure, different adaptations or requirements of ecologically similar species. Stone marten (Martes foina) and pine marten (Martes martes) occur sympatrically over a large area in Central Europe and utilize similar habitats and food, therefore it is expected that their coexistence requires differentiation in at least one of their niche dimensions or the mechanisms through which these dimensions are used. To test this hypothesis, we used differences in the species activity patterns and habitat selection, estimated with a resource selection function (RSF), to predict the relative probability of occurrence of the two species within a large forest complex in the northern geographic range of the stone marten. Stone martens were significantly heavier, have a longer body and a better body condition than pine martens. We found weak evidence for temporal niche segregation between the species. Stone and pine martens were both primarily nocturnal, but pine martens were active more frequently during the day and significantly reduced the duration of activity during autumn-winter. Stone and pine martens utilized different habitats and almost completely separated their habitat niches. Stone marten strongly preferred developed areas and avoided meadows and coniferous or deciduous forests. Pine marten preferred deciduous forest and small patches covered by trees, and avoided developed areas and meadows. We conclude that complete habitat segregation of the two marten species facilitates sympatric coexistence in this area. However, spatial niche segregation between these species was more likely due to differences in adaptation to cold climate, avoidance of high predator pressure and/or food preferences by both species than competitive interaction between them.	[Wereszczuk, Anna; Zalewski, Andrzej] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Wereszczuk, A (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	awereszczuk@ibs.bialowieza.pl	Zalewski, Andrzej/K-7271-2012; Wereszczuk, Anna/J-7384-2016; Wereszczuk, Anna/AAF-5974-2020	Zalewski, Andrzej/0000-0003-4518-2787; Wereszczuk, Anna/0000-0002-2936-5690; Wereszczuk, Anna/0000-0002-2936-5690	National Science Centre Poland [UMO-2011/01/NZ/NZ8/04525]	National Science Centre Poland(National Science Centre, Poland)	Funded by National Science Centre Poland (https://www.ncn.gov.pl/?language=en) Grant number UMO-2011/01/NZ/NZ8/04525 (PRELUDIUM program) to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Anderson E., 1970, Acta Zoologica Fennica, VNo.130,1970, P1; [Anonymous], 2014, R LANG ENV STAT COMP; BAKER JA, 1981, COPEIA, P178, DOI 10.2307/1444052; Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Balestrieri A, 2013, ITAL J ZOOL, V80, P60, DOI 10.1080/11250003.2012.730067; Balestrieri A, 2011, ACTA THERIOL, V56, P199, DOI 10.1007/s13364-010-0015-8; Balestrieri A, 2010, MAMM BIOL, V75, P412, DOI 10.1016/j.mambio.2009.05.003; Baltrunaite Laima, 2006, Acta Zoologica Lituanica, V16, P46, DOI 10.1080/13921657.2006.10512709; Barton K., 2014, MUMIN MULTIMODEL INF; Becker R, 1988, COMPUTER SCI SERIES; Bissonette JA, 1997, WILDLIFE AND LANDSCAPE ECOLOGY, P368; Brainerd SM, 2002, WILDLIFE BIOL, V8, P289, DOI 10.2981/wlb.2002.026; Brzezinski M, 2010, FOLIA ZOOL, V59, P183; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Buskirk Steven W., 1994, P283; Carvalho JC, 2004, J ZOOL, V263, P275, DOI 10.1017/S0952836904005266; Caryl FM, 2012, J MAMMAL, V93, P464, DOI 10.1644/11-MAMM-A-149.1; Caryl FM, 2008, THESIS U STIRLING; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; CLEVENGER AP, 1994, ECOGRAPHY, V17, P257, DOI 10.1111/j.1600-0587.1994.tb00101.x; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Croitor R, 2010, QUATERN INT, V212, P98, DOI 10.1016/j.quaint.2009.06.001; Dalen L, 2004, MOL ECOL, V13, P2389, DOI 10.1111/j.1365-294X.2004.02249.x; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Delibes M., 1983, Acta Zoologica Fennica, P229; ERLINGE S, 1988, OIKOS, V53, P242, DOI 10.2307/3566069; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Feller NL, 1993, THESIS U NEUCHATEL; Finke J, 2008, ECOL INFORM, V3, P26, DOI 10.1016/j.ecoinf.2007.04.006; Fisher JT, 2013, ECOGRAPHY, V36, P240, DOI 10.1111/j.1600-0587.2012.07556.x; FRAFJORD K, 1989, ARCTIC, V42, P354; Gause G. F., 1934, STRUGGLE EXISTENCE; Genovesi Piero, 1997, P110; Geue D, 2008, CAN J ZOOL, V86, P1419, DOI 10.1139/Z08-129; GOSZCZYNSKI J, 1976, Acta Theriologica, V21, P527; Goszczynski J, 2007, CAN J ZOOL, V85, P239, DOI 10.1139/Z06-212; Gutman R, 2005, ECOLOGY, V86, P164, DOI 10.1890/03-0369; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HARPER JL, 1961, EVOLUTION, V15, P209, DOI 10.2307/2406081; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Herr J, 2009, J ZOOL, V277, P54, DOI 10.1111/j.1469-7998.2008.00510.x; Herr J, 2008, THESIS U SUSSEX; Herr J, 2010, MAMM BIOL, V75, P138, DOI 10.1016/j.mambio.2008.12.002; Hughes S.S., 2012, BIOL CONSERVATION MA, P3; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; JACKSON JBC, 1981, AM ZOOL, V21, P889; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Kitchen AM, 1999, CAN J ZOOL, V77, P1645, DOI 10.1139/cjz-77-10-1645; Koenig J, 2002, J HERPETOL, V36, P62; Lack D., 1940, British Birds, V84, P80; Lanszki J, 2003, FOLIA ZOOL, V52, P367; Lele S. R, 2014, RESOURCESELECTION RE; Lele SR, 2006, ECOLOGY, V87, P3021, DOI 10.1890/0012-9658(2006)87[3021:WDAEOR]2.0.CO;2; Lele SR, 2009, J WILDLIFE MANAGE, V73, P122, DOI 10.2193/2007-535; Macdonald DW, 2003, NEW ZEAL J ZOOL, V30, P421, DOI 10.1080/03014223.2003.9518350; Manly B.F.J., 2002, RESOURCE SELECTION A; Marchesi P., 1989, THESIS U NEUCHATEL; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Mergey M, 2011, J MAMMAL, V92, P328, DOI 10.1644/09-MAMM-A-366.1; Monterroso P, 2013, THESIS U PORTO; Monterroso P, 2014, BEHAV ECOL SOCIOBIOL, V68, P1403, DOI 10.1007/s00265-014-1748-1; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Mustonen A-M, 2015, MAMMAL RES, V60, P1; Okla K, 2000, SYSTEM INFORM PRZEST; Pereboom V, 2008, CAN J ZOOL, V86, P983, DOI 10.1139/Z08-076; Pereira P, 2012, ECOL RES, V27, P745, DOI 10.1007/s11284-012-0949-1; Pinheiro J., 2014, NLME LINEAR NONLINEA, V3, P1; Posillico Mario, 1995, Hystrix, V7, P79; Posluszny M, 2007, ANN ZOOL FENN, V44, P269; Powell R.A., 1983, Acta Zoologica Fennica, P223; Proulx G, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P21; Pucek Z., 1981, KEYS VERTEBRATES POL; REIG S, 1992, J MAMMAL, V73, P744, DOI 10.2307/1382193; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROMANOWSKI J, 1991, ACTA THERIOL, V36, P201, DOI 10.4098/AT.arch.91-19; Rosellini S, 2008, WILDLIFE RES, V35, P434, DOI 10.1071/WR07030; ROSENZWEIG ML, 1966, J MAMMAL, V47, P602, DOI 10.2307/1377891; Sacchi Oreste, 1995, Hystrix, V7, P99; Santos MJ, 2010, EUR J WILDLIFE RES, V56, P275, DOI 10.1007/s10344-009-0317-9; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seiler A, 2006, ENVIRONM POLLUT SER, V10, P165, DOI 10.1007/1-4020-4504-2_8; Shafer ABA, 2012, ECOLOGY, V93, P1317; Sidorovich V, 1999, J ZOOL, V248, P521, DOI 10.1017/S0952836999008110; Sidorovich VE, 2010, BIOL INVASIONS, V12, P2207, DOI 10.1007/s10530-009-9631-0; Skirnisson K, 1986, UNTERSUCHUNGEN ZUM R, V6, P1; Skorka P, 2009, POL J ECOL, V57, P597; Sommer R, 2004, MAMMAL REV, V34, P249, DOI 10.1111/j.1365-2907.2004.00043.x; STORCH I, 1990, ACTA THERIOL, V35, P311, DOI 10.4098/AT.arch.90-36; Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8; Tomjalojc L, 1978, POLISH ECOL STUDIES, V5, P141; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Valeix M, 2007, OECOLOGIA, V153, P739, DOI 10.1007/s00442-007-0764-5; Virgos E, 1998, Z SAUGETIERKD, V63, P193; Virgos E, 2002, ACTA OECOL, V23, P231, DOI 10.1016/S1146-609X(02)01142-6; Virgos E, 2012, BIOL CONSERVATION MA, P255; WAECHTER A, 1975, Terre et la Vie, V29, P399; Wang ZL, 2005, ECOL MODEL, V181, P17, DOI 10.1016/j.ecolmodel.2004.06.020; Weckworth BV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1756; WOLSAN M, 1993, ACTA THERIOL, V38, P345, DOI 10.4098/AT.arch.93-29; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zalewski A, 2000, J ZOOL, V251, P439, DOI 10.1111/j.1469-7998.2000.tb00799.x; Zalewski A, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P77; Zalewski A, 2006, ECOGRAPHY, V29, P31, DOI 10.1111/j.2005.0906-7590.04313.x; Zalewski A, 1997, ACTA THERIOL, V42, P153, DOI 10.4098/AT.arch.97-18; Zalewski A, 2001, ACTA THERIOL, V46, P295, DOI 10.1007/BF03192436; Zalewski A, 2007, ACTA THERIOL, V52, P237, DOI 10.1007/BF03194220; Zhou YB, 2011, J BIOGEOGR, V38, P137, DOI 10.1111/j.1365-2699.2010.02396.x	114	52	55	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139852	10.1371/journal.pone.0139852	http://dx.doi.org/10.1371/journal.pone.0139852			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444280	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600092
J	Wittmann, C; Reischl, M; Shah, AH; Kronfuss, E; Mikut, R; Liebel, U; Grabher, C				Wittmann, Christine; Reischl, Markus; Shah, Asmi H.; Kronfuss, Eva; Mikut, Ralf; Liebel, Urban; Grabher, Clemens			A Zebrafish Drug-Repurposing Screen Reveals sGC-Dependent and sGC-Independent Pro-Inflammatory Activities of Nitric Oxide	PLOS ONE			English	Article							S-NITROSYLATION; SIGNALING PATHWAY; CHEMICAL SCREENS; SPINAL-CORD; IN-VIVO; ASSAY; IDENTIFICATION; VERTEBRATE; INHIBITORS; SYNTHASES	Tissue injury and infection trigger innate immune responses. However, dysregulation may result in chronic inflammation and is commonly treated with corticosteroids and non-steroidal anti-inflammatory drugs. Unfortunately, long-term administration of both therapeutic classes can cause unwanted side effects. To identify alternative immune-modulatory compounds we have previously established a novel screening method using zebrafish larvae. Using this method we here present results of an in vivo high-content drug-repurposing screen, identifying 63 potent anti-inflammatory drugs that are in clinical use for other indications. Our approach reveals a novel pro-inflammatory role of nitric oxide. Nitric oxide affects leukocyte recruitment upon peripheral sensory nervous system or epithelial injury in zebrafish larvae both via soluble guanylate cyclase and in a soluble guanylate cyclase - independent manner through protein S-nitrosylation. Together, we show that our screening method can help to identify novel immune-modulatory activities and provide new mechanistic insights into the regulation of inflammatory processes.	[Wittmann, Christine; Shah, Asmi H.; Kronfuss, Eva; Liebel, Urban; Grabher, Clemens] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Reischl, Markus; Mikut, Ralf] Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Reischl, M (corresponding author), Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany.	markus.reischl@kit.edu	Reischl, Markus/H-6970-2013; Mikut, Ralf/A-5949-2013	Reischl, Markus/0000-0002-7780-6374; Mikut, Ralf/0000-0001-9100-5496	KIT; DKFZ; Marie Curie International Reintegration Grant within the 7th European Community Framework Program [PIRG07-GA-2010-267552]; Heidelberg-Karlsruhe Research Bridge (HeiKa)	KIT; DKFZ(Helmholtz Association); Marie Curie International Reintegration Grant within the 7th European Community Framework Program; Heidelberg-Karlsruhe Research Bridge (HeiKa)	This work was supported by a Helmholtz joint project initiative between KIT and DKFZ (CW), Marie Curie International Reintegration Grant within the 7th European Community Framework Program (PIRG07-GA-2010-267552), and the Heidelberg-Karlsruhe Research Bridge (HeiKa) (synthetic biology platform) (CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benicky J, 2009, CELL MOL NEUROBIOL, V29, P781, DOI 10.1007/s10571-009-9368-4; Bowman TV, 2010, ACS CHEM BIOL, V5, P159, DOI 10.1021/cb100029t; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Duan YL, 2009, DEV NEUROBIOL, V69, P60, DOI 10.1002/dneu.20689; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hall CJ, 2014, DIS MODEL MECH, V7, P1069, DOI 10.1242/dmm.016873; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Lantz-McPeak S, 2015, J APPL TOXICOL, V35, P261, DOI 10.1002/jat.3029; Leet JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104190; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Martz L, 2011, SCI BUSINESS EXCHANG, V4; Namazi MR, 2008, J CLIN PHARM THER, V33, P215, DOI 10.1111/j.1365-2710.2008.00907.x; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pan LT, 2008, BIOCHEM BIOPH RES CO, V377, P1320, DOI 10.1016/j.bbrc.2008.11.001; Peterson RT, 2011, METHOD CELL BIOL, V105, P525, DOI 10.1016/B978-0-12-381320-6.00023-0; Raftery TD, 2014, ENVIRON SCI TECHNOL, V48, P804, DOI 10.1021/es404322p; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; Rieger JM, 2001, J MED CHEM, V44, P531, DOI 10.1021/jm0003642; Robertson AL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007672; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Wang XG, 2014, DIS MODEL MECH, V7, P163, DOI 10.1242/dmm.012047; Weger BD, 2012, ACS CHEM BIOL, V7, P1178, DOI 10.1021/cb3000474; Westhoff JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082137; Willmott NJ, 2000, J NEUROSCI, V20, P1767; Wittmann C, 2012, JOVE-J VIS EXP, DOI 10.3791/4203; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yozzo KL, 2013, ENVIRON SCI TECHNOL, V47, P11302, DOI 10.1021/es403360y	41	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137286	10.1371/journal.pone.0137286	http://dx.doi.org/10.1371/journal.pone.0137286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444552	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600010
J	Wu, Q; Su, NN; Chen, Q; Shen, WB; Shen, ZG; Xia, Y; Cui, J				Wu, Qi; Su, Nana; Chen, Qin; Shen, Wenbiao; Shen, Zhenguo; Xia, Yan; Cui, Jin			Cadmium-Induced Hydrogen Accumulation Is Involved in Cadmium Tolerance in Brassica campestris by Reestablishment of Reduced Glutathione Homeostasis	PLOS ONE			English	Article							OXIDATIVE STRESS; CARBON-DIOXIDE; SALT STRESS; ASCORBATE; ANTIOXIDANT; PLANTS; COPPER; CYCLE; RICE; ELONGATION	Hydrogen gas (H-2) was recently proposed as a therapeutic antioxidant and signaling molecule in clinical trials. However, the underlying physiological roles of H-2 in plants remain unclear. In the present study, hydrogen-rich water (HRW) was used to characterize the physiological roles of H-2 in enhancing the tolerance of Brassica campestris against cadmium (Cd). The results showed that both 50 mu M CdCl2 and 50%-saturated HRW induced an increase of endogenous H-2 in Brassica campestris seedlings, and HRW alleviated Cd toxicity related to growth inhibition and oxidative damage. Seedlings supplied with HRW exhibited increased root length and reduced lipid peroxidation, similar to plants receiving GSH post-treatment. Additionally, seedlings post-treated with HRW accumulated higher levels of reduced glutathione (GSH) and ascorbic acid (AsA) and showed increased GST and GPX activities in roots. Molecular evidence illustrated that the expression of genes such as GS, GR1 and GR2, which were down-regulated following the addition of Cd, GSH or BSO, could be reversed to varying degrees by the addition of HRW. Based on these results, it could be proposed that H-2 might be an important regulator for enhancing the tolerance of Brassica campestris seedlings against Cd, mainly by governing reduced glutathione homeostasis.	[Wu, Qi; Su, Nana; Chen, Qin; Shen, Wenbiao; Shen, Zhenguo; Xia, Yan; Cui, Jin] Lab Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China		Cui, J (corresponding author), Lab Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	cuijin@njau.edu.cn	Cui, Jin/I-4496-2016		National Natural Science Foundation of China [31171998]; Fundamental Research Funds for the Central Universities [KYZ201316]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31171998) and the Fundamental Research Funds for the Central Universities (KYZ201316).	Ali B, 2014, BIOL PLANTARUM, V58, P131, DOI 10.1007/s10535-013-0358-5; Ali B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123328; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Anjum NA, 2012, ENVIRON EXP BOT, V75, P307, DOI 10.1016/j.envexpbot.2011.07.002; Aravind Parameswaran, 2005, Braz. J. Plant Physiol., V17, P3, DOI 10.1590/S1677-04202005000100002; Arisi ACM, 1997, PLANTA, V203, P362, DOI 10.1007/s004250050202; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Chen F, 2010, PLANT PHYSIOL BIOCH, V48, P663, DOI 10.1016/j.plaphy.2010.05.001; Chen HJ, 2013, J PLANT PHYSIOL, V170, P1471, DOI 10.1016/j.jplph.2013.05.015; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Chen M, 2014, J HAZARD MATER, V267, P40, DOI 10.1016/j.jhazmat.2013.12.029; Cho UH, 2005, PLANT SCI, V168, P113, DOI 10.1016/j.plantsci.2004.07.021; Cui WT, 2013, J HAZARD MATER, V260, P715, DOI 10.1016/j.jhazmat.2013.06.032; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; Vivancos PD, 2010, PLANT J, V64, P825, DOI 10.1111/j.1365-313X.2010.04371.x; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Drazkiewicz M, 2003, PLANT SCI, V164, P195, DOI 10.1016/S0168-9452(02)00383-7; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2001, TRENDS PLANT SCI, V6, P486, DOI 10.1016/S1360-1385(01)02086-6; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gaffron H, 1939, NATURE, V143, P204, DOI 10.1038/143204a0; Han B, 2014, MOL PLANT, V7, P388, DOI 10.1093/mp/sst122; Hassan MJ, 2005, PLANT SOIL, V277, P359, DOI 10.1007/s11104-005-8160-6; Hawrylak-Nowak B, 2015, PLANT PHYSIOL BIOCH, V94, P225, DOI 10.1016/j.plaphy.2015.06.012; Hu HL, 2014, FOOD CHEM, V156, P100, DOI 10.1016/j.foodchem.2014.01.067; Huang J, 2012, PLANT PHYSIOL, V158, P1779, DOI 10.1104/pp.111.192872; Jez JM, 2004, J BIOL CHEM, V279, P42726, DOI 10.1074/jbc.M407961200; Jin QJ, 2013, PLANT CELL ENVIRON, V36, P956, DOI 10.1111/pce.12029; Lin YT, 2014, J PLANT PHYSIOL, V171, P1, DOI 10.1016/j.jplph.2013.08.009; Liu JN, 2008, J HAZARD MATER, V151, P261, DOI 10.1016/j.jhazmat.2007.08.016; Marquez-Garcia B, 2012, ENVIRON EXP BOT, V75, P159, DOI 10.1016/j.envexpbot.2011.09.009; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Mellado M, 2012, PLANT PHYSIOL BIOCH, V51, P102, DOI 10.1016/j.plaphy.2011.10.007; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Millar AH, 2003, PLANT PHYSIOL, V133, P443, DOI 10.1104/pp.103.028399; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Muller M, 2002, PLANT PHYSIOL BIOCH, V40, P585, DOI 10.1016/S0981-9428(02)01420-1; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Noctor Graham, 2011, Arabidopsis Book, V9, pe0142, DOI 10.1199/tab.0142; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Paila RV, 2012, ECOTOX ENVIRON SAFE, V75, P127, DOI 10.1016/j.ecoenv.2011.08.023; Podazza G, 2012, J HAZARD MATER, V215, P83, DOI 10.1016/j.jhazmat.2012.02.031; Pomponi M, 2006, PLANTA, V223, P180, DOI 10.1007/s00425-005-0073-3; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; RAO MV, 1995, PLANT PHYSIOL, V109, P421, DOI 10.1104/pp.109.2.421; RENWICK GM, 1964, PLANT PHYSIOL, V39, P303, DOI 10.1104/pp.39.3.303; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Srivastava PK, 2012, ECOTOX ENVIRON SAFE, V83, P79, DOI 10.1016/j.ecoenv.2012.06.009; Su NN, 2014, J AGR FOOD CHEM, V62, P6454, DOI 10.1021/jf5019593; Sung CH, 2010, PLANT BIOTECHNOL REP, V4, P243, DOI 10.1007/s11816-010-0138-z; TORRES V, 1984, ANN NY ACAD SCI, V434, P296, DOI 10.1111/j.1749-6632.1984.tb29849.x; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Wang JL, 2013, AGR ECOSYST ENVIRON, V165, P39, DOI 10.1016/j.agee.2012.12.006; Wei SH, 2004, PROG NAT SCI-MATER, V14, P495, DOI 10.1080/10020070412331343851; Wu FB, 2004, CHEMOSPHERE, V57, P447, DOI 10.1016/j.chemosphere.2004.06.042; Wu Q, 2015, J PLANT PHYSIOL, V175, P174, DOI 10.1016/j.jplph.2014.09.017; Xia XJ, 2009, J AGR FOOD CHEM, V57, P8406, DOI 10.1021/jf901915a; Xiao D, 2012, FUNCT PLANT BIOL, V39, P342, DOI 10.1071/FP11246; Xie YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049800; Xu S, 2013, PLANT SOIL, V370, P47, DOI 10.1007/s11104-013-1614-3; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Zhao XF, 2013, J INTEGR AGR, V12, P1540, DOI 10.1016/S2095-3119(13)60417-7	64	15	17	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139956	10.1371/journal.pone.0139956	http://dx.doi.org/10.1371/journal.pone.0139956			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445361	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600112
J	Li, YX; Xu, M; Wang, N; Li, YG				Li, Yixing; Xu, Meng; Wang, Ning; Li, Youguo			A JAZ Protein in Astragalus sinicus Interacts with a Leghemoglobin through the TIFY Domain and Is Involved in Nodule Development and Nitrogen Fixation	PLOS ONE			English	Article							NITRIC-OXIDE; SYMBIOTIC LEGHEMOGLOBINS; HEMOGLOBIN GENES; SOYBEAN NODULES; JASMONIC ACID; ROOT-NODULES; EXPRESSION; TRANSCRIPTION; FAMILY; DIFFERENTIATION	Leghemoglobins (Lbs) play an important role in legumes-rhizobia symbiosis. Lbs bind O-2 and protect nitrogenase activity from damage by O-2 in nodules, therefore, they are regarded as a marker of active nitrogen fixation in nodules. Additionally, Lbs are involved in the nitric oxide (NO) signaling pathway, acting as a NO scavenger during nodule development and nitrogen fixation. However, regulators responsible for Lb expression and modulation of Lb activity have not been characterized. In our previous work, a Jasmonate-Zim-domain (JAZ) protein interacting with a Lb (AsB2510) in Astragalus sinicus was identified and designated AsJAZ1. In this study, the interaction between AsJAZ1 and AsB2510 was verified using a yeast two-hybrid system and in vitro Glutathione S-transferase (GST) pull-down assays, resulting in identification of the interaction domain as a TIFY (previously known as zinc-finger protein expressed in inflorescence meristem, ZIM) domain. TIFY domain is named after the most conserved amino acids within the domain. Bimolecular fluorescence complementation (BiFC) was used to confirm the interaction between AsJAZ1 and AsB2510 in tobacco cells, demonstrating that AsJAZ1-AsB2510 interaction was localized to the cell membrane and cytoplasm. Furthermore, the expression patterns and the symbiotic phenotypes of AsJAZ1 were investigated. Knockdown of AsJAZ1 expression via RNA interference led to decreased number of nodules, abnormal development of bacteroids, accumulation of poly-x-hydroxybutyrate (PHB) and loss of nitrogenase activity. Taken together, our results suggest that AsJAZ1 interacts with AsB2510 and participates in nodule development and nitrogen fixation. Our results provide novel insights into the functions of Lbs or JAZ proteins during legume-rhizobia symbiosis.	[Xu, Meng; Wang, Ning; Li, Youguo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Li, Yixing] Guangxi Univ, Guangxi Expt Ctr Sci & Technol, Nanning 530004, Peoples R China; [Li, Yixing] Guangxi Univ, Coll Anim Sci & Technol, Nanning 530004, Peoples R China	Huazhong Agricultural University; Guangxi University; Guangxi University	Li, YG (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	youguoli@mail.hzau.edu.cn			National Natural Science Foundation of China [31371549, 31460056, 31000115]; Major State Basic Research Development Program of China (973 Program) [2010CB126502]; Foundation of Guangxi Experiment Centre of Science and Technology [YXKT2014004]; Guangxi Natural Science Foundation [2015GXNSFAA139048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Foundation of Guangxi Experiment Centre of Science and Technology; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by National Natural Science Foundation of China to YGL (no. 31371549), National Natural Science Foundation of China to YXL (no. 31460056), National Natural Science Foundation of China to YXL (no. 31000115), the Major State Basic Research Development Program of China (973 Program) to YGL (no. 2010CB126502), Foundation of Guangxi Experiment Centre of Science and Technology to YXL (no. YXKT2014004), and Guangxi Natural Science Foundation (no. 2015GXNSFAA139048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEBY CA, 1984, ANNU REV PLANT PHYS, V35, P443, DOI 10.1146/annurev.pp.35.060184.002303; Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen T, 2012, PLANT CELL, V24, P823, DOI 10.1105/tpc.112.095984; CHEN WX, 1991, INT J SYST BACTERIOL, V41, P275, DOI 10.1099/00207713-41-2-275; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Cho HJ, 2002, PLANT CELL TISS ORG, V69, P259, DOI 10.1023/A:1015624316573; Chou MX, 2006, J EXP BOT, V57, P2673, DOI 10.1093/jxb/erl030; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Ferguson BJ, 2014, J CHEM ECOL, V40, P770, DOI 10.1007/s10886-014-0472-7; Fu WQ, 2007, APPL MICROBIOL BIOT, V75, P777, DOI 10.1007/s00253-007-0887-y; Gunther C, 2007, MOL PLANT MICROBE IN, V20, P1596, DOI 10.1094/MPMI-20-12-1596; HARDY R W F, 1973, Soil Biology and Biochemistry, V5, P47, DOI 10.1016/0038-0717(73)90093-X; HARPER JW, 1993, CELL, V75, P805; Harutyunyan EH, 1996, J MOL BIOL, V264, P152, DOI 10.1006/jmbi.1996.0630; Herold S, 2005, J BIOL INORG CHEM, V10, P935, DOI 10.1007/s00775-005-0046-9; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Hunt PW, 2001, PLANT MOL BIOL, V47, P677, DOI 10.1023/A:1012440926982; Ishiga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075728; James P, 1996, GENETICS, V144, P1425; Kang H, 2011, PLANT PHYSIOL, V155, P1312, DOI 10.1104/pp.110.167965; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YX, 2008, NEW PHYTOL, V180, P185, DOI 10.1111/j.1469-8137.2008.02562.x; Liu Yan, 2010, Weishengwu Xuebao, V50, P1607; Mabood F, 2006, PLANT PHYSIOL BIOCH, V44, P759, DOI 10.1016/j.plaphy.2006.10.025; MARCKER A, 1984, EMBO J, V3, P1691, DOI 10.1002/j.1460-2075.1984.tb02033.x; Mathieu C, 1998, FREE RADICAL BIO MED, V24, P1242, DOI 10.1016/S0891-5849(97)00440-1; Mur LAJ, 2012, J EXP BOT, V63, P4375, DOI 10.1093/jxb/ers116; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagata M, 2008, MOL PLANT MICROBE IN, V21, P1175, DOI 10.1094/MPMI-21-9-1175; Nakagawa T, 2006, PLANT CELL PHYSIOL, V47, P176, DOI 10.1093/pcp/pci222; Oh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057868; Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042; Ott T, 2009, MOL PLANT MICROBE IN, V22, P800, DOI 10.1094/MPMI-22-7-0800; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Rosas S, 1998, PLANT MOL BIOL, V38, P1161, DOI 10.1023/A:1006064807870; Sanchez C, 2011, BIOCHEM SOC T, V39, P184, DOI 10.1042/BST0390184; Sanchez C, 2010, MOL PLANT MICROBE IN, V23, P702, DOI 10.1094/MPMI-23-5-0702; Seo HS, 2007, MOL CELLS, V24, P185; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shimoda Y, 2009, PLANT J, V57, P254, DOI 10.1111/j.1365-313X.2008.03689.x; Smagghe BJ, 2009, BIOPOLYMERS, V91, P1083, DOI 10.1002/bip.21256; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Sun JH, 2006, PLANT J, V46, P961, DOI 10.1111/j.1365-313X.2006.02751.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toda Y, 2013, PLANT CELL, V25, P1709, DOI 10.1105/tpc.113.112052; Uchiumi T, 2002, PLANT CELL PHYSIOL, V43, P1351, DOI 10.1093/pcp/pcf165; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vigeolas H, 2011, PLANT PHYSIOL, V155, P1435, DOI 10.1104/pp.110.166462; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wager A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00041; Wang J, 2015, PLANT MOL BIOL; Watts RA, 2001, P NATL ACAD SCI USA, V98, P10119, DOI 10.1073/pnas.191349198; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Xiao S, 2004, PLANT CELL, V16, P1132, DOI 10.1105/tpc.020370; Xie XA, 2013, NEW PHYTOL, V198, P836, DOI 10.1111/nph.12188; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zhou XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121824; Zhu H, 2008, PLANT PHYSIOL, V148, P337, DOI 10.1104/pp.108.119164; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	65	8	10	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139964	10.1371/journal.pone.0139964	http://dx.doi.org/10.1371/journal.pone.0139964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460857	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300041
J	Ma, RY; Zhang, JL; Cavaleri, MA; Sterck, F; Strijk, JS; Cao, KF				Ma, Ren-Yi; Zhang, Jiao-Lin; Cavaleri, Molly A.; Sterck, Frank; Strijk, Joeri S.; Cao, Kun-Fang			Convergent Evolution towards High Net Carbon Gain Efficiency Contributes to the Shade Tolerance of Palms (Arecaceae)	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; LEAF DARK RESPIRATION; LIFE-SPAN; TRAITS; LIGHT; LEAVES; AREA; NITROGEN; PATTERNS; ECOLOGY	Most palm species occur in the shaded lower strata of tropical rain forests, but how their traits relate to shade adaptation is poorly understood. We hypothesized that palms are adapted to the shade of their native habitats by convergent evolution towards high net carbon gain efficiency (CGE(n)), which is given by the maximum photosynthetic rate to dark respiration rate ratio. Leaf mass per area, maximum photosynthetic rate, dark respiration and N and P concentrations were measured in 80 palm species grown in a common garden, and combined with data of 30 palm species growing in their native habitats. Compared to other species from the global leaf economics data, dicotyledonous broad-leaved trees in tropical rainforest or other monocots in the global leaf economics data, palms possessed consistently higher CGE(n), achieved by lowered dark respiration and fairly high foliar P concentration. Combined phylogenetic analyses of evolutionary signal and trait evolution revealed convergent evolution towards high CGEn in palms. We conclude that high CGE(n) is an evolutionary strategy that enables palms to better adapt to shady environments than coexisting dicot tree species, and may convey advantages in competing with them in the tropical forest understory. These findings provide important insights for understanding the evolution and ecology of palms, and for understanding plant shade adaptations of lower rainforest strata. Moreover, given the dominant role of palms in tropical forests, these findings are important for modelling carbon and nutrient cycling in tropical forest ecosystems.	[Ma, Ren-Yi; Zhang, Jiao-Lin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Ma, Ren-Yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Cavaleri, Molly A.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Sterck, Frank] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AP Wageningen, Netherlands; [Strijk, Joeri S.; Cao, Kun-Fang] Guangxi Univ, Plant Ecophysiol & Evolut Grp, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China; [Strijk, Joeri S.; Cao, Kun-Fang] Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Michigan Technological University; Wageningen University & Research; Guangxi University; Guangxi University	Cao, KF (corresponding author), Guangxi Univ, Plant Ecophysiol & Evolut Grp, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi, Peoples R China.	kunfangcao@gxu.edu.cn	Cao, Kun-Fang/D-2157-2009; Strijk, Joeri S./F-8220-2019; Ma, Ren-Yi/D-1896-2009	Cao, Kun-Fang/0000-0002-2253-7189; Strijk, Joeri S./0000-0003-1109-7015; Ma, Ren-Yi/0000-0002-2218-7043; Cavaleri, Molly/0000-0003-0984-611X	National Natural Science Foundation of China [31170399]; CAS '135' programs [XTBG-T01, XTBG-F01]; U.S. National Science Foundation [ATM-0223284]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS '135' programs; U.S. National Science Foundation(National Science Foundation (NSF))	This study is financially supported by the National Natural Science Foundation of China (grant No.: 31170399) and the CAS '135' programs (XTBG-T01, XTBG-F01). The functional traits of 12 palm species provided by MAC are based on support from the U.S. National Science Foundation (ATM-0223284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; Anten NPR, 2001, FUNCT ECOL, V15, P252, DOI 10.1046/j.1365-2435.2001.00517.x; Ataroff Michele, 1994, Principes, V38, P24; Atkin OK, 2015, NEW PHYTOL, V206, P614, DOI 10.1111/nph.13253; Baker WJ, 2011, ANN BOT-LONDON, V108, P1417, DOI 10.1093/aob/mcr020; Baker WJ, 2009, SYST BIOL, V58, P240, DOI 10.1093/sysbio/syp021; BONGERS F, 1990, BOT GAZ, V151, P354, DOI 10.1086/337836; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BULLOCK SH, 1984, OECOLOGIA, V63, P426, DOI 10.1007/BF00390677; Cavaleri MA, 2008, PLANT CELL ENVIRON, V31, P473, DOI 10.1111/j.1365-3040.2008.01775.x; Cavaleri MA, 2006, GLOBAL CHANGE BIOL, V12, P2442, DOI 10.1111/j.1365-2486.2006.01269.x; Cavaleri MA, 2010, ECOLOGY, V91, P1730, DOI 10.1890/09-1326.1; CHAZDON RL, 1986, J ECOL, V74, P995, DOI 10.2307/2260229; CHAZDON RL, 1986, AM NAT, V127, P9, DOI 10.1086/284464; Chazdon RL, 1986, PRINCIPLES, V30, P92; Clark DB, 2008, ECOL LETT, V11, P163, DOI 10.1111/j.1461-0248.2007.01134.x; Couvreur TLP, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-48; Couvreur TLP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-44; CRONSHAW J, 1981, ANNU REV PLANT PHYS, V32, P465, DOI 10.1146/annurev.pp.32.060181.002341; Cunningham SA, 1997, OECOLOGIA, V111, P36, DOI 10.1007/s004420050205; Denton MD, 2007, PLANT CELL ENVIRON, V30, P1557, DOI 10.1111/j.1365-3040.2007.01733.x; Dominy NJ, 2008, ANN BOT-LONDON, V101, P1363, DOI 10.1093/aob/mcn046; Donovan LA, 2014, J ECOL, V102, P302, DOI 10.1111/1365-2745.12193; Dransfield J., 2008, GENERA PALMARUM THE; Edwards PJ, 2015, NEW PHYTOL, V206, P990, DOI 10.1111/nph.13272; Eiserhardt WL, 2011, ANN BOT-LONDON, V108, P1391, DOI 10.1093/aob/mcr146; Falster DS, 2012, NEW PHYTOL, V193, P409, DOI 10.1111/j.1469-8137.2011.03940.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fisher J. B., 2008, Palms, V52, P113; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Grubb PJ, 2008, ANN BOT-LONDON, V101, P1379, DOI 10.1093/aob/mcn047; Hao GY, 2011, ECOLOGY, V92, P2117, DOI 10.1890/11-0269.1; Horn JW, 2009, AM J BOT, V96, P1462, DOI 10.3732/ajb.0800396; Ingram T, 2013, METHODS ECOL EVOL, V4, P416, DOI 10.1111/2041-210X.12034; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Lusk CH, 2008, TRENDS ECOL EVOL, V23, P299, DOI 10.1016/j.tree.2008.02.006; McPherson K, 1998, OECOLOGIA, V117, P460, DOI 10.1007/s004420050681; Meir P, 2007, PLANT ECOL, V192, P277, DOI 10.1007/s11258-007-9320-y; National Soil Survey Office, 1992, SOIL SURV TECHN CHIN; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Poorter L, 2007, ECOLOGY, V88, P1000, DOI 10.1890/06-0984; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2013, TRACER MCMC TRACE AN; Reich PB, 1998, OECOLOGIA, V114, P471, DOI 10.1007/s004420050471; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; RICH PM, 1995, AM J BOT, V82, P328, DOI 10.2307/2445578; Santiago LS, 2009, INT J PLANT SCI, V170, P83, DOI 10.1086/593044; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; Slot M, 2014, FUNCT ECOL, V28, P1074, DOI 10.1111/1365-2435.12263; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weerasinghe LK, 2014, TREE PHYSIOL, V34, P564, DOI 10.1093/treephys/tpu016; Westoby M, 2000, AM NAT, V155, P649, DOI 10.1086/303346; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2006, NEW PHYTOL, V169, P309, DOI 10.1111/j.1469-8137.2005.01590.x; Zhang YJ, 2015, NEW PHYTOL, V206, P817, DOI 10.1111/nph.13274	61	11	13	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140384	10.1371/journal.pone.0140384	http://dx.doi.org/10.1371/journal.pone.0140384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461108	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300087
J	Tachinardi, P; Toien, O; Valentinuzzi, VS; Buck, CL; Oda, GA				Tachinardi, Patricia; Toien, Oivind; Valentinuzzi, Veronica S.; Buck, C. Loren; Oda, Gisele A.			Nocturnal to Diurnal Switches with Spontaneous Suppression of Wheel-Running Behavior in a Subterranean Rodent	PLOS ONE			English	Article							UNSTRIPED NILE RAT; CIRCADIAN-RHYTHMS; BODY-TEMPERATURE; CTENOMYS-TALARUM; PHASE-SHIFTS; ENERGETICS; CLOCK; TUCO; THERMOREGULATION; ENTRAINMENT	Several rodent species that are diurnal in the field become nocturnal in the lab. It has been suggested that the use of running-wheels in the lab might contribute to this timing switch. This proposition is based on studies that indicate feed-back of vigorous wheel-running on the period and phase of circadian clocks that time daily activity rhythms. Tuco-tucos (Ctenomys aff. knighti) are subterranean rodents that are diurnal in the field but are robustly nocturnal in laboratory, with or without access to running wheels. We assessed their energy metabolism by continuously and simultaneously monitoring rates of oxygen consumption, body temperature, general motor and wheel running activity for several days in the presence and absence of wheels. Surprisingly, some individuals spontaneously suppressed running-wheel activity and switched to diurnality in the respirometry chamber, whereas the remaining animals continued to be nocturnal even after wheel removal. This is the first report of timing switches that occur with spontaneous wheel-running suppression and which are not replicated by removal of the wheel.	[Tachinardi, Patricia; Oda, Gisele A.] Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil; [Toien, Oivind] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Valentinuzzi, Veronica S.] Ctr Reg Invest Cient & Transferencia Tecnol CRILA, La Rioja, Argentina; [Buck, C. Loren] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA	Universidade de Sao Paulo; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Anchorage	Valentinuzzi, VS (corresponding author), Ctr Reg Invest Cient & Transferencia Tecnol CRILA, La Rioja, Argentina.	vvalentinuzzi@crilar-conicet.gob.ar; Loren.Buck@nau.edu; gaoda@ib.usp.br	Buck, C. Loren/AAI-8110-2020; oda, gisele a/F-4283-2012	Buck, C. Loren/0000-0001-6008-7257; oda, gisele a/0000-0001-7776-5368; Toien, Oivind/0000-0001-5967-2483	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [12/15767-2, 12/16362-6, 13/50482-1, 12/23393-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [142215/2012-0]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-11420090100252]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-1979]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br): grants 12/15767-2, 12/16362-6, 13/50482-1 to GAO; 12/23393-5 to PT, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br): grant 142215/2012-0 to PT, Consejo Nacional de Investigaciones Cientificas y Tecnicas (www.conicet.gov.ar): grant PIP-11420090100252 to VSV and the Agencia Nacional de Promocion Cientifica y Tecnologica (www.agencia.mincyt.gob.ar): grant PICT 2011-1979 to VSV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barak O, 2013, CHRONOBIOL INT, V30, P1123, DOI 10.3109/07420528.2013.805337; Bednarczyk MR, 2011, HIPPOCAMPUS, V21, P1334, DOI 10.1002/hipo.20831; Bishop B, 2000, AM J PHYSIOL-REG I, V279, pR1378, DOI 10.1152/ajpregu.2000.279.4.R1378; Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Blanchong JA, 2000, J MAMMAL, V81, P595, DOI 10.1644/1545-1542(2000)081<0595:TPOAOT>2.0.CO;2; Buffenstein R, 2000, LIFE UNDERGROUND BIO, P183; Burda H, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P21, DOI 10.1007/978-3-540-69276-8_3; BUSCH C, 1989, COMP BIOCHEM PHYS A, V93, P345, DOI 10.1016/0300-9629(89)90048-0; Cohen R, 2009, CHRONOBIOL INT, V26, P430, DOI 10.1080/07420520902820939; Daan S., 1981, HDB BEHAVIOURAL NEUR, P275, DOI DOI 10.1007/978-1-4615-6552-9_15; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; Dubreucq S, 2015, BEHAV BRAIN RES, V282, P1, DOI 10.1016/j.bbr.2014.12.042; Dubreucq S, 2011, HIPPOCAMPUS, V21, P239, DOI 10.1002/hipo.20778; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; Flores DEFL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068243; FULK GW, 1976, J MAMMAL, V57, P495, DOI 10.2307/1379298; Hagenauer MH, 2008, BIOL RHYTHM RES, V39, P269, DOI 10.1080/09291010701683425; Halle S, 2000, ECOL STU AN, V141, P67; HOOGENBOOM I, 1984, OECOLOGIA, V61, P18, DOI 10.1007/BF00379084; Hut RA, 2012, PROG BRAIN RES, V199, P281, DOI 10.1016/B978-0-444-59427-3.00017-4; Hut RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017527; Jarsky TM, 2000, J APPL PHYSIOL, V89, P2130, DOI 10.1152/jappl.2000.89.6.2130; Kas MJH, 1999, J NEUROSCI, V19, P328, DOI 10.1523/JNEUROSCI.19-01-00328.1999; Kenagy G.J., 1982, P322; Kenagy GJ, 2004, J MAMMAL, V85, P260, DOI 10.1644/1545-1542(2004)085<0260:MOSABO>2.0.CO;2; Kenagy GJ, 2002, REV CHIL HIST NAT, V75, P567; Kronfeld-Schor N, 2001, J THERM BIOL, V26, P139, DOI 10.1016/S0306-4565(00)00034-6; Labyak Susan E., 1997, American Journal of Physiology, V273, pR1058; Lacey EA, 2000, LIFE UNDERGROUND BIO; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Luna F, 2002, CAN J ZOOL, V80, P2144, DOI 10.1139/Z02-201; Luna F, 2007, COMP BIOCHEM PHYS A, V146, P559, DOI 10.1016/j.cbpa.2005.12.025; Luna F, 2009, PHYSIOL BIOCHEM ZOOL, V82, P226, DOI 10.1086/597526; MATHER JG, 1981, MAMMAL REV, V11, P41, DOI 10.1111/j.1365-2907.1981.tb00246.x; Meijer JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0210; Mortola JP, 2000, J APPL PHYSIOL, V88, P365, DOI 10.1152/jappl.2000.88.2.365; MROSOVSKY N, 1995, CIBA F SYMP, V183, P154; National Research Council, 2011, GUIDE CARE USE LAB A; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; Perissinotti PP, 2009, COMP BIOCHEM PHYS A, V154, P298, DOI 10.1016/j.cbpa.2009.05.013; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; REEBS SG, 1989, J COMP PHYSIOL A, V165, P819, DOI 10.1007/BF00610880; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; Refinetti R, 1996, PHYSIOL BEHAV, V60, P959; Riccio AP, 2000, PHYSIOL BEHAV, V71, P16; Ruf T, 2000, ECOL STU AN, V141, P217; Valentinuzzi VS, 2009, CHRONOBIOL INT, V26, P14, DOI 10.1080/07420520802686331; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Tachinardi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085674; Toien O, 2013, J APPL PHYSIOL, V114, P1094, DOI 10.1152/japplphysiol.01494.2012; Tomotani BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037918; Van der Vinne V, 2014, PNAS; VANREETH O, 1989, NATURE, V339, P49, DOI 10.1038/339049a0; Weinert D, 2007, PHYSIOL BEHAV, V90, P325, DOI 10.1016/j.physbeh.2006.09.019; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120	58	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140500	10.1371/journal.pone.0140500	http://dx.doi.org/10.1371/journal.pone.0140500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460828	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300107
J	Yusuf, HM; Treydte, AC; Sauerborn, J				Yusuf, Hasen M.; Treydte, Anna C.; Sauerborn, Jauchim			Managing Semi-Arid Rangelands for Carbon Storage: Grazing and Woody Encroachment Effects on Soil Carbon and Nitrogen	PLOS ONE			English	Article							INNER-MONGOLIA; SHRUB ENCROACHMENT; AFRICAN SAVANNA; ORGANIC-CARBON; MIXED-GRASS; BUSH COVER; PLANT; FIRE; MANAGEMENT; DYNAMICS	High grazing intensity and wide-spread woody encroachment may strongly alter soil carbon (C) and nitrogen (N) pools. However, the direction and quantity of these changes have rarely been quantified in East African savanna ecosystem. As shifts in soil C and N pools might further potentially influence climate change mitigation, we quantified and compared soil organic carbon (SOC) and total soil nitrogen (TSN) content in enclosures and communal grazing lands across varying woody cover i.e. woody encroachment levels. Estimated mean SOC and TSN stocks at 0-40 cm depth varied across grazing regimes and among woody encroachment levels. The open grazing land at the heavily encroached site on sandy loam soil contained the least SOC (30 +/- 2.1 Mg ha(-1)) and TSN (5 +/- 0.57 Mg ha(-1)) while the enclosure at the least encroached site on sandy clay soil had the greatest mean SOC (81.0 +/- 10.6 Mg ha(-1)) and TSN (9.2 +/- 1.48 Mg ha(-1)). Soil OC and TSN did not differ with grazing exclusion at heavily encroached sites, but were twice as high inside enclosure compared to open grazing soils at low encroached sites. Mean SOC and TSN in soils of 0-20 cm depth were up to 120% higher than that of the 21-40 cm soil layer. Soil OC was positively related to TSN, cation exchange capacity (CEC), but negatively related to sand content. Our results show that soil OC and TSN stocks are affected by grazing, but the magnitude is largely influenced by woody encroachment and soil texture. We suggest that improving the herbaceous layer cover through a reduction in grazing and woody encroachment restriction are the key strategies for reducing SOC and TSN losses and, hence, for climate change mitigation in semi-arid rangelands.	[Yusuf, Hasen M.] Wollega Univ, Coll Agr & Nat Resources, Nekemte, Ethiopia; [Treydte, Anna C.; Sauerborn, Jauchim] Univ Hohenheim, Inst Plant Prod & Agroecol Trop & Subtrop, D-70593 Stuttgart, Germany	University Hohenheim	Yusuf, HM (corresponding author), Wollega Univ, Coll Agr & Nat Resources, 395 Nekemte, Nekemte, Ethiopia.	hasanyusuf12@gmail.com		Treydte, Anna/0000-0003-0605-3069	Dr. Hermann Eiselen PhD grant (Foundation fiat panis); DAAD (German Academic Exchange Service) scholarship in the frame of the Food Security Center of the University of Hohenheim	Dr. Hermann Eiselen PhD grant (Foundation fiat panis); DAAD (German Academic Exchange Service) scholarship in the frame of the Food Security Center of the University of Hohenheim(Deutscher Akademischer Austausch Dienst (DAAD))	This research was financially supported by the Dr. Hermann Eiselen PhD grant (Foundation fiat panis) and a DAAD (German Academic Exchange Service) scholarship in the frame of the Food Security Center of the University of Hohenheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SA, 2013, J ARID ENVIRON, V89, P67, DOI 10.1016/j.jaridenv.2012.10.002; Allard V, 2003, GLOBAL CHANGE BIOL, V9, P1731, DOI 10.1111/j.1365-2486.2003.00711.x; Angassa A, 2008, HUM ECOL, V36, P201, DOI 10.1007/s10745-007-9156-z; Angassa A, 2010, J ARID ENVIRON, V74, P111, DOI 10.1016/j.jaridenv.2009.07.015; [Anonymous], 1998, ASSESSMENT INDIGENOU; Archer S. R., 2001, GLOBAL BIOGEOCHEM CY, P115, DOI DOI 10.1016/B978-012631260-7/50011-X; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Baisden WT, 2003, ECOL APPL, V13, P649; Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Chapin FS, 2009, J ECOL, V97, P840, DOI 10.1111/j.1365-2745.2009.01529.x; Coppock D. L., 1994, BORANA PLATEAU SO ET; COSSINS NJ, 1988, AGR SYST, V27, P251, DOI 10.1016/0308-521X(88)90035-2; Daryanto S, 2013, AGR ECOSYST ENVIRON, V169, P1, DOI 10.1016/j.agee.2013.02.001; Dell CJ, 2005, ECOLOGY, V86, P1280, DOI 10.1890/03-0790; Gee G. W., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P383; Gibbens RP, 2001, J ARID ENVIRON, V49, P221, DOI 10.1006/jare.2000.0784; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hasen-Yusuf M, 2013, J ARID ENVIRON, V96, P64, DOI 10.1016/j.jaridenv.2013.04.007; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Homann S, 2008, LAND DEGRAD DEV, V19, P368, DOI 10.1002/ldr.845; Hudak AT, 2003, AUSTRAL ECOL, V28, P173, DOI 10.1046/j.1442-9993.2003.01265.x; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jahnke H. E., 1982, Livestock production systems and livestock development in tropical Africa.; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kamara A., 2001, THESIS; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Kochy M, 2001, J ECOL, V89, P807, DOI 10.1046/j.0022-0477.2001.00600.x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Mekuria W, 2013, ARID LAND RES MANAG, V27, P153, DOI 10.1080/15324982.2012.721858; Mwendera EJ, 1997, AGR ECOSYST ENVIRON, V64, P33, DOI 10.1016/S0167-8809(96)01127-9; Napier A, REV PASTORAL RANGELA; Oba G, 2001, LAND DEGRAD DEV, V12, P461, DOI 10.1002/ldr.463; Oba G, 2000, LANDSCAPE ECOL, V15, P535, DOI 10.1023/A:1008106625096; Pei SF, 2008, AGR ECOSYST ENVIRON, V124, P33, DOI 10.1016/j.agee.2007.08.008; Pineiro G, 2009, GLOBAL BIOGEOCHEM CY, P23; Pineiro G, 2006, GLOBAL CHANGE BIOL, V12, P1267, DOI 10.1111/j.1365-2486.2006.01173.x; Qiu LP, 2012, PLANT SOIL, V355, P299, DOI 10.1007/s11104-011-1099-x; Rau BM, 2011, J ARID ENVIRON, V75, P827, DOI 10.1016/j.jaridenv.2011.04.005; Reeder JD, 2004, ENVIRON MANAGE, V33, P485, DOI 10.1007/s00267-003-9106-5; Reeder JD, 2002, ENVIRON POLLUT, V116, P457, DOI 10.1016/S0269-7491(01)00223-8; Reid Robin S., 2004, Environment Development and Sustainability, V6, P91, DOI 10.1023/B:ENVI.0000003631.43271.6b; Roques KG, 2001, J APPL ECOL, V38, P268, DOI 10.1046/j.1365-2664.2001.00567.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Savadogo P, 2007, AGR ECOSYST ENVIRON, V118, P80, DOI 10.1016/j.agee.2006.05.002; SCHLESINGER WH, 1977, ANNU REV ECOL SYST, V8, P51, DOI 10.1146/annurev.es.08.110177.000411; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Scholes R.J., 1996, SCOPE, V56, P69; Schuman GE, 1999, ECOL APPL, V9, P65, DOI 10.1890/1051-0761(1999)009[0065:IOGMOT]2.0.CO;2; Semmartin M, 2010, PLANT SOIL, V328, P471, DOI 10.1007/s11104-009-0126-7; Shackleton CM, 2011, S AFR J BOT, V77, P184, DOI 10.1016/j.sajb.2010.07.014; Shrestha G, 2008, AGR ECOSYST ENVIRON, V125, P173, DOI 10.1016/j.agee.2007.12.007; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Stewart AM, 2008, OECOLOGIA, V157, P453, DOI 10.1007/s00442-008-1088-9; Su YZ, 2005, CATENA, V59, P267, DOI 10.1016/j.catena.2004.09.001; t'Mannetje L., 2000, FIELD LAB METHODS GR; Thomas G. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P159; Throop HL, 2012, OECOLOGIA, V169, P373, DOI 10.1007/s00442-011-2217-4; Tolera A, LIVESTOCK RES RURAL, P19; Vagen TG, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015011; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wang CH, 2006, SOIL BIOL BIOCHEM, V38, P1101, DOI 10.1016/j.soilbio.2005.09.009; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Yayneshet T, 2009, J ARID ENVIRON, V73, P542, DOI 10.1016/j.jaridenv.2008.12.002	69	29	29	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0109063	10.1371/journal.pone.0109063	http://dx.doi.org/10.1371/journal.pone.0109063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461478	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300001
J	Kleinhenz, JM; Murphy, TC; Pokutta-Paskaleva, AP; Gleason, RL; Lyle, AN; Taylor, WR; Blount, MA; Cheng, J; Yang, QL; Sutliff, RL; Hart, CM				Kleinhenz, Jennifer M.; Murphy, Tamara C.; Pokutta-Paskaleva, Anastassia P.; Gleason, Rudolph L.; Lyle, Alicia N.; Taylor, W. Robert; Blount, Mitsi A.; Cheng, Juan; Yang, Qinglin; Sutliff, Roy L.; Hart, C. Michael			Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-gamma Disrupts Vascular Wall Structure and Function	PLOS ONE			English	Article							PPAR-GAMMA; INFLAMMATORY RESPONSE; CAROTID ARTERIES; GENE-EXPRESSION; ADIPOSE-TISSUE; CELLS; HYPERTENSION; DYSFUNCTION; ROSIGLITAZONE; INTERFERENCE	Activation of the nuclear hormone receptor, PPAR., with pharmacological agonists promotes a contractile vascular smooth muscle cell phenotype and reduces oxidative stress and cell proliferation, particularly under pathological conditions including vascular injury, restenosis, and atherosclerosis. However, pharmacological agonists activate both PPAR gamma-dependent and -independent mechanisms in multiple cell types confounding efforts to clarify the precise role of PPAR gamma in smooth muscle cell structure and function in vivo. We, therefore, designed and characterized a mouse model with smooth muscle cell-targeted PPAR. overexpression (smPPAR gamma OE). Our results demonstrate that smPPAR gamma OE attenuated contractile responses in aortic rings, increased aortic compliance, caused aortic dilatation, and reduced mean arterial pressure. Molecular characterization revealed that compared to littermate control mice, aortas from smPPAR gamma OE mice expressed lower levels of contractile proteins and increased levels of adipocyte-specific transcripts. Morphological analysis demonstrated increased lipid deposition in the vascular media and in smooth muscle of extravascular tissues. In vitro adenoviral-mediated PPAR gamma overexpression in human aortic smooth muscle cells similarly increased adipocyte markers and lipid uptake. The findings demonstrate that smooth muscle PPAR gamma overexpression disrupts vascular wall structure and function, emphasizing that balanced PPAR gamma activity is essential for vascular smooth muscle homeostasis.	[Kleinhenz, Jennifer M.; Murphy, Tamara C.; Taylor, W. Robert; Sutliff, Roy L.; Hart, C. Michael] Atlanta VA Med Ctr, Decatur, GA 30033 USA; [Kleinhenz, Jennifer M.; Murphy, Tamara C.; Lyle, Alicia N.; Taylor, W. Robert; Blount, Mitsi A.; Cheng, Juan; Sutliff, Roy L.; Hart, C. Michael] Emory Univ, Atlanta, GA 30322 USA; [Pokutta-Paskaleva, Anastassia P.; Gleason, Rudolph L.; Taylor, W. Robert] Georgia Inst Technol, Atlanta, GA 30332 USA; [Yang, Qinglin] Univ Alabama Birmingham, Birmingham, AL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; University System of Georgia; Georgia Institute of Technology; University of Alabama System; University of Alabama Birmingham	Hart, CM (corresponding author), Atlanta VA Med Ctr, Decatur, GA 30033 USA.	michael.hart3@va.gov		Lyle, Alicia/0000-0001-7527-9200	National Institutes of Health [R01 HL102167]; Veteran's Affairs Basic and Laboratory Research Merit Review Award [1I01BX001910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs Basic and Laboratory Research Merit Review Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01 HL102167) to RLS and CMH and a Veteran's Affairs Basic and Laboratory Research Merit Review Award (1I01BX001910) to CMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Beyer AM, 2008, HYPERTENSION, V51, P867, DOI 10.1161/HYPERTENSIONAHA.107.103648; Chang L, 2012, CIRCULATION, V126, P1067, DOI 10.1161/CIRCULATIONAHA.112.104489; Chang L, 2009, CIRCULATION, V119, P2161, DOI 10.1161/CIRCULATIONAHA.108.815803; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Diep QN, 2001, HYPERTENSION, V38, P249, DOI 10.1161/01.HYP.38.2.249; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Duvall CL, 2008, ARTERIOSCL THROM VAS, V28, P290, DOI 10.1161/ATVBAHA.107.158485; Fisher EA, 2014, CIRCULATION, V129, P1545, DOI 10.1161/CIRCULATIONAHA.114.009075; Ghosh AK, 2009, FASEB J, V23, P2968, DOI 10.1096/fj.08-128736; Gleason RL, 2004, J BIOMECH ENG-T ASME, V126, P787, DOI 10.1115/1.1824130; Halabi CM, 2008, CELL METAB, V7, P215, DOI 10.1016/j.cmet.2007.12.008; Hamblin M, 2010, J VASC SURG, V52, P984, DOI 10.1016/j.jvs.2010.05.089; Hodara R, 2011, ARTERIOSCL THROM VAS, V31, P2203, DOI 10.1161/ATVBAHA.111.233247; Kim Teayoun, 2013, Methods Mol Biol, V952, P57, DOI 10.1007/978-1-62703-155-4_4; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Lim HJ, 2006, PROSTAG OTH LIPID M, V80, P165, DOI 10.1016/j.prostaglandins.2006.06.006; Lim S, 2006, ARTERIOSCL THROM VAS, V26, P808, DOI 10.1161/01.ATV.0000204634.26163.a7; Liu JA, 2011, HYPERTENSION, V57, P223, DOI 10.1161/HYPERTENSIONAHA.110.164590; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyle AN, 2012, ARTERIOSCL THROM VAS, V32, P1383, DOI 10.1161/ATVBAHA.112.248922; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Reed AL, 2011, AM J PHYSIOL-HEART C, V301, pH824, DOI 10.1152/ajpheart.00407.2010; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Sakomura Y, 2002, CIRCULATION, V106, pI259, DOI 10.1161/01.cir.0000032914.33237.3b; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Thulin P, 2013, INT J MOL MED, V31, P1003, DOI 10.3892/ijmm.2013.1311; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wan W, 2010, ANN BIOMED ENG, V38, P3605, DOI 10.1007/s10439-010-0114-3; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Wang NN, 2009, TOXICOL PATHOL, V37, P21, DOI 10.1177/0192623308328545; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wilcox R, 2008, AM HEART J, V155, P712, DOI 10.1016/j.ahj.2007.11.029; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhang LL, 2010, J BIOL CHEM, V285, P13666, DOI 10.1074/jbc.M109.087718	47	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139756	10.1371/journal.pone.0139756	http://dx.doi.org/10.1371/journal.pone.0139756			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451838	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200016
J	Nilakantan, H; Kuttippurathu, L; Parrish, A; Hoek, JB; Vadigepalli, R				Nilakantan, Harshavardhan; Kuttippurathu, Lakshmi; Parrish, Austin; Hoek, Jan B.; Vadigepalli, Rajanikanth			In Vivo Zonal Variation and Liver Cell-Type Specific NF-kappa B Localization after Chronic Adaptation to Ethanol and following Partial Hepatectomy	PLOS ONE			English	Article							GENE-EXPRESSION; RAT-LIVER; FATE DECISIONS; ACTIVATION; REGENERATION; GROWTH; ALPHA; INVOLVEMENT; CONSUMPTION; APOPTOSIS	NF-kappa B is a major inflammatory response mediator in the liver, playing a key role in the pathogenesis of alcoholic liver injury. We investigated zonal as well as liver cell type-specific distribution of NF-kappa B activation across the liver acinus following adaptation to chronic ethanol intake and 70% partial hepatectomy (PHx). We employed immunofluorescence staining, digital image analysis and statistical distributional analysis to quantify subcellular localization of NF-kappa B in hepatocytes and hepatic stellate cells (HSCs). We detected significant spatial heterogeneity of NF-kappa B expression and cellular localization between cytoplasm and nucleus across liver tissue. Our main aims involved investigating the zonal bias in NF-kappa B localization and determining to what extent chronic ethanol intake affects this zonal bias with in hepatocytes at baseline and post-PHx. Hepatocytes in the periportal area showed higher NF-kappa B expression than in the pericentral region in the carbohydrate-fed controls, but not in the ethanol group. However, the distribution of NF-kappa B nuclear localization in hepatocytes was shifted towards higher levels in pericentral region than in periportal area, across all treatment conditions. Chronic ethanol intake shifted the NF-kappa B distribution towards higher nuclear fraction in hepatocytes as compared to the pair-fed control group. Ethanol also stimulated higher NF-kappa B expression in a subpopulation of HSCs. In the control group, PHx elicited a shift towards higher NF-kappa B nuclear fraction in hepatocytes. However, this distribution remained unchanged in the ethanol group post-PHx. HSCs showed a lower NF-kappa B expression following PHx in both ethanol and control groups. We conclude that adaptation to chronic ethanol intake attenuates the liver zonal variation in NF-kappa B expression and limits the PHx-induced NF-kappa B activation in hepatocytes, but does not alter the NF-kappa B expression changes in HSCs in response to PHx. Our findings provide new insights as to how ethanol treatment may affect cell-type specific processes regulated by NF-kappa B activation in liver cells.	[Nilakantan, Harshavardhan; Kuttippurathu, Lakshmi; Parrish, Austin; Hoek, Jan B.; Vadigepalli, Rajanikanth] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Daniel Baugh Inst Funct Genom & Computat Biol, Philadelphia, PA 19107 USA; [Hoek, Jan B.; Vadigepalli, Rajanikanth] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Mitochondrial Res, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Vadigepalli, R (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Daniel Baugh Inst Funct Genom & Computat Biol, Philadelphia, PA 19107 USA.	rajanikanth.vadigepalli@jefferson.edu		Kuttippurathu, Lakshmi/0000-0001-6612-9040; Vadigepalli, Rajanikanth/0000-0002-8405-1037; Hoek, Jan/0000-0001-7127-4218	National Institute on Alcohol Abuse and Alcoholism [R01 AA018873, R21 AA022417, T32 AA007463]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018873, R21AA022417, T32AA007463] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institute on Alcohol Abuse and Alcoholism: R01 AA018873, R21 AA022417, T32 AA007463.	Abourbeh G, 2012, J NEUROSCI, V32, P5728, DOI 10.1523/JNEUROSCI.2900-11.2012; Abshagen K, 2007, AM J PHYSIOL-GASTR L, V292, pG1570, DOI 10.1152/ajpgi.00399.2006; [Anonymous], 1998, CLIN LIVER DIS, V2, P723, DOI [10.1016/S1089-3261(05)70038-6, DOI 10.1016/S1089-3261(05)70038-6]; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Clemens DL, 2007, WORLD J GASTROENTERO, V13, P4955, DOI 10.3748/wjg.v13.i37.4955; Corton JC, 2012, MUTAT RES-GEN TOX EN, V746, P104, DOI 10.1016/j.mrgentox.2011.12.017; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gebhardt R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-21; Grumm S, 2008, HEPATOLOGY, V48, P898, DOI 10.1002/hep.22421; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hailfinger S, 2006, HEPATOLOGY, V43, P407, DOI 10.1002/hep.21082; Hellerbrand C, 1998, AM J PHYSIOL-GASTR L, V275, pG269, DOI 10.1152/ajpgi.1998.275.2.G269; HIGGINS PJ, 1986, BIOCHEM PHARMACOL, V35, P3857, DOI 10.1016/0006-2952(86)90676-3; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Isse K, 2012, AM J TRANSPLANT, V12, P27, DOI 10.1111/j.1600-6143.2011.03797.x; Jokelainen K, 2001, CYTOKINE, V16, P36, DOI 10.1006/cyto.2001.0930; Jokelainen K, 1998, BIOCHEM BIOPH RES CO, V253, P834, DOI 10.1006/bbrc.1998.9863; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Juskeviciute E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-527; Kang Liang-I, 2012, Cells, V1, P1261, DOI 10.3390/cells1041261; Kasama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091373; Kim JK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r7; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Koteish A, 2002, ALCOHOL CLIN EXP RES, V26, P1710, DOI 10.1097/01.ALC.0000036923.77613.59; Kurinna S, 2011, INT J BIOCHEM CELL B, V43, P189, DOI 10.1016/j.biocel.2010.03.013; Lamers WH, 1997, HEPATOLOGY, V26, P398, DOI 10.1002/hep.510260221; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; LIEBER CS, 1994, METHOD ENZYMOL, V233, P585; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nanji AA, 1999, HEPATOLOGY, V30, P934, DOI 10.1002/hep.510300402; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Park J, 2014, GENOME RES, V24, P930, DOI 10.1101/gr.161802.113; Petersen BE, 1998, HEPATOLOGY, V27, P1030, DOI 10.1002/hep.510270419; Rojdmark S, 2001, J ENDOCRINOL INVEST, V24, P476; Sakuda S, 2002, J HEPATOL, V36, P527, DOI 10.1016/S0168-8278(01)00310-5; SASSE D, 1975, FEBS LETT, V57, P83, DOI 10.1016/0014-5793(75)80157-8; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shotton DM, 1991, NEW TECHNIQUES OPTIC, P1; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Valles SL, 2003, ALCOHOL CLIN EXP RES, V27, P1979, DOI 10.1097/01.ALC.0000099261.87880.21; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Xing DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024021; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yang L, 2005, AM J PHYSIOL-GASTR L, V289, pG530, DOI 10.1152/ajpgi.00526.2004; Yang SQ, 1998, AM J PHYSIOL-GASTR L, V275, pG696, DOI 10.1152/ajpgi.1998.275.4.G696; Zambrano S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090104; Zeldin G, 1996, ALCOHOL CLIN EXP RES, V20, P1639, DOI 10.1111/j.1530-0277.1996.tb01710.x; ZIEVE L, 1986, TOXICOL APPL PHARM, V86, P147, DOI 10.1016/0041-008X(86)90045-1	57	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140236	10.1371/journal.pone.0140236	http://dx.doi.org/10.1371/journal.pone.0140236			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452159	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200051
J	Hay, CW; Hunter, I; MacKenzie, A; McEwan, IJ				Hay, Colin W.; Hunter, Irene; MacKenzie, Alasdair; McEwan, Iain J.			An Sp1 Modulated Regulatory Region Unique to Higher Primates Regulates Human Androgen Receptor Promoter Activity in Prostate Cancer Cells	PLOS ONE			English	Article							PUR-ALPHA; TRANSCRIPTION INITIATION; EXPRESSION; GENE; BINDING; OVEREXPRESSION; ACTIVATION; CHROMATIN; GROWTH; AMPLIFICATION	Androgen receptor (AR) mediated signalling is necessary for normal development of the prostate gland and also drives prostate cancer (PCa) cell growth and survival, with many studies showing a correlation between increased receptor levels and therapy resistance with progression to fatal castrate recurrent PCa (CRPC). Although it has been held for some time that the transcription factor Sp1 is the main stimulator of AR gene transcription, comprehensive knowledge of the regulation of the AR gene remains incomplete. Here we describe and characterise in detail two novel active regulatory elements in the 5'UTR of the human AR gene. Both of these elements contain overlapping binding sites for the positive transcription factor Sp1 and the repressor protein pur-a. Aberrant cell signalling is characteristic of PCa and the transcriptional activity of the AR promoter in PCa cells is dependent upon the relative amounts of the two transcription factors. Together with our corroboration of the dominant role of Sp1, the findings support the rationale of targeting this transcription factor to inhibit tumour progression. This should be of particular therapeutic relevance in CRPC where the levels of the repressor pur-alpha are reduced.	[Hay, Colin W.; Hunter, Irene; MacKenzie, Alasdair; McEwan, Iain J.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Aberdeen	McEwan, IJ (corresponding author), Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland.	iain.mcewan@abdn.ac.uk			Chief Scientist's Office (CSO) of the Scottish Government [CZB-4-477, ETM/382]; MRC [G0701003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D004659/1] Funding Source: researchfish; Medical Research Council [G0701003] Funding Source: researchfish; Chief Scientist Office [ETM/382, ETM/258, CZB/4/477] Funding Source: researchfish	Chief Scientist's Office (CSO) of the Scottish Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by the Chief Scientist's Office (CSO) of the Scottish Government (http://www.cso.scot.nhs.uk/): CWH (CZB-4-477) and IH (ETM/382).	Azzouni F, 2012, UROL CLIN N AM, V39, P435, DOI 10.1016/j.ucl.2012.07.002; Beklernisheva AA, 2007, PROSTATE, V67, P863, DOI 10.1002/pros.20472; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chen S, 1997, MOL ENDOCRINOL, V11, P3, DOI 10.1210/me.11.1.3; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Chen Z, 2015, EMBO J, V34, P502, DOI 10.15252/embj.201490306; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FABER PW, 1993, J BIOL CHEM, V268, P9296; Green SM, 2012, MOL CELL ENDOCRINOL, V360, P3, DOI 10.1016/j.mce.2011.09.046; GROSSMANN ME, 1995, J BIOL CHEM, V270, P10968, DOI 10.1074/jbc.270.18.10968; GROSSMANN ME, 1994, MOL ENDOCRINOL, V8, P448, DOI 10.1210/me.8.4.448; Hay CW, 2007, BBA-GENE STRUCT EXPR, V1769, P79, DOI 10.1016/j.bbaexp.2007.01.005; Hay CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032514; Hay CW, 2014, HORM CANC; He B, 2014, P NATL ACAD SCI USA, V111, P18261, DOI 10.1073/pnas.1421415111; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Inoue T, 2008, PROSTATE, V68, P1048, DOI 10.1002/pros.20764; Johnson EM, 2013, J CELL PHYSIOL, V228, P930, DOI 10.1002/jcp.24237; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; Latil A, 2001, CANCER RES, V61, P1919; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Linja MJ, 2001, CANCER RES, V61, P3550; Liu XM, 2010, PROSTATE, V70, P179, DOI 10.1002/pros.21051; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Malek A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035130; MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77; Palmberg C, 1997, EUR UROL, V31, P216; Ren FG, 2000, ONCOGENE, V19, P1924, DOI 10.1038/sj.onc.1203511; Sankpal UT, 2011, MED CHEM, V7, P518; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shah S, 2012, CANCER RES, V72, P1248, DOI 10.1158/0008-5472.CAN-11-0943; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Song K, 2008, CANCER RES, V68, P8173, DOI 10.1158/0008-5472.CAN-08-2290; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Takane KK, 1996, MOL CELL ENDOCRINOL, V119, P83, DOI 10.1016/0303-7207(96)03800-2; Tararova ND, 2007, PROSTATE, V67, P1801, DOI 10.1002/pros.20662; Tewari AK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R88, 10.1186/gb-2012-13-10-r88]; Tretiakova A, 1999, J CELL PHYSIOL, V181, P160, DOI 10.1002/(SICI)1097-4652(199910)181:1<160::AID-JCP17>3.0.CO;2-H; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Wang LG, 2004, ONCOGENE, V23, P5175, DOI 10.1038/sj.onc.1207654; Wang Long G, 2006, Transl Oncogenomics, V1, P19; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; White MK, 2009, CELL CYCLE, V8, P414, DOI 10.4161/cc.8.3.7585; World Health Organization (WHO), 2008, GLOBOCAN 2008; Wu DY, 2014, NUCLEIC ACIDS RES, V42, P3607, DOI 10.1093/nar/gkt1382; Wu DY, 2011, TRENDS ENDOCRIN MET, V22, P474, DOI 10.1016/j.tem.2011.07.006; Yuan HQ, 2005, CARCINOGENESIS, V26, P793, DOI 10.1093/carcin/bgi021; Yuan HQ, 2008, BIOCHEM PHARMACOL, V75, P2112, DOI 10.1016/j.bcp.2008.03.005	62	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139990	10.1371/journal.pone.0139990	http://dx.doi.org/10.1371/journal.pone.0139990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448047	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000076
J	Kesby, JP; Kim, JJ; Scadeng, M; Woods, G; Kado, DM; Olefsky, JM; Jeste, DV; Achim, CL; Semenova, S				Kesby, James P.; Kim, Jane J.; Scadeng, Miriam; Woods, Gina; Kado, Deborah M.; Olefsky, Jerrold M.; Jeste, Dilip V.; Achim, Cristian L.; Semenova, Svetlana			Spatial Cognition in Adult and Aged Mice Exposed to High-Fat Diet	PLOS ONE			English	Article							INSULIN SENSITIVITY; METHAMPHETAMINE EXPOSURE; GP120 EXPRESSION; MEMORY; INFLAMMATION; IMPAIRMENT; DISEASE; OBESITY; CONSUMPTION; DECLINE	Aging is associated with a decline in multiple aspects of cognitive function, with spatial cognition being particularly sensitive to age-related decline. Environmental stressors, such as high-fat diet (HFD) exposure, that produce a diabetic phenotype and metabolic dysfunction may indirectly lead to exacerbated brain aging and promote the development of cognitive deficits. The present work investigated whether exposure to HFD exacerbates age-related cognitive deficits in adult versus aged mice. Adult (5 months old) and aged (15 months old) mice were exposed to control diet or HFD for three months prior to, and throughout, behavioral testing. Anxiety-like behavior in the light-dark box test, discrimination learning and memory in the novel object/place recognition tests, and spatial learning and memory in the Barnes maze test were assessed. HFD resulted in significant gains in body weight and fat mass content with adult mice gaining significantly more weight and adipose tissue due to HFD than aged mice. Weight gain was attributed to food calories sourced from fat, but not total calorie intake. HFD increased fasting insulin levels in all mice, but adult mice showed a greater increase relative to aged mice. Behaviorally, HFD increased anxiety-like behavior in adult but not aged mice without significantly affecting spatial cognition. In contrast, aged mice fed either control or HFD diet displayed deficits in novel place discrimination and spatial learning. Our results suggest that adult mice are more susceptible to the physiological and anxiety-like effects of HFD consumption than aged mice, while aged mice displayed deficits in spatial cognition regardless of dietary influence. We conclude that although HFD induces systemic metabolic dysfunction in both adult and aged mice, overall cognitive function was not adversely affected under the current experimental conditions.	[Kesby, James P.; Jeste, Dilip V.; Achim, Cristian L.; Semenova, Svetlana] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Kim, Jane J.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Scadeng, Miriam] Univ Calif San Diego, Dept Radiol, Sch Med, La Jolla, CA 92093 USA; [Woods, Gina; Kado, Deborah M.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Family Med & Publ Hlth & Internal Med, Sch Med, La Jolla, CA 92093 USA; [Jeste, Dilip V.; Achim, Cristian L.] Univ Calif San Diego, Sch Med, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Semenova, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA.	ssemenova@ucsd.edu	Kesby, James/A-4958-2011	Kesby, James/0000-0002-5814-8062; Kim, Jane/0000-0002-0228-0128; Kado, Deborah/0000-0002-2582-5573; Scadeng, Miriam/0000-0002-9593-2956	NIMH [R01 MH094151, T32 MH019934]; Sam and Rose Stein Institute for Research on Aging; Translational Methamphetamine AIDS Research Center NIDA grant (TMARC) [P50 DA26306]; NIH [DK075479, DK97412, DK063491, DK074868, DK054441]; Interdisciplinary Research Fellowship in NeuroAIDS (IRFN) [R25MH081482]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK097412, K08DK075479, P01DK074868, P01DK054441, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH081482, R01MH094151, T32MH019934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA026306] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sam and Rose Stein Institute for Research on Aging; Translational Methamphetamine AIDS Research Center NIDA grant (TMARC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Research Fellowship in NeuroAIDS (IRFN); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work has been supported by NIMH grants (R01 MH094151 and T32 MH019934 to DVJ), the Sam and Rose Stein Institute for Research on Aging (all the authors), Translational Methamphetamine AIDS Research Center NIDA grant (TMARC P50 DA26306 to SS and CLA), NIH grants (DK075479 and DK97412 to JJK; DK063491, DK074868 and DK054441 to JMO), and by the Interdisciplinary Research Fellowship in NeuroAIDS (IRFN, R25MH081482 to JPK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JPK, JJK, MS, GW, DMK, JMO, DVJ, CLA, and SS have nothing to disclose.	Aslan AKD, 2015, AGE AGEING, V44, P59, DOI 10.1093/ageing/afu108; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Bakhtiyari M, 2013, EAT BEHAV, V14, P107, DOI 10.1016/j.eatbeh.2012.12.007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Barnes SA, 2015, MOL PSYCHIA IN PRESS; Boitard C, 2014, BRAIN BEHAV IMMUN, V40, P9, DOI 10.1016/j.bbi.2014.03.005; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Dahl AK, 2013, EPIDEMIOL REV, V35, P22, DOI 10.1093/epirev/mxs002; Depp Colin A, 2007, Curr Psychiatry Rep, V9, P7, DOI 10.1007/s11920-007-0003-0; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; Gerstein H, 2013, NEUROBIOL AGING, V34, P1963, DOI 10.1016/j.neurobiolaging.2013.02.006; Haberman RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083674; Jeste DV, 2010, WORLD PSYCHIATRY, V9, P78; Kesby JP, 2015, NEUROPSYCHOPHARMACOL, V40, P1899, DOI 10.1038/npp.2015.39; Kesby JP, 2015, EUR NEUROPSYCHOPHARM, V25, P141, DOI 10.1016/j.euroneuro.2014.07.014; Klencklen G, 2012, AGEING RES REV, V11, P123, DOI 10.1016/j.arr.2011.10.001; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McNeilly AD, 2011, BEHAV BRAIN RES, V217, P134, DOI 10.1016/j.bbr.2010.10.017; Mielke JG, 2006, BEHAV BRAIN RES, V175, P374, DOI 10.1016/j.bbr.2006.09.010; Morrison CD, 2010, J NEUROCHEM, V114, P1581, DOI 10.1111/j.1471-4159.2010.06865.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pancani T, 2013, NEUROBIOL AGING, V34, P1977, DOI 10.1016/j.neurobiolaging.2013.02.019; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Schoenfeld R, 2014, BEHAV BRAIN RES, V270, P47, DOI 10.1016/j.bbr.2014.04.036; Schwartz DH, 2013, INT J OBESITY, V37, P1336, DOI 10.1038/ijo.2013.104; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1339, DOI 10.1093/gerona/glu080; Uranga RM, 2010, J NEUROCHEM, V114, P344, DOI 10.1111/j.1471-4159.2010.06803.x; Valladolid-Acebes I, 2013, NEUROBIOL LEARN MEM, V106, P18, DOI 10.1016/j.nlm.2013.06.012; Xu CX, 2015, INT J OBES IN PRESS; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Yamamoto N, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00014; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808	35	50	52	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140034	10.1371/journal.pone.0140034	http://dx.doi.org/10.1371/journal.pone.0140034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448649	Green Published, gold			2022-12-26	WOS:000362511000082
J	Ko, HC; Powers, AR; Sheu, RD; Kerns, SL; Rosenstein, BS; Krieger, SC; Mourad, WF; Hu, KS; Gupta, V; Bakst, RL				Ko, Huaising C.; Powers, Allison R.; Sheu, Ren-dih; Kerns, Sarah L.; Rosenstein, Barry S.; Krieger, Stephen C.; Mourad, Waleed F.; Hu, Kenneth S.; Gupta, Vishal; Bakst, Richard L.			Lhermitte's Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism	PLOS ONE			English	Article							CERVICAL-SPINAL-CORD; INDUCED APOPTOSIS; RAT; OLIGODENDROCYTES; IRRADIATION; MYELOPATHY; INJURY; OXALIPLATIN; TOLERANCE; DISEASE	Purpose/Objectives We observed a number of patients who developed Lhermitte's sign (LS) following radiation to the head and neck (H/N), since instituting volumetric modulated arc therapy (VMAT). We aimed to investigate the incidence of LS following VMAT-based RT without chemotherapy, and determine the dosimetric parameters that predict its development. We explored whether the role of inhomogeneous dose distribution across the spinal cord, causing a "bath-and-shower" effect, explains this finding. Methods and Materials From 1/20/2010-12/9/2013, we identified 33 consecutive patients receiving adjuvant RT using VMAT to the H/N without chemotherapy at our institution. Patients' treatment plans were analyzed for dosimetric parameters, including dose gradients along the anterior, posterior, right, and left quadrants at each cervical spine level. Institutional Review Board approval was obtained. Results 5 out of 33 (15.2%) patients developed LS in our patient group, all of whom had RT to the ipsilateral neck only. LS patients had a steeper dose gradient between left and right quadrants across all cervical spine levels (repeated-measures ANOVA, p = 0.030). Within the unilateral treatment group, LS patients received a higher mean dose across all seven cervical spinal levels (repeated-measures ANOVA, p = 0.046). Dose gradients in the anteriorposterior direction and mean doses to the cord were not significant between LS and non-LS patients. Conclusions Dose gradients along the axial plane of the spinal cord may contribute to LS development; however, a threshold dose within the high dose region of the cord may still be required. This is the first clinical study to suggest that inhomogeneous dose distributions in the cord may be relevant in humans. Further investigation is warranted to determine treatment-planning parameters associated with development of LS.	[Ko, Huaising C.; Powers, Allison R.; Sheu, Ren-dih; Kerns, Sarah L.; Rosenstein, Barry S.; Mourad, Waleed F.; Hu, Kenneth S.; Gupta, Vishal; Bakst, Richard L.] Mt Sinai Hosp, Icahn Sch Med, Dept Radiat Oncol, New York, NY 10029 USA; [Kerns, Sarah L.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Krieger, Stephen C.] Mt Sinai Hosp, Icahn Sch Med, Dept Neurol, New York, NY 10029 USA; [Mourad, Waleed F.; Hu, Kenneth S.] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Mt Sinai, New York, NY 10003 USA; [Mourad, Waleed F.] Montefiore Med Ctr, Dept Radiat Oncol, Albert Einstein Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Rochester; Icahn School of Medicine at Mount Sinai; Harvard University; Beth Israel Deaconess Medical Center; Montefiore Medical Center; Yeshiva University	Bakst, RL (corresponding author), Mt Sinai Hosp, Icahn Sch Med, Dept Radiat Oncol, New York, NY 10029 USA.	Richard.Bakst@mountsinai.org						Atkinson S, 2003, INT J RADIAT ONCOL, V57, P1093, DOI 10.1016/S0360-3016(03)00735-1; Atkinson SL, 2005, INT J RADIAT ONCOL, V62, P535, DOI 10.1016/j.ijrobp.2005.01.061; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Bijl HP, 2006, INT J RADIAT ONCOL, V64, P1204, DOI 10.1016/j.ijrobp.2005.06.046; Bijl HP, 2003, INT J RADIAT ONCOL, V57, P274, DOI [10.1016/S0360-3016(03)00529-7, 10.1016/s0360-3016(03)00529-7]; Bijl HP, 2002, INT J RADIAT ONCOL, V52, P205, DOI 10.1016/S0360-3016(01)02687-6; BODEN G, 1948, BRIT J RADIOL, V21, P464, DOI 10.1259/0007-1285-21-249-464; Chari DM, 2003, J NEUROSCI RES, V73, P787, DOI 10.1002/jnr.10700; Ciucci G, 2003, EUR J NEUROL, V10, P328, DOI 10.1046/j.1468-1331.2003.00579.x; DELATTRE JY, 1988, BRAIN, V111, P1319, DOI 10.1093/brain/111.6.1319; Esik O, 2003, PATHOL ONCOL RES, V9, P115, DOI 10.1007/BF03033755; FEIN DA, 1993, INT J RADIAT ONCOL, V27, P1029, DOI 10.1016/0360-3016(93)90519-2; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Gemici C, 2010, CRIT REV ONCOL HEMAT, V74, P79, DOI 10.1016/j.critrevonc.2009.04.009; JONES A, 1964, BRIT J RADIOL, V37, P727, DOI 10.1259/0007-1285-37-442-727; Jurado JM, 2008, ANN ONCOL, V19, P2093, DOI 10.1093/annonc/mdn684; Kurita H, 2001, NEUROL RES, V23, P869, DOI 10.1179/016164101101199324; Leung WM, 2005, HEAD NECK-J SCI SPEC, V27, P187, DOI 10.1002/hed.20140; Li YQ, 1996, RADIOTHER ONCOL, V39, P35, DOI 10.1016/0167-8140(96)01705-7; Li YQ, 1996, CANCER RES, V56, P5417; Lu FG, 2004, INT J RADIAT BIOL, V80, P39, DOI 10.1080/09553000310001642876; Mul VEM, 2012, STRAHLENTHER ONKOL, V188, P71, DOI 10.1007/s00066-011-0010-2; Pak D, 2012, INT J RADIAT ONCOL, V83, P1528, DOI 10.1016/j.ijrobp.2011.10.052; Quan EZM, 2012, INT J RADIAT ONCOL, V83, P1169, DOI 10.1016/j.ijrobp.2011.09.015; Sano K, 2000, NEUROL MED-CHIR, V40, P495, DOI 10.2176/nmc.40.495; St Clair WH, 2003, SEMIN RADIAT ONCOL, V13, P322, DOI 10.1016/S1053-4296(03)00025-0; WORD JA, 1980, INT J RADIAT ONCOL, V6, P1731, DOI 10.1016/0360-3016(80)90261-8	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139448	10.1371/journal.pone.0139448	http://dx.doi.org/10.1371/journal.pone.0139448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448647	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511000027
J	Xie, DD; Li, J; Chen, JT; Eyi, UM; Matesa, RA; Obono, MMO; Ehapo, CS; Yang, LY; Yang, H; Yang, HT; Lin, M				Xie, Dong-De; Li, Jian; Chen, Jiang-Tao; Eyi, Urbano Monsuy; Matesa, Rocio Apicante; Obono, Maximo Miko Ondo; Ehapo, Carlos Sala; Yang, Li-Ye; Yang, Hui; Yang, Hui-Tian; Lin, Min			Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Treponema pallidum Infections among Blood Donors on Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TRANSFUSION; POPULATION; PREVALENCE; RISK; EPIDEMIOLOGY; DISEASES	Background Regular screening of transfusion-transmissible infections (TTIs), such as human immunodeficiency virus (HIV), hepatitis B and hepatitis C virus (HBV and HCV, respectively), and Treponema pallidum, in blood donors is essential to guaranteeing clinical transfusion safety. This study aimed to determine the seroprevalence of four TTIs among blood donors on Bioko Island, Equatorial Guinea (EG). Methods A retrospective survey of blood donors from January 2011 to April 2013 was conducted to assess the presence of HIV, HBV, HCV and T. pallidum. The medical records were analyzed to verify the seroprevalence of these TTIs among blood donations stratified by gender, age and geographical region. Results Of the total 2937 consecutive blood donors, 1098 (37.39%) had a minimum of one TTI and 185 (6.29%) harbored co-infections. The general seroprevalence of HIV, HBV, HCV and T. pallidum were 7.83%, 10.01%, 3.71% and 21.51%, respectively. The most frequent TTI coinfections were HBV-T. pallidum 60 (2.04%) and HIV-T. pallidum 46 (1.57%). The seroprevalence of HIV, HBV, HCV and T. pallidum were highest among blood donors 38 to 47 years, 18 to 27 years and >= 48 years age, respectively (P<0.05). The seroprevalence of TTIs varied according to the population from which the blood was collected on Bioko Island. Conclusions Our results firstly provide a comprehensive overview of TTIs among blood donors on Bioko Island. Strict screening of blood donors and improved hematological examinations using standard operating procedures are recommended.	[Xie, Dong-De; Chen, Jiang-Tao] Peoples Hosp Jiangmen, Lab Med Ctr, Jiangmen, Guangdong, Peoples R China; [Xie, Dong-De; Chen, Jiang-Tao] Chinese Med Aid Team Republ Equatorial Guinea, Guangzhou, Guangdong, Peoples R China; [Li, Jian] Renmin Hosp, Dept Infect Dis, Shiyan, Hubei, Peoples R China; [Li, Jian] Hubei Univ Med, Coll Basic Med, Dept Parasitol, Shiyan, Hubei, Peoples R China; [Chen, Jiang-Tao] Huizhou Municipal Cent Hosp, Lab Med Ctr, Huizhou, Guangdong, Peoples R China; [Eyi, Urbano Monsuy; Matesa, Rocio Apicante; Obono, Maximo Miko Ondo; Ehapo, Carlos Sala] Malabo Reg Hosp, Med Lab, Cent Blood Transfus Serv, Malabo, Guinea; [Yang, Li-Ye; Yang, Hui; Yang, Hui-Tian; Lin, Min] Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China	Hubei University of Medicine; Southern Medical University - China	Lin, M (corresponding author), Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China.	Konfutea@hotmail.com	Li, Jian/GMW-4332-2022; Li, Jian/H-3549-2019	Li, Jian/0000-0001-9434-7803; 	China Postdoctoral Science Foundation [201542195]; Medical Science Fund of Guangdong Province [A2013780, B2015062]; Initial Project for Post-Graduates of Hubei University of Medicine [2013QDJZR04]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical Science Fund of Guangdong Province; Initial Project for Post-Graduates of Hubei University of Medicine	This work was partially supported by the China Postdoctoral Science Foundation (contract/grant number 201542195 to ML), the Medical Science Fund of Guangdong Province (contract/grant number A2013780 to ML), the Initial Project for Post-Graduates of Hubei University of Medicine (contract/grant number 2013QDJZR04 to JL) and the Medical Science Fund of Guangdong Province (contract/grant number B2015062 to D-DX). The funders had no role in the study design and data analysis, the decision to publish, or reparation of the manuscript.	Basaras M, 1999, T ROY SOC TROP MED H, V93, P250, DOI 10.1016/S0035-9203(99)90010-X; Bloch EM, 2012, TRANSFUS MED REV, V26, P164, DOI 10.1016/j.tmrv.2011.07.006; Botte C, 1996, NEPHROL DIAL TRANSPL, V11, P19; Buseri FI, 2009, BLOOD TRANSFUS-ITALY, V7, P293, DOI 10.2450/2009.0071-08; DELAPORTE E, 1994, ANN TROP MED PARASIT, V88, P97, DOI 10.1080/00034983.1994.11812844; Diro Ermias, 2008, Ethiop Med J, V46, P7; Dodd RY, 2007, CURR OPIN HEMATOL, V14, P671; Field SP, 2007, J CLIN PATHOL, V60, P1073, DOI 10.1136/jcp.2006.043505; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Kiire CF, 1996, GUT, V38, pS5, DOI 10.1136/gut.38.Suppl_2.S5; KOWO MP, 1995, T ROY SOC TROP MED H, V89, P484, DOI 10.1016/0035-9203(95)90076-4; Li J., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089893; Maresch C, 2008, TRANSFUSION, V48, P273, DOI 10.1111/j.1537-2995.2007.01521.x; Matee MIN, 1999, E AFR MED J, V76, P167; Mbanya D, 2013, CLIN MICROBIOL INFEC, V19, P416, DOI 10.1111/1469-0691.12184; Mogtomo Martin Luther Koanga, 2009, Sante, V19, P3, DOI 10.1684/san.2009.0144; Nagalo BM, 2012, TROP MED INT HEALTH, V17, P247, DOI 10.1111/j.1365-3156.2011.02902.x; Rivas P, 2013, AM J TROP MED HYG, V88, P789, DOI 10.4269/ajtmh.12-0319; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Tagny CT, 2010, TRANSFUSION MED, V20, P1, DOI 10.1111/j.1365-3148.2009.00958.x	20	26	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139947	10.1371/journal.pone.0139947	http://dx.doi.org/10.1371/journal.pone.0139947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448460	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000068
J	Yamada, C; Saegusa, Y; Nahata, M; Sadakane, C; Hattori, T; Takeda, H				Yamada, Chihiro; Saegusa, Yayoi; Nahata, Miwa; Sadakane, Chiharu; Hattori, Tomohisa; Takeda, Hiroshi			Influence of Aging and Gender Differences on Feeding Behavior and Ghrelin-Related Factors during Social Isolation in Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CHRONIC STRESS; ENERGY-EXPENDITURE; LOCOMOTOR-ACTIVITY; PLASMA GHRELIN; INDUCED HYPOPHAGIA; NOVELTY STRESS; AGED MICE; RATS; DOPAMINE	Psychological stress due to social isolation is known to cause abnormal feeding behaviors, but the influences of gender and aging on subchronic stress-induced changes in feeding behaviors are unknown. Thus, we examined the changes in body weight, food intake, and orexigenic ghrelin-related factors during 2 weeks of isolation stress in young and aged mice. Food intake increased significantly in young mice in the isolation group compared with the group-housed control throughout the experimental period. This isolation-induced increase in food intake was not observed in aged mice. In young mice, there were no significant differences in body weight between the isolated group and group-housed control up to 2 weeks. However, aged male mice exhibited significant weight loss at 2 weeks and a similar tendency was observed in aged female mice. Young male mice, but not female mice, had significantly increased (2.2-fold) plasma acylated ghrelin levels after 1 week of isolation compared with the group-housed control. A significant but lower increase (1.3-fold) was also observed in aged male mice. Hypothalamic preproghrelin gene expression decreased significantly with isolation in young male mice, whereas it increased significantly in female mice. The expression levels of NPY and AGRP in the hypothalamus, which are transmitted by elevated peripheral ghrelin signals, increased significantly in isolated young male mice, whereas the AGRP expression levels decreased significantly in young female mice. Isolation caused no significant differences in the expression levels of these genes in aged mice. In isolation, young female mice exhibited markedly increased dark- and light-phase locomotor activities compared with male mice, whereas male and female aged mice exhibited no obvious increases in activity immediately after the dark phase started. We conclude that the gender-specific homeostatic regulatory mechanisms required to maintain body weight operated during subchronic psychological stress in young mice but not in aged mice.	[Yamada, Chihiro; Saegusa, Yayoi; Nahata, Miwa; Sadakane, Chiharu; Hattori, Tomohisa] Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan; [Takeda, Hiroshi] Hokkaido Univ, Fac Pharmaceut Sci, Pathophysiol & Therapeut, Sapporo, Hokkaido 060, Japan; [Takeda, Hiroshi] Hokkaido Univ Hosp Gastroenterol Med, Sapporo, Hokkaido, Japan	Tsumura & Company; Hokkaido University; Hokkaido University	Hattori, T (corresponding author), Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan.	hattori_tomohisa@mail.tsumura.co.jp		Nahata, Miwa/0000-0002-4462-6887; Yamada, Chihiro/0000-0002-3690-893X	Tsumura Co.	Tsumura Co.(Tsumura & Company)	Tsumura & Co. provided support in the form of salaries for authors CY, YS, MN, CS and TH. The specific roles of these authors are articulated in the "author contributions" section. This study was funded by Tsumura & Co. Tsumura & Co. was responsible for the study design, and the collection, analysis and interpretation of data.	Abizaid A, 2009, J NEUROENDOCRINOL, V21, P787, DOI 10.1111/j.1365-2826.2009.01896.x; Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680; Asarian L, 2013, AM J PHYSIOL-REG I, V305, pR1215, DOI 10.1152/ajpregu.00446.2012; Campioli E, 2011, OBESITY, V19, P703, DOI 10.1038/oby.2010.244; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Dickson SL, 2011, MOL CELL ENDOCRINOL, V340, P80, DOI 10.1016/j.mce.2011.02.017; Foster MT, 2009, ENDOCRINOLOGY, V150, P2325, DOI 10.1210/en.2008-1426; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Galaj E, 2014, PSYCHOPHARMACOLOGY, V231, P501, DOI 10.1007/s00213-013-3254-y; Goebel-Stengel M, 2014, AM J PHYSIOL-REG I, V306, pR164, DOI 10.1152/ajpregu.00335.2013; Handa RJ, 2014, FRONT NEUROENDOCRIN, V35, P197, DOI 10.1016/j.yfrne.2013.11.001; Handa RJ, 2012, NEUROENDOCRINOLOGY, V96, P111, DOI 10.1159/000338397; Iwen KAH, 2008, J ENDOCRINOL, V196, P465, DOI 10.1677/JOE-07-0299; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Koide T, 2000, MAMM GENOME, V11, P664, DOI 10.1007/s003350010129; Kristenssson E, 2006, REGUL PEPTIDES, V134, P114, DOI 10.1016/j.regpep.2006.02.003; Kumar J, 2013, APPETITE, V64, P81, DOI 10.1016/j.appet.2012.12.023; Lamont EW, 2014, EUR J NEUROSCI, V39, P207, DOI 10.1111/ejn.12390; Lenze EJ, 2001, DEPRESS ANXIETY, V14, P86, DOI 10.1002/da.1050; Liu S, 2015, NEUROSCIENCE, V289, P19, DOI 10.1016/j.neuroscience.2014.12.046; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Mason BL, 2014, ANNU REV PHYSIOL, V76, P519, DOI 10.1146/annurev-physiol-021113-170310; MCGREGOR IS, 1994, PSYCHOPHARMACOLOGY, V116, P475, DOI 10.1007/BF02247481; Miura H, 2002, SYNAPSE, V46, P116, DOI 10.1002/syn.10133; Miwa H, 2010, J GASTROENTEROL, V45, P478, DOI 10.1007/s00535-009-0180-1; Mizoguchi K, 2009, NEUROSCIENCE, V159, P259, DOI 10.1016/j.neuroscience.2008.12.020; Moles A, 2006, PSYCHONEUROENDOCRINO, V31, P623, DOI 10.1016/j.psyneuen.2006.01.004; Nahata M, 2013, PSYCHONEUROENDOCRINO, V38, P2051, DOI 10.1016/j.psyneuen.2013.03.014; Ochi M, 2008, LIFE SCI, V82, P862, DOI 10.1016/j.lfs.2008.01.020; Patterson ZR, 2013, ENDOCRINOLOGY, V154, P1080, DOI 10.1210/en.2012-1834; Patterson ZR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00167; Quarta D, 2014, EUR J PHARM SCI, V57, P2, DOI 10.1016/j.ejps.2014.01.008; Saegusa Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE685, DOI 10.1152/ajpendo.00121.2011; Samson WK, 2010, ACTA PHYSIOL, V198, P313, DOI 10.1111/j.1748-1716.2009.02056.x; Sato T, 2005, ENDOCRINOLOGY, V146, P2510, DOI 10.1210/en.2005-0174; Seematter G, 2000, AM J PHYSIOL-ENDOC M, V279, pE799, DOI 10.1152/ajpendo.2000.279.4.E799; Takeda H, 2010, ENDOCRINOLOGY, V151, P244, DOI 10.1210/en.2009-0633; Tsvirkun D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039923; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Yakabi K, 2011, AM J PHYSIOL-ENDOC M, V301, pE72, DOI 10.1152/ajpendo.00695.2010; Yamada C, 2015, PSYCHONEUROENDOCRINO, V55, P81, DOI 10.1016/j.psyneuen.2015.02.006; Yamada C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/792940	44	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140094	10.1371/journal.pone.0140094	http://dx.doi.org/10.1371/journal.pone.0140094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448274	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000089
J	Diouf, M; Roy, V; Mora, P; Frechault, S; Lefebvre, T; Herve, V; Rouland-Lefevre, C; Miambi, E				Diouf, Michel; Roy, Virginie; Mora, Philippe; Frechault, Sophie; Lefebvre, Thomas; Herve, Vincent; Rouland-Lefevre, Corinne; Miambi, Edouard			Profiling the Succession of Bacterial Communities throughout the Life Stages of a Higher Termite Nasutitermes arborum (Termitidae, Nasutitermitinae) Using 16S rRNA Gene Pyrosequencing	PLOS ONE			English	Article							GUT MICROBIOTA; DIVERSITY; SYMBIONTS; EMBRYOS	Previous surveys of the gut microbiota of termites have been limited to the worker caste. Termite gut microbiota has been well documented over the last decades and consists mainly of lineages specific to the gut microbiome which are maintained across generations. Despite this intimate relationship, little is known of how symbionts are transmitted to each generation of the host, especially in higher termites where proctodeal feeding has never been reported. The bacterial succession across life stages of the wood-feeding higher termite Nasutitermes arborum was characterized by 16S rRNA gene deep sequencing. The microbial community in the eggs, mainly affiliated to Proteobacteria and Actinobacteria, was markedly different from the communities in the following developmental stages. In the first instar and last instar larvae and worker caste termites, Proteobacteria and Actinobacteria were less abundant than Firmicutes, Bacteroidetes, Spirochaetes, Fibrobacteres and the candidate phylum TG3 from the last instar larvae. Most of the representatives of these phyla (except Firmicutes) were identified as termite-gut specific lineages, although their relative abundances differed. The most salient difference between last instar larvae and worker caste termites was the very high proportion of Spirochaetes, most of which were affiliated to the Treponema Ic, Ia and If subclusters, in workers. The results suggest that termite symbionts are not transmitted from mother to offspring but become established by a gradual process allowing the offspring to have access to the bulk of the microbiota prior to the emergence of workers, and, therefore, presumably through social exchanges with nursing workers.	[Diouf, Michel; Roy, Virginie; Mora, Philippe; Frechault, Sophie; Miambi, Edouard] Univ Paris Est Creteil, Inst Ecol & Sci Environm Paris IEES, Dept SOLeO, F-94010 Creteil, France; [Lefebvre, Thomas] YNSECT Biotechnol Environm & Agroind, F-91058 Evry, France; [Herve, Vincent] INRA, Interact Arbres Microorganismes, UMR1136, F-54280 Champenoux, France; [Herve, Vincent] Univ Lorraine, Interact Arbres Microorganismes, UMR1136, F-54500 Vandoeuvre Les Nancy, France; [Rouland-Lefevre, Corinne] Ctr IRD France Nord, IEES, Dept SOLeO, UMR211, F-93143 Bondy, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE; Universite de Lorraine; Universite de Lorraine; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Diouf, M (corresponding author), Univ Paris Est Creteil, Inst Ecol & Sci Environm Paris IEES, Dept SOLeO, Batiment P4,61 Ave Gen Gaulle, F-94010 Creteil, France.	michel.diouf@u-pec.fr		Roy, Virginie/0000-0003-1908-0074; DIOUF, Michel/0000-0002-6263-8216; Herve, Vincent/0000-0002-3495-561X				Alibert J., 1963, Insectes Sociaux Paris, V10, P1, DOI 10.1007/BF02223519; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Davidson SK, 2008, ISME J, V2, P510, DOI 10.1038/ismej.2008.16; Lima VLD, 2013, REV BRAS ENTOMOL, V57, P309, DOI 10.1590/S0085-56262013005000019; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; GILTURNES MS, 1992, BIOL BULL, V182, P105, DOI 10.2307/1542184; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Grasse L., 1945, Bulletin Biologique de la France et de la Belgique, V79, P273; Grasse P-P, 1982, TERMITOLOGIA, P363; Grasse P-P, 1986, TERMITOLOGIA, P41; GRASSE PIERRE P., 1952, TIJDSCHR ENT, V95, P70; Hail D, 2012, ENVIRON ENTOMOL, V41, P98, DOI 10.1603/EN11198; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Hongoh Y, 2006, APPL ENVIRON MICROB, V72, P6780, DOI 10.1128/AEM.00891-06; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kohler T, 2014, APPL ENVIRON MICROB, V78, P4691; Lefebvre T, 2009, INSECT SOC, V56, P269, DOI 10.1007/s00040-009-0020-6; Miyata R, 2007, BIOSCI BIOTECH BIOCH, V71, P1244, DOI 10.1271/bbb.60672; NOIROT CHARLES, 1955, ANN SCI NAT ZOOL, V17, P399; Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15; Otani S, 2014, MOL ECOL, V23, P4631, DOI 10.1111/mec.12874; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; Roy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116070; Salem H, 2013, ENVIRON MICROBIOL, V15, P1956, DOI 10.1111/1462-2920.12001; Santos AV, 2004, FEMS MICROBIOL LETT, V239, P319, DOI 10.1016/j.femsle.2004.09.005; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6018, DOI 10.1128/AEM.69.10.6018-6024.2003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thongaram T, 2005, EXTREMOPHILES, V9, P229, DOI 10.1007/s00792-005-0440-9; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Yashiro T, 2014, P NATL ACAD SCI USA, V111, P17212, DOI 10.1073/pnas.1412481111; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209	39	18	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140014	10.1371/journal.pone.0140014	http://dx.doi.org/10.1371/journal.pone.0140014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444989	Green Published, gold			2022-12-26	WOS:000362510600121
J	Lan, YT; Huang, KH; Liu, CA; Tai, LC; Chen, MH; Chao, Y; Li, AFY; Chiou, SH; Shyr, YM; Wu, CW; Fang, WL				Lan, Yuan-Tzu; Huang, Kuo-Hung; Liu, Chien-An; Tai, Ling-Chen; Chen, Ming-Huang; Chao, Yee; Li, Anna Fen-Yau; Chiou, Shih-Hwa; Shyr, Yi-Ming; Wu, Chew-Wun; Fang, Wen-Liang			A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; OF-THE-LITERATURE; CERVICAL-CARCINOMA; HISTOLOGY PREDICTS; GASTRIC-CANCER; LUNG; ADENOCARCINOMA; STAGE; STOMACH; HYSTERECTOMY	Background Adenosqamous carcinoma (ASC) is a rare disease involving various organs, yet there are no large-scale population-based comparative studies on ASC among different organs. Methods The incidence and overall survival of ASC among various organs in cases diagnosed in Taiwan from January 1, 2003 to December 31, 2010 were calculated and compared using data from the Taiwan Cancer Registry (TCR). The various organs were classified and divided into three different systems: the female reproductive, respiratory, and alimentary systems. Survival analysis were also compared among 30,850 patients diagnosed as ASC, adenocarcinoma (AC) or squamous cell carcinoma (SCC) in organs with frequent ASC. Results During the study period, a total of 576 ASC cases were diagnosed in Taiwan. The most common primary system was respiratory (73.8%), followed by alimentary (16.2%) and female reproductive (10%). The overall survival were significantly higher for cases involving the female reproductive system, followed by the respiratory and alimentary systems (P = 0.016). The median overall survival were worse in males than females for cases involving the respiratory system (22.4 vs. 31.8 months, P = 0.044). Multivariate analysis showed that age >= 65, more advanced T and N categories were independent unfavorable prognostic factors of overall survival in ASC. ASC histology is an independent unfavorable prognostic factor compared with AC and SCC. Conclusions ASC at an old age and more advanced T and N categories were found to be associated with a poor prognosis.	[Lan, Yuan-Tzu] Taipei Vet Gen Hosp, Div Colon & Rectal Surg, Dept Surg, Taipei, Taiwan; [Huang, Kuo-Hung; Tai, Ling-Chen; Shyr, Yi-Ming; Wu, Chew-Wun; Fang, Wen-Liang] Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Liu, Chien-An] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chen, Ming-Huang; Chao, Yee] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Li, Anna Fen-Yau] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan; [Lan, Yuan-Tzu; Huang, Kuo-Hung; Liu, Chien-An; Chen, Ming-Huang; Chao, Yee; Li, Anna Fen-Yau; Shyr, Yi-Ming; Wu, Chew-Wun; Fang, Wen-Liang] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Kuo-Hung; Chiou, Shih-Hwa] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Fang, WL (corresponding author), Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.	s821094@hotmail.com			Szu-Yuan Research Foundation of Internal Medicine [103024]	Szu-Yuan Research Foundation of Internal Medicine	The current analysis was supported by the Szu-Yuan Research Foundation of Internal Medicine (Number: 103024). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY DJB, 1967, THORAX, V22, P431, DOI 10.1136/thx.22.5.431; AUERBACH O, 1982, CANCER, V50, P2079, DOI 10.1002/1097-0142(19821115)50:10<2079::AID-CNCR2820501019>3.0.CO;2-H; Bosman F. T., 2010, WHO CLASSIFICATION O; Bureau of Health Promotion Department of Health the Executive Yuan Taiwan, CANCER REGISTRY ANNU; Cha Yoon Jin, 2014, Korean J Pathol, V48, P229, DOI 10.4132/KoreanJPathol.2014.48.3.229; Chen SB, 2013, WORLD J GASTROENTERO, V19, P8382, DOI 10.3748/wjg.v19.i45.8382; Chen YY, 2015, PATHOL ONCOL RES, V21, P547, DOI 10.1007/s12253-014-9890-7; EIFEL PJ, 1995, GYNECOL ONCOL, V59, P38, DOI 10.1006/gyno.1995.1265; Farley JH, 2003, CANCER, V97, P2196, DOI 10.1002/cncr.11371; FITZGIBBONS PL, 1985, HUM PATHOL, V16, P463, DOI 10.1016/S0046-8177(85)80083-6; GERUGHTY RM, 1968, CANCER, V22, P1140, DOI 10.1002/1097-0142(196811)22:6<1140::AID-CNCR2820220610>3.0.CO;2-1; Hong SM, 2008, INT J CLIN EXP PATHO, V1, P147; Huang YT, 2012, INT J RADIAT ONCOL, V84, P420, DOI 10.1016/j.ijrobp.2011.12.013; Imura J, 2005, APMIS, V113, P140, DOI 10.1111/j.1600-0463.2005.apm1130208.x; KERN WH, 1968, CANCER, V21, P772, DOI 10.1002/1097-0142(196804)21:4<772::AID-CNCR2820210430>3.0.CO;2-U; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lea JS, 2003, GYNECOL ONCOL, V91, P558, DOI 10.1016/j.ygyno.2003.08.020; Lee JY, 2015, GYNECOL OBSTET INVES, V80, P15, DOI 10.1159/000369387; Liu C, 2014, NAT MED, V20, P596, DOI 10.1038/nm.3548; Look KY, 1996, GYNECOL ONCOL, V63, P304, DOI 10.1006/gyno.1996.0327; Masoomi H, 2012, DIS COLON RECTUM, V55, P509, DOI 10.1097/DCR.0b013e3182420953; Mori E, 2000, SURG TODAY, V30, P643, DOI 10.1007/s005950070105; Nakanishi T, 2000, GYNECOL ONCOL, V79, P289, DOI 10.1006/gyno.2000.5935; NAUNHEIM KS, 1987, ANN THORAC SURG, V44, P462, DOI 10.1016/S0003-4975(10)62102-9; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Saito S, 2012, J DIGEST DIS, V13, P407, DOI 10.1111/j.1751-2980.2012.00610.x; Schick U, 2013, OR SURG OR MED OR PA, V116, P313, DOI 10.1016/j.oooo.2013.05.003; Shin Hai-Rim, 2008, J Prev Med Public Health, V41, P84; Song ZB, 2013, J CHIN MED ASSOC, V76, P481, DOI 10.1016/j.jcma.2013.05.007; TAKAMORI S, 1991, CANCER, V67, P649, DOI 10.1002/1097-0142(19910201)67:3<649::AID-CNCR2820670321>3.0.CO;2-B; Terada Tadashi, 2009, Cases J, V2, P6661, DOI 10.1186/1757-1626-0002-0000006661; Tochigi N, 2011, AM J CLIN PATHOL, V135, P783, DOI 10.1309/AJCP08IQZAOGYLFL; Tohma T, 2009, HEPATO-GASTROENTEROL, V56, P568; Toyota N, 1996, J GASTROENTEROL, V31, P105, DOI 10.1007/BF01211195; Yesner R, 1965, ANN THORAC SURG, V10, P33; Zhang HD, 2014, DIS ESOPHAGUS, V27, P783, DOI 10.1111/dote.12153	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139748	10.1371/journal.pone.0139748	http://dx.doi.org/10.1371/journal.pone.0139748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445240	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600075
J	Martin, S; Vincent, A; Taylor, AW; Atlantis, E; Jenkins, A; Januszewski, A; O'Loughlin, P; Wittert, G				Martin, Sean; Vincent, Andrew; Taylor, Anne W.; Atlantis, Evan; Jenkins, Alicia; Januszewski, Andrzej; O'Loughlin, Peter; Wittert, Gary			Lower Urinary Tract Symptoms, Depression, Anxiety and Systemic Inflammatory Factors in Men: A Population-Based Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; OVERACTIVE BLADDER; UNITED-STATES; HEALTH; INCONTINENCE; ASSOCIATION; PREVALENCE; DISORDER; IMPACT; WOMEN	Background The relationship between lower urinary tract symptoms (LUTS) and common mental health disorders such as depression and anxiety in men remains unclear. Inflammation has recently been identified as an independent risk factor for LUTS and depression. This study aimed to assess the association between depression, anxiety and LUTS, and the moderating influence of systemic inflammation, in the presence of other biopsychosocial confounders. Methods Participants were randomly-selected from urban, community-dwelling males aged 35-80 years at recruitment (n = 1195; sample response rate:67.8%). Of these, 730 men who attended baseline (2002-5) and follow-up clinic visits (2007-10), with complete outcome measures, and without prostate or bladder cancer and/or surgery, neurodegenerative conditions, or antipsychotic medications use, were selected for the present study. Unadjusted and multi-adjusted regression models of incident storage and voiding LUTS and incident depression and anxiety were combined with serum inflammatory markers (high-sensitive C-reactive protein (hsCRP), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), myeloperoxidase (MPO), soluble e-selectin (e-Sel)) and socio-demographic, lifestyle, and health-related factors. Hierarchical multiple regression was used to assessed the moderating effect of inflammatory markers. Results The incidence of storage, voiding LUTS, depression and anxiety was 16.3% (n = 108), 12.1% (n = 88), 14.5% (n = 108), and 12.2% (n = 107). Regression models demonstrated that men with depression and anxiety at baseline were more likely to have incident storage, but not voiding LUTS (OR: 1.26, 99%CI: 1.01-4.02; and OR: 1.74; 99%CI: 1.05-2.21, respectively). Men with anxiety and storage LUTS at baseline were more likely to have incident depression (OR: 2.77, 99%CI: 1.65-7.89; and OR: 1.45; 99%CI: 1.05-2.36, respectively), while men with depression and voiding LUTS were more likely to have anxiety at follow-up (OR: 5.06, 99%CI: 2.81-9.11; and OR: 2.40; 99%CI: 1.16-4.98, respectively). CRP, TNF-alpha, and e-Sel were found to have significant moderating effects on the development of storage LUTS (1.06, 0.91-1.96, R-2 change: 12.7%), depression (1.17, 1.01-1.54, R-2 change: 9.8%), and anxiety (1.35, 1.03-1.76, R-2 change: 10.6%), respectively. Conclusions There is a bidirectional relationship between storage, but not voiding, LUTS and both depression and anxiety. We observed variable moderation effects for selected inflammatory markers on the development of depression, anxiety and storage LUTS.	[Martin, Sean; Vincent, Andrew; Wittert, Gary] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia; [Martin, Sean; Vincent, Andrew; Atlantis, Evan; Wittert, Gary] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Taylor, Anne W.] Univ Adelaide, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Atlantis, Evan] Univ Western Sydney, Sch Nursing & Midwifery, Sydney, NSW, Australia; [Jenkins, Alicia; Januszewski, Andrzej] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia; [O'Loughlin, Peter] SA Pathol, Chem Pathol, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; Western Sydney University; University of Sydney; SA Pathology	Martin, S (corresponding author), Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia.	sean.martin@adelaide.edu.au	wittert, gary/AAE-2398-2019; Atlantis, Evan/ABC-8075-2021; Januszewski, Andrzej/N-2006-2015; Jenkins, Alicia/N-2482-2015; Taylor, Anne/F-5708-2010	Atlantis, Evan/0000-0001-5877-6141; Januszewski, Andrzej/0000-0003-0995-4524; Jenkins, Alicia/0000-0003-0583-3717; Taylor, Anne/0000-0002-4422-7974; Wittert, Gary/0000-0001-6818-6065	University of Adelaide's Florey Foundation; National Health and Medical Research Council (Australia) [627227]	University of Adelaide's Florey Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	The study was initially supported by The University of Adelaide's Florey Foundation and then funded by a project grant (#627227) from the National Health and Medical Research Council (Australia).	BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Barry MJ, 1992, J UROLOGY, V148, P64; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; Brenes GA, 2006, AGING MENT HEALTH, V10, P298, DOI 10.1080/13607860500409898; Brennan AM, 2009, DIABETES CARE, V32, P926, DOI 10.2337/dc08-1979; Breyer BN, 2014, J UROLOGY, V191, P1333, DOI 10.1016/j.juro.2013.12.012; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.109; Chung RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076017; Coyne KS, 2008, BJU INT, V101, P1267, DOI 10.1111/j.1464-410X.2008.07598.x; Coyne KS, 2012, EUR UROL, V61, P88, DOI 10.1016/j.eururo.2011.07.049; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Freedland SJ, 2009, AM J EPIDEMIOL, V169, P1291, DOI 10.1093/aje/kwp084; Huang CY, 2011, J AFFECT DISORDERS, V135, P395, DOI 10.1016/j.jad.2011.07.001; Hung SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085588; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.2381; Kupelian V, 2009, J UROLOGY, V182, P616, DOI 10.1016/j.juro.2009.04.025; Latz I, 2013, WORLD J UROL, V31, P673, DOI 10.1007/s00345-012-0937-7; Lee YI, 2013, KOREAN J UROL, V54, P762, DOI 10.4111/kju.2013.54.11.762; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Martin S, 2007, INT J EPIDEMIOL, V36, P302, DOI 10.1093/ije/dyl279; Martin SA, 2011, WORLD J UROL, V29, P179, DOI 10.1007/s00345-010-0605-8; Milsom I, 2012, UROLOGY, V80, P90, DOI 10.1016/j.urology.2012.04.004; O'Brien SM, 2007, J PSYCHIAT RES, V41, P326, DOI 10.1016/j.jpsychires.2006.05.013; Patel A, 2013, PSYCHIAT DANUB, V25, pS216; Pennanen L, 2013, NEUROPSYCHOPHARMACOL, V38, P957, DOI 10.1038/npp.2012.258; Postolache Teodor T, 2008, Int J Child Health Hum Dev, V1, P313; Prather AA, 2009, BRAIN BEHAV IMMUN, V23, P1109, DOI 10.1016/j.bbi.2009.07.001; Punnen S, 2013, BJU INT, V112, pE67, DOI 10.1111/bju.12209; Robertson C, 2007, BJU INT, V99, P347, DOI 10.1111/j.1464-410X.2007.06609.x; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Sauver JLS, 2009, AM J EPIDEMIOL, V169, P1281, DOI 10.1093/aje/kwp085; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Wong SY, 2010, AGING MALE, V13, P113, DOI 10.3109/13685530903440432	38	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137903	10.1371/journal.pone.0137903	http://dx.doi.org/10.1371/journal.pone.0137903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445118	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600014
J	Wang, K; Li, LW; Yin, HX; Zhang, TZ; Wan, WB				Wang, Kai; Li, Liwei; Yin, Huaixian; Zhang, Tiezhu; Wan, Wubo			Thermal Modelling Analysis of Spiral Wound Supercapacitor under Constant-Current Cycling	PLOS ONE			English	Article							ULTRACAPACITOR; GRAPHENE; STATE; TIME	A three-dimensional modelling approach is used to study the effects of operating and ambient conditions on the thermal behaviour of the spiral wound supercapacitor. The transient temperature distribution during cycling is obtained by using the finite element method with an implicit predictor-multicorrector algorithm. At the constant current of 2A, the results show that the maximum temperature appears in core area. After 5 cycles, the maximum temperature is 34.5 degrees C, while in steady state, it's up to 42.5 degrees C. This paper further studies the relationship between the maximum temperature and charge-discharge current. The maximum temperature will be more than 60 degrees C after 5 cycles at the current of 4A, and cooling measurements should be taken at that time. It can provide thoughts on inner temperature field distribution and structure design of the spiral wound supercapacitor in working process.	[Wang, Kai; Li, Liwei; Yin, Huaixian; Zhang, Tiezhu] Qingdao Univ, Sch Automat Engn, Dynam Integrat & Energy Storage Syst Engn Technol, Qingdao 266071, Shandong, Peoples R China; [Wan, Wubo] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Qingdao University; Zhejiang University of Technology	Wang, K (corresponding author), Qingdao Univ, Sch Automat Engn, Dynam Integrat & Energy Storage Syst Engn Technol, Qingdao 266071, Shandong, Peoples R China.	wkwj888@163.com	Wang, Kai/P-1433-2015; Wan, Wubo/D-1042-2016	Wang, Kai/0000-0002-3513-3511; Wan, Wubo/0000-0002-7056-8510				Al Sakka M, 2009, J POWER SOURCES, V194, P581, DOI 10.1016/j.jpowsour.2009.06.038; Cao J, 2012, IEEE T POWER ELECTR, V27, DOI 10.1109/TPEL.2011.2151206; Cottineau T, 2006, APPL PHYS A-MATER, V82, P599, DOI 10.1007/s00339-005-3401-3; Gualous H, 2003, J POWER SOURCES, V123, P86, DOI 10.1016/S0378-7753(03)00527-5; Gualous H, 2009, IEEE T IND APPL, V45, P1035, DOI 10.1109/TIA.2009.2018879; Guo GF, 2010, J POWER SOURCES, V195, P2393, DOI 10.1016/j.jpowsour.2009.10.090; Hu H, 2014, J MATER CHEM A, V2, P3756, DOI 10.1039/c3ta14840h; Hu XS, 2015, APPL ENERG, V137, P913, DOI 10.1016/j.apenergy.2014.05.013; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2013, J POWER SOURCES, V239, P449, DOI 10.1016/j.jpowsour.2013.03.157; Hu XS, 2009, INT C INTEL HUM MACH, P392, DOI 10.1109/IHMSC.2009.106; Hun Lee Dae, 2008, J POWER SOURCES, V175, P664; Kotz R, 2000, ELECTROCHIM ACTA, V45, P2483, DOI 10.1016/s0013-4686(00)00354-6; Li SE, 2014, J POWER SOURCES, V258, P9, DOI 10.1016/j.jpowsour.2014.02.045; Mahon PJ, 2000, J POWER SOURCES, V91, P68, DOI 10.1016/S0378-7753(00)00488-2; Song ZK, 2014, NONLINEAR DYNAM, V78, P173, DOI 10.1007/s11071-014-1430-1; Song ZK, 2014, ISA T, V53, P117, DOI 10.1016/j.isatra.2013.08.008; Song ZK, 2014, ISA T, V53, P125, DOI 10.1016/j.isatra.2013.07.017; Wang K, 2014, ENERGY, V70, P612, DOI 10.1016/j.energy.2014.04.034; Wang K, 2014, RUSS J ELECTROCHEM+, V50, P176, DOI 10.1134/S1023193513060128; Wang K, 2014, J MATER ENG PERFORM, V23, P588, DOI 10.1007/s11665-013-0811-9; Wang K, 2013, ENERGY, V59, P440, DOI 10.1016/j.energy.2013.07.064; Wang RZ, 2011, ENERGY, V36, P5425, DOI 10.1016/j.energy.2011.07.008; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204; Zhang Y, 2009, INT J HYDROGEN ENERG, V34, P4889, DOI 10.1016/j.ijhydene.2009.04.005; Zubieta L, 2000, IEEE T IND APPL, V36, P199, DOI 10.1109/28.821816	28	32	32	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138672	10.1371/journal.pone.0138672	http://dx.doi.org/10.1371/journal.pone.0138672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444687	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600035
J	Jang, Y; Shin, A				Jang, Yeonsoo; Shin, Anna			Sex-Based Differences in Asthma among Preschool and School-Aged Children in Korea	PLOS ONE			English	Article							ATOPIC-DERMATITIS; CHILDHOOD; PREVALENCE; OBESITY; GENDER; HEALTH; ASSOCIATION; DISPARITIES; ADOLESCENTS; OVERWEIGHT	The purpose of this study was to explore risk factors related to asthma prevalence among preschool and school-aged children using a representative national dataset from the Korea National Health and Nutrition Examination Survey (KNHANES) conducted from 2009-2011. We evaluated the demographic information, health status, household environment, socioeconomic status, and parents' health status of 3,542 children aged 4-12 years. A sex-stratified multivariate logistic regression was used to obtain adjusted prevalence odds ratios (ORs) and 95% confidence intervals after accounting for primary sample units, stratification, and sample weights. The sex-specific asthma prevalence in the 4- to 12-year-old children was 7.39% in boys and 6.27% in girls. Boys and girls with comorbid atopic dermatitis were more likely to have asthma than those without atopic dermatitis (boys: OR = 2.20, p = 0.0071; girls: OR = 2.33, p = 0.0031). Boys and girls with >= 1 asthmatic parent were more likely to have asthma than those without asthmatic parents (boys: OR = 3.90, p = 0.0006; girls: OR = 3.65, p = 0.0138). As girls got older, the prevalence of asthma decreased (OR = 0.90, p = 0.0408). Girls residing in rural areas were 60% less likely to have asthma than those residing in urban areas (p = 0.0309). Boys with >= 5 family members were more likely to have asthma than those with <= 3 family members (OR = 2.45, p = 0.0323). The factors related to asthma prevalence may differ depending on sex in preschool and school-aged children. By understanding the characteristics of sex-based differences in asthma, individualized asthma management plans may be established clinically.	[Jang, Yeonsoo] Yonsei Univ, Coll Nursing, Mo Kim Nursing Res Inst, Seoul 120749, South Korea; [Shin, Anna] Yonsei Univ, Coll Med, Dept Publ Hlth, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, A (corresponding author), Yonsei Univ, Coll Med, Dept Publ Hlth, Seoul, South Korea.	sheisannie@hotmail.com		Jang, Yeonsoo/0000-0002-1898-025X				Aarts MJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-98; Ahmad N, 2009, J ASTHMA, V46, P642, DOI 10.1080/02770900802503123; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bisgaard H, 2010, J ALLERGY CLIN IMMUN, V126, P187, DOI 10.1016/j.jaci.2010.07.011; Broms K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-303; Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Chen YC, 2013, OBES REV, V14, P222, DOI 10.1111/j.1467-789X.2012.01055.x; Cho YM, 2014, J ASTHMA, V51, P373, DOI 10.3109/02770903.2013.876648; Clement LT, 2008, AM J MED SCI, V335, P260, DOI 10.1097/MAJ.0b013e318169031c; Crespo NC, 2011, J CHILD HEALTH CARE, V15, P358, DOI 10.1177/1367493510397680; Genuneit J, 2013, PEDIAT ALLERG IMM-UK, V24, P293, DOI 10.1111/pai.12053; Gonzalez-Barcala FJ, 2013, J PEDIAT-BRAZIL, V89, P294, DOI 10.1016/j.jped.2012.11.001; Hancox RJ, 2005, AM J RESP CRIT CARE, V171, P440, DOI 10.1164/rccm.200405-623OC; Heinrich J, 2011, INT J HYG ENVIR HEAL, V214, P3, DOI 10.1016/j.ijheh.2010.08.009; Korea Centers for Disease Control and Prevention, 2013, GUID PREV CONTR ASTH; Korea Centers for Disease Control and Prevention, 2013, KOR NAT HLTH NUTR EX; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lawson JA, 2011, ANN ALLERG ASTHMA IM, V107, P220, DOI 10.1016/j.anai.2011.06.014; Lee YL, 2005, PEDIAT ALLERG IMM-UK, V16, P157, DOI 10.1111/j.1399-3038.2005.00211.x; Moon JS, 2007, KOREAN J PEDIAT, V1, P1, DOI DOI 10.3345/KJP.2008.51.1.1; Oh IH, 2011, J KOREAN MED ASSOC, V54, P646, DOI 10.5124/jkma.2011.54.6.646; Ownby DR, 2007, J ASTHMA, V44, P885, DOI 10.1080/02770900701752698; Prevention KCfDCa, 2012, 2011 KOR YOUTH RISK; Protudjer JLP, 2014, ANN ALLERG ASTHMA IM, V112, P78, DOI 10.1016/j.anai.2013.10.015; Pyun BY, 2007, J KOREAN MED ASSOC, V50, P533, DOI 10.5124/jkma.2007.50.6.533; Rodriguez-Martinez CE, 2014, PEDIATR PULM, V49, P1058, DOI 10.1002/ppul.22936; Scholtens S, 2009, J ALLERGY CLIN IMMUN, V123, P1312, DOI 10.1016/j.jaci.2009.02.029; Strachan DP, 2015, CLIN EXP ALLERGY, V45, P126, DOI 10.1111/cea.12349; Tse SM, 2014, PEDIAT PULMONOL; Vazquez-Nava F, 2010, THESCIENTIFICWORLDJO, V10, P1339, DOI 10.1100/tsw.2010.134; Vink NM, 2010, J ALLERGY CLIN IMMUN, V126, P498, DOI 10.1016/j.jaci.2010.06.018; Wandalsen GF, 2015, ALLERGOL IMMUNOPATHO; Wang L, 2015, RESP MED; World Health Organization, 2014, ASTHMA; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0140057	10.1371/journal.pone.0140057	http://dx.doi.org/10.1371/journal.pone.0140057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441284	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510300095
J	Du, J; Yang, M; Chen, S; Li, D; Chang, Z; Dong, Z				Du, J.; Yang, M.; Chen, S.; Li, D.; Chang, Z.; Dong, Z.			PDK1 promotes tumor growth and metastasis in a spontaneous breast cancer model	ONCOGENE			English	Article							MAMMARY EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; PHARMACOLOGICAL INHIBITION; SIGNALING PATHWAYS; SUPPRESSOR GENE; PHOSPHORYLATION; IDENTIFICATION; TRANSFORMATION; INACTIVATION; EXPRESSION	Because malignant cells have altered, usually accelerated, energy consumption, targeting metabolic signaling represents a prevailing strategy for tumor therapy. Phosphoinositide-dependent kinase 1 (PDK1) is a proximal signaling molecule of phosphatidylinositol 3-kinase, which is required for metabolic activation. It is still lacking definitive evidence whether inactivation of PDK1 can overwhelm tumorigenesis in vivo. Herein we revealed that mammary-specific ablation of PDK1 could delay tumor initiation, progression and metastasis in a spontaneous mouse tumor model. We also demonstrated that inducible deletion of PDK1 could noticeably shrink the growing breast tumors. However, a small portion of PDK1-deficient tumorigenic cells eventually established tumor lesions, albeit at a relatively later phase, most likely owing to compensatory upregulation of extracellular signalregulated kinase 1/2 (Erk1/2) phosphorylation. Consequently, simultaneous inhibition of PDK1 and Erk1/2 impeded the survival of breast cancer cells. Thus we identify PDK1 as a potential therapeutic target for breast cancer, particularly in combination with an Erk1/2 inhibitor.	[Du, J.; Yang, M.; Chen, S.; Li, D.; Dong, Z.] Tsinghua Univ, Sch Med, Biotech Bldg 4-314,1 Tsinghuayuan, Beijing 100086, Peoples R China; [Chen, S.] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Chang, Z.] Tsinghua Univ, Ctr Anim Facil, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Dong, Z (corresponding author), Tsinghua Univ, Sch Med, Biotech Bldg 4-314,1 Tsinghuayuan, Beijing 100086, Peoples R China.	dongzj@biomed.tsinghua.edu.cn	Chang, Zhijie/AAH-8109-2019		Natural Science Foundation of China [81322041, 81273198, 81361128016, 81471523]; Beijing Natural Science Foundation [5132018]; Postdoctoral Foundation at Tsinghua-Peking Center for Life Sciences;  [2013CB944901]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Postdoctoral Foundation at Tsinghua-Peking Center for Life Sciences; 	We thank Dr Dario R Alessi (University of Dundee) for sharing the PDK1<SUP>fl/fl</SUP> mice. This work was supported by grants to Dr Zhongjun Dong's laboratory from Natural Science Foundation of China (81322041, 81273198, 81361128016 and 81471523), Minister of Science and Technology of China (2013CB944901) and Beijing Natural Science Foundation (5132018). Juan Du and Meixiang Yang were supported by Postdoctoral Foundation at Tsinghua-Peking Center for Life Sciences.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bayascas JR, 2005, CURR BIOL, V15, P1839, DOI 10.1016/j.cub.2005.08.066; Cairns P, 1997, CANCER RES, V57, P4997; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cope CL, 2014, J CELL SCI, V127, P788, DOI 10.1242/jcs.137588; Dennis MD, 2013, J BIOL CHEM, V288, P10, DOI 10.1074/jbc.M112.402461; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Ellwood-Yen K, 2011, CANCER RES, V71, P3052, DOI 10.1158/0008-5472.CAN-10-2282; Emerling BM, 2011, CANCER RES, V71, P7351, DOI 10.1158/0008-5472.CAN-11-1699; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fyffe Chanse, 2013, Cancer Manag Res, V5, P271, DOI 10.2147/CMAR.S35026; Gagliardi PA, 2012, NEOPLASIA, V14, P719, DOI 10.1593/neo.12856; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Halachmi N, 1998, GENE CHROMOSOME CANC, V23, P239, DOI 10.1002/(SICI)1098-2264(199811)23:3<239::AID-GCC5>3.0.CO;2-2; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; Kim MS, 2003, CANCER RES, V63, P5454; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Liu Y, 2009, MOL CANCER RES, V7, P944, DOI 10.1158/1541-7786.MCR-08-0368; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Mikaelian I, 2013, CANCER RES, V73, P6621, DOI 10.1158/0008-5472.CAN-13-0560; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Nagashima K, 2011, J BIOL CHEM, V286, P6433, DOI 10.1074/jbc.M110.156463; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Pazarentzos E, 2016, ONCOGENE, V35, P1198, DOI 10.1038/onc.2015.173; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Qiu TH, 2004, CANCER RES, V64, P5973, DOI 10.1158/0008-5472.CAN-04-0242; Raimondi C, 2010, BREAST CANCER RES, V12, pS3, DOI 10.1186/bcr2500; Bayascas JR, 2010, CURR TOP MICROBIOL, V346, P9, DOI 10.1007/82_2010_43; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rodriguez-Viciana P, 2006, P NATL ACAD SCI USA, V103, P19290, DOI 10.1073/pnas.0609343103; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Scortegagna M, 2014, ONCOGENE, V33, P4330, DOI 10.1038/onc.2013.383; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ZH, 2003, CANCER RES, V63, P5370; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Zeng X, 2002, CANCER RES, V62, P3538; Zhang HY, 2013, ONCOL LETT, V6, P161, DOI 10.3892/ol.2013.1331; Zhang XB, 2013, CURR CANCER DRUG TAR, V13, P175, DOI 10.2174/1568009611313020007	50	41	41	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3314	3323		10.1038/onc.2015.393	http://dx.doi.org/10.1038/onc.2015.393			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26455327				2022-12-26	WOS:000378306400010
J	Stolting, G; Bungert-Plumke, S; Franzen, A; Fahlke, C				Stoelting, Gabriel; Bungert-Pluemke, Stefanie; Franzen, Arne; Fahlke, Christoph			Carboxyl-terminal Truncations of CIC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-CAUSING MUTATIONS; MUSCLE CHLORIDE CHANNELS; CALCIUM-SENSING RECEPTOR; SYNDROME TYPE-IV; FUNCTIONAL-CHARACTERIZATION; HYPOKALEMIC ALKALOSIS; TORPEDO ELECTROPLAX; SURFACE EXPRESSION; PORE VESTIBULE; BETA-SUBUNIT	ClC-K chloride channels are crucial for auditory transduction and urine concentration. Mutations in CLCNKB, the gene encoding the renal chloride channel hClC-Kb, cause Bartter syndrome type III, a human genetic condition characterized by polyuria, hypokalemia, and alkalosis. In recent years, several Bartter syndrome-associated mutations have been described that result in truncations of the intracellular carboxyl terminus of hClC-Kb. We here used a combination of whole-cell patch clamp, confocal imaging, co-immunoprecipitation, and surface biotinylation to study the functional consequences of a frequent CLCNKB mutation that creates a premature stop codon at Trp-610. We found that W610X leaves the association of hClC-Kb and the accessory subunit barttin unaffected, but impairs its regulation by barttin. W610X attenuates hClC-Kb surface membrane insertion. Moreover, W610X results in hClC-Kb channel opening in the absence of barttin and prevents further barttin-mediated activation. To describe how the carboxyl terminus modifies the regulation by barttin we used V166E rClC-K1. V166E rClC-K1 is active without barttin and exhibits prominent, barttin-regulated voltage-dependent gating. Electrophysiological characterization of truncated V166E rClC-K1 demonstrated that the distal carboxyl terminus is necessary for slow cooperative gating. Since barttin modifies this particular gating process, channels lacking the distal carboxyl-terminal domain are no longer regulated by the accessory subunit. Our results demonstrate that the carboxyl terminus of hClC-Kb is not part of the binding site for barttin, but functionally modifies the interplay with barttin. The loss-of-activation of truncated hClC-Kb channels in heterologous expression systems fully explains the reduced basolateral chloride conductance in affected kidneys and the clinical symptoms of Bartter syndrome patients.	[Stoelting, Gabriel; Bungert-Pluemke, Stefanie; Franzen, Arne; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst 4, Zellulare Biophys, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Stolting, G (corresponding author), Forschungszentrum Julich, Inst Complex Syst 4, Zellulare Biophys, D-52425 Julich, Germany.	g.stoelting@fz-juelich.de; c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013; Stolting, Gabriel/G-3704-2014	Fahlke, Christoph/0000-0001-8602-9952; Franzen, Arne/0000-0002-8731-674X; Stolting, Gabriel/0000-0002-2339-0545	Deutsche Forschungsgemeinschaft [FA301/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FA301/10-1, to Ch. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrini O., 2013, PFLUGERS ARCH, V466, P1713; Andrini O, 2015, AM J PHYSIOL-RENAL, V308, pF1324, DOI 10.1152/ajprenal.00004.2015; Barlassina C, 2007, HUM MOL GENET, V16, P1630, DOI 10.1093/hmg/ddm112; BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bettinelli A, 2007, AM J KIDNEY DIS, V49, P91, DOI 10.1053/j.ajkd.2006.10.001; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Cappola TP, 2011, P NATL ACAD SCI USA, V108, P2456, DOI 10.1073/pnas.1017494108; Carr G, 2003, BIOCHEM BIOPH RES CO, V310, P600, DOI 10.1016/j.bbrc.2003.09.057; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2001, J BIOL CHEM, V276, P1759, DOI 10.1074/jbc.M007649200; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fischer M, 2010, J AM SOC NEPHROL, V21, P1281, DOI 10.1681/ASN.2009121274; Fukuyama S, 2004, J CLIN ENDOCR METAB, V89, P5847, DOI 10.1210/jc.2004-0775; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Imbrici P, 2014, BBA-BIOMEMBRANES, V1838, P2484, DOI 10.1016/j.bbamem.2014.05.017; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Keck M, 2013, HUM MUTAT, V34, P1269, DOI 10.1002/humu.22361; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; L'Hoste S, 2013, BBA-BIOMEMBRANES, V1828, P2399, DOI 10.1016/j.bbamem.2013.06.012; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee BH, 2012, NEPHROL DIAL TRANSPL, V27, P1516, DOI 10.1093/ndt/gfr475; Liantonio A, 2006, MOL PHARMACOL, V69, P165, DOI 10.1124/mol.105.017384; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Ludwig M, 2005, HUM GENET, V117, P228, DOI 10.1007/s00439-005-1303-2; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Martinez GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002746; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nomura N, 2013, BIOCHEM BIOPH RES CO, V441, P544, DOI 10.1016/j.bbrc.2013.10.129; Nomura N, 2011, AM J PHYSIOL-RENAL, V301, pF297, DOI 10.1152/ajprenal.00604.2010; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Nozu K, 2010, J CLIN ENDOCR METAB, V95, pE511, DOI 10.1210/jc.2010-0392; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Steinke KV, 2015, J BIOL CHEM, V290, P17390, DOI 10.1074/jbc.M114.631705; Stolting G, 2014, PFLUG ARCH EUR J PHY, V466, P2191, DOI 10.1007/s00424-014-1490-6; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Stolting G, 2013, PFLUG ARCH EUR J PHY, V465, P1423, DOI 10.1007/s00424-013-1286-0; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Vandewalle A, 1997, AM J PHYSIOL-RENAL, V272, pF678, DOI 10.1152/ajprenal.1997.272.5.F678; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Velazquez H, 2003, AM J PHYSIOL-RENAL, V285, pF49, DOI 10.1152/ajprenal.00389.2002; Waldegger S., 2014, PFLUGERS ARCH, V444, P411; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Weinberger S, 2012, J PHYSIOL-LONDON, V590, P3449, DOI 10.1113/jphysiol.2012.232785; Wojciechowski D, 2015, J BIOL CHEM, V290, P18732, DOI 10.1074/jbc.M114.625376	63	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30406	30416		10.1074/jbc.M115.675827	http://dx.doi.org/10.1074/jbc.M115.675827			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26453302	Green Published, hybrid			2022-12-26	WOS:000366738200018
J	Saelices, L; Johnson, LM; Liang, WY; Sawaya, MR; Cascio, D; Ruchala, P; Whitelegge, J; Jiang, L; Riek, R; Eisenberg, DS				Saelices, Lorena; Johnson, Lisa M.; Liang, Wilson Y.; Sawaya, Michael R.; Cascio, Duilio; Ruchala, Piotr; Whitelegge, Julian; Jiang, Lin; Riek, Roland; Eisenberg, David S.			Uncovering the Mechanism of Aggregation of Human Transthyretin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; inhibition mechanism; peptide interaction; protein aggregation; x-ray crystallography; mutational analysis; TTR; transthyretin amyloidosis	AMYLOID FIBRIL FORMATION; SENILE SYSTEMIC AMYLOIDOSIS; CONFORMATIONAL-CHANGES; PROTEIN TRANSTHYRETIN; TETRAMER DISSOCIATION; MAXIMUM-LIKELIHOOD; THYROXINE-BINDING; PROLINE MUTATIONS; BETA-STRANDS; IN-VITRO	The tetrameric thyroxine transport protein transthyretin (TTR) forms amyloid fibrils upon dissociation and monomer unfolding. The aggregation of transthyretin has been reported as the cause of the life-threatening transthyretin amyloidosis. The standard treatment of familial cases of TTR amyloidosis has been liver transplantation. Although aggregation-preventing strategies involving ligands are known, understanding the mechanism of TTR aggregation can lead to additional inhibition approaches. Several models of TTR amyloid fibrils have been proposed, but the segments that drive aggregation of the protein have remained unknown. Here we identify -strands F and H as necessary for TTR aggregation. Based on the crystal structures of these segments, we designed two non-natural peptide inhibitors that block aggregation. This work provides the first characterization of peptide inhibitors for TTR aggregation, establishing a novel therapeutic strategy.	[Saelices, Lorena; Johnson, Lisa M.; Liang, Wilson Y.; Sawaya, Michael R.; Cascio, Duilio; Jiang, Lin; Eisenberg, David S.] Univ Calif Los Angeles, Dept Chem & Biochem, Dept Biol Chem, Los Angeles, CA 90095 USA; [Saelices, Lorena; Johnson, Lisa M.; Liang, Wilson Y.; Sawaya, Michael R.; Cascio, Duilio; Jiang, Lin; Eisenberg, David S.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Saelices, Lorena; Riek, Roland] ETH Honggerberg, Swiss Fed Inst Technol Zurich ETH, Phys Chem, CH-8093 Zurich, Switzerland; [Ruchala, Piotr; Whitelegge, Julian] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Ruchala, Piotr; Whitelegge, Julian] Jane & Terry Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Los Angeles	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Dept Biol Chem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Saelices Gomez, Lorena/0000-0002-1904-2150; Sawaya, Michael/0000-0003-0874-9043; RUCHALA, PIOTR/0000-0002-5574-2779; Riek, Roland/0000-0002-6333-066X	DOE [DE-FC02-02ER63421, DE-AC02-06CH11357]; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P41 GM103403-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048120, R01AG029430, RF1AG048120] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kevin Chung for help with the analysis of monomeric TTR, Rebecca Nelson for discussions, and Joshua A. Chou for technical assistance. We thank the Electron Imaging Center for NanoMachines of California NanoSystems Institute (CNSI) at UCLA for using TEM. We thank Michael Collazo of the UCLA Crystallization Facility and the UCLA-Department of Energy (DOE) X-ray Crystallography Core Facility. We thank M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy at Northeastern Collaborative Access Team beamlines 24-ID at the Advanced Photon Source (APS). The UCLA-DOE X-ray Crystallography Core Facility is supported by DOE Grant DE-FC02-02ER63421. APS staff is supported by National Center for Research Resources Grant 5P41RR015301-10) and National Institute of General Medical Sciences Grant 8 P41 GM103403-10 from the National Institutes of Health. Use of the APS is supported by DOE Contract DE-AC02-06CH11357.	Abedini A, 2006, J MOL BIOL, V355, P274, DOI 10.1016/j.jmb.2005.10.052; Alhamadsheh MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002473; ALVES IL, 1993, J CLIN ENDOCR METAB, V77, P484, DOI 10.1210/jc.77.2.484; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Castano Adam, 2012, Congest Heart Fail, V18, P315, DOI 10.1111/j.1751-7133.2012.00303.x; Chiu CC, 2013, BIOPHYS J, V105, P1227, DOI 10.1016/j.bpj.2013.07.029; Chung CM, 2001, AMYLOID, V8, P75, DOI 10.3109/13506120109007348; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Cruz M, 2004, J PEPT RES, V63, P324, DOI 10.1111/j.1399-3011.2004.00156.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eldridge B, 2009, PROTEIN ENG DES SEL, V22, P691, DOI 10.1093/protein/gzp052; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kroth H, 2012, J BIOL CHEM, V287, P34786, DOI 10.1074/jbc.M112.357665; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Lim KH, 2013, J MOL BIOL, V425, P977, DOI 10.1016/j.jmb.2013.01.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misumi Y, 2013, LAB INVEST, V93, P911, DOI 10.1038/labinvest.2013.83; MUNRO SL, 1989, J CLIN ENDOCR METAB, V68, P1141, DOI 10.1210/jcem-68-6-1141; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Pires RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044992; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schormann N, 1998, AMYLOID, V5, P175, DOI 10.3109/13506129809003843; Sekijima Y, 2014, J CLIN PHARM THER, V39, P225, DOI 10.1111/jcpt.12145; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; Shnyrov VL, 2000, BIOPHYS CHEM, V88, P61, DOI 10.1016/S0301-4622(00)00199-X; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; SIPE JD, 1994, CRIT REV CL LAB SCI, V31, P325, DOI 10.3109/10408369409084679; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; Takahashi T, 2008, ACCOUNTS CHEM RES, V41, P1309, DOI 10.1021/ar8000475; Takeuchi M, 2007, PROTEINS, V66, P716, DOI 10.1002/prot.21252; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	58	85	86	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28932	28943		10.1074/jbc.M115.659912	http://dx.doi.org/10.1074/jbc.M115.659912			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26459562	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000365762300032
J	Young, SK; Willy, JA; Wu, C; Sachs, MS; Wek, RC				Young, Sara K.; Willy, Jeffrey A.; Wu, Cheng; Sachs, Matthew S.; Wek, Ronald C.			Ribosome Reinitiation Directs Gene-specific Translation and Regulates the Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; EIF2-ALPHA DEPHOSPHORYLATION; ENDOPLASMIC-RETICULUM; SELECTIVE-INHIBITION; INITIATION; PHOSPHORYLATION; CELLS; PROTEOSTASIS; EXPRESSION	In the integrated stress response, phosphorylation of eIF2 alpha (eIF2 alpha-P) reduces protein synthesis to conserve resources and facilitate preferential translation of transcripts that promote stress adaptation. Preferentially translated GADD34 (PPP1R15A) and constitutively expressed CReP (PPP1R15B) function to dephosphorylate eIF2 alpha-P and restore protein synthesis. The 5'-leaders of GADD34 and CReP contain two upstream ORFs (uORFs). Using biochemical and genetic approaches we show that features of these uORFs are central for their differential expression. In the absence of stress, translation of an inhibitory uORF in GADD34 acts as a barrier that prevents reinitiation at the GADD34 coding region. Enhanced eIF2a-P during stress directs ribosome bypass of the uORF, facilitating translation of the GADD34 coding region. CReP expression occurs independent of eIF2 alpha-P via an uORF that allows for translation reinitiation at the CReP coding region independent of stress. Importantly, alterations in the GADD34 uORF affect the status of eIF2 alpha-P, translational control, and cell adaptation to stress. These results show that properties of uORFs that permit ribosome reinitiation are critical for directing gene-specific translational control in the integrated stress response.	[Young, Sara K.; Willy, Jeffrey A.; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Wu, Cheng; Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Wek, RC (corresponding author), Indiana Univ Sch Med, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu	Regan, Clinton/E-6250-2012	Young-Baird, Sara/0000-0002-8915-3139; Sachs, Matthew/0000-0001-9891-9223	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049164 (to R. C. W.) and the Ralph W. and Grace M. Showalter Research Trust Fund.	Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904	25	45	45	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28257	28271		10.1074/jbc.M115.693184	http://dx.doi.org/10.1074/jbc.M115.693184			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446796	Green Published, hybrid			2022-12-26	WOS:000365761900019
J	Yu, FJ; Zheng, JJ; Mao, YQ; Dong, PH; Lu, ZQ; Li, GJ; Guo, CY; Liu, ZJ; Fan, XM				Yu, Fujun; Zheng, Jianjian; Mao, Yuqing; Dong, Peihong; Lu, Zhongqiu; Li, Guojun; Guo, Chuanyong; Liu, Zhanju; Fan, Xiaoming			Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELLS; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; FEEDBACK LOOP; CANCER; PROLIFERATION; EXPRESSION; FIBROSIS; MIRNAS; ACTIVATION	Effective control of hepatic stellate cell (HSC) activation and proliferation is critical to the treatment of liver fibrosis, Long non-coding RNAs have been shown to play a pivotal role in the regulation of cellular processes. It has been reported that growth arrest-specific transcript 5 (GAS 5) acts as a crucial mediator in the control of cell proliferation and growth. However, little is known about the role and underlying mechanism of GAS5 in liver fibrosis. In this study, our results indicated that GAS5 expression was reduced in mouse, rat, and human fibrotic liver samples and in activated HSCs. Overexpression of GAS5 suppressed the activation of primary HSCs in vitro and alleviated the accumulation of collagen in fibrotic liver tissues in vivo. We identified GASS as a target of microRNA-222 (miR-222) and showed that miR-222 could inhibit the expression of GAS5. Interestingly, GAS5 could also repress miR-222 expression. A pulldown assay further validated that GAS5 could directly bind to miR-222. As a competing endogenous RNAs, GAS5 had no effect on primary miR-222 expression. In addition, GAS5 was mainly localized in the cytoplasm. Quantitative RT-PCR further demonstrated that the copy numbers of GAS5 per cell are higher than those of miR-222. GAS5 increased the level of p27 protein by functioning as a competing endogenous RNA for miR-222, thereby inhibiting the activation and proliferation of HSCs. Taken together, a new regulatory circuitry in liver fibrosis has been identified in which RNAs cross-talk by competing for shared microRNAs. Our findings may provide a new therapeutic strategy for liver fibrosis.	[Yu, Fujun; Mao, Yuqing; Fan, Xiaoming] Fudan Univ, Jinshan Hosp, Dept Gastroenterol, Shanghai 201508, Peoples R China; [Zheng, Jianjian] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou Key Lab Surg, Wenzhou 325000, Peoples R China; [Dong, Peihong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Infect Dis, Wenzhou 325000, Peoples R China; [Lu, Zhongqiu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Emergency, Wenzhou 325000, Peoples R China; [Li, Guojun] Ningbo Yinzhou Second Hosp, Dept Hepatol, Ningbo 315000, Zhejiang, Peoples R China; [Guo, Chuanyong; Liu, Zhanju] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Gastroenterol, Shanghai 200072, Peoples R China; [Fan, Xiaoming] Fudan Univ, Shanghai Med Coll, Dept Internal Med, Shanghai 201508, Peoples R China	Fudan University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Tongji University; Fudan University	Fan, XM (corresponding author), Fudan Univ, Jinshan Hosp, Dept Gastroenterol, 1508 Longhang Rd, Shanghai 201508, Peoples R China.	ktsqdph@163.com		Guo, Chuanyong/0000-0002-6527-4673; mao, yuqing/0000-0003-4573-6567; Zheng, Jianjian/0000-0001-8770-4219; yu, fujun/0000-0001-5321-7228; LU, Zhongqiu/0000-0002-0569-4182	Science and Technology Commission of Shanghai Municipality [11ZR1405700]; Key Clinical Disciplines Construction of Shanghai Municipality [ZK2012B20]; National Natural Science Foundation of China [81000176/H0317, 81100292/H0317, 81500458/H0317]; Zhejiang Provincial Natural Science Foundation of China [Y2090326, Y2110634, LY16H030012]; Wenzhou Municipal Science and Technology Bureau [Y20110033, Y20120127]; Wang Bao-En Liver Fibrosis Foundation [20120127]; Key Disciplines in Colleges and Universities of Zhejiang Province	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Clinical Disciplines Construction of Shanghai Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Bureau; Wang Bao-En Liver Fibrosis Foundation; Key Disciplines in Colleges and Universities of Zhejiang Province	This work was supported by Science and Technology Commission of Shanghai Municipality Grant 11ZR1405700; Key Clinical Disciplines Construction of Shanghai Municipality Grant ZK2012B20; National Natural Science Foundation of China Grants 81000176/H0317, 81100292/H0317, and 81500458/H0317; Zhejiang Provincial Natural Science Foundation of China Grants Y2090326, Y2110634, and LY16H030012; Wenzhou Municipal Science and Technology Bureau Grants Y20110033 and Y20120127; Wang Bao-En Liver Fibrosis Foundation Grant 20120127; and the Key Disciplines in Colleges and Universities of Zhejiang Province. The authors declare that they have no conflicts of interest with the contents of this article.	Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Gao Y, 2015, HUM MOL GENET, V24, P841, DOI 10.1093/hmg/ddu502; Gao Y, 2014, NUCLEIC ACIDS RES, V42, P13799, DOI 10.1093/nar/gku1160; Greco S, 2015, J MOL CELL CARDIOL, V83, P142, DOI DOI 10.1016/j.yjmcc.2015.01.011; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Han XR, 2015, FASEB J, V29, P3054, DOI 10.1096/fj.14-259952; Hsu SJ, 2015, HEPATOLOGY, V61, P1672, DOI 10.1002/hep.27679; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lambrecht J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00209; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Lemoinne S, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.7; Li A, 2015, EUR J PHARMACOL, V747, P71, DOI 10.1016/j.ejphar.2014.11.040; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717; Orabi AI, 2015, J BIOL CHEM, V290, P11309, DOI 10.1074/jbc.M115.647933; Piccoli MT, 2015, J MOL CELL CARDIOL, V89, P59, DOI 10.1016/j.yjmcc.2015.02.002; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; Pippa R, 2012, ONCOGENE, V31, P4207, DOI 10.1038/onc.2011.582; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Renganathan A, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-119; Roy S, 2015, HEPATOBIL SURG NUTR, V4, P24, DOI 10.3978/j.issn.2304-3881.2015.01.05; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarkar N, 2015, INT J MOL SCI, V16, P17746, DOI 10.3390/ijms160817746; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Song J, 2014, J ORTHOP RES, V32, P1628, DOI 10.1002/jor.22718; Sun M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-319; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Wang K, 2014, CIRC RES, V114, P1377, DOI 10.1161/CIRCRESAHA.114.302476; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Wu ZM, 2014, CELL MOL BIOL LETT, V19, P561, DOI 10.2478/s11658-014-0212-6; Xiao YT, 2014, CELL SIGNAL, V26, P925, DOI 10.1016/j.cellsig.2014.01.003; Yacqub-Usman K, 2015, PROSTATE, V75, P693, DOI 10.1002/pros.22952; Yin DD, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0253-8; Yu FJ, 2015, LAB INVEST, V95, P781, DOI 10.1038/labinvest.2015.58; Zaghlool A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-99; Zhang A, 2014, J MOL CELL BIOL, V6, P181, DOI 10.1093/jmcb/mju013; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110; Zhang ZP, 2013, J BIOL CHEM, V288, P37082, DOI 10.1074/jbc.M113.517953; Zheng JJ, 2014, FEBS J, V281, P88, DOI 10.1111/febs.12574; Zhu LJ, 2015, MOL CANCER RES, V13, P41, DOI 10.1158/1541-7786.MCR-14-0239	48	108	115	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28286	28298		10.1074/jbc.M115.683813	http://dx.doi.org/10.1074/jbc.M115.683813			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446789	Green Published, hybrid			2022-12-26	WOS:000365761900021
J	Borewicz, KA; Kim, HB; Singer, RS; Gebhart, CJ; Sreevatsan, S; Johnson, T; Isaacson, RE				Borewicz, Klaudyna A.; Kim, Hyeun Bum; Singer, Randall S.; Gebhart, Connie J.; Sreevatsan, Srinand; Johnson, Timothy; Isaacson, Richard E.			Changes in the Porcine Intestinal Microbiome in Response to Infection with Salmonella enterica and Lawsonia intracellularis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SWINE; PIGS; TYPHIMURIUM; TYLOSIN; FECES; HERDS	Salmonella enterica is a leading cause of food borne illness. Recent studies have shown that S. enterica is a pathogen capable of causing alterations to the composition of the intestinal microbiome. A recent prospective study of French pork production farms found a statistically significant association between Lawsonia intracellularis and carriage of S. enterica. In the current study the composition of the gut microbiome was determined in pigs challenged with S. enterica serovar Typhimurium and or L. intracellularis and compared to non-challenged control pigs. Principal coordinate analysis demonstrated that there was a disruption in the composition of the gut microbiome in the colon and cecum of pigs challenged with either pathogen. The compositions of the microbiomes of challenged pigs were similar to each other but differed from the non-challenged controls. There also were statistically significant increases in Anaerobacter, Barnesiella, Pediococcus, Sporacetigenium, Turicibacter, Catenibacterium, Prevotella, Pseudobutyrivibrio, and Xylanibacter in the challenged pigs. To determine if these changes were specific to experimentally challenged pigs, we determined the compositions of the fecal microbiomes of naturally infected pigs that were carriers of S. enterica. Pigs that were frequent shedders of S. enterica were shown to have similar fecal microbiomes compared to non-shedders or pigs that shed S. enterica infrequently. In a comparison of the differentially abundant bacteria in the naturally infected pigs compared to experimentally challenged pigs, 9 genera were differentially abundant and each exhibited the same increase or decrease in abundance between the two groups. Thus, there were similar changes in the GI microbiome associated with carriage of S. enterica regardless of whether the pigs were experimentally challenged with S. enterica or acquired it naturally.	[Borewicz, Klaudyna A.; Kim, Hyeun Bum; Singer, Randall S.; Gebhart, Connie J.; Sreevatsan, Srinand; Johnson, Timothy; Isaacson, Richard E.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Isaacson, RE (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA.	isaac015@umn.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403	Emerging Infectious Diseases signature research program, College of Veterinary Medicine, University of Minnesota; USDA/AFRI [2007-35212-18046]	Emerging Infectious Diseases signature research program, College of Veterinary Medicine, University of Minnesota; USDA/AFRI(United States Department of Agriculture (USDA))	This work was supported by a grant from the Emerging Infectious Diseases signature research program, College of Veterinary Medicine, University of Minnesota and by a grant from the USDA/AFRI #2007-35212-18046. REI was the principal investigator on the two grants. The funders did not play a role in the experimental design or protocols.	Batz M. B., 2011, RANKING RISKS 10 PAT, P1; Beloeil PA, 2004, PREV VET MED, V63, P103, DOI 10.1016/j.prevetmed.2004.01.010; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Deatherage Kaiser BL, 2013, PLOS ONE, V8; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FEDORKACRAY PJ, 1994, VET MICROBIOL, V41, P333, DOI 10.1016/0378-1135(94)90029-9; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Gray JT, 1996, AM J VET RES, V57, P313; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hurd HS, 2001, J FOOD PROTECT, V64, P939, DOI 10.4315/0362-028X-64.7.939; Isaacson RE, 1999, AM J VET RES, V60, P1155; Isaacson Richard, 2012, Animal Health Research Reviews, V13, P100, DOI 10.1017/S1466252312000084; Jacobson M, 2010, VET J, V184, P264, DOI 10.1016/j.tvjl.2009.05.010; Johnson JR, 2000, CLIN DIAGN LAB IMMUN, V7, P258, DOI 10.1128/CDLI.7.2.258-264.2000; KAMPELMACHER E H, 1969, Zentralblatt fuer Veterinaermedizin Reihe B, V16, P717; Kim HB, 2014, AM J VET RES, V75, P460, DOI 10.2460/ajvr.75.5.460; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Lawson GHK, 2000, J COMP PATHOL, V122, P77, DOI 10.1053/jcpa.1999.0347; Letellier A, 1999, VET MICROBIOL, V67, P299, DOI 10.1016/S0378-1135(99)00049-8; Looft T, 2012, P NATL ACAD SCI; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Singer RS, 2006, J VET DIAGN INVEST, V18, P319, DOI 10.1177/104063870601800401; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-140; Wattanaphansak S, 2010, J VET DIAGN INVEST, V22, P598, DOI 10.1177/104063871002200416; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; WOOD RL, 1989, AM J VET RES, V50, P1015	32	52	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139106	10.1371/journal.pone.0139106	http://dx.doi.org/10.1371/journal.pone.0139106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461107	Green Submitted, gold, Green Published			2022-12-26	WOS:000362962300010
J	Kochupurakkal, BS; Wang, ZGC; Hua, T; Culhane, AC; Rodig, SJ; Rajkovic-Molek, K; Lazaro, JB; Richardson, AL; Biswas, DK; Iglehart, JD				Kochupurakkal, Bose S.; Wang, Zhigang C.; Hua, Tony; Culhane, Aedin C.; Rodig, Scott J.; Rajkovic-Molek, Koraljka; Lazaro, Jean-Bernard; Richardson, Andrea L.; Biswas, Debajit K.; Iglehart, J. Dirk			RelA-Induced Interferon Response Negatively Regulates Proliferation	PLOS ONE			English	Article							NF-KAPPA-B; MAMMARY EPITHELIAL-CELLS; HUMAN BREAST-CANCER; KINASE 4/6 INHIBITOR; FACTOR-I; CYCLE ARREST; SECRETORY PHENOTYPE; THERAPEUTIC TARGET; TRANSGENIC MICE; GENE-EXPRESSION	Both oncogenic and tumor-suppressor activities are attributed to the Nuclear Factor kappa B (NF-kB) pathway. Moreover, NF-kB may positively or negatively regulate proliferation. The molecular determinants of these opposing roles of NF-kB are unclear. Using primary human mammary epithelial cells (HMEC) as a model, we show that increased RelA levels and consequent increase in basal transcriptional activity of RelA induces IRF1, a target gene. Induced IRF1 upregulates STAT1 and IRF7, and in consort, these factors induce the expression of interferon response genes. Activation of the interferon pathway down-regulates CDK4 and up-regulates p27 resulting in Rb hypo-phosphorylation and cell cycle arrest. Stimulation of HMEC with IFN-gamma elicits similar phenotypic and molecular changes suggesting that basal activity of RelA and IFN-gamma converge on IRF1 to regulate proliferation. The anti-proliferative RelA-IRF1-CDK4 signaling axis is retained in ER+/HER2-breast tumors analyzed by The Cancer Genome Atlas (TCGA). Using immuno-histochemical analysis of breast tumors, we confirm the negative correlation between RelA levels and proliferation rate in ER+/HER2-breast tumors. These findings attribute an anti-proliferative tumor-suppressor role to basal RelA activity. Inactivation of Rb, down-regulation of RelA or IRF1, or upregulation of CDK4 or IRF2 rescues the RelA-IRF1-CDK4 induced proliferation arrest in HMEC and are points of disruption in aggressive tumors. Activity of the RelA-IRF1-CDK4 axis may explain favorable response to CDK4/6 inhibition observed in patients with ER+ Rb competent tumors.	[Kochupurakkal, Bose S.; Wang, Zhigang C.; Hua, Tony; Lazaro, Jean-Bernard; Richardson, Andrea L.; Biswas, Debajit K.; Iglehart, J. Dirk] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Culhane, Aedin C.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Rodig, Scott J.; Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Iglehart, J. Dirk] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Rajkovic-Molek, Koraljka] Clin Hosp Ctr Rijeka, Dept Cytol, Rijeka, Croatia	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Rijeka	Kochupurakkal, BS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	bose_kochupurakkal@dfci.harvard.edu; jiglehart@partners.org	Rodig, Scott/Y-3889-2019; Culhane, Aedin/AAG-8490-2019; Rajković-Molek, Koraljka/T-2097-2018	Culhane, Aedin/0000-0002-1395-9734; Rajković-Molek, Koraljka/0000-0003-3245-5125	DF/HCC SPORE [CA89393]; Women's Cancer Program at Dana-Farber Cancer Institute; Teri Brodeur Fellowship; Hale Family Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER	DF/HCC SPORE; Women's Cancer Program at Dana-Farber Cancer Institute; Teri Brodeur Fellowship; Hale Family Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The research was supported by the DF/HCC SPORE (CA89393) and the Women's Cancer Program at Dana-Farber Cancer Institute. BSK is a recipient of the Teri Brodeur and Hale Family Fellowships.	Armstrong MJ, 2012, CANCER LETT, V319, P56, DOI 10.1016/j.canlet.2011.12.027; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Bash J, 1997, MOL CELL BIOL, V17, P6526, DOI 10.1128/MCB.17.11.6526; Biswas Debajit K, 2005, Sci STKE, V2005, ppe27, DOI 10.1126/stke.2882005pe27; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Biswas DK, 2001, P NATL ACAD SCI USA, V98, P10386, DOI 10.1073/pnas.151257998; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Bouker KB, 2004, CANCER RES, V64, P4030, DOI 10.1158/0008-5472.CAN-03-3602; Bowie ML, 2008, ADV EXP MED BIOL, V617, P367, DOI 10.1007/978-0-387-69080-3_35; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman RS, 2000, ONCOGENE, V19, P6386, DOI 10.1038/sj.onc.1204016; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Comstock CES, 2013, ONCOGENE, V32, P5481, DOI 10.1038/onc.2013.83; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Doherty GM, 2001, ANN SURG, V233, P623, DOI 10.1097/00000658-200105000-00005; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Drew PD, 1995, J NEUROIMMUNOL, V63, P157, DOI 10.1016/0165-5728(95)00140-9; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Harvat BL, 1997, ONCOGENE, V14, P2111, DOI 10.1038/sj.onc.1201055; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Jacque E, 2013, ONCOGENE, V32, P2661, DOI 10.1038/onc.2012.282; Jones RL, 2011, J CLIN PATHOL, V64, P130, DOI 10.1136/jcp.2010.082966; Karst AM, 2012, NAT PROTOC, V7, P1755, DOI 10.1038/nprot.2012.097; Kim PKM, 2004, ONCOGENE, V23, P1125, DOI 10.1038/sj.onc.1207023; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kochupurakkal BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068509; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li QF, 2008, MOL CANCER RES, V6, P770, DOI 10.1158/1541-7786.MCR-07-0114; Liu MR, 2009, AM J PATHOL, V174, P1910, DOI 10.2353/ajpath.2009.080706; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Ning YX, 2010, MOL CANCER THER, V9, P1274, DOI 10.1158/1535-7163.MCT-09-1169; Parrish AB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008672; Rajkovic-Molek K, 2014, APPL IMMUNOHISTO M M, V22, P464, DOI 10.1097/PAI.0b013e31829271ce; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Reddy HKDL, 2005, CANCER RES, V65, P10174, DOI 10.1158/0008-5472.CAN-05-2639; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ricca A, 2001, BRIT J CANCER, V85, P1914, DOI 10.1054/bjoc.2001.2174; Romieu-Mourez R, 2003, MOL CELL BIOL, V23, P5738, DOI 10.1128/MCB.23.16.5738-5754.2003; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schwartz JL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/912102; Schwartz-Roberts JL, 2015, CANCER RES, V75, P1046, DOI 10.1158/0008-5472.CAN-14-1851; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sheehy AM, 1999, J BIOL CHEM, V274, P8708, DOI 10.1074/jbc.274.13.8708; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Shultz DB, 2009, J INTERF CYTOK RES, V29, P817, DOI 10.1089/jir.2009.0034; Silke J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008730; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Utermark T, 2007, J VIROL, V81, P7069, DOI 10.1128/JVI.00115-07; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Yanai H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/onci.22475; Yim JH, 2003, J INTERF CYTOK RES, V23, P501, DOI 10.1089/10799900360708623; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zhang JY, 2005, J CELL BIOL, V168, P561, DOI 10.1083/jcb.200411060; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006; Zhu YL, 2006, INT J ONCOL, V28, P67	97	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140243	10.1371/journal.pone.0140243	http://dx.doi.org/10.1371/journal.pone.0140243			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460486	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300071
J	Deng, XF; Zhu, YZ; Wang, SD; Zhang, Y; Han, H; Zheng, DQ; Ding, ZH; Wong, KKL				Deng, Xuefei; Zhu, Youzhi; Wang, Shidong; Zhang, Yu; Han, Hui; Zheng, Dengquan; Ding, Zihai; Wong, Kelvin K. L.			CT and MRI Determination of Intermuscular Space within Lumbar Paraspinal Muscles at Different Intervertebral Disc Levels	PLOS ONE			English	Article							MINIMALLY INVASIVE APPROACH; SPLITTING APPROACH; SPINE; WILTSE	Background Recognition of the intermuscular spaces within lumbar paraspinal muscles is critically important for using the paramedian muscle-splitting approach to the lumbar spine. As such, it is important to determine the intermuscular spaces within the lumbar paraspinal muscles by utilizing modern medical imaging such as computed tomography (CT) and magnetic resonance imaging (MRI). Methods A total of 30 adult cadavers were studied by sectional anatomic dissection, and 60 patients were examined using CT (16 slices, 3-mm thickness, 3-mm intersection gap, n = 30) and MRI (3.0T, T2-WI, 5-mm thickness, 1-mm intersection gap, n = 30). The distances between the midline and the superficial points of the intermuscular spaces at different intervertebral disc levels were measured. Results Based on study of our cadavers, the mean distances from the midline to the intermuscular space between multifidus and longissimus, from intervertebral disc levels L1-L2 to L5-S1, were 0.9, 1.1, 1.7, 3.0, and 3.5 cm, respectively. Compared with the upper levels (L1-L3), the superficial location at the lower level (L4-S1) is more laterally to the midline (P<0.05). The intermuscular space between sacrospinalis and quadratus lumborum, and that between longissimus and iliocostalis did not exist at L4-S1. The intermuscular spaces in patients also varied at different levels of the lumbar spine showing a low discontinuous density in CT and a high signal in MRI. There were no significant differences between the observations in cadavers and those made using CT and MRI. Conclusion The intermuscular spaces within the paraspinal muscles vary at different intervertebral disc levels. Preoperative CT and MRI can facilitate selection of the muscle-splitting approach to the lumbar spine. This paper demonstrates the efficacy of medical imaging techniques in surgical planning.	[Deng, Xuefei; Ding, Zihai] Southern Med Univ, Anat Inst Minimally Invas Surg, Guangzhou, Guangdong, Peoples R China; [Deng, Xuefei; Han, Hui] Anhui Med Univ, Dept Anat, Hefei, Anhui, Peoples R China; [Zhu, Youzhi; Zhang, Yu] 105th Hosp PLA, Dept Radiol, Hefei, Anhui, Peoples R China; [Wang, Shidong; Zheng, Dengquan] Shucheng Peoples Hospitial, Dept Orthopaed Surg, Shucheng, Anhui, Peoples R China; [Wong, Kelvin K. L.] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia	Southern Medical University - China; Anhui Medical University; Western Sydney University	Ding, ZH (corresponding author), Southern Med Univ, Anat Inst Minimally Invas Surg, Guangzhou, Guangdong, Peoples R China.	dingzih@139.com; kelvin.wong@westernsydney.edu.au	Wong, Kelvin/AAL-8636-2021; Wong, Kelvin Kian Loong/ABA-3915-2021	Wong, Kelvin Kian Loong/0000-0002-8600-1105				BOGDUK N, 1982, J ANAT, V134, P383; BUSTAMI FMF, 1986, J ANAT, V144, P81; Cheng XF, 2013, EUR SPINE J, V22, P123, DOI 10.1007/s00586-012-2464-z; Cholewicki J, 1997, SPINE, V22, P2207, DOI 10.1097/00007632-199710010-00003; Fan Shun-wu, 2010, Orthop Surg, V2, P194, DOI 10.1111/j.1757-7861.2010.00086.x; Fan SW, 2010, SPINE, V35, P1615, DOI 10.1097/BRS.0b013e3181c70fe3; Foley KT, 2003, SPINE, V28, pS26, DOI 10.1097/00007632-200308011-00006; Fujibayashi S, 2010, J NEUROSURG-SPINE, V13, P500, DOI 10.3171/2010.4.SPINE09691; Gandhi RH, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.5.FOCUS13163; Hoh DJ, 2010, NEUROSURGERY, V66, P13, DOI 10.1227/01.NEU.0000350866.25760.33; Jiang R, 2011, CHIN J TRAUMATOL, V14, P3, DOI 10.3760/cma.j.issn.1008-1275.2011.01.001; Jiang XZ, 2012, J INT MED RES, V40, P1343, DOI 10.1177/147323001204000413; Kunert P, 2010, NEUROL NEUROCHIR POL, V44, P554; MACINTOSH JE, 1987, SPINE, V12, P658, DOI 10.1097/00007632-198709000-00004; Mannion RJ, 2012, J SPINAL DISORD TECH, V25, P47, DOI 10.1097/BSD.0b013e31820baa1e; Mannion RJ, 2011, NEUROSURGERY, V68, DOI 10.1227/NEU.0b013e318207b3c7; Nagesh K. R., 2006, Legal Medicine, V8, P269, DOI 10.1016/j.legalmed.2006.05.007; Olivier E, 2006, SURG RADIOL ANAT, V28, P494, DOI 10.1007/s00276-006-0123-y; Ota M, 2010, SPINE, V35, pE452, DOI 10.1097/BRS.0b013e3181ce0696; Palmer DK, 2011, SPINE, V36, P1263, DOI 10.1097/BRS.0b013e3181f520e8; Reulen HJ, 1996, NEUROSURGERY, V39, P345, DOI 10.1097/00006123-199608000-00022; Tessitore E, 2004, NEUROSURGERY, V54, P939, DOI 10.1227/01.NEU.0000115154.62636.77; Vialle R, 2005, EUR SPINE J, V14, P366, DOI 10.1007/s00586-004-0802-5; Vialle R, 2007, SPINE, V32, pE631, DOI 10.1097/BRS.0b013e3181573ecc; Vialle R, 2006, CLIN ORTHOP RELAT R, P175, DOI 10.1097/01.blo.0000203466.20314.2a; Voyadzis JM, 2010, MINIM INVAS NEUROSUR, V53, P122, DOI 10.1055/s-0030-1249102; Ward SR, 2009, J BONE JOINT SURG AM, V91A, P176, DOI 10.2106/JBJS.G.01311; WATKINS M B, 1953, J Bone Joint Surg Am, V35-A, P1014; Watkins M B, 1964, Clin Orthop Relat Res, V35, P80; Weaver EN, 2007, J NEUROSURG-SPINE, V7, P270, DOI 10.3171/SPI-07/08/270; WILTSE LL, 1968, J BONE JOINT SURG AM, VA 50, P919, DOI 10.2106/00004623-196850050-00004; WILTSE LL, 1988, SPINE, V13, P696	32	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140315	10.1371/journal.pone.0140315	http://dx.doi.org/10.1371/journal.pone.0140315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458269	Green Published, gold, Green Submitted			2022-12-26	WOS:000362961100030
J	Kutszegi, N; Semsei, AF; Gezsi, A; Sagi, JC; Nagy, V; Csordas, K; Jakab, Z; Lautner-Csorba, O; Gabor, KM; Kovacs, GT; Erdelyi, DJ; Szalai, C				Kutszegi, Nora; Semsei, Agnes F.; Gezsi, Andras; Sagi, Judit C.; Nagy, Viktoria; Csordas, Katalin; Jakab, Zsuzsanna; Lautner-Csorba, Orsolya; Gabor, Krisztina Mita; Kovacs, Gabor T.; Erdelyi, Daniel J.; Szalai, Csaba			Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity	PLOS ONE			English	Article							HUMAN T-CELLS; GLUTAMATE RECEPTORS; PHARMACOGENETICS; ADOLESCENTS; CHILDREN; GRIA1; TRIAL	L-asparaginase (ASP) is a key element in the treatment of paediatric acute lymphoblastic leukaemia (ALL). However, hypersensitivity reactions (HSRs) to ASP are major challenges in paediatric patients. Our aim was to investigate genetic variants that may influence the risk to Escherichia coli-derived ASP hypersensitivity. Sample and clinical data collection was carried out from 576 paediatric ALL patients who were treated according to protocols from the Berlin-Frankfurt-Munster Study Group. A total of 20 single nucleotide polymorphisms (SNPs) in GRIA1 and GALNT10 genes were genotyped. Patients with GRIA1 rs4958351 AA/AG genotype showed significantly reduced risk to ASP hypersensitivity compared to patients with GG genotype in the T-cell ALL subgroup (OR = 0.05 (0.01-0.26); p = 4.70E-04), while no such association was found in pre-B-cell ALL. In the medium risk group two SNPs of GRIA1 (rs2055083 and rs707176) were associated significantly with the occurrence of ASP hypersensitivity (OR = 0.21 (0.09-0.53); p = 8.48E-04 and OR = 3.02 (1.36-6.73); p = 6.76E-03, respectively). Evaluating the genders separately, however, the association of rs707176 with ASP HSRs was confined only to females. Our results suggest that genetic variants of GRIA1 might influence the risk to ASP hypersensitivity, but subgroups of patients can differ significantly in this respect.	[Kutszegi, Nora; Semsei, Agnes F.; Gezsi, Andras; Sagi, Judit C.; Lautner-Csorba, Orsolya] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Nagy, Viktoria; Csordas, Katalin; Jakab, Zsuzsanna; Kovacs, Gabor T.; Erdelyi, Daniel J.; Szalai, Csaba] Semmelweis Univ, Dept Paediat 2, H-1085 Budapest, Hungary; [Gabor, Krisztina Mita] Univ Szeged, Fac Med, Dept Pediat, Szeged, Hungary; [Gabor, Krisztina Mita] Univ Szeged, Fac Med, Pediat Hlth Care Ctr, Szeged, Hungary; [Szalai, Csaba] Heim Pal Children Hosp, Cent Lab, Budapest, Hungary	Semmelweis University; Semmelweis University; Szeged University; Szeged University	Szalai, C (corresponding author), Semmelweis Univ, Dept Paediat 2, H-1085 Budapest, Hungary.	szalaics@gmail.com	Kutszegi, Nóra/AAM-3399-2020; Erdelyi, Daniel J/N-8957-2017; Sagi, Judit C/O-2861-2015	Erdelyi, Daniel J/0000-0001-5544-9209; Sagi, Judit C/0000-0003-2186-9357; Kutszegi, Nora/0000-0001-5957-3215	OTKA (Hungarian Scientific Research Fund) [K81941, K112872, K115861]; Economic Competitiveness Operational Program, Hungary [GVOP 3.1.1-2004-05-0022/3.0]; NKTH (National Research and Technology) [TECH_08-A1/2-2008-0120]	OTKA (Hungarian Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Economic Competitiveness Operational Program, Hungary; NKTH (National Research and Technology)(National Office for Research and Technology)	This study was supported by OTKA (Hungarian Scientific Research Fund): K81941, K112872 (CS); K115861 (DJE) and the Economic Competitiveness Operational Program, Hungary GVOP 3.1.1-2004-05-0022/3.0 (DJE); and NKTH (National Research and Technology) TECH_08-A1/2-2008-0120: (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AF, 2014, CLIN MED INSIGHTS-ON, V8, P95, DOI 10.4137/CMO.S10242; Avramis VI, 2006, INT J NANOMED, V1, P241; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop JR, 2012, PSYCHIAT RES, V199, P74, DOI 10.1016/j.psychres.2012.03.048; Chen SH, 2010, CLIN PHARMACOL THER, V88, P191, DOI 10.1038/clpt.2010.94; EGEBJERG J, 1994, P NATL ACAD SCI USA, V91, P10270, DOI 10.1073/pnas.91.22.10270; Erdilyi DJ, 2008, PHARMACOGENOMICS J, V8, P321, DOI 10.1038/sj.tpj.6500480; Fernandez CA, 2015, BLOOD, V126, P69, DOI 10.1182/blood-2015-02-628800; Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362; Ganor Y, 2014, J NEURAL TRANSM, V121, P983, DOI 10.1007/s00702-014-1167-5; Garami M, 2014, ORVOSI HETILAP, V155, P732, DOI 10.1556/OH.2014.29918; Gezsi A, 2014, PHARMACOGENOMICS J; Kawedia JD, 2014, CL LYMPH MYELOM LEUK, V14, pS14, DOI 10.1016/j.clml.2014.06.017; Lombardi G, 2001, BRIT J PHARMACOL, V133, P936, DOI 10.1038/sj.bjp.0704134; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; Magri C, 2006, AM J MED GENET B, V141B, P287, DOI 10.1002/ajmg.b.30294; Moricke A, 2009, BLOOD, V113, P4478; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pagani M, 2010, MED CLIN N AM, V94, P835, DOI 10.1016/j.mcna.2010.03.002; Pession A, 2005, J CLIN ONCOL, V23, P7161, DOI 10.1200/JCO.2005.11.411; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Pieters R, 2008, BLOOD, V112, P4832, DOI 10.1182/blood-2008-04-149443; Rajic V, 2015, LEUKEMIA LYMPHOMA, P1; Rizzari C, 2013, CURR OPIN ONCOL, V25, pS1, DOI 10.1097/CCO.0b013e32835d7d85; Shinnick SE, 2013, J PEDIATR ONCOL NURS, V30, P63, DOI 10.1177/1043454212471728; Stary J, 2014, J CLIN ONCOL, V32, P174, DOI 10.1200/JCO.2013.48.6522; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Woo MH, 2000, J CLIN ONCOL, V18, P1525, DOI 10.1200/JCO.2000.18.7.1525	32	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140136	10.1371/journal.pone.0140136	http://dx.doi.org/10.1371/journal.pone.0140136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457809	gold, Green Submitted, Green Published			2022-12-26	WOS:000362961100024
J	Hu, QN; Wood, CR; Cimen, S; Venkatachalam, AB; Alwayn, IPJ				Hu, Qianni; Wood, Caroline Ruth; Cimen, Sanem; Venkatachalam, Ananda Baskaran; Alwayn, Ian Patrick Joseph			Mitochondrial Damage-Associated Molecular Patterns (MTDs) Are Released during Hepatic Ischemia Reperfusion and Induce Inflammatory Responses	PLOS ONE			English	Article							LIVER ISCHEMIA; ISCHEMIA/REPERFUSION INJURY; RECEPTOR 9; CIRCULATORY DEATH; HEME OXYGENASE-1; KUPFFER CELLS; CUTTING EDGE; DNA; ACTIVATION; PROTECTS	Ischemia/reperfusion injury (IRI) during the course of liver transplantation enhances the immunogenicity of allografts and thus impacts overall graft outcome. This sterile inflammatory insult is known to activate innate immunity and propagate organ damage through the recognition of damage-associate molecular pattern (DAMP) molecules. The purpose of the present study was to investigate the role of mitochondrial DAMPs (MTDs) in the pathogenesis of hepatic IRI. Using in vitro models we observed that levels of MTDs were significantly higher in both transplantation-associated and warm IR, and that co-culture of MTDs with human and rat hepatocytes significantly increased cell death. MTDs were also released in an in vivo rat model of hepatic IRI and associated with increased secretion of inflammatory cytokines (TNF-alpha, IL-6, and IL-10) and increased liver injury compared to the sham group. Our results suggest that hepatic IR results in a significant increase of MTDs both in vitro and in vivo suggesting that MTDs may serve as a novel marker in hepatic IRI. Co-culture of MTDs with hepatocytes showed a decrease in cell viability in a concentration dependent manner, which indicates that MTDs is a toxic mediator participating in the pathogenesis of liver IR injury.	[Hu, Qianni; Alwayn, Ian Patrick Joseph] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Wood, Caroline Ruth; Cimen, Sanem; Venkatachalam, Ananda Baskaran; Alwayn, Ian Patrick Joseph] Dalhousie Univ, Dept Surg, Halifax, NS B3H 4H2, Canada; [Alwayn, Ian Patrick Joseph] Dalhousie Univ, Dept Microbiol, Halifax, NS, Canada; [Alwayn, Ian Patrick Joseph] Dalhousie Univ, Dept Immunol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Alwayn, IPJ (corresponding author), Dalhousie Univ, Dept Surg, Halifax, NS B3H 4H2, Canada.	ian.alwayn@cdha.nshealth.ca	Cimen, Sanem/AAH-3070-2021; Cimen, Sanem Guler/ABB-3148-2020	Cimen, Sanem Guler/0000-0002-5266-9529	Canadian Institutes of Health Research Canadian National Transplant Research Program [RES0017362]	Canadian Institutes of Health Research Canadian National Transplant Research Program(Canadian Institutes of Health Research (CIHR))	Funding was provided by Canadian Institutes of Health Research Canadian National Transplant Research Program, Grant number: RES0017362, http://www.cihr-irsc.gc.ca/e/46632.html, IA.	Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Bamboat ZM, 2010, J CLIN INVEST, V120, P559, DOI 10.1172/JCI40008; Ben-Ari Z, 2013, APOPTOSIS, V18, P547, DOI 10.1007/s10495-013-0814-x; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Corti A., 2004, TUMOR NECROSIS FACTO; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; DuBray BJ, 2015, J SURG RES, V194, P653, DOI 10.1016/j.jss.2014.10.024; Evankovich J, 2010, GASTROENTEROL RES PR, V2010; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Goulopoulou S, 2012, CLIN SCI, V123, P429, DOI 10.1042/CS20120130; Huang H, 2014, HEPATOLOGY, V59, P1984, DOI 10.1002/hep.26976; Huang H, 2013, J IMMUNOL, V191, P2665, DOI 10.4049/jimmunol.1202733; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Kuramitsu K, 2007, TRANSPLANTATION, V84, P166, DOI 10.1097/01.tp.0000269103.87633.06; Lee YL, 2014, J SURG RES, V191, P286, DOI 10.1016/j.jss.2014.06.003; Lemasters JJ, 2009, HYPOXIC ISCHEMIC REP; Liu B, 2014, PLOS ONE, V9; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106184; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lutterova M, 2000, CRYOBIOLOGY, V41, P301, DOI 10.1006/cryo.2000.2293; McGill MR, 2014, HEPATOLOGY, V60, P1336, DOI 10.1002/hep.27265; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Morrissey PE, 2014, TRANSPLANTATION, V97, P258, DOI 10.1097/01.TP.0000437178.48174.db; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Papadopoulos D, 2013, ARCH TRAUMA RES, V2, P63, DOI 10.5812/atr.12501; Pardo M, 2008, FREE RADICAL BIO MED, V45, P1073, DOI 10.1016/j.freeradbiomed.2008.06.029; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Perera MTPR, 2014, BRIT J SURG, V101, P775, DOI 10.1002/bjs.9478; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Teoh NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104376; Teoh NC, 2011, J GASTROEN HEPATOL, V26, P180, DOI 10.1111/j.1440-1746.2010.06584.x; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Wenceslau CF, 2013, MED HYPOTHESES, V81, P532, DOI 10.1016/j.mehy.2013.06.026; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhang JX, 2009, SCI CHINA SER C, V52, P147, DOI 10.1007/s11427-009-0002-y; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	45	42	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140105	10.1371/journal.pone.0140105	http://dx.doi.org/10.1371/journal.pone.0140105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451593	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511200038
J	Llorca, CM; Berendzen, KW; Malik, WA; Mahn, S; Piepho, HP; Zentgraf, U				Llorca, Carles Marco; Berendzen, Kenneth Wayne; Malik, Waqas Ahmed; Mahn, Stefan; Piepho, Hans-Peter; Zentgraf, Ulrike			The Elucidation of the Interactome of 16 Arabidopsis bZIP Factors Reveals Three Independent Functional Networks	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; TRANSCRIPTION FACTOR HY5; PROTEIN-PROTEIN INTERACTION; AMINO-ACID-METABOLISM; HELICAL COILED COILS; BOX BINDING-FACTORS; GENE-EXPRESSION; DNA-BINDING; OLIGOMERIZATION STATE; SEEDLING DEVELOPMENT	The function of the bZIP transcription factors is strictly dependent on their ability to dimerize. Heterodimerization has proven to be highly specific and is postulated to operate as a combinatorial mechanism allowing the generation of a large variety of dimers with unique qualities by specifically combining a small set of monomers; an assumption that has not yet been tested systematically. Here, the interaction pattern and the transactivation properties of 16 Arabidopsis thaliana bZIPs are examined in transiently transformed Arabidopsis protoplasts to deliver a perspective on the relationship between bZIP dimerization and function. An interaction matrix of bZIPs belonging to the C, G, H, and S1 bZIP groups was resolved by Bimolecular Fluorescent Complementation (BiFC) coupled to quantitative flow cytometric analysis, while an extensive GUS reporter gene assay was carried out to determine the effect of different bZIP pairs on the expression of four different known bZIP-targeted promoters. Statistical data treatment and complementary bioinformatic analysis were performed to substantiate the biological findings. According to these results, the 16 bZIPs interact in three isolated networks, within which their members dimerize non-specifically and exhibit a significant level of functional redundancy. A coherent explanation for these results is supported by in silico analysis of differences in the length, structure and composition of their leucine zippers and appears to explain their dimerization specificity and dynamics observed in vivo quite well. A model in which the bZIP networks act as functional units is proposed.	[Llorca, Carles Marco; Berendzen, Kenneth Wayne; Mahn, Stefan; Zentgraf, Ulrike] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Tubingen, Germany; [Malik, Waqas Ahmed; Piepho, Hans-Peter] Univ Hohenheim, Inst Crop Sci, Biostat Unit, Stuttgart, Germany	Eberhard Karls University of Tubingen; University Hohenheim	Zentgraf, U (corresponding author), Univ Tubingen, Ctr Plant Mol Biol ZMBP, Tubingen, Germany.	ulrike.zentgraf@uni-tuebingen.de		Berendzen, Kenneth/0000-0001-9870-6164; Malik, Waqas Ahmed/0000-0001-6455-5353; Piepho, Hans-Peter/0000-0001-7813-2992	Deutsche Forschungsgemeinschaft [ZE 313/8-2, ZE 313/9-1, Sonderforschungsbereich SFB1101]; European Union [FP7] [ITN MERIT 264474]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union [FP7]	This work was supported by Deutsche Forschungsgemeinschaft [ZE 313/8-2, ZE 313/9-1 and the Sonderforschungsbereich SFB1101, www.dfg.de], and European Union [FP7, ITN MERIT 264474, www.http://ec.europa.eu/research/fp7/index_en.cfm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Acharya A, 2002, BIOCHEMISTRY-US, V41, P14122, DOI 10.1021/bi020486r; Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Berendzen KW, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-25; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Boruc J, 2010, PLANT SIGNAL BEHAV, V5, P1276, DOI 10.4161/psb.5.10.13037; Deppmann CD, 2004, NUCLEIC ACIDS RES, V32, P3435, DOI 10.1093/nar/gkh653; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dietrich K, 2011, PLANT CELL, V23, P381, DOI 10.1105/tpc.110.075390; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Fior S, 2009, PLANT SCI, V176, P130, DOI 10.1016/j.plantsci.2008.10.001; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gehl C, 2011, PLANT J, V67, P542, DOI 10.1111/j.1365-313X.2011.04607.x; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Hanson J, 2008, PLANT J, V53, P935, DOI 10.1111/j.1365-313X.2007.03385.x; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Horstman A, 2014, INT J MOL SCI, V15, P9628, DOI 10.3390/ijms15069628; Hsieh WP, 2012, PLANT CELL, V24, P3997, DOI 10.1105/tpc.112.105478; Iglesias-Fernandez R, 2014, J EXP BOT, V65, P2009, DOI 10.1093/jxb/eru055; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Kang SG, 2010, MOL PLANT, V3, P361, DOI 10.1093/mp/ssp115; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lee SS., 2006, PLANT BIOTECHNOL, V23, P249, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.23.249; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; McCullagh P, 1989, GEN LINEAR MODELS; MENKENS AE, 1994, P NATL ACAD SCI USA, V91, P2522, DOI 10.1073/pnas.91.7.2522; Moitra J, 1997, BIOCHEMISTRY-US, V36, P12567, DOI 10.1021/bi971424h; Moreau VH, 2004, BIOCHEMISTRY-US, V43, P4862, DOI 10.1021/bi035905e; Morell M, 2008, NAT PROTOC, V3, P22, DOI 10.1038/nprot.2007.496; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Ngo B, 2013, J BIOL CHEM, V288, P34403, DOI 10.1074/jbc.M113.490524; Para A, 2014, P NATL ACAD SCI USA, V111, P10371, DOI 10.1073/pnas.1404657111; Potapov V, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004046; Prasad VBR, 2012, MECH DEVELOP, V129, P298, DOI 10.1016/j.mod.2012.06.004; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Reddy ASN, 2012, PLANT PHYSIOL, V158, P67, DOI 10.1104/pp.111.186700; Reinke AW, 2013, SCIENCE, V340, P730, DOI 10.1126/science.1233465; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Satoh R, 2004, PLANT CELL PHYSIOL, V45, P309, DOI 10.1093/pcp/pch036; SCHEFFE H, 1953, BIOMETRIKA, V40, P87, DOI 10.1093/biomet/40.1-2.87; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; Sehnke PC, 2005, CELL RES, V15, P567, DOI 10.1038/sj.cr.7290326; Shaikhali J, 2012, J BIOL CHEM, V287, P27510, DOI 10.1074/jbc.M112.361394; Shen HS, 2008, BMB REP, V41, P132, DOI 10.5483/BMBRep.2008.41.2.132; Shen HS, 2007, BIOCHEM BIOPH RES CO, V362, P425, DOI 10.1016/j.bbrc.2007.08.026; Shin DH, 2006, PROTEIN SCI, V15, P921, DOI 10.1110/ps.051993506; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Silveira AB, 2007, PLANT SCI, V172, P1148, DOI 10.1016/j.plantsci.2007.03.003; Singh A, 2012, J BIOL CHEM, V287, P25995, DOI 10.1074/jbc.M111.333906; Smykowski A, 2010, PLANT PHYSIOL, V153, P1321, DOI 10.1104/pp.110.157180; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Tamai H, 2002, PLANT CELL PHYSIOL, V43, P99, DOI 10.1093/pcp/pcf011; Tome F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00353; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Van Buskirk EK, 2012, PLANT PHYSIOL, V158, P52, DOI 10.1104/pp.111.186411; Veerabagu M, 2014, MOL PLANT, V7, P1560, DOI 10.1093/mp/ssu074; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wagschal K, 1999, PROTEIN SCI, V8, P2312; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang L, 2013, FLOW CYTOMETRIC ANAL, DOI [10.3791/50529, DOI 10.3791/50529]; Weltmeier F, 2006, EMBO J, V25, P3133, DOI 10.1038/sj.emboj.7601206; Weltmeier F, 2009, PLANT MOL BIOL, V69, P107, DOI 10.1007/s11103-008-9410-9; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yoon MK, 2006, PROTEINS, V65, P856, DOI 10.1002/prot.21089; Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507	82	18	18	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139884	10.1371/journal.pone.0139884	http://dx.doi.org/10.1371/journal.pone.0139884			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452049	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200018
J	Lee, JH; Jeong, DW				Lee, Jong-Hoon; Jeong, Do-Won			Characterization of Mobile Staphylococcus equorum Plasmids Isolated from Fermented Seafood That Confer Lincomycin Resistance	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; QUATERNARY AMMONIUM-COMPOUNDS; ROLLING-CIRCLE REPLICATION; ANTIBIOTIC-RESISTANCE; ENTEROCOCCUS-FAECALIS; BACTERIAL COMMUNITY; GENE-TRANSFER; IN-VITRO; AUREUS; IDENTIFICATION	The complete nucleotide sequences of lincomycin-resistance gene (lnuA)-containing plasmids in Staphylococcus equorum strains isolated from the high-salt-fermented seafood jeotgal were determined. These plasmids, designated pSELNU1-3, are 2638-bp long, have two polymorphic sites, and encode typical elements found in plasmids that replicate via a rolling-circle mechanism including the replication protein gene (rep), a double-stranded origin of replication, a single-stranded origin of replication, and counter-transcribed RNA sequence, as well as lnuA. Plasmid sequences exhibit over 83% identity to other Staphylococcus plasmids that harbor rep and lnuA genes. Further, three pairs of identified direct repeats may be involved in inter-plasmid recombination. One plasmid, pSELNU1, was successfully transferred to other Staphylococcus species, Enterococcus faecalis, and Tetragenococcus halophilus in vitro. Antibiotic susceptibility of the transconjugants was host-dependent, and transconjugants maintained a lincomycin resistance phenotype in the absence of selective pressure over 60 generations.	[Lee, Jong-Hoon] Kyonggi Univ, Dept Food Sci & Biotechnol, Suwon 443760, South Korea; [Jeong, Do-Won] Shinansan Univ, Dept Food Sci & Biotechnol, Ansan 425792, South Korea	Kyonggi University; Ansan College	Jeong, DW (corresponding author), Shinansan Univ, Dept Food Sci & Biotechnol, Ansan 425792, South Korea.	wony744@gmail.com		Lee, Jong-Hoon/0000-0001-8889-5504; Jeong, Do-Won/0000-0001-6586-748X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2057003]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2057003; http://www.nrf.re.kr).	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Bjorland J, 2006, J ANTIMICROB CHEMOTH, V57, P46, DOI 10.1093/jac/dki407; Bjorland J, 2003, ANTIMICROB AGENTS CH, V47, P3046, DOI 10.1128/AAC.47.10.3046-3052.2003; Bjorland J, 2001, J CLIN MICROBIOL, V39, P3999, DOI 10.1128/JCM.39.11.3999-4004.2001; Boguslawska J, 2009, APPL ENVIRON MICROB, V75, P6352, DOI 10.1128/AEM.00470-09; Bzymek M, 2001, GENETICS, V158, P527; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; *CLSI, 2007, PERF STAND ANT SUS S; Cocconcelli PS, 2003, INT J FOOD MICROBIOL, V88, P315, DOI 10.1016/S0168-1605(03)00194-6; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Devirgiliis C, 2010, J APPL MICROBIOL, V109, P313, DOI 10.1111/j.1365-2672.2010.04661.x; DUNNY GM, 1979, PLASMID, V2, P454, DOI 10.1016/0147-619X(79)90029-5; Florez AB, 2008, INT J FOOD MICROBIOL, V121, P189, DOI 10.1016/j.ijfoodmicro.2007.11.029; Gazzola S, 2012, FOOD MICROBIOL, V30, P348, DOI 10.1016/j.fm.2011.12.005; Guan L, 2011, FOOD MICROBIOL, V28, P101, DOI 10.1016/j.fm.2010.09.001; Jeong Do-Won, 2015, Microbiology and Biotechnology Letters, V43, P84, DOI 10.4014/mbl.1501.01001; Jeong DW, 2014, INT J FOOD MICROBIOL, V188, P108, DOI 10.1016/j.ijfoodmicro.2014.07.022; Jeong DW, 2014, J MICROBIOL BIOTECHN, V24, P648, DOI 10.4014/jmb.1401.01009; Kennedy AD, 2010, J CLIN MICROBIOL, V48, P4504, DOI 10.1128/JCM.01050-10; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; Kramer MG, 1998, J BACTERIOL, V180, P83, DOI 10.1128/JB.180.1.83-89.1998; Li MS, 2009, J MICROBIOL, V47, P466, DOI 10.1007/s12275-009-0020-2; Lina G, 1999, ANTIMICROB AGENTS CH, V43, P1062, DOI 10.1128/AAC.43.5.1062; Loeza-Lara PD, 2004, PLASMID, V52, P48, DOI 10.1016/j.plasmid.2004.03.001; Lozano C, 2012, J ANTIMICROB CHEMOTH, V67, P2804, DOI 10.1093/jac/dks320; Luthje P, 2007, J ANTIMICROB CHEMOTH, V59, P600, DOI 10.1093/jac/dkm008; Marsin S, 1998, MOL MICROBIOL, V27, P1183, DOI 10.1046/j.1365-2958.1998.00759.x; Marty E, 2012, INT J FOOD MICROBIOL, V159, P74, DOI 10.1016/j.ijfoodmicro.2012.07.025; Miller HK, 2012, J BACTERIOL, V194, P4342, DOI 10.1128/JB.00484-12; Nawaz M, 2011, CURR MICROBIOL, V62, P1081, DOI 10.1007/s00284-010-9856-2; NOVICK RP, 1989, ANNU REV MICROBIOL, V43, P537, DOI 10.1146/annurev.micro.43.1.537; Rizzotti L, 2005, J FOOD PROTECT, V68, P955, DOI 10.4315/0362-028X-68.5.955; ROBERTS RC, 1990, J BACTERIOL, V172, P6204, DOI 10.1128/jb.172.11.6204-6216.1990; Ammor MS, 2007, FOOD MICROBIOL, V24, P559, DOI 10.1016/j.fm.2006.11.001; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Swaminathan TR, 2007, INDIAN VET J, V84, P686; Teuber M, 2003, INT J FOOD MICROBIOL, V88, P325, DOI 10.1016/S0168-1605(03)00195-8; Togay SO, 2010, J APPL MICROBIOL, V109, P1084, DOI 10.1111/j.1365-2672.2010.04763.x; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Zdolec N, 2013, FOOD TECHNOL BIOTECH, V51, P240; Zhai ZY, 2009, PLASMID, V62, P30, DOI 10.1016/j.plasmid.2009.02.005; Zonenschain D, 2009, J APPL MICROBIOL, V107, P1559, DOI 10.1111/j.1365-2672.2009.04338.x	44	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140190	10.1371/journal.pone.0140190	http://dx.doi.org/10.1371/journal.pone.0140190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448648	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000104
J	Malzer, I; Helm, B				Malzer, Iain; Helm, Barbara			The Seasonal Dynamics of Artificial Nest Predation Rates along Edges in a Mosaic Managed Reedbed	PLOS ONE			English	Article							WARBLER ACROCEPHALUS-ARUNDINACEUS; PHRAGMITES-AUSTRALIS; HABITAT EDGES; EMBERIZA-SCHOENICLUS; BREEDING ASSEMBLAGE; WATER-DEPTH; PATTERNS; SURVIVAL; SUCCESS; FOREST	Boundaries between different habitats can be responsible for changes in species interactions, including modified rates of encounter between predators and prey. Such 'edge effects' have been reported in nesting birds, where nest predation rates can be increased at habitat edges. The literature concerning edge effects on nest predation rates reveals a wide variation in results, even within single habitats, suggesting edge effects are not fixed, but dynamic throughout space and time. This study demonstrates the importance of considering dynamic mechanisms underlying edge effects and their relevance when undertaking habitat management. In reedbed habitats, management in the form of mosaic winter reed cutting can create extensive edges which change rapidly with reed regrowth during spring. We investigate the seasonal dynamics of reedbed edges using an artificial nest experiment based on the breeding biology of a reedbed specialist. We first demonstrate that nest predation decreases with increasing distance from the edge of cut reed blocks, suggesting edge effects have a pivotal role in this system. Using repeats throughout the breeding season we then confirm that nest predation rates are temporally dynamic and decline with the regrowth of reed. However, effects of edges on nest predation were consistent throughout the season. These results are of practical importance when considering appropriate habitat management, suggesting that reed cutting may heighten nest predation, especially before new growth matures. They also contribute directly to an overall understanding of the dynamic processes underlying edge effects and their potential role as drivers of time-dependent habitat use.	[Malzer, Iain; Helm, Barbara] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	University of Glasgow	Malzer, I (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	i.malzer.1@research.gla.ac.uk		Helm, Barbara/0000-0002-6648-1463	Carnegie Trust for the Universities of Scotland; Tay Ringing Group	Carnegie Trust for the Universities of Scotland; Tay Ringing Group	The Carnegie Trust for the Universities of Scotland (www.carnegie-trust.org) provided the funding for this work, with additional support provided by the Tay Ringing Group (www.tayringinggroup.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELSTAM P, 1986, OIKOS, V47, P365, DOI 10.2307/3565450; Baldi A, 2005, FOLIA ZOOL, V54, P285; Baldi Andras, 2000, Acta Ornithologica (Warsaw), V35, P53; Baldi Andras, 2005, Wetlands Ecology and Management, V13, P183, DOI 10.1007/s11273-004-0313-5; Batary P, 2005, BIOLOGIA, V60, P215; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Batary P, 2004, J ORNITHOL, V145, P59, DOI 10.1007/s10336-003-0010-9; Beemster N, 2010, ARDEA, V98, P339, DOI 10.5253/078.098.0308; BENSCH S, 1994, BEHAV ECOL SOCIOBIOL, V35, P309, DOI 10.1007/BF00184420; Boulton RL, 2006, NEW ZEAL J ECOL, V30, P377; Brennan PLR, 2010, J AVIAN BIOL, V41, P419, DOI 10.1111/j.1600-048X.2010.04999.x; Campbell L, 1992, BR BIRDS, V89, P335; CHEN JQ, 1993, ECOL MODEL, V67, P179, DOI 10.1016/0304-3800(93)90004-C; Coops H, 1996, AQUAT BOT, V54, P11, DOI 10.1016/0304-3770(96)01025-X; COWIE NR, 1992, J APPL ECOL, V29, P277, DOI 10.2307/2404496; CRABTREE RL, 1989, J WILDLIFE MANAGE, V53, P129, DOI 10.2307/3801319; Cramp S., 1993, BIRDS W PALEARCTIC, V7; CRICK HQP, 1994, BIRD STUDY, V41, P88, DOI 10.1080/00063659409477203; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; DEMASO SJ, 1992, WILDLIFE SOC B, V20, P94; Di Maggio R, 2013, J ORNITHOL, V154, P901, DOI 10.1007/s10336-013-0954-3; Dinno A., 2012, PARAN HORNS TEST PRI; Eaton Mark A., 2009, British Birds, V102, P296; Eising CM, 2001, IBIS, V143, P482, DOI 10.1111/j.1474-919X.2001.tb04950.x; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Fox J., 2002, R S PLUS COMPANION A; FRANKLIN SB, 1995, J VEG SCI, V6, P99, DOI 10.2307/3236261; FRETWELL S D, 1972, P217; Fulton GR, 2003, EMU, V103, P255, DOI 10.1071/MU02007; Graveland J, 1998, ARDEA, V86, P187; Graveland J, 1999, J AVIAN BIOL, V30, P469, DOI 10.2307/3677019; Hansson B, 2000, ECOLOGY, V81, P319, DOI 10.2307/177429; Hawke CJ, 1996, REEDBED MANAGEMENT F; HOI H, 1994, OECOLOGIA, V98, P436, DOI 10.1007/BF00324234; Hoi H, 2001, THE ECOLOGY OF REED; Honza M, 1998, BIRD STUDY, V45, P104, DOI 10.1080/00063659809461083; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hulme M, 2008, RSPB REPORT, P1; Ibanez-Alamo JD, 2012, IBIS, V154, P5, DOI 10.1111/j.1474-919X.2011.01186.x; JARVINEN A, 1989, ORNIS FENNICA, V66, P24; Jedlikowski J, 2015, BIRD STUDY, V62, P190, DOI 10.1080/00063657.2015.1031080; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kleindorfer S, 2003, AVIAN SCI, V3, P1; Lahti DC, 2001, BIOL CONSERV, V99, P365, DOI 10.1016/S0006-3207(00)00222-6; Leighton PA, 2011, ANIM CONSERV, V14, P186, DOI 10.1111/j.1469-1795.2010.00422.x; Major RE, 1996, IBIS, V138, P298, DOI 10.1111/j.1474-919X.1996.tb04342.x; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Moller AP, 2002, J ANIM ECOL, V71, P201, DOI 10.1046/j.1365-2656.2002.00589.x; Moore RP, 2004, ECOLOGY, V85, P1562, DOI 10.1890/03-0088; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nur N, 2004, CONDOR, V106, P457, DOI 10.1650/7336; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; Peach W., 2000, CONSERV SCI DEPT RSP; PEARSON DJ, 1975, BIRD STUDY, V22, P205, DOI 10.1080/00063657509476466; Perry EF, 2008, AUK, V125, P643, DOI 10.1525/auk.2008.07001; PICMAN J, 1993, AUK, V110, P89; Poulin B, 2000, J FIELD ORNITHOL, V71, P443, DOI 10.1648/0273-8570-71.3.443; Poulin B, 2002, BIOL CONSERV, V107, P315, DOI 10.1016/S0006-3207(02)00070-8; Poulin B, 2002, BIODIVERS CONSERV, V11, P1567, DOI 10.1023/A:1016866116220; Purger JJ, 2012, ACTA ZOOL ACAD SCI H, V58, P369; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Rangen SA, 2000, AUK, V117, P136, DOI 10.1642/0004-8038(2000)117[0136:VAOAOA]2.0.CO;2; Richardson TW, 2009, J WILDLIFE MANAGE, V73, P287, DOI 10.2193/2007-566; Robinson RA, 2005, BTO RESEARCH REPORT; Sara M, 2012, AVIAN BIOL RES, V5, P209, DOI 10.3184/175815512X13535044854571; Sathitsuksanoh N, 2009, IND ENG CHEM RES, V48, P6441, DOI 10.1021/ie900291s; Schiegg K, 2007, IBIS, V149, P365, DOI 10.1111/j.1474-919X.2007.00654.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schmidt MH, 2005, BIOL CONSERV, V121, P157, DOI 10.1016/j.biocon.2004.03.032; Skagen SK, 1999, WILSON BULL, V111, P415; SMALL MF, 1988, OECOLOGIA, V76, P62, DOI 10.1007/BF00379601; Soderstrom B, 1999, ECOGRAPHY, V22, P455, DOI 10.1111/j.1600-0587.1999.tb00582.x; Stance C, 2010, NEW FLORA BRIT ISLES; Surmacki A, 2003, ACTA ORNITHOL, V38, P123, DOI 10.3161/068.038.0209; Suvorov P, 2014, ACTA OECOL, V59, P91, DOI 10.1016/j.actao.2014.06.003; Svobodova J, 2012, EUR J WILDLIFE RES, V58, P315, DOI 10.1007/s10344-011-0582-2; Tarr JA, 2004, LAND DEGRAD DEV, V15, P487, DOI 10.1002/ldr.629; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Trnka A, 2006, BIOLOGIA, V61, P225, DOI 10.2478/s11756-006-0034-8; Trnka A, 2014, WETL ECOL MANAG, V22, P227, DOI 10.1007/s11273-013-9325-3; Trnka A, 2011, ORNIS FENNICA, V88, P179; Trnka A, 2009, ARDEA, V97, P109, DOI 10.5253/078.097.0113; Vadasz C, 2008, ACTA ZOOL ACAD SCI H, V54, P177; Valkama E, 2008, BIOL CONSERV, V141, P364, DOI 10.1016/j.biocon.2007.11.006; Venables WN, 2002, MASS MODERN APPL STA; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Vetter D, 2013, BIOL CONSERV, V159, P382, DOI 10.1016/j.biocon.2012.12.023; Watson JEM, 2004, BIOL CONSERV, V120, P311, DOI 10.1016/j.biocon.2004.03.004; Wilson J, 2006, ANIM CONSERV, V9, P463, DOI 10.1111/j.1469-1795.2006.00063.x; Zanette L, 2002, BIOL CONSERV, V103, P323, DOI 10.1016/S0006-3207(01)00143-4	92	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140247	10.1371/journal.pone.0140247	http://dx.doi.org/10.1371/journal.pone.0140247			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448338	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000362511000111
J	Ammanuel, S; Chan, WC; Adler, DA; Lakshamanan, BM; Gupta, SS; Ewen, JB; Johnston, MV; Marcus, CL; Naidu, S; Kadam, SD				Ammanuel, Simon; Chan, Wesley C.; Adler, Daniel A.; Lakshamanan, Balaji M.; Gupta, Siddharth S.; Ewen, Joshua B.; Johnston, Michael V.; Marcus, Carole L.; Naidu, Sakkubai; Kadam, Shilpa D.			Heightened Delta Power during Slow-Wave-Sleep in Patients with Rett Syndrome Associated with Poor Sleep Efficiency	PLOS ONE			English	Article							EEG; CHILDREN; EPILEPSY; BRAIN; AGE; ELECTROENCEPHALOGRAM; POLYSOMNOGRAPHY; TRAJECTORIES; METAANALYSIS; MATURATION	Sleep problems are commonly reported in Rett syndrome (RTT); however the electroencephalographic (EEG) biomarkers underlying sleep dysfunction are poorly understood. The aim of this study was to analyze the temporal evolution of quantitative EEG (qEEG) biomarkers in overnight EEGs recorded from girls (2-9 yrs. old) diagnosed with RTT using a non-traditional automated protocol. In this study, EEG spectral analysis identified high delta power cycles representing slow wave sleep (SWS) in 8-9h overnight sleep EEGs from the frontal, central and occipital leads (AP axis), comparing age-matched girls with and without RTT. Automated algorithms quantitated the area under the curve (AUC) within identified SWS cycles for each spectral frequency wave form. Both age-matched RTT and control EEGs showed similar increasing trends for recorded delta wave power in the EEG leads along the antero-posterior (AP). RTT EEGs had significantly fewer numbers of SWS sleep cycles; therefore, the overall time spent in SWS was also significantly lower in RTT. In contrast, the AUC for delta power within each SWS cycle was significantly heightened in RTT and remained heightened over consecutive cycles unlike control EEGs that showed an overnight decrement of delta power in consecutive cycles. Gamma wave power associated with these SWS cycles was similar to controls. However, the negative correlation of gamma power with age (r = -.59; p<0.01) detected in controls (2-5 yrs. vs. 6-9 yrs.) was lost in RTT. Poor % SWS (i.e., time spent in SWS overnight) in RTT was also driven by the younger age-group. Incidence of seizures in RTT was associated with significantly lower number of SWS cycles. Therefore, qEEG biomarkers of SWS in RTT evolved temporally and correlated significantly with clinical severity.	[Ammanuel, Simon; Chan, Wesley C.; Adler, Daniel A.; Kadam, Shilpa D.] Kennedy Krieger, Hugo Moser Res Inst, Neurosci Lab, Baltimore, MD 21205 USA; [Lakshamanan, Balaji M.; Ewen, Joshua B.] Kennedy Krieger, Hugo Moser Res Inst, Dept Neurol & Dev Med, Baltimore, MD USA; [Gupta, Siddharth S.; Ewen, Joshua B.; Johnston, Michael V.; Naidu, Sakkubai; Kadam, Shilpa D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gupta, Siddharth S.; Johnston, Michael V.; Naidu, Sakkubai] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Ammanuel, Simon; Chan, Wesley C.; Adler, Daniel A.] Johns Hopkins Univ, Dept Biomed Engn, Whiting Sch Engn, Baltimore, MD USA; [Marcus, Carole L.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Sleep Ctr, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Kadam, SD (corresponding author), Kennedy Krieger, Hugo Moser Res Inst, Neurosci Lab, Baltimore, MD 21205 USA.	Kadam@kennedykrieger.org	Adler, Daniel/ABA-6839-2020	Adler, Daniel/0000-0003-3328-0312; Ewen, Joshua/0000-0002-9203-9564	National Institute of Child Health and Human Development [R21HD073105]; FDA Food and Drug Administration, Orphan Drug Research Grant [FD-R-002408]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD073105] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [R01FD002408] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FDA Food and Drug Administration, Orphan Drug Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Support was provided by National Institute of Child Health and Human Development R21HD073105 (to SDK), and by the FDA Food and Drug Administration, Orphan Drug Research Grant (FD-R-002408). The funders had no role the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASM, 2007, THE AASM MANUAL FOR; ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; [Anonymous], 2015, IFCN GUIDELINES; [Anonymous], 2015, ACNS GUIDELINES; Arns M, 2013, J ATTEN DISORD, V17, P374, DOI 10.1177/1087054712460087; Baker FC, 2012, J SLEEP RES, V21, P59, DOI 10.1111/j.1365-2869.2011.00930.x; Basar Erol, 2013, Suppl Clin Neurophysiol, V62, P303; Basar Erol, 2013, Suppl Clin Neurophysiol, V62, P19; Benke TA, 2014, EPILEPSY CURR, V14, P283, DOI 10.5698/1535-7597-14.5.283; Blue ME, 2011, ANAT REC, V294, P1624, DOI 10.1002/ar.21380; Blue ME, 1999, EXP NEUROL, V156, P345, DOI 10.1006/exnr.1999.7030; Campbell IG, 2012, P NATL ACAD SCI USA, V109, P5740, DOI 10.1073/pnas.1120860109; Carotenuto M, 2013, SLEEP BREATH, V17, P93, DOI 10.1007/s11325-012-0654-x; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; Dolce A, 2013, PEDIATR NEUROL, V48, P337, DOI 10.1016/j.pediatrneurol.2012.11.001; GILLIN JC, 1981, PSYCHIAT RES, V4, P73, DOI 10.1016/0165-1781(81)90010-X; Glaze D, 2005, MENT RETARD DEV D R, V8, P66, DOI [10.1177/08830738050200090801, DOI 10.1177/08830738050200090801]; Gorbachevskaya N, 2001, BRAIN DEV-JPN, V23, pS90, DOI 10.1016/S0387-7604(01)00349-7; Gratchev VV, 2001, BRAIN DEV-JPN, V23, pS108, DOI 10.1016/S0387-7604(01)00359-X; Honomichl RD, 2002, J AUTISM DEV DISORD, V32, P553, DOI 10.1023/A:1021254914276; Huber R, 2014, TRENDS COGN SCI, V18, P141, DOI 10.1016/j.tics.2013.12.005; Hughes JR, 2008, EPILEPSY BEHAV, V13, P25, DOI 10.1016/j.yebeh.2008.01.011; Jaimchariyatam Nattapong, 2011, Innov Clin Neurosci, V8, P35; Johnston MV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00118; KOZINETZ CA, 1993, PEDIATRICS, V91, P445; Kurth S, 2013, BRAIN SCI, V3, P1445, DOI 10.3390/brainsci3041445; Kurth S, 2010, J NEUROSCI, V30, P13211, DOI 10.1523/JNEUROSCI.2532-10.2010; Lappalainen R, 1996, PEDIATR NEUROL, V15, P213, DOI 10.1016/S0887-8994(96)00218-4; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; MARCUS CL, 1994, J PEDIATR-US, V125, P218, DOI 10.1016/S0022-3476(94)70196-2; McArthur AJ, 1998, DEV MED CHILD NEUROL, V40, P186; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2004, NEUROSCIENTIST, V10, P118, DOI 10.1177/1073858403260995; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Percy AK, 2002, NEUROL CLIN, V20, P1125, DOI 10.1016/S0733-8619(02)00022-1; PIAZZA CC, 1990, BRAIN DEV-JPN, V12, P488, DOI 10.1016/S0387-7604(12)80213-0; Picchioni D, 2014, BRAIN SCI, V4, P150, DOI 10.3390/brainsci4010150; Reinke L, 2014, CRIT CARE, V18, DOI 10.1186/cc13823; Riquet A, 2011, SEIZURE-EUR J EPILEP, V20, P18, DOI 10.1016/j.seizure.2010.09.011; Samaco RC, 2011, J NEUROSCI, V31, P7951, DOI 10.1523/JNEUROSCI.0169-11.2011; Sederberg PB, 2003, J NEUROSCI, V23, P10809; SEGAWA M, 1990, BRAIN DEV-JPN, V12, P55, DOI 10.1016/S0387-7604(12)80178-1; SEGAWA M, 1992, BRAIN DEV-JPN, V14, pS46; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Soroko SI, 2014, INT J DEV NEUROSCI, V38, P127, DOI 10.1016/j.ijdevneu.2014.08.012; Stores G, 2001, Semin Pediatr Neurol, V8, P188, DOI 10.1053/spen.2001.29042; Stores Gregory, 2009, Dialogues Clin Neurosci, V11, P81; UCHIDA S, 1991, BRAIN RES BULL, V27, P93, DOI 10.1016/0361-9230(91)90286-S; Walsh JK., 2009, J CLIN SLEEP MED, V5(2, pS27, DOI [10.5664/jcsm.5.2S.S27, DOI 10.5664/JCSM.5.2S.S27]; Weljie AM, 2015, PROCEEDINGS OF THE N; Wisor JP, 2013, CEREB CORTEX, V23, P1978, DOI 10.1093/cercor/bhs189; Wither RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035396; Wong K, 2015, J SLEEP RES, V24, P223, DOI 10.1111/jsr.12240; Yener Gorsev G, 2013, Suppl Clin Neurophysiol, V62, P343; Young D, 2007, BRAIN DEV-JPN, V29, P609, DOI 10.1016/j.braindev.2007.04.001	56	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138113	10.1371/journal.pone.0138113	http://dx.doi.org/10.1371/journal.pone.0138113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444000	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600019
J	Cheng, CH; Lee, YS; Chang, CJ; Lin, JC; Lin, TY				Cheng, Chi-Hui; Lee, Yun-Shien; Chang, Chee-Jen; Lin, Jui-Che; Lin, Tzou-Yien			Genetic Polymorphisms in Inflammasome-Dependent Innate Immunity among Pediatric Patients with Severe Renal Parenchymal Infections	PLOS ONE			English	Article							EXTENDED VIRULENCE GENOTYPES; URINARY-TRACT-INFECTION; CONFER SUSCEPTIBILITY; ACUTE PYELONEPHRITIS; NLRP3 INFLAMMASOME; CARD8; DISEASE; NALP3; PREDISPOSITION	Background Inflammasome innate immune response activation has been demonstrated in various inflammatory diseases and microbial infections. However, to our knowledge, no study has examined the inflammasome-dependent pathways in patients with urinary tract infection. Defective or variant genes associated with innate immunity are believed to alter the host's susceptibility to microbial infection. This study investigated genetic polymorphisms in genes encoding inflammasomes and the subsequent released cytokines in pediatric patients with severe renal parenchymal infections. Methodology This study included patients diagnosed with acute pyelonephritis (APN) and acute lobar nephronia (ALN) who had no underlying disease or structural anomalies other than vesicoureteral reflux (VUR). Single nucleotide polymorphism (SNP) genotyping was performed in the genes associated with inflammasome formation and activation (NLRP3, CARD8) and subsequent IL-1 beta cytokine generation (IL-1 beta). Principal Findings A total of 40 SNPs were selected for initial genotyping. Analysis of samples from 48 patients each and 96 controls revealed that only nine SNPs (five SNPs in NLRP3; three SNPs in CARD8; one SNP in IL-1 beta) had heterozygosity rates > 0.01. Hardy-Weinberg equilibrium was satisfied for the observed genotype frequencies of these SNPs. Analysis excluding patients with VUR, a well-known risk factor for severe UTIs, revealed a lower frequency of the CC genotype in NLRP3 (rs4612666) in patients with APN and ALN than in controls. Correction for multiple-SNP testing showed that the non-VUR subgroup of the APN+ALN combined patient groups remained significantly different from the control group (P < 0.0055). Conclusions This study is the first to suggest that the inflammasome-dependent innate immunity pathway is associated with the pathogenesis of pediatric severe renal parenchymal infections. Further investigation is warranted to clarify its pathogenic mechanism.	[Cheng, Chi-Hui] Chang Gung Mem Hosp, Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Nephrol, Taoyuan, Taiwan; [Cheng, Chi-Hui; Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Yun-Shien] Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Mem Hosp, Stat Ctr Clin Res, Taoyuan, Taiwan; [Lin, Jui-Che] Natl Cheng Kung Univ, Dept Chem Engn, Inst Oral Med, Tainan, Taiwan; [Lin, Tzou-Yien] Chang Gung Mem Hosp, Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Ming Chuan University; Chang Gung Memorial Hospital; National Cheng Kung University; Chang Gung Memorial Hospital	Cheng, CH (corresponding author), Chang Gung Mem Hosp, Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Nephrol, Taoyuan, Taiwan.	pedneph.cheng@msa.hinet.net	Lin, Jui-Che/C-8230-2012	Lin, Jui-Che/0000-0003-4436-655X; Cheng, Chi-Hui/0000-0002-0070-0571	Ministry of Science and Technology, Taiwan [MOST 103-2314-B-182-022-MY3, NSC 98-2314-B-182A-007-MY3]; Chang Gung Memorial Hospital (CMRPG) [4A0111, 4A0112, 4A0113]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (CMRPG)(Chang Gung Memorial Hospital)	CHC was supported by Ministry of Science and Technology, Taiwan (MOST 103-2314-B-182-022-MY3; NSC 98-2314-B-182A-007-MY3) and the Chang Gung Memorial Hospital (CMRPG 4A0111, 4A0112, 4A0113) for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Bergman DA, 1999, PEDIATRICS, V103, P843; Blomgran R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031326; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Carlstrom M, 2012, EXP DERMATOL, V21, P932, DOI 10.1111/exd.12049; Chang A, 2014, CURR OPIN NEPHROL HY, V23, P204, DOI 10.1097/01.mnh.0000444814.49755.90; Cheng CH, 2006, PEDIATRICS, V117, pE84, DOI 10.1542/peds.2005-0917; Cheng CH, 2007, PEDIATR INFECT DIS J, V26, P228, DOI 10.1097/01.inf.0000254388.66367.13; Cheng CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058687; Cheng CH, 2011, PEDIATR INFECT DIS J, V30, P309, DOI 10.1097/INF.0b013e3181ff84ff; Cheng CH, 2010, PEDIATR INFECT DIS J, V29, P736, DOI 10.1097/INF.0b013e3181dab249; Cheng CH, 2010, J PEDIATR-US, V156, P82, DOI 10.1016/j.jpeds.2009.07.010; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Geldhoff M, 2013, IMMUNOGENETICS, V65, P9, DOI 10.1007/s00251-012-0653-x; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008300; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Ji XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047949; Johnson JR, 2003, INFECT DIS CLIN N AM, V17, P261, DOI 10.1016/S0891-5520(03)00027-8; Johnson JR, 2005, J INFECT DIS, V191, P46, DOI 10.1086/426450; Kastbom A, 2010, ANN RHEUM DIS, V69, P723, DOI 10.1136/ard.2008.106989; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Lewis GJ, 2011, INFLAMM BOWEL DIS, V17, P1387, DOI 10.1002/ibd.21499; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Ma JF, 2004, UROL CLIN N AM, V31, P517, DOI 10.1016/j.ucl.2004.04.016; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Orellana P, 2004, PEDIATR NEPHROL, V19, P1122, DOI 10.1007/s00467-004-1501-5; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Pontillo A, 2013, JAIDS-J ACQ IMM DEF, V63, P147, DOI 10.1097/QAI.0b013e31828f93bb; Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532; Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe; Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474; Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4; Ragnarsdottir B, 2011, NAT REV UROL, V8, P449, DOI 10.1038/nrurol.2011.100; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Tseng CC, 2002, AM J KIDNEY DIS, V39, P744, DOI 10.1053/ajkd.2002.32992; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Verma D, 2012, PIGM CELL MELANOMA R, V25, P506, DOI 10.1111/j.1755-148X.2012.01008.x; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Witkin SS, 2010, J REPROD IMMUNOL, V84, P171, DOI 10.1016/j.jri.2009.11.005; Yang SK, 2011, J HUM GENET, V56, P217, DOI 10.1038/jhg.2010.170	47	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140128	10.1371/journal.pone.0140128	http://dx.doi.org/10.1371/journal.pone.0140128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444566	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600142
J	Vogt, C; Pernemalm, M; Kohonen, P; Laurent, S; Hultenby, K; Vahter, M; Lehtio, J; Toprak, MS; Fadeel, B				Vogt, Carmen; Pernemalm, Maria; Kohonen, Pekka; Laurent, Sophie; Hultenby, Kjell; Vahter, Marie; Lehtio, Janne; Toprak, Muhammet S.; Fadeel, Bengt			Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; PROTEIN CORONA; EFFICIENT INTERNALIZATION; DIFFERENT SIZES; ACTIVATION; SPIONS; CELLS	Superparamagnetic iron oxide nanoparticles (SPIONs) have emerged as promising contrast agents for magnetic resonance imaging. The influence of different surface coatings on the biocompatibility of SPIONs has been addressed, but the potential impact of the so-called corona of adsorbed proteins on the surface of SPIONs on their biological behavior is less well studied. Here, we determined the composition of the plasma protein corona on silica- coated versus dextran-coated SPIONs using mass spectrometry-based proteomics approaches. Notably, gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed distinct protein corona compositions for the two different SPIONs. Relaxivity of silica-coated SPIONs was modulated by the presence of a protein corona. Moreover, the viability of primary human monocyte-derived macrophages was influenced by the protein corona on silica-coated, but not dextran-coated SPIONs, and the protein corona promoted cellular uptake of silica-coated SPIONs, but did not affect internalization of dextran-coated SPIONs.	[Vogt, Carmen; Kohonen, Pekka; Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden; [Pernemalm, Maria; Lehtio, Janne] Sci Life Lab, Dept Oncol Pathol, Clin Prote Mass Spectrometry, Stockholm, Sweden; [Pernemalm, Maria; Lehtio, Janne] Karolinska Inst, Stockholm, Sweden; [Laurent, Sophie] Univ Mons, Dept Gen Organ & Biomed Chem, NMR & Mol Imaging Lab, B-7000 Mons, Belgium; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Electron Microscopy Core Facil, Stockholm, Sweden; [Vahter, Marie] Karolinska Inst, Inst Environm Med, Div Met & Hlth, S-10401 Stockholm, Sweden; [Toprak, Muhammet S.] Royal Inst Technol, Sch Informat & Commun Technol, Funct Mat Div, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Mons; Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology	Fadeel, B (corresponding author), Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden.	bengt.fadeel@ki.se	Toprak, Muhammet S/C-9328-2011; Vahter, Marie/HGB-1674-2022; Kohonen, Pekka/F-9596-2011; Toprak, Muhammet/AAP-4058-2021	Toprak, Muhammet S/0000-0001-5678-5298; Kohonen, Pekka/0000-0002-7845-3611; Pernemalm, Maria/0000-0003-4624-031X; Lehtio, Janne/0000-0002-8100-9562	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Cancer and Allergy Foundation; Swedish Cancer Society; Swedish Research Council; European Commission [309329, 604134]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Cancer and Allergy Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (BF), the Swedish Cancer and Allergy Foundation (BF), the Swedish Cancer Society (JL), the Swedish Research Council (BF, JL), and the European Commission (FP7-NANOSOLUTIONS, grant agreement no. 309329) (BF) and FP7-eNANOMAPPER, grant agreement no. 604134) (BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri H, 2013, NANOSCALE, V5, P8656, DOI 10.1039/c3nr00345k; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Docter D, 2015, NANOMEDICINE-UK, V10, P503, DOI 10.2217/nnm.14.184; Dutta D, 2007, TOXICOL SCI, V100, P303, DOI 10.1093/toxsci/kfm217; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fadeel B, 2013, WIRES NANOMED NANOBI, V5, P111, DOI 10.1002/wnan.1206; Farrera C, 2015, EUR J PHARM BIOPHARM, V95, P3, DOI 10.1016/j.ejpb.2015.03.007; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Jedlovszky-Hajdu A, 2012, LANGMUIR, V28, P14983, DOI 10.1021/la302446h; Karmali PP, 2011, EXPERT OPIN DRUG DEL, V8, P343, DOI 10.1517/17425247.2011.554818; Krais A, 2014, NANOMED-NANOTECHNOL, V10, P1421, DOI 10.1016/j.nano.2014.01.006; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; Kunzmann A, 2011, TOXICOL APPL PHARM, V253, P81, DOI 10.1016/j.taap.2011.03.011; Kunzmann A, 2011, BBA-GEN SUBJECTS, V1810, P361, DOI 10.1016/j.bbagen.2010.04.007; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006; Mahon E, 2012, J CONTROL RELEASE, V161, P164, DOI 10.1016/j.jconrel.2012.04.009; Moghimi SM, 2010, J CONTROL RELEASE, V146, P175, DOI 10.1016/j.jconrel.2010.04.003; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Pernemalm M, 2013, J PROTEOME RES, V12, P1014, DOI 10.1021/pr300817y; Pinho SLC, 2012, J PHYS CHEM C, V116, P2285, DOI 10.1021/jp2086413; POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F; Sakulkhu U, 2014, SCI REP-UK, V4, DOI 10.1038/srep05020; Simberg D, 2009, BIOMATERIALS, V30, P3926, DOI 10.1016/j.biomaterials.2009.03.056; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vogt C, 2010, J NANOPART RES, V12, P1137, DOI 10.1007/s11051-009-9661-7; Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Wang FJ, 2013, NANOMED-NANOTECHNOL, V9, P1159, DOI 10.1016/j.nano.2013.04.010; Witasp E, 2009, TOXICOL APPL PHARM, V239, P306, DOI 10.1016/j.taap.2009.06.011	35	53	53	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0129008	10.1371/journal.pone.0129008	http://dx.doi.org/10.1371/journal.pone.0129008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444829	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600001
J	Labrador-Garrido, A; Cejudo-Guillen, M; Daturpalli, S; Leal, MM; Klippstein, R; De Genst, EJ; Villadiego, J; Toledo-Aral, JJ; Dobson, CM; Jackson, SE; Pozo, D; Roodveldt, C				Labrador-Garrido, Adahir; Cejudo-Guillen, Marta; Daturpalli, Soumya; Leal, Maria M.; Klippstein, Rebecca; De Genst, Erwin J.; Villadiego, Javier; Toledo-Aral, Juan J.; Dobson, Christopher M.; Jackson, Sophie E.; Pozo, David; Roodveldt, Cintia			Chaperome screening leads to identification of Grp94/Gp96 and FKBP4/52 as modulators of the alpha-synuclein-elicited immune response	FASEB JOURNAL			English	Article						misfolding/amyloid disease; Parkinson; heat-shock protein; immunotherapy	PEPTIDYL-PROLYL ISOMERASES; HEAT-SHOCK PROTEINS; PARKINSONS-DISEASE; INNATE; MODEL; IMMUNOPHILINS; IMMUNOTHERAPY; IMMUNIZATION; AGGREGATION; ASSOCIATION	We have investigated the potential role of molecular chaperones as modulators of the immune response by using alpha-synuclein (alpha Syn) as an aggregation-prone model protein. We first performed an in vitro immunoscreening with 21 preselected candidate chaperones and selected 2 from this set as displaying immunological activity with differential profiles, Grp94/Gp96 and FKBP4/52. We then immunized mice with both chaperone/alpha-synuclein combinations using monomeric or oligomeric alpha-synuclein (M alpha Syn or O alpha Syn, respectively), and we characterized the immune response generated in each case. We found that Grp94 promoted aSyn-specific T-helper (T-h) 1/T(h)17 and IgG1 antibody responses (up to a 3-fold increase) with MaSyn and O alpha Syn, respectively, coupled to a T(h)2-type general phenotype (generating 2.5-fold higher IgG1/IgG2 levels). In addition, we observed that FKBP4 favored a Th1-skewed phenotype with MaSyn but strongly supported a T(h)2-type phenotype with OaSyn (with a 3-fold higher IL-10/IFN-gamma serum levels). Importantly, results from adoptive transfer of splenocytes from immunized animals in a Parkinson's disease mousemodel indicates that these effects are robust, stable in time, and physiologically relevant. Taken together, Grp94 and FKBP4 are able to generate differential immuneresponses to a-synuclein-based immunizations, depending both on the nature of the chaperone and on the aggregation state of a-synuclein. Our work reveals that several chaperones are potential modulators of the immune response and suggests that different chaperones could be exploited to redirect the amyloid-elicited immunity both for basic studies of the immunological processes associated with neurodegeneration and for immunotherapy of pathologies associated with protein misfolding and aggregation.	[Labrador-Garrido, Adahir; Cejudo-Guillen, Marta; Leal, Maria M.; Klippstein, Rebecca; Pozo, David; Roodveldt, Cintia] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Labrador-Garrido, Adahir; Cejudo-Guillen, Marta; Klippstein, Rebecca; Pozo, David] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Seville, Spain; [Villadiego, Javier; Toledo-Aral, Juan J.] Univ Seville, Sch Med, Dept Med Physiol & Biophys, Seville, Spain; [Daturpalli, Soumya; De Genst, Erwin J.; Dobson, Christopher M.; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Villadiego, Javier; Toledo-Aral, Juan J.] Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Seville IBiS, Seville, Spain; [Villadiego, Javier; Toledo-Aral, Juan J.] Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla; University of Sevilla; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Roodveldt, C (corresponding author), Edificio Cabimer,Ave Amer Vespucio S-N,Cartuja 93, Seville 41092, Spain.	cintia.roodveldt@cabimer.es	Cejudo-Guillén, Marta/L-1941-2017; IBIS, TERAPIA CELULA/P-3297-2015; Roodveldt, Cintia/I-9118-2014; Pozo, David/C-2149-2017; Lasarte, María Magdalena Leal/AAB-3380-2020; Toledo-Aral, Juan J/F-2613-2015; Villadiego, Javier/F-2594-2015	Cejudo-Guillén, Marta/0000-0003-3320-5419; Roodveldt, Cintia/0000-0003-4124-8769; Pozo, David/0000-0002-3732-4960; Lasarte, María Magdalena Leal/0000-0001-5250-8680; Toledo-Aral, Juan J/0000-0001-7512-7135; Villadiego, Javier/0000-0003-2131-9013; Jackson, Sophie/0000-0002-7470-9800; Labrador-Garrido, Adahir/0000-0001-5098-9601	Carlos III Institute of Health of Spain (Spanish Ministry of Economy and Competitiveness) [CP10/00527, PI14-01600]; Fonds Europeen de Developpement Economique et Regional (FEDER) funds; Spanish Ministry of Economy and Competitiveness [SAF-2012/39720]; FEDER funds; Andalusian Ministry of Economy, Science and Innovation [P10-CTS-6928, P11-CTS-8161]; Andalusian Plan for Research, Development and Innovation (PAIDI) Program from the Andalusian Government [CTS-677]; Spanish Ministry of Education [AP-2009/3816]; Wellcome Trust; Medical Research Council; Biotechnology and Biological Sciences Research Council of the United Kingdom	Carlos III Institute of Health of Spain (Spanish Ministry of Economy and Competitiveness); Fonds Europeen de Developpement Economique et Regional (FEDER) funds; Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds(European Commission); Andalusian Ministry of Economy, Science and Innovation; Andalusian Plan for Research, Development and Innovation (PAIDI) Program from the Andalusian Government; Spanish Ministry of Education(Spanish Government); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to Jose M. Valpuesta's group (Centro Nacional de Biotecnologia, Madrid, Spain) for kindly providing purified Hip protein. Financial support was provided by the Carlos III Institute of Health of Spain (Spanish Ministry of Economy and Competitiveness) according to the Strategic Action of Health (CP10/00527 to C.R.; PI14-01600 to D.P.), with cofunding by Fonds Europeen de Developpement Economique et Regional (FEDER) funds, from the Spanish Ministry of Economy and Competitiveness (SAF-2012/39720 to C.R.) with cofunding by FEDER funds, the Andalusian Ministry of Economy, Science and Innovation (P10-CTS-6928 and P11-CTS-8161 to D.P.), and the Andalusian Plan for Research, Development and Innovation (PAIDI) Program from the Andalusian Government (CTS-677 to D.P.). A.L.G. holds a Formacion del Profesorado Universitario (FPU) Predoctoral Fellowship from the Spanish Ministry of Education (AP-2009/3816). The work of E.J.D.G. and C.M.D. is supported by the Wellcome Trust, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council of the United Kingdom.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Binder RJ, 2014, J IMMUNOL, V193, P5765, DOI 10.4049/jimmunol.1401417; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Calderwood SK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00075; Chambraud B, 1996, J BIOL CHEM, V271, P32923, DOI 10.1074/jbc.271.51.32923; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Deleersnijder A, 2011, J BIOL CHEM, V286, P26687, DOI 10.1074/jbc.M110.182303; Di Domenico F, 2010, J NEUROSCI RES, V88, P3566, DOI 10.1002/jnr.22528; Gerard M, 2011, MOL NEUROBIOL, V44, P13, DOI 10.1007/s12035-011-8184-2; Ghochikyan A, 2014, NEUROSCI LETT, V560, P86, DOI 10.1016/j.neulet.2013.12.028; Giustiniani J, 2015, FASEB J, V29, P3171, DOI 10.1096/fj.14-268243; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; KATSIKIS PD, 1995, INT IMMUNOL, V7, P1287, DOI 10.1093/intimm/7.8.1287; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kurzawa-Akanbi M, 2012, J NEUROCHEM, V123, P298, DOI 10.1111/j.1471-4159.2012.07879.x; Labrador-Garrido A, 2014, IMMUN INFLAMM DIS, V2, P226, DOI 10.1002/iid3.39; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Munoz-Manchado AB, 2013, NEUROBIOL AGING, V34, P902, DOI 10.1016/j.neurobiolaging.2012.06.001; Nath PR, 2015, IMMUNOL LETT, V163, P120, DOI 10.1016/j.imlet.2014.11.002; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; Randazzo M, 2012, INT J CANCER, V130, P2219, DOI 10.1002/ijc.27332; Reish HEA, 2015, J PARKINSON DIS, V5, P1, DOI 10.3233/JPD-140491; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Roodveldt C, 2011, NEW THERAPIES PARKIN, P57; Roodveldt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079160; Roodveldt C, 2012, BIOCHEMISTRY-US, V51, P8771, DOI 10.1021/bi300558q; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Rosser MFN, 2004, BIOCHEMISTRY-US, V43, P8835, DOI 10.1021/bi049539q; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Sanchez-Guajardo V, 2013, J NEUROPATH EXP NEUR, V72, P624, DOI 10.1097/NEN.0b013e31829768d2; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Srivastava Pramod K, 2005, Curr Oncol Rep, V7, P104, DOI 10.1007/s11912-005-0035-8; Srivastava Pramod K, 2012, Cancer Immun, V12, P1; Valera E, 2013, PHARMACOL THERAPEUT, V138, P311, DOI 10.1016/j.pharmthera.2013.01.013; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]	47	8	8	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					564	577		10.1096/fj.15-275131	http://dx.doi.org/10.1096/fj.15-275131			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443817				2022-12-26	WOS:000369391900010
J	Gristick, HB; Rome, ME; Chartron, JW; Rao, M; Hess, S; Shan, SO; Clemons, WM				Gristick, Harry B.; Rome, Michael E.; Chartron, Justin W.; Rao, Meera; Hess, Sonja; Shan, Shu-ou; Clemons, William M., Jr.			Mechanism of Assembly of a Substrate Transfer Complex during Tail-anchored Protein Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE INSERTION; STRUCTURAL BASIS; GET3; RECOGNITION; ELECTROSTATICS; BINDING; SYSTEM	Tail-anchored (TA) proteins, defined as having a single transmembrane helix at their C terminus, are post-translationally targeted to the endoplasmic reticulum membrane by the guided entry of TA proteins (GET) pathway. In yeast, the handover of TA substrates is mediated by the heterotetrameric Get4/Get5 complex (Get4/5), which tethers the co-chaperone Sgt2 to the targeting factor, the Get3 ATPase. Binding of Get4/5 to Get3 is critical for efficient TA targeting; however, questions remain about the formation of the Get3.Get4/5 complex. Here we report crystal structures of a Get3.Get4/5 complex from Saccharomyces cerevisiae at 2.8 and 6.0 angstrom that reveal a novel interface between Get3 and Get4 dominated by electrostatic interactions. Kinetic and mutational analyses strongly suggest that these structures represent an on-pathway intermediate that rapidly assembles and then rearranges to the final Get3.Get4/5 complex. Furthermore, we provide evidence that the Get3.Get4/5 complex is dominated by a single Get4/5 heterotetramer bound to one monomer of a Get3 dimer, uncovering an intriguing asymmetry in the Get4/5 heterotetramer upon Get3 binding. Ultrafast diffusion-limited electrostatically driven Get3.Get4/5 association enables Get4/5 to rapidly sample and capture Get3 at different stages of the GET pathway.	[Gristick, Harry B.; Rome, Michael E.; Chartron, Justin W.; Rao, Meera; Shan, Shu-ou; Clemons, William M., Jr.] CALTECH, Beckman Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hess, Sonja] CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu; clemons@caltech.edu	Clemons, William M/D-1026-2009; Chartron, Justin/L-9096-2019; Regan, Clinton/E-6250-2012	Clemons, William M/0000-0002-0021-889X; Chartron, Justin/0000-0003-1734-3424; Rao, Meera/0000-0001-8650-6253	National Science Foundation Graduate Research Fellowship [DGE-1144469]; National Institutes of Health [5T32GM007616-33, R01GM097572, R01GM107368]; Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R01GM107368, R01GM097572] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Graduate Research Fellowship DGE-1144469 (to M. E. R.) and National Institutes of Health Training Grant 5T32GM007616-33 (to H. B. G. and M. R.) and Research Grants R01GM097572 (to W. M. C.) and R01GM107368 (to S. S.). The Proteome Exploration Laboratory was supported by Gordon and Betty Moore Foundation Grant GBMF775 and the Beckman Institute (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gristick HB, 2014, NAT STRUCT MOL BIOL, V21, P437, DOI 10.1038/nsmb.2813; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Nguyen TX, 2013, J BIOL CHEM, V288, P13420, DOI 10.1074/jbc.M113.462812; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rome ME, 2014, P NATL ACAD SCI USA, V111, pE4929, DOI 10.1073/pnas.1411284111; Rome ME, 2013, P NATL ACAD SCI USA, V110, P7666, DOI 10.1073/pnas.1222054110; Sandikci A, 2013, NAT STRUCT MOL BIOL, V20, P843, DOI 10.1038/nsmb.2615; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028	39	8	8	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30006	30017		10.1074/jbc.M115.677328	http://dx.doi.org/10.1074/jbc.M115.677328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26451041	Green Published, hybrid			2022-12-26	WOS:000366614700032
J	Deng, ZH; Qin, L; Gao, Y; Weisskopf, AR; Zhang, C; Fuller, DQ				Deng, Zhenhua; Qin, Ling; Gao, Yu; Weisskopf, Alison Ruth; Zhang, Chi; Fuller, Dorian Q.			From Early Domesticated Rice of the Middle Yangtze Basin to Millet, Rice and Wheat Agriculture: Archaeobotanical Macro-Remains from Baligang, Nanyang Basin, Central China (6700-500 BC)	PLOS ONE			English	Article							ASIAN MONSOON; EARLY POTTERY; ORIGINS; CAVE; DISPERSAL; EVOLUTION; INSIGHTS; PROVINCE; REGION; VALLEY	Baligang is a Neolithic site on a northern tributary of the middle Yangtze and provides a long archaeobotanical sequence from the Seventh Millennium BC upto the First Millennium BC. It provides evidence for developments in rice and millet agriculture influenced by shifting cultural affiliation with the north (Yangshao and Longshan) and south (Qujialing and Shijiahe) between 4300 and 1800 BC. This paper reports on plant macro-remains (seeds), from systematic flotation of 123 samples (1700 litres), producing more than 10,000 identifiable remains. The earliest Pre-Yangshao occupation of the sites provide evidence for cultivation of rice (Oryza sativa) between 6300-6700 BC. This rice appears already domesticated in on the basis of a dominance of non-shattering spikelet bases. However, in terms of grain size changes has not yet finished, as grains are still thinner than more recent domesaticated rice and are closer in grain shape to wild rices. This early rice was cultivated alongside collection of wild staple foods, especially acorns (Quercus/Lithicarpus sensu lato). In later periods the sites has evidence for mixed farming of both rice and millets (Setaria italica and Panicum miliaceum). Soybean appears on the site in the Shijiahe period (ca.2500 BC) and wheat (Triticum cf. aestivum) in the Late Longshan levels (2200-1800 BC). Weed flora suggests an intensification of rice agriculture over time with increasing evidence of wetland weeds. We interpret these data as indicating early opportunistic cultivation of alluvial flood-plains and some rainfed rice, developing into more systematic and probably irrigated cultivation starting in the Yangshao period, which intensified in the Qujialing and Shijiahe period, before a shift back to an emphasis on millets with the Late Longshan cultural influence from the north.	[Deng, Zhenhua; Qin, Ling; Gao, Yu; Zhang, Chi] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China; [Weisskopf, Alison Ruth; Fuller, Dorian Q.] UCL, Inst Archaeol, London, England	Peking University; University of London; University College London	Fuller, DQ (corresponding author), UCL, Inst Archaeol, London, England.	d.fuller@ucl.ac.uk	Fuller, Dorian/AAF-7400-2019; Fuller, Dorian Q/C-1908-2008	Fuller, Dorian/0000-0002-4859-080X; Fuller, Dorian Q/0000-0002-4859-080X; Deng, Zhenhua/0000-0002-6412-7399	European Research Council [323842]; National Key Technology R&D Program of China [2013BAK08B05]; National Social Science Foundation of China [12ZD 190]; Natural Environment Research Council [NE/G005540/1]; Natural Environment Research Council (UK) [NE/K003402/1]; NERC [NE/G005540/1, NE/K003402/1] Funding Source: UKRI; Natural Environment Research Council [NE/K003402/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); National Key Technology R&D Program of China(National Key Technology R&D Program); National Social Science Foundation of China; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the European Research Council (grant 323842) to DF, by the National Key Technology R&D Program of China (Grant No. 2013BAK08B05) to LQ and CZ, and the National Social Science Foundation of China (Grant No. 12&ZD 190) to LQ and CZ Natural Environment Research Council (NE/G005540/1)-to DQF (2009) Natural Environment Research Council (UK) grant NE/K003402/1-to DQF (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CB, 2010, CHINESE SCI BULL, V55, P1925, DOI 10.1007/s11434-010-3208-2; [Anonymous], 1999, WUYANGJ; [Anonymous], 2006, ASIAN PERSPECT, V45, P129; Bar-Yosef O, 2011, CURR ANTHROPOL, V52, pS175, DOI 10.1086/659784; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Boaretto E, 2009, P NATL ACAD SCI USA, V106, P9595, DOI 10.1073/pnas.0900539106; Castillo CC, 2016, ARCHAEOL ANTHROP SCI, V8, P523, DOI 10.1007/s12520-015-0236-5; Chi Z, 2013, ANTIQUITY, V87, P46, DOI 10.1017/S0003598X00048614; Cohen D.J., 1998, REV ARCHAEOL, V19, P22; Cohen DJ, 2011, CURR ANTHROPOL, V52, pS273, DOI 10.1086/659965; Crawford GW, 2012, HOLOCENE, V22, P613, DOI 10.1177/0959683611424177; Crawford GW, 1998, ANTIQUITY, V72, P858, DOI 10.1017/S0003598X00087494; Crawford GW, 2013, JIANGHAN ARCHAEOLOGY, V2, P107; Dong JG, 2010, HOLOCENE, V20, P257, DOI 10.1177/0959683609350393; [方修琦 Fang Xiuqi], 2011, [地理科学, Scientia Geographica Sinica], V31, P1287; Fuller D.Q., 2007, SCH ARCHAEOLOGY MUSE, P916; Fuller D. Q., 2009, ANN PLANT REV, V38, P238, DOI DOI 10.1002/9781444314557.CH7; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2014, P NATL ACAD SCI USA, V111, P6147, DOI 10.1073/pnas.1308937110; Fuller DQ, 2011, RICE, V4, P78, DOI 10.1007/s12284-011-9078-7; Fuller DQ, 2008, ROUTLEDGE STUD EARLY, V5, P40; Fuller DQ, 2010, ENVIRON ARCHAEOL, V15, P139, DOI 10.1179/146141010X12640787648531; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Fuller DQ, 2009, WORLD ARCHAEOL, V41, P88, DOI 10.1080/00438240802668321; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Fuller DQ, 2008, ANTIQUITY, V82; Gao Y., 2012, THESIS PEKING U BEIJ; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; Gu HB, 2007, LIXIAN CHENGTOUSHAN, P107; He Y, 2004, QUATERNARY RES, V61, P52, DOI 10.1016/j.yqres.2003.08.004; Higham C, 1998, ANTIQUITY, V72, P867, DOI 10.1017/S0003598X00087500; [侯光良 HOU Guangliang], 2011, [地理科学进展, Progress in Geography], V30, P1075; Hu CY, 2008, EARTH PLANET SC LETT, V266, P221, DOI 10.1016/j.epsl.2007.10.015; Hunan Provincial Institute of Archaeology and Cultural Relics, 2007, LIX CHENGT NEOL SIT, V1; Hunan Provincial Institute of Archaeology and Cultural Relics, 2006, PENGT BASH; Jacquot M., 1987, UPLAND RICE; Jin GY, 2014, J ARCHAEOL SCI, V51, P34, DOI 10.1016/j.jas.2013.01.007; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Lee GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026720; Li XQ, 2007, SCI CHINA SER D, V50, P1707, DOI 10.1007/s11430-007-0066-0; Ling Qin, 2012, SCH ARCHAEOLOGY MUSE, P260; Liu C., 2004, ARCHAEOLOGY, V8, P76; Liu H., 2013, ARCHAEOL CULT RELICS, V4, P106, DOI DOI 10.3969/J.ISSN.1000-7830.2013.04.011; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Liu L, 2010, ANTIQUITY, V84, P816, DOI 10.1017/S0003598X00100249; Nasu H, 2007, VEG HIST ARCHAEOBOT, V16, P481, DOI 10.1007/s00334-006-0068-4; Nasu H, 2012, ARCHAEOL ANTHROP SCI, V4, P1, DOI 10.1007/s12520-011-0077-9; Pan Y., 2013, SE CULT, V6, P54; Pei AP, 1998, ANTIQUITY, V72, P878, DOI 10.1017/S0003598X00087512; Qin L, 2009, SAN MEN XIA NAN JIAO, P427; SCHOLZ H, 1983, PLANT SYST EVOL, V143, P233, DOI 10.1007/BF00986381; School of archaeology and museology of Peking University Institution of Archaeology and Cultural Relics of Nanyang City, 2000, CULTURAL RELICS, V11, P23; School of archaeology and museology of Peking University Institution of Archaeology and Cultural Relics of Nanyang City, 1998, CULTURAL RELICS, V9, P31; School of archaeology and museology of Peking University Institution of Archaeology and Cultural Relics of Nanyang City, 1997, DISC 1992 EXC BAL SI, V12, P1; Song, 2011, THESIS U COLL LONDON; Song JX, 2013, VEG HIST ARCHAEOBOT, V22, P141, DOI 10.1007/s00334-012-0366-y; Song YB, 2008, COLLECTION STUDIES A, P519; The editorial Committee, 1990, FARML WEEDS CHIN; Wang ZR., 1990, FARMLAND WEEDS CHINA; Weisskopf A, ARCHAEOLOGICAL UNPUB; Weisskopf A, 2014, J ARCHAEOL SCI, V51, P43, DOI 10.1016/j.jas.2013.04.026; Weisskopf AR., 2014, MILLETS RICE FARMERS; Wu XH, 2012, SCIENCE, V336, P1696, DOI 10.1126/science.1218643; Yan W., 1982, AGR ARCHAEOLOGY, V1, P151; Yan W.M., 1982, AGRICUL ARCHAEOL, V1, P19; Yan W M, 1997, ARCHAEOLOGY, V9, P71; Yan WM, 1989, AGR ARCHAEOLOGY NONG, V2, P72; Yasuda, 2002, ORIGINS POTTERY AGR, P157; Zhang C., 2011, CULTURAL RELICS, V3, P46; Zhang C., 2002, ORIGINS POTTERY AGR, P185; Zhang JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052146; Zhang JZ, 2009, AGR ARCHAEOLOGY, V1, P35; [张永辉 Zhang Yonghui], 2011, [第四纪研究, Quaternary Sciences], V31, P891; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zhao Zhijun, 2009, KAOGU, V8, P84; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zhejiang Ministry of Agriculture P. R, 2000, CHIN COL WEED ILL BO; Zhejiang Provincial Institute of Archaeology and Cultural Relics, 2004, KUAH	80	60	70	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139885	10.1371/journal.pone.0139885	http://dx.doi.org/10.1371/journal.pone.0139885			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CT6ZJ	26460975	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300031
J	Lagerlund, M; Merlo, J; Vicente, RP; Zackrisson, S				Lagerlund, Magdalena; Merlo, Juan; Vicente, Raquel Perez; Zackrisson, Sophia			Does the Neighborhood Area of Residence Influence Non-Attendance in an Urban Mammography Screening Program? A Multilevel Study in a Swedish City	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; SOCIOECONOMIC PREDICTORS; LOGISTIC-REGRESSION; INDIVIDUAL HEALTH; BREAST; PARTICIPATION; WOMEN; DETERMINANTS; MODEL	Background and aim The public health impact of population-based mammography screening programs depends on high participation rates. Thus, monitoring participation rates, as well as understanding and considering the factors influencing attendance, is important. With the goal to acquire information on the appropriate level of intervention for increasing screening participation our study aimed to (1) examine whether, over and above individual factors, the neighborhood of residence influences a woman's mammography non-attendance, and (2) evaluate, whether knowing a woman's neighborhood of residence would be sufficient to predict non-attendance. Methods We analyze all women invited to mammography screening in 2005-09, residing in the city of Malmo, Sweden. Information regarding mammography screening attendance was linked to data on area of residence, demographic and socioeconomic characteristics available from Statistics Sweden. The influence of individual and neighborhood factors was assessed by multilevel logistic regression analysis with 29,901 women nested within 212 neighborhoods. Results The prevalence of non-attendance among women was 18.3%. After adjusting for individual characteristics, the prevalence in the 212 neighborhoods was 3.6%. Neighborhood of residence had little influence on non-attendance. The multilevel analysis indicates that 8.4% of the total individual differences in the propensity of non-attendance were at the neighborhood level. However, when adjusting for specific individual characteristics this general contextual effect decreased to 1.8%. This minor effect was explained by the sociodemographic characteristic of the neighborhoods. The discriminatory accuracy of classifying women according to their non-attendance was 0.747 when considering only individual level variables, and 0.760 after including neighborhood level as a random effect. Conclusion Our results suggest that neighborhoods of residence in Malmo, Sweden (as defined by small-area market statistics (SAMS) areas) do not condition women's participation in population based mammography screening. Thus, interventions should be directed to the whole city and target women with a higher risk of non-attendance.	[Lagerlund, Magdalena; Zackrisson, Sophia] Lund Univ, Skane Univ Hosp, Dept Translat Med, Diagnost Radiol, Malmo, Sweden; [Merlo, Juan; Vicente, Raquel Perez] Lund Univ, Dept Clin Sci, Fac Med, Unit Social Epidemiol, Malmo, Sweden	Lund University; Skane University Hospital; Lund University	Lagerlund, M (corresponding author), Lund Univ, Skane Univ Hosp, Dept Translat Med, Diagnost Radiol, Malmo, Sweden.	mlagerlu@gmail.com	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708	Swedish Cancer Society [CAN 2008/864]; Swedish Research Council [2013-2484]; Research funds of the Faculty of Medicine at Lund University; Governmental funding of Clinical research within the National Health Services (ALF grant)	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Research funds of the Faculty of Medicine at Lund University; Governmental funding of Clinical research within the National Health Services (ALF grant)	This research was funded by the Swedish Cancer Society (CAN 2008/864), the Swedish Research Council (2013-2484), Research funds of the Faculty of Medicine at Lund University, and Governmental funding of Clinical research within the National Health Services (ALF grant).	Aarts MJ, 2011, BREAST CANCER RES TR, V128, P517, DOI 10.1007/s10549-011-1363-z; Akinyemiju TF, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-16; Aro AR, 2001, BREAST CANCER RES TR, V70, P145, DOI 10.1023/A:1012939228916; Bingenheimer JB, 2004, ANNU REV PUBL HEALTH, V25, P53, DOI 10.1146/annurev.publhealth.25.050503.153925; Browne W., 2009, MCMC ESTIMATION MLWI; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; Dailey AB, 2007, CANCER EPIDEM BIOMAR, V16, P2293, DOI 10.1158/1055-9965.EPI-06-1076; Damiani G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-99; DONATO F, 1991, J EPIDEMIOL COMMUN H, V45, P59, DOI 10.1136/jech.45.1.59; Fukuda Y, 2005, PUBLIC HEALTH, V119, P875, DOI 10.1016/j.puhe.2005.03.013; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Islam MK, 2006, HEALTH ECON POLICY L, V1, P209, DOI 10.1017/S174413310600301X; Ivert AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081127; Johnell K, 2004, J EPIDEMIOL COMMUN H, V58, P59, DOI 10.1136/jech.58.1.59; Kothari AR, 2004, CAN J PUBLIC HEALTH, V95, P290, DOI 10.1007/BF03405134; Lagerlund M, 2000, PREV MED, V31, P417, DOI 10.1006/pmed.2000.0723; Lagerlund M, 2000, EUR J CANCER PREV, V9, P25, DOI 10.1097/00008469-200002000-00004; Lagerlund M, 2015, EUR J CANCER PREV, V24, P44, DOI 10.1097/CEJ.0000000000000025; Lagerlund M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-33; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lindstrom M, 2004, PREV MED, V39, P135, DOI 10.1016/j.ypmed.2004.01.011; Lindstrom M, 2002, SOC SCI MED, V54, P1779, DOI 10.1016/S0277-9536(01)00147-2; Litaker D, 2007, J WOMENS HEALTH, V16, P36, DOI 10.1089/jwh.2006.0090; Lopez-de-Andres A, 2010, J WOMENS HEALTH, V19, P1675, DOI 10.1089/jwh.2009.1828; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Meersman SC, 2009, CANCER CAUSE CONTROL, V20, P1469, DOI 10.1007/s10552-009-9373-4; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2003, AM J EPIDEMIOL, V157, P774, DOI 10.1093/aje/kwg053; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P791, DOI 10.1136/jech.55.11.791; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Morere JF, 2011, EUR J CANCER PREV, V20, pS8, DOI 10.1097/01.cej.0000391562.18512.4a; National Board of Health and Welfare, 1986, GENERAL GUIDELINES O; Ohlsson H, 2011, SOC SCI MED, V73, P1145, DOI 10.1016/j.socscimed.2011.08.005; Olsson S, 2000, J MED SCREEN, V7, P14, DOI 10.1136/jms.7.1.14; Olsson S, 1995, Lakartidningen, V92, P552; Ouedraogo S, 2014, PREV MED, V63, P103, DOI 10.1016/j.ypmed.2013.12.007; Palencia L, 2010, INT J EPIDEMIOL, V39, P757, DOI 10.1093/ije/dyq003; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pornet C, 2010, CANCER EPIDEMIOL, V34, P309, DOI 10.1016/j.canep.2010.03.010; Rosenberg L, 2005, CANCER EPIDEM BIOMAR, V14, P2628, DOI 10.1158/1055-9965.EPI-05-0441; Schootman M, 2006, J EPIDEMIOL COMMUN H, V60, P202, DOI 10.1136/jech.2005.041020; Schueler KM, 2008, J WOMENS HEALTH, V17, P1477, DOI 10.1089/jwh.2007.0603; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Statistics Sweden, 2015, POP MUN MAR STAT AG; Swedish Association of Local Authorities and Regions, 2013, 4 SWED ASS LOC AUTH; Wagner P, 2014, 20 IEA WORLD C EP WC; Wubker A, 2014, EUR J HEALTH ECON, V15, P497, DOI 10.1007/s10198-013-0490-3; Zackrisson S, 2004, INT J CANCER, V108, P754, DOI 10.1002/ijc.11622; Zackrisson S, 2007, SCAND J PUBLIC HEALT, V35, P548, DOI 10.1080/14034940701291716	58	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140244	10.1371/journal.pone.0140244	http://dx.doi.org/10.1371/journal.pone.0140244			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT6ZJ	26460609	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300072
J	Potuckova, E; Roh, J; Machacek, M; Sahni, S; Stariat, J; Sestak, V; Jansova, H; Haskova, P; Jirkovska, A; Vavrova, K; Kovarikova, P; Kalinowski, DS; Richardson, DR; Simunek, T				Potuckova, Eliska; Roh, Jaroslav; Machacek, Miloslav; Sahni, Sumit; Stariat, Jan; Sestak, Vit; Jansova, Hana; Haskova, Pavlina; Jirkovska, Anna; Vavrova, Katerina; Kovarikova, Petra; Kalinowski, Danuta S.; Richardson, Des R.; Simunek, Tomas			In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites	PLOS ONE			English	Article							2-BENZOYLPYRIDINE THIOSEMICARBAZONE SERIES; EFFECTIVE ANTIPROLIFERATIVE AGENTS; SELECTIVE ANTINEOPLASTIC ACTIVITY; ISONICOTINOYL HYDRAZONE CLASS; CELL-CYCLE PROGRESSION; IRON CHELATORS; ANTITUMOR-ACTIVITY; NEOPLASTIC-CELLS; DRUG DISCOVERY; REDOX ACTIVITY	Cancer cells have a high iron requirement and many experimental studies, as well as clinical trials, have demonstrated that iron chelators are potential anti-cancer agents. The ligand, 2-benzoylpyridine 4-ethyl-3-thiosemicarbazone (Bp4eT), demonstrates both potent anti-neoplastic and anti-retroviral properties. In this study, Bp4eT and its recently identified amidrazone and semicarbazone metabolites were examined and compared with respect to their anti-proliferative activity towards cancer cells (HL-60 human promyelocytic leukemia, MCF-7 human breast adenocarcinoma, HCT116 human colon carcinoma and A549 human lung adenocarcinoma), non-cancerous cells (H9c2 neonatal rat-derived cardiomyoblasts and 3T3 mouse embryo fibroblasts) and their interaction with intracellular iron pools. Bp4eT was demonstrated to be a highly potent and selective anti-neoplastic agent that induces S phase cell cycle arrest, mitochondrial depolarization and apoptosis in MCF-7 cells. Both semicarbazone and amidrazone metabolites showed at least a 300-fold decrease in cytotoxic activity than Bp4eT towards both cancer and normal cell lines. The metabolites also lost the ability to: (1) promote the redox cycling of iron; (2) bind and mobilize iron from labile intracellular pools; and (3) prevent Fe-59 uptake from Fe-59-labeled transferrin by MCF-7 cells. Hence, this study demonstrates that the highly active ligand, Bp4eT, is metabolized to non-toxic and pharmacologically inactive analogs, which most likely contribute to its favorable pharmacological profile. These findings are important for the further development of this drug candidate and contribute to the understanding of the structure-activity relationships of these agents.	[Potuckova, Eliska; Machacek, Miloslav; Jansova, Hana; Haskova, Pavlina; Jirkovska, Anna; Simunek, Tomas] Charles Univ Prague, Fac Pharm, Dept Biochem Sci, CS-50165 Hradec Kralove, Czech Republic; [Roh, Jaroslav; Vavrova, Katerina] Charles Univ Prague, Fac Pharm, Dept Inorgan & Organ Chem, CS-50165 Hradec Kralove, Czech Republic; [Sahni, Sumit; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Bosch Inst, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; [Sahni, Sumit; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; [Stariat, Jan; Sestak, Vit; Kovarikova, Petra] Charles Univ Prague, Fac Pharm, Dept Pharmaceut Chem & Drug Anal, CS-50165 Hradec Kralove, Czech Republic	Charles University Prague; Charles University Prague; University of Sydney; University of Sydney; Charles University Prague	Richardson, DR (corresponding author), Univ Sydney, Bosch Inst, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au; Tomas.Simunek@faf.cuni.cz	Simunek, Tomas/A-3938-2008; Roh, Jaroslav/S-7863-2017; Sterbova, Petra/T-5493-2017; Machacek, Miloslav/T-3378-2017; Hašková, Pavlína/ABC-6019-2021; Jansova, Hana/S-5847-2017; Jirkovska, Anna/E-8419-2012; Sestak, Vit/AAE-6304-2021; Vavrova, Katerina/A-2895-2008	Simunek, Tomas/0000-0001-5464-4176; Roh, Jaroslav/0000-0003-4698-8379; Sterbova, Petra/0000-0002-1242-5706; Machacek, Miloslav/0000-0001-7221-5914; Jansova, Hana/0000-0002-5377-518X; Jirkovska, Anna/0000-0002-0131-6010; Vavrova, Katerina/0000-0002-8502-4372; Sestak, Vit/0000-0002-4688-2577; Richardson, Des/0000-0002-5506-3274; Kalinowski, Danuta/0000-0002-9303-7405; Sahni, Sumit/0000-0002-2900-8845; Richardson, Des/0000-0003-0960-6415	Czech Science Foundation [13-15008S]; National Health and Medical Research Council of Australia; NHMRC R.D. Wright Training Fellowship	Czech Science Foundation(Grant Agency of the Czech Republic); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC R.D. Wright Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Czech Science Foundation (grant 13-15008S; www.gacr.cz). D.R.R. thanks the National Health and Medical Research Council of Australia for a Senior Principal Research Fellowship and Project Grants. D.S.K appreciated an NHMRC R.D. Wright Training Fellowship and a Project Grant (www.nhmrc.gov.au).	ALLEGRETTI PE, 2003, INT J CHEM SCI, V1, P1; BAKER E, 1992, HEPATOLOGY, V15, P492, DOI 10.1002/hep.1840150323; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Becker E, 1999, J LAB CLIN MED, V134, P510, DOI 10.1016/S0022-2143(99)90173-7; BECTON DL, 1989, CANCER RES, V49, P4809; Biederbick A, 1995, EUR J CELL BIOL, V6, P3; Chao J, 2012, CANCER CHEMOTH PHARM, V69, P835, DOI 10.1007/s00280-011-1779-5; Chaston TB, 2004, CLIN CANCER RES, V10, P7365, DOI 10.1158/1078-0432.CCR-04-0865; CHIU SHL, 1995, TOXICOL PATHOL, V23, P124; Debebe Z, 2012, J CHROMATOGR B, V906, P25, DOI 10.1016/j.jchromb.2012.08.011; Debebe Z, 2011, MOL PHARMACOL, V79, P185, DOI 10.1124/mol.110.069062; Delie F, 1997, CRIT REV THER DRUG, V14, P221; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Glickstein H, 2006, BLOOD, V108, P3195, DOI 10.1182/blood-2006-05-020867; Gutierrez E, 2014, J BIOL CHEM, V289, P33568, DOI 10.1074/jbc.M114.599480; Honda O, 2000, INT J ONCOL, V16, P283; Kalinowski DS, 2007, J MED CHEM, V50, P3716, DOI 10.1021/jm070445z; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Korolchuk V. I., 2012, BIOCHEMIST, V34, P8; Kralova V, 2012, TOXICOL IN VITRO, V26, P258, DOI 10.1016/j.tiv.2011.12.010; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lane DJR, 2014, BBA-REV CANCER, V1845, P166, DOI 10.1016/j.bbcan.2014.01.005; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; LEDERMAN HM, 1984, BLOOD, V64, P748; Liang Y, 2001, ONCOGENE, V20, P6570, DOI 10.1038/sj.onc.1204815; Lin JH, 1997, PHARMACOL REV, V49, P403; Lui GYL, 2013, MOL PHARMACOL, V83, P179, DOI 10.1124/mol.112.081893; Mackova E, 2012, CHEM-BIOL INTERACT, V197, P69, DOI 10.1016/j.cbi.2012.03.010; Merlot AM, 2013, MOL PHARMACOL, V84, P911, DOI 10.1124/mol.113.088393; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; Merlot AM, 2010, MOL PHARMACOL, V78, P675, DOI 10.1124/mol.110.066126; Miao QH, 2010, BIOMATERIALS, V31, P7364, DOI 10.1016/j.biomaterials.2010.06.012; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mladenka P, 2009, CHEM RES TOXICOL, V22, P208, DOI 10.1021/tx800331j; Mortazavi A, 2013, INVEST NEW DRUG, V31, P685, DOI 10.1007/s10637-012-9863-1; Munafo DB, 2001, J CELL SCI, V114, P3619; Ocean AJ, 2011, CANCER CHEMOTH PHARM, V68, P379, DOI 10.1007/s00280-010-1481-z; Potuckova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088754; RICHARDSON D, 1992, J BIOL CHEM, V267, P13972; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Rodriguez-Lucena D, 2010, BIOORGAN MED CHEM, V18, P689, DOI 10.1016/j.bmc.2009.11.057; Sahni S, 2014, J BIOL CHEM, V289, P9692, DOI 10.1074/jbc.M113.529511; Stariat J, 2014, BIOMED CHROMATOGR, V28, P621, DOI 10.1002/bmc.3080; Stariat J, 2012, ANAL BIOANAL CHEM, V403, P309, DOI 10.1007/s00216-012-5766-4; Stariat J, 2010, ANAL BIOANAL CHEM, V397, P161, DOI 10.1007/s00216-009-3448-7; Stefani C, 2013, J MED CHEM, V56, P357, DOI 10.1021/jm301691s; Stefani C, 2011, J MED CHEM, V54, P6936, DOI 10.1021/jm200924c; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; WEST DX, 1995, POLYHEDRON, V14, P2189, DOI 10.1016/0277-5387(95)00010-P; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	55	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139929	10.1371/journal.pone.0139929	http://dx.doi.org/10.1371/journal.pone.0139929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460540	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300038
J	Saekmose, SG; Mossner, B; Christensen, PB; Lindvig, K; Schlosser, A; Holst, R; Barington, T; Holmskov, U; Sorensen, GL				Saekmose, Susanne Gjorup; Mossner, Belinda; Christensen, Peer Brehm; Lindvig, Kristoffer; Schlosser, Anders; Holst, Rene; Barington, Torben; Holmskov, Uffe; Sorensen, Grith Lykke			Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CHRONIC VIRAL-HEPATITIS; TRANSIENT ELASTOGRAPHY; GLYCOPROTEIN MAGP-36; DRUG-USERS; STIFFNESS; DISEASE; LUNG; PERFORMANCE; EXPRESSION	Background and Aims A method for assessment of liver fibrosis and cirrhosis without the need for a liver biopsy is desirable. Microfibrillar-associated protein 4 (MFAP4) is a suggested biomarker for identification of high-risk patients with severe fibrosis stages. This study aimed to examine associations between plasma MFAP4 (pMFAP4) and transient elastography or chronic hepatitis C virus infection in drug users and in a mixed patient cohort with increased risk of liver disease. Moreover, the study aimed to identify comorbidities that significantly influence pMFAP4. Methods pMFAP4 was measured in samples from 351 drug users attending treatment centres and from 248 acutely hospitalized medical patients with mixed diagnoses. Linear and logistic multivariate regression analyses were performed and nonparametric receiver operating characteristic-curves for cirrhosis were used to estimate cut-off points for pMFAP4. Univariate and subgroup analyses were performed using non-parametric methods. Results pMFAP4 increased significantly with liver fibrosis score. pMFAP4 was significantly associated with chronic viral infection in the drug users and with transient elastography in both cohorts. In the mixed patient cohort, pMFAP4 was significantly increased among patients with a previous diagnosis of liver disease or congestive heart failure compared to patients with other diagnoses. Conclusions pMFAP4 has the potential to be used as an outreach-screening tool for liver fibrosis in drug users and in mixed medical patients. pMFAP4 level is positively associated with transient elastography, but additional studies are warranted to validate the possible use of pMFAP4 in larger cohorts and in combination with transient elastography.	[Saekmose, Susanne Gjorup; Schlosser, Anders; Holmskov, Uffe; Sorensen, Grith Lykke] Univ Southern Denmark, Inst Mol Med, Odense, Denmark; [Saekmose, Susanne Gjorup] Naestved Hosp, Dept Clin Immunol, Naestved, Denmark; [Mossner, Belinda; Christensen, Peer Brehm; Lindvig, Kristoffer] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Holst, Rene] Univ Southern Denmark, Inst Reg Hlth Res, Dept Biostat, Odense, Denmark; [Barington, Torben] Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense, Denmark; [Barington, Torben] Odense Univ Hosp, Odense Patient Data Explorat Network OPEN, DK-5000 Odense, Denmark	University of Southern Denmark; Naestved Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Sorensen, GL (corresponding author), Univ Southern Denmark, Inst Mol Med, Odense, Denmark.	glsorensen@health.sdu.dk	Barington, Torben/C-3922-2009; Barington, Torben/R-6841-2019; Holmskov, Uffe/AAA-3056-2022	Barington, Torben/0000-0001-6968-148X; Holmskov, Uffe/0000-0002-2391-9445; Sorensen, Grith Lykke/0000-0002-5273-1097; Saekmose, Susanne Gjorup/0000-0002-1346-0052; Christensen, Peer Brehm/0000-0003-1394-058X	Region of Southern Denmark PhD-resources; Fonden til Laege-videnskabens Fremme; Overlaegeradet at Odense University Hospital; Free Research Funds from Odense University Research Pool; Lundbeck Foundation [R164-2013-15355, R108-2012-10802, R67-2010-6409] Funding Source: researchfish; Novo Nordisk Fonden [NNF15SA0018400] Funding Source: researchfish	Region of Southern Denmark PhD-resources; Fonden til Laege-videnskabens Fremme; Overlaegeradet at Odense University Hospital; Free Research Funds from Odense University Research Pool; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Region of Southern Denmark PhD-resources (SGS, http://regionsyddanmark.dk/wm325002), Fonden til Laege-videnskabens Fremme (SGS, http://www.apmollerfonde.dk/ansoegning/laegefonden.aspx), Overlaegeradet at Odense University Hospital (SGS), and The Free Research Funds from Odense University Research Pool (SGS). The funders had no role in study design, data collection and analysis, decision to publish, or prepara-tion of the manuscript.	ALTER MJ, 1997, HEPATOLOGY S1, V26, P62; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bracht T, 2015, J PROTEOME RES, V14, P2278, DOI 10.1021/acs.jproteome.5b00053; Brandsma CA, 2015, THORAX, V70, P21, DOI 10.1136/thoraxjnl-2014-205091; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen PB, 2007, SCAND J INFECT DIS, V39, P245, DOI 10.1080/00365540600978864; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Holm AT, 2015, AM J PHYSL IN PRESS; Johansson SL, 2014, RESP MED, V108, P1336, DOI 10.1016/j.rmed.2014.06.003; Kasamatsu S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00164; Lausen M, 1999, J BIOL CHEM, V274, P32234, DOI 10.1074/jbc.274.45.32234; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Lindvig K, 2012, EUR J CLIN INVEST, V42, P146, DOI 10.1111/j.1365-2362.2011.02571.x; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Molleken C, 2009, HEPATOLOGY, V49, P1257, DOI 10.1002/hep.22764; Moessner BK, 2011, ADDICTION, V106, P970, DOI 10.1111/j.1360-0443.2010.03246.x; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Mossner BK, 2010, J MED VIROL, V82, P1635, DOI 10.1002/jmv.21836; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pilecki B, 2015, THORAX, V70, P862, DOI 10.1136/thoraxjnl-2014-206609; Saekmose SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082383; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x; Toyoshima T, 2005, EXP CELL RES, V307, P224, DOI 10.1016/j.yexcr.2005.03.005; Toyoshima T, 1999, J HISTOCHEM CYTOCHEM, V47, P1049, DOI 10.1177/002215549904700809; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; World Health Organization, 2013, GLOB POL REP PREV CO; Wulf-Johansson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082243; Yoshioka K, 2008, HEPATOL RES, V38, P1063, DOI 10.1111/j.1872-034X.2008.00386.x; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589	32	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140418	10.1371/journal.pone.0140418	http://dx.doi.org/10.1371/journal.pone.0140418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460565	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300093
J	Soler, GA; Edgar, GJ; Thomson, RJ; Kininmonth, S; Campbell, SJ; Dawson, TP; Barrett, NS; Bernard, ATF; Galvan, DE; Willis, TJ; Alexander, TJ; Stuart-Smith, RD				Soler, German A.; Edgar, Graham J.; Thomson, Russell J.; Kininmonth, Stuart; Campbell, Stuart J.; Dawson, Terence P.; Barrett, Neville S.; Bernard, Anthony T. F.; Galvan, David E.; Willis, Trevor J.; Alexander, Timothy J.; Stuart-Smith, Rick D.			Reef Fishes at All Trophic Levels Respond Positively to Effective Marine Protected Areas	PLOS ONE			English	Article							SOUTHERN AUSTRALIA; CORAL-REEFS; ASSEMBLAGES; DIVERSITY; ABUNDANCE; CASCADES; IMPACTS; ECOLOGY	Marine Protected Areas (MPAs) offer a unique opportunity to test the assumption that fishing pressure affects some trophic groups more than others. Removal of larger predators through fishing is often suggested to have positive flow-on effects for some lower trophic groups, in which case protection from fishing should result in suppression of lower trophic groups as predator populations recover. We tested this by assessing differences in the trophic structure of reef fish communities associated with 79 MPAs and open-access sites worldwide, using a standardised quantitative dataset on reef fish community structure. The biomass of all major trophic groups (higher carnivores, benthic carnivores, planktivores and herbivores) was significantly greater (by 40% - 200%) in effective no-take MPAs relative to fished open-access areas. This effect was most pronounced for individuals in large size classes, but with no size class of any trophic group showing signs of depressed biomass in MPAs, as predicted from higher predator abundance. Thus, greater biomass in effective MPAs implies that exploitation on shallow rocky and coral reefs negatively affects biomass of all fish trophic groups and size classes. These direct effects of fishing on trophic structure appear stronger than any top down effects on lower trophic levels that would be imposed by intact predator populations. We propose that exploitation affects fish assemblages at all trophic levels, and that local ecosystem function is generally modified by fishing.	[Soler, German A.; Edgar, Graham J.; Thomson, Russell J.; Kininmonth, Stuart; Barrett, Neville S.; Stuart-Smith, Rick D.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Kininmonth, Stuart] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Campbell, Stuart J.] Wildlife Conservat Soc, Indonesia Marine Program, Bogor, Indonesia; [Dawson, Terence P.] Univ Dundee, Sch Environm, Dundee DD1 4HN, Scotland; [Bernard, Anthony T. F.] South African Environm Observat Network Elwandle, Grahamstown, South Africa; [Bernard, Anthony T. F.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Galvan, David E.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Willis, Trevor J.] Univ Portsmouth, Sch Biol Sci, Inst Marine Sci, Portsmouth, Hants, England; [Alexander, Timothy J.] EAWAG Swiss Fed Inst Aquat Sci & Technol, Dept Fish Ecol & Evolut, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland; [Alexander, Timothy J.] Univ Bern, Div Aquat Ecol & Evolut, Inst Ecol & Evolut, Bern, Switzerland	University of Tasmania; Stockholm University; Wildlife Conservation Society - Indonesia; University of Dundee; Rhodes University; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Portsmouth; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern	Soler, GA (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	gasoler@utas.edu.au	Stuart-Smith, Rick/I-5214-2019; Barrett, Neville S/J-7593-2014; Edgar, Graham/AAY-3797-2020; Bernard, Anthony/M-8292-2019; Stuart-Smith, Rick D/M-1829-2013; Willis, Trevor/F-5337-2012; Thomson, Russell J/H-5653-2012; Dawson, Terence Peter/E-4724-2011; Kininmonth, Stuart/N-9299-2013	Stuart-Smith, Rick/0000-0002-8874-0083; Barrett, Neville S/0000-0002-6167-1356; Edgar, Graham/0000-0003-0833-9001; Bernard, Anthony/0000-0003-0482-6283; Stuart-Smith, Rick D/0000-0002-8874-0083; Willis, Trevor/0000-0002-0357-1189; Thomson, Russell J/0000-0003-4949-4120; Dawson, Terence Peter/0000-0002-4314-1378; Kininmonth, Stuart/0000-0001-9198-3396; Campbell, Stuart/0000-0002-1158-3200; Galvan, David/0000-0001-8132-6069	Australian Research Council, a postgraduate scholarship from IMAS-CSIRO; Marine Biodiversity Hub, a collaborative partnership funded under the Australian Government's National Environmental Research Program; National Geographic Society; Conservation International; Wildlife Conservation Society; Winifred Violet Scott Trust; Tasmanian Parks and Wildlife Service; Winston Churchill Memorial Trust; University of Tasmania; ASSEMBLE Marine	Australian Research Council, a postgraduate scholarship from IMAS-CSIRO(Australian Research Council); Marine Biodiversity Hub, a collaborative partnership funded under the Australian Government's National Environmental Research Program; National Geographic Society(National Geographic Society); Conservation International; Wildlife Conservation Society; Winifred Violet Scott Trust; Tasmanian Parks and Wildlife Service; Winston Churchill Memorial Trust; University of Tasmania; ASSEMBLE Marine	This study was supported by the Australian Research Council, a postgraduate scholarship from IMAS-CSIRO (to GAS), and the Marine Biodiversity Hub, a collaborative partnership funded under the Australian Government's National Environmental Research Program. Surveys were assisted by grants from the National Geographic Society, Conservation International, Wildlife Conservation Society, Winifred Violet Scott Trust, Tasmanian Parks and Wildlife Service, the Winston Churchill Memorial Trust, University of Tasmania, and ASSEMBLE Marine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Ban NC, 2012, AQUAT CONSERV, V22, P262, DOI 10.1002/aqc.2224; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P53, DOI 10.1016/0022-0981(95)00083-6; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P107, DOI 10.1016/0022-0981(95)00085-2; Edgar GJ, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.7; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Halpern BS, 2003, ECOL APPL, V13, pS117; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; Jones PJS, 2001, REV FISH BIOL FISHER, V11, P197, DOI 10.1023/A:1020327007975; Kelaher BP, 2015, BIOL CONSERV, V182, P205, DOI 10.1016/j.biocon.2014.12.011; Kelble CR, 2005, ESTUARIES, V28, P560, DOI 10.1007/BF02696067; Kellner JB, 2010, ECOL APPL, V20, P1979, DOI 10.1890/09-1217.1; Kingsland SE, 2002, ENVIRON MODEL ASSESS, V7, P61, DOI 10.1023/A:1015633830223; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Pauly D, 2005, PHILOS T ROY SOC B, V360, P415, DOI 10.1098/rstb.2004.1597; Pauly D, 2000, AM SCI, V88, P46; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Silverman B.W, 1986, MONOGRAPHS STAT APPL, V26, P175, DOI New York; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Willis TJ, 2005, ECOL LETT, V8, P47, DOI 10.1111/j.1461-0248.2004.00692.x; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209	42	39	39	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140270	10.1371/journal.pone.0140270	http://dx.doi.org/10.1371/journal.pone.0140270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461104	Green Published, gold			2022-12-26	WOS:000362962300076
J	Baldwin, GS; George, GN; Pushie, MJ				Baldwin, Graham S.; George, Graham N.; Pushie, M. Jake			High Affinity Binding of Indium and Ruthenium Ions by Gastrins	PLOS ONE			English	Article							GLYCINE-EXTENDED GASTRIN; NON-AMIDATED GASTRINS; BIOLOGICAL-ACTIVITY; FERRIC IONS; BISMUTH IONS; K-EDGE; COMPLEXES; PROGASTRIN; CANCER; SPECTROSCOPY	The peptide hormone gastrin binds two ferric ions with high affinity, and iron binding is essential for the biological activity of non-amidated forms of the hormone. Since gastrins act as growth factors in gastrointestinal cancers, and as peptides labelled with Ga and In isotopes are increasingly used for cancer diagnosis, the ability of gastrins to bind other metal ions was investigated systematically by absorption spectroscopy. The coordination structures of the complexes were characterized by extended X-ray absorption fine structure (EXAFS) spectroscopy. Changes in the absorption of gastrin in the presence of increasing concentrations of Ga3+ were fitted by a 2 site model with dissociation constants (K-d) of 3.3 x 10(-7) and 1.1 x 10(-6) M. Although the absorption of gastrin did not change upon the addition of In3+ ions, the changes in absorbance on Fe3+ ion binding in the presence of indium ions were fitted by a 2 site model with K-d values for In3+ of 6.5 x 10(-15) and 1.7 x 10(-7) M. Similar results were obtained with Ru3+ ions, although the K-d values for Ru3+ of 2.6 x 10(-13) and 1.2 x 10(-5) M were slightly larger than observed for In3+. The structures determined by EXAFS all had metal: gastrin stoichiometries of 2:1 but, while the metal ions in the Fe, Ga and In complexes were bridged by a carboxylate and an oxygen with a metal-metal separation of 3.0-3.3 angstrom, the Ru complex clearly demonstrated a short range Ru-Ru separation, which was significantly shorter, at 2.4 angstrom, indicative of a metal-metal bond. We conclude that gastrin selectively binds two In3+ or Ru3+ ions, and that the affinity of the first site for In3+ or Ru3+ ions is higher than for ferric ions. Some of the metal ion-gastrin complexes may be useful for cancer diagnosis and therapy.	[Baldwin, Graham S.] Univ Melbourne, Dept Surg, Austin Hlth, Heidelberg, Vic 3084, Australia; [George, Graham N.; Pushie, M. Jake] Univ Saskatchewan, Dept Geol Sci, Mol & Environm Sci Res Grp, Saskatoon, SK S7N 5E2, Canada	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Saskatchewan	Baldwin, GS (corresponding author), Univ Melbourne, Dept Surg, Austin Hlth, Heidelberg, Vic 3084, Australia.	grahamsb@unimelb.edu.au		Pushie, M. Jake/0000-0001-7494-5427; George, Graham/0000-0002-0420-7493	National Health and Medical Research Council of Australia [400062, 454322, 1020983]; Canada Research Chairs program; Canadian Institutes of Health Research (CIHR); Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC); Sylvia Fedoruk Canadian Centre for Nuclear Innovation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canada Research Chairs program(Canada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sylvia Fedoruk Canadian Centre for Nuclear Innovation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Health and Medical Research Council of Australia (400062, 454322, 1020983; GSB). Research at the University of Saskatchewan is supported by funding from the Canada Research Chairs program (GNG), the Canadian Institutes of Health Research (CIHR), the Saskatchewan Health Research Foundation and the Natural Sciences and Engineering Research Council of Canada (NSERC). MJP is an Associate in the CIHR-Training in Health Research Using Synchrotron Techniques program, and is additionally supported by the Sylvia Fedoruk Canadian Centre for Nuclear Innovation. The Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393).	Allen F, 1994, STRUCTURE CORRELATIO, P71, DOI DOI 10.1002/9783527616091; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Aly A, 2004, BBA-REV CANCER, V1704, P1, DOI 10.1016/j.bbcan.2004.01.004; Baldwin GS, 2004, PROTEIN J, V23, P65, DOI 10.1023/B:JOPC.0000016259.59562.6c; Baldwin GS, 2001, BIOCHEMISTRY-US, V40, P10741, DOI 10.1021/bi010016h; Baldwin GS, 2001, J BIOL CHEM, V276, P7791, DOI 10.1074/jbc.M009985200; Cotton F. A., 2005, MULTIPLE BONDS METAL; CRAMER SP, 1988, NUCL INSTRUM METH A, V266, P586, DOI 10.1016/0168-9002(88)90449-4; DEWITT JG, 1995, INORG CHEM, V34, P2505, DOI 10.1021/ic00114a007; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; Ferrand A, 2006, CANCER LETT, V238, P15, DOI 10.1016/j.canlet.2005.06.025; George GN, 1996, J AM CHEM SOC, V118, P8588, DOI 10.1021/ja961218h; George MJ, 2000, J SYNCHROTRON RADIAT, V7, P283, DOI 10.1107/S090904950000683X; HARRIS WR, 1994, INORG CHEM, V33, P4991, DOI 10.1021/ic00100a024; Harris WR., 1998, STRUCT BOND, V92, P121; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Kovac S, 2012, BIOCHEM PHARMACOL, V83, P524, DOI 10.1016/j.bcp.2011.11.030; Kovac S, 2011, BBA-MOL CELL RES, V1813, P889, DOI 10.1016/j.bbamcr.2011.02.007; Kowalski-Chauvel A, 2012, J BIOL CHEM, V287, P41458, DOI 10.1074/jbc.M112.382465; Lin ZZ, 2005, EUR J INORG CHEM, P1927, DOI 10.1002/ejic.200400968; Naqvi SAR, 2013, PAK J PHARM SCI, V26, P299; Okamoto K, 2003, INORG CHEM, V42, P8682, DOI 10.1021/ic034373n; Pannequin J, 2004, J ENDOCRINOL, V181, P315, DOI 10.1677/joe.0.1810315; Pannequin J, 2004, J BIOL CHEM, V279, P2453, DOI 10.1074/jbc.M309806200; Pannequin J, 2002, J BIOL CHEM, V277, P48602, DOI 10.1074/jbc.M208440200; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; Reubi JC, 1997, CANCER RES, V57, P1377; Roosenburg S, AMINO ACIDS, V41, P1049; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROYER CA, 1993, ANAL BIOCHEM, V210, P91, DOI 10.1006/abio.1993.1155; ROYER CA, 1990, ANAL BIOCHEM, V191, P287, DOI 10.1016/0003-2697(90)90221-T; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; Singh P, 2007, ONCOGENE, V26, P425, DOI 10.1038/sj.onc.1209798; Urdaneta M, 2013, J NUCL MED, V54, P1195; von Guggenberg E, 2012, MOL IMAGING BIOL, V14, P366, DOI 10.1007/s11307-011-0506-2; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Yoon SG, 2004, J AM CHEM SOC, V126, P16692, DOI 10.1021/ja044489y	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140126	10.1371/journal.pone.0140126	http://dx.doi.org/10.1371/journal.pone.0140126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457677	Green Published, gold			2022-12-26	WOS:000362961100023
J	Evans, LE; Cheeseman, MD; Yahya, N; Jones, K				Evans, Lindsay E.; Cheeseman, Matthew D.; Yahya, Norhakim; Jones, Keith			Investigating Apoptozole as a Chemical Probe for HSP70 Inhibition	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; HEAT-SHOCK-PROTEIN; TARGET VALIDATION; ATPASE ACTIVITY; HSC70; IDENTIFICATION; CHAPERONES; APOPTOSIS; BINDING; DOMAIN	The use of chemical tools to validate clinical targets has gained in popularity over recent years and the importance of understanding the activity, selectivity and mechanism of action of these compounds is well recognized. Dysregulation of the HSP70 protein family has been linked to multiple cancer types and drug resistance, highlighting their importance as popular targets for anti-cancer drug development. Apoptozole is a recently identified small molecule, which has been reported to possess strong affinity for the HSP70 isoforms HSP72 and HSC70. We investigated apoptozole as a potential chemical tool for HSP70 inhibition. Unfortunately, using both biochemical and biophysical techniques, we were unable to find any experimental evidence that apoptozole binds to HSP70 in a specific and developable way. Instead, we provide experimental evidence that apoptozole forms aggregates under aqueous conditions that could interact with HSP70 proteins in a non-specific manner.	[Evans, Lindsay E.; Cheeseman, Matthew D.; Yahya, Norhakim; Jones, Keith] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SW7 3RP, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Jones, K (corresponding author), Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SW7 3RP, England.	Keith.Jones@icr.ac.uk	Jones, Keith/R-7629-2016; Cheeseman, Matthew/Q-9527-2016	Jones, Keith/0000-0002-9440-4094; Cheeseman, Matthew/0000-0003-1121-6985	Wellcome Trust studentship; Cancer Research UK [C309/A8274, C309/A11566]; Cancer Research UK [11566] Funding Source: researchfish	Wellcome Trust studentship(Wellcome Trust); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Wellcome Trust studentship http://www.wellcome.ac.uk/ (LEE), and Cancer Research UK, C309/A8274 and C309/A11566 www.cancerresearchuk.org/ (MDC, NY, KJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NAT CHEM BIOL, V9, P193, DOI 10.1038/nchembio.1226; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Blagg J, 2014, CURR OPIN PHARMACOL, V17, P87, DOI 10.1016/j.coph.2014.07.007; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Cho HJ, 2015, MOL BIOSYST, V11, P2763, DOI 10.1039/c4mb00695j; Cho HJ, 2011, J AM CHEM SOC, V133, P20267, DOI 10.1021/ja206762p; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Davis BJ, 2013, BIOORG MED CHEM LETT, V23, P2844, DOI 10.1016/j.bmcl.2013.03.028; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Haney CM, 2009, BIOORG MED CHEM LETT, V19, P3828, DOI 10.1016/j.bmcl.2009.04.062; Huang XY, 2003, J BIOMOL SCREEN, V8, P34, DOI 10.1177/1087057102239666; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kang YL, 2008, BIOORG MED CHEM LETT, V18, P3749, DOI 10.1016/j.bmcl.2008.05.046; Ko SK, 2015, CHEM BIOL, V22, P391, DOI 10.1016/j.chembiol.2015.02.004; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Massey AJ, 2010, J MED CHEM, V53, P7280, DOI 10.1021/jm100342z; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Owen SC, 2012, ACS CHEM BIOL, V7, P1429, DOI 10.1021/cb300189b; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Schuster D, 2005, CURR PHARM DESIGN, V11, P3545, DOI 10.2174/138161205774414510; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Williams DR, 2008, ANGEW CHEM INT EDIT, V47, P7466, DOI 10.1002/anie.200802801; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013	38	16	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140006	10.1371/journal.pone.0140006	http://dx.doi.org/10.1371/journal.pone.0140006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458144	Green Submitted, Green Published, gold			2022-12-26	WOS:000362961100018
J	Megchelenbrink, W; Rossell, S; Huynen, MA; Notebaart, RA; Marchiori, E				Megchelenbrink, Wout; Rossell, Sergio; Huynen, Martijn A.; Notebaart, Richard A.; Marchiori, Elena			Estimating Metabolic Fluxes Using a Maximum Network Flexibility Paradigm	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; DRUG TARGETS; SCALE MODELS; INTEGRATION; CONSISTENT; GROWTH; CANCER	Motivation Genome-scale metabolic networks can be modeled in a constraint-based fashion. Reaction stoichiometry combined with flux capacity constraints determine the space of allowable reaction rates. This space is often large and a central challenge in metabolic modeling is finding the biologically most relevant flux distributions. A widely used method is flux balance analysis (FBA), which optimizes a biologically relevant objective such as growth or ATP production. Although FBA has proven to be highly useful for predicting growth and byproduct secretion, it cannot predict the intracellular fluxes under all environmental conditions. Therefore, alternative strategies have been developed to select flux distributions that are in agreement with experimental "omics" data, or by incorporating experimental flux measurements. The latter, unfortunately can only be applied to a limited set of reactions and is currently not feasible at the genome-scale. On the other hand, it has been observed that micro-organisms favor a suboptimal growth rate, possibly in exchange for a more "flexible" metabolic network. Instead of dedicating the internal network state to an optimal growth rate in one condition, a suboptimal growth rate is used, that allows for an easier switch to other nutrient sources. A small decrease in growth rate is exchanged for a relatively large gain in metabolic capability to adapt to changing environmental conditions. Results Here, we propose Maximum Metabolic Flexibility (MMF) a computational method that utilizes this observation to find the most probable intracellular flux distributions. By mapping measured flux data from central metabolism to the genome-scale models of Escherichia coli and Saccharomyces cerevisiae we show that i) indeed, most of the measured fluxes agree with a high adaptability of the network, ii) this result can be used to further reduce the space of feasible solutions iii) this reduced space improves the quantitative predictions made by FBA and contains a significantly larger fraction of the measured fluxes compared to the flux space that was reduced by a uniform sampling approach and iv) MMF can be used to select reactions in the network that contribute most to the steady-state flux space. Constraining the selected reactions improves the quantitative predictions of FBA considerably more than adding an equal amount of flux constraints, selected using a more naive approach. Our method can be applied to any cell type without requiring prior information.	[Megchelenbrink, Wout; Marchiori, Elena] Radboud Univ Nijmegen, ICIS, NL-6525 ED Nijmegen, Netherlands; [Megchelenbrink, Wout; Rossell, Sergio; Huynen, Martijn A.; Notebaart, Richard A.] Radboud Univ Nijmegen, Med Ctr, CMBI, NL-6525 ED Nijmegen, Netherlands; [Megchelenbrink, Wout; Rossell, Sergio; Huynen, Martijn A.; Notebaart, Richard A.; Marchiori, Elena] Radboud Univ Nijmegen, Med Ctr, CSBB, NL-6525 ED Nijmegen, Netherlands; [Rossell, Sergio] Netherlands Canc Inst NKI, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Netherlands Cancer Institute	Megchelenbrink, W (corresponding author), Radboud Univ Nijmegen, ICIS, NL-6525 ED Nijmegen, Netherlands.	W.Megchelenbrink@cs.ru.nl; Richard.Notebaart@radboudumc.nl	Huynen, Martijn A/A-1530-2014	Huynen, Martijn A/0000-0001-6189-5491	CSBR (Centres for Systems Biology Research) from the Netherlands Organisation for Scientific Research (NWO) [CSBR09/013V]	CSBR (Centres for Systems Biology Research) from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by CSBR (Centres for Systems Biology Research) from the Netherlands Organisation for Scientific Research (NWO) (CSBR09/ 013V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.145122; Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Massucci FA, 2013, METABOLITES, V3, P838, DOI 10.3390/metabo3030838; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Bonarius HPJ, 1997, TRENDS BIOTECHNOL, V15, P308, DOI 10.1016/S0167-7799(97)01067-6; Braunstein A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-240; Bro C, 2006, METAB ENG, V8, P102, DOI 10.1016/j.ymben.2005.09.007; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; De Martino D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122670; DYER ME, 1988, SIAM J COMPUT, V17, P967, DOI 10.1137/0217060; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Holm AK, 2010, J BIOL CHEM, V285, P17498, DOI 10.1074/jbc.M109.095570; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jensen PA, 2011, BIOINFORMATICS, V27, P541, DOI 10.1093/bioinformatics/btq702; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jerby L, 2012, CLIN CANCER RES, V18, P5572, DOI 10.1158/1078-0432.CCR-12-1856; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Larhlimi A, 2011, BIOSYSTEMS, V106, P1, DOI 10.1016/j.biosystems.2011.06.002; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Megchelenbrink W, 2014, PLOONE PUBLIC LIB, V9; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osterlund T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-36; Ovacik MA, 2008, CURR BIOINFORM, V3, P142, DOI 10.2174/157489308785909223; Pach J., 1993, COMPLEXITY VOLUME CO, P91; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reimers AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135636; Rintala E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-461; Rossell S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002988; Schellenberger Jan, 2012, BMC Syst Biol, V6, P9, DOI 10.1186/1752-0509-6-9; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; Schmidt BJ, 2013, BIOINFORMATICS, V29, P2900, DOI 10.1093/bioinformatics/btt493; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Schultz A, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0153-3; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Smith RL, 1996, P WINT SIM C, DOI [10.1109/WSC.1996.873287, DOI 10.1109/WSC.1996.873287]; Suthers PF, 2007, METAB ENG, V9, P387, DOI 10.1016/j.ymben.2007.05.005; Tepper N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075370; Teusink B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000410; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Wiechert W, 2002, GENET ENG P, V24, P215; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	56	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0139665	10.1371/journal.pone.0139665	http://dx.doi.org/10.1371/journal.pone.0139665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457579	Green Published, gold, Green Submitted			2022-12-26	WOS:000362961100012
J	Stoof, SP; Buisman, AM; van Rooijen, DM; Boonacker, R; van der Klis, FRM; Sanders, EAM; Berbers, GAM				Stoof, Susanne P.; Buisman, Anne-Marie; van Rooijen, Debbie M.; Boonacker, Rianne; van der Klis, Fiona R. M.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.			Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?	PLOS ONE			English	Article							MULTIPLEX IMMUNOASSAY; SERUM ANTIBODIES; UNITED-KINGDOM; POLYSACCHARIDE; CARRIAGE; RESPONSES; IMMUNITY; DISEASE; SEROPROTECTION; IMMUNIZATION	Background Antibody levels wane rapidly after Meningococcal serogroup C conjugate (MenCC) vaccination in young children, rendering the need for an adolescent booster dose. It is not clear whether circulating memory B cells are associated with persistence of MenC-specific antibody levels. Methods Measurement of MenC-specific IgG and IgA memory B cells and levels of serum and salivary MenC-specific IgG and IgA in healthy 10-, 12- and 15-year-olds prior to and one month and one year after a MenCC booster vaccination. All participants had received a primary MenCC vaccination nine years earlier. Results The number of circulating MenC-specific IgG memory B cells prior to booster was low and not predictive for MenC-specific IgG responses in serum or saliva post-booster, whereas the number of MenC-specific IgA memory B cells pre-booster positively correlated with MenC-specific IgA levels in saliva post-booster (R = 0.5, P<0.05). The booster induced a clear increase in the number of MenC-specific IgG and IgA memory B cells. The number of MenC-PS-specific IgG memory B cells at 1 month post-booster was highest in the 12-year-olds. The number of MenC-specific memory B cells at one month post-booster showed no correlation with the rate of MenC-specific antibody decay throughout the first year post-booster. Conclusions Circulating MenC-specific IgA memory B cells correlate with IgA responses in saliva, whereas circulating MenC-specific IgG memory B cells are not predictive for MenC-specific IgG responses in serum or saliva. Our results are suggestive for age-dependent differences in pre-existing memory against MenC.	[Stoof, Susanne P.; Buisman, Anne-Marie; van Rooijen, Debbie M.; Boonacker, Rianne; van der Klis, Fiona R. M.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.] Ctr Infect Dis Control, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Stoof, Susanne P.; Sanders, Elisabeth A. M.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Immunol & Infect Dis, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Stoof, SP (corresponding author), Ctr Infect Dis Control, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	susanne.stoof@rivm.nl; guy.berbers@rivm.nl			Dutch Ministry of Health	Dutch Ministry of Health	This study was funded by the Dutch Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bijlsma MW, 2014, CLIN INFECT DIS, V59, P1216, DOI 10.1093/cid/ciu601; Buisman AM, 2009, VACCINE, V28, P179, DOI 10.1016/j.vaccine.2009.09.102; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Clarke ET, 2013, MUCOSAL IMMUNOL, V6, P288, DOI 10.1038/mi.2012.70; de Voer RM, 2008, CLIN VACCINE IMMUNOL, V15, P1188, DOI 10.1128/CVI.00478-07; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; de Whalley PCS, 2013, ARCH DIS CHILD, V98, P686, DOI 10.1136/archdischild-2013-303893; European Centre for Disease Prevention and Control (ECDC), 2014, VACC SCHED 2014; Findlow H, 2011, CLIN VACCINE IMMUNOL, V18, P424, DOI 10.1128/CVI.00503-10; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Jeppesen CA, 2015, J INFECTION, V71, P43, DOI 10.1016/j.jinf.2015.02.006; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Lal G, 2004, CLIN DIAGN LAB IMMUN, V11, P272, DOI 10.1128/CDLI.11.2.272-279.2004; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Nanan R, 2001, VACCINE, V20, P498, DOI 10.1016/S0264-410X(01)00328-0; Nieminen T, 1998, VACCINE, V16, P313, DOI 10.1016/S0264-410X(97)00162-X; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016/j.vaccine.2011.12.062; Perrett KP, 2012, J IMMUNOL, V189, P2673, DOI 10.4049/jimmunol.1200451; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Snape MD, 2008, BRIT MED J, V336, P1487, DOI 10.1136/bmj.39563.545255.AE; Snape MD, 2006, CLIN INFECT DIS, V43, P1387, DOI 10.1086/508776; Snape MD, 2005, PEDIATR INFECT DIS J, V24, P128, DOI 10.1097/01.inf.0000151029.58752.27; Stoof SP, 2015, VACCINE, V33, P3933, DOI 10.1016/j.vaccine.2015.06.055; Stoof SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100651; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0138665	10.1371/journal.pone.0138665	http://dx.doi.org/10.1371/journal.pone.0138665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458006	Green Published, gold, Green Submitted			2022-12-26	WOS:000362961100006
J	Brandewie, EJ; Oxenham, AJ				Brandewie, Eugene J.; Oxenham, Andrew J.			Retroactive Streaming Fails to Improve Concurrent Vowel Identification	PLOS ONE			English	Article							PITCH PERCEPTION; ONSET ASYNCHRONY; RECOGNITION; SEGREGATION; ADAPTATION; MASKING; ABSENCE; SEPARATION; TONES; SOUND	The sequential organization of sound over time can interact with the concurrent organization of sounds across frequency. Previous studies using simple acoustic stimuli have suggested that sequential streaming cues can retroactively affect the perceptual organization of sounds that have already occurred. It is unknown whether such effects generalize to the perception of speech sounds. Listeners' ability to identify two simultaneously presented vowels was measured in the following conditions: no context, a preceding context stream (precursors), and a following context stream (postcursors). The context stream was comprised of brief repetitions of one of the two vowels, and the primary measure of performance was listeners' ability to identify the other vowel. Results in the precursor condition showed a significant advantage for the identification of the second vowel compared to the no-context condition, suggesting that sequential grouping mechanisms aided the segregation of the concurrent vowels, in agreement with previous work. However, performance in the postcursor condition was significantly worse compared to the no-context condition, providing no evidence for an effect of stream segregation, and suggesting a possible interference effect. Two additional experiments involving inharmonic (jittered) vowels were performed to provide additional cues to aid retroactive stream segregation; however, neither manipulation enabled listeners to improve their identification of the target vowel. Taken together with earlier studies, the results suggest that retroactive streaming may require large spectral differences between concurrent sources and thus may not provide a robust segregation cue for natural broadband sounds such as speech.	[Brandewie, Eugene J.; Oxenham, Andrew J.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Brandewie, EJ (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	ebrandew@umn.edu	Brandewie, Eugene J./AAG-4069-2021	Brandewie, Eugene J./0000-0003-2198-4857; Oxenham, Andrew/0000-0002-9365-1157	National Institute of Deafness and Communication Disorders [R01 DC007657]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007657] Funding Source: NIH RePORTER	National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work supported by the National Institute of Deafness and Communication Disorders, R01 DC007657. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bregman A.S., 1990, AUDITORY SCENE ANAL; CHIMENTO TC, 1991, J ACOUST SOC AM, V90, P263, DOI 10.1121/1.401296; Christiansen SK, 2014, J ACOUST SOC AM, V135, P3520, DOI 10.1121/1.4872300; CIOCCA V, 1993, J ACOUST SOC AM, V93, P2870, DOI 10.1121/1.405806; CULLING JF, 1993, J ACOUST SOC AM, V93, P3454, DOI 10.1121/1.405675; CULLING JF, 1995, J ACOUST SOC AM, V98, P785, DOI 10.1121/1.413571; DARWIN CJ, 1992, J ACOUST SOC AM, V91, P3381, DOI 10.1121/1.402828; Darwin CJ, 1999, J EXP PSYCHOL HUMAN, V25, P617, DOI 10.1037/0096-1523.25.3.617; DARWIN CJ, 1984, J ACOUST SOC AM, V76, P1636, DOI 10.1121/1.391610; DARWIN CJ, 1989, PERCEPT PSYCHOPHYS, V45, P333, DOI 10.3758/BF03204948; DARWIN CJ, 1995, J ACOUST SOC AM, V98, P880, DOI 10.1121/1.413513; Dau T, 2009, J ACOUST SOC AM, V125, P2182, DOI 10.1121/1.3082121; DECHEVEIGNE A, 1995, J ACOUST SOC AM, V97, P3736, DOI 10.1121/1.412389; HALL JW, 1984, J ACOUST SOC AM, V76, P50, DOI 10.1121/1.391005; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; HOLM S, 1979, SCAND J STAT, V6, P65; Jones DM, 1997, Q J EXP PSYCHOL-A, V50, P337, DOI 10.1080/027249897392125; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; MASSARO DW, 1975, J ACOUST SOC AM, V58, P1059, DOI 10.1121/1.380765; MOORE BCJ, 1986, J ACOUST SOC AM, V80, P479, DOI 10.1121/1.394043; Oxenham AJ, 2001, J ACOUST SOC AM, V110, P402, DOI 10.1121/1.1373443; Scheffers MTM., 1983, THESIS GRONINGEN U; SHACKLETON TM, 1992, J ACOUST SOC AM, V91, P3579, DOI 10.1121/1.402811; Shinn-Cunningham BG, 2007, P NATL ACAD SCI USA, V104, P12223, DOI 10.1073/pnas.0704641104; SMITH RL, 1979, J ACOUST SOC AM, V65, P166, DOI 10.1121/1.382260; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V336, P357, DOI 10.1098/rstb.1992.0069; SUMMERFIELD Q, 1989, PERCEPT PSYCHOPHYS, V45, P529, DOI 10.3758/BF03208060; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; Vliegen J, 1999, J ACOUST SOC AM, V105, P339, DOI 10.1121/1.424503; Vliegen J, 1999, J ACOUST SOC AM, V106, P938, DOI 10.1121/1.427140; ZWICKER UT, 1984, SPEECH COMMUN, V3, P265, DOI 10.1016/0167-6393(84)90023-2	32	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140466	10.1371/journal.pone.0140466	http://dx.doi.org/10.1371/journal.pone.0140466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451598	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200070
J	Chung, RY; Mercer, S; Lai, FTT; Yip, BHK; Wong, MCS; Wong, SYS				Chung, Roger Y.; Mercer, Stewart; Lai, Francisco T. T.; Yip, Benjamin H. K.; Wong, Martin C. S.; Wong, Samuel Y. S.			Socioeconomic Determinants of Multimorbidity: A Population-Based Household Survey of Hong Kong Chinese	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; CHRONIC DISEASES; GENERAL-PRACTICE; LIFE; EPIDEMIOLOGY; COMORBIDITY; PREVALENCE; EDUCATION; IMPACT; AREAS	Introduction Multimorbidity has been well researched in terms of consequences and healthcare implications. Nevertheless, its risk factors and determinants, especially in the Asian context, remain understudied. We tested the hypothesis of a negative relationship between socioeconomic status and multimorbidity, with contextually different patterns from those observed in the West. Methods We conducted our study in the general Hong Kong (HK) population. Data on current health conditions, health behaviours, socio-demographic and socioeconomic characteristics was obtained from HK Government's Thematic Household Survey. 25,780 individuals aged 15 or above were sampled. Binary logistic and negative binomial regression analyses were conducted to identify risk factors for presence of multimorbidity and number of chronic conditions, respectively. Sub-analysis of possible mediation effect through financial burden borne by private housing residents on multimorbidity was also conducted. Results Unadjusted and adjusted models showed that being female, being 25 years or above, having an education level of primary schooling or below, having less than HK$ 15,000 monthly household income, being jobless or retired, and being past daily smoker were significant risk factors for the presence of multimorbidity and increased number of chronic diseases. Living in private housing was significantly associated with higher chance of multimorbidity and increased number of chronic diseases only after adjustments. Conclusions Less advantaged people tend to have higher risks of multimorbidity and utilize healthcare from the public sector with poorer primary healthcare experience. Moreover, middle-class people who are not eligible for government subsidized public housing may be of higher risk of multimorbidity due to psychosocial stress from paying for the severely unaffordable private housing.	[Chung, Roger Y.; Lai, Francisco T. T.; Yip, Benjamin H. K.; Wong, Martin C. S.; Wong, Samuel Y. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Mercer, Stewart] Univ Glasgow, Inst Hlth & Wellbeing, Gen Practice & Primary Care, Glasgow, Lanark, Scotland	Chinese University of Hong Kong; University of Glasgow	Wong, SYS (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China.	yeungshanwong@cuhk.edu.hk	Chung, Roger Y. N./B-7288-2016; Wong, Martin/L-4568-2014; Lai, Francisco TT/F-3842-2019; Yip, Benjamin/AAC-7845-2019; WONG, Samuel Yeung Shan/D-7311-2013	Wong, Martin/0000-0001-7706-9370; Lai, Francisco TT/0000-0002-9121-1959; Yip, Benjamin/0000-0002-4749-7611; WONG, Samuel Yeung Shan/0000-0003-0934-6385; Mercer, Stewart William/0000-0002-1703-3664				Agborsangaya CB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-201; Alaba O, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-63; Andrade LH, 2010, BRAZ J MED BIOL RES, V43, P483, DOI 10.1590/S0100-879X2010007500024; [Anonymous], 2014, R LANG ENV STAT COMP; Ataguba JEO, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-64; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bertaud A., 2014, 10 ANN DEMOGRAPHIA I; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Campbell-Scherer Denise, 2010, Evid Based Med, V15, P165, DOI 10.1136/ebm1154; Chau K, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-65; Chung RY, 2012, EPIDEMIOL INFECT, V140, P1904, DOI 10.1017/S0950268811002469; Chung RY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099906; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; FaH Bureau, 2008, HEALTHC REF CONS DOC; Fortin M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-52; Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Habib RR, 2014, EUR J PUBLIC HEALTH, V24, P727, DOI 10.1093/eurpub/cku089; Hong Kong Census and Statistics Department, 2013, 50 HONG KONG SPEC AD; Hong Kong Census and Statistics Department, 2010, HONG KONG STAT; Hong Kong Census and Statistics Department, 2012, Q REP GEN HOUS SURV; Hong Kong Census and Statistics Department, 2006, TABL 1960 POP TYP HO; Hong Kong Census and Statistics Department, 2011, TABL 54C 2009 10 HOU; Hong Kong Government, 2013, FACT SHEET REH; Imai K, 2011, AM POLIT SCI REV, V105, P765, DOI 10.1017/S0003055411000414; Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P319, DOI 10.1016/j.jamda.2013.01.001; Lee J, 2006, J FAM HIST, V31, P66, DOI 10.1177/0363199005283008; Leung GM, 2005, SOC SCI MED, V61, P577, DOI 10.1016/j.socscimed.2004.12.029; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Nagel G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-384; Orueta JF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-918; Payne RA, 2013, CAN MED ASSOC J, V185, pE221, DOI 10.1503/cmaj.121349; Ripley B, 2014, SUPPORT FUNCTIONS DA; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Schooling CM, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.086553; Solar O, 2010, CONCEPTUAL FRAMEWORK; Tingley D, 2014, CAUSAL MEDIATION ANA; Tucker-Seeley RD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-313; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Violan C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-530; Wong SYS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-397	54	37	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140040	10.1371/journal.pone.0140040	http://dx.doi.org/10.1371/journal.pone.0140040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TY	26451589	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000362511200030
J	Chang, CJ; Wu, CJ; Hsu, HC; Wu, CH; Shih, FY; Wang, SW; Wu, YH; Chang, CM; Tu, YF; Chi, CH; Shih, HI				Chang, Chih-Jan; Wu, Chi-Jung; Hsu, Hsiang-Chin; Wu, Chiu-Hui; Shih, Fang-Ying; Wang, Shou-Wen; Wu, Yi-Hui; Chang, Chia-Ming; Tu, Yi-Fang; Chi, Chih-Hsien; Shih, Hsin-I			Factors Associated with Blood Culture Contamination in the Emergency Department: Critical Illness, End-Stage Renal Disease, and Old Age	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTISEPTIC-RESISTANCE; QUALITY IMPROVEMENT; IMPACT; SUSCEPTIBILITY; GUIDELINES; PNEUMONIA; REDUCE; TIME	Background Blood culture contamination in emergency departments (ED) that experience a high volume of patients has negative impacts on optimal patient care. It is therefore important to identify risk factors associated with blood culture contamination in EDs. Methodology/Principal Findings A prospectively observational study in a university-affiliated hospital were conducted between August 2011 and December 2012. Positive monomicrobial and negative blood cultures drawn from adult patients in the ED were analyzed to evaluate the possible risk factors for contamination. A total of 1,148 positive monomicrobial cases, 391 contamination cases, and 13,689 cases of negative blood culture were identified. Compared to patients with negative blood cultures, patients in triage levels 1 and 2 (Incidence Rate Ratio, IRR = 2.24), patients with end-stage renal disease (ESRD) (IRR = 2.05), and older patients (IRR: 1.02 per year) were more likely to be associated with ED blood culture contamination. Conclusions/Significance Critical patients (triage levels 1 and 2), ESRD patients, and older patients were more commonly associated with blood culture contamination in the ED. Further studies to evaluate whether the characteristics of skin commensals contribute to blood culture contamination is warranted, especially in hospitals populated with high-risk patients.	[Chang, Chih-Jan; Hsu, Hsiang-Chin; Chi, Chih-Hsien; Shih, Hsin-I] Natl Cheng Kung Univ, Coll Med, Dept Emergency Med, Natl Cheng Kung Univ Hosp, Tainan 70101, Taiwan; [Wu, Chi-Jung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Wu, Chiu-Hui; Shih, Fang-Ying; Wang, Shou-Wen; Wu, Yi-Hui] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Nursing, Tainan 70101, Taiwan; [Chang, Chia-Ming] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Geriatr,Dept Internal Med, Tainan 70101, Taiwan; [Chang, Chia-Ming] Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan 70428, Taiwan; [Wu, Yi-Hui; Tu, Yi-Fang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70101, Taiwan; [Shih, Hsin-I] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Shih, HI (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Emergency Med, Natl Cheng Kung Univ Hosp, Tainan 70101, Taiwan.	n506594@mail.hosp.ncku.edu.tw			 [NCKUH-10405024];  [NCKUH-10406035]	; 	The authors did not receive funding for this work. The manuscript publication was sponsored by NCKUH-10405024 and NCKUH-10406035.	Alahmadi YM, 2011, J HOSP INFECT, V77, P233, DOI 10.1016/j.jhin.2010.09.033; Archibald LK, 2006, J CLIN MICROBIOL, V44, P4425, DOI 10.1128/JCM.01215-06; Association EN, CLIN PRACT GUID PREV; Bamber AI, 2009, BRIT J BIOMED SCI, V66, P6; BATES DW, 1991, JAMA-J AM MED ASSOC, V265, P365, DOI 10.1001/jama.265.3.365; Batra R, 2010, CLIN INFECT DIS, V50, P210, DOI 10.1086/648717; Carr BG, 2007, J TRAUMA, V63, P9, DOI 10.1097/TA.0b013e31805d8f6b; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Ghasemzadeh-Moghaddam H, 2014, MICROB DRUG RESIST, V20, P472, DOI 10.1089/mdr.2013.0222; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Halverson S, 2013, J CLIN MICROBIOL, V51, P1721, DOI 10.1128/JCM.03422-12; Lee Ching-Chi, 2007, Journal of Microbiology Immunology and Infection, V40, P438; Lee H, 2013, DIAGN MICR INFEC DIS, V75, P308, DOI 10.1016/j.diagmicrobio.2012.11.025; Li TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-153; MACGREGOR RR, 1972, ARCH INTERN MED, V130, P84, DOI 10.1001/archinte.130.1.84; Madeo M, 2005, EMERG MED J, V22, P810, DOI 10.1136/emj.2005.003079; Microbiology AS, 2010, MANUAL CLIN MICROBIO; Pines JM, 2007, ANN EMERG MED, V50, P510, DOI 10.1016/j.annemergmed.2007.07.021; Plumhoff EA, 2008, MAYO CLIN COMMUN, V33, P1; Qamruddin A, 2008, J CLIN PATHOL, V61, P509, DOI 10.1136/jcp.2007.047647; Self WH, 2014, ACAD EMERG MED, V21, P274, DOI 10.1111/acem.12337; Self WH, 2013, ACAD EMERG MED, V20, P89, DOI 10.1111/acem.12057; Sheng WH, 2009, DIAGN MICR INFEC DIS, V63, P309, DOI 10.1016/j.diagmicrobio.2008.11.014; Sung SF, 2013, EMERG MED J, V30, P454, DOI 10.1136/emermed-2012-201423; Taha M, 2014, TRANSFUSION, V54, P2974, DOI 10.1111/trf.12728; Towns ML, 2010, J MICROBIOL IMMUNOL, V43, P347, DOI 10.1016/S1684-1182(10)60054-0; Wojtyczka RD, 2014, INT J ENV RES PUB HE, V11, P4619, DOI 10.3390/ijerph110504619; Zhang M, 2011, J HOSP INFECT, V78, P113, DOI 10.1016/j.jhin.2011.02.018	28	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0137653	10.1371/journal.pone.0137653	http://dx.doi.org/10.1371/journal.pone.0137653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448628	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000004
J	Nielsen, KR; Steffensen, R; Bendtsen, MD; Rodrigo-Domingo, M; Baech, J; Haunstrup, TM; Bergkvist, KS; Schmitz, A; Boedker, JS; Johansen, P; Dybkaeaer, K; Boeogsted, M; Johnsen, HE				Nielsen, Kaspar Rene; Steffensen, Rudi; Bendtsen, Mette Dahl; Rodrigo-Domingo, Maria; Baech, John; Haunstrup, Thure Mors; Bergkvist, Kim Steve; Schmitz, Alexander; Boedker, Julie Stoeveve; Johansen, Preben; Dybkaeaer, Karen; Boeogsted, Martin; Johnsen, Hans Erik			Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival	PLOS ONE			English	Article							INNATE IMMUNITY GENES; PROMOTER POLYMORPHISMS; POOLED ANALYSIS; PLASMA-CELLS; INTERLEUKIN-10; SUSCEPTIBILITY; EXPRESSION; BINDING; LYMPHOCYTES; CYTOKINE	Background Malignant B-cell clones are affected by both acquired genetic alterations and by inherited genetic variations changing the inflammatory tumour microenvironment. Methods We investigated 50 inflammatory response gene polymorphisms in 355 B-cell non-Hodgkin's lymphoma (B-NHL) samples encompassing 216 diffuse large B cell lymphoma (DLBCL) and 139 follicular lymphoma (FL) and 307 controls. The effect of single genes and haplotypes were investigated and gene-expression analysis was applied for selected genes. Since interaction between risk genes can have a large impact on phenotype, twoway gene-gene interaction analysis was included. Results We found inherited SNPs in genes critical for inflammatory pathways; TLR9, IL4, TAP2, IL2RA, FCGR2A, TNFA, IL10RB, GALNT12, IL12A and IL1B were significantly associated with disease risk and SELE, IL1RN, TNFA, TAP2, MBL2, IL5, CX3CR1, CHI3L1 and IL12A were, associated with overall survival (OS) in specific diagnostic entities of B-NHL. We discovered noteworthy interactions between DLBCL risk alleles on IL10 and IL4RA and FL risk alleles on IL4RA and IL4. In relation to OS, a highly significant interaction was observed in DLBCL for IL4RA (rs1805010) * IL10 (rs1800890) (HR = 0.11 (0.02-0.50)). Finally, we explored the expression of risk genes from the gene-gene interaction analysis in normal B-cell subtypes showing a different expression of IL4RA, IL10, IL10RB genes supporting a pathogenetic effect of these interactions in the germinal center. Conclusions The present findings support the importance of inflammatory genes in B-cell lymphomas. We found association between polymorphic sites in inflammatory response genes and risk as well as outcome in B-NHL and suggest an effect of gene-gene interactions during the stepwise oncogenesis.	[Nielsen, Kaspar Rene; Steffensen, Rudi; Baech, John; Haunstrup, Thure Mors] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark; [Rodrigo-Domingo, Maria; Bergkvist, Kim Steve; Schmitz, Alexander; Boedker, Julie Stoeveve; Dybkaeaer, Karen; Boeogsted, Martin; Johnsen, Hans Erik] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Johansen, Preben] Aalborg Univ Hosp, Dept Haematopathol, Aalborg, Denmark; [Johnsen, Hans Erik] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark; [Bendtsen, Mette Dahl; Dybkaeaer, Karen; Boeogsted, Martin; Johnsen, Hans Erik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University	Johnsen, HE (corresponding author), Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark.	haej@rn.dk		Bendtsen, Mette Dahl/0000-0003-2403-3520; Bogsted, Martin/0000-0001-9192-1814; Johnsen, Hans Erik/0000-0001-8253-2913; Dybkaer, Karen/0000-0003-2488-435X				Aschebrook-Kilfoy B, 2012, J CANCER SURVIV, V6, P102, DOI 10.1007/s11764-010-0164-4; Bergkvist KS, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-3; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Butterbach K, 2011, BRIT J HAEMATOL, V153, P318, DOI 10.1111/j.1365-2141.2011.08632.x; Carvalho A, 2012, GENES IMMUN, V13, P197, DOI 10.1038/gene.2011.59; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Cerhan JR, 2007, BLOOD, V109, P5439, DOI 10.1182/blood-2006-11-058040; Cerhan JR, 2014, NAT GENET, V46, P1233, DOI 10.1038/ng.3105; Cerhan JR, 2012, CANCER EPIDEM BIOMAR, V21, P1799, DOI 10.1158/1055-9965.EPI-12-0696; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Dybkaer K, 2015, J CLIN ONCOL, V33, P1379, DOI 10.1200/JCO.2014.57.7080; El-Galaly TC, 2015, LEUKEMIA LYMPHOMA, V56, P2476, DOI 10.3109/10428194.2014.1001984; Eurich D, 2011, LIVER INT, V31, P1006, DOI 10.1111/j.1478-3231.2011.02522.x; Forrest MS, 2006, BRIT J HAEMATOL, V134, P180, DOI 10.1111/j.1365-2141.2006.06141.x; Gascoyne RD, 2010, LEUKEMIA LYMPHOMA, V51, P11, DOI 10.3109/10428194.2010.500046; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson TM, 2012, AM J HEMATOL, V87, P724, DOI 10.1002/ajh.23184; Green MR, 2014, CELL CYCLE, V13, P1831, DOI 10.4161/cc.29326; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Habermann TM, 2008, BLOOD, V112, P2694, DOI 10.1182/blood-2007-09-111658; Hohaus S, 2007, ANN ONCOL, V18, P1376, DOI 10.1093/annonc/mdm132; Hosgood HD, 2011, BRIT J HAEMATOL, V152, P721, DOI 10.1111/j.1365-2141.2010.08518.x; Howell WM, 2007, J NUTR, V137, p194S, DOI 10.1093/jn/137.1.194S; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Johnsen HE, 2014, LEUKEMIA LYMPHOMA, V55, P1251, DOI 10.3109/10428194.2013.839785; Johnsen Hans Erik, 2009, Eur J Cancer, V45 Suppl 1, P194, DOI 10.1016/S0959-8049(09)70033-4; Kay NE, 2003, LEUKEMIA LYMPHOMA, V44, P897, DOI 10.1080/1042819031000068007; Kobayashi N, 2002, CLIN EXP IMMUNOL, V129, P446, DOI 10.1046/j.1365-2249.2002.01932.x; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Kube D, 2008, CLIN CANCER RES, V14, P3777, DOI 10.1158/1078-0432.CCR-07-5182; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Lan Q, 2011, BRIT J HAEMATOL, V153, P341, DOI 10.1111/j.1365-2141.2010.08424.x; Lech-Maranda E, 2004, BLOOD, V103, P3529, DOI 10.1182/blood-2003-06-1850; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lu Y, 2011, THESCIENTIFICWORLDJO, V11, P2062, DOI 10.1100/2011/373876; Nielsen KR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3391; Nielsen KR, 2015, LEUKEMIA LYMPHOMA, V56, P3257, DOI 10.3109/10428194.2015.1058936; Nieters A, 2006, GENES IMMUN, V7, P615, DOI 10.1038/sj.gene.6364337; Pound JD, 1997, BLOOD, V89, P919, DOI 10.1182/blood.V89.3.919; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Rasmussen T, 2010, HAEMATOL-HEMATOL J, V95, P1730, DOI 10.3324/haematol.2010.024778; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Schoof N, 2009, ANN ONCOL, V20, P1548, DOI 10.1093/annonc/mdp110; Scott DW, 2014, NAT REV CANCER, V14, P517, DOI 10.1038/nrc3774; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Takatsu K, 1998, CYTOKINE GROWTH F R, V9, P25, DOI 10.1016/S1359-6101(97)00034-8; van der Bol JM, 2010, ONCOLOGIST, V15, P1063, DOI 10.1634/theoncologist.2010-0033; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Warzocha K, 1998, BLOOD, V91, P3574	59	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139329	10.1371/journal.pone.0139329	http://dx.doi.org/10.1371/journal.pone.0139329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448050	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000021
J	Chen, CH; Chen, HC; Chang, CC; Peng, YJ; Lee, CH; Shieh, YS; Hung, YJ; Lin, YF				Chen, Chen-Hung; Chen, Hsiang-Cheng; Chang, Chi-Ching; Peng, Yi-Jen; Lee, Chien-Hsing; Shieh, Yi-Shing; Hung, Yi-Jen; Lin, Yuh-Feng			Growth Arrest-Specific 6 Protein in Patients with Sjogren Syndrome: Determination of the Plasma Level and Expression in the Labial Salivary Gland	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECEPTOR TYROSINE KINASES; DISEASE-ACTIVITY; AUTOIMMUNE EPITHELITIS; DENDRITIC CELLS; TYRO-3 FAMILY; TAM RECEPTORS; GAS6; PATHOGENESIS; APOPTOSIS	Aims Growth arrest-specific protein 6 (Gas6) is a vitamin K-dependent protein expressed by endothelial cells and leukocytes that are involved in cell survival, migration, and proliferation in response to inflammatory processes. The aim of this study was to assess the implications of Gas6 in Sjogren syndrome (SS) and its expression in the labial salivary gland. Methods and Results A total of 254 adults, including 159 with primary Sjogren syndrome (pSS), 34 with secondary Sjogren syndrome (sSS), and 61 normal controls, were recruited. Plasma Gas6 concentrations were determined, and Gas6 expressions in labial salivary gland (LSG) tissues from controls and pSS and sSS patients were also evaluated. Plasma Gas6 concentrations were significantly lower among patients with pSS than normal controls (13.5 +/- 8.6 vs. 19.9 +/- 13.4 ng/ml, p < 0.001). There were, however, no significant differences in plasma Gas6 levels between pSS and sSS patients (13.5 +/- 8.6 vs. 16.9 +/- 11.2 ng/ml, p = 0.068). In multivariate logistic regression analysis, after adjustment for white blood cell count, hemoglobin level, platelet count, lymphocyte count, and C3 and C4 levels, lower plasma Gas6 concentrations were significantly associated with an increased risk of SS. Moreover, by using a semi-quantitative scale to evaluate Gas6 expression in LSG tissues, Gas6 expression was found to be markedly lower in LSG tissues from pSS patients than in tissues from normal controls. Conclusions Decreased plasma Gas6 concentration and LSG expression were associated with pSS. As such, Gas6 may represent a novel independent risk factor for pSS, with a potential role in salivary gland inflammation and dysfunction.	[Chen, Chen-Hung; Chang, Chi-Ching; Lin, Yuh-Feng] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Chen-Hung] Tzu Chi Univ, Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp,Sch Med, Div Rheumatol Immunol & Allergy,Dept Internal Med, Hualien, Taiwan; [Chen, Chen-Hung; Chen, Hsiang-Cheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Rheumatol Immunol & Allergy, Taipei, Taiwan; [Chang, Chi-Ching] Taipei Med Univ Hosp, Dept Internal Med, Div Rheumatol Immunol & Allergy, Taipei, Taiwan; [Peng, Yi-Jen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Lee, Chien-Hsing; Hung, Yi-Jen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Shieh, Yi-Shing] Triserv Gen Hosp, Natl Def Med Ctr, Dept Oral Diag & Pathol, Sch Dent, Taipei, Taiwan; [Lin, Yuh-Feng] Taipei Med Univ, Shuang Ho Hosp, Dept Med, Div Nephrol, New Taipei, Taiwan	Taipei Medical University; Tzu Chi University; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Shuang Ho Hospital	Lin, YF (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan.	linyf@shh.org.tw	Chen, Hsiang-Cheng/O-1312-2016; Chen, Hsiang-Cheng/CAG-3864-2022; Chen, Hsiang-Cheng/AGQ-6364-2022; Peng, Yi-Jen/X-9124-2019	Chen, Hsiang-Cheng/0000-0002-0753-6161; Chen, Hsiang-Cheng/0000-0002-0753-6161; Chen, Hsiang-Cheng/0000-0002-0753-6161; Peng, Yi-Jen/0000-0003-4630-2103	Tri-Service General Hospital, Taiwan [TSGH-C103-071, TSGH-C104-007-007-S03]	Tri-Service General Hospital, Taiwan	This work was supported by research grants from Tri-Service General Hospital (TSGH-C103-071 and TSGH-C104-007-007-S03), Taiwan for Dr. Yi-Jen Hung.	Abu-Helu RF, 2001, J AUTOIMMUN, V17, P141, DOI 10.1006/jaut.2001.0524; Alamanos Y, 2006, RHEUMATOLOGY, V45, P187, DOI 10.1093/rheumatology/kei107; Alciato F, 2008, J IMMUNOASS IMMUNOCH, V29, P167, DOI 10.1080/15321810801888480; Alciato F, 2010, J LEUKOCYTE BIOL, V87, P869, DOI 10.1189/jlb.0909610; Aoki A, 2000, Nihon Rinsho Meneki Gakkai Kaishi, V23, P124; Bassyouni IH, 2017, INT J RHEUM DIS, V20, P53, DOI 10.1111/1756-185X.12367; Bowman SJ, 2004, SCAND J RHEUMATOL, V33, P39, DOI 10.1080/03009740310004676; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Dimitriou ID, 2002, EUR J ORAL SCI, V110, P21, DOI 10.1034/j.1600-0722.2002.00152.x; Ekman C, 2011, RHEUMATOLOGY, V50, P1064, DOI 10.1093/rheumatology/keq459; Garcia-Carrasco M, 2002, MEDICINE, V81, P270, DOI 10.1097/00005792-200207000-00003; Gheita TA, 2012, J CLIN IMMUNOL, V32, P1279, DOI 10.1007/s10875-012-9743-7; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Huang Y.-C., 2002, J MED SCI, V22, P221; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Kim HA, 2013, J CLIN IMMUNOL, V33, P143, DOI 10.1007/s10875-012-9765-1; Kramer JM, 2014, CYTOKINE, V67, P92, DOI 10.1016/j.cyto.2014.02.009; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Manganelli P, 2003, SEMIN ARTHRITIS RHEU, V33, P49, DOI 10.1053/sarh.2003.50019; Manoussakis MN, 2007, ARTHRITIS RHEUM-US, V56, P3977, DOI 10.1002/art.23073; Manoussakis MN, 2010, J AUTOIMMUN, V35, P219, DOI 10.1016/j.jaut.2010.06.011; Mitsias DI, 2006, ORAL DIS, V12, P523, DOI 10.1111/j.1601-0825.2006.01292.x; MOUTSOPOULOS HM, 1994, CLIN IMMUNOL IMMUNOP, V72, P162, DOI 10.1006/clin.1994.1123; Nguyen CQ, 2009, OCUL SURF, V7, P11, DOI 10.1016/S1542-0124(12)70289-6; Ohlsson M, 2002, SCAND J IMMUNOL, V56, P456, DOI 10.1046/j.1365-3083.2002.01072_79.x; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Polihronis M, 1998, CLIN EXP IMMUNOL, V114, P485; Recarte-Pelz P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4199; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Shen L, 2013, J IMMUNOL, V191, P608, DOI 10.4049/jimmunol.1203440; Shen L, 2012, CLIN IMMUNOL, V145, P251, DOI 10.1016/j.clim.2012.09.013; Suh CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3088; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trontzas PI, 2005, ANN RHEUM DIS, V64, P1240, DOI 10.1136/ard.2004.031021; Tzioufas AG, 2012, J AUTOIMMUN, V39, P4, DOI 10.1016/j.jaut.2012.01.002; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Yao YH, 2013, AUTOIMMUN REV, V12, P558, DOI 10.1016/j.autrev.2012.10.006	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139955	10.1371/journal.pone.0139955	http://dx.doi.org/10.1371/journal.pone.0139955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445266	gold, Green Submitted, Green Published			2022-12-26	WOS:000362510600111
J	Matsui, H; Fushimi, K; Yasunaga, H				Matsui, Hiroki; Fushimi, Kiyohide; Yasunaga, Hideo			Variation in Risk-Standardized Mortality of Stroke among Hospitals in Japan	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; GRADING SCALE; VOLUME; CARE; PREDICTION; OUTCOMES; ACCESS; RATES	Despite recent advances in care, stroke remains a life-threatening disease. Little is known about current hospital mortality with stroke and how it varies by hospital in a national clinical setting in Japan. Using the Diagnosis Procedure Combination database (a national inpatient database in Japan), we identified patients aged >= 20 years who were admitted to the hospital with a primary diagnosis of stroke within 3 days of stroke onset from April 2012 to March 2013. We constructed a multivariable logistic regression model to predict in-hospital death for each patient with patient-level factors, including age, sex, type of stroke, Japan Coma Scale, and modified Rankin Scale. We defined risk-standardized mortality ratio as the ratio of the actual number of in-hospital deaths to the expected number of such deaths for each hospital. A hospital-level multivariable linear regression was modeled to analyze the association between risk-standardized mortality ratio and hospital-level factors. We performed a patient-level Cox regression analysis to examine the association of in-hospital death with both patient-level and hospital-level factors. Of 176,753 eligible patients from 894 hospitals, overall in-hospital mortality was 10.8%. The risk-standardized mortality ratio for stroke varied widely among the hospitals; the proportions of hospitals with risk-standardized mortality ratio categories of <= 0.50, 0.51-1.00, 1.01-1.50, 1.51-2.00, and > 2.00 were 3.9%, 47.9%, 41.4%, 5.2%, and 1.5%, respectively. Academic status, presence of a stroke care unit, higher hospital volume and availability of endovascular therapy had a significantly lower risk-standardized mortality ratio; distance from the patient's residence to the hospital was not associated with the risk-standardized mortality ratio. Our results suggest that stroke-ready hospitals play an important role in improving stroke mortality in Japan.	[Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU)	Yasunaga, H (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan.	yasunagah-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H27-Policy-Designated- 009]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan (grant number: H27-Policy-Designated- 009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya AB, 2011, J STROKE CEREBROVASC, V20, P295, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.009; Ash A, 1994, RISK ADJUSTMENT MEAS, P313; El Khoury R, 2012, NEUROLOGY, V79, pS26, DOI 10.1212/WNL.0b013e3182695a2a; Fonarow GC, 2011, STROKE, V42, P159, DOI 10.1161/STROKEAHA.110.601831; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hankey GJ, 2003, CEREBROVASC DIS, V16, P14, DOI 10.1159/000069936; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; HUBENY I, 1990, ASTROPHYS J, V351, P632, DOI 10.1086/168501; Inoue T, 2013, STROKE, V44, P3142, DOI 10.1161/STROKEAHA.113.001684; Lichtman JH, 2012, STROKE, V43, P2741, DOI 10.1161/STROKEAHA.112.665646; Matsuda S., 2011, ASIAN PACIFIC J DIS, V5, P81, DOI [10.7223/apjdm.5.81, DOI 10.7223/APJDM.5.81]; Miyata H, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-229; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Reed SD, 2001, STROKE, V32, P1832, DOI 10.1161/01.STR.32.8.1832; Ruiz-Sandoval JL, 2007, STROKE, V38, P1641, DOI 10.1161/STROKEAHA.106.478222; Saposnik G, 2007, NEUROLOGY, V69, P1142, DOI 10.1212/01.wnl.0000268485.93349.58; Shigematsu K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002736; Tamm A, 2014, STROKE, V45, P211, DOI 10.1161/STROKEAHA.113.002504; Tsugawa Y, 2013, MED CARE, V51, P782, DOI 10.1097/MLR.0b013e31829c8b70; Tung YC, 2009, MED CARE, V47, P1018, DOI 10.1097/MLR.0b013e3181a81144; Votruba ME, 2006, MED CARE, V44, P1129, DOI 10.1097/01.mlr.0000237424.15716.47; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139216	10.1371/journal.pone.0139216	http://dx.doi.org/10.1371/journal.pone.0139216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444695	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600047
J	Tax, CMW; Chamberland, M; van Stralen, M; Viergever, MA; Whittingstall, K; Fortin, D; Descoteaux, M; Leemans, A				Tax, Chantal M. W.; Chamberland, Maxime; van Stralen, Marijn; Viergever, Max A.; Whittingstall, Kevin; Fortin, David; Descoteaux, Maxime; Leemans, Alexander			Seeing More by Showing Less: Orientation-Dependent Transparency Rendering for Fiber Tractography Visualization	PLOS ONE			English	Article							IN-DIFFUSION MRI; TRACKING; BRAIN	Fiber tractography plays an important role in exploring the architectural organization of fiber trajectories, both in fundamental neuroscience and in clinical applications. With the advent of diffusion MRI (dMRI) approaches that can also model "crossing fibers", the complexity of the fiber network as reconstructed with tractography has increased tremendously. Many pathways interdigitate and overlap, which hampers an unequivocal 3D visualization of the network and impedes an efficient study of its organization. We propose a novel fiber tractography visualization approach that interactively and selectively adapts the transparency rendering of fiber trajectories as a function of their orientation to enhance the visibility of the spatial context. More specifically, pathways that are oriented (locally or globally) along a user-specified opacity axis can be made more transparent or opaque. This substantially improves the 3D visualization of the fiber network and the exploration of tissue configurations that would otherwise be largely covered by other pathways. We present examples of fiber bundle extraction and neurosurgical planning cases where the added benefit of our new visualization scheme is demonstrated over conventional fiber visualization approaches.	[Tax, Chantal M. W.; van Stralen, Marijn; Viergever, Max A.; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Chamberland, Maxime; Whittingstall, Kevin; Fortin, David; Descoteaux, Maxime] Ctr Rech CHUS, Sherbrooke, PQ, Canada; [Chamberland, Maxime; Descoteaux, Maxime] Univ Sherbrooke, Fac Sci, Dept Comp Sci, SCIL, Sherbrooke, PQ J1K 2R1, Canada; [Chamberland, Maxime; Whittingstall, Kevin] Univ Sherbrooke, Dept Nucl Med & Radiobiol, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; [Whittingstall, Kevin] Univ Sherbrooke, Dept Diagnost Radiol, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; [Fortin, David] Univ Sherbrooke, Div Neurosurg & Neurooncol, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada	Utrecht University; Utrecht University Medical Center; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Tax, CMW (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	chantal@isi.uu.nl	Viergever, Max A/J-1215-2014; Chamberland, Maxime/AAX-3302-2020; Leemans, Alexander/A-1784-2011	Chamberland, Maxime/0000-0001-7064-0984; Leemans, Alexander/0000-0002-9306-6126	Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO) [612.001.104]; Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program (CGS-D3) from the Natural Sciences and Engineering Research Council of Canada (NSERC); NWO [639.072.411]	Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO); Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program (CGS-D3) from the Natural Sciences and Engineering Research Council of Canada (NSERC); NWO(Netherlands Organization for Scientific Research (NWO))	Chantal Tax is supported by a grant (No. 612.001.104) from the Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO). Maxime Chamberland is supported by the Alexander Graham Bell Canada Graduate Scholarships-Doctoral Program (CGS-D3) from the Natural Sciences and Engineering Research Council of Canada (NSERC). The research of Alexander Leemans is supported by VIDI Grant 639.072.411 from NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson D, 2008, P 15 ANN M ISMRM, P79; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Bernier M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00715; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Chamberland M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00275; Chamberland M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00059; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Eichelbaum S, 2013, BIOMED TECH; Eichelbaum S, 2013, IEEE T VIS COMPUT GR, V19, P433, DOI 10.1109/TVCG.2012.142; Everts MH, 2009, IEEE T VIS COMPUT GR, V15, P1299, DOI 10.1109/TVCG.2009.138; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Girard G., 2012, INT C MED IM COMP CO, P55; Hau J, 2014, ANN M ORG HUM BRAIN, P3930; Heemskerk AM, 2015, P 23 ANN M ISMRM, P2855; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Jones DK, 2005, MAGNET RESON MED, V53, P1462, DOI 10.1002/mrm.20484; Jones DK, 2010, DIFFUSION MRI THEORY; Leemans, 2010, DIFFUSION MRI THEORY; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Mardia KV, 2009, DIRECTIONAL STAT; Margulies DS, 2013, NEUROIMAGE, V80, P445, DOI 10.1016/j.neuroimage.2013.04.111; Merhof D, 2006, IEEE T VIS COMPUT GR, V12, P1181, DOI 10.1109/TVCG.2006.151; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Peeters T.H.J.M., 2006, P ASCI, P66; Petrovic V, 2007, IEEE T VIS COMPUT GR, V13, P1488, DOI 10.1109/TVCG.2007.70532; Presseau C, 2015, NEUROIMAGE, V109, P73, DOI 10.1016/j.neuroimage.2014.12.058; Reina G., 2006, P EUROGRAPHICS IEEE, P35; Schurade R., 2010, P 2 EUROGRAPHICS C V, P41; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Tax CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101524; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; Tax CMW, 2014, P 21 ANN M ISMRM, P4529; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Vaillancourt O, 2015, MATH VIS, P191, DOI 10.1007/978-3-319-15090-1_10; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vos SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081453; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Whittingstall K, 2014, CORTEX, V56, P85, DOI 10.1016/j.cortex.2013.02.004; Zhang S, 2003, IEEE T VIS COMPUT GR, V9, P454, DOI 10.1109/TVCG.2003.1260740	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139434	10.1371/journal.pone.0139434	http://dx.doi.org/10.1371/journal.pone.0139434			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444010	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600055
J	Cobb, MM; Austin, DC; Sack, JT; Trimmer, JS				Cobb, Melanie M.; Austin, Daniel C.; Sack, Jon T.; Trimmer, James S.			Cell Cycle-dependent Changes in Localization and Phosphorylation of the Plasma Membrane Kv2.1 K+ Channel Impact Endoplasmic Reticulum Membrane Contact Sites in COS-1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; MOLECULAR-MECHANISMS; C-TERMINUS; EXPRESSION; INSULIN; MODULATION; ACTIVATION; CANCER; BRAIN; IDENTIFICATION	The plasma membrane (PM) comprises distinct subcellular domains with diverse functions that need to be dynamically coordinated with intracellular events, one of the most impactful being mitosis. The Kv2.1 voltage-gated potassium channel is conditionally localized to large PM clusters that represent specialized PM: endoplasmic reticulum membrane contact sites (PM: ER MCS), and overexpression of Kv2.1 induces more exuberant PM: ER MCS in neurons and in certain heterologous cell types. Localization of Kv2.1 at these contact sites is dynamically regulated by changes in phosphorylation at one or more sites located on its large cytoplasmic C terminus. Here, we show that Kv2.1 expressed in COS-1 cells undergoes dramatic cell cycle-dependent changes in its PM localization, having diffuse localization in interphase cells, and robust clustering during M phase. The mitosis-specific clusters of Kv2.1 are localized to PM: ER MCS, and M phase clustering of Kv2.1 induces more extensive PM: ER MCS. These cell cycle-dependent changes in Kv2.1 localization and the induction of PM: ER MCS are accompanied by increased mitotic Kv2.1 phosphorylation at several C-terminal phosphorylation sites. Phosphorylation of exogenously expressed Kv2.1 is significantly increased upon metaphase arrest in COS-1 and CHO cells, and in a pancreatic beta cell line that express endogenous Kv2.1. The M phase clustering of Kv2.1 at PM: ER MCS in COS-1 cells requires the same C-terminal targeting motif needed for conditional Kv2.1 clustering in neurons. The cell cycle-dependent changes in localization and phosphorylation of Kv2.1 were not accompanied by changes in the electrophysiological properties of Kv2.1 expressed in CHO cells. Together, these results provide novel insights into the cell cycle-dependent changes in PM protein localization and phosphorylation.	[Cobb, Melanie M.; Trimmer, James S.] Univ Calif Davis, Sch Med, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Austin, Daniel C.; Sack, Jon T.; Trimmer, James S.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Sack, Jon T.] Univ Calif Davis, Sch Med, Dept Anesthesiol & Pain Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Trimmer, JS (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 NS042225]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS042225 (to J. S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; Baver SB, 2012, NEUROSCIENCE, V217, P56, DOI 10.1016/j.neuroscience.2012.04.054; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Bocksteins E, 2009, AM J PHYSIOL-CELL PH, V296, pC1271, DOI 10.1152/ajpcell.00088.2009; Cerda O, 2011, J BIOL CHEM, V286, P28738, DOI 10.1074/jbc.M111.251942; Cicenas J, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.61; Deng XL, 2007, CELL PROLIFERAT, V40, P656, DOI 10.1111/j.1365-2184.2007.00458.x; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; DREWE JA, 1992, J NEUROSCI, V12, P538; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; English AR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013227; Fox PD, 2015, J CELL SCI, V128, P2096, DOI 10.1242/jcs.166009; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Henne WM, 2015, CURR OPIN CELL BIOL, V35, P123, DOI 10.1016/j.ceb.2015.05.001; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; Herve JC, 2015, BBA-BIOMEMBRANES, V1848, P2473, DOI 10.1016/j.bbamem.2015.06.017; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 2012, J GEN PHYSIOL, V140, P245, DOI 10.1085/jgp.201210874; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang X, 2014, J CELL BIOL, V206, P151, DOI 10.1083/jcb.201404136; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Kaufmann WA, 2009, J COMP NEUROL, V515, P215, DOI 10.1002/cne.22066; King AN, 2014, J COMP NEUROL, V522, P2594, DOI 10.1002/cne.23551; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Lastraioli E, 2015, BBA-BIOMEMBRANES, V1848, P2685, DOI 10.1016/j.bbamem.2014.12.016; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; LEE BS, 1991, J BIOL CHEM, V266, P11448; Levin M, 2014, MOL BIOL CELL, V25, P3835, DOI 10.1091/mbc.E13-12-0708; Li XY, 2013, J PHARMACOL EXP THER, V344, P407, DOI 10.1124/jpet.112.199083; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mandikian D, 2014, J COMP NEUROL, V522, P3555, DOI 10.1002/cne.23641; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x; Medema RH, 2011, TRENDS BIOCHEM SCI, V36, P578, DOI 10.1016/j.tibs.2011.08.006; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Park Kang-Sik, 2007, Channels (Austin), V1, P59; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Prakriya M, 2013, CURR TOP MEMBR, V71, P1, DOI 10.1016/B978-0-12-407870-3.00001-9; Preisinger C, 2001, Sci STKE, V2001, ppe38; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Sack JT, 2006, J GEN PHYSIOL, V128, P119, DOI 10.1085/jgp.200609492; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; Shah NH, 2014, J NEUROSCI, V34, P4326, DOI 10.1523/JNEUROSCI.5184-13.2014; SHI GY, 1994, J BIOL CHEM, V269, P23204; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Smyth JT, 2012, CURR BIOL, V22, P1487, DOI 10.1016/j.cub.2012.05.057; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Song MY, 2012, J PROTEOME RES, V11, P1018, DOI 10.1021/pr200770v; Su JP, 2001, PFLUG ARCH EUR J PHY, V442, P49, DOI 10.1007/s004240000508; Suzuki T, 2004, INT J ONCOL, V25, P153; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Tilley DC, 2014, P NATL ACAD SCI USA, V111, pE4789, DOI 10.1073/pnas.1406876111; Trapani JG, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-15; Trimmer J.S., 2015, HDB ION CHANNELS, P531; Trimmer JS, 2015, NEURON, V85, P238, DOI 10.1016/j.neuron.2014.12.042; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; WARD GE, 1985, SCIENCE, V227, P768, DOI 10.1126/science.2857502; Wellman GC, 2003, CELL CALCIUM, V34, P211, DOI 10.1016/S0143-4160(03)00124-6; Wu XL, 2013, J BIOL CHEM, V288, P4128, DOI 10.1074/jbc.M112.440933; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Zheng YJ, 2002, J BIOL CHEM, V277, P32268, DOI 10.1074/jbc.M202105200	92	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29189	29201		10.1074/jbc.M115.690198	http://dx.doi.org/10.1074/jbc.M115.690198			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26442584	Green Published, hybrid			2022-12-26	WOS:000366613400007
J	Lee, KH; Lee, CH; Jeong, J; Jang, AH; Yoo, CG				Lee, Kyoung-Hee; Lee, Chang-Hoon; Jeong, Jiyeong; Jang, An-Hee; Yoo, Chul-Gyu			Neutrophil Elastase Differentially Regulates Interleukin 8 (IL-8) and Vascular Endothelial Growth Factor (VEGF) Production by Cigarette Smoke Extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ANTIPROTEASE IMBALANCE; OXIDATIVE STRESS; CELL APOPTOSIS; PART I; COPD; PATHOGENESIS; INFLAMMATION; EMPHYSEMA; RELEASE	Inflammation by IL-8-induced neutrophil recruitment and apoptosis of epithelial cells by decreased expression of VEGE have been suggested as one of the complicated pathogenic mechanisms of chronic obstructive pulmonary disease (COPD). The role of neutrophil elastase (NE) in the development of COPD is also well known. However, little is known about how they interact. The objective of this study was to elucidate the effect of NE on cigarette smoke extract (CSE)-induced IL-8 and VEGE production and its molecular mechanism in bronchial epithelial cells. CSE increased both IL-8 and VEGE production in human bronchial epithelial cells (BEAS-2B). Although NE significantly enhanced CSE-induced IL-8 production, it suppressed VEGF production. This differential regulation was not CSE-specific. The effect of NE on IL-8 production, but not VEGF, was ERK-dependent. Interestingly, in contrast to decreased VEGE protein expression, NE accelerated VEGF transcription by (SF, suggesting post-translational modification. When cells were incubated with purified NE, it was detected in the cytoplasm, suggesting the intracellular translocation of NE. Furthermore, NE fragmented recombinant human VEGE in vitro but not recombinant human IL-8. These results indicate that VEGF down-regulation is due to direct degradation by NE, which is translocated into cells. Similar to in vitro cell experiments, elastase treatment increased CST-induced IL-8; however, it suppressed VEGE production in bronchoalveolar lavage fluid of (SF-treated mice. Moreover, elastase treatment enhanced CSE-induced emphysema in mice. Considering the actions of IL-8 and VEGF, our results suggest that NE contributes to the pathogenesis of COPD by enhancing inflammation and apoptosis.	[Lee, Kyoung-Hee; Lee, Chang-Hoon; Jeong, Jiyeong; Jang, An-Hee; Yoo, Chul-Gyu] Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110744, South Korea; [Lee, Chang-Hoon; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Yoo, CG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 151, South Korea.	cgyoo@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021					Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Baker RR, 2004, FOOD CHEM TOXICOL, V42, pS3, DOI 10.1016/S0278-6915(03)00189-3; Beisswenger C, 2004, RESPIRATION, V71, P402, DOI 10.1159/000079647; Deslee G, 2010, AM J RESP CELL MOL, V43, P576, DOI 10.1165/rcmb.2009-0221OC; Farid M, 2013, TOXICOL LETT, V220, P126, DOI 10.1016/j.toxlet.2013.04.011; Fischer BM, 2011, INT J CHRONIC OBSTR, V6, P413, DOI 10.2147/COPD.S10770; Gregory AD, 2012, J BIOL CHEM, V287, P35341, DOI 10.1074/jbc.M112.385617; Gross NJ, 2012, CHEST, V142, P1300, DOI 10.1378/chest.11-2766; HUNNINGHAKE GW, 1981, SCIENCE, V212, P925, DOI 10.1126/science.7233186; Ishii T, 2001, AM J PHYSIOL-LUNG C, V280, pL1189, DOI 10.1152/ajplung.2001.280.6.L1189; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Lee JH, 2012, LUNG, V190, P69, DOI 10.1007/s00408-011-9326-z; Mak JCW, 2008, INT J TUBERC LUNG D, V12, P368; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Morissette Mathieu C, 2009, Int J Chron Obstruct Pulmon Dis, V4, P19; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Plataki Maria, 2006, Int J Chron Obstruct Pulmon Dis, V1, P161, DOI 10.2147/copd.2006.1.2.161; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Roth M, 2008, INT J TUBERC LUNG D, V12, P375; Sapey E, 2010, AM J RESP CRIT CARE, V182, P192, DOI 10.1164/rccm.200912-1846OC; Suzuki M, 2008, INHAL TOXICOL, V20, P349, DOI 10.1080/08958370701866412 ; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Thaikoottathil JV, 2009, EUR RESPIR J, V33, P835, DOI 10.1183/09031936.00080708; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Yang JJ, 2001, AM J PATHOL, V158, P581, DOI 10.1016/S0002-9440(10)64000-X; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910	29	24	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28438	28445		10.1074/jbc.M115.663567	http://dx.doi.org/10.1074/jbc.M115.663567			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26453303	Green Published, hybrid			2022-12-26	WOS:000365761900037
J	Rojas, A; Aguilar, R; Henriquez, B; Lian, JB; Stein, JL; Stein, GS; van Wijnen, AJ; van Zundert, B; Allende, ML; Montecino, M				Rojas, Adriana; Aguilar, Rodrigo; Henriquez, Berta; Lian, Jane B.; Stein, Janet L.; Stein, Gary S.; van Wijnen, Andre J.; van Zundert, Brigitte; Allende, Miguel L.; Montecino, Martin			Epigenetic Control of the Bone-master Runx2 Gene during Osteoblast-lineage Commitment by the Histone Demethylase JARID1B/KDM5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE 27; MESENCHYMAL STEM-CELLS; WD-40 REPEAT PROTEIN; OSTEOGENIC DIFFERENTIATION; RESPONSE ELEMENTS; OSTEOCALCIN GENE; METHYLATION; CHROMATIN; EXPRESSION; POLYCOMB	Transcription factor Runx2 controls bone development and osteoblast differentiation by regulating expression of a significant number of bone-related target genes. Here, we report that transcriptional activation and repression of the Runx2 gene via its osteoblast-specific P1 promoter (encoding mRNA for the Runx2/p57 isoform) is accompanied by selective deposition and elimination of histone marks during differentiation of mesenchymal cells to the osteogenic and myoblastic lineages. These epigenetic profiles are mediated by key components of the Trithorax/COMPASS-like and Polycomb group complexes together with histone arginine methylases like PRMT5 and lysine demethylases like JARID1B/KDM5B. Importantly, knockdown of the H3K4me2/:3 demethylase JARID1B, but not of the demethylases UTX and N066, prevents repression of the Runx2 P1 promoter during myogenic differentiation of mesenchymal cells. The epigenetically forced expression of Runx2/p57 and osteocalcin, a classical bone-related target gene, under myoblastic-differentiation is accompanied by enrichment of the H3K/Ime3 and H3K27ac marks at the Runx2 P1 promoter region. Our results identify JARID1B as a key component of a potent epigenetic switch that controls mesenchymal cell fate into myogenic and osteogenic lineages.	[Rojas, Adriana; Aguilar, Rodrigo; Henriquez, Berta; van Zundert, Brigitte; Montecino, Martin] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago 8370146, Chile; [Rojas, Adriana; Aguilar, Rodrigo; Henriquez, Berta; van Zundert, Brigitte; Montecino, Martin] Univ Andres Bello, Fac Med, Santiago 8370146, Chile; [Rojas, Adriana; Allende, Miguel L.] Univ Chile, Fac Sci, Santiago 7800003, Chile; [Rojas, Adriana; Aguilar, Rodrigo; Allende, Miguel L.; Montecino, Martin] FONDAP Ctr Genome Regulat, Santiago, Chile; [Lian, Jane B.; Stein, Janet L.; Stein, Gary S.] Univ Vermont, Sch Med, Burlington, VT 05405 USA; [van Wijnen, Andre J.] Mayo Clin, Rochester, MN 55905 USA	Universidad Andres Bello; Universidad Andres Bello; Universidad de Chile; University of Vermont; Mayo Clinic	Montecino, M (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Ctr Invest Biomed, Ave Republ 239, Santiago 8370146, Chile.	mmontecino@unab.cl	Regan, Clinton/E-6250-2012; Aguilar, Rodrigo/AAG-6178-2019; van Wijnen, Andre J./AAG-3578-2019; Allende, Miguel L/C-5167-2008	van Wijnen, Andre J./0000-0002-4458-0946; Allende, Miguel L/0000-0002-2783-2152; Aguilar, Rodrigo/0000-0003-0410-5478; Rojas, Adriana/0000-0001-8528-4433	Fondo de Finaciamiento de Centros de Investigacion en Areas Prioritarias [15090007]; Fondo Nacional de Ciencia y Tecnologia [FONDECYT 1130706]; NIH [R01 AR049069, R01 AR039588]; COLCIENCIAS; Institut de Genetica Humana, Pontificia Universidad Javeriana, Bogota, Colombia; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	Fondo de Finaciamiento de Centros de Investigacion en Areas Prioritarias; Fondo Nacional de Ciencia y Tecnologia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Institut de Genetica Humana, Pontificia Universidad Javeriana, Bogota, Colombia; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from Fondo de Finaciamiento de Centros de Investigacion en Areas Prioritarias (15090007; to M. L. A. and M. M.), Fondo Nacional de Ciencia y Tecnologia (FONDECYT 1130706; to M. M.), and NIH Grants R01 AR049069 (to A. J. vW.) and R01 AR039588 (to G. S. S.). The authors declare that they have no conflicts of interest with the contents of this article; Supported in part by doctoral fellowships from COLCIENCIAS and Institut de Genetica Humana, Pontificia Universidad Javeriana, Bogota, 110231, Colombia.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Banck MS, 2009, EPIGENETICS-US, V4, P100, DOI 10.4161/epi.4.2.7953; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bradley EW, 2011, CRIT REV EUKAR GENE, V21, P101; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cruzat F, 2009, BIOCHEMISTRY-US, V48, P7287, DOI 10.1021/bi9004792; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Ezura Y, 2009, ARTHRITIS RHEUM, V60, P1416, DOI 10.1002/art.24472; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gori F, 2004, ENDOCRINOLOGY, V145, P1050, DOI 10.1210/en.2003-1314; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Henriquez B, 2011, J CELL PHYSIOL, V226, P3043, DOI 10.1002/jcp.22652; Hovhannisyan H, 2013, J CELL PHYSIOL, V228, P313, DOI 10.1002/jcp.22109; Kim S, 2014, MOL CELL, V56, P564, DOI 10.1016/j.molcel.2014.10.003; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Stojic L, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-16; Tai PWL, 2014, GENE, V550, P1, DOI 10.1016/j.gene.2014.05.044; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ye L, 2012, CELL STEM CELL, V11, P50, DOI 10.1016/j.stem.2012.04.009; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	65	48	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28329	28342		10.1074/jbc.M115.657825	http://dx.doi.org/10.1074/jbc.M115.657825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26453309	hybrid, Green Published			2022-12-26	WOS:000365761900025
J	Gonzalez-Dominguez, E; Caffi, T; Ciliberti, N; Rossi, V				Gonzalez-Dominguez, Elisa; Caffi, Tito; Ciliberti, Nicola; Rossi, Vittorio			A Mechanistic Model of Botrytis cinerea on Grapevines That Includes Weather, Vine Growth Stage, and the Main Infection Pathways	PLOS ONE			English	Article							DECISION-SUPPORT-SYSTEMS; GREY MOLD; WETNESS DURATION; BUNCH ROT; BERRIES; GRAPES; TEMPERATURE; INOCULUM; LATENCY; SUSCEPTIBILITY	A mechanistic model for Botrytis cinerea on grapevine was developed. The model, which accounts for conidia production on various inoculum sources and for multiple infection pathways, considers two infection periods. During the first period ("inflorescences clearly visible" to "berries groat-sized"), the model calculates: i) infection severity on inflorescences and young clusters caused by conidia (SEV1). During the second period ("majority of berries touching" to "berries ripe for harvest"), the model calculates: ii) infection severity of ripening berries by conidia (SEV2); and iii) severity of berry-to-berry infection caused by mycelium (SEV3). The model was validated in 21 epidemics (vineyard x year combinations) between 2009 and 2014 in Italy and France. A discriminant function analysis (DFA) was used to: i) evaluate the ability of the model to predict mild, intermediate, and severe epidemics; and ii) assess how SEV1, SEV2, and SEV3 contribute to epidemics. The model correctly classified the severity of 17 of 21 epidemics. Results from DFA were also used to calculate the daily probabilities that an ongoing epidemic would be mild, intermediate, or severe. SEV1 was the most influential variable in discriminating between mild and intermediate epidemics, whereas SEV2 and SEV3 were relevant for discriminating between intermediate and severe epidemics. The model represents an improvement of previous B. cinerea models in viticulture and could be useful for making decisions about Botrytis bunch rot control.	[Gonzalez-Dominguez, Elisa; Caffi, Tito; Ciliberti, Nicola; Rossi, Vittorio] Univ Cattolica Sacro Cuore, Dept Sustainable Crop Prod, Piacenza, Italy	Catholic University of the Sacred Heart	Rossi, V (corresponding author), Univ Cattolica Sacro Cuore, Dept Sustainable Crop Prod, Piacenza, Italy.	vittorio.rossi@unicatt.it	Rossi, Vittorio/I-7869-2012; Caffi, Tito/I-3626-2012	Rossi, Vittorio/0000-0003-4090-6117; Caffi, Tito/0000-0001-9929-4130; Gonzalez-Dominguez, Elisa/0000-0001-6598-0204	Emilia-Romagna Region (coordinated by CRPV); Universita Cattolica del Sacro Cuore	Emilia-Romagna Region (coordinated by CRPV); Universita Cattolica del Sacro Cuore	This study was funded by Emilia-Romagna Region (coordinated by CRPV) and Universita Cattolica del Sacro Cuore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon R, 1973, VIGNE VINS, V220, P5; Agulhon R., 1969, POURRITURE GRISE RAI; Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; Albertini C, 2002, MYCOL RES, V106, P1171, DOI 10.1017/S0953756202006561; Angelini RMD, 2014, PEST MANAG SCI, V70, P1884, DOI 10.1002/ps.3748; Angelini RMD, 2012, PEST MANAG SCI, V68, P1231, DOI 10.1002/ps.3281; Baldacci E., 1962, NOT MAL PIANTE, V62, P29; Belanger MC, 2011, INT J REMOTE SENS, V32, P3835, DOI 10.1080/01431161003782064; Bisiach M, 1978, INF AGRAR, V24, P2283; Bisiach M., 1975, GIORNATE FITOPATOLOG, P753; Bisiach M, 1978, INF AGRAR, V24, P2287; Bolay A., 1975, Revue Suisse de Viticulture Arboriculture Horticulture, V7, P137; BROOME JC, 1995, PHYTOPATHOLOGY, V85, P97, DOI 10.1094/Phyto-85-97; BULIT J., 1970, Phytiatrie-Phytopharmacie, V19, P159; Caffi T, 2010, PLANT DIS, V94, P709, DOI 10.1094/PDIS-94-6-0709; Caffi T, 2012, PLANT DIS, V96, P104, DOI 10.1094/PDIS-06-11-0484; CHASTAGNER GA, 1978, PHYTOPATHOLOGY, V68, P1172, DOI 10.1094/Phyto-68-1172; Ciliberti N, 2015, AUST J GRAP IN PRESS; Ciliberti N, 2015, PHYTOPATHOLOGY, V105, P1090, DOI 10.1094/PHYTO-10-14-0264-R; Ciliberti N, 2015, PHYTOPATHOLOGY, V105, P325, DOI 10.1094/PHYTO-05-14-0152-R; Coley-Smith J., 1980, BIOL BOTRYTIS, P85; De Miccolis A, 2004, J PLANT PATHOL, V110, P208; Deytieux-Belleau C, 2009, EUR J PLANT PATHOL, V125, P551, DOI 10.1007/s10658-009-9503-6; Egger E, 1994, VALUTAZIONE MODELLO, P157; Elad Y, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P1; Ellison P, 1998, AGR SYST, V56, P209, DOI 10.1016/S0308-521X(97)00036-X; Ellison P, 1998, AGR SYST, V56, P185, DOI 10.1016/S0308-521X(97)00035-8; Elmer P.A., 2007, BOTRYTIS BIOL PATHOL, P243; Fekete E, 2012, MICROBIOL RES, V167, P283, DOI 10.1016/j.micres.2011.10.006; FERMAUD M, 1992, PHYTOPATHOLOGY, V82, P1393, DOI 10.1094/Phyto-82-1393; FERMAUD M, 1989, PHYTOPATHOLOGY, V79, P651, DOI 10.1094/Phyto-79-651; FERMAUD M, 1994, PLANT PATHOL, V43, P953, DOI 10.1111/j.1365-3059.1994.tb01644.x; Fernandez-ortuno D, 2014, PHYTOPATHOLOGY, V105, P424; Fournier E, 2003, MYCOLOGIA, V95, P251, DOI 10.2307/3762036; Gabler FM, 2003, PHYTOPATHOLOGY, V93, P1263, DOI 10.1094/PHYTO.2003.93.10.1263; Gartel W, 1977, VIGNE VINS, V260, P15; Gent DH, 2013, ANNU REV PHYTOPATHOL, V51, P267, DOI 10.1146/annurev-phyto-082712-102356; Gent DH, 2011, PHYTOPATHOLOGY, V101, P640, DOI 10.1094/PHYTO-04-10-0124; Giraud T, 1999, PHYTOPATHOLOGY, V89, P967, DOI 10.1094/PHYTO.1999.89.10.967; Hau B., 1990, EPIDEMICS PLANT DIS, P12, DOI DOI 10.1007/978-3-642-75398-5_2; HILL G, 1981, PHYTOPATHOL Z, V102, P328; Holtz G., 2007, BOTRYTIS BIOL PATHOL, P9; Holz G, 2003, PLANT DIS, V87, P351, DOI 10.1094/PDIS.2003.87.4.351; Holz G., 1997, Phytopathology, V87, pS43; Huberty C., 2006, APPL MANOVA DISCRIMI; Jacometti MA, 2010, AUST J GRAPE WINE R, V16, P154, DOI 10.1111/j.1755-0238.2009.0067.x; Jarvis WR, 1977, BOTRYOTINIA BOTRYTIS; Jaspers MV, 2013, PLANT PATHOL, V62, P130, DOI 10.1111/j.1365-3059.2012.02631.x; Rodriguez-Rajo FJ, 2010, GRANA, V49, P56, DOI 10.1080/00173130903472393; Jimenez-Diaz RM, 2011, PHYTOPATHOLOGY, V101, P304, DOI 10.1094/PHYTO-07-10-0176; Keller M, 2003, PHYTOPATHOLOGY, V93, P316, DOI 10.1094/PHYTO.2003.93.3.316; Keough MJ, 2011, EXPT DESIGN DATA ANA; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kretschmer M, 2007, J PHYTOPATHOL, V155, P258, DOI 10.1111/j.1439-0434.2007.01216.x; Lafon R, 1972, REV ZOOL AGR PATHOL, V1, P31; Latorre B. A., 2002, Ciencia e Investigacion Agraria, V29, P67; Latorre B. A., 2001, Ciencia e Investigacion Agraria, V28, P61; Leffelaar PA, 1989, SIMULATION SYSTEMS M, P19; Lorenz D.H., 1994, VITIC ENOL SCI, V49, P66, DOI DOI 10.1111/J.1755-0238.1995.TB00085.X; Martinez F, 2005, PHYTOPATHOLOGY, V95, P692, DOI 10.1094/PHYTO-95-0692; Martinez F, 2003, EUR J PLANT PATHOL, V109, P479, DOI 10.1023/A:1024222206991; MCCLELLAN WD, 1973, PHYTOPATHOLOGY, V63, P1151, DOI 10.1094/Phyto-63-1151; Molitor D, 2011, VITIS, V50, P81; Molot B., 1987, Progres Agricole et Viticole, V104, P355; Mundy D. C., 2012, New Zealand Plant Protection, V65, P218; Mundy D. C., 2012, New Zealand Plant Protection, V65, P236; Mundy D. C., 2007, New Zealand Plant Protection, V60, P123; Munoz G, 2002, MYCOL RES, V106, P594, DOI 10.1017/S0953756202005981; NAIR NG, 1993, MYCOL RES, V97, P1012, DOI 10.1016/S0953-7562(09)80871-X; Nair NG, 1995, AUST J EXP AGR, V35, P1177, DOI 10.1071/EA9951177; NAIR NG, 1987, J PHYTOPATHOL, V119, P42, DOI 10.1111/j.1439-0434.1987.tb04382.x; NAIR NG, 1985, PLANT PATHOL, V34, P302, DOI 10.1111/j.1365-3059.1985.tb01365.x; NAIR NG, 1988, NEW ZEAL J EXP AGR, V16, P257, DOI 10.1080/03015521.1988.10425648; NELSON KE, 1951, PHYTOPATHOLOGY, V41, P319; PADGETT M, 1990, J AM SOC HORTIC SCI, V115, P269, DOI 10.21273/JASHS.115.2.269; Pezet R, 2003, J PHYTOPATHOL, V151, P208, DOI 10.1046/j.1439-0434.2003.00707.x; Pezet R., 1986, Revue Suisse de Viticulture, d'Arboriculture et d'Horticulture, V18, P317; Raw V., 2012, New Zealand Plant Protection, V65, P249; Rossi V, 2007, PLANT PATHOL, V56, P957, DOI 10.1111/j.1365-3059.2007.01685.x; Rossi V, 2014, COMPUT ELECTRON AGR, V100, P88, DOI 10.1016/j.compag.2013.10.011; Rossi V, 2012, PHYTOPATHOL MEDITERR, V51, P457; Rossi V, 2010, PRECISION CROP PROTECTION - THE CHALLENGE AND USE OF HETEROGENEITY, P241, DOI 10.1007/978-90-481-9277-9_15; Salinari F, 2006, GLOBAL CHANGE BIOL, V12, P1299, DOI 10.1111/j.1365-2486.2006.01175.x; Sanogo S, 2004, PHYTOPATHOLOGY, V94, P1004, DOI 10.1094/PHYTO.2004.94.9.1004; Santos J., 2013, EFFICIENCY MEASURES, P37, DOI [10.1007/978-94-007-5739-4_3, DOI 10.1007/978-94-007-5739-4_3]; Seyb A., 2000, NZ PLANT PROT, V53, P451; Shtienberg D, 2007, BOTRYTIS BIOL PATHOL, P335; Shtienberg D, 2013, ANNU REV PHYTOPATHOL, V51, P1, DOI 10.1146/annurev-phyto-082712-102244; SOSAALVAREZ M, 1995, PLANT DIS, V79, P609, DOI 10.1094/PD-79-0609; Strizyk S., 1985, MODELE ETAT POTENTIA; THOMAS A C, 1981, Phytophylactica, V13, P157; THOMAS AC, 1983, PHYTOPATHOLOGY, V73, P1374, DOI 10.1094/Phyto-73-1374; THOMAS CS, 1988, PHYTOPATHOLOGY, V78, P260, DOI 10.1094/Phyto-78-260; Vaczy KZ, 2008, PHYTOPATHOLOGY, V98, P1312, DOI 10.1094/PHYTO-98-12-1312; VAIL ME, 1991, PHYTOPATHOLOGY, V81, P188, DOI 10.1094/Phyto-81-188; Valdes-Gomeza H, 2008, CROP PROT, V27, P1174, DOI 10.1016/j.cropro.2008.02.003; VERCESI A, 1982, RIV PATOL VEG, V18, P13; Vercesi A, 1990, NOT MAL PIANTE, V111, P125; Viret O, 2004, PHYTOPATHOLOGY, V94, P850, DOI 10.1094/PHYTO.2004.94.8.850; Walker AS, 2011, PHYTOPATHOLOGY, V101, P1433, DOI 10.1094/PHYTO-04-11-0104; Wilcox WF, 2002, NZ GRAPEGROW WINEMAK, V10, P22; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Workneh F, 2008, PHYTOPATHOLOGY, V98, P95, DOI 10.1094/PHYTO-98-1-0095; YUNIS H, 1989, PHYTOPARASITICA, V17, P13, DOI 10.1007/BF02979601; Zerbetto F, 1988, NOT MAL PIANTE, V109, P28	105	40	40	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140444	10.1371/journal.pone.0140444	http://dx.doi.org/10.1371/journal.pone.0140444			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457808	gold, Green Submitted, Green Published			2022-12-26	WOS:000362961100034
J	Brima, N; Burns, F; Fakoya, I; Kargbo, B; Conteh, S; Copas, A				Brima, Nataliya; Burns, Fiona; Fakoya, Ibidun; Kargbo, Brima; Conteh, Suleiman; Copas, Andrew			Factors Associated with HIV Prevalence and HIV Testing in Sierra Leone: Findings from the 2008 Demographic Health Survey	PLOS ONE			English	Article							SEXUAL RISK BEHAVIORS; TRANSMISSION RISK; MALE CIRCUMCISION; INFECTED ADULTS; INTERVENTIONS; PREVENTION; WOMEN; KNOWLEDGE; KENYA; AIDS	Background The Sierra Leone Demographic Health Survey 2008 found an HIV prevalence of 1.5%. This study investigates associations with HIV infection and HIV testing. Methods Households were selected using stratified multi-stage sampling. In all selected households women aged 15-49 were eligible. In every second household men aged 15-59 were also eligible. Participants were asked to consent for anonymous HIV testing. All participants interviewed and tested were analysed. Multiple logistic regression identified associations with HIV infection, undiagnosed infection and with ever having a voluntary HIV test among sexually active participants. Results Of 7495 invited 86% (6,475) agreed to an interview and HIV test. Among 96 HIV positive participants, 78% had never taken a voluntary HIV test so were unaware of their serostatus, and 86% were sexually active in the last 12 months among whom 96% did not use a condom at last intercourse. 11% of all participants had previously voluntarily tested. Among women who had tested, 60% did so in antenatal care. We found that those living in an urban area, and those previously married, were more likely to be HIV infected. Voluntary HIV testing was more common in those aged 25-44, living in an urban area, females, having secondary or higher education, having first sexual intercourse at age 17 years or older, and using condoms at last sex. Although 82% of men and 69% of women had heard of HIV, only 35% and 29% respectively had heard of antiretroviral therapy. Conclusions The HIV prevalence in Sierra Leone has been stable. HIV testing, however, is uncommon and most infected individuals are unaware of their serostatus. This could allow the epidemic to escalate as individuals with undiagnosed infection are unlikely to change their behaviour or access treatment. Improving knowledge and increasing testing need to remain central to HIV prevention interventions in Sierra Leone.	[Brima, Nataliya; Burns, Fiona; Fakoya, Ibidun; Copas, Andrew] UCL, Res Dept Infect & Populat Hlth, London, England; [Burns, Fiona] UCL, Royal Free London NHS Fdn Trust, London, England; [Kargbo, Brima] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Conteh, Suleiman] Natl AIDS Control Program, Freetown, Sierra Leone	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; Ministry of Health & Sanitation Sierra Leone	Brima, N (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	n.brima@ucl.ac.uk	Brima, Nataliya/GRR-7577-2022	Fakoya, Ibidun/0000-0003-3490-7607; Copas, Andrew/0000-0001-8968-5963	UCL Grand Challenge Global Heath Fund	UCL Grand Challenge Global Heath Fund	Small grant from the UCL Grand Challenge Global Heath Fund with URL http://www.ucl.ac.uk/global-health/.	ALLEN S, 1991, JAMA-J AM MED ASSOC, V266, P1657, DOI 10.1001/jama.266.12.1657; Anand A, 2009, AIDS, V23, P1565, DOI 10.1097/QAD.0b013e32832cb10c; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baggaley R, 2012, B WORLD HEALTH ORGAN, V90, P633; Bhoobun S, 2014, J COMMUN HEALTH, V39, P514, DOI 10.1007/s10900-013-9788-4; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Casey SE, 2006, GLOB PUBLIC HEALTH, V1, P2006; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Hearst N, 1997, AIDS, V11, pS1; Hensen B, 2012, TROP MED INT HEALTH, V17, P59, DOI 10.1111/j.1365-3156.2011.02893.x; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; LINDAN C, 1991, AIDS, V5, P993, DOI 10.1097/00002030-199108000-00011; Mwangi M, 2011, JAIDS-J ACQ IMM DEF, V58, P80, DOI 10.1097/QAI.0b013e3182251001; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; NAGLER J, 1994, AM J POLIT SCI, V38, P230, DOI 10.2307/2111343; National Population Commission (NPC) Federal Republic of Nigeria Abuja, GHAN COUNTR AIDS PRO; Nigeria and ICF Macro, 2008, NIG DEM HLTH SURV 20; Pearson CR, 2007, AIDS CARE, V19, P594, DOI 10.1080/09540120701203337; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Statistics Sierra Leone (SSL) and ICF Macro, 2009, SIERR LEON DEM HLTH; Statistics Sierra Leone (SSL) and ICF Macro, 2013, SIERR LEON DEM HLTH; Staveteig S, 2013, Demographic patterns of HIV testing uptake in sub-Saharan Africa, V30; UNAIDS, DHS PROGR DEM HLTH S; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; World Health Organization, 2011, UN ACC SCAL PRIOR HI	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0137055	10.1371/journal.pone.0137055	http://dx.doi.org/10.1371/journal.pone.0137055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TY	26452051	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200002
J	Potapov, A; Merrill, E; Pybus, M; Lewis, MA				Potapov, Alex; Merrill, Evelyn; Pybus, Margo; Lewis, Mark A.			Empirical Estimation of R-0 for Unknown Transmission Functions: The Case of Chronic Wasting Disease in Alberta	PLOS ONE			English	Article							DEER	We consider the problem of estimating the basic reproduction number R-0 from data on prevalence dynamics at the beginning of a disease outbreak. We derive discrete and continuous time models, some coefficients of which are to be fitted from data. We show that prevalence of the disease is sufficient to determine R-0. We apply this method to chronic wasting disease spread in Alberta determining a range of possible R-0 and their sensitivity to the probability of deer annual survival.	[Potapov, Alex; Merrill, Evelyn; Pybus, Margo; Lewis, Mark A.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2G1, Canada; [Potapov, Alex; Lewis, Mark A.] Univ Alberta, Ctr Math Biol, Edmonton, AB T6G 2G1, Canada; [Potapov, Alex; Lewis, Mark A.] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB T6G 2G1, Canada; [Pybus, Margo] Alberta Sustainable Resource Dev, Edmonton, AB T6H 4P2, Canada	University of Alberta; University of Alberta; University of Alberta	Potapov, A (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2G1, Canada.	apotapov@ualberta.ca	Lewis, Mark A/C-5015-2008; Merrill, Evelyn/N-5801-2015	Lewis, Mark A/0000-0002-7155-7426; Merrill, Evelyn/0000-0001-7737-958X	Alberta Prion Research Institute and Alberta Innovation [RES0004230]; Natural Sciences and Engineering Research Council of Canada Discovery Grants; Alberta Conservation Association Grant; NSERC Accelerator Grant; Killam Research Fellowship; Canada Research Chair	Alberta Prion Research Institute and Alberta Innovation; Natural Sciences and Engineering Research Council of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Conservation Association Grant; NSERC Accelerator Grant; Killam Research Fellowship; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work has been supported by Alberta Prion Research Institute and Alberta Innovation through grants (E. Merrill: RES0004230), Natural Sciences and Engineering Research Council of Canada Discovery Grants (EM, MAL) Alberta Conservation Association Grant (EM,AP), and an NSERC Accelerator Grant, a Killam Research Fellowship and a Canada Research Chair to MAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-arydah M., 2012, ISRN BIOMATHEMATICS; Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; Conner MM, 2004, ECOL APPL, V14, P1870, DOI 10.1890/03-5309; Cullingham CI, 2011, CAN J ZOOL, V89, P134, DOI 10.1139/Z10-104; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Farnsworth ML, 2006, ECOL APPL, V16, P1026, DOI 10.1890/1051-0761(2006)016[1026:LCWDTM]2.0.CO;2; Fulford GR, 2002, THEOR POPUL BIOL, V61, P15, DOI 10.1006/tpbi.2001.1553; Hadeler KP, 1997, MATH BIOSCI, V146, P15, DOI 10.1016/S0025-5564(97)00027-8; Heesterbeek JAP, 1995, ECOLOGY INFECT DIS N; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Li CK, 2002, J MATH BIOL, V44, P450, DOI 10.1007/s002850100132; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Merrill E.H., 2011, FINAL REPORT; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nobert BR, 2012, THESIS U ALBERTA EDM; Potapov A, 2013, P ROY SOC B, V279, P3139; Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012; ROBINETTE WL, 1966, J WILDLIFE MANAGE, V30, P335, DOI 10.2307/3797822; Sharp A, 2011, ECOL APPL, V21, P1024, DOI 10.1890/10-1449.1; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x	25	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140024	10.1371/journal.pone.0140024	http://dx.doi.org/10.1371/journal.pone.0140024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452231	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511200028
J	Bellini, G; Grandone, A; Torella, M; del Giudice, EM; Nobili, B; Perrone, L; Maione, S; Rossi, F				Bellini, Giulia; Grandone, Anna; Torella, Marco; del Giudice, Emanuele Miraglia; Nobili, Bruno; Perrone, Laura; Maione, Sabatino; Rossi, Francesca			The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche	PLOS ONE			English	Article							PROTEIN-KINASE-B; MAMMALIAN TARGET; ASSOCIATIONS; POLYMORPHISM; ACTIVATION; PI3K/AKT; LIN28B; LEPTIN; RISK; LOCI	Background The ovary is an important site where gene variants modulate pubertal timing. The cannabinoid receptor 2 (CB2) is expressed in the ovary, plays a role in folliculogenesis and ovulation, and can be modulated by estrogens. Obesity is strictly associated with early menarche and is characterized by sex hormone and endocannabinoid derangement. Aim In this study, we investigated the role of the CB2 receptor in determining the age at menarche in obese girls. Methods We studied a cohort of 240 obese girls (age 11.9 +/- 3 years; BMI z-score 2.8 +/- 0.8). The age at menarche (if it had already occurred) was recorded at the time of the visit or via phonecall. The CNR2 rs35761398 polymorphism, which leads to the CB2 Q63R variant, was detected by the TaqMan assay. Results In total, 105 patients were homozygous for the R63-coding allele (RR), 113 were QR and 22 were QQ. Variance analysis revealed a significantly earlier age of menarche in subjects carrying the Q63 allele, which was also found after adjusting for BMI z-score (11 +/- 1.2 vs. 11.6 +/- 1.2 years, p = 0.0003). Logistic regression analysis demonstrated that patients homozygous for the Q allele had a 2.2-fold higher risk (odds ratio = 2.2; CI1.1-3.4; p = 0.02) of presenting with an early menarche (age at menarche < 12 years). Conclusion We demonstrated for the first time the association between the CB2 Q63R functional variant and the age at menarche in a cohort of Italian obese girls.	[Bellini, Giulia; Maione, Sabatino] Univ Naples 2, Div Pharmacol, Dept Expt Med, Naples, Italy; [Grandone, Anna; Torella, Marco; del Giudice, Emanuele Miraglia; Nobili, Bruno; Perrone, Laura; Rossi, Francesca] Univ Naples 2, Dept Woman Child & Gen & Specialist Surg, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Rossi, F (corresponding author), Univ Naples 2, Dept Woman Child & Gen & Specialist Surg, Naples, Italy.	francesca.rossi@unina2.it	del Giudice, Emanuele Muraglia/AAC-2824-2019	Torella, Marco/0000-0001-8853-5760; Rossi, Francesca/0000-0003-2879-6277; Maione, Sabatino/0000-0003-3850-6704	Department of Woman, Child and of General and Specialist Surgery, Second University of Naples, Naples, Italy	Department of Woman, Child and of General and Specialist Surgery, Second University of Naples, Naples, Italy	This study was supported by the Department of Woman, Child and of General and Specialist Surgery, Second University of Naples, Naples, Italy.	Abir R, 2005, FERTIL STERIL, V84, P1779, DOI 10.1016/j.fertnstert.2005.05.067; Ahmed ML, 2009, TRENDS ENDOCRIN MET, V20, P237, DOI 10.1016/j.tem.2009.02.004; Banerjee I, 2007, J NEUROENDOCRINOL, V19, P831, DOI 10.1111/j.1365-2826.2007.01598.x; Bellini G, 2015, SCAND J RHEUMATOL, V14, P1; Carrasquer A, 2010, PHARMACOGENET GENOM, V20, P157, DOI 10.1097/FPC.0b013e3283367c6b; Cecconi S, 2014, EUR J OBSTET GYN R B, V178, P6, DOI 10.1016/j.ejogrb.2014.04.011; Cecconi S, 2012, INT J DEV BIOL, V56, P809, DOI 10.1387/ijdb.120146sc; Chou SH, 2014, J ENDOCRINOL, V223, pT49, DOI 10.1530/JOE-14-0245; Condorelli RA, 2014, J ENDOCRINOL INVEST; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Dreyfus J, 2015, J PEDIAT; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Gomez O, 2011, BRIT J PHARMACOL, V163, P1520, DOI 10.1111/j.1476-5381.2011.01414.x; Gomez O, 2015, J NEUROIMMUNE PHARM, V10, P309, DOI 10.1007/s11481-015-9609-x; Grandone A, 2013, J ADOLESCENT HEALTH, V52, P375, DOI 10.1016/j.jadohealth.2012.10.273; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; Kalous J, 2009, REPRODUCTION, V138, P645, DOI 10.1530/REP-08-0461; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Li Q, 2013, CELL PHYSIOL BIOCHEM, V31, P693, DOI 10.1159/000350088; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pinkney J, 2014, J CLIN ENDOCR METAB, V99, P3224, DOI 10.1210/jc.2013-3902; Rossi F, 2013, PHARMACOL RES, V68, P7, DOI 10.1016/j.phrs.2012.10.017; Rossi F, 2012, PHARMACOL RES, V66, P88, DOI 10.1016/j.phrs.2012.03.011; Rossi F, 2011, HAEMATOL-HEMATOL J, V96, P1883, DOI 10.3324/haematol.2011.045732; Rothenbuhler A, 2006, J CLIN ENDOCR METAB, V91, P3534, DOI 10.1210/jc.2006-0150; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Tomek W, 2005, REPRODUCTION, V130, P423, DOI 10.1530/rep.1.00754; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wagner IV, 2012, NAT REV ENDOCRINOL, V8, P246, DOI 10.1038/nrendo.2011.241; Wan Wen, 2012, Open J Pediatr, V2, DOI 10.4236/ojped.2012.22020	33	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140142	10.1371/journal.pone.0140142	http://dx.doi.org/10.1371/journal.pone.0140142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447698	Green Submitted, gold, Green Published			2022-12-26	WOS:000362511000095
J	Chen, CL; Chen, YP; Lin, MW; Huang, YB; Chang, FR; Duh, TH; Wu, DC; Wu, WC; Kao, YC; Yang, PH				Chen, Chun-Lin; Chen, Ying-Pin; Lin, Ming-Wei; Huang, Yaw-Bin; Chang, Fang-Rong; Duh, Tsai-Hui; Wu, Deng-Chyang; Wu, Wei-Chiang; Kao, Yu-Chen; Yang, Pei-Hua			Euphol from Euphorbia tirucalli Negatively Modulates TGF-beta Responsiveness via TGF-beta Receptor Segregation inside Membrane Rafts	PLOS ONE			English	Article							CANCER-CELLS; LIPID RAFTS; CHOLESTEROL DEPLETION; SIGNALING PATHWAY; CA2+ ENTRY; GROWTH; ACTIVATION; BINDING; INHIBITION; PROTEIN	Transforming growth factor-beta (TGF-beta) responsiveness in cultured cells can be modulated by TGF-beta partitioning between lipid raft/caveolae- and clathrin-mediated endocytosis pathways. Lipid rafts are plasma membrane microdomains with an important role in cell survival signaling, and cholesterol is necessary for the lipid rafts' structure and function. Euphol is a euphane-type triterpene alcohol that is structurally similar to cholesterol and has a wide range of pharmacological properties, including anti-inflammatory and anti-cancer effects. In the present study, euphol suppressed TGF-beta signaling by inducing TGF-beta receptor movement into lipid-raft microdomains and degrading TGF-beta receptors.	[Chen, Chun-Lin; Chen, Ying-Pin; Huang, Yaw-Bin; Kao, Yu-Chen; Yang, Pei-Hua] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Chen, Chun-Lin] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Chen, Chun-Lin] Acad Sinica, Kaohsiung, Taiwan; [Lin, Ming-Wei; Huang, Yaw-Bin] Kaohsiung Med Univ, Sch Pharm, Dept Pharm, Kaohsiung, Taiwan; [Chang, Fang-Rong] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Duh, Tsai-Hui] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan; [Wu, Deng-Chyang] Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Wu, Wei-Chiang] Kaohsiung Med Univ, Fac Pharm, Kaohsiung, Taiwan; [Chen, Chun-Lin; Lin, Ming-Wei; Huang, Yaw-Bin; Chang, Fang-Rong; Wu, Deng-Chyang] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University; Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chen, CL (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.	chunlinchen@mail.nsysu.edu.tw	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Huang, Yaw-Bin/0000-0002-6024-0108; Chang, Fang-Rong/0000-0003-2549-4193	National Science Council of Taiwan [101-2320-B-110-003, 102-2320-B-110-007, 103-2314-B-037-064, 103-2320-B-037-014]; KMU Center for Stem Cell Research [KMU-TP103G01, KMU-TP103G00, KMU-TP103G03, KMU-TP103G04, KMU-TP103G05]; NSYSU-KMU Joint Research Project [NSYSUKMU2013-I006]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); KMU Center for Stem Cell Research; NSYSU-KMU Joint Research Project	This work is supported by the National Science Council of Taiwan (101-2320-B-110-003, 102-2320-B-110-007, 103-2314-B-037-064, and 103-2320-B-037-014), KMU Center for Stem Cell Research (KMU-TP103G01, KMU-TP103G00, KMU-TP103G03, KMU-TP103G04 & KMU-TP103G05) and NSYSU-KMU Joint Research Project (NSYSUKMU2013-I006).	Akihisa T, 2001, LIPIDS, V36, P507, DOI 10.1007/s11745-001-0750-4; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Baniadam S, 2014, IRAN J PHARM RES, V13, P135; Bauge C, 2012, BBA-MOL CELL RES, V1823, P983, DOI 10.1016/j.bbamcr.2012.02.017; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Chen CL, 2008, J CELL PHYSIOL, V215, P223, DOI 10.1002/jcp.21303; Chen CL, 2007, J CELL SCI, V120, P3509, DOI 10.1242/jcs.006916; Chen CL, 2011, J NUTR BIOCHEM, V22, P649, DOI 10.1016/j.jnutbio.2010.05.004; Chen CL, 2006, J BIOL CHEM, V281, P11506, DOI 10.1074/jbc.M512821200; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Duarte N, 2009, ANTICANCER RES, V29, P4467; Dutra RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027122; Dutra RC, 2012, BIOCHEM PHARMACOL, V83, P531, DOI 10.1016/j.bcp.2011.11.026; Hammond S M, 1977, Prog Med Chem, V14, P105, DOI 10.1016/S0079-6468(08)70148-6; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hinzey AH, 2012, INDIAN J BIOCHEM BIO, V49, P329; Hsieh WT, 2011, NUTR CANCER, V63, P1339, DOI 10.1080/01635581.2011.608481; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Jilani K, 2013, TOXICOL IN VITRO, V27, P52, DOI 10.1016/j.tiv.2012.09.004; Jilani K, 2011, J NAT PROD, V74, P2181, DOI 10.1021/np2005133; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; Lin MW, 2012, FOOD CHEM TOXICOL, V50, P4333, DOI 10.1016/j.fct.2012.05.029; Madureira AM, 2006, J NAT PROD, V69, P950, DOI 10.1021/np060046r; Mason RP, 2004, CIRCULATION, V109, P34, DOI 10.1161/01.CIR.0000129503.62747.03; MASSAGUE J, 1990, ANN NY ACAD SCI, V593, P59; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Nabi IR, 2009, NAT CELL BIOL, V11, P789, DOI 10.1038/ncb0709-789; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Passos GF, 2013, EUR J PHARMACOL, V698, P413, DOI 10.1016/j.ejphar.2012.10.019; Pettit GR, 2002, J NAT PROD, V65, P1886, DOI 10.1021/np020216+; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Poncelet AC, 1999, KIDNEY INT, V56, P1354, DOI 10.1046/j.1523-1755.1999.00680.x; Ringerike T, 2002, J CELL SCI, V115, P1331; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Thafeni MA, 2012, MOL BIOL REP, V39, P10785, DOI 10.1007/s11033-012-1972-6; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trapani JA, 2005, CANCER CELL, V8, P349, DOI 10.1016/j.ccr.2005.10.018; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Verma SP, 2009, CURR DRUG TARGETS, V10, P51, DOI 10.2174/138945009787122851; Wang L, 2013, MOL MED REP, V8, P1279, DOI 10.3892/mmr.2013.1650; Wang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041249; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Yang JL, 2013, MOL MED REP, V7, P1403, DOI 10.3892/mmr.2013.1380; Yawata A, 2009, EUR J PHARM SCI, V38, P355, DOI 10.1016/j.ejps.2009.08.011; Yi JS, 2009, BIOCHEM BIOPH RES CO, V385, P154, DOI 10.1016/j.bbrc.2009.05.028; Zheng YZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007146	61	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140249	10.1371/journal.pone.0140249	http://dx.doi.org/10.1371/journal.pone.0140249			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448474	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000112
J	Dhayat, SA; Husing, A; Senninger, N; Schmidt, HH; Haier, J; Wolters, H; Kabar, I				Dhayat, Sameer A.; Huesing, Anna; Senninger, Norbert; Schmidt, Hartmut H.; Haier, Joerg; Wolters, Heiner; Kabar, Iyad			Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma	PLOS ONE			English	Article							EXPRESSION PROFILE; BIOMARKERS; CANCER; PLASMA; IDENTIFICATION; PANEL	Goals In this clinical study, we aimed to evaluate the role of circulating microRNA-200 family as a non-invasive tool to identify patients with cirrhosis-associated hepatocellular carcinoma (HCC). Background Prognosis of HCC remains poor with increasing incidence worldwide, mainly related to liver cirrhosis. So far, no reliable molecular targets exist for early detection of HCC at surgically manageable stages. Recently, we identified members of the microRNA-200 family as potential diagnostic markers of cirrhosis-associated HCC in patient tissue samples. Their value as circulating biomarkers for HCC remained undefined. Methods Blood samples and clinicopathological data of consecutive patients with liver diseases were collected prospectively. Expression of the microRNA-200 family was investigated by qRT-PCR in blood serum samples of 22 HCC patients with and without cirrhosis. Serum samples of patients with non-cancerous chronic liver cirrhosis (n = 22) and of healthy volunteers (n = 15) served as controls. Results MicroRNA-141 and microRNA-200a were significantly downregulated in blood serum of patients with HCC compared to liver cirrhosis (p<0.007) and healthy controls (p<0.002). MicroRNA-141 and microRNA-200a could well discriminate patients with cirrhosis-associated HCC from healthy volunteers with area under the receiver-operating characteristic curve (AUC) values of 0.85 and 0.82, respectively. Additionally, both microRNAs could differentiate between HCC and non-cancerous liver cirrhosis with a fair accuracy. Conclusions Circulating microRNA-200family members are significantly deregulated in patients with HCC and liver cirrhosis. Further studies are necessary to confirm the diagnostic value of the microRNA-200 family as accurate serum marker for cirrhosis-associated HCC.	[Dhayat, Sameer A.; Senninger, Norbert; Wolters, Heiner] Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany; [Huesing, Anna; Schmidt, Hartmut H.; Kabar, Iyad] Univ Hosp Muenster, Dept Transplant Med, Munster, Germany; [Haier, Joerg] Univ Hosp Muenster, Comprehens Canc Ctr Muenster, Munster, Germany	University of Munster; University of Munster; University of Munster	Dhayat, SA (corresponding author), Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany.	sameer.dhayat@ukmuenster.de		Schmidt, Hartmut/0000-0002-2402-7764				Abu El Makarem Mona, 2012, Hepat Mon, V12, pe6122; Bojmar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084815; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Dhayat SA, 2014, J SURG ONCOL, V110, P430, DOI 10.1002/jso.23668; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Huang YS, 2008, J GASTROEN HEPATOL, V23, P87, DOI 10.1111/j.1440-1746.2007.05223.x; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ji JF, 2009, CANCER BIOL THER, V8, P1683, DOI 10.4161/cbt.8.18.8898; Khare S, 2013, WORLD J GASTROENTERO, V19, P5439, DOI 10.3748/wjg.v19.i33.5439; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Li G, 2015, CLIN TRANSL ONCOL, V17, P684, DOI 10.1007/s12094-015-1294-y; Liu Y., 2014, BIORESOURCE TECHNOLO, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0088393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Rekker K, 2015, FERTIL STERIL, V104, P938, DOI 10.1016/j.fertnstert.2015.06.029; Romero-Perez L, 2013, MODERN PATHOL, V26, P1514, DOI 10.1038/modpathol.2013.93; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Tan YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107986; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Wang YJ, 2015, CANCER BIOMARK, V15, P171, DOI 10.3233/CBM-140451; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu C, 2014, BRIT J CANCER, V110, P2291, DOI 10.1038/bjc.2014.119	26	25	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140066	10.1371/journal.pone.0140066	http://dx.doi.org/10.1371/journal.pone.0140066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447841	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000086
J	Griebel, J; Giessler, S; Poxleitner, M; Faria, AN; Yin, MB; Wolinska, J				Griebel, Johanna; Giessler, Sabine; Poxleitner, Monika; Faria, Amanda Navas; Yin, Mingbo; Wolinska, Justyna			Extreme Environments Facilitate Hybrid Superiority - The Story of a Successful Daphnia galeata x longispina Hybrid Clone	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; INTERSPECIFIC HYBRIDIZATION; SEXUAL REPRODUCTION; SPECIES COMPLEX; FISH PREDATION; FOOD QUALITY; DIVERSITY; DYNAMICS; GROWTH; WATER	Hybridization within the animal kingdom has long been underestimated. Hybrids have often been considered less fit than their parental species. In the present study, we observed that the Daphnia community of a small lake was dominated by a single D. galeata x D. longispina hybrid clone, during two consecutive years. Notably, in artificial community set-ups consisting of several clones representing parental species and other hybrids, this hybrid clone took over within about ten generations. Neither the fitness assay conducted under different temperatures, or under crowded and non-crowded environments, nor the carrying capacity test revealed any outstanding life history parameters of this hybrid clone. However, under simulated winter conditions (i.e. low temperature, food and light), the hybrid clone eventually showed a higher survival probability and higher fecundity compared to parental species. Hybrid superiority in cold-adapted traits leading to an advantage of overwintering as parthenogenetic lineages might consequently explain the establishment of successful hybrids in natural communities of the D. longispina complex. In extreme cases, like the one reported here, a superior hybrid genotype might be the only clone alive after cold winters. Overall, superiority traits, such as enhanced overwintering here, might explain hybrid dominance in nature, especially in extreme and rapidly changing environments. Although any favoured gene complex in cyclic parthenogens could be frozen in successful clones independent of hybridization, we did not find similarly successful clones among parental species. We conclude that the emergence of the observed trait is linked to the production of novel recombined hybrid genotypes.	[Griebel, Johanna; Wolinska, Justyna] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany; [Griebel, Johanna; Giessler, Sabine; Poxleitner, Monika; Faria, Amanda Navas] Ludwig Maximilian Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Yin, Mingbo] Fudan Univ, Sch Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China; [Wolinska, Justyna] Free Univ Berlin, Inst Biol, Dept Biol, Chem,Pharm, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Munich; Fudan University; Free University of Berlin	Griebel, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany.	griebel@igb-berlin.de	Yin, Mingbo/E-3677-2017; Wolinska, Justyna/N-6455-2014	Yin, Mingbo/0000-0002-0742-5031	German Science Foundation [WO 1587/4-1]	German Science Foundation(German Research Foundation (DFG))	German Science Foundation grant to JW (WO 1587/4-1).	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Anderson EC, 2002, GENETICS, V160, P1217; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; Baranwal VK, 2012, J EXP BOT, V63, P6309, DOI 10.1093/jxb/ers291; Barton NH, 2013, J EVOLUTION BIOL, V26, P267, DOI 10.1111/jeb.12015; Belkhir K, 2004, 5000 CNRS UMR; BOERSMA M, 1994, J PLANKTON RES, V16, P1793, DOI 10.1093/plankt/16.12.1793; Brede N, 2006, MOL ECOL NOTES, V6, P536, DOI 10.1111/j.1471-8286.2005.01218.x; Brendonck L, 2003, HYDROBIOLOGIA, V491, P65, DOI 10.1023/A:1024454905119; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Burns CW, 2000, FRESHWATER BIOL, V43, P19, DOI 10.1046/j.1365-2427.2000.00510.x; Capaul M, 2003, EVOLUTION, V57, P249, DOI 10.1111/j.0014-3820.2003.tb00260.x; Carvajal-Salamanca JL, 2008, J PLANKTON RES, V30, P1117, DOI 10.1093/plankt/fbn071; COX DR, 1972, J R STAT SOC B, V34, P187; Declerck S, 2003, HYDROBIOLOGIA, V500, P83, DOI 10.1023/A:1024656602248; Dittrich-Reed DR, 2013, EVOL BIOL, V40, P310, DOI 10.1007/s11692-012-9209-0; Dokulil MT, 2009, AQUAT ECOL, V43, P715, DOI 10.1007/s10452-009-9282-3; Domis LND, 2007, OECOLOGIA, V150, P682, DOI 10.1007/s00442-006-0549-2; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Dudycha JL, 2004, FRESHWATER BIOL, V49, P505, DOI 10.1111/j.1365-2427.2004.01201.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; George DG, 2000, FRESHWATER BIOL, V45, P111, DOI 10.1046/j.1365-2427.2000.00673.x; Giessler S, 1999, J EVOLUTION BIOL, V12, P710; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GRANT BR, 1993, P ROY SOC B-BIOL SCI, V251, P111, DOI 10.1098/rspb.1993.0016; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; Guttel Y, 2014, INT J PARASITOL, V44, P1001, DOI 10.1016/j.ijpara.2014.06.011; Hamrova E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-231; Hebert PDN, 2001, HEREDITY, V87, P153, DOI 10.1046/j.1365-2540.2001.00885.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jeschke JM, 2000, OECOLOGIA, V123, P391, DOI 10.1007/s004420051026; Keller B, 2004, LIMNOL OCEANOGR, V49, P1393, DOI 10.4319/lo.2004.49.4_part_2.1393; Keller B, 2008, PHILOS T R SOC B, V363, P2943, DOI 10.1098/rstb.2008.0044; Keller B, 2007, LIMNOL OCEANOGR, V52, P984, DOI 10.4319/lo.2007.52.3.0984; Klekowski EJ, 2003, BIOL J LINN SOC, V79, P61, DOI 10.1046/j.1095-8312.2003.00183.x; LAMB PJ, 1987, B AM METEOROL SOC, V68, P1218, DOI 10.1175/1520-0477(1987)068<1218:NAOCAA>2.0.CO;2; Lampert W, 2010, LIMNOL OCEANOGR, V55, P1893, DOI 10.4319/lo.2010.55.5.1893; Mergeay J, 2005, LIMNOL OCEANOGR, V50, P1278, DOI 10.4319/lo.2005.50.4.1278; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Parris MJ, 2001, ECOLOGY, V82, P3001, DOI 10.2307/2679830; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petrusek A, 2008, ZOOL SCR, V37, P507, DOI 10.1111/j.1463-6409.2008.00336.x; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pratt DM, 1943, BIOL BULL-US, V85, P116, DOI 10.2307/1538274; R Core Team, 2021, R LANGUAGE ENV STAT; Rellstab C, 2009, J PLANKTON RES, V31, P261, DOI 10.1093/plankt/fbn120; Remus-Emsermann MNP, 2012, ISME J, V6, P756, DOI 10.1038/ismej.2011.209; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Saetre GP, 2013, J EVOLUTION BIOL, V26, P256, DOI 10.1111/jeb.12005; SCHWENK K, 1993, MOL BIOL EVOL, V10, P1289; Schwenk K., 1997, EXS, V82, P199; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seidendorf B, 2007, LIMNOL OCEANOGR, V52, P385, DOI 10.4319/lo.2007.52.1.0385; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SPAAK P, 1995, ECOLOGY, V76, P553, DOI 10.2307/1941213; Spaak P, 2004, J PLANKTON RES, V26, P625, DOI 10.1093/plankt/fbh064; Spaak P, 1997, LIMNOL OCEANOGR, V42, P753, DOI 10.4319/lo.1997.42.4.0753; Straile D, 2000, OECOLOGIA, V122, P44, DOI 10.1007/PL00008834; Therneau T. M, 1997, TECHNICAL REPORT; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Vrijenhoek RC, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P99, DOI 10.1007/978-90-481-2770-2_6; Weider LJ, 2008, OECOLOGIA, V158, P47, DOI 10.1007/s00442-008-1126-7; WEIDER LJ, 1991, OECOLOGIA, V87, P506, DOI 10.1007/BF00320413; Wolinska J, 2006, P ROY SOC B-BIOL SCI, V273, P1977, DOI 10.1098/rspb.2006.3523; Wolinska J, 2008, OIKOS, V117, P1637, DOI 10.1111/j.1600-0706.2008.16760.x; Wolinska J, 2007, FRESHWATER BIOL, V52, P1198, DOI 10.1111/j.1365-2427.2007.01757.x; Yin MB, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-80; Yin MB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-12; Yin MB, 2010, MOL ECOL, V19, P4168, DOI 10.1111/j.1365-294X.2010.04807.x; ZEHNDER A, 1960, CAN J MICROBIOL, V6, P645, DOI 10.1139/m60-077	76	10	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140275	10.1371/journal.pone.0140275	http://dx.doi.org/10.1371/journal.pone.0140275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448651	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511000115
J	Ishii, K; Enda, H; Noda, M; Kajino, M; Kim, A; Kurimoto, E; Sato, K; Nakano, A; Kobayashi, Y; Yagi, H; Uchiyama, S; Kato, K				Ishii, Kentaro; Enda, Hiroki; Noda, Masanori; Kajino, Megumi; Kim, Akemi; Kurimoto, Eiji; Sato, Ken; Nakano, Akihiko; Kobayashi, Yuji; Yagi, Hirokazu; Uchiyama, Susumu; Kato, Koichi			pH-Dependent Assembly and Segregation of the Coiled-Coil Segments of Yeast Putative Cargo Receptors Emp46p and Emp47p	PLOS ONE			English	Article							LEGUMINOUS LECTINS; ERGIC-53; RECOGNITION; HOMOLOG; DOMAIN; VIP36	Emp46p and Emp47p are yeast putative cargo receptors that recycle between the endoplasmic reticulum and the Golgi apparatus. These receptors can form complexes in a pH-dependent manner, but their molecular mechanisms remain unclear. Here, we successfully reproduced their interactions in vitro solely with their coiled-coil segments, which form stable heterotetramers in the neutral condition but segregate at lower pH. Mutational data identified a key glutamate residue of Emp46p that serves as the pH-sensing switch of their oligomer formation. Our findings elucidate the mechanisms of the dynamic cargo receptor interactions in the secretory pathway and the design framework of the environment-responsive molecular assembly and disassembly systems.	[Ishii, Kentaro; Uchiyama, Susumu; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan; [Enda, Hiroki; Kajino, Megumi; Kim, Akemi; Kurimoto, Eiji; Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch & Fac Pharmaceut Sci, Nagoya, Aichi, Japan; [Noda, Masanori; Kobayashi, Yuji; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Kurimoto, Eiji] Meijo Univ, Fac Pharm, Nagoya, Aichi 468, Japan; [Sato, Ken] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Nakano, Akihiko] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan; [Nakano, Akihiko] RIKEN Ctr Adv Photon, Live Cell Super Resolut Imaging Res Team, Wako, Saitama, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; Osaka University; Meijo University; University of Tokyo; University of Tokyo; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Kato, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan.	kkatonmr@ims.ac.jp	Yagi, Hirokazu/ABH-6151-2020; UCHIYAMA, Susumu/F-9590-2017; Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/A-6420-2016	UCHIYAMA, Susumu/0000-0002-5181-179X; Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; Kato, Koichi/0000-0001-7187-9612; Yagi, Hirokazu/0000-0001-9296-0225; Ishii, Kentaro/0000-0003-1722-2673	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23590058, 26102509, 24249002, 25102008, 15H02491, 25121722, 26102530]; Okazaki ORION project; Joint Studies Program in the Okazaki BIO-NEXT project of the Okazaki Institute for Integrative Bioscience; Grants-in-Aid for Scientific Research [25102008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okazaki ORION project; Joint Studies Program in the Okazaki BIO-NEXT project of the Okazaki Institute for Integrative Bioscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants (23590058 to E.K., 26102509 to K.S., 24249002, 25102008, and 15H02491 to K.K. and 25121722 and 26102530 to S.U.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, by the Okazaki ORION project, and by the Joint Studies Program (2014-2015) in the Okazaki BIO-NEXT project of the Okazaki Institute for Integrative Bioscience.	Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; FIEDLER K, 1994, CELL, V77, P625, DOI 10.1016/0092-8674(94)90047-7; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kawasaki N, 2008, BLOOD, V111, P1972, DOI 10.1182/blood-2007-06-097022; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Sato K, 2004, J BIOL CHEM, V279, P1330, DOI 10.1074/jbc.C300457200; Sato K, 2003, MOL BIOL CELL, V14, P3055, DOI 10.1091/mbc.E03-02-0115; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Satoh T, 2006, J BIOL CHEM, V281, P10410, DOI 10.1074/jbc.M512258200; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Suzuki K, 1997, BIOCHEMISTRY-US, V36, P15140, DOI 10.1021/bi971655o; Yagi-Utsumi M, 2011, INT J ALZHEIMERS DIS, V2011	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140287	10.1371/journal.pone.0140287	http://dx.doi.org/10.1371/journal.pone.0140287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447473	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000116
J	Scheffer, M; Vergnon, R; van Nes, EH; Cuppen, JGM; Peeters, ETHM; Leijs, R; Nilsson, AN				Scheffer, Marten; Vergnon, Remi; van Nes, Egbert H.; Cuppen, Jan G. M.; Peeters, Edwin T. H. M.; Leijs, Remko; Nilsson, Anders N.			The Evolution of Functionally Redundant Species; Evidence from Beetles	PLOS ONE			English	Article							SUBTERRANEAN DIVING BEETLES; LIMITING SIMILARITY; EMERGENT NEUTRALITY; DIVERSITY; MODEL; PHYTOPLANKTON; BIODIVERSITY; COEXISTENCE; ABUNDANCE; PLANKTON	While species fulfill many different roles in ecosystems, it has been suggested that numerous species might actually share the same function in a near neutral way. So-far, however, it is unclear whether such functional redundancy really exists. We scrutinize this question using extensive data on the world's 4168 species of diving beetles. We show that across the globe these animals have evolved towards a small number of regularly-spaced body sizes, and that locally co-existing species are either very similar in size or differ by at least 35%. Surprisingly, intermediate size differences (10-20%) are rare. As body-size strongly reflects functional aspects such as the food that these generalist predators can eat, these beetles thus form relatively distinct groups of functional look-a-likes. The striking global regularity of these patterns support the idea that a self-organizing process drives such species-rich groups to self-organize evolutionary into clusters where functional redundancy ensures resilience through an insurance effect.	[Scheffer, Marten; Vergnon, Remi; van Nes, Egbert H.; Cuppen, Jan G. M.; Peeters, Edwin T. H. M.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands; [Leijs, Remko] S Australian Museum, Adelaide, SA 5000, Australia; [Leijs, Remko] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Leijs, Remko] Flinders Univ South Australia, Sch Biol Sci, Adelaide, SA, Australia; [Nilsson, Anders N.] Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden	Wageningen University & Research; University of Adelaide; Flinders University South Australia; Umea University	Scheffer, M (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, POB 47, NL-6700 AA Wageningen, Netherlands.	marten.scheffer@wur.nl	van Nes, Egbert H/F-2681-2011	van Nes, Egbert/0000-0002-6345-104X; Peeters, Edwin T.H.M./0000-0003-2541-1829	ERC-Advanced Grant; Spinoza Award	ERC-Advanced Grant(European Research Council (ERC)); Spinoza Award	This research was partly funded by an ERC-Advanced Grant and Spinoza Award received by M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that there where were no additional funding sources for this study.	Allen CR., 2008, DISCONTINUITIES ECOS; Baskin Y, 1997, SCIENCE, V275, P311, DOI 10.1126/science.275.5298.311; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Cadotte MW, 2007, P ROY SOC B-BIOL SCI, V274, P2739, DOI 10.1098/rspb.2007.0925; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fort H, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/05/P05005; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Hubbell Stephen P., 2001, V32, pi; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Leijs R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034260; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Nee S, 2006, NATURE, V441, P417, DOI 10.1038/441417a; NILSSON A., 1996, A TAXONOMIC HDB, V1; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Schwilk DW, 2005, ECOL LETT, V8, P272, DOI 10.1111/j.1461-0248.2004.00720.x; Segura AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01037; Segura AM, 2011, P ROY SOC B-BIOL SCI, V278, P2355, DOI 10.1098/rspb.2010.2464; SOMMER U, 1984, LIMNOL OCEANOGR, V29, P633, DOI 10.4319/lo.1984.29.3.0633; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vergnon R, 2013, AM NAT, V182, P67, DOI 10.1086/670589; Vergnon R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1663; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Yu DW, 1998, ECOL LETT, V1, P193	36	25	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0137974	10.1371/journal.pone.0137974	http://dx.doi.org/10.1371/journal.pone.0137974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447476	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000362511000006
J	Yazawa, A; Inoue, Y; Stickley, A; Li, DD; Du, JW; Watanabe, C				Yazawa, Aki; Inoue, Yosuke; Stickley, Andrew; Li, Dandan; Du, Jianwei; Watanabe, Chiho			The Effects of Season of Birth on the Inflammatory Response to Psychological Stress in Hainan Island, China	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TYPE-2 DIABETES-MELLITUS; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; AMBIENT-TEMPERATURE; DIETARY PATTERNS; DRINKING-WATER; ASSOCIATION; HEALTH	Season of birth (SOB) has been investigated as one of the environmental factors that might epigenetically determine the physiology of individuals. This study investigated the role of SOB in the association between Quality of Life (QOL), a proxy of psychological stress status, and C-reactive protein (CRP) concentration (i.e., inflammatory status) among 1,085 adults (aged 20-57 years old) in Hainan Island, China. High sensitivity CRP concentration was measured in dried blood spot samples, while the abbreviated version of the World Health Organization's QOL questionnaire was used to gather information on six QOL domains. Analysis stratified by three historically distinct age groups revealed a significant association between CRP concentration, SOB, QOL and an interaction between SOB and QOL among the youngest and oldest groups. In the oldest group, those born in the dry season had a higher CRP concentration with worse QOL whereas in the youngest group, there was a higher CRP concentration with better QOL. Annual per capita rice production, a proxy of population nutritional status in the year of birth, was found to predict CRP concentration only among the second oldest group. These findings suggest that the early environment might affect the immune response to psychological stress in adulthood and that its effect may differ by the time period in which people were born.	[Yazawa, Aki; Inoue, Yosuke; Stickley, Andrew; Watanabe, Chiho] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, Tokyo, Japan; [Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth & Social Change Scohost, Stockholm, Sweden; [Li, Dandan; Du, Jianwei] Hainan Ctr Dis Control & Prevent, Haikou, Hainan, Peoples R China	University of Tokyo; Sodertorn University	Yazawa, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, Tokyo, Japan.	aki-y@humeco.m.u-tokyo.ac.jp	Yazawa, Aki/R-9176-2019		Japan Society for the Promotion of Science; Institutional Program for Young Researcher Overseas Visits (International Training Program); KAKENHI [11J02876, 13J06172]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institutional Program for Young Researcher Overseas Visits (International Training Program); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant sponsor: The Japan Society for the Promotion of Science (http://www.jsps.go.jp); Contract Grant number: A Grant-in-Aid for Scientific Research (KAKENHI project no. 11J02876, 13J06172) and Institutional Program for Young Researcher Overseas Visits (International Training Program to Produce New Leaders in Global Health). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2010, DEATH STUD, V34, P757, DOI 10.1080/07481181003772499; Antonsen Jon Honerod, 2012, Neuropsychopharmacol Hung, V14, P177; Bianco L, 2011, CHINA PERSPECTIVES, P74; Blay SL, 2011, CAD SAUDE PUBLICA, V27, P677, DOI 10.1590/S0102-311X2011000400007; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Brindle E, 2010, J IMMUNOL METHODS, V362, P112, DOI 10.1016/j.jim.2010.09.014; Chang Y, 2014, PLOS ONE, V10; Chen ZR, 2014, ARCH VIROL, V159, P631, DOI 10.1007/s00705-013-1863-8; Chodick G, 2009, HUM BIOL, V81, P463, DOI 10.3378/027.081.0405; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Esmaillzadeh A, 2007, J NUTR, V137, P992, DOI 10.1093/jn/137.4.992; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Geffken DF, 2001, AM J EPIDEMIOL, V153, P242, DOI 10.1093/aje/153.3.242; Hainan Provincial Office of Gazetters, 2003, HIST HAIN PROV FOOD; Inoue Y, 2014, AM J HUM BIOL, V26, P51, DOI 10.1002/ajhb.22478; Inoue Y, 2012, ANTHROPOL SCI, V120, P51, DOI 10.1537/ase.110523; Jiang HW, 2006, ANTHROPOL SCI, V114, P165, DOI 10.1537/ase.050810; Jousilahti P, 2003, J EPIDEMIOL COMMUN H, V57, P730, DOI 10.1136/jech.57.9.730; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; McDade TW, 2013, BRAIN BEHAV IMMUN, V31, P23, DOI 10.1016/j.bbi.2012.08.010; McDade TW, 2010, P ROY SOC B-BIOL SCI, V277, P1129, DOI 10.1098/rspb.2009.1795; MOE CL, 1991, B WORLD HEALTH ORGAN, V69, P305; Nelson RJ, 1996, Q REV BIOL, V71, P511, DOI 10.1086/419555; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Riala K, 2009, CHRONOBIOL INT, V26, P1660, DOI 10.3109/07420520903534484; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Sattar N, 2004, ARTERIOSCL THROM VAS, V24, P583, DOI 10.1161/01.ATV.0000118277.41584.63; Schreier N, 2013, INT J CIRCUMPOL HEAL, V72, DOI 10.3402/ijch.v72i0.21466; Shirk Susan., 1993, POLITICAL LOGIC EC R; Skevington SM, 2010, SOC PSYCH PSYCH EPID, V45, P999, DOI 10.1007/s00127-009-0138-x; Strand LB, 2011, ENVIRON RES, V111, P451, DOI 10.1016/j.envres.2011.01.023; Thompson AL, 2014, AM J HUM BIOL, V26, P18, DOI 10.1002/ajhb.22462; Umezaki M., 2009, SE ASIA STUD, V47, P348; VANDERSLICE J, 1994, B WORLD HEALTH ORGAN, V72, P589; Villegas R, 2012, NUTR METAB CARDIOVAS, V22, P223, DOI 10.1016/j.numecd.2010.07.007; Wattie N, 2008, EARLY HUM DEV, V84, P539, DOI 10.1016/j.earlhumdev.2007.12.010; World Health Organization, 2015, WHOQOL US MAN 1998; Xirasagar S, 2006, EUR J PEDIATR, V165, P747, DOI 10.1007/s00431-006-0164-6; Xu ZM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06450; Yazawa A, 2014, AM J HUM BIOL, V26, P36, DOI 10.1002/ajhb.22467	45	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139602	10.1371/journal.pone.0139602	http://dx.doi.org/10.1371/journal.pone.0139602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447471	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000039
J	Morley, R; Cardenas, A; Hawkins, P; Suzuki, Y; Paton, V; Phan, SC; Merchant, M; Hsu, J; Yu, W; Xia, Q; Koralek, D; Luhn, P; Aldairy, W				Morley, Roland; Cardenas, Alison; Hawkins, Peter; Suzuki, Yasuyo; Paton, Virginia; Phan, See-Chun; Merchant, Mark; Hsu, Jessie; Yu, Wei; Xia, Qi; Koralek, Daniel; Luhn, Patricia; Aldairy, Wassim			Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; SCATTER FACTOR; VENOUS THROMBOEMBOLISM; MONOVALENT ANTIBODY; MOLECULAR-CLONING; FACTOR RECEPTOR; HEART-FAILURE; RISK-FACTORS; PHASE-II	Background Onartuzumab, a recombinant humanized monovalent monoclonal antibody directed against MET, the receptor for the hepatocyte growth factor, has been investigated for the treatment of solid tumors. This publication describes the safety profile of onartuzumab in patients with solid tumors using data from the global onartuzumab clinical development program. Methods Adverse event (AE) and laboratory data from onartuzumab phase II/III studies were analyzed and coded into standardized terms according to industry standards. The severity of AEs was assessed using the NCI Common Toxicity Criteria, Version 4. Medical Dictionary for Regulatory Activities (MedDRA) AEs were grouped using the standardized MedDRA queries (SMQs) "gastrointestinal (GI) perforation", "embolic and thrombotic events, venous (VTE)", and "embolic and thrombotic events, arterial (ATE)", and the Adverse Event Group Term (AEGT) "edema." The safety evaluable populations (patients who received at least one dose of study treatment) for each study were included in this analysis. Results A total of 773 onartuzumab-treated patients from seven studies (phase II, n = 6; phase III, n = 1) were included. Edema and VTEs were reported in onartuzumab-treated patients in all seven studies. Edema events in onartuzumab arms were generally grade 1-2 in severity, observed more frequently than in control arms and at incidences ranging from 25.4-65.7% for all grades and from 1.2-14.1% for grade 3. Hypoalbuminemia was also more frequent in onartuzumab arms and observed at frequencies between 77.8% and 98.3%. The highest frequencies of all grade and grade >= 3 VTE events were 30.3% and 17.2%, respectively in onartuzumab arms. The cumulative incidence of all grade ATE events ranged from 0-5.6% (grade >= 3, 0-5.1%) in onartuzumab arms. The frequency of GI perforation was below 10% in all studies; the highest estimates were observed in studies with onartuzumab plus bevacizumab for all grades (0-6.2%) and grade >= 3(0-6.2%). Conclusions The frequencies of VTE, ATE, GI perforation, hypoalbuminemia, and edema in clinical studies were higher in patients receiving onartuzumab than in control arms; these are considered to be expected events in patients receiving onartuzumab.	[Morley, Roland; Cardenas, Alison; Hawkins, Peter; Suzuki, Yasuyo; Paton, Virginia; Phan, See-Chun; Merchant, Mark; Hsu, Jessie; Yu, Wei; Xia, Qi; Koralek, Daniel; Luhn, Patricia; Aldairy, Wassim] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Morley, R (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	morley.roland@gene.com			Genentech Inc	Genentech Inc(Roche HoldingGenentech)	This work was supported by Genentech Inc, the sponsors were involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript. All authors are employees of Genentech. Editing services were provided by Charlotte Kennerley of Gardiner-Caldwell Communications.	Ageno W, 2006, SEMIN THROMB HEMOST, V32, P651, DOI 10.1055/s-2006-951293; [Anonymous], AVASTIN 25 MG ML CON; Bardelli C, 2005, BIOCHEM BIOPH RES CO, V334, P1172, DOI 10.1016/j.bbrc.2005.07.020; BENDELL JC, 2015, J CLIN ONCOL S, V33; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Cho S, 2002, AM J MED, V113, P580, DOI 10.1016/S0002-9343(02)01322-0; Cloughesy T, 2014, NEURO ONCOL S5, V16, pv81; Conway K, 2006, WOUND REPAIR REGEN, V14, P2, DOI 10.1111/j.1743-6109.2005.00081.x; Dieras V, 2013 SAN ANT BREAST; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; Ely JW, 2006, J AM BOARD FAM MED, V19, P148, DOI 10.3122/jabfm.19.2.148; Frishman WH, 2002, AM J CARDIOL, V89, p18D; GHERARDI E, 1990, NATURE, V346, P228, DOI 10.1038/346228b0; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Greenall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034658; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Hirsch FR, 2014, INT J RADIAT ONCOL, V90, pS37, DOI 10.1016/j.ijrobp.2014.08.215; Hou W, 2009, MED CLIN N AM, V93, P801, DOI 10.1016/j.mcna.2009.03.007; Kakkar T, 2007, PHARM RES, V24, P1910, DOI 10.1007/s11095-007-9316-2; Kris MG, 2012, ANN ONCOL, V23, P34; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Lee JM, 2014, ONCOGENE, V33, P34, DOI 10.1038/onc.2012.551; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Mai E, 2014, MOL CANCER THER, V13, P540, DOI 10.1158/1535-7163.MCT-13-0494; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Messerli Franz H, 2002, Curr Cardiol Rep, V4, P479, DOI 10.1007/s11886-002-0110-9; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; Miyazawa K, 2010, FEBS J, V277, P2208, DOI 10.1111/j.1742-4658.2010.07637.x; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Pietrapiana D, 2005, FEBS LETT, V579, P4550, DOI 10.1016/j.febslet.2005.06.072; Prat M, 1998, J CELL SCI, V111, P237; Previdi S, 2010, EUR J CANCER, V46, P1679, DOI 10.1016/j.ejca.2010.02.036; Ryan CJ, 2013, CLIN CANCER RES, V19, P215, DOI 10.1158/1078-0432.CCR-12-2605; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Samsky MD, 2013, J AM COLL CARDIOL, V61, P2397, DOI 10.1016/j.jacc.2013.03.042; Shah M.A., 2015, J CLIN ONCOL S3, V33; SHIMOMURA T, 1993, J BIOL CHEM, V268, P22927; Shin DH, 2013, COMPR PHYSIOL, V3, P799, DOI 10.1002/cphy.c120022; Silverberg DS, 2006, INT UROL NEPHROL, V38, P295, DOI 10.1007/s11255-006-0064-8; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Smyth EC, 2014, ONCOTARGETS THER, V7, P1001, DOI 10.2147/OTT.S44941; Spigel DR, 2014, J CLIN ONCOL, V32; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Wakelee HA, 2014, INT J RADIAT ONCOL, V90, pS37, DOI 10.1016/j.ijrobp.2014.08.216; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; Xiang H, 2013, CLIN CANCER RES, V19, P5068, DOI 10.1158/1078-0432.CCR-13-0260; Xin Y, 2013, J CLIN PHARMACOL, V53, P1103, DOI 10.1002/jcph.148; ZARNEGAR R, 1989, CANCER RES, V49, P3314	55	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139679	10.1371/journal.pone.0139679	http://dx.doi.org/10.1371/journal.pone.0139679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445503	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600066
J	Vieira, CP; Alvares, TS; Gomes, LS; Torres, AG; Paschoalin, VMF; Conte, CA				Vieira, C. P.; Alvares, T. S.; Gomes, L. S.; Torres, A. G.; Paschoalin, V. M. F.; Conte-Junior, C. A.			Kefir Grains Change Fatty Acid Profile of Milk during Fermentation and Storage	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; NUTRITIONAL QUALITY; DAIRY-PRODUCTS; CLA CONTENT; IN-VITRO; BACTERIA; CHOLESTEROL; CANCER; MEAT; ATHEROGENICITY	Several studies have reported that lactic acid bacteria may increase the production of free fatty acids by lipolysis of milk fat, though no studies have been found in the literature showing the effect of kefir grains on the composition of fatty acids in milk. In this study the influence of kefir grains from different origins [Rio de Janeiro (AR), Vicosa (AV) e Lavras (AD)], different time of storage, and different fat content on the fatty acid content of cow milk after fermentation was investigated. Fatty acid composition was determined by gas chromatography. Values were considered significantly different when p<0.05. The highest palmitic acid content, which is antimutagenic compost, was seen in AV grain (36.6g/100g fatty acids), which may have contributed to increasing the antimutagenic potential in fermented milk. Higher monounsaturated fatty acid (25.8g/100g fatty acids) and lower saturated fatty acid (72.7g/100g fatty acids) contents were observed in AV, when compared to other grains, due to higher Delta 9-desaturase activity (0.31) that improves the nutritional quality of lipids. Higher oleic acid (25.0g/100g fatty acids) and monounsaturated fatty acid (28.2g/100g fatty acids) and lower saturated fatty acid (67.2g/100g fatty acids) contents were found in stored kefir relatively to fermented kefir leading to possible increase of antimutagenic and anticarcinogenic potential and improvement of nutritional quality of lipids in storage milk. Only highlipidic matrix displayed increase polyunsaturated fatty acids after fermentation. These findings open up new areas of study related to optimizing desaturase activity during fermentation in order to obtaining a fermented product with higher nutritional lipid quality.	[Vieira, C. P.; Gomes, L. S.; Torres, A. G.; Paschoalin, V. M. F.; Conte-Junior, C. A.] Univ Fed Rio de Janeiro, Food Sci Program, Rio De Janeiro, Rio De Janeiro, Brazil; [Alvares, T. S.] Univ Fed Rio de Janeiro, Inst Nutr, Rio De Janeiro, Rio De Janeiro, Brazil; [Conte-Junior, C. A.] Univ Fed Fluminense, Dept Food Technol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense	Conte, CA (corresponding author), Univ Fed Rio de Janeiro, Food Sci Program, Rio De Janeiro, Rio De Janeiro, Brazil.	carlosconte@id.uff.br	Alvares, Thiago/GSJ-3655-2022; Paschoalin, Vania/Q-4997-2019; Alvares, Thiago/AAO-7782-2020; Conte-Junior, Carlos A./J-5815-2014; Vieira, Carla/AAM-7631-2021; Paschoalin, Vania M F/J-1746-2014; Torres, Alexandre/F-8910-2015	Conte-Junior, Carlos A./0000-0001-6133-5080; Vieira, Carla/0000-0002-4255-6088; Paschoalin, Vania M F/0000-0001-6093-134X; Torres, Alexandre/0000-0002-7376-4939	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E26/201.185/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [311361/2013]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. E26/201.185/2014 (www.faperj.br). CACJ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. 311361/2013 (www.cnpq.brCACJ).	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; [Anonymous], 2005, OFFICIAL METHODS ANA, V20th; Ansorena D, 2004, FOOD CHEM, V87, P69, DOI 10.1016/j.foodchem.2003.10.019; Belviso S, 2009, DAIRY SCI TECHNOL, V89, P169, DOI 10.1051/dst/2009004; Bocca C, 2010, CHEM-BIOL INTERACT, V183, P187, DOI 10.1016/j.cbi.2009.09.022; Caldeira L. A., 2010, Revista do Instituto Adolfo Lutz, V69, P545; Castro HP, 1995, APPL MICROBIOL BIOT, V44, P172, DOI [10.1007/BF00164498, 10.1007/s002530050537]; Chatterjee MT, 2000, MICROBIOL-UK, V146, P877, DOI 10.1099/00221287-146-4-877; Chen HC, 2008, FOOD MICROBIOL, V25, P492, DOI 10.1016/j.fm.2008.01.003; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Coskun H, 2004, J MICROBIOL, V42, P133; Costa MP, 2014, J DAIRY SCI, V97, P2610, DOI 10.3168/jds.2013-7617; Dionisi F, 1999, LIPIDS, V34, P1107, DOI 10.1007/s11745-999-0462-8; DiRusso CC, 1999, PROG LIPID RES, V38, P129, DOI 10.1016/S0163-7827(98)00022-8; DYKES GA, 1995, INT J FOOD MICROBIOL, V28, P89, DOI 10.1016/0168-1605(94)00161-X; El-Salam MHA, 2010, INT J DAIRY TECHNOL, V63, P62, DOI 10.1111/j.1471-0307.2009.00541.x; Farnworth E. R., 2005, Food Science and Technology Bulletin:  Functional Foods, V2, P1, DOI 10.1616/1476-2137.13938; Florence ACR, 2012, FOOD CHEM, V135, P2207, DOI 10.1016/j.foodchem.2012.07.026; Florence ACR, 2012, LWT-FOOD SCI TECHNOL, V49, P89, DOI 10.1016/j.lwt.2012.04.023; Garcia-Romero J, 2014, AQUACULTURE, V420, P231, DOI 10.1016/j.aquaculture.2013.10.035; Guerzoni ME, 2001, MICROBIOL-SGM, V147, P2255, DOI 10.1099/00221287-147-8-2255; Gursoy O, 2012, INT J FOOD SCI NUTR, V63, P610, DOI 10.3109/09637486.2011.643295; Guzel-Seydim ZB, 2006, INT J DAIRY TECHNOL, V59, P209, DOI 10.1111/j.1471-0307.2006.00265.x; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hernandez ERS, 2007, ARCH LATINOAM NUTR, V57, P173; Hoenselaar R, 2012, BRIT J NUTR, V107, P450, DOI 10.1017/S0007114511006581; Huebner ES, 2006, GASTROENTEROL CLIN N, V35, P355, DOI 10.1016/j.gtc.2006.03.005; Jain M, 1998, NUTR RES, V18, P905, DOI 10.1016/S0271-5317(98)00075-X; Kim YJ, 2002, J FOOD SCI, V67, P1731, DOI 10.1111/j.1365-2621.2002.tb08714.x; Kramer JKC, 1997, LIPIDS, V32, P1219, DOI 10.1007/s11745-997-0156-3; Lai KL, 2005, LIPIDS, V40, P1107, DOI 10.1007/s11745-005-1474-1; Leite AMO, 2015, J DAIRY SCI, V98, P3622, DOI 10.3168/jds.2014-9265; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Lock AL, 2003, LIVEST PROD SCI, V79, P47, DOI 10.1016/S0301-6226(02)00118-5; Lucquin I, 2012, FOOD MICROBIOL, V29, P187, DOI 10.1016/j.fm.2011.08.001; Lye HS, 2010, J DAIRY SCI, V93, P1383, DOI 10.3168/jds.2009-2574; Lye HS, 2010, INT DAIRY J, V20, P169, DOI 10.1016/j.idairyj.2009.10.003; Molina S, 2013, CHEM PHYS LIPIDS, V175, P50, DOI 10.1016/j.chemphyslip.2013.07.011; Nadathur SR, 1996, MUTAT RES-ENVIR MUTA, V359, P179, DOI 10.1016/S0165-1161(96)90265-4; Nantapo CTW, 2014, FOOD CHEM, V146, P127, DOI 10.1016/j.foodchem.2013.09.009; Norat T, 2003, EUR J CLIN NUTR, V57, P1, DOI 10.1038/sj.ejcn.1601522; Osmari EK, 2011, SMALL RUMINANT RES, V98, P128, DOI 10.1016/j.smallrumres.2011.03.030; Ozdestan O, 2010, EUR FOOD RES TECHNOL, V231, P101, DOI 10.1007/s00217-010-1258-y; Pala V, 2011, INT J CANCER, V129, P2712, DOI 10.1002/ijc.26193; Perdigon G, 2002, EUR J CLIN NUTR, V56, pS65, DOI 10.1038/sj.ejcn.1601490; Piironen V, 2002, J FOOD COMPOS ANAL, V15, P705, DOI 10.1006/jfca.2002.1095; Pourahmad R., 2012, Australian Journal of Basic and Applied Sciences, V6, P418; Ramsden CE, 2010, BRIT J NUTR, V104, P1586, DOI 10.1017/S0007114510004010; Remagni MC, 2013, FOLIA MICROBIOL, V58, P443, DOI 10.1007/s12223-013-0228-8; Sah BNP, 2014, FOOD CHEM, V156, P264, DOI 10.1016/j.foodchem.2014.01.105; Sakamoto T, 1997, MOL MICROBIOL, V23, P1281, DOI 10.1046/j.1365-2958.1997.3071676.x; Santos-Silva J, 2002, LIVEST PROD SCI, V77, P187, DOI 10.1016/S0301-6226(02)00059-3; Serafeimidou A, 2012, FOOD CHEM, V134, P1839, DOI 10.1016/j.foodchem.2012.03.102; Stajic S, 2011, PROC FOOD SCI, V1, P568, DOI 10.1016/j.profoo.2011.09.086; Testi S, 2006, FOOD CHEM, V98, P104, DOI 10.1016/j.foodchem.2005.05.053; Torok Z, 1997, P NATL ACAD SCI USA, V94, P2192, DOI 10.1073/pnas.94.6.2192; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; VUJICIC IF, 1992, BIOTECHNOL LETT, V14, P847, DOI 10.1007/BF01029151; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xiao ZW, 2013, BJU INT, V112, pE201, DOI 10.1111/j.1464-410X.2012.11737.x; Yadav H, 2007, INT DAIRY J, V17, P1006, DOI 10.1016/j.idairyj.2006.12.003; Yao AA, 2008, J FOOD PROTECT, V71, P431, DOI 10.4315/0362-028X-71.2.431	62	37	37	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139910	10.1371/journal.pone.0139910	http://dx.doi.org/10.1371/journal.pone.0139910			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444286	gold, Green Submitted, Green Published			2022-12-26	WOS:000362510600104
J	Zhao, L; Xu, JH; Liang, F; Li, A; Zhang, Y; Sun, J				Zhao, Lu; Xu, Jianhua; Liang, Fang; Li, Ao; Zhang, Yong; Sun, Jue			Effect of Chronic Psychological Stress on Liver Metastasis of Colon Cancer in Mice	PLOS ONE			English	Article							IMPROVED SURVIVAL; BREAST-CANCER; BETA-BLOCKERS; COLORECTAL-CANCER; TUMOR PROGRESSION; CELLS; EXPRESSION; MORTALITY; PATHWAYS; SYSTEM	Metastasis to the liver is a main factor in colorectal cancer mortality. Previous studies suggest that chronic psychological stress is important in cancer progression, but its effect on liver metastasis has not been investigated. To address this, we established a liver metastasis model in BALB/c nude mice to investigate the role of chronic stress in liver metastasis. Our data suggest that chronic stress elevates catecholamine levels and promotes liver metastasis. Chronic stress was also associated with increased tumor associated macrophages infiltration into the primary tumor and increased the expression of metastatic genes. Interestingly, beta-blocker treatment reversed the effects of chronic stress on liver metastasis. Our results suggest the beta-adrenergic signaling pathway is involved in regulating colorectal cancer progression and liver metastasis. Additionally, we submit that adjunctive therapy with a beta-blocker may complement existing colorectal cancer therapies.	[Zhao, Lu; Xu, Jianhua; Liang, Fang; Li, Ao; Zhang, Yong; Sun, Jue] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Oncol, Shanghai, Peoples R China; [Xu, Jianhua] Shanghai Univ Tradit Chinese Med, Intervent Canc Inst Chinese Integrat Med, Putuo Hosp, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Xu, JH (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Oncol, Shanghai, Peoples R China.	xujianhua_50@126.com; ptliangfang@126.com			National Natural Science Foundation [81403350]; Independent Innovation Project of Putuo District, Shanghai [2012PTKW004]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Independent Innovation Project of Putuo District, Shanghai	This study was supported by National Natural Science Foundation (81403350) and Independent Innovation Project of Putuo District, Shanghai (2012PTKW004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Cardwell CR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-28; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Eng JWL, 2014, CANCER IMMUNOL IMMUN, V63, P1115, DOI 10.1007/s00262-014-1617-9; Engineer DR, 2013, TRANSL ONCOL, V6, P539, DOI 10.1593/tlo.13346; Gallagher DJ, 2010, ONCOLOGY-BASEL, V78, P237, DOI 10.1159/000315730; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; Hicks BM, 2013, ANN ONCOL, V24, P3100, DOI 10.1093/annonc/mdt381; Jansen L, 2014, CANCER-AM CANCER SOC, V120, P1178, DOI 10.1002/cncr.28546; Jin JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074497; Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285; Lin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061435; Lutgendorf SK, 2008, CLIN CANCER RES, V14, P6839, DOI 10.1158/1078-0432.CCR-08-0230; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Menen RS, 2012, IN VIVO, V26, P565; Mundy-Bosse BL, 2011, CELL IMMUNOL, V270, P80, DOI 10.1016/j.cellimm.2011.04.003; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Shi M, 2013, J IMMUNOL, V190, P5600, DOI 10.4049/jimmunol.1202364; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-269; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Thaker PH, 2007, CELL CYCLE, V6, P430, DOI 10.4161/cc.6.4.3829; Wang HM, 2013, ANN ONCOL, V24, P1312, DOI 10.1093/annonc/mds616	27	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139978	10.1371/journal.pone.0139978	http://dx.doi.org/10.1371/journal.pone.0139978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444281	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600116
J	Hahlweg, P; Hoffmann, J; Harter, M; Frosch, DL; Elwyn, G; Scholl, I				Hahlweg, Pola; Hoffmann, Jana; Haerter, Martin; Frosch, Dominick L.; Elwyn, Glyn; Scholl, Isabelle			In Absentia: An Exploratory Study of How Patients Are Considered in Multidisciplinary Cancer Team Meetings	PLOS ONE			English	Article							SHARED DECISION-MAKING; EVIDENCE-BASED MEDICINE; CARE; PREFERENCES; BARRIERS; POLICY	Background Multidisciplinary team meetings and shared decision-making are potential means of delivering patient-centred care. Not much is known about how those two paradigms fit together in cancer care. This study aimed to investigate how decisions are made in multidisciplinary team meetings and whether patient perspectives are incorporated in these decisions. Materials and Methods A qualitative study was conducted using non-participant observation at multidisciplinary team meetings (also called tumor boards) at the University Cancer Center Hamburg-Eppendorf, Germany. Two researchers recorded structured field notes from a total of N = 15 multidisciplinary team meetings. Data were analyzed using content analysis and descriptive statistics. Results Physicians mainly exchanged medical information and based their decision-making on this information. Individual patient characteristics or their treatment preferences were rarely considered or discussed. In the few cases where patient preferences were raised as a topic, this information did not seem to be taken into account in decision-making processes about treatment recommendations. Conclusion The processes in multidisciplinary team meetings we observed did not exhibit shared decision-making. Patient perspectives were absent. If multidisciplinary team meetings wish to become more patient-centred they will have to modify their processes and find a way to include patient preferences into the decision-making process.	[Hahlweg, Pola; Hoffmann, Jana; Haerter, Martin; Scholl, Isabelle] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Frosch, Dominick L.] Gordon & Betty Moore Fdn, Palo Alto, CA USA; [Frosch, Dominick L.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Elwyn, Glyn] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of California System; University of California Los Angeles; Dartmouth College	Hahlweg, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	p.hahlweg@uke.de	Elwyn, G./L-4292-2015; Hahlweg, Pola/AAQ-2945-2020; Scholl, Isabelle/AAN-9450-2020; Elwyn, Glyn/B-4798-2009	Scholl, Isabelle/0000-0002-7639-0880; Harter, Martin/0000-0001-7443-9890; Hahlweg, Pola/0000-0002-8768-8594; Elwyn, Glyn/0000-0002-0917-6286	German Research Foundation [SCHO 155/1-1]	German Research Foundation(German Research Foundation (DFG))	This study was funded by the German Research Foundation (grant number: SCHO 155/1-1). The sponsors were not involved in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Ansmann L, 2014, BREAST, V23, P865, DOI 10.1016/j.breast.2014.09.004; Arztekammer Westfalen-Lippe, 2013, VERF ZERT BRUSTZ NRW, P23; Atun R, 2009, ANAL NATL CANC CONTR; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Blazeby JM, 2006, ANN ONCOL, V17, P457, DOI 10.1093/annonc/mdj102; Borras JM, 2014, EUR J CANCER, V50, P475, DOI 10.1016/j.ejca.2013.11.012; Bundesministerium fur Gesundheit, 2012, BQS BUND 2008 GEB, P1; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Choy ET, 2007, BREAST, V16, P178, DOI 10.1016/j.breast.2006.10.002; Devitt B, 2010, J ONCOL PRACT, V6, pE17, DOI 10.1200/JOP.2010.000023; Dew K, 2015, QUAL HEALTH RES, V25, P397, DOI 10.1177/1049732314553010; Fleissig A, 2006, LANCET ONCOL, V7, P935, DOI 10.1016/S1470-2045(06)70940-8; Frosch D, OVERCOMING IN PRESS; Guyatt G, 2004, BRIT MED J, V329, P990, DOI 10.1136/bmj.329.7473.990; Harter M, 2011, Z EVIDENZ FORTBILD Q, V105, P229, DOI 10.1016/j.zefq.2011.04.018; Haidet P, 2009, PATIENT EDUC COUNS, V77, P450, DOI 10.1016/j.pec.2009.09.020; Hong NJL, 2010, J SURG ONCOL, V102, P125, DOI 10.1002/jso.21589; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Katz SJ, 2013, JAMA-J AM MED ASSOC, V310, P1559, DOI 10.1001/jama.2013.278944; Kidger J, 2009, BJOG-INT J OBSTET GY, V116, P511, DOI 10.1111/j.1471-0528.2008.02066.x; Lamb BW, 2013, ANN SURG ONCOL, V20, P1408, DOI 10.1245/s10434-012-2676-9; Lamb BW, 2011, ANN SURG ONCOL, V18, P2116, DOI 10.1245/s10434-011-1675-6; Lanceley A, 2008, INT J GYNECOL CANCER, V18, P215, DOI 10.1111/j.1525-1438.2007.00991.x; Legare F, 2014, COCHRANE DB SYST REV, V9; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Leitlinienprogramm Onkologie, 2012, INT S3 GUID DIAGN TR; Montori VM, 2008, JAMA-J AM MED ASSOC, V300, P1814, DOI 10.1001/jama.300.15.1814; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Ruhstaller T, 2006, EUR J CANCER, V42, P2459, DOI 10.1016/j.ejca.2006.03.034; Saini KS, 2012, ANN ONCOL, V23, P853, DOI 10.1093/annonc/mdr352; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Sharma RA, 2009, LANCET ONCOL, V10, P98, DOI 10.1016/S1470-2045(09)70006-3; Taylor C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0488-2; Tietbohl C, 2013, BMC MED INFORM DECIS, V13; Whitney SN, 2003, MED DECIS MAKING, V23, P275, DOI 10.1177/0272989X03256006; Williams J.P., 2008, SAGE ENCY QUALITATIV, P562; Wood JJ, 2008, COLORECTAL DIS, V10, P769, DOI 10.1111/j.1463-1318.2007.01464.x; Wright FC, 2007, EUR J CANCER, V43, P1002, DOI 10.1016/j.ejca.2007.01.025; Zwarenstein M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-494	40	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139921	10.1371/journal.pone.0139921	http://dx.doi.org/10.1371/journal.pone.0139921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TP	26441328	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510300077
J	Thomas, JT; Chen, Q; Gauger, PC; Gimenez-Lirola, LG; Sinha, A; Harmon, KM; Madson, DM; Burrough, ER; Magstadt, DR; Salzbrenner, HM; Welch, MW; Yoon, KJ; Zimmerman, JJ; Zhang, JQ				Thomas, Joseph T.; Chen, Qi; Gauger, Phillip C.; Gimenez-Lirola, Luis G.; Sinha, Avanti; Harmon, Karen M.; Madson, Darin M.; Burrough, Eric R.; Magstadt, Drew R.; Salzbrenner, Holly M.; Welch, Michael W.; Yoon, Kyoung-Jin; Zimmerman, Jeffrey J.; Zhang, Jianqiang			Effect of Porcine Epidemic Diarrhea Virus Infectious Doses on Infection Outcomes in Naive Conventional Neonatal and Weaned Pigs	PLOS ONE			English	Article							UNITED-STATES; CELL; STRAIN; PATHOGENESIS; EMERGENCE; GERMANY; PIGLETS; SWINE	Porcine epidemic diarrhea virus (PEDV) was identified in the United States (U.S.) swine population for the first time in April 2013 and rapidly spread nationwide. However, no information has been published regarding the minimum infectious dose (MID) of PEDV in different pig models. The main objective of this study was to determine the oral minimum infectious dose of PEDV in naive conventional neonatal piglets and weaned pigs. A U.S. virulent PEDV prototype isolate (USA/IN19338/2013) with known infectious titer was serially ten-fold diluted in virus-negative cell culture medium. Dilutions with theoretical infectious titers from 560 to 0.0056 TCID50/ml together with a medium control were orogastrically inoculated (10ml/pig) into 7 groups of 5-day-old neonatal pigs (n = 4 per group) and 7 groups of 21-day-old weaned pigs (n = 6 per group). In 5-day-old pigs, 10ml of inoculum having titers 560-0.056 TCID50/ml, corresponding to polymerase chain reaction (PCR) cycle threshold (Ct) values 24.2-37.6, resulted in 100% infection in each group; 10ml of inoculum with titer 0.0056 TCID50/ml (Ct> 45) caused infection in 25% of the inoculated pigs. In 21-day-old pigs, 10ml of inoculum with titers 560-5.6 TCID50/ml (Ct 24.2-31.4) resulted in 100% infection in each group while 10ml of inoculum with titers 0.56-0.0056 TCID50/ml (Ct values 35.3 -> 45) did not establish infection in any pigs under study conditions as determined by clinical signs, PCR, histopathology, immunohistochemistry, and antibody response. These data reveal that PEDV infectious dose is age-dependent with a significantly lower MID for neonatal pigs compared to weaned pigs. This information should be taken into consideration when interpreting clinical relevance of PEDV PCR results and when designing a PEDV bioassay model. The observation of such a low MID in neonates also emphasizes the importance of strict biosecurity and thorough cleaning/disinfection on sow farms.	[Thomas, Joseph T.; Chen, Qi; Gauger, Phillip C.; Gimenez-Lirola, Luis G.; Sinha, Avanti; Harmon, Karen M.; Madson, Darin M.; Burrough, Eric R.; Magstadt, Drew R.; Salzbrenner, Holly M.; Welch, Michael W.; Yoon, Kyoung-Jin; Zimmerman, Jeffrey J.; Zhang, Jianqiang] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA	Iowa State University	Zhang, JQ (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	jqzhang@iastate.edu	Zimmerman, Jeff/ABC-6361-2020; Sinha, Avanti/AAJ-7055-2020; Gauger, Phillip/AAQ-9806-2021	Zimmerman, Jeff/0000-0002-8107-2422; 	Iowa Pork Producers Association [14-231]; Iowa State University College of Veterinary Medicine Start-up fund	Iowa Pork Producers Association; Iowa State University College of Veterinary Medicine Start-up fund	This study was supported by the Iowa Pork Producers Association (Grant no. 14-231) and the Iowa State University College of Veterinary Medicine Start-up fund awarded to Dr. Jianqiang Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1; Chen Q, 2015, VIROLOGY, V482, P51, DOI 10.1016/j.virol.2015.03.024; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Cima G, 2014, JAVMA-J AM VET MED A, V245, P166; Gimenez-Lirola LG, 2014, PORCINE EPIDEMIC DIA; Gimenez-Lirola LG, 2014, 22 ANN SWIN DIS C SW, P34; Grasland B, 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.00535-15e00535-15, DOI 10.1128/GENOMEA.00535-15E00535-15]; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; International Committee on Taxonomy of Viruses, 2012, VIR TAX 2012 REL; Jung K, 2015, VET MICROBIOL, V178, P31, DOI 10.1016/j.vetmic.2015.04.022; Lee S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01116-14; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Lin CN, 2014, J VET MED SCI, V76, P1297, DOI 10.1292/jvms.14-0098; Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628; MacLachlan NJ, 2011, FENNER'S VETERINARY VIROLOGY, 4TH EDITION, P393, DOI 10.1016/B978-0-12-375158-4.00024-9; Madson DM, 2016, VET PATHOL, V53, P44, DOI 10.1177/0300985815591080; Madson DM, 2014, VET MICROBIOL, V174, P60, DOI 10.1016/j.vetmic.2014.09.002; Martelli R, 2008, VET REC, V162, P307, DOI 10.1136/vr.162.10.307; MOON HW, 1975, VET PATHOL, V12, P434, DOI 10.1177/0300985875012005-00610; MOON HW, 1971, P SOC EXP BIOL MED, V137, P151, DOI 10.3181/00379727-137-35533; NOWACKI W, 1993, VET IMMUNOL IMMUNOP, V37, P113, DOI 10.1016/0165-2427(93)90059-D; Ojkic D, 2015, CAN VET J, V56, P149; Oldham J, 1972, PIG FARMING, V10, P72, DOI DOI 10.1016/0094-114X(72)90046-8; OSBURN BI, 1982, J AM VET MED ASSOC, V181, P1049; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Puranaveja S, 2009, EMERG INFECT DIS, V15, P1112, DOI 10.3201/eid1507.081256; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saif L. J., 2012, DIS SWINE, P501; Shibata I, 2000, VET MICROBIOL, V72, P173, DOI 10.1016/S0378-1135(99)00199-6; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stadler J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0454-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Stokes C. R., 2001, P59, DOI 10.1079/9780851995175.0059; Theuns S, 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.00506-15e00506-15, DOI 10.1128/GENOMEA.00506-15E00506-15]; TIVEY DR, 1989, HISTOCHEM J, V21, P601, DOI 10.1007/BF01753361; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Vui DT, 2014, GENOME ANNOUNC, V2; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195	38	87	92	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139266	10.1371/journal.pone.0139266	http://dx.doi.org/10.1371/journal.pone.0139266			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441071	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510300018
J	Kronert, WA; Melkani, GC; Melkani, A; Bernstein, SI				Kronert, William A.; Melkani, Girish C.; Melkani, Anju; Bernstein, Sanford I.			A Failure to Communicate MYOSIN RESIDUES INVOLVED IN HYPERTROPHIC CARDIOMYOPATHY AFFECT INTER-DOMAIN INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN; MUSCLE FUNCTION; DROSOPHILA-MELANOGASTER; ALTERNATIVE RELAY; CONVERTER DOMAINS; POWER STROKE; MUTATIONS; MOTOR; GENE; ISOFORM	Our molecular modeling studies suggest a charge-dependent interaction between residues Glu-497 in the relay domain and Arg-712 in the converter domain of human beta-cardiac myosin. To test the significance of this putative interaction, we generated transgenic Drosophila expressing indirect flight muscle myosin with charge reversal mutations in the relay (E496R) or converter (R713E). Each mutation yielded dramatic reductions in myosin Ca-ATPase activity (similar to 80%) as well as in basal (similar to 67%) and actin-activated (similar to 84%) Mg-ATPase activity. E496R myosin-induced in vitro actin-sliding velocity was reduced by 71% and R713E myosin permitted no actin motility. Indirect flight muscles of late pupae from each mutant displayed disrupted myofibril assembly, with adults having severely abnormal myofibrils and no flight ability. To understand the molecular basis of these defects, we constructed a putative compensatory mutant that expresses myosin with both E496R and R713E. Intriguingly, ATPase values were restored to similar to 73% of wild-type and actin-sliding velocity increased to 40%. The double mutation suppresses myofibril assembly defects in pupal indirect flight muscles and dramatically reduces myofibril disruption in young adults. Although sarcomere organization is not sustained in older flies and flight ability is not restored in homozygotes, young heterozygotes fly well. Our results indicate that this charge-dependent interaction between the myosin relay and converter domains is essential to the mechanochemical cycle and sarcomere assembly. Furthermore, the same inter-domain interaction is disrupted when modeling human beta-cardiac myosin heavy chain cardiomyopathy mutations E497D or R712L, implying that abolishing this salt bridge is one cause of the human disease.	[Bernstein, Sanford I.] San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Heart, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Bernstein, SI (corresponding author), San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA.	sbernstein@mail.sdsu.edu	Regan, Clinton/E-6250-2012	Melkani, Girish/0000-0003-0353-4633; Bernstein, Sanford/0000-0001-7094-5390	National Institutes of Health [R01 GM32443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM32443 (to S. I. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; BECKER KD, 1992, J CELL BIOL, V116, P669, DOI 10.1083/jcb.116.3.669; BEJSOVEC A, 1990, CELL, V60, P133, DOI 10.1016/0092-8674(90)90723-R; BERNSTEIN SI, 1983, NATURE, V302, P393, DOI 10.1038/302393a0; Bloemink MJ, 2009, J MOL BIOL, V389, P707, DOI 10.1016/j.jmb.2009.04.036; Colegrave M, 2014, ANAT REC, V297, P1670, DOI 10.1002/ar.22973; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Kronert WA, 2008, J MOL BIOL, V379, P443, DOI 10.1016/j.jmb.2008.04.010; Kronert WA, 2014, J BIOL CHEM, V289, P12779, DOI 10.1074/jbc.M114.550673; Kronert WA, 2012, J MOL BIOL, V416, P543, DOI 10.1016/j.jmb.2011.12.044; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Liu X, 2005, J BIOL CHEM, V280, P26974, DOI 10.1074/jbc.M504453200; Lowey S, 2008, J BIOL CHEM, V283, P20579, DOI 10.1074/jbc.M800554200; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; ODONNELL PT, 1989, GENE DEV, V3, P1233, DOI 10.1101/gad.3.8.1233; ROZEK CE, 1983, CELL, V32, P23, DOI 10.1016/0092-8674(83)90493-2; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sakthivel S, 2000, Hum Mutat, V15, P298, DOI 10.1002/(SICI)1098-1004(200003)15:3<298::AID-HUMU22>3.0.CO;2-7; Shih WM, 2001, J BIOL CHEM, V276, P19491, DOI 10.1074/jbc.M010887200; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; Swank DM, 2000, MICROSC RES TECHNIQ, V50, P430, DOI 10.1002/1097-0029(20000915)50:6<430::AID-JEMT2>3.0.CO;2-E; Swank DM, 2001, J BIOL CHEM, V276, P15117, DOI 10.1074/jbc.M008379200; Tang S, 2007, J MOL BIOL, V373, P1361, DOI 10.1016/j.jmb.2007.08.059; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Winkelmann DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8974; Yamashita H, 2000, J BIOL CHEM, V275, P28045; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023	37	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29270	29280		10.1074/jbc.M115.681874	http://dx.doi.org/10.1074/jbc.M115.681874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26446785	Green Published, hybrid			2022-12-26	WOS:000366613400015
J	Endow, JK; Singhal, R; Fernandez, DE; Inoue, K				Endow, Joshua K.; Singhal, Rajneesh; Fernandez, Donna E.; Inoue, Kentaro			Chaperone-assisted Post-translational Transport of Plastidic Type I Signal Peptidase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; chloroplast; protein export; signal peptidase; transmembrane domain; Sec channel; thylakoid	SEC-INDEPENDENT INSERTION; INNER ENVELOPE MEMBRANE; IRON-SULFUR PROTEIN; THYLAKOID MEMBRANE; LEADER PEPTIDASE; TRANSMEMBRANE DOMAIN; FLUORESCENT PROTEIN; COMPLEX-FORMATION; LUMENAL PROTEINS; QUALITY-CONTROL	Type I signal peptidase (SPase I) is an integral membrane Ser/Lys protease with one or two transmembrane domains (TMDs), cleaving transport signals off translocated precursor proteins. The catalytic domain of SPase I folds to form a hydrophobic surface and inserts into the lipid bilayers at the trans-side of the membrane. In bacteria, SPase I is targeted co-translationally, and the catalytic domain remains unfolded until it reaches the periplasm. By contrast, SPases I in eukaryotes are targeted post-translationally, requiring an alternative strategy to prevent premature folding. Here we demonstrate that two distinct stromal components are involved in post-translational transport of plastidic SPase I 1 (Plsp1) from Arabidopsis thaliana, which contains a single TMD. During import into isolated chloroplasts, Plsp1 was targeted to the membrane via a soluble intermediate in an ATP hydrolysis-dependent manner. Insertion of Plsp1 into isolated chloroplast membranes, by contrast, was found to occur by two distinct mechanisms. The first mechanism requires ATP hydrolysis and the protein conducting channel cpSecY1 and was strongly enhanced by exogenously added cpSecA1. The second mechanism was independent of nucleoside triphosphates and proteinaceous components but with a high frequency of mis-orientation. This unassisted insertion was inhibited by urea and stroma extract. During import-chase assays using intact chloroplasts, Plsp1 was incorporated into a soluble 700-kDa complex that co-migrated with the Cpn60 complex before inserting into the membrane. The TMD within Plsp1 was required for the cpSecA1-dependent insertion but was dispensable for association with the 700-kDa complex and also for unassisted membrane insertion. These results indicate cooperation of Cpn60 and cpSecA1 for proper membrane insertion of Plsp1 by cpSecY1.	[Endow, Joshua K.; Inoue, Kentaro] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Singhal, Rajneesh; Fernandez, Donna E.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA	University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison	Inoue, K (corresponding author), Univ Calif Davis, Dept Plant Sci, 221 Asmundson Hall,One Shields Ave, Davis, CA 95616 USA.	kinoue@ucdavis.edu	singhal, rajneesh/AAZ-4198-2020	singhal, rajneesh/0000-0002-0412-3011; Endow-Monteiro, Joshua/0000-0002-5845-0077	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Dept. of Energy [DE-FG02-08ER15963]; National Science Foundation [MCB-1158173]; University of California Davis Plant Sciences Departmental Graduate Student Researcher Assistantship; Direct For Biological Sciences [1158173] Funding Source: National Science Foundation	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Dept. of Energy; National Science Foundation(National Science Foundation (NSF)); University of California Davis Plant Sciences Departmental Graduate Student Researcher Assistantship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Dept. of Energy through Grant DE-FG02-08ER15963 (to K. I.). Establishment of recombinant cpSecA1 preparation was supported by National Science Foundation Grant MCB-1158173 (to D. E. F.). Purchase of reagents for in vitro transcription and translation was supported by a Henry A. Jastro Research Scholarship (to J. K. E.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a University of California Davis Plant Sciences Departmental Graduate Student Researcher Assistantship.	Albiniak AM, 2012, J EXP BOT, V63, P1689, DOI 10.1093/jxb/err444; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BLOOM MV, 1983, P NATL ACAD SCI-BIOL, V80, P1013, DOI 10.1073/pnas.80.4.1013; Bonk M, 1997, EUR J BIOCHEM, V247, P942, DOI 10.1111/j.1432-1033.1997.00942.x; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; CHEN GG, 1994, P NATL ACAD SCI USA, V91, P11497, DOI 10.1073/pnas.91.24.11497; Chiang CF, 2001, ARCH BIOCHEM BIOPHYS, V394, P229, DOI 10.1006/abbi.2001.2537; Chou ML, 2003, EMBO J, V22, P2970, DOI 10.1093/emboj/cdg281; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1989, J BIOL CHEM, V264, P14225; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dabney-Smith C, 2014, ADVAN PL BIO, V5, P271, DOI 10.1007/978-1-4939-1136-3_10; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Di Cola A, 2005, BIOCHEM SOC T, V33, P1024, DOI 10.1042/BST20051024; Dunschede B, 2015, J BIOL CHEM, V290, P13104, DOI 10.1074/jbc.M114.597922; ELLIS RJ, 1988, PHOTOSYNTH RES, V16, P101, DOI 10.1007/BF00039488; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Endow JK, 2013, FEBS LETT, V587, P2226, DOI 10.1016/j.febslet.2013.05.050; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Froehlich JE, 2011, PLANT J, V68, P844, DOI 10.1111/j.1365-313X.2011.04735.x; GATENBY AA, 1988, EMBO J, V7, P1307, DOI 10.1002/j.1460-2075.1988.tb02945.x; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Houben E, 1999, PLANT CELL, V11, P1553; Hsu SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027258; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; Inoue K, 2014, ADVAN PL BIO, V5, P305, DOI 10.1007/978-1-4939-1136-3_12; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KIM YT, 1995, EUR J BIOCHEM, V234, P358, DOI 10.1111/j.1432-1033.1995.358_c.x; Kouranov A, 1999, J BIOL CHEM, V274, P25181, DOI 10.1074/jbc.274.35.25181; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; LEE JI, 1992, J BIOL CHEM, V267, P938; Li HM, 2013, TRENDS PLANT SCI, V18, P360, DOI 10.1016/j.tplants.2013.04.003; LUBBEN TH, 1989, PLANT CELL, V1, P1223, DOI 10.1105/tpc.1.12.1223; MADUENO F, 1993, PLANT CELL, V5, P1865, DOI 10.1105/tpc.5.12.1865; MADUENO F, 1994, J BIOL CHEM, V269, P17458; Mao J, 2015, P NATL ACAD SCI USA, V112, P4152, DOI 10.1073/pnas.1413392111; Midorikawa T, 2014, PLANT J, V80, P592, DOI 10.1111/tpj.12655; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; NAKAI M, 1994, J BIOL CHEM, V269, P31338; Pace C N, 1986, Methods Enzymol, V131, P266; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 2014, BBA-MOL CELL RES, V1843, P1497, DOI 10.1016/j.bbamcr.2013.12.003; Paila YD, 2015, J MOL BIOL, V427, P1038, DOI 10.1016/j.jmb.2014.08.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rocco AG, 2008, BIOPHYS J, V94, P2241, DOI 10.1529/biophysj.107.115535; Rodrigues RAO, 2011, PLANT J, V65, P600, DOI 10.1111/j.1365-313X.2010.04448.x; ROY H, 1988, PLANT PHYSIOL, V86, P50, DOI 10.1104/pp.86.1.50; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; SANMILLAN JL, 1989, J BACTERIOL, V171, P5536, DOI 10.1128/jb.171.10.5536-5541.1989; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shipman RL, 2009, FEBS LETT, V583, P938, DOI 10.1016/j.febslet.2009.02.016; Shipman-Roston RL, 2010, PLANT PHYSIOL, V152, P1297, DOI 10.1104/pp.109.151977; Teng YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001416; Thompson SJ, 1998, J BIOL CHEM, V273, P18979, DOI 10.1074/jbc.273.30.18979; Thompson SJ, 1999, J BIOL CHEM, V274, P4059, DOI 10.1074/jbc.274.7.4059; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Trosch R, 2015, BBA-BIOENERGETICS, V1847, P872, DOI 10.1016/j.bbabio.2015.01.002; TSUGEKI R, 1993, FEBS LETT, V320, P198, DOI 10.1016/0014-5793(93)80585-I; van Klompenburg W, 1998, FEBS LETT, V431, P75, DOI 10.1016/S0014-5793(98)00733-9; WOLFE PB, 1985, J BIOL CHEM, V260, P1836; Woolhead CA, 2001, J BIOL CHEM, V276, P14607, DOI 10.1074/jbc.M009600200; Woolhead CA, 2001, J BIOL CHEM, V276, P40841, DOI 10.1074/jbc.M106523200; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633; YUAN JG, 1994, J BIOL CHEM, V269, P18463	73	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28778	28791		10.1074/jbc.M115.684829	http://dx.doi.org/10.1074/jbc.M115.684829			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26446787	hybrid, Green Published			2022-12-26	WOS:000365762300020
J	Wood, SJ; Goldufsky, JW; Bello, D; Masood, S; Shafikhani, SH				Wood, Stephen J.; Goldufsky, Josef W.; Bello, Daniella; Masood, Sara; Shafikhani, Sasha H.			Pseudomonas aeruginosa ExoT Induces Mitochondrial Apoptosis in Target Host Cells in a Manner That Depends on Its GTPase-activating Protein (GAP) Domain Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; bacterial toxin; Bax; c-Jun N-terminal kinase (JNK); c-Jun transcription factor; Pseudomonas aeruginosa (P; aeruginosa); BCL-2; Bim; cytochrome c; ExoT; JNK; c-Jun; Bax; Bid	SECRETED TOXIN EXOT; EPITHELIAL-CELLS; PREVENTS APOPTOSIS; DEATH PATHWAYS; BAX ACTIVATION; CANCER-CELLS; KINASE; JNK; CYTOKINESIS; NECROSIS	Pseudomonas aeruginosa is the most common cause of hospital-acquired pneumonia and a killer of immunocompromised patients. We and others have demonstrated that the type III secretion system (T3SS) effector protein ExoT plays a pivotal role in facilitating P. aeruginosa pathogenesis. ExoT possesses an N-terminal GTPase-activating protein (GAP) domain and a C-terminal ADP-ribosyltransferase (ADPRT) domain. Because it targets multiple non-overlapping cellular targets, ExoT performs several distinct virulence functions for P. aeruginosa, including induction of apoptosis in a variety of target host cells. Both the ADPRT and the GAP domain activities contribute to ExoT-induced apoptosis. The ADPRT domain of ExoT induces atypical anoikis by transforming an innocuous cellular protein, Crk, into a cytotoxin, which interferes with integrin survival signaling. However, the mechanism underlying the GAP-induced apoptosis remains unknown. In this study, we demonstrate that the GAP domain activity is both necessary and sufficient to induce mitochondrial (intrinsic) apoptosis. We show that intoxication with GAP domain results in: (i) JNK1/2 activation; (ii) substantial increases in the mitochondrial levels of activated pro-apoptotic proteins Bax and Bid, and to a lesser extent Bim; (iii) loss of mitochondrial membrane potential and cytochrome c release; and (iv) activation of initiator caspase-9 and executioner caspase-3. Further, GAP-induced apoptosis is partially mediated by JNK1/2, but it is completely dependent on caspase-9 activity. Together, the ADPRT and the GAP domains make ExoT into a highly versatile and potent cytotoxin, capable of inducing multiple forms of apoptosis in target host cells.	[Wood, Stephen J.; Goldufsky, Josef W.; Bello, Daniella; Masood, Sara; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Shafikhani, Sasha H.] Rush Univ, Med Ctr, Ctr Canc, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Shafikhani, SH (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	Sasha_Shafikhani@rush.edu	Regan, Clinton/E-6250-2012; Shafikhani, Sasha/AAM-3460-2021	Shafikhani, Sasha/0000-0003-1755-9997	National Institutes of Health [R21 AI110685-01]; Bears Care [56613]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bears Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21 AI110685-01 (to S. H. S.) and Grant 56613 from The Bears Care (to S. H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Balachandran P, 2007, J CLIN INVEST, V117, P419, DOI 10.1172/JCI28792; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Bijian K, 2005, AM J PHYSIOL-RENAL, V289, pF1313, DOI 10.1152/ajprenal.00106.2005; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; deBentzmann S, 1996, AM J RESP CRIT CARE, V154, pS155, DOI 10.1164/ajrccm/154.4_Pt_2.S155; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Engel JN, 2003, P C C I D, V7, P201; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Feltman H., 2001, ASM ABSTR, pD22; Garrity-Ryan L, 2004, INFECT IMMUN, V72, P546, DOI 10.1128/IAI.72.1.546-558.2004; Garrity-Ryan L, 2000, INFECT IMMUN, V68, P7100, DOI 10.1128/IAI.68.12.7100-7113.2000; Goldufsky J, 2015, J MED MICROBIOL, V64, P164, DOI 10.1099/jmm.0.000003-0; Goldufsky J, 2015, WOUND REPAIR REGEN, V23, P557, DOI 10.1111/wrr.12310; Gomez J, 1997, EUR J IMMUNOL, V27, P2793, DOI 10.1002/eji.1830271108; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Jia J, 2003, INFECT IMMUN, V71, P3361, DOI 10.1128/IAI.71.6.3361-3370.2003; Kaufman MR, 2000, MICROBIOL-UK, V146, P2531, DOI 10.1099/00221287-146-10-2531; Kazmierczak BI, 2002, INFECT IMMUN, V70, P2198, DOI 10.1128/IAI.70.4.2198-2205.2002; Koch C, 2002, PEDIATR PULM, V34, P232, DOI 10.1002/ppul.10135; Krall R, 2000, INFECT IMMUN, V68, P6066, DOI 10.1128/IAI.68.10.6066-6068.2000; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Ozoren N, 2000, CANCER RES, V60, P6259; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Philchenkov A, 2004, J CELL MOL MED, V8, P432, DOI 10.1111/j.1582-4934.2004.tb00468.x; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; Shafikhani S, 2002, ENVIRON MICROBIOL, V4, P482, DOI 10.1046/j.1462-2920.2002.00326.x; Shafikhani SH, 2008, CELL CYCLE, V7, P2868, DOI 10.4161/cc.7.18.6674; Shafikhani SH, 2008, CELL MICROBIOL, V10, P994, DOI 10.1111/j.1462-5822.2007.01102.x; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; TSANG KWT, 1994, EUR RESPIR J, V7, P1746, DOI 10.1183/09031936.94.07101746; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Wang XW, 2009, FEBS LETT, V583, P1873, DOI 10.1016/j.febslet.2009.04.045; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wood S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004934; Wood S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054646; Wood S, 2011, CELL CYCLE, V10, P648, DOI 10.4161/cc.10.4.14813; YAMAGUCHI T, 1991, AM REV RESPIR DIS, V144, P1147, DOI 10.1164/ajrccm/144.5.1147; ZAHM JM, 1991, AM J RESP CELL MOL, V5, P242, DOI 10.1165/ajrcmb/5.3.242; Zeng CW, 2012, MOL PHARMACOL, V81, P578, DOI 10.1124/mol.111.076794; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	53	30	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29063	29073		10.1074/jbc.M115.689950	http://dx.doi.org/10.1074/jbc.M115.689950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26451042	Green Published, hybrid			2022-12-26	WOS:000365762300044
J	Fracassetti, M; Griffin, PC; Willi, Y				Fracassetti, Marco; Griffin, Philippa C.; Willi, Yvonne			Validation of Pooled Whole-Genome Re-Sequencing in Arabidopsis lyrata	PLOS ONE			English	Article							DETECTING SELECTIVE SWEEPS; NEXT-GENERATION; ALLELE FREQUENCIES; SAMPLES; POPULATIONS; DNA; DIFFERENTIATION; DOMESTICATION; ADAPTATION; DISCOVERY	Sequencing pooled DNA of multiple individuals from a population instead of sequencing individuals separately has become popular due to its cost-effectiveness and simple wet-lab protocol, although some criticism of this approach remains. Here we validated a protocol for pooled whole-genome re-sequencing (Pool-seq) of Arabidopsis lyrata libraries prepared with low amounts of DNA (1.6 ng per individual). The validation was based on comparing single nucleotide polymorphism (SNP) frequencies obtained by pooling with those obtained by individual-based Genotyping By Sequencing (GBS). Furthermore, we investigated the effect of sample number, sequencing depth per individual and variant caller on population SNP frequency estimates. For Pool-seq data, we compared frequency estimates from two SNP callers, VarScan and Snape; the former employs a frequentist SNP calling approach while the latter uses a Bayesian approach. Results revealed concordance correlation coefficients well above 0.8, confirming that Pool-seq is a valid method for acquiring population-level SNP frequency data. Higher accuracy was achieved by pooling more samples (25 compared to 14) and working with higher sequencing depth (4.1x per individual compared to 1.4x per individual), which increased the concordance correlation coefficient to 0.955. The Bayesian-based SNP caller produced somewhat higher concordance correlation coefficients, particularly at low sequencing depth. We recommend pooling at least 25 individuals combined with sequencing at a depth of 100x to produce satisfactory frequency estimates for common SNPs (minor allele frequency above 0.05).	[Fracassetti, Marco; Griffin, Philippa C.; Willi, Yvonne] Univ Neuchatel, Evolutionary Bot, Inst Biol, CH-2000 Neuchatel, Switzerland; [Griffin, Philippa C.] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia	University of Neuchatel; University of Melbourne	Fracassetti, M (corresponding author), Univ Neuchatel, Evolutionary Bot, Inst Biol, CH-2000 Neuchatel, Switzerland.	marco.fracassetti@unine.ch	Fracassetti, Marco/F-2383-2018; Fracassetti, Marco/P-4819-2019	Fracassetti, Marco/0000-0002-2962-2669; Fracassetti, Marco/0000-0002-2962-2669; Griffin, Philippa/0000-0003-1538-8389	Swiss National Science Foundation [PP00P3-123396, PP00P3-146342]; Fondation Pierre Mercier pour la Science, Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Pierre Mercier pour la Science, Lausanne	This work was supported by the Swiss National Science Foundation (PP00P3-123396 and PP00P3-146342 to YW) and the Fondation Pierre Mercier pour la Science (to YW), Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2014, MOL ECOL, V23, P502, DOI 10.1111/mec.12609; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Bastide H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003534; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boitard S, 2013, MOL ECOL RESOUR, V13, P337, DOI 10.1111/1755-0998.12063; Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090; Burke MK, 2014, MOL BIOL EVOL, V31, P3228, DOI 10.1093/molbev/msu256; Carr D., HEXBIN HEXAGONAL BIN; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Clement JAJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002591; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Esteve-Codina A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-148; Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522; Fischer MC, 2013, MOL ECOL, V22, P5594, DOI 10.1111/mec.12521; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kofler R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002487; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lynch M, 2014, GENOME BIOL EVOL, V6, P1210, DOI 10.1093/gbe/evu085; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Pandey V, 2008, NEXT GENERATION GENO, P29, DOI DOI 10.1002/9783527625130.CH3; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raineri E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-239; Rellstab C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080422; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Smit AFA, 2010, REPEATMASKER OPEN 3; Stevenson M.A., 2015, EPIR TOOLS ANAL EPID; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901	51	32	32	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140462	10.1371/journal.pone.0140462	http://dx.doi.org/10.1371/journal.pone.0140462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461136	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300098
J	Ozawa, Y; Abe, T; Omae, M; Matsui, T; Kato, M; Hasegawa, H; Enomoto, Y; Ishihara, T; Inui, N; Yamada, K; Yokomura, K; Suda, T				Ozawa, Yuichi; Abe, Takefumi; Omae, Minako; Matsui, Takashi; Kato, Masato; Hasegawa, Hirotsugu; Enomoto, Yasunori; Ishihara, Takeaki; Inui, Naoki; Yamada, Kazunari; Yokomura, Koshi; Suda, Takafumi			Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer	PLOS ONE			English	Article							CRYPTOGENIC FIBROSING ALVEOLITIS; STEREOTACTIC BODY RADIOTHERAPY; RESPIRATORY-DISTRESS-SYNDROME; AUTOMATED QUANTIFICATION; THORACIC IRRADIATION; COMPUTED-TOMOGRAPHY; DOSIMETRIC FACTORS; RISK; SURVIVAL; EXACERBATION	Introduction This study investigated the clinical characteristics and predictive factors for developing acute extended radiation pneumonitis with a focus on the presence and radiological characteristics of preexisting interstitial lung disease. Methods Of 1429 irradiations for lung cancer from May 2006 to August 2013, we reviewed 651 irradiations involving the lung field. The presence, compatibility with usual interstitial pneumonia, and occupying area of preexisting interstitial lung disease were retrospectively evaluated by pretreatment computed tomography. Cases of non-infectious, non-cardiogenic, acute respiratory failure with an extended bilateral shadow developing within 30 days after the last irradiation were defined as acute extended radiation pneumonitis. Results Nine (1.4%) patients developed acute extended radiation pneumonitis a mean of 6.7 days after the last irradiation. Although preexisting interstitial lung disease was found in 13% of patients (84 patients), 78% of patients (7 patients) with acute extended radiation pneumonitis cases had preexisting interstitial lung disease, which resulted in incidences of acute extended radiation pneumonitis of 0.35 and 8.3% in patients without and with preexisting interstitial lung disease, respectively. Multivariate logistic analysis indicated that the presence of preexisting interstitial lung disease (odds ratio = 22.6; 95% confidence interval = 5.29-155; p < 0.001) and performance status (>= 2; odds ratio = 4.22; 95% confidence interval = 1.06-20.8; p = 0.049) were significant predictive factors. Further analysis of the 84 patients with preexisting interstitial lung disease revealed that involvement of more than 10% of the lung field was the only independent predictive factor associated with the risk of acute extended radiation pneumonitis (odds ratio = 6.14; 95% confidence interval = 1.0-37.4); p = 0.038). Conclusions Pretreatment computed tomography evaluations of the presence of and area size occupied by preexisting interstitial lung disease should be assessed for safer irradiation of areas involving the lung field.	[Ozawa, Yuichi; Abe, Takefumi; Omae, Minako; Matsui, Takashi; Kato, Masato; Hasegawa, Hirotsugu; Enomoto, Yasunori; Yokomura, Koshi] Seirei Mikatahara Gen Hosp, Dept Resp Med, Resp Dis Ctr, Hamamatsu, Shizuoka, Japan; [Ishihara, Takeaki; Yamada, Kazunari] Seirei Mikatahara Gen Hosp, Dept Radiat Oncol, Hamamatsu, Shizuoka, Japan; [Inui, Naoki] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan; [Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Ozawa, Y (corresponding author), Seirei Mikatahara Gen Hosp, Dept Resp Med, Resp Dis Ctr, Hamamatsu, Shizuoka, Japan.	u1.ozawa@sis.seirei.or.jp	Ozawa, Yuichi/AAK-2190-2021	Ozawa, Yuichi/0000-0003-3798-3488				BENNETT DE, 1969, CANCER-AM CANCER SOC, V23, P1001, DOI 10.1002/1097-0142(196905)23:5<1001::AID-CNCR2820230505>3.0.CO;2-E; BYHARDT RW, 1988, INT J RADIAT ONCOL, V15, P1441, DOI 10.1016/0360-3016(88)90241-6; Fay M, 2005, INT J RADIAT ONCOL, V61, P1355, DOI 10.1016/j.ijrobp.2004.08.025; FULKERSON WJ, 1986, CANCER, V57, P1941, DOI 10.1002/1097-0142(19860515)57:10<1941::AID-CNCR2820571009>3.0.CO;2-9; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062; Hwang JH, 2000, J KOREAN MED SCI, V15, P712, DOI 10.3346/jkms.2000.15.6.712; Kenmotsu H, 2011, J THORAC ONCOL, V6, P1242, DOI 10.1097/JTO.0b013e318216ee6b; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Leprieur EG, 2013, J CANCER RES THER, V9, P447, DOI 10.4103/0973-1482.119339; Liu H, 2012, INT J RADIAT ONCOL, V84, P1017, DOI 10.1016/j.ijrobp.2012.02.020; Makimoto T, 1999, JPN J CLIN ONCOL, V29, P192, DOI 10.1093/jjco/29.4.192; Maldonado F, 2014, EUR RESPIR J, V43, P204, DOI 10.1183/09031936.00071812; Martin F, 1999, CYTOKINE, V11, P80, DOI 10.1006/cyto.1998.0398; MORGAN GW, 1995, INT J RADIAT ONCOL, V31, P361, DOI 10.1016/0360-3016(94)00477-3; Ozawa Y, 2009, RESPIROLOGY, V14, P723, DOI 10.1111/j.1440-1843.2009.01547.x; Park J, 2001, EUR RESPIR J, V17, P1216, DOI 10.1183/09031936.01.99055301; Pluzanska Anna, 1995, Acta Haematologica Polonica, V26, P219; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rancati T, 2003, RADIOTHER ONCOL, V67, P275, DOI 10.1016/S0167-8140(03)00119-1; Robnett TJ, 2000, INT J RADIAT ONCOL, V48, P89, DOI 10.1016/S0360-3016(00)00648-9; Rosas IO, 2011, CHEST, V140, P1590, DOI 10.1378/chest.10-2545; Sanuki N, 2012, J RADIAT RES, V53, P110, DOI 10.1269/jrr.110142; Scott HR, 2002, BRIT J CANCER, V87, P264, DOI 10.1038/sj.bjc.6600466; Shi AH, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-35; SMITH JC, 1964, AM REV RESPIR DIS, V89, P264; Sugiura H, 2012, ANN THORAC SURG, V93, P937, DOI 10.1016/j.athoracsur.2011.12.010; Takeda A, 2012, BRIT J RADIOL, V85, P636, DOI 10.1259/bjr/71635286; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsujino K, 2014, J THORAC ONCOL, V9, P983, DOI 10.1097/JTO.0000000000000187; TURNERWARWICK M, 1980, THORAX, V35, P496, DOI 10.1136/thx.35.7.496; Ueki N, 2015, J THORAC ONCOL, V10, P116, DOI 10.1097/JTO.0000000000000359; Yamaguchi S, 2013, LUNG CANCER, V82, P260, DOI 10.1016/j.lungcan.2013.08.024	33	40	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140437	10.1371/journal.pone.0140437	http://dx.doi.org/10.1371/journal.pone.0140437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460792	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300095
J	Rasmussen, MM; Opintan, JA; Frimodt-Moller, N; Styrishave, B				Rasmussen, Mette Marie; Opintan, Japheth A.; Frimodt-Moller, Niels; Styrishave, Bjarne			Beta-Lactamase Producing Escherichia coli Isolates in Imported and Locally Produced Chicken Meat from Ghana	PLOS ONE			English	Article							EXTENDED-SPECTRUM; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL USE; UNITED-STATES; AMPC; VIRULENCE; GENES; FOOD; PREVALENCE; ANIMALS	The use of antibiotics in food animals is of public health concern, because resistant zoonotic pathogens can be transmitted to humans. Furthermore, global trade with food may rapidly spread multi-resistant pathogens between countries and even continents. The purpose of the study was to investigate whether imported chicken meat and meat from locally reared chicken are potential sources for human exposure to multi resistant Escherichia coli isolates. 188 samples from imported and locally produced chicken meat were sampled and analyzed. 153 bacteria isolates were successfully cultured and identified as E. coli using MALDI-ToF. Of these 109 isolates were from meat whereas the remaining 44 were isolated from the cloaca of locally reared live chickens. Antimicrobial susceptibility test was done on the identified E. coli isolates. Additionally, beta-lactamases production (ESBL and/or AmpC) were phenotypically confirmed on all isolates showing resistance to cefpodoxime. Beta-lactamase producing (BLP) E. coli meat isolates were further genotyped. Antimicrobial resistance to four antibiotic markers with highest resistance was detected more frequently in isolates from local chickens compared to imported chickens (tetracycline 88.9% vs. 57.5%, sulphonamide 75.0% vs. 46.6%, ampicillin 69.4% vs. 61.6% and trimethoprim 66.7% vs. 38.4%). Beta-lactamase production was found in 29 E. coli meat isolates, with 56.9% of them being multiple drug resistant (>= 3). The predominant phylogroup identified was B1 followed by A and D, with similar distribution among the isolates from meat of locally reared chickens and imported chickens. Beta-lactamase producing genotype bla(CTX-M-15) (50%; 10/20) was the most frequently drug resistant gene detected. More BLP E. coli isolates were found in imported chicken meat compared to locally reared chickens, demonstrating that these isolates may be spreading through food trade. In conclusion, both imported and locally produced chicken meats are potential sources for human exposure to BLP E. coli.	[Rasmussen, Mette Marie; Styrishave, Bjarne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Toxicol Lab,Analyt Biosci, Copenhagen, Denmark; [Opintan, Japheth A.] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana; [Frimodt-Moller, Niels] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen OE, Denmark	University of Copenhagen; University of Ghana; Rigshospitalet	Styrishave, B (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Toxicol Lab,Analyt Biosci, Copenhagen, Denmark.	bjarne.styrishave@sund.ku.dk	Frimodt-Moller, Niels/G-1187-2018	Frimodt-Moller, Niels/0000-0003-1966-8302; Styrishave, Bjarne/0000-0003-1619-2468	Danida, the Ministry of Foreign Affairs of Denmark [09-099SSI]	Danida, the Ministry of Foreign Affairs of Denmark	The project was funded by Danida, the Ministry of Foreign Affairs of Denmark to NFM, Grant number 09-099SSI [http://um.dk/da/danida/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup Frank M., 2006, pXI; Adzitey F., 2013, J WORLDS POULT RES, V3, P1; [Anonymous], 2012, J VET ADV; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09; Danzeisen JL, 2013, AVIAN DIS, V57, P104, DOI 10.1637/10218-042812-ResNote.1; Donkor ES, 2012, TROP MED INT HEALTH, V17, P462, DOI 10.1111/j.1365-3156.2012.02955.x; European Committee on Antimicrobial Susceptibility Testing, 2014, BREAKP TABL INT MICS; European Committee on Antimicrobial Susceptibility Testing, 2013, ANT SUSC TEST EUCAST; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Guilfoile P, 2006, ANTIOBITIC RESISTANT; Jakobsen L, 2010, FOODBORNE PATHOG DIS, V7, P537, DOI 10.1089/fpd.2009.0409; Johnson JR, 2009, CLIN INFECT DIS, V49, P195, DOI 10.1086/599830; Jorgensen RL, 2010, J ANTIMICROB CHEMOTH, V65, P460, DOI 10.1093/jac/dkp484; Kohr M, 2006, IMPACT GLOBALIZATION; Lerbech AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113055; Levy SB, 1997, CIBA F SYMP, V207, P1; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; National Food Institute, 2012, DAT ACT DAN APPR SUR; Newman Mercy J, 2011, Infect Drug Resist, V4, P215, DOI 10.2147/IDR.S21769; Nys S, 2004, J ANTIMICROB CHEMOTH, V54, P952, DOI 10.1093/jac/dkh448; Obeng-Nkrumah N, 2014, THESIS U GHANA LEGON; Ojer-Usoz E, 2013, MEAT SCI, V93, P316, DOI 10.1016/j.meatsci.2012.09.009; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Reich F, 2013, EMERG INFECT DIS, V19, P1253, DOI 10.3201/eid1908.120879; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; Sundsfjord A, 2004, APMIS, V112, P815, DOI 10.1111/j.1600-0463.2004.apm11211-1208.x; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10; Thomson KS, 2001, EMERG INFECT DIS, V7, P333, DOI 10.3201/eid0702.010238; Tollefson L, 2004, MED MALADIES INFECT, V34, P514, DOI [10.1016/j.medmal.2004.07.028, 10.1016/j/medmal.2004.07.028]; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412	45	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139706	10.1371/journal.pone.0139706	http://dx.doi.org/10.1371/journal.pone.0139706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461270	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300022
J	Balasubramanian, S; Pleasant, DL; Kasiganesan, H; Quinones, L; Zhang, YH; Sundararaj, KP; Roche, S; O'Connor, R; Bradshaw, AD; Kuppuswamy, D				Balasubramanian, Sundaravadivel; Pleasant, Dorea L.; Kasiganesan, Harinath; Quinones, Lakeya; Zhang, Yuhua; Sundararaj, Kamala P.; Roche, Sandra; O'Connor, Robert; Bradshaw, Amy D.; Kuppuswamy, Dhandapani			Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction Model	PLOS ONE			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; MYOCARDIAL FIBROSIS; HEART-FAILURE; HYPERTROPHYING MYOCARDIUM; DIASTOLIC DYSFUNCTION; EJECTION FRACTION; BETA-3 INTEGRIN; C-SRC; KINASE; ACTIVATION	Reactive cardiac fibrosis resulting from chronic pressure overload (PO) compromises ventricular function and contributes to congestive heart failure. We explored whether nonreceptor tyrosine kinases (NTKs) play a key role in fibrosis by activating cardiac fibroblasts (CFb), and could potentially serve as a target to reduce PO-induced cardiac fibrosis. Our studies were carried out in PO mouse myocardium induced by transverse aortic constriction (TAC). Administration of a tyrosine kinase inhibitor, dasatinib, via an intraperitoneally implanted mini-osmotic pump at 0.44 mg/kg/day reduced PO-induced accumulation of extracellular matrix (ECM) proteins and improved left ventricular geometry and function. Furthermore, dasatinib treatment inhibited NTK activation (primarily Pyk2 and Fak) and reduced the level of FSP1 positive cells in the PO myocardium. In vitro studies using cultured mouse CFb showed that dasatinib treatment at 50 nM reduced: (i) extracellular accumulation of both collagen and fibronectin, (ii) both basal and PDGF-stimulated activation of Pyk2, (iii) nuclear accumulation of Ki67, SKP2 and histone-H2B and (iv) PDGF-stimulated CFb proliferation and migration. However, dasatinib did not affect cardiomyocyte morphologies in either the ventricular tissue after in vivo administration or in isolated cells after in vitro treatment. Mass spectrometric quantification of dasatinib in cultured cells indicated that the uptake of dasatinib by CFb was greater that that taken up by cardiomyocytes. Dasatinib treatment primarily suppressed PDGF but not insulin-stimulated signaling (Erk versus Akt activation) in both CFb and cardiomyocytes. These data indicate that dasatinib treatment at lower doses than that used in chemotherapy has the capacity to reduce hypertrophy-associated fibrosis and improve ventricular function.	[Balasubramanian, Sundaravadivel; Pleasant, Dorea L.; Kasiganesan, Harinath; Quinones, Lakeya; Zhang, Yuhua; Sundararaj, Kamala P.; Bradshaw, Amy D.; Kuppuswamy, Dhandapani] Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Roche, Sandra; O'Connor, Robert] Dublin City Univ, Dublin 9, Ireland	Medical University of South Carolina; Dublin City University	Kuppuswamy, D (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, 114 Doughty St, Charleston, SC 29425 USA.	kuppusd@musc.edu	Roche, Sandra/AAM-9800-2021	Roche, Sandra/0000-0002-4363-4607; Jenkins, Dorea/0000-0001-9510-8601	National Institutes of Health [RHL092124A, T32HL07260]; UNCF/Merck Graduate Science Research Dissertation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092124, T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF/Merck Graduate Science Research Dissertation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health grant (RHL092124A to D. K), by the National Institutes of Health postdoctoral fellowship (T32HL07260 to K.S.), and predoctoral fellowships, T32HL07260, and 2014 UNCF/Merck Graduate Science Research Dissertation Fellowship to D.L.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Gerges N, 2013, J MOL CELL CARDIOL, V64, P108, DOI 10.1016/j.yjmcc.2013.09.004; Akhmetshina A, 2008, FASEB J, V22, P2214, DOI 10.1096/fj.07-105627; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Balasubramanian S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045076; Balasubramanian Sundaravadivel, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P52; Beyer C, 2013, BBA-MOL BASIS DIS, V1832, P897, DOI 10.1016/j.bbadis.2012.06.008; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Brenner DA, 2012, PROCEEDINGS OF FIBRO, V5, pS17, DOI [10.1186/1755-1536-5-S1-S17, DOI 10.1186/1755-1536-5-S1-S17]; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Chan D, 2012, ONCOL LETT, V3, P807, DOI 10.3892/ol.2012.579; Chen MH, 2008, CIRCULATION, V118, P84, DOI 10.1161/CIRCULATIONAHA.108.776831; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; Distler JHW, 2008, RHEUMATOLOGY, V47, pV10, DOI 10.1093/rheumatology/ken276; Ekwall B, 1990, SHORT TERM TOXICITY, P76; Gonzalez A, 2004, MED CLIN N AM, V88, P83, DOI 10.1016/S0025-7125(03)00125-1; Gratacap MP, 2009, BLOOD; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HENRY WL, 1980, CIRCULATION, V62, P212, DOI 10.1161/01.CIR.62.2.212; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kai H, 2005, HYPERTENS RES, V28, P483, DOI 10.1291/hypres.28.483; KENT RL, 1989, AM J PHYSIOL, V257, pH1717, DOI 10.1152/ajpheart.1989.257.5.H1717; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; Lau ATY, 2011, J BIOL CHEM, V286, P26628, DOI 10.1074/jbc.M110.215590; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lucas JA, 2010, AM J PHYSIOL-HEART C, V298, pH424, DOI 10.1152/ajpheart.00529.2009; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; Mani SK, 2008, AM J PHYSIOL-HEART C, V295, pH314, DOI 10.1152/ajpheart.00085.2008; Palanisamy AP, 2015, J CELL BIOCHEM, V116, P2793, DOI 10.1002/jcb.25224; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Roche S, 2009, J CHROMATOGR B, V877, P3982, DOI 10.1016/j.jchromb.2009.10.008; Shah NP, 2014, BLOOD, V123, P2317, DOI 10.1182/blood-2013-10-532341; Skhirtladze C, 2008, ARTHRITIS RHEUM, V58, P1475, DOI 10.1002/art.23436; Snyder DS, 2009, EXPERT REV ANTICANC, V9, P285, DOI 10.1586/14737140.9.3.285; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Suryakumar G, 2010, J CARDIOVASC PHARM, V55, P567, DOI 10.1097/FJC.0b013e3181d9f5d4; Touvron M, 2012, DIS MODEL MECH, V5, P481, DOI 10.1242/dmm.009456; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Wang XY, 2010, J CELL COMMUN SIGNAL, V4, P15, DOI 10.1007/s12079-009-0083-1; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; WEBER KT, 1992, J AM COLL CARDIOL, V20, P3, DOI 10.1016/0735-1097(92)90130-F; Willey CD, 2003, J MOL CELL CARDIOL, V35, P671, DOI 10.1016/S0022-2828(03)00112-3; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215; Zile MR, 2013, J CARDIOVASC TRANSL, V6, P501, DOI 10.1007/s12265-013-9472-1	47	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140273	10.1371/journal.pone.0140273	http://dx.doi.org/10.1371/journal.pone.0140273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458186	Green Published, Green Submitted, gold			2022-12-26	WOS:000362961100028
J	Bauer, RK; Fromentin, JM; Demarcq, H; Brisset, B; Bonhommeau, S				Bauer, Robert Klaus; Fromentin, Jean-Marc; Demarcq, Herve; Brisset, Blandine; Bonhommeau, Sylvain			Co-Occurrence and Habitat Use of Fin Whales, Striped Dolphins and Atlantic Bluefin Tuna in the Northwestern Mediterranean Sea	PLOS ONE			English	Article							STENELLA-COERULEOALBA; BALAENOPTERA-PHYSALUS; THUNNUS-THYNNUS; AERIAL SURVEY; DELPHINUS-DELPHIS; COMMON DOLPHINS; WEST GREENLAND; ABUNDANCE; GULF; TRACKING	Different dolphin and tuna species have frequently been reported to aggregate in areas of high frontal activity, sometimes developing close multi-species associations to increase feeding success. Aerial surveys are a common tool to monitor the density and abundance of marine mammals, and have recently become a focus in the search for methods to provide fisheries-independent abundance indicators for tuna stock assessment. In this study, we present first density estimates corrected for availability bias of fin whales (Balaenoptera physalus) and striped dolphins (Stenella coeruleoalba) from the Golf of Lions (GoL), compared with uncorrected estimates of Atlantic bluefin tuna (ABFT; Thunnus thynnus) densities from 8 years of line transect aerial surveys. The raw sighting data were further used to analyze patterns of spatial co-occurrence and density of these three top marine predators in this important feeding ground in the Northwestern Mediterranean Sea. These patterns were investigated regarding known species-specific feeding preferences and environmental characteristics (i. e. mesoscale activity) of the survey zone. ABFT was by far the most abundant species during the surveys in terms of schools and individuals, followed by striped dolphins and fin whales. However, when accounted for availability bias, schools of dolphins and fin whales were of equal density. Direct interactions of the species appeared to be the exception, but results indicate that densities, presence and core sighting locations of striped dolphins and ABFT were correlated. Core sighting areas of these species were located close to an area of high mesoscale activity (oceanic fronts and eddies). Fin whales did not show such a correlation. The results further highlight the feasibility to coordinate research efforts to explore the behaviour and abundance of the investigated species, as demanded by the Marine Strategy Framework Directive (MSFD).	[Bauer, Robert Klaus; Fromentin, Jean-Marc; Brisset, Blandine; Bonhommeau, Sylvain] IFREMER, Resarch Unit Marbec Marine Biodivers Exploitat &, F-34203 Sete, France; [Demarcq, Herve] IRD, Resarch Unit Marbec Marine Biodivers Exploitat &, Sete, France	Ifremer; Institut de Recherche pour le Developpement (IRD)	Fromentin, JM (corresponding author), IFREMER, Resarch Unit Marbec Marine Biodivers Exploitat &, F-34203 Sete, France.	Jean.Marc.Fromentin@ifremer.fr	Bonhommeau, Sylvain/P-8654-2014	Bonhommeau, Sylvain/0000-0002-0882-5918; Bauer, Robert Klaus/0000-0003-4224-8023; Fromentin, Jean-Marc/0000-0002-1496-4332	EU project STROMBOLI; Ifremer; French administration (convention IFREMER-DPMA); France Filiere Peche [LM-2012-144]; IFREMER (fellowship contract)	EU project STROMBOLI; Ifremer; French administration (convention IFREMER-DPMA); France Filiere Peche; IFREMER (fellowship contract)	The aerial surveys were firstly funded by the EU project STROMBOLI (2000-2002), then by Ifremer (2003) and the French administration (convention IFREMER-DPMA, 2009 onwards). This author RKB was supported by a PhD grant from France Filiere Peche (No LM-2012-144) and IFREMER (fellowship contract).	Andre G, 2005, OCEAN DYNAM, V55, P294, DOI 10.1007/s10236-005-0013-6; Andriolo A., 2006, Journal of Cetacean Research and Management, V8, P307; Bauer RK, 2015, MAR ECOL PROG SER, V534, P221, DOI 10.3354/meps11392; Bearzi G, 2003, MAMMAL REV, V33, P224, DOI 10.1046/j.1365-2907.2003.00032.x; Beaubrun P., 1999, European Research on Cetaceans, V13, P162; Beavers SC, 1998, J WILDLIFE MANAGE, V62, P948, DOI 10.2307/3802547; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; BLANCO C, 1995, J ZOOL, V237, P151, DOI 10.1111/j.1469-7998.1995.tb02753.x; Borchers DL, 1998, BIOMETRICS, V54, P1207, DOI 10.2307/2533651; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Canadas A., 2008, Endangered Species Research, V4, P309, DOI 10.3354/esr00073; Canadas A, 2002, DEEP-SEA RES PT I, V49, P2053, DOI 10.1016/S0967-0637(02)00123-1; CAUGHLEY G, 1976, J WILDLIFE MANAGE, V40, P290, DOI 10.2307/3800428; Clua E, 2001, AQUAT LIVING RESOUR, V14, P11, DOI 10.1016/S0990-7440(00)01097-4; di Natale A., 1983, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V28, P201; Di Natale A., 1990, FAO FISH REP, V449, P167; Doniol-Valcroze T, 2007, MAR ECOL PROG SER, V335, P207, DOI 10.3354/meps335207; Druon JN, 2012, MAR ECOL PROG SER, V464, P289, DOI 10.3354/meps09810; Evans PGH, 2008, MAMMALS BRIT ISLES H, P655; Forcada J, 2004, MAR ECOL PROG SER, V275, P275, DOI 10.3354/meps275275; Forcada J, 1998, J SEA RES, V39, P313, DOI 10.1016/S1385-1101(97)00063-4; Forcada J, 1996, J ZOOL, V238, P23, DOI 10.1111/j.1469-7998.1996.tb05377.x; Frantzis Alexandros, 2002, Aquatic Mammals, V28, P188; Fromentin JM, 2014, ICES J MAR SCI, V71, P510, DOI 10.1093/icesjms/fst157; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Gannier A, 2005, REV ECOL-TERRE VIE, V60, P223; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; de Segura AG, 2006, MAR BIOL, V150, P149, DOI 10.1007/s00227-006-0334-0; Gosselin JF, 2007, CAN SCI ADVIS SECR R, V2007/025; GREENE CH, 1988, SCIENCE, V241, P359, DOI 10.1126/science.241.4863.359; Hall MA, 1998, REV FISH BIOL FISHER, V8, P1, DOI 10.1023/A:1008854816580; Heide-Jorgensen M. P., 2010, Journal of Cetacean Research and Management, V11, P83; Heide-Jorgensen M. P., 2010, Journal of Cetacean Research and Management, V11, P75; Hernandez V. A., 1990, COL VOL SCI PAP ICCA, V33, P101; Hu ZY, 2011, J MARINE SYST, V88, P3, DOI 10.1016/j.jmarsys.2011.02.008; ICCAT, 2011, COLLECT VOL SCI PAP, V68, P1; IUCN, 2012, MAR MAMM SEA TURTL M; Jahoda M, 2003, MAR MAMMAL SCI, V19, P96, DOI 10.1111/j.1748-7692.2003.tb01095.x; Jordi A, 2006, OCEAN SCI, V2, P173, DOI 10.5194/os-2-173-2006; Laake J, 2013, MRDS MARK RECAPTURE; Laake J, 2008, WILDLIFE RES, V35, P289, DOI 10.1071/WR07065; Laake JL, 1997, J WILDLIFE MANAGE, V61, P63, DOI 10.2307/3802415; Lauriano G, 2011, MAR ECOL PROG SER, V437, P291, DOI 10.3354/meps09261; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; MAGNAGHI L, 1987, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V128, P235; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Meotti C, 1997, ATTI SOC IT SCI NAT, V137, P5; Monestiez P, 2006, ECOL MODEL, V193, P615, DOI 10.1016/j.ecolmodel.2005.08.042; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Mussi B., 1999, European Research on Cetaceans, V13, P330; Nieto K, 2012, REMOTE SENS ENVIRON, V123, P339, DOI 10.1016/j.rse.2012.03.028; Notarbartolo-di-Sciara G, 2003, MAMMAL REV, V33, P105, DOI 10.1046/j.1365-2907.2003.00005.x; Panigada Simone, 2005, Journal of Cetacean Research and Management, V7, P137; Panigada S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022878; Rowat D, 2009, J EXP MAR BIOL ECOL, V368, P1, DOI 10.1016/j.jembe.2008.09.001; Royer F, 2004, MAR ECOL PROG SER, V269, P249, DOI 10.3354/meps269249; Scales KL, 2014, J APPL ECOL, V51, P1575, DOI 10.1111/1365-2664.12330; SCOTT JM, 1969, CALIF FISH GAME, V55, P136; Scott MD, 2012, MAR ECOL PROG SER, V458, P283, DOI 10.3354/meps09740; Sergeant D. E., 1977, Report int. Whal. Commn, V27, P460; Spitz J, 2006, J SEA RES, V55, P309, DOI 10.1016/j.seares.2006.02.001; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Thomas L, 2012, DISTANCE SAMPLING, P687; Tudela S., 2000, EPINT759GEF FAO FISH; Vella A., 2005, ECS NEWSLETTER, V45, P4; Venables WN., 2002, MODERN APPL STAT S 4; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WURTZ M, 1993, J MAR BIOL ASSOC UK, V73, P571, DOI 10.1017/S0025315400033117	72	18	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0139218	10.1371/journal.pone.0139218	http://dx.doi.org/10.1371/journal.pone.0139218			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458254	gold, Green Published, Green Submitted			2022-12-26	WOS:000362961100009
J	Hu, LP; Liu, DP; Chen, QY; Harrison, TJ; He, X; Wang, XY; Li, H; Tan, C; Yang, QL; Li, KW; Fang, ZL				Hu, Li-Ping; Liu, De-Ping; Chen, Qin-Yan; Harrison, Tim J.; He, Xiang; Wang, Xue-Yan; Li, Hai; Tan, Chao; Yang, Qing-Li; Li, Kai-Wen; Fang, Zhong-Liao			Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection	PLOS ONE			English	Article							BETA-BAND OSCILLATIONS; FRONTAL-MIDLINE THETA; MEDITATION EXPERIENCE; FOCUSED-ATTENTION; ZEN MEDITATION; SELF-AWARENESS; BODY-SCAN; TOP-DOWN; MINDFULNESS; MEMORY	The importance of transmission of occult HBV infection (OBI) via transfusion, organ transplantation and hemodialysis has been widely recognized. However, data regarding the transmission of OBI through close contact remain limited. In this study, serum samples were obtained from a child and his parents. The child had received the standard vaccination regimen at birth and produced protective antibody. Sera were tested for HBV serological markers. Nested PCR assays were used to detect HBV DNA and the amplicons were cloned and their sequences subjected to phylogenetic analysis. The results showed that both parents had occult infections while the child had an overt infection. Twelve, eleven and nine clones, from the father, mother and son, respectively, were sequenced. Serotypes adrq+, ayw1, ayw and ayr were found in the father and ayw1, adw2 and adwq+ in the mother; adrq+ was the only serotype in son. Genotype B, subgenotype C2 and a recombinant were identified in the father and genotype B, subgenotype C5 and three recombinants were found in the mother. Subgenotype C2 was the only genotype identified in the child. A phylogenetic tree showed that all of the child's sequences and most of the father's sequences clustered together. However, none of mother's sequences clustered with those of the child. The surface gene from the child and his father had the same amino acid substitution pattern (T118K, T123N and G145A). We concluded that the father was the source of the son's HBV infection, suggesting that occult HBV infection may be transmitted through close contact and manifest as an overt infection.	[Hu, Li-Ping; Chen, Qin-Yan; Wang, Xue-Yan; Li, Hai; Tan, Chao; Yang, Qing-Li; Li, Kai-Wen; Fang, Zhong-Liao] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Guangxi Key Lab Prevent & Control Viral Hepatitis, Nanning 530028, Guangxi, Peoples R China; [Hu, Li-Ping; Li, Kai-Wen] Guangxi Med Univ, Sch Preclin Med, Nanning 530021, Guangxi, Peoples R China; [Liu, De-Ping] Chong Zuo Ctr Dis Prevent & Control, Chong Zuo 532200, Guangxi, Peoples R China; [Harrison, Tim J.] UCL Med Sch, Div Med, London, England; [He, Xiang] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou 511430, Guangdong, Peoples R China	Guangxi Medical University; University of London; University College London; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Fang, ZL (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Guangxi Key Lab Prevent & Control Viral Hepatitis, Nanning 530028, Guangxi, Peoples R China.	zhongliaofang@hotmail.com	He, Xiang/E-7082-2013	He, Xiang/0000-0003-2428-5349	National Natural Science Foundation of China [81260439/H2609]; Guangxi Science Foundation [1140003A-37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Science Foundation	This work was supported by the National Natural Science Foundation of China (Grant No. 81260439/H2609) and the Guangxi Science Foundation (Gui Ke Gong 1140003A-37).	Ahani A, 2013, INT IEEE EMBS C NEUR, P1738; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; Berkovich-Ohana A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00912; Bittencourt J, 2012, NEUROSCI LETT, V523, P148, DOI 10.1016/j.neulet.2012.06.066; Bob P, 2013, CLIN EEG NEUROSCI, V44, P39, DOI 10.1177/1550059412451705; Borghini G, 2012, IEEE ENG MED BIO, P6442, DOI 10.1109/EMBC.2012.6347469; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Brown CA, 2010, PAIN, V150, P428, DOI 10.1016/j.pain.2010.04.017; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Cartier C, 2012, BRAIN RES BULL, V87, P103, DOI 10.1016/j.brainresbull.2011.10.013; Cavanagh K, 2013, BEHAV RES THER, V51, P573, DOI 10.1016/j.brat.2013.06.003; Chiesa A, 2010, PSYCHOL MED, V40, P1239, DOI 10.1017/S0033291709991747; Chiesa A, 2013, CLIN PSYCHOL REV, V33, P82, DOI 10.1016/j.cpr.2012.10.006; Chiesa A, 2009, J ALTERN COMPLEM MED, V15, P585, DOI 10.1089/acm.2008.0416; Colzato LS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00116; Creswell JD, 2012, BRAIN BEHAV IMMUN, V26, P1095, DOI 10.1016/j.bbi.2012.07.006; Dickenson J, 2013, SOC COGN AFFECT NEUR, V8, P40, DOI 10.1093/scan/nss030; Dor-Ziderman Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00582; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Ferrarelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073417; Fiebelkorn IC, 2012, NEUROIMAGE C, V69c, P126; Fox KCR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045370; Gola M, 2012, INT J PSYCHOPHYSIOL, V85, P62, DOI 10.1016/j.ijpsycho.2011.09.001; Grant JA, 2011, PAIN, V152, P150, DOI 10.1016/j.pain.2010.10.006; Hauswald A, 2015, NEUROIMAGE, V108, P265, DOI 10.1016/j.neuroimage.2014.12.065; Hinterberger T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00099; Huang H. -Y., 2009, Journal of Medical Engineering & Technology, V33, P314, DOI 10.1080/03091900802602677; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KABATZINN J, 1992, AM J PSYCHIAT, V149, P936; Kerr CE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00012; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kubota Y, 2001, COGNITIVE BRAIN RES, V11, P281, DOI 10.1016/S0926-6410(00)00086-0; Lagopoulos J, 2009, J ALTERN COMPLEM MED, V15, P1187, DOI 10.1089/acm.2009.0113; Lavretsky Helen, 2009, Aging health, V5, P61, DOI 10.2217/1745509X.5.1.61; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; Mirams L, 2013, CONSCIOUS COGN, V22, P348, DOI 10.1016/j.concog.2012.07.009; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Moraes H, 2007, ARQ NEURO-PSIQUIAT, V65, P637, DOI 10.1590/S0004-282X2007000400018; Perlman DM, 2010, EMOTION, V10, P65, DOI 10.1037/a0018440; Roca-Stappung M, 2012, NEUROSCI LETT, V510, P115, DOI 10.1016/j.neulet.2012.01.015; Saggar M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00256; Sedlmeier P, 2012, PSYCHOL BULL, V138, P1139, DOI 10.1037/a0028168; Segal Z. V., 2002, MINDFULNESS BASED CO; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Soler J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086622; Tanaka GK, 2014, ARQ NEURO-PSIQUIAT, V72, P687, DOI 10.1590/0004-282X20140133; Travis F, 2010, CONSCIOUS COGN, V19, P1110, DOI 10.1016/j.concog.2010.01.007; Ussher M, 2014, J BEHAV MED, V37, P127, DOI 10.1007/s10865-012-9466-5; Vago DR, 2014, ANN NY ACAD SCI, V1307, P28, DOI 10.1111/nyas.12270; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; van den Hurk PAM, 2010, INT J PSYCHOPHYSIOL, V78, P151, DOI 10.1016/j.ijpsycho.2010.07.002; Yu XJ, 2011, INT J PSYCHOPHYSIOL, V80, P103, DOI 10.1016/j.ijpsycho.2011.02.004	54	11	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0138552	10.1371/journal.pone.0138552	http://dx.doi.org/10.1371/journal.pone.0138552			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457811	Green Published, Green Submitted, gold			2022-12-26	WOS:000362961100005
J	Henderson, MJ; Baldwin, HA; Werley, CA; Boccardo, S; Whitaker, LR; Yan, XK; Holt, GT; Schreiter, ER; Looger, LL; Cohen, AE; Kim, DS; Harvey, BK				Henderson, Mark J.; Baldwin, Heather A.; Werley, Christopher A.; Boccardo, Stefano; Whitaker, Leslie R.; Yan, Xiaokang; Holt, Graham T.; Schreiter, Eric R.; Looger, Loren L.; Cohen, Adam E.; Kim, Douglas S.; Harvey, Brandon K.			A Low Affinity GCaMP3 Variant (GCaMPer) for Imaging the Endoplasmic Reticulum Calcium Store	PLOS ONE			English	Article							FLUORESCENT PROTEINS; CA2+; RELEASE; EXPRESSION; REGULATOR; INDICATOR; NEURONS; VECTOR; KDEL	Endoplasmic reticulum calcium homeostasis is critical for cellular functions and is disrupted in diverse pathologies including neurodegeneration and cardiovascular disease. Owing to the high concentration of calcium within the ER, studying this subcellular compartment requires tools that are optimized for these conditions. To develop a single-fluorophore genetically encoded calcium indicator for this organelle, we targeted a low affinity variant of GCaMP3 to the ER lumen (GCaMPer (10.19)). A set of viral vectors was constructed to express GCaMPer in human neuroblastoma cells, rat primary cortical neurons, and human induced pluripotent stem cell-derived cardiomyocytes. We observed dynamic changes in GCaMPer (10.19) fluorescence in response to pharmacologic manipulations of the ER calcium store. Additionally, periodic calcium efflux from the ER was observed during spontaneous beating of cardiomyocytes. GCaMPer (10.19) has utility in imaging ER calcium in living cells and providing insight into luminal calcium dynamics under physiologic and pathologic states.	[Henderson, Mark J.; Baldwin, Heather A.; Whitaker, Leslie R.; Yan, Xiaokang; Harvey, Brandon K.] NIDA, NIH, Baltimore, MD 21224 USA; [Werley, Christopher A.; Boccardo, Stefano; Cohen, Adam E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Cohen, Adam E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Cohen, Adam E.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Cohen, Adam E.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Holt, Graham T.; Schreiter, Eric R.; Looger, Loren L.; Kim, Douglas S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Henderson, MJ (corresponding author), NIDA, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	hendersonmj@mail.nih.gov; BHarvey@intra.nida.nih.gov	Harvey, Brandon Keith/AAY-4080-2021	Harvey, Brandon Keith/0000-0002-4036-1383; Kim, Douglas/0000-0001-9029-314X; Henderson, Mark/0000-0001-8590-7338; Schreiter, Eric/0000-0002-2864-7469; Baldwin, Heather/0000-0002-3163-2487; Ramsey, Leslie/0000-0001-8129-612X	Intramural Research Program, National Institute on Drug Abuse; Howard Hughes Medical Institute; US National Institutes of Health [1-R01-EB012498-01, 1-DP2-OD007428]; Office of Naval Research PECASE award [N00014-11-1-0549]; Roche Postdoctoral Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZICDA000555, ZIADA000443] Funding Source: NIH RePORTER	Intramural Research Program, National Institute on Drug Abuse; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research PECASE award(Office of Naval Research); Roche Postdoctoral Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the Intramural Research Program, National Institute on Drug Abuse (MJH HAB LWR BKH); Howard Hughes Medical Institute (ERS LLL DSK); US National Institutes of Health grants 1-R01-EB012498-01 and New Innovator grant 1-DP2-OD007428, and Office of Naval Research PECASE award N00014-11-1-0549 (CAW, SB, AEC). AEC is supported by the Howard Hughes Medical Institute. SB was supported by a Roche Postdoctoral Fellowship.	Alanen HI, 2011, J MOL BIOL, V409, P291, DOI 10.1016/j.jmb.2011.03.070; Belal C, 2012, HUM MOL GENET, V21, P963, DOI 10.1093/hmg/ddr502; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bezprozvanny I, 2011, NEUROCHEM RES, V36, P1186, DOI 10.1007/s11064-010-0393-y; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen X, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-81; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; de la Fuente S, 2013, CELL CALCIUM, V54, P37, DOI 10.1016/j.ceca.2013.04.001; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Henderson MJ, 2014, MOL BIOL CELL, V25, P2828, DOI 10.1091/mbc.E14-06-1141; HOFER AM, 1994, AM J PHYSIOL, V267, pG442, DOI 10.1152/ajpgi.1994.267.3.G442; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Kao JPY, 2010, METHOD CELL BIOL, V99, P113, DOI [10.1016/S0091-679X(10)99005-5, 10.1016/B978-0-12-374841-6.00005-0]; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; ONEILL SC, 1990, J PHYSIOL-LONDON, V430, P519, DOI 10.1113/jphysiol.1990.sp018305; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Rehberg M, 2008, CELL CALCIUM, V44, P386, DOI 10.1016/j.ceca.2008.02.002; Rodriguez-Garcia A, 2014, P NATL ACAD SCI USA, V111, P2584, DOI 10.1073/pnas.1316539111; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Smith IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068924; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Solovyova N, 2002, J NEUROSCI METH, V122, P1, DOI 10.1016/S0165-0270(02)00300-X; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Tang S, 2011, P NATL ACAD SCI USA, V108, P16265, DOI 10.1073/pnas.1103015108; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wang C, 2002, J CEREBR BLOOD F MET, V22, P206, DOI 10.1097/00004647-200202000-00008; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Wu JH, 2014, BIOCHEM J, V464, P13, DOI 10.1042/BJ20140931; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	47	44	44	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139273	10.1371/journal.pone.0139273	http://dx.doi.org/10.1371/journal.pone.0139273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451944	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200009
J	Alvi, A; Fatima, N; Jerah, AA; Rizwan, M; Hobani, YH; Al Sunosi, R; Taha, MME; Habiballah, EM; Agarwal, PK; Abdulwahab, SI				Alvi, Ayesha; Fatima, Nuzhath; Jerah, Ahmed Ali; Rizwan, Mohammed; Hobani, Yahya Hasan; Al Sunosi, Rashad; Taha, Manal Mohamed El Hassan; Habiballah, Eldaw Mohamed; Agarwal, Pradeep Kumar; Abdulwahab, Siddig Ibrahim			Correlation between Resistin, Tuberculosis and Khat Addiction: A Study from South Western Province of Saudi Arabia	PLOS ONE			English	Article							INFLAMMATION; MACROPHAGES; INFECTIONS	Tuberculosis(TB) is a disease of global significance, which accounts for a death in every 15 seconds. Recent studies shows TB is rising in certain parts of the world, and Saudi Arabia is one of them. Several factor contribute in predisposing the subjects for infection including but not limited to addiction to various compounds which have immune modulation properties, such as amphetamines and Heroin etc. Khat a plant whose leaves are chewed for its euphoric effect in east Africa and Arabian Peninsula including Saudi Arabia, is considered as mildly addictive, and its principle compound, Cathinone shares structural and functional similarity with amphetamine a known immunomodulator. Tuberculosis being a disease of immune modulation has a varied spectrum of complex interplay of proinflammatory molecules, resistin is one of them. In the present study, we try to explore the trinity of khat addiction, serum resistin level and tuberculosis by correlating the serum resistin level in non khat addicted healthy subjects, khat addicted healthy subjects, and in patients, both khat addicted and non khat addicted, with active tuberculosis. We observed significantly higher resistin level among the apparently healthy khat addicted subjects as compared to non addicted healthy controls. Thereafter, when we compare the resistin levels between khat addicted and non khat addicted TB patients we did not found significant difference between the two groups. However bacillary load was observe to be significantly higher among the khat addicted TB patient as compare to non addicted one. Validation of above results in animal model revealed dose dependant increase in bacillary growth in the Wistar rats treated with khat. Taken together these results suggest the role of khat in immune modulation albeit in the limited frame of resistin level.	[Alvi, Ayesha; Hobani, Yahya Hasan] Jazan Univ, Fac Appl Med Sci, Dept Genet & Mol Biol, Jazan, Saudi Arabia; [Fatima, Nuzhath] Jazan Univ, Fac Appl Med Sci, Dept Microbiol, Jazan, Saudi Arabia; [Jerah, Ahmed Ali] Jazan Univ, Fac Appl Med Sci, Dept Biochem, Jazan, Saudi Arabia; [Rizwan, Mohammed] Jazan Univ, Coll Nursing, Dept Biochem, Jazan, Saudi Arabia; [Al Sunosi, Rashad] Jazan Univ, Substance Abuse Res Ctr, Jazan, Saudi Arabia; [Taha, Manal Mohamed El Hassan; Habiballah, Eldaw Mohamed; Abdulwahab, Siddig Ibrahim] Jazan Univ, Med Res Ctr, Dept Biomed Res Unit, Jazan, Saudi Arabia; [Agarwal, Pradeep Kumar] Chest Hosp, Abu Areesh, Jazan, Saudi Arabia	Jazan University; Jazan University; Jazan University; Jazan University; Jazan University; Jazan University	Alvi, A (corresponding author), Jazan Univ, Fac Appl Med Sci, Dept Genet & Mol Biol, Jazan, Saudi Arabia.	dra.alvi@gmail.com	TAHA, MANAL M/C-5968-2011; Hobani, Yahya/GRJ-3130-2022	Taha, Manal/0000-0003-0166-8929	Deanship of Scientific Research Jazan university, Jazan KSA [P37]	Deanship of Scientific Research Jazan university, Jazan KSA	The project was funded by Deanship of Scientific Research Jazan university, Jazan KSA. (project number P37). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Habori M, 2005, POTENTIAL ADVERSE EF; Al-Hajoj Sahal Abdulaziz, 2010, J Infect Public Health, V3, P17, DOI 10.1016/j.jiph.2009.12.001; al-Meshal I A, 1991, J Subst Abuse, V3, P107; Al-Motarreb A, 2002, PHYTOTHER RES, V16, P403, DOI 10.1002/ptr.1106; Al-Orainey I, 2013, ANN THORAC MED, V8, P148, DOI 10.4103/1817-1737.114303; Alvi A, 2014, MED HYPOTHESES, V82, P667, DOI 10.1016/j.mehy.2014.02.026; Aruna B, 2003, BIOCHEMISTRY-US, V42, P10554, DOI 10.1021/bi034782v; Aruna B, 2008, BIOCHEMISTRY-US, V47, P12457, DOI 10.1021/bi801266k; Bostrom EA, 2009, BBA-MOL CELL RES, V1793, P1894, DOI 10.1016/j.bbamcr.2009.09.008; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; Chao W-C, 2014, MICROBES INFECT; Deffert C, 2014, CELL MICROBIOL, V16, P1168, DOI 10.1111/cmi.12322; Ehtesham NZ, 2011, TUBERCULOSIS, V91, P293, DOI 10.1016/j.tube.2011.04.007; Filkova M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; HOUSE RV, 1994, IMMUNOPHARM IMMUNOT, V16, P1, DOI 10.3109/08923979409029897; Johansson L, 2007, CRITICAL CARE S4, V11, pP10; Johansson L, 2009, J IMMUNOL, V183, P4047, DOI 10.4049/jimmunol.0901541; Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005; Kumar N, 2014, TUBERCULOSIS, V94, P282, DOI 10.1016/j.tube.2014.02.004; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; LUSTER MI, 1993, ENVIRON HEALTH PERSP, V100, P219, DOI 10.2307/3431528; Narvaiz de Kantor I, 1998, LAB SERVICES TUBERCU; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Senolt L, 2007, ANN RHEUM DIS, V66, P458, DOI 10.1136/ard.2006.054734; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Singhal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018632; Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077635; WHO, 2014, GLOB TUB REP 2014 WH	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140245	10.1371/journal.pone.0140245	http://dx.doi.org/10.1371/journal.pone.0140245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448186	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000110
J	Amiri, E; Meixner, M; Nielsen, SL; Kryger, P				Amiri, Esmaeil; Meixner, Marina; Nielsen, Steen Lykke; Kryger, Per			Four Categories of Viral Infection Describe the Health Status of Honey Bee Colonies	PLOS ONE			English	Article							DEFORMED-WING VIRUS; APIS-MELLIFERA L.; ACUTE PARALYSIS VIRUS; VARROA-DESTRUCTOR; SACBROOD VIRUS; NATIONAL-SURVEY; PCR ANALYSIS; LOSSES; TRANSMISSION; POPULATIONS	Honey bee virus prevalence data are an essential prerequisite for managing epidemic events in a population. A survey study was carried out for seven viruses in colonies representing a healthy Danish honey bee population. In addition, colonies from apiaries with high level Varroa infestation or high level of winter mortality were also surveyed. Results from RT-qPCR showed a considerable difference of virus levels between healthy and sick colonies. In the group of healthy colonies, no virus was detected in 36% of cases, while at least one virus was found in each of the sick colonies. Virus titers varied among the samples, and multiple virus infections were common in both groups with a high prevalence of Sacbrood virus (SBV), Black queen cell virus (BQCV) and Deformed wing virus (DWV). Based on the distribution of virus titers, we established four categories of infection: samples free of virus (C = 0), samples with low virus titer (estimated number of virus copies 0 < C < 10(3)), samples with medium virus titer (10(3) <= C < 10(7)) and samples with high virus titer (C >= 10(7)). This allowed us to statistically compare virus levels in healthy and sick colonies. Using categories to communicate virus diagnosis results to beekeepers may help them to reach an informed decision on management strategies to prevent further spread of viruses among colonies.	[Amiri, Esmaeil; Nielsen, Steen Lykke; Kryger, Per] Aarhus Univ, Dept Agroecol, Slagelse, Denmark; [Meixner, Marina] Bieneninst Kirchhain, LLH, Kirchhain, Germany	Aarhus University	Amiri, E (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.	e.amiri79@gmail.com	Kryger, Per/H-4600-2019; Kryger, Per/C-1773-2013; Meixner, Marina/ABD-6400-2021	Kryger, Per/0000-0001-5306-3230; Kryger, Per/0000-0001-5306-3230; Meixner, Marina/0000-0002-7785-4894; Amiri, Esmaeil/0000-0001-8536-5815				BAILEY L, 1963, VIROLOGY, V21, P390, DOI 10.1016/0042-6822(63)90200-9; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; Bailey L, 2015, ANN APP BIOL, V63, P483, DOI [10.1111/j.1744-7348.1969.tb02844, DOI 10.1111/J.1744-7348.1969.TB02844]; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Balasubramanyam M., 2011, BIOSCAN, V6, P631; Blanchard P, 2007, J VIROL METHODS, V141, P7, DOI 10.1016/j.jviromet.2006.11.021; Blanchard P, 2014, J VIROL METHODS, V197, P7, DOI 10.1016/j.jviromet.2013.09.012; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Chejanovsky N, 2014, VIROLOGY, V454, P176, DOI 10.1016/j.virol.2014.02.012; Chen YP, 2005, J INVERTEBR PATHOL, V90, P118, DOI 10.1016/j.jip.2005.08.005; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Chen YP, ADVANCES IN VIRUS RE, V702007, P33; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Delaplane K. S., 2000, CROP POLLINATION BY; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Francis RM, 2012, J APIC SCI, V56, P137, DOI 10.2478/v10289-012-0014-x; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Goic B, 2012, CURR OPIN MICROBIOL, V15, P531, DOI 10.1016/j.mib.2012.06.002; Grabensteiner E, 2001, CLIN DIAGN LAB IMMUN, V8, P93, DOI 10.1128/CDLI.8.1.93-104.2001; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Huang Q, 2014, ANIM GENET, V45, P267, DOI 10.1111/age.12114; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; KULINCEVIC JM, 1975, J INVERTEBR PATHOL, V25, P289, DOI 10.1016/0022-2011(75)90084-1; KULINCEVIC JM, 1989, J APICULT RES, V28, P79; Le Conte Y, 2011, INSECT MOL BIOL, V20, P399, DOI 10.1111/j.1365-2583.2011.01074.x; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Meixner MD, 2014, J APICULT RES, V53, P215, DOI 10.3896/IBRA.1.53.2.04; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nielsen SL, 2008, APIDOLOGIE, V39, P310, DOI 10.1051/apido:2008007; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; R Development Core Team, 2010, R A LANGUAGE AND ENV; Retschnig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085261; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vejsnaes F, 2010, J APICULT RES, V49, P109, DOI 10.3896/IBRA.1.49.1.20; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	67	33	34	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140272	10.1371/journal.pone.0140272	http://dx.doi.org/10.1371/journal.pone.0140272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448627	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000114
J	Godel, M; Temerinac, D; Grahammer, F; Hartleben, B; Kretz, O; Riederer, BM; Propst, F; Kohl, S; Huber, TB				Goedel, Markus; Temerinac, Dunja; Grahammer, Florian; Hartleben, Bjoern; Kretz, Oliver; Riederer, Beat M.; Propst, Friedrich; Kohl, Stefan; Huber, Tobias B.			Microtubule Associated Protein 1b (MAP1B) Is a Marker of the Microtubular Cytoskeleton in Podocytes but Is Not Essential for the Function of the Kidney Filtration Barrier in Mice	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; NEURONS; DIFFERENTIATION; REGENERATION; EXPRESSION; REVEALS; MOUSE; GENE; RAT	Podocytes are essential for the function of the kidney glomerular filter. A highly differentiated cytoskeleton is requisite for their integrity. Although much knowledge has been gained on the organization of cortical actin networks in podocyte's foot processes, less is known about the molecular organization of the microtubular cytoskeleton in primary processes and the cell body. To gain an insight into the organization of the microtubular cytoskeleton of the podocyte, we systematically analyzed the expression of microtubule associated proteins (Maps), a family of microtubules interacting proteins with known functions as regulator, scaffold and guidance proteins. We identified microtubule associated protein 1b (MAP1B) to be specifically enriched in podocytes in human and rodent kidney. Using immunogold labeling in electron microscopy, we were able to demonstrate an enrichment of MAP1B in primary processes. A similar association of MAP1B with the microtubule cytoskeleton was detected in cultured podocytes. Subcellular distribution of MAP1B HC and LC1 was analyzed using a double fluorescent reporter MAP1B fusion protein. Subsequently we analyzed mice constitutively depleted of MAP1B. Interestingly, MAP1B KO was not associated with any functional or structural alterations pointing towards a redundancy of MAP proteins in podocytes. In summary, we established MAP1B as a specific marker protein of the podocyte microtubular cytoskeleton.	[Goedel, Markus; Temerinac, Dunja; Grahammer, Florian; Hartleben, Bjoern; Kretz, Oliver; Kohl, Stefan; Huber, Tobias B.] Univ Med Ctr Freiburg, Div Renal, Freiburg, Germany; [Kretz, Oliver] Univ Freiburg, Dept Neuroanat, D-79106 Freiburg, Germany; [Riederer, Beat M.] Univ Lausanne, CHUV, Hosp Psychiat, Ctr Psychiat Neurosci,Prote Unit, Prilly, Switzerland; [Propst, Friedrich] Univ Vienna, Vienna Biocenter VBC, MFPL, Dept Biochem & Cell Biol, Vienna, Austria; [Kohl, Stefan] Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA USA; [Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Huber, Tobias B.] Univ Freiburg, Ctr Syst Biol ZBSA, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Harvard University; Boston Children's Hospital; Harvard Medical School; University of Freiburg; University of Freiburg	Godel, M (corresponding author), Univ Med Ctr Freiburg, Div Renal, Freiburg, Germany.	markus.goedel@uniklinik-freiburg.de; tobias.huber@uniklinik-freiburg.de	Grahammer, Florian/ABB-7775-2021	Kretz, Oliver/0000-0003-1152-5956; Huber, Tobias B./0000-0001-7175-5062	German Research Foundation (DFG) [CRC 1140]; Heisenberg program; European Research Council (ERC grant); Excellence Initiative of the German Federal and State Governments (Spemann Graduate School and BIOSS) [GSC-4]; "Forschungsstipendium" of the German Society of Nephrology; German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Heisenberg program(German Research Foundation (DFG)); European Research Council (ERC grant)(European Research Council (ERC)); Excellence Initiative of the German Federal and State Governments (Spemann Graduate School and BIOSS); "Forschungsstipendium" of the German Society of Nephrology; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This research was funded by the German Research Foundation (DFG): CRC 1140 and Heisenberg program, http://http://www.dfg.de/; European Research Council (ERC grant), http://erc.europa.eu/; and Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School and BIOSS), http://www.dfg.de/ en/research_funding/programmes/excellence_initiative/, to TBH; and "Forschungsstipendium" of the German Society of Nephrology, http://www.dgfn.eu/, to MG. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PM, 1977, AM J ANAT, V150, P53, DOI 10.1002/aja.1001500104; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Dehmelt L, 2005, GENOME BIOL, V6; Edelmann W, 1996, P NATL ACAD SCI USA, V93, P1270, DOI 10.1073/pnas.93.3.1270; Gonzalez-Billault C, 2004, J NEUROBIOL, V58, P48, DOI 10.1002/neu.10283; Gonzalez-Billault C, 2002, BRAIN RES, V943, P56, DOI 10.1016/S0006-8993(02)02534-9; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Kobayashi N, 1998, J CELL BIOL, V143, P1961, DOI 10.1083/jcb.143.7.1961; Kobayashi N, 2000, BIOCHEM BIOPH RES CO, V268, P306, DOI 10.1006/bbrc.2000.2126; Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077; Kobayashi N, 2001, HISTOCHEM CELL BIOL, V115, P255; Kutschera W, 1998, GENOMICS, V49, P430, DOI 10.1006/geno.1998.5294; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; OSHIMA T, 1992, BRAIN RES, V590, P53, DOI 10.1016/0006-8993(92)91081-O; Pangratz-Fuehrer S, 2005, BEHAV BRAIN RES, V164, P188, DOI 10.1016/j.bbr.2005.06.018; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; RIEDERER BM, 1995, J NEUROCYTOL, V24, P45, DOI 10.1007/BF01370159; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Silja Kerstin Sanden WK, 1996, THESIS; Takei Y, 1997, J CELL BIOL, V137, P1615, DOI 10.1083/jcb.137.7.1615; Walter P, 2007, MOL BIOL CELL, V5th	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140116	10.1371/journal.pone.0140116	http://dx.doi.org/10.1371/journal.pone.0140116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448484	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000091
J	Hehar, H; Yeates, K; Kolb, B; Esser, MJ; Mychasiuk, R				Hehar, Harleen; Yeates, Keith; Kolb, Bryan; Esser, Michael J.; Mychasiuk, Richelle			Impulsivity and Concussion in Juvenile Rats: Examining Molecular and Structural Aspects of the Frontostriatal Pathway	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SEX-DIFFERENCES; INHIBITORY CONTROL; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; CHILDREN; ADHD; DOPAMINE	Impulsivity and poor executive control have been implicated in the pathogenesis of many developmental and neuropsychiatric disorders. Similarly, concussions/mild traumatic brain injuries (mTBI) have been associated with increased risk for neuropsychiatric disorders and the development of impulsivity and inattention. Researchers and epidemiologists have therefore considered whether or not concussions induce symptoms of attention-deficit/hyperactivity disorder (ADHD), or merely unmask impulsive tendencies that were already present. The purpose of this study was to determine if a single concussion in adolescence could induce ADHD-like impulsivity and impaired response inhibition, and subsequently determine if inherent impulsivity prior to a pediatric mTBI would exacerbate post-concussion symptomology with a specific emphasis on impulsive and inattentive behaviours. As these behaviours are believed to be associated with the frontostriatal circuit involving the nucleus accumbens (NAc) and the prefrontal cortex (PFC), the expression patterns of 8 genes (Comt, Drd2, Drd3, Drd4, Maoa, Sert, Tph1, and Tph2) from these two regions were examined. In addition, Golgi-Cox staining of medium spiny neurons in the NAc provided a neuroanatomical examination of mTBI-induced structural changes. The study found that a single early brain injury could induce impulsivity and impairments in response inhibition that were more pronounced in males. Interestingly, when animals with inherent impulsivity experienced mTBI, injury-related deficits were exacerbated in female animals. The single concussion increased dendritic branching, but reduced synaptic density in the NAc, and these changes were likely associated with the increase in impulsivity. Finally, mTBI-induced impulsivity was associated with modifications to gene expression that differed dramatically from the gene expression pattern associated with inherent impulsivity, despite very similar behavioural phenotypes. Our findings suggest the need to tailor treatment strategies for mTBI in light of an individual's premorbid characteristics, given significant differences in molecular profiles of the frontostriatal circuits that depend upon sex and the etiology of the behavioural phenotype.	[Hehar, Harleen; Esser, Michael J.; Mychasiuk, Richelle] Univ Calgary, Fac Med, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada; [Yeates, Keith] Univ Calgary, Dept Psychol, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 1N4, Canada; [Kolb, Bryan] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada	Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Lethbridge	Mychasiuk, R (corresponding author), Univ Calgary, Fac Med, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada.	rmmychas@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith Owen/0000-0001-7680-2892	Alberta Children's Hospital Research Institute (ACHRI); Alberta Children's Hospital Foundation; Canadian Institute for Health Research (CIHR); Markin USRP for Health and Wellness	Alberta Children's Hospital Research Institute (ACHRI); Alberta Children's Hospital Foundation; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Markin USRP for Health and Wellness	The authors would like to thank the Alberta Children's Hospital Research Institute (ACHRI), the Alberta Children's Hospital Foundation, the Canadian Institute for Health Research (CIHR) and the Markin USRP for Health and Wellness for their financial support.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Biederman J, 2002, AM J PSYCHIAT, V159, P36, DOI 10.1176/appi.ajp.159.1.36; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Clacy A, 2013, OA SPORTS MED, V1, P4; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Dalley JW, 2012, NEUROSCIENCE, V215, P42, DOI 10.1016/j.neuroscience.2012.03.065; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dias TGC, 2013, EUR NEUROPSYCHOPHARM, V23, P33, DOI 10.1016/j.euroneuro.2012.10.015; Durston S, 2008, J AM ACAD CHILD PSY, V47, P61, DOI 10.1097/chi.0b013e31815a5f17; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Halperin JM, 2011, NEUROSCI BIOBEHAV R, V35, P621, DOI 10.1016/j.neubiorev.2010.07.006; Hayes DJ, 2011, NEUROSCI BIOBEHAV R, V35, P1419, DOI 10.1016/j.neubiorev.2011.03.005; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iaboni F, 1997, PSYCHOPHYSIOLOGY, V34, P116, DOI 10.1111/j.1469-8986.1997.tb02422.x; Itohara S, 2015, CURR OPIN BEHAV SCI, V2, P46, DOI 10.1016/j.cobeha.2014.09.002; Johansen EB, 2002, BEHAV BRAIN RES, V130, P37, DOI 10.1016/S0166-4328(01)00434-X; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Konrad KN, 2000, BRAIN INJURY, V14, P859; Martel MM, 2011, J ABNORM CHILD PSYCH, V39, P1, DOI 10.1007/s10802-010-9439-5; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, BRAIN INJURY, V12, P41; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2014, JOVE, V8; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Mychasiuk R, 2013, JOVE-J VIS EXP, DOI 10.3791/50694; Palasis S, 2013, J PEDIATR NEURORADIO, V2, P87, DOI 10.3233/PNR-13049; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Purper-Ouakil D, 2011, PEDIATR RES, V69, p69R, DOI 10.1203/PDR.0b013e318212b40f; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Rommelse NNJ, 2008, AM J MED GENET B, V147B, P1524, DOI 10.1002/ajmg.b.30845; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sagiv SK, 2013, J ATTEN DISORD, V17, P47, DOI 10.1177/1087054711427563; Sanchez F, 2011, SYNAPSE, V65, P198, DOI 10.1002/syn.20837; Scholes KE, 2007, NEUROPSYCHOPHARMACOL, V32, P1600, DOI 10.1038/sj.npp.1301262; Shiloh R, 2002, ATLAS PSYCHIAT PHARM; Simon NW, 2013, EUR J NEUROSCI, V37, P1779, DOI 10.1111/ejn.12191; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sonuga-Barke EJS, 2007, J AM ACAD CHILD PSY, V46, P701, DOI 10.1097/chi.0b013e31804659f1; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; White RD, 2014, SPORTS HEALTH, V6, P149, DOI 10.1177/1941738113484679; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zilles K., 1985, P1	57	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139842	10.1371/journal.pone.0139842	http://dx.doi.org/10.1371/journal.pone.0139842			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448536	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000058
J	Laurin, EL; McKenna, SLB; Sanchez, J; Bach, H; Rodriguez-Lecompte, JC; Chaffer, M; Keefe, GP				Laurin, Emilie L.; McKenna, Shawn L. B.; Sanchez, Javier; Bach, Horacio; Rodriguez-Lecompte, Juan Carlos; Chaffer, Marcelo; Keefe, Greg P.			Novel Cell Preservation Technique to Extend Bovine In Vitro White Blood Cell Viability	PLOS ONE			English	Article							INTERFERON-GAMMA ASSAY; PARATUBERCULOSIS; STIMULATION; LYMPHOCYTES; ELISA	Although cell-mediated immunity based diagnostics can be integral assays for early detection of various diseases of dairy cows, processing of blood samples for these tests is time-sensitive, often within 24 hours of collection, to maintain white blood cell viability. Therefore, to improve utility and practicality of such assays, the objective of this study was to assess the use of a novel white blood cell preservation technology in whole bovine blood. Blood samples from ten healthy cows were each divided into an unpreserved control sample and a test sample preserved with commercially-available cell transport medium. Samples were maintained at room temperature and stimulated with the mitogens pokeweed and concana-valinA, as well as with interleukin-12 p40. Stimulation was completed on days 1, 5, and 8 post-sampling. Viability of white blood cells was assessed through interferon gamma production determined with a commercial enzyme linked immunosorbent assay. In addition, mononuclear cell viability was assessed with propidium iodide flow cytometry. Greater interferon gamma production was observed on days 5 and 8 post-collection in preserved samples, with both pokeweed and concanavalinA stimulating positive interferon gamma production on day 5 post-collection. A greater proportion of the amount of interferon gamma produced on day 1 continued to be produced on days 5 and 8 post-collection with concanavalinA stimulation (with or without interleukin 12) as compared to pokeweed stimulation. Additionally, viable mononuclear cells were still present at eight days post-collection, with a higher mean proportion detected at days 5 and 8 in all stimulated preserved samples. This practical and simple method to extend in vitro white blood cell viability could benefit the efficient utilization of cell-based blood tests in ruminants.	[Laurin, Emilie L.; McKenna, Shawn L. B.; Sanchez, Javier; Rodriguez-Lecompte, Juan Carlos; Chaffer, Marcelo; Keefe, Greg P.] Univ Prince Edward Isl, Dept Hlth Management, Atlantic Vet Coll, Charlottetown, PE C1A 4P3, Canada; [Bach, Horacio] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V5Z 3J5, Canada	University of Prince Edward Island; University of British Columbia	Laurin, EL (corresponding author), Univ Prince Edward Isl, Dept Hlth Management, Atlantic Vet Coll, 550 Univ Ave, Charlottetown, PE C1A 4P3, Canada.	elaurin@upei.ca	Rodriguez-Lecompte, Juan/AAN-4012-2020; sanchez, javier/AAA-4179-2022	McKenna, Shawn/0000-0002-9699-1464	Maritime Quality Milk (Atlantic Veterinary College); Innovation PEI (Prince Edward Island) Graduate Student and Post-Doctoral Fellowship	Maritime Quality Milk (Atlantic Veterinary College); Innovation PEI (Prince Edward Island) Graduate Student and Post-Doctoral Fellowship	Funding for this research and personal support was provided by Maritime Quality Milk (Atlantic Veterinary College) and Innovation PEI (Prince Edward Island) Graduate Student and Post-Doctoral Fellowship (www.innovationpei.com/fellowship). Funding sources were grant-based only, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTA O, 1981, COMP IMMUNOL MICROB, V4, P209, DOI 10.1016/0147-9571(81)90006-0; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Gershwin LJ, 2005, IMMUNOLOGY IMMUNOPAT, P105; Jungersen G, 2002, CLIN DIAGN LAB IMMUN, V9, P453, DOI 10.1128/CDLI.9.2.453-460.2002; Jungersen G, 2006, ICP 2005, P501; Jungersen G, 2012, VET IMMUNOL IMMUNOP, V148, P48, DOI 10.1016/j.vetimm.2011.05.010; KLEIN A, 1991, IN VITRO CELL DEV B, V27, P307; KRISTENSEN F, 1982, VET IMMUNOL IMMUNOP, V3, P203, DOI 10.1016/0165-2427(82)90036-8; Mikkelsen H, 2009, VET IMMUNOL IMMUNOP, V127, P235, DOI 10.1016/j.vetimm.2008.10.315; Nair PP, 2011, J GASTROINTEST DIG S, P8; Nielsen SS, 2006, J DAIRY SCI, V89, P569, DOI 10.3168/jds.S0022-0302(06)72120-8; Plain KM, 2012, VET IMMUNOL IMMUNOP, V149, P28, DOI 10.1016/j.vetimm.2012.05.023; Price SJ, 2007, IMMUNOLOGY, V120, P57, DOI 10.1111/j.1365-2567.2006.02477.x; Robbe-Austerman S, 2006, J VET MED B, V53, P213, DOI 10.1111/j.1439-0450.2006.00944.x; SENOGLES DR, 1978, AM J VET RES, V39, P341; Stabel JR, 1996, J VET DIAGN INVEST, V8, P345, DOI 10.1177/104063879600800311; Stabel JR, 2001, VET IMMUNOL IMMUNOP, V79, P69, DOI 10.1016/S0165-2427(01)00253-7; Stabel JR, 2010, PARATUBERCULOSIS: ORGANISM, DISEASE, CONTROL, P230, DOI 10.1079/9781845936136.0230; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Yim JY, 2013, CYTOKINE, V64, P62, DOI 10.1016/j.cyto.2013.07.027	21	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140046	10.1371/journal.pone.0140046	http://dx.doi.org/10.1371/journal.pone.0140046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447691	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000084
J	Planello, R; Herrero, O; Gomez-Sande, P; Ozaez, I; Cobo, F; Servia, MJ				Planello, Rosario; Herrero, Oscar; Gomez-Sande, Pablo; Ozaez, Irene; Cobo, Fernando; Servia, Maria J.			Ecdysone-Related Biomarkers of Toxicity in the Model Organism Chironomus riparius: Stage and Sex-Dependent Variations in Gene Expression Profiles	PLOS ONE			English	Article							INSECT NUCLEAR RECEPTORS; PROTEIN MESSENGER-RNA; DROSOPHILA-MELANOGASTER; ECDYSTEROID RECEPTOR; JUVENILE-HORMONE; MANDUCA-SEXTA; SILVER NANOPARTICLES; ENVIRONMENTAL-STRESS; TOBACCO HORNWORM; AQUATIC LARVAE	Despite being considered a model organism in toxicity studies, particularly in assessing the environmental impact of endocrine disrupting compounds (EDCs) and other chemicals, the molecular basis of development is largely unknown in Chironomus riparius. We have characterized the expression patterns of important genes involved in the ecdysone pathway from embryos to pupa, but specially during the different phases of C. riparius fourth larval instar, according to the development of genital and thoracic imaginal discs. Real-Time PCR was used to analyze: EcR and usp, two genes encoding the two dimerizing partners of the functional ecdysone receptor; E74, an early response gene induced by ecdysteroids; vg (vitellogenin), an effector gene; hsp70 and hsc70, two heat-shock genes involved in the correct folding of the ecdysone receptor; and rpL13, as a part of the ribosomal machinery. Our results show for the first time stage and sex-dependent variations in ecdysone-responsive genes, specially during the late larval stage of C. riparius. The induction in the expression of EcR and usp during the VII-VIII phase of the fourth instar is concomitant with a coordinated response in the activity of the other genes analyzed, suggesting the moment where larvae prepare for pupation. This work is particularly relevant given that most of the analyzed genes have been proposed previously in this species as sensitive biomarkers for the toxicological evaluation of aquatic ecosystems. Identifying the natural regulation of these molecular endpoints throughout the Chironomus development will contribute to a more in-depth and accurate evaluation of the disrupting effects of EDCs in ecotoxicological studies.	[Planello, Rosario; Herrero, Oscar; Ozaez, Irene] Univ Nacl Educ Distancia, Fac Ciencias, Grp Biol & Toxicol Ambiental, Madrid 28040, Spain; [Gomez-Sande, Pablo; Cobo, Fernando] Univ Santiago de Compostela, Dept Zool & Antropol Fis, Santiago De Compostela 15782, Spain; [Gomez-Sande, Pablo; Cobo, Fernando] Univ Santiago de Compostela, EHEC, Estn Hidrobiol Encoro do Con, Vilagarcia De Arousa 36617, Pontevedra, Spain; [Servia, Maria J.] Univ A Coruna, Fac Ciencias, UDC, Dept Biol Anim Biol Vegetal & Ecol, La Coruna 15008, Spain	Universidad Nacional de Educacion a Distancia (UNED); Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade da Coruna	Planello, R (corresponding author), Univ Nacl Educ Distancia, Fac Ciencias, Grp Biol & Toxicol Ambiental, Paseo Senda Rey 9, Madrid 28040, Spain.	rplanello@ccia.uned.es	Planello, Rosario/V-1462-2019; Cobo, Fernando/AAA-1318-2019; Servia, María J./N-7230-2015; Herrero, Óscar/B-3782-2012; Planelló, Rosario/AAQ-5881-2020; Planelló, Rosario/E-9975-2015	Servia, María J./0000-0001-8503-5357; Herrero, Óscar/0000-0002-1410-368X; Planelló, Rosario/0000-0003-3730-9549; Planelló, Rosario/0000-0003-3730-9549; Ozaez, Irene/0000-0002-8809-7331	Ministerio de Ciencia e Innovacion [CTM2009-07189]; Ministerio de Economia y Competitividad [CTM-2012-37547]; Ministerio de Ciencia e Innovacion, Spain [CGL2009-10868]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	IO's research was funded by an FPI grant from Ministerio de Ciencia e Innovacion (http://www.idi.mineco.gob.es; CTM2009-07189). Research funding was provided by Ministerio de Economia y Competitividad (grant number CTM-2012-37547) and Ministerio de Ciencia e Innovacion (grant number CGL2009-10868), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger EM, 2005, VITAM HORM, V73, P175, DOI 10.1016/S0083-6729(05)73006-5; Blariza MJ, 2014, GENE, V543, P118, DOI 10.1016/j.gene.2014.03.054; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CHO WL, 1995, INSECT BIOCHEM MOLEC, V25, P19, DOI 10.1016/0965-1748(94)00045-J; Comas D, 2001, MOL CELL ENDOCRINOL, V183, P93, DOI 10.1016/S0303-7207(01)00589-5; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; EPA, 2000, METH MEAS TOX BIOACC, P212; Fahrbach SE, 2012, ANNU REV ENTOMOL, V57, P83, DOI 10.1146/annurev-ento-120710-100607; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; Govinda S, 2000, J BIOCHEM MOL TOXIC, V14, P195, DOI 10.1002/(SICI)1099-0461(2000)14:4<195::AID-JBT3>3.0.CO;2-2; Hahn T, 2002, ENVIRON POLLUT, V120, P525, DOI 10.1016/S0269-7491(02)00189-6; Hansen IA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00103; HELPS NR, 1995, GENE, V162, P245, DOI 10.1016/0378-1119(95)00356-B; HENRICH VC, 1995, INSECT BIOCHEM MOLEC, V25, P881, DOI 10.1016/0965-1748(95)00030-Y; HENRICH VC, 1994, DEV BIOL, V165, P38, DOI 10.1006/dbio.1994.1232; Herrero O, 2015, CHEMOSPHERE IN PRESS; Herrero O, 2015, CHEMOSPHERE, V128, P266, DOI 10.1016/j.chemosphere.2015.01.059; Hiruma K, 2010, J INSECT PHYSIOL, V56, P1390, DOI 10.1016/j.jinsphys.2010.03.029; IMHOF MO, 1993, INSECT BIOCHEM MOLEC, V23, P115, DOI 10.1016/0965-1748(93)90089-B; Kapitskaya M, 1996, MOL CELL ENDOCRINOL, V121, P119, DOI 10.1016/0303-7207(96)03847-6; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Karouna-Renier NK, 2009, INSECT MOL BIOL, V18, P87, DOI 10.1111/j.1365-2583.2008.00853.x; Langelan RE, 2000, DEV BIOL, V227, P481, DOI 10.1006/dbio.2000.9895; Luchmann KH, 2014, AQUAT TOXICOL, V152, P324, DOI 10.1016/j.aquatox.2014.04.021; Martinez-Guitarte JL, 2007, COMP BIOCHEM PHYS B, V147, P590, DOI 10.1016/j.cbpb.2007.03.015; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morales M, 2013, COMP BIOCHEM PHYS C, V158, P57, DOI 10.1016/j.cbpc.2013.05.005; Morales M, 2011, COMP BIOCHEM PHYS C, V153, P150, DOI 10.1016/j.cbpc.2010.10.003; Nair PMG, 2012, ENVIRON TOXICOL PHAR, V33, P98, DOI 10.1016/j.etap.2011.09.006; Nair PMG, 2011, COMP BIOCHEM PHYS B, V159, P157, DOI 10.1016/j.cbpb.2011.03.006; OECD, 2004, TEST 218 SED WAT CHI, P21; Ozaez I, 2014, ENVIRON POLLUT, V192, P19, DOI 10.1016/j.envpol.2014.04.038; Ozaez I, 2013, SCI TOTAL ENVIRON, V456, P120, DOI 10.1016/j.scitotenv.2013.03.081; Park K, 2012, COMP BIOCHEM PHYS C, V156, P113, DOI 10.1016/j.cbpc.2012.05.002; Park K, 2010, COMP BIOCHEM PHYS C, V151, P439, DOI 10.1016/j.cbpc.2010.01.009; Park K, 2009, COMP BIOCHEM PHYS C, V150, P361, DOI 10.1016/j.cbpc.2009.05.015; Parthasarathy R, 2007, J INSECT PHYSIOL, V53, P216, DOI 10.1016/j.jinsphys.2006.09.009; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P429, DOI 10.1016/j.ibmb.2010.04.002; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Planello R, 2008, CHEMOSPHERE, V71, P1870, DOI 10.1016/j.chemosphere.2008.01.033; Planello R, 2007, SCI TOTAL ENVIRON, V373, P113, DOI 10.1016/j.scitotenv.2006.10.038; Planello R, 2010, SCI TOTAL ENVIRON, V408, P1598, DOI 10.1016/j.scitotenv.2010.01.004; Planello R, 2015, ENVIRON TOXICOL, V30, P383, DOI 10.1002/tox.21893; Planello R, 2011, AQUAT TOXICOL, V105, P62, DOI 10.1016/j.aquatox.2011.05.011; Porte C, 2006, COMP BIOCHEM PHYS C, V143, P303, DOI 10.1016/j.cbpc.2006.03.004; Rauch P, 1998, INSECT BIOCHEM MOLEC, V28, P265, DOI 10.1016/S0965-1748(98)00026-5; RICHARDS G, 1981, MOL CELL ENDOCRINOL, V21, P181, DOI 10.1016/0303-7207(81)90013-7; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Schwedes CC, 2012, J INSECT PHYSIOL, V58, P293, DOI 10.1016/j.jinsphys.2012.01.013; Segner H, 2003, ECOTOX ENVIRON SAFE, V54, P302, DOI 10.1016/S0147-6513(02)00039-8; Servia MJ, 2006, ENVIRON ENTOMOL, V35, P865, DOI 10.1603/0046-225X-35.4.865; Siegel S., 1988, NONPARAMETRIC STAT B, P213, DOI DOI 10.1177/014662168901300212; Stilwell GE, 2003, DEV BIOL, V258, P76, DOI 10.1016/S0012-1606(03)00105-2; Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Vogtli M, 1999, INSECT BIOCHEM MOLEC, V29, P931, DOI 10.1016/S0965-1748(99)00068-5; Wang SF, 2000, DEV BIOL, V218, P99, DOI 10.1006/dbio.1999.9575; Warren JT, 1996, INSECT BIOCHEM MOLEC, V26, P917, DOI 10.1016/S0965-1748(96)00058-6; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Westerlund S, 2004, THESIS U BAYREUTH; WULKER W, 1968, Zeitschrift fuer Morphologie der Tiere, V62, P363, DOI 10.1007/BF00401562; Zhang QR, 2010, J INSECT PHYSIOL, V56, P138, DOI 10.1016/j.jinsphys.2009.09.013	68	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140239	10.1371/journal.pone.0140239	http://dx.doi.org/10.1371/journal.pone.0140239			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448051	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000109
J	Rubio, M; March, F; Garrigo, M; Moreno, C; Espanol, M; Coll, P				Rubio, Marc; March, Francesca; Garrigo, Montserrat; Moreno, Carmen; Espanol, Montserrat; Coll, Pere			Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; MACROLIDE RESISTANCE; SUBSP ABSCESSUS; SUSCEPTIBILITY; MASSILIENSE; BOLLETII; CHELONAE; STRAINS; GENE; IDENTIFICATION	Purpose Clarithromycin was considered the cornerstone for the treatment of Mycobacterium abscessus complex infections. Genetic resistance mechanisms have been described and many experts propose amikacin as an alternative. Nevertheless, clarithromycin has several advantages; therefore, it is necessary to identify the non-functional erm(41) allele to determine the most suitable treatment. The aims of this study were to characterize the molecular mechanisms of clarithromycin resistance in a collection of Mycobacterium abscessus complex isolates and to verify the relationship between these mechanisms and the antibiogram. Materials and Methods Clinical isolates of M. abscessus complex (n = 22) from 16 patients were identified using four housekeeping genes (rpoB, secA1, sodA and hsp65), and their genetic resistance was characterized by studying erm(41) and rrl genes. Nine strains were recovered from the clinical isolates and subjected to E-test and microdilution clarithromycin susceptibility tests, with readings at 3, 7 and 14 days. Results We classified 11/16 (68.8%) M. abscessus subsp. abscessus, 4/16 (25.0%) M. abscessus subsp. bolletii, and 1/16 (6.3%) M. abscessus subsp. massiliense. T28 erm(41) allele was observed in 8 Mycobacterium abscessus subps. abscessus and 3 Mycobacterium abscessus subsp. bolletii. One strain of M. abscessus subsp. bolletii had an erm(41) gene truncated and was susceptible to clarithromycin. No mutations were observed in rrl gene first isolates. In three patients, follow-up of initial rrl wild-type strains showed acquired resistance. Conclusions Most clinical isolates of M. abscessus complex had inducible resistance to clarithromycin and total absence of constitutive resistance. Our findings showed that the acquisition of resistance mutations in rrl gene was associated with functional and non-functional erm( 41) gene. Caution is needed when using erm(41) sequencing alone to identify M. abscessus subspecies. This study reports an acquired mutation at position 2057 of rrl gene, conferring medium-low clarithromycin constitutive resistance.	[Rubio, Marc; Coll, Pere] Univ Autonoma Barcelona, Dept Genet Microbiol, Bellaterra 08193, Cerdanyola Del, Spain; [March, Francesca; Garrigo, Montserrat; Moreno, Carmen; Espanol, Montserrat; Coll, Pere] Fundacio Gestio Hosp Santa Creu & Sant Pau, Serv Microbiol, Barcelona 08026, Spain	Autonomous University of Barcelona	Coll, P (corresponding author), Univ Autonoma Barcelona, Dept Genet Microbiol, Edifici C, Bellaterra 08193, Cerdanyola Del, Spain.	PColl@santpau.cat	Espanol, Montserrat/AAO-2528-2020	Coll, Pere/0000-0003-1782-9782; Espanol, Montserrat/0000-0002-2365-5750; Rubio, Marc/0000-0002-4811-0642	Ministerio de Economia y Competitividad; Instituto de Salud Carlos III; European Development Regional Fund, "A way to achieve Europe" ERDF; Spanish Network for the Research in Infectious Diseases (REIPI) [RD12/0015/0017]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Development Regional Fund, "A way to achieve Europe" ERDF(European Commission); Spanish Network for the Research in Infectious Diseases (REIPI)	This work was supported by the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III and co-financed by the European Development Regional Fund, "A way to achieve Europe" ERDF, and the Spanish Network for the Research in Infectious Diseases (REIPI) RD12/0015/0017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Biehle JONR, 1995, EVALUATION ETEST SUS, V33; Blauwendraat C, 2012, EUR J CLIN MICROBIOL, V31, P1847, DOI 10.1007/s10096-011-1510-9; Brown-Elliott BA, 2015, J CLIN MICROBIOL, V53, P1211, DOI 10.1128/JCM.02950-14; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Cho YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081560; Choo SW, 2014, SCI REP-UK, V4, DOI 10.1038/srep04061; Clinical and Laboratory Standards Institute, 2011, M24A2 CLIN LAB STAND, V2nd; Fangous MS, 2014, J CLIN MICROBIOL, V52, P3362, DOI 10.1128/JCM.00788-14; Gray TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102290; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Lee SH, 2014, ANN LAB MED, V34, P31, DOI 10.3343/alm.2014.34.1.31; Lee SH, 2014, J CLIN LAB ANAL, V28, P409, DOI 10.1002/jcla.21702; Luo RF, 2015, J CLIN MICROBIOL, V53, P2337, DOI 10.1128/JCM.00132-15; Macheras E, 2009, J CLIN MICROBIOL, V47, P2596, DOI 10.1128/JCM.00037-09; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Nie WJ, 2014, INT J INFECT DIS, V25, P170, DOI 10.1016/j.ijid.2014.02.014; Sassi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-359; Tan JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-879; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; WALLACE RJ, 1983, REV INFECT DIS, V5, P657; Wong YL, 2012, J CLIN MICROBIOL, V50, P3084, DOI 10.1128/JCM.00753-12; Woods GL, 2000, J CLIN MICROBIOL, V38, P656, DOI 10.1128/JCM.38.2.656-661.2000; Yoshida S, 2014, DIAGN MICR INFEC DIS, V79, P331, DOI 10.1016/j.diagmicrobio.2014.04.001; Yoshida S, 2013, INT J ANTIMICROB AG, V42, P226, DOI 10.1016/j.ijantimicag.2013.04.029; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08; Zhang ZQ, 1997, INT J LEPROSY, V65, P469	33	43	43	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140166	10.1371/journal.pone.0140166	http://dx.doi.org/10.1371/journal.pone.0140166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448181	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000099
J	Abledu, JK; Abledu, GK; Offei, EB; Antwi, EM				Abledu, Jubilant Kwame; Abledu, Godfred Kwame; Offei, Eric Bekoe; Antwi, Emmanuel Mensah			Determination of Sex from Footprint Dimensions in a Ghanaian Population	PLOS ONE			English	Article							BODY-WEIGHT; FOOT; STATURE; GUJJARS	The present study sought to verify the utility and reliability of footprint dimensions in sex determination in a Ghanaian population. Bilateral footprints were obtained from 126 Ghanaian students (66 males and 60 females) aged 18-30 years at Koforidua Polytechnic using an ink pad and white papers. Seven dimensions-length of each toe (designated T1-T5) from the most anterior point of the toe to the mid-rear heel point, breadth at ball (BAB) and breadth at heel (BAH)-and the heel-ball (HB) index were obtained from each footprint. Some footprint dimensions (i.e. T2, T3, T4 and T5) showed statistically significant bilateral asymmetry in males only. All the footprint dimensions, except HB index, were significantly greater in males than females (p<0.001). Applied singly in discriminant function analysis, the footprint dimensions allowed 69.8%-80.3% of cases to be correctly classified into their sex groups; the accuracy of sex classification was higher using left footprints than right footprints. With all dimensions subjected to stepwise discriminant function analysis 80.3% and 77% of cases could be correctly classified, combining both T5 and BAH for left footprints and T1, BAB and BAH for left footprints respectively. The present study has demonstrated, for the first time among Ghanaian subjects, the utility and reliability of sex determination standards developed from footprint dimensions. The results thus provide the baseline for elaborated studies in the future.	[Abledu, Jubilant Kwame; Offei, Eric Bekoe] Univ Ghana, Sch Vet Med, Coll Basic & Appl Sci, Accra, Ghana; [Abledu, Godfred Kwame; Antwi, Emmanuel Mensah] Koforidua Polytech, Fac Appl Sci & Technol, Dept Appl Math, Koforidua, Ghana	University of Ghana	Abledu, JK (corresponding author), Univ Ghana, Sch Vet Med, Coll Basic & Appl Sci, Accra, Ghana.	jkabledu@gmail.com	abledu, jubilant/P-7371-2016	abledu, jubilant/0000-0002-8580-1557				Abledu JK, 2016, AUST J FORENSIC SCI, V48, P195, DOI 10.1080/00450618.2015.1045553; Atamturk D, 2010, ANTHROPOL ANZ, V68, P21, DOI 10.1127/0003-5548/2010/0026; Bates KT, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0009; Deepashini H., 2014, POL ANN MED, V21, P51, DOI DOI 10.1016/J.POAMED.2014.03.003; Ezeani M.G.C., 2013, INT J BIOMED ADV RES, V4, P827; Fawzy IA, 2010, J FORENSIC SCI, V55, P884, DOI 10.1111/j.1556-4029.2010.01372.x; Hatala KG, 2013, J HUM EVOL, V65, P21, DOI 10.1016/j.jhevol.2013.03.009; Kanchan T, 2012, HOMO, V63, P468, DOI 10.1016/j.jchb.2012.09.004; Kanchan T., 2007, J INDIAN ACAD FORENS, V30, P281; Kennedy RB, 1996, FORENSIC SCI INT, V82, P81, DOI 10.1016/0379-0738(96)01969-X; Kennedy RB, 2003, J FORENSIC SCI, V48, P55; Krauss I, 2008, ERGONOMICS, V51, P1693, DOI 10.1080/00140130802376026; Krishan K, 2008, FORENSIC SCI INT, V179, P63, DOI 10.1016/j.forsciint.2008.04.015; Krishan K, 2008, FORENSIC SCI INT, V175, P93, DOI 10.1016/j.forsciint.2007.05.014; Krishan K, 2007, FORENSIC SCI INT, V169, P137, DOI 10.1016/j.forsciint.2006.08.006; Krishan K, 2012, J FORENSIC SCI, V57, P172, DOI 10.1111/j.1556-4029.2011.01960.x; Machado M., 2014, EGYPT J FORENSIC SCI, V4, P29, DOI DOI 10.1016/J.EJFS.2014.02.002; Mall G, 2000, FORENSIC SCI INT, V113, P315, DOI 10.1016/S0379-0738(00)00240-1; Moorthy NT, 2014, EGYPT J FORENSIC SCI, DOI [10.1016/j.ejfs.2014.04.003, DOI 10.1016/J.EJFS.2014.04.003]; Moorthy TN, 2014, AUST J FORENSIC SCI, V46, P136, DOI 10.1080/00450618.2013.825813; Nataraja M, 2014, FORENSIC SCI, V4, P7, DOI DOI 10.1016/J.EJFS.2013.10.002; Ozden H, 2005, FORENSIC SCI INT, V147, P181, DOI 10.1016/j.forsciint.2004.09.072; Patil KR, 2005, FORENSIC SCI INT, V147, P175, DOI 10.1016/j.forsciint.2004.09.071; Periyasamy R, 2011, Foot (Edinb), V21, P142, DOI 10.1016/j.foot.2011.03.001; Putti A B, 2010, Foot Ankle Surg, V16, P21, DOI 10.1016/j.fas.2009.03.005; ROBBINS LM, 1986, J FORENSIC SCI, V31, P143; Tsung BYS, 2003, J REHABIL RES DEV, V40, P517, DOI 10.1682/JRRD.2003.11.0517; Wunderlich RE, 2001, MED SCI SPORT EXER, V33, P605	28	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139891	10.1371/journal.pone.0139891	http://dx.doi.org/10.1371/journal.pone.0139891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26445236	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600099
J	Jonca, J; Zuk, M; Wasag, B; Janaszak-Jasiecka, A; Lewandowski, K; Wielgomas, B; Waleron, K; Jasiecki, J				Jonca, Joanna; Zuk, Monika; Wasag, Bartosz; Janaszak-Jasiecka, Anna; Lewandowski, Krzysztof; Wielgomas, Bartosz; Waleron, Krzysztof; Jasiecki, Jacek			New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; GENETIC-VARIANTS; ACETYLCHOLINESTERASE ACTIVITY; COLORIMETRIC DETERMINATION; CHOLINESTERASE ACTIVITY; ENZYME-ACTIVITY; RISK-FACTORS; IDENTIFICATION; INHIBITION; PESTICIDES	Butyrylcholinesterase (BChE) activity assay and inhibitor phenotyping can help to identify patients at risk of prolonged paralysis following the administration of neuromuscular blocking agents. The assay plays an important role in clinical chemistry as a good diagnostic marker for intoxication with pesticides and nerve agents. Furthermore, the assay is also commonly used for in vitro characterization of cholinesterases, their toxins and drugs. There is still lack of standardized procedure for measurement of BChE activity and many laboratories use different substrates at various concentrations. The purpose of this study was to validate the BChE activity assay to determine the best dilution of human serum and the most optimal concentration of substrates and inhibitors. Serum BChE activity was measured using modified Ellman's method applicable for a microplate reader. We present our experience and new insights into the protocol for high-throughput routine assays of human plasma cholinesterase activities adapted to a microplate reader. During our routine assays used for the determination of BChE activity, we have observed that serum dilution factor influences the results obtained. We show that a 400-fold dilution of serum and 5mM S-butyrylthiocholine iodide can be successfully used for the accurate measurement of BChE activity in human serum. We also discuss usage of various concentrations of dibucaine and fluoride in BChE phenotyping. This study indicates that some factors of such a multicomponent clinical material like serum can influence kinetic parameters of the BChE. The observed inhibitory effect is dependent on serum dilution factor used in the assay.	[Jonca, Joanna; Zuk, Monika; Wasag, Bartosz; Janaszak-Jasiecka, Anna; Lewandowski, Krzysztof; Wielgomas, Bartosz; Waleron, Krzysztof; Jasiecki, Jacek] Med Univ Gdansk, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk	Jasiecki, J (corresponding author), Med Univ Gdansk, Gdansk, Poland.	jjasiecki@gumed.edu.pl	Wielgomas, Bartosz/AAW-1231-2021; Janaszak-Jasiecka, Anna/T-7507-2018; Wasag, Bartosz/Q-9630-2018; Waleron, Krzysztof/R-9457-2018	Wielgomas, Bartosz/0000-0003-4245-9197; Janaszak-Jasiecka, Anna/0000-0002-2695-4756; Wasag, Bartosz/0000-0002-3634-7562; Waleron, Krzysztof/0000-0002-9989-0984; Zuk, Monika/0000-0003-3600-5578; Jasiecki, Jacek/0000-0001-8192-6486; Jonca, Joanna/0000-0001-9811-7378	Faculty of Pharmacy; Subfaculty of Laboratory Medicine, Medical University of Gdansk, KNOW Program - Ministry of Science and Higher Education of the Republic of Poland	Faculty of Pharmacy; Subfaculty of Laboratory Medicine, Medical University of Gdansk, KNOW Program - Ministry of Science and Higher Education of the Republic of Poland	This work was supported by Faculty of Pharmacy with Subfaculty of Laboratory Medicine, Medical University of Gdansk, KNOW Program funded by Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara VM, 2002, SCAND J CLIN LAB INV, V62, P399, DOI 10.1080/00365510260296564; [Anonymous], 2009, CALCULATING NUCL ACI; Benyamin B, 2011, HUM MOL GENET, V20, P4504, DOI 10.1093/hmg/ddr375; BRIMIJOIN S, 1988, J NEUROCHEM, V51, P1227, DOI 10.1111/j.1471-4159.1988.tb03091.x; Chen VP, 2015, P NATL ACAD SCI USA, V112, P2251, DOI 10.1073/pnas.1421536112; COYE MJ, 1986, J OCCUP ENVIRON MED, V28, P619, DOI 10.1097/00043764-198608000-00018; Das UN, 2012, ANN HEPATOL, V11, P409, DOI 10.1016/S1665-2681(19)30940-8; DAVIES RO, 1960, CAN J BIOCHEM PHYS, V38, P545; De Vriese C, 2004, ENDOCRINOLOGY, V145, P4997, DOI 10.1210/en.2004-0569; DIETZ AA, 1973, CLIN CHEM, V19, P1309; DOCTOR BP, 1987, ANAL BIOCHEM, V166, P399, DOI 10.1016/0003-2697(87)90590-2; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; GARRY PJ, 1971, CLIN CHEM, V17, P183; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; Iwasaki T, 2007, INTERNAL MED, V46, P1633, DOI 10.2169/internalmedicine.46.0049; JBILO O, 1994, TOXICON, V32, P1445, DOI 10.1016/0041-0101(94)90416-2; Johnson G, 2012, NEUROCHEM INT, V61, P783, DOI 10.1016/j.neuint.2012.06.016; Kalman J, 2004, LIFE SCI, V75, P1195, DOI 10.1016/j.lfs.2004.02.019; Kovarik Zrinka, 2003, Arhiv za Higijenu Rada i Toksikologiju, V54, P239; Li B, 2008, CHEM-BIOL INTERACT, V175, P88, DOI 10.1016/j.cbi.2008.03.009; Lima JK, 2013, GENE, V532, P24, DOI 10.1016/j.gene.2013.08.068; Lockridge O, 2000, NEUROTOXICOLOGY, V21, P113; Lockridge O, 2015, PHARMACOL THERAPEUT, V148, P34, DOI 10.1016/j.pharmthera.2014.11.011; Lothar T., 1998, CLIN LAB DIAGNOSTICS, P1727; Maekawa M, 1997, CLIN CHEM, V43, P924; Manoharan I, 2007, J NEURAL TRANSM, V114, P939, DOI 10.1007/s00702-007-0631-x; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; Miao YQ, 2010, CHEM REV, V110, P5216, DOI 10.1021/cr900214c; Naik RS, 2013, J APPL TOXICOL, V33, P290, DOI 10.1002/jat.2730; NOGUEIRA CP, 1992, AM J HUM GENET, V51, P821; Strelitz J, 2014, OCCUP ENVIRON MED, V71, P842, DOI 10.1136/oemed-2014-102315; Vaisi-Raygani A, 2010, MOL BIOL REP, V37, P2083, DOI 10.1007/s11033-009-9666-4; Worek F, 1999, CLIN CHIM ACTA, V288, P73, DOI 10.1016/S0009-8981(99)00144-8	36	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139480	10.1371/journal.pone.0139480	http://dx.doi.org/10.1371/journal.pone.0139480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444431	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600057
J	Jones, R; Fisher, R; Stark, C; Ridd, P				Jones, Ross; Fisher, Rebecca; Stark, Clair; Ridd, Peter			Temporal Patterns in Seawater Quality from Dredging in Tropical Environments	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; SEDIMENT RESUSPENSION; SUSPENDED SEDIMENT; TERRESTRIAL RUNOFF; WATER CLARITY; TURBIDITY; ZOOXANTHELLAE; PREDICTIONS; MANAGEMENT	Maintenance and capital dredging represents a potential risk to tropical environments, especially in turbidity-sensitive environments such as coral reefs. There is little detailed, published observational time-series data that quantifies how dredging affects seawater quality conditions temporally and spatially. This information is needed to test realistic exposure scenarios to better understand the seawater-quality implications of dredging and ultimately to better predict and manage impacts of future projects. Using data from three recent major capital dredging programs in North Western Australia, the extent and duration of natural (baseline) and dredging-related turbidity events are described over periods ranging from hours to weeks. Very close to dredging i.e. < 500 m distance, a characteristic features of these particular case studies was high temporal variability. Over several hours suspended sediment concentrations (SSCs) can range from 100-500 mg L-1. Less turbid conditions (10-80 mg L-1) can persist over several days but over longer periods (weeks to months) averages were < 10 mg L-1. During turbidity events all benthic light was sometimes extinguished, even in the shallow reefal environment, however a much more common feature was very low light 'caliginous' or daytime twilight periods. Compared to pre-dredging conditions, dredging increased the intensity, duration and frequency of the turbidity events by 10-, 5-and 3-fold respectively (at sites < 500 m from dredging). However, when averaged across the entire dredging period of 80-180 weeks, turbidity values only increased by 2-3 fold above pre-dredging levels. Similarly, the upper percentile values (e.g., P99, P95) of seawater quality parameters can be highly elevated over short periods, but converge to values only marginally above baseline states over longer periods. Dredging in these studies altered the overall probability density distribution, increasing the frequency of extreme values. As such, attempts to understand the potential biological impacts must consider impacts across telescoping-time frames and changes to extreme conditions in addition to comparing central tendency (mean/median). An analysis technique to capture the entire range of likely conditions over time-frames from hours to weeks is described using a running means/percentile approach.	[Jones, Ross; Fisher, Rebecca] Australian Inst Marine Sci, Perth, WA, Australia; [Jones, Ross; Fisher, Rebecca; Stark, Clair; Ridd, Peter] Western Australian Marine Sci Inst, Perth, WA, Australia; [Stark, Clair; Ridd, Peter] Coll Sci Technol & Engn, Intelligent Syst Informat & Modelling, Townsville, Qld, Australia; [Jones, Ross; Fisher, Rebecca] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia	Australian Institute of Marine Science; University of Western Australia	Jones, R (corresponding author), Australian Inst Marine Sci, Perth, WA, Australia.	r.jones@aims.gov.au	Fisher, Rebecca/C-5459-2011; Jones, Ross/N-4651-2013; Stark, Clair/O-2189-2017	Fisher, Rebecca/0000-0001-5148-6731; Jones, Ross/0000-0003-1661-4149; Stark, Clair/0000-0003-3598-724X	Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node; Chevron Australia; Woodside Energy Limited; BHP Billiton	Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node; Chevron Australia; Woodside Energy Limited; BHP Billiton	This project was funded by the Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node, and made possible through investment from Chevron Australia, Woodside Energy Limited, BHP Billiton as environmental offsets and by co-investment from the WAMSI Joint Venture partners. This research was also enabled by data provided by Woodside Energy Ltd, Rio Tinto Iron Ore and Chevron. The commercial investors and data providers had no role in the data analysis, data interpretation, the decision to publish or in the preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Anthony K.R.N., 2000, P 9 INT COR REEF S, V1, P239; BAK RPM, 1978, MAR POLLUT BULL, V9, P14, DOI 10.1016/0025-326X(78)90275-8; CEDA, 2015, INFORM PAPER; Cooper TF, 2008, MAR FRESHWATER RES, V59, P703, DOI 10.1071/MF08016; Davies-Colley RJ, 2001, J AM WATER RESOUR AS, V37, P1085, DOI 10.1111/j.1752-1688.2001.tb03624.x; Death G., 2008, GREAT BARRIER REEF M; EPA, 2011, ENV ASS GUID MAR DRE, P36; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Evans RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051668; Fabricius KE, 2014, MAR POLLUT BULL, V84, P191, DOI 10.1016/j.marpolbul.2014.05.012; Fabricius KE, 2013, ESTUAR COAST SHELF S, V116, P57, DOI 10.1016/j.ecss.2012.03.010; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Falkenberg LJ, 2014, ECOL INDIC, V45, P529, DOI 10.1016/j.ecolind.2014.05.006; Foster T., 2010, 108 PIANC ENV COMM; GAINES SD, 1993, ECOLOGY, V74, P1677, DOI 10.2307/1939926; Harris CA, 2014, ENVIRON SCI TECHNOL, V48, P3100, DOI 10.1021/es4047507; Jing L, 1996, COAST ENG, V29, P169, DOI 10.1016/S0378-3839(96)00023-3; JOHANNES R E, 1970, Marine Pollution Bulletin, V1, P186, DOI 10.1016/0025-326X(70)90104-9; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Jones RJ, 2008, MAR BIOL, V154, P65, DOI 10.1007/s00227-007-0900-0; Junjie RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107195; KEVIN KM, 1979, J EXP MAR BIOL ECOL, V36, P157, DOI 10.1016/0022-0981(79)90106-0; Kvale EP, 2006, MAR GEOL, V235, P5, DOI 10.1016/j.margeo.2006.10.001; Larcombe P, 2001, SEDIMENTOLOGY, V48, P811, DOI 10.1046/j.1365-3091.2001.00396.x; LARCOMBE P, 1995, CORAL REEFS, V14, P163, DOI 10.1007/BF00367235; Lawrence D, 2004, MAR ECOL PROG SER, V266, P1, DOI 10.3354/meps266001; Macdonald RK, 2013, MAR POLLUT BULL, V74, P82, DOI 10.1016/j.marpolbul.2013.07.026; McArthur C, 2002, P 3 SPEC C DREDG DRE, P1; McCook L.J., 2015, SYNTHESIS CURRENT KN; NEWCOMBE C P, 1991, North American Journal of Fisheries Management, V11, P72, DOI 10.1577/1548-8675(1991)011<0072:EOSSOA>2.3.CO;2; Norris RH, 2012, FRESHW SCI, V31, P5, DOI 10.1899/11-027.1; Ogston AS, 2010, J COASTAL RES, V26, P1027, DOI 10.2112/JCOASTRES-D-09-00064.1; Ogston AS, 2004, CORAL REEFS, V23, P559, DOI 10.1007/s00338-004-0415-9; Orpin AR, 2012, CONT SHELF RES, V47, P55, DOI 10.1016/j.csr.2012.06.013; Orpin AR, 2004, MAR POLLUT BULL, V49, P602, DOI 10.1016/j.marpolbul.2004.03.020; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; STAFFORDSMITH MG, 1992, AUST J MAR FRESH RES, V43, P683, DOI 10.1071/MF9920683; Stoddart J, 2004, CORALS DAMPIER HARBO, P13; Thompson A, 2014, CEREBELLAR LOCALIZAT, P1; Trimarchi S, 2007, ENV REV ECOPORTS MON, V24; Tuszynski Jarek, 2013, CATOOLS TOOLS MOVING; Verspecht F, 2010, CONT SHELF RES, V30, P1971, DOI 10.1016/j.csr.2010.09.008; Wilber DH, 2001, N AM J FISH MANAGE, V21, P855, DOI 10.1577/1548-8675(2001)021<0855:BEOSSA>2.0.CO;2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yonge C. M., 1931, GREAT BARRIER REEF E; Zeileis A, 2005, J STAT SOFTW, V14, P1, DOI [10.18637/jss.v014.i06, DOI 10.18637/JSS.V014.I06]; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	48	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137112	10.1371/journal.pone.0137112	http://dx.doi.org/10.1371/journal.pone.0137112			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444284	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000362510600008
J	Kvaloy, K; Holmen, J; Hveem, K; Holmen, TL				Kvaloy, Kirsti; Holmen, Jostein; Hveem, Kristian; Holmen, Turid Lingaas			Genetic Effects on Longitudinal Changes from Healthy to Adverse Weight and Metabolic Status-The HUNT Study	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; OBESITY; VARIANTS; ASSOCIATION; FTO; POPULATION; LIFE; OVERWEIGHT; GENOTYPE; APOA5	Introduction The complexity of obesity and onset and susceptibility of cardio-metabolic disorders are still poorly understood and is addressed here through studies of genetic influence on weight gain and increased metabolic risk longitudinally. Subjects/Methods Twenty seven previously identified obesity, eating disorder or metabolic risk susceptibility SNPs were tested for association with weight or metabolically related traits longitudinally in 3999 adults participating both in the HUNT2 (1995-97) and HUNT3 (2006-08) surveys. Regression analyses were performed with changes from normal weight to overweight/obesity or from metabolically healthy to adverse developments with regards to blood pressure, glucose, HDL cholesterol, triglycerides or metabolic syndrome as outcomes. Additionally, a sub-sample of 1380 adolescents was included for testing association of nine SNPs with longitudinal weight gain into young adulthood. Results The most substantial effect on BMI-based weight gain from normal to overweight/obesity in adults was observed for the DRD2 variant (rs6277)(OR: 0.79, 95% CI: 0.69-0.90, P = 3.9x10(-4), adj. P = 0.015). DRD2 was not associated with BMI on a cross-sectional level. In the adolescent sample, FTO (rs1121980) was associated with change to overweight at adulthood in the combined male-female sample (OR: 1.27, 95% CI: 1.09-1.49, P = 3.0x10(-3), adj. P = 0.019) and in females (OR: 1.53, 95% CI: 1.23-1.91, P = 1.8x10(-4), adj. P = 0.003). When testing for association to longitudinal adverse developments with regard to blood pressure, blood lipids and glucose, only rs964184 (ZNF259/APOA5) was significantly associated to unfavourable triglyceride changes (OR: 1.66, 95% CI: 1.36-2.03, P = 5.7x10(-7), adj. P = 0.001). Pleiotropic effects on metabolic traits, however, were observed for several genetic loci cross-sectionally, ZNF259/APOA5, LPL and GRB14 being the most important. Conclusions DRD2 exhibits effects on weight gain from normal weight to overweight/obesity in adults, while, FTO is associated to weight gain from adolescence to young adulthood. Unhealthy longitudinal triglyceride development is strongly affected by ZNF259/APOA. Our main finding, linking the DRD2 variant directly to the longitudinal weight gain observed, has not previously been identified. It suggests a genetic pre-disposition involving the dopaminergic signalling pathways known to play a role in food reward and satiety linked mechanisms.	[Kvaloy, Kirsti; Holmen, Jostein; Hveem, Kristian; Holmen, Turid Lingaas] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Fac Med, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Kvaloy, K (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Fac Med, N-7034 Trondheim, Norway.	kirsti.kvaloy@ntnu.no	Hveem, Kristian/AFV-4683-2022		Norwegian Research Council; Central Norway Regional Health Authority; NTNU	Norwegian Research Council(Research Council of NorwayEuropean Commission); Central Norway Regional Health Authority; NTNU	This study was supported by the Norwegian Research Council (http://www.forskningsradet.no/), The Liaison Committee between the Central Norway Regional Health Authority and NTNU (https://www.ntnu.no/dmf/rad/samorg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alsio J, 2012, FRONT NEUROENDOCRIN, V33, P127, DOI 10.1016/j.yfrne.2012.01.002; Andreassen OA, 2014, HYPERTENSION, V63, P819, DOI 10.1161/HYPERTENSIONAHA.113.02077; Ariza MJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-66; Begum G, 2013, ENDOCRINOLOGY, V154, P4560, DOI 10.1210/en.2013-1693; Carpenter CL, 2013, OBESITY, V21, pE467, DOI 10.1002/oby.20202; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Cuypers KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046912; Delahanty LM, 2012, DIABETES CARE, V35, P363, DOI 10.2337/dc11-1328; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Franceschini Nora, 2011, Circ Cardiovasc Genet, V4, P661, DOI 10.1161/CIRCGENETICS.111.960096; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Heber D, 2011, MOL NEUROBIOL, V44, P160, DOI 10.1007/s12035-011-8180-6; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Hong CJ, 2010, PHARMACOGENET GENOM, V20, P359, DOI 10.1097/FPC.0b013e3283397d06; Huang T, 2014, AM J CLIN NUTR, V99, P1126, DOI 10.3945/ajcn.113.082164; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kullo IJ, 2005, AM J HYPERTENS, V18, P99, DOI 10.1016/j.amjhyper.2004.09.002; Kvaloy K, 2013, INT J OBESITY, V37, P1221, DOI 10.1038/ijo.2012.220; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Lu YC, 2008, J LIPID RES, V49, P2582, DOI 10.1194/jlr.M800232-JLR200; Midthjell K, 2013, CLIN OBES, V3, P12, DOI 10.1111/cob.12009; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Park JY, 2011, EUR J CLIN NUTR, V65, P357, DOI 10.1038/ejcn.2010.259; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sagoo GS, 2008, AM J EPIDEMIOL, V168, P1233, DOI 10.1093/aje/kwn235; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Schwenk RW, 2013, MOL METAB, V2, P337, DOI 10.1016/j.molmet.2013.09.002; Shen Y, 2013, HUM GENET, V132, P1275, DOI 10.1007/s00439-013-1332-1; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Stice E, 2013, NEUROSCI BIOBEHAV R, V37, P2047, DOI 10.1016/j.neubiorev.2012.12.001; Stice E, 2010, NEUROIMAGE, V50, P1618, DOI 10.1016/j.neuroimage.2010.01.081; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; van Vliet-Ostaptchouk JV, 2013, DIABETOLOGIA, V56, P2134, DOI 10.1007/s00125-013-2985-y; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Walia GK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101688; Yamada Y, 2008, MOL MED REP, V1, P407; Zhang XM, 2012, AM J CLIN NUTR, V96, P917, DOI 10.3945/ajcn.112.040907; Zhang Z, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004124	53	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139632	10.1371/journal.pone.0139632	http://dx.doi.org/10.1371/journal.pone.0139632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445370	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600064
J	Sherf, O; Zolotov, LN; Liser, K; Tilleman, H; Jovanovic, VM; Zega, K; Jukic, MM; Brodski, C				Sherf, Orna; Zolotov, Limor Nashelsky; Liser, Keren; Tilleman, Hadas; Jovanovic, Vukasin M.; Zega, Ksenija; Jukic, Marin M.; Brodski, Claude			Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons	PLOS ONE			English	Article							VENTRAL MIDBRAIN; IN-VIVO; MID/HINDBRAIN ORGANIZER; TRANSCRIPTION FACTORS; ISTHMIC ORGANIZER; FATE; HINDBRAIN; DIFFERENTIATION; SPECIFICATION; PROGENITORS	Studying the development of mesodiencephalic dopaminergic (mdDA) neurons provides an important basis for better understanding dopamine-associated brain functions and disorders and is critical for establishing cell replacement therapy for Parkinson's disease. The transcription factors Otx2 and Lmx1b play a key role in the development of mdDA neurons. However, little is known about the genes downstream of Otx2 and Lmx1b in the pathways controlling the formation of mdDA neurons in vivo. Here we report on our investigation of Lmx1b as downstream target of Otx2 in the formation of mdDA neurons. Mouse mutants expressing Otx2 under the control of the En1 promoter (En1(+/Otx2)) showed increased Otx2 expression in the mid-hindbrain region, resulting in upregulation of Lmx1b and expansion of mdDA neurons there. In contrast, Lmx1b(-/-) mice showed decreased expression of Otx2 and impairments in several aspects of mdDA neuronal formation. To study the functional interaction between Otx2 and Lmx1b, we generated compound mutants in which Otx2 expression was restored in mice lacking Lmx1b (En1(+/Otx2);Lmx1b(-/-)). In these animals Otx2 was not sufficient to rescue any of the aberrations in the formation of mdDA neurons caused by the loss of Lmx1b, but rescued the loss of ocular motor neurons. Gene expression studies in Lmx1b(-/-) embryos indicated that in these mutants Wnt1, En1 and Fgf8 expression are induced but subsequently lost in the mdDA precursor domain and the mid-hindbrain organizer in a specific, spatio-temporal manner. In summary, we demonstrate that Otx2 critically depends on Lmx1b for the formation of mdDA neurons, but not for the generation of ocular motor neurons. Moreover, our data suggest that Lmx1b precisely maintains the expression pattern of Wnt1, Fgf8 and En1, which are essential for mid-hindbrain organizer function and the formation of mdDA neurons.	[Sherf, Orna; Zolotov, Limor Nashelsky; Liser, Keren; Tilleman, Hadas; Jovanovic, Vukasin M.; Zega, Ksenija; Jukic, Marin M.; Brodski, Claude] Ben Gurion Univ Negev, Fac Hlth Sci, Zlotowski Ctr Neurosci, Dept Physiol & Cell Biol, IL-84105 Beer Sheva, Israel	Ben Gurion University	Brodski, C (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Zlotowski Ctr Neurosci, Dept Physiol & Cell Biol, IL-84105 Beer Sheva, Israel.	claude@bgu.ac.il	Jukic, Marin/AAK-9934-2021; Jukic, Marin/CAA-2694-2022	Jovanovic, Vukasin/0000-0002-0226-1998; Jukic, Marin/0000-0002-5296-4245	Israel Science Foundation [1391/11]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation grant 1391/11 to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston Z, 2009, DEVELOPMENT, V136, P3311, DOI 10.1242/dev.037770; Anderegg A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003973; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Andersson ER, 2013, P NATL ACAD SCI USA, V110, pE602, DOI 10.1073/pnas.1208524110; Arenas E, 2010, BIOCHEM BIOPH RES CO, V396, P152, DOI 10.1016/j.bbrc.2010.04.037; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blaess S, WILEY INTERDISCIP RE, V4, P113; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Brodski C, 2003, J NEUROSCI, V23, P4199; Burbach JPH, 2003, ANN NY ACAD SCI, V991, P61; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; Deng QL, 2011, DEVELOPMENT, V138, P3399, DOI 10.1242/dev.065482; Ellisor D, 2012, DEV BIOL, V372, P249, DOI 10.1016/j.ydbio.2012.09.019; Fedtsova N, 2008, DEV BIOL, V316, P6, DOI 10.1016/j.ydbio.2007.12.040; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Le Pen G, 2008, PARK RELAT DISORD S2, V14; Lee SMK, 1997, DEVELOPMENT, V124, P959; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; Millett S, 1999, NATURE, V401, P161, DOI 10.1038/43664; Nakatani T, 2010, DEV BIOL, V339, P101, DOI 10.1016/j.ydbio.2009.12.017; Omodei D, 2008, DEVELOPMENT, V135, P3459, DOI 10.1242/dev.027003; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2009, DEVELOPMENT, V136, P2545, DOI 10.1242/dev.031781; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Tilleman H, 2010, MOL CELL NEUROSCI, V45, P1, DOI 10.1016/j.mcn.2010.05.003; Veenvliet JV, 2013, DEVELOPMENT, V140, P3373, DOI 10.1242/dev.094565; Veenvliet JV, 2014, CELLULAR MOL LIFE SC; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Yan CH, 2011, J NEUROSCI, V31, P12413, DOI 10.1523/JNEUROSCI.1077-11.2011; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	44	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139697	10.1371/journal.pone.0139697	http://dx.doi.org/10.1371/journal.pone.0139697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444681	gold, Green Submitted, Green Published			2022-12-26	WOS:000362510600071
J	Walton, EM; Cronan, MR; Beerman, RW; Tobin, DM				Walton, Eric M.; Cronan, Mark R.; Beerman, Rebecca W.; Tobin, David M.			The Macrophage-Specific Promoter mfap4 Allows Live, Long-Term Analysis of Macrophage Behavior during Mycobacterial Infection in Zebrafish	PLOS ONE			English	Article							MESSENGER-RNA; FLUORESCENT PROTEINS; EXPRESSION; MODEL; HOST; TRANSGENESIS; PATHOGENESIS; LISTERIA; CLONING; MARINUM	Transgenic labeling of innate immune cell lineages within the larval zebrafish allows for real-time, in vivo analyses of microbial pathogenesis within a vertebrate host. To date, labeling of zebrafish macrophages has been relatively limited, with the most specific expression coming from the mpeg1 promoter. However, mpeg1 transcription at both endogenous and transgenic loci becomes attenuated in the presence of intracellular pathogens, including Salmonella typhimurium and Mycobacterium marinum. Here, we describe mfap4 as a macrophage-specific promoter capable of producing transgenic lines in which transgene expression within larval macrophages remains stable throughout several days of infection. Additionally, we have developed a novel macrophage-specific Cre transgenic line under the control of mfap4, enabling macrophage-specific expression using existing floxed transgenic lines. These tools enrich the repertoire of transgenic lines and promoters available for studying zebrafish macrophage dynamics during infection and inflammation and add flexibility to the design of future macrophage-specific transgenic lines.	[Walton, Eric M.; Cronan, Mark R.; Beerman, Rebecca W.; Tobin, David M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Tobin, David M.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Walton, Eric M.; Cronan, Mark R.; Beerman, Rebecca W.; Tobin, David M.] Duke Univ, Med Ctr, Ctr Host Microbial Interact, Durham, NC USA	Duke University; Duke University; Duke University	Tobin, DM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	david.tobin@duke.edu		Beerman, Rebecca/0000-0002-2057-4170; Tobin, David/0000-0003-3465-5518; Cronan, Mark/0000-0002-3760-1649	American Cancer Society [PF-13-223-01-MPC]; Mallinckrodt Scholar Award; Searle Scholar Award; National Institutes of Health [1DP2OD008614]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008614] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Mallinckrodt Scholar Award; Searle Scholar Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by an American Cancer Society Postdoctoral Fellowship PF-13-223-01-MPC (MRC), a Mallinckrodt Scholar Award, a Searle Scholar Award, and a New Innovator Award from the National Institutes of Health, 1DP2OD008614 (DMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Benard EL, 2015, J INNATE IMMUN, V7, P136, DOI 10.1159/000366103; Berman JN, 2005, EXP HEMATOL, V33, P997, DOI 10.1016/j.exphem.2005.06.010; Berthier E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003289; Brannon MK, 2009, CELL MICROBIOL, V11, P755, DOI 10.1111/j.1462-5822.2009.01288.x; Brothers KM, 2011, EUKARYOT CELL, V10, P932, DOI 10.1128/EC.05005-11; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Clatworthy AE, 2009, INFECT IMMUN, V77, P1293, DOI 10.1128/IAI.01181-08; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Ellett Felix, 2011, Blood, V117, pe49, DOI 10.1182/blood-2010-10-314120; Gabor KA, 2014, DIS MODEL MECH, V7, P1227, DOI 10.1242/dmm.014746; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gray C, 2011, THROMB HAEMOSTASIS, V105, P811, DOI 10.1160/TH10-08-0525; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hsu K, 2004, BLOOD, V104, P1291, DOI 10.1182/blood-2003-09-3105; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kikuta Hiroshi, 2009, V546, P69, DOI 10.1007/978-1-60327-977-2_5; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Levraud JP, 2009, INFECT IMMUN, V77, P3651, DOI 10.1128/IAI.00408-09; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003; Menudier A, 1996, PATHOL BIOL, V44, P783; Nguyen-Chi M, 2015, ELIFE, V4, DOI 10.7554/eLife.07288; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Palha N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003619; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Rawls JF, 2007, P NATL ACAD SCI USA, V104, P7622, DOI 10.1073/pnas.0702386104; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Renshaw SA, 2012, DIS MODEL MECH, V5, P38, DOI 10.1242/dmm.007138; Sanderson LE, 2015, DEV COMP IMMUNOL, V53, P63, DOI 10.1016/j.dci.2015.06.013; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Shiau CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117513; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Torraca V, 2014, DIS MODEL MECH, V7, P785, DOI 10.1242/dmm.015594; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873	56	80	80	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138949	10.1371/journal.pone.0138949	http://dx.doi.org/10.1371/journal.pone.0138949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445458	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600041
J	Xu, Q; Tang, B; Zou, Q; Zheng, HZ; Liu, XJ; Wang, SG				Xu, Qi; Tang, Bin; Zou, Qi; Zheng, Huizhen; Liu, Xiaojun; Wang, Shigui			Effects of Pyriproxyfen on Female Reproduction in the Common Cutworm, Spodoptera litura (F.) (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							BUTTERFLY BICYCLUS-ANYNANA; JUVENILE-HORMONE ANALOG; ECDYSONE RECEPTOR; INSECTICIDE RESISTANCE; VITELLOGENIN SYNTHESIS; METHOPRENE-TOLERANT; RHODNIUS-PROLIXUS; APIS-MELLIFERA; ULTRASPIRACLE; METAMORPHOSIS	The common cutworm, Spodoptera litura, is a rapidly reproducing pest of numerous agricultural ecosystems worldwide. The use of pesticides remains the primary means for controlling S. litura, despite their negative ecological impact and potential threat to human health. The use of exogenous hormone analogs may represent an alternative to insecticides. Juvenile hormones (JHs) play an important role in the reproductive systems of female insects, but the effects of pyriproxyfen, a JH analog, on reproduction in S. litura were poorly understood. In this paper, we topically treated the newly emerged females with 20, 60, or 100 mu g of pyriproxyfen to determine its effects on reproduction. Then, we examined the expression of vitellogenin (Vg) and three hormone receptors, USP, HR3, and EcR, using quantitative reverse transcription and real-time polymerase chain reaction (qRT-PCR), and found that pyriproxyfen up-regulated the expression of Vg, USP, and HR3, whereas the expression of EcR was unaffected. An analysis of fecundity showed that the peak oviposition day, lifespan, and oviposition period were progressively shortened as the pyriproxyfen dosage increased. We also found that pyriproxyfen decreased egg laying amount, whereas the number of mature eggs that remained in the ovarioles of dead females increased as the pyriproxyfen dosage increased. We examined oocytes using transmission electron microscopy and found that treatment with 100 mu g of pyriproxyfen increased the metabolism by increasing the amount of rough endoplasmic reticulum and mitochondria in the primary oocytes. Our results suggest that the topical application of pyriproxyfen on newly emerged females can efficiently reduce reproduction in S. litura and may represent an alternative to the use of insecticides for controlling the agricultural pest.	[Xu, Qi; Tang, Bin; Zou, Qi; Zheng, Huizhen; Liu, Xiaojun; Wang, Shigui] Hangzhou Normal Univ, Sch Life & Environm Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou 310036, Zhejiang, Peoples R China	Hangzhou Normal University	Wang, SG (corresponding author), Hangzhou Normal Univ, Sch Life & Environm Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou 310036, Zhejiang, Peoples R China.	sgwang@mail.hz.zj.cn			National Natural Science Foundation of China [IBN-30970473, 31270459]; Qianjiang Talents Project of the technology office in Zhejiang Province [2010R10093]; Zhejiang Provincial Natural Science Foundation of China [Y307551]; Middle-aged and Young Talents Subject Leaders in Zhejiang Province; Hangzhou Science and Technology Development Program of China [20081443B03]; Program for Excellent Young Teachers in Hangzhou Normal University [JTAS 2011-01-031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talents Project of the technology office in Zhejiang Province; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Middle-aged and Young Talents Subject Leaders in Zhejiang Province; Hangzhou Science and Technology Development Program of China; Program for Excellent Young Teachers in Hangzhou Normal University	This work was supported by National Natural Science Foundation of China (Grant IBN-30970473 and 31270459), Qianjiang Talents Project of the technology office in Zhejiang Province (2010R10093), Zhejiang Provincial Natural Science Foundation of China (Grant No. Y307551), the Middle-aged and Young Talents Subject Leaders in Zhejiang Province, Hangzhou Science and Technology Development Program of China (Grant No. 20081443B03), and the Program for Excellent Young Teachers in Hangzhou Normal University (Grant No. JTAS 2011-01-031).	Armes NJ, 1997, PESTIC SCI, V50, P240, DOI 10.1002/(SICI)1096-9063(199707)50:3&lt;240::AID-PS579&gt;3.0.CO;2-9; Bakr RFA, 2013, EGYPT ACAD J BIOL SC, V6, P107; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; BELL WJ, 1975, BIOL REV, V50, P373, DOI 10.1111/j.1469-185X.1975.tb01058.x; Bernardi F, 2009, DEV BIOL, V328, P541, DOI 10.1016/j.ydbio.2009.01.013; Bomtorin AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086923; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Clements AN., 1992, BIOL MOSQUITOES DEV; Clifton ME, 2012, J INSECT PHYSIOL, V58, P1007, DOI 10.1016/j.jinsphys.2012.05.005; Clifton ME, 2011, J INSECT PHYSIOL, V57, P1274, DOI 10.1016/j.jinsphys.2011.06.002; Cole TJ, 2002, ARCH INSECT BIOCHEM, V49, P10, DOI 10.1002/arch.10007; CUSSON M, 1994, J INSECT PHYSIOL, V40, P129, DOI 10.1016/0022-1910(94)90084-1; DAVEY KG, 1981, AM ZOOL, V21, P701; Delisle J, 1999, J INSECT PHYSIOL, V45, P515, DOI 10.1016/S0022-1910(98)00155-3; Etman AAM, 1980, AUST J ENTOMOL, V18, P363; Geister TL, 2008, J INSECT PHYSIOL, V54, P1253, DOI 10.1016/j.jinsphys.2008.06.002; Guo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043567; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; HATAKOSHI M, 1992, J INSECT PHYSIOL, V38, P793, DOI 10.1016/0022-1910(92)90032-9; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kranthi KR, 2002, CROP PROT, V21, P449, DOI 10.1016/S0261-2194(01)00131-4; Lenkic LE, 2009, J INSECT PHYSIOL, V55, P967, DOI 10.1016/j.jinsphys.2009.06.008; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Liu SS, 2012, MED VET ENTOMOL, V26, P379, DOI 10.1111/j.1365-2915.2012.01013.x; Maiza A., 2004, Communications in Agricultural and Applied Biological Sciences, V69, P257; Marchal E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106737; Meola R, 1996, J MED ENTOMOL, V33, P670, DOI 10.1093/jmedent/33.4.670; Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868; Munyiri FN, 2004, J INSECT PHYSIOL, V50, P1075, DOI 10.1016/j.jinsphys.2004.09.009; Nose Y, 1997, INSECT BIOCHEM MOLEC, V27, P1047, DOI 10.1016/S0965-1748(97)00091-X; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P429, DOI 10.1016/j.ibmb.2010.04.002; PIMENTEL D, 1986, BIOSCIENCE, V36, P86, DOI 10.2307/1310108; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; Ramaswamy SB, 1997, ARCH INSECT BIOCHEM, V35, P539, DOI 10.1002/(SICI)1520-6327(1997)35:4<539::AID-ARCH12>3.0.CO;2-B; RAO GVR, 1993, INSECT SCI APPL, V14, P273, DOI 10.1017/S1742758400014764; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; ROHDENDORF EB, 1973, J INSECT PHYSIOL, V19, P37, DOI 10.1016/0022-1910(73)90220-5; RUTZ W, 1976, J INSECT PHYSIOL, V22, P1485, DOI 10.1016/0022-1910(76)90214-6; SATYANARAYANA K, 1992, INVERTEBR REPROD DEV, V21, P169, DOI 10.1080/07924259.1992.9672235; Shpigler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100650; Sorge D, 2000, J INSECT PHYSIOL, V46, P969, DOI 10.1016/S0022-1910(99)00207-3; Steigenga MJ, 2006, ENTOMOL SCI, V9, P269, DOI 10.1111/j.1479-8298.2006.00173.x; Tay JW, 2014, J ECON ENTOMOL, V107, P1216, DOI 10.1603/EC14030; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Tripathi Priyanka, 2013, AIJRFANS, V4, P33; Tufail M, 2014, ENTOMOL SCI, V17, P269, DOI 10.1111/ens.12086; ULLMANN SL, 1973, J EMBRYOL EXP MORPH, V30, P179; VENKATESH K, 1988, INSECT BIOCHEM, V18, P53, DOI 10.1016/0020-1790(88)90036-4; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028163; WANG ZW, 1992, INSECT BIOCHEM MOLEC, V22, P757, DOI 10.1016/0965-1748(92)90054-I; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zeng F, 1997, ARCH INSECT BIOCHEM, V34, P287, DOI 10.1002/(SICI)1520-6327(1997)34:3<287::AID-ARCH4>3.0.CO;2-S; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047611; Zhao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059527	55	10	11	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138171	10.1371/journal.pone.0138171	http://dx.doi.org/10.1371/journal.pone.0138171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444432	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600021
J	Zhou, Y; Li, CY; Huijbregts, MAJ; Mumtaz, MM				Zhou, Ying; Li, Chaoyang; Huijbregts, Mark A. J.; Mumtaz, M. Moiz			Carcinogenic Air Toxics Exposure and Their Cancer-Related Health Impacts in the United States	PLOS ONE			English	Article							CHEMICAL-MIXTURES; SYSTEMATIC ANALYSIS; RISK-ASSESSMENT; GLOBAL BURDEN; 21 REGIONS; POLLUTION; DISEASE	Public health protection from air pollution can be achieved more effectively by shifting from a single-pollutant approach to a multi-pollutant approach. To develop such multi-pollutant approaches, identifying which air pollutants are present most frequently is essential. This study aims to determine the frequently found carcinogenic air toxics or hazardous air pollutants (HAPs) combinations across the United States as well as to analyze the health impacts of developing cancer due to exposure to these HAPs. To identify the most commonly found carcinogenic air toxics combinations, we first identified HAPs with cancer risk greater than one in a million in more than 5% of the census tracts across the United States, based on the National-Scale Air Toxics Assessment (NATA) by the U.S. EPA for year 2005. We then calculated the frequencies of their two-component (binary), and three-component (ternary) combinations. To quantify the cancer-related health impacts, we focused on the 10 most frequently found HAPs with national average cancer risk greater than one in a million. Their cancer-related health impacts were calculated by converting lifetime cancer risk reported in NATA 2005 to years of healthy life lost or Disability-Adjusted Life Years (DALYs). We found that the most frequently found air toxics with cancer risk greater than one in a million are formaldehyde, carbon tetrachloride, acetaldehyde, and benzene. The most frequently occurring binary pairs and ternary mixtures are the various combinations of these four air toxics. Analysis of urban and rural HAPs did not reveal significant differences in the top combinations of these chemicals. The cumulative annual cancer-related health impacts of inhaling the top 10 carcinogenic air toxics included was about 1,600 DALYs in the United States or 0.6 DALYs per 100,000 people. Formaldehyde and benzene together contribute nearly 60 percent of the total cancer-related health impacts. Our study shows that although there are many carcinogenic air toxics, only a few of them affect public health significantly at the national level in the United States, based on the frequency of occurrence of air toxics mixtures and cancer-related public health impacts. Future research is needed on their joint toxicity and cumulative health impacts.	[Zhou, Ying; Li, Chaoyang] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Environm Hlth Tracking Branch, Div Environm Hazards & Hlth Effects, Atlanta, GA 30322 USA; [Huijbregts, Mark A. J.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Environm Sci, NL-6500 GL Nijmegen, Netherlands; [Mumtaz, M. Moiz] Ctr Dis Control & Prevent, Agcy Tox Subst & Dis Registry, Div Toxicol & Human Hlth Sci, Computat Toxicol Lab, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Radboud University Nijmegen; Centers for Disease Control & Prevention - USA	Zhou, Y (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Environm Hlth Tracking Branch, Div Environm Hazards & Hlth Effects, Atlanta, GA 30322 USA.	yzhou2@cdc.gov	Huijbregts, Mark A.J./B-8971-2011; Li, Chao/GSM-8117-2022; Huijbregts, Mark/ABF-3842-2021	Huijbregts, Mark A.J./0000-0002-7037-680X; Li, Chao/0000-0001-6110-6210; Huijbregts, Mark/0000-0002-7037-680X; Zhou, Ying/0000-0002-1413-6377				[Anonymous], GLOBAL BURDEN DIS CO; ATSDR, 2012, TOX PROF; *ATSDR, 2004, GUID MAN ASS JOINT T; ATSDR. Agency for Toxic Substances and Disease Registry, 2011, PRIOR LIST HAZ SUBST; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Eastern Research Group Inc, 2010, RES 2005 NATA MOD TO; Geelen LMJ, 2009, ATMOS ENVIRON, V43, P1613, DOI 10.1016/j.atmosenv.2008.12.002; George BJ, 2011, ATMOS ENVIRON, V45, P3301, DOI 10.1016/j.atmosenv.2011.03.031; Johns DO, 2012, ENVIRON HEALTH PERSP, V120, P1238, DOI 10.1289/ehp.1204939; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Logue JM, 2011, ATMOS ENVIRON, V45, P476, DOI 10.1016/j.atmosenv.2010.09.053; MUMTAZ MM, 1992, TOXICOL IND HEALTH, V8, P377; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Toxicology Program, 2014, REP CARC; OEHHA, 2011, OEHHA TOX CRIT DAT; Pratt GC, 2012, RISK ANAL, V32, P96, DOI 10.1111/j.1539-6924.2011.01640.x; Ray RM, 1996, FOOD CHEM TOXICOL, V34, P1163; Sexton K, 2007, ENVIRON HEALTH PERSP, V115, P1388, DOI 10.1289/ehp.10043; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; U.S. EPA, 2014, 2005 NAT SCAL AIR TO; U.S. EPA, 1991, 50000 USEPA CASRN; U.S. EPA, 1991, 75070 USEPA CASRN; U.S. EPA, 2010, 56235 USEPA CASRN; U.S. EPA, 2000, 71432 USEPA CASRN; United States Environmental Protection Agency (US EPA), 2012, NAT AMB AIR QUAL STA; US EPA, 2000, EPA630R00002 US EPA; US EPA O, 2015, 2011 NAT AIR TOX ASS; US EPA (US Environmental protection Agency), 2014, INT RISK INF SYST; Wilbur SB, 2004, ENVIRON TOXICOL PHAR, V18, P223, DOI 10.1016/j.etap.2003.03.001; YANG RSH, 1987, TOXICOLOGY, V47, P15, DOI 10.1016/0300-483X(87)90158-2; Young GS, 2012, INT J ENV RES PUB HE, V9, P2204, DOI 10.3390/ijerph9062204	32	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140013	10.1371/journal.pone.0140013	http://dx.doi.org/10.1371/journal.pone.0140013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444872	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600120
J	Huang, JF; Yeh, ML; Yu, ML; Huang, CF; Dai, CY; Hsieh, MY; Hsieh, MH; Huang, CI; Lin, ZY; Chen, SC; Hsiao, PJ; Shin, SJ; Chuang, WL				Huang, Jee-Fu; Yeh, Ming-Lun; Yu, Ming-Lung; Huang, Chung-Feng; Dai, Chia-Yen; Hsieh, Ming-Yen; Hsieh, Meng-Hsuan; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Chern; Hsiao, Pi-Jung; Shin, Shyi-Jang; Chuang, Wan-Long			Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BODY-MASS INDEX; ASIA-PACIFIC REGION; CHRONIC HEPATITIS-C; URIC-ACID; INSULIN-RESISTANCE; METABOLIC SYNDROME; SCORING SYSTEM; RISK-FACTORS; PREVALENCE	Background & Aims Asians are more susceptible to non-alcoholic steatohepatitis (NASH) as well as metabolic disorder than other ethnicities. We aimed to assess the interaction between metabolic factors and fibrosis in Taiwanese NASH patients. Methods A total of 130 biopsy-proven Taiwanese NASH patients (94 males, age = 43.0 +/- 13.0 years) were consecutively enrolled. Their demographic, metabolic profiles and histopathological manifestations were analyzed. Results Twenty-four (18.5%) NASH patients were non-obese. Thirty-three (25.4%) patients had significant fibrosis (F2) or more: 22 (16.9%) patients were of F2, whilst 11 (8.5%) patients were of advanced fibrosis (F3-4). The prevalence of metabolic syndrome, diabetes and hypertension were 60.8%, 39.4%, and 61.5%, respectively. There was a significant inverse correlation between hyperuricemia and fibrosis stages, ranging from 48.4% of F0-1, 33.3% of F2, and 9.1% of F3-4, respectively (P = 0.01, linear trend). Multivariate logistic regression analysis showed that a decreased serum albumin level (OR = 40.0, 95% CI = 4.5-300, P = 0.001) and normal uric acid level (OR = 5.6, 95% CI = 1.5-21.7, P = 0.01) were the significant factors associated with significant fibrosis. Conclusions Hyperuricemia inversely predicts fibrosis stages. Females might carry a more disease severity than males in Taiwanese NASH patients.	[Huang, Jee-Fu; Yeh, Ming-Lun; Yu, Ming-Lung; Huang, Chung-Feng; Dai, Chia-Yen; Hsieh, Ming-Yen; Hsieh, Meng-Hsuan; Huang, Ching-I; Lin, Zu-Yau; Chen, Shinn-Chern; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Jee-Fu; Yu, Ming-Lung; Dai, Chia-Yen; Chuang, Wan-Long] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Huang, Jee-Fu; Yeh, Ming-Lun; Yu, Ming-Lung; Huang, Chung-Feng; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Chern; Hsiao, Pi-Jung; Shin, Shyi-Jang; Chuang, Wan-Long] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan; [Huang, Chung-Feng; Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsiao, Pi-Jung; Shin, Shyi-Jang] Kaohsiung Med Univ Hosp, Div Endocrine, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chuang, WL (corresponding author), Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan.	jf71218@gmail.com; wloch@cc.kmu.edu.tw	Hsieh, Meng Hsuan/AAY-7973-2021; Yu, Ming-Lung/AAZ-4306-2020; Huang, Jee-Fu/AAX-4622-2020; Chuang, Wan-Long/ABF-7427-2021	Yu, Ming-Lung/0000-0001-8145-1900; Huang, Jee-Fu/0000-0002-2752-7051; Chuang, Wan-Long/0000-0002-2376-421X; Hsieh, Meng-Hsuen/0000-0001-9739-3901; Hsiao, Pi-Jung/0000-0001-5024-9371	National Science Council, Taiwan [NSC 98WFD2100412]; Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University [KMHK-99-023, KMHK-100-013]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University	This study was supported partly by grants from the National Science Council, Taiwan (NSC 98WFD2100412) and Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University (KMHK-99-023 and KMHK-100-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, DIABETES CARE, V37, pS4, DOI 10.2337/dc14-S004; Baden R, 2014, J INFECT DIS, V209, pS81, DOI 10.1093/infdis/jiu057; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; Dai CY, 2009, J HEPATOL, V50, P712, DOI 10.1016/j.jhep.2008.12.017; de Oliveira EP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-12; DECAUX G, 1984, METABOLISM, V33, P750, DOI 10.1016/0026-0495(84)90217-8; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Farrell GC, 2003, J GASTROEN HEPATOL, V18, P124, DOI 10.1046/j.1440-1746.2003.02989.x; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x; Hsieh MH, 2007, JPN J INFECT DIS, V60, P377; Huang JF, 2008, AM J GASTROENTEROL, V103, P1933, DOI 10.1111/j.1572-0241.2008.01996.x; Kimura Y, 2011, J GASTROEN HEPATOL, V26, P517, DOI 10.1111/j.1440-1746.2010.06567.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Palaniappan LP, 2011, INT J OBESITY, V35, P393, DOI 10.1038/ijo.2010.152; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Sertoglu E, 2014, CLIN BIOCHEM, V47, P383, DOI 10.1016/j.clinbiochem.2014.01.029; Su HM, 2014, INT J CARDIOL, V172, P464, DOI 10.1016/j.ijcard.2013.12.263; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Wang CC, 2012, KAOHSIUNG J MED SCI, V28, P151, DOI 10.1016/j.kjms.2011.10.005; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Wong RJ, 2014, J COMMUN HEALTH, V39, P437, DOI 10.1007/s10900-013-9792-8; Wong VWS, 2006, ALIMENT PHARM THER, V24, P1215, DOI 10.1111/j.1365-2036.2006.03112.x; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Yoneda M, 2014, CLIN BIOCHEM, V47, P1138, DOI 10.1016/j.clinbiochem.2014.04.026; Zafrani ES, 2004, VIRCHOWS ARCH, V444, P3, DOI 10.1007/s00428-003-0943-7	37	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139796	10.1371/journal.pone.0139796	http://dx.doi.org/10.1371/journal.pone.0139796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441244	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510300057
J	Shen, JL; Pan, YP; Fang, YP				Shen, Jilu; Pan, Yaping; Fang, Yaping			Role of the Outer Membrane Protein OprD(2) in Carbapenem-Resistance Mechanisms of Pseudomonas aeruginosa	PLOS ONE			English	Article							PORIN OPRD; IMIPENEM; STRAINS	We investigated the relationship between the outer membrane protein OprD(2) and carbapenem-resistance in 141 clinical isolates of Pseudomonas aeruginosa collected between January and December 2013 from the First Affiliated Hospital of Anhui Medical University in China. Agar dilution methods were employed to determine the minimum inhibitory concentration of meropenem (MEM) and imipenem (IMP) for P. aeruginosa. The gene encoding OprD(2) was amplified from141 P. aeruginosa isolates and analyzed by PCR and DNA sequencing. Differences between the effects of IMPR and IMPS groups on the resistance of the P. aeruginosa were observed by SDS-poly acrylamide gel electrophoresis (SDS-PAGE). Three resistance types were classified in the 141 carbapenem-resistant P. aeruginosa (CRPA) isolates tested, namely (IMPMEMR)-M-R (66.7%), (IMPMEMS)-M-R (32.6%), and (IMPMEMS)-M-R (0.7%). DNA sequencing revealed significant diverse gene mutations in the OprD(2-)encoding gene in these strains. Thirty-four strains had large fragment deletions in the OprD(2)gene, in 6 strains the gene contained fragment inserts, and in 96 resistant strains, the gene featured small fragment deletions or multi-site mutations. Only 4 metallo-beta-lactamase strains and 1 imipenem-sensitive (meropenem-resistant) strain showed a normal OprD(2) gene. Using SDS-PAGE to detect the outer membrane protein in 16 CRPA isolates, it was found that 10 IMPRMEMR strains and 5 (IMPMEMS)-M-R strains had lost the OprD(2) protein, while the (IMPMEMR)-M-S strain contained a normal 46-kDa protein. In conclusion, mutation or loss of the OprD(2)-encoding gene caused the loss of OprD(2), which further led to carbapenem-resistance of P. aeruginosa. Our findings provide insights into the mechanism of carbapenem resistance in P. aeruginosa.	[Shen, Jilu; Pan, Yaping] Anhui Med Univ, Affiliated Hosp 1, Dept Lab Med, Hefei, Anhui, Peoples R China; [Fang, Yaping] Anhui Med Univ, Affiliated Hosp 2, Dept Lab Med, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Shen, JL (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Lab Med, Hefei, Anhui, Peoples R China.	shenjilu@126.com			National Natural Science Fund [81171618]	National Natural Science Fund(National Natural Science Foundation of China (NSFC))	The study was funded by the National Natural Science Fund Project (project approval NO: 81171618).	Berges L, 2007, J ANTIMICROB CHEMOTH, V59, P812, DOI 10.1093/jac/dkm001; [陈瑞 Chen Rui], 2006, [中华传染病杂志, Chinese Journal of Infections Diseases], V24, P80; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Fang ZL, 2014, INFECT GENET EVOL, V21, P124, DOI 10.1016/j.meegid.2013.10.027; Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098; Jin DY, 1996, MOL CLONING EXPT GUI, P888; [李耘 Li Yun], 2012, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V28, P883; Lian Z, 1999, Chin Med Sci J, V14, P57; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; LYNCH MJ, 1987, ANTIMICROB AGENTS CH, V31, P1892, DOI 10.1128/AAC.31.12.1892; Meletis G, 2014, EUR J CLIN MICROBIOL, V33, P253, DOI 10.1007/s10096-013-1952-3; Naenna P, 2010, SE ASIAN J TROP MED, V41, P614; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Rojo-Bezares B, 2014, INT J MED MICROBIOL, V304, P405, DOI 10.1016/j.ijmm.2014.01.001; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Wang J, 2010, INT J ANTIMICROB AG, V35, P486, DOI 10.1016/j.ijantimicag.2009.12.014; YONEYAMA H, 1993, ANTIMICROB AGENTS CH, V37, P2385, DOI 10.1128/AAC.37.11.2385; Zeng ZR, 2014, DIAGN MICR INFEC DIS, V78, P268, DOI 10.1016/j.diagmicrobio.2013.11.014	21	21	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139995	10.1371/journal.pone.0139995	http://dx.doi.org/10.1371/journal.pone.0139995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440806	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510300092
J	Arts, FA; Chand, D; Pecquet, C; Velghe, AI; Constantinescu, S; Hallberg, B; Demoulin, JB				Arts, F. A.; Chand, D.; Pecquet, C.; Velghe, A. I.; Constantinescu, S.; Hallberg, B.; Demoulin, J-B			PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib	ONCOGENE			English	Article							GASTROINTESTINAL STROMAL TUMORS; BASAL GANGLIA CALCIFICATION; RECEPTOR TYROSINE KINASES; CELL-TRANSFORMATION; ACTIVATING MUTATION; OF-FUNCTION; GROWTH; GENE; GAIN; DISORDERS	Recently, germline and somatic heterozygous mutations in the platelet-derived growth factor receptor beta (PDGFRB) have been associated with familial infantile myofibromatosis (IM), which is characterized by soft tissue tumors, and overgrowth syndrome, a disease that predisposes to cancer. These mutations have not been functionally characterized. In the present study, the activity of three PDGFRB mutants associated with familial IM (R561C, P660T and N666K) and one PDGFRB mutant found in patients with overgrowth syndrome (P584R) was tested in various models. The P660T mutant showed no difference with the wild-type receptor, suggesting that it might represent a polymorphic variant unrelated to the disease. By contrast, the three other mutants were constitutively active and able to transform NIH3T3 and Ba/F3 cells to different extents. In particular, the germline mutant identified in overgrowth syndrome, P584R, was a stronger oncogene than the germline R561C mutant associated with myofibromatosis. The distinct phenotypes associated with these two mutations could be related to this difference of potency. Importantly, all activated mutants were sensitive to tyrosine kinase inhibitors such as imatinib, nilotinib and ponatinib. In conclusion, the PDGFRB mutations previously identified in familial IM and overgrowth syndrome activate the receptor in the absence of ligand, supporting the hypothesis that these mutations cause the diseases. Moreover, imatinib seems to be a promising treatment for patients carrying these mutations. To our knowledge, these are the first confirmed gain-of-function point mutations of PDGFRB in human cancer.	[Arts, F. A.; Pecquet, C.; Velghe, A. I.; Constantinescu, S.; Demoulin, J-B] Catholic Univ Louvain, Duve Inst, Ave Hippocrate 75,Box B1-74-05, B-1200 Brussels, Belgium; [Chand, D.; Hallberg, B.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Chand, D.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Pecquet, C.; Constantinescu, S.] Ludwig Inst Canc Res, Brussels, Belgium	Universite Catholique Louvain; University of Gothenburg; Umea University; Ludwig Institute for Cancer Research	Demoulin, JB (corresponding author), Catholic Univ Louvain, Duve Inst, Ave Hippocrate 75,Box B1-74-05, B-1200 Brussels, Belgium.	jb.demoulin@uclouvain.be		Demoulin, Jean-Baptiste/0000-0002-8016-6689; Christian, Pecquet/0000-0002-8623-3483; Constantinescu, Stefan N./0000-0002-8599-2699	FRS-FNRS - Televie [7.4501.13 F]	FRS-FNRS - Televie(Fonds de la Recherche Scientifique - FNRS)	We would like to thank Nicolas Dauguet for cell sorting, and Anabelle Decottignies, Guy Warnier and Laure Dumoutier for generous donation of reagents. We are grateful to Ahmed Essaghir for statistical analysis. FAA is the recipient of a fellowship from FRS-FNRS - Televie (grant number 7.4501.13 F).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ang P, 2004, CUTIS, V73, P229; Arts FA, 2015, J CELL MOL MED, V19, P239, DOI 10.1111/jcmm.12443; Barker KT, 2003, EUR J HUM GENET, V11, P665, DOI 10.1038/sj.ejhg.5201026; BRACKO M, 1992, CANCER-AM CANCER SOC, V69, P1294; Cheung YH, 2013, AM J HUM GENET, V92, P996, DOI 10.1016/j.ajhg.2013.04.026; Chiara F, 2004, J BIOL CHEM, V279, P42516, DOI 10.1074/jbc.M406051200; CHUNG EB, 1981, CANCER, V48, P1807, DOI 10.1002/1097-0142(19811015)48:8<1807::AID-CNCR2820480818>3.0.CO;2-G; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; David M, 2007, BLOOD, V109, P61, DOI 10.1182/blood-2006-05-024828; Demoulin JB, 2000, CANCER RES, V60, P3971; Demoulin JB, 2003, ONCOGENE, V22, P1763, DOI 10.1038/sj.onc.1206253; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; KEATING MT, 1989, J BIOL CHEM, V264, P9129; Lacerda LD, 2014, RADIOL RES PRACT, V2014, DOI 10.1155/2014/947451; Li-Wan-Po A, 2010, EUR J CLIN PHARMACOL, V66, P369, DOI 10.1007/s00228-009-0779-4; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Linhares ND, 2014, GENET MOL RES, V13, P6287, DOI 10.4238/2014.August.15.11; Looman C, 2007, INT J DEV BIOL, V51, P361, DOI 10.1387/ijdb.072301cl; Martignetti JA, 2013, AM J HUM GENET, V92, P1001, DOI 10.1016/j.ajhg.2013.04.024; Mashiah J, 2014, J AM ACAD DERMATOL, V71, P264, DOI 10.1016/j.jaad.2014.03.035; Medves S, 2010, LEUKEMIA, V24, P1052, DOI 10.1038/leu.2010.13; Medves S, 2011, HAEMATOL-HEMATOL J, V96, P1406, DOI 10.3324/haematol.2011.040147; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; Millot F, 2014, EUR J CANCER, V50, P3206, DOI 10.1016/j.ejca.2014.10.007; Nakahara M, 1998, GASTROENTEROLOGY, V115, P1090, DOI 10.1016/S0016-5085(98)70079-4; Nicolas G, 2013, BRAIN, V136, P3395, DOI 10.1093/brain/awt255; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; Noel LA, 2014, MOL ONCOL, V8, P728, DOI 10.1016/j.molonc.2014.02.003; Schonherr C, 2011, BIOCHEM J, V440, P405, DOI 10.1042/BJ20101796; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Toffalini F, 2010, BLOOD, V116, P2429, DOI 10.1182/blood-2010-04-279752; Velghe AI, 2014, ONCOGENE, V33, P2568, DOI 10.1038/onc.2013.218; Verstraete K, 2012, NAT REV CANCER, V12, P753, DOI 10.1038/nrc3371; WISWELL TE, 1985, PEDIATRICS, V76, P981; Zand DJ, 2004, AM J MED GENET A, V126A, P261, DOI 10.1002/ajmg.a.20598	40	48	50	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3239	3248		10.1038/onc.2015.383	http://dx.doi.org/10.1038/onc.2015.383			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26455322				2022-12-26	WOS:000378306400003
J	Singh, J; Wen, XH; Scales, SJ				Singh, Jaskirat; Wen, Xiaohui; Scales, Suzie J.			The Orphan G Protein-coupled Receptor Gpr175 (Tpra40) Enhances Hedgehog Signaling by Modulating cAMP Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; KINASE-A; ZEBRAFISH DEVELOPMENT; TUMOR-SUPPRESSOR; NEURAL-TUBE; CELL-LINES; BETA-TRCP; GLI3; PATHWAY; ACTIVATION	The Hedgehog (Hh) signaling pathway plays an essential role in vertebrate embryonic tissue patterning of many developing organs. Signaling occurs predominantly in primary cilia and is initiated by the entry of theGprotein-coupled receptor (GPCR)like protein Smoothened into cilia and culminates in gene transcription via the Gli family of transcription factors upon their nuclear entry. Here we identify an orphan GPCR, Gpr175 (also known as Tpra1 or Tpra40: transmembrane protein, adipocyte associated 1 or of 40 kDa), which also localizes to primary cilia upon Hh stimulation and positively regulates Hh signaling. Interaction experiments place Gpr175 at the level of PKA and upstream of the G alpha(i) component of heterotrimeric G proteins, which itself localizes to cilia and can modulate Hh signaling. Gpr175 or G alpha(i1) depletion leads to increases in cellular cAMP levels and in Gli3 processing into its repressor form. Thus we propose that Gpr175 coupled to G alpha(i1) normally functions to inhibit the production of cAMP by adenylyl cyclase upon Hh stimulation, thus maximizing signaling by turning off PKA activity and hence Gli3 repressor formation. Taken together our data suggest that Gpr175 is a novel positive regulator of the Hh signaling pathway.	[Singh, Jaskirat; Wen, Xiaohui; Scales, Suzie J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Scales, SJ (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	sscales@gene.com	Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283				Aki T, 2008, J CELL PHYSIOL, V217, P194, DOI 10.1002/jcp.21492; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Barzi M, 2011, J BIOL CHEM, V286, P8067, DOI 10.1074/jbc.M110.178772; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen Y, 2011, J BIOL CHEM, V286, P13502, DOI 10.1074/jbc.M110.217604; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Goldman J, 2015, CLIN CANCER RES, V21, P1002, DOI 10.1158/1078-0432.CCR-14-1234; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Hsu SHC, 2011, DEVELOPMENT, V138, P3791, DOI 10.1242/dev.069492; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Mo R, 1997, DEVELOPMENT, V124, P113; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang H, 1999, ENDOCRINOLOGY, V140, P2859, DOI 10.1210/en.140.6.2859; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	62	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29663	29675		10.1074/jbc.M115.665810	http://dx.doi.org/10.1074/jbc.M115.665810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26451044	hybrid, Green Published			2022-12-26	WOS:000366613400046
J	Yamamoto, H; Shima, T; Yamaguchi, M; Mochizuki, Y; Hoshida, H; Kakuta, S; Kondo-Kakuta, C; Noda, NN; Inagaki, F; Itoh, T; Akada, R; Ohsumi, Y				Yamamoto, Hayashi; Shima, Takayuki; Yamaguchi, Masaya; Mochizuki, Yuh; Hoshida, Hisashi; Kakuta, Soichiro; Kondo-Kakuta, Chika; Noda, Nobuo N.; Inagaki, Fuyuhiko; Itoh, Takehiko; Akada, Rinji; Ohsumi, Yoshinori			The Thermotolerant Yeast Kluyveromyces marxianus Is a Useful Organism for Structural and Biochemical Studies of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; ATG12-ATG5 CONJUGATE; PROTEIN LIPIDATION; ATG PROTEINS; COMPLEX; SYSTEM; CYTOPLASM; MUTANTS; GENES	Autophagy is a conserved degradation process in which autophagosomes are generated by cooperative actions of multiple autophagy-related (Atg) proteins. Previous studies using the model yeast Saccharomyces cerevisiae have provided various insights into the molecular basis of autophagy; however, because of the modest stability of several Atg proteins, structural and biochemical studies have been limited to a subset of Atg proteins, preventing us from understanding how multiple Atg proteins function cooperatively in autophagosome formation. With the goal of expanding the scope of autophagy research, we sought to identify a novel organism with stable Atg proteins that would be advantageous for in vitro analyses. Thus, we focused on a newly isolated thermotolerant yeast strain, Kluyveromyces marxianus DMKU3-1042, to utilize as a novel system elucidating autophagy. We developed experimental methods to monitor autophagy in K. marxianus cells, identified the complete set of K. marxianus Atg homologs, and confirmed that each Atg homolog is engaged in autophagosome formation. Biochemical and bioinformatic analyses revealed that recombinant K. marxianus Atg proteins have superior thermostability and solubility as compared with S. cerevisiae Atg proteins, probably due to the shorter primary sequences of KmAtg proteins. Furthermore, bioinformatic analyses showed that more than half of K. marxianus open reading frames are relatively short in length. These features make K. marxianus proteins broadly applicable as tools for structural and biochemical studies, not only in the autophagy field but also in other fields.	[Yamamoto, Hayashi; Shima, Takayuki; Kakuta, Soichiro; Kondo-Kakuta, Chika; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Yamaguchi, Masaya; Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Dept Biol Struct, Sapporo, Hokkaido 0600812, Japan; [Mochizuki, Yuh; Itoh, Takehiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Silico Funct Genom, Yokohama, Kanagawa 2268501, Japan; [Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Ube, Yamaguchi 7558611, Japan; [Noda, Nobuo N.] Inst Microbial Chem, Tokyo 1410021, Japan	Tokyo Institute of Technology; Hokkaido University; Tokyo Institute of Technology; Yamaguchi University	Yamamoto, H (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan.	yamamoto-hayashi@iri.titech.ac.jp; yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Itoh, Takehiko/E-8873-2014; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Itoh, Takehiko/0000-0002-6113-557X; Noda, Nobuo/0000-0002-6940-8069; Yamaguchi, Masaya/0000-0001-6886-8058	Ministry of Education, Culture, Sports, Science and Technology of Japan [26111508, 23000015]; Grants-in-Aid for Scientific Research [25111004, 26111508] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Innovative Areas 26111508 (to H. Y.) and Grant-in-aid for Specially Promoted Research 23000015 (to Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fonseca GG, 2008, APPL MICROBIOL BIOT, V79, P339, DOI 10.1007/s00253-008-1458-6; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Hong SB, 2011, NAT STRUCT MOL BIOL, V18, P1323, DOI 10.1038/nsmb.2165; Hoshida H, 2014, YEAST, V31, P29, DOI 10.1002/yea.2993; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2009, BIOCHEM BIOPH RES CO, V389, P612, DOI 10.1016/j.bbrc.2009.09.034; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kneller D. G., 1997, SPARKY VERSION 3 105; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Limtong S, 2007, BIORESOURCE TECHNOL, V98, P3367, DOI 10.1016/j.biortech.2006.10.044; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Noda N. N., 1994, METHODS YEAST GENETI; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tamura N, 2010, J CELL SCI, V123, P4107, DOI 10.1242/jcs.070045; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Watanabe Y, 2012, J BIOL CHEM, V287, P31681, DOI 10.1074/jbc.M112.397570; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yamaguchi M, 2012, NAT STRUCT MOL BIOL, V19, P1250, DOI 10.1038/nsmb.2451; Yamaguchi M, 2012, STRUCTURE, V20, P1244, DOI 10.1016/j.str.2012.04.018; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yamaguti M, 2007, ACTA CRYSTALLOGR F, V63, P443, DOI [10.1107/S1744309107017472, 10.1107/S174430910701]; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yarimizu T, 2013, YEAST, V30, P485, DOI 10.1002/yea.2985	59	10	30	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29506	U476		10.1074/jbc.M115.684233	http://dx.doi.org/10.1074/jbc.M115.684233			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26442587	Green Published, hybrid			2022-12-26	WOS:000366613400033
J	Adam, CL; Thomson, LM; Williams, PA; Ross, AW				Adam, Clare L.; Thomson, Lynn M.; Williams, Patricia A.; Ross, Alexander W.			Soluble Fermentable Dietary Fibre (Pectin) Decreases Caloric Intake, Adiposity and Lipidaemia in High-Fat Diet-Induced Obese Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BODY-WEIGHT GAIN; FOOD-INTAKE; METABOLIC-RESPONSES; HEPATIC STEATOSIS; GUAR GUM; SATIETY; MEAL; RESTRICTION; EXPRESSION	Consumption of a high fat diet promotes obesity and poor metabolic health, both of which may be improved by decreasing caloric intake. Satiety-inducing ingredients such as dietary fibre may be beneficial and this study investigates in diet-induced obese (DIO) rats the effects of high or low fat diet with or without soluble fermentable fibre (pectin). In two independently replicated experiments, young adult male DIO rats that had been reared on high fat diet (HF; 45% energy from fat) were given HF, low fat diet (LF; 10% energy from fat), HF with 10% w/w pectin (HF+P), or LF with 10% w/w pectin (LF+P) ad libitum for 4 weeks (n = 8/group/experiment). Food intake, body weight, body composition (by magnetic resonance imaging), plasma hormones, and plasma and liver lipid concentrations were measured. Caloric intake and body weight gain were greatest in HF, lower in LF and HF+P, and lowest in the LF+P group. Body fat mass increased in HF, was maintained in LF, but decreased significantly in LF+P and HF+P groups. Final plasma leptin, insulin, total cholesterol and triglycerides were lower, and plasma satiety hormone PYY concentrations were higher, in LF+P and HF+P than in LF and HF groups, respectively. Total fat and triglyceride concentrations in liver were greatest in HF, lower in LF and HF+P, and lowest in the LF+P group. Therefore, the inclusion of soluble fibre in a high fat (or low fat) diet promoted increased satiety and decreased caloric intake, weight gain, adiposity, lipidaemia, leptinaemia and insulinaemia. These data support the potential of fermentable dietary fibre for weight loss and improving metabolic health in obesity.	[Adam, Clare L.; Thomson, Lynn M.; Williams, Patricia A.; Ross, Alexander W.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Obes & Metab Hlth Div, Ingest Behav Grp, Aberdeen AB21 9SB, Scotland	University of Aberdeen	Adam, CL (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Obes & Metab Hlth Div, Ingest Behav Grp, Aberdeen AB21 9SB, Scotland.	c.adam@abdn.ac.uk		Ross, Alexander/0000-0002-1799-1432	Scottish Government Rural and Environment Science and Analytical Services Division	Scottish Government Rural and Environment Science and Analytical Services Division	This work was funded by the Scottish Government Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115438; Adam CL, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-36; Anastasovska J, 2012, OBESITY, V20, P1016, DOI 10.1038/oby.2012.6; Archer ZA, 2003, OBES RES, V11, P1376, DOI 10.1038/oby.2003.186; Arora T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043263; Arora T, 2011, APPETITE, V56, P511, DOI 10.1016/j.appet.2011.01.016; Brockman DA, 2014, J NUTR, V144, P1415, DOI 10.3945/jn.114.191577; Brouns F, 2012, EUR J CLIN NUTR, V66, P591, DOI 10.1038/ejcn.2011.208; Cani PD, 2005, OBES RES, V13, P1000, DOI 10.1038/oby.2005.117; Chiba T, 2009, MOL CELL ENDOCRINOL, V309, P17, DOI 10.1016/j.mce.2009.05.001; Clark MJ, 2013, J AM COLL NUTR, V32, P200, DOI 10.1080/07315724.2013.791194; Crescenzo R, 2014, EXP PHYSIOL, V99, P1203, DOI 10.1113/expphysiol.2014.079632; Duarte FO, 2012, EXP PHYSIOL, V97, P882, DOI 10.1113/expphysiol.2011.064121; Duca FA, 2013, J NUTR BIOCHEM, V24, P1663, DOI 10.1016/j.jnutbio.2013.05.005; Esmael OA, 2015, TOXICOL IND HEALTH, V31, P281, DOI 10.1177/0748233712472526; Espinal-Ruiz M, 2014, FOOD FUNCT, V5, P3083, DOI 10.1039/c4fo00615a; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P7, DOI 10.1016/0031-9384(94)90255-0; Hadri Z, 2015, PHYSIOL BEHAV, V147, P198, DOI 10.1016/j.physbeh.2015.04.039; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang XF, 2011, MOL NUTR FOOD RES, V55, P1118, DOI 10.1002/mnfr.201100095; Institute of Medicine, 2005, DIET REF INT EN CARB; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Komatsu T, 2006, J GERONTOL A-BIOL, V61, P890, DOI 10.1093/gerona/61.9.890; Lattimer JM, 2010, NUTRIENTS, V2, P1266, DOI 10.3390/nu2121266; LECLERE CJ, 1994, AM J CLIN NUTR, V59, P914, DOI 10.1093/ajcn/59.4.914; Lin N, 2013, MOL NUTR FOOD RES, V57, P1291, DOI 10.1002/mnfr.201200695; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; Mah AT, 2014, ENDOCRINOLOGY, V155, P3302, DOI 10.1210/en.2014-1112; Nakamura Y, 2017, BIOFACTORS, V43, P145, DOI 10.1002/biof.147; Nascimento RC, 2013, INT J GEN MED, V6, P479, DOI 10.2147/IJGM.S35482; Rebello C, 2014, CURR OPIN CLIN NUTR, V17, P596, DOI 10.1097/MCO.0000000000000110; Rosini TC, 2012, REV ASSOC MED BRAS, V58, P383; Schroeder N, 2013, NUTRIENTS, V5, P2093, DOI 10.3390/nu5062093; Shen L, 2009, OBESITY, V17, P40, DOI 10.1038/oby.2008.483; Trigueros L, 2013, CRIT REV FOOD SCI, V53, P929, DOI 10.1080/10408398.2011.574215; Turner ND, 2011, ADV NUTR, V2, P151, DOI 10.3945/an.110.000281; van Nieuwenhoven MA, 2001, J AM COLL NUTR, V20, P87, DOI 10.1080/07315724.2001.10719019; Vasselli JR, 2013, ADV NUTR, V4, P164, DOI 10.3945/an.112.003152; Williams LM, 2012, P NUTR SOC, V71, P521, DOI 10.1017/S002966511200078X	40	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140392	10.1371/journal.pone.0140392	http://dx.doi.org/10.1371/journal.pone.0140392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447990	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000120
J	Azeredo, R; Perez-Sanchez, J; Sitja-Bobadilla, A; Fouz, B; Tort, L; Aragao, C; Oliva-Teles, A; Costas, B				Azeredo, Rita; Perez-Sanchez, Jaume; Sitja-Bobadilla, Ariadna; Fouz, Belen; Tort, Lluis; Aragao, Claudia; Oliva-Teles, Aires; Costas, Benjamin			European Sea Bass (Dicentrarchus labrax) Immune Status and Disease Resistance Are Impaired by Arginine Dietary Supplementation	PLOS ONE			English	Article							INDUCED INFLAMMATORY RESPONSE; CARPIO VAR. JIAN; GROWTH-PERFORMANCE; AEROMONAS-SALMONICIDA; VIBRIO-ANGUILLARUM; JUVENILE JIAN; AMINO-ACIDS; IN-VITRO; FISH; GLUTAMINE	Infectious diseases and fish feeds management are probably the major expenses in the aquaculture business. Hence, it is a priority to define sustainable strategies which simultaneously avoid therapeutic procedures and reinforce fish immunity. Currently, one preferred approach is the use of immunostimulants which can be supplemented to the fish diets. Arginine is a versatile amino acid with important mechanisms closely related to the immune response. Aiming at finding out how arginine affects the innate immune status or improve disease resistance of European seabass (Dicentrarchus labrax) against vibriosis, fish were fed two arginine-supplemented diets (1% and 2% arginine supplementation). A third diet meeting arginine requirement level for seabass served as control diet. Following 15 or 29 days of feeding, fish were sampled for blood, spleen and gut to assess cell-mediated immune parameters and immune-related gene expression. At the same time, fish from each dietary group were challenged against Vibrio anguillarum and survival was monitored. Cell-mediated immune parameters such as the extracellular superoxide and nitric oxide decreased in fish fed arginine-supplemented diets. Interleukins and immune-cell marker transcripts were down-regulated by the highest supplementation level. Disease resistance data were in accordance with a generally depressed immune status, with increased susceptibility to vibriosis in fish fed arginine supplemented diets. Altogether, these results suggest a general inhibitory effect of arginine on the immune defences and disease resistance of European seabass. Still, further research will certainly clarify arginine immunomodulation pathways thereby allowing the validation of its potential as a prophylactic strategy.	[Azeredo, Rita; Oliva-Teles, Aires; Costas, Benjamin] Univ Porto, CIIMAR, P-4050123 Oporto, Portugal; [Azeredo, Rita; Oliva-Teles, Aires] Univ Porto FCUP, Fac Ciencias, Dept Biol, P-4169007 Oporto, Portugal; [Tort, Lluis] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol Anim & Immunol, Bellaterra, Spain; [Perez-Sanchez, Jaume] IATS CSIC, Inst Aquaculture Torre Sal, Nutrigen & Fish Growth Endocrinol Grp, Ribera De Cabanes 12595, Castellon, Spain; [Sitja-Bobadilla, Ariadna] IATS CSIC, Inst Aquaculture Torre Sal, Fish Pathol Grp, Ribera De Cabanes 12595, Castellon, Spain; [Fouz, Belen] Univ Valencia, Fac Biol, Dept Microbiol & Ecol, E-46100 Valencia, Spain; [Aragao, Claudia] Univ Algarve, Ctr Ciencias Mar, P-8005139 Faro, Portugal	Universidade do Porto; Universidade do Porto; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University of Valencia; Universidade do Algarve	Azeredo, R (corresponding author), Univ Porto, CIIMAR, Rua Bragas 289, P-4050123 Oporto, Portugal.	mleme@ciimar.up.pt; bcostas@ciimar.up.pt	Aragão, Cláudia/K-2310-2012; Sánchez, Jaume Pérez/AAJ-6628-2021; Sitjà-Bobadilla, Ariadna/J-2715-2014; Fouz, Belén/N-8048-2015; sanchez, jaume perez/K-3231-2014; Oliva-Teles, Aires/B-3555-2008; Quality, Aquaculture Seafood/AAD-7718-2019; Costas, Benjamín/F-9350-2010; Tort, Lluis/H-5650-2011	Aragão, Cláudia/0000-0002-9217-0183; Sánchez, Jaume Pérez/0000-0003-2506-1523; Sitjà-Bobadilla, Ariadna/0000-0002-7473-3413; Fouz, Belén/0000-0001-9751-0143; sanchez, jaume perez/0000-0003-2506-1523; Oliva-Teles, Aires/0000-0002-5730-836X; Costas, Benjamín/0000-0003-3758-0849; Azeredo, Rita/0000-0003-2486-595X; Tort, Lluis/0000-0002-3907-722X	European Union's Seventh Framework Programme AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research) [262336]; AQUAIMPROV [NORTE-07-0124-FEDER-000038]; North Portugal Regional Operational Programme (ON. 2 - O Novo Norte) , under the National Strategic Reference Framework, through the European Regional Development Fund; North Portugal Regional Operational Programme (ON. 2 - O Novo Norte), under the National Strategic Reference Framework through the COMPETE - Operational Competitiveness Programme; Fundacao para a Ciencia e Tecnologia; Fundacao para a Ciencia e Tecnologia [SFRH/BD/89457/2012, SFRH/BPD/77210/2011]; Generalitat Valenciana through the project REVIDPAQUA [ISIC/2012/003];  [PEst-C/MAR/LA0015/2013];  [UID/Multi/04423/2013]	European Union's Seventh Framework Programme AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research); AQUAIMPROV; North Portugal Regional Operational Programme (ON. 2 - O Novo Norte) , under the National Strategic Reference Framework, through the European Regional Development Fund; North Portugal Regional Operational Programme (ON. 2 - O Novo Norte), under the National Strategic Reference Framework through the COMPETE - Operational Competitiveness Programme; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Generalitat Valenciana through the project REVIDPAQUA; ; 	This work was partially funded by European Union's Seventh Framework Programme AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, grant agreement no. 262336), AQUAIMPROV (reference NORTE-07-0124-FEDER-000038), PEst-C/MAR/LA0015/2013 and UID/Multi/04423/2013. It was co-financed by the North Portugal Regional Operational Programme (ON. 2 - O Novo Norte), under the National Strategic Reference Framework, through the European Regional Development Fund, and through the COMPETE - Operational Competitiveness Programme and national funds through the Fundacao para a Ciencia e Tecnologia, respectively. RA and BC were supported by Fundacao para a Ciencia e Tecnologia (grants SFRH/BD/89457/2012 and SFRH/BPD/77210/2011, respectively). Additional funding was obtained from the Generalitat Valenciana through the project REVIDPAQUA (ISIC/2012/003).	Ahmed TJ, 2014, DRUG DISCOV TODAY, V19, P1166, DOI 10.1016/j.drudis.2014.05.020; Andersen SM, 2013, BRIT J NUTR, V110, P1968, DOI 10.1017/S0007114513001402; Ballantyne J.S., 2001, Fish Physiology, V20, P77; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Breuillard C, 2015, AMINO ACIDS, V47, P685, DOI 10.1007/s00726-015-1932-2; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Buentello JA, 2001, J AQUAT ANIM HEALTH, V13, P194, DOI 10.1577/1548-8667(2001)013&lt;0194:EOEDAO&gt;2.0.CO;2; Chen GF, 2015, FISH SHELLFISH IMMUN, V44, P195, DOI 10.1016/j.fsi.2015.02.027; Chen Y, 2012, BRIT J NUTR, V108, P1069, DOI 10.1017/S0007114511006350; Cheng ZY, 2012, AQUACULTURE, V362, P39, DOI 10.1016/j.aquaculture.2012.07.015; Cheng ZY, 2011, AQUACULTURE, V319, P247, DOI 10.1016/j.aquaculture.2011.06.025; Costas B, 2013, AQUACULT NUTR, V19, P25, DOI 10.1111/anu.12086; Fouz B, 2010, J FISH DIS, V33, P383, DOI 10.1111/j.1365-2761.2009.01130.x; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Galeottia M, 2013, VACCINE, V31, P1224, DOI 10.1016/j.vaccine.2012.12.041; GRAHAM S, 1988, J FISH DIS, V11, P389, DOI 10.1111/j.1365-2761.1988.tb00734.x; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Jiang J, 2015, FISH SHELLFISH IMMUN, V42, P457, DOI 10.1016/j.fsi.2014.11.030; Kapp K, 2014, J LEUKOCYTE BIOL, V96, P1047, DOI 10.1189/jlb.3AB0214-082R; Kaushik SJ, 1998, AQUAT LIVING RESOUR, V11, P355, DOI 10.1016/S0990-7440(98)80007-7; Kleinert H., 2010, NITRIC OXIDE-BIOL CH, P211, DOI [10.1016/B978-0- 12-373866-0.00007-1, DOI 10.1016/B978-0-12-373866-0.00007-1, 10.1016/ B978-0-12-373866-0.00007-1]; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leland KM, 2011, INT IMMUNOPHARMACOL, V11, P1341, DOI 10.1016/j.intimp.2011.04.018; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Li P, 2009, AMINO ACIDS, V37, P43, DOI 10.1007/s00726-008-0171-1; Lin HZ, 2015, AQUACULTURE, V437, P382, DOI 10.1016/j.aquaculture.2014.12.025; Machado M, 2015, FISH SHELLFISH IMMUN, V42, P353, DOI 10.1016/j.fsi.2014.11.024; Nakaya N, 2007, MOL CELL BIOL, V27, P5430, DOI 10.1128/MCB.00551-06; Nikoskelainen S, 2005, DEV COMP IMMUNOL, V29, P525, DOI 10.1016/j.dci.2004.10.006; Nomura A, 2003, BRIT J PHARMACOL, V139, P715, DOI 10.1038/sj.bjp.0705316; Plouffe DA, 2005, XENOTRANSPLANTATION, V12, P266, DOI 10.1111/j.1399-3089.2005.00227.x; Pohlenz C, 2014, AQUAC RES, V45, P491, DOI 10.1111/j.1365-2109.2012.03252.x; Popovic PJ, 2007, J NUTR, V137, p1681S, DOI 10.1093/jn/137.6.1681S; Prolo C, 2014, BIOFACTORS, V40, P215, DOI 10.1002/biof.1150; Rengpipat S, 2008, AQUAC RES, V39, P134, DOI 10.1111/j.1365-2109.2007.01864.x; Ringo E, 2010, AQUACULT NUTR, V16, P117, DOI 10.1111/j.1365-2095.2009.00731.x; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; Sepulcre MP, 2007, MOL IMMUNOL, V44, P3751, DOI 10.1016/j.molimm.2007.03.021; Sikalidis AK, 2015, PATHOL ONCOL RES, V21, P9, DOI 10.1007/s12253-014-9860-0; Srivastava S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066057; Tan JZ, 2014, BRIT J NUTR, V111, P1394, DOI 10.1017/S0007114513003863; Tang L, 2009, AQUACULT NUTR, V15, P477, DOI 10.1111/j.1365-2095.2008.00613.x; Tejera N, 2007, AQUACULTURE, V270, P218, DOI 10.1016/j.aquaculture.2007.01.019; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Uribe C, 2011, VET MED-CZECH, V56, P486, DOI 10.17221/3294-VETMED; Wood CM, 2001, NITROGEN EXCRETION, P201, DOI DOI 10.1016/S1546-5098(01)20007-7; Zhao K, 2010, BIOSCIENCE REP, V30, P233, DOI 10.1042/BSR20090048; Zhou QC, 2015, AQUACULTURE, V437, P84, DOI 10.1016/j.aquaculture.2014.11.030	49	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139967	10.1371/journal.pone.0139967	http://dx.doi.org/10.1371/journal.pone.0139967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447480	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000072
J	Cardno, TS; Shimaki, Y; Sleebs, BE; Lackovic, K; Parisot, JP; Moss, RM; Crowe-McAuliffe, C; Mathew, SF; Edgar, CD; Kleffmann, T; Tate, WP				Cardno, Tony S.; Shimaki, Yosuke; Sleebs, Brad E.; Lackovic, Kurt; Parisot, John P.; Moss, Rebecca M.; Crowe-McAuliffe, Caillan; Mathew, Suneeth F.; Edgar, Christina D.; Kleffmann, Torsten; Tate, Warren P.			HIV-1 and Human PEG10 Frameshift Elements Are Functionally Distinct and Distinguished by Novel Small Molecule Modulators	PLOS ONE			English	Article							STEM-LOOP RNA; RIBOSOMAL FRAMESHIFT; MESSENGER-RNA; SITE; IDENTIFICATION; SIGNAL; ASSAY; MECHANISM; SEQUENCE; TARGET	Frameshifting during translation of viral or in rare cases cellular mRNA results in the synthesis of proteins from two overlapping reading frames within the same mRNA. In HIV-1 the protease, reverse transcriptase, and integrase enzymes are in a second reading frame relative to the structural group-specific antigen (gag), and their synthesis is dependent upon frameshifting. This ensures that a strictly regulated ratio of structural proteins and enzymes, which is critical for HIV-1 replication and viral infectivity, ismaintained during protein synthesis. The frameshift element in HIV-1 RNA is an attractive target for the development of a new class of anti HIV-1 drugs. However, a number of examples are now emerging of human genes using -1 frameshifting, such as PEG10 and CCR5. In this study we have compared the HIV-1 and PEG10 frameshift elements and shown they have distinct functional characteristics. Frameshifting occurs at several points within each element. Moreover, frameshift modulators that were isolated by high-throughput screening of a library of 114,000 lead-like compounds behaved differently with the PEG10 frameshift element. The most effective compounds affecting the HIV-1 element enhanced frameshifting by 2.5-fold at 10 mu M in two different frameshift reporter assay systems. HIV-1 protease: gag protein ratio was affected by a similar amount in a specific assay of virally-infected cultured cell, but the modulation of frameshifting of the firstiteration compounds was not sufficient to show significant effects on viral infectivity. Importantly, two compounds did not affect frameshifting with the human PEG10 element, while one modestly inhibited rather than enhanced frameshifting at the human element. These studies indicate that frameshift elements have unique characteristics thatmay allow targeting of HIV-1 and of other viruses specifically for development of antiviral therapeutic molecules without effect on human genes like PEG10 that use the same genericmechanism.	[Cardno, Tony S.; Shimaki, Yosuke; Crowe-McAuliffe, Caillan; Mathew, Suneeth F.; Edgar, Christina D.; Kleffmann, Torsten; Tate, Warren P.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Cardno, Tony S.; Sleebs, Brad E.; Lackovic, Kurt; Moss, Rebecca M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Sleebs, Brad E.; Lackovic, Kurt; Parisot, John P.; Moss, Rebecca M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Kleffmann, Torsten] Univ Otago, Ctr Prot Res, Dunedin, New Zealand	University of Otago; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Otago	Tate, WP (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	warren.tate@otago.ac.nz	; Sleebs, Brad/J-9639-2014	Tate, Warren/0000-0002-6971-7734; Crowe-McAuliffe, Caillan/0000-0003-2157-4639; Kleffmann, Torsten/0000-0001-9305-5980; Sleebs, Brad/0000-0001-9117-1048	Health Research Council of New Zealand's International Investment Opportunities Fund [IIOF 09_04]; Walter and Eliza Hall Institute; Otago Innovation Pty Ltd.; National Health and Medical Research Council of Australia [1010326]; Australian Cancer Research Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS	Health Research Council of New Zealand's International Investment Opportunities Fund(Health Research Council of New Zealand); Walter and Eliza Hall Institute; Otago Innovation Pty Ltd.; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Health Research Council of New Zealand's International Investment Opportunities Fund (IIOF 09_04 to W.P.T., J.P.P and T.SC) and co-funded by the Walter and Eliza Hall Institute and Otago Innovation Pty Ltd. The authors thank the National Health and Medical Research Council of Australia (App. 1010326 for funding B.E.S.), the Australian Cancer Research Foundation, and a Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Belew AT, 2014, NATURE, V512, P265, DOI 10.1038/nature13429; Biswas P, 2004, J VIROL, V78, P2082, DOI 10.1128/JVI.78.4.2082-2087.2004; Cardno TS, 2009, RNA, V15, P1614, DOI 10.1261/rna.1586709; Clark MB, 2007, J BIOL CHEM, V282, P37359, DOI 10.1074/jbc.M705676200; Cohen J, 2002, SCIENCE, V296, P2320, DOI 10.1126/science.296.5577.2320; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dulude D, 2006, VIROLOGY, V345, P127, DOI 10.1016/j.virol.2005.08.048; Dulude D, 2002, NUCLEIC ACIDS RES, V30, P5094, DOI 10.1093/nar/gkf657; Dulude D, 2008, RNA, V14, P981, DOI 10.1261/rna.887008; Farabaugh PJ, 2000, PROG NUCLEIC ACID RE, V64, P131, DOI 10.1016/S0079-6603(00)64004-7; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; Hung M, 1998, J VIROL, V72, P4819, DOI 10.1128/JVI.72.6.4819-4824.1998; Irvine JH, 1998, NEW ZEAL MED J, V111, P222; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Kalman Yoram M., 1994, European Journal of Human Genetics, V2, P77; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Marcheschi RJ, 2011, ACS CHEM BIOL, V6, P857, DOI 10.1021/cb200082d; Mathew SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122176; McNaughton BR, 2007, J AM CHEM SOC, V129, P11306, DOI 10.1021/ja072114h; Ofori LO, 2014, J MED CHEM, V57, P723, DOI 10.1021/jm401438g; Palde PB, 2010, J MED CHEM, V53, P6018, DOI 10.1021/jm100231t; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; Plant EP, 2006, RNA, V12, P666, DOI 10.1261/rna.2225206; Ramsay JP, 2015, P NATL ACAD SCI USA, V112, P4104, DOI 10.1073/pnas.1501574112; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shimaki Y, 2015, THESIS; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Telenti A, 2002, J VIROL, V76, P7868, DOI 10.1128/JVI.76.15.7868-7873.2002; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; UNAIDS, 2010, GLOBAL REPORT UNAIDS; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200; Yan SN, 2015, CELL, V160, P870, DOI 10.1016/j.cell.2015.02.003; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	40	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139036	10.1371/journal.pone.0139036	http://dx.doi.org/10.1371/journal.pone.0139036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447468	gold, Green Published			2022-12-26	WOS:000362511000017
J	Rabkin, M; Mutiti, A; Chung, C; Zhang, Y; Wei, Y; El-Sadr, WM				Rabkin, Miriam; Mutiti, Anthony; Chung, Christine; Zhang, Yuan; Wei, Ying; El-Sadr, Wafaa M.			Missed Opportunities to Address Cardiovascular Disease Risk Factors amongst Adults Attending an Urban HIV Clinic in South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; PREDICTION CHARTS; HYPERTENSION; PREVALENCE; MIDDLE; SOCIETY	We assessed cardiovascular disease (CVD) risk factor prevalence and risk stratification amongst adults on antiretroviral therapy in South Africa. Of the 175 patients screened, 37.8% had high blood pressure (HBP), 15.4% were current smokers, 10.4% had elevated cholesterol, and 4.1% had diabetes, but very few (3.6%) had a 10-year CVD risk >10%. One-third of those with HBP, 40% of those with diabetes, and two-thirds of those with high cholesterol had not previously been diagnosed. Although participants were adherent with chronic HIV care, screening for and management of CVDRF were suboptimal, representing a missed opportunity to reduce non-AIDS morbidity and mortality.	[Rabkin, Miriam; El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, ICAP Columbia, New York, NY 10027 USA; [Rabkin, Miriam; El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Rabkin, Miriam; El-Sadr, Wafaa M.] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Mutiti, Anthony] ICAP South Africa, Pretoria, South Africa; [Chung, Christine] ICAP Malawi, Lilongwe, Malawi; [Zhang, Yuan; Wei, Ying] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Rabkin, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, ICAP Columbia, New York, NY 10027 USA.	mr84@columbia.edu			Medtronic Philanthropy	Medtronic Philanthropy	Funding for the study was provided by Medtronic Philanthropy.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Dave JA, 2011, JAIDS-J ACQ IMM DEF, V57, P284, DOI 10.1097/QAI.0b013e318221863f; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Julius H, 2011, CURR HIV RES, V9, P247, DOI 10.2174/157016211796320360; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Narayan KMV, 2014, JAIDS-J ACQ IMM DEF, V67, pS2, DOI 10.1097/QAI.0000000000000267; Ogah OS, 2013, HEART, V99, P1390, DOI 10.1136/heartjnl-2012-303227; Otgontuya D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-539; Peer N, 2014, DIABETES RES CLIN PR, V103, P197, DOI 10.1016/j.diabres.2013.11.006; Shishana O, 2014, S AFRICAN NATL HLTH; Sreeramareddy CT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0243-x; Tibazarwa K, 2009, INT J CARDIOL, V132, P233, DOI 10.1016/j.ijcard.2007.11.067; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237; World Health Organization, 2007, PREV CARD DIS GUID A	26	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140298	10.1371/journal.pone.0140298	http://dx.doi.org/10.1371/journal.pone.0140298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447777	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000118
J	Torres, JB; Vilar, MG; Torres, GA; Gaieski, JB; Hernandez, RB; Browne, ZE; Stevenson, M; Walters, W; Schurr, TG				Torres, Jada Benn; Vilar, Miguel G.; Torres, Gabriel A.; Gaieski, Jill B.; Hernandez, Ricardo Bharath; Browne, Zoila E.; Stevenson, Marlon; Walters, Wendell; Schurr, Theodore G.		Genographic Consortium	Genetic Diversity in the Lesser Antilles and Its Implications for the Settlement of the Caribbean Basin	PLOS ONE			English	Article							Y-CHROMOSOMAL DIVERSITY; DNA MACROHAPLOGROUP M; MITOCHONDRIAL-DNA; MUTATION-RATE; SEQUENCE VARIATION; PUERTO-RICO; AFRICAN; POPULATION; ANCESTRY; MTDNA	Historical discourses about the Caribbean often chronicle West African and European influence to the general neglect of indigenous people's contributions to the contemporary region. Consequently, demographic histories of Caribbean people prior to and after European contact are not well understood. Although archeological evidence suggests that the Lesser Antilles were populated in a series of northward and eastern migratory waves, many questions remain regarding the relationship of the Caribbean migrants to other indigenous people of South and Central America and changes to the demography of indigenous communities post-European contact. To explore these issues, we analyzed mitochondrial DNA and Y-chromosome diversity in 12 unrelated individuals from the First Peoples Community in Arima, Trinidad, and 43 unrelated Garifuna individuals residing in St. Vincent. In this community-sanctioned research, we detected maternal indigenous ancestry in 42% of the participants, with the remainder having haplotypes indicative of African and South Asian maternal ancestry. Analysis of Y-chromosome variation revealed paternal indigenous American ancestry indicated by the presence of haplogroup Q-M3 in 28% of the male participants from both communities, with the remainder possessing either African or European haplogroups. This finding is the first report of indigenous American paternal ancestry among indigenous populations in this region of the Caribbean. Overall, this study illustrates the role of the region's first peoples in shaping the genetic diversity seen in contemporary Caribbean populations.	[Torres, Jada Benn; Torres, Gabriel A.] Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA; [Vilar, Miguel G.; Gaieski, Jill B.; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Vilar, Miguel G.] Natl Geog Soc, Missions Programs, Washington, DC USA; [Hernandez, Ricardo Bharath] Santa Rosa First Peoples Community, Arima, Trinidad Tobago; [Browne, Zoila E.; Stevenson, Marlon; Walters, Wendell] Garifuna Heritage Fdn Inc, Kingston, St Vincent	University of Notre Dame; University of Pennsylvania; National Geographic Society	Torres, JB (corresponding author), Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA.	jbenntor@nd.edu	Santos, Fabrício Rodrigues/H-2370-2011; Haber, Marc/Y-5090-2019	Santos, Fabrício Rodrigues/0000-0001-9088-1750; Haber, Marc/0000-0003-1000-1448; Royyuru, Ajay/0000-0003-4440-4755; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Quintana-Murci, Lluis/0000-0003-2429-6320; Benn Torres, Jada/0000-0001-9678-4038; mele, marta/0000-0001-8874-6453	National Geographic Society; IBM; Waitt Family Foundation; University of Pennsylvania; Institute for Scholarship and Learning at the University of Notre Dame	National Geographic Society(National Geographic Society); IBM(International Business Machines (IBM)); Waitt Family Foundation; University of Pennsylvania; Institute for Scholarship and Learning at the University of Notre Dame	This work was supported by the National Geographic Society, IBM, Waitt Family Foundation, the University of Pennsylvania, and the Institute for Scholarship and Learning at the University of Notre Dame. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi JFA, 1985, HIST W AFRICA; ALLAIRE L, 1980, AM ANTIQUITY, V45, P238, DOI 10.2307/279283; Allaire L., 2003, GEN HIST CARIBBEAN, V1, P195; Anderson M., 2009, BLACK INDIGENOUS GAR; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], [No title captured]; Athey TW., 2006, J GENET GENEAL, V2, P34; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Beckles Hilary McDonald, 2008, CARIBBEAN Q, V54, P77; Bisso-Machado R, 2011, AM J HUM BIOL, V23, P563, DOI 10.1002/ajhb.21173; Borjas Lisbeth, 2008, Legal Medicine, V10, P107, DOI 10.1016/j.legalmed.2007.08.005; Boucher PP., 1992, TERRAE INCOGNITAE, V24, P55; Brereton B, 1996, INTRO HIST TRIN TOB; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Buckova J, 2013, AM J PHYS ANTHROPOL, V151, P10, DOI 10.1002/ajpa.22236; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Callaghan RT, 2003, LAT AM ANTIQ, V14, P323, DOI 10.2307/3557564; Callaghan RT, 2001, CURR ANTHROPOL, V42, P308, DOI 10.1086/320012; CARICOM SS, 2011, CARICOM STAT MID YEA; de Guerra DC, 2012, FORENSIC SCI INT-GEN, V6, pE131, DOI 10.1016/j.fsigen.2011.11.004; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Curet L.A., 2011, ISLANDS CROSSROADS M; DAVIS DD, 1990, AM ANTIQUITY, V55, P37, DOI 10.2307/281491; Deason ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-24; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L., 2006, INTEGRATED SOFTWARE; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fitzpatrick SM, 2006, LAT AM ANTIQ, V17, P389; Fitzpatrick SM, 2011, RADIOCARBON, V53, P595, DOI 10.1017/S0033822200039072; Fitzpatrick SM., 2013, OXFORD HDB CARIBBEAN; Forte MC, 2006, RES ECON AN, V24, P329; Forte MC, 2002, SINCRONIA, V1, P2; Forte MC., 2005, RUINS ABSENSE PRESEN; Gaieski JB, 2011, AM J PHYS ANTHROPOL, V146, P392, DOI 10.1002/ajpa.21588; Gene Codes Corporation, 2009, SEQ VERS 4 9 S; Gonzalez NancieL., 1988, SOJOURNERS CARIBBEAN; Gonzalez NLS, 1971, PEOPLES CULTURES CAR, P133; Granberry J., 2013, OXFORD HDB CARIBBEAN; Gullick CJMR, 1984, BLACK CARIBS CASE ST, V3, P37, DOI [DOI 10.1007/978-1-4613-2649-6_3, 10.1007/978-1-4613-2649-6_3]; Haag W, 1964, P 1 ICSPCLA, V1, P9; Harris KA, 2006, INT C SER, V1288, P412; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Higman Barry W., 1984, SLAVE POPULATIONS BR; Hulme Peter, 1992, COLONIAL ENCOUNTERS; Hunley KL, 2007, AM J PHYS ANTHROPOL, V132, P622, DOI 10.1002/ajpa.20542; IBM Corp. Released, 2011, IBM SPSS STAT WINDOW; Ingram AK, 2008, CARIBBEAN STUD, V36, P65; Jota MS, 2011, AM J PHYS ANTHROPOL, V146, P553, DOI 10.1002/ajpa.21519; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Kim JC, 2013, EARLY AM STUD, V11, P117, DOI 10.1353/eam.2013.0007; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Knight Franklin W., 1997, SLAVE SOC CARIBBEAN; Knight Franklin W., 1990, CARIBBEAN GENESIS FR; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Lalueza-Fox C, 2003, AM J PHYS ANTHROPOL, V121, P97, DOI 10.1002/ajpa.10236; Lalueza-Fox C, 2001, ANN HUM GENET, V65, P137, DOI 10.1017/S0003480001008533; Laurence K.O., 1994, QUESTION LABOUR INDE; Leite FPN, 2008, AM J HUM BIOL, V20, P359, DOI 10.1002/ajhb.20702; Leland A, 2014, YURUMEIN HOMELAND RE; Lewis M. Paul, 2013, ETHNOLOGUE LANGUAGES; Maji S, 2009, J GENET, V88, P127, DOI 10.1007/s12041-009-0020-3; Marcheco-Teruel B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004488; Martinez-Cruzado JC, 2005, AM J PHYS ANTHROPOL, V128, P131, DOI 10.1002/ajpa.20108; Matamoros Mireya, 2009, Legal Medicine, V11, P251, DOI 10.1016/j.legalmed.2009.06.001; Mazieres S, 2011, ANN HUM BIOL, V38, P76, DOI 10.3109/03014460.2010.492793; Mendisco F, 2015, THE ROYAL SOC, V370; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Miljkovic-Gacic I, 2005, HUM HERED, V60, P129, DOI 10.1159/000089553; Minority Rights Group, 1995, NO LONG INV AFRL AM; Mol AAA, 2007, COSTLY GIVING GIVING; Muzzio M, 2011, INT J LEGAL MED, V125, P143, DOI 10.1007/s00414-009-0404-1; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; National Library and Information System Authority, 2013, 1 PEOPL PRES TRIN TO; Nei M, 2000, MOL EVOL PHYLOGENET; Palacio J, 2000, RECONSIDERATION NATI, P9; PATTERSON TC, 1991, DIALECT ANTHROPOL, V16, P1; Perego UA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038337; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Raff JA, 2011, AM J PHYS ANTHROPOL, V146, P503, DOI 10.1002/ajpa.21594; Ramdin Ron, 2000, ARISING BONDAGE HIST; Reddy BM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001141; Renault-Lescure O, 2009, LOANWORDS IN THE WORLD'S LANGUAGES, P968, DOI 10.1515/9783110218442.968; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Romero Rosa Elena, 2008, Forensic Sci Int Genet, V2, pe5, DOI 10.1016/j.fsigen.2007.09.005; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; ROUSE I, 1986, MIGRATIONS PREHISTOR; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruitberg CM, 2001, NUCLEIC ACIDS RES, V29, P320, DOI 10.1093/nar/29.1.320; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schurr TG, 2012, AM J PHYS ANTHROPOL, V147, P263; Scientific Working Group on DNA Analysis Methods (SWGDAM) United States of America, 2009, Y CHROM SHORT TAND R; Simms TM, 2013, GENE, V516, P82, DOI 10.1016/j.gene.2012.11.006; Simms TM, 2012, AM J PHYS ANTHROPOL, V148, P618, DOI 10.1002/ajpa.22090; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stefflova K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014495; Sued-Badillo J, 2003, AUTOCHTHONOUS SOC; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Thomas Hugh, 1997, THE SLAVE TRADE; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Toro-Labrador G, 2003, CARIBB J SCI, V39, P11; Torres JB, 2007, ANN HUM GENET, V71, P782, DOI 10.1111/j.1469-1809.2007.00380.x; Torres JB, 2013, AM J PHYS ANTHROPOL, V151, P135, DOI 10.1002/ajpa.22261; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vilar MG, 2014, AM J PHYS ANTHROPOL, V155, P352, DOI 10.1002/ajpa.22569; Vona G, 2005, AM J PHYS ANTHROPOL, V127, P361, DOI 10.1002/ajpa.20070; Wang CC, 2015, J GENET GENOMICS, V42, P403, DOI 10.1016/j.jgg.2015.03.008; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; Wei W, 2013, FORENSIC SCI INT-GEN, V7, P568, DOI 10.1016/j.fsigen.2013.03.014; Weller JA, 1968, E INDINA INDENTURE T; Willey GR, 1956, PREHISTORIC SETTLEME; Williams E, 1984, COLUMBUS CASTRO HIST; Wilson Samuel M., 1997, INDIGENOUS PEOPLE CA; Wolf E. R., 2010, EUROPE PEOPLE HIST; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141; Zhadanov SI, 2010, AM J PHYS ANTHROPOL, V142, P579, DOI 10.1002/ajpa.21281; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	132	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139192	10.1371/journal.pone.0139192	http://dx.doi.org/10.1371/journal.pone.0139192			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CT0TW	26447794	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000019
J	Warren, JR; Falster, MO; Tran, B; Jorm, L				Warren, James R.; Falster, Michael O.; Tran, Bich; Jorm, Louisa			Association of Continuity of Primary Care and Statin Adherence	PLOS ONE			English	Article							MEDICATION ADHERENCE; RISK; NONADHERENCE; OUTCOMES; THERAPY	Purpose Deficiencies in medication adherence are a major barrier to effectiveness of chronic condition management. Continuity of primary care may promote adherence. We assessed the association of continuity of primary care with adherence to long-term medication as exemplified by statins. Research Design We linked data from a prospective study of 267,091 Australians aged 45 years and over to national data sets on prescription reimbursements, general practice claims, hospitalisations and deaths. For participants having a statin dispense within 90 days of study entry, we computed medication possession ratio (MPR) and usual provider continuity index (UPI) for the subsequent two years. We used multivariate Poisson regression to calculate the relative risk (RR) and 95% confidence interval (CI) for the association between tertiles of UPI and MPR adjusted for socio-demographic and health-related patient factors, including age, gender, remoteness of residence, smoking, alcohol intake, fruit and vegetable intake, physical activity, prior heart disease and speaking a language other than English at home. We performed a comparison approach using propensity score matching on a subset of the sample. Results 36,144 participants were eligible and included in the analysis among whom 58% had UPI greater than 75%. UPI was significantly associated with 5% increased MPR for statin adherence (95% CI 1.04-1.06) for highest versus lowest tertile. Dichotomised analysis using a cut-off of UPI at 75% showed a similar effect size. The association between UPI and statin adherence was independent of socio-demographic and health-related factors. Stratification analyses further showed a stronger association among those who were new to statins (RR 1.33, 95% CI 1.15-1.54). Conclusions Greater continuity of care has a positive association with medication adherence for statins which is independent of socio-demographic and health-related factors.	[Warren, James R.] Univ Auckland, Dept Comp Sci, Auckland 1, New Zealand; [Falster, Michael O.; Tran, Bich; Jorm, Louisa] Univ New S Wales, Ctr Big Data Res Hlth, Kensington, NSW 2033, Australia	University of Auckland; University of New South Wales Sydney	Warren, JR (corresponding author), Univ Auckland, Dept Comp Sci, Auckland 1, New Zealand.	jim@cs.auckland.ac.nz	Falster, Michael/X-7118-2019; Jorm, Louisa/AAN-6874-2020	Falster, Michael/0000-0001-6444-7272; Jorm, Louisa/0000-0003-0390-661X; Warren, James/0000-0002-8660-8951	National Health and Medical Research Council Partnership Project [1036858]; Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation; NSW Bureau of Health Information	National Health and Medical Research Council Partnership Project; Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation; NSW Bureau of Health Information	This work was supported by a National Health and Medical Research Council Partnership Project Grant (#1036858) and by partner agencies the Australian Commission on Safety and Quality in Health Care, the Agency for Clinical Innovation and the NSW Bureau of Health Information. The authors thank the men and women participating in the 45 and Up Study, which is owned and managed by the Sax Institute, Sydney, NSW (www.saxinstitute.org.au) in collaboration with major partner Cancer Council NSW and other partners which, at the time of writing, include: National Heart Foundation of Australia (NSW Division), NSW Ministry of Health, beyondblue, Ageing, Disability and Home Care, Department of Family and Community Services, the Australian Red Cross Blood Service and UnitingCare Ageing. The authors thank the Sax Institute, the NSW Ministry of Health, the NSW Register of Births, Deaths and Marriages and the Department of Human Services for allowing access to the data, and the Centre for Health Record Linkage for conducting the probabilistic linkage of records. The manuscript has been approved for submission for publication subsequent to quality and compliance review coordinated by the Sax Institute.	Australian Government Department of Health, PHARM BEN SCHEM PBS; Australian Government Department of Health and Ageing, FEES PAT CONTR SAF N; Australian Government Department of Human Services, CONC HLTH CAR CARDS; Australian Institute of Health and Welfare (AIHW), 2004, RUR REG REM HLTH GUI; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; BRESLAU N, 1975, J MED EDUC, V50, P965; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Carey IM, 2012, NUTR METAB CARDIOVAS, V22, P400, DOI 10.1016/j.numecd.2010.09.010; Dragomir A, 2010, VALUE HEALTH, V13, P87, DOI 10.1111/j.1524-4733.2009.00583.x; Tran DT, 2012, AUST NZ J PUBL HEAL, V36, P310, DOI 10.1111/j.1753-6405.2012.00893.x; Germano G, 2012, EUR HEART J, V33, P137; Hansen RA, 2015, ANN PHARMACOTHER, V49, P293, DOI 10.1177/1060028014563266; Heisler M, 2008, CIRCULATION, V117, P2884, DOI 10.1161/CIRCULATIONAHA.107.724104; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Kessler R., 1994, FINAL VERSION OUR NO; Lai EJ, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-56; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Mabbott V, 2012, AUSTR STAT MED 2010; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Menec VH, 2005, HEALTH SERV RES, V40, P389, DOI 10.1111/j.1475-6773.2005.0p364.x; National Vascular Disease Prevention Alliance (NVDPA), 2012, GUIDELINES MANAGEMEN; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Parsons LS., 2004, P 20 9 ANN SAS US GR; Pittman DG, 2012, AM J CARDIOL, V110, P1459, DOI 10.1016/j.amjcard.2012.07.008; Ponsonby AL, 1996, AUST NZ J PUBL HEAL, V20, P54, DOI 10.1111/j.1467-842X.1996.tb01336.x; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Rodgers P T, 1998, Manag Care Interface, V11, P58; Schedlbauer A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004371.pub3; SHORTELL SM, 1976, MED CARE, V14, P377, DOI 10.1097/00005650-197605000-00001; SMEDBY O, 1986, MED CARE, V24, P511; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stewart AL, 1992, MEASURING FUNCTIONIN; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Thornley S, 2012, EUR J PREV CARDIOL, V19, P349, DOI 10.1177/1741826711403069; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; Warren JR, 2013, PHARMACOEPIDEM DR S, V22, P1298, DOI 10.1002/pds.3526; Wisnivesky JP, 2012, ANN ALLERG ASTHMA IM, V109, P179, DOI 10.1016/j.anai.2012.06.016; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140008	10.1371/journal.pone.0140008	http://dx.doi.org/10.1371/journal.pone.0140008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448561	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000080
J	Brahmi, M; Thiesse, P; Ranchere, D; Mognetti, T; Pinson, S; Renard, C; Decouvelaere, AV; Blay, JY; Combemale, P				Brahmi, Mehdi; Thiesse, Philippe; Ranchere, Dominique; Mognetti, Thomas; Pinson, Stephane; Renard, Caroline; Decouvelaere, Anne-Valerie; Blay, Jean-Yves; Combemale, Patrick			Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SARCOMATOUS TRANSFORMATION; MRI	Background Malignant peripheral nerve sheath tumors (MPNST) are one of the most frequent causes of death in patients with neurofibromatosis type 1 (NF1). Early detection is crucial because complete surgical resection is the only curative treatment. It has been previously reported that an F-18-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) image with a T/L (Tumor/Liver) SUVmax ratio > 1.5 provides a high negative predictive value; however, it is not specific enough to make a NF1-related MPNST diagnosis. A formal proof of malignant transformation from a histological analysis is necessary before surgical excision because the procedure can cause mutilation. The objective of the present work was to investigate the effectiveness of and complications associated with PET/CT-guided percutaneous biopsies for an NF1-related MPNST diagnosis. Methods PET/CT-guided percutaneous biopsy procedures performed on 26 NF1 patients with a clinical suspicion of MPNST and a suspect lesion from a PET/CT scan (T/L SUVmax ratio > 1.5) were retrospectively evaluated. The localization of the suspected malignant site was determined using PET/CT. A stereotactic (ultrasonic and CT control) core biopsy technique was used with a local anesthesia. Results The first PET/CT-guided percutaneous biopsies enabled a pathological diagnosis for all of the patients (no "inconclusive" results were obtained), and no secondary procedures were needed. Among the 26 patients, the histopathological results from the biopsy were malignant in 17 cases and benign (BPNST with atypical cells) in nine cases. No complications from the diagnostic procedure were observed. A surgical resection was performed in 18 patients (seven benign and 11 malignant biopsies), removing the fine needle biopsy scar. In addition, six locally advanced/metastatic MPNST were treated with chemo/radiotherapy, and two BPNST had no progression after a follow-up of 14 and 39 months, respectively. The PET/CT-guided percutaneous biopsy gave 25 accurate diagnoses and one false negative (BPNST with atypical cells on the biopsy and MPNST on the operated tumor), resulting in a diagnostic accuracy rate of 96%. This false negative case may be explained by the high heterogeneity of the tumor: benign areas were contiguous with the malignant ones and associated with inflammation. Conclusions PET/CT-guided percutaneous biopsies are an effective and relatively non-traumatic procedure for diagnosis of NF1-related MPNST. It is the most reliable approach for early detection of MPNST.	[Brahmi, Mehdi; Thiesse, Philippe; Ranchere, Dominique; Mognetti, Thomas; Renard, Caroline; Decouvelaere, Anne-Valerie; Blay, Jean-Yves; Combemale, Patrick] Ctr Leon Berard, F-69373 Lyon, France; [Pinson, Stephane] Hop Edouard Herriot, Genet Lab, Lyon, France	UNICANCER; Centre Leon Berard; CHU Lyon	Combemale, P (corresponding author), Ctr Leon Berard, F-69373 Lyon, France.	patrick.combemale@lyon.unicancer.fr	Blay, Jean-Yves/N-3966-2016	Blay, Jean-Yves/0000-0001-7190-120X				Beert E, 2011, GENE CHROMOSOME CANC, V50, P1021, DOI 10.1002/gcc.20921; Benz MR, 2010, CANCER-AM CANCER SOC, V116, P451, DOI 10.1002/cncr.24755; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Chander S, 2004, CLIN NUCL MED, V29, P415, DOI 10.1097/01.rlu.0000129121.55248.f5; Chirindel A, 2015, J NUCL MED, V56, P379, DOI 10.2967/jnumed.114.142372; Combemale P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085954; De Schepper A M, 1992, J Belge Radiol, V75, P286; DEMAS BE, 1988, AM J ROENTGENOL, V150, P615, DOI 10.2214/ajr.150.3.615; Doorn P F, 1995, Eur J Surg Oncol, V21, P78, DOI 10.1016/S0748-7983(05)80073-3; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2008, ANN ONCOL, V19, P390, DOI 10.1093/annonc/mdm450; Ferner RE, 2000, J NEUROL NEUROSUR PS, V68, P353, DOI 10.1136/jnnp.68.3.353; Gielen JLMA, 2004, EUR RADIOL, V14, P2320, DOI 10.1007/s00330-004-2431-0; Hsu CH, 2003, ANN NUCL MED, V17, P609, DOI 10.1007/BF03006677; Nielsen GP, 1999, AM J PATHOL, V155, P1879, DOI 10.1016/S0002-9440(10)65507-1; Otsuka H, 2005, ANN NUCL MED, V19, P55, DOI 10.1007/BF02986337; Pinson S, 2001, ANN DERMATOL VENER, V128, P567; Ramanathan RC, 1999, EUR J SURG ONCOL, V25, P190, DOI 10.1053/ejso.1998.0625; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Solomon SB, 2001, CLIN NUCL MED, V26, P525, DOI 10.1097/00003072-200106000-00009; Urban T, 2014, CLIN NUCL MED, V39, pE301, DOI 10.1097/RLU.0b013e3182a757d3; Valeyrie-Allanore L, 2005, BRIT J DERMATOL, V153, P79, DOI 10.1111/j.1365-2133.2005.06558.x; Van Herendael BH, 2006, SKELETAL RADIOL, V35, P745, DOI 10.1007/s00256-006-0160-y; Zou CY, 2009, ANN SURG, V249, P1014, DOI 10.1097/SLA.0b013e3181a77e9a	25	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138386	10.1371/journal.pone.0138386	http://dx.doi.org/10.1371/journal.pone.0138386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445379	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600028
J	Crispim, AC; Kelly, MJ; Guimaraes, SEF; Silva, FFE; Fortes, MRS; Wenceslau, RR; Moore, S				Crispim, Aline Camporez; Kelly, Matthew John; Facioni Guimaraes, Simone Eliza; Fonseca e Silva, Fabyano; Salinas Fortes, Marina Rufino; Wenceslau, Raphael Rocha; Moore, Stephen			Multi-Trait GWAS and New Candidate Genes Annotation for Growth Curve Parameters in Brahman Cattle	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-WEIGHT; IDENTIFICATION; EXPRESSION; VARIANTS; TMEM18; LOCI; SMN; AGE	Understanding the genetic architecture of beef cattle growth cannot be limited simply to the genome-wide association study (GWAS) for body weight at any specific ages, but should be extended to a more general purpose by considering the whole growth trajectory over time using a growth curve approach. For such an approach, the parameters that are used to describe growth curves were treated as phenotypes under a GWAS model. Data from 1,255 Brahman cattle that were weighed at birth, 6, 12, 15, 18, and 24 months of age were analyzed. Parameter estimates, such as mature weight (A) and maturity rate (K) from nonlinear models are utilized as substitutes for the original body weights for the GWAS analysis. We chose the best nonlinear model to describe the weight-age data, and the estimated parameters were used as phenotypes in a multi-trait GWAS. Our aims were to identify and characterize associated SNP markers to indicate SNP-derived candidate genes and annotate their function as related to growth processes in beef cattle. The Brody model presented the best goodness of fit, and the heritability values for the parameter estimates for mature weight (A) and maturity rate (K) were 0.23 and 0.32, respectively, proving that these traits can be a feasible alternative when the objective is to change the shape of growth curves within genetic improvement programs. The genetic correlation between A and K was -0.84, indicating that animals with lower mature body weights reached that weight at younger ages. One hundred and sixty seven (167) and two hundred and sixty two (262) significant SNPs were associated with A and K, respectively. The annotated genes closest to the most significant SNPs for A had direct biological functions related to muscle development (RAB28), myogenic induction (BTG1), fetal growth (IL2), and body weights (APEX2); K genes were functionally associated with body weight, body height, average daily gain (TMEM18), and skeletal muscle development (SMN1). Candidate genes emerging from this GWAS may inform the search for causative mutations that could underpin genomic breeding for improved growth rates.	[Crispim, Aline Camporez; Facioni Guimaraes, Simone Eliza; Fonseca e Silva, Fabyano] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Kelly, Matthew John; Moore, Stephen] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Salinas Fortes, Marina Rufino] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Wenceslau, Raphael Rocha] Univ Fed Minas Gerais, Inst Anim Sci, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa; University of Queensland; University of Queensland; Universidade Federal de Minas Gerais	Crispim, AC (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.	aline.crispim@ufv.br	Silva, Fabyano/Y-9223-2019; Fortes, Marina R S/G-2302-2012; Wenceslau, Raphael/W-3869-2019; Fortes, Marina/AAN-6815-2020; Silva, Fabyano Fonseca/D-8158-2017; facioni guimaraes, simone eliza/HHZ-5341-2022	Fortes, Marina R S/0000-0002-7254-1960; Fortes, Marina/0000-0002-7254-1960; Rocha Wenceslau, Raphael/0000-0002-0034-1484; Moore, Stephen/0000-0002-9758-166X; facioni guimaraes, simone eliza/0000-0003-3704-8131	Coordination of Improvement of Higher Education Personnel - CAPES [A125/2013]	Coordination of Improvement of Higher Education Personnel - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	ACC is a member of project number A125/2013, funded by Coordination of Improvement of Higher Education Personnel - CAPES.	Almen MS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-58; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Brody S., 1945, BIOENERGETICS GROWTH, DOI [10.1002/ajpa.1330040117, DOI 10.1002/AJPA.1330040117]; BROWN JE, 1976, J ANIM SCI, V42, P810, DOI 10.2527/jas1976.424810x; Busson M, 2005, ONCOGENE, V24, P1698, DOI 10.1038/sj.onc.1208373; Buzanskas ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094802; Carbonetto P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003770; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Corbet NJ, 2013, ANIM PROD SCI, V53, P101, DOI 10.1071/AN12163; Coster Albart, 2010, BMC Proc, V4 Suppl 1, pS3, DOI 10.1186/1753-6561-4-S1-S3; Das K, 2011, HUM HERED, V72, P110, DOI 10.1159/000330781; Das K, 2011, HUM GENET, V129, P629, DOI 10.1007/s00439-011-0960-6; Denise RSK, 1985, GENETIC ENV ASPECTS, P1431; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; Forni S, 2007, J ANIM SCI, V85, P3189, DOI 10.2527/jas.2006-677; Forni S, 2009, J ANIM SCI, V87, P496, DOI 10.2527/jas.2008-0845; Fortes MRS, 2013, ANIM GENET, V44, P91, DOI 10.1111/j.1365-2052.2012.02367.x; France J, 2008, MATHEMATICAL MODELLING IN ANIMAL NUTRITION, P1, DOI 10.1079/9781845933548.0000; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gutierrez-Gil B, 2009, J ANIM SCI, V87, P24, DOI 10.2527/jas.2008-0922; Haupt A, 2010, OBESITY, V18, P1212, DOI 10.1038/oby.2009.413; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Ide Y, 2004, BLOOD, V104, P4097, DOI 10.1182/blood-2004-04-1476; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kneeland J, 2004, J ANIM SCI, V82, P3405; Littlejohn M, 2012, ANIM GENET, V43, P591, DOI 10.1111/j.1365-2052.2011.02293.x; Lopes FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075423; Lu D, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-80; Ma CX, 2002, GENETICS, V161, P1751; Ma W, 2012, GENES GENOM, V34, P591, DOI 10.1007/s13258-012-0034-8; Menchaca MA, 1996, J ANIM SCI, V74, P2140; Meyer K, 2012, GENETICS, V190, P275, DOI 10.1534/genetics.111.134841; NELDER JA, 1961, BIOMETRICS, V17, P89, DOI 10.2307/2527498; Piles M, 2003, J ANIM SCI, V81, P2714; Piper EK, 2009, CLIN VACCINE IMMUNOL, V16, P1074, DOI 10.1128/CVI.00157-09; Pong-Wong Ricardo, 2010, BMC Proc, V4 Suppl 1, pS4; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Rask-Andersen M, 2012, EUR J HUM GENET, V20, P192, DOI 10.1038/ejhg.2011.176; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rodier A, 2001, ONCOGENE, V20, P2691, DOI 10.1038/sj.onc.1204398; Roux P-F, 2014, RESEQUENCING DATA RE, V9, DOI [10.1371/journal.pone.0111299, DOI 10.1371/JOURNAL.PONE.0111299]; Saatchi M, 2014, QTLS ASS DRY MATTER, V15, P1, DOI [10.1186/1471-2164-15-1004, DOI 10.1186/1471-2164-15-1004]; Santana MHA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-21; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Snelling WM, 2013, J ANIM SCI, V91, P537, DOI 10.2527/jas.2012-5784; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Takahashi LY, 1988, AJAS, V1, P149; Vargas B, 2000, J DAIRY SCI, V83, P1371, DOI 10.3168/jds.S0022-0302(00)75005-3; Verbeek EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079921; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Warr N, 2009, DEV BIOL, V326, P273, DOI 10.1016/j.ydbio.2008.11.023; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804	59	34	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139906	10.1371/journal.pone.0139906	http://dx.doi.org/10.1371/journal.pone.0139906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445451	Green Published, gold			2022-12-26	WOS:000362510600101
J	Frizzi, F; Ciofi, C; Dapporto, L; Natali, C; Chelazzi, G; Turillazzi, S; Santini, G				Frizzi, Filippo; Ciofi, Claudio; Dapporto, Leonardo; Natali, Chiara; Chelazzi, Guido; Turillazzi, Stefano; Santini, Giacomo			The Rules of Aggression: How Genetic, Chemical and Spatial Factors Affect Intercolony Fights in a Dominant Species, the Mediterranean Acrobat Ant Crematogaster scutellaris	PLOS ONE			English	Article							NEST MATE RECOGNITION; DEAR-ENEMY PHENOMENON; NASTY NEIGHBORS RATHER; CUTICULAR HYDROCARBONS; ARGENTINE ANT; INTRASPECIFIC AGGRESSION; QUEEN NUMBER; COLONY ODOR; HYMENOPTERA; POPULATION	Nest-mate recognition plays a key role in the biology of ants. Although individuals coming from a foreign nest are, in most cases, promptly rejected, the degree of aggressiveness towards non nest-mates may be highly variable among species and relies on genetic, chemical and environmental factors. We analyzed intraspecific relationships among neighboring colonies of the dominant Mediterranean acrobat ant Crematogaster scutellaris integrating genetic, chemical and behavioral analyses. Colony structure, parental relationships between nests, cuticular hydrocarbons profiles (CHCs) and aggressive behavior against non nest-mates were studied in 34 nests located in olive tree trunks. Bayesian clustering analysis of allelic variation at nine species-specific microsatellite DNA markers pooled nests into 14 distinct clusters, each representing a single colony, confirming a polydomous arrangement of nests in this species. A marked genetic separation among colonies was also detected, probably due to long distance dispersion of queens and males during nuptial flights. CHCs profiles varied significantly among colonies and between nests of the same colony. No relationship between CHCs profiles and genetic distances was detected. The level of aggressiveness between colonies was inversely related to chemical and spatial distance, suggesting a 'nasty neighbor' effect. Our findings also suggest that CHCs profiles in C. scutellaris may be linked to external environmental factors rather than genetic relationships.	[Frizzi, Filippo; Ciofi, Claudio; Dapporto, Leonardo; Natali, Chiara; Chelazzi, Guido; Turillazzi, Stefano; Santini, Giacomo] Univ Florence, Dept Biol, I-50019 Sesto Fiorentino, FI, Italy	University of Florence	Frizzi, F (corresponding author), Univ Florence, Dept Biol, Via Madonna del Piano 6, I-50019 Sesto Fiorentino, FI, Italy.	filippo.frizzi@unifi.it	Frizzi, Filippo/GYE-2065-2022; Dapporto, Leonardo/E-5752-2010; Ciofi, Claudio/AAH-9461-2019; Santini, Giacomo/H-7366-2013	Frizzi, Filippo/0000-0002-1419-0445; Dapporto, Leonardo/0000-0001-7129-4526; CIOFI, CLAUDIO/0000-0001-8537-8659	Ente Cassa di Risparmio di Firenze [2008,0732]; Universita degli Studi di Firenze [F.S.1.12.03]	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Universita degli Studi di Firenze	This work was supported by Ente Cassa di Risparmio di Firenze, http://www.entecarifirenze.it/, grant number 2008,0732; and Universita degli Studi di Firenze, grant number F.S.1.12.03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1971, INSECT SOC; Baroni Urbani C., 1971, MEMORIA SOC ENTOMOLO, V50, P5; Benedek K, 2014, NORTH-WEST J ZOOL, V10, P245; Bernard F, 1968, LES FOURMIS HYM FORM; Beye M, 1998, BEHAV ECOL SOCIOBIOL, V43, P67, DOI 10.1007/s002650050467; Beye M, 1997, INSECT SOC, V44, P49, DOI 10.1007/s000400050022; Bjorkman-Chiswell BT, 2008, INSECT SOC, V55, P207, DOI 10.1007/s00040-008-0990-9; BONAVITACOUGOURDAN A, 1987, J ENTOMOL SCI, V22, P1; Boulay R, 2004, INSECT SOC, V51, P55, DOI 10.1007/s00040-003-0706-0; Boulay R, 2007, ANIM BEHAV, V74, P985, DOI 10.1016/j.anbehav.2007.02.013; BREED MD, 1983, ANIM BEHAV, V31, P86, DOI 10.1016/S0003-3472(83)80176-6; Buczkowski G, 2006, ANIM BEHAV, V71, P327, DOI 10.1016/j.anbehav.2005.04.012; Burnham K. P., 2002, MODEL SELECTION AND; Cammell ME, 1996, INSECT SOC, V43, P37, DOI 10.1007/BF01253954; Casevitz-Weulersse J., 1972, Bulletin Soc Ent France, V77, P12; Chapuisat M, 2004, EVOLUTION, V58, P1064, DOI 10.1111/j.0014-3820.2004.tb00440.x; Chen JSC, 2000, ANN ENTOMOL SOC AM, V93, P1333, DOI 10.1603/0013-8746(2000)093[1333:NRAIAB]2.0.CO;2; Corander J, 2013, BAPS BAYESIAN ANALYS; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crozier R. H., 1996, EVOLUTION OF SOCIAL; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; d'Ettorre P, 2010, ANT ECOLOGY, P194; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; Dimarco RD, 2010, BEHAV ECOL, V21, P304, DOI 10.1093/beheco/arp190; Dronnet S, 2006, J CHEM ECOL, V32, P1027, DOI 10.1007/s10886-006-9043-x; Errard C, 2008, INSECT SOC, V55, P115, DOI 10.1007/s00040-008-0979-4; ESPELIE KE, 1994, J CHEM ECOL, V20, P1677, DOI 10.1007/BF02059889; Fletcher DJC, 1987, KIN RECOGNITION IN A; Frizzi F, 2014, REDIA, V97, P165; Frizzi F, 2009, CONSERV GENET RESOUR, V1, P425, DOI 10.1007/s12686-009-9098-4; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; GORDON DM, 1989, OECOLOGIA, V81, P198, DOI 10.1007/BF00379806; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; Heinze J, 1996, ETHOLOGY, V102, P510; Helantera H, 2011, BEHAV ECOL, V22, P710, DOI 10.1093/beheco/arr037; Hernandez JV, 2002, J INSECT PHYSIOL, V48, P287, DOI 10.1016/S0022-1910(01)00173-1; Holldobler B., 1980, Life Sciences Research Report, P35; Holldobler B., 1990, pi; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holzer B, 2006, J EVOLUTION BIOL, V19, P2031, DOI 10.1111/j.1420-9101.2006.01133.x; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Jackson DE, 2007, CURR BIOL, V17, pR1063, DOI 10.1016/j.cub.2007.10.031; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katzav-Gozansky T, 2004, NATURWISSENSCHAFTEN, V91, P186, DOI 10.1007/s00114-004-0513-0; Knaden M, 2003, J INSECT BEHAV, V16, P717, DOI 10.1023/B:JOIR.0000007706.38674.73; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Langen TA, 2000, BEHAV ECOL SOCIOBIOL, V48, P285, DOI 10.1007/s002650000223; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Martin SJ, 2008, J CHEM ECOL, V34, P1072, DOI 10.1007/s10886-008-9482-7; Martin SJ, 2012, BEHAV GENET, V42, P323, DOI 10.1007/s10519-011-9503-0; Menzel F, 2010, ECOL ENTOMOL, V35, P711, DOI 10.1111/j.1365-2311.2010.01231.x; Modlmeier AP, 2011, BEHAV ECOL, V22, P1026, DOI 10.1093/beheco/arr086; Muller CA, 2007, P ROY SOC B-BIOL SCI, V274, P959, DOI 10.1098/rspb.2006.0222; Newey PS, 2010, ECOLOGY, V91, P2366, DOI 10.1890/09-0561.1; Ottonetti L, 2008, AGR FOREST ENTOMOL, V10, P29, DOI 10.1111/j.1461-9563.2007.00358.x; Pamilo P, 1997, ANNU REV ECOL SYST, V28, P1, DOI 10.1146/annurev.ecolsys.28.1.1; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Pirk CWW, 2001, BEHAV ECOL SOCIOBIOL, V49, P366, DOI 10.1007/s002650000315; Ravary F, 2007, CURR BIOL, V17, P1308, DOI 10.1016/j.cub.2007.06.047; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Roulston TH, 2003, INSECT SOC, V50, P151, DOI 10.1007/s00040-003-0624-1; Sanada-Morimura S, 2003, BEHAV ECOL, V14, P713, DOI 10.1093/beheco/arg057; Santini G, 2007, ECOL ENTOMOL, V32, P319, DOI 10.1111/j.1365-2311.2007.00882.x; Santini G, 2011, ECOL ENTOMOL, V36, P625, DOI 10.1111/j.1365-2311.2011.01306.x; Schatz B, 2003, ECOL ENTOMOL, V28, P359, DOI 10.1046/j.1365-2311.2003.00519.x; Schmolke A, 2009, AM NAT, V173, P772, DOI 10.1086/598493; Silverman J, 2001, NATURWISSENSCHAFTEN, V88, P73, DOI 10.1007/s001140000198; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Soroker V, 2003, INSECT SOC, V50, P212, DOI 10.1007/s00040-003-0669-1; Sorvari J, 2008, BEHAV ECOL, V19, P441, DOI 10.1093/beheco/arm160; Starks PT, 1998, ETHOLOGY, V104, P573, DOI 10.1111/j.1439-0310.1998.tb00092.x; Steiner FM, 2004, INSECT SOC, V51, P24, DOI 10.1007/s00040-003-0699-8; Strassmann JE, 2011, NATURE, V471, pE5, DOI 10.1038/nature09833; Stuart RJ, 2000, BEHAV ECOL, V11, P676, DOI 10.1093/beheco/11.6.676; Sturgis SJ, 2012, MYRMECOL NEWS, V16, P101; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; Sudd JH, 1987, THE BEHAVIORAL ECOLO; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Thomas ML, 2007, INSECT SOC, V54, P225, DOI 10.1007/s00040-007-0935-8; Thomas ML, 2005, J ANIM ECOL, V74, P532, DOI 10.1111/j.1365-2656.2005.00952.x; Thomas ML, 1999, NATURWISSENSCHAFTEN, V86, P87, DOI 10.1007/s001140050578; Thurin N, 2008, ANIM BEHAV, V75, P1023, DOI 10.1016/j.anbehav.2007.08.013; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Urbani C. B., 1962, Bull Soc Hist nat Toulouse, V97, P29; van Wilgenburg E, 2007, ETHOLOGY, V113, P1185, DOI 10.1111/j.1439-0310.2007.01431.x; van Wilgenburg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053548; Van Wilgenburg E, 2010, BIOL LETTERS, V6, P152, DOI 10.1098/rsbl.2009.0616; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; Vander Meer Robert K., 1998, P79; Wagner D, 2000, J CHEM ECOL, V26, P2245, DOI 10.1023/A:1005529224856; Way MJ, 1997, INSECT SOC, V44, P415, DOI 10.1007/s000400050062; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	102	32	32	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137919	10.1371/journal.pone.0137919	http://dx.doi.org/10.1371/journal.pone.0137919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445245	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600015
J	Wang, B; Ye, TM; Lee, KF; Chiu, PCN; Pang, RTK; Ng, EHY; Yeung, WSB				Wang, Bing; Ye, Tian-Min; Lee, Kai-Fai; Chiu, Philip C. N.; Pang, Ronald T. K.; Ng, Ernest H. Y.; Yeung, William S. B.			Annexin A2 Acts as an Adhesion Molecule on the Endometrial Epithelium during Implantation in Mice	PLOS ONE			English	Article							EMBRYO IMPLANTATION; PROTEOMIC ANALYSIS; CALCIUM INFLUX; PROTEIN; MOUSE; EXPRESSION; GENE; IDENTIFICATION; BLASTOCYST; CELLS	To determine the function of Annexin A2 (Axna2) in mouse embryo implantation in vivo, experimental manipulation of Axna2 activities was performed in mouse endometrial tissue in vivo and in vitro. Histological examination of endometrial tissues was performed throughout the reproduction cycle and after steroid treatment. Embryo implantation was determined after blockage of the Axna2 activities by siRNA or anti-Axna2 antibody. The expression of Axna2 immunoreactivies in the endometrial luminal epithelium changed cyclically in the estrus cycle and was upregulated by estrogen. After nidatory estrogen surge, there was a concentration of Axna2 immunoreactivities at the interface between the implanting embryo and the luminal epithelium. The phenomenon was likely to be induced by the implanting embryos as no such concentration of signal was observed in the inter-implantation sites and in pseudopregnancy. Knockdown of Axna2 by siRNA reduced attachment of mouse blastocysts onto endometrial tissues in vitro. Consistently, the number of implantation sites was significantly reduced after infusion of anti-Axna2 antibody into the uterine cavity. Steroids and embryos modulate the expression of Axna2 in the endometrial epithelium. Axna2 may function as an adhesion molecule during embryo implantation in mice.	[Wang, Bing; Ye, Tian-Min; Lee, Kai-Fai; Chiu, Philip C. N.; Pang, Ronald T. K.; Ng, Ernest H. Y.; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Wang, Bing] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Key Lab Med Reprogramming Technol, Shenzhen, Peoples R China; [Ye, Tian-Min; Lee, Kai-Fai; Ng, Ernest H. Y.; Yeung, William S. B.] Univ Hong Kong, Shenzhen Hosp, Shenzhen Key Lab Fertil Regulat, Shenzhen, Peoples R China; [Lee, Kai-Fai; Chiu, Philip C. N.; Pang, Ronald T. K.; Ng, Ernest H. Y.; Yeung, William S. B.] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Shenzhen University; University of Hong Kong; University of Hong Kong	Yeung, WSB (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	wsbyeung@hku.hk	Lee, Calvin Kai Fai/C-4328-2009; Chiu, Chi Ngong/C-4245-2009	Lee, Calvin Kai Fai/0000-0001-5957-439X; Chiu, Chi Ngong/0000-0001-6217-1970; Yeung, Shu Biu William/0000-0003-0670-0879; Ng, Ernest/0000-0002-7688-4557				Banerjee A, 2011, SYST BIOL REPROD MED, V57, P186, DOI 10.3109/19396368.2010.539660; Banerjee Aryamitra, 2009, Journal of Basic and Clinical Physiology and Pharmacology, V20, P43; BURGOYNE RD, 1988, NATURE, V331, P20, DOI 10.1038/331020a0; Chakraborty I, 1996, J MOL ENDOCRINOL, V16, P107, DOI 10.1677/jme.0.0160107; Cui XS, 2005, REPROD FERT DEVELOP, V17, P625, DOI 10.1071/RD05019; Das SK, 1994, DEVELOPMENT, V120, P1071; Dimitriadis E, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-44; Dominguez F, 2009, HUM REPROD, V24, P2607, DOI 10.1093/humrep/dep230; ERIKSON E, 1980, CELL, V21, P829, DOI 10.1016/0092-8674(80)90446-8; Fey MF, 1996, BBA-GENE STRUCT EXPR, V1306, P160, DOI 10.1016/0167-4781(95)00238-3; Garrido-Gomez T, 2012, FASEB J, V26, P3715, DOI 10.1096/fj.12-204008; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Hitchcock JK, 2014, J CELL COMMUN SIGNAL, V8, P125, DOI 10.1007/s12079-014-0231-0; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; Lee YL, 2009, MOL REPROD DEV, V76, P301, DOI 10.1002/mrd.20955; Li J, 2011, FERTIL STERIL, V95, P1161, DOI 10.1016/j.fertnstert.2010.09.033; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Liu XM, 2012, J CLIN ENDOCR METAB, V97, P3672, DOI 10.1210/jc.2012-2075; Myrvang HK, 2013, FEBS LETT, V587, P3210, DOI 10.1016/j.febslet.2013.08.012; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; SAKOFF JA, 1994, J REPROD FERTIL, V101, P97; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; Singh H, 2015, MOL HUM REPROD, V21, P81, DOI 10.1093/molehr/gau087; Talbot NC, 2010, ANIM REPROD SCI, V120, P187, DOI 10.1016/j.anireprosci.2010.03.009; Tinel H, 2000, MOL HUM REPROD, V6, P1119, DOI 10.1093/molehr/6.12.1119; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Wang J, 2000, DEVELOPMENT, V127, P33; Wang J, 2007, DEV BIOL, V302, P143, DOI 10.1016/j.ydbio.2006.09.015; Yap J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-73; Ye TM, 2012, FERTIL STERIL, V98, P1581, DOI 10.1016/j.fertnstert.2012.08.013	33	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139506	10.1371/journal.pone.0139506	http://dx.doi.org/10.1371/journal.pone.0139506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444699	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600059
J	Maan, R; van der Meer, AJ; Brouwer, WP; Plompen, EPC; Sonneveld, MJ; Roomer, R; van der Eijk, AA; Groothuismink, ZMA; Hansen, BE; Veldt, BJ; Janssen, HLA; Boonstra, A; de Knegt, RJ				Maan, Raoel; van der Meer, Adriaan J.; Brouwer, Willem Pieter; Plompen, Elisabeth P. C.; Sonneveld, Milan J.; Roomer, Robert; van der Eijk, Annemiek A.; Groothuismink, Zwier M. A.; Hansen, Bettina E.; Veldt, Bart J.; Janssen, Harry L. A.; Boonstra, Andre; de Knegt, Robert J.			ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENOME-WIDE ASSOCIATION; PEGYLATED INTERFERON; PEGINTERFERON ALPHA; RIBAVIRIN THERAPY; TRIPLE THERAPY; ANEMIA; VARIANTS; THROMBOCYTOPENIA; ERYTHROPOIETIN	Background/Objective Genetic polymorphisms in the inosine triphosphatase (ITPA) gene have been associated with the protection from early ribavirin(RBV)-induced hemolytic anemia among patients with chronic hepatitis C virus (HCV) infection. The aim of the present study was to investigate the association between the functional ITPA variants and hematological side effects during antiviral therapy with pegylated interferon (PegIFN) and RBV. Patients and Methods This cohort study included all consecutive Caucasian patients treated for chronic HCV infection with PegIFN and RBV between 2000 and 2009 for whom a serum sample was available for genetic testing. The predicted inosine triphosphate pyrophosphatase (ITPase) activity was based on the genotypes of the SNPs rs1127354 and rs7270101. Decline in hemoglobin (Hb) during antiviral therapy, as well as dose reductions, blood transfusions and use of erythropoietin were assessed. Results In total, 213 patients were included. The predicted ITPase activity was normal among 152 (71%) patients; 61 (29%) patients had ITPase deficiency. By multivariable linear regression, RBV dose in mg per kilogram (Beta 0.09, 95% CI 0.04-0.13, p<0.001) and normal ITPase activity (Beta 0.89, 95% CI 0.64-1.14, p<0.001) were associated with more Hb decline at week 4 of treatment. Patients with normal ITPase activity underwent more dose adjustments of RBV than patients with ITPase deficiency (19(13%) vs 1(2%), p = 0.014) and received erythropoietin more frequently (12 (8%) vs 0 (0%), p = 0.024). Conclusion Genetic variants in the ITPA gene protected against RBV treatment-induced anemia among Caucasian patients with chronic HCV infection. Patients with normal ITPase activity underwent more dose reductions of RBV and received erythropoietin more frequently.	[Maan, Raoel; van der Meer, Adriaan J.; Brouwer, Willem Pieter; Plompen, Elisabeth P. C.; Sonneveld, Milan J.; Roomer, Robert; Groothuismink, Zwier M. A.; Hansen, Bettina E.; Veldt, Bart J.; Janssen, Harry L. A.; Boonstra, Andre; de Knegt, Robert J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [van der Eijk, Annemiek A.] Erasmus MC Univ Med Ctr Rotterdam, Dept Virosci, Rotterdam, Netherlands; [Janssen, Harry L. A.] Toronto Western & Gen Hosp, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Maan, R (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	r.maan@erasmusmc.nl	Brouwer, Willem Pieter/P-5444-2014; Sonneveld, Milan/AAM-5546-2021; De Knegt, Robert/X-4629-2019; Plompen, Elisabeth/P-5461-2014; Maan, Raoel/P-5453-2014	Brouwer, Willem Pieter/0000-0001-8713-1481; Sonneveld, Milan/0000-0002-9253-563X; De Knegt, Robert/0000-0003-0934-6975; Plompen, Elisabeth/0000-0003-1284-2398; Maan, Raoel/0000-0001-6402-398X; Boonstra, Andre/0000-0001-8607-1616	Virgo consortium - Dutch government [FES0908]; Netherlands Genomics Initiative (NGI) [050-060-452]; Foundation for Liver and Gastrointestinal Research in Rotterdam	Virgo consortium - Dutch government; Netherlands Genomics Initiative (NGI); Foundation for Liver and Gastrointestinal Research in Rotterdam	This study was sponsored by the Virgo consortium, funded by the Dutch government project number FES0908, and by the Netherlands Genomics Initiative (NGI) project number 050-060-452. The study was also funded by the Foundation for Liver and Gastrointestinal Research in Rotterdam. This foundation was established in 1985 as an institution without purpose of financial gain and has the mission to stimulate scientific research in the field of diseases of the liver and the gastrointestinal tract. A major part of its activities are undertaken at the Erasmus MC in Rotterdam, the Netherlands.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Aghemo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095881; Akamatsu S, 2015, J VIRAL HEPATITIS, V22, P166, DOI 10.1111/jvh.12275; [Anonymous], 2014, J HEPATOL, V61, P373, DOI DOI 10.1016/J.JHEP.2014.05.001; Asselah T, 2013, J HEPATOL, V58, pS482, DOI 10.1016/S0168-8278(13)61187-3; Boglione L, 2014, J VIRAL HEPATITIS, V21, P260, DOI 10.1111/jvh.12170; BROUDY VC, 1995, BLOOD, V85, P1719, DOI 10.1182/blood.V85.7.1719.bloodjournal8571719; Cardier JE, 1997, STEM CELLS, V15, P286, DOI 10.1002/stem.150286; Clark PJ, 2013, J VIRAL HEPATITIS, V20, P858, DOI 10.1111/jvh.12113; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hitomi Y, 2011, GASTROENTEROLOGY, V140, P1314, DOI 10.1053/j.gastro.2010.12.038; Holmes JA, 2014, HEPATOLOGY, V59, P2152, DOI 10.1002/hep.27022; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; Maan R, 2014, J HEPATOL, V61, P482, DOI 10.1016/j.jhep.2014.04.021; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Ogawa E, 2013, J HEPATOL, V59, P667, DOI 10.1016/j.jhep.2013.05.017; Poordad F, 2013, GASTROENTEROLOGY, V145, P1035, DOI 10.1053/j.gastro.2013.07.051; Rembeck K, 2014, HEPATOLOGY, V59, P2131, DOI 10.1002/hep.27009; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Roomer R, 2010, HEPATOLOGY, V52, P1225, DOI 10.1002/hep.23842; Roomer R, 2010, J HEPATOL, V53, P455, DOI 10.1016/j.jhep.2010.04.013; Russo MW, 2003, GASTROENTEROLOGY, V124, P1711, DOI 10.1016/S0016-5085(03)00394-9; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Shiffman ML, 2007, GASTROENTEROLOGY, V132, P103, DOI 10.1053/j.gastro.2006.11.011; Shipkova M, 2006, CLIN CHEM, V52, P240, DOI 10.1373/clinchem.2005.059501; Sulkowski MS, 2013, HEPATOLOGY, V57, P974, DOI 10.1002/hep.26096; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Suzuki F, 2011, HEPATOLOGY, V53, P415, DOI 10.1002/hep.24058; Tanaka Y, 2011, HUM MOL GENET, V20, P3507, DOI 10.1093/hmg/ddr249; Thompson AJ, 2012, J HEPATOL, V56, P313, DOI 10.1016/j.jhep.2011.04.021; Thompson AJ, 2011, HEPATOLOGY, V53, P389, DOI 10.1002/hep.24068; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	37	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139317	10.1371/journal.pone.0139317	http://dx.doi.org/10.1371/journal.pone.0139317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441325	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510300020
J	Barbachano, A; Fernandez-Barral, A; Pereira, F; Segura, MF; Ordonez-Moran, P; Pau, ECD; Gonzalez-Sancho, JM; Hanniford, D; Martinez, N; Costales-Carrera, A; Real, FX; Palmer, HG; Rojas, JM; Hernando, E; Munoz, A				Barbachano, A.; Fernandez-Barral, A.; Pereira, F.; Segura, M. F.; Ordonez-Moran, P.; Carrillo-de Santa Pau, E.; Gonzalez-Sancho, J. M.; Hanniford, D.; Martinez, N.; Costales-Carrera, A.; Real, F. X.; Palmer, H. G.; Rojas, J. M.; Hernando, E.; Munoz, A.			SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; MESENCHYMAL TRANSITION; DOWN-REGULATION; CANCER-CELLS; MIR-200 FAMILY; BETA-CATENIN; EPIGENETIC INACTIVATION; TRANSCRIPTION FACTOR; COLORECTAL-CANCER; GENE-EXPRESSION	SPROUTY-2 (SPRY2) is a modulator of tyrosine kinase receptor signaling with receptor-and cell type-dependent inhibitory or enhancing effects. Studies on the action of SPRY2 in major cancers are conflicting and its role remains unclear. Here we have dissected SPRY2 action in human colon cancer. Global transcriptomic analyses show that SPRY2 downregulates genes encoding tight junction proteins such as claudin-7 and occludin and other cell-to-cell and cell-to-matrix adhesion molecules in human SW480-ADH colon carcinoma cells. Moreover, SPRY2 represses LLGL2/HUGL2, PATJ1/INADL and ST14, main regulators of the polarized epithelial phenotype, and ESRP1, an epithelial-to-mesenchymal transition (EMT) inhibitor. A key action of SPRY2 is the upregulation of the major EMT inducer ZEB1, as these effects are reversed by ZEB1 knock-down by means of RNA interference. Consistently, we found an inverse correlation between the expression level of claudin-7 and those of SPRY2 and ZEB1 in human colon tumors. Mechanistically, ZEB1 upregulation by SPRY2 results from the combined induction of ETS1 transcription factor and the repression of microRNAs (miR-200 family, miR-150) that target ZEB1 RNA. Moreover, SPRY2 increased AKT activation by epidermal growth factor, whereas AKT and also Src inhibition reduced the induction of ZEB1. Altogether, these data suggest that AKT and Src are implicated in SPRY2 action. Collectively, these results show a tumorigenic role of SPRY2 in colon cancer that is based on the dysregulation of tight junction and epithelial polarity master genes via upregulation of ZEB1. The dissection of the mechanism of action of SPRY2 in colon cancer cells is important to understand the upregulation of this gene in a subset of patients with this neoplasia that have poor prognosis.	[Barbachano, A.; Fernandez-Barral, A.; Pereira, F.; Ordonez-Moran, P.; Gonzalez-Sancho, J. M.; Costales-Carrera, A.; Munoz, A.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Canc Biol, Madrid, Spain; [Segura, M. F.; Hanniford, D.; Hernando, E.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Carrillo-de Santa Pau, E.; Real, F. X.] CSIC, Epithelial Carcinogenesis Grp, Madrid, Spain; [Martinez, N.] Inst Salud Carlos III, Unidad Func Invest Enfermedades Cron, Unidad Biol Celular, Madrid, Spain; [Real, F. X.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Palmer, H. G.] Vall dHebron Inst Oncol, Stem Cells & Canc Grp, Barcelona, Spain; [Segura, M. F.] Vall dHebron Inst Recerca VHIR, E-08035 Barcelona, Spain; [Ordonez-Moran, P.] Ecole Polytech Fed Lausanne, Canc Stem Cell Lab, CH-1015 Lausanne, Switzerland	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); New York University; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC); Pompeu Fabra University; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Munoz, A (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain.	amunoz@iib.uam.es	Barbachano, Antonio/O-7731-2015; Arribas, Francisco X Real/H-5275-2015; Gonzalez-Sancho, Jose/AAA-6010-2019; Miquel, Josep Maria/AAG-3508-2019; Rojas, José M/D-3718-2018; Hanniford, Douglas/AAS-1480-2020; Rojas, José M./AAA-3354-2021; Munoz, Alberto/O-6393-2014; Fernández-Barral, Asunión/O-8133-2015; Costales, ALba/F-2773-2017; Segura, Miguel F/J-4749-2013; de Santa Pau, Enrique Carrillo/AAV-7544-2021; Palmer, Héctor G./AAG-8332-2019; Ordonez-Moran, Paloma/B-6371-2016; Hanniford, Doug/M-8251-2014	Barbachano, Antonio/0000-0002-1248-5143; Arribas, Francisco X Real/0000-0001-9501-498X; Gonzalez-Sancho, Jose/0000-0001-5875-1964; Rojas, José M/0000-0002-5383-3482; Rojas, José M./0000-0002-7547-2825; Munoz, Alberto/0000-0003-3890-4251; Fernández-Barral, Asunión/0000-0002-1278-4645; Costales, ALba/0000-0002-9075-1646; Segura, Miguel F/0000-0003-0916-3618; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; Palmer, Hector/0000-0002-9823-5638; Ordonez-Moran, Paloma/0000-0001-7688-1252; Hanniford, Doug/0000-0001-6790-8441; Hernando, Eva/0000-0003-1023-0312; Pires Pereira, Fabio/0000-0002-9991-2805	FEDER-Instituto de Salud Carlos III [RD12/0036/0021, RD12/0036/0034, RD12/0036/0016, RD12/0036/0012, RD06/0020/0003, PS09/00562, PI13/00703]; Comunidad de Madrid [S2010/BMD-2344 Colomics2]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer; US Department of Defense [CA093471, CA110602]; National Institutes of Health/National Cancer Institute [1R01CA155234-01]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R21AR062239-01]; Melanoma Research Alliance; Ministerio de Economia y Competitividad of Spain; Fondo Europeo de Desarrollo Regional (FEDER) [SAF2013-43468-R, SAF2011-29530]; NATIONAL CANCER INSTITUTE [R01CA155234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062239] Funding Source: NIH RePORTER	FEDER-Instituto de Salud Carlos III(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; US Department of Defense(United States Department of Defense); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Melanoma Research Alliance; Ministerio de Economia y Competitividad of Spain(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs G Goodall, T Brabletz and A Garcia de Herreros for kindly providing us reagents, T Martinez and X Langa for technical assistance and Robin Rycroft for help with the English manuscript. This study was supported by the Ministerio de Economia y Competitividad of Spain and Fondo Europeo de Desarrollo Regional (FEDER) (grant SAF2013-43468-R to AM, SAF2011-29530 to FXR); FEDER-Instituto de Salud Carlos III (RD12/0036/0021 to AM and JMR, RD12/0036/0034 to FXR, RD12/0036/0016 to MS, RD12/0036/0012 to HGP, RD06/0020/0003, PS09/00562 and PI13/00703 to JMR); Comunidad de Madrid (S2010/BMD-2344 Colomics2 to AM); Fundacion Cientifica de la Asociacion Espanola contra el Cancer (to JMR); US Department of Defense (CA093471 and CA110602 to EH); National Institutes of Health/National Cancer Institute (1R01CA155234-01 to EH); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (1R21AR062239-01 to EH); and the Melanoma Research Alliance (to EH).	Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; [Anonymous], 2010, R LANG ENV STAT COMP; Barbachano A, 2010, ONCOGENE, V29, P4800, DOI 10.1038/onc.2010.225; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Bornholdt J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-65; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Darido C, 2008, CANCER RES, V68, P4258, DOI 10.1158/0008-5472.CAN-07-5805; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; Feng YH, 2011, CANCER BIOL THER, V11, P111, DOI 10.4161/cbt.11.1.13965; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Holgren C, 2010, ONCOGENE, V29, P5241, DOI 10.1038/onc.2010.264; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kohno Y, 2006, J BIOL CHEM, V281, P38941, DOI 10.1074/jbc.M608389200; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Lei ZL, 2012, DEV BIOL, V371, P136, DOI 10.1016/j.ydbio.2012.07.005; Li X, 2004, J CELL SCI, V117, P6007, DOI 10.1242/jcs.01519; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Merikallio H, 2011, J CLIN PATHOL, V64, P136, DOI 10.1136/jcp.2010.086678; Nakayama F, 2008, PATHOBIOLOGY, V75, P177, DOI 10.1159/000124978; Ono H, 2012, ONCOGENE, V31, P4923, DOI 10.1038/onc.2011.646; Ordonez-Moran P, 2014, ONCOGENE, V33, P1975, DOI 10.1038/onc.2013.140; Ozaki K, 2005, J CELL SCI, V118, P5861, DOI 10.1242/jcs.02711; Punzon I, 2004, BLOOD, V103, P580, DOI 10.1182/blood-2003-07-2298; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sanchez A, 2008, ONCOGENE, V27, P4969, DOI 10.1038/onc.2008.129; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; van der Gun BTF, 2013, BRIT J CANCER, V108, P881, DOI 10.1038/bjc.2013.45; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Watanabe T, 2011, EUR J CANCER, V47, P1946, DOI 10.1016/j.ejca.2011.03.029; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499	61	31	34	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 9	2016	35	23					2991	3003		10.1038/onc.2015.366	http://dx.doi.org/10.1038/onc.2015.366			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0NB	26455323	Green Accepted, Green Submitted			2022-12-26	WOS:000377474500005
J	Magierowska, K; Magierowski, M; Hubalewska-Mazgaj, M; Adamski, J; Surmiak, M; Sliwowski, Z; Kwiecien, S; Brzozowski, T				Magierowska, Katarzyna; Magierowski, Marcin; Hubalewska-Mazgaj, Magdalena; Adamski, Juliusz; Surmiak, Marcin; Sliwowski, Zbigniew; Kwiecien, Slawomir; Brzozowski, Tomasz			Carbon Monoxide (CO) Released from Tricarbonyldichlororuthenium (II) Dimer (CORM-2) in Gastroprotection against Experimental Ethanol-Induced Gastric Damage	PLOS ONE			English	Article							GUANYLATE-CYCLASE ACTIVATION; HEME OXYGENASE-1/CARBON MONOXIDE; NITRIC-OXIDE; OXIDATIVE DAMAGE; MUCOSAL DEFENSE; PATHWAY; EXPRESSION; RATS; STRESS; INHIBITION	The physiological gaseous molecule, carbon monoxide (CO) becomes a subject of extensive investigation due to its vasoactive activity throughout the body but its role in gastroprotection has been little investigated. We determined the mechanism of CO released from its donor tricarbonyldichlororuthenium (II) dimer (CORM-2) in protection of gastric mucosa against 75% ethanol-induced injury. Rats were pretreated with CORM-2 30 min prior to 75% ethanol with or without 1) non-selective (indomethacin) or selective cyclooxygenase (COX)-1 (SC-560) and COX-2 (celecoxib) inhibitors, 2) nitric oxide (NO) synthase inhibitor L-NNA, 3) ODQ, a soluble guanylyl cyclase (sGC) inhibitor, hemin, a heme oxygenase (HO)-1 inductor or zinc protoporphyrin IX (ZnPPIX), an inhibitor of HO-1 activity. The CO content in gastric mucosa and carboxyhemoglobin (COHb) level in blood was analyzed by gas chromatography. The gastric mucosal mRNA expression for HO-1, COX-1, COX-2, iNOS, IL-4, IL-1 beta was analyzed by real-time PCR while HO-1, HO-2 and Nrf2 protein expression was determined by Western Blot. Pretreatment with CORM-2 (0.5-10 mg/kg) dose-dependently attenuated ethanol-induced lesions and raised gastric blood flow (GBF) but large dose of 100 mg/kg was ineffective. CORM-2 (5 mg/kg and 50 mg/kg i.g.) significantly increased gastric mucosal CO content and whole blood COHb level. CORM-2-induced protection was reversed by indomethacin, SC-560 and significantly attenuated by celecoxib, ODQ and L-NNA. Hemin significantly reduced ethanol damage and raised GBF while ZnPPIX which exacerbated ethanol-induced injury inhibited CORM-2- and hemininduced gastroprotection and the accompanying rise in GBF. CORM-2 significantly increased gastric mucosal HO-1 mRNA expression and decreased mRNA expression for iNOS, IL-1 beta, COX-1 and COX-2 but failed to affect HO-1 and Nrf2 protein expression decreased by ethanol. We conclude that CORM-2 released CO exerts gastroprotection against ethanol-induced gastric lesions involving an increase in gastric microcirculation mediated by sGC/cGMP, prostaglandins derived from COX-1, NO-NOS system and its anti-inflammatory properties.	[Magierowska, Katarzyna; Magierowski, Marcin; Hubalewska-Mazgaj, Magdalena; Surmiak, Marcin; Sliwowski, Zbigniew; Kwiecien, Slawomir; Brzozowski, Tomasz] Jagiellonian Univ, Coll Med, Dept Physiol, Krakow, Poland; [Adamski, Juliusz] Inst Forens Res, Dept Forens Toxicol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Magierowski, M (corresponding author), Jagiellonian Univ, Coll Med, Dept Physiol, Krakow, Poland.	magierowskim@yahoo.pl	Surmiak, Marcin/GYU-3390-2022	Surmiak, Marcin/0000-0001-8396-1488; Kwiecien, Slawomir/0000-0002-4806-8042; Magierowski, Marcin/0000-0003-0175-5600	Jagiellonian University Medical College [K/DSC/001379]; Department of Physiology, Jagiellonian University Medical College, Cracow, Poland; Malopolskie Centre of Entrepreneurship; Polpharma Scientific Foundation	Jagiellonian University Medical College; Department of Physiology, Jagiellonian University Medical College, Cracow, Poland; Malopolskie Centre of Entrepreneurship; Polpharma Scientific Foundation	This study was supported by a grant from the Jagiellonian University Medical College (No. K/DSC/001379) for KM, Department of Physiology, Jagiellonian University Medical College, Cracow, Poland. KM is supported by a scholarship for PhD candidates from Malopolskie Centre of Entrepreneurship. MM is supported by a scholarship from Polpharma Scientific Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adamski J, 2012, PROBLEMS FORENSIC SC, V89, P86; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Brzozowski T, 2008, J PHYSIOL PHARMACOL, V59, P89; Brzozowski T, 2006, J PHARMACOL EXP THER, V319, P477, DOI 10.1124/jpet.106.105932; Cechova S, 2004, ANESTH ANALG, V99, P752, DOI 10.1213/01.ANE.0000132695.77191.F3; Chen CY, 2013, J CHIN MED ASSOC, V76, P258, DOI 10.1016/j.jcma.2013.02.001; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Chi P.L., 2014, MOL NEUROBIOL; Costa NRD, 2013, EUR J PHARMACOL, V700, P51, DOI 10.1016/j.ejphar.2012.12.007; Dal-Secco D, 2010, N-S ARCH PHARMACOL, V381, P483, DOI 10.1007/s00210-010-0500-2; De Backer O, 2009, GUT, V58, P347, DOI 10.1136/gut.2008.155481; Durante W, 1997, CIRC RES, V80, P557, DOI 10.1161/01.RES.80.4.557; El-Omar EM, 2001, GUT, V48, P743, DOI 10.1136/gut.48.6.743; Failli P, 2012, CARDIOVASC DRUG THER, V26, P285, DOI 10.1007/s10557-012-6400-6; Foresti R, 1999, FREE RADICAL RES, V31, P459, DOI 10.1080/10715769900301031; Garcia-Arnandis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024591; Gemici B, 2015, J SURG RES, V193, P626, DOI 10.1016/j.jss.2014.08.048; Gerjevic Lisa Nicole, 2011, World J Biol Chem, V2, P252, DOI 10.4331/wjbc.v2.i12.252; Gibbons SJ, 2013, ALIMENT PHARM THER, V38, P689, DOI 10.1111/apt.12467; Gibbons SJ, 2004, J PHYSIOL-LONDON, V556, P325, DOI 10.1113/jphysiol.2003.056556; Gomes AS, 2010, EUR J PHARMACOL, V642, P140, DOI 10.1016/j.ejphar.2010.05.023; Haschemi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026376; Hirai K, 2007, INT J CANCER, V120, P500, DOI 10.1002/ijc.22287; Hosick PA, 2012, AM J PHYSIOL-REG I, V302, pR207, DOI 10.1152/ajpregu.00517.2011; Ibrahim I, 2012, J PHYSIOL BIOCHEM, V68, P319, DOI 10.1007/s13105-011-0143-x; Jackson LM, 2000, GUT, V47, P762, DOI 10.1136/gut.47.6.762; jamal Uddin M., 2015, CELL MOL IMMUNOL; KHARITONOV VG, 1995, P NATL ACAD SCI USA, V92, P2568, DOI 10.1073/pnas.92.7.2568; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; KLATT P, 1992, BIOCHEM J, V288, P15, DOI 10.1042/bj2880015; KONTUREK SJ, 1995, EUR J PHARMACOL, V273, P57, DOI 10.1016/0014-2999(94)00674-V; KONTUREK SJ, 1992, SCAND J GASTROENTERO, V27, P39, DOI 10.3109/00365529209096004; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Li YY, 2013, TOXICOL APPL PHARM, V273, P53, DOI 10.1016/j.taap.2013.08.019; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu S, 2012, TOXICOL IN VITRO, V26, P74, DOI 10.1016/j.tiv.2011.10.013; Magierowski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118972; Magierowski M, 2014, INT J MOL SCI, V15, P4946, DOI 10.3390/ijms15034946; MAINES MD, 1993, MOL CELL NEUROSCI, V4, P389, DOI 10.1006/mcne.1993.1049; Medeiros CA, 2011, J MED MICROBIOL, V60, P1146, DOI 10.1099/jmm.0.028910-0; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; Motterlini R, 2003, CURR PHARM DESIGN, V9, P2525, DOI 10.2174/1381612033453785; Motterlini R, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-28; Naito Y, 2011, J CLIN BIOCHEM NUTR, V48, P126, DOI 10.3164/jcbn.10-61; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Park CH, 2013, LIFE SCI, V92, P740, DOI 10.1016/j.lfs.2013.02.008; Piepoli AL, 2008, NEUROGASTROENT MOTIL, V20, P1251, DOI 10.1111/j.1365-2982.2008.01193.x; Qin SY, 2015, INFLAMM RES, V64, P537, DOI 10.1007/s00011-015-0834-9; ROBERT A, 1981, GUT, V22, P728, DOI 10.1136/gut.22.9.728; Rochette L, 2013, PHARMACOL THERAPEUT, V137, P133, DOI 10.1016/j.pharmthera.2012.09.007; Rodrigues SS, 2011, VUS- 2011-038955-A1, Patent No. 2011038955; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924; Ryter SW, 2004, BIOESSAYS, V26, P270, DOI 10.1002/bies.20005; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwer CI, 2013, INT J BIOCHEM CELL B, V45, P201, DOI 10.1016/j.biocel.2012.09.020; Soni H, 2011, THROMB RES, V127, P551, DOI 10.1016/j.thromres.2011.02.009; Srisook K, 2006, BIOCHEM PHARMACOL, V71, P307, DOI 10.1016/j.bcp.2005.10.042; Sun BW, 2008, INT J BIOL SCI, V4, P270; Origassa CST, 2013, WORLD J HEPATOL, V5, P541, DOI 10.4254/wjh.v5.i10.541; Takahashi S, 1999, J PHARMACOL EXP THER, V291, P634; Takasuka H, 2011, J PHARMACOL EXP THER, V337, P293, DOI 10.1124/jpet.110.175216; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yang Yong, 2014, COMPUT MATH METHOD M, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100677; Yin YJ, 2012, EXP BIOL MED, V237, P362, DOI 10.1258/ebm.2011.011193; Zenclussen AC, 2003, AM J REPROD IMMUNOL, V50, P66, DOI 10.1034/j.1600-0897.2003.00047.x; Zhang YZ, 2006, FEBS J, V273, P3136, DOI 10.1111/j.1742-4658.2006.05319.x	73	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140493	10.1371/journal.pone.0140493	http://dx.doi.org/10.1371/journal.pone.0140493			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460608	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300105
J	Zhang, Y; Wang, C; Su, P; Liao, XL				Zhang, Ya; Wang, Chong; Su, Pin; Liao, Xiaolan			Control Effect and Possible Mechanism of the Natural Compound Phenazine-1-Carboxamide against Botrytis cinerea	PLOS ONE			English	Article							GRAY-MOLD; GREY MOLD; BIOLOGICAL-CONTROL; ESSENTIAL OILS; FLUDIOXONIL RESISTANCE; INTEGRATED MANAGEMENT; INFECTION MECHANISM; CLONOSTACHYS-ROSEA; STRAWBERRY FRUITS; 1ST REPORT	To develop new agents against strawberry grey mould and to aid in the development of biological pesticides, we investigated the inhibitory effect of a natural compound, phenazine-1-carboxamide (PCN), against Botrytis cinerea using a growth rate assay. Additionally, indoor toxicity and the in vitro control effect of PCN were further studied to determine its potential mechanisms of action on B. cinerea. PCN was inhibitory against B. cinerea with a 50% effective concentration (EC50) of 108.12 mu g/mL; the toxicity of PCN was equivalent to that of carbendazim (CBM). The best in vitro control effect of PCN against grey mould in strawberry (fruit) reached 75.32%, which was slightly higher than that of CBM. The field control effect of PCN against grey mould reached a maximum of 72.31% at a PCN concentration of 700 mu g/mL, which was 1.02 times higher than that of CBM. Fungistatic activity was observed at low concentrations of PCN, while high concentrations of PCN resulted in fungicidal activity against B. cinerea. This natural compound strongly inhibited both spore and sclerotium germination of B. cinerea, with the best relative inhibition rates of 77.03% and 82.11%, respectively. The inhibitory effect of PCN on mycelial growth of B. cinerea was significant and reached levels of 87.32%. Scanning electron microscopy observations revealed that after 48 h of PCN treatment, the mycelia appeared loose, locally twisted, and folded, with exudation of contents; the mycelia was withered and twisted, with edge burrs, deformations, ruptures and a sheet-like structure. Transmission electron microscopy observations revealed that after 48 h of PCN treatment, the structure of the cell nucleus was unclear and the vacuoles had ruptured; additionally, various organelles exhibited disordered structures, there were substantial non-membrane transparent inclusions, the cells were plasmolysed, the cell walls were collapsed in some cases, and the hyphal tissue was essentially necrotic. A PCN dosage of 35-140 mu g/mL had no effect on the cell membrane permeability of the mycelia, while a PCN dosage of 700 mu g/mL resulted in significant permeability. PCN inhibited B. cinerea toxin; the mycotoxin level was approximately 0.41 of the value recorded for the control at a PCN dosage of 700 mu g/mL. PCN affected the activity of pectin methylgalacturonase (PMG), polygalacturonase (PG), cellulase (Cx) and beta-glucosidase (BG); the lowest activities of PMG, PG, BG and Cx reached 0.3 U/mg, 0.62 U/mg, 0.64 U/mg, and 0.79 U/mg, respectively, after treatment with 700 mu g/mL PCN.	[Zhang, Ya; Liao, Xiaolan] Hunan Agr Univ, Dept Plant Protect, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Wang, Chong] Hunan Agr Univ, Dept Chem, Coll Sci, Changsha, Hunan, Peoples R China; [Su, Pin] Hunan Acad Agr Sci, Inst Plant Protect, Lab Biocontrol, Changsha, Hunan, Peoples R China; [Zhang, Ya; Liao, Xiaolan] Hunan Prov Key Lab Biol & Control Plant Dis & Pla, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Hunan Academy of Agricultural Sciences	Liao, XL (corresponding author), Hunan Agr Univ, Dept Plant Protect, Coll Plant Protect, Changsha, Hunan, Peoples R China.	lxllxl423@163.com			Industry of National public welfare (Agricultural) scientific research [201303025]; Scientific Research Fund of Hunan Provincial Education Department [14B086]	Industry of National public welfare (Agricultural) scientific research; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was financially supported by the Industry of National public welfare (Agricultural) scientific research (No. 201303025), and the Scientific Research Fund of Hunan Provincial Education Department (14B086).	Bull CT, 1997, BIOL CONTROL, V8, P81, DOI 10.1006/bcon.1996.0476; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chen Jie, 1996, Acta Phytopathologica Sinica, V26, P171; Chen ZW, 2013, ACTA AGR NUCL SINICA, V27, P1156; Colmenares AJ, 2002, J CHEM ECOL, V28, P997, DOI 10.1023/A:1015209817830; Cota LV, 2008, PHYTOPATHOLOGY, V98, pS41; Cota LV, 2009, PHYTOPATHOLOGY, V99, pS25; Cota LV, 2009, BIOL CONTROL, V50, P222, DOI 10.1016/j.biocontrol.2009.04.017; Essghaier B, 2009, J APPL MICROBIOL, V106, P833, DOI 10.1111/j.1365-2672.2008.04053.x; Fang XL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04300; Fernandez-Ortuno D, 2014, PLANT DIS, V98, P848, DOI 10.1094/PDIS-10-13-1020-PDN; Fernandez-Ortuno D, 2014, PLANT DIS, V98, P692, DOI 10.1094/PDIS-08-13-0875-PDN; Fernandez-Ortuno D, 2013, PLANT DIS, V97, P81, DOI 10.1094/PDIS-06-12-0539-RE; Grabke A, 2014, PHYTOPATHOLOGY, V104, P396, DOI 10.1094/PHYTO-06-13-0156-R; Hong FS, 2002, PROG BIOCHEM BIOPHYS, V29, P74; Huang R, 2011, PHYTOPATHOLOGY, V101, P859, DOI 10.1094/PHYTO-09-10-0255; Kim HJ, 2007, J MICROBIOL BIOTECHN, V17, P438; Li BaoJu, 2000, Acta Phytopathologica Sinica, V30, P13; Li BaoJu, 2003, Acta Phytopathologica Sinica, V33, P209; LIM HS, 1991, APPL ENVIRON MICROB, V57, P510, DOI 10.1128/AEM.57.2.510-516.1991; Liu F, 2006, WORLD PESTICIDE, V28, P10; Liu X, 2009, J APPL MICROBIOL, V107, P1450, DOI 10.1111/j.1365-2672.2009.04328.x; Liu XP, 2007, INT J FOOD MICROBIOL, V119, P223, DOI 10.1016/j.ijfoodmicro.2007.07.054; Ministry of Agriculture of the People's Republic of China, 2004, PEST GUID FIELD 120; Moraga J, 2012, FEBS J, V279, P238; Nam MH, 2011, KOREAN J HORTIC SCI, V29, P151; Prokkola S, 2007, AGR FOOD SCI, V16, P25, DOI 10.2137/145960607781635886; Rabolle M, 2006, J AGR FOOD CHEM, V54, P900, DOI 10.1021/jf052302w; Regnier T, 2010, POSTHARVEST BIOL TEC, V57, P176, DOI 10.1016/j.postharvbio.2010.03.010; Shao X, 2013, J APPL MICROBIOL, V114, P1642, DOI 10.1111/jam.12193; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; Song Feng-ping, 2009, Chinese Journal of Pesticide Science, V11, P213; Soylu EM, 2010, INT J FOOD MICROBIOL, V143, P183, DOI 10.1016/j.ijfoodmicro.2010.08.015; Su P, 2012, THESIS HUNAN AGR U C; Ugolini L, 2014, POSTHARVEST BIOL TEC, V90, P34, DOI 10.1016/j.postharvbio.2013.12.002; Vagelas I, 2009, BIOTECHNOL BIOTEC EQ, V23, P1489, DOI 10.2478/V10133-009-0017-3; Valiuskaite A, 2008, ZEMDIRBYSTE, V95, P221; Vitoratos A, 2013, NOT BOT HORTI AGROBO, V41, P86; Wafaa MH, 2013, CURR OPIN BIOTECH, V24, pS45, DOI 10.1016/j.copbio.2013.05.102; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; WILSON CL, 1989, ANNU REV PHYTOPATHOL, V27, P425, DOI 10.1146/annurev.py.27.090189.002233; Xu XM, 2012, AGRON SUSTAIN DEV, V32, P531, DOI 10.1007/s13593-011-0032-2; Yin D, 2015, EUR J PLANT PATHOL, V141, P169, DOI 10.1007/s10658-014-0535-1; Zamani-Zadeh M, 2014, POSTHARVEST BIOL TEC, V92, P149, DOI 10.1016/j.postharvbio.2014.01.019; Zhu BC, 1994, ACTA PHYTOPATHOLOGIC, V21, P239	45	11	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140380	10.1371/journal.pone.0140380	http://dx.doi.org/10.1371/journal.pone.0140380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460973	gold, Green Published, Green Submitted			2022-12-26	WOS:000362962300086
J	Pretorius, S; Stewart, S; Carrington, MJ; Lamont, K; Sliwa, K; Crowther, NJ				Pretorius, Sandra; Stewart, Simon; Carrington, Melinda J.; Lamont, Kim; Sliwa, Karen; Crowther, Nigel J.			Is There an Association between Sleeping Patterns and Other Environmental Factors with Obesity and Blood Pressure in an Urban African Population?	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; METABOLIC SYNDROME; SEX-DIFFERENCES; HEART-DISEASE; SOUTH-AFRICA; DURATION; ADULTS	Beyond changing dietary patterns, there is a paucity of data to fully explain the high prevalence of obesity and hypertension in urban African populations. The aim of this study was to determine whether other environmental factors (including sleep duration, smoking and physical activity) are related to body anthropometry and blood pressure (BP). Data were collected on 1311 subjects, attending two primary health care clinics in Soweto, South Africa. Questionnaires were used to obtain data on education, employment, exercise, smoking and sleep duration. Anthropometric and BP measurements were taken. Subjects comprised 862 women (mean age 41 +/- 16 years and mean BMI 29.9 +/- 9.2 kg/m(2)) and 449 men (38 +/- 14 years and 24.8 +/- 8.3 kg/m(2)). In females, ANOVA showed that former smokers had a higher BMI (p<0.001) than current smokers, while exposure to second hand smoking was associated with a lower BMI (p<0.001) in both genders. Regression analyses demonstrated that longer sleep duration was associated with a lower BMI (p<0.05) in older females only, and not in males, whilst in males napping during the day for >30 minutes was related to a lower BMI (beta = -0.04, p<0.01) and waist circumference (beta = -0.03, p<0.001). Within males, napping for >30 minutes/day was related to lower systolic (beta = -0.02, p<0.05) and lower diastolic BP (beta = -0.02, p = 0.05). Longer night time sleep duration was associated with higher diastolic (beta = 0.005, p<0.01) and systolic BP (beta = 0.003, p<0.05) in females. No health benefits were noted for physical activity. These data suggest that environmental factors rarely collected in African populations are related, in gender-specific ways, to body anthropometry and blood pressure. Further research is required to fully elucidate these associations and how they might be translated into public health programs to combat high levels of obesity and hypertension.	[Pretorius, Sandra; Stewart, Simon; Lamont, Kim; Sliwa, Karen] Univ Witwatersrand, Soweto Cardiovasc Res Unit, Johannesburg, South Africa; [Pretorius, Sandra; Stewart, Simon; Carrington, Melinda J.; Lamont, Kim; Sliwa, Karen] Australia Ctr Res Excellence Reduce Inequal Heart, Baker IDI Heart & Diabet Inst, Preventat Cardiol Natl Hlth & Med Res Council, Melbourne, Vic, Australia; [Stewart, Simon; Carrington, Melinda J.; Sliwa, Karen] Univ Cape Town, Dept Med, Fac Hlth Sci, Hatter Cardiovasc Res Inst, ZA-7925 Cape Town, South Africa; [Crowther, Nigel J.] Univ Witwatersrand, Dept Chem Pathol, Natl Hlth Lab Serv, Johannesburg, South Africa	University of Witwatersrand; Baker Heart and Diabetes Institute; University of Cape Town; National Health Laboratory Service; University of Witwatersrand	Pretorius, S (corresponding author), Univ Witwatersrand, Soweto Cardiovasc Res Unit, Johannesburg, South Africa.	sandra@nutriafrica.co.za	Stewart, Simon/M-3316-2016	Stewart, Simon/0000-0001-9032-8998; Crowther, Nigel/0000-0002-5766-1745; Carrington, Melinda J/0000-0003-3865-1645	Soweto Cardiovascular Research Unit; University of the Witwatersrand; Wits/NIH Non-Communicable Diseases Leadership Program through the Fogarty International Centre of the NIH Millennium Promise Awards: Non-communicable Chronic Diseases Research Training Program (NCoD) [D43, 1D43TW008330-01A1]; FOGARTY INTERNATIONAL CENTER [D43TW008330] Funding Source: NIH RePORTER	Soweto Cardiovascular Research Unit; University of the Witwatersrand; Wits/NIH Non-Communicable Diseases Leadership Program through the Fogarty International Centre of the NIH Millennium Promise Awards: Non-communicable Chronic Diseases Research Training Program (NCoD); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Soweto Cardiovascular Research Unit, University of the Witwatersrand and the Wits/NIH Non-Communicable Diseases Leadership Program, Funded through the Fogarty International Centre of the NIH Millennium Promise Awards: Non-communicable Chronic Diseases Research Training Program (NCoD) (D43), Grant Number: 1D43TW008330-01A1.	Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Braun JM, 2010, PAEDIATR PERINAT EP, V24, P524, DOI 10.1111/j.1365-3016.2010.01146.x; Calvin AD, 2013, CHEST, V144, P79, DOI 10.1378/chest.12-2829; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Dhand R, 2006, CURR OPIN PULM MED, V12, P379; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Eriksson JW, 2008, HYPERTENSION, V52, P1030, DOI 10.1161/HYPERTENSIONAHA.108.119404; Fang J, 2012, AM J HYPERTENS, V25, P335, DOI 10.1038/ajh.2011.201; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Godfrey R, 2005, CLIN MED, V5, P137, DOI 10.7861/clinmedicine.5-2-137; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Grandner MA, 2013, APPETITE, V64, P71, DOI 10.1016/j.appet.2013.01.004; Jean-Louis G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-290; Kobayashi D, 2012, SLEEP BREATH, V16, P829, DOI 10.1007/s11325-011-0583-0; Kruger A, 2012, J HEALTH POPUL NUTR, V30, P56, DOI 10.3329/jhpn.v30i1.11277; Kwok MK, 2010, PEDIATRICS, V126, pE46, DOI 10.1542/peds.2009-2642; Lima MG, 2012, SLEEP MED, V13, P139, DOI 10.1016/j.sleep.2011.07.011; Loucks EB, 2007, ANN EPIDEMIOL, V17, P782, DOI 10.1016/j.annepidem.2007.05.003; Magee CA, 2009, PREV MED, V49, P461, DOI 10.1016/j.ypmed.2009.10.006; Mahan L.K., KRAUSES FOOD NUTR CA; Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Patel SR, 2009, OBES REV, V10, P61, DOI 10.1111/j.1467-789X.2009.00664.x; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Sanchez-Johnsen Lisa A P, 2005, J Natl Med Assoc, V97, P1630; Santos AC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-62; Sayon-Orea C, 2013, OBESITY FACTS, V6, P337, DOI 10.1159/000354746; Seedat YK, 2012, S AFR FAM PRACT, V54, pS4, DOI 10.1080/20786204.2012.10874201; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Sliwa K, 2010, CLIN RES CARDIOL, V99, P65, DOI 10.1007/s00392-009-0094-1; St-Onge MP, 2011, AM J CLIN NUTR, V94, P410, DOI 10.3945/ajcn.111.013904; Stang A, 2012, SLEEP, V35, P1705, DOI 10.5665/sleep.2248; Stewart S, 2012, INT J CARDIOL, V158, P205, DOI 10.1016/j.ijcard.2011.01.022; Stewart S, 2011, EUR HEART J, V32, P492, DOI 10.1093/eurheartj/ehq439; Steyn NP, 2006, CHRONIC DIS LIFESTYL, P33; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; Yoon YS, 2006, OBESITY, V14, P909, DOI 10.1038/oby.2006.105; Zuo CS, 2008, MAGN RESON IMAGING, V26, P629, DOI 10.1016/j.mri.2008.01.003	40	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0131081	10.1371/journal.pone.0131081	http://dx.doi.org/10.1371/journal.pone.0131081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448340	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000001
J	Vogtmann, E; Corley, DA; Almers, LM; Cardwell, CR; Murray, LJ; Abnet, CC				Vogtmann, Emily; Corley, Douglas A.; Almers, Lucy M.; Cardwell, Chris R.; Murray, Liam J.; Abnet, Christian C.			Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers	PLOS ONE			English	Article							MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; LOW BONE-DENSITY; ESOPHAGEAL CANCER; NATIONWIDE POPULATION; PREVENT FRACTURES; COLORECTAL-CANCER; ALENDRONATE; OSTEOPOROSIS; VALIDATION; MORTALITY	The association between oral bisphosphonate use and upper gastrointestinal cancer has been controversial. Therefore, we examined the association with esophageal and gastric cancer within the Kaiser Permanente, Northern California population. A total of 1,011 cases of esophageal (squamous cell carcinoma and adenocarcinoma) and 1,923 cases of gastric adenocarcinoma (cardia, non-cardia and other) diagnosed between 1997 and 2011 from the Kaiser Permanente, Northern California cancer registry were matched to 49,886 and 93,747 controls, respectively. Oral bisphosphonate prescription fills at least one year prior to the index date were extracted. Conditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (95% CI) for the associations between prospectively evaluated oral bisphosphonate use with incident esophageal and gastric cancer diagnoses with adjustment for potential confounders. After adjustment for potential confounders, no significant associations were found for esophageal squamous cell carcinoma (OR 0.88; 95% CI: 0.51, 1.52), esophageal adenocarcinoma (OR 0.68; 95% CI: 0.37, 1.24), or gastric non-cardia adenocarcinoma (OR 0.83, 95% CI: 0.59, 1.18), but we observed an adverse association with gastric cardia adenocarcinoma (OR 1.64; 95% CI: 1.07, 2.50). In conclusion, we observed no association between oral bisphosphonate use and esophageal cancer risk within a large community-based population. A significant association was detected with gastric cardia and other adenocarcinoma risk, although this needs to be replicated.	[Vogtmann, Emily; Abnet, Christian C.] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Vogtmann, Emily] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Corley, Douglas A.; Almers, Lucy M.] Kaiser Permanente, Div Res, Oakland, CA USA; [Cardwell, Chris R.; Murray, Liam J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kaiser Permanente; Queens University Belfast	Vogtmann, E (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	emily.vogtmann@nih.gov	Vogtmann, Emily/O-9125-2017; Abnet, Christian C/C-4111-2015	Vogtmann, Emily/0000-0003-1355-5593; Abnet, Christian C/0000-0002-3008-7843; Cardwell, Chris/0000-0002-2689-4335	Intramural Research Program; Cancer Prevention Fellowship Program of the National Institutes of Health; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Intramural Research Program; Cancer Prevention Fellowship Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program and the Cancer Prevention Fellowship Program of the National Institutes of Health and the National Cancer Institute.	Abrahamsen B, 2012, J BONE MINER RES, V27, P679, DOI 10.1002/jbmr.1481; Abrahamsen B, 2009, NEW ENGL J MED, V360, P1789, DOI 10.1056/NEJMc096026; Bishehsari F, 2014, WORLD J GASTROENTERO, V20, P6055, DOI 10.3748/wjg.v20.i20.6055; Campbell PT, 2015, CANCER EPIDEM BIOMAR, V24, P1229, DOI 10.1158/1055-9965.EPI-15-0094; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YM, 2011, J AM GERIATR SOC, V59, P2379, DOI 10.1111/j.1532-5415.2011.03693.x; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Gnant M, 2012, CANCER TREAT REV, V38, P407, DOI 10.1016/j.ctrv.2011.09.003; Graham DY, 1999, ALIMENT PHARM THER, V13, P515; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Ho YF, 2012, CANCER EPIDEM BIOMAR, V21, P993, DOI 10.1158/1055-9965.EPI-12-0259; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; National Osteoporosis Foundation, 2013, NOF REL NEW DAT DET; Nguyen DM, 2010, DIGEST DIS SCI, V55, P3404, DOI 10.1007/s10620-010-1198-1; Ogino S, 2015, CANCER CAUSE CONTROL, V26, P959, DOI 10.1007/s10552-015-0596-2; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Solomon DH, 2009, NEW ENGL J MED, V360, P1789; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P434, DOI 10.1007/s00223-011-9539-4; Vinogradova Y, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f114; WHOCC, 2013, ATC DDD IND 2013; Wright E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047616; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140180	10.1371/journal.pone.0140180	http://dx.doi.org/10.1371/journal.pone.0140180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445463	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600149
J	Wang, M; Bjorkenstam, C; Alexanderson, K; Runeson, B; Tinghog, P; Mittendorfer-Rutz, E				Wang, Mo; Bjoerkenstam, Charlotte; Alexanderson, Kristina; Runeson, Bo; Tinghoeg, Petter; Mittendorfer-Rutz, Ellenor			Trajectories of Work-Related Functional Impairment prior to Suicide	PLOS ONE			English	Article							4.9 MILLION INHABITANTS; TERM SICKNESS ABSENCE; DISABILITY PENSIONERS; MENTAL-DISORDERS; RISK-FACTORS; FOLLOW-UP; ALL-CAUSE; MORTALITY; HEALTH; BEHAVIOR	Background Work-related functional impairment in terms of sickness absence and disability pension (SA/DP) has been reported to be associated with subsequent suicide. However, there is only limited knowledge on SA/DP patterns prior to suicide. The aim was to identify trajectories of work-related functional impairment prior to suicide and to describe associations of socio-demographic and medical factors with such trajectories. Methods This is a population-based retrospective cohort study of the 4 209 individuals aged 22-65 years who committed suicide during 2007-2010 in Sweden. Work-related functional impairment was measured as mean annual number of months of SA/DP. We analyzed trajectories of SA/DP during five years prior to suicide (i.e., 2002-2009) by a group-based trajectory method. Associations between socio-demographic and medical factors with different groups of trajectories were estimated by chi(2)-test and multinomial logistic regression. Results Five different functional impairment trajectory groups were identified prior to suicide. One group had constant low levels of SA/DP (46%), while 30% had constant high levels of SA/DP. Two groups (16%) showed increasing number of SA/DP months. The remaining 7% showed decreasing number of SA/DP months before the suicide. Sex, age, educational level, family situation, and diagnosis-specific healthcare were significantly associated with different trajectory groups (Likelihood ratio X-2 tests <0.05). A larger proportion of higher educated and younger men with a lower proportion of previous suicide attempts were found in the group with constant low levels. Opposite characteristics were displayed in the group with constant high levels. Conclusions This study identified five different groups of work-related functional impairment trajectories before suicide. These differences might be partly explained by the variations in socio-demographic profiles and health care consumptions five years before suicide.	[Wang, Mo; Bjoerkenstam, Charlotte; Alexanderson, Kristina; Tinghoeg, Petter; Mittendorfer-Rutz, Ellenor] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Runeson, Bo] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Wang, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden.	mo.wang@ki.se	Wang, Mo/AAJ-9414-2020		Swedish Research Council [522-2010-2683]; Karolinska Institutet funds for doctoral education, the Swedish Research Council for Health, Working Life and Welfare	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet funds for doctoral education, the Swedish Research Council for Health, Working Life and Welfare	This work was supported by the Swedish Research Council (grant number 522-2010-2683) and Karolinska Institutet funds for doctoral education, the Swedish Research Council for Health, Working Life and Welfare.	Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; Angst J, 2002, EUR ARCH PSY CLIN N, V252, P201, DOI 10.1007/s00406-002-0381-6; [Anonymous], 2013, SOC INS FIG 2013; Bjorkenstam Charlotte, 2015, Mult Scler J Exp Transl Clin, V1, p2055217315595638, DOI 10.1177/2055217315595638; Bjorkenstam C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1247; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Bryngelson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067887; Burns BJ, 2000, INT J PSYCHIAT MED, V30, P127, DOI 10.2190/TLXJ-YXLX-F4YA-6PHA; Chen Q, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3769; Ejlertsson G, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-20; Elliott Jane, 2013, LIFE COURSE APPROACH, P118; Ferrie JE, 2011, OCCUP ENVIRON MED, V68, P729, DOI 10.1136/oem.2010.060210; Floderus B, 2005, J REHABIL MED, V37, P291, DOI 10.1080/16501970510034422; Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P168, DOI 10.1177/1403494808100937; Goldston K, 2008, CLIN PSYCHOL REV, V28, P288, DOI 10.1016/j.cpr.2007.05.005; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Ishtiak-Ahmed K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-492; Janssens H, 2014, EUR J PUBLIC HEALTH, V24, P428, DOI 10.1093/eurpub/cku009; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jonsson U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002286; Karlsson NE, 2007, SCAND J PUBLIC HEALT, V35, P341, DOI 10.1080/14034940601159229; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Knudsen AK, 2013, ACTA PSYCHIAT SCAND, V127, P287, DOI 10.1111/j.1600-0447.2012.01902.x; Leone SS, 2010, BRIT J PSYCHIAT, V197, P86, DOI 10.1192/bjp.bp.109.076604; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Mittendorfer-Rutz E., 2012, PLOS ONE, V7, P1; Runeson BS, 1996, ACTA PSYCHIAT SCAND, V93, P35, DOI 10.1111/j.1600-0447.1996.tb10616.x; Socialstyrelsen, 2009, CAUS DEATH REG; STANSFELD S, 1995, SOC SCI MED, V40, P189, DOI 10.1016/0277-9536(94)E0064-Y; TAYLOR PJ, 1972, P ROY SOC MED, V65, P577, DOI 10.1177/003591577206500634; Taylor R, 1998, SOC SCI MED, V47, P1677, DOI 10.1016/S0277-9536(98)00243-3; Thorsen SV, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-115; Virtanen M, 2015, DIABET MED; Wallman T, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-103; Wang M, 2014, OCCUP ENVIRON MED, V71, P12, DOI 10.1136/oemed-2013-101462; World Health Organization, 2009, EUR HLTH ALL DAT	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139937	10.1371/journal.pone.0139937	http://dx.doi.org/10.1371/journal.pone.0139937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26444997	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600109
J	Wang, HL; Li, CX; Jian, ZX; Ou, YL; Ou, JR				Wang, Huiling; Li, Caixia; Jian, Zhixiang; Ou, Yingliang; Ou, Jinrui			TGF-beta 1 Reduces miR-29a Expression to Promote Tumorigenicity and Metastasis of Cholangiocarcinoma by Targeting HDAC4	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HUMAN HEPATOCELLULAR-CARCINOMA; II HISTONE DEACETYLASES; BILIARY-TRACT CANCER; TGF-BETA; SUPPRESSES TUMORIGENICITY; CELL-LINES; MICRO-RNA; APOPTOSIS; DIFFERENTIATION	Transforming growth factor beta 1 (TGF-beta 1) and miRNAs play important roles in cholangiocarcinoma progression. In this study, miR-29a level was found significantly decreased in both cholangiocarcinoma tissues and tumor cell lines. TGF-beta 1 reduced miR-29a expression in tumor cell lines. Furthermore, anti-miR-29a reduced the proliferation and metastasis capacity of cholangiocarcinoma cell lines in vitro, overexpression of miR-29a counteracted TGF beta 1-mediated cell growth and metastasis. Subsequent investigation identified HDAC4 is a direct target of miR-29a. In addition, restoration of HDAC4 attenuated miR-29a-mediated inhibition of cell proliferation and metastasis. Conclusions: TGF-beta 1/miR-29a/HDAC4 pathway contributes to the pathogenesis of cholangiocarcinoma and our data provide new therapeutic targets for cholangiocarcinoma.	[Wang, Huiling; Jian, Zhixiang; Ou, Yingliang; Ou, Jinrui] Guangdong Gen Hosp, Dept Gen Surg, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Huiling; Jian, Zhixiang; Ou, Yingliang; Ou, Jinrui] Guangdong Acad Med Sci, Guangzhou 510080, Guangdong, Peoples R China; [Li, Caixia] Guangdong Pharmaceut Univ, Sch Clin Med, Affiliated Hosp 1, Dept Rheumatol, Guangzhou 510080, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Pharmaceutical University	Ou, JR (corresponding author), Guangdong Gen Hosp, Dept Gen Surg, Guangzhou 510080, Guangdong, Peoples R China.	sygdwk@126.com						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benckert C, 2003, CANCER RES, V63, P1083; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Bluethner T, 2007, WORLD J GASTROENTERO, V13, P4761, DOI 10.3748/wjg.v13.i35.4761; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chang YX, 2013, J HEPATOL, V59, P518, DOI 10.1016/j.jhep.2013.04.034; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Chen YJ, 2011, DIGEST DIS SCI, V56, P1693, DOI 10.1007/s10620-010-1481-1; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025872; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Goggins M, 1998, CANCER RES, V58, P5329; Grady WM, 1999, CANCER RES, V59, P320; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Jeon HS, 2010, J THORAC ONCOL, V5, P417, DOI 10.1097/JTO.0b013e3181ce3afd; Khabele D, 2007, CANCER BIOL THER, V6, P795, DOI 10.4161/cbt.6.5.4007; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Qiu YH, 2014, MOL BIOSYST, V10, P679, DOI 10.1039/c3mb70479c; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Sato Y, 2010, AM J PATHOL, V177, P141, DOI 10.2353/ajpath.2010.090747; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu LN, 2008, WORLD J GASTROENTERO, V14, P2578, DOI 10.3748/wjg.14.2578; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yuan JH, 2011, HEPATOLOGY, V54, P2025, DOI 10.1002/hep.24606	44	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0136703	10.1371/journal.pone.0136703	http://dx.doi.org/10.1371/journal.pone.0136703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441331	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510300001
J	Bachmann, AL; Mootz, HD				Bachmann, Anne-Lena; Mootz, Henning D.			An Unprecedented Combination of Serine and Cysteine Nucleophiles in a Split Intein with an Atypical Split Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotechnology; intein; metagenomics; post-translational modification (PTM); protein splicing; site-directed mutagenesis; structural model	SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; HIGHLY EFFICIENT; ADENOSINE-TRIPHOSPHATASE; CHEMICAL-MODIFICATION; DIRECTED EVOLUTION; DNAB INTEIN; PROTEIN; MECHANISM; IDENTIFICATION	Protein splicing mediated by inteins is a self-processive reaction leading to the excision of the internal intein domain from a precursor protein and the concomitant ligation of the flanking sequences, the extein-N and extein-C parts, thereby reconstituting the host protein. Most inteins employ a splicing pathway in which the upstream scissile peptide bond is consecutively rearranged into two thioester or oxoester intermediates before intein excision and rearrangement into the new peptide bond occurs. The catalytically critical amino acids involved at the two splice junctions are cysteine, serine, or threonine. Notably, the only potential combination not observed so far in any of the known or engineered inteins corresponds to the transesterification from an oxoester to a thioester, which suggested that this formal uphill reaction with regard to the thermodynamic stability might be incompatible with intein-mediated catalysis. We show that corresponding mutations also led to inactive gp41-1 and AceL-TerL inteins. We report the novel GOS-TerL split intein identified from metagenomic databases as the first intein harboring the combination of Ser1 and Cys+1 residues. Mutational analysis showed that its efficient splicing reaction indeed follows the shift from oxoester to thioester and thus represents a rare diversion from the canonical pathway. Furthermore, the GOS-TerL intein has an atypical split site close to the N terminus. The Int(N) fragment could be shortened from 37 to 28 amino acids and exchanged with the 25-amino acid Int(N) fragment from the AceL-TerL intein, indicating a high degree of promiscuity of the Int(C) fragment of the GOS-TerL intein.	[Bachmann, Anne-Lena; Mootz, Henning D.] Univ Munster, Inst Biochem, Dept Chem & Pharm, D-48149 Munster, Germany	University of Munster	Mootz, HD (corresponding author), Univ Munster, Inst Biochem, Dept Chem & Pharm, D-48149 Munster, Germany.	Henning.Mootz@uni-muenster.de			Deutsche Forschungsgemeinschaft [MO 1073-3, MO 1073-2, SPP1623]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants MO 1073-3,2 and SPP1623. The authors declare that they have no conflicts of interest with the contents of this article.	Anraku Y, 2005, IUBMB LIFE, V57, P563, DOI 10.1080/15216540500215499; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Binschik J, 2013, ANGEW CHEM INT EDIT, V52, P4260, DOI 10.1002/anie.201208863; Brenzel S, 2009, CHEMBIOCHEM, V10, P983, DOI 10.1002/cbic.200900039; Carvajal-Vallejos P, 2012, J BIOL CHEM, V287, P28686, DOI 10.1074/jbc.M112.372680; Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Dassa B, 2009, NUCLEIC ACIDS RES, V37, P2560, DOI 10.1093/nar/gkp095; DAVIS EO, 1992, CELL, V71, P201, DOI 10.1016/0092-8674(92)90349-H; Dearden AK, 2013, PROTEIN SCI, V22, P557, DOI 10.1002/pro.2236; Dhar T, 2011, CHEM COMMUN, V47, P3063, DOI 10.1039/c0cc04172f; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Du ZM, 2011, J BIOL CHEM, V286, P38638, DOI 10.1074/jbc.M111.290569; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Ghosh I, 2001, J BIOL CHEM, V276, P24051, DOI 10.1074/jbc.M011049200; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; HIRATA R, 1990, J BIOL CHEM, V265, P6726; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kurpiers T, 2008, CHEMBIOCHEM, V9, P2317, DOI 10.1002/cbic.200800319; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Mills KV, 2014, J BIOL CHEM, V289, P14498, DOI 10.1074/jbc.R113.540310; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Novikova O, 2014, J BIOL CHEM, V289, P14490, DOI 10.1074/jbc.R114.548255; Oeemig JS, 2012, J MOL BIOL, V421, P85, DOI 10.1016/j.jmb.2012.04.029; Pereira B, 2011, J MOL BIOL, V406, P430, DOI 10.1016/j.jmb.2010.12.024; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Qi XM, 2011, PROTEIN PEPTIDE LETT, V18, P1226, DOI 10.2174/092986611797642760; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shah NH, 2014, CHEM SCI, V5, P446, DOI 10.1039/c3sc52951g; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Thiel IV, 2014, ANGEW CHEM INT EDIT, V53, P1306, DOI 10.1002/anie.201307969; Tori K, 2012, BIOCHEMISTRY-US, V51, P2496, DOI 10.1021/bi201840k; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Volkmann G, 2013, CELL MOL LIFE SCI, V70, P1185, DOI 10.1007/s00018-012-1120-4; Wasmuth A, 2013, BIOORGAN MED CHEM, V21, P3495, DOI 10.1016/j.bmc.2013.03.065; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang W, 2001, J AM CHEM SOC, V123, P11004, DOI 10.1021/ja010726a; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003	52	19	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28792	28804		10.1074/jbc.M115.677237	http://dx.doi.org/10.1074/jbc.M115.677237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453311	hybrid, Green Published			2022-12-26	WOS:000365762300021
J	Yamasaki, K; Daiho, T; Danko, S; Suzuki, H				Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi			Assembly of a Tyr(122) Hydrophobic Cluster in Sarcoplasmic Reticulum Ca2+-ATPase Synchronizes Ca2+ Affinity Reduction and Release with Phosphoenzyme Isomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-INSENSITIVE PHOSPHOENZYME; CALCIUM ADENOSINE-TRIPHOSPHATASE; STABLE STRUCTURAL ANALOG; REACTION-MECHANISM; SENSITIVE PHOSPHOENZYME; CRYSTAL-STRUCTURES; TRANSPORT SITES; ATP HYDROLYSIS; OCCLUDED CA2+; PHOSPHORYLATION	The mechanism whereby events in and around the catalytic site/head of Ca2+-ATPase effect Ca2+ release to the lumen from the transmembrane helices remains elusive. We developed a method to determine deoccluded bound Ca2+ by taking advantage of its rapid occlusion upon formation of E1PCa(2) and of stabilization afforded by a high concentration of Ca2+. The assay is applicable to minute amounts of Ca2+-ATPase expressed in COS-1 cells. It was validated by measuring the Ca2+ binding properties of unphosphorylated Ca2+-ATPase. The method was then applied to the isomerization of the phosphorylated intermediate associated with the Ca2+ release process E1PCa(2) -> E2PCa(2) -> E2P + 2Ca(2+). In the wild type, Ca2+ release occurs concomitantly with EP isomerization fitting with rate-limiting isomerization (E1PCa(2) -> E2PCa(2)) followed by very rapid Ca2+ release. In contrast, with alanine mutants of Leu(119) and Tyr(122) on the cytoplasmic part of the second transmembrane helix (M2) and Ile(179) on the A domain, Ca2+ release in 10 mu M Ca2+ lags EP isomerization, indicating the presence of a transient E2P state with bound Ca2+. The results suggest that these residues function in Ca2+ affinity reduction in E2P, likely via a structural rearrangement at the cytoplasmic part of M2 and a resulting association with the A and P domains, therefore leading to Ca2+ release.	[Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Univ, Dept Biochem, Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [15H04346] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) (to K. Y.) and (B) (to H. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1987, J BIOL CHEM, V262, P16338; INESI G, 1980, J BIOL CHEM, V255, P3025; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LACAPERE JJ, 1990, J BIOL CHEM, V265, P8583; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P8626, DOI 10.1021/bi00423a018; PETITHORY JR, 1986, BIOCHEMISTRY-US, V25, P4493, DOI 10.1021/bi00364a006; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P4157; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; WAKABAYASHI S, 1984, J BIOL CHEM, V259, P4427; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; Webb RJ, 2000, J BIOL CHEM, V275, P977, DOI 10.1074/jbc.275.2.977; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMADA S, 1980, J BIOL CHEM, V255, P3108; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200; Yamasaki K, 2010, J BIOL CHEM, V285, P38674, DOI 10.1074/jbc.M110.183343	45	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27868	27879		10.1074/jbc.M115.693770	http://dx.doi.org/10.1074/jbc.M115.693770			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26442589	Green Published, hybrid			2022-12-26	WOS:000365757500036
J	Poleg-Polsky, A				Poleg-Polsky, Alon			Effects of Neural Morphology and Input Distribution on Synaptic Processing by Global and Focal NMDA-Spikes	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; IN-VIVO; BASAL DENDRITES; SENSORY INPUT; APICAL DENDRITES; CORTICAL LAYERS; TUFT DENDRITES; VISUAL-CORTEX; CELLS; INTEGRATION	Cortical neurons can respond to glutamatergic stimulation with regenerative N-Methyl-D-aspartic acid (NMDA)-spikes. NMDA-spikes were initially thought to depend on clustered synaptic activation. Recent work had shown however a new variety of a global NMDA-spike, which can be generated by randomly distributed inputs. Very little is known about the factors that influence the generation of these global NMDA-spikes, as well the potentially distinct rules of synaptic integration and the computational significance conferred by the two types of NMDA-spikes. Here I show that the input resistance (R-IN) plays a major role in influencing spike initiation; while the classical, focal NMDA-spike depended upon the local (dendritic) RIN, the threshold of global NMDA-spike generation was set by the somatic RIN. As cellular morphology can exert a large influence on RIN, morphologically distinct neuron types can have dissimilar rules for NMDA-spikes generation. For example, cortical neurons in superficial layers were found to be generally prone to global NMDA-spike generation. In contrast, electric properties of cortical layer 5b cells clearly favor focal NMDA-spikes. These differences can translate into diverse synaptic integration rules for the different classes of cortical cells; simulated superficial layers neurons were found to exhibit strong synaptic interactions between different dendritic branches, giving rise to a single integrative compartment mediated by the global NMDA-spike. In these cells, efficiency of postsynaptic activation was relatively little dependent on synaptic distribution. By contrast, layer 5b neurons were capable of true multi-unit computation involving independent integrative compartments formed by clustered synaptic input which could trigger focal NMDA-spikes. In a sharp contrast to superficial layers neurons, randomly distributed synaptic inputs were not very effective in driving firing the layer 5b cells, indicating a possibility for different computation performed by these important cortical neurons.	Natl Inst Neurol Disorder & Stroke, Synapt Physiol Sect, NIH, Bethesda, MD 20824 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Poleg-Polsky, A (corresponding author), Natl Inst Neurol Disorder & Stroke, Synapt Physiol Sect, NIH, Bethesda, MD 20824 USA.	polegpolskya@mail.nih.gov			NINDS Intramural Research Program [NS003145]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003039, ZIANS003145] Funding Source: NIH RePORTER	NINDS Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NINDS Intramural Research Program (NS003145).	Andjelic S, 2009, J NEUROPHYSIOL, V101, P641, DOI 10.1152/jn.91094.2008; Antic SD, 2010, J NEUROSCI RES, V88, P2991, DOI 10.1002/jnr.22444; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Behabadi BF, 2014, P NATL ACAD SCI USA, V111, P498, DOI 10.1073/pnas.1217645111; Behabadi BF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002599; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Chalifoux JR, 2011, J NEUROSCI, V31, P16435, DOI 10.1523/JNEUROSCI.2777-11.2011; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Farinella M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003590; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harnett MT, 2013, NEURON, V79, P516, DOI 10.1016/j.neuron.2013.06.005; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hill DN, 2013, P NATL ACAD SCI USA, V110, P13618, DOI 10.1073/pnas.1312599110; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Jadi M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002550; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Makara JK, 2013, NEURON, V80, P1438, DOI 10.1016/j.neuron.2013.10.033; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Milojkovic BA, 2005, J NEUROSCI, V25, P3940, DOI 10.1523/JNEUROSCI.5314-04.2005; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Palmer LM, 2014, NAT NEUROSCI, V17, P383, DOI 10.1038/nn.3646; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Polsky A, 2009, J NEUROSCI, V29, P11891, DOI 10.1523/JNEUROSCI.5250-08.2009; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Rhodes P, 2006, J NEUROSCI, V26, P6704, DOI 10.1523/JNEUROSCI.3791-05.2006; Rhodes PA, 2008, NEURAL COMPUT, V20, P2000, DOI 10.1162/neco.2008.04-07-511; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Sarid L, 2015, CEREB CORTEX, V25, P849, DOI 10.1093/cercor/bht268; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Trevelyan AJ, 2002, J PHYSIOL-LONDON, V539, P623, DOI 10.1013/jphysiol.2001.013291; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Wu XE, 2009, NEURON, V62, P31, DOI 10.1016/j.neuron.2009.02.021; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995	62	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140254	10.1371/journal.pone.0140254	http://dx.doi.org/10.1371/journal.pone.0140254			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460829	Green Published, gold, Green Submitted			2022-12-26	WOS:000362962300074
J	Guerra-Perez, N; Ramos, E; Garcia-Hernandez, M; Pinto, C; Soto, M; Martin, ME; Gonzalez, VM				Guerra-Perez, Natalia; Ramos, Edurne; Garcia-Hernandez, Marta; Pinto, Celia; Soto, Manuel; Elena Martin, M.; Gonzalez, Victor M.			Molecular and Functional Characterization of ssDNA Aptamers that Specifically Bind Leishmania infantum PABP	PLOS ONE			English	Article							IN-VITRO SELECTION; MESSENGER-RNA; POLY(A)-BINDING PROTEIN; CUTANEOUS LEISHMANIASIS; AFRICAN TRYPANOSOMES; TRANSLATION; THERAPEUTICS; EXPRESSION; ERF3/GSPT; LIGANDS	-Summary A poly (A)-binding protein from Leishmania infantum (LiPABP) has been recently cloned and characterized in our laboratory. Although this protein shows a very high homology with PABPs from other eukaryotic organisms including mammals and other parasites, exist divergences along the sequence that convert them in potential diagnostic markers and/or therapeutics targets. Aptamers are oligonucleotide ligands that are selected in vitro by their affinity and specificity for the target as a consequence of the particular tertiary structure that they are able to acquire depending on their sequence. Development of high-affinity molecules with the ability to recognize specifically Leishmania proteins is essential for the progress of this kind of study. Results We have selected a ssDNA aptamer population against a recombinant 6xHIS-LiPABP protein (rLiPABP) that is able to recognize the target with a low Kd. Cloning, sequencing and in silico analysis of the aptamers obtained from the population yielded three aptamers (ApPABP#3, ApPABP#7 and ApPABP#11) that significantly bound to PABP with higher affinity than the naive population. These aptamers were analyzed by ELONA and slot blot to establish affinity and specificity for rLiPABP. Results demonstrated that the three aptamers have high affinity and specificity for the target and that they are able to detect an endogenous LiPABP (eLiPABP) protein amount corresponding to 2500 L. infantum promastigotes in a significant manner. The functional analysis of the aptamers also revealed that ApPABP#11 disrupts the binding of both Myc-LiPABP and eLiPABP to poly (A) in vitro. On the other hand, these aptamers are able to bind and purify LiPABP from complex mixes. Conclusion Results presented here demonstrate that aptamers represent new reagents for characterization of LiPABP and that they can affect LiPABP activity. At this respect, the use of these aptamers as therapeutic tool affecting the physiological role of PABP has to be analyzed.	[Guerra-Perez, Natalia; Ramos, Edurne; Pinto, Celia; Elena Martin, M.; Gonzalez, Victor M.] IRYCIS Hosp Ramon y Cajal, Serv Bioquim Invest, Lab Aptamers, Madrid, Spain; [Garcia-Hernandez, Marta] Aptus Biotech SL, Madrid, Spain; [Soto, Manuel] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Biol Mol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Gonzalez, VM (corresponding author), IRYCIS Hosp Ramon y Cajal, Serv Bioquim Invest, Lab Aptamers, Madrid, Spain.	victor.m.gonzalez@hrc.es	Álvarez, Manuel Soto/Q-5234-2018; Guerra-Pérez, Natalia/I-1879-2017; Martín, María/HDL-9512-2022; Gonzalez, Victor M/F-7396-2010	Álvarez, Manuel Soto/0000-0001-6825-841X; Guerra-Pérez, Natalia/0000-0002-4851-3361; Gonzalez, Victor M/0000-0001-7538-0552; MARTIN, M. ELENA/0000-0003-2131-874X; Ramos, Edurne/0000-0001-5388-0281	Ministerio de Economia y Competitividad (Spain) [PI05/0453, SAF2010-21663]	Ministerio de Economia y Competitividad (Spain)	This work was supported by Grants PI05/0453 and SAF2010-21663 from the Ministerio de Economia y Competitividad (Spain). MEM and VMG are researchers from FIBio-HRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Marta Garcia-Hernandez is employed by Aptus Biotech SL. The funder provided support in the form of salaries for MG-H, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bag J, RNA BIOL, V7, P5; Barfod A, 2009, PARASITOL RES, V105, P1557, DOI 10.1007/s00436-009-1583-x; Bates EJ, 2000, NUCLEIC ACIDS RES, V28, P1211, DOI 10.1093/nar/28.5.1211; BATISTA JAN, 1994, MOL BIOCHEM PARASIT, V67, P301, DOI 10.1016/0166-6851(94)00133-2; Bhattacharyya SN, 2002, MOL CELL BIOL, V22, P4372, DOI 10.1128/MCB.22.12.4372-4382.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruno J.G., 2007, J CLIN LIGAND ASSAY, V30, P1; Chekanova JA, 2003, RNA, V9, P1476, DOI 10.1261/rna.5128903; Lima TDD, 2010, EUKARYOT CELL, V9, P1484, DOI 10.1128/EC.00148-10; Martin ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078886; ELLINGTON AD, 1992, NATURE, V355, P850, DOI 10.1038/355850a0; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gorgoni Barbara, 2004, Briefings in Functional Genomics & Proteomics, V3, P125, DOI 10.1093/bfgp/3.2.125; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; Guerra N, 2011, FEBS LETT, V585, P193, DOI 10.1016/j.febslet.2010.11.042; Homann M, 2001, BIOORGAN MED CHEM, V9, P2571, DOI 10.1016/S0968-0896(01)00032-3; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Hoshino S, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1367; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hotchkiss TL, 1999, MOL BIOCHEM PARASIT, V98, P117, DOI 10.1016/S0166-6851(98)00156-X; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Iborra S, 2004, VACCINE, V22, P3865, DOI 10.1016/j.vaccine.2004.04.015; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Lorger M, 2003, EUKARYOT CELL, V2, P84, DOI 10.1128/EC.2.1.84-94.2003; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; MARTIN ME, 1993, NEUROSCI LETT, V156, P109; Moreno M, 2003, BIOCHEM BIOPH RES CO, V308, P214, DOI 10.1016/S0006-291X(03)01352-4; Moreno M, 2010, ANALYST; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Ndao M., 2009, Interdisciplinary Perspectives on Infectious Diseases, V2009, P278246, DOI 10.1155/2009/278246; Niles JC, 2009, P NATL ACAD SCI USA, V106, P13266, DOI 10.1073/pnas.0906370106; O'Loghlen A, 2007, BBA-MOL CELL RES, V1773, P1416, DOI 10.1016/j.bbamcr.2007.05.009; Ramos E, 2007, LAB INVEST, V87, P409, DOI 10.1038/labinvest.3700535; Ramos E, 2010, OLIGONUCLEOTIDES, V20, P207, DOI 10.1089/oli.2010.0240; Santosh B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/540451; Schwartz E, 2006, LANCET INFECT DIS, V6, P342, DOI 10.1016/S1473-3099(06)70492-3; Shi PY, 1997, BIOTECHNIQUES, V23, P1036, DOI 10.2144/97236bm15; Silva FP, 2002, MEM I OSWALDO CRUZ, V97, P335, DOI 10.1590/S0074-02762002000300010; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Ulrich H, 2002, J BIOL CHEM, V277, P20756, DOI 10.1074/jbc.M111859200; Uphoff KW, 1996, CURR OPIN STRUC BIOL, V6, P281, DOI 10.1016/S0959-440X(96)80045-5; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; Zhao XC, 2006, NUCLEIC ACIDS RES, V34, P3755, DOI 10.1093/nar/gkl470	48	17	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140048	10.1371/journal.pone.0140048	http://dx.doi.org/10.1371/journal.pone.0140048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457419	Green Published, gold			2022-12-26	WOS:000362961100021
J	Gruebner, O; Lautenbach, S; Khan, MMH; Kipruto, S; Epprecht, M; Galea, S				Gruebner, Oliver; Lautenbach, Sven; Khan, M. M. H.; Kipruto, Samuel; Epprecht, Michael; Galea, Sandro			Place of Residence Moderates the Risk of Infant Death in Kenya: Evidence from the Most Recent Census 2009	PLOS ONE			English	Article							ENVIRONMENTAL DETERMINANTS; CHILDHOOD MORTALITY; NEONATAL-MORTALITY; HEALTH; CHILDREN; OBESITY; SERVICES; EQUITY; SLUMS; DHAKA	Background Substantial progress has been made in reducing childhood mortality worldwide from 19902015 (Millennium Development Goal, target 4). Achieving target goals on this however remains a challenge in Sub-Saharan Africa. Kenya's infant mortality rates are higher than the global average and are more pronounced in urban areas as compared to rural areas. Only limited knowledge exists about the differences in individual level risk factors for infant death among rural, non-slum urban, and slum areas in Kenya. Therefore, this paper aims at 1) assess individual and socio-ecological risk factors for infant death in Kenya, and at 2) identify whether living in rural, non-slum urban, or slum areas moderated individual or socioecological risk factors for infant death in Kenya. Methodology We used a cross-sectional study design based on the most recent Kenya Population and Housing Census of 2009 and extracted the records of all females who had their last child born in 12 months preceding the survey (N = 1,120,960). Multivariable regression analyses were used to identify risk factors that accounted for the risk of dying before the age of one at the individual level in Kenya. Place of residence (rural, non-slum urban, slum) was used as an interaction term to account for moderating effects in individual and socio-ecological risk factors. Results Individual characteristics of mothers and children (older age, less previously born children that died, better education, girl infants) and household contexts (better structural quality of housing, improved water and sanitation, married household head) were associated with lower risk for infant death in Kenya. Living in non-slum urban areas was associated with significantly lower infant death as compared to living in rural or slum areas, when all predictors were held at their reference levels. Moreover, place of residence was significantly moderating individual level predictors: As compared to rural areas, living in urban areas was a protective factor for mothers who had previous born children who died, and who were better educated. However, living in urban areas also reduced the health promoting effects of better structural quality of housing (i.e. poor or good versus non-durable). Furthermore, durable housing quality in urban areas turned out to be a risk factor for infant death as compared to rural areas. Living in slum areas was also a protective factor for mothers with previous child death, however it also reduced the promoting effects of older ages in mothers. Conclusions While urbanization and slum development continues in Kenya, public health interventions should invest in healthy environments that ideally would include improvements to access to safe water and sanitation, better structural quality of housing, and to access to education, health care, and family planning services, especially in urban slums and rural areas. In non-slum urban areas however, health education programs that target healthy diets and promote physical exercise may be an important adjunct to these structural interventions.	[Gruebner, Oliver] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Lautenbach, Sven] Univ Bonn, Inst Geodesy & Geoinformat, Bonn, Germany; [Khan, M. M. H.] Univ Bielefeld, Dept Publ Hlth Med, Sch Publ Hlth, D-33615 Bielefeld, Germany; [Kipruto, Samuel] Kenya Bur Stat KNBS, Nairobi, Kenya; [Gruebner, Oliver; Epprecht, Michael] Univ Bern, CDE, Bern, Switzerland; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA	Columbia University; University of Bonn; University of Bielefeld; University of Bern; Boston University	Gruebner, O (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	gruebner@hsph.harvard.edu	Gruebner, Oliver/G-5126-2010; Gruebner, Oliver/X-2675-2019; Galea, Sandro/GLR-6066-2022; Lautenbach, Sven/C-1235-2010; Gruebner, Oliver/H-7947-2019	Gruebner, Oliver/0000-0001-9783-4770; Gruebner, Oliver/0000-0001-9783-4770; Lautenbach, Sven/0000-0003-1825-9996; Gruebner, Oliver/0000-0001-9783-4770; Galea, Sandro/0000-0002-7534-0945	German Research Foundation (DFG) [GR 4302/1-1]; National Centre of Competence in Research "North-South" (NCCR) [RP 14]	German Research Foundation (DFG)(German Research Foundation (DFG)); National Centre of Competence in Research "North-South" (NCCR)(Swiss National Science Foundation (SNSF))	This work was supported by the German Research Foundation (DFG, GR 4302/1-1, to OG), http://www.dfg.de/en/index.jsp; and National Centre of Competence in Research "North-South" (NCCR, RP 14, to ME), http://www.snf.ch/en/funding/programmes/national-centres-of-competence-in-research-nccr/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2005, INDIAN PEDIATR, V42, P233; [Anonymous], 2014, COMM CHILD SURV; Balayla J, 2011, WOMEN HEALTH ISS, V21, P361, DOI 10.1016/j.whi.2011.04.001; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Demombynes G, 2012, WHAT HAS DRIVEN DECL, P1; DGEpi German Society for Epidemiology in collaboration with GMDS German Association for Medical Informatics and Epidemiology DGAFSMAPAD-IGROTIBAB, 2008, GUID REC ASS GOOD EP; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Finlay JE, 2015, MATERN CHILD HLTH J, P1; Galea S, 2005, SOC SCI MED, V60, P1017, DOI 10.1016/j.socscimed.2004.06.036; Garenne M, 2003, J BIOSOC SCI, V35, P601, DOI 10.1017/S0021932003006047; Gruebner O, 2011, IHDP UPDATE ISSUE, P42; GUBHAJU B, 1991, J BIOSOC SCI, V23, P425, DOI 10.1017/S0021932000019532; Hajizadeh M, 2014, SOC SCI MED, V101, P36, DOI 10.1016/j.socscimed.2013.11.019; Houweling TAJ, 2010, BRIT MED BULL, V93, P7, DOI 10.1093/bmb/ldp048; Khan MMH, 2012, J PUBLIC HEALTH-UK, V34, P261, DOI 10.1093/pubmed/fdr108; Kimani-Murage EW, 2014, HEALTH PLACE, V29, P95, DOI 10.1016/j.healthplace.2014.06.003; Kjellstrom T, 2008, ENVIRON URBAN, V20, P551, DOI 10.1177/0956247808096128; KNBS Kenya National Bureau of Statistics, 2010, KEN NAT POP HOUS CEN; Kraas F, 2007, GEOGR J, V173, P79, DOI 10.1111/j.1475-4959.2007.232_2.x; Liu L, 2014, LANCET; Marsh David R, 2002, J Perinatol, V22, P572, DOI 10.1038/sj.jp.7210793; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; Mbochi RW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-823; Meehan S, 2014, PEDIATRICS, V133, P863, DOI 10.1542/peds.2013-1480; Monden CWS, 2013, INT J EPIDEMIOL, V42, P211, DOI 10.1093/ije/dys201; Mwangi TW, 2013, EXPLORING KENYAS INE; NAEYE RL, 1971, PEDIATRICS, V48, P902; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; National Research Council, 2003, CIT TRANSF; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Pongou R, 2013, DEMOGRAPHY, V50, P421, DOI 10.1007/s13524-012-0161-5; Pullum T. W., 2006, ASSESSMENT AGE DATE; Quentin W, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-95; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ramaiya Astha, 2014, BMC Res Notes, V7, P750, DOI 10.1186/1756-0500-7-750; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Shaw M, 2004, ANNU REV PUBL HEALTH, V25, P397, DOI 10.1146/annurev.publhealth.25.101802.123036; Stevenson M., 2015, PACKAGE EPIR TOOLS A; Steyn NP, 2011, SCAND J PUBLIC HEALT, V39, P88, DOI 10.1177/1403494810384426; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25363; Toda M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-75; UN Habitat, 2003, SLUMS WORLD FAC URB; UN-Habitat, 2012, STAT WORLDS CIT 2012; Unger A, 2013, ARCH DIS CHILD, V98, P799, DOI 10.1136/archdischild-2011-301621; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; Venables WN., 2002, MODERN APPL STAT S 4; Wafula SW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-441; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO (World Health Organization), 2014, WHO WORLD HLTH STAT	51	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139545	10.1371/journal.pone.0139545	http://dx.doi.org/10.1371/journal.pone.0139545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TY	26452226	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200012
J	Seidinger, AL; Fortes, FP; Mastellaro, MJ; Cardinalli, IA; Zambaldi, LG; Aguiar, SS; Yunes, JA				Seidinger, Ana Luiza; Fortes, Fernanda Paschoal; Mastellaro, Maria Jose; Cardinalli, Izilda Aparecida; Zambaldi, Lilian Girotto; Aguiar, Simone Santos; Yunes, Jose Andres			Occurrence of Neuroblastoma among TP53 p.R337H Carriers	PLOS ONE			English	Article							SIMULTANEOUS ADRENOCORTICAL CARCINOMA; TUMOR-SUPPRESSOR GENE; LI-FRAUMENI-SYNDROME; P53 GENE; BREAST-CANCER; MUTATION; FREQUENCY; CRITERIA; SARCOMAS; FAMILY	The high incidence of adrenocortical tumors and choroid plexus carcinoma in children from South and Southeastern regions of Brazil is associated with the germline p.R337H mutation of TP53 gene. The concomitant occurrence of neuroblastoma and adrenocortical tumors in pediatric patients harboring the p.R337H mutation at our institution prompted us to investigate the putative association between p.R337H and pediatric neuroblastoma. Genomic DNA samples from 83 neuroblastoma patients referred to a single institution during the period of 20002014 were screened for the p.R337H mutation. Available samples from carriers were investigated for both nuclear p53 accumulation and loss of heterozigosity in tumor. Clinical data were obtained from medical records in order to assess the impact of 337H allele on manifestation of the disease. Seven out 83 neuroblastoma patients (8.4%) were carriers of the TP53 p.R337Hmutation in our cohort. Immunohistochemical analysis of p.R337H-positive tumors revealed nuclear p53 accumulation. Loss of heterozigosity was not found among available samples. The presence of 337H allele was associated with increased proportion of stage I tumors. Our data indicate that in addition to adrenocortical tumors, choroid plexus carcinoma, breast cancer and osteosarcoma, genetic counseling and clinical surveillance should consider neuroblastoma as a potential neoplasia affecting p.R337H carriers.	[Seidinger, Ana Luiza; Fortes, Fernanda Paschoal; Yunes, Jose Andres] Boldrini Childrens Ctr, Mol Biol Lab, Sao Paulo, Brazil; [Mastellaro, Maria Jose; Aguiar, Simone Santos] Boldrini Childrens Ctr, Dept Pediat Oncol, Sao Paulo, Brazil; [Cardinalli, Izilda Aparecida] Boldrini Childrens Ctr, Dept Pathol, Sao Paulo, Brazil; [Zambaldi, Lilian Girotto] Boldrini Childrens Ctr, Cytogenet Lab, Sao Paulo, Brazil; [Aguiar, Simone Santos] Univ Estadual Campinas, Fac Med Sci, Ctr Res Pediat, Sao Paulo, Brazil; [Yunes, Jose Andres] Univ Estadual Campinas, Fac Med Sci, Dept Med Genet, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Yunes, JA (corresponding author), Boldrini Childrens Ctr, Mol Biol Lab, Sao Paulo, Brazil.	andres@boldrini.org.br	Seidinger, Ana Luiza/AAB-2438-2021	Fortes, Fabiane/0000-0001-6217-3474; Yunes, Jose Andres/0000-0002-1316-3525	Brazilian National Counsel of Technological and Scientific Development [401991/2010-JAY]; Coordination for the Improvement of Higher Education Personnel, PROCAD [247/2007-JAY]; Brazilian National Counsel of Technological and Scientific Development	Brazilian National Counsel of Technological and Scientific Development; Coordination for the Improvement of Higher Education Personnel, PROCAD; Brazilian National Counsel of Technological and Scientific Development	Brazilian National Counsel of Technological and Scientific Development (www.cnpq.br), grant number 401991/2010-JAY; Coordination for the Improvement of Higher Education Personnel (www.capes.gov.br), PROCAD grant number 247/2007-JAY. JAY received a Productivity fellowship from the Brazilian National Counsel of Technological and Scientific Development (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assumpcao JG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-357; Behjati S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096531; BIRCH JM, 1994, CANCER RES, V54, P1298; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Bougeard G, 2015, J CLIN ONCOL, V33, P2345, DOI 10.1200/JCO.2014.59.5728; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2011, PRINCIPLES PRACTICE, P886; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; CASTRESANA JS, 1994, GENE CHROMOSOME CANC, V10, P136, DOI 10.1002/gcc.2870100209; Cattelani S, 2012, NEOPLASIA, V14, P634, DOI 10.1593/neo.12594; Chompret A, 2001, J MED GENET, V38, P43, DOI 10.1136/jmg.38.1.43; Courtney R, 2015, J PEDIAT HEMATOL ONC, V37, P215, DOI 10.1097/MPH.0000000000000281; Cury NM, 2014, HERED CANCER CLIN PR, V12, DOI 10.1186/1897-4287-12-8; Custodio G, 2013, J CLIN ONCOL, V31, P2619, DOI 10.1200/JCO.2012.46.3711; Custodio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018015; da Silva EM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-449; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Diskin SJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju047; EELES RA, 1993, CANCER SURV, V18, P57; Eeles RA, 2000, GERMLINE MUTATIONS T; Feinberg-Gorenshtein G, 2009, GENE CHROMOSOME CANC, V48, P539, DOI 10.1002/gcc.20662; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Giacomazzi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099893; Giacomazzi J, 2013, CANCER-AM CANCER SOC, V119, P4341, DOI 10.1002/cncr.28346; Giacomazzi J, 2013, VIRCHOWS ARCH, V463, P17, DOI 10.1007/s00428-013-1439-8; HOSOI G, 1994, CANCER, V73, P3087, DOI 10.1002/1097-0142(19940615)73:12<3087::AID-CNCR2820731230>3.0.CO;2-9; IMAMURA J, 1993, CANCER RES, V53, P4053; KOMURO H, 1993, CANCER RES, V53, P5284; Kusafuka T, 1997, J PEDIATR SURG, V32, P1175, DOI 10.1016/S0022-3468(97)90677-1; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Maia AT, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2458; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; Malkin D., 2011, GENES CANC, V2, P475, DOI DOI 10.1177/1947601911413466; Manhani R, 1997, MED PEDIATR ONCOL, V29, P206, DOI 10.1002/(SICI)1096-911X(199709)29:3<206::AID-MPO7>3.0.CO;2-H; OHGAKI H, 1993, MOL CARCINOGEN, V8, P74, DOI 10.1002/mc.2940080203; Olivier M, 2003, CANCER RES, V63, P6643; Omura-Minamisawa M, 2001, CLIN CANCER RES, V7, P3481; Palmero EI, 2008, CANCER LETT, V261, P21, DOI 10.1016/j.canlet.2007.10.044; Pivnick EK, 1998, J MED GENET, V35, P328, DOI 10.1136/jmg.35.4.328; PORTER DE, 1992, J BONE JOINT SURG BR, V74, P883; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Rossbach HC, 2008, PEDIATR BLOOD CANCER, V50, P681, DOI 10.1002/pbc.21219; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Seidinger AL, 2011, CANCER-AM CANCER SOC, V117, P2228, DOI 10.1002/cncr.25826; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Tinat J, 2009, J CLIN ONCOL, V27, pE108, DOI 10.1200/JCO.2009.22.7967; VOGAN K, 1993, CANCER RES, V53, P5269; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039	57	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140356	10.1371/journal.pone.0140356	http://dx.doi.org/10.1371/journal.pone.0140356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452166	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511200067
J	Banerjee, S; Aditya, G; Saha, GK				Banerjee, Soumyajit; Aditya, Gautam; Saha, Goutam K.			Household Wastes as Larval Habitats of Dengue Vectors: Comparison between Urban and Rural Areas of Kolkata, India	PLOS ONE			English	Article							MOSQUITOS AEDES-AEGYPTI; PUBLIC-HEALTH; DARJEELING HIMALAYAS; MICROBIAL PATHOGENS; UNITED-STATES; PUERTO-RICO; MANAGEMENT; ALBOPICTUS; CULICIDAE; DIPTERA	Porcelain and plastic materials constitute bulk of household wastes. Owing to resistibility and slow degradability that accounts for higher residence time, these materials qualify as potential hazardous wastes. Retention of water permits these wastes to form a congenial biotope for the breeding of different vector mosquitoes. Thus porcelain and plastic wastes pose a risk from public health viewpoint. This proposition was validated through the study on the porcelain and plastic household wastes as larval habitats of Dengue vectors (Aedes spp.) in rural and urban areas around Kolkata, India. The wastes were characterized in terms of larval productivity, seasonal variation and a comparison between urban and rural areas was made using data of two subsequent years. The number of wastes positive as larval habitats and their productivity of Aedes spp. varied among the types of household wastes with reference to months and location. Multivariate analysis revealed significant differences in the larval productivity of the household wastes based on the materials, season, and urban-rural context. Results of Discriminant Analysis indicated differences in abundance of Ae. aegypti and Ae. albopictus for the urban and rural areas. The porcelain and plastic wastes were more productive in urban areas compared to the rural areas, indicating a possible difference in the household waste generation. A link between household wastes with Aedes productivity is expected to increase the risk of dengue epidemics if waste generation is continued without appropriate measures to limit addition to the environment. Perhaps, alternative strategies and replacement of materials with low persistence time can reduce this problem of waste and mosquito production.	[Banerjee, Soumyajit; Aditya, Gautam; Saha, Goutam K.] Univ Calcutta, Dept Zool, Kolkata 700019, India; [Aditya, Gautam] Univ Burdwan, Dept Zool, Burdwan 713104, W Bengal, India	University of Calcutta; University of Burdwan	Aditya, G (corresponding author), Univ Calcutta, Dept Zool, 35 BC Rd, Kolkata 700019, India.	gautamaditya2001@gmail.com	ADITYA, GAUTAM/AAF-6536-2020	ADITYA, GAUTAM/0000-0001-9445-879X	UGC through SAP-RFSMS Junior Research Fellowship [F4-1/2006 (BSR)/7-45/2007(BSR)]; UGC through CSIR Senior Research Fellowship [09 /020 (0832) / 2010- EMR-1]	UGC through SAP-RFSMS Junior Research Fellowship; UGC through CSIR Senior Research Fellowship	The project was partially funded by UGC through SAP-RFSMS Junior Research Fellowship [Sanction no. F4-1/2006 (BSR)/7-45/2007(BSR)] and CSIR Senior Research Fellowship to SB [Sanction no. 09 /020 (0832) / 2010- EMR-1, dated 29.03.2011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achudume AC, 2007, J ENVIRON BIOL, V28, P151; Addinsoft SARL, 2010, XLSTAT SOFTWARE 2010; Adeleke M A, 2008, Tanzan J Health Res, V10, P103; Adeyeba O A, 2002, East Afr Med J, V79, P604; Aditya G, 2008, INSECT SCI, V15, P245, DOI 10.1111/j.1744-7917.2008.00207.x; Aditya G, 2009, INDIAN J MED RES, V129, P455; Angel B, 2009, INDIAN J MED RES, V129, P665; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Asian Productivity Organization, 2007, SOLID WASTE MANAGEME; Balakrishnan N, 2006, J Commun Dis, V38, P164; Banerjee S, 2013, WASTE MANAGE, V33, P233, DOI 10.1016/j.wasman.2012.09.013; Banerjee S, 2010, ENVIRON MONIT ASSESS, V168, P597, DOI 10.1007/s10661-009-1137-9; BARRERA R, 1993, J AM MOSQUITO CONTR, V9, P189; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Baruah Sangeeta, 2012, Asian Journal of Experimental Biological Sciences, V3, P559; Biswas AK, 2010, RESOUR CONSERV RECY, V55, P129, DOI 10.1016/j.resconrec.2010.08.003; Blight G. E., 1996, J SOLID WASTE TECHNO, V23, P19; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Burke R, 2010, MED VET ENTOMOL, V24, P117, DOI 10.1111/j.1365-2915.2010.00864.x; Chakrabarti S, 2009, HABITAT INT, V33, P125, DOI 10.1016/j.habitatint.2008.05.009; Focks DA, 2006, WHO TDR IRM DEN 06 1; Gerba CP, 2011, WASTE MANAGE RES, V29, P781, DOI 10.1177/0734242X10397968; Giusti L, 2009, WASTE MANAGE, V29, P2227, DOI 10.1016/j.wasman.2009.03.028; Gupta S, 1998, RESOUR CONSERV RECY, V24, P137, DOI 10.1016/S0921-3449(98)00033-0; Hamer G, 2003, BIOTECHNOL ADV, V22, P71, DOI 10.1016/j.biotechadv.2003.08.007; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Irwin P, 2008, ECOHEALTH, V5, P49, DOI 10.1007/s10393-007-0152-y; Jeffery JAL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039067; Jude PJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-106; Khajuria A, 2010, J ENVIRON BIOL, V31, P649; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kumar S, 2009, WASTE MANAGE, V29, P883, DOI 10.1016/j.wasman.2008.04.011; Legendre P., 2012, NUMERICAL ECOLOGY; Macoris M L, 1997, Rev Panam Salud Publica, V1, P280, DOI 10.1590/S1020-49891997000400004; Malandrakis GN, 2008, ENVIRON EDUC RES, V14, P579, DOI 10.1080/13504620802465046; Mangudo C, 2011, J VECTOR ECOL, V36, P227, DOI 10.1111/j.1948-7134.2011.00162.x; Mariappan T, 2008, J MED ENTOMOL, V45, P148, DOI 10.1603/0022-2585(2008)45[148:DRHSAD]2.0.CO;2; Mazine CAB, 1996, ACTA TROP, V62, P1, DOI 10.1016/S0001-706X(96)00013-7; Medronho RA, 2009, AM J TROP MED HYG, V80, P401, DOI 10.4269/ajtmh.2009.80.401; Misra V, 2005, ENVIRON INT, V31, P417, DOI 10.1016/j.envint.2004.08.005; Nath KJ, 2003, INT J ENVIRON HEAL R, V13, pS19, DOI 10.1080/0960312031000102778; Nguyen LAP, 2011, INT HEALTH, V3, P115, DOI 10.1016/j.inhe.2010.11.002; Pramanik Mihir K., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P442; Rakesh Katyal, 1997, Dengue Bulletin, V21, P93; Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369; Rao BB, 2010, SE ASIAN J TROP MED, V41, P536; Ratho R K, 2005, Indian J Med Sci, V59, P518; Reinert JF, 2006, ZOOL J LINN SOC-LOND, V148, P1, DOI 10.1111/j.1096-3642.2006.00254.x; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082; Schreiber E, 1993, J FLORIDA MOSQ CONTR, V63, P7; Shah R., 2012, INT J THEOR APPL SCI, V4, P72; Sharholy M, 2008, WASTE MANAGE, V28, P459, DOI 10.1016/j.wasman.2007.02.008; Sujauddin M, 2008, WASTE MANAGE, V28, P1688, DOI 10.1016/j.wasman.2007.06.013; Tewari SC, 2004, TROP MED INT HEALTH, V9, P499, DOI 10.1111/j.1365-3156.2004.01103.x; Topuz E, 2011, ENVIRON INT, V37, P393, DOI 10.1016/j.envint.2010.10.013; Troyo A, 2008, J VECTOR ECOL, V33, P76, DOI 10.3376/1081-1710(2008)33[76:SPOAAD]2.0.CO;2; Tstuzuki A, 2009, AM J TROP MED HYG, V81, P645, DOI 10.4269/ajtmh.2009.08-0175; TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543; Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x; WHO, 2009, WHO HTM NTD DEN 2009; WHO-SEARO, 2006, DENGUE STATUS OF IND; WHO-SEARO, 2011, COMPREHENSIVE GUIDEL; Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2; Zar KH, 1999, BIOSTATISTICALANALYS	66	26	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138082	10.1371/journal.pone.0138082	http://dx.doi.org/10.1371/journal.pone.0138082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447690	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000007
J	Doring, J; Frisch, M; Tittmann, S; Stoll, M; Kauer, R				Doering, Johanna; Frisch, Matthias; Tittmann, Susanne; Stoll, Manfred; Kauer, Randolf			Growth, Yield and Fruit Quality of Grapevines under Organic and Biodynamic Management	PLOS ONE			English	Article							LEAF-AREA INDEX; AMINO-ACIDS; COPPER EXPOSURE; SOIL QUALITY; COVER CROP; VINEYARD; NITROGEN; GRAPES; PERFORMANCE; PRESSURE	The main objective of this study was to determine growth, yield and fruit quality of grapevines under organic and biodynamic management in relation to integrated viticultural practices. Furthermore, the mechanisms for the observed changes in growth, yield and fruit quality were investigated by determining nutrient status, physiological performance of the plants and disease incidence on bunches in three consecutive growing seasons. A field trial (Vitis vinifera L. cv. Riesling) was set up at Hochschule Geisenheim University, Germany. The integrated treatment was managed according to the code of good practice. Organic and biodynamic plots were managed according to Regulation (EC) No 834/2007 and Regulation (EC) No 889/2008 and according to ECOVIN- and Demeter-Standards, respectively. The growth and yield of the grapevines differed strongly among the different management systems, whereas fruit quality was not affected by the management system. The organic and the biodynamic treatments showed significantly lower growth and yield in comparison to the integrated treatment. The physiological performance was significantly lower in the organic and the biodynamic systems, which may account for differences in growth and cluster weight and might therefore induce lower yields of the respective treatments. Soil management and fertilization strategy could be responsible factors for these changes. Yields of the organic and the biodynamic treatments partially decreased due to higher disease incidence of downy mildew. The organic and the biodynamic plant protection strategies that exclude the use of synthetic fungicides are likely to induce higher disease incidence and might partially account for differences in the nutrient status of vines under organic and biodynamic management. Use of the biodynamic preparations had little influence on vine growth and yield. Due to the investigation of important parameters that induce changes especially in growth and yield of grapevines under organic and biodynamic management the study can potentially provide guidance for defining more effective farming systems.	[Doering, Johanna; Tittmann, Susanne; Stoll, Manfred; Kauer, Randolf] Hsch Geisenheim Univ, Dept Gen & Organ Viticulture, Geisenheim, Germany; [Frisch, Matthias] Univ Giessen, Inst Agron & Plant Breeding 2, D-35390 Giessen, Germany	Justus Liebig University Giessen	Doring, J (corresponding author), Hsch Geisenheim Univ, Dept Gen & Organ Viticulture, Geisenheim, Germany.	johanna.doering@hs-gm.de	Frisch, Matthias/R-1564-2019	Frisch, Matthias/0000-0003-4234-8972	Forschungsring des deutschen Weinbaus; Software AG Stiftung	Forschungsring des deutschen Weinbaus; Software AG Stiftung	Funding was provided by Forschungsring des deutschen Weinbaus: http://www.forschungsring-weinbau.de/, JD; Software AG Stiftung: http://www.software-ag-stiftung.com/, JD. The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	Abele U, 1973, THESIS JUSTUS LIEBIG; ABELE U, 1987, PRODUKTQUALITAT DUNG; [Anonymous], 2014, WEINBAUKARTEI LANDES; Anunciacao O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076300; Bachinger J, 1996, THESIS JUSTUS LIEBIG; Barberi P., 2006, Long-term field experiments in organic farming, P1; Bavaresco L., 1995, Bulletin de l'OIV, V68, P404; Bourguignon C., 2000, IFOAM 2000 - the world grows organic. Proceedings, 6th International Congress on Organic Viticulture, Convention Center, Basel, Switzerland, 25-26 August 2000, P92; Carpenter-Boggs L, 2000, BIOL AGRIC HORTIC, V17, P313, DOI 10.1080/01448765.2000.9754852; Carpenter-Boggs L., 2000, American Journal of Alternative Agriculture, V15, P110, DOI 10.1017/S0889189300008614; Carpenter-Boggs L, 2000, SOIL SCI SOC AM J, V64, P1651, DOI 10.2136/sssaj2000.6451651x; Celette F, 2008, EUR J AGRON, V29, P153, DOI 10.1016/j.eja.2008.04.007; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; Corvers M., 1994, THESIS JUSTUS LIEBIG; Danner R, 1985, THESIS U BODENKULTUR; Doring J, 2014, AM J ENOL VITICULT, V65, P153, DOI 10.5344/ajev.2013.13073; Doring J., 2013, 18 GIESCO 2013 7 11, P8; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Dukes BC, 1998, AM J ENOL VITICULT, V49, P125; Dupin I., 2000, American Journal of Enology and Viticulture, V51, P299; Elsaidy SM, 1982, THESIS JUSTUS LIEBIG; ERICKSON RO, 1957, AM J BOT, V44, P297, DOI 10.2307/2438380; FAO, 1999, FAO POS PAP ORG AGR; Forster D, 2013, PLOS ONE, V8, P1; Fox R, 2010, REBE WEIN, V2, P14; Fritz J, 2000, THESIS RHEINISCHE FR; Gehlen P, 1988, WEINWISSENSCHAFT, V43, P161; Geier B., 2000, IFOAM 2000 - the world grows organic. Proceedings, 6th International Congress on Organic Viticulture, Convention Center, Basel, Switzerland, 25-26 August 2000, P20; Glover JD, 2000, AGR ECOSYST ENVIRON, V80, P29, DOI 10.1016/S0167-8809(00)00131-6; Granstedt AG, QUALITY PLANT PRODUC, P3; Greene C., 2000, Agricultural Outlook, P9; Hamm U, 13 INT IFOAM SCI C W, P507; HARDIE WJ, 1976, AM J ENOL VITICULT, V27, P55; Henick-Kling T., 3 ORG GRAP WIN PROD, P89; HEPPERLY P, 2006, CAN J PLANT SCI, V1, P15; Hernandez-Orte P, 2005, FOOD CHEM, V89, P163, DOI 10.1016/j.foodchem.2004.02.021; Hofmann U., 1991, THESIS JUSTUS LIEBIG; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JACKSON DI, 1993, AM J ENOL VITICULT, V44, P409; Kauer R, 1994, THESIS JUSTUS LIEBIG; Kliewer WM, 2005, AM J ENOL VITICULT, V56, P170; Konig UJ, 1988, THESIS GEORG AUGUST; Kopke U., 2006, Long-term field experiments in organic farming, P33; Kotschi J., 1980, THESIS JUSTUS LIEBIG; Kristiansen P, 2006, ORGANIC AGRICULTURE: A GLOBAL PERSPECTIVE, P1, DOI 10.1079/9781845931698.0001; Linder C, 2006, HORTICULTURE, V38, P235; Llorens N, 2000, PLANT SCI, V160, P159, DOI 10.1016/S0168-9452(00)00379-4; Lohnertz O, 1988, UNTERSUCHUNGEN ZEITL; Lopes C, 2005, VITIS, V44, P55; Lopes C, 2004, VITIS, V43, P111; Mabrouk H., 1996, Progres Agricole et Viticole, V113, P392; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; MARCHETTI R, 1984, VITIS, V23, P55; Martins V, 2014, PLANT PHYSIOL BIOCH, V82, P270, DOI 10.1016/j.plaphy.2014.06.016; MATTHEWS MA, 1989, AM J ENOL VITICULT, V40, P52; McCarthy M.G., 1997, AUST J GRAPE WINE R, V3, P2, DOI DOI 10.1111/J.1755-0238.1997.TB00128.X; Meissner G, 2015, THESIS JUSTUS LIEBIG; Mitchell AE, 2007, J AGR FOOD CHEM, V55, P6154, DOI 10.1021/jf070344+; Monteiro A, 2007, AGR ECOSYST ENVIRON, V121, P336, DOI 10.1016/j.agee.2006.11.016; Moutinho-Pereira JM, 2001, VITIS, V40, P117; Mueller P., 2006, Long-term field experiments in organic farming, P79; Netto AT, 2005, SCI HORTIC-AMSTERDAM, V104, P199, DOI 10.1016/j.scienta.2004.08.013; Ojeda H, 2001, VITIS, V40, P141; Oliva J, 2011, FOOD CHEM, V129, P1676, DOI 10.1016/j.foodchem.2011.06.030; Ollat N, 1998, VITIS, V37, P73; Organisation Eampp, GUID EFF EV FUNG PLA, p1/31; Parpinello GP, 2015, FOOD CHEM, V167, P145, DOI 10.1016/j.foodchem.2014.06.093; Penfold CM, 1995, AUST J EXP AGR, V35, P849, DOI 10.1071/EA9950849; Peschke J, 1994, THESIS JUSTUS LIEBIG; Petterson BD, 1992, DUNGUNG BODENEIGENSC; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Poni S, 2009, AUST J GRAPE WINE R, V15, P185, DOI 10.1111/j.1755-0238.2008.00044.x; Pool RM, 3 ORGANIC GRAPE WINE, P7; Porter PM, 2003, AGRON J, V95, P233, DOI 10.2134/agronj2003.0233; PRATT C, 1971, AM J ENOL VITICULT, V22, P92; Probst B, 2008, BIOL FERT SOILS, V44, P443, DOI 10.1007/s00374-007-0225-7; Raupp J., 2006, Long-term field experiments in organic farming, P135; Raupp J, 1996, BIOL AGRIC HORTIC, V13, P175, DOI 10.1080/01448765.1996.9754776; Raviv M., 2006, Long-term field experiments in organic farming, P157; Reeve JR, 2010, BIORESOURCE TECHNOL, V101, P5658, DOI 10.1016/j.biortech.2010.01.144; Reeve JR, 2005, AM J ENOL VITICULT, V56, P367; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; REGANOLD JP, 1987, NATURE, V330, P370, DOI 10.1038/330370a0; REGANOLD JP, 1993, SCIENCE, V260, P344, DOI 10.1126/science.260.5106.344; Robinson J.B., 1992, VITICULTURE VOL 2, P178; Romeu-Moreno A, 1999, J AGR FOOD CHEM, V47, P2519, DOI 10.1021/jf9809838; Samaras F., 1980, THESIS JUSTUS LIEBIG; Santiago I., 2011, Wine and Viticulture Journal, V26, P61; Schaller K, 2000, PRAKTIKUM BODENKUNDE; Scheller E, 2005, BIOL AGRIC HORTIC, V22, P379, DOI 10.1080/01448765.2005.9755299; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Smart R, INT S COOL CLIM VIT, P1; Spiess H, 1978, THESIS JUSTUS LIEBIG; Spornberger Andreas, 2007, Mitteilungen Klosterneuburg, V57, P239; Spring J. L., 2011, Revue Suisse de Viticulture, Arboriculture et Horticulture, V43, P162; SRINIVASAN C, 1981, AM J ENOL VITICULT, V32, P47; Steiner R., 2005, GEISTESWISSENSCHAFTL; Stoll M, 1 IW VIN MECH GRAP W, P211; Tassoni A., 2014, Food and Nutrition Sciences, V5, P8, DOI 10.4236/fns.2014.51002; Tassoni A, 2013, FOOD CHEM, V139, P405, DOI 10.1016/j.foodchem.2013.01.041; Tello J, 2014, VITIS, V53, P9; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; TURNER NC, 1988, IRRIGATION SCI, V9, P289, DOI 10.1007/BF00296704; Watson C, 2006, ORGANIC AGRICULTURE: A GLOBAL PERSPECTIVE, P361, DOI 10.1079/9781845931698.0361; White GB, ORGANIC GRAPE WINE P, P76; Willer H., 2013, WORLD ORGANIC AGR ST, P33; Willer Helga, 2008, 16 IFOAM ORG WORLD C; ZOECKLEIN BW, 1992, AM J ENOL VITICULT, V43, P139	109	45	46	4	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138445	10.1371/journal.pone.0138445	http://dx.doi.org/10.1371/journal.pone.0138445			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447762	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511000008
J	Lefebvre, A; Bertrand, X; Vanhems, P; Lucet, JC; Chavanet, P; Astruc, K; Thouverez, M; Quantin, C; Aho-Glele, LS				Lefebvre, Annick; Bertrand, Xavier; Vanhems, Philippe; Lucet, Jean-Christophe; Chavanet, Pascal; Astruc, Karine; Thouverez, Michelle; Quantin, Catherine; Aho-Glele, Ludwig Serge			Detection of Temporal Clusters of Healthcare-Associated Infections or Colonizations with Pseudomonas aeruginosa in Two Hospitals: Comparison of SaTScan and WHONET Software Packages	PLOS ONE			English	Article								The identification of temporal clusters of healthcare-associated colonizations or infections is a challenge in infection control. WHONET software is available to achieve these objectives using laboratory databases of hospitals but it has never been compared with SaTScan regarding its detection performance. This study provided the opportunity to evaluate the performance of WHONET software in comparison with SaTScan software as a reference to detect clusters of Pseudomonas aeruginosa. A retrospective study was conducted in two French university hospitals. Cases of P. aeruginosa colonizations or infections occurring between 1st January 2005 and 30th April 2014 in the first hospital were analyzed overall and by medical ward/care unit. Poisson temporal and space-time permutation models were used. Analyses were repeated for the second hospital on data from 1st July 2007 to 31st December 2013 to validate WHONET software (in comparison with SaTScan) in another setting. During the study period, 3,946 isolates of P. aeruginosa were recovered from 2,996 patients in the first hospital. The incidence rate was 89.8 per 100,000 patient-days (95% CI [87.0; 92.6]). Several clusters were observed overall and at the unit level and some of these were detected whatever the method used. WHONET results were consistent with the analyses that took patient-days and temporal trends into account in both hospitals. Because it is more flexible and easier to use than SaTScan, WHONET software seems to be a useful tool for the prospective surveillance of hospital data although it does not take populations at risk into account.	[Lefebvre, Annick; Astruc, Karine; Aho-Glele, Ludwig Serge] Dijon Univ Hosp, Hosp Epidemiol & Infect Control Dept, Dijon, France; [Lefebvre, Annick; Chavanet, Pascal] Univ Burgundy, Lab Environm Microbiol & Hlth Risks, Dijon, France; [Bertrand, Xavier; Thouverez, Michelle] CHU Besancon, Infect Control Dept, F-25030 Besancon, France; [Bertrand, Xavier] Univ Franche Comte, CNRS, Chronoenvironm Lab, UMR 6249, F-25030 Besancon, France; [Vanhems, Philippe] Hosp Grp Edouard Herriot, Infect Control Epidemiol & Prevent Dept, Lyon, France; [Vanhems, Philippe] Univ Lyon 1, Epidemiol & Publ Hlth Team, F-69365 Lyon, France; [Lucet, Jean-Christophe] Hosp Grp Bichat Claude Bernard, UHLIN, HUPNVS, AP HP, Paris, France; [Lucet, Jean-Christophe] Univ Paris 07, Paris, France; [Chavanet, Pascal] Dijon Univ Hosp, Dept Infect Dis, Dijon, France; [Quantin, Catherine] Dijon Univ Hosp, Biostat & Med Informat Dept, Dijon, France; [Quantin, Catherine] Univ Burgundy, Dept Epidemiol, EA 4184, Dijon, France	CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne	Lefebvre, A (corresponding author), Dijon Univ Hosp, Hosp Epidemiol & Infect Control Dept, Dijon, France.	annick.lefebvre@chu-dijon.fr	Bertrand, Xavier/AAL-3809-2021; AHO, ludwig/AAR-5753-2021; Serge, Aho Glele Ludwig/AAP-8863-2021; Bertrand, Xavier/AAK-3270-2021	Serge, Aho Glele Ludwig/0000-0001-7590-8644; Bertrand, Xavier/0000-0002-8028-1396; Quantin, Catherine/0000-0001-5134-9411				[Anonymous], 2005, SATSCANTM V6 0 SOFTW; Comite de l'Antibiogramme de la Societe Francaise de Microbiologie, 2013, COM ANT SOC FRANC MI; Huang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000238; Kleinman KP, 2005, EPIDEMIOL INFECT, V133, P409, DOI 10.1017/S0950268804003528; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995	6	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139920	10.1371/journal.pone.0139920	http://dx.doi.org/10.1371/journal.pone.0139920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448036	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000065
J	McKee, LS; Brumer, H				McKee, Lauren S.; Brumer, Harry			Growth of Chitinophaga pinensis on Plant Cell Wall Glycans and Characterisation of a Glycoside Hydrolase Family 27 beta-L-Arabinopyranosidase Implicated in Arabinogalactan Utilisation	PLOS ONE			English	Article							ALPHA-N-ACETYLGALACTOSAMINIDASE; 1.9 ANGSTROM STRUCTURE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; PHANEROCHAETE-CHRYSOSPORIUM; MAXIMUM-LIKELIHOOD; MOLECULAR-BASIS; L-ARABINOSIDASE; GALACTOSIDASE; ENZYMES	The genome of the soil bacterium Chitinophaga pinensis encodes a diverse array of carbohydrate active enzymes, including nearly 200 representatives from over 50 glycoside hydrolase (GH) families, the enzymology of which is essentially unexplored. In light of this genetic potential, we reveal that C. pinensis has a broader saprophytic capacity to thrive on plant cell wall polysaccharides than previously reported, and specifically that secretion of beta-L-arabinopyranosidase activity is induced during growth on arabinogalactan. We subsequently correlated this activity with the product of the Cpin_5740 gene, which encodes the sole member of glycoside hydrolase family 27 (GH27) in C. pinensis, CpArap27. Historically, GH27 is most commonly associated with alpha-D-galactopyranosidase and alpha-D-N-acetylgalactosaminidase activity. A new phylogenetic analysis of GH27 highlighted the likely importance of several conserved secondary structural features in determining substrate specificity and provides a predictive framework for identifying enzymes with the less common beta-L-arabinopyranosidase activity.	[McKee, Lauren S.; Brumer, Harry] Royal Inst Technol KTH, AlbaNova Univ Ctr, Div Glycosci, Sch Biotechnol, S-10691 Stockholm, Sweden; [McKee, Lauren S.; Brumer, Harry] Wallenberg Wood Sci Ctr, S-10044 Stockholm, Sweden; [Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada	Royal Institute of Technology; University of British Columbia; University of British Columbia	Brumer, H (corresponding author), Royal Inst Technol KTH, AlbaNova Univ Ctr, Div Glycosci, Sch Biotechnol, S-10691 Stockholm, Sweden.	brumer@msl.ubc.ca	McKee, Lauren/A-2782-2013	McKee, Lauren/0000-0002-3372-8773	Knut and Alice Wallenberg Foundation via the Wallenberg Wood Science Centre; Swedish Research Council Formas via CarboMat - The KTH Advanced Carbohydrate Materials Consortium; Formas Strong Research Environment; National Science and Engineering Research Council of Canada (NSERC)	Knut and Alice Wallenberg Foundation via the Wallenberg Wood Science Centre; Swedish Research Council Formas via CarboMat - The KTH Advanced Carbohydrate Materials Consortium(Swedish Research Council Formas); Formas Strong Research Environment; National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the Knut and Alice Wallenberg Foundation via the Wallenberg Wood Science Centre (http://wwsc.se/, https://www.wallenberg.com/kaw/en); The Swedish Research Council Formas via CarboMat - The KTH Advanced Carbohydrate Materials Consortium, A Formas Strong Research Environment (http://www.biotech.kth.se/glycoscience/CarboMat, http://www.formas.se/en/); National Science and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; BELDMAN G, 1997, ADV MACROMOL CARB R, V1, P1; Bouws H, 2008, APPL MICROBIOL BIOT, V80, P381, DOI 10.1007/s00253-008-1572-5; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; Cardoso SM, 2002, CARBOHYD RES, V337, P917, DOI 10.1016/S0008-6215(02)00082-4; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Del Rio TG, 2010, STAND GENOMIC SCI, V2, P87, DOI 10.4056/sigs.661199; DEY PM, 1973, BIOCHIM BIOPHYS ACTA, V302, P393, DOI 10.1016/0005-2744(73)90167-8; DEY PM, 1983, BIOCHIM BIOPHYS ACTA, V746, P8, DOI 10.1016/0167-4838(83)90003-1; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Eklof JM, 2013, J BIOL CHEM, V288, P15786, DOI 10.1074/jbc.M113.462887; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Fernandez-Leiro R, 2010, J BIOL CHEM, V285, P28020, DOI 10.1074/jbc.M110.144584; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Goodrum LJ, 2000, PHYTOCHEMISTRY, V54, P99, DOI 10.1016/S0031-9422(00)00043-1; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAQ S, 1961, CAN J CHEM, V39, P1563, DOI 10.1139/v61-199; Hart DO, 2000, BIOCHEMISTRY-US, V39, P9826, DOI 10.1021/bi0008074; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; Hemsworth GR, 2015, BIOCHEMICAL SOCIETY; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; Huisman MMH, 2001, CARBOHYD RES, V330, P103, DOI 10.1016/S0008-6215(00)00269-X; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; Ishii T, 2005, PHYTOCHEMISTRY, V66, P2418, DOI 10.1016/j.phytochem.2005.08.007; Jindou S, 2002, J BACTERIOL, V184, P600, DOI 10.1128/JB.184.2.600-604.2002; Joint Genome Institute (United States Department of Energy), J PHYLOGENETIC DIVER; Jones J. K. N., 1963, Journal of Polymer Science, P63; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Lansky S, 2014, ACTA CRYSTALLOGR D, V70, P2994, DOI 10.1107/S139900471401863X; Larsbrink J, 2014, MOL MICROBIOL, V94, P418, DOI 10.1111/mmi.12776; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Martens EC, 2014, J MOL BIOL, V426, P3851, DOI 10.1016/j.jmb.2014.06.022; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; McCleary BV, 2004, US Patent, Patent No. [US7785771, 7785771]; MELROSE J, 1983, CARBOHYD RES, V118, P247, DOI 10.1016/0008-6215(83)88052-5; Miller JH., 1975, EXPT MOL GENETICS; Nie SP, 2013, FOOD HYDROCOLLOID, V31, P42, DOI 10.1016/j.foodhyd.2012.09.014; Ochoa-Leyva A, 2011, J MOL BIOL, V411, P143, DOI 10.1016/j.jmb.2011.05.027; Ochoa-Leyva A, 2009, J MOL BIOL, V387, P949, DOI 10.1016/j.jmb.2009.02.022; ODONMAZIG P, 1994, CARBOHYD RES, V252, P317, DOI 10.1016/0008-6215(94)90028-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponder GR, 1997, CARBOHYD POLYM, V34, P251, DOI 10.1016/S0144-8617(97)00099-4; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rahman AKMS, 2003, CARBOHYD RES, V338, P1469, DOI 10.1016/S0008-6215(03)00203-9; Rigden DJ, 2003, FEBS LETT, V544, P103, DOI 10.1016/s0014-5793(03)00481-2; Sakamoto T, 2010, APPL MICROBIOL BIOT, V86, P1115, DOI 10.1007/s00253-009-2344-6; Salama R, 2012, FEBS LETT, V586, P2436, DOI 10.1016/j.febslet.2012.05.062; SANGKHOBOL V, 1981, INT J SYST BACTERIOL, V31, P285, DOI 10.1099/00207713-31-3-285; Schubert C, 2006, NAT BIOTECHNOL, V24, P777, DOI 10.1038/nbt0706-777; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sly LI, 1999, INT J SYST BACTERIOL, V49, P479, DOI 10.1099/00207713-49-2-479; Stick RV, 2009, CARBOHYDRATES: THE ESSENTIAL MOLECULES OF LIFE, 2ND EDITION, P1; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Westphal Y, 2010, CARBOHYD RES, V345, P1180, DOI 10.1016/j.carres.2010.03.042; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Willfor S, 2002, WOOD SCI TECHNOL, V36, P101, DOI 10.1007/s00226-001-0137-x; Withers SG, CAZYPEDIA	71	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139932	10.1371/journal.pone.0139932	http://dx.doi.org/10.1371/journal.pone.0139932			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448175	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511000066
J	Peng, J; He, X; Ye, HM				Peng, Jie; He, Xiang; Ye, Hanming			Analytical solution for vacuum preloading considering the nonlinear distribution of horizontal permeability within the smear zone	PLOS ONE			English	Article							VERTICAL DRAINS; CONSOLIDATION; CLAY; SURCHARGE	The vacuum preloading is an effective method which is widely used in ground treatment. In consolidation analysis, the soil around prefabricated vertical drain (PVD) is traditionally divided into smear zone and undisturbed zone, both with constant permeability. In reality, the permeability of soil changes continuously within the smear zone. In this study, the horizontal permeability coefficient of soil within the smear zone is described by an exponential function of radial distance. A solution for vacuum preloading consolidation considers the nonlinear distribution of horizontal permeability within the smear zone is presented and compared with previous analytical results as well as a numerical solution, the results show that the presented solution correlates well with the numerical solution, and is more precise than previous analytical solution.	[Peng, Jie; He, Xiang; Ye, Hanming] Hohai Univ, Res Inst Geotech Engn, Nanjing 210098, Jiangsu, Peoples R China	Hohai University	Peng, J (corresponding author), Hohai Univ, Res Inst Geotech Engn, Nanjing 210098, Jiangsu, Peoples R China.	pengjiehhu@gmail.com			Natural Science Foundation of China [51578214]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study presented in this article is substantially supported by the Natural Science Foundation of China (Grant No. 51578214). The support is gratefully acknowledged.	Abuel-Naga HM, 2012, GEOTEXT GEOMEMBRANES, V32, P1, DOI 10.1016/j.geotexmem.2011.10.007; [Anonymous], 2000, GROUND IMPROVEMENT I, DOI DOI 10.1680/GRIM.2000.4.2.73; ATKINSON MS, 1981, GEOTECHNIQUE, V31, P33, DOI 10.1680/geot.1981.31.1.33; Barron RA., 1948, TRANSACTIONS; BERGADO DT, 1993, GEOTEXT GEOMEMBRANES, V12, P615, DOI 10.1016/0266-1144(93)90032-J; Bo MW., 2003, SOIL IMPROVEMENT PRE; Chai JC, 1999, J GEOTECH GEOENVIRON, V125, P216, DOI 10.1061/(ASCE)1090-0241(1999)125:3(216); Chen Guo-hong, 2011, Journal of Zhejiang University, V45, P665, DOI 10.3785/j.issn.1008-973X.2011.04.013; Geng XY, 2011, CAN GEOTECH J, V48, P970, DOI 10.1139/T11-011; Geng XY, 2012, INT J GEOMECH, V12, P27, DOI 10.1061/(ASCE)GM.1943-5622.0000106; Hansbo S., 1979, GROUND ENG, V12, P16; Hawlader BC, 2002, GEOTEXT GEOMEMBRANES, V20, P213, DOI 10.1016/S0266-1144(02)00012-2; Indraratna B, 1998, J GEOTECH GEOENVIRON, V124, P180, DOI 10.1061/(ASCE)1090-0241(1998)124:2(180); Indraratna B, 2000, CAN GEOTECH J, V37, P132, DOI 10.1139/cgj-37-1-132; Indraratna B., 2005, INT J GEOMECH, V5, P114, DOI [10.1061/(ASCE)1532-3641(2005)5:2(114), DOI 10.1061/(ASCE)1532-3641(2005)5:2(114)]; Iyathurai S, 2008, INT J GEOMECH, V8, P355; Kianfar K, 2013, GEOTECHNIQUE, V63, P1060, DOI [10.1680/geot.12.E163, 10.1680/geot.12.P.163]; Kjellman W, 1952, PROC C SOIL STABILIZ, P258; Lo D, 1998, T HONG KONG I ENG, V5, P34; Mohamedelhassan E, 2002, CAN GEOTECH J, V39, P1126, DOI 10.1139/T02-052; Onoue A., 1988, SOILS FOUND, V28, P165, DOI [DOI 10.3208/SANDF1972.28.4165, 10.3208/sandf1972.28.4_165, DOI 10.3208/SANDF1972.28.4_165]; Qian J. H., 1992, COMPUT GEOTECH, V13, P103, DOI [DOI 10.1016/0266-352X(92)90027-Q, DOI 10.1016/0148-9062(76)91937-9]; Rujikiatkamjorn C, 2007, CAN GEOTECH J, V44, P188, DOI 10.1139/T06-111; Sharma JS, 2000, CAN GEOTECH J, V37, P1265, DOI 10.1139/cgj-37-6-1265; Walker R, 2006, J GEOTECH GEOENVIRON, V132, P937, DOI 10.1061/(ASCE)1090-0241(2006)132:7(937); Wu H, 2012, MECH RES COMMUN, V44, P9, DOI 10.1016/j.mechrescom.2012.04.005; Xu Y., 2008, THESIS ZHEJIANG U; Yoshikuni H, 1974, SOILS FOUND, V14, P36	28	0	0	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139660	10.1371/journal.pone.0139660	http://dx.doi.org/10.1371/journal.pone.0139660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447973	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000043
J	Waraya, M; Yamashita, K; Ema, A; Katada, N; Kikuchi, S; Watanabe, M				Waraya, Mina; Yamashita, Keishi; Ema, Akira; Katada, Natsuya; Kikuchi, Shiro; Watanabe, Masahiko			Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HELICOBACTER-PYLORI INFECTION; ABERRANT DNA METHYLATION; RECEPTOR-TYPE 2B; PROMOTER METHYLATION; DIFFUSE-TYPE; ADJUVANT CHEMOTHERAPY; EPIGENETIC REGULATION; PGP9.5; EXPRESSION	Background A comprehensive search for DNA methylated genes identified candidate tumor suppressor genes that have been proven to be involved in the apoptotic process of the p53 pathway. In this study, we investigated p53 mutation in relation to such epigenetic alteration in primary gastric cancer. Methods The methylation profiles of the 3 genes: PGP9.5, NMDAR2B, and CCNA1, which are involved in the p53 tumor suppressor pathway in combination with p53 mutation were examined in 163 primary gastric cancers. The effect of epigenetic reversion in combination with chemotherapeutic drugs on apoptosis was also assessed according to the tumor p53 mutation status. Results p53 gene mutations were found in 44 primary gastric tumors (27%), and super-high methylation of any of the 3 genes was only found in cases with wild type p53. Higher p53 pathway aberration was found in cases with male gender (p = 0.003), intestinal type (p = 0.005), and non-infiltrating type (p = 0.001). The p53 pathway aberration group exhibited less recurrence in lymph nodes, distant organs, and peritoneum than the p53 non-aberration group. In the NUGC4 gastric cancer cell line (p53 wild type), epigenetic treatment augmented apoptosis by chemotherapeutic drugs, partially through p53 transcription activity. On the other hand, in the KATO III cancer cell line (p53 mutant), epigenetic treatment alone induced robust apoptosis, with no trans-activation of p53. Conclusion In gastric cancer, p53 relevant and non-relevant pathways exist, and tumors with either pathway type exhibited unique clinical features. Epigenetic treatments can induce apoptosis partially through p53 activation, however their apoptotic effects may be explained largely by mechanism other than through p53 pathways.	[Waraya, Mina; Yamashita, Keishi; Ema, Akira; Katada, Natsuya; Kikuchi, Shiro; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Kitasato University	Yamashita, K (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520374, Japan.	keishi23@med.kitasato-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Japanese Foundation for Multidisciplinary Treatment of Cancer; Grants-in-Aid for Scientific Research [25462036] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Foundation for Multidisciplinary Treatment of Cancer(Japanese Foundation for Multidisciplinary Treatment of Cancer); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Grant-in Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan and by the Japanese Foundation for Multidisciplinary Treatment of Cancer. The funding agencies had no role in the design of the study, data collection, or analysis; in the interpretation of the results; in the preparation of the manuscript; or in the decision to submit the manuscript for publication.	Bataille F, 2003, J CLIN PATHOL-MOL PA, V56, P286; Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Ema A, 2014, GASTRIC CANCER, V17, P67, DOI 10.1007/s10120-013-0253-y; Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; Lim BHG, 1996, INT J CANCER, V69, P200, DOI 10.1002/(SICI)1097-0215(19960621)69:3<200::AID-IJC9>3.0.CO;2-3; Liu JW, 2007, INT J CANCER, V121, P1994, DOI 10.1002/ijc.22934; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mitsui Y, 2012, CANCER EPIDEM BIOMAR, V21, P487, DOI 10.1158/1055-9965.EPI-11-0970; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Ooki A, 2013, MOL CANCER RES, V11, P1362, DOI 10.1158/1541-7786.MCR-13-0091; RANZANI GN, 1995, CANCER EPIDEM BIOMAR, V4, P223; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Rivera A, 2006, CELL MOL LIFE SCI, V63, P1425, DOI 10.1007/s00018-006-5521-5; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; SHIAO YH, 1994, AM J PATHOL, V144, P511; Tamura H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-220; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Tokumaru Y, 2008, INT J CANCER, V123, P753, DOI 10.1002/ijc.23354; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; UCHINO S, 1993, INT J CANCER, V54, P759, DOI 10.1002/ijc.2910540509; Weiss D, 2011, MOL CARCINOGEN, V50, P680, DOI 10.1002/mc.20798; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiang TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029783; Yamashita K, 2006, CANCER RES, V66, P3921, DOI 10.1158/0008-5472.CAN-05-1511; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2009, HEPATO-GASTROENTEROL, V56, P276; Yamashita K, 2001, ARCH PATHOL LAB MED, V125, P347; Yamashita K, 2008, MOL CANCER RES, V6, P31, DOI 10.1158/1541-7786.MCR-07-0213; Yamashita K, 2011, SURG TODAY, V41, P24, DOI 10.1007/s00595-010-4370-5; Yang N, 2009, CANCER EPIDEM BIOMAR, V18, P3000, DOI 10.1158/1055-9965.EPI-09-0405; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343	44	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139902	10.1371/journal.pone.0139902	http://dx.doi.org/10.1371/journal.pone.0139902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447864	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000064
J	Choi, JH; Lee, MJ; Jang, M; Kim, EJ; Shim, I; Kim, HJ; Lee, S; Lee, SW; Kim, YO; Cho, IH				Choi, Jong Hee; Lee, Min Jung; Jang, Minhee; Kim, Eun-Jeong; Shim, Insop; Kim, Hak-Jae; Lee, Sanghyun; Lee, Sang Won; Kim, Young Ock; Cho, Ik-Hyun			An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response	PLOS ONE			English	Article							ARALIA-CONTINENTALIS; BUPLEURUM-FALCATUM; ANTIINFLAMMATORY ACTIVITIES; SCHIZONEPETA-TENUIFOLIA; OSTERICUM-KOREANUM; AQUEOUS EXTRACTS; KAPPA-B; ANTIOXIDANT; ACID; BETA	The preventive and therapeutic mechanisms in multiple sclerosis are not clearly understood. We investigated whether Hyungbangpaedok-san (HBPDS), a traditional herbal medicine, has a beneficial effect in experimental autoimmune encephalomyelitis (EAE) mice immunized with myelin oligodendrocyte glycoprotein peptide (MOG(35-55)). Onset-treatment with 4 types of HBPDS (extracted using distilled water and 30%/70%/100% ethanol as the solvent) alleviated neurological signs, and HBPDS extracted within 30% ethanol (henceforth called HBPDS) was more effective. Onset-treatment with HBPDS reduced demyelination and the recruitment/infiltration and activation of microglia/macrophages in the spinal cord of EAE mice, which corresponded to the reduced mRNA expression of pro-inflammatory cytokines (TNF-alpha, IL-6, and IL-1 beta), iNOS, and chemokines (MCP-1, MIP-1 alpha, and RANTES) in the spinal cord. Onset-treatment with HBPDS inhibited changes in the components of the blood-brain barrier such as astrocytes, adhesion molecules (ICAM-1 and VCAM-1), and junctional molecules (claudin-3, claudin-5, and zona occludens-1) in the spinal cord of EAE mice. Onset-treatment with HBPDS reduced the elevated population of CD4(+), CD4(+)/IFN-gamma(+), and CD4(+)/IL-17(+) T cells in the spinal cord of EAE mice but it further increased the elevated population of CD4(+)/CD25(+)/Foxp3(+) and CD4(+)/Foxp3(+)/Helios(+) T cells. Pre-, onset-, post-, but not peak-treatment, with HBPDS had a beneficial effect on behavioral impairment in EAE mice. Taken together, HBPDS could alleviate the development/progression of EAE by regulating the recruitment/infiltration and activation of microglia and peripheral immune cells (macrophages, Th1, Th17, and Treg cells) in the spinal cord. These findings could help to develop protective strategies using HBPDS in the treatment of autoimmune disorders including multiple sclerosis.	[Choi, Jong Hee; Lee, Min Jung; Jang, Minhee; Kim, Eun-Jeong; Cho, Ik-Hyun] Kyung Hee Univ, Coll Korean Med, Dept Convergence Med Sci, Seoul 130701, South Korea; [Choi, Jong Hee; Lee, Min Jung; Kim, Eun-Jeong; Shim, Insop; Cho, Ik-Hyun] Kyung Hee Univ, Coll Korean Med, Brain Korea Plus Program 21, Seoul 130701, South Korea; [Shim, Insop] Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul 130701, South Korea; [Kim, Hak-Jae] Soonchunhyang Univ, Coll Med, Dept Clin Pharmacol, Cheonan 336745, South Korea; [Lee, Sanghyun] Chung Ang Univ, Dept Integrat Plant Sci, Anseong 456756, South Korea; [Lee, Sang Won; Kim, Young Ock] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Dept Med Crop Res Inst, Eumseong 369873, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Coll Korean Med, Inst Koreran Med, Seoul 130701, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Soonchunhyang University; Chung Ang University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kyung Hee University	Cho, IH (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Convergence Med Sci, Seoul 130701, South Korea.	ihcho@khu.ac.kr	Kim, Hak-Jae/Q-9368-2019; Cho, Ik-Hyun/A-9348-2014; Kim, Hak-Jae/AAI-3338-2020	Kim, Hak-Jae/0000-0003-1212-7861; Lee, Minjung/0000-0003-4206-6713; Shim, Insop/0000-0002-8014-9782	Traditional Korean Medicine R&D program - Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI) [HI13C0263]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2014R1A2A1A11051240]	Traditional Korean Medicine R&D program - Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by the Traditional Korean Medicine R&D program founded by the Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI) (HI13C0263) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2014R1A2A1A11051240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	이수영, 2005, [Journal of Sasang Constitutional Medicine, 사상체질의학회지], V17, P91; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Akihisa T, 2009, J NAT PROD, V72, P1786, DOI 10.1021/np9003239; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Byun MW, 2014, J MED FOOD, V17, P350, DOI 10.1089/jmf.2013.2928; Chen SJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/970789; Chen WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088076; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chiang LC, 2003, AM J CHINESE MED, V31, P225, DOI 10.1142/S0192415X03000874; Choi RJ, 2011, PHYTOMEDICINE, V18, P677, DOI 10.1016/j.phymed.2010.11.010; Cuzzola VF, 2012, PHARMACOGENOMICS J, V12, P453, DOI 10.1038/tpj.2012.41; Fabis MJ, 2007, P NATL ACAD SCI USA, V104, P5656, DOI 10.1073/pnas.0701252104; [樊永平 FAN YongPing], 2006, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V29, P273; Finkelsztejn A, 2014, PERSPECT MED CHEM, V6, P65, DOI 10.4137/PMC.S13213; Fissolo N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-139; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Gao Z, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/383087; Huh J, 1610, DONGUIBOGAM; Hwang YP, 2009, FOOD CHEM TOXICOL, V47, P75, DOI 10.1016/j.fct.2008.10.011; Islam MN, 2012, J ETHNOPHARMACOL, V144, P175, DOI 10.1016/j.jep.2012.08.048; Jahromi SR, 2014, IRAN J BASIC MED SCI, V17, P509; Jang M, 2014, BRAIN BEHAV IMMUN, V38, P151, DOI 10.1016/j.bbi.2014.01.015; Jonas RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030763; Jung HW, 2010, INT IMMUNOPHARMACOL, V10, P155, DOI 10.1016/j.intimp.2009.10.010; 허정원, 2009, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V23, P443; Kang TJ, 2009, ACTA ONCOL, V48, P895, DOI 10.1080/02841860902824925; Kawakami N, 2012, IMMUNOL REV, V248, P140, DOI 10.1111/j.1600-065X.2012.01133.x; Kim JB, 2009, KOREAN J ORIENTAL PH, V23; Kim SJ, 2008, AM J CHINESE MED, V36, P1145, DOI 10.1142/S0192415X0800648X; Kong XY, 2013, J ETHNOPHARMACOL, V148, P842, DOI 10.1016/j.jep.2013.05.023; Kou S, 2014, J ETHNOPHARMACOL, V158, P102, DOI 10.1016/j.jep.2014.10.007; Kwon S, 2010, PROG NEURO-PSYCHOPH, V34, P265, DOI 10.1016/j.pnpbp.2009.11.015; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lanz TV, 2013, P NATL ACAD SCI USA, V110, P14735, DOI 10.1073/pnas.1302569110; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Lee B, 2012, J MICROBIOL BIOTECHN, V22, P422, DOI 10.4014/jmb.1110.10077; Lee Jee Youn, 2010, Exp Neurobiol, V19, P146, DOI 10.5607/en.2010.19.3.146; Lee M. J., 2015, MOL NEUROBIOL; Lee MJ, 2015, MOL NEUROBIOLOGY; LI SZ, 1578, BEN CAO GANG MU; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Liu JP, 2013, J ETHNOPHARMACOL, V150, P371, DOI 10.1016/j.jep.2013.09.003; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Minagar A, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/249101; Namjooyan Foroogh, 2014, J Tradit Complement Med, V4, P145, DOI 10.4103/2225-4110.136543; Park HJ, 2005, PHYTOTHER RES, V19, P511, DOI 10.1002/ptr.1693; Park KH, 2002, PHYTOTHER RES, V16, P359, DOI 10.1002/ptr.903; Petermann F, 2011, FEBS LETT, V585, P3747, DOI 10.1016/j.febslet.2011.03.064; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; [宋丽君 SONG Li-jun], 2010, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V25, P745; Tai J, 2007, ONCOL REP, V18, P227; Takatori H, 2015, ARTHRITIS RHEUMATOL, V67, P1491, DOI 10.1002/art.39091; Teng L, 2014, NEURAL REGEN RES, V9, P407, DOI 10.4103/1673-5374.128246; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wang BS, 2012, FOOD CHEM TOXICOL, V50, P526, DOI 10.1016/j.fct.2011.12.010; Wang L, 2008, CHINA J EXPT TRADITI, V4, P42; Wang Y, 2013, ADV CIV ENG, V2013, DOI 10.1155/2013/189105; Willis CL, 2011, TOXICOL PATHOL, V39, P172, DOI 10.1177/0192623310385830; 박진우, 2012, [The Journal Of Korean Medical Classics, 대한한의학원전학회지], V25, P17; Ye CL, 2011, INT J BIOL MACROMOL, V49, P466, DOI 10.1016/j.ijbiomac.2011.05.026; Zhao D, 2012, ARCH PHARM RES, V35, P179, DOI 10.1007/s12272-012-0120-0; Zhao YY, 2012, J ETHNOPHARMACOL, V144, P775, DOI 10.1016/j.jep.2012.09.033	66	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138592	10.1371/journal.pone.0138592	http://dx.doi.org/10.1371/journal.pone.0138592			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444423	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600033
J	Lisowska, B; Lisowski, A; Siewruk, K				Lisowska, Barbara; Lisowski, Aleksander; Siewruk, Katarzyna			Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; GENE-RELATED PEPTIDE; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; NERVE-FIBERS; SYNOVIOCYTES; OSTEOARTHRITIS; LOCALIZATION; TACHYKININS; SEVERITY	Objective Evidence suggests that substance P (SP) is involved in chronic joint inflammation, such as the pathogenesis of rheumatoid arthritis and osteoarthritis. The goal of the research was to evaluate the correlation between chronic pain and changes in the SP level in patients with chronic inflammation of the connective tissue. Methods Patients with osteoarthritis and rheumatoid arthritis were enrolled in this study. The relationship between chronic pain intensity and the serum SP concentration was evaluated in these groups of patients with osteoarthritis and rheumatoid arthritis. Results The results showed a positive correlation between the serum SP concentrations and chronic pain intensity. Conclusions 1. The SP serum concentration was significantly different between the groups of patients with OA and RA. 2. There was a positive correlation between the serum SP concentration and chronic pain intensity in OA and RA patients.	[Lisowska, Barbara] Adam Gruca Clin Hosp, Dept Anaesthesiol, Med Ctr Postgrad Educ, Postgrad Med Educ Ctr, Otwock, Poland; [Lisowski, Aleksander] Warsaw Univ Life Sci, Fac Prod Engn, Warsaw, Poland; [Siewruk, Katarzyna] Warsaw Univ Life Sci, Fac Vet Med, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences	Siewruk, K (corresponding author), Warsaw Univ Life Sci, Fac Vet Med, Warsaw, Poland.	siewruk.katarzyna@gmail.com	Lisowska, Barbara/R-5045-2017; Lisowski, Aleksander/R-4884-2017	Lisowska, Barbara/0000-0002-1964-5330; Lisowski, Aleksander/0000-0001-8394-0396				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baerwald CGO, 2000, RHEUM DIS CLIN N AM, V26, P841, DOI 10.1016/S0889-857X(05)70172-1; Basbaum A.I., 2002, CAN J ANAESTH, V49, pR1; Eser F, 2012, RHEUMATOL INT, V32, P1521, DOI 10.1007/s00296-011-1822-1; Garip Y, 2011, ACTA REUMATOL PORT, V36, P364; Goto T, 2002, MICROSC RES TECHNIQ, V58, P91, DOI 10.1002/jemt.10123; Grimsholm O, 2005, ARTHRITIS RES THER, V7, pR416, DOI 10.1186/ar1503; Hernanz A, 2003, REGUL PEPTIDES, V115, P19, DOI 10.1016/S0167-0115(03)00127-7; HERNANZ A, 1993, BRIT J RHEUMATOL, V32, P31; Karagiannides I, 2011, ENDOCRINOLOGY, V152, P2197, DOI 10.1210/en.2010-1345; Keeble JE, 2004, NEUROSCI LETT, V361, P176, DOI 10.1016/j.neulet.2003.12.020; Khan MM, 2012, J NEUROIMMUNOL, V242, P1, DOI 10.1016/j.jneuroim.2011.10.012; Lambert N, 1998, CLIN EXP IMMUNOL, V113, P269; LEVINE JD, 1985, J IMMUNOL, V135, pS843; LEVINE JD, 1984, SCIENCE, V226, P547, DOI 10.1126/science.6208609; Lisowska B, 2007, GERIATRIA POLSKA, V3, P63; LOTZ M, 1987, SCIENCE, V235, P893, DOI 10.1126/science.2433770; MARSHALL KW, 1990, ARTHRITIS RHEUM, V33, P87; MATUCCICERINIC M, 1991, CLIN EXP RHEUMATOL, V9, P440; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; O'Shaughnessy MC, 2006, INFLAMM RES, V55, P236, DOI 10.1007/s00011-006-0079-8; PARTSCH G, 1991, SCAND J RHEUMATOL, V20, P98, DOI 10.3109/03009749109165283; Pezet S, 2002, BRAIN RES REV, V40, P240, DOI 10.1016/S0165-0173(02)00206-0; Rocha VZ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/529061; Saxler G, 2005, Z ORTHOP GRENZGEB, V143, P424, DOI 10.1055/s-2005-836832; Saxler G, 2007, EUR J PAIN, V11, P67, DOI 10.1016/j.ejpain.2005.12.011; Straub RH, 2001, ARTHRITIS RHEUM-US, V44, P493, DOI 10.1002/1529-0131(200103)44:3<493::AID-ANR95>3.0.CO;2-U; Weidler C, 2005, ANN RHEUM DIS, V64, P13, DOI 10.1136/ard.2003.016154; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang Y, 2006, CURR DRUG TARGETS, V7, P1011, DOI 10.2174/138945006778019363	30	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139206	10.1371/journal.pone.0139206	http://dx.doi.org/10.1371/journal.pone.0139206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444559	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600046
J	Pietruszka, M; Haduch-Sendecka, A				Pietruszka, Mariusz; Haduch-Sendecka, Aleksandra			Ion Frequency Landscape in Growing Plants	PLOS ONE			English	Article							POLLEN-TUBE; OSCILLATIONS; GROWTH; WALL	It has been interesting that nearly all of the ion activities that have been analysed thus far have exhibited oscillations that are tightly coupled to growth. Here, we present discrete Fourier transform (DFT) spectra with a finite sampling of tip-growing cells and organs that were obtained from voltage measurements of the elongating coleoptiles of maize in situ. The electromotive force (EMF) oscillations (similar to 0.1 mu V) were measured in a simple but highly sensitive resistor-inductor circuit (RL circuit), in which the solenoid was initially placed at the tip of the specimen and then was moved thus changing its position in relation to growth (EMF can be measured first at the tip, then at the sub-apical part and finally at the shank). The influx- and efflux-induced oscillations of Ca2+, along with H+, K+ and Cl- were densely sampled (preserving the Nyquist theorem in order to 'grasp the structure' of the pulse), the logarithmic amplitude of pulse spectrum was calculated, and the detected frequencies, which displayed a periodic sequence of pulses, were compared with the literature data. A band of life vital individual pulses was obtained in a single run of the experiment, which not only allowed the fundamental frequencies (and intensities of the processes) to be determined but also permitted the phase relations of the various transport processes in the plasma membrane and tonoplast to be established. A discrete (quantised) frequency spectrum was achieved for a growing plant for the first time, while all of the metabolic and enzymatic functions of the life cell cycle were preserved using this totally non-invasive treatment.	[Pietruszka, Mariusz; Haduch-Sendecka, Aleksandra] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Physiol, Katowice, Poland	University of Silesia in Katowice	Pietruszka, M (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Plant Physiol, Katowice, Poland.	mariusz.pietruszka@us.edu.pl		Pietruszka, Mariusz/0000-0001-5852-9095				[Anonymous], 2008, INDUCTANCE MAGNETIC; Berg JM, 2009, BIOCHEMISTRY-US, P345; Braidwood L, 2014, NEW PHYTOL, V201, P388, DOI 10.1111/nph.12473; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Dieckmann A, 2011, AMPLITUDE PHASE DISC; FRIESEN WO, 1984, AM J PHYSIOL, V246, pR847, DOI 10.1152/ajpregu.1984.246.6.R847; Harris CM, 1998, J NEUROSCI METH, V83, P15, DOI 10.1016/S0165-0270(98)00080-6; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Kroeger JH, 2013, MATH MODEL NAT PHENO, V8, P25, DOI 10.1051/mmnp/20138403; Martin O, 2009, ORIGINS LIFE EVOL B, V39, P533, DOI 10.1007/s11084-009-9170-9; Martins Teresa Vaz, 2013, Plants-Basel, V2, P541, DOI 10.3390/plants2040541; Matlak M, 2004, PHYS STATUS SOLIDI B, V241, P163, DOI 10.1002/pssb.200301945; Matlak M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.052101; McKane AJ, 2007, J STAT PHYS, V128, P165, DOI 10.1007/s10955-006-9221-9; Pietruszka M, 2015, GEN PHYSIOL BIOPHYS, V34, P145, DOI 10.4149/gpb_2014035; Reid Brian, 2011, Commun Integr Biol, V4, P524, DOI 10.4161/cib.4.5.16182; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Shabala SN, 1997, PLANT PHYSIOL, V113, P111, DOI 10.1104/pp.113.1.111; Taiz L, 2006, PLANT PHYSIOL, P108; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; Zonia L, PLANT CELL	22	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138839	10.1371/journal.pone.0138839	http://dx.doi.org/10.1371/journal.pone.0138839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445131	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600038
J	Ren, JJ; Yu, Z; Yang, FL; Lv, D; Hung, S; Zhang, J; Lin, P; Liu, SX; Zhang, N; Bachert, C				Ren, Jian-jun; Yu, Zhao; Yang, Feng-Ling; Lv, Dan; Hung, Shi; Zhang, Jie; Lin, Ping; Liu, Shi-Xi; Zhang, Nan; Bachert, Claus			Effects of Bifidobacterium Breve Feeding Strategy and Delivery Modes on Experimental Allergic Rhinitis Mice	PLOS ONE			English	Article							T-CELL TOLERANCE; HYGIENE HYPOTHESIS; ATOPIC-DERMATITIS; B-CELLS; PROBIOTICS; MICROBIOTA; DISEASES; SYNBIOTICS; INDUCTION; SYMPTOMS	Background Different delivery modes may affect the susceptibility to allergic diseases. It is still unknown whether early intervention with probiotics would counteract this effect. Objectives The effect of different delivery modes on immune status and nasal symptoms was investigated on established allergic rhinitis (AR) mouse model. In addition, the immunoregulatory effects and mechanisms of different feeding manners with Bifidobacterium breve(B. breve) were examined. Methods Live lyophilized B. breve was orally administered to BALB/c mice born via vaginal delivery (VD) or cesarean delivery (CD) for 8 consecutive weeks, after which they were sensitized by ovalbumin(OVA) to establish experimental AR. Nasal symptoms, serum immunoglobulins, cytokines, splenic percentages of CD4(+)CD25(+)Foxp3(+) regulatory T(Treg) cells and nasal eosinophil infiltration were evaluated. Results Compared with VD mice, mice delivered via CD demonstrated more serious nasal symptoms, higher concentrations of OVA-specific immunoglobulin (Ig) E, more nasal eosinophils and lower percentages of splenic CD4(+)CD25(+)Foxp3(+) Treg cells after establishing experimental AR. These parameters were reversed by administering B. breves hortly after birth. However, the effect of B. breve did not differ between different delivery modes. Conclusion CD aggravates the nasal symptoms of AR mice compared to VD. This is the first report that oral administration of B. breve shortly after birth can significantly alleviate the symptoms of AR mice born via both deliveries, probably via activation of the regulatory capacity of CD4(+)CD25(+)Foxp3(+) Treg cells.	[Ren, Jian-jun; Yu, Zhao; Yang, Feng-Ling; Lv, Dan; Hung, Shi; Liu, Shi-Xi] Sichuan Univ, West China Med Sch, West China Hosp, Dept Otorhinolaryngol, Chengdu 610064, Peoples R China; [Zhang, Jie; Lin, Ping] Sichuan Univ, Upper Airways Res Lab, West China Hosp, Chengdu 610064, Peoples R China; [Zhang, Nan; Bachert, Claus] Univ Ghent, Dept Otorhinolaryngol, Upper Airways Res Lab URL, B-9000 Ghent, Belgium	Sichuan University; Sichuan University; Ghent University	Yu, Z (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, Dept Otorhinolaryngol, Chengdu 610064, Peoples R China.	yutzhao@163.com	Ren, Jianjun/P-1965-2019; ren, Jianjun/AAC-6157-2021; Bachert, Claus/J-8825-2012; Zhao, Yu/ABC-6762-2021; Zhang, Nan/AAQ-3944-2020	Ren, Jianjun/0000-0002-5938-688X; 	National Natural Science Foundation of China [81170898, 30801280]; Ghent University; Sichuan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ghent University(Ghent University); Sichuan University(Sichuan University)	This study was supported by the National Natural Science Foundation of China (No. 81170898, No. 30801280) and collaboration between the Ghent and Sichuan Universities.	Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Bendiks M, 2013, CURR ALLERGY ASTHM R, V13, P487, DOI 10.1007/s11882-013-0382-8; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; de Kivit S, 2012, ALLERGY, V67, P343, DOI 10.1111/j.1398-9995.2011.02771.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Forsythe P, 2011, CHEST, V139, P901, DOI 10.1378/chest.10-1861; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Guarner F, 1998, INT J FOOD MICROBIOL, V39, P237, DOI 10.1016/S0168-1605(97)00136-0; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Iemoli E, 2012, J CLIN GASTROENTEROL, V46, pS33, DOI 10.1097/MCG.0b013e31826a8468; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Lau S, 2013, CURR OPIN ALLERGY CL, V13, P293, DOI 10.1097/ACI.0b013e328360ede9; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Murphy D, 1993, METHODS MOL BIOL, V18; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Orihara K, 2007, J ALLERGY CLIN IMMUN, V120, P960, DOI 10.1016/j.jaci.2007.05.036; Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Rutten NBMM, 2011, BENEF MICROBES, V2, P183, DOI 10.3920/BM2011.0012; Sagar S, 2014, BBA-MOL BASIS DIS, V1842, P573, DOI 10.1016/j.bbadis.2014.01.005; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Steinke JW, 2014, ANN ALLERG ASTHMA IM, V112, P195, DOI 10.1016/j.anai.2013.12.020; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; van de Pol MA, 2011, ALLERGY, V66, P39, DOI 10.1111/j.1398-9995.2010.02454.x; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Zhu LP, 2012, J BIOMED RES, V26, P226, DOI 10.7555/JBR.26.20120023	32	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140018	10.1371/journal.pone.0140018	http://dx.doi.org/10.1371/journal.pone.0140018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445348	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600124
J	Zou, C; Andersen, JP				Zou, Christopher; Andersen, Judith P.			Comparing the Rates of Early Childhood Victimization across Sexual Orientations: Heterosexual, Lesbian, Gay, Bisexual, and Mostly Heterosexual	PLOS ONE			English	Article							PEER VICTIMIZATION; RETROSPECTIVE REPORTS; UNITED-STATES; YOUNG-WOMEN; LIFE-SPAN; GENDER; HEALTH; ABUSE; RISK; EXPERIENCES	Few studies have examined the rates of childhood victimization among individuals who identify as "mostly heterosexual" (MH) in comparison to other sexual orientation groups. For the present study, we utilized a more comprehensive assessment of adverse childhood experiences to extend prior literature by examining if MH individuals' experience of victimization more closely mirrors that of sexual minority individuals or heterosexuals. Heterosexual (n = 422) and LGB (n = 561) and MH (n = 120) participants were recruited online. Respondents completed surveys about their adverse childhood experiences, both maltreatment by adults (e.g., childhood physical, emotional, and sexual abuse and childhood household dysfunction) and peer victimization (i.e., verbal and physical bullying). Specifically, MH individuals were 1.47 times more likely than heterosexuals to report childhood victimization experiences perpetrated by adults. These elevated rates were similar to LGB individuals. Results suggest that rates of victimization of MH groups are more similar to the rates found among LGBs, and are significantly higher than heterosexual groups. Our results support prior research that indicates that an MH identity falls within the umbrella of a sexual minority, yet little is known about unique challenges that this group may face in comparison to other sexual minority groups.	[Zou, Christopher; Andersen, Judith P.] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Zou, C (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	christopher.zou@mail.utoronto.ca; judith.andersen@utoronto.ca		Andersen, Judith/0000-0001-8477-1432				Alexander KW, 2005, PSYCHOL SCI, V16, P33, DOI 10.1111/j.0956-7976.2005.00777.x; Alvy LM, 2013, J INTERPERS VIOLENCE, V28, P2088, DOI 10.1177/0886260512471081; Amnesty International, 2013, LGBT HUM RIGHTS; Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; Andersen JP, 2013, PLOS ONE, V9; Andersen JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054691; [Anonymous], 2005, REMEMBERING TRAUMA; Austin SB, 2008, AM J PUBLIC HEALTH, V98, P1015, DOI 10.2105/AJPH.2006.099473; Austin S Bryn, 2007, J LGBT Health Res, V3, P55; Balsam KF, 2005, J CONSULT CLIN PSYCH, V73, P477, DOI 10.1037/0022-006X.73.3.477; Berlan ED, 2010, J ADOLESCENT HEALTH, V46, P366, DOI 10.1016/j.jadohealth.2009.10.015; Bernstein JY, 1997, J INTERPERS VIOLENCE, V12, P483, DOI 10.1177/088626097012004001; Bogaert AF, 2006, REV GEN PSYCHOL, V10, P241, DOI 10.1037/1089-2680.10.3.241; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021982; Collier KL, 2013, J SEX RES, V50, P299, DOI 10.1080/00224499.2012.750639; Corliss HL, 2009, J WOMENS HEALTH, V18, P2005, DOI 10.1089/jwh.2009.1488; Corliss HL, 2002, CHILD ABUSE NEGLECT, V26, P1165, DOI 10.1016/S0145-2134(02)00385-X; Dube SR, 2004, CHILD ABUSE NEGLECT, V28, P729, DOI 10.1016/j.chiabu.2003.08.009; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Eslea M, 2001, AGGRESSIVE BEHAV, V27, P419, DOI 10.1002/ab.1027; Finkelhor D, 2013, JAMA PEDIATR, V167, P70, DOI 10.1001/jamapediatrics.2013.420; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Frankowski BL, 2004, PEDIATRICS, V113, P1827, DOI 10.1542/peds.113.6.1827; Friedman MS, 2011, AM J PUBLIC HEALTH, V101, P1481, DOI 10.2105/AJPH.2009.190009; HANSEN CE, 1985, J HOMOSEXUAL, V11, P1, DOI 10.1300/J082v11n01_01; Herman JL, 1997, J TRAUMA STRESS, V10, P557, DOI 10.1023/A:1024889601838; Hollander G, 2000, SCHOOL PSYCHOL REV, V29, P173; Hong JS, 2012, AGGRESS VIOLENT BEH, V17, P311, DOI 10.1016/j.avb.2012.03.003; Horn SS, 2007, J YOUTH ADOLESCENCE, V36, P363, DOI 10.1007/s10964-006-9111-0; Horwitz AV, 2001, J HEALTH SOC BEHAV, V42, P184, DOI 10.2307/3090177; Hughes TL, 2010, ADDICT BEHAV, V35, P1152, DOI 10.1016/j.addbeh.2010.07.004; Johnson SB, 2012, J ADOLESCENT HEALTH, V51, pS1, DOI 10.1016/j.jadohealth.2012.06.001; Kann Laura, 2011, Morbidity and Mortality Weekly Report, V60, P1; Keppel B, 2006, J BISEX, V6, P85; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kowalski R.M., 2012, CYBERBULLYING BULLYI; Loosier PS, 2010, J PRIM PREV, V31, P261, DOI 10.1007/s10935-010-0228-2; Marshall Cavendish Corporation, 2010, SEX SOC GEN PILL, V2; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Mulick P. S., 2002, J BISEXUALITY, V2, P45, DOI [10.1300/J159v02n04_03, DOI 10.1300/J159V02N04_03]; Mulick PS, 2011, J BISEXUALITY, V11, P453, DOI 10.1080/15299716.2011.620486; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Ochs R., 1996, BIOSEXUALITY PSYCHOL; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Ploderl M, 2009, ARCH SEX BEHAV, V38, P400, DOI 10.1007/s10508-007-9244-6; Quas JA, 1999, J EXP CHILD PSYCHOL, V72, P235, DOI 10.1006/jecp.1999.2491; Rivers I, 2001, BRIT J DEV PSYCHOL, V19, P129, DOI 10.1348/026151001166001; Roberts AL, 2014, ARCH SEX BEHAV, V43, P191, DOI 10.1007/s10508-013-0239-1; Roberts AL, 2012, AM J PUBLIC HEALTH, V102, P1587, DOI 10.2105/AJPH.2011.300530; Ross J., 2010, CHI 10 EXTENDED ABST; RUST PC, 1993, J SEX RES, V30, P214, DOI 10.1080/00224499309551705; Rutledge CM, 2008, J SCHOOL HEALTH, V78, P459, DOI 10.1111/j.1746-1561.2008.00331.x; Saewyc E. M., 2007, NOT YET EQUAL HLTH L; Savin-Williams RC, 2013, DEV REV, V33, P58, DOI 10.1016/j.dr.2013.01.001; Seals D, 2003, ADOLESCENCE, V38, P735; Smith PK, 2003, BRIT J PSYCHOL, V05, P94; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Thompson EM, 2008, DEV PSYCHOL, V44, P15, DOI 10.1037/0012-1649.44.1.15; Thompson MP, 2002, J INTERPERS VIOLENCE, V17, P1115, DOI 10.1177/088626002236663; Toomey RB, 2010, DEV PSYCHOL, V46, P1580, DOI 10.1037/a0020705; Twyman KA, 2010, J DEV BEHAV PEDIATR, V31, P1, DOI 10.1097/DBP.0b013e3181c828c8; U.S. Department of Justice. Office of Justice Programs. Bureau of Justice Statistics, 2009, NAT CRIM VICT SURV S; US Department of Justice, 2000, FIND NAT VIOL WOM SU; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Vrangalova Z, 2014, J SEX RES, V51, P410, DOI [10.1080/00224499.2014.910745, 10.1080/00224499.2014.883589]; Vrangalova Z, 2012, ARCH SEX BEHAV, V41, P85, DOI 10.1007/s10508-012-9921-y; Wang J, 2009, J ADOLESCENT HEALTH, V45, P368, DOI 10.1016/j.jadohealth.2009.03.021; Wilsnack SC, 2012, CHILD ABUSE NEGLECT, V36, P260, DOI 10.1016/j.chiabu.2011.10.008; Ziyadeh NJ, 2007, DRUG ALCOHOL DEPEN, V87, P119, DOI 10.1016/j.drugalcdep.2006.08.004; Zou C, 2013, J AM PSYCHIAT NURSES, V19, P356, DOI 10.1177/1078390313510739	71	32	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139198	10.1371/journal.pone.0139198	http://dx.doi.org/10.1371/journal.pone.0139198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26444428	Green Published, gold			2022-12-26	WOS:000362510600045
J	Mayer, KM; Vuong, QC; Thornton, IM				Mayer, Katja M.; Vuong, Quoc C.; Thornton, Ian M.			Do People "Pop Out"?	PLOS ONE			English	Article							HIGH-LEVEL POP; BIOLOGICAL-MOTION; NEURAL MECHANISMS; SEARCH ASYMMETRY; BODY; ATTENTION; PERCEPTION; FACE; SELECTIVITY; AREA	The human body is a highly familiar and socially very important object. Does this mean that the human body has a special status with respect to visual attention? In the current paper we tested whether people in natural scenes attract attention and "pop out" or, alternatively, are at least searched for more efficiently than targets of another category (machines). Observers in our study searched a visual array for dynamic or static scenes containing humans amidst scenes containing machines and vice versa. The arrays consisted of 2, 4, 6 or 8 scenes arranged in a circular array, with targets being present or absent. Search times increased with set size for dynamic and static human and machine targets, arguing against pop out. However, search for human targets was more efficient than for machine targets as indicated by shallower search slopes for human targets. Eye tracking further revealed that observers made more first fixations to human than to machine targets and that their on-target fixation durations were shorter for human compared to machine targets. In summary, our results suggest that searching for people in natural scenes is more efficient than searching for other categories even though people do not pop out.	[Mayer, Katja M.; Vuong, Quoc C.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mayer, Katja M.] Max Plank Inst Human Cognit & Brain Sci, Neural Mechanisms Human Commun, Leipzig, Germany; [Thornton, Ian M.] Univ Malta, Fac Media & Knowledge Sci, Dept Cognit Sci, Msida, Malta	Newcastle University - UK; Max Planck Society; University of Malta	Mayer, KM (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	katja.m.mayer@gmail.com		Vuong, Quoc/0000-0002-5983-964X; Thornton, Ian/0000-0001-6328-3536				BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Bindemann M, 2010, J EXP PSYCHOL HUMAN, V36, P1477, DOI 10.1037/a0019057; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bosbach S, 2004, J EXP PSYCHOL HUMAN, V30, P39, DOI 10.1037/0096-1523.30.1.39; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bulthoff I, 1998, NAT NEUROSCI, V1, P254, DOI 10.1038/699; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Downing PE, 2011, COGN NEUROSCI-UK, V2, P186, DOI 10.1080/17588928.2011.582945; Downing PE, 2004, COGNITION, V93, pB27, DOI 10.1016/j.cognition.2003.10.010; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; Gervais WM, 2010, ATTEN PERCEPT PSYCHO, V72, P1437, DOI 10.3758/APP.72.6.1437; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hershler O, 2006, VISION RES, V46, P3028, DOI 10.1016/j.visres.2006.03.023; Hiris E, 2007, J VISION, V7, DOI 10.1167/7.12.4; Ikeda H, 2013, J VISION, V13, DOI 10.1167/13.4.20; Itti L, 2005, PROC CVPR IEEE, P631; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johnson K., 2013, PEOPLE WATCHING SOCI; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Lucas B. D., 1981, P IM UND WORKSH; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; O'Toole AJ, 2011, VISION RES, V51, P74, DOI 10.1016/j.visres.2010.09.035; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Shi JF, 2010, COGNITION, V117, P348, DOI 10.1016/j.cognition.2010.09.001; Stein T, 2012, COGNITION, V125, P64, DOI 10.1016/j.cognition.2012.06.005; Stoesz BM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00193; Thirkettle M, 2009, J VISION, V9, DOI 10.1167/9.3.28; Thompson J, 2012, NEUROIMAGE, V59, P4, DOI 10.1016/j.neuroimage.2011.05.044; Thornton IM, 2002, PERCEPTION, V31, P837, DOI 10.1068/p3072; Thornton IM, 2004, CURR BIOL, V14, P1084, DOI 10.1016/j.cub.2004.06.025; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; van Boxtel JJA, 2011, J VISION, V11, DOI 10.1167/11.7.19; van Koningsbruggen MG, 2013, J NEUROSCI, V33, P7003, DOI 10.1523/JNEUROSCI.2853-12.2013; Vangeneugden J, 2014, J NEUROSCI, V34, P574, DOI 10.1523/JNEUROSCI.4032-13.2014; VanRullen R, 2006, VISION RES, V46, P3017, DOI 10.1016/j.visres.2005.07.009; Vuong QC, 2006, J VISION, V6, P87, DOI 10.1167/6.1.8; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Wang L, 2010, PSYCHOL SCI, V21, P1083, DOI 10.1177/0956797610376072; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006	49	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139618	10.1371/journal.pone.0139618	http://dx.doi.org/10.1371/journal.pone.0139618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441221	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510300038
J	Zhang, XQ; Zhang, JG; Duan, AG				Zhang, Xiongqing; Zhang, Jianguo; Duan, Aiguo			A Hierarchical Bayesian Model to Predict Self-Thinning Line for Chinese Fir in Southern China	PLOS ONE			English	Article							SIZE-DENSITY RELATIONSHIPS; SELECTING DATA POINTS; COASTAL DOUGLAS-FIR; BOUNDARY LINE; BLACK SPRUCE; TREE; PINE; REGRESSION; STANDS; DIAGRAMS	Self-thinning is a dynamic equilibrium between forest growth and mortality at full site occupancy. Parameters of the self-thinning lines are often confounded by differences across various stand and site conditions. For overcoming the problem of hierarchical and repeated measures, we used hierarchical Bayesian method to estimate the self-thinning line. The results showed that the self-thinning line for Chinese fir (Cunninghamia lanceolata (Lamb.) Hook.) plantations was not sensitive to the initial planting density. The uncertainty of model predictions was mostly due to within-subject variability. The simulation precision of hierarchical Bayesian method was better than that of stochastic frontier function (SFF). Hierarchical Bayesian method provided a reasonable explanation of the impact of other variables (site quality, soil type, aspect, etc.) on self-thinning line, which gave us the posterior distribution of parameters of self-thinning line. The research of self-thinning relationship could be benefit from the use of hierarchical Bayesian method.	[Zhang, Xiongqing; Zhang, Jianguo; Duan, Aiguo] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Res Inst Forestry, Beijing 100091, Peoples R China; [Zhang, Xiongqing; Zhang, Jianguo; Duan, Aiguo] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing 210037, Jiangsu, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Nanjing Forestry University	Zhang, JG (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Res Inst Forestry, Beijing 100091, Peoples R China.	zhangjg@caf.ac.cn	Zhang, Xiongqing/AAW-6171-2020		Chinese Academy of Forestry [CAFYBB2014QB002]; National Natural Science Foundation of China [31300537]; Research Institute of Forestry, Chinese Academy of Forestry [RIF2013-09]	Chinese Academy of Forestry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Institute of Forestry, Chinese Academy of Forestry	The study was supported by the special fund of Chinese Academy of Forestry (CAFYBB2014QB002), the National Natural Science Foundation of China (No. 31300537), and the Research Institute of Forestry, Chinese Academy of Forestry for fund for Young Scholars (No. RIF2013-09).	BECK MB, 1987, WATER RESOUR RES, V23, P1393, DOI 10.1029/WR023i008p01393; Begin E, 2001, CAN J FOREST RES, V31, P950, DOI 10.1139/cjfr-31-6-950; Bernardo JM, 1994, BAYESIAN THEORY; Bi HQ, 2004, AUSTRAL ECOL, V29, P408, DOI 10.1111/j.1442-9993.2004.01379.x; Bi HQ, 2001, FOREST SCI, V47, P361; Bi HQ, 1997, AUST J ECOL, V22, P356, DOI 10.1111/j.1442-9993.1997.tb00683.x; Bi HQ, 2000, ECOLOGY, V81, P1477, DOI 10.1890/0012-9658(2000)081[1477:ETSTBL]2.0.CO;2; Bullock BP, 2007, FOREST ECOL MANAG, V242, P127, DOI 10.1016/j.foreco.2007.01.024; Burkhart HE, 2013, FOREST ECOL MANAG, V289, P404, DOI 10.1016/j.foreco.2012.10.041; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; CAO QV, 1994, J APPL ECOL, V31, P693, DOI 10.2307/2404159; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Comeau PG, 2010, FORESTRY, V83, P461, DOI 10.1093/forestry/cpq028; CURTIS RO, 1970, FOREST SCI, V16, P403; del Rio M, 2001, FOREST ECOL MANAG, V142, P79, DOI 10.1016/S0378-1127(00)00341-8; Deng JM, 2012, P NATL ACAD SCI USA, V109, P15823, DOI 10.1073/pnas.1210955109; Deng JM, 2012, P NATL ACAD SCI USA, V109, P8600, DOI 10.1073/pnas.1205663109; DREW TJ, 1977, FOREST SCI, V23, P517; Econometric Software Inc, 1998, LIMDEP 7 0 US MAN CO; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Gelman A., 2004, BAYESIAN DATA ANAL; Hammond ST, 2009, AM J BOT, V96, P1430, DOI 10.3732/ajb.0900063; Harrington CA., 1986, METHOD SITE QUALITY; HYNYNEN J, 1993, SCAND J FOREST RES, V8, P326, DOI 10.1080/02827589309382781; Leon RV., 2011, THESIS U GEORGIA; Li RX, 2012, FORESTRY, V85, P17, DOI 10.1093/forestry/cpr050; Liu J. F., 1980, Scientia Silvae Sinicae, V16, P241; MacGibbon B., 1989, SURV METHODOL, V15, P237; MOHLER CL, 1978, J ECOL, V66, P599, DOI 10.2307/2259153; Monserud RA, 2004, FOREST SCI, V50, P848; Newton PF, 2012, ENVIRON MODELL SOFTW, V35, P171, DOI 10.1016/j.envsoft.2012.02.019; Newton PF, 2006, FOREST ECOL MANAG, V226, P49, DOI 10.1016/j.foreco.2006.01.023; NEWTON PF, 1990, CAN J FOREST RES, V20, P887, DOI 10.1139/x90-119; Omlin M, 1999, ECOL MODEL, V115, P45, DOI 10.1016/S0304-3800(98)00174-4; OSAWA A, 1989, ECOLOGY, V70, P279, DOI 10.2307/1938435; Pittman SD, 2003, CAN J FOREST RES, V33, P1661, DOI [10.1139/x03-086, 10.1139/X03-086]; Pretzsch H, 2006, OECOLOGIA, V146, P572, DOI 10.1007/s00442-005-0126-0; Pretzsch H, 2005, FOREST SCI, V51, P304; PUETTMANN KJ, 1993, FOREST SCI, V39, P7; Reineke LH, 1933, J AGRIC RES, V46, P0627; Scharf FS, 1998, ECOLOGY, V79, P448, DOI 10.1890/0012-9658(1998)079[0448:IERFTE]2.0.CO;2; Smith D.J, 1997, 48 ONT MIN NAT RES; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stankova TV, 2007, NEW FOREST, V34, P123, DOI 10.1007/s11056-007-9043-x; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Sun Hong-Gang, 2010, Chinese Journal of Plant Ecology, V34, P409, DOI 10.3773/j.issn.1005-264x.2010.04.006; Sun HG, 2011, FOREST ECOL MANAG, V261, P1010, DOI 10.1016/j.foreco.2010.12.019; TANG SZ, 1995, FOREST ECOL MANAG, V75, P61, DOI 10.1016/0378-1127(95)03538-L; Turnblom EC, 2000, CAN J FOREST RES, V30, P1410, DOI 10.1139/cjfr-30-9-1410; VanderSchaaf CL, 2007, FOREST SCI, V53, P435; VONGADOW K, 1986, S AFR J SCI, V82, P364; Weiskittel A, 2009, FOREST SCI, V55, P84; WESTOBY M, 1984, ADV ECOL RES, V14, P167, DOI 10.1016/S0065-2504(08)60171-3; WHITE J, 1981, J THEOR BIOL, V89, P475, DOI 10.1016/0022-5193(81)90363-5; Wilson Duncan S., 1999, Northern Journal of Applied Forestry, V16, P48; WILSON JB, 1988, NEW ZEAL J BOT, V26, P193, DOI 10.1080/0028825X.1988.10410112; Wu Z., 1984, CHINESE FIR; Yang Y, 2002, FOREST ECOL MANAG, V168, P259, DOI 10.1016/S0378-1127(01)00741-1; ZEGER SL, 1991, J AM STAT ASSOC, V86, P79, DOI 10.2307/2289717; ZEIDE B, 1987, FOREST SCI, V33, P517; Zeide B, 2001, FOREST ECOL MANAG, V154, P165, DOI 10.1016/S0378-1127(00)00621-6; Zhang L, 2005, CAN J FOREST RES, V35, P1; Zhang X, 2013, PLOS ONE, V11; Zhang XiongQing, 2014, Scientia Silvae Sinicae, V50, P69	66	8	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139788	10.1371/journal.pone.0139788	http://dx.doi.org/10.1371/journal.pone.0139788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440942	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510300055
J	Ren, JQ; Chen, YCI; Mackey, AM; Liu, PK				Ren, Jiaqian; Chen, Yinching I.; Mackey, Ashley M.; Liu, Philip K.			Imaging rhodopsin degeneration in vivo in a new model of ocular ischemia in living mice	FASEB JOURNAL			English	Article						chimeric MR CA; nanotechnology; retinopathy; target-guided delivery strategies	MANGANESE-ENHANCED MRI; DIABETIC-RETINOPATHY; CEREBRAL-ISCHEMIA; MOUSE RETINA; BRAINS; PROBES; AMPHETAMINE; HYPOTHERMIA; EXPOSURE; STROKE	Delivery of antibodies to monitor key biomarkers of retinopathy in vivo represents a significant challenge because living cells do not take up immunoglobulins to cellular antigens. We met this challenge by developing novel contrast agents for retinopathy, which we used with magnetic resonance imaging (MRI). Biotinylated rabbit polyclonal to chick IgY (rIgPxcIgY) and phosphorylthioate-modified oligoDNA (sODN) with random sequence (bio-sODN-Ran) were conjugated with NeutrAvidin-activated superparamagnetic iron oxide nanoparticles (SPION). The resulting Ran-SPION-rIgPxcIgY carries chick polyclonal to microtubule-associated protein 2 (MAP2) as Ran-SPION-rIgP/cIgY-MAP2, or torhodopsin (Rho) as anti-Rho-SPION-Ran. We examined the uptake of Ran-SPION-rIgP/cIgY-MAP2 or SPION-rIgP/cIgY-MAP2 in normal C57black6 mice (n = 3 each, 40 mu g/kg, i. c. v.); we found retention of Ran-SPION-rIgP/cIgY-MAP2 using molecular contrastenhanced MRI in vivo and validated neuronal uptake using Cy5-goat IgPxcIgY ex vivo. Applying this novel method to monitor retinopathy in a bilateral carotid artery occlusion-induced ocular ischemia, we observed pericytes (at d 2, using Gd-nestin, by eyedrop solution), significant photoreceptor degeneration (at d 20, using anti-Rho-SPION-Ran, eyedrops, P = 0.03, Student's t test), and gliosis in M " uller cells (at 6 mo, using SPION-glial fibrillary acidic protein administered by intraperitoneal injection) in surviving mice (n >= 5). Molecular contrastenhanced MRI results were confirmed by optical and electron microscopy. We conclude that chimera and molecular contrast-enhanced MRI provide sufficient sensitivity for monitoring retinopathy and for theranostic applications.-	[Ren, Jiaqian; Chen, Yinching I.; Liu, Philip K.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Mackey, Ashley M.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Liu, PK (corresponding author), CNY149-13th St, Charlestown, MA 02129 USA.	philipl@mgh.harvard.edu			U.S. National Institutes of Health [R01EB013768, P30DK057521-14]; Boston Area, Diabetes Endocrinology Research Center;  [S10RR023009]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area, Diabetes Endocrinology Research Center; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. A. Kazlauskas (Schepens Eye Research Institute at the Massachusetts Eye and Ear Infirmary, Harvard Medical School), J. Blanks, and H. Prentice (Florida Atlantic University) for discussion of retinopathy; Dr. C.-M. Liu for sODN synthesis; and Drs. C. H. Liu, J. S. Yang, and S. Wu for MRI of the brain. This project was supported by U.S. National Institutes of Health Grants R01EB013768 (P. K. Liu), P30DK057521-14, the Boston Area, Diabetes Endocrinology Research Center (J. Avruch), and S10RR023009 (J. Ackerman).	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Baker ML, 2010, STROKE, V41, P2143, DOI 10.1161/STROKEAHA.110.594317; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; Chan KC, 2012, MAGN RESON MED, V68, P1202, DOI 10.1002/mrm.24123; Chen JJ, 2011, NMR BIOMED, V24, P447, DOI 10.1002/nbm.1609; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; De Schryver ELLM, 2006, J NEUROL NEUROSUR PS, V77, P734, DOI 10.1136/jnnp.2005.085613; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Dougherty CJ, 2008, MOL VIS, V14, P471; Gregory AD, 2010, J LEUKOCYTE BIOL, V88, P123, DOI 10.1189/jlb.0709499; Grosso A, 2011, J HYPERTENS, V29, P1667, DOI 10.1097/HJH.0b013e3283496655; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Liu CH, 2004, MAGN RESON MED, V51, P978, DOI 10.1002/mrm.20047; Liu CH, 2008, FASEB J, V22, P1193, DOI 10.1096/fj.07-9557com; Liu CH, 2007, FASEB J, V21, P3004, DOI 10.1096/fj.07-8203com; Liu CH, 2007, MOL IMAGING, V6, P156, DOI 10.2310/7290.2007.00011; Liu CH, 2014, FASEB J, V28, P464, DOI 10.1096/fj.13-234229; Liu CH, 2013, FASEB J, V27, P712, DOI 10.1096/fj.12-220061; Liu CH, 2012, FASEB J, V26, P1652, DOI 10.1096/fj.11-199547; Liu CH, 2009, J NEUROSCI, V29, P10663, DOI 10.1523/JNEUROSCI.2167-09.2009; Liu CH, 2009, J NEUROSCI, V29, P3508, DOI 10.1523/JNEUROSCI.5332-08.2009; Liu PK, 2011, METHODS MOL BIOL, V711, P363, DOI 10.1007/978-1-61737-992-5_18; LIU PK, 1994, ANN NEUROL, V36, P566, DOI 10.1002/ana.410360405; McMillan D E, 1997, Vasc Med, V2, P132; Nag TC, 2012, MICRON, V43, P759, DOI 10.1016/j.micron.2012.01.011; Pan CL, 2012, AMINO ACIDS, V43, P845, DOI 10.1007/s00726-011-1141-6; Ren J., 2015, GENE THER IN PRESS; Rey-Funes M, 2013, INVEST OPHTH VIS SCI, V54, P2836, DOI 10.1167/iovs.12-11198; Robison W G Jr, 1988, Adv Exp Med Biol, V246, P365; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; Wang XD, 2002, NEUROL RES, V24, P730, DOI 10.1179/016164102101200663; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	35	2	2	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					612	623		10.1096/fj.15-280677	http://dx.doi.org/10.1096/fj.15-280677			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443823	Green Published			2022-12-26	WOS:000369391900014
J	Murphy, KC; Stilhano, RS; Mitra, D; Zhou, DJ; Batarni, S; Silva, EA; Leach, JK				Murphy, Kaitlin C.; Stilhano, Roberta S.; Mitra, Debika; Zhou, Dejie; Batarni, Samir; Silva, Eduardo A.; Leach, J. Kent			Hydrogel biophysical properties instruct coculture-mediated osteogenic potential	FASEB JOURNAL			English	Article						fibrin; mesenchymal stem cell; ECFC; BMP-2; osteogenesis	ENDOTHELIAL PROGENITOR CELLS; COLONY-FORMING CELLS; ACID-BASED HYDROGEL; BONE REGENERATION; STEM-CELLS; IN-VIVO; BIOACTIVE GLASS; STROMAL CELLS; FIBRIN GELS; DIFFERENTIATION	Cell-based approaches for bone formation require instructional cues from the surrounding environment. As an alternative to pharmacological strategies or transplanting single cell populations, one approach is to coimplant populations that can establish a new vasculature and differentiate to bone-forming osteoblasts. Mesenchymal stem/stromal cells (MSCs) possess osteogenic potential and produce numerous angiogenic growth factors. Endothelial colony-forming cells (ECFCs) are a subpopulation of endothelial progenitor cells capable of vasculogenesis in vivo and may provide endogenous cues to support MSC function. We investigated the contribution of the carrier biophysical properties to instruct entrapped human MSCs and ECFCs to simultaneously promote their osteogenic and proangiogenic potential. Compared with gels containing MSCs alone, fibrin gels engineered with increased compressive stiffness simultaneously increased the osteogenic and proangiogenic potential of entrapped cocultured cells. ECFCs produced bone morphogenetic protein-2 (BMP-2), a potent osteoinductive molecule, and increases in BMP-2 secretion correlated with gel stiffness. Coculture of MSCs with ECFCs transduced to knockdown BMP-2 production abrogated the osteogenic response to levels observed with MSCs alone. These results demonstrate that physical properties of engineered hydrogels modulate the function of cocultured cells in the absence of inductive cues, thus increasing the translational potential of coimplantation to speed bone formation and repair.	[Murphy, Kaitlin C.; Stilhano, Roberta S.; Mitra, Debika; Zhou, Dejie; Batarni, Samir; Silva, Eduardo A.; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Leach, J. Kent] Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Davis, CA 95616 USA; [Stilhano, Roberta S.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	University of California System; University of California Davis; University of California System; University of California Davis; Universidade Federal de Sao Paulo (UNIFESP)	Leach, JK (corresponding author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dri, Davis, CA 95616 USA.	jkleach@ucdavis.edu	Silva, Eduardo A./M-2711-2015; STILHANO, roberta/F-6923-2015	Silva, Eduardo A./0000-0003-3173-7622; STILHANO, roberta/0000-0002-0653-5968; Fogg, Kaitlin/0000-0003-3572-778X	U.S. National Institutes of Health; National Institute of Dental and Craniofacial Research [R03-DE021704]; AO Foundation (Davos, Switzerland) [C10-39L]; American Heart Association Western States Affiliate Pre-doctoral Fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM083894] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); AO Foundation (Davos, Switzerland); American Heart Association Western States Affiliate Pre-doctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant R03-DE021704, and the AO Foundation (Davos, Switzerland) (C10-39L to J.K.L.). K.M. was supported by the American Heart Association Western States Affiliate Pre-doctoral Fellowship. The authors declare no conflicts of interest.	American Academy of Orthopaedic Surgeons, 2000, MUSC INJ REP INC RIS; Bajada S, 2008, J TISSUE ENG REGEN M, V2, P169, DOI 10.1002/term.83; Binder BYK, 2014, TISSUE ENG PT A, V20, P1156, DOI [10.1089/ten.tea.2013.0487, 10.1089/ten.TEA.2013.0487]; Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662; Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029; Das A, 2011, TISSUE ENG PART B-RE, V17, P403, DOI [10.1089/ten.teb.2011.0190, 10.1089/ten.TEB.2011.0190]; Davis HE, 2011, ACTA BIOMATER, V7, P691, DOI 10.1016/j.actbio.2010.09.007; Decaris ML, 2011, ANN BIOMED ENG, V39, P1174, DOI 10.1007/s10439-010-0217-x; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; Dyer LA, 2014, TRENDS ENDOCRIN MET, V25, P472, DOI 10.1016/j.tem.2014.05.003; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; Fioretta ES, 2012, J BIOMECH, V45, P736, DOI 10.1016/j.jbiomech.2011.11.013; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875; Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013; Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033; He JW, 2012, TISSUE ENG PT A, V18, P1520, DOI [10.1089/ten.tea.2011.0127, 10.1089/ten.TEA.2011.0127]; Herzog DPE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/320123; Hoch AI, 2014, STEM CELL TRANSL MED, V3, P643, DOI 10.5966/sctm.2013-0196; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Joo HJ, 2015, INT J CARDIOL, V197, P33, DOI 10.1016/j.ijcard.2015.06.013; Kaigler D, 2006, J DENT RES, V85, P633, DOI 10.1177/154405910608500710; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050; Kim J, 2009, J BIOMED MATER RES A, V88A, P967, DOI 10.1002/jbm.a.31947; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033; Leu A, 2009, TISSUE ENG PT A, V15, P877, DOI 10.1089/ten.tea.2008.0018; Lin RZ, 2014, P NATL ACAD SCI USA, V111, P10137, DOI 10.1073/pnas.1405388111; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Murphy KC, 2015, ANN BIOMED ENG, V43, P2010, DOI 10.1007/s10439-014-1227-x; Murphy Kaitlin C, 2012, BMC Res Notes, V5, P423, DOI 10.1186/1756-0500-5-423; Oelker AM, 2011, BIOMACROMOLECULES, V12, P1658, DOI 10.1021/bm200039s; Saleh FA, 2011, STEM CELLS DEV, V20, P391, DOI 10.1089/scd.2010.0168; Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937; Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815; Spotnitz William D, 2014, ISRN Surg, V2014, P203943, DOI 10.1155/2014/203943; Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047	46	16	16	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					477	486		10.1096/fj.15-279984	http://dx.doi.org/10.1096/fj.15-279984			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	26443826	Green Published			2022-12-26	WOS:000367621000044
J	Wang, XW; Yang, J; Han, L; Zhao, KX; Wu, QS; Bao, LM; Li, ZY; Lv, L; Li, B				Wang, Xiuwen; Yang, Jing; Han, Lei; Zhao, Kaixia; Wu, Qingsi; Bao, Liming; Li, Zhiyuan; Lv, Ling; Li, Bin			TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORt in Promoting IL-17A Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; T helper cells; TNF receptor-associated factor (TRAF); transcription factor; ubiquitylation (ubiquitination); RORt	NF-KAPPA-B; GAMMA-T; RECEPTOR; CELLS; ACTIVATION; DIFFERENTIATION; TRAF5; INFLAMMATION; ASSOCIATION; DEGRADATION	Background: RORt is required for Th17 cell function and differentiation. Results: TRAF5 stabilizes RORt by ubiquitination and augments RORt-mediated transcriptional expression of IL-17A. Conclusion: TRAF5 is a positive regulator for RORt. Significance: TRAF5 could be a novel target for modulating RORt-mediated inflammation and autoimmune diseases, including systemic lupus erythematosus. Retinoid-related orphan nuclear receptor t (RORt) is a key transcription factor for the development and function of Th17 cells. In this study, we show that tumor necrosis factor receptor-associated factor 5 (TRAF5), known as an E3 ubiquitin protein ligase and signal transducer, interacts with and ubiquitinates RORt via Lys-63-linked polyubiquitination. TRAF5 stabilizes the RORt protein level depending on its RING finger domain. Depletion of TRAF5 in Th17 cells destabilizes RORt protein and down-regulates Th17-related genes, including IL-17A, an inflammatory cytokine involved in pathogenic mechanisms of several autoimmune diseases such as systemic lupus erythematosus. Moreover, up-regulation of the TRAF5 mRNA level was found in systemic lupus erythematosus patient CD4(+) T cells. Our findings reveal a direct link between TRAF5-mediated ubiquitination and RORt protein regulation, which may aggravate inflammatory progress and provide new therapeutic drug targets for autoimmune diseases.	[Wang, Xiuwen; Han, Lei; Zhao, Kaixia; Lv, Ling] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200040, Peoples R China; [Yang, Jing; Li, Zhiyuan; Li, Bin] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Shanghai Inst Biol Sci, Unit Mol Immunol,Inst Pasteur Shanghai, Shanghai 200032, Peoples R China; [Wu, Qingsi] Anhui Med Univ, Dept Immunol, Hefei 230032, Peoples R China; [Bao, Liming] Dartmouth Coll, Dept Pathol & Lab Med, Geisel Sch Med, Lebanon, NH 03756 USA	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Anhui Medical University; Dartmouth College	Lv, L (corresponding author), Fudan Univ, Huashan Hosp, Div Rheumatol, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	huashanlvling@sina.com; binli@sibs.ac.cn	lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884; Yang, Jing/0000-0001-6441-709X	Chinese National Program on Key Basic Research Project [2014CB541800, 2014CB541900]; NSFC [81330072, 31300711, 31370863, 31170825, 31200646, 31200647, 81271835, 81302532]; Shanghai Key Grant [14JC1406100]; Shanghai Three-year Plan on Promoting TCM Development Grant [ZY3-LCPT-2-1003]	Chinese National Program on Key Basic Research Project; NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Key Grant; Shanghai Three-year Plan on Promoting TCM Development Grant	Our research is supported by Chinese National Program on Key Basic Research Project Grants 2014CB541800, 2014CB541900, NSFC 81330072, 31300711, 31370863, 31170825, 31200646, 31200647, 81271835, and 81302532; Shanghai Key Grant 14JC1406100; and Shanghai Three-year Plan on Promoting TCM Development Grant ZY3-LCPT-2-1003. The authors declare that they have no conflicts of interest with the contents of this article.	Bian ZY, 2014, J CELL BIOCHEM, V115, P349, DOI 10.1002/jcb.24669; Buchta CM, 2014, J IMMUNOL, V192, P145, DOI 10.4049/jimmunol.1301901; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Esparza EM, 2006, J BIOL CHEM, V281, P8559, DOI 10.1074/jbc.M512915200; Han L, 2015, FRONT MED-PRC, V9, P10, DOI 10.1007/s11684-015-0388-9; Han L, 2014, J BIOL CHEM, V289, P25546, DOI 10.1074/jbc.M114.565291; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; Kraus ZJ, 2008, J IMMUNOL, V181, P7800, DOI 10.4049/jimmunol.181.11.7800; Liu XK, 2013, J EXP MED, V210, P1575, DOI 10.1084/jem.20122327; Manku H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003554; McKeon JE, 2015, CELL MOL LIFE SCI, V72, P1811, DOI 10.1007/s00018-014-1781-2; Nagashima H, 2014, NAT IMMUNOL, V15, P449, DOI 10.1038/ni.2863; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Potter C, 2007, ANN RHEUM DIS, V66, P1322, DOI 10.1136/ard.2006.065706; Qu FF, 2012, MOL CELL BIOL, V32, P3925, DOI 10.1128/MCB.00268-12; Rajabi P, 2012, INFLAMM RES, V61, P1347, DOI 10.1007/s00011-012-0535-6; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Shen J, 2013, INT J MED SCI, V10, P156, DOI 10.7150/ijms.5457; Xiang Q, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4293; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Yang J, 2015, J IMMUNOL, V194, P4094, DOI 10.4049/jimmunol.1401451; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zhou XJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/597921; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	25	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29086	29094		10.1074/jbc.M115.664573	http://dx.doi.org/10.1074/jbc.M115.664573			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453305	hybrid, Green Published			2022-12-26	WOS:000365762300046
J	Shibata, N; Ohoka, N; Sugaki, Y; Onodera, C; Inoue, M; Sakuraba, Y; Takakura, D; Hashii, N; Kawasaki, N; Gondo, Y; Naito, M				Shibata, Norihito; Ohoka, Nobunnichi; Sugaki, Yusuke; Onodera, Chiaki; Inoue, Mizuho; Sakuraba, Yoshiyuki; Takakura, Daisuke; Hashii, Noritaka; Kawasaki, Nana; Gondo, Yoichi; Naito, Mikihiko			Degradation of Stop Codon Read-through Mutant Proteins via the Ubiquitin-Proteasorne System Causes Hereditary Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; MESSENGER-RNA; TRANSLATION; MUTAGENESIS; DEFICIENCY; RIBOSOME; SIGNALS; OXIDASE; TRIM21; PLAYS	During translation, stop codon read-through occasionally happens when the stop codon is misread, skipped, or mutated, resulting in the production of aberrant proteins with C-terminal extension. These extended proteins are potentially deleterious, but their regulation is poorly understood. Here we show in vitro and in vivo evidence that mouse cFLIP-I, with a 46-amino acid extension encoded by a read-through mutant gene is rapidly degraded by the ubiquitin-proteasome system, causing hepatocyte apoptosis during embryogenesis. The extended peptide interacts with an E3 ubiquitin ligase, TRIM21, to induce ubiquitylation of the mutant protein. In humans, 20 read-through mutations are related to hereditary disorders, and extended peptides found in human PNPO and HSD3B2 similarly destabilize these proteins, involving TRIM21 for PNPO degradation. Our findings indicate that degradation of aberrant proteins with C-terminal extension encoded by read-through mutant genes is a mechanism for loss of function resulting in hereditary disorders.	[Shibata, Norihito; Ohoka, Nobunnichi; Naito, Mikihiko] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Takakura, Daisuke; Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; [Sugaki, Yusuke; Onodera, Chiaki] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Inoue, Mizuho] Univ Tokyo, Fac Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sakuraba, Yoshiyuki; Gondo, Yoichi] RIKEN BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki 3050074, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; University of Tokyo; University of Tokyo; RIKEN	Naito, M (corresponding author), Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	miki-naito@nihs.go.jp	Gondo, Yoichi/A-5375-2016; Sakuraba, Yoshiyuki/D-5614-2009	Gondo, Yoichi/0000-0003-2184-6489; Sakuraba, Yoshiyuki/0000-0003-4698-5530; SHIBATA, NORIHITO/0000-0001-5792-8510	Japan Society for the Promotion of Science KAKENHI [25112521, 26860050, 25241016]; Health and Labor Sciences Research [26401201]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labor Sciences Research(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 25112521 (to M. N.), 26860050 (to N. S.), and 25241016 (to Y. G.) and by Health and Labor Sciences Research Grant 26401201 (to N. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Cassan M, 2001, BMC Mol Biol, V2, P3, DOI 10.1186/1471-2199-2-3; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Inoue M, 2004, HUM MOL GENET, V13, P1147, DOI 10.1093/hmg/ddh133; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Ngo EO, 1998, BIOCHEMISTRY-US, V37, P7741, DOI 10.1021/bi972983r; Ohoka N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.471; Oke V, 2012, J AUTOIMMUN, V39, P77, DOI 10.1016/j.jaut.2012.01.014; Pang S., 2001, ENDOCRIN METAB CLIN, V30, pvi; Pang SY, 2002, J CLIN ENDOCR METAB, V87, P2556, DOI 10.1210/jc.87.6.2556; Pang SY, 2001, ENDOCRIN METAB CLIN, V30, P81, DOI 10.1016/S0889-8529(08)70020-3; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492	23	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28428	28437		10.1074/jbc.M115.670901	http://dx.doi.org/10.1074/jbc.M115.670901			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26442586	hybrid, Green Published			2022-12-26	WOS:000365761900036
J	Muir, KR; Lima, MJ; Docherty, HM; McGowan, NWA; Forbes, S; Heremans, Y; Forbes, SJ; Heimberg, H; Casey, J; Docherty, K				Muir, Kenneth R.; Lima, Maria Joao; Docherty, Hilary M.; McGowan, Neil W. A.; Forbes, Shareen; Heremans, Yves; Forbes, Stuart J.; Heimberg, Harry; Casey, John; Docherty, Kevin			Kruppel-Like Factor 4 Overexpression Initiates a Mesenchymal-to-Epithelial Transition and Redifferentiation of Human Pancreatic Cells following Expansion in Long Term Adherent Culture	PLOS ONE			English	Article							HUMAN BETA-CELLS; LINEAGE TRACING EVIDENCE; IN-VITRO; PRECURSOR CELLS; ISLET TRANSPLANTATION; TRANSCRIPTION FACTORS; STROMAL CELLS; PROLIFERATION; EXPRESSION; VIVO	A replenishable source of insulin-producing cells has the potential to cure type 1 diabetes. Attempts to culture and expand pancreatic beta-cells in vitro have resulted in their transition from insulin-producing epithelial cells to mesenchymal stromal cells (MSCs) with high proliferative capacity but devoid of any hormone production. The aim of this study was to determine whether the transcription factor Kruppel-like factor 4 (KLF4), could induce a mesenchymal-to-epithelial transition (MET) of the cultured cells. Islet-enriched pancreatic cells, allowed to dedifferentiate and expand in adherent cell culture, were transduced with an adenovirus containing KLF4 (Ad-Klf4). Cells were subsequently analysed for changes in cell morphology by light microscopy, and for the presence of epithelial and pancreatic markers by immunocytochemistry and quantitative RT/PCR. Infection with Ad-Klf4 resulted in morphological changes, down-regulation of mesenchymal markers, and re-expression of both epithelial and pancreatic cell markers including insulin and transcription factors specific to beta-cells. This effect was further enhanced by culturing cells in suspension. However, the effects of Ad-KLf4 were transient and this was shown to be due to increased apoptosis in Klf4-expressing cells. Klf4 has been recently identified as a pioneer factor with the ability to modulate the structure of chromatin and enhance reprogramming/transdifferentiation. Our results show that Klf4 may have a role in the redifferentiation of expanded pancreatic cells in culture, but before this can be achieved the off-target effects that result in increased apoptosis would need to be overcome.	[Muir, Kenneth R.; Lima, Maria Joao; Docherty, Hilary M.; Docherty, Kevin] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen, Scotland; [McGowan, Neil W. A.; Casey, John] Univ Edinburgh, Royal Edinburgh Infirm, Dept Surg, Edinburgh EH10 5HF, Midlothian, Scotland; [Forbes, Shareen] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland; [Heremans, Yves; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Forbes, Stuart J.] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	University of Aberdeen; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Vrije Universiteit Brussel; University of Edinburgh	Docherty, K (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen, Scotland.	k.docherty@abdn.ac.uk	Forbes, Shareen/AAG-1816-2021; Lima, Maria Joao/HHR-9895-2022	Forbes, Shareen/0000-0002-9127-0641; Lima, Maria Joao/0000-0003-0597-7892; Docherty, Kevin/0000-0001-6765-2060; Forbes, Stuart/0000-0003-3715-2561; Heimberg, Harry/0000-0003-1954-7375	National Services Division of the National Health Service (NHS) Scotland; Wellcome Trust/Scottish Translational Medicines and Therapeutics Initiative [85664]; Medical Research Council (MRC) [MR/J015277/1]; MRC [MR/J015377/1] Funding Source: UKRI; Medical Research Council [MR/J015377/1] Funding Source: researchfish	National Services Division of the National Health Service (NHS) Scotland; Wellcome Trust/Scottish Translational Medicines and Therapeutics Initiative; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Scottish Islet Transplant Programme is funded by the National Services Division of the National Health Service (NHS) Scotland. KRM was supported by a Fellowship from the Wellcome Trust/Scottish Translational Medicines and Therapeutics Initiative (85664). This work also received support from the Medical Research Council (MRC) http://www.mrc.ac.uk/ MR/J015277/1 (KD).	ANDERSSON A, 1976, J CLIN INVEST, V57, P1295, DOI 10.1172/JCI108397; Ankrum JA, 2014, NAT BIOTECHNOL; Banerjee M, 2012, MOL CELL ENDOCRINOL, V355, P78, DOI 10.1016/j.mce.2012.01.020; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bar Y, 2012, J BIOL CHEM, V287, P17269, DOI 10.1074/jbc.M111.319152; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Chase LG, 2007, DIABETES, V56, P3, DOI 10.2337/db06-1165; Davani B, 2007, STEM CELLS, V25, P3215, DOI 10.1634/stemcells.2007-0323; Efrat S, 2012, TRENDS ENDOCRIN MET, V23, P278, DOI 10.1016/j.tem.2012.03.005; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jaager K, 2014, GENE, V533, P173, DOI 10.1016/j.gene.2013.09.094; Koopmansch B, 2013, BIOCHEM BIOPH RES CO, V431, P652, DOI 10.1016/j.bbrc.2013.01.070; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lima MJ, 2013, DIABETES, V62, P2821, DOI 10.2337/db12-1256; Lima MJ, 2012, MOL CELL ENDOCRINOL, V358, P69, DOI 10.1016/j.mce.2012.02.024; Morton RA, 2007, MOL CELL ENDOCRINOL, V270, P87, DOI 10.1016/j.mce.2007.02.005; Muir KR, 2014, QJM-INT J MED, V107, P253, DOI 10.1093/qjmed/hcu025; NIELSEN JH, 1979, DIABETOLOGIA, V16, P97, DOI 10.1007/BF01225457; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2013, CELL CYCLE, V12, P1487, DOI 10.4161/cc.24663; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654; White MG, 2011, J ENDOCRINOL, V211, P169, DOI 10.1530/JOE-11-0123; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Zanini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028175	36	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140352	10.1371/journal.pone.0140352	http://dx.doi.org/10.1371/journal.pone.0140352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457418	Green Published, Green Submitted, gold			2022-12-26	WOS:000362961100031
J	Olson, NC; Doyle, MF; de Boer, IH; Huber, SA; Jenny, NS; Kronmal, RA; Psaty, BM; Tracy, RP				Olson, Nels C.; Doyle, Margaret F.; de Boer, Ian H.; Huber, Sally A.; Jenny, Nancy Swords; Kronmal, Richard A.; Psaty, Bruce M.; Tracy, Russell P.			Associations of Circulating Lymphocyte Subpopulations with Type 2 Diabetes: Cross-Sectional Results from the Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							INSULIN-RESISTANCE ATHEROSCLEROSIS; ADIPOSE-TISSUE; T-CELLS; SYSTEMIC INFLAMMATION; MEDIATED INFLAMMATION; GLUCOSE-METABOLISM; OBESITY; EXPRESSION; MELLITUS; RISK	Objective Distinct lymphocyte subpopulations have been implicated in the regulation of glucose homeostasis and obesity-associated inflammation in mouse models of insulin resistance. Information on the relationships of lymphocyte subpopulations with type 2 diabetes remain limited in human population-based cohort studies. Methods Circulating levels of innate (gamma delta T, natural killer (NK)) and adaptive immune (CD4(+) naive, CD4(+) memory, Th1, and Th2) lymphocyte subpopulations were measured by flow cytometry in the peripheral blood of 929 free-living participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Cross-sectional relationships of lymphocyte subpopulations with type 2 diabetes (n = 154) and fasting glucose and insulin concentrations were evaluated by generalized linear models. Results Each standard deviation (SD) higher CD4(+) memory cells was associated with a 21% higher odds of type 2 diabetes (95% CI: 1-47%) and each SD higher naive cells was associated with a 22% lower odds (95% CI: 4-36%) (adjusted for age, gender, race/ethnicity, and BMI). Among participants not using diabetes medication, higher memory and lower naive CD4(+) cells were associated with higher fasting glucose concentrations (p<0.05, adjusted for age, sex, and race/ethnicity). There were no associations of gamma delta T, NK, Th1, or Th2 cells with type 2 diabetes, glucose, or insulin. Conclusions A higher degree of chronic adaptive immune activation, reflected by higher memory and lower naive CD4(+) cells, was positively associated with type 2 diabetes. These results are consistent with a role of chronic immune activation and exhaustion augmenting chronic inflammatory diseases, and support the importance of prospective studies evaluating adaptive immune activation and type 2 diabetes.	[Olson, Nels C.; Doyle, Margaret F.; Huber, Sally A.; Jenny, Nancy Swords; Tracy, Russell P.] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT 05405 USA; [de Boer, Ian H.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [de Boer, Ian H.] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Kronmal, Richard A.] Univ Washington, Dept Biostat, Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Epidemiol, Hlth Serv, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Tracy, Russell P.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Vermont	Tracy, RP (corresponding author), Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT 05405 USA.	russell.tracy@med.uvm.edu	de Boer, Ian/GYJ-3282-2022	Doyle, Margaret/0000-0001-6769-5386	National Heart, Lung, and Blood Institute [R01-HL-077449]; National Heart, Lung, and Blood Institute post-doctoral training award [5T32HL007894];  [N01-HC-95159];  [N01-HC-95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077449] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute post-doctoral training award; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by contracts N01-HC-95159 through N01-HC-95169 and by R01-HL-077449 (RPT) from the National Heart, Lung, and Blood Institute. NCO was supported by the National Heart, Lung, and Blood Institute post-doctoral training award 5T32HL007894. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062418; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen SJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-18; Cucak H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107140; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Falorni A, 2000, J CLIN ENDOCR METAB, V85, P309, DOI 10.1210/jc.85.1.309; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Festa A, 2003, CIRCULATION, V108, P1822, DOI 10.1161/01.CIR.0000091339.70120.53; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Genuth S, 2003, DIABETES CARE, V26, P3160; Goossens GH, 2012, MOL IMMUNOL, V50, P142, DOI 10.1016/j.molimm.2012.01.005; Grieco FA, 2014, DIABETOLOGIA, V57, P502, DOI 10.1007/s00125-013-3135-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han JM, 2014, J IMMUNOL, V192, P623, DOI 10.4049/jimmunol.1302181; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Lorenzo C, 2014, DIABETOLOGIA, V57, P83, DOI 10.1007/s00125-013-3080-0; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Mehta P, 2015, J LEUKOCYTE BIOL, V97, P121, DOI 10.1189/jlb.3A0414-211RR; Nazmi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-706; Nikolajczyk BS, 2012, IMMUNOL REV, V249, P253, DOI 10.1111/j.1600-065X.2012.01142.x; Olson NC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071498; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Samaras K, 2013, DIABETOLOGIA, V56, P2564, DOI 10.1007/s00125-013-3033-7; Sane F, 2011, EXPERT REV CLIN IMMU, V7, P357, DOI [10.1586/ECI.11.11, 10.1586/eci.11.11]; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Shi Y, 2010, SCAND J IMMUNOL, V72, P250, DOI 10.1111/j.1365-3083.2010.02425.x; Simar D, 2014, METABOLISM, V63, P1188, DOI 10.1016/j.metabol.2014.05.014; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Sumarac-Dumanovic M, 2013, IMMUNOBIOLOGY, V218, P1113, DOI 10.1016/j.imbio.2013.03.002; Tracy RP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000117; van der Weerd K, 2012, DIABETES, V61, P401, DOI 10.2337/db11-1065; Viardot A, 2007, ENDOCRINOLOGY, V148, P346, DOI 10.1210/en.2006-0686; Wang YY, 2010, RES J BIOTECHNOL, V5, P5; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Zeng C, 2012, J MOL MED, V90, P175, DOI 10.1007/s00109-011-0816-5; Zhao RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085770	51	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0139962	10.1371/journal.pone.0139962	http://dx.doi.org/10.1371/journal.pone.0139962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458065	gold, Green Published, Green Submitted			2022-12-26	WOS:000362961100017
J	Schulte, JB; Zeto, RW; Roundy, D				Schulte, Jeff B.; Zeto, Rene W.; Roundy, David			Theoretical Prediction of Disrupted Min Oscillation in Flattened Escherichia coli	PLOS ONE			English	Article							CELL-DIVISION; ASSEMBLY DYNAMICS; PROTEIN DYNAMICS; Z-RING; SYSTEM; MODEL; PATTERNS; GROWTH; FTSZ; LOCALIZATION	The dynamics of the Min-protein system help Escherichia coli regulate the process of cell division by identifying the center of the cell. While this system exhibits robust bipolar oscillations in wild-type cell shapes, recent experiments have shown that when the cells are mechanically deformed into wide, flattened out, irregular shapes, the spatial regularity of these oscillations breaks down. We employ widely used stochastic and deterministic models of the Min system to simulate cells with flattened shapes. The deterministic model predicts strong bipolar oscillations, in contradiction with the experimentally observed behavior, while the stochastic model, which is based on the same reaction-diffusion equations, predicts more spatially irregular oscillations. We further report simulations of flattened but more symmetric shapes, which suggest that the flattening and lateral expansion may contribute as much to the irregular oscillation behavior as the asymmetry of the cell shapes.	[Schulte, Jeff B.; Zeto, Rene W.; Roundy, David] Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA	Oregon State University	Schulte, JB (corresponding author), Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA.	schuljef@physics.oregonstate.edu	Roundy, David/AAG-2356-2019	Roundy, David/0000-0001-5287-5472				Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Dekker, 2010, P MICROTAS 2010 GRON, P1346; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fischer-Friedrich E, 2010, P NATL ACAD SCI USA, V107, P6134, DOI 10.1073/pnas.0911708107; Fu G, 2013, COMPUTATIONAL ADV BI, P1; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Halatek J, 2012, CELL REP, V1, P741, DOI 10.1016/j.celrep.2012.04.005; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Huang KC, 2004, PHYS BIOL, V1, P229, DOI 10.1088/1478-3967/1/4/005; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Kerr RA, 2006, P NATL ACAD SCI USA, V103, P347, DOI 10.1073/pnas.0505825102; Kraus M, 1996, CELL CALCIUM, V19, P461, DOI 10.1016/S0143-4160(96)90055-X; Kruse K, 2002, BIOPHYS J, V82, P618, DOI 10.1016/S0006-3495(02)75426-X; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; KURAMOTO Y, 1978, SUP PROG THEOR PHYS, P346, DOI 10.1143/PTPS.64.346; Lawson MJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003139; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Mannik J, 2009, P NATL ACAD SCI USA, V106, P14861, DOI 10.1073/pnas.0907542106; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meacci G, 2005, PHYS BIOL, V2, P89, DOI 10.1088/1478-3975/2/2/002; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Oguz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096726; PIERUCCI O, 1972, J BACTERIOL, V109, P848, DOI 10.1128/JB.109.2.848-854.1972; Robb ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103636; Rudiger S, 2014, PHYS REP, V534, P39, DOI 10.1016/j.physrep.2013.09.002; Schulte J, 2015, MIND SIMULATION GITH; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Varma A, 2008, J BACTERIOL, V190, P2106, DOI 10.1128/JB.00720-07; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x; Zhang B, 2007, APPL OPTICS, V46, P1819, DOI 10.1364/AO.46.001819	38	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0139813	10.1371/journal.pone.0139813	http://dx.doi.org/10.1371/journal.pone.0139813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457805	gold, Green Published, Green Submitted			2022-12-26	WOS:000362961100014
J	Akbar, H; Batistel, F; Drackley, JK; Loor, JJ				Akbar, Haji; Batistel, Fernanda; Drackley, James K.; Loor, Juan J.			Alterations in Hepatic FGF21, Co-Regulated Genes, and Upstream Metabolic Genes in Response to Nutrition, Ketosis and Inflammation in Peripartal Holstein Cows	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DAIRY-COWS; PPAR-ALPHA; GROWTH-HORMONE; FATTY-ACIDS; TRANSITION PERIOD; POSTPARTUM INDUCTION; NUTRIENT METABOLISM; LIPID-METABOLISM; PREPARTUM INTAKE	In rodents, fibroblast growth factor 21 (FGF21) has emerged as a key metabolic regulator produced by liver. To gather preliminary data on the potential importance of FGF1, co-regulated genes, and upstream metabolic genes, we examined the hepatic mRNA expression in response to nutrition and inflammation in dairy cows. In experiment 1, induction of ketosis through feed restriction on d 5 postpartum upregulated FGF21, its co-receptor KLB, and PPARA but only elicited a numerical increase in serum FGF21 concentration. In experiment 2, cows in control (CON) or receiving 50 g/d of L-carnitine (C50) from -14 through 21 d had increased FGF21, PPARA, and NFIL3 on d 10 compared with d 2 postpartum. In contrast, compared with CON and C50, 100 g/d L-carnitine (C100) resulted in lower FGF21, KLB, ANGPTL4, and ARNTL expression on d 10. In experiment 3, cows were fed during the dry period either a higher-energy (OVE; 1.62 Mcal/kg DM) or lower-energy (CON; 1.34 Mcal/kg DM) diet and received 0 (OVE:N, CON:N) or 200 mu g of LPS (OVE:Y, CON:Y) into the mammary gland at d 7 postpartum. For FGF21 mRNA expression in CON, the LPS challenge (CON:Y) prevented a decrease in expression between d 7 and 14 postpartum such that cows in CON:N had a 4-fold lower expression on d 14 compared with d 7. The inflammatory stimulus induced by LPS in CON:Y resulted in upregulation of PPARA on d 14 to a similar level as cows in OVE:N. In OVE:Y, expression of PPARA was lower than CON:N on d 7 and remained unchanged on d 14. On d 7, LPS led to a 4-fold greater serum FGF21 only in OVE but not in CON cows. In fact, OVE:Y reached the same serum FGF21 concentration as CON:N, suggesting a carryover effect of dietary energy level on signaling mechanisms within liver. Overall, results indicate that nutrition, ketosis, and inflammation during the peripartal period can alter hepatic FGF21, co-regulated genes, and upstream metabolic genes to various extents. The functional outcome of these changes merits further study, and in particular the mechanisms regulating transcription in response to changes in energy balance and feed intake.	[Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Loor, JJ (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	jloor@illinois.edu	Loor, Juan J./H-3760-2012; Batistel, Fernanda/AAD-3867-2019	Loor, Juan J./0000-0003-1586-4365; Batistel, Fernanda/0000-0001-7313-7153	USDA National Institute of Food and Agriculture (NIFA); NIFA [NC-2040 (ILLU-538-914)]; COMSATS Institute of Information and Technology (Pakistan)	USDA National Institute of Food and Agriculture (NIFA); NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); COMSATS Institute of Information and Technology (Pakistan)	Funding for the gene expression work was provided by USDA National Institute of Food and Agriculture (NIFA) and by Hatch funds allocated to JJL by NIFA under project NC-2040 (ILLU-538-914). Partial fellowship support from COMSATS Institute of Information and Technology (Pakistan) to H. Akbar during his doctoral degree is acknowledged.	Adewuyi AA, 2005, VET QUART, V27, P117, DOI 10.1080/01652176.2005.9695192; Akbar H, 2015, J DAIRY SCI, V98, P1019, DOI 10.3168/jds.2014-8584; Akers RM, 2006, J DAIRY SCI, V89, P1222, DOI 10.3168/jds.S0022-0302(06)72191-9; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2010, AM J PHYSIOL-ENDOC M, V299, pE607, DOI 10.1152/ajpendo.00263.2010; BIDEN TJ, 1983, BIOCHEM J, V212, P371, DOI 10.1042/bj2120371; BIONAZ M, 2013, PPAR RES, DOI DOI 10.1155/2013/684159; Bradford BJ, 2008, DOMEST ANIM ENDOCRIN, V34, P196, DOI 10.1016/j.domaniend.2007.02.002; Bykov I, 2003, ALCOHOL ALCOHOLISM, V38, P400, DOI 10.1093/alcalc/agg109; Carlson DB, 2007, J DAIRY SCI, V90, P3422, DOI 10.3168/jds.2006-811; Carriquiry M, 2009, J DAIRY SCI, V92, P4889, DOI 10.3168/jds.2008-1676; Dann HM, 2005, J DAIRY SCI, V88, P3851, DOI 10.3168/jds.S0022-0302(05)73070-8; Dann HM, 2005, J DAIRY SCI, V88, P3249, DOI 10.3168/jds.S0022-0302(05)73008-3; DEBOER G, 1985, J DAIRY SCI, V68, P326, DOI 10.3168/jds.S0022-0302(85)80829-8; Domouzoglou EM, 2011, AM J CLIN NUTR, V93, p901S, DOI 10.3945/ajcn.110.001941; Drackley J. K., 2001, Journal of Dairy Science, V84, pE100, DOI 10.3168/jds.S0022-0302(01)70204-4; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Graugnard DE, 2013, J DAIRY SCI, V96, P918, DOI 10.3168/jds.2012-5676; Habegger KM, 2013, DIABETES, V62, P1453, DOI 10.2337/db12-1116; Hayirli A, 2002, J DAIRY SCI, V85, P3430, DOI 10.3168/jds.S0022-0302(02)74431-7; Hippen AR, 1999, J DAIRY SCI, V82, P1139, DOI 10.3168/jds.S0022-0302(99)75337-3; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ji P, 2012, J DAIRY SCI, V95, P4333, DOI 10.3168/jds.2011-5079; Jiang H, 2005, J DAIRY SCI, V88, P1370, DOI 10.3168/jds.S0022-0302(05)72804-6; Khan MJ, 2014, GENE REGUL SYST BIO, V8, P97, DOI 10.4137/GRSB.S14116; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; Li XF, 2009, FEBS LETT, V583, P3230, DOI 10.1016/j.febslet.2009.09.012; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; Lucy MC, 2008, REPROD DOMEST ANIM, V43, P31, DOI 10.1111/j.1439-0531.2008.01140.x; Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177; Nafikov RA, 2006, J DAIRY SCI, V89, P1533, DOI 10.3168/jds.S0022-0302(06)72221-4; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olsson U., 2005, J STAT ED, V13, P1, DOI [10.1080/10691898.2005.11910638, DOI 10.1080/10691898.2005.11910638]; Palin MF, 2004, J ANIM FEED SCI, V13, P445, DOI 10.22358/jafs/73962/2004; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Schlegel G, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-28; Schoenberg KM, 2011, ENDOCRINOLOGY, V152, P4652, DOI 10.1210/en.2011-1425; Sigalet DL, 2007, AM J PHYSIOL-GASTR L, V293, pG211, DOI 10.1152/ajpgi.00530.2006; Spaniol M, 2003, J LIPID RES, V44, P144, DOI 10.1194/jlr.M200200-JLR200; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Sypniewska G, 2015, CLIN BIOCHEM, V48, P370, DOI 10.1016/j.clinbiochem.2014.12.024; Tong X, 2013, J BIOL CHEM, V288, P5417, DOI 10.1074/jbc.M112.433482; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Uebanso T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022976; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang M, 2015, J DAIRY SCI, V98, P4601, DOI 10.3168/jds.2015-9430; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Yu J, 2012, ENDOCRINOLOGY, V153, P750, DOI 10.1210/en.2011-1591	61	12	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139963	10.1371/journal.pone.0139963	http://dx.doi.org/10.1371/journal.pone.0139963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451842	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200024
J	Ju, R; Wu, W; Tang, QQ; Wu, D; Xia, YK; Wu, J; Wang, XR				Ju, Rong; Wu, Wei; Tang, Qiuqin; Wu, Di; Xia, Yankai; Wu, Jie; Wang, Xinru			Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; HEXOSE-6-PHOSPHATE DEHYDROGENASE; GENETIC POLYMORPHISMS; MUTATIONS; WOMEN; 11-BETA-HSD1; EXPRESSION; DISORDERS; REGULATOR; PHENOTYPE	Objectives To evaluate whether single nucleotide polymorphisms of HSD11B1 (rs846908) and H6PD (rs6688832 and rs17368528) are associated with polycystic ovary syndrome (PCOS) in Chinese population. Materials and Methods A case-control study was implemented to investigate the association between HSD11B1 and H6PD polymorphisms and PCOS. Patients with PCOS (n = 335) and controls (n = 354) were recruited in this study. Genetic variants of HSD11B1 (rs846908) and H6PD (rs6688832 and rs17368528) were analyzed by TaqMan method. Results We found a significantly 0.79-fold lower risk of G allele of rs6688832 in control group compared with the patients with PCOS (adjusted OR, 0.79; 95% CI = 0.63-0.99; P = 0.040). Additionally, significant difference in the levels of follicle stimulating hormone (FSH) was observed between AA and AG genotype in rs6688832. The rs6688832 AG genotype was associated with lower level of FSH (P = 0.039) and higher risk of hyperandrogenism (P = 0.016) in patients with PCOS. When all subjects were divided into different subgroups according to age and body mass index (BMI), we found that the frequency of G allele of rs6688832 was significantly higher in controls than that in PCOS patients in the subgroup of BMI > 23 (adjusted OR, 0.70; 95% CI = 0.50-0.98; P = 0.037). Conclusions Our findings showed a statistical association between H6PD rs6688832 and PCOS risk in Chinese population. The G allele of rs6688832 in H6PD might exert potential genetic protective role against the development of PCOS, especially in overweight women. PCOS patients with AG genotype of rs6688832 might confer risk to the phenotype of hyperandrogenemia of PCOS.	[Ju, Rong] Nanjing Med Univ, Nanjing Jiangning Hosp, Dept Obstet & Gynaecol, Nanjing, Jiangsu, Peoples R China; [Ju, Rong; Wu, Wei; Wu, Di; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Ju, Rong; Wu, Wei; Wu, Di; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Tang, Qiuqin] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Obstet, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wu, Jie] Nanjing Med Univ, Affiliated Hosp 1, State Key Lab Reprod Med, Dept Gynaecol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wu, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, State Key Lab Reprod Med, Dept Gynaecol, 300 Guangzhou Rd, Nanjing, Jiangsu, Peoples R China.	jie.wuyale@gmail.com; xrwang@njmu.edu.cn	Wu, Wei/C-4409-2012; Tang, Qiuqin/X-4817-2019; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Wu, Wei/0000-0002-0267-1284; Tang, Qiuqin/0000-0001-9110-9973; Wang, Xin/0000-0002-4457-7376; 	National Natural Science Foundation of China [81302457, 81102147, 81401213]; Jiangsu Natural Science Foundation [BK20130894]; China Postdoctoral Science Foundation [2013M531388]; Jiangsu Postdoctoral Science Foundation [1301053B]; University Natural Science Research Project in Jiangsu Province [13KJB330002]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation); University Natural Science Research Project in Jiangsu Province; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This work was supported by the National Natural Science Foundation of China (81302457, 81102147, and 81401213), Jiangsu Natural Science Foundation (BK20130894), China Postdoctoral Science Foundation (2013M531388), Jiangsu Postdoctoral Science Foundation (1301053B), the University Natural Science Research Project in Jiangsu Province (13KJB330002) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptiste CG, 2010, J STEROID BIOCHEM, V122, P42, DOI 10.1016/j.jsbmb.2009.12.010; Chakraborty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064446; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Constantinopoulos P, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0626; Cooper MS, 2009, J CLIN ENDOCR METAB, V94, P4645, DOI 10.1210/jc.2009-1412; Draper N, 2003, NAT GENET, V34, P434, DOI 10.1038/ng1214; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; Franks S, 2004, REV ENDOCR METAB DIS, V5, P69, DOI 10.1023/B:REMD.0000016125.05878.96; Gambineri A, 2011, EUR J ENDOCRINOL, V165, P283, DOI 10.1530/EJE-11-0091; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Lavery GG, 2008, J CLIN ENDOCR METAB, V93, P3827, DOI 10.1210/jc.2008-0743; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Legro RS, 1999, ENDOCRIN METAB CLIN, V28, P379, DOI 10.1016/S0889-8529(05)70075-X; Martinez-Garcia MA, 2012, GENE, V497, P38, DOI 10.1016/j.gene.2012.01.047; McCartney CR, 2007, J CLIN ENDOCR METAB, V92, P430, DOI 10.1210/jc.2006-2002; Morgan SA, 2014, P NATL ACAD SCI USA, V111, pE2482, DOI 10.1073/pnas.1323681111; Nair S, 2004, DIABETOLOGIA, V47, P1088, DOI 10.1007/s00125-004-1407-6; Qin KN, 2011, STEROIDS, V76, P135, DOI 10.1016/j.steroids.2010.10.001; San Millan JL, 2005, J CLIN ENDOCR METAB, V90, P4157, DOI 10.1210/jc.2004-1523; Shimodaira M, 2013, GYNECOL ENDOCRINOL, V29, P657, DOI 10.3109/09513590.2013.788623; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Valkenburg O, 2011, HUM REPROD, V26, P2902, DOI 10.1093/humrep/der222; Vassiliadi DA, 2009, J CLIN ENDOCR METAB, V94, P3558, DOI 10.1210/jc.2009-0837; Walker EA, 2001, J BIOL CHEM, V276, P21343, DOI 10.1074/jbc.M011142200	27	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140326	10.1371/journal.pone.0140326	http://dx.doi.org/10.1371/journal.pone.0140326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452272	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200061
J	Povitz, M; Hanly, PJ; Pendharkar, SR; James, MT; Tsai, WH				Povitz, Marcus; Hanly, Patrick J.; Pendharkar, Sachin R.; James, Matthew T.; Tsai, Willis H.			Treatment of Sleep Disordered Breathing Liberates Obese Hypoxemic Patients from Oxygen	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; HYPOVENTILATION SYNDROME; SUPPLEMENTAL OXYGEN; HYPERCAPNIA; COPD; ADHERENCE; APNEA; CPAP; TERM	Background Obese hypoxemic patients have a high prevalence of sleep disordered breathing (SDB). It is unclear to what extent treatment of SDB can improve daytime hypoxemia. Methods We performed a retrospective cohort study of obese hypoxemic individuals, all of whom underwent polysomnography, arterial blood gas analysis, and subsequent initiation of positive airway pressure (PAP) therapy for SDB. Patients were followed for one year for change in partial pressure of arterial oxygen and the need for supplemental oxygen. Results One hundred and seventeen patients were treated with nocturnal PAP and had follow-up available. Adherence to PAP was satisfactory in 60%, and was associated with a significant improvement in daytime hypoxemia and hypercapnea; 56% of these patients were able to discontinue supplemental oxygen. Adherence to PAP therapy and the baseline severity of OSA predicted improvement in hypoxemia, but only adherence to PAP therapy predicted liberation from supplemental oxygen. Conclusions The identification and treatment of SDB in obese hypoxemic patients improves daytime hypoxemia. It is important to identify SDB in these patients, since supplemental oxygen can frequently be discontinued following treatment with PAP therapy.	[Povitz, Marcus; Pendharkar, Sachin R.; James, Matthew T.; Tsai, Willis H.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Povitz, Marcus] Univ Western Ontario, Dept Med, London, ON, Canada; [Hanly, Patrick J.; Pendharkar, Sachin R.; James, Matthew T.; Tsai, Willis H.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hanly, Patrick J.; Pendharkar, Sachin R.; Tsai, Willis H.] Foothills Med Ctr, Sleep Ctr, Calgary, AB, Canada	University of Calgary; Western University (University of Western Ontario); University of Calgary; University of Calgary	Tsai, WH (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.	tsai@ucalgary.ca	Pendharkar, Sachin R./AAS-5513-2020; Povitz, Marcus/F-6615-2018; Pendharkar, Sachin R./AAS-5520-2020	Pendharkar, Sachin R./0000-0002-4693-0831; Pendharkar, Sachin R./0000-0002-4693-0831				[Anonymous], 2011, RESP POLICIES PROCED, P1; Bahammam A, 1999, SLEEP, V22, P740, DOI 10.1093/sleep/22.6.740; Bardwell Wayne A, 2007, Behav Sleep Med, V5, P21, DOI 10.1207/s15402010bsm0501_2; Berg G, 2001, CHEST, V120, P377, DOI 10.1378/chest.120.2.377; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Budweiser S, 2007, J INTERN MED, V261, P375, DOI 10.1111/j.1365-2796.2007.01765.x; de Llano LAP, 2005, CHEST, V128, P587, DOI 10.1378/chest.128.2.587; Drager LF, 2015, THORAX, V70, P258, DOI 10.1136/thoraxjnl-2014-205361; Fleetham John, 2006, Can Respir J, V13, P387; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gotay CC, 2013, CAN J PUBLIC HEALTH, V104, pE64, DOI 10.1007/BF03405657; Gottlieb DJ, 2014, NEW ENGL J MED, V370, P2276, DOI 10.1056/NEJMoa1306766; Hollier CA, 2014, THORAX, V69, P346, DOI 10.1136/thoraxjnl-2013-204389; Kohnlein T, 2014, LANCET RESP MED, V2, P698, DOI 10.1016/S2213-2600(14)70153-5; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; Lumachi F, 2010, IN VIVO, V24, P329; McEvoy RD, 2009, THORAX, V64, P561, DOI 10.1136/thx.2008.108274; McNicholas WT, 2013, EUR RESPIR REV, V22, P365, DOI 10.1183/09059180.00003213; Mokhlesi B, 2006, J CLIN SLEEP MED, V2, P57; Pepin JL, 2012, AM J RESP CRIT CARE, V186, P1205, DOI 10.1164/rccm.201210-1922ED; Piper AJ, 2011, AM J RESP CRIT CARE, V183, P292, DOI 10.1164/rccm.201008-1280CI; Povitz M, 2015, ANN AM THORAC SOC, V12, P921, DOI 10.1513/AnnalsATS.201412-551OC; Priou P, 2010, CHEST, V138, P84, DOI 10.1378/chest.09-2472; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reid J, 2014, TOBACCO USE CANADA; Ronksley PE, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-50; Struik FM, 2014, THORAX, V69, P826, DOI 10.1136/thoraxjnl-2014-205126; Villar I, 2009, SLEEP, V32, P623, DOI 10.1093/sleep/32.5.623; Wijesinghe M, 2011, CHEST, V139, P1018, DOI 10.1378/chest.10-1280; Zavorsky GS, 2008, OBES REV, V9, P326, DOI 10.1111/j.1467-789X.2008.00471.x	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140135	10.1371/journal.pone.0140135	http://dx.doi.org/10.1371/journal.pone.0140135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451835	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200040
J	Urban-Chmiel, R; Wernicki, A; Stegierska, D; Dec, M; Dudzic, A; Puchalski, A				Urban-Chmiel, Renata; Wernicki, Andrzej; Stegierska, Diana; Dec, Marta; Dudzic, Anna; Puchalski, Andrzej			Isolation and Characterization of Lytic Properties of Bacteriophages Specific for M. haemolytica Strains	PLOS ONE			English	Article							MANNHEIMIA-HAEMOLYTICA; TEMPERATE BACTERIOPHAGES; PASTEURELLA-HAEMOLYTICA; IDENTIFICATION; DIVERSITY; THERAPY; BOVINE; PHAGE	Aim of Study The objective of this study was isolation and morphological characterization of temperate bacteriophages obtained from M. haemolytica strains and evaluation of their lytic properties in vitro against M. haemolytica isolated from the respiratory tract of calves. Material and Methods The material for the study consisted of the reference strain M. haemolytica serotype 1 (ATCC (R)) BAA-410 (TM), reference serotypes A1, A2, A5, A6, A7, A9 and A11, and wild-type isolates of M. haemolytica. Bacteriophages were induced from an overnight bacterial starter culture of all examined M. haemolytica strains treated with mitomycin C. The lytic properties and host ranges were determined by plaque assays. The morphology of the bacteriophages was examined in negative-stained smears with 5% uranyl acetate solution using a transmission electron microscope. The genetic analysis of the bacteriophages was followed by restriction analysis of bacteriophage DNA. This was followed by analysis of genetic material by polymerase chain reaction (PCR). Results Eight bacteriophages were obtained, like typical of the families Myoviridae, Siphoviridae and Podoviridae. Most of the bacteriophages exhibited lytic properties against the M. haemolytica strains. Restriction analysis revealed similarities to the P2-like phage obtained from the strain M. haemolytica BAA-410. The most similar profiles were observed in the case of bacteriophages phi A1 and phi A5. All of the bacteriophages obtained were characterized by the presence of additional fragments in the restriction profiles with respect to the P2-like reference phage. In the analysis of PCR products for the P2-like reference phage phi-MhaA1-PHL101 (DQ426904) and the phages of the M. haemolytica serotypes, a 734-bp phage PCR product was obtained. The primers were programmed in Primer-Blast software using the structure of the sequence DQ426904 of reference phage PHL101. Conclusions The results obtained indicate the need for further research aimed at isolating and characterizing bacteriophages, including sequence analysis of selected fragments. Moreover, standardization of methods for obtaining them in order to eliminate M. haemolytica bacteria involved in the etiopathogenesis of BRDC is essential.	[Urban-Chmiel, Renata; Wernicki, Andrzej; Stegierska, Diana; Dec, Marta; Dudzic, Anna; Puchalski, Andrzej] Univ Life Sci, Sub Dept Vet Prevent & Avian Dis, Inst Biol Bases Anim Dis, Fac Vet Med, PL-20033 Lublin, Poland		Urban-Chmiel, R (corresponding author), Univ Life Sci, Sub Dept Vet Prevent & Avian Dis, Inst Biol Bases Anim Dis, Fac Vet Med, PL-20033 Lublin, Poland.	renata.urban@up.lublin.pl	Nowaczek, Anna/AAZ-3698-2021; Dec, Marta/ABI-8451-2020	Nowaczek, Anna/0000-0002-8725-2803; Dec, Marta/0000-0002-5456-9652; Wernicki, Andrzej/0000-0002-5661-3899; Puchalski, Andrzej/0000-0001-5135-1634; Urban-Chmiel, Renata/0000-0001-8245-1646				Brussow H, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P129; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Davies RL, 2006, FEMS MICROBIOL LETT, V260, P162, DOI 10.1111/j.1574-6968.2006.00314.x; Froshauer S, 1996, ANTIMICROB AGENTS CH, V40, P1561, DOI 10.1128/AAC.40.6.1561; Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311; Golec P, 2011, J GEN VIROL, V92, P997, DOI 10.1099/vir.0.027326-0; Han JE, 2013, RES VET SCI, V95, P758, DOI 10.1016/j.rvsc.2013.06.001; Highlander SK, 2006, VIROLOGY, V350, P79, DOI 10.1016/j.virol.2006.03.024; Hsu YH, 2013, J APPL MICROBIOL, V114, P1592, DOI 10.1111/jam.12185; Matsuzaki S, 2003, J INFECT DIS, V187, P613, DOI 10.1086/374001; Rice J. A., 2007, Animal Health Research Reviews, V8, P117, DOI 10.1017/S1466252307001375; RICHARDS AB, 1985, AM J VET RES, V46, P1215; Saxena S. P., 1959, Journal of Veterinary Research, V3, P53; Wernicki A, 1999, MED WETER, V55, P623; Xie HJ, 2005, J GEN APPL MICROBIOL, V51, P159, DOI 10.2323/jgam.51.159	15	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140140	10.1371/journal.pone.0140140	http://dx.doi.org/10.1371/journal.pone.0140140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451916	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511200041
J	Ficker, M; Petersen, JF; Hansen, JS; Christensen, JB				Ficker, Mario; Petersen, Johannes F.; Hansen, Jon S.; Christensen, Jorn B.			Guest-Host Chemistry with Dendrimers-Binding of Carboxylates in Aqueous Solution	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; PAMAM DENDRIMERS; SIRNA DELIVERY; IN-VITRO; SOLUBILITY	Recognition and binding of anions in water is difficult due to the ability of water molecules to form strong hydrogen bonds and to solvate the anions. The complexation of two different carboxylates with 1-(4-carbomethoxypyrrolidone)-terminated PAMAM dendrimers was studied in aqueous solution using NMR and ITC binding models. Sodium 2-naphthoate and sodium 3-hydroxy-2-naphthoate were chosen as carboxylate model compounds, since they carry structural similarities to many non-steroidal anti-inflammatory drugs and they possess only a limited number of functional groups, making them ideal to study the carboxylate-dendrimer interaction selectively. The binding stoichiometry for 3-hydroxy-2-naphthoate was found to be two strongly bound guest molecules per dendrimer and an additional 40 molecules with weak binding affinity. The NOESY NMR showed a clear binding correlation of sodium 3-hydroxy-2-naphthoate with the lyophilic dendrimer core, possibly with the two high affinity guest molecules. In comparison, sodium 2-naphthoate showed a weaker binding strength and had a stoichiometry of two guests per dendrimer with no additional weakly bound guests. This stronger dendrimer interaction with sodium 3-hydroxy-2-naphthoate is possibly a result of the additional interactions of the dendrimer with the extra hydroxyl group and an internal stabilization of the negative charge due to the hydroxyl group. These findings illustrate the potential of the G4 1-(4-carbomethoxy) pyrrolidone dendrimer to complex carboxylate guests in water and act as a possible carrier of such molecules.	[Ficker, Mario; Petersen, Johannes F.; Hansen, Jon S.; Christensen, Jorn B.] Univ Copenhagen, Dept Chem, DK-1871 Frederiksberg C, Denmark	University of Copenhagen	Christensen, JB (corresponding author), Univ Copenhagen, Dept Chem, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	jbc@chem.ku.dk	Christensen, Jørn B./J-8124-2012	Christensen, Jørn B./0000-0002-7641-8302	University of Copenhagen; Lundbeck Foundation [R48-2009-4618] Funding Source: researchfish	University of Copenhagen; Lundbeck Foundation(Lundbeckfonden)	For financial support the authors would like to thank the University of Copenhagen. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnusch CJ, 2007, BIOCHEMISTRY-US, V46, P13437, DOI 10.1021/bi7015553; Avila-Salas F, 2012, J PHYS CHEM B, V116, P2031, DOI 10.1021/jp2069122; Biswas T, 2010, ANAL BIOCHEM, V406, P91, DOI 10.1016/j.ab.2010.06.050; Caminade AM, 2008, CHEM-EUR J, V14, P7422, DOI 10.1002/chem.200800584; Cheng YY, 2007, EUR J MED CHEM, V42, P1032, DOI 10.1016/j.ejmech.2006.12.035; Ciolkowski M, 2012, NANOMED-NANOTECHNOL, V8, P815, DOI 10.1016/j.nano.2012.03.009; Donald A., 2012, DENDRIMERS DENDRONS; Ficker M, 2015, CHEM COMMUN, V51, P9957, DOI 10.1039/c5cc00347d; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Freire E., 1990, ANAL CHEM, V62, P950; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Gramage-Doria R, 2013, CHEMISTRYOPEN, V2, P176, DOI 10.1002/open.201300033; Gupta U, 2007, J PHARM PHARM SCI, V10, P358; Hansen JS, 2013, J PHYS CHEM B, V117, P14865, DOI 10.1021/jp408613z; Hu JJ, 2012, CHEM REV, V112, P3856, DOI 10.1021/cr200333h; Janaszewska A, 2015, NANOMED-NANOTECHNOL, V11, P409, DOI 10.1016/j.nano.2014.09.011; Janaszewska A, 2013, NANOMED-NANOTECHNOL, V9, P461, DOI 10.1016/j.nano.2013.01.010; Kang SO, 2010, CHEM SOC REV, V39, P3980, DOI 10.1039/c0cs00083c; Kim SK, 2010, CHEM SOC REV, V39, P3784, DOI 10.1039/c002694h; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Liu XX, 2009, CHEMMEDCHEM, V4, P1302, DOI 10.1002/cmdc.200900076; Morgan MT, 2006, CANCER RES, V66, P11913, DOI 10.1158/0008-5472.CAN-06-2066; Pavan GM, 2010, CHEM-EUR J, V16, P7781, DOI 10.1002/chem.200903258; Tarazona-Vasquez F, 2007, J PHYS CHEM A, V111, P945, DOI 10.1021/jp065016b; Tomalia D. A., 2001, DENDRIMERS OTHER DEN; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Wu L. P., 2015, BIOCONJUGATE CHEM; Yang K, 2011, J PHYS CHEM B, V115, P2185, DOI 10.1021/jp111044k; Zeng FW, 1997, CHEM REV, V97, P1681, DOI 10.1021/cr9603892	30	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138706	10.1371/journal.pone.0138706	http://dx.doi.org/10.1371/journal.pone.0138706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448138	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000011
J	Matsumoto, R; Fukuoka, H; Iguchi, G; Odake, Y; Yoshida, K; Bando, H; Suda, K; Nishizawa, H; Takahashi, M; Yamada, S; Ogawa, W; Takahashi, Y				Matsumoto, Ryusaku; Fukuoka, Hidenori; Iguchi, Genzo; Odake, Yukiko; Yoshida, Kenichi; Bando, Hironori; Suda, Kentaro; Nishizawa, Hitoshi; Takahashi, Michiko; Yamada, Shozo; Ogawa, Wataru; Takahashi, Yutaka			Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; LENGTH; ASSOCIATION; DISEASE; MORTALITY; CELLS; PROTECTS; STRESS; BLOOD; RISK	Objective Patients with acromegaly exhibit reduced life expectancy and increased prevalence of age-related diseases, such as diabetes, hypertension, and cardiovascular disease. However, the underlying mechanism has not been fully elucidated. Telomere shortening is reportedly associated with reduced life expectancy and increased prevalence of these age-related diseases. Methods We measured telomere length in patients with acromegaly using quantitative PCR method. The effect of GH and IGF-I on telomere length and cellular senescence was examined in human skin fibroblasts. Results Patients with acromegaly exhibited shorter telomere length than age-, sex-, smoking-, and diabetes-matched control patients with non-functioning pituitary adenoma (0.62 +/- 0.23 vs. 0.75 +/- 0.35, respectively, P = 0.047). In addition, telomere length in acromegaly was negatively correlated with the disease duration (R-2 = 0.210, P = 0.003). In vitro analysis revealed that not GH but IGF-I induced telomere shortening in human skin fibroblasts. Furthermore, IGF-I-treated cells showed increased senescence-associated beta-galactosidase activity and expression of p53 and p21 protein. IGF-I-treated cells reached the Hayflick limit earlier than GH- or vehicle-treated cells, indicating that IGF-I induces cellular senescence. Conclusion Shortened telomeres in acromegaly and cellular senescence induced by IGF-I can explain, in part, the underlying mechanisms by which acromegaly exhibits an increased morbidity and mortality in association with the excess secretion of IGF-I.	[Matsumoto, Ryusaku; Odake, Yukiko; Yoshida, Kenichi; Bando, Hironori; Suda, Kentaro; Nishizawa, Hitoshi; Takahashi, Michiko; Ogawa, Wataru; Takahashi, Yutaka] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 657, Japan; [Fukuoka, Hidenori; Iguchi, Genzo] Kobe Univ Hosp, Div Diabet & Endocrinol, Kobe, Hyogo, Japan; [Yamada, Shozo] Toranomon Gen Hosp, Dept Hypothalam & Pituitary Surg, Minato Ku, Tokyo, Japan	Kobe University; Kobe University; Toranomon Hospital	Takahashi, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 657, Japan.	takahash@med.kobe-u.ac.jp	Hidenori, Fukuoka/AAK-1812-2020; OGAWA, Wataru/AAQ-9586-2020; Fukuoka, Hidenori/AAK-1045-2020; Fukuoka, Hidenori/AHC-2224-2022	Fukuoka, Hidenori/0000-0001-9255-653X; Fukuoka, Hidenori/0000-0001-9255-653X; Bando, Hironori/0000-0002-7421-2714; Suda, Kentaro/0000-0001-6734-5183	Japanese Ministry of Education, Culture, Sports, Science, and Technology [26670459, 23659477, 23591354, 22591012]; Japanese Ministry of Health, Labor, and Welfare	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (http://www.mext.go.jp/english/) 26670459, 23659477, 23591354, and 22591012, and Grants-in-Aid for Scientific Research (research on hypothalamic-hypophyseal disorders; no available number) from the Japanese Ministry of Health, Labor, and Welfare (http://www.mhlw.go.jp/english/). YT received these grants. The funding supported the clinical and in vitro analysis in the study.	ADAMS SO, 1984, ENDOCRINOLOGY, V115, P520, DOI 10.1210/endo-115-2-520; Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005; Aulinas A, 2014, EUR J ENDOCRINOL, V171, P21, DOI 10.1530/EJE-14-0098; Aulinas A, 2013, CLIN ENDOCRINOL, V79, P751, DOI 10.1111/cen.12310; Bayram F, 2014, GROWTH HORM IGF RES, V24, P29, DOI 10.1016/j.ghir.2013.12.002; Bhupatiraju C, 2012, AM J HUM BIOL, V24, P573, DOI 10.1002/ajhb.22264; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; ETXABE J, 1993, J ENDOCRINOL INVEST, V16, P181, DOI 10.1007/BF03344942; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Handayaningsih AE, 2012, BIOCHEM BIOPH RES CO, V425, P478, DOI 10.1016/j.bbrc.2012.07.140; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Jiang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068254; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Katznelson L, 2011, ENDOCR PRACT, V17, P636, DOI 10.4158/EP.17.4.636; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Li QL, 2014, J CLIN ENDOCR METAB, V99, pE234, DOI 10.1210/jc.2013-3685; Mason PJ, 2013, TRANSL RES, V162, P333, DOI 10.1016/j.trsl.2013.08.009; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Nishizawa H, 2012, GROWTH HORM IGF RES, V22, P64, DOI 10.1016/j.ghir.2012.02.001; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Tu WW, 1999, BRIT J HAEMATOL, V104, P785, DOI 10.1046/j.1365-2141.1999.01272.x; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wetterau LA, 2003, J CLIN ENDOCR METAB, V88, P3354, DOI 10.1210/jc.2002-021326; Zhao JY, 2014, DIABETES, V63, P354, DOI 10.2337/db13-0744	43	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140189	10.1371/journal.pone.0140189	http://dx.doi.org/10.1371/journal.pone.0140189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448623	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000103
J	Sun, XM; Yan, B; Zhang, XZ; Rong, CT				Sun, Xuemei; Yan, Bo; Zhang, Xinzhong; Rong, Chuitian			An Integrated Intrusion Detection Model of Cluster-Based Wireless Sensor Network	PLOS ONE			English	Article							GRAPHS; ENERGY	Considering wireless sensor network characteristics, this paper combines anomaly and mis-use detection and proposes an integrated detection model of cluster-based wireless sensor network, aiming at enhancing detection rate and reducing false rate. Adaboost algorithm with hierarchical structures is used for anomaly detection of sensor nodes, cluster-head nodes and Sink nodes. Cultural-Algorithm and Artificial-Fish-Swarm-Algorithm optimized Back Propagation is applied to mis-use detection of Sink node. Plenty of simulation demonstrates that this integrated model has a strong performance of intrusion detection.	[Sun, Xuemei; Yan, Bo; Zhang, Xinzhong; Rong, Chuitian] Tianjin Polytech Univ, Sch Comp Sci & Software, Tianjin 300387, Peoples R China	Tiangong University	Sun, XM (corresponding author), Tianjin Polytech Univ, Sch Comp Sci & Software, Tianjin 300387, Peoples R China.	seesea_sun@163.com	Rong, Chuitian/AAD-5741-2019; Rong, Chuitian/AAU-2331-2021	Rong, Chuitian/0000-0003-2949-3892; Rong, Chuitian/0000-0003-2949-3892	National Natural Science Foundation of China [61173032]; Young Scientists Fund of the Natural Science Foundation of China [61402329]; Natural Science Foundation of Tianjin [13JCYBJC15500, 12JCYBJC31900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scientists Fund of the Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This study was supported by The National Natural Science Foundation of China (No. 61173032, http://www.nsfc.gov.cn/): the design of heuristic algorithm; The Young Scientists Fund of the Natural Science Foundation of China (No. 61402329): the design of classification method; The Natural Science Foundation of Tianjin (No. 13JCYBJC15500): the research of BP neural network prediction algorithm; The Natural Science Foundation of Tianjin (No. 12JCYBJC31900): the research of network security.	Akyildiz IF, 2002, IEEE COMMUN MAG, V40, P102, DOI 10.1109/MCOM.2002.1024422; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Ji SJ, 2013, MATCH-COMMUN MATH CO, V70, P697; Li W, 2009, FIFTH INTERNATIONAL CONFERENCE ON INFORMATION ASSURANCE AND SECURITY, VOL 2, PROCEEDINGS, P651, DOI 10.1109/IAS.2009.260; [李晓磊 Li Xiaolei], 2002, [系统工程理论与实践, Systems Engineering-Theory & Practice], V22, P32; Li XL, 2014, MATCH-COMMUN MATH CO, V72, P183; Li XL, 2013, MATCH-COMMUN MATH CO, V70, P85; Livani AM, 2011, P 2011 INT S COMP NE, P55; Nabil Ali, 2013, INT J DISTRIBUTED SE, V2013; Rassam MA, 2011, P 7 INT C INF ASS SE, P350; Robert G, 1996, P IEEE INT C EV COMP, P94; Schapire R., 1996, P ICML, V13, P148; Sun XM, 2015, APPL MATH COMPUT, V250, P58, DOI 10.1016/j.amc.2014.10.091; Tan DZ, 2012, ADV MATER RES-SWITZ, V433-440, P4625, DOI 10.4028/www.scientific.net/AMR.433-440.4625; Wang SS, 2011, EXPERT SYST APPL, V38, P15234, DOI 10.1016/j.eswa.2011.05.076; WANG Y, 2013, SYSTEMS MAN CYBERN A, V24, P342, DOI DOI 10.1109/TPDS.2012.105; Xie M, 2013, IEEE T PARALL DISTR, V24, P1661, DOI 10.1109/TPDS.2012.261; Yang X, 2012, CHINESE J SENSORS AC, V25	19	6	7	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139513	10.1371/journal.pone.0139513	http://dx.doi.org/10.1371/journal.pone.0139513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447696	Green Submitted, gold, Green Published			2022-12-26	WOS:000362511000029
J	Dilshad, E; Cusido, RM; Estrada, KR; Bonfill, M; Mirza, B				Dilshad, Erum; Maria Cusido, Rosa; Ramirez Estrada, Karla; Bonfill, Mercedes; Mirza, Bushra			Genetic Transformation of Artemisia carvifolia Buch with rol Genes Enhances Artemisinin Accumulation	PLOS ONE			English	Article							AMORPHA-4,11-DIENE SYNTHASE; ANTHRAQUINONE PRODUCTION; ANTIMALARIAL-DRUG; ANNUA; EXPRESSION; ACID; BIOSYNTHESIS; ONCOGENE; CLONING; AUXIN	The potent antimalarial drug artemisinin has a high cost, since its only viable source to date is Artemisia annua (0.01-0.8% DW). There is therefore an urgent need to design new strategies to increase its production or to find alternative sources. In the current study, Artemisia carvifolia Buch was selected with the aim of detecting artemisinin and then enhancing the production of the target compound and its derivatives. These metabolites were determined by LC-MS in the shoots of A. carvifolia wild type plants at the following concentrations: artemisinin (8 mu g/g), artesunate (2.24 mu g/g), dihydroartemisinin (13.6 mu g/g) and artemether (12.8 mu g/g). Genetic transformation of A. carvifolia was carried out with Agrobacterium tumefaciens GV3101 harboring the rol B and rol C genes. Artemisinin content increased 3-7-fold in transgenics bearing the rol B gene, and 2.3-6-fold in those with the rol C gene. A similar pattern was observed for artemisinin analogues. The dynamics of artemisinin content in transgenics and wild type A. carvifolia was also correlated with the expression of genes involved in its biosynthesis. Real time qPCR analysis revealed the differential expression of genes involved in artemisinin biosynthesis, i.e. those encoding amorpha-4, 11 diene synthase (ADS), cytochrome P450 (CYP71AV1), and aldehyde dehydrogenase 1 (ALDH1), with a relatively higher transcript level found in transgenics than in the wild type plant. Also, the gene related to trichome development and sesquiterpenoid biosynthesis (TFAR1) showed an altered expression in the transgenics compared to wild type A. carvifolia, which was in accordance with the trichome density of the respective plants. The trichome index was significantly higher in the rol B and rol C gene-expressing transgenics with an increased production of artemisinin, thereby demonstrating that the rol genes are effective inducers of plant secondary metabolism.	[Dilshad, Erum; Mirza, Bushra] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan; [Maria Cusido, Rosa; Ramirez Estrada, Karla; Bonfill, Mercedes] Univ Barcelona, Fac Farm, Lab Fisiol Vegetal, E-08007 Barcelona, Spain	Quaid I Azam University; University of Barcelona	Mirza, B (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan.	dr.bushramirza@gmail.com	Cusido, Rosa Maria/K-3337-2014; Mirza, Bushra/I-8013-2015; Mirza, Bushra/AAC-5744-2022; Dilshad, Erum/GLS-2030-2022; Bonfill, Mercedes/K-3680-2014	Cusido, Rosa Maria/0000-0002-8398-0619; Dilshad, Erum/0000-0002-0854-7428; Bonfill, Mercedes/0000-0003-0664-3755; Ramirez-Estrada, Karla/0000-0002-7840-7981				Abdin MZ, 2003, PLANTA MED, V69, P289, DOI 10.1055/s-2003-38871; Ahmed I, 2009, J APPL GENET, V50, P105, DOI 10.1007/BF03195661; Alka Dangash, 2014, Notulae Scientia Biologicae, V6, P349; Arshad W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096979; Benedito Vagner A, 2014, Recent Pat Biotechnol, V8, P61, DOI 10.2174/1872208307666131218125801; Bouwmeester HJ, 1999, PHYTOCHEMISTRY, V52, P843, DOI 10.1016/S0031-9422(99)00206-X; Bulgakov VP, 2008, BIOTECHNOL ADV, V26, P318, DOI 10.1016/j.biotechadv.2008.03.001; Bulgakov VP, 1998, PHYTOCHEMISTRY, V49, P1929, DOI 10.1016/S0031-9422(98)00351-3; Bulgakov VP, 2005, PLANTA, V221, P471, DOI 10.1007/s00425-004-1457-5; Bulgakov VP, 2003, PLANTA, V217, P349, DOI 10.1007/s00425-003-0996-5; Bulgakov VP, 2002, J BIOTECHNOL, V97, P213, DOI 10.1016/S0168-1656(02)00067-6; Chang YJ, 2000, ARCH BIOCHEM BIOPHYS, V383, P178, DOI 10.1006/abbi.2000.2061; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Delfino RT, 2002, J BRAZIL CHEM SOC, V13, P727, DOI 10.1590/S0103-50532002000600003; Duffy PE, 2006, LANCET, V367, P2037, DOI 10.1016/S0140-6736(06)68900-9; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; ESTRUCH JJ, 1991, EMBO J, V10, P3125, DOI 10.1002/j.1460-2075.1991.tb04873.x; Ferreira J. F. S., 1997, Horticultural Reviews, V19, P319; FERREIRA JFS, 1995, PLANTA MED, V61, P167, DOI 10.1055/s-2006-958040; FILIPPINI F, 1994, PLANT CELL PHYSIOL, V35, P767, DOI 10.1093/oxfordjournals.pcp.a078655; Filippini F, 1996, NATURE, V379, P499, DOI 10.1038/379499a0; Geng S, 2001, PLANT SCI, V160, P691, DOI 10.1016/S0168-9452(00)00453-2; Ghosh B, 1997, PLANT SCI, V122, P193, DOI 10.1016/S0168-9452(96)04558-X; Kiani BH, 2013, THESIS QUAID I AZAM; Kiani BH, 2012, PLANT OMICS, V5, P386; Kiselev KV, 2007, J BIOTECHNOL, V128, P681, DOI 10.1016/j.jbiotec.2006.11.008; Kumar S, 2004, IND CROP PROD, V19, P77, DOI 10.1016/j.indcrop.2003.07.003; Li ZQ, 2006, J INTEGR PLANT BIOL, V48, P1486, DOI 10.1111/j.1744-7909.2006.00381.x; Liu T., 2009, CHIN AGR SCI B, V25, P46; Maes L, 2011, NEW PHYTOL, V189, P176, DOI 10.1111/j.1469-8137.2010.03466.x; Mannan A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-310; MAUREL C, 1991, PLANT PHYSIOL, V97, P212, DOI 10.1104/pp.97.1.212; MAUREL C, 1994, PLANT PHYSIOL, V105, P1209, DOI 10.1104/pp.105.4.1209; Mercke P, 1999, ARCH BIOCHEM BIOPHYS, V369, P213, DOI 10.1006/abbi.1999.1358; Nilsson O, 1997, PHYSIOL PLANTARUM, V100, P463, DOI [10.1111/j.1399-3054.1997.tb03050.x, 10.1034/j.1399-3054.1997.1000307.x]; NILSSON O, 1993, PLANT J, V3, P681, DOI 10.1111/j.1365-313X.1993.00681.x; Olofsson L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-45; Olsson ME, 2009, PHYTOCHEMISTRY, V70, P1123, DOI 10.1016/j.phytochem.2009.07.009; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sabater-Jara AB, 2014, PLANT BIOTECHNOL J, V12, P1075, DOI 10.1111/pbi.12214; Safdar N, 2012, THESIS QUAID IZAM U; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMULLING T, 1988, EMBO J, V7, P2621, DOI 10.1002/j.1460-2075.1988.tb03114.x; Shkryl YN, 2008, BIOTECHNOL BIOENG, V100, P118, DOI 10.1002/bit.21727; SPENA A, 1987, EMBO J, V6, P3891, DOI 10.1002/j.1460-2075.1987.tb02729.x; Tellez MR, 1999, PHYTOCHEMISTRY, V52, P1035, DOI 10.1016/S0031-9422(99)00308-8; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Towler MJ, 2007, PLANT CELL REP, V26, P2129, DOI 10.1007/s00299-007-0420-x; Wallaart TE, 2000, PLANTA MED, V66, P57, DOI 10.1055/s-2000-11115; Wallaart TE, 1999, J NAT PROD, V62, P1160, DOI 10.1021/np9900122; Weathers PJ, 2012, PLANTA MED, V78, P1024, DOI 10.1055/s-0032-1314949; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	53	28	30	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140266	10.1371/journal.pone.0140266	http://dx.doi.org/10.1371/journal.pone.0140266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444558	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600154
J	Kwon, MJ; Han, J; Seo, JH; Song, K; Jeong, HM; Choi, JS; Kim, YJ; Lee, SH; Choi, YL; Shin, YK				Kwon, Mi Jeong; Han, Jinil; Seo, Ji Hyun; Song, Kyoung; Jeong, Hae Min; Choi, Jong-Sun; Kim, Yu Jin; Lee, Seon-Heui; Choi, Yoon-La; Shin, Young Kee			CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer	PLOS ONE			English	Article							TUMOR-GROWTH; BASAL-LIKE; EXPRESSION; CELLS; METASTASIS; MECHANISMS; PHENOTYPE; CARCINOMA; SURVIVAL; DISEASE	CD24 is associated with unfavourable prognoses in various cancers, but the prevalence of CD24 expression and its influence on clinical outcome in subtypes of breast cancers remain unclear. CD24 expression was analyzed by immunohistochemistry in 747 breast cancer tissues, and DNA methylation and histone modification status in the promoter region of CD24 were assessed using bisulfite sequencing and chromatin immunoprecipitation assay. 213 (28.5%) samples exhibited high CD24 expression in the membrane and/or cytoplasm of breast cancer cells, and CD24 overexpression was significantly correlated with the presence of lymph node metastasis and more advanced pathological stage. Patients with CD24-high tumours had significantly shorter patient survival than those with CD24-low tumours. Importantly, multivariate analysis that included tumour size, lymph node metastasis and chemotherapy demonstrated that high CD24 expression is independently associated with poorer survival in luminal A and triple-negative breast cancer (TNBC) subtypes. Furthermore, CD24 gene expression was associated with histone acetylation independent of DNA methylation, suggesting its epigenetic regulation in breast cancer. Our results suggest that CD24 overexpression is an independent unfavourable prognostic factor in breast cancer, especially for luminal A and TNBC subtypes, and CD24 may be a promising therapeutic target for specific subtypes of breast cancer.	[Kwon, Mi Jeong] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Kwon, Mi Jeong] Kyungpook Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Daegu, South Korea; [Han, Jinil] Gencurix Inc, Seoul, South Korea; [Seo, Ji Hyun; Jeong, Hae Min; Shin, Young Kee] Seoul Natl Univ, Lab Mol Pathol & Canc Genom, Coll Pharm, Dept Pharm, Seoul, South Korea; [Song, Kyoung] ABION Inc, Seoul, South Korea; [Choi, Jong-Sun; Shin, Young Kee] Seoul Natl Univ, Ctr Anticanc Compan Diagnost, Sch Biol Sci, Inst Entrepreneurial BioConvergence, Seoul, South Korea; [Kim, Yu Jin; Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Lab Canc Genom & Mol Pathol,Samsung Biomed Res In, Seoul, South Korea; [Lee, Seon-Heui] Gachon Univ, Coll Nursing, Dept Nursing Sci, Inchon, South Korea; [Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea; [Choi, Yoon-La] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU); Seoul National University (SNU); Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Gachon University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Choi, YL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Lab Canc Genom & Mol Pathol,Samsung Biomed Res In, Seoul, South Korea.	ylachoi@skku.edu; ykeeshin@snu.ac.kr	Shin, Young Kee/C-8929-2011	Shin, Young Kee/0000-0003-0896-718X; Kwon, Mi Jeong/0000-0002-7599-878X	Kyungpook National University Research Fund from the Samsung Biomedical Research Institute [SMX1132711]; R&D program for Society of the National Research Foundation (NRF) [2013M3C8A1079312]; Basic Science Research Program through the NRF - Ministry of Science, ICT & Future Planning [NRF-2012R1A1A3014050]	Kyungpook National University Research Fund from the Samsung Biomedical Research Institute(Samsung); R&D program for Society of the National Research Foundation (NRF); Basic Science Research Program through the NRF - Ministry of Science, ICT & Future Planning	This work was supported by the Kyungpook National University Research Fund, 2013 & 2014 (MJK), a grant (SMX1132711 [YLC]) from the Samsung Biomedical Research Institute, the R&D program for Society of the National Research Foundation (NRF) (2013M3C8A1079312 [YKS]) and Basic Science Research Program through the NRF (NRF-2012R1A1A3014050 [YLC]) funded by the Ministry of Science, ICT & Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two authors (JH and KS) are employed by a commercial company, Gencurix for JH and ABION for KS, respectively. These commercial affiliations provided support in the form of salaries for authors [JH and KS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bretz N, 2012, CLIN EXP METASTAS, V29, P27, DOI 10.1007/s10585-011-9426-4; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Choi YL, J PATHOL TRANSL MED, V40, P103; Choi YL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-507; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Darwish Nevine S, 2004, Cancer Res Treat, V36, P298, DOI 10.4143/crt.2004.36.5.298; Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hosonaga M, 2014, CANCER SCI, V105, P779, DOI 10.1111/cas.12427; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Kagara N, 2012, AM J PATHOL, V181, P257, DOI 10.1016/j.ajpath.2012.03.019; Kaipparettu BA, 2008, INT J CANCER, V123, P66, DOI 10.1002/ijc.23480; Kim HJ, 2011, BREAST, V20, P78, DOI 10.1016/j.breast.2010.08.001; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2010, LAB INVEST, V90, P1102, DOI 10.1038/labinvest.2010.70; Kwon MJ, 2011, LAB INVEST, V91, P1652, DOI 10.1038/labinvest.2011.117; Lee JH, 2009, ONCOL REP, V22, P1149, DOI 10.3892/or_00000548; Lim J, 2014, ARCH BIOCHEM BIOPHYS, V558, P120, DOI 10.1016/j.abb.2014.06.022; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Perou CM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003293; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Smith SC, 2006, CANCER RES, V66, P1917, DOI 10.1158/0008-5472.CAN-05-3855; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Surowiak P, 2006, BRIT J CANCER, V95, P339, DOI 10.1038/sj.bjc.6603254; Thomas S, 2012, CANCER RES, V72, P5600, DOI 10.1158/0008-5472.CAN-11-3666; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084	36	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139112	10.1371/journal.pone.0139112	http://dx.doi.org/10.1371/journal.pone.0139112			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444008	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600043
J	Nardelli, TC; Erythropel, HC; Robaire, B				Nardelli, Thomas C.; Erythropel, Hanno C.; Robaire, Bernard			Toxicogenomic Screening of Replacements for Di(2-Ethylhexyl) Phthalate (DEHP) Using the Immortalized TM4 Sertoli Cell Line	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; DESIGNING GREEN PLASTICIZERS; HORMONE-SENSITIVE LIPASE; INTENSIVE-CARE-UNIT; IN-UTERO EXPOSURE; DI-(2-ETHYLHEXYL) PHTHALATE; POLY(VINYL CHLORIDE); TESTICULAR DYSGENESIS; GENE-EXPRESSION; BIODEGRADATION	Phthalate plasticizers such as di(2-ethylhexyl) phthalate (DEHP) are being phased out of many consumer products because of their endocrine disrupting properties and their ubiquitous presence in the environment. The concerns raised from the use of phthalates have prompted consumers, government, and industry to find alternative plasticizers that are safe, biodegradable, and have the versatility for multiple commercial applications. We examined the toxicogenomic profile of mono(2-ethylhexyl) phthalate (MEHP, the active metabolite of DEHP), the commercial plasticizer diisononyl cyclohexane-1,2-dicarboxylate (DINCH), and three recently proposed plasticizers: 1,4-butanediol dibenzoate (BDB), dioctyl succinate (DOS), and dioctyl maleate (DOM), using the immortalized TM4 Sertoli cell line. Results of gene expression studies revealed that DOS and BDB clustered with control samples while MEHP, DINCH and DOM were distributed far away from the control-DOS-BDB cluster, as determined by principle component analysis. While no significant changes in gene expression were found after treatment with BDB and DOS, treatment with MEHP, DINCH and DOM resulted in many differentially expressed genes. MEHP upregulated genes downstream of PPAR and targeted pathways of cholesterol biosynthesis without modulating the expression of PPAR's themselves. DOM upregulated genes involved in glutathione stress response, DNA repair, and cholesterol biosynthesis. Treatment with DINCH resulted in altered expression of a large number of genes involved in major signal transduction pathways including ERK/MAPK and Rho signalling. These data suggest DOS and BDB may be safer alternatives to DEHP/MEHP than DOM or the commercial alternative DINCH.	[Nardelli, Thomas C.; Robaire, Bernard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Erythropel, Hanno C.] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada; [Robaire, Bernard] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University	Robaire, B (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	bernard.robaire@mcgill.ca	Erythropel, Hanno/T-5737-2017	Erythropel, Hanno/0000-0003-3443-9794; Nardelli, Thomas/0000-0002-2286-7153	Team Grant from the Institute of Human Development, Child and Youth Health, CIHR [RHF100626]; Reseau Quebecois en Reproduction NSERC-CREATE; CIHR Training Program in Reproduction, Early Development, and the Impact on Health (REDIH); FRQNT-PBEE-V1; McGill Engineering Doctoral Award (MEDA)	Team Grant from the Institute of Human Development, Child and Youth Health, CIHR; Reseau Quebecois en Reproduction NSERC-CREATE; CIHR Training Program in Reproduction, Early Development, and the Impact on Health (REDIH)(Canadian Institutes of Health Research (CIHR)); FRQNT-PBEE-V1; McGill Engineering Doctoral Award (MEDA)	The studies were funded by a Team Grant from the Institute of Human Development, Child and Youth Health, CIHR (RHF100626). TCN is a recipient of studentships from Reseau Quebecois en Reproduction NSERC-CREATE and CIHR Training Program in Reproduction, Early Development, and the Impact on Health (REDIH). HCE is a recipient of studentships from FRQNT-PBEE-V1 and McGill Engineering Doctoral Award (MEDA).	Arenas MI, 2004, HUM PATHOL, V35, P34, DOI 10.1016/j.humpath.2003.08.015; BASF, HEX DINCH SAF PLAST; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bhattacharya N, 2005, BIOL REPROD, V72, P745, DOI 10.1095/biolreprod.104.031583; Bouma K, 2002, FOOD ADDIT CONTAM, V19, P602, DOI 10.1080/02652030210125137; Boverhof DR, 2006, TOXICOL SCI, V89, P352, DOI 10.1093/toxsci/kfj018; Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429; CHAPIN RE, 1988, TOXICOL APPL PHARM, V92, P467, DOI 10.1016/0041-008X(88)90186-X; DANIEL V, 1993, CRIT REV BIOCHEM MOL, V28, P173, DOI 10.3109/10409239309086794; Ellero-Simatos S, 2011, J PROTEOME RES, V10, P5493, DOI 10.1021/pr200765v; Erythropel HC, 2014, APPL MICROBIOL BIOT, V98, P9967, DOI 10.1007/s00253-014-6183-8; Erythropel HC, 2013, CHEMOSPHERE, V91, P358, DOI 10.1016/j.chemosphere.2012.11.061; Erythropel HC, 2012, CHEMOSPHERE, V86, P759, DOI 10.1016/j.chemosphere.2011.10.054; Erythropel HC, 2015, CHEMOSPHERE; Firlotte N, 2009, J VINYL ADDIT TECHN, V15, P99, DOI 10.1002/vnl.20181; Gartshore J, 2003, ENVIRON TOXICOL CHEM, V22, P1244, DOI 10.1897/1551-5028(2003)022&lt;1244:BOPBRR&gt;2.0.CO;2; Gely-Pernot A, 2012, ENDOCRINOLOGY, V153, P438, DOI 10.1210/en.2011-1102; GOSSE JA, 2008, TOXICOGENOMICS POWER, P27; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; HOLST LS, 1994, FEBS LETT, V355, P125, DOI 10.1016/0014-5793(94)01185-0; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077; Josh MKS, 2014, J APPL TOXICOL, V34, P754, DOI 10.1002/jat.2902; Kastner J, 2012, SCI TOTAL ENVIRON, V432, P357, DOI 10.1016/j.scitotenv.2012.06.014; Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008; Leeder JS, 1997, PEDIATR CLIN N AM, V44, P55, DOI 10.1016/S0031-3955(05)70463-6; Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550; Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404; Luhe A, 2005, MUTAT RES-FUND MOL M, V575, P102, DOI 10.1016/j.mrfmmm.2005.02.009; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Markarian J., 2007, PLASTICS ADDIT COMPD, V9, P22, DOI [10.1016/S1464-391X(07)70153-8, DOI 10.1016/S1464-391X(07)70153-8]; Martinez-Arguelles DB, 2014, ENDOCRINOLOGY, V155, P1667, DOI 10.1210/en.2013-1921; MATHER JP, 1982, ANN NY ACAD SCI, V383, P44, DOI 10.1111/j.1749-6632.1982.tb23161.x; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; Mccoy M, 2008, CHEM ENG NEWS, V86, P47; NAKHLA AM, 1984, ENDOCRINOLOGY, V115, P121, DOI 10.1210/endo-115-1-121; NTP-CERHR, 2005, EXP PAN UPD REPR DEV; OECD, GROUP CHEM CHEM CAT; PESCHON JJ, 1992, MOL ENDOCRINOL, V6, P1403, DOI 10.1210/me.6.9.1403; Petersen C, 2005, CYTOKINE, V32, P51, DOI 10.1016/j.cyto.2005.07.014; Piche CD, 2012, ECOTOX ENVIRON SAFE, V79, P108, DOI 10.1016/j.ecoenv.2011.12.008; Plummer J L, 1981, Methods Enzymol, V77, P50; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Pour AK, 2009, CHEMOSPHERE, V77, P258, DOI 10.1016/j.chemosphere.2009.06.048; Pour AK, 2009, J MASS SPECTROM, V44, P662, DOI 10.1002/jms.1541; RASSOULZADEGAN M, 1993, CELL, V75, P997, DOI 10.1016/0092-8674(93)90543-Y; Roberts R, 2003, DRUG METAB REV, V35, P269, DOI 10.1081/DMR-120026395; Silva MJ, 2013, ENVIRON RES, V126, P159, DOI 10.1016/j.envres.2013.05.007; Siu Michelle Ky, 2011, Spermatogenesis, V1, P73; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Stuart A, 2013, EUR POLYM J, V49, P2785, DOI 10.1016/j.eurpolymj.2013.06.023; Stuart A, 2010, POLYM BULL, V65, P589, DOI 10.1007/s00289-010-0271-4; US National Research Council, 2007, TOXICITY TESTING 21; Versar Inc SRC, 2010, REV EXP TOX DAT PHTH; Wagner MS, 2009, MICROSC RES TECHNIQ, V72, P796, DOI 10.1002/jemt.20759; Ward JM, 1998, TOXICOL PATHOL, V26, P240, DOI 10.1177/019262339802600208; Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926; Wong CH, 2005, DEV BIOL, V286, P1, DOI 10.1016/j.ydbio.2005.08.001; Wypych G., 2012, HDB PLASTICIZERS; Yao PL, 2007, J BIOL CHEM, V282, P5420, DOI 10.1074/jbc.M609068200; Yao PL, 2009, BIOL REPROD, V80, P581, DOI 10.1095/biolreprod.108.073122	62	34	35	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138421	10.1371/journal.pone.0138421	http://dx.doi.org/10.1371/journal.pone.0138421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445464	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600029
J	Zaitoun, IS; Johnson, RP; Jamali, N; Almomani, R; Wang, SJ; Sheibani, N; Sorenson, CM				Zaitoun, Ismail S.; Johnson, Ryan P.; Jamali, Nasim; Almomani, Reem; Wang, Shoujian; Sheibani, Nader; Sorenson, Christine M.			Endothelium Expression of Bcl-2 Is Essential for Normal and Pathological Ocular Vascularization	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; C-ELEGANS; APOPTOSIS; ANGIOGENESIS; SURVIVAL; ATTENUATION; INDUCTION; MIGRATION; DELETION; GROWTH	Bcl-2 is an anti-apoptotic protein with important roles in vascular homeostasis and angiogenesis. Mice globally lacking Bcl-2 (Bcl-2-/-) are small in stature and succumb to renal failure shortly after weaning as a result of renal hypoplasia/cystic dysplasia. We have shown that Bcl-2-/- mice displayed attenuated retinal vascular development and neovascularization. In vitro studies indicated that in addition to modulating apoptosis, Bcl-2 expression also impacts endothelial and epithelial cell adhesion, migration and extracellular matrix production. However, studies delineating the cell autonomous role Bcl-2 expression plays in the endothelium during vascular development, pruning and remodeling, and neovascularization are lacking. Here we generated mice carrying a conditional Bcl-2 allele (Bcl-2(Flox/Flox)) and VE-cadherin-cre (Bcl-2(EC) mice). Bcl-2(EC) mice were of normal stature and lifespan and displayed some but not all of the retinal vascular defects previously observed in global Bcl-2 deficient mice. Bcl-2(EC) mice had decreased numbers of endothelial cells, decreased retinal arteries and premature primary branching of the retinal vasculature, but unlike the global knockout mice, spreading of the retinal superficial vascular layer proceeded normally. Choroidal neovascularization was attenuated in Bcl-2(EC) mice, although retinal neovascularization accompanying oxygen-induced ischemic retinopathy was not. Thus, Bcl-2 expression in the endothelium plays a significant role during postnatal retinal vascularization, and pathological choroidal but not retinal neovascularization, suggesting vascular bed specific Bcl-2 function in the endothelium.	[Zaitoun, Ismail S.; Jamali, Nasim; Almomani, Reem; Wang, Shoujian; Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53705 USA; [Johnson, Ryan P.; Sorenson, Christine M.] Univ Wisconsin, Dept Pediat, Madison, WI 53705 USA; [Jamali, Nasim; Sheibani, Nader; Sorenson, Christine M.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sorenson, CM (corresponding author), Univ Wisconsin, Dept Pediat, Madison, WI 53705 USA.	cmsorenson@pediatrics.wisc.edu	Sheibani, Nader/AAG-2379-2020; Jamali, Nasim/Z-3534-2019	Sheibani, Nader/0000-0003-2723-9217; Jamali, Nasim/0000-0003-1851-6585; Zaitoun, ismail/0000-0001-7174-5403	National Institutes of Health [R21EY023024]; Retina Research Foundation; NIH [R24 EY022883, P30 CA014520, P30 EY016665]; Research to Prevent Blindness; American Diabetes Association [1-10-BS-160]; Hilldale Fellowship at the University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY016665, R24EY022883, R21EY023024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); American Diabetes Association(American Diabetes Association); Hilldale Fellowship at the University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work and CMS were supported by a grant from the National Institutes of Health (R21EY023024). CMS was funded, in part, by the Retina Research Foundation/Daniel M. Albert Chair. NS is supported by NIH grant R24 EY022883, P30 CA014520 UW Paul P. Carbone Cancer Center support grant, P30 EY016665, and an unrestricted departmental award from Research to Prevent Blindness. NS is a recipient of a Research Award from American Diabetes Association (1-10-BS-160) and Retina Research Foundation. RPJ is a recipient of a Hilldale Fellowship at the University of Wisconsin-Madison.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Ashimori N, 2009, MOL CANCER THER, V8, P893, DOI 10.1158/1535-7163.MCT-08-1078; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Dias S, 2002, BLOOD, V99, P2532, DOI 10.1182/blood.V99.7.2532; Dong ZH, 2007, EXP CELL RES, V313, P3645, DOI 10.1016/j.yexcr.2007.07.023; DRISCOLL M, 1992, J NEUROBIOL, V23, P1327, DOI 10.1002/neu.480230919; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grutzmacher C, 2010, AM J PHYSIOL-LUNG C, V299, pL607, DOI 10.1152/ajplung.00390.2009; HENGARTNER MO, 1994, PHILOS T R SOC B, V345, P243, DOI 10.1098/rstb.1994.0100; HENGARTNER MO, 1994, CURR OPIN GENET DEV, V4, P581, DOI 10.1016/0959-437X(94)90076-F; Hofmann JJ, 2012, DEVELOPMENT, V139, P4449, DOI 10.1242/dev.084871; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kondo S, 2008, DEV DYNAM, V237, P2450, DOI 10.1002/dvdy.21678; Kondo S, 2008, AM J PHYSIOL-CELL PH, V294, pC1521, DOI 10.1152/ajpcell.90633.2007; Lord CEN, 2012, EUR J CELL BIOL, V91, P603, DOI 10.1016/j.ejcb.2012.02.002; Lutty GA, 2010, EYE, V24, P408, DOI 10.1038/eye.2009.318; Milde F, 2013, INTEGR BIOL-UK, V5, P1426, DOI 10.1039/c3ib40085a; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Nor JE, 2001, CANCER RES, V61, P2183; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; Putcha G, 2004, CELL DEATH DIFFER, V11, P38, DOI 10.1038/sj.cdd.4401352; Reed JC., 1996, MECH LYMPHOCYTE ACTI, V406, P99, DOI [10.1007/978-1-4899-0274-0_10, DOI 10.1007/978-1-4899-0274-0_10]; Sheibani N, 2007, J CELL PHYSIOL, V210, P616, DOI 10.1002/jcp.20858; Sorenson CM, 1996, AM J PHYSIOL-RENAL, V271, pF184, DOI 10.1152/ajprenal.1996.271.1.F184; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Trisciuoglio D, 2011, CELL DEATH DIFFER, V18, P1024, DOI 10.1038/cdd.2010.175; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang SJ, 2011, DEV BIOL, V349, P296, DOI 10.1016/j.ydbio.2010.10.034; Wang SJ, 2005, DEV BIOL, V279, P205, DOI 10.1016/j.ydbio.2004.12.017; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Wong CW, 2014, KIDNEY INT, V85, P1290, DOI 10.1038/ki.2013.491	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139994	10.1371/journal.pone.0139994	http://dx.doi.org/10.1371/journal.pone.0139994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444547	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600118
J	Sakamoto, S; Kawabata, H; Masuda, T; Uchiyama, T; Mizumoto, C; Ohmori, K; Koeffler, HP; Kadowaki, N; Takaori-Kondo, A				Sakamoto, Soichiro; Kawabata, Hiroshi; Masuda, Taro; Uchiyama, Tatsuki; Mizumoto, Chisaki; Ohmori, Katsuyuki; Koeffler, H. Phillip; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi			H-Ferritin Is Preferentially Incorporated by Human Erythroid Cells through Transferrin Receptor 1 in a Threshold-Dependent Manner	PLOS ONE			English	Article							POSITIVE PHILADELPHIA-CHROMOSOME; HEAVY-CHAIN FERRITIN; SERUM FERRITIN; IRON UPTAKE; IN-VIVO; MEGAKARYOBLASTIC LEUKEMIA; DENDRITIC CELLS; BINDING-SITES; TRANSIT SITE; LINE	Ferritin is an iron-storage protein composed of different ratios of 24 light (L) and heavy (H) subunits. The serum level of ferritin is a clinical marker of the body's iron level. Transferrin receptor (TFR)1 is the receptor not only for transferrin but also for H-ferritin, but how it binds two different ligands and the blood cell types that preferentially incorporate H-ferritin remain unknown. To address these questions, we investigated hematopoietic cell-specific ferritin uptake by flow cytometry. Alexa Fluor 488-labeled H-ferritin was preferentially incorporated by erythroid cells among various hematopoietic cell lines examined, and was almost exclusively incorporated by bone marrow erythroblasts among human primary hematopoietic cells of various lineages. H-ferritin uptake by erythroid cells was strongly inhibited by unlabeled H-ferritin but was only partially inhibited by a large excess of holo-transferrin. On the other hand, internalization of labeled holo-transferrin by these cells was not inhibited by H-ferritin. Chinese hamster ovary cells lacking functional endogenous TFR1 but expressing human TFR1 with a mutated RGD sequence, which is required for transferrin binding, efficiently incorporated H-ferritin, indicating that TFR1 has distinct binding sites for H-ferritin and holo-transferrin. H-ferritin uptake by these cells required a threshold level of cell surface TFR1 expression, whereas there was no threshold for holo-transferrin uptake. The requirement for a threshold level of TFR1 expression can explain why among primary human hematopoietic cells, only erythroblasts efficiently take up H-ferritin.	[Sakamoto, Soichiro; Kawabata, Hiroshi; Uchiyama, Tatsuki; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Masuda, Taro] Kyoto Univ, Grad Sch Med, Lab Food Qual Design & Dev, Div Agron & Hort Sci, Kyoto, Japan; [Sakamoto, Soichiro] Japanese Red Cross Takatsuki Hosp, Dept Hematol, Takatsuki, Osaka, Japan; [Uchiyama, Tatsuki; Mizumoto, Chisaki] Japanese Red Cross Otsu Hosp, Dept Hematol & Immunol, Otsu, Shiga, Japan; [Ohmori, Katsuyuki] Kyoto Univ Hosp, Dept Clin Lab, Kyoto 606, Japan; [Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Hematol & Oncol, Sch Med, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Singapore 117548, Singapore; [Kadowaki, Norimitsu] Kagawa Univ, Div Endocrinol & Metab Hematol Rheumatol & Resp M, Dept Internal Med, Grad Sch Med, Takamatsu, Kagawa 760, Japan	Kyoto University; Kyoto University; Kyoto University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; Kagawa University	Kawabata, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan.	hkawabat@kuhp.kyoto-u.ac.jp		Ohmori, Katsuyuki/0000-0002-3794-6970; Masuda, Taro/0000-0002-5549-375X	Ministry of Education, Culture, Sports, Science and Technology of Japan [22591033, 26461400]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant-in-aids for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22591033, 26461400, received by HK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand P, 2007, BLOOD, V109, P4586, DOI 10.1182/blood-2006-10-054924; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; BRETSCHER MS, 1983, EMBO J, V2, P599, DOI 10.1002/j.1460-2075.1983.tb01469.x; BROXMEYER HE, 1986, BLOOD, V68, P1257; BROXMEYER HE, 1991, P NATL ACAD SCI USA, V88, P770, DOI 10.1073/pnas.88.3.770; BROXMEYER HE, 1989, BLOOD, V73, P74; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Della Porta MG, 2006, LEUKEMIA, V20, P549, DOI 10.1038/sj.leu.2404142; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Dubljevic V, 1999, BIOCHEM J, V341, P11, DOI 10.1042/0264-6021:3410011; FARGION S, 1988, BLOOD, V71, P753; FARGION S, 1991, BLOOD, V78, P1056; Gelvan D, 1996, BLOOD, V88, P3200, DOI 10.1182/blood.V88.8.3200.bloodjournal8883200; Ghosh S, 2004, BLOOD, V103, P2369, DOI 10.1182/blood-2003-09-3050; Gray CP, 2002, BLOOD, V99, P3326, DOI 10.1182/blood.V99.9.3326; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Green F, 2002, FEBS LETT, V518, P101, DOI 10.1016/S0014-5793(02)02655-8; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Kawabata H, 2004, BRIT J HAEMATOL, V127, P464, DOI 10.1111/j.1365-2141.2004.05224.x; KOMATSU N, 1993, BLOOD, V82, P456; Lanotte M, 1991, BLOOD; LEVI S, 1988, J BIOL CHEM, V263, P18086; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; LIPSCHITZ DA, 1974, NEW ENGL J MED, V290, P1213, DOI 10.1056/NEJM197405302902201; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Lundin D, 2012, J BIOL CHEM, V287, P20565, DOI 10.1074/jbc.M112.367458; MACARA IG, 1972, BIOCHEM J, V126, P151, DOI 10.1042/bj1260151; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Masuda T, 2010, BIOCHEM BIOPH RES CO, V400, P94, DOI 10.1016/j.bbrc.2010.08.017; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; MOSS D, 1994, BRIT J HAEMATOL, V88, P746, DOI 10.1111/j.1365-2141.1994.tb05113.x; OGURA M, 1985, BLOOD, V66, P1384; Park J, 2009, LEUKEMIA RES, V33, P756, DOI 10.1016/j.leukres.2008.10.018; POLLACK S, 1981, BIOCHEM BIOPH RES CO, V100, P1667, DOI 10.1016/0006-291X(81)90710-5; RAO KK, 1985, MOL CELL BIOL, V5, P595, DOI 10.1128/MCB.5.4.595; ROSENFELD C, 1977, EUR J CANCER, V13, P377, DOI 10.1016/0014-2964(77)90085-8; Sakamoto S, 2013, INT J HEMATOL, V97, P109, DOI 10.1007/s12185-012-1229-0; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Sato T, 2013, J IMMUNOL, V191, P3152, DOI 10.4049/jimmunol.1203517; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shipkova M, 2012, CLIN CHIM ACTA, V413, P1338, DOI 10.1016/j.cca.2011.11.006; Theil EC, 2013, INORG CHEM, V52, P12223, DOI 10.1021/ic400484n; Todorich B, 2008, J NEUROCHEM, V107, P1495, DOI 10.1111/j.1471-4159.2008.05678.x; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8; WORWOOD M, 1976, BIOCHEM J, V157, P97, DOI 10.1042/bj1570097	54	26	27	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139915	10.1371/journal.pone.0139915	http://dx.doi.org/10.1371/journal.pone.0139915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441243	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510300076
J	Hacker, C; Christ, NA; Duchardt-Ferner, E; Korn, S; Gobl, C; Berninger, L; Dusterhus, S; Hellmich, UA; Madl, T; Kotter, P; Entian, KD; Wohnert, J				Hacker, Carolin; Christ, Nina A.; Duchardt-Ferner, Elke; Korn, Sophie; Goebl, Christoph; Berninger, Lucija; Duesterhus, Stefanie; Hellmich, Ute A.; Madl, Tobias; Koetter, Peter; Entian, Karl-Dieter; Woehnert, Jens			The Solution Structure of the Lantibiotic Immunity Protein NisI and Its Interactions with Nisin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; antibiotics; lipoprotein; nuclear magnetic resonance (NMR); protein structure; lantibiotic; nisin binding; small angle x-ray scattering	LACTOCOCCUS-LACTIS 6F3; BACILLUS-SUBTILIS; NMR-SPECTROSCOPY; GENE-CLUSTER; LIPID-II; BIOSYNTHESIS; DYNAMICS; RECOMMENDATIONS; BACTERIOCINS; ELECTROSTATICS	Many Gram-positive bacteria produce lantibiotics, genetically encoded and posttranslationally modified peptide antibiotics, which inhibit the growth of other Gram-positive bacteria. To protect themselves against their own lantibiotics these bacteria express a variety of immunity proteins including the LanI lipoproteins. The structural and mechanistic basis for LanI-mediated lantibiotic immunity is not yet understood. Lactococcus lactis produces the lantibiotic nisin, which is widely used as a food preservative. Its LanI protein NisI provides immunity against nisin but not against structurally very similar lantibiotics from other species such as subtilin from Bacillus subtilis. To understand the structural basis for LanI-mediated immunity and their specificity we investigated the structure of NisI. We found that NisI is a two-domain protein. Surprisingly, each of the two NisI domains has the same structure as the LanI protein from B. subtilis, SpaI, despite the lack of significant sequence homology. The two NisI domains and SpaI differ strongly in their surface properties and function. Additionally, SpaI-mediated lantibiotic immunity depends on the presence of a basic unstructured N-terminal region that tethers SpaI to the membrane. Such a region is absent from NisI. Instead, the N-terminal domain of NisI interacts with membranes but not with nisin. In contrast, the C-terminal domain specifically binds nisin and modulates the membrane affinity of the N-terminal domain. Thus, our results reveal an unexpected structural relationship between NisI and SpaI and shed light on the structural basis for LanI mediated lantibiotic immunity.	[Hacker, Carolin; Christ, Nina A.; Duchardt-Ferner, Elke; Korn, Sophie; Berninger, Lucija; Duesterhus, Stefanie; Koetter, Peter; Entian, Karl-Dieter; Woehnert, Jens] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Duchardt-Ferner, Elke; Hellmich, Ute A.; Woehnert, Jens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, D-60438 Frankfurt, Germany; [Goebl, Christoph; Madl, Tobias] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85748 Garching, Germany; [Madl, Tobias] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Hellmich, Ute A.] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany; [Madl, Tobias] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Madl, Tobias] BioTechMed Graz, Om Ctr Graz, A-8010 Graz, Austria	Goethe University Frankfurt; Goethe University Frankfurt; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johannes Gutenberg University of Mainz; Medical University of Graz	Wohnert, J (corresponding author), Goethe Univ Frankfurt, Inst Mol Biowissensch, Max Von Laue Str 9, D-60438 Frankfurt, Germany.	woehnert@bio.uni-frankfurt.de	Madl, Tobias/B-1682-2012; Goebl, Christoph/G-7578-2016	Madl, Tobias/0000-0002-9725-5231; Hellmich, Ute/0000-0001-7162-285X; Hacker, Carolin/0000-0001-9951-0614; Gobl, Christoph/0000-0001-8614-1434	Deutsche Forschungsgemeinschaft (DFG) [Wo 901/4-1, En 134/11-1, MA 5703/1-1]; Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network); Emmy-Noether program of the Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich (CIPSM)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network); Emmy-Noether program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich (CIPSM)	This work was supported in part by Grants Wo 901/4-1, En 134/11-1, and MA 5703/1-1 (Emmy-Noether program) from the Deutsche Forschungsgemeinschaft (DFG) (to J. W., K. D. E., and T. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network), the Emmy-Noether program of the Deutsche Forschungsgemeinschaft, and the Center for Integrated Protein Science Munich (CIPSM).	AlKhatib Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102246; Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Christ NA, 2012, J BIOL CHEM, V287, P35286, DOI 10.1074/jbc.M112.401620; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dischinger J, 2014, INT J MED MICROBIOL, V304, P51, DOI 10.1016/j.ijmm.2013.09.003; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; ENGELKE G, 1994, APPL ENVIRON MICROB, V60, P814, DOI 10.1128/AEM.60.3.814-825.1994; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fuchs SW, 2011, APPL ENVIRON MICROB, V77, P1698, DOI 10.1128/AEM.01962-10; Gobl C, 2014, PROG NUCL MAG RES SP, V80, P26, DOI 10.1016/j.pnmrs.2014.05.003; Gottstein D, 2012, J BIOMOL NMR, V52, P351, DOI 10.1007/s10858-012-9615-8; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Hacker C, 2015, BIOMOL NMR ASSIGN, V9, P293, DOI 10.1007/s12104-015-9595-1; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Huang JR, 2014, J AM CHEM SOC, V136, P7068, DOI 10.1021/ja502030n; Keller R., 2004, COMPUTER AIDED RESON, V1; KLAENHAMMER TR, 1988, BIOCHIMIE, V70, P337, DOI 10.1016/0300-9084(88)90206-4; KLEIN C, 1992, APPL ENVIRON MICROB, V58, P132, DOI 10.1128/AEM.58.1.132-142.1992; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; KOSEN PA, 1986, BIOCHEMISTRY-US, V25, P2356, DOI 10.1021/bi00357a009; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Montelione GT, 2013, STRUCTURE, V21, P1563, DOI 10.1016/j.str.2013.07.021; Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; OLEARY WM, 1988, MICROBIAL LIPIDS; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Pozzi R, 2016, ENVIRON MICROBIOL, V18, P118, DOI 10.1111/1462-2920.12892; Ra R, 1999, MICROBIOL-SGM, V145, P1227, DOI 10.1099/13500872-145-5-1227; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; SCHMIDT PG, 1984, BIOCHEMISTRY-US, V23, P4261, DOI 10.1021/bi00313a038; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082, DOI 10.1128/AEM.61.3.1082-1089.1995; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; Stein T, 2002, MOL MICROBIOL, V44, P403, DOI 10.1046/j.1365-2958.2002.02869.x; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takala TM, 2006, MICROBIOL-SGM, V152, P3543, DOI 10.1099/mic.0.29083-0; Takala TM, 2004, FEMS MICROBIOL LETT, V237, P171, DOI 10.1111/j.1574-6968.2004.tb09693.x; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	60	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28869	28886		10.1074/jbc.M115.679969	http://dx.doi.org/10.1074/jbc.M115.679969			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26459561	Green Published, hybrid			2022-12-26	WOS:000365762300028
J	Lu, SY; Banerjee, A; Jang, H; Zhang, J; Gaponenko, V; Nussinov, R				Lu, Shaoyong; Banerjee, Avik; Jang, Hyunbum; Zhang, Jian; Gaponenko, Vadim; Nussinov, Ruth			GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; computational biology; nuclear magnetic resonance (NMR); protein conformation; protein dynamic; Ras protein	ACTIVATED PROTEIN-KINASE; H-RAS PROTEIN; STRUCTURAL BASIS; K-RAS; MEMBRANE-BINDING; CAAX MOTIF; INHIBITORS; DYNAMICS; CANCER; PATHWAY	K-Ras4B, a frequently mutated oncogene in cancer, plays an essential role in cell growth, differentiation, and survival. Its C-terminal membrane-associated hypervariable region (HVR) is required for full biological activity. In the active GTP-bound state, the HVR interacts with acidic plasma membrane (PM) headgroups, whereas the farnesyl anchors in the membrane; in the inactive GDP-bound state, the HVR may interact with both the PM and the catalytic domain at the effector binding region, obstructing signaling and nucleotide exchange. Here, using molecular dynamics simulations and NMR, we aim to figure out the effects of nucleotides (GTP and GDP) and frequent (G12C, G12D, G12V, G13D, and Q61H) and infrequent (E37K and R164Q) oncogenic mutations on full-length K-Ras4B. The mutations are away from or directly at the HVR switch I/effector binding site. Our results suggest that full-length wild-type GDP-bound K-Ras4B (K-Ras4B(WT)-GDP) is in an intrinsically autoinhibited state via tight HVR-catalytic domain interactions. The looser association in K-Ras4B(WT)-GTP may release the HVR. Some of the oncogenic mutations weaken the HVR-catalytic domain association in the K-Ras4B-GDP/-GTP bound states, which may facilitate the HVR disassociation in a nucleotide-independent manner, thereby up-regulating oncogenic Ras signaling. Thus, our results suggest that mutations can exert their effects in more than one way, abolishing GTP hydrolysis and facilitating effector binding.	[Lu, Shaoyong; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China; [Lu, Shaoyong; Jang, Hyunbum; Nussinov, Ruth] NCI, Canc & Inflammat Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Banerjee, Avik] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Gaponenko, Vadim] Univ Illinois, Dept Mol Genet & Biochem, Chicago, IL 60607 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Sackler Inst Mol Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tel Aviv University; Sackler Faculty of Medicine	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China.	jian.zhang@sjtu.edu.cn; vadimg@uic.edu; NussinoR@helix.nih.gov	Gaponenko, Vadim/K-9729-2019; Regan, Clinton/E-6250-2012; Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; Nussinov, Ruth/0000-0002-8115-6415; Banerjee, Avik/0000-0002-0668-5480; Gaponenko, Vadim/0000-0002-7891-9223; Jang, Hyunbum/0000-0001-9402-4051	National Basic Research Program of China (973 Program) [2015CB910403]; National Natural Science Foundation of China [81322046, 81302689, 81473137]; Shanghai Rising-Star Program Grant [13QA1402300]; Program for New Century Excellent Talents in University [NCET-12-0355]; National Institutes of Health [R01 CA135341]; American Cancer Society [RGS-09-057-01-GMC]; NCI-Frederick, National Institutes of Health [HHSN261200800001E]; NCI-Frederick, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA188427, ZIABC010441, ZIABC010440, R01CA135341] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program Grant; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NCI-Frederick, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI-Frederick, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Basic Research Program of China (973 Program) Grant 2015CB910403 (to J. Z.), National Natural Science Foundation of China Grants 81322046, 81302689, and 81473137 (to J. Z.), Shanghai Rising-Star Program Grant 13QA1402300) (to J. Z.), Program for New Century Excellent Talents in University (NCET-12-0355) (to J. Z.), National Institutes of Health Grant R01 CA135341 (to V. G.), American Cancer Society Grant RGS-09-057-01-GMC (to V. G.). This work was also supported in whole or in part with Federal funds from the NCI-Frederick, National Institutes of Health under Contract HHSN261200800001E (to R. N.). This work was supported in part by the Intramural Research Program of NCI-Frederick, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham SJ, 2010, PROTEIN EXPRES PURIF, V73, P125, DOI 10.1016/j.pep.2010.05.015; Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Araki M, 2011, J BIOL CHEM, V286, P39644, DOI 10.1074/jbc.M111.227074; Arozarena Imanol, 2011, Genes Cancer, V2, P182, DOI 10.1177/1947601911409213; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bernard V, 2014, INT J CLIN EXP PATHO, V7, P1667; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Chavan T. S., 2015, BIOPHYS J, DOI [10.1158/1538-7445.AM2014-3224, DOI 10.1158/1538-7445.AM2014-3224]; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Evelyn CR, 2015, J BIOL CHEM, V290, P12879, DOI 10.1074/jbc.M114.634493; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Gentry LR, 2015, J BIOL CHEM, V290, P22851, DOI 10.1074/jbc.M115.656710; Gorfe AA, 2007, ANGEW CHEM INT EDIT, V46, P8234, DOI 10.1002/anie.200702379; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Guzman C, 2014, J BIOL CHEM, V289, P9519, DOI 10.1074/jbc.M113.537001; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hernandez-Alcoceba R, 2000, CELL MOL LIFE SCI, V57, P65, DOI 10.1007/s000180050499; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Lu SY, 2015, STRUCTURE, V23, P1725, DOI 10.1016/j.str.2015.06.027; Lu SY, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003831; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Milroy LG, 2014, ACS CHEM BIOL, V9, P2447, DOI 10.1021/cb500555h; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Nussinov R, 2013, TRENDS MOL MED, V19, P695, DOI 10.1016/j.molmed.2013.07.009; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Partridge JR, 2009, J MOL BIOL, V391, P375, DOI 10.1016/j.jmb.2009.06.011; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rosnizeck IC, 2012, ANGEW CHEM INT EDIT, V51, P10647, DOI 10.1002/anie.201204148; Rowinsky EK, 1999, J CLIN ONCOL, V17, P3631, DOI 10.1200/JCO.1999.17.11.3631; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013	59	58	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28887	28900		10.1074/jbc.M115.664755	http://dx.doi.org/10.1074/jbc.M115.664755			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453300	Green Published, hybrid			2022-12-26	WOS:000365762300029
J	Rasconi, S; Gall, A; Winter, K; Kainz, MJ				Rasconi, Serena; Gall, Andrea; Winter, Katharina; Kainz, Martin J.			Increasing Water Temperature Triggers Dominance of Small Freshwater Plankton	PLOS ONE			English	Article							CLIMATE-CHANGE; MESOCOSM EXPERIMENTS; PHYTOPLANKTON; LAKES; GROWTH; ZOOPLANKTON; NUTRIENT; EVENTS; PHOTOSYNTHESIS; CONSEQUENCES	Climate change scenarios predict that lake water temperatures will increase up to 4 degrees C and rainfall events will become more intense and frequent by the end of this century. Concurrently, supply of humic substances from terrestrial runoff is expected to increase, resulting in darker watercolor ("brownification") of aquatic ecosystems. Using a multi-seasonal, low trophic state mesocosm experiment, we investigated how higher water temperature and brownification affect plankton community composition, phenology, and functioning. We tested the hypothesis that higher water temperature (+3 degrees C) and brownification will, a) cause plankton community composition to shift toward small sized phytoplankton and cyanobacteria, and, b) extend the length of the growing season entailing higher phytoplankton production later in the season. We demonstrate that the 3 degrees C increase of water temperature favored the growth of heterotrophic bacteria and small sized autotrophic picophytoplankton cells with significantly higher primary production during warmer fall periods. However, 3X darker water (effect of brownification) caused no significant changes in the plankton community composition or functioning relative to control conditions. Our findings reveal that increased temperature change plankton community structure by favoring smaller sized species proliferation (autotrophic phytoplankton and small size cladocerans), and increase primary productivity and community turnover. Finally, results of this multi-seasonal experiment suggest that warming by 3 degrees C in aquatic ecosystems of low trophic state may cause planktonic food web functioning to become more dominated by fast growing, r-trait species (i.e., small sizes and rapid development).	[Rasconi, Serena; Gall, Andrea; Winter, Katharina; Kainz, Martin J.] Interuniv Ctr Aquat Ecosyst Res, WasserCluster Biol Stn Lunz, A-3293 Lunz Am See, Austria		Rasconi, S (corresponding author), Interuniv Ctr Aquat Ecosyst Res, WasserCluster Biol Stn Lunz, A-3293 Lunz Am See, Austria.	Serena.Rasconi@wcl.ac.at	Kainz, Martin/AAG-6268-2021	Rasconi, Serena/0000-0001-6667-8904	Austrian Science Fund, BiodivERsA [I 1057-B25]; Austrian Science Fund (FWF) [I 1057] Funding Source: researchfish	Austrian Science Fund, BiodivERsA; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (project I 1057-B25) as part of the BiodivERsA 2011-2012 joint call (Biodiversity Dynamics and Tipping Points In Our Future Freshwater Ecosystems).	Abrahams C., 2013, IMPACT EXTREME EVENT; Adrian R, 1996, FRESHWATER BIOL, V36, P757, DOI 10.1046/j.1365-2427.1996.00126.x; Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Agawin NSR, 2000, LIMNOL OCEANOGR, V45, P591, DOI 10.4319/lo.2000.45.3.0591; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BANSE K, 1976, J PHYCOL, V12, P135; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Beardall J., 2006, SCIENCEASIA, V32, P1, DOI DOI 10.2306/SCIENCEASIA1513-1874.2006.32(S1).001; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Bec A, 2006, LIMNOL OCEANOGR, V51, P1699, DOI 10.4319/lo.2006.51.4.1699; Beisner BE, 1997, CAN J FISH AQUAT SCI, V54, P586, DOI 10.1139/cjfas-54-3-586; Bergmann C., 1848, VERHALTNISSE WARMEOK; Chen CY, 1996, LIMNOL OCEANOGR, V41, P1077, DOI 10.4319/lo.1996.41.5.1077; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Domis LND, 2013, FRESHWATER BIOL, V58, P463, DOI 10.1111/fwb.12053; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Ekstrom SM, 2011, ENVIRON SCI TECHNOL, V45, P4733, DOI 10.1021/es104126f; Finkel Z. V., 2009, J PLANKTON RES; Graneli W, 2012, ENCY LAKERESERVOIR, DOI DOI 10.1007/978-1-4020-4410-6_256; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Hartig P, 1998, ROSTOCK MEERESBIOL B, V6, P51; Hongve D, 2004, AQUAT SCI, V66, P231, DOI 10.1007/s00027-004-0708-7; Irwin AJ, 2006, J PLANKTON RES, V28, P459, DOI 10.1093/plankt/fbi148; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Kiorboe T., 2008, MECH APPROACH PLANKT; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; Kremer C.T., 2014, ECOLOGY, V95, P2984, DOI DOI 10.1890/14-0603.1; Kritzberg ES, 2014, FRESHWATER BIOL, V59, P325, DOI 10.1111/fwb.12267; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Liboriussen L, 2005, LIMNOL OCEANOGR-METH, V3, P1, DOI 10.4319/lom.2005.3.1; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Meis S, 2009, FRESHWATER BIOL, V54, P1888, DOI 10.1111/j.1365-2427.2009.02240.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Moser KA, 1998, HYDROBIOLOGIA, V377, P25, DOI 10.1023/A:1003225527053; Moser M, 2009, J PLANKTON RES, V31, P349, DOI 10.1093/plankt/fbn123; Nicolle A, 2012, FRESHWATER BIOL, V57, P684, DOI 10.1111/j.1365-2427.2012.02733.x; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Ozen A, 2013, FRESHWATER BIOL, V58, P483, DOI 10.1111/j.1365-2427.2012.02824.x; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peeters F, 2007, GLOBAL CHANGE BIOL, V13, P1898, DOI 10.1111/j.1365-2486.2007.01412.x; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Raven J.A, 2013, AQUATIC PHOTOSYNTHES; Reid P.C, 2010, CLIMATE CHANGE IMPAC, V56, DOI DOI 10.1002/9781444327397; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Rivkin RB, 1997, LIMNOL OCEANOGR, V42, P730, DOI 10.4319/lo.1997.42.4.0730; Schwartz MD, 2003, PHENOLOGY INTEGRATIV; Shimoda Y, 2011, J GREAT LAKES RES, V37, P173, DOI 10.1016/j.jglr.2010.10.004; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Sommer U, 2011, GLOBAL CHANGE BIOL, V17, P154, DOI 10.1111/j.1365-2486.2010.02182.x; Spivak AC, 2011, FRESHWATER BIOL, V56, P279, DOI 10.1111/j.1365-2427.2010.02495.x; Stewart RIA, 2013, ADV ECOL RES, V48, P71, DOI 10.1016/B978-0-12-417199-2.00002-1; Stocker TF, 2013, CONTRIBUTION WORKING; Taipale SJ, 2012, FEMS MICROBIOL ECOL, V82, P50, DOI 10.1111/j.1574-6941.2012.01406.x; Tian RC, 2004, DEEP-SEA RES PT I, V51, P413, DOI 10.1016/j.dsr.2003.10.015; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Vadadi-Fulop C, 2014, J LIMNOL, V73, P1, DOI 10.4081/jlimnol.2014.770; Vazquez-Dominguez E, 2012, AQUAT MICROB ECOL, V67, P107, DOI 10.3354/ame01583; Viergutz C, 2007, OECOLOGIA, V151, P115, DOI 10.1007/s00442-006-0544-7; Wagner C, 2009, LIMNOL OCEANOGR, V54, P2460, DOI 10.4319/lo.2009.54.6_part_2.2460; Wagner C, 2009, GLOBAL CHANGE BIOL, V15, P1104, DOI 10.1111/j.1365-2486.2008.01833.x; Wohlers-Zollner J, 2012, MAR BIOL, V159, P2503, DOI 10.1007/s00227-012-1958-x; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	65	76	77	7	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140449	10.1371/journal.pone.0140449	http://dx.doi.org/10.1371/journal.pone.0140449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461029	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300097
J	Li, DD; Hu, B; Wang, Q; Liu, HC; Pan, F; Wu, W				Li, Dandan; Hu, Bo; Wang, Qing; Liu, Hongchang; Pan, Feng; Wu, Wei			Identification and Evaluation of Reference Genes for Accurate Transcription Normalization in Safflower under Different Experimental Conditions	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; REAL-TIME PCR; CARTHAMUS-TINCTORIUS L.; INTERNAL CONTROL GENES; HOUSEKEEPING GENES; ABIOTIC STRESS; EXPRESSION; SELECTION; VALIDATION; QUANTIFICATION	Safflower (Carthamus tinctorius L.) has received a significant amount of attention as a medicinal plant and oilseed crop. Gene expression studies provide a theoretical molecular biology foundation for improving new traits and developing new cultivars. Real-time quantitative PCR (RT-qPCR) has become a crucial approach for gene expression analysis. In addition, appropriate reference genes (RGs) are essential for accurate and rapid relative quantification analysis of gene expression. In this study, fifteen candidate RGs involved in multiple metabolic pathways of plants were finally selected and validated under different experimental treatments, at different seed development stages and in different cultivars and tissues for real-time PCR experiments. These genes were ABCS, 60SRPL10, RANBP1, UBCL, MFC, UBCE2, EIF5A, COA, EF1-beta, EF1, GAPDH, ATPS, MBF1, GTPB and GST. The suitability evaluation was executed by the geNorm and NormFinder programs. Overall, EF1, UBCE2, EIF5A, ATPS and 60SRPL10 were the most stable genes, and MBF1, as well as MFC, were the most unstable genes by geNorm and NormFinder software in all experimental samples. To verify the validation of RGs selected by the two programs, the expression analysis of 7 CtFAD2 genes in safflower seeds at different developmental stages under cold stress was executed using different RGs in RT-qPCR experiments for normalization. The results showed similar expression patterns when the most stable RGs selected by geNorm or NormFinder software were used. However, the differences were detected using the most unstable reference genes. The most stable combination of genes selected in this study will help to achieve more accurate and reliable results in a wide variety of samples in safflower.	[Li, Dandan; Hu, Bo; Wang, Qing; Liu, Hongchang; Pan, Feng; Wu, Wei] Sichuan Agr Univ, Agron Coll, Chengdu 611130, Sichuan, Peoples R China	Sichuan Agricultural University	Wu, W (corresponding author), Sichuan Agr Univ, Agron Coll, Chengdu 611130, Sichuan, Peoples R China.	ewuwei@gmail.com		Wu, Wei/0000-0003-3559-1974	National Natural Science Foundation of China [81274020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (#81274020).	Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cao SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-5; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Dombrowski JE, 2009, PLANT SCI, V176, P390, DOI 10.1016/j.plantsci.2008.12.005; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; FERNANDEZMARTINEZ J, 1993, EUPHYTICA, V69, P115, DOI 10.1007/BF00021734; Futehally S, 1981, 1 INT SAFFL C DAV CA, P56; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Guan LL, 2014, GENET MOL RES, V13, P6623, DOI [10.4238/2014.August.28.7, 10.4238/2014]; Guan LL, 2008, PHILIPP AGRIC SCI, V91, P383; Guan LL, 2012, PLANT MOL BIOL REP, V30, P391, DOI 10.1007/s11105-011-0349-7; Guan LL, 2012, PLANT MOL BIOL REP, V30, P139, DOI 10.1007/s11105-011-0322-5; Guan LL, 2011, ACCUMULATION PATTERN; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hamdan YAS, 2009, EUPHYTICA, V168, P61, DOI 10.1007/s10681-008-9879-y; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang LK, 2014, BIOENERG RES, V7, P1201, DOI 10.1007/s12155-014-9457-1; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li DJ., 1993, CHARACTERIZATION EVA; Li DJ, 1993, 3 INT SAFFL C BEIJ C, P35; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mirzajani F, 2015, J FOOD MEAS CHARACT, V9, P332, DOI 10.1007/s11694-015-9240-9; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sakamoto T, 2002, PLANT PHYSIOL, V124, P1697; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu Q, 2009, AFR J BIOTECHNOL, V8, P1782; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	51	12	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140218	10.1371/journal.pone.0140218	http://dx.doi.org/10.1371/journal.pone.0140218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457898	Green Submitted, Green Published, gold			2022-12-26	WOS:000362961100025
J	Selvarajah, D; Cash, T; Davies, J; Sankar, A; Rao, G; Grieg, M; Pallai, S; Gandhi, R; Wilkinson, ID; Tesfaye, S				Selvarajah, Dinesh; Cash, Tom; Davies, Jennifer; Sankar, Adithya; Rao, Ganesh; Grieg, Marni; Pallai, Shillo; Gandhi, Rajiv; Wilkinson, Iain D.; Tesfaye, Solomon			SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy	PLOS ONE			English	Article							SMALL FIBER NEUROPATHY; RISK; POLYNEUROPATHY; MANAGEMENT; SENSATION; SYMPTOMS; DEVICE; QUICK	Clinical methods of detecting diabetic peripheral neuropathy (DPN) are not objective and reproducible. We therefore evaluated if SUDOSCAN, a new method developed to provide a quick, non-invasive and quantitative assessment of sudomotor function can reliably screen for DPN. 70 subjects (45 with type 1 diabetes and 25 healthy volunteers [HV]) underwent detailed assessments including clinical, neurophysiological and 5 standard cardiovascular reflex tests (CARTs). Using the American Academy of Neurology criteria subjects were classified into DPN and No-DPN groups. Based on CARTs subjects were also divided into CAN, subclinical-CAN and no-CAN. Sudomotor function was assessed with measurement of hand and foot Electrochemical Skin Conductance (ESC) and calculation of the CAN risk score. Foot ESC (mu S) was significantly lower in subjects with DPN [n = 24; 53.5(25.1)] compared to the No-DPN [77.0(7.9)] and HV [77.1(14.3)] groups (ANCOVA p<0.001). Sensitivity and specificity of foot ESC for classifying DPN were 87.5% and 76.2%, respectively. The area under the ROC curve (AUC) was 0.85. Subjects with CAN had significantly lower foot [55.0(28.2)] and hand [53.5(19.6)] ESC compared to No-CAN [foot ESC, 72.1(12.2); hand ESC 64.9(14.4)] and HV groups (ANCOVA p<0.001 and 0.001, respectively). ROC analysis of CAN risk score to correctly classify CAN revealed a sensitivity of 65.0% and specificity of 80.0%. AUC was 0.75. Both foot and hand ESC demonstrated strong correlation with individual parameters and composite scores of nerve conduction and CAN. SUDOSCAN, a non-invasive and quick test, could be used as an objective screening test for DPN in busy diabetic clinics, insuring adherence to current recommendation of annual assessments for all diabetic patients that remains unfulfilled.	[Selvarajah, Dinesh] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Cash, Tom; Davies, Jennifer; Sankar, Adithya; Grieg, Marni; Pallai, Shillo; Gandhi, Rajiv; Tesfaye, Solomon] Sheffield Teaching Hosp, Diabet Res Unit, Sheffield, S Yorkshire, England; [Rao, Ganesh] Sheffield Teaching Hosp, Dept Neurophysiol, Sheffield, S Yorkshire, England; [Wilkinson, Iain D.] Univ Sheffield, Acad Unit Radiol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Selvarajah, D (corresponding author), Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England.	d.selvarajah@sheffield.ac.uk		Wilkinson, Iain/0000-0003-2703-6890; Selvarajah, Dinesh/0000-0001-7426-1105; Tesfaye, Solomon/0000-0003-1190-1472				Armstrong David G, 2007, Int Wound J, V4, P286; Bastyr EJ, 2005, CLIN THER, V27, P1278, DOI 10.1016/j.clinthera.2005.08.002; Boulton AJM, 2004, NEW ENGL J MED, V351, P48, DOI 10.1056/NEJMcp032966; Bowling FL, 2012, DIABETIC MED, V29, P1550, DOI 10.1111/j.1464-5491.2012.03730.x; Bracewell N, 2012, DIABETIC MED, V29, P1553, DOI 10.1111/j.1464-5491.2012.03729.x; Calvet JH, 2013, EXP CLIN ENDOCR DIAB, V121, P80, DOI 10.1055/s-0032-1323777; Casellini CM, 2013, DIABETES TECHNOL THE, V15, P948, DOI 10.1089/dia.2013.0129; Dworkin RH, 2010, J PAIN, V11, P360, DOI 10.1016/j.jpain.2009.08.005; Dyck P.J., 1999, DIABETIC NEUROPATHY, V2nd ed.; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; DYCK PJ, 1993, NEUROLOGY, V43, P1500, DOI 10.1212/WNL.43.8.1500; DYCK PJ, 1993, NEUROLOGY, V43, P1508, DOI 10.1212/WNL.43.8.1508; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; FEALEY RD, 1989, MAYO CLIN PROC, V64, P617, DOI 10.1016/S0025-6196(12)65338-5; Forsblom CM, 1998, DIABETOLOGIA, V41, P1253, DOI 10.1007/s001250051062; Gin H, 2011, DIABETES METAB, V37, P527, DOI 10.1016/j.diabet.2011.05.003; Hsu WC, 2012, EUR J NEUROL, V19, P1192, DOI 10.1111/j.1468-1331.2011.03659.x; Hubert D, 2011, J CYST FIBROS, V10, P15, DOI 10.1016/j.jcf.2010.09.002; Kempler P, 2011, DIABETES-METAB RES, V27, P665, DOI 10.1002/dmrr.1223; Kong Xuan, 2008, J Diabetes Sci Technol, V2, P268; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; McArthur JC, 1998, ARCH NEUROL-CHICAGO, V55, P1513, DOI 10.1001/archneur.55.12.1513; O'Brien I A, 1985, Diabet Med, V2, P143; Radoiu H, 2005, J AM PODIAT MED ASSN, V95, P438, DOI 10.7547/0950438; Rayman G, 2011, DIABETES CARE, V34, P1517, DOI 10.2337/dc11-0156; RITHNAJARIAN SJ, 1992, DIABETES CARE, V15, P1386, DOI 10.2337/diacare.15.10.1386; Tesfaye S, 2013, DIABETES CARE, V36, P2456, DOI 10.2337/dc12-1964; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Trignano E, 2016, MICROSURG, V36, P37, DOI 10.1002/micr.22378; Weisman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058783; Yajnik CS, 2013, DIABETES METAB, V39, P126, DOI 10.1016/j.diabet.2012.09.004; Yajnik Chittaranjan S, 2012, ISRN Endocrinol, V2012, P103714, DOI 10.5402/2012/103714; Young M, 2008, DIABETIC FOOT J, V11, P106	35	103	113	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0138224	10.1371/journal.pone.0138224	http://dx.doi.org/10.1371/journal.pone.0138224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457582	gold, Green Accepted, Green Published			2022-12-26	WOS:000362961100003
J	van Gils, JA; Salem, MVA				van Gils, Jan A.; Salem, Mohamed Vall Ahmedou			Validating the Incorporation of C-13 and N-15 in a Shorebird That Consumes an Isotopically Distinct Chemosymbiotic Bivalve	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; RED KNOT; ANIMAL ECOLOGY; TROPHIC SHIFT; BANC DARGUIN; DIET; NITROGEN; CARBON; BLOOD; FRACTIONATION	The wealth of field studies using stable isotopes to make inferences about animal diets require controlled validation experiments to make proper interpretations. Despite several pleas in the literature for such experiments, validation studies are still lagging behind, notably in consumers dwelling in chemosynthesis-based ecosystems. In this paper we present such a validation experiment for the incorporation of C-13 and N-15 in the blood plasma of a medium-sized shorebird, the red knot (Calidris canutus canutus), consuming a chemosymbiotic lucinid bivalve (Loripes lucinalis). Because this bivalve forms a symbiosis with chemoautotrophic sulphide-oxidizing bacteria living inside its gill, the bivalve is isotopically distinct from 'normal' bivalves whose food has a photosynthetic basis. Here we experimentally tested the hypothesis that isotope discrimination and incorporation dynamics are different when consuming such chemosynthesis-based prey. The experiment showed that neither the isotopic discrimination factor, nor isotopic turnover time, differed between birds consuming the chemosymbiotic lucinid and a control group consuming a photosynthesis-based bivalve. This was true for C-13 as well as for N-15. However, in both groups the N-15 discrimination factor was much higher than expected, which probably had to do with the birds losing body mass over the course of the experiment.	[van Gils, Jan A.] NIOZ Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; [Salem, Mohamed Vall Ahmedou] Univ Sci Technol & Med, Dept Biol, EBIOME Ecobiol Marine & Environm, Nouakchott, Mauritania; [Salem, Mohamed Vall Ahmedou] Fac Sci, Dept Biol, Lab Biol Appl & Pathol, Tetouan, Morocco; [Salem, Mohamed Vall Ahmedou] Parc Natl Banc Arguin, Nouakchott, Mauritania	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Abdelmalek Essaadi University of Tetouan	van Gils, JA (corresponding author), NIOZ Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands.	Jan.van.Gils@nioz.nl	van Gils, Jan/B-5544-2008	van Gils, Jan/0000-0002-4132-8243	Netherlands Organisation for Scientific Research (NWO) [864.09.002]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Support was provided by VIDI grant (no. 864.09.002) from the Netherlands Organisation for Scientific Research (NWO) awarded to Jan A. van Gils.	Ahmedou Salem MV, 2014, ESTUAR COAST SHELF S, V136, P26, DOI 10.1016/j.ecss.2013.11.009; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bond AL, 2012, WATERBIRDS, V35, P324, DOI 10.1675/063.035.0213; Catry T, 2016, FUNCT ECOL, V30, P468, DOI 10.1111/1365-2435.12506; Caut S, 2013, BIOL OPEN, V2, P629, DOI 10.1242/bio.20134945; Caut S, 2011, J EXP BIOL, V214, P538, DOI 10.1242/jeb.045104; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Conway N.M., 1994, P158; Coplen TB, 1996, PALEOCEANOGRAPHY, V11, P369, DOI 10.1029/96PA01420; de Fouw J, MULTIPLE DI IN PRESS; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dietz MW, 2013, ISOT ENVIRON HEALT S, V49, P283, DOI 10.1080/10256016.2013.776045; Dietz MW, 2010, CONDOR, V112, P48, DOI 10.1525/cond.2010.090139; Dreier A, 2014, GEOBIOLOGY, V12, P406, DOI 10.1111/gbi.12093; Dreier A, 2012, FEMS MICROBIOL ECOL, V81, P480, DOI 10.1111/j.1574-6941.2012.01374.x; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Focken U, 2001, ISOT ENVIRON HEALT S, V37, P199, DOI 10.1080/10256010108033296; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; HOCH MP, 1992, LIMNOL OCEANOGR, V37, P1447, DOI 10.4319/lo.1992.37.7.1447; Honkoop PJC, 2008, J SEA RES, V60, P235, DOI 10.1016/j.seares.2008.07.005; Huber M, 2015, MOLLUSCABASE WORLD R; JOHNSON M, 1994, SYMBIOSIS, V17, P1; KENNICUTT MC, 1992, CHEM GEOL, V101, P293, DOI 10.1016/0009-2541(92)90009-T; Klaassen M, 2001, NATURE, V413, P794, DOI 10.1038/35101654; KLAASSEN M, 1990, ARDEA, V78, P209; Klaassen M, 2010, FUNCT ECOL, V24, P796, DOI 10.1111/j.1365-2435.2010.01689.x; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Lee TN, 2012, J EXP BIOL, V215, P3354, DOI 10.1242/jeb.068528; LePennec M, 1995, OLSEN INT S, P139; Leyrer J, 2012, BEHAV ECOL, V23, P1226, DOI 10.1093/beheco/ars106; Lourenco PM, 2015, J EXP MAR BIOL ECOL, V472, P89, DOI 10.1016/j.jembe.2015.07.006; Mae A, 2007, PALAEOGEOGR PALAEOCL, V245, P411, DOI 10.1016/j.palaeo.2006.09.003; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; Onrust J, 2013, BIRD STUDY, V60, P298, DOI 10.1080/00063657.2013.811213; Oudman T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136144; Oudman T, 2014, AM NAT, V183, P650, DOI 10.1086/675759; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; Piersma T, 1996, PHYSIOL ZOOL, V69, P191, DOI 10.1086/physzool.69.1.30164207; PIERSMA T, 1993, ARDEA, V81, P1; Piersma T, 2007, J ORNITHOL, V148, pS45, DOI 10.1007/s10336-007-0240-3; Pinheiro J, 2015, NLME LINEAR NONLINEA; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2021, R LANGUAGE ENV STAT; Rossi F, 2013, J EXP MAR BIOL ECOL, V440, P108, DOI 10.1016/j.jembe.2012.12.010; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; RUBY EG, 1987, APPL ENVIRON MICROB, V53, P1940, DOI 10.1128/AEM.53.8.1940-1943.1987; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; van der Geest M, 2013, THESIS; van der Geest M, 2014, MAR ECOL PROG SER, V501, P113, DOI 10.3354/meps10702; Van Dover CL, 2007, ECOL METHOD CONCEPT, P202, DOI 10.1002/9780470691854.ch8; Van Dover CL, 2004, J EXP MAR BIOL ECOL, V300, P273, DOI 10.1016/j.jembe.2003.12.024; van Gils JA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0861; van Gils JA, 2012, ECOLOGY, V93, P1143, DOI 10.1890/11-1282.1; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z	62	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0140221	10.1371/journal.pone.0140221	http://dx.doi.org/10.1371/journal.pone.0140221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26458005	gold, Green Published			2022-12-26	WOS:000362961100026
J	Baumfeld, Y; Novack, L; Wiznitzer, A; Sheiner, E; Henkin, Y; Sherf, M; Novack, V				Baumfeld, Yael; Novack, Lena; Wiznitzer, Arnon; Sheiner, Eyal; Henkin, Yakov; Sherf, Michael; Novack, Victor			Pre-Conception Dyslipidemia Is Associated with Development of Preeclampsia and Gestational Diabetes Mellitus	PLOS ONE			English	Article							BODY-MASS INDEX; LIPID-LEVELS; PREGNANCY; RISK; TRIGLYCERIDES; EXERCISE; WOMEN	Introduction The association between glucose intolerance, elevated blood pressure and abnormal lipid levels is well established and comprises the basis of metabolic syndrome pathophysiology. We hypothesize that abnormal preconception lipid levels are associated with the increased risk of severe pregnancy complications such as preeclampsia and gestational diabetes mellitus. Methods We included all singleton deliveries (n = 27,721) of women without known cardiovascular morbidity and preeclampsia and gestational diabetes mellitus during previous pregnancies. Association between preconception low high density lipoprotein cholesterol (HDLc level <= 50 mg/dL), high triglycerides (level <= 150 mg/dL) and the primary outcome (composite of gestational diabetes mellitus/or preeclampsia) was assessed using Generalized Estimation Equations. Results Primary outcome of preeclampsia and/or gestational diabetes was observed in a total of 3,243 subjects (11.7%). Elevated triglycerides and low HDLc were independently associated with the primary outcome: with odds ratio (OR) of 1.61 (95% CI 1.29-2.01) and OR = 1.33 (95% CI 1.09-1.63), respectively, after adjusting for maternal age, weight, blood pressure, repeated abortions, fertility treatments and fasting glucose. There was an interaction between the effects of HDLc <= 50 mg/dL and triglycerides <= 150 mg/dL with an OR of 2.69 (95% CI 1.73-4.19). Conclusions Our analysis showed an increased rate of preeclampsia and/or gestational diabetes in women with low HDLc and high triglycerides values prior to conception. In view of the severity of these pregnancy complications, we believe this finding warrants a routine screening for the abnormal lipid profile among women of a child-bearing age.	[Baumfeld, Yael; Novack, Victor] Soroka Univ, Med Ctr, Soroka Clin Res Ctr, Beer Sheva, Israel; [Baumfeld, Yael; Wiznitzer, Arnon; Sheiner, Eyal] Soroka Univ, Med Ctr, Dept Obstet & Gynecol, Beer Sheva, Israel; [Novack, Lena] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel; [Henkin, Yakov] Soroka Univ, Med Ctr, Dept Cardiol, Beer Sheva, Israel; [Sherf, Michael] Clalit Hlth Serv, Med Adm, Tel Aviv, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Clalit Health Services	Novack, V (corresponding author), Soroka Univ, Med Ctr, Soroka Clin Res Ctr, Beer Sheva, Israel.	victorno@clalit.org.il	NOVACK, LENA/AAH-8343-2021	NOVACK, LENA/0000-0003-3748-2632				Aucott L, 2011, OBES REV, V12, pe412, DOI 10.1111/j.1467-789X.2010.00819.x; Baksu B, 2005, J OBSTET GYNAECOL RE, V31, P277, DOI 10.1111/j.1447-0756.2005.00276.x; Barrett HL, 2014, DIABETES CARE, V37, P1484, DOI 10.2337/dc13-1934; Bartels A, 2012, J OBSTET GYNAECOL, V32, P747, DOI 10.3109/01443615.2012.714017; Bukan N, 2012, J MATERN-FETAL NEO M, V25, P912, DOI 10.3109/14767058.2011.600363; Catov JM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.024; Emonts P, 2008, HYPERTENS PREGNANCY, V27, P237, DOI 10.1080/10641950802000901; Enquobahrie DA, 2004, AM J HYPERTENS, V17, P574, DOI 10.1016/j.amjhyper.2004.03.666; Ferrara A, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.04.019; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harville EW, 2014, GYNECOL ENDOCRINOL, V30, P840, DOI 10.3109/09513590.2014.937336; HOLLINGSWORTH DR, 1987, AM J OBSTET GYNECOL, V157, P1359, DOI 10.1016/S0002-9378(87)80224-7; Hopkins SA, 2011, CLIN ENDOCRINOL, V74, P495, DOI 10.1111/j.1365-2265.2010.03964.x; Hoppu U, 2014, NUTRITION, V30, P159, DOI 10.1016/j.nut.2013.07.009; Kaaja R, 1999, METABOLISM, V48, P892, DOI 10.1016/S0026-0495(99)90225-1; Kastelein JJP, 2014, J CLIN LIPIDOL, V8, P94, DOI 10.1016/j.jacl.2013.10.003; Khoury J, 2005, AM J OBSTET GYNECOL, V193, P1292, DOI 10.1016/j.ajog.2005.05.016; Loprinzi PD, 2013, J WOMENS HEALTH, V22, P953, DOI 10.1089/jwh.2013.4394; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; MASEKI M, 1981, CLIN CHIM ACTA, V115, P155; Nerenberg K, 2014, CAN J CARDIOL, V30, P765, DOI 10.1016/j.cjca.2013.12.030; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Vahratian A, 2010, OBSTET GYNECOL, V116, P107, DOI 10.1097/AOG.0b013e3181e45d23; Wiznitzer A, 2009, AJOG; Zhao YN, 2014, J OBSTET GYNAECOL RE, V40, P705, DOI 10.1111/jog.12240	27	31	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139164	10.1371/journal.pone.0139164	http://dx.doi.org/10.1371/journal.pone.0139164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452270	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200005
J	Kelling, S; Johnston, A; Hochachka, WM; Iliff, M; Fink, D; Gerbracht, J; Lagoze, C; La Sorte, FA; Moore, T; Wiggins, A; Wong, WK; Wood, C; Yu, J				Kelling, Steve; Johnston, Alison; Hochachka, Wesley M.; Iliff, Marshall; Fink, Daniel; Gerbracht, Jeff; Lagoze, Carl; La Sorte, Frank A.; Moore, Travis; Wiggins, Andrea; Wong, Weng-Keen; Wood, Chris; Yu, Jun			Can Observation Skills of Citizen Scientists Be Estimated Using Species Accumulation Curves?	PLOS ONE			English	Article							SCIENCE; CONSERVATION; EBIRD; NETWORK; BIAS; TOOL	Volunteers are increasingly being recruited into citizen science projects to collect observations for scientific studies. An additional goal of these projects is to engage and educate these volunteers. Thus, there are few barriers to participation resulting in volunteer observers with varying ability to complete the project's tasks. To improve the quality of a citizen science project's outcomes it would be useful to account for inter-observer variation, and to assess the rarely tested presumption that participating in a citizen science projects results in volunteers becoming better observers. Here we present a method for indexing observer variability based on the data routinely submitted by observers participating in the citizen science project eBird, a broad-scale monitoring project in which observers collect and submit lists of the bird species observed while birding. Our method for indexing observer variability uses species accumulation curves, lines that describe how the total number of species reported increase with increasing time spent in collecting observations. We find that differences in species accumulation curves among observers equates to higher rates of species accumulation, particularly for harder-to-identify species, and reveals increased species accumulation rates with continued participation. We suggest that these properties of our analysis provide a measure of observer skill, and that the potential to derive post-hoc data-derived measurements of participant ability should be more widely explored by analysts of data from citizen science projects. We see the potential for inferential results from analyses of citizen science data to be improved by accounting for observer skill.	[Kelling, Steve; Hochachka, Wesley M.; Iliff, Marshall; Fink, Daniel; Gerbracht, Jeff; La Sorte, Frank A.; Wood, Chris] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Johnston, Alison] British Trust Ornithol, Thetford, Norfolk, England; [Lagoze, Carl] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA; [Moore, Travis; Wong, Weng-Keen; Yu, Jun] Oregon State Univ, Sch Elect Engn & Comp Sci, Corvallis, OR 97331 USA; [Wiggins, Andrea] Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA	Cornell University; British Trust for Ornithology; University of Michigan System; University of Michigan; Oregon State University; University System of Maryland; University of Maryland College Park	Kelling, S (corresponding author), Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA.	stk2@cornell.edu	Hochachka, Wesley M./J-9768-2012; Johnston, Alison/N-4820-2016	Hochachka, Wesley M./0000-0002-0595-7827; Johnston, Alison/0000-0001-8221-013X	Leon Levy Foundation; Seaver Institute; Wolf Creek Foundation; National Science Foundation [IIS-1238371, IIS-1209714]; Div Of Biological Infrastructure [1356308] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1209714] Funding Source: National Science Foundation	Leon Levy Foundation; Seaver Institute; Wolf Creek Foundation; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the Leon Levy Foundation (http://leonlevyfoundation.org), Seaver Institute, Wolf Creek Foundation, and the National Science Foundation (IIS-1238371 and IIS-1209714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Comber A, 2013, INT J APPL EARTH OBS, V23, P37, DOI 10.1016/j.jag.2012.11.002; Crowston K, 2013, P ANN HICSS, P450, DOI 10.1109/HICSS.2013.413; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Farmer RG, 2014, ECOL EVOL, V4, P2563, DOI 10.1002/ece3.1101; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; GINI C, 1965, J R STAT SOC SER A-G, V128, P89, DOI 10.2307/2343438; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Kelling S, 2015, AMBIO J HUM IN PRESS; Kelling S., 2011, CITIZEN SCI PUBLIC C; Kelling S, 2011, E SCI WORKSH 2011 IE; Kelling S, 2013, AI MAG, V34, P10; Kepler C.B., 1981, Studies in Avian Biology, P366; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Pearman PB, 2007, BIOL CONSERV, V138, P109, DOI 10.1016/j.biocon.2007.04.005; Pinheiro J., 2019, NLME LINEAR NONLINEA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Sauer JR, 2003, J WILDLIFE MANAGE, V67, P372, DOI 10.2307/3802778; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Simons TR, 2009, ENVIRON ECOL STAT SE, V3, P237, DOI 10.1007/978-0-387-78151-8_10; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Vittoz P, 2010, J VEG SCI, V21, P1035, DOI 10.1111/j.1654-1103.2010.01216.x; Wilkinson DM, 2008, EC'08: PROCEEDINGS OF THE 2008 ACM CONFERENCE ON ELECTRONIC COMMERCE, P302; Wood C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001220; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	40	55	57	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139600	10.1371/journal.pone.0139600	http://dx.doi.org/10.1371/journal.pone.0139600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451728	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200015
J	Kozanian, OO; Abbott, CW; Huffman, KJ				Kozanian, Olga O.; Abbott, Charles W.; Huffman, Kelly J.			Rapid Changes in Cortical and Subcortical Brain Regions after Early Bilateral Enucleation in the Mouse	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; EVENT-RELATED POTENTIALS; PRIMARY VISUAL-CORTEX; LIFE-SPAN ANALYSIS; CONGENITALLY BLIND; EPHRIN-AS; INTRANEOCORTICAL CONNECTIONS; GENE-EXPRESSION; THALAMOCORTICAL PROJECTIONS; POSTNATAL-DEVELOPMENT	Functional sensory and motor areas in the developing mammalian neocortex are formed through a complex interaction of cortically intrinsic mechanisms, such as gene expression, and cortically extrinsic mechanisms such as those mediated by thalamic input from the senses. Both intrinsic and extrinsic mechanisms are believed to be involved in cortical patterning and the establishment of areal boundaries in early development; however, the nature of the interaction between intrinsic and extrinsic processes is not well understood. In a previous study, we used a perinatal bilateral enucleation mouse model to test some aspects of this interaction by reweighting sensory input to the developing cortex. Visual deprivation at birth resulted in a shift of intraneocortical connections (INCs) that aligned with ectopic ephrin A5 expression in the same location ten days later at postnatal day (P) 10. A prevailing question remained: Does visual deprivation first induce a change in gene expression, followed by a shift in INCs, or vice versa? In the present study, we address this question by investigating the neuroanatomy and patterns of gene expression in post-natal day (P) 1 and 4 mice following bilateral enucleation at birth. Our results demonstrate a rapid reduction in dorsal lateral geniculate nucleus (dLGN) size and ephrin A5 gene expression 24-hours post-enucleation, with more profound effects apparent at P4. The reduced nuclear size and diminished gene expression mirrors subtle changes in ephrin A5 expression evident in P1 and P4 enucleated neocortex, 11 and 8 days prior to natural eye opening, respectively. Somatosensory and visual INCs were indistinguishable between P1 and P4 mice bilaterally enucleated at birth, indicating that perinatal bilateral enucleation initiates a rapid change in gene expression (within one day) followed by an alteration of sensory INCs later on (second postnatal week). With these results, we gain a deeper understanding of how gene expression and sensory input together regulate cortical arealization and plasticity during early development.	[Kozanian, Olga O.; Huffman, Kelly J.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Abbott, Charles W.; Huffman, Kelly J.] Univ Calif Riverside, Interdept Neurosci Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Huffman, KJ (corresponding author), Univ Calif Riverside, Dept Psychol, 900 Univ Ave, Riverside, CA 92521 USA.	kelly.huffman@ucr.edu			National Institutes of Mental Health [5R03MH080502-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH080502] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Mental Health (5R03MH080502-02 to KJH) (http://www.nimh.nih.gov/index.shtml).	Abbott CW, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00144; Antonini A, 1999, J NEUROSCI, V19, P4388; ASANUMA C, 1990, NEUROSCIENCE, V39, P533, DOI 10.1016/0306-4522(90)90241-U; Bansal A, 2000, J NEUROSCI, V20, P7672; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Campi KL, 2010, J COMP NEUROL, V518, P4491, DOI 10.1002/cne.22466; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; CYNADER M, 1983, DEV BRAIN RES, V8, P155, DOI 10.1016/0165-3806(83)90002-0; Dahlhaus M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005413; Dehay C, 1996, J COMP NEUROL, V367, P70, DOI 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G; Dye CA, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-5; Dye CA, 2011, CEREB CORTEX, V21, P1331, DOI 10.1093/cercor/bhq213; Dye CA, 2011, CEREB CORTEX, V21, P1311, DOI 10.1093/cercor/bhq212; Feldheim DA, 2010, COLD SPRING HARB PER, V2, P1; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gordon JA, 1996, J NEUROSCI, V16, P3274; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; HEUMANN D, 1980, EXP BRAIN RES, V38, P75; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huffman KJ, 2004, J NEUROSCI, V24, P8917, DOI 10.1523/JNEUROSCI.2086-04.2004; Izraeli R, 2002, EUR J NEUROSCI, V15, P693, DOI 10.1046/j.1460-9568.2002.01902.x; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Karlen SJ, 2009, CEREB CORTEX, V19, P1360, DOI 10.1093/cercor/bhn176; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Molnar Z, 2003, CEREB CORTEX, V13, P661, DOI 10.1093/cercor/13.6.661; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; ROBERTSON RT, 1989, DEV BRAIN RES, V47, P209, DOI 10.1016/0165-3806(89)90177-6; Roder B, 2000, NEUROPSYCHOLOGIA, V38, P1482, DOI 10.1016/S0028-3932(00)00057-9; Roder B, 1999, NEUROSCI LETT, V264, P53, DOI 10.1016/S0304-3940(99)00182-2; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; WARTON SS, 1988, EXP NEUROL, V100, P23, DOI 10.1016/0014-4886(88)90198-7; Weeks R, 2000, J NEUROSCI, V20, P2664; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Williams AL, 2002, J COMP NEUROL, V445, P269, DOI 10.1002/cne.10171; WILLIAMS R W, 1987, Society for Neuroscience Abstracts, V13, P1044; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Yaka R, 1999, EUR J NEUROSCI, V11, P1301, DOI 10.1046/j.1460-9568.1999.00536.x; Zacharaki T, 2010, BRAIN RES, V1344, P62, DOI 10.1016/j.brainres.2010.05.021	59	7	7	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140391	10.1371/journal.pone.0140391	http://dx.doi.org/10.1371/journal.pone.0140391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452243	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200068
J	Sisnande, T; Guerreiro, LH; Braga, RR; Jotha-Mattos, L; Erthal, LCS; Tinoco, P; Ferreira, BM; Lima, LMTR				Sisnande, Thana; Guerreiro, Luiz Henrique; Braga, Raquel R.; Jotha-Mattos, Luana; Erthal, Luiza C. S.; Tinoco, Priscilla; Ferreira, Bruno M.; Lima, Luis Mauricio T. R.			Monoconjugation of Human Amylin with Methylpolyethyleneglycol	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; INSULIN-DEGRADING ENZYME; AMERICAN-DIABETES-ASSOCIATION; FIBRIL FORMATION; CALCITONIN RECEPTORS; POSITION STATEMENT; GLUCOSE-METABOLISM; GLUCAGON-SECRETION; GLYCEMIC CONTROL; LIPID-MEMBRANES	Amylin is a pancreatic hormone cosecreted with insulin that exerts unique roles in metabolism and glucose homeostasis. The therapeutic restoration of postprandial and basal amylin levels is highly desirable in diabetes mellitus. Protein conjugation with the biocompatible polymer polyethylene glycol (PEG) has been shown to extend the biological effects of bio-pharmaceuticals. We have designed a PEGylated human amylin by using the aminoreactive compound methoxylpolyethylene glycol succinimidyl carbonate (mPEGsc). The synthesis in organic solvent resulted in high yields of monoPEGylated human amylin, which showed large stability against aggregation, an 8 times increase in half-life in vivo compared to the non-conjugated amylin, and pharmacological activity as shown by modulation of cAMP production in MCF-7 cell line, decrease in glucagon and modulation of glycemia following subcutaneous administration in mice. Altogether these data reveal the potential use of PEGylated human amylin for the restoration of fasting amylin levels.	[Sisnande, Thana; Braga, Raquel R.; Jotha-Mattos, Luana; Erthal, Luiza C. S.; Ferreira, Bruno M.; Lima, Luis Mauricio T. R.] Fed Univ Rio de Janeiro UFRJ, CCS, BR-21941590 Rio De Janeiro, RJ, Brazil; [Guerreiro, Luiz Henrique; Tinoco, Priscilla] Univ Fed Rural Rio de Janeiro, Rural Fed Univ Rio de Janeiro, Inst Exact Sci, Dept Chem, BR-23890000 Seropedica, RJ, Brazil; [Lima, Luis Mauricio T. R.] Brazilian Natl Inst Metrol Qual & Technol INMETRO, Lab Macromol LAMAC DIMAV, BR-25250020 Rio De Janeiro, Brazil; [Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Natl Inst Sci & Technol Struct Biol & Bioimaging, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Lima, LMTR (corresponding author), Fed Univ Rio de Janeiro UFRJ, CCS, Bss24, BR-21941590 Rio De Janeiro, RJ, Brazil.	lml@ufrj.br	Rosado, Luiz L H/N-1472-2015; Lima, Luis Mauricio/AAL-2098-2021	Rosado, Luiz L H/0000-0002-9390-8397; Sisnande, Thayna/0000-0002-9474-0581; TR Lima, Luis Mauricio/0000-0001-6020-0504	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [403525/2012-8, 472779/2012-5]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ) [E-26/103.260/2011, E-26-111.383/2010]; BioZeus Desenvolvimento de Produtos Biofarmaceuticos S.A.	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); BioZeus Desenvolvimento de Produtos Biofarmaceuticos S.A.	This research was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; www.cnpq.br; 403525/2012-8; 472779/2012-5), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ; www.faperj.br; E-26/103.260/2011; E-26-111.383/2010) and the BioZeus Desenvolvimento de Produtos Biofarmaceuticos S.A. (for financial support for the cAMP assay). The funding agencies had no role in the study design, data collection and analysis, or decision to publish, or prepare of the manuscript.	Abedini A, 2006, ANAL BIOCHEM, V351, P181, DOI 10.1016/j.ab.2005.11.029; Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Akesson B, 2003, REGUL PEPTIDES, V111, P55, DOI 10.1016/S0167-0115(02)00252-5; Amylin Pharmaceuticals, 2015, SYML R PRAML AC INJ; [Anonymous], 1999, Drugs R D, V2, P118; Bellia F, 2014, J MASS SPECTROM, V49, P274, DOI 10.1002/jms.3338; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Castle AL, 1998, AM J PHYSIOL-ENDOC M, V274, pE6, DOI 10.1152/ajpendo.1998.274.1.E6; Chen WJ, 1997, MOL PHARMACOL, V52, P1164, DOI 10.1124/mol.52.6.1164; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; CHISHOLM DJ, 1993, MED J AUSTRALIA, V159, P721, DOI 10.5694/j.1326-5377.1993.tb141332.x; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Clodi M, 1998, AM J PHYSIOL-ENDOC M, V274, pE903, DOI 10.1152/ajpendo.1998.274.5.E903; COOPER GJS, 1988, P NATL ACAD SCI USA, V85, P7763, DOI 10.1073/pnas.85.20.7763; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; COOPER GJS, 1991, MED HYPOTHESES, V36, P284, DOI 10.1016/0306-9877(91)90150-W; Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Fahrmann ER, 2015, DIABETES RES CLIN PR, V107, P280, DOI 10.1016/j.diabres.2014.10.007; Fee CJ, 2009, MILESTONES DRUG THER, P113, DOI 10.1007/978-3-7643-8679-5_7; Freitas DD, 2010, INT J PHARMACEUT, V392, P111, DOI 10.1016/j.ijpharm.2010.03.036; Gedulin BR, 1997, METABOLISM, V46, P67, DOI 10.1016/S0026-0495(97)90170-0; Gedulin BR, 2006, REGUL PEPTIDES, V137, P121, DOI 10.1016/j.regpep.2006.06.004; Gilead S, 2006, ANGEW CHEM INT EDIT, V45, P6476, DOI 10.1002/anie.200602034; Guerreiro L, 2013, AN ACAD BRAS CIENC, V85, P143; Guerreiro LH, 2013, AAPS PHARMSCITECH, V14, P1083, DOI 10.1208/s12249-013-9987-4; Guerreiro LH, 2012, COLLOID SURFACE B, V94, P101, DOI 10.1016/j.colsurfb.2012.01.021; Guterres MF, 2013, PROTEIN PEPT LETT; Hollander PA, 2003, DIABETES CARE, V26, P784, DOI 10.2337/diacare.26.3.784; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jaikaran ETAS, 2004, BIOCHEM J, V377, P709, DOI 10.1042/bj20030852; Jha S, 2009, J MOL BIOL, V389, P907, DOI 10.1016/j.jmb.2009.04.077; Jiang P, 2010, J PHYS CHEM B, V114, P10176, DOI 10.1021/jp101811u; Joslin EP, 1924, CAN MED ASSOC J, V14, P808; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Knight JD, 2008, PROTEIN SCI, V17, P1850, DOI 10.1110/ps.036350.108; Knowles NG, 2002, DIABETES CARE, V25, P292, DOI 10.2337/diacare.25.2.292; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson JL, 2004, J MOL BIOL, V335, P221, DOI 10.1016/j.jmb.2003.10.045; Ludvik B, 2003, EUR J CLIN INVEST, V33, P316, DOI 10.1046/j.1365-2362.2003.01142.x; Lutz TA, 2010, AM J PHYSIOL-REG I, V298, pR1475, DOI 10.1152/ajpregu.00703.2009; MacArthur DLA, 1999, DIABETOLOGIA, V42, P1219, DOI 10.1007/s001250051295; Marrero DG, 2007, DIABETES CARE, V30, P210, DOI 10.2337/dc06-1026; Masad A, 2007, FEBS LETT, V581, P3489, DOI 10.1016/j.febslet.2007.06.061; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Milton NGN, 2013, MICRON, V44, P246, DOI 10.1016/j.micron.2012.07.001; Mirhashemi Seyyed Mehdi, 2011, Pak J Biol Sci, V14, P288; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen L, 2001, J PHARM SCI-US, V90, P29, DOI 10.1002/1520-6017(200101)90:1<29::AID-JPS4>3.0.CO;2-4; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; Nilsson MR, 2001, ANAL BIOCHEM, V288, P76, DOI 10.1006/abio.2000.4887; Nyholm B, 1999, METABOLISM, V48, P935, DOI 10.1016/S0026-0495(99)90232-9; Opie EL, 1901, J EXP MED, V5, P527, DOI 10.1084/jem.5.5.527; Palmieri LC, 2013, BIOPHYS CHEM, V180, P135, DOI 10.1016/j.bpc.2013.07.013; PANAGIOTIDIS G, 1992, DIABETES RES CLIN PR, V18, P167, DOI 10.1016/0168-8227(92)90142-E; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pencek R, 2010, DIABETES OBES METAB, V12, P548, DOI 10.1111/j.1463-1326.2010.01201.x; Porat Y, 2003, BIOCHEMISTRY-US, V42, P10971, DOI 10.1021/bi034889i; Riddle M, 2007, DIABETES CARE, V30, P2794, DOI 10.2337/dc07-0589; Salamekh S, 2011, J MOL BIOL, V410, P294, DOI 10.1016/j.jmb.2011.05.015; Scaramuzza S, 2012, J CONTROL RELEASE, V164, P355, DOI 10.1016/j.jconrel.2012.06.026; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seeliger J, 2012, ANGEW CHEM INT EDIT, V51, P679, DOI 10.1002/anie.201105877; Sellin D, 2010, BIOPHYS CHEM, V150, P73, DOI 10.1016/j.bpc.2010.01.006; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Traina AN, 2011, DIABETES EDUCATOR, V37, P426, DOI 10.1177/0145721711403011; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Wang F, 1999, AM J PHYSIOL-ENDOC M, V276, pE19, DOI 10.1152/ajpendo.1999.276.1.E19; Ward B, 2008, J INORG BIOCHEM, V102, P371, DOI 10.1016/j.jinorgbio.2007.09.010; Wei L, 2009, BIOCHEMISTRY-US, V48, P2368, DOI 10.1021/bi802097b; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Weyer C, 2005, AM J HEALTH-SYST PH, V62, P816, DOI 10.1093/ajhp/62.8.816; Young A., 2005, AMYLIN PHYSL PHARM; Young AA, 1996, DRUG DEVELOP RES, V37, P231, DOI 10.1002/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M; YOUNG DA, 1990, AM J PHYSIOL, V259, pE457, DOI 10.1152/ajpendo.1990.259.3.E457; Younk LM, 2011, EXPERT OPIN PHARMACO, V12, P1439, DOI 10.1517/14656566.2011.581663; Zimmermann U, 1997, J ENDOCRINOL, V155, P423, DOI 10.1677/joe.0.1550423; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	82	17	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0138803	10.1371/journal.pone.0138803	http://dx.doi.org/10.1371/journal.pone.0138803			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448437	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511000013
J	Yokoyama, T; Yoshizaki, A; Simon, KL; Kirby, MR; Anderson, SM; Candotti, F				Yokoyama, Tadafumi; Yoshizaki, Ayumi; Simon, Karen L.; Kirby, Martha R.; Anderson, Stacie M.; Candotti, Fabio			Age-Dependent Defects of Regulatory B Cells in Wiskott-Aldrich Syndrome Gene Knockout Mice	PLOS ONE			English	Article							SYNDROME PROTEIN-DEFICIENCY; T-CELLS; AUTOIMMUNITY; WASP; ABNORMALITIES; HOMEOSTASIS; IGA	The Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency characterized by recurrent infections, thrombocytopenia, eczema, and high incidence of malignancy and autoimmunity. The cellular mechanisms underlying autoimmune complications in WAS have been extensively studied; however, they remain incompletely defined. We investigated the characteristics of IL-10-producing CD19(+)CD1d(high)CD5(+) B cells (CD1d(high)CD5(+) Breg) obtained from Was gene knockout (WKO) mice and found that their numbers were significantly lower in these mice compared to wild type (WT) controls. Moreover, we found a significant age-dependent reduction of the percentage of IL-10-expressing cells in WKO CD1d(high)CD5(+) Breg cells as compared to age-matched WT control mice. CD1d(high)CD5(+) Breg cells from older WKO mice did not suppress the in vitro production of inflammatory cytokines from activated CD4(+) T cells. Interestingly, CD1d(high)CD5(+) Breg cells from older WKO mice displayed a basal activated phenotype which may prevent normal cellular responses, among which is the expression of IL-10. These defects may contribute to the susceptibility to autoimmunity with age in patients with WAS.	[Yokoyama, Tadafumi; Simon, Karen L.; Kirby, Martha R.; Anderson, Stacie M.; Candotti, Fabio] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Yokoyama, Tadafumi; Simon, Karen L.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Yoshizaki, Ayumi] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan; [Candotti, Fabio] Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Tokyo; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Candotti, F (corresponding author), NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.	Fabio.Candotti@chuv.ch	Yoshizaki, Ayumi/AAN-1548-2021	Yoshizaki, Ayumi/0000-0002-8194-9140; Candotti, Fabio/0000-0001-6399-6042	National Human Genome Research Institute, NIH [Z01-HG000121]; Swiss National Science Foundation [310030_156795]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200350, Z01HG000121] Funding Source: NIH RePORTER	National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Funds of the National Human Genome Research Institute, NIH (Project Z01-HG000121), and the Swiss National Science Foundation (Grant no. 310030_156795).	Adriani M, 2007, CLIN IMMUNOL, V124, P41, DOI 10.1016/j.clim.2007.02.001; Adriani M, 2011, BLOOD, V117, P6608, DOI 10.1182/blood-2010-12-322834; Bouma G, 2014, EUR J IMMUNOL, V44, P2692, DOI 10.1002/eji.201344245; Du HQ, 2015, SCAND J IMMUNOL, V81, P483, DOI 10.1111/sji.12282; Dupuis-Girod S, 2003, PEDIATRICS, V111, pE622, DOI 10.1542/peds.111.5.e622; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; Ramesh N, 2009, IMMUNOL RES, V44, P99, DOI 10.1007/s12026-008-8086-1; Recher M, 2012, BLOOD, V119, P2819, DOI 10.1182/blood-2011-09-379412; Schurman SH, 2003, CURR OPIN RHEUMATOL, V15, P446, DOI 10.1097/00002281-200307000-00012; Shimizu M, 2012, CLIN IMMUNOL, V142, P160, DOI 10.1016/j.clim.2011.10.001; Shimizu M, 2013, J ALLERGY CLIN IMMUN, V131, P587, DOI 10.1016/j.jaci.2012.08.040; Simon KL, 2014, J ALLERGY CLIN IMMUN, V133, P896, DOI 10.1016/j.jaci.2013.08.050; Wada T, 2005, BLOOD, V106, P3895, DOI 10.1182/blood-2005-06-2336; Westerberg LS, 2008, BLOOD, V112, P4139, DOI 10.1182/blood-2008-02-140715; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	20	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139729	10.1371/journal.pone.0139729	http://dx.doi.org/10.1371/journal.pone.0139729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448644	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000049
J	Kang, M; Eisen, TJ; Eisen, EA; Chakraborty, AK; Eisen, HN				Kang, Myungsun; Eisen, Timothy J.; Eisen, Ellen A.; Chakraborty, Arup K.; Eisen, Herman N.			Affinity Inequality among Serum Antibodies That Originate in Lymphoid Germinal Centers	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; B-CELL SELECTION; PURIFIED ANTIBODY; DENDRITIC CELLS; ANTIGEN; BINDING; HAPTEN; AZOPROTEINS; REPERTOIRE; MATURATION	Upon natural infection with pathogens or vaccination, antibodies are produced by a process called affinity maturation. As affinity maturation ensues, average affinity values between an antibody and ligand increase with time. Purified antibodies isolated from serum are invariably heterogeneous with respect to their affinity for the ligands they bind, whether macromolecular antigens or haptens (low molecular weight approximations of epitopes on antigens). However, less is known about how the extent of this heterogeneity evolves with time during affinity maturation. To shed light on this issue, we have taken advantage of previously published data from Eisen and Siskind (1964). Using the ratio of the strongest to the weakest binding subsets as a metric of heterogeneity (or affinity inequality), we analyzed antibodies isolated from individual serum samples. The ratios were initially as high as 50-fold, and decreased over a few weeks after a single injection of small antigen doses to around unity. This decrease in the effective heterogeneity of antibody affinities with time is consistent with Darwinian evolution in the strong selection limit. By contrast, neither the average affinity nor the heterogeneity evolves much with time for high doses of antigen, as competition between clones of the same affinity is minimal.	[Kang, Myungsun; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kang, Myungsun; Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Eisen, Timothy J.; Eisen, Herman N.] MIT, Dept Biol, Cambridge, MA USA; [Eisen, Timothy J.] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; [Eisen, Ellen A.] Univ Calif Berkeley, Sch Publ Hlth, Environm Hlth Sci, Berkeley, CA 94720 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Massachusetts Gen Hosp, MIT, Ragon Inst, Cambridge, MA USA; [Chakraborty, Arup K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Eisen, Herman N.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Chakraborty, AK (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	arupc@mit.edu; eeisen@berkeley.edu			Ragon Institute of MGH; Samsung Scholarship Foundation; National Science Foundation Graduate Research Fellowship [1122374]; Ragon Institute of MIT; Ragon Institute of Harvard	Ragon Institute of MGH; Samsung Scholarship Foundation(Samsung); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ragon Institute of MIT; Ragon Institute of Harvard	AKC and MSK are supported by the Ragon Institute of MGH, MIT, & Harvard (ragoninstitute.org) and the Samsung Scholarship Foundation (http://www.ssscholarship.com/), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TJE is supported by National Science Foundation Graduate Research Fellowship under Grant No. 1122374. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EAE and HNE received no specific funding for this work.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Boyd WC, 1937, J IMMUNOL, V33, P111; BRENNEMAN L, 1968, P NATL ACAD SCI USA, V60, P258, DOI 10.1073/pnas.60.1.258; CHEN LL, 1978, J CELL BIOL, V79, P184, DOI 10.1083/jcb.79.1.184; EISEN HERMAN N., 1966, HARVEY LECT, V60, P1; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; EISEN HN, 1949, J AM CHEM SOC, V71, P363, DOI 10.1021/ja01169a505; Fields BA, 1996, BIOCHEMISTRY-US, V35, P15494, DOI 10.1021/bi961709e; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; FUJIO H, 1966, BIOCHEMISTRY-US, V5, P1856, DOI 10.1021/bi00870a011; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gray EE, 2013, LYMPH NODE MACROPHAG, V4, P424; KARUSH F, 1956, J AM CHEM SOC, V78, P5519, DOI 10.1021/ja01602a017; KARUSH F, 1962, ADV IMMUNOL, V2, P1; KARUSH F, 1957, J IMMUNOL, V78, P296; KARUSH F, 1950, ANAL CHEM, V22, P175, DOI 10.1021/ac60037a035; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; Landsteiner K, 1936, J EXP MED, V63, P325, DOI 10.1084/jem.63.3.325; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; Meyer-Hermann M, 2001, J THEOR BIOL, V210, P265, DOI 10.1006/jtbi.2001.2297; Meyer-Hermann M, 2012, CELL REP, V2, P162, DOI 10.1016/j.celrep.2012.05.010; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; NISONOFF A, 1958, J IMMUNOL, V80, P417; O'Neill SK, 2009, P NATL ACAD SCI USA, V106, P6262, DOI 10.1073/pnas.0812922106; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; PARKER CW, 1967, BIOCHEMISTRY-US, V6, P3408, DOI 10.1021/bi00863a011; Pauling L, 1944, J AM CHEM SOC, V66, P784, DOI 10.1021/ja01233a039; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Shannon M, 1999, J IMMUNOL, V162, P3950; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922; TEW JG, 1980, IMMUNOL REV, V53, P175; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; WERBLIN TP, 1972, IMMUNOCHEMISTRY, V9, P987, DOI 10.1016/0019-2791(72)90110-3; Zhang JS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000800	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139222	10.1371/journal.pone.0139222	http://dx.doi.org/10.1371/journal.pone.0139222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444899	Green Published, gold			2022-12-26	WOS:000362510600048
J	Reither, K; Jugheli, L; Glass, TR; Sasamalo, M; Mhimbira, FA; Weetjens, BJ; Cox, C; Edwards, TL; Mulder, C; Beyene, NW; Mahoney, A				Reither, Klaus; Jugheli, Levan; Glass, Tracy R.; Sasamalo, Mohamed; Mhimbira, Francis A.; Weetjens, Bart J.; Cox, Christophe; Edwards, Timothy L.; Mulder, Christiaan; Beyene, Negussie W.; Mahoney, Amanda			Evaluation of Giant African Pouched Rats for Detection of Pulmonary Tuberculosis in Patients from a High-Endemic Setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SPUTUM; SENSITIVITY; DIAGNOSIS; MICROFLORA; VOLATILES; HIV	Background This study established evidence about the diagnostic performance of trained giant African pouched rats for detecting Mycobacterium tuberculosis in sputum of well-characterised patients with presumptive tuberculosis (TB) in a high-burden setting. Methods The TB detection rats were evaluated using sputum samples of patients with presumptive TB enrolled in two prospective cohort studies in Bagamoyo, Tanzania. The patients were characterised by sputum smear microscopy and culture, including subsequent antigen or molecular confirmation of Mycobacterium tuberculosis, and by clinical data at enrolment and for at least 5-months of follow-up to determine the reference standard. Seven trained giant African pouched rats were used for the detection of TB in the sputum samples after shipment to the APOPO project in Morogoro, Tanzania. Results Of 469 eligible patients, 109 (23.2%) were culture-positive for Mycobacterium tuberculosis and 128 (27.3%) were non-TB controls with sustained recovery after 5 months without anti-TB treatment. The HIV prevalence was 46%. The area under the receiver operating characteristic curve of the seven rats for the detection of culture-positive pulmonary tuberculosis was 0.72 (95% CI 0.66-0.78). An optimal threshold could be defined at >= 2 indications by rats in either sample with a corresponding sensitivity of 56.9% (95% CI 47.0-66.3), specificity of 80.5% (95% CI 72.5-86.9), positive and negative predictive value of 71.3% (95% CI 60.6-80.5) and 68.7%(95% CI 60.6-76.0), and an accuracy for TB diagnosis of 69.6%. The diagnostic performance was negatively influenced by low burden of bacilli, and independent of the HIV status. Conclusion Giant African pouched rats have potential for detection of tuberculosis in sputum samples. However, the diagnostic performance characteristics of TB detection rats do not currently meet the requirements for high-priority, rapid sputum-based TB diagnostics as defined by the World Health Organization.	[Reither, Klaus; Jugheli, Levan; Glass, Tracy R.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Reither, Klaus; Jugheli, Levan; Glass, Tracy R.] Univ Basel, Basel, Switzerland; [Reither, Klaus; Jugheli, Levan; Sasamalo, Mohamed; Mhimbira, Francis A.] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Weetjens, Bart J.; Cox, Christophe; Edwards, Timothy L.; Mulder, Christiaan; Beyene, Negussie W.; Mahoney, Amanda] APOPO, Morogoro, Tanzania; [Edwards, Timothy L.; Mahoney, Amanda] Western Michigan Univ, Dept Psychol, Kalamazoo, MI 49008 USA; [Mulder, Christiaan] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; Western Michigan University	Reither, K (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	Klaus.Reither@unibas.ch	Mahoney, Amanda/AAY-6458-2021; Glass, Tracy R/D-5046-2017; Mahoney, Amanda/AAA-2398-2019	Mahoney, Amanda/0000-0002-2239-0295; Glass, Tracy R/0000-0001-7075-9803; Edwards, Timothy/0000-0002-1569-5656; Mhimbira, Francis/0000-0001-8989-6832; Reither, Klaus/0000-0001-6195-8237; Beyene, Negussie/0000-0003-0529-6667	Rudolf Geigy Foundation, Switzerland; European and Developing Countries Clinical Trials Partnership (EDCTP) as part of project "Evaluation of new and emerging diagnostics for childhood tuberculosis in high burden countries" [IP.2009.32040.007]; UBS Optimus Foundation	Rudolf Geigy Foundation, Switzerland; European and Developing Countries Clinical Trials Partnership (EDCTP) as part of project "Evaluation of new and emerging diagnostics for childhood tuberculosis in high burden countries"; UBS Optimus Foundation	The TB Cohort project was supported by the Rudolf Geigy Foundation, Switzerland (http://www.geigystiftung.ch/de/die-stiftung.html). The TB CHILD project was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) as part of project "Evaluation of new and emerging diagnostics for childhood tuberculosis in high burden countries" [IP.2009.32040.007] (http://www.edctp.org/annualreport2010/grants_2010/lwilla. html). The APOPO project was partially funded by UBS Optimus Foundation (https://www.ubs.com/global/en/wealth_management/optimusfoundation/support/all-projects.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bomers MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7396; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Chamie G, 2010, INT J TUBERC LUNG D, V14, P1295; Dang NA, 2015, J CHROMATOGR B, V986, P115, DOI 10.1016/j.jchromb.2015.01.045; Denkinger CM, 2015, J INFECT DIS, V211, pS29, DOI 10.1093/infdis/jiu821; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Hegde MC, 2014, INDIAN J OTOLARYNGOL, V66, pS126, DOI 10.1007/s12070-011-0370-z; Huang L, 2009, RESPIROLOGY, V14, P474, DOI 10.1111/j.1440-1843.2009.01534.x; Joloba ML, 2000, INT J TUBERC LUNG D, V4, P528; Mahoney Amanda, 2012, Tuberc Res Treat, V2012, P716989, DOI 10.1155/2012/716989; Mahoney AM, 2011, PAN AFR MED J, V9; Mgode GF, 2015, CURR MICROBIOL, V70, P212, DOI 10.1007/s00284-014-0705-6; Mgode GF, 2012, TUBERCULOSIS, V92, P535, DOI 10.1016/j.tube.2012.07.006; Mgode GF, 2012, TUBERCULOSIS, V92, P182, DOI 10.1016/j.tube.2011.11.008; Mgode GF, 2012, J CLIN MICROBIOL, V50, P274, DOI 10.1128/JCM.01199-11; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Nawrath T, 2012, BEILSTEIN J ORG CHEM, V8, P290, DOI 10.3762/bjoc.8.31; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P509, DOI 10.1586/14737159.6.4.509; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Peeling RW, 2006, NAT REV MICROBIOL, pS2, DOI [10.1038/nrmicro1522, 10.1038/nrmicro1568, 10.1038/nrmico1522]; Poling A, 2011, BEHAV ANALYST, V34, P47, DOI 10.1007/BF03392234; Poling A, 2010, AM J TROP MED HYG, V83, P1308, DOI 10.4269/ajtmh.2010.10-0180; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; van Leth F, 2013, 1 TUBERCULOSIS PREVA; Weetjens BJ, 2009, INT J TUBERC LUNG D, V13, P737; Weetjens BJ, 2009, GLOBAL FORUM UPDATE, P6; WHO, GLOB TUB REP 2014; World Health Organization, SYST SCREEN ACT TUB; World Health Organization, 2014, HIGH PRIOR TARG PROD; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	33	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0135877	10.1371/journal.pone.0135877	http://dx.doi.org/10.1371/journal.pone.0135877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445086	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600003
J	White, WT; Appleyard, SA; Sabub, B; Kyne, PM; Harris, M; Lis, R; Baje, L; Usu, T; Smart, JJ; Corrigan, S; Yang, L; Naylor, GJP				White, William T.; Appleyard, Sharon A.; Sabub, Benthly; Kyne, Peter M.; Harris, Mark; Lis, Rickson; Baje, Leontine; Usu, Thomas; Smart, Jonathan J.; Corrigan, Shannon; Yang, Lei; Naylor, Gavin J. P.			Rediscovery of the Threatened River Sharks, Glyphis garricki and G-glyphis, in Papua New Guinea	PLOS ONE			English	Article							BIOLOGY	Recent surveys of the shark and ray catches of artisanal fishers in the Western Province of Papua New Guinea (PNG) resulted in the rediscovery of the threatened river sharks, Glyphis garricki and Glyphis glyphis. These represent the first records of both species in PNG since the 1960s and 1970s and highlight the lack of studies of shark biodiversity in PNG. Two individuals of G. garricki and three individuals of G. glyphis were recorded from coastal marine waters of the Daru region of PNG in October and November 2014. The two G. garricki specimens were small individuals estimated to be 100-105 cm and similar to 113 cm total length (TL). The three G. glyphis specimens were all mature, one a pregnant female and two adult males. These are the first adults of G. glyphis recorded to date providing a more accurate maximum size for this species, i.e. similar to 260 cm TL. A single pup which was released from the pregnant female G. glyphis, was estimated to be similar to 65 cm TL. Anecdotal information from the fishers of pregnant females of G. glyphis containing 6 or 7 pups provides the first estimate of litter size for this species. The jaws of the pregnant female G. glyphis were retained and a detailed description of the dentition is provided, since adult dentition has not been previously documented for this species. Genetic analyses confirmed the two species cluster well within samples from these species collected in northern Australia.	[White, William T.; Appleyard, Sharon A.] CSIRO, Natl Res Collect Australia, Australian Natl Fish Collect, Hobart, Tas, Australia; [White, William T.; Appleyard, Sharon A.] CSIRO, Oceans & Atmosphere, Hobart, Tas, Australia; [Sabub, Benthly; Lis, Rickson; Baje, Leontine; Usu, Thomas] Natl Fisheries Author, Port Moresby, Papua N Guinea; [Kyne, Peter M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Harris, Mark] FFC Elasmobranch Studies, New Port Richey, FL USA; [Smart, Jonathan J.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Smart, Jonathan J.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Corrigan, Shannon; Yang, Lei; Naylor, Gavin J. P.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Darwin University; James Cook University; James Cook University; College of Charleston	White, WT (corresponding author), CSIRO, Natl Res Collect Australia, Australian Natl Fish Collect, Hobart, Tas, Australia.	william.white@csiro.au	Corrigan, Shannon/AAV-5862-2020; Smart, jonathan/W-2971-2019; White, William T/B-9748-2009; appleyard, sharon/D-6076-2012; Appleyard, Sharon/AAJ-9942-2020	Corrigan, Shannon/0000-0003-0093-5028; Smart, jonathan/0000-0003-2070-3208; White, William T/0000-0001-9705-2453; appleyard, sharon/0000-0002-3105-1690; Appleyard, Sharon/0000-0002-3105-1690; Kyne, Peter/0000-0003-4494-2625	Australian Centre for International Agricultural Research (ACIAR) [FIS/2012/102]; Marine Biodiversity Hub from the Australian Government's National Environmental Research Program (NERP); Northern Australia Hub from the Australian Government's National Environmental Research Program (NERP); National Science Foundation (NSF) [DEB-01132229]	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); Marine Biodiversity Hub from the Australian Government's National Environmental Research Program (NERP); Northern Australia Hub from the Australian Government's National Environmental Research Program (NERP); National Science Foundation (NSF)(National Science Foundation (NSF))	This project was funded by the Australian Centre for International Agricultural Research (ACIAR; project FIS/2012/102); special thanks to Drs Chris Barlow and Jes Sammut for their support of this project. PMK was supported by the Marine Biodiversity Hub and the Northern Australia Hub, collaborative partnerships supported through funding from the Australian Government's National Environmental Research Program (NERP). Three authors (SC, LY and GN) were supported by a National Science Foundation (NSF; http://www.nsf.gov) grant (Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life; DEB-01132229).	Carrier JC, 2004, CRC MAR BIOL SER, P269; Chen X, 2014, MITOCHONDR DNA, V25, P431, DOI 10.3109/19401736.2013.809443; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; COMPAGNO LJV, 2008, DESCRIPTIONS NEW AUS, P203; Compagno LJV, 2009, IUCN RED LIST THREAT; Feutry P, 2014, MITOCHONDRIAL DNA EA, P1; Feutry P, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0232-x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kailola PJ, 1978, RES B, V20; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Munro ISR, 1967, FISHES NEW GUINEA; Peverell S.C., 2006, Zootaxa, V1233, P53; Pillans Richard D., 2010, Endangered Species Research, V10, P321; Pogonoski J, 2003, IUCN RED LIST THREAT; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Warfe DM, 2011, FRESHWATER BIOL, V56, P2169, DOI 10.1111/j.1365-2427.2011.02660.x; WHITLEY G. P., 1949, PROC ROY ZOOL SOC N S WALES, V1947, P24; Wynen L, 2009, MAR FRESHWATER RES, V60, P554, DOI 10.1071/MF08201	20	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140075	10.1371/journal.pone.0140075	http://dx.doi.org/10.1371/journal.pone.0140075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445387	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000362510600136
J	Greil, C; Krohs, J; Schnerch, D; Follo, M; Felthaus, J; Engelhardt, M; Wasch, R				Greil, C.; Krohs, J.; Schnerch, D.; Follo, M.; Felthaus, J.; Engelhardt, M.; Waesch, R.			The role of APC/C-Cdh1 in replication stress and origin of genomic instability	ONCOGENE			English	Article							ANAPHASE-PROMOTING COMPLEX; MCM4,6,7 HELICASE ACTIVITY; E3 UBIQUITIN LIGASES; CELL-CYCLE; S-PHASE; TUMOR SUPPRESSION; DNA-REPLICATION; CHROMOSOMAL INSTABILITY; DEPENDENT PROTEOLYSIS; MAMMALIAN-CELLS	It has been proposed that the APC/C-Cdh1 functions as a tumor suppressor by maintaining genomic stability. However, the exact nature of genomic instability following loss of Cdh1 is unclear. Using biochemistry and live cell imaging of single cells we found that Cdh1 knockdown (kd) leads to strong nuclear stabilization of the substrates cyclin A and B and deregulated kinetics of DNA replication. Restoration of the Cdh1-dependent G2 DNA damage checkpoint did not result in G2 arrest but blocked cells in prometaphase, suggesting that these cells enter mitosis despite incomplete replication. This results in DNA double-strand breaks, anaphase bridges, cytokinesis defects and tetraploidization. Tetraploid cells are the source of supernumerary centrosomes following Cdh1-kd, leading to multipolar mitosis or centrosome clustering, in turn resulting in merotelic attachment and lagging chromosomes. Whereas some of these events cause apoptosis during mitosis, surviving cells may accumulate chromosomal aberrations.	[Greil, C.; Krohs, J.; Schnerch, D.; Follo, M.; Felthaus, J.; Engelhardt, M.; Waesch, R.] Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplanta, Hugstetter Str 55, D-79106 Freiburg, Germany; [Krohs, J.] Univ Freiburg, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Schnerch, D.] Univ Basel, Biozentrum, Basel, Switzerland	University of Freiburg; University of Freiburg; University of Basel	Wasch, R (corresponding author), Univ Med Ctr, Dept Hematol Oncol & Stem Cell Transplanta, Hugstetter Str 55, D-79106 Freiburg, Germany.	ralph.waesch@uniklinik-freiburg.de	Waesch, Ralph/F-6282-2019	Follo, Marie/0000-0002-3090-7442	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is supported by Deutsche Forschungsgemeinschaft. We thank G Ihorst for statistical advice.	Alver RC, 2014, DNA REPAIR, V19, P182, DOI 10.1016/j.dnarep.2014.03.012; Ayuda-Duran P, 2014, NUCLEIC ACIDS RES, V42, P7057, DOI 10.1093/nar/gku313; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Clijsters L, 2013, J CELL BIOL, V201, P1013, DOI 10.1083/jcb.201211019; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Drosopoulos K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4686; Eguren M, 2014, CELL REP, V6, P670, DOI 10.1016/j.celrep.2014.01.017; Eguren M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3880; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Hendrickson M, 1996, P NATL ACAD SCI USA, V93, P12223, DOI 10.1073/pnas.93.22.12223; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; Ishimi Y, 2001, J BIOL CHEM, V276, P34428, DOI 10.1074/jbc.M104480200; Johansson P, 2014, J BIOL CHEM, V289, P18514, DOI 10.1074/jbc.M114.559930; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Komamura-Kohno Y, 2006, FEBS J, V273, P1224, DOI 10.1111/j.1742-4658.2006.05146.x; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Qiao XX, 2010, CELL CYCLE, V9, P3904, DOI 10.4161/cc.9.19.13585; Schnerch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074379; Schnerch D, 2012, CELL CYCLE, V11, P310, DOI 10.4161/cc.11.2.18737; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Skaar JR, 2008, NAT CELL BIOL, V10, P755, DOI 10.1038/ncb0708-755; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wheeler LW, 2008, CELL CYCLE, V7, P2179, DOI 10.4161/cc.7.14.6270; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yuan X, 2014, MOL BIOL CELL, V25, P441, DOI 10.1091/mbc.E13-08-0480; Zhang JF, 2014, BBA-REV CANCER, V1845, P277, DOI 10.1016/j.bbcan.2014.02.001	50	24	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 9	2016	35	23					3062	3070		10.1038/onc.2015.367	http://dx.doi.org/10.1038/onc.2015.367			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0NB	26455319				2022-12-26	WOS:000377474500011
J	Liu, XS; Liu, Z; Gerarduzzi, C; Choi, DE; Ganapathy, S; Pandolfi, PP; Yuan, ZM				Liu, X-S; Liu, Z.; Gerarduzzi, C.; Choi, D. E.; Ganapathy, S.; Pandolfi, P. P.; Yuan, Z-M			Somatic human ZBTB7A zinc finger mutations promote cancer progression	ONCOGENE			English	Article							TRANSCRIPTIONAL REPRESSOR; POZ DOMAIN; GENE; PROTEINS; LRF	We recently reported that ZBTB7A is a bona fide transcription repressor of key glycolytic genes and its downregulation in human cancer contributes to tumor metabolism. As reduced expression of ZBTB7A is found only in a subset of human cancers, we explored alternative mechanisms of its inactivation by mining human cancer genome databases. We discovered recurrent somatic mutations of ZBTB7A in multiple types of human cancers with a marked enrichment of mutations within the zinc finger domain. Functional characterization of the mutants demonstrated that mutations within the zinc finger region of ZBTB7A invariably resulted in loss of function. As a consequence, the glycolytic genes were markedly upregulated in cancer cells harboring ZBTB7A zinc finger mutation, leading to increased glycolysis and proliferation. Our study uncovers the loss-of-function mutation in ZBTB7A as a novel mechanism causing elevated glycolysis in human cancer, which carries important therapeutic implication.	[Liu, X-S; Gerarduzzi, C.; Choi, D. E.; Ganapathy, S.; Yuan, Z-M] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA; [Liu, X-S] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201203, Peoples R China; [Liu, Z.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Pandolfi, P. P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Pandolfi, P. P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Pathol, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; ShanghaiTech University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Yuan, ZM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu	Liu, Xue-Song/ADF-2183-2022	Liu, Xue-Song/0000-0002-7736-0077; Pandolfi, Pier Paolo/0000-0002-5352-5295; Gerarduzzi, Casimiro/0000-0001-7098-1455; Liu, Zhonghua/0000-0003-3048-9823	Morningside Foundation; NIH/NCI [R01CA085679, RO1CA167814, RO1CA125144]; NATIONAL CANCER INSTITUTE [R01CA183074, R01CA167814, R01CA085679, R01CA125144] Funding Source: NIH RePORTER	Morningside Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to current and former members of the Yuan lab for experimental support, advice and helpful discussions. This work was supported in part by the Morningside Foundation and grants from NIH/NCI (R01CA085679, RO1CA167814 and RO1CA125144).	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee SU, 2012, IMMUNOL REV, V247, P107, DOI 10.1111/j.1600-065X.2012.01116.x; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Liu XS, 2014, GENE DEV, V28, P1917, DOI 10.1101/gad.245910.114; LOCOCO F, 1994, BLOOD, V83, P1757, DOI 10.1182/blood.V83.7.1757.bloodjournal8371757; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Sakurai N, 2011, J CLIN INVEST, V121, P2583, DOI 10.1172/JCI45682; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Wang GC, 2013, NAT GENET, V45, P739, DOI 10.1038/ng.2654; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	24	23	24	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 9	2016	35	23					3071	3078		10.1038/onc.2015.371	http://dx.doi.org/10.1038/onc.2015.371			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0NB	26455326	Green Accepted			2022-12-26	WOS:000377474500012
J	Pangon, L; Ng, I; Giry-Laterriere, M; Currey, N; Morgan, A; Benthani, F; Tran, PN; Al-Sohaily, S; Segelov, E; Parker, BL; Cowley, MJ; Wright, DC; St Heaps, L; Carey, L; Rooman, I; Kohonen-Corish, MRJ				Pangon, L.; Ng, I.; Giry-Laterriere, M.; Currey, N.; Morgan, A.; Benthani, F.; Tran, P. N.; Al-Sohaily, S.; Segelov, E.; Parker, B. L.; Cowley, M. J.; Wright, D. C.; St Heaps, L.; Carey, L.; Rooman, I.; Kohonen-Corish, M. R. J.			JRK is a positive regulator of beta-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer	ONCOGENE			English	Article							INHIBITION; JERKY; BCL9	The loss of beta-catenin inhibitory components is a well-established mechanism of carcinogenesis but beta-catenin hyperactivity can also be enhanced through its coactivators. Here we first interrogated a highly validated genomic screen and the largest repository of cancer genomics data and identified JRK as a potential new oncogene and therapeutic target of the beta-catenin pathway. We proceeded to validate the oncogenic role of JRK in colon cancer cells and primary tumors. Consistent with a beta-catenin activator function, depletion of JRK in several cancer cell lines repressed beta-catenin transcriptional activity and reduced cell proliferation. Importantly, JRK expression was aberrantly elevated in 21% of colorectal cancers, 15% of breast and ovarian cancers and was associated with increased expression of beta-catenin target genes and increased cell proliferation. This study shows that JRK is required for beta-catenin hyperactivity regardless of the adenomatous polyposis coli/beta-catenin mutation status and targeting JRK presents new opportunities for therapeutic intervention in cancer.	[Pangon, L.; Ng, I.; Giry-Laterriere, M.; Currey, N.; Morgan, A.; Benthani, F.; Tran, P. N.; Al-Sohaily, S.; Cowley, M. J.; Rooman, I.; Kohonen-Corish, M. R. J.] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW 2010, Australia; [Pangon, L.; Benthani, F.; Segelov, E.; Cowley, M. J.; Rooman, I.; Kohonen-Corish, M. R. J.] UNSW Australia, UNSW Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Parker, B. L.] Garvan Inst Med Res, Biol Mass Spectrometry Unit, Sydney, NSW 2010, Australia; [Parker, B. L.] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Cowley, M. J.] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Sydney, NSW 2010, Australia; [Wright, D. C.; St Heaps, L.; Carey, L.] Childrens Hosp Westmead, Cytogenet, Westmead, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Garvan Institute of Medical Research; University of Sydney; Garvan Institute of Medical Research; University of Sydney	Pangon, L (corresponding author), Garvan Inst Med Res, Canc Div, 384 Victoria St, Sydney, NSW 2010, Australia.	l.pangon@garvan.org.au	Segelov, Eva/Q-7611-2019; Kohonen-Corish, Maija/Q-9763-2019; Cowley, Mark/K-8731-2019; Parker, Beth L/E-6013-2019	Segelov, Eva/0000-0002-4410-6144; Kohonen-Corish, Maija/0000-0002-4073-1479; Cowley, Mark/0000-0002-9519-5714; Parker, Beth L/0000-0002-5513-7333; Rooman, Ilse/0000-0001-7264-2246; Dyson, Nicola/0000-0002-4173-1913; Benthani, Fahad/0000-0002-3283-307X	National Health and Medical Research Council of Australia [GNT1020406]; Cure Cancer Australia/Cancer Australia [1049846]; Cancer Institute NSW [13ECF1-46, 10CDF232]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cure Cancer Australia/Cancer Australia; Cancer Institute NSW	We thank the South Western Sydney Colorectal Tissue Bank for the colorectal cancer patient specimens and Dr Christopher Henderson (Liverpool Hospital, Sydney, Australia) for helping with immunohistochemistry scoring. beta-Catenin constructs were a gift from A/Prof Beric Henderson (Westmead Institute for Cancer Research, Westmead Millennium Institute, Sydney, Australia). JRK-FLAG and TCf7L2 constructs were a gift from Dr Benchabane (Department of Genetics and the Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH, USA). The M50 Super 8x TOPFlash and M51 Super 8x FOPFlash reporter constructs were obtained from Addgene and originally provided by Prof Randall Moon (University of Washington, Seattle, Washington). This work was supported by grants from the National Health and Medical Research Council of Australia (GNT1020406), Cure Cancer Australia/Cancer Australia (1049846), Cancer Institute NSW (13ECF1-46) and Cancer Institute NSW (10CDF232). The contents of the published material are solely the responsibility of the administering institution, participating institutions or individual authors and do not reflect the views of NHMRC.	Al-Sohaily S, 2014, HISTOPATHOLOGY, V65, P155, DOI 10.1111/his.12295; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benchabane H, 2011, EMBO J, V30, P1444, DOI 10.1038/emboj.2011.67; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; de la Roche M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1680; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; Donovan GP, 1997, J NEUROSCI, V17, P4562; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Kawamoto SA, 2012, J MED CHEM, V55, P1137, DOI 10.1021/jm201125d; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Moore T, 2001, EPILEPSY RES, V46, P157, DOI 10.1016/S0920-1211(01)00275-3; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pangon L, 2015, INT J CANCER, V136, P55, DOI 10.1002/ijc.28967; Pangon L, 2012, BBA-MOL CELL RES, V1823, P1058, DOI 10.1016/j.bbamcr.2012.03.011; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Takada K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003808; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Waldron R, 2004, BIOCHEM SOC T, V32, P920, DOI 10.1042/BST0320920	28	14	14	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 2	2016	35	22					2834	2841		10.1038/onc.2015.347	http://dx.doi.org/10.1038/onc.2015.347			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0MT	26455321				2022-12-26	WOS:000377473700003
J	Butler, B; Saha, K; Rana, T; Becker, JP; Sambo, D; Davari, P; Goodwin, JS; Khoshbouei, H				Butler, Brittany; Saha, Kaustuv; Rana, Tanu; Becker, Jonas P.; Sambo, Danielle; Davari, Paran; Goodwin, J. Shawn; Khoshbouei, Habibeh			Dopamine Transporter Activity Is Modulated by alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; MEMBRANE DEPOLARIZATION; FLUORESCENCE RECOVERY; AMPHETAMINE; TRAFFICKING; MOBILITY; MUTATION; BINDING; EFFLUX; NA+	The duration and strength of the dopaminergic signal are regulated by the dopamine transporter (DAT). Drug addiction and neurodegenerative and neuropsychiatric diseases have all been associated with altered DAT activity. The membrane localization and the activity of DAT are regulated by a number of intracellular proteins. alpha-Synuclein, a protein partner of DAT, is implicated in neurodegenerative disease and drug addiction. Little is known about the regulatory mechanisms of the interaction between DAT and alpha-synuclein, the cellular location of this interaction, and the functional consequences of this interaction on the basal, amphetamine-induced DAT-mediated dopamine efflux, and membrane microdomain distribution of the transporter. Here, we found that the majority of DAT.alpha-synuclein protein complexes are found at the plasma membrane of dopaminergic neurons or mammalian cells and that the amphetamine-mediated increase in DAT activity enhances the association of these proteins at the plasma membrane. Further examination of the interaction of DAT and alpha-synuclein revealed a transient interaction between these two proteins at the plasma membrane. Additionally, we found DAT-induced membrane depolarization enhances plasma membrane localization of alpha-synuclein, which in turn increases dopamine efflux and enhances DAT localization in cholesterol-rich membrane microdomains.	[Khoshbouei, Habibeh] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA; [Khoshbouei, Habibeh] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Meharry Medical College	Goodwin, JS (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, 1005 Dr DB Todd Jr,Blvd, Nashville, TN 37208 USA.	jgoodwin@mmc.edu; Habibeh@ufl.edu	Becker, Jonas Philipp/AAQ-4959-2021; Becker, Jonas/GZG-4234-2022; Regan, Clinton/E-6250-2012; Becker, Jonas/AAH-3484-2019; Becker, Jonas/ABB-1688-2021	Becker, Jonas Philipp/0000-0002-1594-9652; Khoshbouei, Habibeh/0000-0002-1533-8771; SAHA, KAUSTUV/0000-0002-2931-1422	National Institutes of Health [MD007593, MD007586, CA163069, RR0254970]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026947, R24DA036420] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Benjamin Richardson for the insightful suggestions and critical review of the manuscript. We also thank Dr. Etienne Cartier for technical assistance. Some of the confocal microscopy experiments were conducted at the Meharry Morphology Core, which is supported by National Institutes of Health Grants MD007593, MD007586, CA163069, and RR0254970.	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Alfonta L, 2001, ANAL CHEM, V73, P5287, DOI 10.1021/ac010542e; Amara S G, 1998, Adv Pharmacol, V42, P164; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Baba M, 1998, AM J PATHOL, V152, P879; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chen NH, 1999, J PHARMACOL EXP THER, V290, P940; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Feng LR, 2010, EUR J NEUROSCI, V32, P10, DOI 10.1111/j.1460-9568.2010.07266.x; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Fraser R, 2014, MOL PHARMACOL, V86, P76, DOI 10.1124/mol.114.091926; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; GIRGUS JS, 1975, CAN J PSYCHOL, V29, P59, DOI 10.1037/h0082021; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Gualandris A, 1996, J NEUROSCI, V16, P2220; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kahlig KM, 2006, MOL PHARMACOL, V70, P542, DOI 10.1124/mol.106.023952; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; KILBOURNE EJ, 1991, J NEUROSCI METH, V40, P193, DOI 10.1016/0165-0270(91)90068-B; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kolanos R, 2013, ACS CHEM NEUROSCI, V4, P1524, DOI 10.1021/cn4001236; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Li LB, 2000, J NEUROCHEM, V74, P1538, DOI 10.1046/j.1471-4159.2000.0741538.x; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Mash DC, 2003, J NEUROSCI, V23, P2564; Melikian HE, 1999, J NEUROSCI, V19, P7699; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Qin YJ, 2005, NEUROREPORT, V16, P1489, DOI 10.1097/01.wnr.0000175617.39054.ba; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Roitman MF, 1999, AM J PHYSIOL-REG I, V276, pR1339, DOI 10.1152/ajpregu.1999.276.5.R1339; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Saha K, 2014, J BIOL CHEM, V289, P22246, DOI 10.1074/jbc.M114.563056; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snapp Erik L, 2006, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1709s32; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2013, TRAFFIC, V14, P709, DOI 10.1111/tra.12059; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stockl M, 2012, MOL BIOSYST, V8, P338, DOI 10.1039/c1mb05293d; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Varrone A, 2001, MOVEMENT DISORD, V16, P1023, DOI 10.1002/mds.1256; VAZ WLC, 1982, BIOCHEMISTRY-US, V21, P5608, DOI 10.1021/bi00265a034; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wersinger C, 2006, EUR J NEUROSCI, V24, P3141, DOI 10.1111/j.1460-9568.2006.05181.x; Wersinger C, 2006, EUR J NEUROSCI, V24, P55, DOI 10.1111/j.1460-9568.2006.04900.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhen J, 2005, NEUROPHARMACOLOGY, V49, P769, DOI 10.1016/j.neuropharm.2005.07.002	67	61	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29542	29554		10.1074/jbc.M115.691592	http://dx.doi.org/10.1074/jbc.M115.691592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26442590	hybrid, Green Published			2022-12-26	WOS:000366613400036
J	Ramirez, J; Martinez, A; Lectez, B; Lee, SY; Franco, M; Barrio, R; Dittmar, G; Mayor, U				Ramirez, Juanma; Martinez, Aitor; Lectez, Benoit; Lee, So Young; Franco, Maribel; Barrio, Rosa; Dittmar, Gunnar; Mayor, Ugo			Proteomic Analysis of the Ubiquitin Landscape in the Drosophila Embryonic Nervous System and the Adult Photoreceptor Cells	PLOS ONE			English	Article							ANGELMAN SYNDROME; PROTEINS; DEGRADATION; DESTRUCTION; HOMEOSTASIS; MUTATIONS; SUBSTRATE; REVEALS; MODEL; MOUSE	Background Ubiquitination is known to regulate physiological neuronal functions as well as to be involved in a number of neuronal diseases. Several ubiquitin proteomic approaches have been developed during the last decade but, as they have been mostly applied to non-neuronal cell culture, very little is yet known about neuronal ubiquitination pathways in vivo. Methodology/Principal Findings Using an in vivo biotinylation strategy we have isolated and identified the ubiquitinated proteome in neurons both for the developing embryonic brain and for the adult eye of Drosophila melanogaster. Bioinformatic comparison of both datasets indicates a significant difference on the ubiquitin substrates, which logically correlates with the processes that are most active at each of the developmental stages. Detection within the isolated material of two ubiquitin E3 ligases, Parkin and Ube3a, indicates their ubiquitinating activity on the studied tissues. Further identification of the proteins that do accumulate upon interference with the proteasomal degradative pathway provides an indication of the proteins that are targeted for clearance in neurons. Last, we report the proof-of-principle validation of two lysine residues required for nSyb ubiquitination. Conclusions/Significance These data cast light on the differential and common ubiquitination pathways between the embryonic and adult neurons, and hence will contribute to the understanding of the mechanisms by which neuronal function is regulated. The in vivo biotinylation methodology described here complements other approaches for ubiquitome study and offers unique advantages, and is poised to provide further insight into disease mechanisms related to the ubiquitin proteasome system.	[Ramirez, Juanma; Martinez, Aitor; Mayor, Ugo] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Leioa, Bizkaia, Spain; [Ramirez, Juanma; Martinez, Aitor; Lectez, Benoit; Lee, So Young; Franco, Maribel; Barrio, Rosa; Mayor, Ugo] CIC BioGUNE, Funct Genom Unit, Derio, Spain; [Martinez, Aitor] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Lectez, Benoit] Turku Ctr Biotechnol, Mollecular Cell Biol, Turku, Finland; [Franco, Maribel] CSIC UMH, Inst Neurosci, Dev Neurobiol, Alicante, Spain; [Dittmar, Gunnar] Max Delbruck Ctr Mol Med, Berlin, Germany; [Mayor, Ugo] Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain	University of Basque Country; CIC bioGUNE; University of Liverpool; University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Basque Foundation for Science	Mayor, U (corresponding author), Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Leioa, Bizkaia, Spain.	ugo.mayor@ehu.eus	Franco, Maribel/AAE-8375-2019; Barrio, Rosa/F-8712-2011; Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016; Ramírez, Juanma/AAZ-8953-2021; Mayor, Ugo/F-5890-2011	Barrio, Rosa/0000-0002-9663-0669; Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Ramirez, Juanma/0000-0002-8500-7521; Martinez Zarate, Aitor/0000-0003-1648-9448; Mayor, Ugo/0000-0003-2812-8287; Lee, So Young/0000-0003-3130-785X; Lectez, Benoit/0000-0001-9796-1606	Basque Government research grant [PI2011-24]; Asociacion Sindrome de Angelman; March of Dimes Basil O'Connor Award [5-FY12-16]; CIC bioGUNE PhD fellowship	Basque Government research grant; Asociacion Sindrome de Angelman; March of Dimes Basil O'Connor Award(March of Dimes); CIC bioGUNE PhD fellowship	UM was supported by the Basque Government research grant (PI2011-24), the Asociacion Sindrome de Angelman, and the March of Dimes Basil O'Connor Award (5-FY12-16). JR was supported by the CIC bioGUNE PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Broadie KS, 1999, INT REV NEUROBIOL, V43, P45, DOI 10.1016/S0074-7742(08)60540-1; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Chiba A, 1999, INT REV NEUROBIOL, V43, P1, DOI 10.1016/S0074-7742(08)60538-3; Chiba A, 1996, DEV BIOL, V180, P424, DOI 10.1006/dbio.1996.0316; Choi SY, 2013, NUCLEIC ACIDS RES, V41, P2180, DOI 10.1093/nar/gks1319; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Ding M, 2008, BIOESSAYS, V30, P1075, DOI 10.1002/bies.20843; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Franco M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002188; Gillingwater TH, 2013, NEUROPATH APPL NEURO, V39, P320, DOI 10.1111/nan.12014; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hallengren J, 2013, CELL BIOCHEM BIOPHYS, V67, P67, DOI 10.1007/s12013-013-9634-4; Hamilton AM, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/196848; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HAYDON PG, 1995, TRENDS NEUROSCI, V18, P196, DOI 10.1016/0166-2236(95)93901-9; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Jackson GR, 2008, PLOS BIOL, V6, P236, DOI 10.1371/journal.pbio.0060053; Kanashova T, 2015, ANAL BIOANAL CHEM, V407, P5965, DOI 10.1007/s00216-015-8595-4; Keller BO, 2008, ANAL CHIM ACTA, V627, P71, DOI 10.1016/j.aca.2008.04.043; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lectez B, 2014, J PROTEOME RES, V13, P3016, DOI 10.1021/pr5001913; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Li WZ, 2012, GENET MOL RES, V11, P1997, DOI 10.4238/2012.August.6.4; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lipinszki Z, 2009, J CELL SCI, V122, P3083, DOI 10.1242/jcs.049049; Lopitz-Otsoa F, 2012, J PROTEOMICS, V75, P2998, DOI 10.1016/j.jprot.2011.12.001; Lu YB, 2009, HUM MOL GENET, V18, P454, DOI 10.1093/hmg/ddn373; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mayor T, 2007, MOL CELL PROTEOMICS, V6, P1885, DOI 10.1074/mcp.M700264-MCP200; Mayor U, 2012, METHODS MOL BIOL, V832, P65, DOI 10.1007/978-1-61779-474-2_3; Min MW, 2014, MOL CELL PROTEOMICS, V13, P2411, DOI 10.1074/mcp.M113.033498; Min MW, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130097; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Ossig R, 2000, EMBO J, V19, P6000, DOI 10.1093/emboj/19.22.6000; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peng JM, 2008, BMB REP, V41, P177, DOI 10.5483/BMBRep.2008.41.3.177; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rinetti GV, 2010, J NEUROSCI, V30, P3157, DOI 10.1523/JNEUROSCI.3712-09.2010; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vasilescu J, 2005, J PROTEOME RES, V4, P2192, DOI 10.1021/pr050265i; Wagner S, 2007, J COMP NEUROL, V500, P601, DOI 10.1002/cne.21138; Wishart TM, 2014, J CLIN INVEST, V124, P1821, DOI 10.1172/JCI71318; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	60	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139083	10.1371/journal.pone.0139083	http://dx.doi.org/10.1371/journal.pone.0139083			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460970	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000362962300009
J	Booth, MPS; Kosmopoulou, M; Poirel, L; Nordmann, P; Spencer, J				Booth, Michael P. S.; Kosmopoulou, Magda; Poirel, Laurent; Nordmann, Patrice; Spencer, James			Crystal Structure of DIM-1, an Acquired Subclass B1 Metallo-beta-Lactamase from Pseudomonas stutzeri	PLOS ONE			English	Article							ACTIVE-SITE; BACILLUS-CEREUS; BACTEROIDES-FRAGILIS; CLINICAL ISOLATE; MOLECULAR CHARACTERIZATION; POTENT INHIBITORS; PROTEIN-STRUCTURE; AERUGINOSA; ZINC; HYDROLYSIS	Metallo-beta-lactamases (MBLs) hydrolyze almost all classes of beta-lactam antibiotic, including carbapenems-currently first choice drugs for opportunistic infections by Gram-negative bacterial pathogens. MBL inhibitor development is complicated by the diversity within this group of enzymes, and by the appearance of new enzymes that continue to be identified both as chromosomal genes and on mobile genetic elements. One such newly discovered MBL is DIM-1, a mobile enzyme originally discovered in the opportunist pathogen Pseudomonas stutzeri but subsequently identified in other species and locations. DIM-1 is a subclass B1 MBL more closely related to the TMB-1, GIM-1 and IMP enzymes than to other clinically encountered MBLs such as VIM and NDM; and possesses Arg, rather than the more usual Lys, at position 224 in the putative substrate binding site. Here we report the crystallization and structure determination of DIM-1. DIM-1 possesses a binuclear metal center with a 5 (rather than the more usual 4) co-ordinate tri-histidine (Zn1) site and both 4- and 5-co-ordinate Cys-His-Asp-(Zn2) sites observed in the two molecules of the crystallographic asymmetric unit. These data indicate a degree of variability in metal co-ordination geometry in the DIM-1 active site, as well as facilitating inclusion of DIM-1 in structurebased MBL inhibitor discovery programmes.	[Booth, Michael P. S.; Kosmopoulou, Magda; Spencer, James] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Poirel, Laurent; Nordmann, Patrice] Univ Fribourg, Fac Sci, Dept Med, Med & Mol Microbiol Unit, CH-1700 Fribourg, Switzerland	University of Bristol; University of Fribourg	Spencer, J (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	Jim.Spencer@bristol.ac.uk	Poirel, Laurent/ABE-6736-2020	Poirel, Laurent/0000-0001-5160-5286	British Society for Antimicrobial Chemotherapy [GA820]; U.K. Medical Research Council [G1100135]; U.S. National Institutes of Allergy and Infectious Disease [1R01AI100560-01]; MRC [G1100135] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100560] Funding Source: NIH RePORTER; Medical Research Council [G1100135] Funding Source: researchfish	British Society for Antimicrobial Chemotherapy; U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. National Institutes of Allergy and Infectious Disease; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the British Society for Antimicrobial Chemotherapy (www.bsac.org; grant no. GA820 to J.S.), the U.K. Medical Research Council (www.mrc.ac.uk; grant no. G1100135 to J.S.), and the U.S. National Institutes of Allergy and Infectious Disease (http://www.niaid.nih.gov/; grant no. 1R01AI100560-01 to J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISON AW, 1984, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9840001349; Badarau A, 2008, J BIOL INORG CHEM, V13, P919, DOI 10.1007/s00775-008-0379-2; BICKNELL R, 1986, BIOCHEMISTRY-US, V25, P7208, DOI 10.1021/bi00370a066; Bonnin RA, 2014, FUTURE MICROBIOL, V9, P33, DOI 10.2217/fmb.13.69; Borra PS, 2013, ANTIMICROB AGENTS CH, V57, P848, DOI 10.1128/AAC.02227-12; Brown NG, 2011, ANTIMICROB AGENTS CH, V55, P5696, DOI 10.1128/AAC.00340-11; Castanheira M, 2004, ANTIMICROB AGENTS CH, V48, P4654, DOI 10.1128/AAC.48.12.4654-4661.2004; Castanheira M, 2014, J ANTIMICROB CHEMOTH, V69, P1804, DOI 10.1093/jac/dku048; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Davies AM, 2005, BIOCHEMISTRY-US, V44, P4841, DOI 10.1021/bi047709t; Deshpande LM, 2014, ANTIMICROB AGENTS CH, V58, P596, DOI 10.1128/AAC.01541-13; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; El Salabi A, 2012, ANTIMICROB AGENTS CH, V56, P2241, DOI 10.1128/AAC.05640-11; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garcia-Saez I, 2008, J MOL BIOL, V375, P604, DOI 10.1016/j.jmb.2007.11.012; Garcia-Saez I, 2003, J BIOL CHEM, V278, P23868, DOI 10.1074/jbc.M301062200; Garrity JD, 2005, BIOCHEMISTRY-US, V44, P1078, DOI 10.1021/bi048385b; Gonzalez JM, 2012, NAT CHEM BIOL, V8, P698, DOI [10.1038/NCHEMBIO.1005, 10.1038/nchembio.1005]; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Karsisiotis AI, 2014, METALLOMICS, V6, P1181, DOI 10.1039/c4mt00066h; Karsisiotis AI, 2013, BIOCHEM J, V456, P397, DOI 10.1042/BJ20131003; Kim Y, 2013, FASEB J, V27, P1917, DOI 10.1096/fj.12-224014; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leski TA, 2013, J CLIN MICROBIOL, V51, P2435, DOI 10.1128/JCM.00832-13; Makena A, 2013, CHEMMEDCHEM, V8, P1923, DOI 10.1002/cmdc.201300350; Materon IC, 2001, PROTEIN SCI, V10, P2556, DOI 10.1110/ps.ps.40884; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Moali C, 2003, CHEM BIOL, V10, P319, DOI 10.1016/S1074-5521(03)00070-X; Murphy TA, 2006, J MOL BIOL, V357, P890, DOI 10.1016/j.jmb.2006.01.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P2420, DOI 10.1128/AAC.01456-09; Pollini S, 2013, ANTIMICROB AGENTS CH, V57, P410, DOI 10.1128/AAC.01953-12; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Salsbury FR, 2001, PROTEINS, V44, P448, DOI 10.1002/prot.1110; Scrofani SDB, 1999, BIOCHEMISTRY-US, V38, P14507, DOI 10.1021/bi990986t; Sekiguchi J, 2008, ANTIMICROB AGENTS CH, V52, P4194, DOI 10.1128/AAC.01337-07; Toney JH, 1998, CHEM BIOL, V5, P185, DOI 10.1016/S1074-5521(98)90632-9; Toney JH, 2001, J BIOL CHEM, V276, P31913, DOI 10.1074/jbc.M104742200; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaguchi Y, 2007, J MED CHEM, V50, P6647, DOI 10.1021/jm701031n; Yamaguchi Y, 2010, J BIOCHEM, V147, P905, DOI 10.1093/jb/mvq029; Yanchak MP, 2000, BIOCHEMISTRY-US, V39, P11330, DOI 10.1021/bi0010524; Yang H, 2014, J AM CHEM SOC, V136, P7273, DOI 10.1021/ja410376s; Yang YJ, 1999, J BIOL CHEM, V274, P15706, DOI 10.1074/jbc.274.22.15706; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	63	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140059	10.1371/journal.pone.0140059	http://dx.doi.org/10.1371/journal.pone.0140059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451836	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200032
J	Chui, PL; Abdullah, KL; Wong, LP; Taib, NA				Chui, Ping Lei; Abdullah, Khatijah Lim; Wong, Li Ping; Taib, Nur Aishah			Quality of Life in CAM and Non-CAM Users among Breast Cancer Patients during Chemotherapy in Malaysia	PLOS ONE			English	Article							ALTERNATIVE MEDICINE USE; COMPLEMENTARY/ALTERNATIVE MEDICINE; EORTC QLQ-C30; WOMEN; VALIDATION; VERSION; TRIALS; IMPACT	Background Complementary and alternative medicine (CAM) use has become increasingly popular among patients with cancer. The purposes of this study were to compare the QOL in CAM users and non-CAM users and to determine whether CAM use influences QOL among breast cancer patients during chemotherapy. Methodology A cross-sectional survey was conducted at two outpatient chemotherapy centers. A total of 546 patients completed the questionnaires on CAM use. QOL was evaluated based on the European Organization for Research and Treatment of Cancer (EORTC) core quality of life (QLQ-C30) and breast cancer-specific quality of life (QLQ-BR23) questionnaires. Results A total of 70.7% of patients were identified as CAM users. There was no significant difference in global health status scores and in all five subscales of the QLQ C30 functional scales between CAM users and non-CAM users. On the QLQ-C30 symptom scales, CAM users (44.96 +/- 3.89) had significantly (p = 0.01) higher mean scores for financial difficulties than non-CAM users (36.29 +/- 4.81). On the QLQ-BR23 functional scales, CAM users reported significantly higher mean scores for sexual enjoyment (6.01 +/- 12.84 vs. 4.64 +/- 12.76, p = 0.04) than non-CAM users. On the QLQ-BR23 symptom scales, CAM users reported higher systemic therapy side effects (41.34 +/- 2.01 vs. 37.22 +/- 2.48, p = 0.04) and breast symptoms (15.76 +/- 2.13 vs. 11.08 +/- 2.62, p = 0.02) than non-CAM users. Multivariate logistic regression analysis indicated that the use of CAM modality was not significantly associated with higher global health status scores (p = 0.71). Conclusion While the findings indicated that there was no significant difference between users and nonusers of CAM in terms of QOL, CAM may be used by health professionals as a surrogate to monitor patients with higher systemic therapy side effects and breast symptoms. Furthermore, given that CAM users reported higher financial burdens (which may have contributed to increased distress), patients should be encouraged to discuss the potential benefits and/or disadvantages of using CAM with their healthcare providers.	[Chui, Ping Lei; Abdullah, Khatijah Lim] Univ Malaya, Fac Med, Dept Nursing Sci, Kuala Lumpur, Malaysia; [Wong, Li Ping] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Taib, Nur Aishah] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Chui, PL (corresponding author), Univ Malaya, Fac Med, Dept Nursing Sci, Kuala Lumpur, Malaysia.	chuipinglei@um.edu.my	Chui, Ping Lei/B-8417-2010; Taib, Nur Aishah Mohd/B-2370-2010; Abdullah, Khatijah Lim/B-8782-2010; WONG, LI PING/B-2782-2010	Chui, Ping Lei/0000-0002-6918-1204; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Abdullah, Khatijah Lim/0000-0002-7185-6004; WONG, LI PING/0000-0002-0107-0532	University Malaya Research Grant, Health and Translational Medicine Cluster [RG238/10HTM]	University Malaya Research Grant, Health and Translational Medicine Cluster	This study was funded by a University Malaya Research Grant, Health and Translational Medicine Cluster, Project No. RG238/10HTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn E, 2009, BREAST CANCER RES TR, V116, P609, DOI 10.1007/s10549-008-0209-9; Al-Naggar RA., 2013, WORLD J MED SCI, V8, P157; Ashing-Giwa K. T, 2009, ONCOL NURS FORUM; Balneaves LG, 2006, J ALTERN COMPLEM MED, V12, P459, DOI 10.1089/acm.2006.12.459; Bautista C., 2011, APPL CLIN TRIALS, V6; Calhoun EA, 2003, BLOOD, V102, p749A; Can G, 2011, EUR J ONCOL NURS, V15, P3, DOI 10.1016/j.ejon.2009.10.010; Centers for Disease Control and Prevention, 2010, NUTRITION; Chang O, 2014, ASIAN PAC J CANCER P, V15, P8607, DOI 10.7314/APJCP.2014.15.20.8607; Chie WC, 2003, PSYCHO-ONCOLOGY, V12, P729, DOI 10.1002/pon.727; Efficace F, 2007, ANN ONCOL, V18, P775, DOI 10.1093/annonc/mdl494; Er O, 2008, TUMORI, V94, P833; Ernst E, 1998, CANCER-AM CANCER SOC, V83, P777, DOI 10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O; Farooqui M., 2013, ALTERN INTEGR MED, V2, P121, DOI 10.4172/2327-5162.1000121; Fayers P, 2001, EORTC QLQ C30 SCORIN; Frenkel M, 2010, INTEGR CANCER THER, V9, P177, DOI 10.1177/1534735410363706; Gopal RR, 2013, MAL J PUB HLTH MED, V13, P11; Hasan Syed Shahzad, 2009, Complement Ther Clin Pract, V15, P152, DOI 10.1016/j.ctcp.2009.02.003; Hlubocky FJ, 2007, J CLIN ONCOL, V25, P548, DOI 10.1200/JCO.2005.03.9800; Horneber M, 2012, INTEGR CANCER THER, V11, P187, DOI 10.1177/1534735411423920; Jassim GA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-212; Kang E, 2012, SUPPORT CARE CANCER, V20, P461, DOI 10.1007/s00520-011-1094-z; Kremser T, 2008, BREAST, V17, P387, DOI 10.1016/j.breast.2007.12.006; Kresevic DM, 2014, AM J ORTHOP, V31, P24; Lee PY, 2007, ASIA PACIFIC FAMILY, V6; Lim CL, 2006, MALAYSIAN J NUTR S, V12, pS102; Lim MK, 2005, COMPLEMENT THER MED, V13, P16, DOI 10.1016/j.ctim.2004.11.002; Longman A J, 1999, Oncol Nurs Forum, V26, P909; Molassiotis A, 2005, ANN ONCOL, V16, P655, DOI 10.1093/annonc/mdi110; National Center for Complementary and Integrative Health, 2013, COMPL ALT INT HLTH W; Ngelangel CA, 2008, ASIA PACIFIC OCOLOGY, V1, P18; Pinar R, 2003, TURKISH J CANC, V33, P96; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Puataweepong P, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/670408; Saghatchian M, 2014, BREAST, V23, P279, DOI 10.1016/j.breast.2014.01.009; Saibul N, 2012, ASIAN PAC J CANCER P, V13, P4081, DOI 10.7314/APJCP.2012.13.8.4081; Saini A, 2011, QUAL LIFE RES, V20, P683, DOI 10.1007/s11136-010-9795-1; Salonen P, 2009, CANCER NURS, V32, P177, DOI 10.1097/NCC.0b013e31819b5b65; Saw Jun Tze, 2006, Complement Ther Clin Pract, V12, P236, DOI 10.1016/j.ctcp.2006.06.002; Shen FR, 2012, ASIAN PAC J CANCER P, V13, P3747, DOI 10.7314/APJCP.2012.13.8.3747; Shih V, 2009, ANN ONCOL, V20, P752, DOI 10.1093/annonc/mdn659; Soraya HS, 2011, ALTERN THER HEALTH M, V17, P50; SPSS I, 2009, PASW STAT 18; Tan ML, 2014, ASIA-PAC J ONCOL NUR, V1, P22, DOI 10.4103/2347-5625.135817; Tarhan O, 2009, J BUON, V14, P265; Tautz E, 2012, EUR J CANCER, V48, P3133, DOI 10.1016/j.ejca.2012.04.021; Wyatt G, 2010, NURS RES, V59, P58, DOI 10.1097/NNR.0b013e3181c3bd26; Yong D, 2009, PALLIATIVE MED, P1; Yusoff N, 2010, INT MED J MALAYS, V9, P45	49	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139952	10.1371/journal.pone.0139952	http://dx.doi.org/10.1371/journal.pone.0139952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TY	26451732	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511200023
J	Zhou, H; Malik, MA; Arab, A; Hill, MT; Shikanov, A				Zhou, Hong; Malik, Malika Amattullah; Arab, Aarthi; Hill, Matthew Thomas; Shikanov, Ariella			Hydrogel Based 3-Dimensional (3D) System for Toxicity and High-Throughput (HTP) Analysis for Cultured Murine Ovarian Follicles	PLOS ONE			English	Article							REPRODUCTIVE TOXICOLOGY; GRANULOSA-CELLS; RHESUS-MONKEYS; BISPHENOL-A; GROWTH; GONADOTROPINS; MATURATION	Various toxicants, drugs and their metabolites carry potential ovarian toxicity. Ovarian follicles, the functional unit of the ovary, are susceptible to this type of damage at all stages of their development. However, despite of the large scale of potential negative impacts, assays that study ovarian toxicity are limited. Exposure of cultured ovarian follicles to toxicants of interest served as an important tool for evaluation of toxic effects for decades. Mouse follicles cultured on the bottom of a culture dish continue to serve an important approach for mechanistic studies. In this paper, we demonstrated the usefulness of a hydrogel based 3-dimensional (3D) mouse ovarian follicle culture as a tool to study ovarian toxicity in a different setup. The 3D in vitro culture, based on fibrin alginate interpenetrating network (FA-IPN), preserves the architecture of the ovarian follicle and physiological structure-function relationship. We applied the novel 3D high-throughput (HTP) in vitro ovarian follicle culture system to study the ovotoxic effects of an anti-cancer drug, Doxorobucin (DXR). The fibrin component in the system is degraded by plasmin and appears as a clear circle around the encapsulated follicle. The degradation area of the follicle is strongly correlated with follicle survival and growth. To analyze fibrin degradation in a high throughput manner, we created a custom MATLAB (R) code that converts brightfield micrographs of follicles encapsulated in FA-IPN to binary images, followed by image analysis. We did not observe any significant difference between manually processed images to the automated MATLAB (R) method, thereby confirming that the automated program is suitable to measure fibrin degradation to evaluate follicle health. The cultured follicles were treated with DXR at concentrations ranging from 0.005 nM to 200 nM, corresponding to the therapeutic plasma levels of DXR in patients. Follicles treated with DXR demonstrated decreased survival rate in greater DXR concentrations. We observed partial follicle survival of 35% +/- 3% (n = 80) in 0.01nM treatment and 48% +/- 2% (n = 92) in 0.005 nM, which we identified as the IC50 for secondary follicles. In summary, we established a 3D in vitro ovarian follicle culture system that could be used in an HTP approach to measure toxic effects on ovarian follicles.	[Zhou, Hong; Arab, Aarthi; Hill, Matthew Thomas; Shikanov, Ariella] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Malik, Malika Amattullah] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA; [Shikanov, Ariella] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shikanov, A (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	shikanov@umich.edu	Shikanov, Ariella/AAR-3724-2020	Shikanov, Ariella/0000-0003-0159-6419; Arab, Aarthi/0000-0002-3711-1789	University of Michigan	University of Michigan(University of Michigan System)	This work was supported by the start-up funding from the University of Michigan to AS.	Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001; Astashkina AI, 2012, BIOMATERIALS, V33, P4712, DOI 10.1016/j.biomaterials.2012.03.001; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; Clarke HG, 2006, REPRODUCTION, V132, P119, DOI 10.1530/rep.1.00960; Combes RD, 2004, ATLA-ALTERN LAB ANIM, V32, P163, DOI 10.1177/026119290403200304; Cortvrindt RG, 2002, HUM REPROD UPDATE, V8, P243, DOI 10.1093/humupd/8.3.243; Dorato M. A., 2007, CURRENT PROTOCOLS TO; Eppig JJ, 2005, BIOL REPROD, V73, P351, DOI 10.1095/biolreprod.105.041798; Gupta RK, 2010, TOXICOL APPL PHARM, V242, P224, DOI 10.1016/j.taap.2009.10.011; Hareng L, 2005, REPROD TOXICOL, V20, P441, DOI 10.1016/j.reprotox.2005.04.003; Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176; Lenie S, 2008, MUTAT RES-GEN TOX EN, V651, P71, DOI 10.1016/j.mrgentox.2007.10.017; Lopes F, 2014, MOL HUM REPROD, V20, P948, DOI 10.1093/molehr/gau057; Mark-Kappeler CJ, 2011, BIOL REPROD, V85, P871, DOI 10.1095/biolreprod.111.091173; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Roti ECR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108174; Roti ECR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042293; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shikanov A, 2011, JOVE-J VIS EXP, DOI 10.3791/2695; Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054; Stefansdottir A, 2014, REPROD TOXICOL, V49, P117, DOI 10.1016/j.reprotox.2014.08.001; Sun FY, 2004, MUTAGENESIS, V19, P13, DOI 10.1093/mutage/geg040; Woodruff TJ, 2008, FERTIL STERIL, V89, P281, DOI [10.1016/j.fertnstert.2007.10.002, 10.1016/j.fertnstert.2008.01.065]; Xu J, 2013, HUM REPROD, V28, P2187, DOI 10.1093/humrep/det093; Xu J, 2011, HUM REPROD, V26, P1061, DOI 10.1093/humrep/der049; Xu J, 2010, REPRODUCTION, V140, P685, DOI 10.1530/REP-10-0284; Xu Y, 2015, REPROD FERTIL DEV; Ziv-Gal A, 2013, REPROD TOXICOL, V42, P58, DOI 10.1016/j.reprotox.2013.07.022	30	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140205	10.1371/journal.pone.0140205	http://dx.doi.org/10.1371/journal.pone.0140205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451950	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200049
J	Hielpos, MS; Ferrero, MC; Fernandez, AG; Bonetto, J; Giambartolomei, GH; Fossati, CA; Baldi, PC				Soledad Hielpos, M.; Ferrero, Mariana C.; Fernandez, Andrea G.; Bonetto, Josefina; Giambartolomei, Guillermo H.; Fossati, Carlos A.; Baldi, Pablo C.			CCL20 and Beta-Defensin 2 Production by Human Lung Epithelial Cells and Macrophages in Response to Brucella abortus Infection	PLOS ONE			English	Article							HUMAN BETA-DEFENSIN-2; ANTIMICROBIAL PEPTIDES; MYCOBACTERIUM-TUBERCULOSIS; PROINFLAMMATORY RESPONSE; ENDOTHELIAL-CELLS; HOST-DEFENSE; EXPRESSION; INNATE; LIPOPOLYSACCHARIDE; RELEASE	Both CCL20 and human beta-defensin 2 (hBD2) interact with the same membrane receptor and display chemotactic and antimicrobial activities. They are produced by airway epithelia in response to infectious agents and proinflammatory cytokines. Whereas Brucella spp. can infect humans through inhalation, their ability to induce CCL20 and hBD2 in lung cells is unknown. Here we show that B. abortus induces CCL20 expression in human alveolar (A549) or bronchial (Calu-6) epithelial cell lines, primary alveolar epithelial cells, primary human monocytes, monocyte-derived macrophages and the monocytic cell line THP-1. CCL20 expression was mainly mediated by JNK1/2 and NF-kappa B in both Calu-6 and THP-1 cells. CCL20 secretion was markedly induced in A549, Calu-6 and THP-1 cells by heat-killed B. abortus or a model Brucella lipoprotein (L-Omp19) but not by the B. abortus lipopolysaccharide (LPS). Accordingly, CCL20 production by B. abortus-infected cells was strongly TLR2-dependent. Whereas hBD2 expression was not induced by B. abortus infection, it was significantly induced in A549 cells by conditioned media from B. abortus-infected THP-1 monocytes (CMB). A similar inducing effect was observed on CCL20 secretion. Experiments using blocking agents revealed that IL-1 beta, but not TNF-alpha, was involved in the induction of hBD2 and CCL20 secretion by CMB. In the in vitro antimicrobial assay, the lethal dose (LD) 50 of CCL20 for B. abortus (>50 mu g/ml) was markedly higher than that against E. coli (1.5 mu g/ ml) or a B. abortus mutant lacking the O polysaccharide in its LPS (8.7 ug/ml). hBD2 did not kill any of the B. abortus strains at the tested concentrations. These results show that human lung epithelial cells secrete CCL20 and hBD2 in response to B. abortus and/or to cytokines produced by infected monocytes. Whereas these molecules do not seem to exert antimicrobial activity against this pathogen, they could recruit immune cells to the infection site.	[Soledad Hielpos, M.; Ferrero, Mariana C.; Fernandez, Andrea G.; Bonetto, Josefina; Baldi, Pablo C.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral,IDEHU,CONICET UBA, Buenos Aires, DF, Argentina; [Giambartolomei, Guillermo H.] Hosp Clin Jose San Martin, Inst Inmunol Genet & Metab INIGEM,CONICET UBA, Buenos Aires, DF, Argentina; [Fossati, Carlos A.] Univ Nacl La Plata, Fac Ciencias Exactas, Inst Estudios Inmunol & Fisiopatol IIFP CONICET U, La Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Hospital de Clinicas Jose de San Martin; National University of La Plata	Baldi, PC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral,IDEHU,CONICET UBA, Buenos Aires, DF, Argentina.	pablobal@ffyb.uba.ar	Baldi, Pablo/AAS-4736-2020	Baldi, Pablo/0000-0002-2500-6682	Agencia Nacional de Promocion Cientifica (ANPCYT) [20080764, 2013-0170]; Universidad de Buenos Aires [UBACYT 20020100100379, 20020130100151BA]	Agencia Nacional de Promocion Cientifica (ANPCYT)(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by grants 20080764 and 2013-0170 from Agencia Nacional de Promocion Cientifica (ANPCYT, www.agencia.mincyt.gov.ar), and grants UBACYT 20020100100379 and 20020130100151BA from Universidad de Buenos Aires (http://www.uba.ar/secyt/contenido.php?id=42&s=50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; Auvynet C, 2009, FEBS J, V276, P6497, DOI 10.1111/j.1742-4658.2009.07360.x; Baggetta R, 2010, EUR J IMMUNOL, V40, P2182, DOI 10.1002/eji.200939995; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Barabas N, 2013, IMMUNOBIOLOGY, V218, P1005, DOI 10.1016/j.imbio.2012.11.007; Bist P, 2014, INFECT IMMUN, V82, P1112, DOI 10.1128/IAI.01459-13; Chan DI, 2008, ANTIMICROB AGENTS CH, V52, P883, DOI 10.1128/AAC.00805-07; DETEJADA GM, 1995, INFECT IMMUN, V63, P3054; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Ferrero MC, 2014, INFECT IMMUN, V82, P626, DOI 10.1128/IAI.01237-13; Ferrero MC, 2011, MICROBES INFECT, V13, P852, DOI 10.1016/j.micinf.2011.04.010; Ferrero MC, 2010, MICROBES INFECT, V12, P736, DOI 10.1016/j.micinf.2010.05.002; Ferrero MC, 2009, MICROBES INFECT, V11, P476, DOI 10.1016/j.micinf.2009.01.010; Ghannam S, 2011, J IMMUNOL, V186, P1411, DOI 10.4049/jimmunol.1000597; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; GOLDSTEIN J, 1992, INFECT IMMUN, V60, P1385, DOI 10.1128/IAI.60.4.1385-1389.1992; Grahnert A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087341; Halling SM, 1996, VET MICROBIOL, V51, P187, DOI 10.1016/0378-1135(96)00027-2; Han S, 2008, BIOCHEM BIOPH RES CO, V371, P670, DOI 10.1016/j.bbrc.2008.04.092; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V142, P285, DOI 10.1111/j.1365-2249.2005.02912.x; Ishii H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-87; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kaufmann A F, 1980, Ann N Y Acad Sci, V353, P105, DOI 10.1111/j.1749-6632.1980.tb18912.x; Khan MA, 2008, INFECT IMMUN, V76, P1410, DOI 10.1128/IAI.01141-07; Kim TB, 2009, J CLIN IMMUNOL, V29, P629, DOI 10.1007/s10875-009-9306-8; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Li Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/791392; Marcet B, 2007, J CELL PHYSIOL, V211, P716, DOI 10.1002/jcp.20979; March C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010033; Marriott HM, 2012, INFECT IMMUN, V80, P1140, DOI 10.1128/IAI.05697-11; Miao HM, 2012, MOL ENDOCRINOL, V26, P423, DOI 10.1210/me.2011-1233; Moranta D, 2010, INFECT IMMUN, V78, P1135, DOI 10.1128/IAI.00940-09; MORENO E, 1981, INFECT IMMUN, V31, P362, DOI 10.1128/IAI.31.1.362-370.1981; Murphy S. A., 1999, Methods in Cell Science, V21, P31, DOI 10.1023/A:1009825008023; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Niyonsaba F, 2002, INT IMMUNOL, V14, P421, DOI 10.1093/intimm/14.4.421; O'Neil DA, 1999, J IMMUNOL, V163, P6718; OLLEGOIG JE, 1987, AM J PUBLIC HEALTH, V77, P335, DOI 10.2105/AJPH.77.3.335; Osterholzer JJ, 2005, J IMMUNOL, V175, P874, DOI 10.4049/jimmunol.175.2.874; Pappas G, 2006, CELL MOL LIFE SCI, V63, P2229, DOI 10.1007/s00018-006-6311-4; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Phadke AP, 2007, AM J RESP CRIT CARE, V175, P1165, DOI 10.1164/rccm.200602-256OC; Pichavant M, 2006, J IMMUNOL, V177, P5912, DOI 10.4049/jimmunol.177.9.5912; QURESHI N, 1994, J ENDOTOXIN RES, V1, P137; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Rivas-Santiago B, 2005, INFECT IMMUN, V73, P4505, DOI 10.1128/IAI.73.8.4505-4511.2005; Rivero-Lezcano OM, 2010, CLIN EXP IMMUNOL, V162, P289, DOI 10.1111/j.1365-2249.2010.04168.x; Rohrl J, 2010, J BIOL CHEM, V285, P7028, DOI 10.1074/jbc.M109.091090; Scharf S, 2010, AM J PHYSIOL-LUNG C, V298, pL687, DOI 10.1152/ajplung.00365.2009; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sim SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007308; Starner TD, 2003, AM J RESP CELL MOL, V29, P627, DOI 10.1165/rcmb.2002-0272OC; Takahashi K, 2008, ORAL MICROBIOL IMMUN, V23, P320, DOI 10.1111/j.1399-302X.2008.00431.x; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Traxler RM, 2013, J CLIN MICROBIOL, V51, P3055, DOI 10.1128/JCM.00135-13; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Van Maele L, 2014, MUCOSAL IMMUNOL, V7, P489, DOI 10.1038/mi.2013.66; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; Yagupsky P, 2005, EMERG INFECT DIS, V11, P1180, DOI 10.3201/eid1108.041197; Yamamoto K, 2012, J IMMUNOL, V189, P2450, DOI 10.4049/jimmunol.1200634; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yu Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120855	77	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140408	10.1371/journal.pone.0140408	http://dx.doi.org/10.1371/journal.pone.0140408			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448160	Green Published, gold			2022-12-26	WOS:000362511000121
J	Francis, JM; Weiss, HA; Mshana, G; Baisley, K; Grosskurth, H; Kapiga, SH				Francis, Joel M.; Weiss, Helen A.; Mshana, Gerry; Baisley, Kathy; Grosskurth, Heiner; Kapiga, Saidi H.			The Epidemiology of Alcohol Use and Alcohol Use Disorders among Young People in Northern Tanzania	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INTIMATE PARTNER VIOLENCE; DRINKING MOTIVES; RISK-FACTORS; DRUG-USE; SCHOOL-STUDENTS; HIV-INFECTION; GLOBAL BURDEN; SOUTH-AFRICA; ADOLESCENTS	Introduction Alcohol use is a global public health problem, including as a risk factor for HIV infection, but few data are available on the epidemiology of alcohol use and alcohol use disorders (AUD) among young people in sub-Saharan Africa. Methods We conducted a cross-sectional survey among 4 groups of young people aged 15-24 years old (secondary school students, college/university students, employees of local industries and casual labourers) in two regions (Kilimanjaro and Mwanza) of northern Tanzania. Using a multistage stratified random sampling strategy, we collected information on demographics, alcohol use, and behavioural factors. We screened severity of alcohol use using the Alcohol Use Disorder Identification Test (AUDIT) and estimated the quantity and frequency of alcohol consumption using the timeline-follow-back-calendar (TLFB) method. Results A total of 1954 young people were surveyed. The prevalence of reported alcohol use was higher among males (47-70% ever users and 20-45% current users) than females (24-54% ever users and 12-47% current users). Prevalence of use was substantially higher in Kilimanjaro than Mwanza region. In both regions, participants reported high exposure to alcohol advertisements, and wide alcohol availability. College students reported the highest prevalence of current alcohol use (45% among males; 26% among females) and of heavy episodic drinking (71% among males; 27% among females) followed by casual labourers. Males were more likely to have AUD (an AUDIT score >= 8) than females, with 11-28% of males screening positive for AUD. Alcohol use was associated with male gender, being in a relationship, greater disposable income, non-Muslim religion and a higher number of sexual partners. Conclusions Alcohol use is a significant problem among young people in northern Tanzania. There is an urgent need to develop, pilot and deliver interventions to help young people delay initiation and reduce levels of harmful drinking, particularly among college students and casual labourers.	[Francis, Joel M.; Weiss, Helen A.; Baisley, Kathy; Grosskurth, Heiner; Kapiga, Saidi H.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Francis, Joel M.; Mshana, Gerry; Grosskurth, Heiner; Kapiga, Saidi H.] Natl Inst Med Res, Mwanza Ctr, Mwanza, Tanzania; [Grosskurth, Heiner; Kapiga, Saidi H.] MITU, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Francis, JM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	joelmfrancis@gmail.com	Francis, Joel/B-1271-2019; weiss, helen/ABC-7823-2021	Francis, Joel/0000-0003-1902-2683; weiss, helen/0000-0003-3547-7936; Grosskurth, Heiner/0000-0001-9960-7280; Kapiga, Saidi/0000-0003-1753-4060	STRIVE RPC - UK Department for International Development (DFID); Medical Research Council (MRC) of the United Kingdom; Medical Research Council [G0901756, MR/K012126/1] Funding Source: researchfish; Department for International Development (DFID) [201447] Funding Source: researchfish; MRC [G0901756] Funding Source: UKRI	STRIVE RPC - UK Department for International Development (DFID); Medical Research Council (MRC) of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the STRIVE RPC, an international research consortium funded by the UK Department for International Development (DFID) to investigate structural drivers of HIV. The views expressed in this work do not necessarily reflect the official policies of the funding agency. HW, SK and HG receive salary support from the Medical Research Council (MRC) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AT, 2006, DIABETIC MED, V23, P795, DOI 10.1111/j.1464-5491.2006.01878.x; Amemori M, 2011, COMMUNITY DENT HLTH, V28, P95, DOI 10.1922/CDH_2498Amemori04; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Azar MM, 2010, DRUG ALCOHOL DEPEN, V112, P178, DOI 10.1016/j.drugalcdep.2010.06.014; Babor T.F., 2001, ALCOHOL USE DISORDER, V2nd ed; Bellis MA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-380; Bhana A, 2008, ADDICTION, V103, P1935, DOI 10.1111/j.1360-0443.2008.02396.x; Bryden A, 2013, HEALTH PLACE, V21, P70, DOI 10.1016/j.healthplace.2013.01.012; Bryden A, 2012, HEALTH PLACE, V18, P349, DOI 10.1016/j.healthplace.2011.11.003; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; Dean AG, OPENEPI OPEN SOURCE; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Francis JM, 2014, TROP MED INT HEALTH, V19, P476, DOI 10.1111/tmi.12267; Gmel G, 2003, ALCOHOL RES HEALTH, V27, P52; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Howell AN, 2010, ADDICT BEHAV, V35, P1144, DOI 10.1016/j.addbeh.2010.07.003; Humensky JL, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-19; Kaufman ZA, 2014, AIDS BEHAV, V18, P1661, DOI 10.1007/s10461-014-0816-x; KITANGE HM, 1993, J EPIDEMIOL COMMUN H, V47, P303, DOI 10.1136/jech.47.4.303; Kuntsche E, 2005, CLIN PSYCHOL REV, V25, P841, DOI 10.1016/j.cpr.2005.06.002; Kuntsche E, 2006, ADDICT BEHAV, V31, P1844, DOI 10.1016/j.addbeh.2005.12.028; Kuntsche E, 2006, ALCOHOL ALCOHOLISM, V41, P566, DOI 10.1093/alcalc/agl046; Lee H., 2010, SECTION SURVEY RES M, V2010, P1280; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; McKee SA, 1998, ADDICT BEHAV, V23, P17, DOI 10.1016/S0306-4603(97)00008-7; Naar-King S, 2008, J PEDIATR PSYCHOL, V33, P441, DOI 10.1093/jpepsy/jsm087; Norris AH, 2009, SOC SCI MED, V69, P1167, DOI 10.1016/j.socscimed.2009.07.015; O'Malley PM, 2002, J STUD ALCOHOL, P23, DOI 10.15288/jsas.2002.s14.23; Pengpid S, 2013, INT J ENV RES PUB HE, V10, P2043, DOI 10.3390/ijerph10052043; Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Sobell L. C., 1992, TIMELINE FOLLOWBACK; Swahn MH, 2010, J SCHOOL HEALTH, V80, P353, DOI 10.1111/j.1746-1561.2010.00513.x; Swahn MH, 2010, ADDICT BEHAV, V35, P452, DOI 10.1016/j.addbeh.2009.12.017; Tengia-Kessy A, 1998, E AFR MED J, V75, P528; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2009, ALCOHOL AND INJURIES: EMERGENCY DEPARTMENT STUDIES IN AN INTERNATIONAL PERSPECTIVE, P1; World Health Organization, 2000, INT GUID MON ALC CON; Zaleski M, 2010, REV SAUDE PUBL, V44, P53, DOI 10.1590/S0034-89102010000100006	40	45	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140041	10.1371/journal.pone.0140041	http://dx.doi.org/10.1371/journal.pone.0140041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26444441	gold, Green Published, Green Accepted			2022-12-26	WOS:000362510600129
J	Greig, K; Boocock, J; Prost, S; Horsburgh, KA; Jacomb, C; Walter, R; Matisoo-Smith, E				Greig, Karen; Boocock, James; Prost, Stefan; Horsburgh, K. Ann; Jacomb, Chris; Walter, Richard; Matisoo-Smith, Elizabeth			Complete Mitochondrial Genomes of New Zealand's First Dogs	PLOS ONE			English	Article							ANCIENT DNA; SOUTHEAST-ASIA; SEQUENCE; ALIGNMENT; NETWORKS; DINGOES; ORIGIN	Dogs accompanied people in their migrations across the Pacific Ocean and ultimately reached New Zealand, which is the southern-most point of their oceanic distribution, around the beginning of the fourteenth century AD. Previous ancient DNA analyses of mitochondrial control region sequences indicated the New Zealand dog population included two lineages. We sequenced complete mitochondrial genomes of fourteen dogs from the colonisation era archaeological site of Wairau Bar and found five closely-related haplotypes. The limited number of mitochondrial lineages present at Wairau Bar suggests that the founding population may have comprised only a few dogs; or that the arriving dogs were closely related. For populations such as that at Wairau Bar, which stemmed from relatively recent migration events, control region sequences have insufficient power to address questions about population structure and founding events. Sequencing mitogenomes provided the opportunity to observe sufficient diversity to discriminate between individuals that would otherwise be assigned the same haplotype and to clarify their relationships with each other. Our results also support the proposition that at least one dispersal of dogs into the Pacific was via a south-western route through Indonesia.	[Greig, Karen; Boocock, James; Prost, Stefan; Matisoo-Smith, Elizabeth] Univ Otago, Dept Anat, Allan Wilson Ctr, Dunedin, New Zealand; [Greig, Karen; Jacomb, Chris; Walter, Richard] Univ Otago, Dept Anthropol & Archaeol, Dunedin, New Zealand; [Boocock, James] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Prost, Stefan] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Horsburgh, K. Ann] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Horsburgh, K. Ann] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa	University of Otago; University of Otago; University of Otago; University of California System; University of California Berkeley; Southern Methodist University; University of Witwatersrand	Greig, K (corresponding author), Univ Otago, Dept Anat, Allan Wilson Ctr, Dunedin, New Zealand.	karen.greig@anatomy.otago.ac.nz; lisa.matisoo-smith@anatomy.otago.ac.nz	Horsburgh, K. Ann/B-9369-2016	Horsburgh, K. Ann/0000-0003-0959-8013; Boocock, James/0000-0003-0323-8818; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Prost, Stefan/0000-0002-6229-3596; Boocock, James/0000-0002-5923-3701	Skinner Fund; Allan Wilson Centre for Molecular Ecology and Evolution; Department of Anatomy, University of Otago; Marsden Fund of the Royal Society of New Zealand [UoO0926]; Royal Society of New Zealand	Skinner Fund; Allan Wilson Centre for Molecular Ecology and Evolution; Department of Anatomy, University of Otago; Marsden Fund of the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Royal Society of New Zealand(Royal Society of New Zealand)	Financial support was provided by The Skinner Fund, Royal Society of New Zealand (KG); the Allan Wilson Centre for Molecular Ecology and Evolution (LMS); the Department of Anatomy, University of Otago (KG and LMS); and the Marsden Fund of the Royal Society of New Zealand (Contract UoO0926) (LMS).	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blust R., 2013, ENCY GLOBAL HUMAN MI, V1, P276; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Davidson J., 1984, THE PREHISTORY OF NE; Diamond, 1960, CULTURE HIST ESSAYS, P190; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gollan K., 1984, P921; Green R.C., 1991, MAN HALF ESSAYS PACI, P491; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Horsburgh KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071956; Jacomb C, 2014, J ARCHAEOL SCI, V50, P24, DOI 10.1016/j.jas.2014.05.023; Joly S, 2007, SYST BIOL, V56, P857, DOI 10.1080/10635150701633153; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kim KS, 1998, MOL PHYLOGENET EVOL, V10, P210, DOI 10.1006/mpev.1998.0513; Kirch PV, 2000, ON THE ROAD OF THE W; Knapp M, 2012, P NATL ACAD SCI USA, V109, P18350, DOI 10.1073/pnas.1209896109; Knapp M, 2012, METHODS MOL BIOL, V840, P155, DOI 10.1007/978-1-61779-516-9_19; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Koler-Matzinick Janice, 2007, Australian Mammalogy, V29, P47; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Matisoo-Smith E., 2007, GENES LANGUAGE CULTU, P157; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Oskarsson MCR, 2012, P ROY SOC B-BIOL SCI, V279, P967, DOI 10.1098/rspb.2011.1395; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohland N, 2007, BIOTECHNIQUES; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Sawyer S, 2012, PLOS ONE, V7; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Smith BP, 2009, ANTHROZOOS, V22, P111, DOI 10.2752/175303709X434149; Specht J, 2014, J ARCHAEOL RES, V22, P89, DOI 10.1007/s10814-013-9070-4; Team RDC, 2008, R A LANGUAGE AND ENV; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; WANDELER AI, 1988, REV INFECT DIS, V10, pS684; Wickham H, GGPLOT2 ELEGANT GRAP; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Witt KE, 2015, J HUM EVOL, V79, P105, DOI 10.1016/j.jhevol.2014.10.012	51	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138536	10.1371/journal.pone.0138536	http://dx.doi.org/10.1371/journal.pone.0138536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444283	gold, Green Published			2022-12-26	WOS:000362510600032
J	Knoll, F; Witmer, LM; Ridgely, RC; Ortega, F; Sanz, JL				Knoll, Fabien; Witmer, Lawrence M.; Ridgely, Ryan C.; Ortega, Francisco; Luis Sanz, Jose			A New Titanosaurian Braincase from the Cretaceous "Lo Hueco" Locality in Spain Sheds Light on Neuroanatomical Evolution within Titanosauria	PLOS ONE			English	Article							SAUROPOD DINOSAUR; SAURISCHIA; OSTEOLOGY; REDESCRIPTION; INSIGHTS; ANATOMY; CUENCA; GENUS; EAR	Despite continuous improvements, our knowledge of the neurocranial anatomy of sauropod dinosaurs as a whole is still poor, which is especially true for titanosaurians even though their postcranial remains are common in many Upper Cretaceous sites worldwide. Here we describe a braincase from the uppermost Cretaceous locality of "Lo Hueco" in Spain that is one of the most complete titanosaurian braincases found so far in Europe. Although the titanosaurian Ampelosaurus sp. is known from the same locality, this specimen is clearly a distinct taxon and presents a number of occipital characters found in Antarctosaurus and Jainosaurus, which are approximately coeval taxa from southern Gondwana. The specimen was subjected to X-ray computed tomographic (CT) scanning, allowing the generation of 3D renderings of the endocranial cavity enclosing the brain, cranial nerves, and blood vessels, as well as the labyrinth of the inner ear. These findings add considerable knowledge to the field of sauropod paleoneuroanatomy in general and titanosaurian endocast diversity in particular. Compared with that of many sauropodomorphs, the endocast appears only slightly flexed in lateral view and bears similarities (e.g., reduction of the rostral dural expansion) with Gondwanan titanosaurians such as Jainosaurus, Bonatitan, and Antarctosaurus. The vestibular system of the inner ear is somewhat contracted (i.e., the radius of the semicircular canals is small), but less so than expected in derived titanosaurians. However, as far as the new specimen and Jainosaurus can be contrasted, and with the necessary caution due to the small sample of comparative data currently available, the two taxa appear more similar to one another in endocast morphology than to other titanosaurians. Recent phylogenetic analyses of titanosaurians have not included virtually any of the taxa under consideration here, and thus the phylogenetic position of the new Spanish titanosaurianeven its generic, let alone specific, identification-is not possible at the moment. Nevertheless, both the braincase osteology and the endocast morphology suggest that the specimen represents a derived titanosaurian that presumably branched further from the base of Lithostrotia, potentially even near Saltasauridae, comparable in evolutionary terms with Jainosaurus.	[Knoll, Fabien] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Knoll, Fabien] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Knoll, Fabien] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Witmer, Lawrence M.; Ridgely, Ryan C.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Ortega, Francisco] Univ Nacl Educ Distancia, Fac Ciencias, Dept Fis Matemat & Fluidos, E-28040 Madrid, Spain; [Luis Sanz, Jose] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain	University of Manchester; University of Bristol; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University System of Ohio; Ohio University; Universidad Nacional de Educacion a Distancia (UNED); Autonomous University of Madrid	Knoll, F (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England.	fabien.knoll@manchester.ac.uk	Knoll, Fabien/D-3812-2014; Ortega, Francisco/B-5760-2009; Ortega, Francisco/K-3255-2015; Sanz, Jose Luis/O-1421-2019	Knoll, Fabien/0000-0001-7822-8740; Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X; Witmer, Lawrence/0000-0002-7610-0118	Spanish Ministry of Economy and Competitiveness [CGL2009-12143]; European Union [PIEF-GA-2013-624969]; US National Science Foundation [IOB-0517257, IOS-1050154]; Direct For Biological Sciences [1050154, 1456503] Funding Source: National Science Foundation	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union(European Commission); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We acknowledge funding support from the Spanish Ministry of Economy and Competitiveness (CGL2009-12143; FK), the European Union (PIEF-GA-2013-624969; FK), and the US National Science Foundation (IOB-0517257, IOS-1050154; LMW, RCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 1998, THESIS U SCI TECHNIQ; Balanoff AM, 2010, AM MUS NOVIT, P1, DOI 10.1206/591.1; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P405; Bischoff, 1832, NERVI ACCESSORII WIL; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Calvo JO, 2006, AN ACAD BRAS CIENC, V78, P175, DOI 10.1590/S0001-37652006000100015; Carabajal AP, 2008, CRETACEOUS RES, V29, P643, DOI 10.1016/j.cretres.2008.01.011; Carabajal AP, 2014, J VERTEBR PALEONTOL, V34, P870, DOI 10.1080/02724634.2014.838174; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chatterjee Sankar, 1996, Memoirs of the Queensland Museum, V39, P489; Currie P.J., 1997, ENCY DINOSAURS, P81; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; de Souza LM, 2014, J EVOLUTION BIOL, V27, P2001, DOI 10.1111/jeb.12456; Dechaseaux C, 1962, CERVEAUX ANIMAUX DIS; Diaz VD, 2014, CRETACEOUS RES, V51, P285, DOI 10.1016/j.cretres.2014.07.003; Diaz VD, 2012, P GEOLOGIST ASSOC, V123, P626, DOI 10.1016/j.pgeola.2012.04.002; Diaz VD, 2011, ACTA PALAEONTOL POL, V56, P521, DOI 10.4202/app.2010.0043; Galton PM, 2006, GEOL MAG, V143, P905, DOI 10.1017/S0016756806002561; Garcia G, 2010, B SOC GEOL FR, V181, P269, DOI 10.2113/gssgfbull.181.3.269; Garcia RA, 2015, AMEGHINIANA, V52, P29, DOI 10.5710/AMGH.16.07.2014.829; Gomani E. M., 2005, PALAEONTOL ELECTRON, V8, P27; HADZISELIMOVIC H, 1964, ACTA ANAT, V57, P306; Huene F.V., 1933, MEMOIRS GEOLOGICAL S, V21, P1; Huene F. von, 1929, Anales del Museo de La Plata, V3, P1; JOLLIE M. T., 1960, ACTA ZOOL [STOCKHOLM], V41, P1; Knoll F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054991; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; KURZANOV SM, 1983, PALEONTOL ZH, P90; Le Loeuff J, 2005, LIFE O PAST, P115; LELOEUFF J, 1989, CR ACAD SCI II, V309, P851; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Madsen James H. Jr, 1995, Bulletin of Carnegie Museum of Natural History, V31, P1; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2011, J SYST PALAEONTOL, V9, P355, DOI 10.1080/14772019.2010.527379; Marsh O. C, 1880, AM J SCI, V19, P253; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; Mohabey DM, 2005, GONDWANA GEOLOGICAL, P101; Ortega F, 2015, J IBER GEOL, V41, P83, DOI 10.5209/rev_JIGE.2015.v41.n1.48657; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Ostrom J. A., 1966, MARSHS DINOSAURS COL; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Paulina Carabajal A, 2007, AMEGHINIANA, V44, P109; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2014, J VERTEBR PALEONTOL, V34, P606, DOI 10.1080/02724634.2013.822874; Saegusa H, 2014, ZOOTAXA, V3848, P1, DOI 10.11646/zootaxa.3848.1.1; Salgado L, 2005, ACTA PALAEONTOL POL, V50, P79; Salgado L, 2015, HIST BIOL, V27, P525, DOI 10.1080/08912963.2014.894038; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sues HD, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.889145; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vila B, 2012, PALAEOGEOGR PALAEOCL, V350, P19, DOI 10.1016/j.palaeo.2012.06.008; Weishampel DB, 2011, TRANSYLVANIAN DINOSAURS, P1; WEISHAMPEL DB, 1991, RES EXPLOR, V7, P196; WILLISTON S. W., 1925, OSTEOLOGY REPTILES; Wilson J. A., 2009, Contributions from the Museum of Paleontology University of Michigan, V32, P17; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2003, J SYST PALAEONTOL, V1, P125, DOI 10.1017/S1477201903001044; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663	70	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138233	10.1371/journal.pone.0138233	http://dx.doi.org/10.1371/journal.pone.0138233			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444700	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600023
J	Rodriguez-Ruano, SM; Martin-Vivaldi, M; Martin-Platero, AM; Lopez-Lopez, JP; Peralta-Sanchez, JM; Ruiz-Rodriguez, M; Soler, JJ; Valdivia, E; Martinez-Bueno, M				Rodriguez-Ruano, Sonia M.; Martin-Vivaldi, Manuel; Martin-Platero, Antonio M.; Lopez-Lopez, J. Pablo; Peralta-Sanchez, Juan M.; Ruiz-Rodriguez, Magdalena; Soler, Juan J.; Valdivia, Eva; Martinez-Bueno, Manuel			The Hoopoe's Uropygial Gland Hosts a Bacterial Community Influenced by the Living Conditions of the Bird	PLOS ONE			English	Article							ANTIBIOTIC-PRODUCING BACTERIA; FINISHED GENOME SEQUENCE; MICROBIAL DIVERSITY; PIED FLYCATCHERS; PASSERINE BIRD; UPUPA-EPOPS; SPACER; POPULATION; SECRETIONS; EVOLUTION	Molecular methods have revealed that symbiotic systems involving bacteria are mostly based on whole bacterial communities. Bacterial diversity in hoopoe uropygial gland secretion is known to be mainly composed of certain strains of enterococci, but this conclusion is based solely on culture-dependent techniques. This study, by using culture-independent techniques (based on the 16S rDNA and the ribosomal intergenic spacer region) shows that the bacterial community in the uropygial gland secretion is more complex than previously thought and its composition is affected by the living conditions of the bird. Besides the known enterococci, the uropygial gland hosts other facultative anaerobic species and several obligated anaerobic species (mostly clostridia). The bacterial assemblage of this community was largely invariable among study individuals, although differences were detected between captive and wild female hoopoes, with some strains showing significantly higher prevalence in wild birds. These results alter previous views on the hoopoe-bacteria symbiosis and open a new window to further explore this system, delving into the possible sources of symbiotic bacteria (e.g. nest environments, digestive tract, winter quarters) or the possible functions of different bacterial groups in different contexts of parasitism or predation of their hoopoe host.	[Rodriguez-Ruano, Sonia M.; Martin-Platero, Antonio M.; Lopez-Lopez, J. Pablo; Peralta-Sanchez, Juan M.; Valdivia, Eva; Martinez-Bueno, Manuel] Univ Granada, Dept Microbiol, Granada, Spain; [Martin-Vivaldi, Manuel] Univ Granada, Dept Zool, Granada, Spain; [Ruiz-Rodriguez, Magdalena; Soler, Juan J.] CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain	University of Granada; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Rodriguez-Ruano, SM (corresponding author), Univ Granada, Dept Microbiol, Granada, Spain.	soniamrr@ugr.es	Ruiz-Rodríguez, Magdalena/AAZ-6384-2021; Soler, J. J./H-2363-2011; Valdivia, Eva/R-9978-2018; Martin-Platero, Antonio M/H-3201-2018; Ruiz-Rodríguez, Magdalena/D-4226-2014; Peralta-Sanchez, Juan M/L-3159-2017; Martín-Vivaldi, Manuel/F-8256-2016; Martínez, Manuel Martín-Vivaldi/AAJ-6736-2021; Martínez-Bueno, Manuel/N-7021-2016; Rodríguez-Ruano, Sonia María/AAA-9938-2020	Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Soler, J. J./0000-0003-2990-1489; Valdivia, Eva/0000-0002-9429-9634; Martin-Platero, Antonio M/0000-0003-2822-4885; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Peralta-Sanchez, Juan M/0000-0003-4648-7988; Martín-Vivaldi, Manuel/0000-0002-5432-425X; Martínez, Manuel Martín-Vivaldi/0000-0002-5432-425X; Martínez-Bueno, Manuel/0000-0002-1488-5642; Rodríguez-Ruano, Sonia María/0000-0001-6863-717X	Ministerio de Ciencia y Tecnologia [CGL2005-06975/BOSFEDER, CGL2007-61251/BOSFEDER]; Ministerio de Ciencia e Innovacion [CGL2009-14006/BOSFEDER, CGL2010-19233-C03-01/BOSFEDER, CGL2010-19233-C03-03/BOSFEDER]; Ministerio de Economia y Competitividad [CGL2013-48193-C3-1-P/BOSFEDER, CGL2013-48193-C3-2-P/BOSFEDER]; Junta de Andalucia [RNM 345, P09-RNM-4557]; Ministerio de Ciencia e Innovacion (FPI program) [BES-2011-047677]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia e Innovacion (FPI program)	This work was supported by the Ministerio de Ciencia y Tecnologia (projects CGL2005-06975/BOSFEDER; CGL2007-61251/BOSFEDER), the Ministerio de Ciencia e Innovacion (projects CGL2009-14006/BOSFEDER; CGL2010-19233-C03-01/BOSFEDER; CGL2010-19233-C03-03/BOSFEDER), the Ministerio de Economia y Competitividad (projects CGL2013-48193-C3-1-P/BOSFEDER; CGL2013-48193-C3-2-P/BOSFEDER), and the Junta de Andalucia (RNM 345, P09-RNM-4557). SMRR received a grant from the Ministerio de Ciencia e Innovacion (FPI program, BES-2011-047677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Attwood G, 2006, J APPL MICROBIOL, V100, P1261, DOI 10.1111/j.1365-2672.2006.02896.x; Banning JL, 2008, OECOLOGIA, V156, P423, DOI 10.1007/s00442-008-1002-5; Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Benskin CMH, 2015, ECOL EVOL, V5, P821, DOI 10.1002/ece3.1384; Benskin CMH, 2010, MOL ECOL, V19, P5531, DOI 10.1111/j.1365-294X.2010.04892.x; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Berger S, 2003, J ORNITHOL, V144, P317, DOI 10.1007/BF02465631; Bisson IA, 2009, MICROB ECOL, V58, P212, DOI 10.1007/s00248-009-9490-3; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Burger BV, 2004, J CHEM ECOL, V30, P1603, DOI 10.1023/B:JOEC.0000042071.65335.f3; Cabreiro F, 2013, EMBO MOL MED, V5, P1300, DOI 10.1002/emmm.201100972; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaston J, 2010, FEMS MICROBIOL REV, V34, P41, DOI 10.1111/j.1574-6976.2009.00193.x; Cramp S, 1998, COMPLETE BIRDS W PAL; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Dando SJ, 2014, CLIN MICROBIOL REV, V27, P691, DOI 10.1128/CMR.00118-13; Dunlap PV, 2007, CLADISTICS, V23, P507, DOI 10.1111/j.1096-0031.2007.00157.x; Ehinger M, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-8; Felsenstein J., 2005, PHYLIP 3 6; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Giogha C, 2014, CYTOKINE GROWTH F R, V25, P235, DOI 10.1016/j.cytogfr.2013.12.012; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Hamdi C, 2011, J APPL ENTOMOL, V135, P524, DOI 10.1111/j.1439-0418.2010.01609.x; Hayashi K, 2012, WORLD J MICROB BIOT, V28, P2403, DOI 10.1007/s11274-012-1049-7; Hugon P, 2013, STAND GENOMIC SCI, V8, P500, DOI 10.4056/sigs.4047997; Hupton G, 2003, CONDOR, V105, P453, DOI 10.1650/7246; Hussa EA, 2013, ANNU REV MICROBIOL, V67, P161, DOI 10.1146/annurev-micro-092412-155723; Janiga M, 2007, J ORNITHOL, V148, P135, DOI 10.1007/s10336-006-0104-2; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kaltenpoth M, 2009, FEMS MICROBIOL ECOL, V69, P373, DOI 10.1111/j.1574-6941.2009.00722.x; Klomp JE, 2008, J AVIAN BIOL, V39, P530, DOI 10.1111/j.0908-8857.2008.04333.x; Kuhn I, 2003, INT J FOOD MICROBIOL, V88, P133, DOI 10.1016/S0168-1605(03)00176-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Lu JR, 2008, APPL ENVIRON MICROB, V74, P3969, DOI 10.1128/AEM.00019-08; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Mandel MJ, 2010, TRENDS MICROBIOL, V18, P504, DOI 10.1016/j.tim.2010.07.005; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Martin-Vivaldi M, 1999, BIRD STUDY, V46, P205, DOI 10.1080/00063659909461132; Martin-Vivaldi M, 2006, J AVIAN BIOL, V37, P467, DOI 10.1111/j.0908-8857.2006.03660.x; Martin-Vivaldi M, 2014, J ANIM ECOL, V83, P1289, DOI 10.1111/1365-2656.12243; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; Martin-Vivaldi M, 2009, J AVIAN BIOL, V40, P191, DOI 10.1111/j.1600-048X.2009.04393.x; Martinez-Garcia A, 2015, MICROB ECOL, V70, P1024, DOI 10.1007/s00248-015-0636-1; Mishra AK, 2013, STAND GENOMIC SCI, V7, P357, DOI [10.4056/sigs.32766871, 10.4056/sigs.3276687]; Moran NA, 2002, AM NAT, V160, pS1, DOI 10.1086/342113; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moreno J, 2003, AUK, V120, P784, DOI 10.1642/0004-8038(2003)120[0784:BEOCBO]2.0.CO;2; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NAKAGAWA T, 1992, J BACTERIOL, V174, P8163, DOI 10.1128/JB.174.24.8163-8165.1992; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Ogier JC, 2002, APPL ENVIRON MICROB, V68, P3691, DOI 10.1128/AEM.68.8.3691-3701.2002; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Perez-Brocal V, 2013, CURR TOP MICROBIOL, V358, P215, DOI 10.1007/82_2011_190; Piters WAAD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0294; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Core Team, 2021, R LANGUAGE ENV STAT; RAINEY FA, 1994, SYST APPL MICROBIOL, V17, P202, DOI 10.1016/S0723-2020(11)80008-1; Rajchard J, 2010, VET MED-CZECH, V55, P413, DOI 10.17221/2981-VETMED; Rajilic-Stojanovic M, 2013, BEST PRACT RES CL GA, V27, P5, DOI 10.1016/j.bpg.2013.03.006; Rambaut A., 2009, FIGTREE TREE FIGURE; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reichlin TS, 2013, OECOLOGIA, V171, P591, DOI 10.1007/s00442-012-2418-5; Ruiz-de-Castaneda R, 2011, J FIELD ORNITHOL, V82, P215, DOI 10.1111/j.1557-9263.2011.00324.x; Ruiz-Rodriguez M, 2009, J EXP BIOL, V212, P3621, DOI 10.1242/jeb.031336; Ruiz-Rodriguez M, 2014, APPL ENVIRON MICROB, V80, P6714, DOI 10.1128/AEM.02242-14; Ruiz-Rodriguez M, 2013, FEMS MICROBIOL ECOL, V85, P495, DOI 10.1111/1574-6941.12138; Ruiz-Rodriguez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041843; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Vesth T, 2013, STAND GENOMIC SCI, V9, P431, DOI 10.4056/sigs.2981345; Weng L, 2006, GENOME RES, V16, P316, DOI 10.1101/gr.3676406; Wernegreen JJ, 2012, CURR BIOL, V22, pR555, DOI 10.1016/j.cub.2012.06.010	89	17	17	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139734	10.1371/journal.pone.0139734	http://dx.doi.org/10.1371/journal.pone.0139734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445111	Green Published, gold			2022-12-26	WOS:000362510600074
J	Shabelnikov, S; Kiselev, A				Shabelnikov, Sergey; Kiselev, Artem			Cysteine-Rich Atrial Secretory Protein from the Snail Achatina achatina: Purification and Structural Characterization	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; CIRCULAR-DICHROISM SPECTROSCOPY; IONIZATION MASS-SPECTROMETRY; ACCESSIBLE SURFACE-AREA; FOLD-RECOGNITION; GRANULAR-CELLS; URINARY PROTEINS; VHS DOMAIN; I-TASSER; ALIGNMENT	Despite extensive studies of cardiac bioactive peptides and their functions in molluscs, soluble proteins expressed in the heart and secreted into the circulation have not yet been reported. In this study, we describe an 18.1-kDa, cysteine-rich atrial secretory protein (CRASP) isolated from the terrestrial snail Achatina achatina that has no detectable sequence similarity to any known protein or nucleotide sequence. CRASP is an acidic, 158-residue, N-glycosylated protein composed of eight alpha-helical segments stabilized with five disulphide bonds. A combination of fold recognition algorithms and ab initio folding predicted that CRASP adopts an all-alpha, right-handed superhelical fold. CRASP is most strongly expressed in the atrium in secretory atrial granular cells, and substantial amounts of CRASP are released from the heart upon nerve stimulation. CRASP is detected in the haemolymph of intact animals at nanomolar concentrations. CRASP is the first secretory protein expressed in molluscan atrium to be reported. We propose that CRASP is an example of a taxonomically restricted gene that might be responsible for adaptations specific for terrestrial pulmonates.	[Shabelnikov, Sergey] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg 199034, Russia; [Shabelnikov, Sergey; Kiselev, Artem] Russian Acad Sci, Inst Cytol, Lab Cell Morphol, St Petersburg 194064, Russia; [Kiselev, Artem] Almazov Fed Med Res Ctr, Inst Mol Biol & Genet, St Petersburg, Russia	Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Almazov National Medical Research Centre	Shabelnikov, S (corresponding author), St Petersburg State Univ, Dept Cytol & Histol, St Petersburg 199034, Russia.	sergey.v.shabelnikov@gmail.com	Shabelnikov, Sergey/AAE-9263-2021; Kiselev, Artem M/H-1283-2016	Shabelnikov, Sergey/0000-0002-5693-5310; Kiselev, Artem M/0000-0002-5524-6900	Saint-Petersburg State University [1.50.1042.2014]; Russian Foundation for Basic Research [11-04-00400a]; Russian Science Foundation [15-15-20026]; Dynasty Foundation	Saint-Petersburg State University; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Dynasty Foundation	The authors acknowledge Saint-Petersburg State University (http://eng.spbu.ru/) for a research grant 1.50.1042.2014; Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) for a research grant 11-04-00400a to SS; and Russian Science Foundation for a research grant 15-15-20026 (http://rscf.ru/en/). The protein sequencing costs were covered by grant from Dynasty Foundation (http://www.dynastyfdn.com/english/) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKELEY DF, 1953, J AM CHEM SOC, V75, P5685, DOI 10.1021/ja01118a062; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arendsee ZW, 2014, TRENDS PLANT SCI, V19, P698, DOI 10.1016/j.tplants.2014.07.003; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bose R, 2000, COMP BIOCHEM PHYS A, V125, P485, DOI 10.1016/S1095-6433(00)00176-8; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; Byron O, 1997, BIOPHYS J, V72, P408, DOI 10.1016/S0006-3495(97)78681-8; Bystrova OA, 2014, ACTA HISTOCHEM, V116, P14, DOI 10.1016/j.acthis.2013.04.014; Cavaggioni A, 1999, ARCH ITAL BIOL, V137, P193; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; Chuang CC, 2003, PROTEINS, V53, P1, DOI 10.1002/prot.10492; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; COTTRELL GA, 1969, COMP BIOCHEM PHYSIOL, V28, P1455, DOI 10.1016/0010-406X(69)90584-2; CROLL RP, 1983, BIOL REV, V58, P293, DOI 10.1111/j.1469-185X.1983.tb00391.x; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DEWITH ND, 1993, PEPTIDES, V14, P783, DOI 10.1016/0196-9781(93)90114-V; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; Erdelyi L., 1972, Acta Biol Szeged, V18, P253; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Excretion A.W. M., 1983, MOLLUSCA, P353; Fainzilber M, 1996, SCIENCE, V274, P1540, DOI 10.1126/science.274.5292.1540; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; GERAERTS WPM, 1984, COMP BIOCHEM PHYS C, V78, P339, DOI 10.1016/0742-8413(84)90094-X; Gromova I., 2006, CELL BIOL LAB HDB, P219, DOI DOI 10.1016/B978-012164730-8/50212-4; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Gutternigg M, 2007, GLYCOCONJUGATE J, V24, P475, DOI 10.1007/s10719-007-9040-5; Hahn DK, 2006, J CHEM THEORY COMPUT, V2, P1416, DOI 10.1021/ct600062y; Haszprunar G, 2012, CURR BIOL, V22, pR510, DOI 10.1016/j.cub.2012.05.039; Hermann PM, 2000, J NEUROSCI, V20, P6355, DOI 10.1523/JNEUROSCI.20-17-06355.2000; Jaroszewski L, 2000, PROTEIN SCI, V9, P1487, DOI 10.1110/ps.9.8.1487; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kim D, 2003, PROTEIN ENG, V16, P641, DOI 10.1093/protein/gzg081; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kodirov SA, 2011, COMP BIOCHEM PHYS A, V160, P102, DOI 10.1016/j.cbpa.2011.06.014; Konermann L, 1998, J AM SOC MASS SPECTR, V9, P1248, DOI 10.1016/S1044-0305(98)00103-2; Konermann L, 1997, BIOCHEMISTRY-US, V36, P12296, DOI 10.1021/bi971266u; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; LEMAIRE M, 1980, ANAL BIOCHEM, V106, P12, DOI 10.1016/0003-2697(80)90112-8; LLOYD PE, 1982, FED PROC, V41, P2948; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lohi O, 2002, FEBS LETT, V513, P19, DOI 10.1016/S0014-5793(01)03287-2; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Ma JZ, 2013, BIOINFORMATICS, V29, P257, DOI 10.1093/bioinformatics/btt210; Madera M, 2008, BIOINFORMATICS, V24, P2630, DOI 10.1093/bioinformatics/btn504; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MARTIN AW, 1958, J EXP BIOL, V35, P260; Martynova MG, 2007, CELL BIOL INT, V31, P413, DOI 10.1016/j.cellbi.2007.01.027; Martynova M.G., 2004, Tsitologiya, V46, P448; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Minneci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063754; Mirabello C, 2013, BIOINFORMATICS, V29, P2056, DOI 10.1093/bioinformatics/btt344; Misra S, 2000, BIOCHEMISTRY-US, V39, P11282, DOI 10.1021/bi0013546; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietrzyk AJ, 2012, ACTA CRYSTALLOGR D, V68, P1140, DOI 10.1107/S0907444912021555; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; REYNAUD J, 1970, BIOCHIM BIOPHYS ACTA, V221, P367, DOI 10.1016/0005-2795(70)90277-1; Roche DB, 2011, NUCLEIC ACIDS RES, V39, pW171, DOI 10.1093/nar/gkr184; ROZSA KS, 1967, COMP BIOCHEM PHYSIOL, V23, P373, DOI 10.1016/0010-406X(67)90393-3; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Saleuddin ASM, 1983, MOLLUSCA, P189; Shabelnikov S. V., 2008, CELL TISSUE BIOL, V2, P451, DOI [DOI 10.1134/S1990519X08040159, 10.1134/S1990519X08040159]; Shabelnikov SV, 2009, J EXP BIOL, V212, P3211, DOI 10.1242/jeb.029108; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shimizu K, 2007, BIOINFORMATICS, V23, P2337, DOI 10.1093/bioinformatics/btm330; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; TAYLOR JF, 1948, J BIOL CHEM, V173, P591; Tetin SY, 2003, ANAL BIOCHEM, V321, P183, DOI 10.1016/S0003-2697(03)00458-5; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; VOLKMERRIBEIRO C, 1970, COMP BIOCHEM PHYSIOL, V37, P481, DOI 10.1016/0010-406X(70)90094-0; WAGNER ML, 1956, J PHYS CHEM-US, V60, P1066, DOI 10.1021/j150542a012; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P3522, DOI 10.1093/nar/gkp212; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilkins MR, 1999, METH MOL B, V112, P531; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; WONG KP, 1973, J BIOL CHEM, V248, P8518; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Yang J, 2015, BIOINFORMATICS; Yang JP, 2011, J STRUCT BIOL, V175, P97, DOI 10.1016/j.jsb.2011.04.003; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101; Zhang Yang, 2014, Proteins, V82 Suppl 2, P175, DOI 10.1002/prot.24341; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	110	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138787	10.1371/journal.pone.0138787	http://dx.doi.org/10.1371/journal.pone.0138787			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444993	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600037
J	Xu, HT; Xue, ZC; Ding, HL; Qin, H; An, ZQ				Xu, Haitao; Xue, Zichao; Ding, Haoliang; Qin, Hui; An, Zhiquan			Callus Formation and Mineralization after Fracture with Different Fixation Techniques: Minimally Invasive Plate Osteosynthesis versus Open Reduction Internal Fixation	PLOS ONE			English	Article							DISTAL TIBIAL FRACTURES; PROXIMAL HUMERUS; SHAFT FRACTURES; IN-VIVO; RADIUS; MIPO; DIAPHYSEAL; MODEL; SHEEP; RAT	Minimally invasive plate osteosynthesis(MIPO) has been considered as an alternative for fracture treatment. Previous study has demonstrated that MIPO technique has the advantage of less soft tissue injury compared with open reduction internal fixation (ORIF). However, the comparison of callus formation and mineralization between two plate osteosynthesis methods remains unknown. In this experiment, ulna fracture model was established in 42 beagle dogs. The fractures underwent reduction and internal fixation with MIPO or ORIF. Sequential fluorescent labeling and radiographs were applied to determine new callus formation and mineralization in two groups after operation. At 4, 8 and 12 weeks post-operatively, the animals were selected to be sacrificed and the ulna specimens were analyzed by Micro-CT. The sections were also treated with Masson staining for histological evaluation. More callus formation was observed in MIPO group in early stage of fracture healing. The fracture union rate has no significant difference between two groups. The results indicate that excessive soft tissue stripping may impact early callus formation. As MIPO technique can effectively reduce soft tissue injury with little incision, it is considered to be a promising alternative for fracture fixation.	[Xu, Haitao; Xue, Zichao; Ding, Haoliang; Qin, Hui; An, Zhiquan] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	An, ZQ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 200030, Peoples R China.	zhiquan_an@163.com	An, Zhiquan/CAJ-4467-2022		National Natural Science Foundation of China [81171704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (Grant No. 81171704; http://www.nsfc.gov.cn/). ZA, HX, ZX, HD, and HQ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZQ, 2010, INT ORTHOP, V34, P131, DOI 10.1007/s00264-009-0753-x; Apivatthakakul T, 2009, INT ORTHOP, V33, P1119, DOI 10.1007/s00264-008-0603-2; Ashman BD, 2014, INJURY, V45, P1549, DOI 10.1016/j.injury.2014.04.032; Buckley R, 2011, INJURY, V42, P194, DOI 10.1016/j.injury.2010.08.024; Checa S, 2011, J BIOMECH, V44, P1237, DOI 10.1016/j.jbiomech.2011.02.074; Chen CY, 2015, ARCH ORTHOP TRAUM SU, V135, P361, DOI 10.1007/s00402-015-2162-5; Dejardin LM, 2014, VET SURG, V43, P271, DOI 10.1111/j.1532-950X.2014.12136.x; Devkota P, 2014, J ORTHOP SURG-HONG K, V22, P299, DOI 10.1177/230949901402200306; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Dwek JR, 2010, SKELETAL RADIOL, V39, P319, DOI 10.1007/s00256-009-0849-9; Epari DR, 2008, BONE, V43, P734, DOI 10.1016/j.bone.2008.06.007; Erasmo R, 2014, INJURY, V45, pS43, DOI 10.1016/j.injury.2014.10.022; Farouk O, 1997, INJURY, V28, pSA7; Fu YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091581; Gardner MJ, 2006, J ORTHOP TRAUMA, V20, P602, DOI 10.1097/01.bot.0000246412.10176.14; Hasenboehler E, 2007, INJURY, V38, P365, DOI 10.1016/j.injury.2006.10.024; He XF, 2014, ORTHOPEDICS, V37, pE925, DOI 10.3928/01477447-20140924-61; Iacobellis C, 2013, Musculoskelet Surg, V97, P229, DOI 10.1007/s12306-013-0292-x; Iacobellis C, 2013, ACTA BIO MEDICA ATEN, V84, P202; Imatani J, 2005, J HAND SURG-BRIT EUR, V30B, P220, DOI 10.1016/j.jhsb.2004.12.009; Kim JW, 2014, JOURNAL OF ORTHOPAED; Li Q, 2014, GENET MOL RES, V13, P5361, DOI 10.4238/2014.July.24.15; Nasab SAM, 2012, TRAUMA MON, V17, P245, DOI 10.5812/traumamon.4497; Nicholls F, 2013, J ORTHOP RES, V31, P1323, DOI 10.1002/jor.22351; Oh CW, 2012, ORTHOP TRAUMATOL-SUR, V98, P54, DOI 10.1016/j.otsr.2011.09.016; Oh HK, 2015, ARCH ORTHOP TRAUM SU, V135, P235, DOI 10.1007/s00402-014-2138-x; Pozzi A, 2012, JAVMA-J AM VET MED A, V241, P744, DOI 10.2460/javma.241.6.744; Ricci WM, 2014, J ORTHOP TRAUMA, V28, P83, DOI 10.1097/BOT.0b013e31829e6dd0; Schulte LM, 2014, J AM ACAD ORTHOP SUR, V22, P437, DOI 10.5435/JAAOS-22-07-437; Vicenti G, 2014, INJURY, V45, pS27, DOI 10.1016/j.injury.2014.10.019; Yanez A, 2014, MED ENG PHYS, V36, P1543, DOI 10.1016/j.medengphy.2014.08.004; Yang TY, 2014, ORTHOPEDICS, V37, P679, DOI 10.3928/01477447-20140924-05; Yi JW, 2013, ARCH ORTHOP TRAUM SU, V133, P811, DOI 10.1007/s00402-013-1727-4; Zhang PX, 2012, CHINESE MED J-PEKING, V125, P140, DOI 10.3760/cma.j.issn.0366-6999-2012.01.026	34	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140037	10.1371/journal.pone.0140037	http://dx.doi.org/10.1371/journal.pone.0140037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444295	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600128
J	Zhu, GR; Chen, GX; Zhu, JT; Zhu, Y; Lu, XB; Li, XH; Hu, YK; Yan, YM				Zhu, Gengrui; Chen, Guanxing; Zhu, Jiantang; Zhu, Yan; Lu, Xiaobing; Li, Xiaohui; Hu, Yingkao; Yan, Yueming			Molecular Characterization and Expression Profiling of NAC Transcription Factors in Brachypodium distachyon L	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; FACTOR FAMILY; FUNCTIONAL DIVERGENCE; GENE DUPLICATION; DROUGHT RESISTANCE; STRESS RESPONSES; LEAF SENESCENCE; OSMOTIC-STRESS; PLANT; ARABIDOPSIS	NAC (NAM, ATAF1/2, CUC2) transcription factors are involved in regulating plant developmental processes and response to environmental stresses. Brachypodium distachyon is an emerging model system for cereals, temperate grasses and biofuel crops. In this study, a comprehensive investigation of the molecular characterizations, phylogenetics and expression profiles under various abiotic stresses of the NAC gene family in Brachypodium distachyon was performed. In total, 118 BNAC genes in B. distachyon were identified, of which 22 (18.64%) were tandemly duplicated and segmentally duplicated, respectively. The Bayesian phylogenetic inference using Markov Chain Monte Carlo (MCMC) algorithms showed that they were divided into two clades and fourteen subfamilies, supported by similar motif compositions within one subfamily. Some critical amino acids detected using DIVERGE v3.0 might contribute to functional divergence among subfamilies. The different exon-intron organizations among subfamilies revealed structural differentiation. Promoter sequence predictions showed that the BNAC genes were involved in various developmental processes and diverse stress responses. Three NAC domain-encoding genes (BNAC012, BNAC078 and BNAC108), orthologous of NAC1, were targeted by five miRNA164 (Bdi-miR164a-c, e, f), suggesting that they might function in lateral organ enlargement, floral development and the responses to abiotic stress. Eleven (similar to 9.32%) BNAC proteins containing alpha-helical transmembrane motifs were identified. 23 representative BNAC genes were analyzed by quantitative real-time PCR, showing different expression patterns under various abiotic stresses, of which 18, 17 and 11 genes were upregulated significantly under drought, H2O2 and salt stresses, respectively. Only four and two genes were up-regulated under cold and cadmium stresses, respectively. Dynamic transcriptional expression analysis revealed that six genes showed constitutive expression and period-specific expression. The current results provide novel insights into the structure and function of the plant NAC gene family.	[Zhu, Gengrui; Chen, Guanxing; Zhu, Jiantang; Zhu, Yan; Lu, Xiaobing; Li, Xiaohui; Hu, Yingkao; Yan, Yueming] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China	Capital Normal University	Hu, YK (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China.	yingkaohu@sohu.com; yanym@cnu.edu.cn		Hu, Yingkao/0000-0003-1848-7374	National Natural Science Foundation of China [31471485]; Natural Science Foundation of Beijing City; Key Developmental Project of Science Technology, Beijing Municipal Commission of Education [KZ201410028031]; National Key Project for Transgenic Crops in China [2014ZX08009-003]; International Science & Technology Cooperation Program of China [2013DFG30530]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing City(Beijing Natural Science Foundation); Key Developmental Project of Science Technology, Beijing Municipal Commission of Education; National Key Project for Transgenic Crops in China; International Science & Technology Cooperation Program of China	This research was financially supported by grants from the National Natural Science Foundation of China (31471485), Natural Science Foundation of Beijing City and the Key Developmental Project of Science Technology, Beijing Municipal Commission of Education (KZ201410028031), the National Key Project for Transgenic Crops in China (2014ZX08009-003) and International Science & Technology Cooperation Program of China (2013DFG30530).	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; ArguelloAstorga GR, 1996, PLANT PHYSIOL, V112, P1151, DOI 10.1104/pp.112.3.1151; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Gaucher EA, 2002, TRENDS BIOCHEM SCI, V27, P6; Gavryushkina A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003919; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hall BG, 2005, MOL BIOL EVOL, V22, P792, DOI 10.1093/molbev/msi066; Hao YJ, 2010, PLANTA, V232, P1033, DOI 10.1007/s00425-010-1238-2; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang H, 2012, PLANT SCI, V193, P18, DOI 10.1016/j.plantsci.2012.05.004; Huh SU, 2012, MOL CELLS, V34, P305, DOI 10.1007/s10059-012-0122-2; Jensen MK, 2010, PLANT SIGNAL BEHAV, V5, P907, DOI 10.4161/psb.5.7.12099; Jin H, 2013, SCI WORLD J, V2013, P768; Kim SG, 2008, PLANT J, V55, P77, DOI 10.1111/j.1365-313X.2008.03493.x; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim SY, 2007, NUCLEIC ACIDS RES, V35, P203, DOI 10.1093/nar/gkl1068; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Larue CT, 2009, PLANT J, V58, P450, DOI 10.1111/j.1365-313X.2009.03796.x; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Lin RM, 2007, PLANT SCI, V172, P120, DOI 10.1016/j.plantsci.2006.07.019; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu QP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-313; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; LOIS R, 1989, EMBO J, V8, P1641, DOI 10.1002/j.1460-2075.1989.tb03554.x; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Meshi T, 1995, PLANT CELL PHYSIOL, V36, P1405; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pascuzzi P, 1998, J BIOL CHEM, V273, P26631, DOI 10.1074/jbc.273.41.26631; Pastori GM, 2002, PLANT PHYSIOL, V129, P460, DOI 10.1104/pp.011021; Pastuglia M, 1997, PLANT CELL, V9, P49, DOI 10.1105/tpc.9.1.49; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Shen H, 2009, BIOENERG RES, V2, P217, DOI 10.1007/s12155-009-9047-9; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang MH, 2009, GENE, V432, P19, DOI 10.1016/j.gene.2008.11.018; WERNEKE JM, 1989, PLANT CELL, V1, P815, DOI 10.1105/tpc.1.8.815; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xie ZX, 2010, SEMIN CELL DEV BIOL, V21, P790, DOI 10.1016/j.semcdb.2010.03.012; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; YAMAGUCHISHINOZAKI K, 1993, PLANT PHYSIOL, V101, P1119, DOI 10.1104/pp.101.3.1119; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; Yoon HK, 2008, MOL CELLS, V25, P438; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Zheng Y, 2007, J EXP ZOOL PART B, V308B, P85, DOI 10.1002/jez.b.21140; Zhu Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-93	81	23	26	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139794	10.1371/journal.pone.0139794	http://dx.doi.org/10.1371/journal.pone.0139794			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444425	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600081
J	Zunhammer, M; Halski, A; Eichhammer, P; Busch, V				Zunhammer, Matthias; Halski, Agnes; Eichhammer, Peter; Busch, Volker			Theory of Mind and Emotional Awareness in Chronic Somatoform Pain Patients	PLOS ONE			English	Article							ALEXITHYMIA; SOMATIZATION; DEPRESSION; SCALE	Objective The present study aimed at investigating whether chronic pain patients are impaired in Theory of Mind (ToM), or Emotional Awareness. Methods Thirty inpatients suffering from chronic somatoform pain, as well as thirty healthy controls matched for age, sex, and education were recruited. ToM abilities were measured using the Frith-Happe animation task, in which participants interpret video-clips depicting moving geometric forms that mimic social interactions. The responses given were scored for appropriateness and the degree of inferred intentionality according to established protocols. Emotional awareness was measured using the Levels of Emotional Awareness Scale (LEAS), for which participants provide written descriptions of feelings in imaginary emotional situations. Standardized scoring was performed to capture the number and quality of emotional terms used. Results Responses lengths were similar in both groups and for both tasks. Patients attained significantly lower intentionality but not appropriateness scores when interpreting ToM interactions. No significant group differences were found when interpreting goal directed interactions. Emotional awareness scores were significantly lower in patients compared to healthy controls. Conclusions Our results suggest that chronic pain patients are impaired in mentalizing and emotional awareness. Future studies are needed to determine whether these ToM and emotional awareness deficits contribute to the etiology of somatoform pain and whether addressing these deficits in therapeutic interventions can improve polymodal pain therapy.	[Zunhammer, Matthias] Univ Klinikum Essen, Lehrstuhl Neuroimaging, Neurol, D-45147 Essen, Germany; [Halski, Agnes; Eichhammer, Peter; Busch, Volker] Univ Klinikum Regensburg, Klin Psychiat & Psychotherapie, D-93053 Regensburg, Germany	University of Duisburg Essen; University of Regensburg	Busch, V (corresponding author), Univ Klinikum Regensburg, Klin Psychiat & Psychotherapie, Univ Str 84, D-93053 Regensburg, Germany.	volker.busch@medbo.de						Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Ciarrochi J, 2003, PERS INDIV DIFFER, V34, P1477, DOI 10.1016/S0191-8869(02)00129-0; De Gucht V, 2003, J PSYCHOSOM RES, V54, P425, DOI 10.1016/S0022-3999(02)00467-1; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Kooiman CG, 2002, J PSYCHOSOM RES, V53, P1083, DOI 10.1016/S0022-3999(02)00348-3; Kupfer J, 2001, TORONTO ALEXITHYMIA; Ladegaard N, 2014, PSYCHIAT RES, V216, P37, DOI 10.1016/j.psychres.2013.12.010; LANE RD, 1990, J PERS ASSESS, V55, P124, DOI 10.1207/s15327752jpa5501&2_12; LANE RD, 1987, AM J PSYCHIAT, V144, P133; Lane RD, 2011, PSYCHOSOM MED, V73, P185, DOI 10.1097/PSY.0b013e318203b86a; Lieb R, 2002, EUR PSYCHIAT, V17, P321, DOI 10.1016/S0924-9338(02)00686-7; Mattila AK, 2008, PSYCHOSOM MED, V70, P716, DOI 10.1097/PSY.0b013e31816ffc39; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Price J, 2009, BRIT J PSYCHIAT, V195, P211, DOI 10.1192/bjp.bp.108.051110; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Stonnington CM, 2013, J PSYCHOSOM RES, V74, P479, DOI 10.1016/j.jpsychores.2013.04.004; Subic-Wrana C, 2005, PSYCHOSOM MED, V67, P483, DOI 10.1097/01.psy.0000160461.19239.13; Subic-Wrana C, 2001, PSYCHOTHERAPEUT, V46, P176, DOI 10.1007/s002780100157; Subic-Wrana C, 2010, PSYCHOSOM MED, V72, P404, DOI 10.1097/PSY.0b013e3181d35e83; Waller E, 2004, J PSYCHOSOM RES, V57, P239, DOI 10.1016/S0022-3999(03)00613-5; Wittchen H.-U., 1997, SKID STRUKTURIERTES; World Medical Association Inc, 2009, J Indian Med Assoc, V107, P403; Zunhammer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084911	25	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140016	10.1371/journal.pone.0140016	http://dx.doi.org/10.1371/journal.pone.0140016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26445110	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600122
J	Lennartsson, AK; Theorell, T; Kushnir, MM; Jonsdottir, IH				Lennartsson, Anna-Karin; Theorell, Tores; Kushnir, Mark M.; Jonsdottir, Ingibjorg H.			Low Levels of Dehydroepiandrosterone Sulfate in Younger Burnout Patients	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; ALCOHOL-CONSUMPTION; HORMONES; RISK; ASSOCIATION; DISEASE; STRESS; MEN	Objective Dehydroepiandrosterone sulphate (DHEA-s) is an anabolic protective hormone of importance for maintenance of health. DHEA-s levels peak in young adults and decline thereafter with age. DHEA-s has previously been shown to be lower in individuals reporting prolonged stress. This study investigates DHEA-s levels in patients with clinical burnout, a disorder caused by long-term psychosocial stress. Methods 122 patients (51% men) and 47 controls (51% men) in the age 25-54 years were included in the study. DHEA-s levels were compared between patients and controls in the whole sample and within each of the three 10-year-interval age groups. Results In the youngest age group (25-34 years), DHEA-s levels were on average 25% lower in the patients (p = 0.006). The differences in DHEA-s levels between patients and controls were more pronounced among female than male participants (on average 32% and 13% lower, respectively). There were no differences in DHEA-s levels between patients and controls in the age group 35-44 years (p = 0.927) or 45-54 years (p = 0.897) or when analyzing all age groups together (p = 0.187). Conclusion The study indicates that levels of the health promoting "youth" hormone DHEA-s are low in younger burnout patients. The fact that younger adults have much higher DHEA-s levels and more pronounced inter-subject variability in DHEA-s levels than older individuals might explain why burnout status differentiates patients from controls only among the youngest patients included in this study.	[Lennartsson, Anna-Karin; Jonsdottir, Ingibjorg H.] Inst Stress Med, Gothenburg, Sweden; [Lennartsson, Anna-Karin] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Kushnir, Mark M.] ARUP Inst Clin & Expt Lab, Salt Lake City, UT USA	Karolinska Institutet; Stockholm University	Lennartsson, AK (corresponding author), Inst Stress Med, Gothenburg, Sweden.	anna-karin.lennartsson@ki.se		Kushnir, Mark/0000-0003-4480-0854	Institute of Stress Medicine, Gothenburg, Sweden	Institute of Stress Medicine, Gothenburg, Sweden	No external funding was used for the study. The study was funded by the ordinary resources within the Institute of Stress Medicine, Gothenburg, Sweden.	BARON JA, 1995, J PHARMACOL EXP THER, V272, P151; Barrett-Connor E, 1999, J AM GERIATR SOC, V47, P685, DOI 10.1111/j.1532-5415.1999.tb01590.x; Berr C, 1996, P NATL ACAD SCI USA, V93, P13410, DOI 10.1073/pnas.93.23.13410; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1111/j.1530-0277.1998.tb03991.x; Ghebre MA, 2011, CALCIFIED TISSUE INT, V89, P295, DOI 10.1007/s00223-011-9518-9; Glise K, 2010, INT ARCH OCC ENV HEA, V83, P511, DOI 10.1007/s00420-009-0490-x; Grossi G, 2003, J PSYCHOSOM RES, V55, P309, DOI 10.1016/S0022-3999(02)00633-5; Hechter O, 1997, MED HYPOTHESES, V49, P85, DOI 10.1016/S0306-9877(97)90258-9; Langelaan S, 2006, SCAND J WORK ENV HEA, V32, P339, DOI 10.5271/sjweh.1029; Lennartsson AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072460; MASON JW, 1968, PSYCHOSOM MED, V30, P774, DOI 10.1097/00006842-196809000-00032; MELAMED S, 1992, BEHAV MED, V18, P53, DOI 10.1080/08964289.1992.9935172; Melamed S, 2006, PSYCHOSOM MED, V68, P863, DOI 10.1097/01.psy.0000242860.24009.f0; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Moch SL, 2003, ENDOCRINE, V21, P267, DOI 10.1385/ENDO:21:3:267; Mommersteeg PMC, 2006, PSYCHOSOM MED, V68, P879, DOI 10.1097/01.psy.0000239247.47581.0c; Jeckel CMM, 2010, NEUROIMMUNOMODULAT, V17, P9, DOI 10.1159/000243080; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; Peterson U, 2011, J OCCUP ENVIRON MED, V53, P788, DOI 10.1097/JOM.0b013e318222b1dc; Schell E, 2008, EUR SPINE J, V17, P393, DOI 10.1007/s00586-007-0554-0; Sierksma A, 2004, ALCOHOL CLIN EXP RES, V28, P780, DOI 10.1097/01.ALC.0000125356.70824.81; Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x; Voznesensky M, 2009, AGE AGEING, V38, P401, DOI 10.1093/ageing/afp015	23	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0140054	10.1371/journal.pone.0140054	http://dx.doi.org/10.1371/journal.pone.0140054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441131	gold, Green Published			2022-12-26	WOS:000362510300094
J	Zhou, HZ; Zhu, SS; Quan, R; Wang, J; Wei, L; Yang, B; Xu, F; Wang, JL; Chen, FY; Liu, J				Zhou, Hongzhuan; Zhu, Shanshan; Quan, Rong; Wang, Jing; Wei, Li; Yang, Bing; Xu, Fuzhou; Wang, Jinluo; Chen, Fuyong; Liu, Jue			Identification and Genome Characterization of the First Sicinivirus Isolate from Chickens in Mainland China by Using Viral Metagenomics	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; GENETIC-CHARACTERIZATION; MOLECULAR ANALYSIS; ENTRY SITE; PICORNAVIRUS; DISTINCT; MEMBERS; HEPATITIS; PROTEIN; GENERA	Unlike traditional virus isolation and sequencing approaches, sequence-independent amplification based viral metagenomics technique allows one to discover unexpected or novel viruses efficiently while bypassing culturing step. Here we report the discovery of the first Sicinivirus isolate (designated as strain JSY) of picornaviruses from commercial layer chickens in mainland China by using a viral metagenomics technique. This Sicinivirus isolate, which contains a whole genome of 9,797 nucleotides (nt) excluding the poly(A) tail, possesses one of the largest picornavirus genome so far reported, but only shares 88.83% and 82.78% of amino acid sequence identity to that of ChPV1 100C (KF979332) and Sicinivirus 1 strain UCC001 (NC_023861), respectively. The complete 939 nt 5'UTR of the isolate strain contains at least twelve stem-loop domains (A-L), representing the highest set of loops reported within Sicinivirus genus. The conserved 'barbell-like' structure was also present in the 272 nt 3' UTR of the isolate as that in the 3' UTR of Sicinivirus 1 strain UCC001. The 8,586 nt large open reading frame encodes a 2,862 amino acids polyprotein precursor. Moreover, Sicinivirus infection might be widely present in commercial chicken farms in Yan-cheng region of the Jiangsu Province as evidenced by all the tested stool samples from three different farms being positive (17/17) for Sicinivirus detection. This is the first report on identification of Sicinivirus in commercial layer chickens with a severe clinical disease in mainland China, however, further studies are needed to evaluate the pathogenic potential of this picornavirus in chickens.	[Zhou, Hongzhuan; Zhu, Shanshan; Quan, Rong; Wang, Jing; Wei, Li; Yang, Bing; Xu, Fuzhou; Wang, Jinluo; Liu, Jue] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing 100097, Peoples R China; [Chen, Fuyong] China Agr Univ, Coll Vet Med, Beijing 100197, Peoples R China	Beijing Academy of Agriculture & Forestry; China Agricultural University	Liu, J (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, 9 Shuguang Garden Middle Rd, Beijing 100097, Peoples R China.	liujue@263.net			China Agriculture Research System [CARS-42]	China Agriculture Research System	This work was supported by a grant from China Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Barbosa T, 2008, AVIAN DIS, V52, P245, DOI 10.1637/8100-083107-Reg.1; BECK E, 1987, J VIROL, V61, P1621, DOI 10.1128/JVI.61.5.1621-1629.1987; BECK E, 1983, EMBO J, V2, P555, DOI 10.1002/j.1460-2075.1983.tb01462.x; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Boros A, 2014, INFECT GENET EVOL, V28, P333, DOI 10.1016/j.meegid.2014.10.025; Boros A, 2014, J VIROL, V88, P6434, DOI 10.1128/JVI.03807-13; Boros A, 2013, J GEN VIROL, V94, P1496, DOI 10.1099/vir.0.051797-0; Boros A, 2012, J GEN VIROL, V93, P2171, DOI 10.1099/vir.0.043224-0; Bullman S, 2014, J GEN VIROL, V95, P1094, DOI 10.1099/vir.0.061085-0; Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06; de Breyne S, 2009, P NATL ACAD SCI USA, V106, P9197, DOI 10.1073/pnas.0900153106; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; de Wit JJ, 2011, AVIAN PATHOL, V40, P453, DOI 10.1080/03079457.2011.596813; Ghazi F, 1998, J GEN VIROL, V79, P2641, DOI 10.1099/0022-1317-79-11-2641; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; GRANT RA, 1994, CURR BIOL, V4, P784, DOI 10.1016/S0960-9822(00)00176-7; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hellen CUT, 2007, J VIROL, V81, P5850, DOI 10.1128/JVI.02403-06; Honkavuori KS, 2011, EMERG INFECT DIS, V17, P480, DOI 10.3201/eid1703.101410; Jackson T, 2003, VIRUS RES, V91, P33, DOI 10.1016/S0168-1702(02)00258-7; Jakhesara SJ, 2016, TRANSBOUND EMERG DIS, V63, P523, DOI 10.1111/tbed.12294; Ji J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-184; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Lau SK, 2012, J CLIN MICROBIOL, V45, P3655; Lau SKP, 2014, J GEN VIROL, V95, P1929, DOI 10.1099/vir.0.066597-0; Liu J, 2007, VIRUS GENES, V35, P719, DOI 10.1007/s11262-007-0147-3; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Niepmann M, 2009, BBA-GENE REGUL MECH, V1789, P529, DOI 10.1016/j.bbagrm.2009.05.002; NOTEBORN MHM, 1992, AVIAN PATHOL, V21, P107, DOI 10.1080/03079459208418823; Phelps DK, 2000, CURR OPIN STRUC BIOL, V10, P170, DOI 10.1016/S0959-440X(00)00064-6; Reuter G, 2014, ARCH VIROL, V159, P2723, DOI 10.1007/s00705-014-2113-4; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Sauvage V, 2012, J VIROL, V86, P10036, DOI 10.1128/JVI.00046-12; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith A, 2009, POULTRY SCI, V88, P1580, DOI 10.3382/ps.2009-00148; Stewart SR, 1997, SEMIN VIROL, V8, P242, DOI 10.1006/smvy.1997.0127; Sweeney TR, 2012, J VIROL, V86, P1468, DOI 10.1128/JVI.05862-11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wei L, 2008, J VIROL METHODS, V149, P56, DOI 10.1016/j.jviromet.2008.01.006; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Woo PCY, 2012, J VIROL, V86, P2797, DOI 10.1128/JVI.05481-11; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; Zhao W, 2011, AVIAN DIS, V55, P65, DOI 10.1637/9506-081810-Reg.1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139668	10.1371/journal.pone.0139668	http://dx.doi.org/10.1371/journal.pone.0139668			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461027	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300020
J	Muniz, VS; Baptista-dos-Reis, R; Benjamim, CF; Mata-Santos, HA; Pyrrho, AS; Strauch, MA; Melo, PA; Vicentino, ARR; Silva-Paiva, J; Bandeira-Melo, C; Weller, PF; Figueiredo, RT; Neves, JS				Muniz, Valdirene S.; Baptista-dos-Reis, Renata; Benjamim, Claudia F.; Mata-Santos, Hilton A.; Pyrrho, Alexandre S.; Strauch, Marcelo A.; Melo, Paulo A.; Vicentino, Amanda R. R.; Silva-Paiva, Juliana; Bandeira-Melo, Christianne; Weller, Peter F.; Figueiredo, Rodrigo T.; Neves, Josiane S.			Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response	PLOS ONE			English	Article							CHEMOTACTIC ACTIVITY; P2 RECEPTORS; RELEASE; NUCLEOTIDES; STIMULATION; MECHANISM; INFECTION; PLATELETS; ADENOSINE; FIBROSIS	Identifying new target molecules through which eosinophils secrete their stored proteins may reveal new therapeutic approaches for the control of eosinophilic disorders such as host immune responses to parasites. We have recently reported the expression of the purinergic P2Y12 receptor (P2Y12R) in human eosinophils; however, its functional role in this cell type and its involvement in eosinophilic inflammation remain unknown. Here, we investigated functional roles of P2Y12R in isolated human eosinophils and in a murine model of eosinophilic inflammation induced by Schistosoma mansoni (S. mansoni) infection. We found that adenosine 5'-diphosphate (ADP) induced human eosinophils to secrete eosinophil peroxidase (EPO) in a P2Y12R dependent manner. However, ADP did not interfere with human eosinophil apoptosis or chemotaxis in vitro. In vivo, C57Bl/6 mice were infected with cercariae of the Belo Horizonte strain of S. mansoni. Analyses performed 55 days post infection revealed that P2Y12R blockade reduced the granulomatous hepatic area and the eosinophilic infiltrate, collagen deposition and IL-13/IL-4 production in the liver without affecting the parasite oviposition. As found for humans, murine eosinophils also express the P2Y12R. P2Y12R inhibition increased blood eosinophilia, whereas it decreased the bone marrow eosinophil count. Our results suggest that P2Y12R has an important role in eosinophil EPO secretion and in establishing the inflammatory response in the course of a S. mansoni infection.	[Muniz, Valdirene S.; Baptista-dos-Reis, Renata; Benjamim, Claudia F.; Strauch, Marcelo A.; Melo, Paulo A.; Neves, Josiane S.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil; [Mata-Santos, Hilton A.; Pyrrho, Alexandre S.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, RJ, Brazil; [Vicentino, Amanda R. R.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, RJ, Brazil; [Silva-Paiva, Juliana; Bandeira-Melo, Christianne] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil; [Weller, Peter F.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis & Allergy & Inflammat, Boston, MA 02215 USA; [Figueiredo, Rodrigo T.] Univ Fed Rio de Janeiro, Unit Xerem, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade Federal do Rio de Janeiro	Neves, JS (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.	jneves@icb.ufrj.br	Muniz, Valdirene/AAW-3833-2021; de Melo, Christianne Bandeira/B-7724-2009; Neves, Josiane S/C-3102-2009; Strauch, Marcelo A/J-2443-2016; Benjamim, Claudia/T-5090-2019; Bandeira-Melo, Christianne/X-5619-2019; Neves, Josiane Sabbadini/X-9801-2019; Figueiredo, Rodrigo/F-5176-2016	de Melo, Christianne Bandeira/0000-0003-3305-3865; Benjamim, Claudia/0000-0001-6247-9596; Bandeira-Melo, Christianne/0000-0003-3305-3865; Neves, Josiane Sabbadini/0000-0002-6645-1715; Melo, Paulo A/0000-0003-1250-6933; Figueiredo, Rodrigo/0000-0002-7551-8782; Muniz, Valdirene S/0000-0003-0102-2861	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq-Brazil); Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES-Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ-Brazil); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020241] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES-Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ-Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by funds from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq-Brazil)(JSN), Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES-Brazil)(VSM) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ-Brazil) (JSN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuthota P, 2008, CLIN EXP ALLERGY, V38, P1254, DOI 10.1111/j.1365-2222.2008.03037.x; Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Broze GJ, 2001, THROMB HAEMOSTASIS, V85, P747; BURGERS JA, 1993, BLOOD, V81, P49; CHEEVER A W, 1968, Bulletin of the World Health Organization, V39, P328; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; DAVID JR, 1980, AM J TROP MED HYG, V29, P842, DOI 10.4269/ajtmh.1980.29.842; Davies SJ, 2005, INT J PARASITOL, V35, P851, DOI 10.1016/j.ijpara.2005.02.017; Di Virgilio Francesco, 2001, Trends in Pharmacological Sciences, V22, P5; Dichmann S, 2000, BLOOD, V95, P973, DOI 10.1182/blood.V95.3.973.003k47_973_978; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Ferrari D, 2006, J LEUKOCYTE BIOL, V79, P7, DOI 10.1189/jlb.0505286; Gachet C, 2012, PURINERG SIGNAL, V8, P609, DOI 10.1007/s11302-012-9303-x; GRESELE P, 1985, LANCET, V1, P347; Hechler B, 2011, PURINERG SIGNAL, V7, P293, DOI 10.1007/s11302-011-9247-6; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj.bjp.0705145; Idzko M, 2001, J CELL PHYSIOL, V188, P329, DOI 10.1002/jcp.1129; Isfort K, 2011, J BIOL CHEM, V286, P44776, DOI 10.1074/jbc.M111.289793; Jacob F, 2013, PURINERG SIGNAL, V9, P285, DOI 10.1007/s11302-013-9357-4; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kim S, 2011, PLATELETS, V22, P56, DOI 10.3109/09537104.2010.497231; Klion AD, 2004, J ALLERGY CLIN IMMUN, V113, P30, DOI 10.1016/j.jaci.2003.10.050; KROEGEL C, 1989, J IMMUNOL, V142, P3518; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Leeto M, 2006, AM J PATHOL, V169, P1701, DOI 10.2353/ajpath.2006.060346; Marteau F, 2004, J LEUKOCYTE BIOL, V76, P796, DOI 10.1189/jlb.0104032; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; Muniz VS, 2012, J LEUKOCYTE BIOL, V92, P281, DOI 10.1189/jlb.0212067; Myrtek D, 2007, PURINERG SIGNAL, V3, P5, DOI 10.1007/s11302-006-9032-0; Neves JS, 2010, J ALLERGY CLIN IMMUN, V125, P477, DOI 10.1016/j.jaci.2009.11.029; Neves JS, 2009, J IMMUNOL METHODS, V344, P64, DOI 10.1016/j.jim.2009.03.006; Neves JS, 2008, P NATL ACAD SCI USA, V105, P18478, DOI 10.1073/pnas.0804547105; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Pitchford SC, 2005, BLOOD, V105, P2074, DOI 10.1182/blood-2004-06-2282; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; SCHWEIZER RC, 1994, BLOOD, V83, P3697; Sheikh J, 2009, CURR OPIN HEMATOL, V16, P3, DOI 10.1097/MOH.0b013e32831c841f; Swartz JM, 2006, BLOOD, V108, P2420, DOI 10.1182/blood-2006-04-015933; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; Wang Lingwei, 2004, BMC Immunol, V5, P16, DOI 10.1186/1471-2172-5-16	49	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139805	10.1371/journal.pone.0139805	http://dx.doi.org/10.1371/journal.pone.0139805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448282	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511000056
J	Trentin-Sonoda, M; da Silva, RC; Kmit, FV; Abrahao, MV; Cahli, GM; Brasil, GV; Muzi, H; Silva, PA; Tovar-Moll, FF; Vieyra, A; Medei, E; Carneiro-Ramos, MS				Trentin-Sonoda, Mayra; da Silva, Rogerio Cirino; Kmit, Fernanda Vieira; Abrahao, Mariana Vieira; Cahli, Gustavo Monnerat; Brasil, Guilherme Visconde; Muzi-Filho, Humberto; Silva, Paulo Andre; Tovar-Moll, Fernanda Freire; Vieyra, Adalberto; Medei, Emiliano; Carneiro-Ramos, Marcela Sorelli			Knockout of Toll-Like Receptors 2 and 4 Prevents Renal Ischemia-Reperfusion-Induced Cardiac Hypertrophy in Mice	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-INFARCTION; HEART; INFLAMMATION; ACTIVATION; MECHANISMS; KIDNEY; TLR4; DYSFUNCTION	We investigated whether the pathways linked to Toll-like receptors 2 and 4 (TLRs) are involved in renal ischemia-reperfusion (I/R)-induced cardiac hypertrophy. Wild type (WT) C57BL/6J, TLR2(-/-) and TLR4(-/-) mice were subjected to left kidney ischemia for 60 min followed by reperfusion for 5, 8, 12 and 15 days. Proton density magnetic resonance showed alterations in the injured kidney from WT mice, together with signs of parenchymal edema and higher levels of vimentin mRNA, accompanied by: (i) small, but significant, increase in serum urea after 24 h, (ii) 100% increase in serum creatinine at 24 h. A serum peak of inflammatory cytokines occurred after 5 days of reperfusion. Heart weight/body weight and heart weight/tibia length ratios increased after 12 and 15 days of reperfusion, respectively. Cardiac hypertrophy markers, B-type natriuretic peptide (BNP) and alpha-actin, left ventricle mass, cardiac wall thickness and myocyte width increased after 15 days of reperfusion, together with longer QTc and action potential duration. Cardiac TLRs, MyD88, HSP60 and HSP70 mRNA levels also increased. After 15 days of reperfusion, absence of TLRs prevented cardiac hypertrophy, as reflected by similar values of left ventricular cardiac mass and heart weight/body weight ratio compared to the transgenic Sham. Renal tissular injury also ameliorated in both knockout mice, as revealed by the comparison of their vimentin mRNA levels with those found in the WT on the same day after I/R. The I/R TLR2(-/-) group had TNF-alpha, IFN-gamma and IL-1 beta levels similar to the non-I/R group, whereas the TLR4(-/-) group conserved the p-NF-kappa B/NF-kappa B ratio contrasting with that found in TLR2(-/-). We conclude: (i) TLRs are involved in renal I/R-induced cardiac hypertrophy; (ii) absence of TLRs prevents I/R-induced cardiac hypertrophy, despite renal lesions seeming to evolve towards those of chronic disease; (iii) TLR2 and TLR4 selectively regulate the systemic inflammatory profile and NF-kappa B activation.	[Trentin-Sonoda, Mayra; da Silva, Rogerio Cirino; Kmit, Fernanda Vieira; Abrahao, Mariana Vieira; Carneiro-Ramos, Marcela Sorelli] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil; [Cahli, Gustavo Monnerat; Brasil, Guilherme Visconde; Muzi-Filho, Humberto; Silva, Paulo Andre; Vieyra, Adalberto; Medei, Emiliano] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Cahli, Gustavo Monnerat; Brasil, Guilherme Visconde; Muzi-Filho, Humberto; Silva, Paulo Andre; Tovar-Moll, Fernanda Freire; Vieyra, Adalberto; Medei, Emiliano] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Tovar-Moll, Fernanda Freire] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil; [Tovar-Moll, Fernanda Freire] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil	Universidade Federal do ABC (UFABC); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Carneiro-Ramos, MS (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil.	marcela.ramos@ufabc.edu.br	Carneiro-Ramos, Marcela Sorelli/I-6191-2017; Trentin Sonoda, Mayra/N-9762-2014; Moll, Fernanda Tovar/N-3320-2018; monnerat, gustavo/E-3398-2015; Carneiro-Ramos, Marcela/AAP-6258-2021; BRASIL, GUILHERME VISCONDE/M-7286-2019; Monnerat, Gustavo/J-6907-2019; Sonoda, Mayra Trentin/R-9943-2019; Moll, Fernanda Tovar/AAF-8477-2021	Carneiro-Ramos, Marcela Sorelli/0000-0003-2666-1280; Trentin Sonoda, Mayra/0000-0003-2446-7783; Moll, Fernanda Tovar/0000-0002-0292-5985; monnerat, gustavo/0000-0002-1010-6314; BRASIL, GUILHERME VISCONDE/0000-0002-4695-4710; Sonoda, Mayra Trentin/0000-0003-2446-7783; Moll, Fernanda Tovar/0000-0002-0292-5985; Muzi-Filho, Humberto/0000-0002-9183-1699; Medei, Emiliano/0000-0002-0044-1311	FAPESP agency [2008/1015-4]; Brazilian National Research Council (CNPq) [308168/2012-7, 475218/2012-4]; Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ) [E-26/103.222/2011, E-26/111.171/2011]; National Institute of Science and Technology for Structural Biology and Bioimaging, Brazil [573767/2008-4]	FAPESP agency(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Science and Technology for Structural Biology and Bioimaging, Brazil	FAPESP agency (grant N. 2008/1015-4) for financial support. This work was also funded by the Brazilian National Research Council (CNPq, grants: 308168/2012-7 and 475218/2012-4), the Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ, grants: E-26/103.222/2011 and E-26/111.171/2011) and the National Institute of Science and Technology for Structural Biology and Bioimaging (grant: 573767/2008-4), Brazil.	Arslan F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/704202; Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bagchi AK, 2013, CYTOKINE, V61, P304, DOI 10.1016/j.cyto.2012.10.013; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Beddhu S, 2002, KIDNEY INT, V62, P1776, DOI 10.1046/j.1523-1755.2002.00629.x; Bian ZY, 2014, J CELL BIOCHEM, V115, P349, DOI 10.1002/jcb.24669; Carneiro-Ramos MS, 2007, J PHYSIOL-LONDON, V583, P213, DOI 10.1113/jphysiol.2007.134080; Carroll CJ, 2013, J INTERF CYTOK RES, V33, P542, DOI 10.1089/jir.2012.0165; Chandrasekar B, 1997, FEBS LETT, V401, P30, DOI 10.1016/S0014-5793(96)01426-3; Chang NS, 1997, AM J PHYSIOL-CELL PH, V273, pC1987, DOI 10.1152/ajpcell.1997.273.6.C1987; Cheng Y, 2013, AM J PHYSIOL-HEART C, V305, pH52, DOI 10.1152/ajpheart.00929.2012; Cho E, 2013, NEPHROL DIAL TRANSPL, V28, P2766, DOI 10.1093/ndt/gft376; Dai DF, 2012, ANTIOXID REDOX SIGN, V16, P1492, DOI 10.1089/ars.2011.4179; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Elias RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044004; Feitoza CQ, 2008, MOL MED, V14, P724, DOI 10.2119/2008-00064.Feitoza; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Higashikuni Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000267; Jiang DS, 2014, HYPERTENSION, V63, P96, DOI 10.1161/HYPERTENSIONAHA.113.01506; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Krause M, 2015, CLIN SCI, V128, P789, DOI 10.1042/CS20140695; Kuster N, 2013, ANN BIOL CLIN-PARIS, V71, P409, DOI 10.1684/abc.2013.0877; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lewis R, 2012, UNDERSTANDING CHRONI; Liang FQ, 1999, J CLIN INVEST, V104, P1603, DOI 10.1172/JCI7362; Ma YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040763; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Mathur S, 2011, CIRC J, V75, P2445, DOI 10.1253/circj.CJ-11-0194; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI [10.1159/000349966, 10.1159/000361059]; Medei E, 2010, J MOL CELL CARDIOL, V49, P165, DOI 10.1016/j.yjmcc.2010.04.014; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; POOLEWILSON PA, 1993, J AM COLL CARDIOL, V22, pA22, DOI 10.1016/0735-1097(93)90458-D; Rayego-Mateos S, 2013, J PATHOL, V231, P480, DOI 10.1002/path.4250; Riad A, 2008, EUR J HEART FAIL, V10, P233, DOI 10.1016/j.ejheart.2008.01.004; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Ronco C, 2009, BLOOD PURIFICAT, V27, P114, DOI 10.1159/000167018; SAFIRSTEIN R, 1991, AM J PHYSIOL, V261, pF1095, DOI 10.1152/ajprenal.1991.261.6.F1095; Shishido T, 2006, BIOCHEM BIOPH RES CO, V345, P1446, DOI 10.1016/j.bbrc.2006.05.056; Silva RC, 2013, CELL PHYSIOL BIOCHEM, V31, P179, DOI 10.1159/000343359; Smith G, 2007, EXP PHYSIOL, V92, P973, DOI 10.1113/expphysiol.2007.034314; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang T, 2013, J MOL CELL CARDIOL, V60, P60, DOI 10.1016/j.yjmcc.2013.04.005; Tang Y, 2009, ANAT REC, V292, P1630, DOI 10.1002/ar.20952; Toldo S, 2013, EXP PHYSIOL, V98, P734, DOI 10.1113/expphysiol.2012.069831; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Wu HL, 2014, KIDNEY INT, V85, P824, DOI 10.1038/ki.2013.475; Zanin-Zhorov A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00211	60	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139350	10.1371/journal.pone.0139350	http://dx.doi.org/10.1371/journal.pone.0139350			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448184	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000022
J	Wiewelhove, T; Raeder, C; Meyer, T; Kellmann, M; Pfeiffer, M; Ferrauti, A				Wiewelhove, Thimo; Raeder, Christian; Meyer, Tim; Kellmann, Michael; Pfeiffer, Mark; Ferrauti, Alexander			Markers for Routine Assessment of Fatigue and Recovery in Male and Female Team Sport Athletes during High-Intensity Interval Training	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; CONTRACTILE PROPERTIES; EXERCISE; SOCCER; PERFORMANCE; ENDURANCE; VALIDITY; RELIABILITY; SORENESS; TESTS	Aim Our study aimed to investigate changes of different markers for routine assessment of fatigue and recovery in response to high-intensity interval training (HIIT). Methods 22 well-trained male and female team sport athletes (age, 23.0 +/- 2.7 years; VO2max, 57.6 +/- 8.6 mL.min.kg(-1)) participated in a six-day running-based HIIT-microcycle with a total of eleven HIIT sessions. Repeated sprint ability (RSA; criterion measure of fatigue and recovery), countermovement jump (CMJ) height, jump efficiency in a multiple rebound jump test (MRJ), 20-m sprint performance, muscle contractile properties, serum concentrations of creatinkinase (CK), c-reactive protein (CRP) and urea as well as perceived muscle soreness (DOMS) were measured pre and post the training program as well as after 72 h of recovery. Results Following the microcycle significant changes (p < 0.05) in RSA as well as in CMJ and MRJ performance could be observed, showing a decline (%Delta +/- 90% confidence limits, ES = effect size; RSA: -3.8 +/- 1.0, ES = -1.51; CMJ: 8.4 +/- 2.9, ES = -1.35; MRJ: 17.4 +/- 4.5, ES = -1.60) and a return to baseline level (RSA: 2.8 +/- 2.6, ES = 0.53; CMJ: 4.1 +/- 2.9, ES = 0.68; MRJ: 6.5 +/- 4.5, ES = 0.63) after 72 h of recovery. Athletes also demonstrated significant changes (p < 0.05) in muscle contractile properties, CK, and DOMS following the training program and after the recovery period. In contrast, CRP and urea remained unchanged throughout the study. Further analysis revealed that the accuracy of markers for assessment of fatigue and recovery in comparison to RSA derived from a contingency table was insufficient. Multiple regression analysis also showed no correlations between changes in RSA and any of the markers. Conclusions Mean changes in measures of neuromuscular function, CK and DOMS are related to HIIT induced fatigue and subsequent recovery. However, low accuracy of a single or combined use of these markers requires the verification of their applicability on an individual basis.	[Wiewelhove, Thimo; Raeder, Christian; Kellmann, Michael; Ferrauti, Alexander] Ruhr Univ Bochum, Fac Sport Sci, Bochum, Germany; [Meyer, Tim] Univ Saarland, Inst Sports & Prevent Med, Saarbrucken, Germany; [Kellmann, Michael] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld, Australia; [Kellmann, Michael] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Pfeiffer, Mark] Johannes Gutenberg Univ Mainz, Inst Sports Sci, D-55122 Mainz, Germany	Ruhr University Bochum; Saarland University; University of Queensland; University of Queensland; Johannes Gutenberg University of Mainz	Wiewelhove, T (corresponding author), Ruhr Univ Bochum, Fac Sport Sci, Univ Str 150, Bochum, Germany.	thimo.wiewelhove@ruhr-uni-bochum.de	Wiewelhove, Sport Sc. Thimo/Q-3672-2019; Ferrauti, Alexander/P-9577-2019; Kellmann, Michael/J-3508-2014	Wiewelhove, Sport Sc. Thimo/0000-0003-1020-8780; Alexander, Ferrauti/0000-0001-9807-2755; Kellmann, Michael/0000-0003-1699-9624; Pfeiffer, Mark/0000-0002-9287-5343	German Federal Institute of Sport Science	German Federal Institute of Sport Science	The present study was funded by the German Federal Institute of Sport Science (http://www.bisp.de). The research was realized within REGman-Optimization of Training and Competition: Management of Regeneration in Elite Sports (IIA1-081901/12-16). Funding were received by TM MK MP AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou H, 2008, INTJ SPORT PHYSIOL, V3, P320, DOI 10.1123/ijspp.3.3.320; Ament W, 2009, SPORTS MED, V39, P389, DOI 10.2165/00007256-200939050-00005; Andersson H, 2008, MED SCI SPORT EXER, V40, P372, DOI 10.1249/mss.0b013e31815b8497; Aziz AR, 2008, INT J SPORTS MED, V29, P833, DOI 10.1055/s-2008-1038410; Ball NB, 2012, J STRENGTH COND RES, V26, P1407, DOI 10.1519/JSC.0b013e3182510870; BANGSBO J, 1992, INT J SPORTS MED, V13, P125, DOI 10.1055/s-2007-1021243; Buchheit M, 2008, J STRENGTH COND RES, V22, P365, DOI 10.1519/JSC.0b013e3181635b2e; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Byrne C, 2004, SPORTS MED, V34, P49, DOI 10.2165/00007256-200434010-00005; Cicioni-Kolsky D, 2013, EUR J SPORT SCI, V13, P304, DOI 10.1080/17461391.2011.606844; Cleather DJ, 2007, J SPORT SCI, V25, P845, DOI 10.1080/02640410600908050; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coutts AJ, 2007, J SCI MED SPORT, V10, P372, DOI 10.1016/j.jsams.2007.02.007; Coutts AJ, 2007, EUR J APPL PHYSIOL, V99, P313, DOI 10.1007/s00421-006-0345-z; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Gallagher EJ, 2002, AM J EMERG MED, V20, P287, DOI 10.1053/ajem.2002.33778; Garcia-Garcia O, 2013, J STRENGTH COND RES, V27, P2760, DOI 10.1519/JSC.0b013e31828155cd; Girard O, 2009, J STRENGTH COND RES, V23, P1867, DOI 10.1519/JSC.0b013e3181b3df89; Halson Shona L, 2014, Sports Med, V44 Suppl 2, pS139, DOI 10.1007/s40279-014-0253-z; Hoffman JR, 2005, MED SCI SPORT EXER, V37, P1237, DOI 10.1249/01.mss.0000170068.97498.26; Howatson G, 2009, J STRENGTH COND RES, V23, P2419, DOI 10.1519/JSC.0b013e3181bac52e; Hughes MG, 2006, INT J SPORTS MED, V27, P900, DOI 10.1055/s-2006-923791; Hunter AM, 2012, J ELECTROMYOGR KINES, V22, P334, DOI 10.1016/j.jelekin.2012.01.009; Iaia FM, 2009, INTJ SPORT PHYSIOL, V4, P291, DOI 10.1123/ijspp.4.3.291; Impellizzeri FM, 2008, INT J SPORTS MED, V29, P899, DOI 10.1055/s-2008-1038491; Kellmann M, 2010, SCAND J MED SCI SPOR, V20, P95, DOI 10.1111/j.1600-0838.2010.01192.x; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; Leveritt M, 1999, J STRENGTH COND RES, V13, P47, DOI 10.1519/00124278-199902000-00009; Garcia-Manso JM, 2011, J SPORT SCI, V29, P619, DOI 10.1080/02640414.2010.548822; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Meyer T, 2011, INT J SPORTS MED, V32, P875, DOI 10.1055/s-0031-1280776; Mougios V, 2007, BRIT J SPORT MED, V41, P674, DOI 10.1136/bjsm.2006.034041; Nedelec M, 2012, SPORTS MED, V42, P997, DOI 10.2165/11635270-000000000-00000; Nicol C, 2006, SPORTS MED, V36, P977, DOI 10.2165/00007256-200636110-00004; Oliver JL, 2006, PEDIATR EXERC SCI, V18, P339, DOI 10.1123/pes.18.3.339; Rakobowchuk M, 2008, AM J PHYSIOL-REG I, V295, pR236, DOI 10.1152/ajpregu.00069.2008; Rampinini E, 2007, INT J SPORTS MED, V28, P228, DOI 10.1055/s-2006-924340; Rey E, 2012, J STRENGTH COND RES, V26, P3081, DOI 10.1519/JSC.0b013e3182470d33; Shaffi AS, 2011, J BIOM BIOSTAT, V2, P1, DOI DOI 10.4172/2055-6180.1000128; Simola RAD, 2015, J STRENGTH COND RES, V29, P1339, DOI 10.1519/JSC.0000000000000768; Singh TKR, 2011, J SCI MED SPORT, V14, P441, DOI 10.1016/j.jsams.2011.03.008; Tanner RK, 2013, PHYSIOLOGICAL TESTS; Urhausen A, 2002, SPORTS MED, V32, P95, DOI 10.2165/00007256-200232020-00002	43	59	60	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139801	10.1371/journal.pone.0139801	http://dx.doi.org/10.1371/journal.pone.0139801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444557	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600082
J	Miethe, S; Rasetti-Escargueil, C; Avril, A; Liu, Y; Chahboun, S; Korkeala, H; Mazuet, C; Popoff, MR; Pelat, T; Thullier, P; Sesardic, D; Hust, M				Miethe, Sebastian; Rasetti-Escargueil, Christine; Avril, Arnaud; Liu, Yvonne; Chahboun, Siham; Korkeala, Hannu; Mazuet, Christelle; Popoff, Michel-Robert; Pelat, Thibaut; Thullier, Philippe; Sesardic, Dorothea; Hust, Michael			Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E	PLOS ONE			English	Article							PHRENIC NERVE-HEMIDIAPHRAGM; FOOD-BORNE BOTULISM; HIGH-AFFINITY; RECOMBINANT ANTIBODIES; ENDOPEPTIDASE ACTIVITY; GERMLINE HUMANIZATION; MONOCLONAL-ANTIBODIES; CLINICAL-APPLICATIONS; BACILLUS-ANTHRACIS; IMMUNE GLOBULIN	Background Botulinum neurotoxins (BoNTs) are considered to be the most toxic substances known on earth and are responsible for human botulism, a life-threatening disease characterized by flaccid muscle paralysis that occurs naturally by food-poisoning or colonization of the gastrointestinal tract by BoNT-producing clostridia. BoNTs have been classified as category A agent by the Centers of Disease Control and Prevention (CDC) and are listed among the six agents with the highest risk to be used as bioweapons. Neutralizing antibodies are required for the development of effective anti-botulism therapies to deal with the potential risk of exposure. Results In this study, a macaque (Macaca fascicularis) was immunized with recombinant light chain of BoNT/E3 and an immune phage display library was constructed. After a multi-step panning, several antibody fragments (scFv, single chain fragment variable) with nanomolar affinities were isolated, that inhibited the endopeptidase activity of pure BoNT/E3 in vitro by targeting its light chain. Furthermore, three scFv were confirmed to neutralize BoNT/E3 induced paralysis in an ex vivo mouse phrenic nerve-hemidiaphragm assay. The most effective neutralization (20LD50/mL, BoNT/E3) was observed with scFv ELC18, with a minimum neutralizing concentration at 0.3 nM. Furthermore, ELC18 was highly effective in vivo when administered as an scFv-Fc construct. Complete protection of 1LD50 BoNT/E3 was observed with 1.6 ng/dose in the mouse flaccid paralysis assay. Conclusion These scFv-Fcs antibodies are the first recombinant antibodies neutralizing BoNT/E by targeting its light chain. The human-like nature of the isolated antibodies is predicting a good tolerance for further clinical development.	[Miethe, Sebastian; Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Abt Biotechnol, D-38106 Braunschweig, Germany; [Rasetti-Escargueil, Christine; Liu, Yvonne; Sesardic, Dorothea] Natl Inst Biol Stand & Controls, Div Bacteriol, Potters Bar EN6 3QG, Herts, England; [Avril, Arnaud; Chahboun, Siham; Pelat, Thibaut; Thullier, Philippe] IRBA, CRSSA, Dept Microbiol, Unite Biotechnol Anticorps & Toxines, F-38702 La Tronche, France; [Korkeala, Hannu] Univ Helsinki, Fac Vet Med, Ctr Excellence Microbial Food Safety Res, Dept Food Hyg & Environm Hlth, FIN-00014 Helsinki, Finland; [Mazuet, Christelle; Popoff, Michel-Robert] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, F-75015 Paris, France	Braunschweig University of Technology; National Institute for Biological Standards & Control; University of Helsinki; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hust, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Abt Biotechnol, Spielmannstr 7, D-38106 Braunschweig, Germany.	m.hust@tu-bs.de	Mazuet, Christelle/O-7731-2016; Popoff, Michel/O-7719-2016	Mazuet, Christelle/0000-0001-7619-9050; Popoff, Michel/0000-0001-9305-8989; Rasetti-Escargueil, Christine/0000-0003-0661-695X; AVRIL, Arnaud/0000-0003-1759-7256; Pelat, thibaut/0000-0003-4312-1032; Korkeala, Hannu/0000-0003-0699-1290; Hust, Michael/0000-0003-3418-6045	European Community [241832]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086566] Funding Source: NIH RePORTER; National Centre for the Replacement [G1000086/1] Funding Source: researchfish	European Community(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Centre for the Replacement	The authors acknowledge funding from the European Community's Seventh Framework Program (FP7/2007-2013) under agreement no. 241832 granted to the AntiBotABE project (http://www.antibotabe.com).	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P299; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Avril Arnaud, 2014, Curr Drug Discov Technol, V11, P20; Bakherad H, 2013, MOL BIOTECHNOL, V55, P159, DOI 10.1007/s12033-013-9669-1; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Bozheyeva G, 1999, 1 MONTR I INT STUD; Broad WJ, 1998, NY TIMES; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; Chahboun S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-113; Chassagne S, 2004, MOL IMMUNOL, V41, P539, DOI 10.1016/j.molimm.2004.03.040; Dressler D, 2013, J NEUROL, V260, P701, DOI 10.1007/s00415-012-6615-2; Fischer A, 2008, J BIOL CHEM, V283, P3997, DOI 10.1074/jbc.M707917200; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Froude JW, 2011, TOXINS, V3, P1433, DOI 10.3390/toxins3111433; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Gupta A, 2005, NEUROLOGY, V65, P1694, DOI 10.1212/01.wnl.0000187127.92446.4c; Hibbs RG, 1996, CLIN INFECT DIS, V23, P337, DOI 10.1093/clinids/23.2.337; Horowitz BZ, 2010, CLIN TOXICOL, V48, P880, DOI 10.3109/15563650.2010.526943; Hulseweh B, 2014, MABS-AUSTIN, V6, P717, DOI 10.4161/mabs.28170; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Jalava K, 2011, EUROSURVEILLANCE, V16, P8; Jones RGA, 2008, J IMMUNOL METHODS, V329, P92, DOI 10.1016/j.jim.2007.09.014; Kubota T, 1997, APPL ENVIRON MICROB, V63, P1214, DOI 10.1128/AEM.63.4.1214-1218.1997; Kugler J, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0125-0; Kukreja RV, 2010, BIOCHEMISTRY-US, V49, P2510, DOI 10.1021/bi902096r; Laffly E, 2005, ANTIMICROB AGENTS CH, V49, P3414, DOI 10.1128/AAC.49.8.3414-3420.2005; Lim ECH, 2010, NAT REV NEUROL, V6, P624, DOI 10.1038/nrneurol.2010.149; Long SS, 2007, PEDIATR INFECT DIS J, V26, P261, DOI 10.1097/01.inf.0000256442.06231.17; Mazuet C, 2015, J CLIN MICROBIOL, V53, P722, DOI 10.1128/JCM.02942-14; Meng Q, 2012, ANAL BIOCHEM, V430, P141, DOI 10.1016/j.ab.2012.08.005; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; National Research Council, 2011, GUIDE CARE USE LAB A; Pathan Nuzhat I., 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P163; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2009, MINI-REV MED CHEM, V9, P1633, DOI 10.2174/138955709791012283; Pelat T, 2009, MABS-AUSTIN, V1, P377, DOI 10.4161/mabs.1.4.8635; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Pingeon JM, 2011, EUROSURVEILLANCE, V16, P5; Raphael BH, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-192; Rasetti-Escargueil C, 2011, TOXICON, V57, P1008, DOI 10.1016/j.toxicon.2011.04.003; Rasetti-Escargueil C, 2009, TOXICON, V53, P503, DOI 10.1016/j.toxicon.2009.01.019; Rosenwasser LJ, 2003, J ALLERGY CLIN IMMUN, V112, P563, DOI 10.1067/mai.2003.1709; Rulker T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037242; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schuck P, 1996, ANAL BIOCHEM, V240, P262, DOI 10.1006/abio.1996.0356; Schutte M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006625; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Tan P, 2002, J IMMUNOL, V169, P1119, DOI 10.4049/jimmunol.169.2.1119; Thullier P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065855; Thullier P, 2010, MABS-AUSTIN, V2, P528, DOI 10.4161/mabs.2.5.12545; Thullier P, 2010, J MOL BIOL, V396, P1439, DOI 10.1016/j.jmb.2009.12.041; Tonello F, 1996, ADV EXP MED BIOL, V389, P251; WEBER JT, 1993, J INFECT DIS, V167, P451, DOI 10.1093/infdis/167.2.451; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Wheeler A, 2013, TOXICOLOGY, V306, P124, DOI 10.1016/j.tox.2013.02.006	63	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139905	10.1371/journal.pone.0139905	http://dx.doi.org/10.1371/journal.pone.0139905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440796	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510300073
J	Mishra, J; Verma, RK; Alpini, G; Meng, FY; Kumar, N				Mishra, Jayshree; Verma, Raj K.; Alpini, Gianfranco; Meng, Fanyin; Kumar, Narendra			Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-GRADE INFLAMMATION; TOLL-LIKE RECEPTORS; INSULIN-RESISTANCE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; JAK3 EXPRESSION; CELLS; ACTIVATION; MATURATION; INHIBITOR	Obesity, a worldwide epidemic, is a major risk factor for the development of metabolic syndrome (MetS) including diabetes and associated health complications. Recent studies indicate that chronic low-grade inflammation (CLGI) plays a key role in metabolic deterioration in the obese population. Previously, we reported that Jak3 was essential for mucosal differentiation and enhanced colonic barrier functions and its loss in mice resulted in basal CLGI and predisposition to DSS induced colitis. Since CLGI is associated with diabetes, obesity, and metabolic syndrome, present studies determined the role of Jak3 in development of such conditions. Our data show that loss of Jak3 resulted in increased body weight, basal systemic CLGI, compromised glycemic homeostasis, hyperinsulinemia, and early symptoms of liver steatosis. Lack of Jak3 also resulted in exaggerated symptoms of metabolic syndrome by western high-fat diet. Mechanistically, Jak3 was essential for reduced expression and activation of Toll-like receptors (TLRs) in murine intestinal mucosa and human intestinal epithelial cells where Jak3 interacted with and activated p85, the regulatory subunit of the PI3K, through tyrosine phosphorylation of adapter protein insulin receptor substrate (IRS1). These interactions resulted in activation of PI3K-Akt axis, which was essential for reduced TLR expression and TLR associated NF kappa B activation. Collectively, these results demonstrate the essential role of Jak3 in promoting mucosal tolerance through suppressed expression and limiting activation of TLRs thereby preventing intestinal and systemic CLGI and associated obesity and MetS.	[Mishra, Jayshree; Verma, Raj K.; Kumar, Narendra] Texas A&M Univ Syst Hlth Sci Ctr, ILR Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA; [Alpini, Gianfranco; Meng, Fanyin] Scott & White Digest Dis Res Ctr, Cent Texas Vet Hlth Care Syst, Temple, TX 76504 USA; [Alpini, Gianfranco; Meng, Fanyin] Texas A&M HSC Coll Med, Temple, TX 76504 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Mishra, J (corresponding author), Texas A&M Univ HSC, Coll Pharm, 1010 West Ave B MSC 131, Kingsville, TX 78363 USA.	mishra@pharmacy.tamhsc.edu; nkumar@tamhsc.edu	MISHRA, JAYSHREE/O-3468-2018; Regan, Clinton/E-6250-2012	MISHRA, JAYSHREE/0000-0003-0619-0629; Kumar, Narendra/0000-0002-1193-0954	Crohn's & Colitis Foundation of America (CCFA) [2188]; NIH [DK081661, 1R43GM109528-01]; Baylor Scott & White and VA Merit award [5I01BX000574]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054811, R01DK076898, K01DK081661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM109528] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001724, I01BX000574] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America (CCFA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Scott & White and VA Merit award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by grants from Crohn's & Colitis Foundation of America (CCFA Ref. 2188) and NIH (Grant DK081661) (to N. K.), NIH (sub-awarded) Grant 1R43GM109528-01 (to N. K. and J. M.), and the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology endowment from Baylor Scott & White and VA Merit award (5I01BX000574) (to G. A.). The authors declare that they have no conflicts of interest with the content of this article.	Arslan N, 2014, WORLD J GASTROENTERO, V20, P16452, DOI 10.3748/wjg.v20.i44.16452; Bertrand RL, 2011, ENDOCRINOLOGY, V152, P36, DOI 10.1210/en.2010-0377; Bleau C, 2015, DIABETES-METAB RES, V31, P545, DOI 10.1002/dmrr.2617; Cetkovic-Cyrlje M, 2004, CURR PHARM DESIGN, V10, P1767, DOI 10.2174/1381612043384529; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Chassaing B, 2014, TOXICOL PATHOL, V42, P49, DOI 10.1177/0192623313508481; Crunkhorn S, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3929; Cuda C, 2011, METABOLISM, V60, P1131, DOI 10.1016/j.metabol.2010.12.006; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; DESPRES JP, 1992, MOL CELL BIOCHEM, V113, P151, DOI 10.1007/BF00231535; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Esteve E, 2011, CURR OPIN CLIN NUTR, V14, P483, DOI 10.1097/MCO.0b013e328348c06d; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Fresno Manuel, 2011, Archives of Physiology and Biochemistry, V117, P151, DOI 10.3109/13813455.2011.562514; Grima P, 2012, SCAND J INFECT DIS, V44, P133, DOI 10.3109/00365548.2011.623312; Guarner V, 2015, INTERD T GERONT GERI, V40, P99, DOI 10.1159/000364934; HALL BM, 1991, TRANSPLANTATION, V51, P1141, DOI 10.1097/00007890-199106000-00001; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Jialal I, 2012, CURR DIABETES REP, V12, P172, DOI 10.1007/s11892-012-0258-7; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kim JJ, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/212563; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kumar N.M., 2012, J IMMUNODEFIC DISOR, V1, p1000.; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; LAI KS, 1995, J BIOL CHEM, V270, P25028, DOI 10.1074/jbc.270.42.25028; Lucas K, 2013, MOL NEUROBIOL, V48, P190, DOI 10.1007/s12035-013-8425-7; Malaviya R, 1999, J BIOL CHEM, V274, P27028, DOI 10.1074/jbc.274.38.27028; Maziak Wasim, 2005, BMC Pulm Med, V5, P5, DOI 10.1186/1471-2466-5-5; Mishra J, 2014, J BIOL CHEM, V289, P15951, DOI 10.1074/jbc.C113.527523; Mishra J, 2013, J BIOL CHEM, V288, P31795, DOI 10.1074/jbc.M113.504126; Mishra J, 2013, CRIT REV ONCOL HEMAT, V86, P232, DOI 10.1016/j.critrevonc.2012.09.014; Mishra J, 2012, J BIOL CHEM, V287, P41386, DOI 10.1074/jbc.C112.363507; Mishra J, 2012, AM J PHYSIOL-CELL PH, V302, pC735, DOI 10.1152/ajpcell.00316.2011; Murata Y, 2002, INT IMMUNOL, V14, P627, DOI 10.1093/intimm/dxf031; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Onat A, 2007, INT J OBESITY, V31, P1119, DOI 10.1038/sj.ijo.0803552; Park JS, 2013, PEDIATR GASTROENTERO, V16, P22, DOI 10.5223/pghn.2013.16.1.22; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Phillips CM, 2012, J NUTR BIOCHEM, V23, P239, DOI 10.1016/j.jnutbio.2010.11.020; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Saemann MD, 2003, AM J TRANSPLANT, V3, P1341, DOI 10.1046/j.1600-6143.2003.00225.x; Safford MG, 1997, EXP HEMATOL, V25, P374; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; Stempel DA, 2005, J ALLERGY CLIN IMMUN, V115, P230, DOI 10.1016/j.jaci.2004.10.035; Stepkowski SM, 2002, BLOOD, V99, P680, DOI 10.1182/blood.V99.2.680; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; TILLY BC, 1991, J BIOL CHEM, V266, P2036; TORTOLANI PJ, 1995, J IMMUNOL, V155, P5220; Tulk HMF, 2009, METABOLISM, V58, P1709, DOI 10.1016/j.metabol.2009.05.031; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Ward AC, 2000, BLOOD, V95, P19; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yan ZQ, 2006, ARTERIOSCL THROM VAS, V26, P2582, DOI 10.1161/01.ATV.0000250933.92917.dd	61	19	19	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29301	29312		10.1074/jbc.M115.670331	http://dx.doi.org/10.1074/jbc.M115.670331			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26451047	hybrid, Green Published			2022-12-26	WOS:000366613400018
J	Grywalska, E; Rolinski, J; Pasiarski, M; Korona-Glowniak, I; Maj, M; Surdacka, A; Grafka, A; Stelmach-Goldys, A; Zgurski, M; Gozdz, S; Malm, A; Grabarczyk, P; Staroslawska, E				Grywalska, Ewelina; Rolinski, Jacek; Pasiarski, Marcin; Korona-Glowniak, Izabela; Maj, Maciej; Surdacka, Agata; Grafka, Agnieszka; Stelmach-Goldys, Agnieszka; Zgurski, Michal; Gozdz, Stanislaw; Malm, Anna; Grabarczyk, Piotr; Staroslawska, Elzbieta			High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Associated with Unfavorable Prognosis	PLOS ONE			English	Article							INFECTION; DIAGNOSIS; LYMPHOMA; TIME; CLL; EXPRESSION; PHENOTYPE; DISEASE; ZAP-70; CELLS	Epstein-Barr virus (EBV) is a ubiquitous gamma-herpesvirus that infects more than 90% of the world population. The potential involvement of EBV in the clinical course of chronic lymphocytic leukemia (CLL) remains unexplained. The aim of this study was to determine whether EBV-DNA load in the peripheral blood mononuclear cells (PBMCs) of CLL patients may influence heterogeneity in the course of the disease. The study included peripheral blood samples from 115 previously untreated patients with CLL (54 women and 61 men) and 40 healthy controls (16 women and 24 men). We analyzed the association between the EBV-DNA load in PBMCs and the stage of the disease, adverse prognostic factors, and clinical outcome. Detectable numbers of EBV-DNA copies in PBMCs were found in 62 out of 115 CLL patients (53.91%). The EBV-DNA copy number/mu g DNA was significantly higher in patients who required early implementation of treatment, presented with lymphocyte count doubling time < 12 months, displayed CD38-positive or ZAP-70-positive phenotype, and with the del(11q22.3) cytogenetic abnormality. Furthermore, the EBV-DNA copy number/mu g DNA showed significant positive correlation with the concentrations of lactate dehydrogenase (LDH) and beta-2-microglobulin. We have shown that in CLL patients, higher EBV-DNA copy number predicted shorter survival and shorter time to disease progression, and it was associated with other established unfavorable prognostic factors. This suggests that EBV may negatively affect the outcome of CLL.	[Grywalska, Ewelina; Rolinski, Jacek; Maj, Maciej; Surdacka, Agata; Grafka, Agnieszka; Zgurski, Michal] Med Univ Lublin, Dept Clin Immunol & Immunotherapy, Lublin, Poland; [Grywalska, Ewelina; Rolinski, Jacek; Surdacka, Agata; Grafka, Agnieszka; Staroslawska, Elzbieta] St Johns Canc Ctr, Lublin, Poland; [Pasiarski, Marcin; Stelmach-Goldys, Agnieszka] Holycross Canc Ctr, Dept Hematol, Kielce, Poland; [Korona-Glowniak, Izabela] Med Univ Lublin, Dept Pharmaceut Microbiol, Lublin, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Dept Oncol, Kielce, Poland; [Gozdz, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland; [Grabarczyk, Piotr] Inst Hematol & Transfus Med, Dept Immunohematol, Warsaw, Poland	Medical University of Lublin; Medical University of Lublin; Jan Kochanowski University	Grywalska, E (corresponding author), Med Univ Lublin, Dept Clin Immunol & Immunotherapy, Lublin, Poland.	ewelina.grywalska@gmail.com	Grabarczyk, Piotr/AAA-6224-2020; Kielce, SCO/O-6702-2016; Gozdz, Stanislaw/D-3300-2013	Grabarczyk, Piotr/0000-0001-5200-5629; Maj, Maciej/0000-0002-3435-2544; Malm, Anna/0000-0003-1503-7634; Grywalska, Ewelina/0000-0002-0451-4741; Rolinski, Jacek/0000-0003-4841-6120; Pasiarski, Marcin/0000-0002-8569-4261; Surdacka, Agata/0000-0002-0307-7535; Korona-Glowniak, Izabela/0000-0003-1634-0387; Gozdz, Stanislaw/0000-0001-6902-3807; Rolinski, Jacek Mariusz/0000-0001-5596-2651	Polish National Science Centre [N N402 682440, UMO-2011/01/N/NZ6/01762, UMO-2012/05/B/NZ6/00792]	Polish National Science Centre	This work was supported by research grants no. N N402 682440, no. UMO-2011/01/N/NZ6/01762 and no. UMO-2012/05/B/NZ6/00792 of the Polish National Science Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrebi A, 2010, LEUKEMIA RES, V34, pE248, DOI 10.1016/j.leukres.2010.03.027; Chadeau-Hyam M, 2014, ANN ONCOL, V25, P1065, DOI 10.1093/annonc/mdu056; Cohen JI, 2011, BLOOD, V117, P5835, DOI 10.1182/blood-2010-11-316745; Durig J, 2003, LEUKEMIA, V17, P2426, DOI 10.1038/sj.leu.2403147; EPSTEIN MA, 1964, PATHOL BIOL, V12, P1233; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2013, AM J HEMATOL, V88, P803, DOI 10.1002/ajh.23491; Hardie DR, 2010, TRANSFUS APHER SCI, V42, P177, DOI 10.1016/j.transci.2010.01.015; Herth I, 2014, ANN ONCOL, V25, P200, DOI 10.1093/annonc/mdt511; Huang PY, 2014, LEUKEMIA LYMPHOMA, V55, P2085, DOI 10.3109/10428194.2013.867486; Hus I, 2006, ANN ONCOL, V17, P683, DOI 10.1093/annonc/mdj120; IBSEN KK, 1981, ACTA PATH MICRO IM C, V89, P205; Kern W, 2014, BRIT J HAEMATOL, V164, P565, DOI 10.1111/bjh.12652; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kossiva L, 2013, PEDIATR EMERG CARE, V29, P748, DOI 10.1097/PEC.0b013e318294f3a5; Lu G, 2009, CHINESE MED J-PEKING, V122, P262, DOI 10.3760/cma.j.issn.0366-6999.2009.03.005; Meuleman N, 2008, LEUKEMIA, V22, P1882, DOI 10.1038/leu.2008.190; Mian M, 2013, ANN ONCOL, V24, P1378, DOI 10.1093/annonc/mds646; Morales O, 2014, BRIT J HAEMATOL, V166, P875, DOI 10.1111/bjh.12980; Nakhla PS, 2013, LEUKEMIA LYMPHOMA, V54, P1647, DOI 10.3109/10428194.2012.753449; Parikh SA, 2013, BRIT J HAEMATOL, V162, P774, DOI 10.1111/bjh.12458; Stevens SJC, 2002, J CLIN MICROBIOL, V40, P3986, DOI 10.1128/JCM.40.11.3986-3992.2002; Tarrand JJ, 2010, CANCER-AM CANCER SOC, V116, P880, DOI 10.1002/cncr.24839; Thorley-Lawson DA, 2013, CURR OPIN VIROL, V3, P227, DOI 10.1016/j.coviro.2013.04.005; Tsimberidou AM, 2006, LEUKEMIA LYMPHOMA, V47, P827, DOI 10.1080/10428190500398856; Visco C, 2015, ONCOTARGET	26	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140178	10.1371/journal.pone.0140178	http://dx.doi.org/10.1371/journal.pone.0140178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460692	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300061
J	Konstantopoulos, A; Tan, XW; Goh, GTW; Saraswathi, P; Chen, LY; Nyein, CL; Zhou, L; Beuerman, R; Tan, DTH; Mehta, J				Konstantopoulos, Aris; Tan, Xiao Wei; Goh, Gwendoline Tze Wei; Saraswathi, Padmanabhan; Chen, Liyan; Nyein, Chan Lwin; Zhou, Lei; Beuerman, Roger; Tan, Donald Tiang Hwee; Mehta, Jod			Prophylactic Vancomycin Drops Reduce the Severity of Early Bacterial Keratitis in Keratoprosthesis	PLOS ONE			English	Article							BOSTON TYPE-1 KERATOPROSTHESIS; CORNEAL GRAFT FAILURE; RISK-FACTORS; STAPHYLOCOCCUS-AUREUS; ENDOPHTHALMITIS; GLAUCOMA; OUTCOMES; EYES	Background Artificial cornea transplantation, keratoprosthesis, improves vision for patients at high risk of failure with human cadaveric cornea. However, post-operative infection can cause visual loss and implant extrusion in 3.2-17% of eyes. Long-term vancomycin drops are recommended following keratoprosthesis to prevent bacterial keratitis. Evidence, though, in support of this practice is poor. We investigated whether prophylactic vancomycin drops prevented bacterial keratitis in an animal keratoprosthesis model. Methodology Twenty-three rabbits were assigned either to a prophylactic group (n = 13) that received vancomycin 1.4% drops 5 times/day from keratoprosthesis implantation to sacrifice, or a non-prophylactic group (n = 10) that received no drops. All rabbits had Staphylococcus aureus inoculation into the cornea at 7-12 days post-implantation and were sacrificed at predetermined time-points. Prophylactic and non-prophylactic groups were compared with slit-lamp photography (SLP), anterior segment optical coherence tomography (AS-OCT), and histology, immunohistochemistry and bacterial quantification of excised corneas. Corneal vancomycin pharmacokinetics were studied in 8 additional rabbits. Results On day 1 post-inoculation, the median SLP score and mean +/- SEM AS-OCT corneal thickness (CT) were greater in the non-prophylactic than the prophylactic group (11 vs. 1, rho = 0.049 and 486.9 +/- 61.2 vs. 327.4 +/- 37.1 mu m, rho = 0.029 respectively). On days 2 and 4, SLP scores and CT were not significantly different. Immunohistochemistry showed a greater CD11b+ve/non-CD11b+ve cell ratio in the non-prophylactic group (1.45 vs. 0.71) on day 2. Bacterial counts were not significantly different between the two groups. Corneal vancomycin concentration (2.835 +/- 0.383 mu g/ml) exceeded minimum inhibitory concentration (MIC) for Staphylococcus aureus only after 16 days of vancomycin drops. Two of 3 rabbits still developed infection despite bacterial inoculation after 16 days of prophylactic drops. Conclusions Prophylactic vancomycin drops provided short-term benefit, but did not prevent infection. Achieving MIC in the cornea was not sufficient to prevent Staphylococcus aureus keratitis. Patients should continue to be counselled regarding the risk of infection following keratoprosthesis.	[Konstantopoulos, Aris; Tan, Xiao Wei; Goh, Gwendoline Tze Wei; Saraswathi, Padmanabhan; Chen, Liyan; Nyein, Chan Lwin; Zhou, Lei; Beuerman, Roger; Tan, Donald Tiang Hwee; Mehta, Jod] Singapore Eye Res Inst, Singapore, Singapore; [Konstantopoulos, Aris; Tan, Donald Tiang Hwee; Mehta, Jod] Singapore Natl Eye Ctr, Singapore, Singapore; [Tan, Donald Tiang Hwee; Mehta, Jod] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore; [Mehta, Jod] Nanyang Technol Univ, Singapore 639798, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mehta, J (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.			Zhou, Lei/0000-0001-5893-6002	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme [NMRC/TCR/008-SERI/2013]; LZ; RWB; DTT; JSM	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme; LZ; RWB; DTT; JSM	This research was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme (NMRC/TCR/008-SERI/2013) and administered by the Singapore Ministry of Health's National Medical Research Council. Authors that received funding: LZ, RWB, DTT, JSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpek EK, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009561.pub2; Aldave AJ, 2009, OPHTHALMOLOGY, V116, P640, DOI 10.1016/j.ophtha.2008.12.058; Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120; Avadhanam VS, 2015, BRIT J OPHTHALMOL, V99, P878, DOI 10.1136/bjophthalmol-2014-305359; Barnes SD, 2007, CORNEA, V26, P9, DOI 10.1097/01.ico.0000224650.19837.25; Bradley JC, 2009, CORNEA, V28, P321, DOI 10.1097/ICO.0b013e31818b8bfa; Chan CC, 2012, CORNEA, V31, P1128, DOI 10.1097/ICO.0b013e318245c02a; Chew HF, 2009, CORNEA, V28, P989, DOI 10.1097/ICO.0b013e3181a186dc; Crnej A, 2014, CORNEA, V33, P349, DOI 10.1097/ICO.0000000000000067; Dohlman Claes H., 2002, CLAO Journal, V28, P72; Durand ML, 2009, CORNEA, V28, P896, DOI 10.1097/ICO.0b013e3181983982; Harissi-Dagher M, 2007, CORNEA, V26, P564, DOI 10.1097/ICO.0b013e318041f0a6; Hicks CR, 2006, CORNEA, V25, P1034, DOI 10.1097/01.ico.0000229982.23334.6b; Jin XM, 2009, MOL VIS, V15, P2435; JOHNSON MK, 1990, CURR EYE RES, V9, P1107, DOI 10.3109/02713689008997584; Kim MJ, 2013, OPHTHALMOLOGY, V120, P2209, DOI 10.1016/j.ophtha.2013.05.001; Konstantopoulos A, 2008, AM J OPHTHALMOL, V146, P534, DOI 10.1016/j.ajo.2008.05.030; Konstantopoulos A, 2011, INVEST OPHTH VIS SCI, V52, P1093, DOI 10.1167/iovs.10-6067; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Li Q, 2008, MICROB PATHOGENESIS, V44, P426, DOI 10.1016/j.micpath.2007.11.006; Magalhaes FP, 2013, CORNEA, V32, P407, DOI 10.1097/ICO.0b013e31824a8b9b; MAGUIRE MG, 1994, OPHTHALMOLOGY, V101, P1536; Natarajan JV, 2014, ACS NANO, V8, P419, DOI 10.1021/nn4046024; Okeke CO, 2009, OPHTHALMOLOGY, V116, P191, DOI 10.1016/j.ophtha.2008.09.004; Olthoff CMG, 2005, OPHTHALMOLOGY, V112, P953, DOI 10.1016/j.ophtha.2004.12.035; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Ramchandran RS, 2012, OPHTHALMOLOGY, V119, P674, DOI 10.1016/j.ophtha.2011.10.009; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; Sivaraman KR, 2013, AM J OPHTHALMOL, V155, P814, DOI 10.1016/j.ajo.2012.11.019; Srikumaran D, 2014, OPHTHALMOLOGY, V121, P2159, DOI 10.1016/j.ophtha.2014.05.030; Tan XW, 2014, ANTIMICROB AGENTS CH, V58, P5229, DOI 10.1128/AAC.02859-14; Thiagarajah JR, 2002, J BIOL CHEM, V277, P19139, DOI 10.1074/jbc.M202071200; Tullos NA, 2013, CURR EYE RES, V38, P1036, DOI 10.3109/02713683.2013.804094; von Fischern T, 1998, GRAEF ARCH CLIN EXP, V236, P553, DOI 10.1007/s004170050120; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Williams KA, 2008, TRANSPLANTATION, V86, P1720, DOI 10.1097/TP.0b013e3181903b0a; Zerbe BL, 2006, OPHTHALMOLOGY, V113, P1779, DOI 10.1016/j.ophtha.2006.05.015	37	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139653	10.1371/journal.pone.0139653	http://dx.doi.org/10.1371/journal.pone.0139653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460791	Green Published, gold			2022-12-26	WOS:000362962300018
J	Kramer, A; Beck, HC; Kumar, A; Kristensen, LP; Imhoff, JF; Labes, A				Kramer, Annemarie; Beck, Hans Christian; Kumar, Abhishek; Kristensen, Lars Peter; Imhoff, Johannes F.; Labes, Antje			Proteomic Analysis of Anti-Cancerous Scopularide Production by a Marine Microascus brevicaulis Strain and Its UV Mutant	PLOS ONE			English	Article							PENICILLIUM-CHRYSOGENUM PELLETS; ASPERGILLUS-NIGER; 2-DIMENSIONAL ELECTROPHORESIS; MEMBRANE-PROTEINS; FILAMENTOUS FUNGI; MORPHOLOGY; GENE; IDENTIFICATION; BIOTECHNOLOGY; OPTIMIZATION	The marine fungus Microascus brevicaulis strain LF580 is a non-model secondary metabolite producer with high yields of the two secondary metabolites scopularides A and B, which exhibit distinct activities against tumour cell lines. A mutant strain was obtained using UV mutagenesis, showing faster growth and differences in pellet formation besides higher production levels. Here, we show the first proteome study of a marine fungus. Comparative proteomics were applied to gain deeper understanding of the regulation of production and of the physiology of the wild type strain and its mutant. For this purpose, an optimised protein extraction protocol was established. In total, 4759 proteins were identified. The central metabolic pathway of strain LF580 was mapped using the KEGG pathway analysis and GO annotation. Employing iTRAQ labelling, 318 proteins were shown to be significantly regulated in the mutant strain: 189 were down- and 129 upregulated. Proteomics are a powerful tool for the understanding of regulatory aspects: The differences on proteome level could be attributed to limited nutrient availability in the wild type strain due to a strong pellet formation. This information can be applied for optimisation on strain and process level. The linkage between nutrient limitation and pellet formation in the non-model fungus M. brevicaulis is in consensus with the knowledge on model organisms like Aspergillus niger and Penicillium chrysogenum.	[Kramer, Annemarie; Imhoff, Johannes F.; Labes, Antje] GEOMAR Helmholtz Ctr Ocean Res Kiel, Res Unit Marine Ecol, Kiel, Germany; [Beck, Hans Christian; Kristensen, Lars Peter] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Ctr Clin Prote, DK-5000 Odense, Denmark; [Kumar, Abhishek] Univ Kiel, Inst Bot, Dept Bot & Mol Biol, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Southern Denmark; Odense University Hospital; University of Kiel	Labes, A (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Res Unit Marine Ecol, Kiel, Germany.	alabes@geomar.de	Labes, Antje/AGK-3198-2022; Imhoff, Johannes F./D-2515-2010; Beck, Hans Christian/AAK-9147-2021; Imhoff, Johannes F./AAB-8765-2022	Labes, Antje/0000-0002-4807-3378; Imhoff, Johannes F./0000-0001-8789-0728; Imhoff, Johannes F./0000-0001-8789-0728; Beck, Hans Christian/0000-0002-7763-3637	European Union through the 7th Framework KBBE project MARINE FUNGI [265926]	European Union through the 7th Framework KBBE project MARINE FUNGI	This study was financially supported by the European Union through the 7th Framework KBBE (http://cordis.europa.eu/fp7/kbbe/about-kbbe_en.html) project MARINE FUNGI (project no. 265926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SP, 1998, MYCOLOGIA, V90, P297, DOI 10.2307/3761306; Abbott SP, 2001, MYCOLOGIA, V93, P1211, DOI 10.2307/3761682; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen MR, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r47; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; Barreiro C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/105109; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Bhadauria V, 2010, INDIAN J MICROBIOL, V50, pS127, DOI 10.1007/s12088-010-0072-3; Bohle K, 2009, MORPHOLOGIE PRODUKTI; Bohne W, 2000, INFECT IMMUN, V68, P2268, DOI 10.1128/IAI.68.4.2268-2275.2000; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridge P.D., 2003, METHOD MOL BIOL, V59, P37; Bugni TS, 2004, NAT PROD REP, V21, P143, DOI 10.1039/b301926h; Cagas SE, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010108, 10.1074/mcp.M110.004606]; Cai H, 1999, J BIOL CHEM, V274, P13470, DOI 10.1074/jbc.274.19.13470; Carberry S, 2006, BIOCHEM BIOPH RES CO, V341, P1096, DOI 10.1016/j.bbrc.2006.01.078; Carlsen M, 1996, BIOTECHNOL BIOENG, V49, P266, DOI 10.1002/(SICI)1097-0290(19960205)49:3<266::AID-BIT4>3.0.CO;2-I; Celton M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-317; Chiapello M, 2010, J PROTEOME RES, V9, P3923, DOI 10.1021/pr100133d; Crespo-Sempere A, 2011, INT J FOOD MICROBIOL, V147, P162, DOI 10.1016/j.ijfoodmicro.2011.03.021; CRONENBERG CCH, 1994, BIOPROCESS ENG, V10, P209, DOI 10.1007/s004490050045; Cui YQ, 1998, BIOTECHNOL BIOENG, V60, P216, DOI [10.1002/(SICI)1097-0290(19981020)60:2<216::AID-BIT9>3.0.CO;2-Q, 10.1002/(SICI)1097-0290(19981020)60:2&lt;216::AID-BIT9&gt;3.0.CO;2-Q]; de Oliveira JMPF, 2011, APPL MICROBIOL BIOT, V89, P225, DOI 10.1007/s00253-010-2900-0; Doyle S, 2011, FEMS MICROBIOL LETT, V321, P1, DOI 10.1111/j.1574-6968.2011.02292.x; El-Enshasy HA, 2006, DEUT LEBENSM-RUNDSCH, V102, P555; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grimm LH, 2005, APPL MICROBIOL BIOT, V69, P375, DOI 10.1007/s00253-005-0213-5; Grimm LH, 2004, BIOTECHNOL BIOENG, V87, P213, DOI 10.1002/bit.20130; Gupta P, 2007, TRENDS BIOTECHNOL, V25, P324, DOI 10.1016/j.tibtech.2007.04.005; Hamanaka T, 2001, APPL MICROBIOL BIOT, V56, P233, DOI 10.1007/s002530100649; HAWKINS AR, 1989, MOL GEN GENET, V218, P105, DOI 10.1007/BF00330572; Henry J, 2011, FEBS LETT, V585, P635, DOI 10.1016/j.febslet.2011.01.015; HERNANDEZ G, 1983, J BACTERIOL, V154, P524; Hille A, 2005, BIOTECHNOL BIOENG, V92, P614, DOI 10.1002/bit.20628; Hille A, 2009, BIOTECHNOL BIOENG, V103, P1202, DOI 10.1002/bit.22351; Hille A, 2006, CHEM-ING-TECH, V78, P627, DOI 10.1002/cite.200600018; Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Iwasaki W, 2007, J MOL BIOL, V371, P123, DOI 10.1016/j.jmb.2007.05.007; Jensen PL, 2013, STEM CELLS DEV, V22, P1126, DOI 10.1089/scd.2012.0239; Jones EBG, 2011, FUNGAL DIVERS, V50, P73, DOI 10.1007/s13225-011-0119-8; Josic Djuro, 2008, Biotechnology Journal, V3, P496, DOI 10.1002/biot.200700234; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kelly S, 2006, ENG LIFE SCI, V6, P475, DOI 10.1002/elsc.200620148; Kim Y, 2007, TRENDS BIOTECHNOL, V25, P395, DOI 10.1016/j.tibtech.2007.07.008; Kramer A, 2015, PHYLOGENETIC R UNPUB; Kramer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103320; Krull R, 2013, J BIOTECHNOL, V163, P112, DOI 10.1016/j.jbiotec.2012.06.024; Krull R, 2010, ADV BIOCHEM ENG BIOT, V121, P1, DOI 10.1007/10_2009_60; Kumar A, 2013, 27 FUNG GEN C PAC GR; Kumar A., 2015, PLOS ONE; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakshman DK, 2008, MYCOLOGIA, V100, P867, DOI 10.3852/08-065; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Lukassen MB, 2015, MAR DRUGS, V13, P4331, DOI 10.3390/md13074331; MARTIN JF, 1980, MICROBIOL REV, V44, P230, DOI 10.1128/MMBR.44.2.230-251.1980; Melzer G, 2007, J BIOTECHNOL, V132, P405, DOI 10.1016/j.jbiotec.2007.08.034; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Nagaraj N, 2008, J PROTEOME RES, V7, P5028, DOI 10.1021/pr800412j; Nandakumar MP, 2002, ELECTROPHORESIS, V23, P2216, DOI 10.1002/1522-2683(200207)23:14<2216::AID-ELPS2216>3.0.CO;2-Y; Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526; Rizwan Muhammad, 2010, Mycotoxin Res, V26, P171, DOI 10.1007/s12550-010-0051-x; Sato I, 2009, J BIOL CHEM, V284, P8042, DOI 10.1074/jbc.M807771200; Silber J, 2013, MAR DRUGS, V11, P3309, DOI 10.3390/md11093309; Stoll DA, 2014, INT J FOOD MICROBIOL, V175, P20, DOI 10.1016/j.ijfoodmicro.2014.01.010; Tamminen A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-89; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wickerham LJ, 1951, TAXONOMY OF YEAST; WITTLER R, 1986, BIOTECHNOL BIOENG, V28, P1024, DOI 10.1002/bit.260280713; Wosten HAB, 2013, BIOTECHNOL LETT, V35, P1155, DOI 10.1007/s10529-013-1210-x; Yin YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051853; Yu ZG, 2008, J NAT PROD, V71, P1052, DOI 10.1021/np070580e	74	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140047	10.1371/journal.pone.0140047	http://dx.doi.org/10.1371/journal.pone.0140047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460745	Green Published, Green Accepted, gold			2022-12-26	WOS:000362962300051
J	Forfert, N; Natsopoulou, ME; Frey, E; Rosenkranz, P; Paxton, RJ; Moritz, RFA				Forfert, Nadege; Natsopoulou, Myrsini E.; Frey, Eva; Rosenkranz, Peter; Paxton, Robert J.; Moritz, Robin F. A.			Parasites and Pathogens of the Honeybee (Apis mellifera) and Their Influence on Inter-Colonial Transmission	PLOS ONE			English	Article							COLLAPSE DISORDER; VARROIDAE; BEHAVIOR	Pathogens and parasites may facilitate their transmission by manipulating host behavior. Honeybee pathogens and pests need to be transferred from one colony to another if they are to maintain themselves in a host population. Inter-colony transmission occurs typically through honeybee workers not returning to their home colony but entering a foreign colony ("drifting"). Pathogens might enhance drifting to enhance transmission to new colonies. We here report on the effects infection by ten honeybee viruses and Nosema spp., and Varroa mite infestation on honeybee drifting. Genotyping of workers collected from colonies allowed us to identify genuine drifted workers as well as source colonies sending out drifters in addition to sink colonies accepting them. We then used network analysis to determine patterns of drifting. Distance between colonies in the apiary was the major factor explaining 79% of drifting. None of the tested viruses or Nosema spp. were associated with the frequency of drifting. Only colony infestation with Varroa was associated with significantly enhanced drifting. More specifically, colonies with high Varroa infestation had a significantly enhanced acceptance of drifters, although they did not send out more drifting workers. Since Varroa-infested colonies show an enhanced attraction of drifting workers, and not only those infected with Varroa and its associated pathogens, infestation by Varroa may also facilitate the uptake of other pests and parasites.	[Forfert, Nadege; Natsopoulou, Myrsini E.; Paxton, Robert J.; Moritz, Robin F. A.] Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Saale, Germany; [Frey, Eva; Rosenkranz, Peter] Univ Hohenheim, Apicultural State Inst, Stuttgart, Germany; [Moritz, Robin F. A.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	Martin Luther University Halle Wittenberg; University Hohenheim; University of Pretoria	Forfert, N (corresponding author), Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Saale, Germany.	nadege.forfert@zoologie.uni-halle.de	Natsopoulou, Myrsini/D-4862-2015; Paxton, Robert John/D-7082-2015; Moritz, Robin FA/K-6053-2012	Natsopoulou, Myrsini/0000-0001-7751-3793; Paxton, Robert John/0000-0003-2517-1351; Moritz, Robin FA/0000-0003-0791-887X	Federal Ministry of Food, Agriculture and Consumer Protection (Germany) [511-06.01-28-1-71.007-10]	Federal Ministry of Food, Agriculture and Consumer Protection (Germany)	This work was supported by the Federal Ministry of Food, Agriculture and Consumer Protection (Germany): Fit Bee project (grant 511-06.01-28-1-71.007-10). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoscia D, 2015, APIDOLOGIE, V46, P306, DOI 10.1007/s13592-014-0323-0; Bailey L, 1958, BEE WORLD, V39, P93; Beaurepaire AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135103; Betts AD, 1932, BEE WORLD, V13, P70; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Combes C, 2003, ART ETRE PARASITE AS; Cooke VA, 1962, NZ J AGR, V105, P407; Currie RW, 2006, CAN ENTOMOL, V138, P238; De Smet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047953; Dussaubat C, 2013, J INVERTEBR PATHOL, V113, P42, DOI 10.1016/j.jip.2013.01.002; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; FREE J. B., 1958, JOUR AGRIC SCI, V51, P294; FREE JB, 1961, J AGR SCI, V57, P153, DOI 10.1017/S0021859600047626; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Frey E, 2014, J ECON ENTOMOL, V107, P508, DOI 10.1603/EC13381; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; GONCALVES LS, 1982, AM BEE J, V122, P249; Hinson EM, 2015, APIDOLOGIE, V46, P403, DOI 10.1007/s13592-014-0334-x; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; JAY S C, 1966, Journal of Apicultural Research, V5, P137; JAY S C, 1968, Journal of Apicultural Research, V7, P37; JAY S. CAMERON, 1965, J APICUL RES, V4, P167; JAY SC, 1988, J APICULT RES, V27, P213, DOI 10.1080/00218839.1988.11100805; JAY SC, 1984, J APICULT RES, V23, P143, DOI 10.1080/00218839.1984.11100623; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Moritz RFA, 2008, J INSECT CONSERV, V12, P455, DOI 10.1007/s10841-007-9078-5; Moritz RFA, 2010, APIDOLOGIE, V41, P227, DOI 10.1051/apido/2010010; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pfeiffer KJ, 1998, INSECT SOC, V45, P151, DOI 10.1007/s000400050076; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; R Core Team, 2018, R LANG ENV STAT COMP; RATNIEKS FLW, 1989, ECOL ENTOMOL, V14, P475, DOI 10.1111/j.1365-2311.1989.tb00951.x; Rauschmayer F., 1928, Archiv fuer Bienenkunde, V9, P249; Schmid-Hempel P., 1998, Parasites in social insects.; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Shaibi T, 2008, MOL ECOL RESOUR, V8, P1034, DOI 10.1111/j.1755-0998.2008.02146.x; Sint D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115501; Sint D, 2011, MOL ECOL RESOUR, V11, P795, DOI 10.1111/j.1755-0998.2011.03018.x; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066295; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wolf S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103989	48	38	41	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140337	10.1371/journal.pone.0140337	http://dx.doi.org/10.1371/journal.pone.0140337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451849	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511200064
J	Weyandt, JD; Lampson, BL; Tang, S; Mastrodomenico, M; Cardona, DM; Counter, CM				Weyandt, Jamie D.; Lampson, Benjamin L.; Tang, Sherry; Mastrodomenico, Matthew; Cardona, Diana M.; Counter, Christopher M.			Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer	PLOS ONE			English	Article							N-RAS; ONCOGENIC RAS; SENESCENCE; MAINTENANCE; ACTIVATION; REVEALS; PROTEIN; GROWTH; CELLS; KRAS2	Oncogenic, activating mutations in KRAS initiate pancreatic cancer. There are, however, two other Ras family members, Nras and Hras, which can be activated in the presence of oncogenic Kras. The role of these wild-type Ras proteins in cancer remains unclear, as their disruption has been shown to enhance or inhibit tumorigenesis depending upon the context. As pancreatic cancer is critically dependent upon Ras signaling, we tested and now report that loss of Hras increases tumor load and reduces survival in an oncogenic Kras-driven pancreatic adenocarcinoma mouse model. These effects were traced to the earliest stages of pancreatic cancer, suggesting that wild-type Hras may suppress tumor initiation. In normal cells, activated Ras can suppress proliferation through p53-dependent mechanisms. We find that the tumor suppressive effects of Hras are nullified in a homozygous mutant p53 background. As such, loss of wild-type Hras fosters the earliest stages of pancreatic cancer in a p53-dependent manner.	[Weyandt, Jamie D.; Lampson, Benjamin L.; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Tang, Sherry; Mastrodomenico, Matthew; Cardona, Diana M.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC USA; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University; Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079; Cardona, Diana/0000-0002-6877-2280	National Cancer Institute, USA [CA123031]; NATIONAL CANCER INSTITUTE [R01CA123031, P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER	National Cancer Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute, USA (http://www.cancer.gov) grant CA123031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmain A, 1990, Immunol Ser, V51, P75; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Diaz R, 2002, CANCER RES, V62, P4514; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Gades NM, 2008, COMPARATIVE MED, V58, P271; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Hamilton M, 1998, ONCOGENE, V16, P1417, DOI 10.1038/sj.onc.1201653; HEGI ME, 1994, CANCER RES, V54, P6257; Henis YI, 2009, MOL MEMBR BIOL, V26, P80, DOI 10.1080/09687680802649582; Hill R, 2010, CANCER RES, V70, P7114, DOI 10.1158/0008-5472.CAN-10-1649; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; HUANG DCS, 1993, MOL CELL BIOL, V13, P2420, DOI 10.1128/MCB.13.4.2420; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lampson BL, 2012, CANCER RES, V72, P4472, DOI 10.1158/0008-5472.CAN-12-0057; Li J, 2003, ONCOGENE, V22, P1243, DOI 10.1038/sj.onc.1206192; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Mazur PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013578; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; National Cancer Institute, 2013, SURVEILLANCE EPIDEMI; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shi G, 2013, ONCOGENE, V32, P1950, DOI 10.1038/onc.2012.210; Singh A, 2005, FASEB J, V19, P161, DOI 10.1096/fj.04-2584hyp; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	36	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140253	10.1371/journal.pone.0140253	http://dx.doi.org/10.1371/journal.pone.0140253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452271	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511200053
J	Hunnicut, J; Liu, YH; Richardson, A; Salmon, AB				Hunnicut, JennaLynn; Liu, Yuhong; Richardson, Arlan; Salmon, Adam B.			MsrA Overexpression Targeted to the Mitochondria, but Not Cytosol, Preserves Insulin Sensitivity in Diet-Induced Obese Mice	PLOS ONE			English	Article							METHIONINE-SULFOXIDE-REDUCTASE; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; RESISTANCE; STRESS; PROTEINS; DAMAGE; LOCALIZATION; ANTIOXIDANTS; DYSFUNCTION	There is growing evidence that oxidative stress plays an integral role in the processes by which obesity causes type 2 diabetes. We previously identified that mice lacking the protein oxidation repair enzyme methionine sulfoxide reductase A (MsrA) are particularly prone to obesity-induced insulin resistance suggesting an unrecognized role for this protein in metabolic regulation. The goals of this study were to test whether increasing the expression of MsrA in mice can protect against obesity-induced metabolic dysfunction and to elucidate the potential underlying mechanisms. Mice with increased levels of MsrA in the mitochondria (TgMito MsrA) or in the cytosol (TgCyto MsrA) were fed a high fat/high sugar diet and parameters of glucose homeostasis were monitored. Mitochondrial content, markers of mitochondrial proteostasis and mitochondrial energy utilization were assessed. TgMito MsrA, but not TgCyto MsrA, mice remain insulin sensitive after high fat feeding, though these mice are not protected from obesity. This metabolically healthy obese phenotype of TgMito MsrA mice is not associated with changes in mitochondrial number or biogenesis or with a reduction of proteostatic stress in the mitochondria. However, our data suggest that increased mitochondrial MsrA can alter metabolic homeostasis under diet-induced obesity by activating AMPK signaling, thereby defining a potential mechanism by which this genetic alteration can prevent insulin resistance without affecting obesity. Our data suggest that identification of targets that maintain and regulate the integrity of the mitochondrial proteome, particular against oxidative damage, may play essential roles in the protection against metabolic disease.	[Hunnicut, JennaLynn; Liu, Yuhong; Salmon, Adam B.] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Salmon, Adam B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Salmon, Adam B.] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Richardson, Arlan] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA; [Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Salmon, AB (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.	salmona@uthscsa.edu		Salmon, Adam/0000-0002-1475-7843	Geriatric Research Education and Clinical Center of the South Texas Veterans Healthcare System; American Federation for Aging Research; San Antonio Area Foundation; VISN17 of the Veteran's Affairs Office of Research and Development	Geriatric Research Education and Clinical Center of the South Texas Veterans Healthcare System; American Federation for Aging Research; San Antonio Area Foundation; VISN17 of the Veteran's Affairs Office of Research and Development	This research was supported in part by the Geriatric Research Education and Clinical Center of the South Texas Veterans Healthcare System, and funding from the American Federation for Aging Research, the San Antonio Area Foundation, and VISN17 of the Veteran's Affairs Office of Research and Development. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Al-Aubaidy HA, 2011, EUR J ENDOCRINOL, V164, P899, DOI 10.1530/EJE-11-0053; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Bille DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020640; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Brennan LA, 2009, MOL VIS, V15, P985; Brock JWC, 2008, J LIPID RES, V49, P847, DOI 10.1194/jlr.M800015-JLR200; Aledo JC, 2011, AGING CELL, V10, P198, DOI 10.1111/j.1474-9726.2010.00657.x; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Ciorba MA, 1997, P NATL ACAD SCI USA, V94, P9932, DOI 10.1073/pnas.94.18.9932; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Golbidi S, 2011, CURR DIABETES REV, V7, P106, DOI 10.2174/157339911794940729; Graff M, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.26; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hansel A, 2002, FASEB J, V16, P911, DOI 10.1096/fj.01-0737fje; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Kaya A, 2010, BIOCHEMISTRY-US, V49, P8618, DOI 10.1021/bi100908v; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu YH, 2013, BIOCHEM BIOPH RES CO, V438, P78, DOI 10.1016/j.bbrc.2013.07.029; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268; Lustgarten MS, 2011, AGING CELL, V10, P493, DOI 10.1111/j.1474-9726.2011.00695.x; Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Salmon AB, 2012, PATHOBIOL AGING AGE, V2, DOI 10.3402/pba.v2i0.17101; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Styskal J, 2013, FREE RADICAL BIO MED, V56, P123, DOI 10.1016/j.freeradbiomed.2012.10.544; Tarrago L, 2012, J BIOL CHEM, V287, P24448, DOI 10.1074/jbc.M112.374520; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Uthus EO, 2011, FREE RADICAL RES, V45, P1052, DOI 10.3109/10715762.2011.591793; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhao H, 2010, FREE RADICAL BIO MED, V49, P641, DOI 10.1016/j.freeradbiomed.2010.05.017	48	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139844	10.1371/journal.pone.0139844	http://dx.doi.org/10.1371/journal.pone.0139844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448611	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000059
J	Zhu, LP; Cheng, XX; Sun, JX; Lv, SY; Mei, SZ; Chen, X; Xi, SS; Zhang, J; Yang, MK; Bai, WP; Yan, XY				Zhu, Lingping; Cheng, Xiaoxia; Sun, Jiaxin; Lv, Shiyi; Mei, Suzhen; Chen, Xing; Xi, Sisi; Zhang, Jin; Yang, Mukun; Bai, Wenpei; Yan, Xiaoyan			Association between Menopausal Symptoms and Overactive Bladder: A Cross-Sectional Questionnaire Survey in China	PLOS ONE			English	Article							LOWER URINARY-TRACT; RISK-FACTORS; INCONTINENCE; WOMEN; POPULATION; PREVALENCE; INDEX	Purpose The association between menopause and overactive bladder is controversial. The purpose of this study was to determine the association between menopausal symptoms and overactive bladder, and identify the risk factors for overactive bladder. Methods A cross-sectional study was performed. The study included 403 women aged 36-76 years who visited the menopause clinic at Peking University First Hospital between September 2012 and December 2013. The overactive bladder symptom score and modified Kupperman index questionnaires were used. Differences were assessed using descriptive statistics to determine any association between the overactive bladder symptom score and modified Kupperman index score, and to evaluate the risk factors for overactive bladder. Results A total of 304 women were finally enrolled. The prevalence of overactive bladder was 9.43%, and the modified Kupperman index score; number of sexual problems; and frequency of urinary tract infections, vertigo, melancholia, and mood swings were significantly higher in patients with overactive bladder than in the patients without overactive bladder (p < 0.05). Menopausal symptoms (modified Kupperman index score >= 15) (odds ratio: 1.049, 95% confidence interval: 1.006-1.095, p = 0.025) and a low frequency of sexual intercourse in the last 6 months (odds ratio: 2.580, 95% confidence interval: 1.228-5.422, p = 0.012) were identified as independent risk factors for overactive bladder. The frequency of sexual intercourse was found to decrease with an increase in the severity of overactive bladder (p = 0.004, linear-by-linear association = 0.001). Conclusion Menopausal symptoms may be closely associated with overactive bladder, and sexual activity may be associated with the severity of overactive bladder. Moreover, sexual problems, urinary tract infections, vertigo, melancholia, and mood swings may be associated with overactive bladder.	[Zhu, Lingping; Cheng, Xiaoxia; Sun, Jiaxin; Chen, Xing; Xi, Sisi; Zhang, Jin; Yang, Mukun; Bai, Wenpei] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Lv, Shiyi] Ninth Peoples Hosp, Dept Gynecol & Obstet, Shenzhen, Guangdong, Peoples R China; [Mei, Suzhen] Second Hosp Sanming City, Dept Gynecol & Obstet, Sanming, Fujian Province, Peoples R China; [Yan, Xiaoyan] Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China	Peking University; Peking University	Bai, WP (corresponding author), Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	bwp66@163.com	Yang, Mukun/GQB-2364-2022	Yang, Mukun/0000-0002-3514-1386				Abrams P, 2000, AM J MANAG CARE, V6, pS580; An F., 2014, NEUROUROL URODYN; [Anonymous], 2015, NAT REV UROL, V12, P239; [Anonymous], 1996, WHO TECH REP SER, V866, P1; Avis NE, 2005, AM J MED, V118, P1406, DOI 10.1016/j.amjmed.2005.10.010; Chen YK, 2015, INT UROL NEPHROL, V47, P743, DOI 10.1007/s11255-015-0948-6; Coksuer H, 2011, EUR J OBSTET GYN R B, V159, P213, DOI 10.1016/j.ejogrb.2011.06.024; Delanoe D, 2012, SOC SCI MED, V75, P401, DOI 10.1016/j.socscimed.2012.02.051; Fitzgerald MP, 2007, EUR UROL, V52, P407, DOI 10.1016/j.eururo.2007.03.014; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; Gordon D, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P325, DOI 10.1007/s001929970010; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Hung MJ, 2013, J FORMOS MED ASSOC, V112, P276, DOI 10.1016/j.jfma.2011.09.020; Hunter M, 2007, BEST PRACT RES CL OB, V21, P261, DOI 10.1016/j.bpobgyn.2006.11.001; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Kelleher C., 2005, European Urology Supplements, V4, P59, DOI 10.1016/S1569-9056(05)80236-2; Lai H, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0009-6; Legendre G, 2013, MATURITAS, V74, P26, DOI 10.1016/j.maturitas.2012.10.005; Lisabeth L, 2012, LANCET NEUROL, V11, P82, DOI 10.1016/S1474-4422(11)70269-1; Liu RT, 2011, UROLOGY, V78, P1040, DOI 10.1016/j.urology.2011.05.017; Matthews KA, 2001, INT J OBESITY, V25, P863, DOI 10.1038/sj.ijo.0801618; MCCOY NL, 1985, MATURITAS, V7, P203, DOI 10.1016/0378-5122(85)90041-6; McGrother CW, 2006, AGE AGEING, V35, P16, DOI 10.1093/ageing/afi205; Milsom I, 2009, INT J GYNECOL OBS S2, V107, pS268; Palma T, 2013, ACTAS UROL ESP, V37, P156, DOI 10.1016/j.acuro.2012.07.009; Quinn SD, 2009, CLIMACTERIC, V12, P106, DOI 10.1080/13697130802630083; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Tao MF, 2013, PATIENT PREFER ADHER, V7, P223, DOI 10.2147/PPA.S42852; Tremollieres FA, 1999, ATHEROSCLEROSIS, V142, P415, DOI 10.1016/S0021-9150(98)00252-4; Walsh CA, 2011, NEUROUROL URODYNAM, V30, P32, DOI 10.1002/nau.20927; Yamaguchi O, 2009, INT J UROL, V16, P126, DOI 10.1111/j.1442-2042.2008.02177.x; Yip SK, 2003, AM J OBSTET GYNECOL, V188, P1244, DOI 10.1067/mob.2003.273; Zeyi C, 2007, J OBSTET GYNECOLOGY	33	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139599	10.1371/journal.pone.0139599	http://dx.doi.org/10.1371/journal.pone.0139599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448626	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000037
J	Chuchottaworn, C; Thanachartwet, V; Sangsayunh, P; Than, TZM; Sahassananda, D; Surabotsophon, M; Desakorn, V				Chuchottaworn, Charoen; Thanachartwet, Vipa; Sangsayunh, Piamlarp; Than, Thu Zar Myint; Sahassananda, Duangjai; Surabotsophon, Manoon; Desakorn, Varunee			Risk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of Thailand	PLOS ONE			English	Article							DRUG-SENSITIVE TUBERCULOSIS; PREVIOUSLY TREATED PATIENTS; MYCOBACTERIUM-TUBERCULOSIS; PLEURAL TUBERCULOSIS; NEGATIVE PATIENTS; UPDATED ANALYSIS; HIGH PREVALENCE; CHINA; SURVEILLANCE; SUSCEPTIBILITY	There are limited data available on the risk factors for multidrug-resistant tuberculosis (MDR-TB). Therefore, we here conducted a retrospective matched case-control study among adults with pulmonary TB who received treatment at the Central Chest Institute of Thailand (CCIT) between January 2007 and December 2013, in order to determine the risk factors associated with MDR-TB among patients with pulmonary TB. We identified 145 patients with pulmonary MDR-TB (cases) and 145 patients with drug-sensitive pulmonary TB (controls). Multivariate analysis identified the independent risk factors for MDR-TB as follows: (1) >= 2 episodes of prior pulmonary TB (odds ratio [OR] 39.72, 95% confidence interval (95% CI) 7.86-200.66), (2) duration of illness > 60 days (OR 3.08, 95% CI 1.52-6.22), (3) sputum acid fast bacilli smear 3+ (OR 13.09, 95% CI 4.64-36.91), (4) presence of lung cavities (OR 3.82, 95% CI 1.89-7.73), and (5) presence of pleural effusion (OR 2.75, 95% CI 1.06-7.16). Prior pulmonary TB management with a non-category I regimen (P = 0.012) and having treatment failure or default as treatment outcomes (P = 0.036) were observed in a higher proportion among patients with MDR-TB. Particular characteristics of lung cavities, including the maximum diameter >= 30 mm (P < 0.001), the number of cavities >= 3 (P = 0.001), bilateral involvement (P < 0.001), and >= 2 lung zones involved (P = 0.001) were more commonly observed in patients with MDR-TB. In conclusion, these clinical factors and chest radiographic findings associated with MDR-TB among patients with pulmonary TB may help physicians to provide proper management of cases for prevention of the development and spread of MDR-TB in future.	[Chuchottaworn, Charoen; Sangsayunh, Piamlarp] Cent Chest Inst Thailand, Div Resp Med, Nonthaburi, Thailand; [Thanachartwet, Vipa; Than, Thu Zar Myint; Desakorn, Varunee] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Sahassananda, Duangjai] Mahidol Univ, Fac Trop Med, Informat Technol Unit, Bangkok, Thailand; [Surabotsophon, Manoon] Ramkhamhaeng Hosp, Div Pulm & Crit Care Med, Bangkok, Thailand	Mahidol University; Mahidol University	Thanachartwet, V (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.	vipa.tha@mahidol.edu			Faculty of Tropical Medicine, Mahidol University	Faculty of Tropical Medicine, Mahidol University	This study was supported by the Faculty of Tropical Medicine, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALJARAD N, 1994, THORAX, V49, P808, DOI 10.1136/thx.49.8.808; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Balaji V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009527; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; Bloss E, 2010, INT J TUBERC LUNG D, V14, P275; Bojorquez I, 2013, AM J PUBLIC HEALTH, V103, P1301, DOI 10.2105/AJPH.2012.301039; Budzik JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095645; Cha J, 2009, KOREAN J RADIOL, V10, P207, DOI 10.3348/kjr.2009.10.3.207; Chen SH, 2013, INT J INFECT DIS, V17, pE1116, DOI 10.1016/j.ijid.2013.06.006; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Chung MJ, 2006, EUR RADIOL, V16, P1934, DOI 10.1007/s00330-006-0174-9; Daniel O, 2011, ASIAN PAC J TROP MED, V4, P148, DOI 10.1016/S1995-7645(11)60057-6; Diande S, 2009, MICROB DRUG RESIST, V15, P217, DOI 10.1089/mdr.2009.0906; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Fishman JE, 1998, J THORAC IMAG, V13, P65, DOI 10.1097/00005382-199801000-00015; Fox L, 2011, EUR J CLIN MICROBIOL, V30, P863, DOI 10.1007/s10096-011-1167-4; Goswami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109563; Gunther G, 2015, EMERG INFECT DIS, V21, P409, DOI 10.3201/eid2103.141343; He GX, 2011, EMERG INFECT DIS, V17, P1831, DOI 10.3201/eid1710.110546; Hirpa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-782; Jeon K, 2012, INT J TUBERC LUNG D, V16, P846, DOI 10.5588/ijtld.11.0642; Jonmalung J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-223; Kim HC, 2004, J COMPUT ASSIST TOMO, V28, P366, DOI 10.1097/00004728-200405000-00011; Lam E, 2014, EMERG INFECT DIS, V20, P400, DOI 10.3201/eid2003.130951; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lee SW, 2009, J KOREAN MED SCI, V24, P592, DOI 10.3346/jkms.2009.24.4.592; LEIBOWITZ S, 1973, BRIT J EXP PATHOL, V54, P152; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Metcalfe JZ, 2014, EMERG INFECT DIS, V20, P135, DOI 10.3201/eid2001.130732; Miller LG, 2000, CLIN INFECT DIS, V30, P293, DOI 10.1086/313651; Minion J, 2013, PLOS ONE, V8, DOI [DOI 10.1371/J0URNAL.P0NE.0053466, 10.1371/journal.pone.0053466]; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Ricks PM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-385; Sanders M, 2006, INT J TUBERC LUNG D, V10, P178; Skrahina A, 2013, B WORLD HEALTH ORGAN, V91, P36, DOI 10.2471/BLT.12.104588; Smith KLJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094953; Wang K, 2014, MICROB DRUG RESIST, V20, P294, DOI 10.1089/mdr.2013.0145; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 1998, LAB SERV TUB CONTR 2; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2014, GLOB TUB REP; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	46	30	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139986	10.1371/journal.pone.0139986	http://dx.doi.org/10.1371/journal.pone.0139986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444421	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600117
J	Hoshi, SL; Kondo, M; Okubo, I				Hoshi, Shu-ling; Kondo, Masahide; Okubo, Ichiro			Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan	PLOS ONE			English	Article							AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; COST-EFFECTIVENESS; ADULTS; OLDER; SURVEILLANCE; STRATEGIES; PNEUMONIA; COMMITTEE; IMPACT; MODEL	Background Currently in Japan, both 23-valent pneumococcal polysaccharide vaccine (PPSV-23) and 13-valent pneumococcal conjugate vaccine (PCV-13) are available for the elderly for the prevention of S. pneumoniae-related diseases. PPSV-23 was approved in 1988, while the extended use of PCV-13 was approved for adults aged 65 and older in June 2014. Despite these two vaccines being available, the recently launched national immunisation programme for the elderly only subsidised PPSV-23. The framework of the current immunisation programme lasts for five years. The elderly population eligible for the subsidised PPSV-23 shot for the 1st year are those aged 65, 70, 75, 80, 85, 90, 95 and >= 100. While from the 2nd year to the 5th year, those who will age 65, 70, 75, 80, 85, 90, 95 and 100 will receive the same subsidised shot. Methods We performed economic evaluations to (1) evaluate the efficiency of alternative strategies of PPSV-23 single-dose immunisation programme, and (2) investigate the efficiency of PCV-13 inclusion in the list for single-dose pneumococcal vaccine immunisation programme. Three alternative strategies were created in this study, namely: (1) current PPSV23 strategy, (2) 65 to 80 (as "65-80 PPSV-23 strategy"), and (3) 65 and older (as ">= 65 PPSV-23 strategy"). We constructed a Markov model depicting the S. pneumoniae-related disease course pathways. The transition probabilities, utility weights to estimate quality adjusted life year (QALY) and disease treatment costs were either calculated or cited from literature. Cost of per shot of vaccine was (sic) 8,116 (US$74; US$1 = (sic)110) for PPSV-23 and (sic)10,776 (US$98) for PCV-13. The model runs for 15 years with one year cycle after immunisation. Discounting was at 3%. Results Compared to current PPSV-23 strategy, 65-80 PPSV-23 strategy cost less but gained less, while the incremental cost-effectiveness ratios (ICERs) of >= 65 PPSV-23 strategy was (sic)5,025,000 (US$45,682) per QALY gained. PCV-13 inclusion into the list for single-dose subsidy has an ICER of (sic)377,000 (US$3,427) per QALY gained regardless of the PCV-13 diffusion level. These ICERs were found to be cost-effective since they are lower than the suggested criterion by WHO of three times GDP ((sic)11,000,000 or US$ 113,636 per QALY gained), which is the benchmark used in judging the cost-effectiveness of an immunisation programmne. Conclusions The results suggest that switching current PPSV-23 strategy to >= 65 PPSV-23 strategy or including PCV-13 into the list for single-dose subsidy to the elderly in Japan has value for money.	[Hoshi, Shu-ling; Kondo, Masahide; Okubo, Ichiro] Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, Tsukuba, Ibaraki, Japan	University of Tsukuba	Hoshi, SL (corresponding author), Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, Tsukuba, Ibaraki, Japan.	hoshi@hcs.tsukuba.ac.jp			research grant for Research on Emerging and Re-emerging Infectious Diseases, Health and Labour Sciences Research Grants from Ministry of Health, Labour and Welfare, Japan; Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology	research grant for Research on Emerging and Re-emerging Infectious Diseases, Health and Labour Sciences Research Grants from Ministry of Health, Labour and Welfare, Japan; Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology	This study was supported by research grant for Research on Emerging and Re-emerging Infectious Diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan, and Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, The Ministry of Education, Culture, Sports, Science and Technology.	[Anonymous], 2013, AUSTR IMM HDB; [Anonymous], 2014, NATL HLTH INSURANCE; [Anonymous], 2014, INFECT AGENTS SURVEI, V35, P229; [Anonymous], 2014, INFECT AGENTS SURVEI, V35, P238; [Anonymous], 2013, INFECT AGENTS SURVEI, V34, P55; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Borek A, 2014, COMPUT IND, V65, P354, DOI 10.1016/j.compind.2013.12.004; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Drummond MF, 2004, METHODS EC EVALUATIO; Hoshi SL, 2012, AGING RES, V4, pe8; Infectious Disease Sectional committee of the Tuberculosis and Infectious Disease Control Division of the MHLW, 2014, 10 M COMM JUL 16; Ishida Tadashi, 2004, Journal of Infection and Chemotherapy, V10, P359, DOI 10.1007/s10156-004-0351-1; Jackson LA, 2013, VACCINE, V31, P3594, DOI 10.1016/j.vaccine.2013.04.084; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Johnson D, 1997, J ROY STAT SOC D-STA, V46, P387, DOI 10.1111/1467-9884.00091; Kuhlmann A, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-4; Letter from Pfizer Inc, 2014, LAB WELF PRIC PREVN; Medical Economics Division Health Insurance Bureau, 2013, IRY KYUH JIT TYOUS 2; Ministry of Health Labour and Welfare, 2014, REP HLTH CTR ACT HLT; Ministry of Health Labour and Welfare, 2014, VIT STAT JAPN 2013; Ministry of Health Labour and Welfare., INF PNEUM DIS ELD; Ministry of Health Labour and Welfare, 2015, THE 21 LIFE TABLES; Ministry of Internal Affairs and communications, 2014, POP EST OCT 2014; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Naito T, 2014, J INFECT CHEMOTHER, V20, P450, DOI 10.1016/j.jiac.2014.03.004; Ogilvie I, 2009, VACCINE, V27, P4891, DOI 10.1016/j.vaccine.2009.05.061; Pebody R G, 2005, Euro Surveill, V10, P174, DOI 10.2807/esm.10.09.00564-en; Public Health England, 2014, PNEUM POL VACC UPT; Rozenbaum MH, 2010, CLIN THER, V32, P1517, DOI 10.1016/j.clinthera.2010.06.016; Samson SI, 2009, AGING CLIN EXP RES, V21, P210, DOI 10.1007/BF03324912; Shiramoto M, 2014, HUM VACC IMMUNOTHER, V10, P1850, DOI 10.4161/hv.28633; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Smith KJ, 2013, AM J PREV MED, V44, P373, DOI 10.1016/j.amepre.2012.11.035; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Squires S G, 2000, Can Commun Dis Rep, V26, P141; Stein WE, 2009, MATH COMPUT MODEL, V49, P1143, DOI 10.1016/j.mcm.2008.06.013; Takaki M, 2014, JPN J INFECT DIS, V67, P269, DOI 10.7883/yoken.67.269; The National Council on Social Security System, 2008, SIM COSTS HEALTHC LO; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; Ubukata k, 2013, JUUSYOUGATA RENSA KY, P1; Watanabe A, 2012, J INFECT CHEMOTHER, V18, P609, DOI 10.1007/s10156-012-0434-3; Weycker D, 2012, VACCINE, V30, P5437, DOI 10.1016/j.vaccine.2012.05.076; WHO, 2008, WHO GUID STAND EC EV	44	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139140	10.1371/journal.pone.0139140	http://dx.doi.org/10.1371/journal.pone.0139140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444287	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600044
J	Li, X; Zhang, MM; Liu, F; Li, Y; He, Y; Zhang, SA; Wu, JS				Li, Xi; Zhang, Miaomiao; Liu, Feng; Li, Yong; He, Yang; Zhang, Shunan; Wu, Jinshui			The Significance of Myriophyllum elatinoides for Swine Wastewater Treatment: Abundance and Community Structure of Ammonia-Oxidizing Microorganisms in Sediments	PLOS ONE			English	Article							FLOW CONSTRUCTED WETLAND; INFLUENT COD/N RATIOS; NITROGEN REMOVAL; MICROBIAL ECOLOGY; FUNCTIONAL GENES; DISSOLVED-OXYGEN; ARCHAEA; BACTERIA; NITRIFICATION; PERFORMANCE	Myriophyllum elatinoides was reported to effectively treat wastewater by removing nitrogen (N) and phosphorus (P). However, little is known about the abundance and community structure of ammonia-oxidizing microorganisms associated with M. elatinoides purification systems. The objective of this research was to characterize the abundance and community structure of ammonia-oxidizing microorganisms in swine wastewater and determine the main nitrogen removal pathways. In this study, five different waters were treated by M. elatinoides in microcosms for one month. The five waters included tap water (Control), swine wastewater (SW), 50% diluted swine wastewater (50% SW), and two synthetic wastewaters: 200 mg NH4+-N L-1 (200 NH4+-N) and 400 mg NH4+-N L-1 (400 NH4+-N). The most dramatic changes were in NH4+-N and total N (TN) concentrations, with average removal rates of 84% and 90%, respectively, in the treatments containing swine wastewater. On days 7, 14, and 28, the dissolved oxygen (DO) increased by 81.8%, 210.4% and 136.5%, respectively, compared with on day 0, in the swine wastewater. The results also showed that the bacterial amoA (AOB) copy numbers in the sediments of the treatments were significantly higher than those of archaeal amoA (AOA) copy numbers (p = 0.015). In addition, the high DO concentrations in swine wastewater responded well to the high abundance of AOB. The AOA and AOB community distributions were positively related with NO3-N and were negatively related with DO in swine wastewater treatments. In summary, our experimental results suggested that the M. elatinoides purification system could improve the activity of ammonia-oxidizing microorganisms and consequently might contribute to the significant N removal from the swine wastewater.	[Li, Xi; Zhang, Miaomiao; Liu, Feng; Li, Yong; He, Yang; Zhang, Shunan; Wu, Jinshui] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Inst Subtrop Agr, Beijing 410125, Peoples R China; [Li, Xi; Zhang, Miaomiao; Liu, Feng; Li, Yong; He, Yang; Zhang, Shunan; Wu, Jinshui] Chinese Acad Sci, Changsha Res Stn Agr & Environm Monitoring, Inst Subtrop Agr, Changsha 410125, Hunan, Peoples R China; [He, Yang; Zhang, Shunan] Chinese Acad Sci, Grad Univ, Changsha 100039, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, F (corresponding author), Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Inst Subtrop Agr, Beijing 410125, Peoples R China.	liufeng@isa.ac.cn; yli@isa.ac.cn; jswu@isa.ac.cn			CAS/SAFEA International Partnership Program for Creative Research Team [KZCX2-YW-T07, 20100491005-8]; key CAS Programs (100-Talents) [KZZD-EW-11, KZZD-EW-10-5]; National Science and Technology Supporting Project [2014BAD14B01, 2012BAD14B17]; National Natural Science Foundation of China [41101478]	CAS/SAFEA International Partnership Program for Creative Research Team(Chinese Academy of Sciences); key CAS Programs (100-Talents); National Science and Technology Supporting Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the CAS/SAFEA International Partnership Program for Creative Research Team (KZCX2-YW-T07, 20100491005-8), the key CAS Programs (KZZD-EW-11, KZZD-EW-10-5, 100-Talents), the National Science and Technology Supporting Project (2014BAD14B01, 2012BAD14B17), and the National Natural Science Foundation of China (41101478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty LC, 2005, ENVIRON POLLUT, V138, P412, DOI 10.1016/j.envpol.2005.04.022; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; Caselles-Osorio A, 2006, WATER RES, V40, P3603, DOI 10.1016/j.watres.2006.05.038; Chang JJ, 2013, ECOL ENG, V58, P192, DOI 10.1016/j.ecoleng.2013.06.039; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P1001, DOI 10.1111/j.1462-2920.2006.01227.x; Cooper PF, 1996, REED BEDS CONSTRUCTE, P63; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Despland LM, 2014, SCI TOTAL ENVIRON, V484, P167, DOI 10.1016/j.scitotenv.2014.03.030; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Ding Y, 2012, ECOL ENG, V46, P107, DOI 10.1016/j.ecoleng.2012.06.002; Dionisi HM, 2002, APPL ENVIRON MICROB, V68, P245, DOI 10.1128/AEM.68.1.245-253.2002; Dong XL, 2012, ECOL ENG, V40, P189, DOI 10.1016/j.ecoleng.2011.12.022; Feiler Ute, 2004, Journal of Soils and Sediments, V4, P261, DOI 10.1007/BF02991122; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Gorra R, 2007, J APPL MICROBIOL, V103, P1442, DOI 10.1111/j.1365-2672.2007.03357.x; HATANO K, 1994, WATER SCI TECHNOL, V29, P233, DOI 10.2166/wst.1994.0199; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hu B. L., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044122, DOI 10.1371/JOURNAL.PONE.0044122]; Ibekwe AM, 2003, APPL ENVIRON MICROB, V69, P5060, DOI 10.1128/AEM.69.9.5060-5069.2003; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Ji GD, 2012, ECOL ENG, V44, P269, DOI 10.1016/j.ecoleng.2012.04.007; KADLEC RH, 1996, TREATMENT WETLANDS, P893; Kaelin D, 2009, WATER RES, V43, P1680, DOI 10.1016/j.watres.2008.12.039; Knauer K, 2006, PEST MANAG SCI, V62, P715, DOI 10.1002/ps.1226; Kopp JF, 1983, EPA600479020 ENV MON, P521; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Laskov C, 2006, AQUAT BOT, V84, P333, DOI 10.1016/j.aquabot.2005.12.005; Lee CY, 2004, BIORESOURCE TECHNOL, V92, P173, DOI 10.1016/j.biortech.2003.08.012; Lee MS, 2010, WATER RES, V44, P4077, DOI 10.1016/j.watres.2010.05.020; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu L, 2013, ECOL ENG, V57, P10, DOI 10.1016/j.ecoleng.2013.04.019; Mermillod-Blondin F, 2008, FRESHWATER BIOL, V53, P1969, DOI 10.1111/j.1365-2427.2008.02020.x; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Mitsch WJ, 2000, ECOL ENG, V14, P1; Mosier AC, 2012, MICROB ECOL, V64, P955, DOI 10.1007/s00248-012-0075-1; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Park SJ, 2008, EXTREMOPHILES, V12, P605, DOI 10.1007/s00792-008-0165-7; Poach ME, 2004, ECOL ENG, V23, P165, DOI 10.1016/j.ecoleng.2004.09.001; PROSSER JI, 1989, ADV MICROB PHYSIOL, V30, P125; Rittmann B.E., 2001, ENV BIOTECHNOLOGY PR, DOI [10.1016/S0958-1669(96)80047-4, DOI 10.1016/S0958-1669(96)80047-4]; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Truu J, 2005, J ENVIRON SCI HEAL A, V40, P1191, DOI 10.1081/ESE-200055636; Wang SY, 2011, APPL MICROBIOL BIOT, V90, P779, DOI 10.1007/s00253-011-3090-0; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yool A, 2007, NATURE, V447, P999, DOI 10.1038/nature05885	53	6	13	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139778	10.1371/journal.pone.0139778	http://dx.doi.org/10.1371/journal.pone.0139778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444015	Green Published, gold			2022-12-26	WOS:000362510600079
J	Xu, XX; Wang, HY; Zhang, F; Hu, ZT; Liang, SP; Liu, ZH				Xu, Xunxun; Wang, Hengyun; Zhang, Fang; Hu, Zhaotun; Liang, Songping; Liu, Zhonghua			A Comparative Analysis of the Venom Gland Transcriptomes of the Fishing Spiders Dolomedes mizhoanus and Dolomedes sulfurous	PLOS ONE			English	Article							PHONEUTRIA-NIGRIVENTER; PEPTIDE TOXINS; IDENTIFICATION; NEUROTOXINS; CHEMISTS; CHANNELS; WEB	Dolomedes sulfurous and Dolomedes mizhoanus are predaceous arthropods catching and feeding on small fish. They live in the same area and have similar habits. Their venoms exhibit some similarities and differences in biochemical and electrophysiological properties. In the present work, we first performed a transcriptomic analysis by constructing the venom gland cDNA library of D. sulfurous and 127 novel putative toxin sequences were consequently identified, which were classified into eight families. This venom gland transcriptome was then compared with that of D. mizhoanus, which revealed that the putative toxins from both spider venoms might have originated from the same gene ancestors although novel toxins were evolved independently in the two spiders. The putative toxins from both spiders contain 6-12 cysteine residues forming seven cysteine patterns. As revealed by blast search, the two venoms are rich in neurotoxins targeting ion channels with pharmacological and therapeutic significance. This study provides insight into the venoms of two closely related species of spider, which will be of use for future investigations into the structure and function of their toxins.	[Xu, Xunxun; Wang, Hengyun; Zhang, Fang; Hu, Zhaotun; Liang, Songping; Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China	Hunan Normal University	Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China.	liuzh@hunnu.edu.cn			National 973 Project of China [2012CB22305]; National Science Foundation Project [31370783, 31170746]; Science Fund for Distinguished Young Scholars of Hunan Province [14JJ1018]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]	National 973 Project of China(National Basic Research Program of China); National Science Foundation Project(National Science Foundation (NSF)); Science Fund for Distinguished Young Scholars of Hunan Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province	This work was supported by the National 973 Project of China under contract (2012CB22305); the National Science Foundation Project, grant nos. 31370783 and 31170746; the Science Fund for Distinguished Young Scholars of Hunan Province (No. 14JJ1018); the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (No. 20134486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Chaim OM, 2011, TOXINS, V3, P309, DOI 10.3390/toxins3030309; Corzo G, 2003, CELL MOL LIFE SCI, V60, P2409, DOI 10.1007/s00018-003-3108-6; Corzo G, 2007, J BIOL CHEM, V282, P4643, DOI 10.1074/jbc.M605403200; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Doig RLO, 2015, DISCOV MED, V19, P41; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; Gertsch W.J., 1979, AM SPIDERS; Grishin EV, 2010, ANN NEUROL, V67, P680, DOI 10.1002/ana.21949; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Jiang LP, 2013, TOXICON, V73, P23, DOI 10.1016/j.toxicon.2013.07.005; Kalapothakis E, 1998, TOXICON, V36, P1971, DOI 10.1016/S0041-0101(98)00127-5; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kumar CG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-176; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Li JY, 2014, TOXICON, V83, P35, DOI 10.1016/j.toxicon.2014.02.014; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Luo J, 2014, TOXINS, V6, P2177, DOI 10.3390/toxins6072177; Nair A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-48; Nishikawa T, 2002, SILICO BIOL, V2, P5; Pimenta AMC, 2005, RAPID COMMUN MASS SP, V19, P31, DOI 10.1002/rcm.1751; Platnick N. I., 2013, WORLD SPIDER CATALOG; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Satake H, 2004, TOXICON, V44, P149, DOI 10.1016/j.toxicon.2004.05.012; Suter RB, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.19; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; Trachsel C, 2012, FEBS J, V279, P2683, DOI 10.1111/j.1742-4658.2012.08650.x; Wang HY, 2013, TOXICON, V65, P68, DOI 10.1016/j.toxicon.2013.01.014; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Whitton C, 2004, METH MOL B, V270, P75; Wong ESW, 2012, GENE, V496, P1, DOI 10.1016/j.gene.2012.01.009; Zhang Y, 2009, ZOOLOGY JENA, V113, P10	36	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139908	10.1371/journal.pone.0139908	http://dx.doi.org/10.1371/journal.pone.0139908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445494	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600102
J	Chakka, D; Gudla, R; Madikonda, AK; Pandeeti, EVP; Parthasarathy, S; Nandavaram, A; Siddavattam, D				Chakka, Deviprasanna; Gudla, Ramurthy; Madikonda, Ashok Kumar; Pandeeti, Emmanuel Vijay Paul; Parthasarathy, Sunil; Nandavaram, Aparna; Siddavattam, Dayananda			The Organophosphate Degradation (opd) Island-borne Esterase-induced Metabolic Diversion in Escherichia coli and Its Influence on p-Nitrophenol Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECENTLY DIVERGED PHOSPHOTRIESTERASE; FLAVOBACTERIUM SP; METHYL PARATHION; SPHINGOBIUM-FULIGINIS; AROMATIC-COMPOUNDS; ATCC 27551; GENE; BIODEGRADATION; HYDROLASE; LACTONASES	In previous studies of the organophosphate degradation gene cluster, we showed that expression of an open reading frame (orf306) present within the cluster in Escherichia coli allowed growth on p-nitrophenol (PNP) as sole carbon source. We have now shown that expression of orf306 in E. coli causes a dramatic up-regulation in genes coding for alternative carbon catabolism. The propionate, glyoxylate, and methylcitrate cycle pathway-specific enzymes are up-regulated along with hca (phenylpropionate) and mhp (hydroxyphenylpropionate) degradation operons. These hca and mhp operons play a key role in degradation of PNP, enabling E. coli to grow using it as sole carbon source. Supporting growth experiments, PNP degradation products entered central metabolic pathways and were incorporated into the carbon backbone. The protein and RNA samples isolated from E. coli (pSDP10) cells grown in C-14-labeled PNP indicated incorporation of C-14 carbon, suggesting Orf306-dependent assimilation of PNP in E. coli cells.	[Chakka, Deviprasanna; Gudla, Ramurthy; Madikonda, Ashok Kumar; Pandeeti, Emmanuel Vijay Paul; Parthasarathy, Sunil; Nandavaram, Aparna; Siddavattam, Dayananda] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Siddavattam, D (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	sdsl@uohyd.ernet.in	Chakka, Deviprasanna/J-4980-2015	Chakka, Deviprasanna/0000-0002-9703-3823; Pandeeti, Emmanuel/0000-0001-8244-7401	Department of Animal Biology is a Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure in Higher Educational Institutions; Department of Biotechnology-Centre for Education and Research in Biology and Biotechnology; University Grants Commission-Center of Advanced Study; CSIR; DST; DBT	Department of Animal Biology is a Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure in Higher Educational Institutions; Department of Biotechnology-Centre for Education and Research in Biology and Biotechnology; University Grants Commission-Center of Advanced Study; CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India)); DBT(Department of Biotechnology (DBT) India)	The Department of Animal Biology is a Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure in Higher Educational Institutions supported Department. The School of Life Sciences, University of Hyderabad is supported by the Department of Biotechnology-Centre for Education and Research in Biology and Biotechnology and University Grants Commission-Center of Advanced Study. Funding provided by CSIR, DST, and DBT to the D. S. laboratory is respectfully acknowledged. We thank Dr. M. J. Merrick for critical reading of the manuscript and Dr. Manjula Reddy for useful suggestions and providing E. coli mutants. Genotypic Technology Pvt. Ltd. is acknowledged for help in transcriptome data analysis.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Afriat-Jurnou L, 2012, BIOCHEMISTRY-US, V51, P6047, DOI 10.1021/bi300694t; Bar-Rogovsky H, 2013, J BIOL CHEM, V288, P23914, DOI 10.1074/jbc.M112.427922; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Copley SD, 2009, NAT CHEM BIOL, V5, P560, DOI 10.1038/nchembio.197; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Garau G, 2005, ANTIMICROB AGENTS CH, V49, P2778, DOI 10.1128/AAC.49.7.2778-2784.2005; HUGGINS C, 1947, J BIOL CHEM, V170, P467; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; Kawahara K, 2010, J GEN APPL MICROBIOL, V56, P249, DOI 10.2323/jgam.56.249; Khajamohiddin S, 2008, CRIT REV MICROBIOL, V34, P13, DOI [10.1080/10408410701683656, 10.1080/10408410701683656 ]; Longkumer T, 2014, MICROBIOL-SGM, V160, P102, DOI 10.1099/mic.0.070664-0; Manso I, 2009, J BIOL CHEM, V284, P21218, DOI 10.1074/jbc.M109.008243; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Miller JH., 1972, EXPT MOL GENETICS; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; MULBRY WW, 1987, PLASMID, V18, P173, DOI 10.1016/0147-619X(87)90046-1; Pakala SB, 2007, APPL MICROBIOL BIOT, V73, P1452, DOI 10.1007/s00253-006-0595-z; Pandeeti EVP, 2009, LETT APPL MICROBIOL, V48, P566, DOI 10.1111/j.1472-765X.2009.02564.x; Pandeeti EVP, 2012, G3-GENES GENOM GENET, V2, P1541, DOI 10.1534/g3.112.004051; Pandeeti EVP, 2011, PLASMID, V65, P226, DOI 10.1016/j.plasmid.2011.02.003; Pech-Canul A, 2011, J BACTERIOL, V193, P6295, DOI 10.1128/JB.05450-11; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Siddavattam D, 2003, APPL ENVIRON MICROB, V69, P2533, DOI 10.1128/AEM.69.5.2533-2539.2003; Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Stepankova A, 2013, ACTA CRYSTALLOGR F, V69, P346, DOI 10.1107/S1744309113002674; Turlin E, 2001, J MOL MICROB BIOTECH, V3, P127; WALSH K, 1984, J BIOL CHEM, V259, P9646; Wei M, 2009, FEMS MICROBIOL LETT, V292, P85, DOI 10.1111/j.1574-6968.2008.01468.x; Zhang RF, 2006, BIODEGRADATION, V17, P465, DOI 10.1007/s10532-005-9018-6	33	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29920	29930		10.1074/jbc.M115.661249	http://dx.doi.org/10.1074/jbc.M115.661249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26453310	Green Published, hybrid			2022-12-26	WOS:000366614700024
J	Ciesielski, GL; Bermek, O; Rosado-Ruiz, FA; Hovde, SL; Neitzke, OJ; Griffith, JD; Kaguni, LS				Ciesielski, Grzegorz L.; Bermek, Oya; Rosado-Ruiz, Fernando A.; Hovde, Stacy L.; Neitzke, Orrin J.; Griffith, Jack D.; Kaguni, Laurie S.			Mitochondrial Single-stranded DNA-binding Proteins Stimulate the Activity of DNA Polymerase by Organization of the Template DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA replication; electron microscopy (EM); enzyme mechanism; mitochondrial DNA (mtDNA)	ESCHERICHIA-COLI; FUNCTIONAL INTERACTIONS; FACILITATE REPLICATION; DROSOPHILA EMBRYOS; III HOLOENZYME; IN-VITRO; GAMMA; MUTATIONS; HELICASE; DEFECTS	The activity of the mitochondrial replicase, DNA polymerase (Pol ) is stimulated by another key component of the mitochondrial replisome, the mitochondrial single-stranded DNA-binding protein (mtSSB). We have performed a comparative analysis of the human and Drosophila Pols with their cognate mtSSBs, evaluating their functional relationships using a combined approach of biochemical assays and electron microscopy. We found that increasing concentrations of both mtSSBs led to the elimination of template secondary structure and gradual opening of the template DNA, through a series of visually similar template species. The stimulatory effect of mtSSB on Pol on these ssDNA templates is not species-specific. We observed that human mtSSB can be substituted by its Drosophila homologue, and vice versa, finding that a lower concentration of insect mtSSB promotes efficient stimulation of either Pol. Notably, distinct phases of the stimulation by both mtSSBs are distinguishable, and they are characterized by a similar organization of the template DNA for both Pols . We conclude that organization of the template DNA is the major factor contributing to the stimulation of Pol activity. Additionally, we observed that human Pol preferentially utilizes compacted templates, whereas the insect enzyme achieves its maximal activity on open templates, emphasizing the relative importance of template DNA organization in modulating Pol activity and the variation among systems.	[Ciesielski, Grzegorz L.; Kaguni, Laurie S.] Univ Tampere, Inst Biosci & Med Technol, Tampere 33520, Finland; [Ciesielski, Grzegorz L.; Rosado-Ruiz, Fernando A.; Hovde, Stacy L.; Neitzke, Orrin J.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA; [Ciesielski, Grzegorz L.; Rosado-Ruiz, Fernando A.; Hovde, Stacy L.; Neitzke, Orrin J.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48823 USA; [Bermek, Oya; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA	Tampere University; Michigan State University; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd, E Lansing, MI 48823 USA.	lskaguni@msu.edu	Regan, Clinton/E-6250-2012; Ciesielski, Grzegorz/AAK-2235-2020	Ciesielski, Grzegorz/0000-0001-6528-6781	National Institutes of Health [GM45295, GM31819, ES13773]; University of Tampere; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295, R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tampere; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM45295 (to L. S. K.) and GM31819 and ES13773 (to J. D. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the University of Tampere.	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155; Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618; Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073; Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779; Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200; Ghosh S, 2010, J BIOL CHEM, V285, P18103, DOI 10.1074/jbc.M110.107656; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; GUTIERREZ C, 1991, J BIOL CHEM, V266, P2104; HOKE GD, 1990, ARCH BIOCHEM BIOPHYS, V282, P116, DOI 10.1016/0003-9861(90)90094-F; Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653; Johnson AA, 2001, J BIOL CHEM, V276, P38090; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Mikhailov VS, 1996, J BIOL CHEM, V271, P18939, DOI 10.1074/jbc.271.31.18939; Oliveira MT, 2015, GENOME BIOL EVOL, V7, P943, DOI 10.1093/gbe/evv042; Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983; Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379; Oliveira MT, 2009, METHODS MOL BIOL, V554, P37, DOI 10.1007/978-1-59745-521-3_3; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099; THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137; WILLIAMS AJ, 1993, J BIOL CHEM, V268, P24855; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P860, DOI 10.1074/jbc.270.2.860; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	43	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28697	28707		10.1074/jbc.M115.673707	http://dx.doi.org/10.1074/jbc.M115.673707			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26446790	Green Published, hybrid			2022-12-26	WOS:000365762300011
J	Thai, TL; Yu, L; Galarza-Paez, L; Wu, MM; Lam, HYC; Bao, HF; Duke, BJ; Al-Khalili, O; Ma, HP; Liu, BC; Eaton, DC				Thai, Tiffany L.; Yu, Ling; Galarza-Paez, Laura; Wu, Ming Ming; Lam, Ho Yin Colin; Bao, Hui Fang; Duke, Billie Jeanne; Al-Khalili, Otor; Ma, He-Ping; Liu, Bingchen; Eaton, Douglas C.			The Polarized Effect of Intracellular Calcium on the Renal Epithelial Sodium Channel Occurs as a Result of Subcellular Calcium Signaling Domains Maintained by Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium intracellular release; calcium transport; cell polarity; epithelial sodium channel (ENaC); kidney; cortical collecting duct; mitochondrial barrier; polarization	PROTEIN-KINASE-C; NA+ CHANNEL; BLOOD-PRESSURE; ENAC ACTIVITY; A6 CELLS; INHIBITION; MEMBRANE; HYPERTENSION; KIDNEY; ALPHA	The renal epithelial sodium channel (ENaC) provides regulated sodium transport in the distal nephron. The effects of intracellular calcium ([Ca2+](i)) on this channel are only beginning to be elucidated. It appears from previous studies that the [Ca2+](i) increases downstream of ATP administration may have a polarized effect on ENaC, where apical application of ATP and the subsequent [Ca2+](i) increase have an inhibitory effect on the channel, whereas basolateral ATP and [Ca2+](i) have a stimulatory effect. We asked whether this polarized effect of ATP is, in fact, reflective of a polarized effect of increased [Ca2+](i) on ENaC and what underlying mechanism is responsible. We began by performing patch clamp experiments in which ENaC activity was measured during apical or basolateral application of ionomycin to increase [Ca2+](i) near the apical or basolateral membrane, respectively. We found that ENaC does indeed respond to increased [Ca2+](i) in a polarized fashion, with apical increases being inhibitory and basolateral increases stimulating channel activity. In other epithelial cell types, mitochondria sequester [Ca2+](i), creating [Ca2+](i) signaling microdomains within the cell that are dependent on mitochondrial localization. We found that mitochondria localize in bands just beneath the apical and basolateral membranes in two different cortical collecting duct principal cell lines and in cortical collecting duct principal cells in mouse kidney tissue. We found that inhibiting mitochondrial [Ca2+](i) uptake destroyed the polarized response of ENaC to [Ca2+](i). Overall, our data suggest that ENaC is regulated by [Ca2+](i) in a polarized fashion and that this polarization is maintained by mitochondrial [Ca2+](i) sequestration.	[Thai, Tiffany L.; Yu, Ling; Galarza-Paez, Laura; Wu, Ming Ming; Lam, Ho Yin Colin; Bao, Hui Fang; Duke, Billie Jeanne; Al-Khalili, Otor; Ma, He-Ping; Liu, Bingchen; Eaton, Douglas C.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Thai, TL (corresponding author), Emory Univ, Dept Physiol, 615 Michael St,Suite 600, Atlanta, GA 30322 USA.	tiffany.thai@emory.edu	Wu, Ming-Ming/AAP-6543-2021; wu, mingming/GXN-1864-2022; LIU, BING-CHEN/AAG-9141-2020	Wu, Ming-Ming/0000-0002-6861-6376; 	NIDDK/National Institutes of Health [R37-DK037963, R01-DK100582]; American Heart Association [13POST16820072]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100582, R25DK101390, R37DK037963] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK/National Institutes of Health Grants R37-DK037963 (to D. C. E.) and R01-DK100582 (to H. M.) and American Heart Association Grant 13POST16820072 (to T. L. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Alli AA, 2012, AM J PHYSIOL-RENAL, V303, pF800, DOI 10.1152/ajprenal.00703.2011; Bao HF, 2007, AM J PHYSIOL-RENAL, V293, pF1178, DOI 10.1152/ajprenal.00153.2007; Bao HF, 2014, AM J PHYSIOL-RENAL, V306, pF309, DOI 10.1152/ajprenal.00519.2013; Bao HF, 2012, AM J PHYSIOL-CELL PH, V303, pC1129, DOI 10.1152/ajpcell.00139.2012; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Busst CJ, 2013, CLIN EXP PHARMACOL P, V40, P495, DOI 10.1111/1440-1681.12124; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Gilmore ES, 2001, J BIOL CHEM, V276, P42610, DOI 10.1074/jbc.M106919200; Gincel D, 2002, INVEST OPHTH VIS SCI, V43, P2097; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Laffer CL, 2014, J AM SOC HYPERTENS, V8, P475, DOI 10.1016/j.jash.2014.04.011; Liu YQ, 2011, BIOCHEM BIOPH RES CO, V404, P364, DOI 10.1016/j.bbrc.2010.11.124; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Schaeffer C, 2014, NEPHROL DIAL TRANSPL, V29, P33, DOI 10.1093/ndt/gfu231; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Su YR, 2001, DRUG METAB DISPOS, V29, P553; Thai TL, 2014, AM J PHYSIOL-RENAL, V307, pF806, DOI 10.1152/ajprenal.00350.2013; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; Toney GM, 2012, CURR OPIN NEPHROL HY, V21, P52, DOI 10.1097/MNH.0b013e32834db4a0; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wildman SSP, 2009, PURINERG SIGNAL, V5, P481, DOI 10.1007/s11302-009-9150-6; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhang YJ, 2007, AM J PHYSIOL-RENAL, V292, pF1734, DOI 10.1152/ajprenal.00382.2006	33	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28805	28811		10.1074/jbc.M115.668293	http://dx.doi.org/10.1074/jbc.M115.668293			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26451045	Green Published, hybrid			2022-12-26	WOS:000365762300022
J	Dubuke, ML; Maniatis, S; Shaffer, SA; Munson, M				Dubuke, Michelle L.; Maniatis, Stephanie; Shaffer, Scott A.; Munson, Mary			The Exocyst Subunit Sec6 Interacts with Assembled Exocytic SNARE Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION SPECIFICITY; N-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; TETHERING COMPLEX; VACUOLE FUSION; COG COMPLEX; SECRETORY VESICLES; CRYSTAL-STRUCTURE; SM PROTEIN; YEAST	In eukaryotic cells, membrane-bound vesicles carry cargo between intracellular compartments, to and from the cell surface, and into the extracellular environment. Many conserved families of proteins are required for properly localized vesicle fusion, including the multisubunit tethering complexes and the SNARE complexes. These protein complexes work together to promote proper vesicle fusion in intracellular trafficking pathways. However, the mechanism by which the exocyst, the exocytosis-specific multisubunit tethering complex, interacts with the exocytic SNAREs to mediate vesicle targeting and fusion is currently unknown. We have demonstrated previously that the Saccharomyces cerevisiae exocyst subunit Sec6 directly bound the plasma membrane SNARE protein Sec9 in vitro and that Sec6 inhibited the assembly of the binary Sso1-Sec9 SNARE complex. Therefore, we hypothesized that the interaction between Sec6 and Sec9 prevented the assembly of premature SNARE complexes at sites of exocytosis. To map the determinants of this interaction, we used cross-linking and mass spectrometry analyses to identify residues required for binding. Mutation of residues identified by this approach resulted in a growth defect when introduced into yeast. Contrary to our previous hypothesis, we discovered that Sec6 does not change the rate of SNARE assembly but, rather, binds both the binary Sec9-Sso1 and ternary Sec9-Sso1-Snc2 SNARE complexes. Together, these results suggest a new model in which Sec6 promotes SNARE complex assembly, similar to the role proposed for other tether subunit-SNARE interactions.	[Dubuke, Michelle L.; Maniatis, Stephanie; Shaffer, Scott A.; Munson, Mary] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Maniatis, Stephanie; Shaffer, Scott A.] Univ Massachusetts, Sch Med, Prote & Mass Spectrometry Facil, Shrewsbury, MA 01545 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System	Munson, M (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA.	mary.munson@umassmed.edu	Munson, Mary/A-9777-2009; Regan, Clinton/E-6250-2012	Munson, Mary/0000-0003-2297-8053; 	National Institutes of Health [GM068803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM068803 (to M. M.). The authors declare they have no conflicts of interest with the contents of this article.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Arasaki K, 2013, MOL BIOL CELL, V24, P2907, DOI 10.1091/mbc.E13-01-0014; Baek K, 2010, J BIOL CHEM, V285, P10424, DOI 10.1074/jbc.M109.096966; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Brachmann CB, 1998, YEAST, V14, P115; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Brunet S, 2014, TRAFFIC, V15, P1282, DOI 10.1111/tra.12200; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Croteau NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004443; Diefenbacher M, 2011, J BIOL CHEM, V286, P25027, DOI 10.1074/jbc.M110.215657; Dietrich LEP, 2003, BBA-MOL CELL RES, V1641, P111, DOI 10.1016/S0167-4889(03)00094-6; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Farre JC, 2011, CELL, V144, P172, DOI 10.1016/j.cell.2011.01.005; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Izawa R, 2012, J BIOL CHEM, V287, P3445, DOI 10.1074/jbc.M111.307439; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Laufman O, 2013, J CELL SCI, V126, P1506, DOI 10.1242/jcs.122101; Laufman O, 2009, EMBO J, V28, P2006, DOI 10.1038/emboj.2009.168; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Lurick A, 2015, J BIOL CHEM, V290, P5405, DOI 10.1074/jbc.M114.631465; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Morgera F, 2012, MOL BIOL CELL, V23, P337, DOI 10.1091/mbc.E11-08-0670; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Nichols CD, 2010, CURR BIOL, V20, P1316, DOI 10.1016/j.cub.2010.05.065; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Panchaud A, 2010, J PROTEOME RES, V9, P2508, DOI 10.1021/pr9011816; Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09; Radulovic D, 2004, MOL CELL PROTEOMICS, V3, P984, DOI 10.1074/mcp.M400061-MCP200; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; Rost B., 2004, PROTEINS, DOI [10.1110/ps.03503304/full, DOI 10.1110/PS.03503304/FULL]; Shen D, 2013, J CELL BIOL, V202, P509, DOI 10.1083/jcb.201211148; Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145; SIKORSKI RS, 1989, GENETICS, V122, P19; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wong C, 2000, BIOTECHNIQUES, V28, P426, DOI 10.2144/00283bm07; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu H, 2010, MOL BIOL CELL, V21, P430, DOI 10.1091/mbc.E09-06-0501; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Yamashita M, 2010, NAT STRUCT MOL BIOL, V17, P180, DOI 10.1038/nsmb.1722; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	75	26	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28245	28256		10.1074/jbc.M115.673806	http://dx.doi.org/10.1074/jbc.M115.673806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446795	Green Published, hybrid			2022-12-26	WOS:000365761900018
J	Mizuno, S; Yoda, M; Shimoda, M; Tohmonda, T; Okada, Y; Toyama, Y; Takeda, S; Nakamura, M; Matsumoto, M; Horiuchi, K				Mizuno, Sakiko; Yoda, Masaki; Shimoda, Masayuki; Tohmonda, Takahide; Okada, Yasunori; Toyama, Yoshiaki; Takeda, Shin'ichi; Nakamura, Masaya; Matsumoto, Mono; Horiuchi, Keisuke			A Disintegrin and Metalloprotease 10 (ADAM10) Is Indispensable for Maintenance of the Muscle Satellite Cell Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; STEM-CELLS; DISINTEGRIN/METALLOPROTEINASE ADAM10; EPIDERMAL ADAM17; NOTCH ACTIVATION; REGENERATION; MYOGENESIS; REQUIREMENT; QUIESCENCE; ESTABLISHMENT	Satellite cells (SCs) are muscle-specific stem cells that are essential for the regeneration of damaged muscles. Although SCs have a robust capacity to regenerate myofibers, the number of SCs decreases with aging, leading to insufficient recovery after muscle injury. We herein show that ADAM10 (a disintegrin and metalloprotease 10), a membrane-bound proteolytic enzyme with a critical role in Notch processing (S2 cleavage), is essential for the maintenance of SC quiescence. We generated mutant mice in which ADAM10 in SCs can be conditionally abrogated by tamoxifen injection. Tamoxifen-treated mutant mice did not show any apparent defects and grew normally under unchallenged conditions. However, these mice showed a nearly complete loss of muscle regeneration after chemically induced muscle injury, in situ hybridization and flow cytometric analyses revealed that the mutant mice had significantly less SCs compared with wild type controls. Of note, we found that inactivation of ADAM10 in SCs severely compromised Notch signaling and led to dysregulated myogenic differentiation, ultimately resulting in deprivation of the SC pool in vivo. Taken together, the present findings underscore the role of ADAM 10 as an indispensable component of Notch signaling in SCs and for maintaining the SC pool.	[Mizuno, Sakiko; Toyama, Yoshiaki; Nakamura, Masaya; Matsumoto, Mono; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo 1608582, Japan; [Yoda, Masaki; Tohmonda, Takahide; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo 1608582, Japan; [Shimoda, Masayuki; Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan; [Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo 1878502, Japan	Keio University; Keio University; Keio University; National Center for Neurology & Psychiatry - Japan	Horiuchi, K (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	horiuchi@z3.keio.jp	Okada, Yasunori/B-5550-2014; Horiuchi, Keisuke/L-2277-2013; Nakamura, Masaya/K-4111-2013	Okada, Yasunori/0000-0001-9208-4755; Horiuchi, Keisuke/0000-0001-7063-9609; Mizuno, Sakiko/0000-0003-4081-3973	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) KAKENHI [24390358]	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) KAKENHI	This work was supported in part MEXT (Ministry of Education, Culture, Sports, Science, and Technology) KAKENHI (24390358; to K. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00317; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Groot AJ, 2013, J INVEST DERMATOL, V133, P2286, DOI 10.1038/jid.2013.162; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lin SB, 2013, STEM CELLS, V31, P823, DOI 10.1002/stem.1319; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mourikis P, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-2; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Nagao K, 2012, STEM CELLS, V30, P1781, DOI 10.1002/stem.1153; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Saito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054853; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yoda M, 2011, BLOOD, V118, P6939, DOI 10.1182/blood-2011-06-357210	47	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28456	28464		10.1074/jbc.M115.653477	http://dx.doi.org/10.1074/jbc.M115.653477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26453297	Green Published, hybrid			2022-12-26	WOS:000365761900039
J	Chastin, SFM; Palarea-Albaladejo, J; Dontje, ML; Skelton, DA				Chastin, Sebastien F. M.; Palarea-Albaladejo, Javier; Dontje, Manon L.; Skelton, Dawn A.			Combined Effects of Time Spent in Physical Activity, Sedentary Behaviors and Sleep on Obesity and Cardio-Metabolic Health Markers: A Novel Compositional Data Analysis Approach	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADULTS; ASSOCIATIONS; DURATION; RISK; OUTCOMES; METAANALYSIS; MORTALITY; BREAKING; QUALITY	The associations between time spent in sleep, sedentary behaviors (SB) and physical activity with health are usually studied without taking into account that time is finite during the day, so time spent in each of these behaviors are codependent. Therefore, little is known about the combined effect of time spent in sleep, SB and physical activity, that together constitute a composite whole, on obesity and cardio-metabolic health markers. Cross-sectional analysis of NHANES 2005-6 cycle on N = 1937 adults, was undertaken using a compositional analysis paradigm, which accounts for this intrinsic codependence. Time spent in SB, light intensity (LIPA) and moderate to vigorous activity (MVPA) was determined from accelerometry and combined with self-reported sleep time to obtain the 24 hour time budget composition. The distribution of time spent in sleep, SB, LIPA and MVPA is significantly associated with BMI, waist circumference, triglycerides, plasma glucose, plasma insulin (all rho<0.001), and systolic (rho<0.001) and diastolic blood pressure (rho<0.003), but not HDL or LDL. Within the composition, the strongest positive effect is found for the proportion of time spent in MVPA. Strikingly, the effects of MVPA replacing another behavior and of MVPA being displaced by another behavior are asymmetric. For example, re-allocating 10 minutes of SB to MVPA was associated with a lower waist circumference by 0.001% but if 10 minutes of MVPA is displaced by SB this was associated with a 0.84% higher waist circumference. The proportion of time spent in LIPA and SB were detrimentally associated with obesity and cardiovascular disease markers, but the association with SB was stronger. For diabetes risk markers, replacing SB with LIPA was associated with more favorable outcomes. Time spent in MVPA is an important target for intervention and preventing transfer of time from LIPA to SB might lessen the negative effects of physical inactivity.	[Chastin, Sebastien F. M.; Dontje, Manon L.; Skelton, Dawn A.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Palarea-Albaladejo, Javier] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland	Glasgow Caledonian University; James Hutton Institute	Chastin, SFM (corresponding author), Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland.	Sebastien.Chastin@gcu.ac.uk	Skelton, Dawn A/B-7552-2013; Palarea-Albaladejo, Javier/J-5591-2013; Chastin, Sebastien/ABF-1455-2020	Skelton, Dawn A/0000-0001-6223-9840; Palarea-Albaladejo, Javier/0000-0003-0162-669X; Chastin, Sebastien/0000-0003-1421-9348; Dontje, Manon/0000-0002-0348-9556	Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS)	Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS)	The authors (SC, DS, MD) received no specific funding for this work. However the work of J. Palarea-Albaladejo has been supported by the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS).	Aitchinson J, 2003, STAT ANAL COMPOSITIO; Bailey DP, 2015, J SCI MED SPORT, V18, P294, DOI 10.1016/j.jsams.2014.03.008; Bansil P, 2011, J CLIN HYPERTENS, V13, P739, DOI 10.1111/j.1751-7176.2011.00500.x; Buccianti A, 2014, J GEOCHEM EXPLOR, V141, P78, DOI 10.1016/j.gexplo.2014.01.014; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Montero-Serrano JC, 2010, SEDIMENT GEOL, V228, P218, DOI 10.1016/j.sedgeo.2010.04.013; Carvalho MJ, 2009, GERONTOLOGY, V55, P41, DOI 10.1159/000140681; Chastin S, 2013, PLOS ONE; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chayes F., 1975, CONCEPTS GEOSTATISTI, P106; Department of Health, 2011, START ACT STAY ACT R; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Dunstan DW, 2011, CURR OPIN CARDIOL, V26, P412, DOI 10.1097/HCO.0b013e3283496605; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Ford ES, 2012, INT J EPIDEMIOL; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Grandner MA, 2013, NAT SCI SLEEP, V5, P93, DOI 10.2147/NSS.S31063; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; HONAKER J, 2002, POLITICAL, V0010; Hron K, 2012, J APPL STAT, V39, P1115, DOI 10.1080/02664763.2011.644268; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Kotz Catherine M, 2005, Minn Med, V88, P54; Levine JA, 2004, AM J PHYSIOL-ENDOC M, V286, pE675, DOI 10.1152/ajpendo.00562.2003; Lobo Alexandrina, 2010, Int J Family Med, V2010, P486097, DOI 10.1155/2010/486097; Loprinzi PD, 2014, PREV MED, V60, P128, DOI 10.1016/j.ypmed.2013.12.017; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Maher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086403; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; McGuire DK, 2001, CIRCULATION, V104, P1350, DOI 10.1161/circ.104.12.1350; Miller MA, 2007, CURR VASC PHARMACOL, V5, P93, DOI 10.2174/157016107780368280; Mora-Rodriguez R, 2014, NUTR METAB CARDIOVAS, V24, P792, DOI 10.1016/j.numecd.2014.01.011; Owen N, 2009, BRIT J SPORT MED, V43, P81, DOI 10.1136/bjsm.2008.055269; PawlowskyGlahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P1, DOI 10.1002/9781119976462; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Pedisic Z, 2014, KINESIOLOGY, V46, P135; Pierotti MER, 2009, EVOLUTION, V63, P2372, DOI 10.1111/j.1558-5646.2009.00716.x; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Rhodes RE, 2012, AM J PREV MED, V42, P23; Ros-Freixedes R, 2014, J AGR BIOL ENVIR ST, V19, P136, DOI 10.1007/s13253-013-0162-x; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Thorp AA, 2014, MED SCI SPORT EXER, V46, P2053, DOI 10.1249/MSS.0000000000000337; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; US Department of Health and Human Services Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	58	472	477	9	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139984	10.1371/journal.pone.0139984	http://dx.doi.org/10.1371/journal.pone.0139984			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461112	Green Published, Green Submitted, gold			2022-12-26	WOS:000362962300043
J	Fan, XH; Wang, QX; Wang, MB; Jimenez, CV				Fan, Xiaohui; Wang, Qixiang; Wang, Mengben; Villarroel Jimenez, Claudia			Warming Amplification of Minimum and Maximum Temperatures over High-Elevation Regions across the Globe	PLOS ONE			English	Article							TIBETAN PLATEAU; MOUNTAIN REGIONS; CLIMATE-CHANGE; 20TH-CENTURY; TRENDS; URBANIZATION; VARIABILITY; SEASON	An analysis of the annual mean temperature (T-MEAN) (1961-2010) has revealed that warming amplification (altitudinal amplification and regional amplification) is a common feature of major high-elevation regions across the globe against the background of global warming since the mid-20th century. In this study, the authors further examine whether this holds for annual mean minimum temperature (T-MIN) and annual mean maximum temperature (T-MAX) (1961-2010) on a global scale. The extraction method of warming component of altitude, and the paired region comparison method were used in this study. Results show that a significant altitudinal amplification trend in T-MIN (T-MAX) is detected in all (four) of the six high-elevation regions tested, and the average magnitude of altitudinal amplification trend for T-MIN (T-MAX) [0.306 +/- 0.086 degrees C km(-1)(0.154 +/- 0.213 degrees C km(-1))] is substantially larger (smaller) than T-MEAN (0.230 +/- 0.073 degrees C km(-1)) during the period 1961-2010. For the five paired high- and low-elevation regions available, regional amplification is detected in the four high-elevation regions for T-MIN and T-MAX (respectively or as a whole). Qualitatively, highly (largely) consistent results are observed for T-MIN (T-MAX) compared with those for T-MEAN.	[Fan, Xiaohui; Wang, Qixiang; Wang, Mengben] Shanxi Univ, Inst Loess Plateau, Taiyuan, Shanxi Province, Peoples R China; [Villarroel Jimenez, Claudia] Direcc Meteorol Chile, Santiago, Chile	Shanxi University	Wang, MB (corresponding author), Shanxi Univ, Inst Loess Plateau, Taiyuan, Shanxi Province, Peoples R China.	mbwang@sxu.edu.cn	wang, qixiang/X-9159-2019	wang, qixiang/0000-0001-6727-9032	Natural Science Foundation of Shanxi Province for Young Scholars (China) [2013021030-2]; Project for Key and Special Subjects of Shanxi Province (China); Innovative Project for Excellent Graduate Students of Shanxi Province (China)	Natural Science Foundation of Shanxi Province for Young Scholars (China); Project for Key and Special Subjects of Shanxi Province (China); Innovative Project for Excellent Graduate Students of Shanxi Province (China)	This work was supported by the Natural Science Foundation of Shanxi Province for Young Scholars (China) (2013021030-2), the Project for Key and Special Subjects of Shanxi Province (China) and the Innovative Project for Excellent Graduate Students of Shanxi Province (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY RG, 1992, MT RES DEV, V12, P71, DOI 10.2307/3673749; BARRY RG, 1990, MT RES DEV, V10, P161, DOI 10.2307/3673426; Barry RG, 2012, THEOR APPL CLIMATOL, V110, P549, DOI 10.1007/s00704-012-0695-x; Beniston M, 1996, THEOR APPL CLIMATOL, V53, P231, DOI 10.1007/BF00871739; BENISTON M, 1994, THEOR APPL CLIMATOL, V49, P135, DOI 10.1007/BF00865530; Ceppi P, 2012, INT J CLIMATOL, V32, P203, DOI 10.1002/joc.2260; Diaz HF, 1997, CLIMATIC CHANGE, V36, P253, DOI 10.1023/A:1005335731187; Duan AM, 2006, CHINESE SCI BULL, V51, P1396, DOI 10.1007/s11434-006-1396-6; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Easterling DR, 2002, B AM METEOROL SOC, V83, P1327, DOI 10.1175/1520-0477(2002)083&lt;1327:RCIFDA&gt;2.3.CO;2; Falvey M, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010519; Fan XH, 2012, THEOR APPL CLIMATOL, V109, P283, DOI 10.1007/s00704-011-0577-7; Jauregui E, 2005, ATMOSFERA, V18, P249; Jungo P, 2001, THEOR APPL CLIMATOL, V69, P1, DOI 10.1007/s007040170031; Kendall M. G., 1975, RANK CORRELATION MET; Lawrimore JH, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016187; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Liu XD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006915; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Martinez R., 2012, DAILY DATASET CLIMAT; McGuire CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044370; OHMURA A, 1984, J CLIMATOL, V4, P325, DOI 10.1002/joc.3370040309; Ohmura A, 2012, THEOR APPL CLIMATOL, V110, P499, DOI 10.1007/s00704-012-0687-x; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Rangwala I, 2013, INT J CLIMATOL, V33, P897, DOI 10.1002/joc.3477; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Si P, 2012, J GEOGR SCI, V22, P245, DOI 10.1007/s11442-012-0924-3; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Wang Q, 2015, SCI REP IN PRESS; Wang QX, 2014, CLIM DYNAM, V43, P87, DOI 10.1007/s00382-013-1889-3; Wang XL, 2010, RHTESTSV3 USER MANUA; Wang XLL, 2001, J CLIMATE, V14, P2204, DOI 10.1175/1520-0442(2001)014<2204:COEWHI>2.0.CO;2; Weber RO, 1997, CLIMATIC CHANGE, V36, P327, DOI 10.1023/A:1005378702066; Yan L., 2014, J EARTH OCEAN ATMOS, V1, P13; You QL, 2010, GLOBAL PLANET CHANGE, V71, P124, DOI 10.1016/j.gloplacha.2010.01.020; You QL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032669	40	8	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140213	10.1371/journal.pone.0140213	http://dx.doi.org/10.1371/journal.pone.0140213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461461	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300066
J	Kumanomidou, T; Nishio, K; Takagi, K; Nakagawa, T; Suzuki, A; Yamane, T; Tokunaga, F; Iwai, K; Murakami, A; Yoshida, Y; Tanaka, K; Mizushima, T				Kumanomidou, Taichi; Nishio, Kazuya; Takagi, Kenji; Nakagawa, Tomomi; Suzuki, Atsuo; Yamane, Takashi; Tokunaga, Fuminori; Iwai, Kazuhiro; Murakami, Arisa; Yoshida, Yukiko; Tanaka, Keiji; Mizushima, Tsunehiro			The Structural Differences between a Glycoprotein Specific F-Box Protein Fbs1 and Its Homologous Protein FBG3	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; SCF; COMPLEX; FAMILY; EXPRESSION; BINDING	The Skp1-Cul1-F-box protein (SCF) complex catalyzes protein ubiquitination in diverse cellular processes and is one of the best-characterized ubiquitin ligases. F-box proteins determine the substrate specificities of SCF ubiquitin ligases. Among these, Fbs1/FBG1/FBXO2, Fbs2/FBG2/FBXO6, and Fbs3/FBG5/FBXO27 recognize the N-glycans of glycoproteins, whereas FBG3/FBXO44 has no sugar-binding activity, despite the high sequence homology and conservation of the residues necessary for oligosaccharide binding between Fbs1-3 and FBG3. Here we determined the crystal structure of the Skp1-FBG3 complex at a resolution of 2.6 angstrom. The substrate-binding domain of FBG3 is composed of a 10-stranded antiparallel beta-sandwich with three helices. Although the overall structure of FBG3 is similar to that of Fbs1, the residues that form the Fbs1 carbohydrate-binding pocket failed to be superposed with the corresponding residues of FBG3. Structure-based mutational analysis shows that distinct hydrogen bond networks of four FBG3 loops, i.e., beta 2-beta 3, beta 5-beta 6, beta 7-beta 8, and beta 9-beta 10, prevent the formation of the carbohydrate-binding pocket shown in Fbs1.	[Kumanomidou, Taichi; Nakagawa, Tomomi; Suzuki, Atsuo; Yamane, Takashi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nishio, Kazuya; Takagi, Kenji; Mizushima, Tsunehiro] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Picobiol Inst, Kamigori, Hyogo, Japan; [Tokunaga, Fuminori] Gunma Univ, Inst Mol & Cellular Regulat, Mol Cell Biol Lab, Maebashi, Gunma, Japan; [Iwai, Kazuhiro] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Murakami, Arisa; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 113, Japan; [Yoshida, Yukiko] Tokyo Metropolitan Inst Med Sci, Ubiquitin Project, Setagaya Ku, Tokyo 113, Japan	Nagoya University; University of Hyogo; Gunma University; Kyoto University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Yoshida, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Ubiquitin Project, Setagaya Ku, Tokyo 113, Japan.	yoshida-yk@igakuken.or.jp; mizushi@sci.u-hyogo.ac.jp	Yoshida, Yukiko/ABB-7218-2020; IWAI, KAZUHIRO/GSN-7385-2022	Yoshida, Yukiko/0000-0002-0629-0219; Mizushima, Tsunehiro/0000-0002-6631-2889; Iwai, Kazuhiro/0000-0001-5620-5951; Tokunaga, Fuminori/0000-0003-3626-9119	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24112009, 24580152]; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the following grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; http://www.mext.go.jp/english/) of Japan: Grant-in-Aids for Scientific Research on Innovative Areas (24112009 to T.M.) and Scientific Research on Priority Area (24580152 to Y.Y). Part of this work was supported by grants from the Uehara Memorial Foundation (to T. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Kabsch W, 1976, ACTA CRYSTALLOGR A, VA32, P2; Kumanomidou T, 2010, ACTA CRYSTALLOGR F, V66, P95, DOI 10.1107/S1744309109050581; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YF, 2010, J BIOL CHEM, V285, P13896, DOI 10.1074/jbc.M110.111518; Liu J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000527; Lu YZ, 2012, J BIOL CHEM, V287, P41014, DOI 10.1074/jbc.M112.407106; Mizushima T, 2004, NAT STRUCT MOL BIOL, V11, P365, DOI 10.1038/nsmb732; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, 2007, J BIOL CHEM, V282, P7137, DOI 10.1074/jbc.M611168200; Yoshida Y, 2011, BIOCHEM BIOPH RES CO, V410, P24, DOI 10.1016/j.bbrc.2011.05.098; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	30	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140366	10.1371/journal.pone.0140366	http://dx.doi.org/10.1371/journal.pone.0140366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460611	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300083
J	Jegu, T; Domenichini, S; Blein, T; Ariel, F; Christ, A; Kim, SK; Crespi, M; Boutet-Mercey, S; Mouille, G; Bourge, M; Hirt, H; Bergounioux, C; Raynaud, C; Benhamed, M				Jegu, Teddy; Domenichini, Severine; Blein, Thomas; Ariel, Federico; Christ, Aurelie; Kim, Soon-Kap; Crespi, Martin; Boutet-Mercey, Stephanie; Mouille, Gregory; Bourge, Mickael; Hirt, Heribert; Bergounioux, Catherine; Raynaud, Cecile; Benhamed, Moussa			A SWI/SNF Chromatin Remodelling Protein Controls Cytokinin Production through the Regulation of Chromatin Architecture	PLOS ONE			English	Article							CELL-CYCLE; ARABIDOPSIS ROOT; GENE LOOP; MERISTEM; COMPLEX; TRANSCRIPTION; MAINTENANCE; PLANTS; GROWTH; BIOSYNTHESIS	Chromatin architecture determines transcriptional accessibility to DNA and consequently gene expression levels in response to developmental and environmental stimuli. Recently, chromatin remodelers such as SWI/SNF complexes have been recognized as key regulators of chromatin architecture. To gain insight into the function of these complexes during root development, we have analyzed Arabidopsis knock-down lines for one sub-unit of SWI/SNF complexes: BAF60. Here, we show that BAF60 is a positive regulator of root development and cell cycle progression in the root meristem via its ability to down-regulate cytokinin production. By opposing both the deposition of active histone marks and the formation of a chromatin regulatory loop, BAF60 negatively regulates two crucial target genes for cytokinin biosynthesis (IPT3 and IPT7) and one cell cycle inhibitor (KRP7). Our results demonstrate that SWI/SNF complexes containing BAF60 are key factors governing the equilibrium between formation and dissociation of a chromatin loop controlling phytohormone production and cell cycle progression.	[Jegu, Teddy; Domenichini, Severine; Bergounioux, Catherine; Raynaud, Cecile; Benhamed, Moussa] Univ Paris 11, CNRS, Inst Biol Plantes, UMR8618,Saclay Plant Sci, F-91405 Orsay, France; [Blein, Thomas; Ariel, Federico; Christ, Aurelie; Crespi, Martin] CNRS, Inst Sci Vegetal, UPR2355, Saclay Plant Sci, Gif Sur Yvette, France; [Kim, Soon-Kap; Hirt, Heribert; Benhamed, Moussa] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Boutet-Mercey, Stephanie; Mouille, Gregory] AgroParisTech, Inst Jean Pierre Bourgin, INRA, UMR1318, Versailles, France; [Bourge, Mickael] CNRS, IFR87, Ctr Rech Gif, Pole Biol Cellulaire,Imagif, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; King Abdullah University of Science & Technology; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Benhamed, M (corresponding author), Univ Paris 11, CNRS, Inst Biol Plantes, UMR8618,Saclay Plant Sci, F-91405 Orsay, France.	moussa.benhamed@u-psud.fr	Raynaud, Cécile/H-9711-2012; Ariel, Federico/AAU-6726-2020; Blein, Thomas/L-8508-2019; Crespi, Martin/AAB-1424-2020	Raynaud, Cécile/0000-0002-5231-8120; Ariel, Federico/0000-0001-8478-8808; Blein, Thomas/0000-0001-9788-5201; Crespi, Martin/0000-0002-5698-9482; Mouille, Gregory/0000-0002-5493-754X; Bourge, Mickael/0000-0002-4111-6208; Benhamed, Moussa/0000-0002-4181-1702; DOMENICHINI, Severine/0000-0002-5997-2694; Hirt, Heribert/0000-0003-3119-9633	LABEX Saclay Plant Sciences	LABEX Saclay Plant Sciences	This work was funded by LABEX Saclay Plant Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archacki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058588; Argueso CT, 2009, PLANT CELL ENVIRON, V32, P1147, DOI 10.1111/j.1365-3040.2009.01940.x; Ariel F, 2014, MOL CELL, V55, P383, DOI 10.1016/j.molcel.2014.06.011; Bork P, 1993, NUCLEIC ACIDS RES, V21, P1992; BOTTGER M, 1974, PLANTA, V121, P253, DOI 10.1007/BF00389325; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chang L, 2013, J EXP BOT, V64, P5021, DOI 10.1093/jxb/ert291; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Crane YM, 2007, P NATL ACAD SCI USA, V104, P15156, DOI 10.1073/pnas.0706986104; Crevillen P, 2013, EMBO J, V32, P140, DOI 10.1038/emboj.2012.324; Dello Ioio R, 2012, CURR BIOL, V22, P1699, DOI 10.1016/j.cub.2012.07.005; Dello Loio R, 2008, CURR OPIN PLANT BIOL, V11, P23, DOI 10.1016/j.pbi.2007.10.006; Efroni I, 2013, DEV CELL, V24, P438, DOI 10.1016/j.devcel.2013.01.019; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Jegu T, 2014, PLANT CELL, V26, P538, DOI 10.1105/tpc.113.114454; Jerzmanowski A, 2007, BBA-GENE STRUCT EXPR, V1769, P330, DOI 10.1016/j.bbaexp.2006.12.003; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kuderova A, 2008, PLANT CELL PHYSIOL, V49, P570, DOI 10.1093/pcp/pcn029; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Meagher RB, 2005, PLANT PHYSIOL, V139, P1576, DOI 10.1104/pp.105.072447; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Ni DA, 2009, NEW PHYTOL, V184, P311, DOI 10.1111/j.1469-8137.2009.02961.x; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Raynaud C, 2014, J EXP BOT, V65, P2677, DOI 10.1093/jxb/ert433; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sang Y, 2012, PLANT J, V72, P1000, DOI 10.1111/tpj.12009; Sarnowska EA, 2013, PLANT PHYSIOL, V163, P305, DOI 10.1104/pp.113.223933; Schaller GE, 2014, CURR OPIN PLANT BIOL, V21, P7, DOI 10.1016/j.pbi.2014.05.015; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Takahashi N, 2013, CURR BIOL, V23, P1812, DOI 10.1016/j.cub.2013.07.051; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; TORREY JG, 1959, PHYSIOL PLANTARUM, V12, P873, DOI 10.1111/j.1399-3054.1959.tb08922.x; TORREY JG, 1962, PHYSIOL PLANTARUM, V15, P177, DOI 10.1111/j.1399-3054.1962.tb07998.x; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Vercruyssen L, 2014, PLANT CELL, V26, P210, DOI 10.1105/tpc.113.115907; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Zhang WJ, 2013, CURR BIOL, V23, P1979, DOI 10.1016/j.cub.2013.08.008	51	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2015	10	10							e0138276	10.1371/journal.pone.0138276	http://dx.doi.org/10.1371/journal.pone.0138276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6YZ	26457678	Green Published, Green Submitted, gold			2022-12-26	WOS:000362961100004
J	Brobey, RK; German, D; Sonsalla, PK; Gurnani, P; Pastor, J; Hsieh, CC; Papaconstantinou, J; Foster, PP; Kuroo, M; Rosenblatt, KP				Brobey, Reynolds K.; German, Dwight; Sonsalla, Patricia K.; Gurnani, Prem; Pastor, Johanne; Hsieh, C-C; Papaconstantinou, John; Foster, Philip P.; Kuroo, Makoto; Rosenblatt, Kevin P.			Klotho Protects Dopaminergic Neuron Oxidant-Induced Degeneration by Modulating ASK1 and p38 MAPK Signaling Pathways	PLOS ONE			English	Article							OXIDATIVE STRESS; CELL-DEATH; GENE; SUPPRESSION; ACTIVATION; REGULATOR; KINASE; DAMAGE; MPTP; MICE	Klotho transgenic mice exhibit resistance to oxidative stress as measured by their urinal levels of 8-hydroxy-2-deoxyguanosine, albeit this anti-oxidant defense mechanism has not been locally investigated in the brain. Here, we tested the hypothesis that the reactive oxygen species (ROS)-sensitive apoptosis signal-regulating kinase 1 (ASK1)/p38 MAPK pathway regulates stress levels in the brain of these mice and showed that: 1) the ratio of free ASK1 to thioredoxin (Trx)-bound ASK1 is relatively lower in the transgenic brain whereas the reverse is true for the Klotho knockout mice; 2) the reduced p38 activation level in the transgene corresponds to higher level of ASK1-bound Trx, while the KO mice showed elevated p38 activation and lower level of-bound Trx; and 3) that 14-3-3. is hyper phosphorylated (Ser-58) in the transgene which correlated with increased monomer forms. In addition, we evaluated the in vivo robustness of the protection by challenging the brains of Klotho transgenic mice with a neurotoxin, MPTP and analyzed for residual neuron numbers and integrity in the substantia nigra pars compacta. Our results show that Klotho overexpression significantly protects dopaminergic neurons against oxidative damage, partly by modulating p38 MAPK activation level. Our data highlight the importance of ASK1/p38 MAPK pathway in the brain and identify Klotho as a possible anti-oxidant effector.	[Brobey, Reynolds K.; Foster, Philip P.; Rosenblatt, Kevin P.] UTHlth Med Sch, Brown Fdn Inst Mol Med, Ctr Prote & Syst Biol, Houston, TX 78229 USA; [Brobey, Reynolds K.] UTHlth Med Sch, Dept Internal Med, Div Oncol, Houston, TX USA; [German, Dwight; Pastor, Johanne] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Sonsalla, Patricia K.] UMDNJ Robert Wood Johnson Med Ctr, Dept Neurol, Piscataway, NJ USA; [Gurnani, Prem; Rosenblatt, Kevin P.] Compan Dx Reference Lab LLC, Houston, TX USA; [Hsieh, C-C; Papaconstantinou, John] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Foster, Philip P.] Univ Texas MD Anderson Canc Ctr, Dept NanoMed & Biomed Engn, Houston, TX 77030 USA; [Foster, Philip P.] Dept Internal Med, Div Pulm Med, Houston, TX USA; [Kuroo, Makoto] Univ Texas SW Med Ctr Dallas, Ctr Mineral Metab, Dept Pathol, Dallas, TX 75390 USA; [Kuroo, Makoto] Jichi Med Univ, Ctr Mol Med, Shimotsuke, Tochigi, Japan	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Jichi Medical University	Rosenblatt, KP (corresponding author), UTHlth Med Sch, Brown Fdn Inst Mol Med, Ctr Prote & Syst Biol, 1825 Pressler St, Houston, TX 78229 USA.	Kevin.Rosenblatt@uth.tmc.edu			National Heart, Lung and Blood Institute [HHSN268201000037C]; Levit Chair Fundation [70P-1-4116]; Welch Foundation [L-AU-0002];  [5UL1TR000371-07]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Levit Chair Fundation; Welch Foundation(The Welch Foundation); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding was provided by National Heart, Lung and Blood Institute grant no. HHSN268201000037C for KPR; Levit Chair Fundation grant no. 70P-1-4116 for KPR; Welch Foundation grant no. L-AU-0002 for RKB and KPR; Clinical Translational Sciences Awards grant no. 5UL1TR000371-07 for KPR.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Alfinito PD, 2003, J NEUROSCI, V23, P10982; Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Chateau MT, 2010, AGING-US, V2, P567, DOI 10.18632/aging.100195; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Espina V, 2005, CANCER INVEST, V23, P36, DOI 10.1081/CNV-200046434; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Fukui M, 2010, FREE RADICAL BIO MED, V48, P821, DOI 10.1016/j.freeradbiomed.2009.12.024; Geho David H, 2007, Methods Mol Biol, V374, P229; GERMAN DC, 1988, NEUROSCIENCE, V24, P161, DOI 10.1016/0306-4522(88)90320-X; GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x; German DC, 2000, NEUROSCIENCE, V101, P1063, DOI 10.1016/S0306-4522(00)00385-7; Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Mao XR, 2006, J BIOL CHEM, V281, P35863, DOI 10.1074/jbc.M604166200; PAPACONSTANTINOU J, 1994, ANN NY ACAD SCI, V719, P195, DOI 10.1111/j.1749-6632.1994.tb56829.x; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Saito H, 2001, J BIOL CHEM, V276, P29307, DOI 10.1074/jbc.M103740200; SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0; Suh YS, 2001, MECH AGEING DEV, V122, P1797, DOI 10.1016/S0047-6374(01)00301-3; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhou JB, 2009, MOL CELL BIOL, V29, P4167, DOI 10.1128/MCB.01067-08	36	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139914	10.1371/journal.pone.0139914	http://dx.doi.org/10.1371/journal.pone.0139914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452228	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200020
J	Furey, NB; Vincent, SP; Hinch, SG; Welch, DW				Furey, Nathan B.; Vincent, Stephen P.; Hinch, Scott G.; Welch, David W.			Variability in Migration Routes Influences Early Marine Survival of Juvenile Salmon Smolts	PLOS ONE			English	Article							RIVER SOCKEYE-SALMON; FRASER-RIVER; BRITISH-COLUMBIA; OCEAN MIGRATION; CHINOOK SALMON; PACIFIC SALMON; COHO SALMON; HABITAT USE; TRACKING; STRAIT	Variability in animal migratory behavior is expected to influence fitness, but few empirical examples demonstrating this relationship exist. The initial marine phase in the migration of juvenile salmon smolts has been identified as a potentially critical life history stage to overall population productivity, yet how fine-scale migration routes may influence survival are unknown. Large-scale acoustic telemetry studies have estimated survival rates of outmigrant Pacific salmon smolts through the Strait of Georgia (SOG) along the British Columbian coastline to the Pacific Ocean, but these data have not been used to identify and characterize fine-scale movements. Data collected on over 850 sockeye salmon (Oncorhynchus nerka) and steelhead (Oncorhynchus mykiss) smolts detected at an array in the Strait of Georgia in 2004-2008 and 2010-2013 were analyzed to characterize migration routes and link movements to subsequent survival at an array 250 km further along the marine migration pathway. Both species exhibited disproportionate use of the most eastern route in the Strait of Georgia (Malaspina Strait). While many smolts moved across the northern Strait of Georgia acoustic array with no indication of long-term milling or large-scale east-to-west movements, large proportions (20-40% of sockeye and 30-50% of steelhead) exhibited a different behavior, apparently moving in a westward or counterclockwise pattern. Variability in migratory behavior for both species was linked to subsequent survival through the Strait of Georgia. Survival for both species was influenced by initial east-to-west location, and sockeye were further influenced by migration timing and duration of time spent near the northern Strait of Georgia array. Westward movements result in a net transport of smolts from Malaspina Strait to the Strait of Georgia, particularly for steelhead. Counterclockwise movements may be due to the currents in this area during the time of outmigration, and the higher proportion of steelhead smolts exhibiting this counterclockwise behavior may reflect a greater exposure to wind-altered currents for the more surface-oriented steelhead. Our results provide an empirical example of how movements can affect migration survival, for which examples remain rare in movement ecology, confirming that variability in movements themselves are an important part of the migratory process.	[Furey, Nathan B.; Hinch, Scott G.] Univ British Columbia, Dept Forest & Conservat Sci, Pacific Salmon Ecol & Conservat Lab, Vancouver, BC V5Z 1M9, Canada; [Vincent, Stephen P.] Seymour Salmonid Soc, N Vancouver, BC, Canada; [Welch, David W.] Kintama Res Serv Ltd, Nanaimo, BC, Canada	University of British Columbia	Furey, NB (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Pacific Salmon Ecol & Conservat Lab, Vancouver, BC V5Z 1M9, Canada.	n.b.furey@gmail.com	Furey, Nathan/J-4862-2012	Furey, Nathan/0000-0002-8584-7889	Salish Sea Marine Survival Project (SSMSP) via the Pacific Salmon Foundation (PSF); Pacific Salmon Foundation; Pacific Salmon Commission; Canada Ocean Tracking Network (Natural Sciences and Engineering Research Council (NSERC); Dept. of Fisheries and Ocean Canada; British Columbia Habitat & Conservation Trust Fund; NSERC Discovery Grant; Gordon and Betty Moore Foundation; NSERC Vanier Graduate Scholarship; Kintama Research Services	Salish Sea Marine Survival Project (SSMSP) via the Pacific Salmon Foundation (PSF); Pacific Salmon Foundation; Pacific Salmon Commission; Canada Ocean Tracking Network (Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dept. of Fisheries and Ocean Canada; British Columbia Habitat & Conservation Trust Fund; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSERC Vanier Graduate Scholarship; Kintama Research Services	This work received funding from the Salish Sea Marine Survival Project (SSMSP) via the Pacific Salmon Foundation (PSF). Funding for the original telemetry studies that provided the data used in our analyses was provided by the Pacific Salmon Foundation, Pacific Salmon Commission, Canada Ocean Tracking Network (Natural Sciences and Engineering Research Council (NSERC), and the Canada Foundation for Innovation), Dept. of Fisheries and Ocean Canada, British Columbia Habitat & Conservation Trust Fund, and a NSERC Discovery Grant awarded to SGH. Initial funding for the construction of the POST prototype array components within the Salish Sea was provided by the Gordon and Betty Moore Foundation. Funding for NBF was provided by a NSERC Vanier Graduate Scholarship. Kintama Research Services provided support in the form of salary for DWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript apart from salary for DWW. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews KS, 2011, MAR BIOL, V158, P2377, DOI 10.1007/s00227-011-1724-5; [Anonymous], 2014, R LANG ENV STAT COMP; Balfry S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014779; Bauer S, 2009, BIOL LETTERS, V5, P433, DOI 10.1098/rsbl.2009.0324; Beacham TD, 2014, T AM FISH SOC, V143, P1386, DOI 10.1080/00028487.2014.935476; BEAMISH RJ, 1995, CAN J FISH AQUAT SCI, V52, P644, DOI 10.1139/f95-064; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; BEAMISH RJ, 1992, T AM FISH SOC, V121, P444, DOI 10.1577/1548-8659(1992)121<0444:SDPOCA>2.3.CO;2; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Beamish RJ, 2007, N PAC ANADROMOUS FIS, V7, P1; Beeman JW, 2006, T AM FISH SOC, V135, P584, DOI 10.1577/T05-193.1; Burgner R.L., 1991, P1; Burke BJ, 2014, AQUAT BIOL, V20, P77, DOI 10.3354/ab00541; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Byron CJ, 2014, REV FISH BIOL FISHER, V24, P737, DOI 10.1007/s11160-014-9343-0; Chaput G, 2005, ICES J MAR SCI, V62, P131, DOI 10.1016/j.icesjms.2004.10.006; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Cooke SJ, 2011, FISHERIES, V36, P583, DOI 10.1080/03632415.2011.633464; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crossin GT, 2009, PHYSIOL BIOCHEM ZOOL, V82, P635, DOI 10.1086/605878; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Dell M.B., 1986, B INT N PACIFIC FISH, V46, P1; Drenner SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031311; Espinoza M, 2011, FISH RES, V108, P364, DOI 10.1016/j.fishres.2011.01.011; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Foreman MGG, 2012, ATMOS OCEAN, V50, P301, DOI 10.1080/07055900.2012.686900; Furey NB, 2013, J FISH BIOL, V82, P1469, DOI 10.1111/jfb.12074; Gelman A, 2008, STAT MED, V2873; Gerbrandt N, 2013, THESIS S FRASER U; Groot C., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P53; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Healey M. C, 2000, FISH OCEANOGR, P29; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Hinch Scott G., 2006, Fish Physiology, V24, P239; Holyoak M, 2008, P NATL ACAD SCI USA, V105, P19060, DOI 10.1073/pnas.0800483105; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Irvine JR, 2013, MAR COAST FISH, V5, P303, DOI 10.1080/19425120.2013.831002; Jonzen N, 2011, ANIMAL MIGRATION: A SYNTHESIS, P91; Klimley AP, 1998, MAR TECHNOL SOC J, V32, P94; Lacroix GL, 2004, T AM FISH SOC, V133, P1455, DOI 10.1577/T03-032.1; Lemon J., 2006, R R NEWS; Li LB, 2013, PROG OCEANOGR, V115, P90, DOI 10.1016/j.pocean.2013.05.025; Lidgard DC, 2014, MAR ECOL PROG SER, V501, P157, DOI 10.3354/meps10670; Mackas D, 2013, PROG OCEANOGR, V115, P129, DOI 10.1016/j.pocean.2013.05.019; Mathes MT, 2010, CAN J FISH AQUAT SCI, V67, P70, DOI 10.1139/F09-158; McKinnell S, 2014, FISH OCEANOGR, V23, P322, DOI 10.1111/fog.12063; Mellone U, 2011, INT J BIOMETEOROL, V55, P463, DOI 10.1007/s00484-010-0368-3; Melnychuk MC, 2013, ENVIRON BIOL FISH, P325; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Melnychuk MC, 2014, CAN J FISH AQUAT SCI, V71, P831, DOI 10.1139/cjfas-2013-0165; Melnychuk MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012916; MilnerGulland EJ, 2011, ANIMAL MIGRATION: A SYNTHESIS, P1, DOI 10.1093/acprof:oso/9780199568994.001.0001; Mueller T, 2013, SCIENCE, V341, P999, DOI 10.1126/science.1237139; Mueter FJ, 2002, FISH OCEANOGR, V11, P205, DOI 10.1046/j.1365-2419.2002.00192.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; Osterback AMK, 2014, CAN J FISH AQUAT SCI, V71, P1877, DOI 10.1139/cjfas-2014-0097; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Peterman Randall M., 1994, Fisheries Oceanography, V3, P221, DOI 10.1111/j.1365-2419.1994.tb00100.x; Preikshot D, 2012, MAR COAST FISH, V4, P438, DOI 10.1080/19425120.2012.683235; Price MHH, 2013, T AM FISH SOC, V142, P1126, DOI 10.1080/00028487.2013.799517; Putman NF, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0169; Putman NF, 2014, CURR BIOL, V24, P446, DOI 10.1016/j.cub.2014.01.017; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinn TP, 2000, EVOLUTION, V54, P1372, DOI 10.1111/j.0014-3820.2000.tb00569.x; Ramanujan S., 1914, Q J MATH, V45, p[350, 23]; Rechisky EL, 2014, STATE PHYS BIOL SELE, P123; Ryding KE, 1999, CAN J FISH AQUAT SCI, V56, P2374, DOI 10.1139/cjfas-56-12-2374; Satterthwaite WH, 2014, MAR ECOL PROG SER, V511, P237, DOI 10.3354/meps10934; Scheuerell MD, 2009, J APPL ECOL, V46, P983, DOI 10.1111/j.1365-2664.2009.01693.x; STACEY MW, 1986, SCIENCE, V233, P470, DOI 10.1126/science.233.4762.470; Sverdrup K. A., 2009, INTRO WORLDS OCEANS; Thomson R. E., 1981, CAN SPEC PUBL FISH A, V56, P291; Thomson RE, 2014, STRAIT GEORGIA; Tucker S, 2009, T AM FISH SOC, V138, P1458, DOI 10.1577/T08-211.1; Welch DW, 2011, P NATL ACAD SCI USA, V108, P8708, DOI 10.1073/pnas.1014044108; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188	80	23	24	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0139269	10.1371/journal.pone.0139269	http://dx.doi.org/10.1371/journal.pone.0139269			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451837	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200008
J	Song, I; Patel, O; Himpe, E; Muller, CJF; Bouwens, L				Song, Imane; Patel, Oelfah; Himpe, Eddy; Muller, Christo J. F.; Bouwens, Luc			Beta Cell Mass Restoration in Alloxan-Diabetic Mice Treated with EGF and Gastrin	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; GLUCOSE-INFUSION; ALPHA-CELLS; ACINAR-CELL; B-CELLS; REGENERATION; INSULIN; DIFFERENTIATION; RATS; PROLIFERATION	One week of treatment with EGF and gastrin (EGF/G) was shown to restore normoglycemia and to induce islet regeneration in mice treated with the diabetogenic agent alloxan. The mechanisms underlying this regeneration are not fully understood. We performed genetic lineage tracing experiments to evaluate the contribution of beta cell neogenesis in this model. One day after alloxan administration, mice received EGF/G treatment for one week. The treatment could not prevent the initial alloxan-induced beta cell mass destruction, however it did reverse glycemia to control levels within one day, suggesting improved peripheral glucose uptake. In vitro experiments with C2C12 cell line showed that EGF could stimulate glucose uptake with an efficacy comparable to that of insulin. Subsequently, EGF/G treatment stimulated a 3-fold increase in beta cell mass, which was partially driven by neogenesis and beta cell proliferation as assessed by beta cell lineage tracing and BrdU-labeling experiments, respectively. Acinar cell lineage tracing failed to show an important contribution of acinar cells to the newly formed beta cells. No appearance of transitional cells co-expressing insulin and glucagon, a hallmark for alpha-to-beta cell conversion, was found, suggesting that alpha cells did not significantly contribute to the regeneration. An important fraction of the beta cells significantly lost insulin positivity after alloxan administration, which was restored to normal after one week of EGF/G treatment. Alloxan-only mice showed more pronounced beta cell neogenesis and proliferation, even though beta cellmass remained significantly depleted, suggesting ongoing beta cell death in that group. After one week, macrophage infiltration was significantly reduced in EGF/G-treated group compared to the alloxan-only group. Our results suggest that EGF/G-induced beta cell regeneration in alloxan-diabetic mice is driven by beta cell neogenesis, proliferation and recovery of insulin. The glucose-lowering effect of the treatment might play an important role in the regeneration process.	[Song, Imane; Himpe, Eddy; Bouwens, Luc] Free Univ Brussels, Vrije Univ Brussel, Cell Differentiat Lab, Brussels, Belgium; [Patel, Oelfah; Muller, Christo J. F.] South African Med Res Council, Diabet Discovery Platform, Tygerberg, South Africa	Universite Libre de Bruxelles; Vrije Universiteit Brussel; South African Medical Research Council	Song, I (corresponding author), Free Univ Brussels, Vrije Univ Brussel, Cell Differentiat Lab, Brussels, Belgium.	Imane.Song@vub.ac.be			Fund for Scientific Research-Flanders (FWO; Fonds Wetenschappelijk Onderzoek - Vlaanderen) [G003110N]	Fund for Scientific Research-Flanders (FWO; Fonds Wetenschappelijk Onderzoek - Vlaanderen)	This work was supported by Fund for Scientific Research-Flanders (FWO; Fonds Wetenschappelijk Onderzoek - Vlaanderen), URL: http://www.fwo.be/. Grant number: G003110N. Recipient: L.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELRAHMAN MS, 1992, TOXICOL LETT, V63, P155, DOI 10.1016/0378-4274(92)90007-7; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Brand SJ, 2002, PHARMACOL TOXICOL, V91, P414, DOI 10.1034/j.1600-0773.2002.910621.x; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Cras-Meneur C, 2001, DIABETES, V50, P1571, DOI 10.2337/diabetes.50.7.1571; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Ding L, 2013, DIABETES OBES METAB, V15, P98, DOI 10.1111/dom.12164; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gogg S, 2002, J BIOL CHEM, V277, P36045, DOI 10.1074/jbc.M200575200; INMAN WH, 1985, P NATL ACAD SCI USA, V82, P1346, DOI 10.1073/pnas.82.5.1346; ISHII K, 1994, BIOCHEM BIOPH RES CO, V205, P857, DOI 10.1006/bbrc.1994.2743; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Mathijs Iris, 2012, Methods Mol Biol, V933, P317, DOI 10.1007/978-1-62703-068-7_21; McCall M, 2014, SEMIN PEDIATR SURG, V23, P83, DOI 10.1053/j.sempedsurg.2014.03.006; Meier JJ, 2008, DIABETOLOGIA, V51, P703, DOI 10.1007/s00125-008-0936-9; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Rohilla A., 2012, INT J RES PHARM BIOM, V3, P819; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Song I, 2015, CURR DRUG TARGETS; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tellez N, 2011, ENDOCRINOLOGY, V152, P2580, DOI 10.1210/en.2011-0066; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Topp BB, 2004, DIABETOLOGIA, V47, P1602, DOI 10.1007/s00125-004-1493-5; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; VanEppsFung M, 1996, DIABETES, V45, P1619, DOI 10.2337/diabetes.45.11.1619; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Wang MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003835; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Yesil P, 2008, HISTOL HISTOPATHOL, V23, P883, DOI 10.14670/HH-23.883	37	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140148	10.1371/journal.pone.0140148	http://dx.doi.org/10.1371/journal.pone.0140148			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452142	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200043
J	Carrano, A; Das, P				Carrano, Anna; Das, Pritam			Altered Innate Immune and Glial Cell Responses to Inflammatory Stimuli in Amyloid Precursor Protein Knockout Mice	PLOS ONE			English	Article							BRAIN; ACTIVATION; EXPRESSION; INJURY; ALPHA; APP	Amyloid precursor protein (APP) and its cleaved products have been reported to have important functions in CNS health, including in memory and synapse formation, cell survival and neuroprotection. Furthermore APP and its cleaved products have been shown to be transiently increased in response to various CNS stressors, suggesting a role in response to acute cellular injury. In an attempt to further understand the function of APP in response to CNS injury, we have used intracranial LPS injection as an inflammatory injury model in APP knock out mice (APPKO). Our data show that innate immune responses to LPS injection is significantly blunted in APPKO mice compared to APP sufficient wild type (BL6) mice. Morphologically, glial cells in APPKO mice appear less reactive, with shorter ramified processes and smaller cell bodies in response to LPS. Additionally, quantitative RT-PCR analysis for several glia markers and innate immune cytokine levels (e.g. TNF alpha, IL-6, IL-1 beta and IL-10) showed significantly reduced expression levels in LPS injected APPKO mice. In vitro cell culture assays confirmed this attenuated response to LPS stimulation by primary microglial cells isolated from APPKO mice. Our data suggests that APP full length protein and/or its cleaved products are necessary to mount a complete and effective innate immune cell response to inflammatory injury.	[Carrano, Anna; Das, Pritam] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Das, P (corresponding author), Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA.	das.pritam@mayo.edu	Carrano, Anna/R-5592-2019	Carrano, Anna/0000-0002-6773-3108	Mayo Alzheimer's Disease Research Center Pilot grant, Mayo Clinic	Mayo Alzheimer's Disease Research Center Pilot grant, Mayo Clinic	AC: Mayo Alzheimer's Disease Research Center Pilot grant, Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin S. A., 2008, P13, DOI 10.1007/978-0-387-73894-9_2; Baiden-Amissah K, 1998, NEUROPATH APPL NEURO, V24, P346; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Bodles AM, 2005, NEUROBIOL AGING, V26, P9, DOI 10.1016/j.neurobiolaging.2004.02.022; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Koike MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042665; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Sondag CM, 2006, J NEUROCHEM, V97, P449, DOI 10.1111/j.1471-4159.2006.03759.x; Sondag CM, 2004, J BIOL CHEM, V279, P14456, DOI 10.1074/jbc.M313747200; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103	26	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140210	10.1371/journal.pone.0140210	http://dx.doi.org/10.1371/journal.pone.0140210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447481	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000105
J	Radko, S; Jung, R; Olanubi, O; Pelka, P				Radko, Sandi; Jung, Richard; Olanubi, Oladunni; Pelka, Peter			Effects of Adenovirus Type 5 E1A Isoforms on Viral Replication in Arrested Human Cells	PLOS ONE			English	Article							DNA-REPLICATION; MESSENGER-RNA; TRANSCRIPTION ACTIVATION; MONOCLONAL-ANTIBODIES; SIMIAN ADENOVIRUSES; SEQUENCE-ANALYSIS; BINDING PROTEIN; GENE-EXPRESSION; CYCLE; TRANSFORMATION	Human adenovirus has evolved to infect and replicate in terminally differentiated human epithelial cells, predominantly those within the airway, the gut, or the eye. To overcome the block to viral DNA replication present in these cells, the virus expresses the Early 1A proteins (E1A). These immediate early proteins drive cells into S-phase and induce expression of all other viral early genes. During infection, several E1A isoforms are expressed with proteins of 289, 243, 217, 171, and 55 residues being present for human adenovirus type 5. Here we examine the contribution that the two largest E1A isoforms make to the viral life cycle in growth-arrested normal human fibroblasts. Viruses that express E1A289R were found to replicate better than those that do not express this isoform. Importantly, induction of several viral genes was delayed in a virus expressing E1A243R, with several viral structural proteins undetectable by western blot. We also highlight the changes in E1A isoforms detected during the course of viral infection. Furthermore, we show that viral DNA replication occurs more efficiently, leading to higher number of viral genomes in cells infected with viruses that express E1A289R. Finally, induction of S-phase specific genes differs between viruses expressing different E1A isoforms, with those having E1A289R leading to, generally, earlier activation of these genes. Overall, we provide an overview of adenovirus replication using modern molecular biology approaches and further insights into the contribution that E1A isoforms make to the life cycle of human adenovirus in arrested human fibroblasts.	[Radko, Sandi; Jung, Richard; Olanubi, Oladunni; Pelka, Peter] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Pelka, P (corresponding author), Univ Manitoba, Dept Microbiol, 45 Chancellors Circle,Buller Bldg Room 427, Winnipeg, MB R3T 2N2, Canada.	peter.pelka@umanitoba.ca		Radko-Juettner, Sandi/0000-0002-6969-5184	Natural Sciences and Engineering Research Council [RGPIN/435375-2013]; Research Manitoba (MHRC Establishment Grant)	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Research Manitoba (MHRC Establishment Grant)	This work was supported by Natural Sciences and Engineering Research Council (Grant number: RGPIN/435375-2013, http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/index_eng.asp) and Research Manitoba (MHRC Establishment Grant, http://mhrc.mb.ca) to PP.	Avvakumov N, 2004, VIROLOGY, V329, P477, DOI 10.1016/j.virol.2004.08.007; Avvakumov N, 2002, J VIROL, V76, P7968, DOI 10.1128/JVI.76.16.7968-7975.2002; BELLETT AJD, 1985, MOL CELL BIOL, V5, P1933, DOI 10.1128/MCB.5.8.1933; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Bruton RK, 2008, J VIROL, V82, P8476, DOI 10.1128/JVI.00248-08; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; Conboy CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001061; DERY CV, 1987, ONCOGENE, V2, P15; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Ferrari R, 2012, GENOME RES, V22, P1212, DOI 10.1101/gr.132308.111; HALEY KP, 1984, P NATL ACAD SCI-BIOL, V81, P5734, DOI 10.1073/pnas.81.18.5734; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; HAYFLICK L, 1962, AM J HYG, V75, P240, DOI 10.1093/oxfordjournals.aje.a120247; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; KIMELMAN D, 1985, J VIROL, V53, P399, DOI 10.1128/JVI.53.2.399-409.1985; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Lee BH, 1997, P NATL ACAD SCI USA, V94, P4481, DOI 10.1073/pnas.94.9.4481; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Malladi A, 1997, VIROLOGY, V233, P51, DOI 10.1006/viro.1997.8605; Manthei KA, 2013, CELL MOL LIFE SCI, V70, P4067, DOI 10.1007/s00018-013-1325-1; Miller DL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r58; Miller MS, 2012, J VIROL, V86, P4222, DOI 10.1128/JVI.06399-11; MONTELL C, 1982, NATURE, V295, P380, DOI 10.1038/295380a0; MYMRYK JS, 1993, J GEN VIROL, V74, P2131, DOI 10.1099/0022-1317-74-10-2131; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; Ou HD, 2012, CELL, V151, P304, DOI 10.1016/j.cell.2012.08.035; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Pelka P, 2011, J VIROL, V85, P8841, DOI 10.1128/JVI.00539-11; Pelka P, 2009, NUCLEIC ACIDS RES, V37, P1095, DOI 10.1093/nar/gkn1057; Pelka P, 2009, VIROLOGY, V391, P90, DOI 10.1016/j.virol.2009.05.024; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radko S, 2014, J VIROL, V88, P13469, DOI 10.1128/JVI.02538-14; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Schaley JE, 2005, J VIROL, V79, P2301, DOI 10.1128/JVI.79.4.2301-2308.2005; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; SPINDLER KR, 1985, J VIROL, V53, P742, DOI 10.1128/JVI.53.3.742-750.1985; STEPHENS C, 1987, EMBO J, V6, P2027, DOI 10.1002/j.1460-2075.1987.tb02467.x; Tiainen M, 1996, MOL CELL BIOL, V16, P5302; ULFENDAHL PJ, 1987, EMBO J, V6, P2037, DOI 10.1002/j.1460-2075.1987.tb02468.x; VANORMONDT H, 1980, GENE, V11, P299, DOI 10.1016/0378-1119(80)90070-0; WINBERG G, 1984, EMBO J, V3, P1907, DOI 10.1002/j.1460-2075.1984.tb02066.x	49	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140124	10.1371/journal.pone.0140124	http://dx.doi.org/10.1371/journal.pone.0140124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448631	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000093
J	Bao, ZK; Gao, X; Zhang, Q; Lin, J; Hu, WW; Yu, HQ; Chen, JQ; Yang, Q; Yu, QH				Bao, Zekun; Gao, Xue; Zhang, Qiang; Lin, Jian; Hu, Weiwei; Yu, Huiqing; Chen, Jianquan; Yang, Qian; Yu, Qinghua			The Effects of GH Transgenic Goats on the Microflora of the Intestine, Feces and Surrounding Soil	PLOS ONE			English	Article							GENE-TRANSFER; ANTIBIOTIC-RESISTANCE; MOUSE MODEL; PIGS; MICROBIOTA; BACTERIA; OOCYTES; PLANTS; FOOD	The development of genetically engineered animals has brought with it increasing concerns about biosafety issues. We therefore evaluated the risks of growth hormone from transgenic goats, including the probability of horizontal gene transfer and the impact on the microbial community of the goats' gastrointestinal tracts, feces and the surrounding soil. The results showed that neither the GH nor the neoR gene could be detected in the samples. Moreover, there was no significant change in the microbial community of the gastrointestinal tracts, feces and soil, as tested with PCR-denaturing gradient gel electrophoresis and 16S rDNA sequencing. Finally, phylogenetic analysis showed that the intestinal content, feces and soil samples all contained the same dominant group of bacteria. These results demonstrated that expression of goat growth hormone in the mammary of GH transgenic goat does not influence the microflora of the intestine, feces and surrounding soil.	[Bao, Zekun; Gao, Xue; Zhang, Qiang; Lin, Jian; Hu, Weiwei; Yang, Qian; Yu, Qinghua] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Yu, Huiqing; Chen, Jianquan] Shanghai Transgen Res Ctr, Shanghai 201210, Peoples R China	Nanjing Agricultural University	Yu, QH (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	yuqinghua1981@163.com	yu, qing/HGC-4611-2022; Yu, Qinghua/T-3261-2019		National Animal Transgenic Breeding Grand Project [2013ZX08008-004, 2014ZX08008-004]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Animal Transgenic Breeding Grand Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Animal Transgenic Breeding Grand Project (No. 2013ZX08008-004 and 2014ZX08008-004) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Bakke I, 2011, J MICROBIOL METH, V84, P349, DOI 10.1016/j.mimet.2010.12.015; Cabot RA, 2001, ANIM BIOTECHNOL, V12, P205, DOI 10.1081/ABIO-100108347; Chan AWS, 1998, P NATL ACAD SCI USA, V95, P14028, DOI 10.1073/pnas.95.24.14028; Degnan SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00638; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; EBERT KM, 1991, BIO-TECHNOL, V9, P835, DOI 10.1038/nbt0991-835; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Kay E, 2002, APPL ENVIRON MICROB, V68, P3345, DOI 10.1128/AEM.68.7.3345-3351.2002; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P978, DOI 10.1016/j.fct.2008.06.012; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Mathur S, 2005, INT J FOOD MICROBIOL, V105, P281, DOI 10.1016/j.ijfoodmicro.2005.03.008; Metzler BU, 2008, ASIAN AUSTRAL J ANIM, V21, P603, DOI 10.5713/ajas.2008.r.03; Quigley Eamonn M M, 2013, Gastroenterol Hepatol (N Y), V9, P560; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; van den Eede G, 2004, FOOD CHEM TOXICOL, V42, P1127, DOI 10.1016/j.fct.2004.02.001; Van Reenen CG, 2001, J ANIM SCI, V79, P1763; Zeng BH, 2013, CURR MICROBIOL, V67, P313, DOI 10.1007/s00284-013-0360-3; Zhang Q, 2015, GENET MOL RES, V14, P2006, DOI 10.4238/2015.March.20.10; Zhang Q, 2014, MOL BIOL REP, V41, P4759, DOI 10.1007/s11033-014-3347-7	20	2	2	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139822	10.1371/journal.pone.0139822	http://dx.doi.org/10.1371/journal.pone.0139822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445136	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600086
J	Chandrika, BB; Yang, C; Ou, Y; Feng, XK; Muhoza, D; Holmes, AF; Theus, S; Deshmukh, S; Haun, RS; Kaushal, GP				Chandrika, Bhavya B.; Yang, Cheng; Ou, Yang; Feng, Xiaoke; Muhoza, Djamali; Holmes, Alexandrea F.; Theus, Sue; Deshmukh, Sarika; Haun, Randy S.; Kaushal, Gur P.			Endoplasmic Reticulum Stress-Induced Autophagy Provides Cytoprotection from Chemical Hypoxia and Oxidant Injury and Ameliorates Renal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ACUTE KIDNEY INJURY; CELL-DEATH; EPITHELIAL-CELLS; SIGNALING PATHWAYS; PROXIMAL TUBULE; IN-VITRO; ACTIVATION; CYTOTOXICITY; INHIBITION	We examined whether endoplasmic reticulum (ER) stress-induced autophagy provides cytoprotection from renal tubular epithelial cell injury due to oxidants and chemical hypoxia in vitro, as well as from ischemia-reperfusion (IR) injury in vivo. We demonstrate that the ER stress inducer tunicamycin triggers an unfolded protein response, upregulates ER chaperone Grp78, and activates the autophagy pathway in renal tubular epithelial cells in culture. Inhibition of ER stress-induced autophagy accelerated caspase-3 activation and cell death suggesting a pro-survival role of ER stress-induced autophagy. Compared to wild-type cells, autophagy-deficient MEFs subjected to ER stress had enhanced caspase-3 activation and cell death, a finding that further supports the cytoprotective role of ER stress-induced autophagy. Induction of autophagy by ER stress markedly afforded cytoprotection from oxidants H2O2 and tert-Butyl hydroperoxide and from chemical hypoxia induced by antimycin A. In contrast, inhibition of ER stress-induced autophagy or autophagy-deficient cells markedly enhanced cell death in response to oxidant injury and chemical hypoxia. In mouse kidney, similarly to renal epithelial cells in culture, tunicamycin triggered ER stress, markedly upregulated Grp78, and activated autophagy without impairing the autophagic flux. In addition, ER stress-induced autophagy markedly ameliorated renal IR injury as evident from significant improvement in renal function and histology. Inhibition of autophagy by chloroquine markedly increased renal IR injury. These studies highlight beneficial impact of ER stress-induced autophagy in renal ischemia-reperfusion injury both in vitro and in vivo.	[Chandrika, Bhavya B.; Yang, Cheng; Ou, Yang; Muhoza, Djamali; Deshmukh, Sarika; Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA; [Feng, Xiaoke; Haun, Randy S.] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Holmes, Alexandrea F.; Theus, Sue; Haun, Randy S.; Kaushal, Gur P.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Kaushal, GP (corresponding author), Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA.	Kaushalgurp@uams.edu	Muhoza, Djamali/AAE-6111-2022	Muhoza, Djamali/0000-0002-3480-335X	National Institutes of Health [R01DK081690]; VA Merit Award [BX000444, BX000828]; Translational Research Institute through the NIH National Center for Advancing Translational Sciences [UL1TR000039];  [T32DK061921]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061921, R01DK081690] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); Translational Research Institute through the NIH National Center for Advancing Translational Sciences; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grant R01DK081690, VA Merit Award BX000444 to GPK and VA Merit Award BX000828 to RSH, and Translational Research Institute grant UL1TR000039 through the NIH National Center for Advancing Translational Sciences. Sarika Deshmukh was a recipient of fellowship from T32DK061921 grant for training program in the pathophysiology of renal disease.	Arany I, 2004, KIDNEY INT, V65, P1231, DOI 10.1111/j.1523-1755.2004.00500.x; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bush KT, 1999, AM J PHYSIOL-RENAL, V277, pF211, DOI 10.1152/ajprenal.1999.277.2.F211; Choi CH, 2010, MOL PHARMACOL, V78, P114, DOI 10.1124/mol.110.063495; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; Csordas A, 2011, CARDIOVASC RES, V92, P141, DOI 10.1093/cvr/cvr165; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Filipovic DM, 1999, AM J PHYSIOL-RENAL, V277, pF428, DOI 10.1152/ajprenal.1999.277.3.F428; Garcia-Navas R, 2012, AUTOPHAGY, V8, P1557, DOI 10.4161/auto.21315; GAUDIO KM, 1986, AM J PHYSIOL, V251, pF603, DOI 10.1152/ajprenal.1986.251.4.F603; George SK, 2004, BIOCHEM BIOPH RES CO, V322, P223, DOI 10.1016/j.bbrc.2004.07.097; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gray MD, 2005, MOL PHARMACOL, V68, P1699, DOI 10.1124/mol.105.014753; Hara H, 2011, NEUROCHEM INT, V58, P35, DOI 10.1016/j.neuint.2010.10.006; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Hwang MS, 2010, BIOCHEM BIOPH RES CO, V399, P111, DOI 10.1016/j.bbrc.2010.07.050; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Johnson K J, 1993, Curr Opin Nephrol Hypertens, V2, P625, DOI 10.1097/00041552-199307000-00014; Kaushal GP, 2001, KIDNEY INT, V60, P1726, DOI 10.1046/j.1523-1755.2001.00026.x; Kawakami T, 2009, NEPHROL DIAL TRANSPL, V24, P2665, DOI 10.1093/ndt/gfp215; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Liu H, 1998, J BIOL CHEM, V273, P12858, DOI 10.1074/jbc.273.21.12858; Liu SY, 2012, AUTOPHAGY, V8, P826, DOI 10.4161/auto.19419; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oh SH, 2009, J PHARMACOL EXP THER, V329, P112, DOI 10.1124/jpet.108.144113; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Peyrou M, 2007, TOXICOL IN VITRO, V21, P878, DOI 10.1016/j.tiv.2007.03.001; Prachasilchai W, 2008, EUR J PHARMACOL, V592, P138, DOI 10.1016/j.ejphar.2008.06.108; Prachasilchai W, 2009, J PHARMACOL SCI, V109, P311, DOI 10.1254/jphs.08272SC; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Suh DH, 2012, ANN NY ACAD SCI, V1271, P20, DOI 10.1111/j.1749-6632.2012.06739.x; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Walker PD, 1998, KIDNEY INT, V53, P1673, DOI 10.1046/j.1523-1755.1998.00949.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu Y, 2012, CANCER LETT, V314, P232, DOI 10.1016/j.canlet.2011.09.034; Yang PM, 2010, CANCER RES, V70, P7699, DOI 10.1158/0008-5472.CAN-10-1626; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zhong JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039378	66	56	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140025	10.1371/journal.pone.0140025	http://dx.doi.org/10.1371/journal.pone.0140025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444017	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600127
J	Franzen, JL; Aurich, C; Habersetzer, J				Franzen, Jens Lorenz; Aurich, Christine; Habersetzer, Joerg			Description of a Well Preserved Fetus of the European Eocene Equoid Eurohippus messelensis	PLOS ONE			English	Article							MIDDLE	The early Middle Eocene locality of Grube Messel, near Darmstadt (Germany), is famous for its complete vertebrate skeletons. The degree of preservation of soft tissues, such as body silhouettes, internal organs and gut contents, is frequently remarkable. The present specimen was analyzed for remnants of the reproductive system. Classic anatomy and osteology and high-resolution micro-x-ray were applied to describe the fetus of the European Eocene equoid Eurohippus messelensis. Scanning electronic microscopy (SEM) was used for determination of soft tissue remnants. The fetus is the earliest and best-preserved fossil specimen of its kind. The postcranial fetal skeleton is almost complete and largely articulated, allowing the conclusion that the pregnant mare was in late gestation. The apparent intrauterine position of the fetus is normal for the phase of pregnancy. Death of mare and fetus were probably not related to problems associated with parturition. Soft tissue interpreted as the uteroplacenta and a broad uterine ligament are preserved due to bacterial activity and allow considerations on the evolutionary development of the structures.	[Franzen, Jens Lorenz; Habersetzer, Joerg] Senckenberg Forschungsinst Frankfurt, Dept Messelforsch, Frankfurt, Germany; [Franzen, Jens Lorenz] Nat Hist Museum Basel, Dept Geowissensch, Basel, Switzerland; [Aurich, Christine] Vet Med Univ Wien, Dept Univklin Kleintiere & Pferde, Vienna, Austria	Senckenberg Gesellschaft fur Naturforschung (SGN); University of Veterinary Medicine Vienna	Franzen, JL (corresponding author), Senckenberg Forschungsinst Frankfurt, Dept Messelforsch, Frankfurt, Germany.	jfranzen@senckenberg.de						Ackermann M., 1992, MESSEL INSIGHT HIST, P277; ADAMS R, 1988, VET RADIOLOGY, V29, P217, DOI 10.1111/j.1740-8261.1988.tb01503.x; Benesch F, 1957, LEHRBUCH TIERARZTLIC; BOHNER J, 1984, Z SAUGETIERKD, V49, P306; Cameron E.Z., 2001, SCIENCE, V171, P1173; Carter AM, 2008, PLACENTA, V29, P930, DOI 10.1016/j.placenta.2008.07.012; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Franzen J. L., 2007, URPFERDE MORGENROTE; FRANZEN J. L., 1985, P ROY SOC LOND B BIO, V311, P181, DOI [10.1098/Rstb.1985.0150, DOI 10.1098/RSTB.1985.0150]; Franzen Jens Lorenz, 2006, Senckenbergiana Lethaea, V86, P97; Franzen JL, 2006, PALAEONTOGR ABT A, V278, P27, DOI 10.1127/pala/278/2006/27; Franzen Jens Lorenz, 2007, Schweizerische Palaeontologische Abhandlungen, V127, P1; Franzen JL., 2010, RISE HORSES 55 MILLI; Ginther OJ., 1992, REPROD BIOL MARE; Harms F-J, 2001, NAT MUS, V131, P303; Hellmund Meinolf, 2000, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie Beiheft, V12, P1; Jeffcott L B, 1979, J Reprod Fertil Suppl, P563; Koenigswald Wighart V., 2004, Palaeontologische Zeitschrift, V78, P417; MACDONALD D, 2006, NEW ENCY MAMMALS; Maier A, 2000, THESIS; Preuschoft Holger, 2012, Palaeobiodiversity Palaeoenvironments, V92, P459, DOI 10.1007/s12549-012-0103-7; Russe I., 1993, TIERGEBURTSHILFE, V4, P29; Savage DE, 1983, MAMMALIAN PALEOFAUNA; Schlafer D. H., 2004, Proceedings of the 50th Annual Convention of the American Association of Equine Practitioners, Denver, Colorado, USA, 4-8 December, 2004, P144; Senger P.L., 2003, PATHWAYS PREGNANCY P, V2nd; Taverne MA, 2009, VET REPROD OBSTET, P154; von Koenigswald W, 1987, FOSSILIEN MESSEL FOR, P71; WUTTKE M, 1983, Senckenbergiana Lethaea, V64, P509; Wuttke M, 1992, BEHAV BIOGENIC MAT F, V24, P263	29	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137985	10.1371/journal.pone.0137985	http://dx.doi.org/10.1371/journal.pone.0137985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445456	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600017
J	Nadzirah, S; Azizah, N; Hashim, U; Gopinath, SCB; Kashif, M				Nadzirah, Sh.; Azizah, N.; Hashim, Uda; Gopinath, Subash C. B.; Kashif, Mohd			Titanium Dioxide Nanoparticle-Based Interdigitated Electrodes: A Novel Current to Voltage DNA Biosensor Recognizes E. coli O157:H7	PLOS ONE			English	Article							GOLD NANOPARTICLES; TIO2 NANOPARTICLES; OPTICAL-PROPERTIES; ANATASE; TEMPERATURE; O157-H7; SURFACE; FUNCTIONALIZATION; IMMUNOSENSOR; EVOLUTION	Nanoparticle-mediated bio-sensing promoted the development of novel sensors in the front of medical diagnosis. In the present study, we have generated and examined the potential of titanium dioxide (TiO2) crystalline nanoparticles with aluminium interdigitated electrode biosensor to specifically detect single-stranded E. coli O157:H7 DNA. The performance of this novel DNA biosensor was measured the electrical current response using a picoammeter. The sensor surface was chemically functionalized with (3-aminopropyl) triethoxysilane (APTES) to provide contact between the organic and inorganic surfaces of a single-stranded DNA probe and TiO2 nanoparticles while maintaining the sensing system's physical characteristics. The complement of the target DNA of E. coli O157: H7 to the carboxylate-probe DNA could be translated into electrical signals and confirmed by the increased conductivity in the current-to-voltage curves. The specificity experiments indicate that the biosensor can discriminate between the complementary sequences from the base-mismatched and the non-complementary sequences. After duplex formation, the complementary target sequence can be quantified over a wide range with a detection limit of 1.0 x 10(-13)M. With target DNA from the lysed E. coli O157:H7, we could attain similar sensitivity. Stability of DNA immobilized surface was calculated with the relative standard deviation (4.6%), displayed the retaining with 99% of its original response current until 6 months. This high-performance interdigitated DNA biosensor with high sensitivity, stability and non-fouling on a novel sensing platform is suitable for a wide range of biomolecular interactive analyses.	[Nadzirah, Sh.; Azizah, N.; Hashim, Uda; Gopinath, Subash C. B.] Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar 01000, Perlis, Malaysia; [Kashif, Mohd] Univ Malaysia Sarawak, Fac Engn, Dept Elect & Elect Engn, Kota Samarahan 94300, Sarawak, Malaysia	Universiti Malaysia Perlis; University of Malaysia Sarawak	Hashim, U (corresponding author), Univ Malaysia Perlis, Inst Nano Elect Engn, Kangar 01000, Perlis, Malaysia.	uda@unimap.edu.my	Nadzirah, Sharipah/N-9696-2015; Parmin, Nor Azizah/S-6303-2019; Kashif, Muhammad/AAX-8659-2020; Gopinath, Subash/D-2953-2015	Nadzirah, Sharipah/0000-0001-8458-9390; Parmin, Nor Azizah/0000-0002-4919-4550; Kashif, Muhammad/0000-0002-9874-0992; Gopinath, Subash/0000-0002-8347-4687	Geran COEMTUN Grant [9016-00004]	Geran COEMTUN Grant	This study was supported by Geran COEMTUN Grant (number 9016-00004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2015, BIOSENS BIOELECTRON, V67, P656, DOI 10.1016/j.bios.2014.10.005; Ali ME, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/19/195503; Ali M. E., 2011, J NANOMATER, V2011, P32; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Bahsi ZB, 2009, SENSORS-BASEL, V9, P4890, DOI 10.3390/s90604890; Buzby JC, BACTERIAL FOODBORNE; Castro AL, 2008, SOLID STATE SCI, V10, P602, DOI 10.1016/j.solidstatesciences.2007.10.012; Ding YT, 2013, ELECTROCHIM ACTA, V106, P35, DOI 10.1016/j.electacta.2013.05.066; Dou WC, 2013, ELECTROCHIM ACTA, V97, P79, DOI 10.1016/j.electacta.2013.02.136; Foster G, 2003, J APPL MICROBIOL, V95, P155, DOI 10.1046/j.1365-2672.2003.01955.x; Fujimaki M, 2010, OPT EXPRESS, V18, P9; Gopinath SCB, 2014, BIOSENS BIOELECTRON, V60, P332, DOI 10.1016/j.bios.2014.04.014; Gopinath SCB, 2012, ANALYST, V137, P3520, DOI 10.1039/c2an35159e; Gopinath SCB, 2011, SENSOR ACTUAT B-CHEM, V155, P239, DOI 10.1016/j.snb.2010.11.054; Gopinath SCS, 2009, ANAL CHEM, V81, P4963, DOI 10.1021/ac802757z; Ladik A, 2010, NANOSCAPE, V7, P5; Lakshmipriya T, 2013, LANGMUIR, V29, P15107, DOI 10.1021/la4027283; Li K, 2011, TALANTA, V84, P607, DOI 10.1016/j.talanta.2010.12.042; Li Y, 2014, IMPEDANCE BASED DETE, P193; Li Y, 2012, ANAL BIOCHEM, V421, P227, DOI 10.1016/j.ab.2011.10.049; Lin H, 2006, APPL CATAL B-ENVIRON, V68, P1, DOI 10.1016/j.apcatb.2006.07.018; Lin YH, 2008, BIOSENS BIOELECTRON, V23, P1832, DOI 10.1016/j.bios.2008.02.030; Luo CH, 2013, BIOSENS BIOELECTRON, V48, P132, DOI 10.1016/j.bios.2013.03.084; Mao XL, 2006, BIOSENS BIOELECTRON, V21, P1178, DOI 10.1016/j.bios.2005.04.021; Moran LA, 2011, PRINCIPLES BIOCH; Nadzirah S, 2013, IEEE REG S MICR NAN; Niu SY, 2013, SENSOR ACTUAT B-CHEM, V176, P58, DOI 10.1016/j.snb.2012.08.085; Nomura K-i, 2013, NAT COMMUN, P4; Oda M, 2004, APPL ENVIRON MICROB, V70, P527, DOI 10.1128/AEM.70.1.527-534.2004; Ohama Y., 2011, APPL TITANIUM DIOXID; Rao BM, 2014, RSC ADV, V4, P38133, DOI 10.1039/c4ra05882h; Redondo-Marugan J, 2013, SENSOR ACTUAT B-CHEM, V182, P307, DOI 10.1016/j.snb.2013.03.025; Shi XH, 2014, MICROCHIM ACTA, V181, P1, DOI 10.1007/s00604-013-1069-5; Solanki PR, 2011, NPG ASIA MATER, V3, P17, DOI 10.1038/asiamat.2010.137; Song S-H, 2002, MAT SCI ENG B, V94; Sperling RA, 2010, PHILOS T R SOC A, V368, P1333, DOI 10.1098/rsta.2009.0273; Sun Y., 2005, DEP PHSY ASTRONOMY, P1; Uyttendaele M, 1999, INT J FOOD MICROBIOL, V52, P85, DOI 10.1016/S0168-1605(99)00132-4; Vyas S, 2015, SUPERLATTICE MICROST, V80, P215, DOI 10.1016/j.spmi.2014.10.029; Wang LJ, 2009, TALANTA, V78, P647, DOI 10.1016/j.talanta.2008.12.001; Wang SF, 2006, CERAM INT, V32, P121, DOI 10.1016/j.ceramint.2005.01.010; Wetchakun N, 2012, MATER LETT, V82, P195, DOI 10.1016/j.matlet.2012.05.092; Wu JS, 2011, J MATER RES, V26, P1646, DOI 10.1557/jmr.2011.190; Wu VCH, 2007, BIOSENS BIOELECTRON, V22, P2967, DOI 10.1016/j.bios.2006.12.016; Yuan YJ, 2011, OPT ENG, V50, DOI 10.1117/1.3554392	45	43	43	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139766	10.1371/journal.pone.0139766	http://dx.doi.org/10.1371/journal.pone.0139766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445455	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000362510600077
J	Polet, DT; Flynn, MR; Sperling, FAH				Polet, Delyle T.; Flynn, Morris R.; Sperling, Felix A. H.			A Mathematical Model to Capture Complex Microstructure Orientation on Insect Wings	PLOS ONE			English	Article							SURFACES; DROSOPHILA; POLARITY; DESIGN	Microstructures on insect wings can promote directional drop shedding, and the local orientation of these structures is expected to facilitate drop removal. However, microstructures may exhibit very different orientations at different locations on the wing. Using the march fly Penthetria heteroptera, we propose that local orientation of small hairs (microtrichia) reflects a balance of three nonexclusive strategies: (1) preventing water from becoming stuck in intervenous grooves (microtrichia point upslope), (2) shedding water off the wing as readily as possible (microtrichia point towards the nearest edge), and, (3) shedding water away from the body (microtrichia point distally). We present evidence for all three and show that local microtrichial orientation is seldom determined by any one factor. We develop a mathematical model that employs factor-specific weighting values determined via optimization. Our predictions are tested against the orientation of microtrichia randomly sampled from a P. heteroptera specimen. Using the best-fit weighting parameters, the model displays a median residual of 20 degrees; no residual is greater than 46 degrees. The model also reproduces qualitative aspects of microtrichial orientation, such as bifurcation midway between veins and convergence toward peaks. This strong correspondence between modelled and observed orientation supports the role of microtrichia as directional antiwetting devices and highlights the importance of considering both function and wing geometry to explain the organization of natural microstructure arrays.	[Polet, Delyle T.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Polet, Delyle T.; Sperling, Felix A. H.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Flynn, Morris R.] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada; [Flynn, Morris R.] Univ Alberta, Inst Appl Math, Edmonton, AB, Canada	University of Calgary; University of Alberta; University of Alberta; University of Alberta	Polet, DT (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	dtpolet@ucalgary.ca	Polet, Delyle/ABA-8748-2020; Sperling, Felix/H-8376-2012	Polet, Delyle/0000-0002-8299-3434; Flynn, Morris/0000-0002-7559-9463; Sperling, Felix/0000-0001-5148-4226	FAHS; Natural Sciences and Engineering Research Council of Canada granted a USRA; Natural Sciences and Engineering Research Council of Canada granted a CGS-D	FAHS; Natural Sciences and Engineering Research Council of Canada granted a USRA; Natural Sciences and Engineering Research Council of Canada granted a CGS-D	The Natural Sciences and Engineering Research Council of Canada granted a USRA and CGS-D to DTP, and Discovery Grants to MRF and FAHS. The URL for this funder's website is: http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER PN, 1987, DEV GENET, V8, P99, DOI 10.1002/dvg.1020080206; Byun D, 2009, J BIONIC ENG, V6, P63, DOI 10.1016/S1672-6529(08)60092-X; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Hancock MJ, 2012, ADV FUNCT MATER, V22, P2223, DOI 10.1002/adfm.201103017; Hardy DE, 1981, MANUAL NEARCTIC DIPT, V1, P217; Hogan J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001305; Hu HMS, 2011, J EXP BIOL, V214, P915, DOI 10.1242/jeb.051128; Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x; Nishimoto S, 2013, RSC ADV, V3, P671, DOI 10.1039/c2ra21260a; NORBERG RA, 1972, J COMP PHYSIOL, V81, P9; Prakash M, 2011, INT J NONLIN MECH, V46, P607, DOI 10.1016/j.ijnonlinmec.2010.12.003; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; REES CJC, 1975, NATURE, V256, P200, DOI 10.1038/256200a0; Tsuyuki K, 2006, J INTEL MAT SYST STR, V17, P743, DOI 10.1177/1045389X06055767; Valentine M, 2011, FLY, V5, P316, DOI 10.4161/fly.5.4.15836; Watson GS, 2010, ACS NANO, V4, P129, DOI 10.1021/nn900869b; Wisdom KM, 2013, P NATL ACAD SCI USA, V110, P7992, DOI 10.1073/pnas.1210770110; Zheng YM, 2007, SOFT MATTER, V3, P178, DOI 10.1039/b612667g	19	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138282	10.1371/journal.pone.0138282	http://dx.doi.org/10.1371/journal.pone.0138282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444908	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600024
J	Shaw, RF; Johnson, PJ; Macdonald, DW; Feber, RE				Shaw, Rosalind F.; Johnson, Paul J.; Macdonald, David W.; Feber, Ruth E.			Enhancing the Biodiversity of Ditches in Intensively Managed UK Farmland	PLOS ONE			English	Article							AGRICULTURAL DRAINAGE DITCHES; AGRI-ENVIRONMENT SCHEMES; PLANT-SPECIES RICHNESS; CONSERVATION VALUE; SEMINATURAL HABITATS; AQUATIC HABITATS; ARABLE FENLAND; LANDSCAPE; VEGETATION; DIVERSITY	Drainage ditches, either seasonally flooded or permanent, are commonly found on intensively managed lowland farmland in the UK. They are potentially important for wetland biodiversity but, despite their ubiquity, information on their biodiversity and management in the wider countryside is scarce. We surveyed 175 ditches for their physical and chemical characteristics, spatial connectivity, plant communities and aquatic invertebrates in an area of intensively managed farmland in Oxfordshire, UK and collected information on ditch management from farmer interviews. Water depth and shade had a small impact on the diversity of plant and invertebrate communities in ditches. Increased shade over the ditch channel resulted in reduced taxonomic richness of both channel vegetation and aquatic invertebrates and channel vegetation cover was lower at shaded sites. Invertebrate taxonomic richness was higher when water was deeper. Spatial connectivity had no detectable impact on the aquatic invertebrate or plant communities found in ditches. The number of families within the orders Ephemeroptera, Plecoptera and Trichoptera (EPT), which contain many pollution-sensitive species, declined with decreasing pH of ditch water. As time since dredging increased, the number of EPT families increased in permanent ditches but decreased in temporary ditches. Whether or not a ditch was in an agri-environment scheme had little impact on the reported management regime or biodiversity value of the ditch. Measures for increasing the amount of water in ditches, by increasing the water depth or promoting retention of water in ditches, could increase the biodiversity value of ditches in agricultural land. Some temporary ditches for specialised species should be retained. Reducing the amount of shade over narrow ditches by managing adjacent hedgerows is also likely to increase the species diversity of plant and invertebrate communities within the ditch. We recommend that to preserve or enhance the biodiversity value of ditches, and improve their ecosystem service delivery, management prescriptions for hedgerows adjacent to ditches should differ from those aimed at hedgerows only.	[Shaw, Rosalind F.; Johnson, Paul J.; Macdonald, David W.; Feber, Ruth E.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England	University of Oxford	Shaw, RF (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Cornwall Campus, Penryn, Cornwall, England.	r.shaw@exeter.ac.uk			Esmee Fairbairn Foundation [EN/09-2528]	Esmee Fairbairn Foundation	This study was funded by the Esmee Fairbairn Foundation grant number EN/09-2528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency Environment Action Pond, 2002, GUID MON ECOL QUAL P; Anderson D. R., 2008, MODEL BASED INFERENC; Aquilina R., 2007, Aspects of Applied Biology, P261; Armitage PD, 2001, REGUL RIVER, V17, P543, DOI 10.1002/rrr.657.abs; Avery L.M, 2012, RURAL SUSTAINABLE DR; Baker DJ, 2012, J APPL ECOL, V49, P871, DOI 10.1111/j.1365-2664.2012.02161.x; Barton K., 2013, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; Biggs J, 2008, STANDARD WATER FRAME; Biggs J, 2007, AGR ECOSYST ENVIRON, V122, P137, DOI 10.1016/j.agee.2006.11.013; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blann K, 2002, N AM J FISH MANAGE, V22, P441, DOI 10.1577/1548-8675(2002)022<0441:RORBTT>2.0.CO;2; Blomqvist MM, 2009, BASIC APPL ECOL, V10, P368, DOI 10.1016/j.baae.2008.08.007; Boatman N, 2007, MA01028 DEFRA; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BOULTON AJ, 1992, FRESHWATER BIOL, V27, P123, DOI 10.1111/j.1365-2427.1992.tb00528.x; Bradbury RB, 2006, BIOL CONSERV, V129, P530, DOI 10.1016/j.biocon.2005.11.020; Brown CD, 2006, AGR ECOSYST ENVIRON, V113, P307, DOI 10.1016/j.agee.2005.10.015; Buisson RSK, 2008, DRAINAGE CHANNEL BIO; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Davies B, 2008, AGR ECOSYST ENVIRON, V125, P1, DOI 10.1016/j.agee.2007.10.006; Defra, 2014, WILD BIRD POP ENGL 1; Didderen K, 2008, 6 EUR C EC REST GHEN; Drake C. M, 2010, TECHNICAL REPORT; England Natural, 2009, AGR SCHEM ENGL 2009; England Natural, 2010, ENTR LEV STEW ENV ST; European Union, 2010, INTRO NEW EU WAT FRA; Food and Environment Research Agency, 2012, NAT ENGL COMM REP, V102; FOSTER GN, 1989, FRESHWATER BIOL, V22, P343, DOI 10.1111/j.1365-2427.1989.tb01109.x; Fox R, 2011, STATE UKS BUTTERFLIE; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Herzon I, 2008, BIOL CONSERV, V141, P1171, DOI 10.1016/j.biocon.2008.03.005; Janse JH, 1998, ENVIRON POLLUT, V102, P547, DOI 10.1016/S0269-7491(98)80082-1; Jenkins KM, 2003, ECOLOGY, V84, P2708, DOI 10.1890/02-0326; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kraft CE, 2002, ECOL APPL, V12, P749; Kroger R, 2009, AGR WATER MANAGE, V96, P1175, DOI 10.1016/j.agwat.2009.03.002; Leng X, 2009, BIOL CONSERV, V142, P1340, DOI 10.1016/j.biocon.2009.01.019; Leng X, 2011, BASIC APPL ECOL, V12, P38, DOI 10.1016/j.baae.2010.10.005; Leslie AW, 2012, ENVIRON ENTOMOL, V41, P802, DOI 10.1603/EN12049; Mackey RL, 2001, ECOLOGY, V82, P3479, DOI 10.1890/0012-9658(2001)082[3479:TDDRII]2.0.CO;2; Manhoudt AGE, 2007, AGR ECOSYST ENVIRON, V119, P353, DOI 10.1016/j.agee.2006.08.004; Manhoudt AGE, 2005, AGR ECOSYST ENVIRON, V109, P166, DOI 10.1016/j.agee.2005.01.006; Manhoudt AGE, 2003, AGR ECOSYST ENVIRON, V97, P235, DOI 10.1016/S0167-8809(03)00123-3; Mauritzen M, 1999, J APPL ECOL, V36, P409, DOI 10.1046/j.1365-2664.1999.00414.x; McLaren R, 2002, EFFECTIVENESS DITCH; Merckx T, 2012, J APPL ECOL, V49, P1396, DOI 10.1111/j.1365-2664.2012.02211.x; Milsom TP, 2004, AGR ECOSYST ENVIRON, V103, P85, DOI 10.1016/j.agee.2003.10.012; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mountford JO., 2006, AQUATIC PLANT DIVERS; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Otypkova Z, 2006, J VEG SCI, V17, P465, DOI 10.1111/j.1654-1103.2006.tb02467.x; Painter D, 1999, J APPL ECOL, V36, P33, DOI 10.1046/j.1365-2664.1999.00376.x; Palmer M, 2010, MANUAL SURVEY EVALUA; Pavelis G.A, 1987, FARM DRAINAGE US HIS; Pereira M, 2010, J APPL ECOL, V47, P611, DOI 10.1111/j.1365-2664.2010.01804.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pinheiro P, 2012, NLME LINER NONLINEAR; R Development Core Team, 2012, R LANG ENV STAT COMP; RACKHAM Oliver, 1986, HIST COUNTRYSIDE; RSPB, 2007, BD1312 RSPB DEFRA; Russell MA, 2001, J HYDROL, V252, P1, DOI 10.1016/S0022-1694(01)00388-2; Smart SM, 2000, J APPL ECOL, V37, P398, DOI 10.1046/j.1365-2664.2000.00508.x; Smith DR, 2007, J SOIL WATER CONSERV, V62, P252; Stace C., 1997, NEW FLORA BRIT ISLES; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Sutherland WJ, 2010, J APPL ECOL, V47, P955, DOI 10.1111/j.1365-2664.2010.01863.x; Thiere G, 2009, BIOL CONSERV, V142, P964, DOI 10.1016/j.biocon.2009.01.006; Twisk W, 2003, AQUAT ECOL, V37, P191, DOI 10.1023/A:1023944028022; Twisk W., 2000, Aquatic Ecology, V34, P397, DOI 10.1023/A:1011430831180; van Dijk WFA, 2014, BIOL CONSERV, V171, P91, DOI 10.1016/j.biocon.2014.01.006; van Dijk WFA, 2013, BASIC APPL ECOL, V14, P289, DOI 10.1016/j.baae.2013.04.001; Van Geert A, 2010, J ECOL, V98, P178, DOI 10.1111/j.1365-2745.2009.01600.x; van Liere L, 2002, EFFECT NUTR LOADING; Verdonschot RCM, 2011, AQUAT CONSERV, V21, P715, DOI 10.1002/aqc.1220; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8	79	14	14	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138306	10.1371/journal.pone.0138306	http://dx.doi.org/10.1371/journal.pone.0138306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445146	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600026
J	Walke, JB; Becker, MH; Loftus, SC; House, LL; Teotonio, TL; Minbiole, KPC; Belden, LK				Walke, Jenifer B.; Becker, Matthew H.; Loftus, Stephen C.; House, Leanna L.; Teotonio, Thais L.; Minbiole, Kevin P. C.; Belden, Lisa K.			Community Structure and Function of Amphibian Skin Microbes: An Experiment with Bullfrogs Exposed to a Chytrid Fungus	PLOS ONE			English	Article							PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; PLETHODON-CINEREUS; CHYTRIDIOMYCOSIS; DIVERSITY; BACTERIA; INFECTION; SEQUENCES; INVASION; DISEASE; HOST	The vertebrate microbiome contributes to disease resistance, but few experiments have examined the link between microbiome community structure and disease resistance functions. Chytridiomycosis, a major cause of amphibian population declines, is a skin disease caused by the fungus, Batrachochytrium dendrobatidis (Bd). In a factorial experiment, bullfrog skin microbiota was reduced with antibiotics, augmented with an anti-Bd bacterial isolate (Janthinobacterium lividum), or unmanipulated, and individuals were then either exposed or not exposed to Bd. We found that the microbial community structure of individual frogs prior to Bd exposure influenced Bd infection intensity one week following exposure, which, in turn, was negatively correlated with proportional growth during the experiment. Microbial community structure and function differed among unmanipulated, antibiotic-treated, and augmented frogs only when frogs were exposed to Bd. Bd is a selective force on microbial community structure and function, and beneficial states of microbial community structure may serve to limit the impacts of infection.	[Walke, Jenifer B.; Becker, Matthew H.; Belden, Lisa K.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Loftus, Stephen C.; House, Leanna L.] Virginia Tech, Dept Stat, Blacksburg, VA USA; [Teotonio, Thais L.] James Madison Univ, Dept Chem, Harrisonburg, VA 22807 USA; [Minbiole, Kevin P. C.] Villanova Univ, Dept Chem, Philadelphia, PA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; James Madison University; Villanova University	Walke, JB (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	walkejb@gmail.com	Walke, Jenifer/P-9928-2019	Walke, Jenifer/0000-0002-5943-5506; Belden, Lisa/0000-0002-3514-3920	Virginia Tech Fralin Life Science Institute; National Science Foundation [DEB-1136640, CHE-0958973]	Virginia Tech Fralin Life Science Institute; National Science Foundation(National Science Foundation (NSF))	This work was funded by the Virginia Tech Fralin Life Science Institute and the National Science Foundation (DEB-1136640 and CHE-0958973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antwis RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085563; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Becker MH, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2881; Becker MH, 2015, MOL ECOL, V24, P1628, DOI 10.1111/mec.13135; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brucker RM, 2008, J CHEM ECOL, V34, P1422, DOI 10.1007/s10886-008-9555-7; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Conlon JM, 2011, DEV COMP IMMUNOL, V35, P644, DOI 10.1016/j.dci.2011.01.017; Costa R, 2007, ENVIRON MICROBIOL, V9, P2260, DOI 10.1111/j.1462-2920.2007.01340.x; CUMMINS KW, 1974, BIOSCIENCE, V24, P631, DOI 10.2307/1296676; Daszak P, 2004, HERPETOL J, V14, P201; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eskew EA, 2015, ECOHEALTH, V12, P513, DOI 10.1007/s10393-015-1035-2; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Gervasi SS, 2013, ECOHEALTH, V10, P166, DOI 10.1007/s10393-013-0832-8; Gorley C.K., 2006, GETTING STARTED PRIM; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Hughey Myra C., 2014, Herpetological Review, V45, P428; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jani AJ, 2014, P NATL ACAD SCI USA, V111, pE5049, DOI 10.1073/pnas.1412752111; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251; Kung D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087101; Lauer A, 2007, COPEIA, V2007, P30; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Michaels CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095207; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Savage AE, 2015, EVOL APPL, V8, P560, DOI 10.1111/eva.12264; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Walke JB, 2014, ISME J, V8, P2207, DOI 10.1038/ismej.2014.77; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams Douglas C., 2015, Ecology (Washington D C), V96, P595; Woodhams DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096375; Woodhams DC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-197	64	57	57	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139848	10.1371/journal.pone.0139848	http://dx.doi.org/10.1371/journal.pone.0139848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445500	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600090
J	Wei, Z; Huang, JF; Hu, J; Gu, YA; Yang, CL; Mei, XL; Shen, QR; Xu, YC; Friman, VP				Wei, Zhong; Huang, Jian-Feng; Hu, Jie; Gu, Yi-An; Yang, Chun-Lan; Mei, Xin-Lan; Shen, Qi-Rong; Xu, Yang-Chun; Friman, Ville-Petri			Altering Transplantation Time to Avoid Periods of High Temperature Can Efficiently Reduce Bacterial Wilt Disease Incidence with Tomato	PLOS ONE			English	Article							RALSTONIA-SOLANACEARUM; PSEUDOMONAS-SOLANACEARUM; BIOORGANIC FERTILIZER; RACE 3; RESISTANCE; VIRULENCE; STRAINS; SUPPRESSION	Tomato bacterial wilt caused by Ralstonia solanacearumbacterium is a severe problem in Southern China, where relatively high environmental temperatures commonly prevails during the crop seasons. Previous research has indicated that bacterial wilt disease incidence generally increases during the warm months of summer leading to reduced tomato yield. Moreover, the efficacy of bio-organic fertilizers (BOFs)-organic compost fortified with pathogen-suppressive bacteria-is often lost during the periods of high environmental temperatures. Here we studied if the disease incidence could be reduced and the BOF performance enhanced by simply preponing and postponing the traditional seedling transplantation times to avoid tomato plant development during periods of high environmental temperature. To this end, a continuous, two-year field experiment was conducted to evaluate the performance of BOF in two traditional (late-spring [LS] and early-autumn [EA]) and two alternative (early-spring [ES] and late-autumn [LA]) crop seasons. We found that changing the transplantation times reduced the mean disease incidence from 33.9% (LS) and 54.7%(EA) to 11.1%(ES) and 7.1%(LA), respectively. Reduction in disease incidence correlated with the reduction in R. Solanacearum pathogen density in the tomato plant rhizosphere and stem base. Applying BOF during alternative transplantation treatments improved biocontrol efficiency from 43.4% (LS) and 3.1%(EA) to 67.4%(ES) and 64.8%(LA). On average, the mean maximum air temperatures were positively correlated with the disease incidence, and negatively correlated with the BOF biocontrol efficacy over the crop seasons. Crucially, even though preponing the transplantation time reduced the tomato yield in general, it was still economically more profitable compared to LS season due to reduced crop losses and relatively highermarket prices. Preponing and postponing traditional tomato transplantation times to cooler periods could thus offer simple but effective way to control R. solanacearum disease outbreaks.	[Wei, Zhong; Huang, Jian-Feng; Hu, Jie; Gu, Yi-An; Yang, Chun-Lan; Mei, Xin-Lan; Shen, Qi-Rong; Xu, Yang-Chun] Nanjing Agr Univ, Jiangsu Prov Key Lab Organ Solid Waste Utilizat, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing, Jiangsu, Peoples R China; [Huang, Jian-Feng] Guangdong Acad Agr Sci, Guangdong Key Lab Nutrient Cycling & Farmland Con, Inst Agr Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Friman, Ville-Petri] Univ York, Dept Biol, London YO10 5DD, England	Nanjing Agricultural University; Guangdong Academy of Agricultural Sciences; University of York - UK	Xu, YC (corresponding author), Nanjing Agr Univ, Jiangsu Prov Key Lab Organ Solid Waste Utilizat, Natl Engn Res Ctr Organ Based Fertilizers, Weigang 1, Nanjing, Jiangsu, Peoples R China.	ycxu@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Wei, Zhong/AAB-9103-2022; Hu, Jie/AAZ-2740-2021	Hu, Jie/0000-0002-0965-8197; Friman, Ville-Petri/0000-0002-1592-157X	National Natural Science Foundation of China [41301262, 41471213, 31501837]; National Science and Technology Support Program [2013BAD20B05]; Natural Science Foundation of Jiangsu Province [BK20130677]; China Postdoctoral Science Foundation [2013M541687]; Jiangsu Key Technology RD Program [BE2014340]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; Qing Lan Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Key Technology RD Program; Innovative Research Team Development Plan of the Ministry of Education of China; Qing Lan Project(Jiangsu Polytech Institute)	This research was financially supported by the National Natural Science Foundation of China (41301262, Zhong Wei; 41471213, Yang-Chun Xu; and 31501837, Jian-Feng Huang), the National Science and Technology Support Program (2013BAD20B05, Zhong Wei), the Natural Science Foundation of Jiangsu Province (BK20130677, Zhong Wei), the China Postdoctoral Science Foundation (2013M541687, Zhong Wei), the Jiangsu Key Technology R&D Program (BE2014340, Yang-Chun Xu), Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256, Qi-Rong Shen), and the Qing Lan Project (Yang-Chun Xu).	Alvarez B., 2010, CURRENT RES TECHNOLO, P267, DOI DOI 10.1111/MPP.12038; Bocsanczy AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-280; Bocsanczy AM, 2012, PHYTOPATHOLOGY, V102, P185, DOI 10.1094/PHYTO-05-11-0145; Chen XH, 2009, J BIOTECHNOL, V140, P27, DOI 10.1016/j.jbiotec.2008.10.011; Cheng C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3530; CIAMPI L, 1980, AM POTATO J, V57, P307, DOI 10.1007/BF02854025; Correa OS, 2009, APPL SOIL ECOL, V41, P185, DOI 10.1016/j.apsoil.2008.10.007; Dannon EA, 2004, PHYSIOL MOL PLANT P, V64, P233, DOI 10.1016/j.pmpp.2004.09.006; Elphinstone J. G., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P9; French E. R., 1995, Fitopatologia, V30, P126; French ER, 1994, BACTERIAL WILT DIS I, p[199, 8]; Gamliel A, 2000, CROP PROT, V19, P847, DOI 10.1016/S0261-2194(00)00112-5; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; HE LY, 1983, PLANT DIS, V67, P1357, DOI 10.1094/PD-67-1357; Huang JF, 2014, J AGR FOOD CHEM, V62, P10708, DOI 10.1021/jf503136a; Huang XQ, 2011, APPL MICROBIOL BIOT, V91, P741, DOI 10.1007/s00253-011-3259-6; Janse JD, 2004, J PLANT PATHOL, V86, P147; Kang YW, 2002, MOL MICROBIOL, V46, P427, DOI 10.1046/j.1365-2958.2002.03187.x; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; KRAUSZ JP, 1975, PHYTOPATHOLOGY, V65, P1272, DOI 10.1094/Phyto-65-1272; Ling N, 2010, BIOCONTROL, V55, P673, DOI 10.1007/s10526-010-9290-1; Liu YX, 2013, BIOL FERT SOILS, V49, P447, DOI 10.1007/s00374-012-0740-z; MEW TW, 1977, PHYTOPATHOLOGY, V67, P909, DOI 10.1094/Phyto-67-909; Nastro R, 2011, SCI MICROBIAL PATHOG, P1307; OHNO A, 1995, J FERMENT BIOENG, V80, P517, DOI 10.1016/0922-338X(96)80930-5; Ren XL, 2012, BIOL FERT SOILS, V48, P613, DOI 10.1007/s00374-011-0651-4; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Scherf JM, 2010, APPL ENVIRON MICROB, V76, P7061, DOI 10.1128/AEM.01580-10; Trillas MI, 2006, BIOL CONTROL, V39, P32, DOI 10.1016/j.biocontrol.2006.05.007; Wei Z, 2011, APPL SOIL ECOL, V48, P152, DOI 10.1016/j.apsoil.2011.03.013; Wu HS, 2009, BIOCONTROL, V54, P287, DOI 10.1007/s10526-008-9168-7; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; Yuliar, 2015, MICROBES ENVIRON, V30, P1, DOI 10.1264/jsme2.ME14144; Zhang N, 2011, PLANT SOIL, V344, P87, DOI 10.1007/s11104-011-0729-7	34	21	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139313	10.1371/journal.pone.0139313	http://dx.doi.org/10.1371/journal.pone.0139313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441225	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510300019
J	Yang, X; Scott, HA; Monickaraj, F; Xu, J; Ardekani, S; Nitta, CF; Cabrera, A; McGuire, PG; Mohideen, U; Das, A; Ghosh, K				Yang, Xiao; Scott, Harry A.; Monickaraj, Finny; Xu, Jun; Ardekani, Soroush; Nitta, Carolina F.; Cabrera, Andrea; McGuire, Paul G.; Mohideen, Umar; Das, Arup; Ghosh, Kaustabh			Basement membrane stiffening promotes retinal endothelial activation associated with diabetes	FASEB JOURNAL			English	Article						lysyl oxidase; matrix stiffness; nitric oxide; inflammation; diabetic retinopathy	LYSYL OXIDASE; EXTRACELLULAR-MATRIX; PLASMINOGEN-ACTIVATOR; MACULAR EDEMA; EXPRESSION; CELL; INFLAMMATION; FIBRONECTIN; RETINOPATHY; PERMEABILITY	Endothelial activation is a hallmark of the high-glucose (HG)-induced retinal inflammation associated with diabetic retinopathy (DR). However, precisely how HG induces retinal endothelial activation is not fully understood. We hypothesized that HG-induced upregulation of lysyl oxidase (LOX), a collagen-cross-linking enzyme, in retinal capillary endothelial cells (ECs) enhances subendothelial basement membrane (BM) stiffness, which, in turn, promotes retinal EC activation. Diabetic C57BL/6 mice exhibiting a 70 and 50% increase in retinal intercellular adhesion molecule (ICAM)-1 expression and leukocyte accumulation, respectively, demonstrated a 2-fold increase in the levels of BM collagen IV and LOX, key determinants of capillary BM stiffness. Using atomic force microscopy, we confirmed that HG significantly enhances LOX-dependent subendothelial matrix stiffness in vitro, which correlated with an similar to 2.5-fold increase in endothelial ICAM-1 expression, a 4-fold greater monocyte-EC adhesion, and an similar to 2-fold alteration in endothelial NO (decrease) and NF-kappa B activation (increase). Inhibition of LOX-dependent subendothelial matrix stiffening alone suppressed HG-induced retinal EC activation. Finally, using synthetic matrices of tunable stiffness, we demonstrated that subendothelial matrix stiffening is necessary and sufficient to promote EC activation. These findings implicate BM stiffening as a critical determinant of HG-induced retinal EC activation and provide a rationale for examining BM stiffness and underlying mechano-transduction pathways as therapeutic targets for diabetic retinopathy.	[Yang, Xiao; Scott, Harry A.; Ardekani, Soroush; Cabrera, Andrea; Ghosh, Kaustabh] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92507 USA; [Xu, Jun; Mohideen, Umar] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92507 USA; [Monickaraj, Finny; Nitta, Carolina F.; Das, Arup] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; [McGuire, Paul G.] Univ New Mexico, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; [Nitta, Carolina F.; Das, Arup] New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of New Mexico; University of New Mexico	Ghosh, K (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92507 USA.	kghosh@engr.ucr.edu	Xu, Jun/N-8564-2018	Xu, Jun/0000-0001-7735-9554	University of California, Riverside (UCR) Bourns College of Engineering; U. S. National Institutes of Health, National Eye Institute [R01EY022327]; NATIONAL EYE INSTITUTE [R01EY022327] Funding Source: NIH RePORTER	University of California, Riverside (UCR) Bourns College of Engineering; U. S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Initial Complement Funds provided by the University of California, Riverside (UCR) Bourns College of Engineering (to K.G.) and U. S. National Institutes of Health, National Eye Institute Grant R01EY022327 (to A.D.). X.Y., H.A.S., and K.G. disclose a UCR invention. The remaining authors report no conflicts of interest.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Azad N, 2014, DIABETES CARE, V37, P501, DOI 10.2337/dc13-1193; Bandello F, 2014, OPHTHALMIC RES, V52, P89, DOI 10.1159/000362764; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chang KC, 2006, EUR J CLIN INVEST, V36, P1, DOI 10.1111/j.1365-2362.2006.01588.x; Chronopoulos A, 2011, CURR EYE RES, V36, P747, DOI 10.3109/02713683.2011.585735; Chronopoulos A, 2010, DIABETES, V59, P3159, DOI 10.2337/db10-0365; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014; Goldsbury CS, 2009, CURR PROTOC PROTEIN; Grant MB, 1996, EXP EYE RES, V63, P233, DOI 10.1006/exer.1996.0112; Halfter W, 2015, FEBS J, V282, P4466, DOI 10.1111/febs.13495; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Iliaki E, 2009, INVEST OPHTH VIS SCI, V50, P4898, DOI 10.1167/iovs.08-2013; Ito H, 2001, J BIOL CHEM, V276, P24023, DOI 10.1074/jbc.M100861200; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Kothapalli D, 2012, CELL REP, V2, P1259, DOI 10.1016/j.celrep.2012.09.018; Kowluru RA, 2015, PROG RETIN EYE RES, V48, P40, DOI 10.1016/j.preteyeres.2015.05.001; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Lehenkari P P, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400001575; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li QH, 2010, INVEST OPHTH VIS SCI, V51, P5240, DOI 10.1167/iovs.09-5147; Ljubimov AV, 1996, J HISTOCHEM CYTOCHEM, V44, P1469, DOI 10.1177/44.12.8985139; Lutty GA, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12979; Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Marchina E, 1996, INT J BIOCHEM CELL B, V28, P1141, DOI 10.1016/1357-2725(96)00055-6; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; O'Day RF, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-123; Orr AW, 2005, J CELL BIOL, V169, P191, DOI 10.1083/jcb.200410073; OXLUND H, 1989, DIABETOLOGIA, V32, P748, DOI 10.1007/BF00274536; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Palenski TL, 2013, MICROVASC RES, V89, P57, DOI 10.1016/j.mvr.2013.06.007; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116; ROY S, 1994, J CLIN INVEST, V93, P438, DOI 10.1172/JCI116979; Scholl ZN, 2014, J BIOL CHEM, V289, P28607, DOI 10.1074/jbc.M114.582049; Shimizu M, 1997, BBA-PROTEIN STRUCT M, V1339, P53, DOI 10.1016/S0167-4838(96)00214-2; Shirwany NA, 2012, FRONT BIOSCI-LANDMRK, V17, P1140, DOI 10.2741/3978; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; To M, 2013, EXP EYE RES, V116, P298, DOI 10.1016/j.exer.2013.09.011; TRACHE A, 2008, CURR PROTOC MICROBIO, pCH2; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789	54	36	38	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					601	611		10.1096/fj.15-277962	http://dx.doi.org/10.1096/fj.15-277962			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443820	Green Published			2022-12-26	WOS:000369391900013
J	Turanov, AA; Everley, RA; Hybsier, S; Renko, K; Schomburg, L; Gygi, SP; Hatfield, DL; Gladyshev, VN				Turanov, Anton A.; Everley, Robert A.; Hybsier, Sandra; Renko, Kostja; Schomburg, Lutz; Gygi, Steven P.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Regulation of Selenocysteine Content of Human Selenoprotein P by Dietary Selenium and Insertion of Cysteine in Place of Selenocysteine	PLOS ONE			English	Article							CANCER; MOUSE; EXPRESSION; HEALTH; GENE	Selenoproteins are a unique group of proteins that contain selenium in the form of selenocysteine (Sec) co-translationally inserted in response to a UGA codon with the help of cis- and trans-acting factors. Mammalian selenoproteins contain single Sec residues, with the exception of selenoprotein P (SelP) that has 7-15 Sec residues depending on species. Assessing an individual's selenium status is important under various pathological conditions, which requires a reliable selenium biomarker. Due to a key role in organismal selenium homeostasis, high Sec content, regulation by dietary selenium, and availability of robust assays in human plasma, SelP has emerged as a major biomarker of selenium status. Here, we found that Cys is present in various Sec positions in human SelP. Treatment of cells expressing SelP with thiophosphate, an analog of the selenium donor for Sec synthesis, led to a nearly complete replacement of Sec with Cys, whereas supplementation of cells with selenium supported Sec insertion. SelP isolated directly from human plasma had up to 8% Cys inserted in place of Sec, depending on the Sec position. These findings suggest that a change in selenium status may be reflected in both SelP concentration and its Sec content, and that availability of the SelP-derived selenium for selenoprotein synthesis may be overestimated under conditions of low selenium status due to replacement of Sec with Cys.	[Turanov, Anton A.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Turanov, Anton A.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Everley, Robert A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hybsier, Sandra; Renko, Kostja; Schomburg, Lutz] Charite, Dept Urol, Inst Expt Endocrinol, D-13353 Berlin, Germany; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Mouse Canc Genet Program, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Schomburg, Lutz/D-8096-2013	Schomburg, Lutz/0000-0001-9445-1555; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [GM061603]; NATIONAL CANCER INSTITUTE [ZIABC011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM061603 (to VNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; BURK RF, 1991, AM J PHYSIOL, V261, pE26, DOI 10.1152/ajpendo.1991.261.1.E26; Calvo A, 2002, CANCER RES, V62, P5325; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Combs GF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-75; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gonzalez-Moreno O, 2011, PROSTATE, V71, P824, DOI 10.1002/pros.21298; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kurokawa Suguru, 2013, Met Ions Life Sci, V13, P499, DOI 10.1007/978-94-007-7500-8_16; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Meplan C, 2014, CANCER TREAT RES, V159, P145, DOI 10.1007/978-3-642-38007-5_9; Pietschmann N, 2014, METALLOMICS, V6, P1043, DOI 10.1039/c4mt00003j; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; READ R, 1990, J BIOL CHEM, V265, P17899; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; Steinbrenner H, 2007, BIOL CHEM, V388, P1043, DOI 10.1515/BC.2007.136; Tujebajeva RM, 2000, J BIOL CHEM, V275, P6288, DOI 10.1074/jbc.275.9.6288; Xia YM, 2005, AM J CLIN NUTR, V81, P829, DOI 10.1093/ajcn/81.4.829; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2010, P NATL ACAD SCI USA, V107, P21430, DOI 10.1073/pnas.1009947107	22	41	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140353	10.1371/journal.pone.0140353	http://dx.doi.org/10.1371/journal.pone.0140353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452064	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511200066
J	Ventorp, F; Gustafsson, A; Traskman-Bendz, L; Westrin, A; Ljunggren, L				Ventorp, Filip; Gustafsson, Anna; Traskman-Bendz, Lil; Westrin, Asa; Ljunggren, Lennart			Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters	PLOS ONE			English	Article							CYTOKINE LEVELS; DEPRESSION; SCHIZOPHRENIA; METAANALYSIS; MORTALITY; SYSTEM; BLOOD	The soluble form of the urokinase receptor, suPAR, has been suggested as a novel biomarker of low-grade inflammation. Activation of the immune system has been proposed to contribute to the development of depression and suicidal behavior. In order to identify depressed and suicidal individuals who could benefit from an anti-inflammatory treatment, a reliable biomarker of low-grade inflammation is vital. This study evaluates plasma suPAR levels as a biomarker of low-grade inflammation in patients with major depressive disorder and in patients who recently attempted suicide. The plasma suPAR and an established biomarker, C reactive protein (CRP) of suicide attempters (n = 54), depressed patients (n = 19) and healthy controls (n = 19) was analyzed with enzyme-linked immunosorbent assays. The biomarker attributes of sensitivity and sensibility were evaluated using ROC curve analysis. Both the depressed patients and suicide attempters had increased plasma suPAR. The levels of suPAR discriminated better between controls and suicide attempters than did CRP. In the future, plasma suPAR might be a superior prognosticator regarding outcome of treatment applying conventional antidepressants in conjunction with anti-inflammatory drugs.	[Ventorp, Filip; Traskman-Bendz, Lil; Westrin, Asa] Lund Univ, Dept Clin Sci, Div Psychiat, Lund, Sweden; [Gustafsson, Anna; Ljunggren, Lennart] Malmo Univ, Dept Biomed Sci, Malmo, Sweden	Lund University; Malmo University	Westrin, A (corresponding author), Lund Univ, Dept Clin Sci, Div Psychiat, Lund, Sweden.	asa.westrin@med.lu.se	Gustafsson, Anna/AAK-9442-2021	Gustafsson, Anna/0000-0001-9847-5132; Ventorp, Filip/0000-0003-1544-2429	Province of Scania State Grants (ALF)	Province of Scania State Grants (ALF)	This study was supported by Province of Scania State Grants (ALF). This organization had no further role in the study or in the decision to submit the work for publication.	American Psychiatric Association, 2013, DSM 5 TASK FORC DIAG, V5th; Bauer M, 2008, EUR PSYCHIAT, V23, P66, DOI 10.1016/j.eurpsy.2007.11.001; Bienvenu J, 2000, CLIN CHEM LAB MED, V38, P267, DOI 10.1515/CCLM.2000.040; Coryell W, 2005, J CLIN PSYCHIAT, V66, P412, DOI 10.4088/JCP.v66n0401; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Gibney SM, 2013, J NEUROIMMUNE PHARM, V8, P900, DOI 10.1007/s11481-013-9462-8; Gyetko MR, 1996, J CLIN INVEST, V97, P1818, DOI 10.1172/JCI118611; Haack M, 1999, J PSYCHIATR RES, V33, P407, DOI 10.1016/S0022-3956(99)00021-7; Haastrup E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110555; Halaris A, 2013, MOD TR PHARMACOPSYCH, V28, P1; Himmerich H, 2009, FORTSCHR NEUROL PSYC, V77, P334, DOI 10.1055/s-0028-1109420; HOWLAND RH, 2008, J PSYCHOSOC NURS MEN, V46, P21; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Loftis JM, 2004, J AFFECT DISORDERS, V82, P175, DOI 10.1016/j.jad.2004.04.002; Lyngbaek S, 2013, INT J CARDIOL, V167, P781, DOI 10.1016/j.ijcard.2012.03.040; Masli S, 2009, IMMUNOLOGY, V127, P62, DOI 10.1111/j.1365-2567.2008.02933.x; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Muller N, 2013, PSYCHIAT DANUB, V25, P292; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Nielsen J, 2015, SCHIZOPHRENIA BULL, V41, P764, DOI 10.1093/schbul/sbu118; Niwa Y, 2000, ARCH DERMATOL RES, V292, P391, DOI 10.1007/s004030000148; Pal M, 2014, IMMUNOL CELL BIOL, V92, P331, DOI 10.1038/icb.2014.16; Petrovsky Nikolai, 2005, Expert Rev Clin Immunol, V1, P379, DOI 10.1586/1744666X.1.3.379; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Raison Charles L, 2013, Cerebrum, V2013, P10; Rijneveld AW, 2002, J IMMUNOL, V168, P3507, DOI 10.4049/jimmunol.168.7.3507; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; THAVASU PW, 1992, J IMMUNOL METHODS, V153, P115, DOI 10.1016/0022-1759(92)90313-I; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Tonelli LH, 2008, ACTA PSYCHIAT SCAND, V117, P198, DOI 10.1111/j.1600-0447.2007.01128.x; Wrotek A, 2015, ADV EXP MED BIOL, V835, P1, DOI 10.1007/5584_2014_40	41	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140052	10.1371/journal.pone.0140052	http://dx.doi.org/10.1371/journal.pone.0140052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26451727	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511200031
J	Amanatiadou, EP; Papadopoulos, GL; Strouboulis, J; Vizirianakis, IS				Amanatiadou, Elsa P.; Papadopoulos, Giorgio L.; Strouboulis, John; Vizirianakis, Ioannis S.			GATA1 and PU.1 Bind to Ribosomal Protein Genes in Erythroid Cells: Implications for Ribosomopathies	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; GLOBAL TRANSCRIPTOME; DIFFERENTIATION; MECHANISMS; EXPRESSION; REVEAL; STIMULATION; TRANSLATION; BIOGENESIS; COMMITMENT	The clear connection between ribosome biogenesis dysfunction and specific hematopoiesis-related disorders prompted us to examine the role of critical lineage-specific transcription factors in the transcriptional regulation of ribosomal protein (RP) genes during terminal erythroid differentiation. By applying EMSA and ChIP methodologies in mouse erythroleukemia cells we show that GATA1 and PU.1 bind in vitro and in vivo the proximal promoter region of the RPS19 gene which is frequently mutated in Diamond-Blackfan Anemia. Moreover, ChIPseq data analysis also demonstrates that several RP genes are enriched as potential GATA1 and PU.1 gene targets in mouse and human erythroid cells, with GATA1 binding showing an association with higher ribosomal protein gene expression levels during terminal erythroid differentiation in human and mouse. Our results suggest that RP gene expression and hence balanced ribosome biosynthesis may be specifically and selectively regulated by lineage specific transcription factors during hematopoiesis, a finding which may be clinically relevant to ribosomopathies.	[Amanatiadou, Elsa P.; Vizirianakis, Ioannis S.] Aristotle Univ Thessaloniki, Dept Pharmaceut Sci, Pharmacol Lab, GR-54006 Thessaloniki, Greece; [Papadopoulos, Giorgio L.; Strouboulis, John] Biomed Sci Res Ctr Alexander Fleming, Div Mol Oncol, Vari, Greece	Aristotle University of Thessaloniki; Alexander Fleming Biomedical Sciences Research Center	Strouboulis, J (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Div Mol Oncol, Vari, Greece.	john_strouboulis@imbb.forth.gr; ivizir@pharm.auth.gr	Vizirianakis, Ioannis/AAK-6067-2020; Strouboulis, John/U-4459-2019; Vizirianakis, Ioannis/AAK-5795-2020	Vizirianakis, Ioannis/0000-0003-1459-9774; Papadopoulos, Giorgio Lucio/0000-0003-0199-0256; Strouboulis, John/0000-0002-6133-2872	Aristotle University of Thessaloniki; National Institute of Diabetes and Kidney Diseases [RO1DK083389]; Fondazione Cariplo [2012.0517]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083389] Funding Source: NIH RePORTER	Aristotle University of Thessaloniki; National Institute of Diabetes and Kidney Diseases; Fondazione Cariplo(Fondazione Cariplo); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by interdepartmental funding by the Aristotle University of Thessaloniki (ISV), by the National Institute of Diabetes and Kidney Diseases (RO1DK083389 to JS) and Fondazione Cariplo (2012.0517 to JS).	An XL, 2014, BLOOD, V123, P3466, DOI 10.1182/blood-2014-01-548305; Antoniou M, 1991, Methods Mol Biol, V7, P421, DOI 10.1385/0-89603-178-0:421; Barrio AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006172; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; Bottardi S, 2011, NUCLEIC ACIDS RES, V39, P3505, DOI 10.1093/nar/gkq1271; Boultwood J, 2014, NAT MED, V20, P703, DOI 10.1038/nm.3630; Byrska-Bishop M, 2015, J CLIN INVEST, V125, P993, DOI 10.1172/JCI75714; Chlon TM, 2015, HAEMATOLOGICA, V100, P575, DOI 10.3324/haematol.2014.112714; Clinton C GH, 2014, GENEREVIEWS; Cmejlova J, 2006, HAEMATOLOGICA, V91, P1456; Da Costa L, 2003, BLOOD, V101, P318, DOI 10.1182/blood-2002-04-1131; deBoer E, 1988, EMBO J, P7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Filipovska A, 2013, FEBS LETT, V587, P1189, DOI 10.1016/j.febslet.2013.02.032; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Horos R, 2012, BRIT J HAEMATOL, V159, P514, DOI 10.1111/bjh.12058; Ishii K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-37; Ito E, 2010, INT J HEMATOL, V92, P413, DOI 10.1007/s12185-010-0693-7; Juban G, 2009, MOL CELL BIOL, V29, P2852, DOI 10.1128/MCB.01435-08; Komrokji RS, 2013, BEST PRACT RES CL HA, V26, P365, DOI 10.1016/j.beha.2013.10.013; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; Nakhoul H, 2014, CLIN MED INSIGHTS-BL, V7, P7, DOI 10.4137/CMBD.S16952; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; NATHAN DG, 1978, J CLIN INVEST, V61, P489, DOI 10.1172/JCI108960; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Papadopoulos GL, 2013, NUCLEIC ACIDS RES, V41, P4938, DOI 10.1093/nar/gkt167; Parrella S, 2014, PEDIATR BLOOD CANCER, V61, P1319, DOI 10.1002/pbc.24944; Perry RP, 2007, GENE, V401, P1, DOI 10.1016/j.gene.2007.07.007; Perry RP, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-15; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Quigley JG MRJ, 2013, WINTROBES CLIN HEMAT; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Ruggero D, 2014, BLOOD, V124, P2784, DOI 10.1182/blood-2014-04-526301; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; SCHUETZE S, 1992, MOL CELL BIOL, V12, P2967, DOI 10.1128/MCB.12.7.2967; Sieff CA, 2010, BRIT J HAEMATOL, V148, P611, DOI 10.1111/j.1365-2141.2009.07993.x; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tsiftsoglou AS, 2003, PHARMACOL THERAPEUT, V100, P257, DOI 10.1016/j.pharmthera.2003.09.002; Vizirianakis IS, 2015, INT J ONCOL, V47, P303, DOI 10.3892/ijo.2015.3017; Weiss MJ, 2012, J CLIN INVEST, V122, P2346, DOI 10.1172/JCI63989; Wolff L, 2013, STEM CELLS, V31, P1237, DOI 10.1002/stem.1379; Wontakal SN, 2012, P NATL ACAD SCI USA, V109, P3832, DOI 10.1073/pnas.1121019109; Wontakal SN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001392; Xu J, 2012, DEV CELL, V23, P796, DOI 10.1016/j.devcel.2012.09.003; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140077	10.1371/journal.pone.0140077	http://dx.doi.org/10.1371/journal.pone.0140077			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447946	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000087
J	Epele, LB; Miserendino, ML				Beltran Epele, Luis; Laura Miserendino, Maria			Environmental Quality and Aquatic Invertebrate Metrics Relationships at Patagonian Wetlands Subjected to Livestock Grazing Pressures	PLOS ONE			English	Article							LAND-USE; MACROINVERTEBRATE ASSEMBLAGES; WET MEADOWS; COMMUNITIES; IMPACTS; DISTURBANCE; CATTLE; STATE; PONDS	Livestock grazing can compromise the biotic integrity and health of wetlands, especially in remotes areas like Patagonia, which provide habitat for several endemic terrestrial and aquatic species. Understanding the effects of these land use practices on invertebrate communities can help prevent the deterioration of wetlands and provide insights for restoration. In this contribution, we assessed the responses of 36 metrics based on the structural and functional attributes of invertebrates (130 taxa) at 30 Patagonian wetlands that were subject to different levels of livestock grazing intensity. These levels were categorized as low, medium and high based on eight features (livestock stock densities plus seven wetland measurements). Significant changes in environmental features were detected across the gradient of wetlands, mainly related to pH, conductivity, and nutrient values. Regardless of rainfall gradient, symptoms of eutrophication were remarkable at some highly disturbed sites. Seven invertebrate metrics consistently and accurately responded to livestock grazing on wetlands. All of them were negatively related to increased levels of grazing disturbance, with the number of insect families appearing as the most robust measure. A multivariate approach (RDA) revealed that invertebrate metrics were significantly affected by environmental variables related to water quality: in particular, pH, conductivity, dissolved oxygen, nutrient concentrations, and the richness and coverage of aquatic plants. Our results suggest that the seven aforementioned metrics could be used to assess ecological quality in the arid and semi-arid wetlands of Patagonia, helping to ensure the creation of protected areas and their associated ecological services.	[Beltran Epele, Luis; Laura Miserendino, Maria] Ctr Invest Esquel Montana & Estepa Patagon CONICE, RA-9200 Esquel, Chubut, Argentina		Epele, LB (corresponding author), Ctr Invest Esquel Montana & Estepa Patagon CONICE, Roca 780, RA-9200 Esquel, Chubut, Argentina.	luisbepele@hotmail.com		MISERENDINO, MARIA LAURA/0000-0002-8414-0734	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Secretaria de Ciencia y Tecnica; Universidad Nacional de la Patagonia SJB (SECyT-UNPSJB) [061/07 PI FCN 045/07]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de la Patagonia SJB (SECyT-UNPSJB)(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Secretaria de Ciencia y Tecnica and the Universidad Nacional de la Patagonia SJB (SECyT-UNPSJB). Res CS No 061/07 PI FCN 045/07 LBE MLM. This fund was applicable just for covering fuel cost for survey trips, and for fieldwork equipment; publications cost was not considered in this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, 1994, STANDARD METHODS EXA, V16th; Balcombe CK, 2005, HYDROBIOLOGIA, V541, P175, DOI 10.1007/s10750-004-5706-1; Barbour MT, 1996, J N AM BENTHOL SOC, V15, P185, DOI 10.2307/1467948; BARBOUR MT, 1995, BIOL ASSESSMENT CRIT, P63; Batzer DP, 2013, WETLANDS, V33, P1, DOI 10.1007/s13157-012-0360-2; Bazzanti M, 2010, LIMNOLOGICA, V40, P291, DOI 10.1016/j.limno.2009.10.006; Epele LB, 2011, FUND APPL LIMNOL, V178, P219, DOI 10.1127/1863-9135/2011/0178-0219; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Biggs J, 2005, AQUAT CONSERV, V15, P693, DOI 10.1002/aqc.745; Boix D, 2008, HYDROBIOLOGIA, V597, P53, DOI 10.1007/s10750-007-9221-z; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Braak Ter C., 1998, CANOCO REFERENCE MAN; Casamiquela R., 2007, CONFINES DIGITAL; Chipps SR, 2006, WETLANDS, V26, P497, DOI 10.1672/0277-5212(2006)26[497:ABWDAB]2.0.CO;2; Collantes M.B., 1999, T PICOS HUMEDALES SU, P15; Correa M.O., 1978, FLORA PATAGONICA, VVIII; Crego RD, 2014, ENVIRON CONSERV, V41, P122, DOI 10.1017/S037689291300026X; Davies KF, 2010, BIOL CONSERV, V143, P78, DOI 10.1016/j.biocon.2009.09.006; Declerck S, 2006, BIOL CONSERV, V131, P523, DOI 10.1016/j.biocon.2006.02.024; del Valle HF, 1998, ARID SOIL RES REHAB, V12, P95; Dominguez E., 2009, SISTEMATICA BIOL; Epele LB, 2016, J NAT HIST, V50, P711, DOI 10.1080/00222933.2015.1062930; Epele LB, 2012, ZOOL STUD, V51, P1418; Foote AL, 2005, ECOL ENTOMOL, V30, P273, DOI 10.1111/j.0307-6946.2005.00701.x; Gaitan JJ, 2011, WETL ECOL MANAG, V19, P121, DOI 10.1007/s11273-010-9205-z; Galatowitsch SM, 2000, ENVIRON MONIT ASSESS, V60, P121, DOI 10.1023/A:1006159028274; Gleason RA, 2003, WETLANDS, V23, P26, DOI 10.1672/0277-5212(2003)023[0026:EOSLOE]2.0.CO;2; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Ilmonen J, 2013, ECOL INDIC, V30, P165, DOI 10.1016/j.ecolind.2013.02.014; Instituto Nacional de Tecnologia Agropecuaria (INTA), MET DAT; Jobbagy Esteban G., 1995, Ecologia Austral, V5, P47; Kepner WG, 2000, ENVIRON MONIT ASSESS, V64, P179, DOI 10.1023/A:1006427909616; LUDWING JA, 1988, STAT ECOLOGY; Kutschker AM, 2014, ECOL ENG, V64, P37, DOI 10.1016/j.ecoleng.2013.12.007; Maloney KO, 2006, ECOL INDIC, V6, P469, DOI 10.1016/j.ecolind.2005.06.003; Masiokas MH, 2008, GLOBAL PLANET CHANGE, V60, P85, DOI 10.1016/j.gloplacha.2006.07.031; Mazzoni E, 2004, ECOSISTEMAS MALLINES; Menetrey N, 2005, AQUAT CONSERV, V15, P653, DOI 10.1002/aqc.746; Mereta ST, 2013, ECOL INDIC, V29, P510, DOI 10.1016/j.ecolind.2013.01.026; Miserendino ML, 2008, WATER AIR SOIL POLL, V194, P91, DOI 10.1007/s11270-008-9701-4; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Nakamatsu V, 2006, INTA GANADERIA, V20, P87; Neiff ASP., 2003, ECOLOGIA MANEJO MACR, P127; OECD, 1982, EUTR WAT MON ASS CON; Perotti MG, 2005, REV CHIL HIST NAT, V78, P723; Quiros R, 1988, VERH INT VER LIMNOL, V23, P647, DOI DOI 10.1080/03680770.1987.11899688; Schmutzer AC, 2008, FRESHWATER BIOL, V53, P2613, DOI 10.1111/j.1365-2427.2008.02072.x; Semlitsch RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123055; Sharma RC, 2009, ECOL INDIC, V9, P118, DOI 10.1016/j.ecolind.2008.02.004; Siffredi GL, 2007, GUID REC CARG AN MAL; Steinman AD, 2003, WETLANDS, V23, P877, DOI 10.1672/0277-5212(2003)023[0877:IOCGAP]2.0.CO;2; Stewart TW, 2008, WETLANDS, V28, P141, DOI 10.1672/06-130.1; Tangen BA, 2003, WETLANDS, V23, P104, DOI 10.1672/0277-5212(2003)023[0104:WCBMAA]2.0.CO;2; Tell G, 1997, FLORA FAUNA PATAGONI; U.S. EPA, 2002, EPA822R02019 OFF WAT; White DS, 2008, INTRO AQUATIC INSECT, V4th, P571; Wissinger SA, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P1043; [No title captured]	58	29	31	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0137873	10.1371/journal.pone.0137873	http://dx.doi.org/10.1371/journal.pone.0137873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448652	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000005
J	Cockerill, M; Rigozzi, MK; Terentjev, EM				Cockerill, Max; Rigozzi, Michelle K.; Terentjev, Eugene M.			Mechanosensitivity of the 2nd Kind: TGF-beta Mechanism of Cell Sensing the Substrate Stiffness	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SMOOTH MUSCLE ACTIN; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; HYDROSTATIC-PRESSURE; LATENT TGF-BETA-1; EPITHELIAL-CELLS; FOCAL ADHESIONS; FIBROBLASTS; EXPRESSION	Cells can sense forces applied to them, but also the stiffness of their environment. These are two different phenomena, and here we investigate the mechanosensitivity of the 2nd kind: how the cell can measure an elastic modulus at a single point of adhesion-and how the cell can receive and interpret the chemical signal released from the sensor. Our model uses the example of large latent complex of TGF-beta as a sensor. Stochastic theory gives the rate of breaking of latent complex, which initiates the signaling feedback loop after the active TGF-beta release and leads to a change of cell phenotype driven by the a-smooth muscle actin. We investigate the dynamic and steady-state behaviors of the model, comparing them with experiments. In particular, we analyse the timescale of approach to the steady state, the stability of the non-linear dynamical system, and how the steady-state concentrations of the key markers vary depending on the elasticity of the substrate. We discover a crossover region for values of substrate elasticity closely corresponding to that of the fibroblast to myofibroblast transition. We suggest that the cell could actively vary the parameters of its dynamic feedback loop to 'choose' the position of the transition region and the range of substrate elasticity that it can detect. In this way, the theory offers the unifying mechanism for a variety of phenomena, such as the myofibroblast conversion in fibrosis of wounds and lungs and smooth muscle cell dysfunction in cardiac disease.	[Cockerill, Max; Rigozzi, Michelle K.; Terentjev, Eugene M.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Terentjev, EM (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	emt1000@cam.ac.uk	Terentjev, Eugene M/B-7623-2011	Terentjev, Eugene M/0000-0003-3517-6578	EPSRC Critical Mass grant for Theoretical Condensed Matter; Sims Scholarship; Cambridge Trusts; University of Sydney; Engineering and Physical Sciences Research Council [EP/J017639/1] Funding Source: researchfish; EPSRC [EP/J017639/1] Funding Source: UKRI	EPSRC Critical Mass grant for Theoretical Condensed Matter(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Sims Scholarship; Cambridge Trusts; University of Sydney(University of Sydney); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EPSRC Critical Mass grant for Theoretical Condensed Matter, the Sims Scholarship, and the Cambridge Trusts, and the University of Sydney.	ACEVEDO AD, 1993, J CELL PHYSIOL, V157, P603, DOI 10.1002/jcp.1041570321; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benedetto S, 2006, MAGN RESON MED, V56, P711, DOI 10.1002/mrm.21023; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BOURNS B, 1988, CELL MOTIL CYTOSKEL, V10, P380, DOI 10.1002/cm.970100305; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Cooper GM, 2000, CELL MOL APPROACH; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Escude M, 2014, BIOPHYS J, V106, P124, DOI 10.1016/j.bpj.2013.10.042; Fogel-Petrovic M, 2007, INT IMMUNOPHARMACOL, V7, P1924, DOI 10.1016/j.intimp.2007.07.003; Freitas RA., 1999, NANOMEDICINE; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Han SJ, 2012, BIOPHYS J, V103, P640, DOI 10.1016/j.bpj.2012.07.023; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Huang T, 2014, BIOCHEMISTRY-US, V53, P5737, DOI 10.1021/bi500647d; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; PRENDERGAST FG, 1978, BIOCHEMISTRY-US, V17, P3448, DOI 10.1021/bi00610a004; Roberts A.B., 2001, SCI STKE, V113, ppe43, DOI [10.1126/stke.2001.113.pe43, DOI 10.1126/STKE.2001.113.PE43]; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Sinha S, 2002, CARDIOVASC RES, V53, P971, DOI 10.1016/S0008-6363(01)00512-0; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Szafranski JD, 2004, OSTEOARTHR CARTILAGE, V12, P937, DOI 10.1016/j.joca.2004.08.004; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; TOYOSHIMA YY, 1990, P NATL ACAD SCI USA, V87, P7130, DOI 10.1073/pnas.87.18.7130; Unsold C, 2001, J CELL SCI, V114, P187; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Yanagida T., 1995, Biophysical Journal, V68, P312; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	46	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139959	10.1371/journal.pone.0139959	http://dx.doi.org/10.1371/journal.pone.0139959			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448620	Green Published, gold, Green Submitted			2022-12-26	WOS:000362511000070
J	de Camargo, C; Gibbs, HL; Costa, MC; Del-Rio, G; Silveira, LF; Wasko, AP; Francisco, MR				de Camargo, Crisley; Gibbs, H. Lisle; Costa, Mariellen C.; Del-Rio, Glaucia; Silveira, Luis F.; Wasko, Adriane P.; Francisco, Mercival R.			Marshes as "Mountain Tops": Genetic Analyses of the Critically Endangered Sao Paulo Marsh Antwren (Aves: Thamnophilidae)	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPUTER-PROGRAM; DNA VARIATION; ONE-MIGRANT; FLOW; SIZE; FOREST; CONSERVATION; SOFTWARE; TRANSLOCATIONS	Small populations of endangered species can be impacted by genetic processes such as drift and inbreeding that reduce population viability. As such, conservation genetic analyses that assess population levels of genetic variation and levels of gene flow can provide important information for managing threatened species. The Sao Paulo Marsh Antwren (Formicivora paludicola) is a recently-described and critically endangered bird from Sao Paulo State (Brazil) whose total estimated population is around 250-300 individuals, distributed in only 15 isolated marshes around Sao Paulo metropolitan region. We used microsatellite DNA markers to estimate the population genetic characteristics of the three largest remaining populations of this species all within 60 km of each other. We detected a high and significant genetic structure between all populations (overall F-ST = 0.103) which is comparable to the highest levels of differentiation ever documented for birds, (e.g., endangered birds found in isolated populations on the tops of African mountains), but also evidence for first-generation immigrants, likely from small local unsampled populations. Effective population sizes were small (between 28.8-99.9 individuals) yet there are high levels of genetic variability within populations and no evidence for inbreeding. Conservation implications of this work are that the high levels of genetic structure suggests that translocations between populations need to be carefully considered in light of possible local adaptation and that remaining populations of these birds should be managed as conservation units that contain both main populations studied here but also small outlying populations which may be a source of immigrants.	[de Camargo, Crisley; Wasko, Adriane P.] Univ Estadual Paulista, Inst Biociencias, Dept Genet, BR-18618970 Sao Paulo, Brazil; [Gibbs, H. Lisle] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Costa, Mariellen C.; Francisco, Mercival R.] Univ Fed Sao Carlos, Dept Ciencias Ambientais, BR-18052 Sao Paulo, Brazil; [Del-Rio, Glaucia] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Silveira, Luis F.] Univ Sao Paulo, Secao Aves, Museu Zool, BR-04218970 Sao Paulo, Brazil	Universidade Estadual Paulista; University System of Ohio; Ohio State University; Universidade Federal de Sao Carlos; Louisiana State University System; Louisiana State University; Universidade de Sao Paulo	Francisco, MR (corresponding author), Univ Fed Sao Carlos, Dept Ciencias Ambientais, Campus Sorocaba,Rod Joao Leme dos Santos,Km 110, BR-18052 Sao Paulo, Brazil.	mercival@ufscar.br	Costa, Mariellen C/H-6608-2017; Silveira, Luis/V-6161-2019; Silveira, Luis Fabio/F-8337-2012; Wasko, Adriane/AHC-7656-2022; Francisco, Mercival R/G-2497-2013	Costa, Mariellen C/0000-0001-7501-7606; Silveira, Luis/0000-0003-2576-7657; Silveira, Luis Fabio/0000-0003-2576-7657; Francisco, Mercival/0000-0003-2083-7812; Wasko, Adriane/0000-0003-4600-0367	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/09105-7, 2013/01604-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CC has received financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant #2012/09105-7 and Grant #2013/01604-2).	An JH, 2010, MOL ECOL RESOUR, V10, P404, DOI 10.1111/j.1755-0998.2009.02827.x; [Anonymous], 2010, WETLAND ECOLOGY PRIN; Barnett JR, 2007, MOL ECOL NOTES, V7, P1070, DOI 10.1111/j.1471-8286.2007.01780.x; Barnett JR, 2008, CONSERV GENET, V9, P1403, DOI 10.1007/s10592-007-9463-3; Bertrand JAM, 2014, HEREDITY, V112, P190, DOI 10.1038/hdy.2013.91; Brown LM, 2004, CONSERV GENET, V5, P743, DOI 10.1007/s10592-004-1865-x; Callens T, 2011, MOL ECOL, V20, P1829, DOI 10.1111/j.1365-294X.2011.05028.x; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Cornuet JM, 1996, GENETICS, V144, P2001; Buzzetti DRC, 2013, REV BRAS ORNITOL, V21, P269; de Camargo C, 2015, CONSERV GENET RESOUR, V7, P129, DOI 10.1007/s12686-014-0310-9; Del-Rio G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121315; Diamond JM., 1980, CONSERVATION BIOL EV; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Francisco MR, 2007, MOL ECOL, V16, P4908, DOI 10.1111/j.1365-294X.2007.03519.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Garoia F, 2004, HEREDITY, V93, P166, DOI 10.1038/sj.hdy.6800489; GIBBS JP, 1993, WETLANDS, V13, P25, DOI 10.1007/BF03160862; Gibbs JP, 2000, CONSERV BIOL, V14, P314, DOI 10.1046/j.1523-1739.2000.98608.x; Girard P, 2010, CONSERV GENET, V11, P2409, DOI 10.1007/s10592-010-0126-4; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Habel JC, 2013, CONSERV GENET, V14, P1019, DOI 10.1007/s10592-013-0492-9; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heber S, 2013, P ROY SOC LOND B BIO, V280, P1; Hedrick PW, 2014, ANIM CONSERV, V17, P106, DOI 10.1111/acv.12064; Hudson QJ, 2000, BIOL CONSERV, V96, P105, DOI 10.1016/S0006-3207(00)00057-4; Huff DD, 2011, MOL ECOL, V20, P4246, DOI 10.1111/j.1365-294X.2011.05271.x; Laurance SGW, 2004, CONSERV BIOL, V18, P1099, DOI 10.1111/j.1523-1739.2004.00268.x; Lehouck V, 2009, J VEG SCI, V20, P1110, DOI 10.1111/j.1654-1103.2009.01109.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mendez M, 2011, BIOL CONSERV, V144, P2615, DOI 10.1016/j.biocon.2011.07.011; Michalakis Y, 1996, GENETICS, V142, P1061; Miller MP, 2012, CONDOR, V114, P100, DOI 10.1525/cond.2012.110055; MMA, 2014, LIST ESP FAUN BRAS A; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Quantum GIS Development Team, 2015, QUANT GIS GEOGR INF; de Oliveira PRR, 2011, BIOTROPICA, V43, P628, DOI 10.1111/j.1744-7429.2010.00744.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reinert B.L., 2008, THESIS U ESTADUAL PA; Reinert BL, 2007, REV BRAS ORNITOL, V15, P493; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roy CL, 2013, WILSON J ORNITHOL, V125, P402, DOI 10.1676/12-129.1; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; Shoemaker KT, 2013, COPEIA, P324, DOI 10.1643/OT-12-022; Silveira LF, 2009, FAUNA AMEACADA EXTIN; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; United States Geological Survey Project, 2014, EARTH EXPL LANDSAT 8; Victor MAM, 2005, CEM ANOS DEVASTACAO; Vucetich JA, 2000, ANIM CONSERV, V3, P261, DOI 10.1017/S1367943000000986; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiedmann BP, 2014, J WILDLIFE MANAGE, V78, P394, DOI 10.1002/jwmg.669; Woltmann S, 2012, CONSERV GENET, V13, P925, DOI 10.1007/s10592-012-0341-2; Zeisset I, 2013, ANIM CONSERV, V16, P359, DOI 10.1111/acv.12003	72	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0140145	10.1371/journal.pone.0140145	http://dx.doi.org/10.1371/journal.pone.0140145			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26447791	gold, Green Submitted, Green Published			2022-12-26	WOS:000362511000096
J	Luchtman, DW; Chee, MJS; Doslikova, B; Marks, DL; Baracos, VE; Colmers, WF				Luchtman, Dirk W.; Chee, Melissa J. S.; Doslikova, Barbora; Marks, Daniel L.; Baracos, Vickie E.; Colmers, William F.			Defense of Elevated Body Weight Setpoint in Diet-Induced Obese Rats on Low Energy Diet Is Mediated by Loss of Melanocortin Sensitivity in the Paraventricular Hypothalamic Nucleus	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; NEUROPEPTIDE-Y; FEEDING-BEHAVIOR; DORSOMEDIAL HYPOTHALAMUS; FOOD-INTAKE; EFFERENT PROJECTIONS; NEURONS; RECEPTOR; LEPTIN; NPY	Some animals and humans fed a high-energy diet (HED) are diet-resistant (DR), remaining as lean as individuals who were naive to HED. Other individuals become obese during HED exposure and subsequently defend the obese weight (Diet-Induced Obesity-Defenders, DIO-D) even when subsequently maintained on a low-energy diet. We hypothesized that the body weight setpoint of the DIO-D phenotype resides in the hypothalamic paraventricular nucleus (PVN), where anorexigenic melanocortins, including melanotan II (MTII), increase presynaptic GABA release, and the orexigenic neuropeptide Y (NPY) inhibits it. After prolonged return to low-energy diet, GABA inputs to PVN neurons from DIO-D rats exhibited highly attenuated responses to MTII compared with those from DR and HED-naive rats. In DIO-D rats, melanocortin-4 receptor expression was significantly reduced in dorsomedial hypothalamus, a major source of GABA input to PVN. Unlike melanocortin responses, NPY actions in PVN of DIO-D rats were unchanged, but were reduced in neurons of the ventromedial hypothalamic nucleus; in PVN of DR rats, NPY responses were paradoxically increased. MTII-sensitivity was restored in DIO-D rats by several weeks' refeeding with HED. The loss of melanocortin sensitivity restricted to PVN of DIO-D animals, and its restoration upon prolonged refeeding with HED suggest that their melanocortin systems retain the ability to up-and downregulate around their elevated body weight setpoint in response to longer-term changes in dietary energy density. These properties are consistent with a mechanism of body weight setpoint.	[Luchtman, Dirk W.; Chee, Melissa J. S.; Doslikova, Barbora; Colmers, William F.] Univ Alberta, Dept Pharmacol & Neurosci, Edmonton, AB, Canada; [Luchtman, Dirk W.; Chee, Melissa J. S.; Doslikova, Barbora; Colmers, William F.] Univ Alberta, Mental Hlth Inst, Edmonton, AB, Canada; [Marks, Daniel L.] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA; [Baracos, Vickie E.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; Oregon Health & Science University; University of Alberta	Colmers, WF (corresponding author), Univ Alberta, Dept Pharmacol & Neurosci, Edmonton, AB, Canada.	william.colmers@ualberta.ca	Marks, Daniel/C-3712-2009; Chee, Melissa/G-4150-2014	Chee, Melissa/0000-0003-3815-9095	Canadian Institutes of Health Research (CIHR) [MOP 97935]; CIHR Grant [OTG 88592, MOP 10520]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Grant(Canadian Institutes of Health Research (CIHR))	Funding was provided by Canadian Institutes of Health Research (CIHR-http://www.cihr-irsc.gc.ca/e/193.html) Grant # MOP 97935 (VEB, WFC, DLM); CIHR Grant # OTG 88592 (WFC); CIHR Grant # MOP 10520 (WFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer ZA, 2003, OBES RES, V11, P1376, DOI 10.1038/oby.2003.186; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Begriche K, 2011, J BIOL CHEM, V286, P40771, DOI 10.1074/jbc.M111.278374; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Boudaba C, 1996, J NEUROSCI, V16, P7151; Chee MJS, 2008, NUTRITION, V24, P869, DOI 10.1016/j.nut.2008.06.007; Chee MJS, 2010, J NEUROSCI, V30, P3380, DOI 10.1523/JNEUROSCI.4031-09.2010; Chen PL, 2004, J NEUROSCI, V24, P5091, DOI 10.1523/JNEUROSCI.0588-04.2004; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Garza JC, 2008, J ENDOCRINOL, V197, P471, DOI 10.1677/JOE-08-0009; Gautron L, 2010, J COMP NEUROL, V518, P2090, DOI 10.1002/cne.22323; Ghamari-Langroudi M, 2011, P NATL ACAD SCI USA, V108, P355, DOI 10.1073/pnas.1016785108; Harrold JA, 1999, DIABETES, V48, P267, DOI 10.2337/diabetes.48.2.267; Hatoum IJ, 2012, J CLIN ENDOCR METAB, V97, pE1023, DOI 10.1210/jc.2011-3432; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kask A, 2000, BRAIN RES, V887, P460, DOI 10.1016/S0006-8993(00)03034-1; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kishi T, 2005, J COMP NEUROL, V482, P217, DOI 10.1002/cne.20432; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Lee SJ, 2013, J COMP NEUROL, V521, P1891, DOI 10.1002/cne.23265; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; LEVIN BE, 1989, AM J PHYSIOL, V256, pR766, DOI 10.1152/ajpregu.1989.256.3.R766; Levin BE, 2000, AM J PHYSIOL-REG I, V278, pR231, DOI 10.1152/ajpregu.2000.278.1.R231; Levin BE, 2002, AM J PHYSIOL-REG I, V282, pR46, DOI 10.1152/ajpregu.2002.282.1.R46; Levin BE, 2000, OBES RES, V8, P342, DOI 10.1038/oby.2000.41; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; Melnick I, 2007, NEURON, V56, P1103, DOI 10.1016/j.neuron.2007.10.034; Mercer JG, 2008, EUR J PHARMACOL, V585, P31, DOI 10.1016/j.ejphar.2007.11.077; Mercer RE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003207; Mercer RE, 2011, FRONT NEUROENDOCRIN, V32, P398, DOI 10.1016/j.yfrne.2011.06.001; Pravdivyi I, 2015, HUM MOL GENET, V24, P4276, DOI 10.1093/hmg/ddv159; Pronchuk N, 2004, BRIT J PHARMACOL, V141, P1032, DOI 10.1038/sj.bjp.0705699; Pronchuk N, 2002, ENDOCRINOLOGY, V143, P535, DOI 10.1210/en.143.2.535; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Scarlett JM, 2007, ENDOCRINOLOGY, V148, P4217, DOI 10.1210/en.2007-0017; Shah BP, 2014, P NATL ACAD SCI USA, V111, P13193, DOI 10.1073/pnas.1407843111; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Stern JE, 2001, J PHYSIOL-LONDON, V537, P161, DOI 10.1111/j.1469-7793.2001.0161k.x; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; TASKER JG, 1991, J PHYSIOL-LONDON, V434, P271, DOI 10.1113/jphysiol.1991.sp018469; Tiesjema B, 2007, J NEUROSCI, V27, P14139, DOI 10.1523/JNEUROSCI.3280-07.2007; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Ye ZY, 2011, REGUL PEPTIDES, V166, P112, DOI 10.1016/j.regpep.2010.10.001	51	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139462	10.1371/journal.pone.0139462	http://dx.doi.org/10.1371/journal.pone.0139462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444289	Green Submitted, gold, Green Published			2022-12-26	WOS:000362510600056
J	Mei, GY; Sun, YJ; Xu, H; Sergio, DM				Mei Guangyi; Sun Yujun; Xu Hao; Sergio de-Miguel			A Mixed-Effects Model with Different Strategies for Modeling Volume in Cunninghamia lanceolata Plantations	PLOS ONE			English	Article							TAPER EQUATIONS; STEM TAPER; NORTHWESTERN SPAIN; LOBLOLLY-PINE; PREDICTION; DENSITY; CHINA; KOREA; RATIO; FIR	A systematic evaluation of nonlinear mixed-effect taper models for volume prediction was performed. Of 21 taper equations with fewer than 5 parameters each, the best 4-parameter fixed-effect model according to fitting statistics was then modified by comparing its values for the parameters total height (H), diameter at breast height (DBH), and aboveground height (h) to modeling data. Seven alternative prediction strategies were compared using the best new equation in the absence of calibration data, which is often unavailable in forestry practice. The results of this study suggest that because calibration may sometimes be a realistic option, though it is rarely used in practical applications, one of the best strategies for improving the accuracy of volume prediction is the strategy with 7 calculated total heights of 3, 6 and 9 trees in the largest, smallest and medium-size categories, respectively. We cannot use the average trees or dominant trees for calculating the random parameter for further predictions. The method described here will allow the user to make the best choices of taper type and the best random-effect calculated strategy for each practical application and situation at tree level.	[Mei Guangyi; Sun Yujun; Xu Hao] Beijing Forestry Univ, Lab Silviculture & Conservat, Beijing, Peoples R China; [Sergio de-Miguel] Univ Eastern Finland, Fac Sci & Forestry, Joensuu, Finland; [Sergio de-Miguel] Univ Lleida, Agrotecnio Ctr UdL Agrotecnio, Dept Prod Vegetal & Ciencia Forestal, E-25198 Lleida, Spain	Beijing Forestry University; University of Eastern Finland; Universitat de Lleida	Sun, YJ (corresponding author), Beijing Forestry Univ, Lab Silviculture & Conservat, 35 Qinghua East Rd, Beijing, Peoples R China.	sunyj@bjfu.edu.cn	de Miguel, Sergio/B-8358-2016	de Miguel, Sergio/0000-0002-9738-0657	project of forestry science and technology research [201207]; National Technology Extension Fund of Forestry [[2014]26]	project of forestry science and technology research; National Technology Extension Fund of Forestry	This study was supported by the project of forestry science and technology research (No. 201207) and the National Technology Extension Fund of Forestry ([2014]26).	Bennett F.A., 1972, 179 USDA FOR SERV SE; BIGING GS, 1984, FOREST SCI, V30, P1103; Brooks JR, 2008, FOREST ECOL MANAG, V256, P147, DOI 10.1016/j.foreco.2008.04.018; Cao QV, 2011, FOREST ECOL MANAG, V262, P671, DOI 10.1016/j.foreco.2011.04.039; Cao QV, 2009, SOUTH J APPL FOR, V33, P58, DOI 10.1093/sjaf/33.2.58; Cervera JM, 1973, MONTES, V174, P415; Coffre M., 1982, THESIS ING U AUSTRAL, P44; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; de-Miguel S, 2013, FOREST ECOL MANAG, V291, P249, DOI 10.1016/j.foreco.2012.11.026; De-Miguel S, 2012, CAN J FOREST RES, V42, P1383, DOI [10.1139/X2012-090, 10.1139/x2012-090]; DEMAERSCHALK J P, 1973, Canadian Journal of Forest Research, V3, P90, DOI 10.1139/x73-013; DEMAERSCHALK JP, 1972, FOREST SCI, V18, P241, DOI 10.1093/forestscience/18.3.241; Dieguez-Aranda U, 2006, CAN J FOREST RES, V36, P1190, DOI 10.1139/X06-008; Florez V, 2014, BOSQUE, V35, P89, DOI 10.4067/S0717-92002014000100009; FORSLUND RR, 1991, CAN J FOREST RES, V21, P193, DOI 10.1139/x91-023; GOULDING C J, 1976, New Zealand Journal of Forestry Science, V5, P313; Gregoire TG, 2000, BIOMETRICS, V56, P414, DOI 10.1111/j.0006-341X.2000.00414.x; Hjelm B, 2013, J FORESTRY RES, V24, P15, DOI 10.1007/s11676-012-0270-4; Hussein K.A., 2008, SCI SILVAE SIN, V44, P1, DOI 10.11707/j.1001-7488.20080605; Jiang Li-chun, 2011, Journal of Forestry Research (Harbin), V22, P347, DOI 10.1007/s11676-011-0178-4; Kitikidou K., 2008, Journal of Forest Science (Prague), V54, P176, DOI 10.17221/789-JFS; Kozak A, 1997, CAN J FOREST RES, V27, P619, DOI 10.1139/cjfr-27-5-619; Kozak A, 2004, FOREST CHRON, V80, P507, DOI 10.5558/tfc80507-4; KOZAK A, 1969, FOREST CHRON, V45, P278, DOI 10.5558/tfc45278-4; Lee WK, 2003, FOREST ECOL MANAG, V172, P69, DOI 10.1016/S0378-1127(02)00139-1; Leites LP, 2004, FOREST SCI, V50, P204; Lejeune G, 2009, EUR J FOREST RES, V128, P505, DOI 10.1007/s10342-009-0300-8; Lumbres RIC, 2014, J MT SCI-ENGL, V11, P442, DOI 10.1007/s11629-013-2759-5; Manuel AR, 2015, CANADIAN J FOREST RE, V45, P647; MAX TA, 1976, FOREST SCI, V22, P283; Menendez-Miguelez M, 2014, ANN FOREST SCI, V71, P761, DOI 10.1007/s13595-014-0372-6; NEWBERRY JD, 1986, CAN J FOREST RES, V16, P109, DOI 10.1139/x86-018; Newton PF, 2008, SCAND J FOREST RES, V23, P358, DOI 10.1080/02827580801995349; ORMEROD DW, 1973, FOREST CHRON, V49, P136, DOI 10.5558/tfc49136-3; Ozcelik R, 2011, EUR J FOREST RES, V130, P613, DOI 10.1007/s10342-010-0453-5; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prodan M., 1997, MENSURA FORESTAL; Real P., 1986, NC120 USDA FOR SERV, P1037; REED DD, 1984, FOREST SCI, V30, P977; Robert BO, 1968, FOREST SCI, V14, P339; Rodriguez F, 2014, EUR J FOREST RES, V133, P213, DOI 10.1007/s10342-013-0739-5; Rojo A, 2005, EUR J FOREST RES, V124, P177, DOI 10.1007/s10342-005-0066-6; Sharma M, 2001, CAN J FOREST RES, V31, P797, DOI 10.1139/cjfr-31-5-797; Trincado G, 2006, FOREST SCI, V52, P670; Ung CH, 2013, FOREST CHRON, V89, P211, DOI 10.5558/tfc2013-040; Von Gadow K, 1999, MODELLING FOREST DEV, P96; Xia Zhong-Sheng, 2013, Forest Science and Practice, V15, P179, DOI 10.1007/s11632-013-0304-9; Xu H., 2014, J FOOD SCI TECHNOLOG, V6, P445, DOI DOI 10.19026/ajfst.6.53; Yang YQ, 2009, EUR J FOREST RES, V128, P415, DOI 10.1007/s10342-009-0286-2; Zeng WS, 1997, FOREST SCI, V33, P127; Zhang J.G., 2011, SELF THINNING GROWTH	51	9	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140095	10.1371/journal.pone.0140095	http://dx.doi.org/10.1371/journal.pone.0140095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26445505	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600138
J	Murase, K; Tabara, Y; Ito, H; Kobayashi, M; Takahashi, Y; Setoh, K; Kawaguchi, T; Muro, S; Kadotani, H; Kosugi, S; Sekine, A; Yamada, R; Nakayama, T; Mishima, M; Matsuda, S; Matsuda, F; Chin, K				Murase, Kimihiko; Tabara, Yasuharu; Ito, Hiromu; Kobayashi, Masahiko; Takahashi, Yoshimitsu; Setoh, Kazuya; Kawaguchi, Takahisa; Muro, Shigeo; Kadotani, Hiroshi; Kosugi, Shinji; Sekine, Akihiro; Yamada, Ryo; Nakayama, Takeo; Mishima, Michiaki; Matsuda, Shuichi; Matsuda, Fumihiko; Chin, Kazuo			Knee Pain and Low Back Pain Additively Disturb Sleep in the General Population: A Cross-Sectional Analysis of the Nagahama Study	PLOS ONE			English	Article							BODY-MASS INDEX; BIDIRECTIONAL RELATIONSHIP; METABOLIC SYNDROME; DURATION; INSOMNIA; OSTEOARTHRITIS; ASSOCIATION; PREVALENCE; QUALITY; ADULTS	Introduction Association of knee and low back pain with sleep disturbance is poorly understood. We aimed to clarify the independent and combined effects of these orthopedic symptoms on sleep in a large-scale general population. Methods Cross-sectional data about sleep and knee/low back pain were collected for 9,611 community residents (53 +/- 14 years old) by a structured questionnaire. Sleep duration less than 6 h/d was defined as short sleep. Sleep quality and the presence of knee and low back pain were evaluated by dichotomous questions. Subjects who complained about knee or low back pains were graded by tertiles of a numerical response scale (NRS) score and a Roland-Morris disability questionnaire (RDQ) score respectively. Multivariate regression analyses were performed to determine the correlates of short sleep duration and poor sleep quality. Results Frequency of participants who complained of the orthopedic symptoms was as follows; knee pain, 29.0%; low back pain, 42.0% and both knee and low back pain 17.6%. Both knee and low back pain were significantly and independently associated with short sleep duration (knee pain: odds ratio (OR) = 1.19, p<0.01; low back pain: OR = 1.13, p = 0.01) and poor sleep quality (knee pain: OR = 1.22, p<0.01; low back pain; OR = 1.57, p<0.01). The group in the highest tertile of the NRS or RDQ score had the highest risk for short sleep duration and poor sleep quality except for the relationship between the highest tertile of the RDQ score and short sleep duration.(the highest tertile of the NRS: OR for short sleep duration = 1.31, p<0.01; OR for poor sleep quality = 1.47, p<0.01; the highest tertile of the RDQ: OR for short sleep duration = 1.11, p = 0.12; OR for poor sleep quality = 1.81, p<0.01) Further, coincident knee and low back pain raised the odds ratios for short sleep duration (either of knee or low back pain: OR = 1.10, p = 0.06; both knee and low back pain: OR = 1.40, p<0.01) and poor sleep quality (either of knee or low back pain: OR = 1.61, p<0.01; both knee and low back pain: OR = 2.17, p<0.01). Conclusion Knee and low back pains were independently associated with short sleep duration and poor sleep quality. Further, they additively increased the correlation with these sleep problems in the general population.	[Murase, Kimihiko; Muro, Shigeo; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Tabara, Yasuharu; Setoh, Kazuya; Kawaguchi, Takahisa; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Ito, Hiromu; Kobayashi, Masahiko; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Takahashi, Yoshimitsu; Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Kadotani, Hiroshi] Shiga Univ Med Sci, Dept Psychiat, Shiga, Japan; [Kosugi, Shinji] Kyoto Univ, Sch Publ Hlth, Dept Med Eth & Med Genet, Kyoto, Japan; [Sekine, Akihiro] Kyoto Univ, Grad Sch Med, Med Res Support Ctr, Kyoto, Japan; [Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Shiga University of Medical Science; Kyoto University; Kyoto University; Kyoto University	Chin, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	Kadotani, Hiroshi/A-7908-2015; KOSUGI, Shinji/GYR-2946-2022; NAKAYAMA, Takeo/HCH-0537-2022; KOSUGI, Shinji/HCH-0631-2022; TAKAHASHI, Yoshimitsu/GZB-2656-2022	Kadotani, Hiroshi/0000-0001-7474-3315; Yamada, Ryo/0000-0002-1587-630X; Matsuda, Shuichi/0000-0003-0802-1255; Nakayama, Takeo/0000-0002-7918-6252	Ministry of Education, Culture, Sports, Science & Technology in Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25293141] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science & Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a University Grant from the Ministry of Education, Culture, Sports, Science & Technology in Japan, and a research grant from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2008, J RHEUMATOL, V35, P1102; Alsaadi SM, 2014, CLIN J PAIN, V30, P755, DOI 10.1097/AJP.0000000000000055; Alsaadi SM, 2014, ARTHRITIS RHEUMATOL, V66, P1388, DOI 10.1002/art.38329; Arora T, 2011, DIABETES CARE, V34, P2317, DOI 10.2337/dc11-0647; Artner J, 2013, J PAIN RES, V6, P1, DOI 10.2147/JPR.S36386; Axen I, 2015, CLIN J PAIN; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bahouq H, 2013, RHEUMATOL INT, V33, P1277, DOI 10.1007/s00296-012-2550-x; Basner M, 2007, SLEEP, V30, P1085, DOI 10.1093/sleep/30.9.1085; Bianchi MT, 2012, J CLIN SLEEP MED, V8, P547, DOI 10.5664/jcsm.2154; Blay Sergio Luis, 2007, Ann Clin Psychiatry, V19, P169, DOI 10.1080/10401230701468099; Bruno RM, 2013, SLEEP MED, V14, P1157, DOI 10.1016/j.sleep.2013.04.020; Chiang JK, 2014, J CLIN SLEEP MED, V10, P743, DOI 10.5664/jcsm.3862; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Drewes AM, 2000, RHEUMATOLOGY, V39, P1287, DOI 10.1093/rheumatology/39.11.1287; Drewes AM, 1997, SLEEP, V20, P632, DOI 10.1093/sleep/20.8.632; Fang SY, 2009, DRUG ALCOHOL DEPEN, V104, P140, DOI 10.1016/j.drugalcdep.2009.04.017; Fernandez-Mendoza J, 2012, HYPERTENSION, V60, P929, DOI 10.1161/HYPERTENSIONAHA.112.193268; Hale L, 2007, SLEEP, V30, P1096, DOI 10.1093/sleep/30.9.1096; Hall MH, 2008, SLEEP, V31, P635, DOI 10.1093/sleep/31.5.635; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hung HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054304; Hutchings A, 2007, J RHEUMATOL, V34, P2291; Jansson-Frojmark M, 2008, J PSYCHOSOM RES, V64, P443, DOI 10.1016/j.jpsychores.2007.10.016; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Kocabicak E, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/245358; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lou PA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004436; Moraes W, 2013, SLEEP MED, V14, P312, DOI 10.1016/j.sleep.2012.11.010; Morphy H, 2007, SLEEP, V30, P274; Murase K, 2014, SLEEP, V37, P1810, DOI 10.5665/sleep.4176; Murata Y, 2003, J BONE JOINT SURG BR, V85B, P95, DOI 10.1302/0301-620X.85B1.13389; Nakazaki C, 2012, AM J HYPERTENS, V25, P1149, DOI 10.1038/ajh.2012.107; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Ohayon MM, 2005, J PSYCHIAT RES, V39, P151, DOI 10.1016/j.jpsychires.2004.07.001; Okubo N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-562; PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009; Patel SR, 2007, SLEEP, V30, P1077, DOI 10.1093/sleep/30.9.1077; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Rozenberg S, 2004, JOINT BONE SPINE, V71, P56, DOI 10.1016/S1297-319X(03)00066-6; Sasaki E, 2014, ARTHRIT CARE RES, V66, P1027, DOI 10.1002/acr.22258; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Soni A, 2012, ARTHRITIS RHEUM-US, V64, P1145, DOI 10.1002/art.33434; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Suri P, 2010, ARTHRIT CARE RES, V62, P1715, DOI 10.1002/acr.20324; Suzukamo Yoshimi, 2003, J Orthop Sci, V8, P543, DOI 10.1007/s00776-003-0679-x; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tsuji Taichi, 2002, J Orthop Sci, V7, P519, DOI 10.1007/s007760200092; Tu XD, 2012, SLEEP MED, V13, P1138, DOI 10.1016/j.sleep.2012.06.014; Turkiewicz A, 2014, RHEUMATOLOGY OXFORD; van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2; Virtanen M, 2009, SLEEP, V32, P737, DOI 10.1093/sleep/32.6.737; Wilcox S, 2000, J AM GERIATR SOC, V48, P1241, DOI 10.1111/j.1532-5415.2000.tb02597.x; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Wolfe F, 1999, RHEUMATOLOGY, V38, P355, DOI 10.1093/rheumatology/38.4.355; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Zhou ZY, 2014, OBESITY, V22, P2180, DOI 10.1002/oby.20835	60	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0140058	10.1371/journal.pone.0140058	http://dx.doi.org/10.1371/journal.pone.0140058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444713	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600131
J	Sweet, L; Kang, YQ; Czisch, C; Witek, L; Shi, Y; Smay, J; Plant, GW; Yang, YZ				Sweet, Lauren; Kang, Yunqing; Czisch, Christopher; Witek, Lukasz; Shi, Yang; Smay, Jim; Plant, Giles W.; Yang, Yunzhi			Geometrical versus Random beta-TCP Scaffolds: Exploring the Effects on Schwann Cell Growth and Behavior	PLOS ONE			English	Article							PERIPHERAL-NERVE REPAIR; NEURITE OUTGROWTH; STEM-CELLS; FACTOR-BB; VEGF-A; INJURY; REGENERATION; GUIDANCE; TISSUE; PROLIFERATION	Numerous studies have demonstrated that Schwann cells (SCs) play a role in nerve regeneration; however, their role in innervating a bioceramic scaffold for potential application in bone regeneration is still unknown. Here we report the cell growth and functional behavior of SCs on beta-tricalcium phosphate (beta-TCP) scaffolds arranged in 3D printed-lattice (P-beta-TCP) and randomly-porous, template-casted (N-beta-TCP) structures. Our results indicate that SCs proliferated well and expressed the phenotypic markers p75(LNGFR) and the S100-beta subunit of SCs as well as displayed growth morphology on both scaffolds, but SCs showed spindle-shaped morphology with a significant degree of SCs alignment on the P-beta-TCP scaffolds, seen to a lesser degree in the N-beta-TCP scaffold. The gene expressions of nerve growth factor (beta-ngf), neutrophin-3 (nt-3), platelet-derived growth factor (pdgf-bb), and vascular endothelial growth factor (vegf-a) were higher at day 7 than at day 14. While no significant differences in protein secretion were measured between these last two time points, the scaffolds promoted the protein secretion at day 3 compared to that on the cell culture plates. These results together imply that the beta-TCP scaffolds can support SC cell growth and that the 3D-printed scaffold appeared to significantly promote the alignment of SCs along the struts. Further studies are needed to investigate the early and late stage relationship between gene expression and protein secretion of SCs on the scaffolds with refined characteristics, thus better exploring the potential of SCs to support vascularization and innervation in synthetic bone grafts.	[Sweet, Lauren; Kang, Yunqing; Yang, Yunzhi] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Sweet, Lauren] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kang, Yunqing] Florida Atlantic Univ, Dept Ocean & Mech Engn, Boca Raton, FL 33431 USA; [Czisch, Christopher; Plant, Giles W.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Witek, Lukasz; Shi, Yang; Smay, Jim] Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA; [Yang, Yunzhi] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Yang, Yunzhi] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; State University System of Florida; Florida Atlantic University; Stanford University; Oklahoma State University System; Oklahoma State University - Stillwater; Stanford University; Stanford University	Yang, YZ (corresponding author), Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA.	ypyang@stanford.edu	Witek, Lukasz/AAU-5689-2020	Witek, Lukasz/0000-0003-1458-6527; Kang, Yunqing/0000-0002-9721-1837	NIH [R01AR057837, R01DE021468]; DOD [W911NF-14-1-0545, W81XWH-10-1-0966]; Stanford vice-provost undergraduate major grant; Bio-X undergraduate research award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Stanford vice-provost undergraduate major grant; Bio-X undergraduate research award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the following agencies: NIH R01AR057837 (NIAMS), NIH R01DE021468 (NIDCR), DOD W911NF-14-1-0545 (DURIP), DOD W81XWH-10-1-0966 (PRORP), and Stanford vice-provost undergraduate major grant (LS) and Bio-X undergraduate research award (LS).	Barbour HR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-106; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; Chen Bin, 2007, Chin J Traumatol, V10, P3; Chen PR, 2004, BIOMATERIALS, V25, P5667, DOI 10.1016/j.biomaterials.2004.01.052; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Dubovy P, 2013, INT REV NEUROBIOL, V108, P173, DOI 10.1016/B978-0-12-410499-0.00007-1; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Gao HY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/362918; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025; Gravvanis AI, 2007, ACTA NEUROCHIR SUPPL, V100, P51; Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943; Gupta R, 2005, MUSCLE NERVE, V31, P452, DOI 10.1002/mus.20272; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Holthaus MG, 2012, ACTA BIOMATER, V8, P394, DOI 10.1016/j.actbio.2011.07.031; Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI [10.1089/ten.tea.2009.0017, 10.1089/ten.TEA.2009.0017]; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Kaewkhaw R, 2012, NAT PROTOC, V7, P1996, DOI 10.1038/nprot.2012.118; Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018; Kang YQ, 2015, ACTA BIOMATER, V11, P449, DOI 10.1016/j.actbio.2014.09.035; Kang YQ, 2013, ACTA BIOMATER, V9, P4906, DOI 10.1016/j.actbio.2012.08.008; Kang YQ, 2011, EUR POLYM J, V47, P1569, DOI 10.1016/j.eurpolymj.2011.05.004; Kang YQ, 2011, BIOMATERIALS, V32, P6119, DOI 10.1016/j.biomaterials.2011.05.015; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kawachi Y, 2013, EXP DERMATOL, V22, P262, DOI 10.1111/exd.12115; Kemp SWP, 2011, EXP NEUROL, V229, P460, DOI 10.1016/j.expneurol.2011.03.017; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Li WL, 2013, DEV CELL, V24, P359, DOI 10.1016/j.devcel.2013.01.009; Liu YX, 2010, J BIOMED MATER RES A, V92A, P997, DOI 10.1002/jbm.a.32443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobsiger CS, 2000, GLIA, V30, P290, DOI 10.1002/(SICI)1098-1136(200005)30:3<290::AID-GLIA8>3.0.CO;2-6; Lopez-Fagundo C, 2013, ACTA BIOMATER, V9, P7158, DOI 10.1016/j.actbio.2013.03.032; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Masaeli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057157; Meier C, 1999, J NEUROSCI, V19, P3847; Mercado-Pagan AE, 2015, ANN BIOMED ENG; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; PORTER S, 1986, J NEUROSCI, V6, P3070; Renault MA, 2013, CIRC RES, V112, P762, DOI 10.1161/CIRCRESAHA.113.300871; Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007; Richardson JA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046015; Rodrigues MCO, 2012, SCI WORLD J, DOI 10.1100/2012/413091; Sakiyama-Elbert S, 2012, Handb Clin Neurol, V109, P575, DOI 10.1016/B978-0-444-52137-8.00036-X; Salzer James L, 2012, J Peripher Nerv Syst, V17 Suppl 3, P14, DOI 10.1111/j.1529-8027.2012.00425.x; Savarino L, 2005, J BONE JOINT SURG BR, V87B, P571, DOI 10.1302/0301-620X.87B4.15316; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shakhbazau A, 2012, MOL CELL NEUROSCI, V50, P103, DOI 10.1016/j.mcn.2012.04.004; Shen ZL, 2001, MICROSURG, V21, P6, DOI 10.1002/1098-2752(2001)21:1<6::AID-MICR1001>3.0.CO;2-6; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Thompson DM, 2006, ANN BIOMED ENG, V34, P161, DOI 10.1007/s10439-005-9013-4; Valmikinathan CM, 2011, MAT SCI ENG C-MATER, V31, P22, DOI 10.1016/j.msec.2010.04.001; Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020; Yan H, 2009, INT REV NEUROBIOL, V87, P199, DOI 10.1016/S0074-7742(09)87010-4; Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	60	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139820	10.1371/journal.pone.0139820	http://dx.doi.org/10.1371/journal.pone.0139820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444999	Green Published, Green Submitted, gold			2022-12-26	WOS:000362510600085
J	Zhou, XL				Zhou, Xiaolu			Understanding Spatiotemporal Patterns of Biking Behavior by Analyzing Massive Bike Sharing Data in Chicago	PLOS ONE			English	Article							SYSTEM	The growing number of bike sharing systems (BSS) in many cities largely facilitates biking for transportation and recreation. Most recent bike sharing systems produce time and location specific data, which enables the study of travel behavior and mobility of each individual. However, despite a rapid growth of interest, studies on massive bike sharing data and the underneath travel pattern are still limited. Few studies have explored and visualized spatiotemporal patterns of bike sharing behavior using flow clustering, nor examined the station functional profiles based on over-demand patterns. This study investigated the spatiotemporal biking pattern in Chicago by analyzing massive BSS data from July to December in 2013 and 2014. The BSS in Chicago gained more popularity. About 15.9% more people subscribed to this service. Specifically, we constructed bike flow similarity graph and used fastgreedy algorithm to detect spatial communities of biking flows. By using the proposed methods, we discovered unique travel patterns on weekdays and weekends as well as different travel trends for customers and subscribers from the noisy massive amount data. In addition, we also examined the temporal demands for bikes and docks using hierarchical clustering method. Results demonstrated the modeled over-demand patterns in Chicago. This study contributes to offer better knowledge of biking flow patterns, which was difficult to obtain using traditional methods. Given the trend of increasing popularity of the BSS and data openness in different cities, methods used in this study can extend to examine the biking patterns and BSS functionality in different cities.	Georgia So Univ, Dept Geol & Geog, POB 8149, Statesboro, GA 30460 USA	University System of Georgia; Georgia Southern University	Zhou, XL (corresponding author), Georgia So Univ, Dept Geol & Geog, POB 8149, Statesboro, GA 30460 USA.	xzhou@georgiasouthern.edu						Beecham R, 2014, TRANSPORT PLAN TECHN, V37, P83, DOI 10.1080/03081060.2013.844903; Bonnette B, 2007, IMPLEMENTATION PUBLI; Garcia-Palomares JC, 2012, APPL GEOGR, V35, P235, DOI 10.1016/j.apgeog.2012.07.002; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Come E, 2014, TRANSP RES AR TRA 5; Corcoran J, 2014, J TRANSP GEOGR, V41, P292, DOI 10.1016/j.jtrangeo.2014.09.003; Darren F., 2015, NATL HOUSEHOLD TRAVE; Etienne C, 2014, ACM T INTEL SYST TEC, V5, DOI 10.1145/2560188; Faghih-Imani A, 2014, ANAL DESTINATION CHO; Faghih-Imani A, 2015, J TRANSP GEOGR, V44, P53, DOI 10.1016/j.jtrangeo.2015.03.005; Fishman E, 2013, TRANSPORT REV, V33, P148, DOI 10.1080/01441647.2013.775612; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Froehlich J, 2009, SENSING PREDICTING P; Goodman A, 2014, J TRANSP GEOGR, V41, P272, DOI 10.1016/j.jtrangeo.2014.04.004; Guell C, 2012, SOC SCI MED, V75, P233, DOI 10.1016/j.socscimed.2012.01.038; Guo DS, 2009, IEEE T VIS COMPUT GR, V15, P1041, DOI 10.1109/TVCG.2009.143; Han J., 2006, DATA MINING SE ASIA; Holleczek T, 2013, ARXIV13086705; ITDP, 2013, BIK SHAR PLANN GUID; Jappinen S, 2013, APPL GEOGR, V43, P13, DOI 10.1016/j.apgeog.2013.05.010; Jensen P, 2010, TRANSPORT RES D-TR E, V15, P522, DOI 10.1016/j.trd.2010.07.002; Kaltenbrunner A, 2010, PERVASIVE MOB COMPUT, V6, P455, DOI 10.1016/j.pmcj.2010.07.002; Maizlish N, 2013, AM J PUBLIC HEALTH, V103, P703, DOI 10.2105/AJPH.2012.300939; Midgley P, 2009, JOURNEYS, V2, P23; Nadal L., 2007, BIKE SHARING; Nair R, 2013, INT J SUSTAIN TRANSP, V7, P85, DOI 10.1080/15568318.2012.660115; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; O'Brien O, 2014, J TRANSP GEOGR, V34, P262, DOI 10.1016/j.jtrangeo.2013.06.007; Rae A, 2009, COMPUTERS ENV URBAN, V33, P161, DOI DOI 10.1016/j.compenvurbsys.2009.01.007; Shaheen SA, 2013, INT J TRANSP, V1, P35, DOI 10.14257/ijt.2013.1.1.03; Shaheen SA, 2011, TRANSPORT RES REC, P33, DOI 10.3141/2247-05; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Vogel M, 2014, J TRANSP GEOGR, V41, P280, DOI 10.1016/j.jtrangeo.2014.07.005; Woodruff A., 2012, HUBWAY SNAPSHOT 2012; Zhang LH, 2015, J CLEAN PROD, V97, P124, DOI 10.1016/j.jclepro.2014.04.006; Zhao J, 2015, TRANSPORTATION RESEA; Zhu X, 2014, T GIS, V18, P421, DOI 10.1111/tgis.12100	37	87	89	11	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0137922	10.1371/journal.pone.0137922	http://dx.doi.org/10.1371/journal.pone.0137922			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26445357	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600016
J	Boivin, T; Gidoin, C; von Aderkas, P; Safrana, J; Candau, JN; Chalon, A; Sondo, M; El Maataoui, M				Boivin, Thomas; Gidoin, Cindy; von Aderkas, Patrick; Safrana, Jonathan; Candau, Jean-Noel; Chalon, Alain; Sondo, Marion; El Maataoui, Mohamed			Host-Parasite Interactions from the Inside: Plant Reproductive Ontogeny Drives Specialization in Parasitic Insects	PLOS ONE			English	Article							CONIFER SEED CHALCIDS; MEGASTIGMUS-SPERMOTROPHUS; MOLECULAR PHYLOGENY; POPULATION BIOLOGY; TEMPORAL VARIATION; GALL WASPS; OVIPOSITION; HYMENOPTERA; EVOLUTION; CYPRESS	Host plant interactions are likely key drivers of evolutionary processes involved in the diversification of phytophagous insects. Granivory has received substantial attention for its crucial role in shaping the interaction between plants and their seed parasites, but fine-scale mechanisms explaining the role of host plant reproductive biology on specialization of seed parasites remain poorly described. In a comparative approach using plant histological techniques, we tested the hypotheses that different seed parasite species synchronize their life cycles to specific stages in seed development, and that the stage they target depends on major differences in seed development programs. In a pinaceous system, seed storage products are initiated before ovule fertilization and the wasps target the ovule's nucellus during megagametogenesis, a stage at which larvae may benefit from the by-products derived from both secreting cells and dying nucellar cells. In a cupressaceous system, oviposition activity peaks later, during embryogenesis, and the wasps target the ovule's megagametophyte where larvae may benefit from cell disintegration during embryogenesis. Our cytohistological approach shows for the first time how, despite divergent oviposition targets, different parasite species share a common strategy that consists of first competing for nutrients with developing plant structures, and then consuming these developed structures to complete their development. Our results support the prediction that seed developmental program is an axis for specialization in seed parasites, and that it could be an important parameter in models of their ecological and taxonomic divergence. This study provides the basis for further investigating the possibility of the link between plant ontogeny and pre-dispersal seed parasitism.	[Boivin, Thomas; Gidoin, Cindy; Safrana, Jonathan; Candau, Jean-Noel; Chalon, Alain; Sondo, Marion] INRA, UR Ecol Forets Mediterraneennes 629, F-84914 Avignon, France; [von Aderkas, Patrick] Univ Victoria, Dept Biol, Ctr Forest Biol, Victoria, BC V8W 3N5, Canada; [Candau, Jean-Noel] Nat Resources Canada, Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON P6A 2E5, Canada; [El Maataoui, Mohamed] Univ Avignon, EA 4279, F-84916 Avignon 9, France	INRAE; University of Victoria; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre; Avignon Universite	Boivin, T (corresponding author), INRA, UR Ecol Forets Mediterraneennes 629, F-84914 Avignon, France.	thomas.boivin@avignon.inra.fr		Candau, Jean-Noel/0000-0001-9356-3950; Boivin, Thomas/0000-0003-1694-2425	French Agence Nationale pour la Recherche [ANR 10 INTB 1705 04-MACBI]; Natural Sciences and Engineering Research Council of Canada, Strategic Partnership Program grant [STPGP 396881-2010]	French Agence Nationale pour la Recherche(French National Research Agency (ANR)); Natural Sciences and Engineering Research Council of Canada, Strategic Partnership Program grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	TB, CG, MS, AC, JS and MEM received grants from the French Agence Nationale pour la Recherche (ANR 10 INTB 1705 04-MACBI), http://www.agence-nationale-recherche.fr/. PvA and JNC received grants from The Natural Sciences and Engineering Research Council of Canada, Strategic Partnership Program grant (STPGP 396881-2010), http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arista M, 2001, FLORA, V196, P114, DOI 10.1016/S0367-2530(17)30026-9; Auger-Rozenberg MA, 2012, MOL ECOL, V21, P6086, DOI 10.1111/mec.12077; Auger-Rozenberg MA, 2006, SYST ENTOMOL, V31, P47, DOI 10.1111/j.1365-3113.2005.00310.x; Auger-Rozenberg MA, 2012, INTEGR ZOOL, V7, P228, DOI 10.1111/j.1749-4877.2012.00308.x; Boivin T, 2014, MOL ECOL, V23, P2362, DOI 10.1111/mec.12737; Boivin T, 2003, GENET RES, V81, P169, DOI 10.1017/S0016672303006244; Boivin T, 2008, BIOL INVASIONS, V10, P1013, DOI 10.1007/s10530-007-9180-3; Bonal R, 2011, OECOLOGIA, V167, P1053, DOI 10.1007/s00442-011-2036-7; Candau JN, 2015, TICTALK, V12, P22; Chowdhury C. R., 1961, Phytomorphology, V11, P283; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; El Maataoui M, 1999, PLANTA, V208, P345, DOI 10.1007/s004250050568; El Maataoui M, 1998, THEOR APPL GENET, V96, P776, DOI 10.1007/s001220050801; Fabre JP, 2004, BIOL INVASIONS, V6, P11, DOI 10.1023/B:BINV.0000010119.51131.19; Finney D. J., 1978, Statistical method in biological assay.; Gidoin C, 2015, J ANIM ECOL, V84, P396, DOI 10.1111/1365-2656.12303; Grissell E.E., 1999, Contributions of the American Entomological Institute, V31, P1; Hamm CA, 2015, EVOLUTION, V69, P589, DOI 10.1111/evo.12593; Harman HM, 1999, BIOL CONTROL, V15, P228, DOI 10.1006/bcon.1999.0715; HEDLIN A. F., 1956, CANADIAN ENT, V88, P691; Hughes J, 2004, MOL PHYLOGENET EVOL, V32, P601, DOI 10.1016/j.ympev.2004.02.007; Hulme Philip E., 2002, P132; Hulme Philip E., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P32, DOI 10.1078/1433-8319-00050; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Jousselin E, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-56; Kolb A, 2007, PERSPECT PLANT ECOL, V9, P79, DOI 10.1016/j.ppees.2007.09.001; Krouchi F, 2004, FOREST ECOL MANAG, V197, P181, DOI 10.1016/j.foreco.2004.05.013; Linkies A, 2010, NEW PHYTOL, V186, P817, DOI 10.1111/j.1469-8137.2010.03249.x; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; McClure M, 1998, ENTOMOL EXP APPL, V87, P1, DOI 10.1023/A:1003286823299; Miller JM, 1916, J AGRIC RES, V6, P65; Moegenburg SM, 1996, OECOLOGIA, V106, P539, DOI 10.1007/BF00329713; OWENS JN, 1985, FOREST TREE SEED PRO; PETTITT JM, 1977, PROC R SOC SER B-BIO, V195, P497, DOI 10.1098/rspb.1977.0023; POWELL GR, 1991, CAN J BOT, V69, P1179, DOI 10.1139/b91-151; ROQUES A, 1986, J APPL ENTOMOL, V101, P370, DOI 10.1111/j.1439-0418.1986.tb00871.x; ROQUES A, 1984, Ecologia Mediterranea, V10, P147; ROQUES A, 1981, ACTA OECOL-OEC APPL, V2, P161; Roques A, 2003, BIODIVERS CONSERV, V12, P2195, DOI 10.1023/A:1024592716172; Rossi MN, 2011, ARTHROPOD-PLANT INTE, V5, P209, DOI 10.1007/s11829-011-9130-y; Rouault G, 2004, NATURWISSENSCHAFTEN, V91, P472, DOI 10.1007/s00114-004-0554-4; Sallandrouze A, 2002, PHYSIOL PLANTARUM, V114, P608, DOI 10.1034/j.1399-3054.2002.1140415.x; Shorthouse JD, 2005, BASIC APPL ECOL, V6, P423, DOI 10.1016/j.baae.2005.07.006; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; Singh H., 1978, EMBRYOLOGY GYMNOSPER; Stone GN, 1998, P ROY SOC B-BIOL SCI, V265, P979, DOI 10.1098/rspb.1998.0387; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Takagi E, 2010, EUR J ENTOMOL, V107, P197, DOI 10.14411/eje.2010.026; Toth J, 1978, THESIS U MARSEILLES; TURGEON JJ, 1994, ANNU REV ENTOMOL, V39, P179, DOI 10.1146/annurev.en.39.010194.001143; Van Klinken RD, 2005, AUSTRAL ECOL, V30, P414, DOI 10.1111/j.1442-9993.2005.01483.x; von Aderkas P, 2005, P ROY SOC B-BIOL SCI, V272, P1491, DOI 10.1098/rspb.2005.3061; WEIS AE, 1988, ANNU REV ENTOMOL, V33, P467, DOI 10.1146/annurev.en.33.010188.002343; Woodenberg WR, 2010, PLANT GROWTH REGUL, V62, P265, DOI 10.1007/s10725-010-9469-6; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	57	2	2	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139634	10.1371/journal.pone.0139634	http://dx.doi.org/10.1371/journal.pone.0139634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26441311	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510300039
J	Lee, HJ; Lee, HC; Kim, YM; Hwang, YS; Park, YH; Park, TS; Han, JY				Lee, Hong Jo; Lee, Hyung Chul; Kim, Young Min; Hwang, Young Sun; Park, Young Hyun; Park, Tae Sub; Han, Jae Yong			Site-specific recombination in the chicken genome using Flipase recombinase-mediated cassette exchange	FASEB JOURNAL			English	Article						transgene integration; piggyBac transposition; transgenic chicken; primordial germ cell	PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS; TRANSGENIC CHICKENS; EGG-WHITE; EXPRESSION; PROMOTER; MICE; PIGGYBAC; PROTEIN; LINE	Targeted genome recombination has been applied in diverse research fields and has a wide range of possible applications. In particular, the discovery of specific loci in the genome that support robust and ubiquitous expression of integrated genes and the development of genome-editing technology have facilitated rapid advances in various scientific areas. In this study, we produced transgenic (TG) chickens that can induce recombinase-mediated gene cassette exchange (RMCE), one of the site-specific recombination technologies, and confirmed RMCE in TG chicken-derived cells. As a result, we established TG chicken lines that have, Flipase (Flp) recognition target (FRT) pairs in the chicken genome, mediated by piggyBac transposition. The transgene integration patterns were diverse in each TG chicken line, and the integration diversity resulted in diverse levels of expression of exogenous genes in each tissue of the TG chickens. In addition, the replaced gene cassette was expressed successfully and maintained by RMCE in the FRT predominant loci of TGchicken-derived cells. These results indicate that targeted genome recombination technology with RMCE could be adaptable to TG chicken models and that the technology would be applicable to specific gene regulation by cis-element insertion and customized expression of functional proteins at predicted levels without epigenetic influence.	[Lee, Hong Jo; Lee, Hyung Chul; Kim, Young Min; Hwang, Young Sun; Park, Young Hyun; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151921, South Korea; [Park, Tae Sub] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun, Gangwon Do, South Korea; [Park, Tae Sub] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang Gun, Gangwon Do, South Korea; [Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Nagano, Japan	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Shinshu University	Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151921, South Korea.	jaehan@snu.ac.kr		Park, Young Hyun/0000-0003-2482-9211; Hwang, Young Sun/0000-0002-6443-9579	Cooperative Research Program for Agriculture Science and Technology Development (Rural Development Administration, Seoul, Korea) [PJ010533012015]; National Research Foundation of Korea [2015R1A3A2033826]	Cooperative Research Program for Agriculture Science and Technology Development (Rural Development Administration, Seoul, Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was performed with the support of Project PJ010533012015 of the Cooperative Research Program for Agriculture Science and Technology Development (Rural Development Administration, Seoul, Korea) and a National Research Foundation of Korea Grant No. 2015R1A3A2033826 (Ministry of Science, ICT and Future Planning, Seoul, Korea). The authors declare no conflicts of interest.	Cesari F, 2004, GENESIS, V38, P87, DOI 10.1002/gene.20003; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Graham Catriona, 2009, Biotechnology Journal, V4, P108, DOI 10.1002/biot.200800200; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Jang HJ, 2013, MOL BIOTECHNOL, V54, P177, DOI 10.1007/s12033-012-9560-5; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Laible G, 2015, BIOTECHNOL J, V10, P109, DOI 10.1002/biot.201400193; Lee SH, 2013, POULTRY SCI, V92, P2396, DOI 10.3382/ps.2013-03223; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; LOVE J, 1994, BIO-TECHNOL, V12, P60, DOI 10.1038/nbt0194-60; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Ohtsuka M, 2014, METHODS MOL BIOL, V1194, P3, DOI 10.1007/978-1-4939-1215-5_1; Oishi I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-5; Park KE, 2014, REPROD FERT DEVELOP, V26, P65, DOI 10.1071/RD13258; Park SH, 2010, THERIOGENOLOGY, V74, P805, DOI 10.1016/j.theriogenology.2010.04.005; Park TS, 2015, FASEB J, V29, P2386, DOI 10.1096/fj.14-264739; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Radhakrishnan P, 2008, INT J BIOCHEM CELL B, V40, P1944, DOI 10.1016/j.biocel.2008.02.014; Roebroek AJM, 2006, MOL CELL BIOL, V26, P605, DOI 10.1128/MCB.26.2.605-616.2006; SALTER DW, 1986, POULTRY SCI, V65, P1445, DOI 10.3382/ps.0651445; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Schusser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080108; Sonoda E, 2001, PHILOS T ROY SOC B, V356, P111, DOI 10.1098/rstb.2000.0755; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Turan S, 2011, J MOL BIOL, V407, P193, DOI 10.1016/j.jmb.2011.01.004; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	38	19	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					555	563		10.1096/fj.15-274712	http://dx.doi.org/10.1096/fj.15-274712			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26443821				2022-12-26	WOS:000369391900009
J	Riquelme, MA; Burra, S; Kar, R; Lampe, PD; Jiang, JX				Riquelme, Manuel A.; Burra, Sirisha; Kar, Rekha; Lampe, Paul D.; Jiang, Jean X.			Mitogen-activated Protein Kinase (MAPK) Activated by Prostaglandin E2 Phosphorylates Connexin 43 and Closes Osteocytic Hemichannels in Response to Continuous Flow Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; MECHANICAL STRAIN; ERK ACTIVATION; UP-REGULATION; CELLS; RELEASE; RECEPTOR; PGE(2); RATS; E-2	Cx43 hemichannels serve as a portal for the release of prostaglandins, a critical process in mediating biological responses of mechanical loading on bone formation and remodeling. We have previously observed that fluid flow shear stress (FESS) opens hemichannels; however, sustained FESS results in hemichannel closure, as continuous opening of hemichannels is detrimental to cell viability and bone remodeling. However, the mechanism that regulates the closure of the hemichannels is unknown. Here, we show that activation of p44/42 ERK upon continuous ITSS leads to Cx43 phosphorylation at Ser(279)-Ser(282), sites known to be phosphorylated sites by p44/42 MAPK. Incubation of osteocytic MLO-Y4 cells with conditioned media (CM) collected after continuous FESS increased MAPK-dependent phosphorylation of Cx43. CM treatment inhibited hemichannel opening and this inhibition was reversed when cells were pretreated with the MAPK pathway inhibitor. We found that prostaglandin E-2 (PGE(2)) accumulates in the CM in a time-dependent manner. Treatment with PGE, increased phosphop44/42 ERK levels and also Cx43 phosphorylation at Ser(279)-Ser(282) sites. Depletion of PGE(2) from CM, and pre-treatment with a p44/42 ERK pathway-specific inhibitor, resulted in a complete inhibition of ERK-dependent Cx43 phosphorylation and attenuated the inhibition of hemichannels by CM and PGE(2). Consistently, the opening of hemichannels by FESS was blocked by PGE, and CM and this blockage was reversed by U0126 and the CM depleted of PGE(2). A similar observation was also obtained in isolated primary osteocytes. Together, results from this study suggest that extracellular PGE(2) accumulated after continuous FFSS is responsible for activation of p44/42 ERK signaling and subsequently, direct Cx43 phosphorylation by activated ERK leads to hemichannel closure.	[Riquelme, Manuel A.; Burra, Sirisha; Kar, Rekha; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Translat Res Program, Seattle, WA 98109 USA	University of Texas System; University of Texas Health San Antonio; Fred Hutchinson Cancer Center	Jiang, JX (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Riquelme, Manuel/B-1082-2015; Regan, Clinton/E-6250-2012	Riquelme, Manuel/0000-0002-1915-0434; Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [AR46798, GM55632]; Welch Foundation [AQ-1507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR046798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR46798 and GM55632 and Welch Foundation Grant AQ-1507. We declare that they have no conflicts of interest with the contents of this article.	Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Batra N, 2014, J BIOL CHEM, V289, P10582, DOI 10.1074/jbc.M114.550608; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Burra S, 2010, P NATL ACAD SCI USA, V107, P13648, DOI 10.1073/pnas.1009382107; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Harada S I, 1995, Connect Tissue Res, V31, P279, DOI 10.3109/03008209509010823; Johnson KE, 2013, MOL BIOL CELL, V24, P715, DOI 10.1091/mbc.E12-07-0537; Kajii T, 1999, ARCH ORAL BIOL, V44, P233, DOI 10.1016/S0003-9969(98)00120-4; KE HZ, 1992, CALCIFIED TISSUE INT, V50, P245, DOI 10.1007/BF00296289; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; OKUDA A, 1989, BONE MINER, V7, P255, DOI 10.1016/0169-6009(89)90082-2; Ono K, 2002, J BONE MINER RES, V17, P774, DOI 10.1359/jbmr.2002.17.5.774; Pahujaa M, 2007, EXP CELL RES, V313, P4083, DOI 10.1016/j.yexcr.2007.09.010; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Siller-Jackson AJ, 2008, J BIOL CHEM, V283, P26374, DOI 10.1074/jbc.M803136200; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; TenBroek EM, 2001, J CELL BIOL, V155, P1307, DOI 10.1083/jcb.200102017; Tian XY, 2008, BONE, V42, P914, DOI 10.1016/j.bone.2007.12.228; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; Yu L, 2009, INT J CANCER, V125, P2540, DOI 10.1002/ijc.24607	33	37	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28321	28328		10.1074/jbc.M115.683417	http://dx.doi.org/10.1074/jbc.M115.683417			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26442583	Green Published, hybrid			2022-12-26	WOS:000365761900024
J	Davis, KE; Hesketh, TW; Delmer, C; Wills, MA				Davis, Katie E.; Hesketh, Thomas W.; Delmer, Cyrille; Wills, Matthew A.			Towards a Supertree of Arthropoda: A Species-Level Supertree of the Spiny, Slipper and Coral Lobsters (Decapoda: Achelata)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; UNSUPPORTED RELATIONSHIPS; MATRIX REPRESENTATION; MOLECULAR-DATA; CRUSTACEA; SCYLLARIDAE; BUTTERFLIES; LIKELIHOOD; EVOLUTION; SUPPORT	While supertrees have been built for many vertebrate groups (notably birds, mammals and dinosaurs), invertebrates have attracted relatively little attention. The paucity of supertrees of arthropods is particularly surprising given their economic and ecological importance, as well as their overwhelming contribution to biodiversity. The absence of comprehensive archives of machine-readable source trees, coupled with the need for software implementing repeatable protocols for managing them, has undoubtedly impeded progress. Here we present a supertree of Achelata (spiny, slipper and coral lobsters) as a proof of concept, constructed using new supertree specific software (the Supertree Toolkit; STK) and following a published protocol. We also introduce a new resource for archiving and managing published source trees. Our supertree of Achelata is synthesised from morphological and molecular source trees, and represents the most complete species-level tree of the group to date. Our findings are consistent with recent taxonomic treatments, confirming the validity of just two families: Palinuridae and Scyllaridae; Synaxidae were resolved within Palinuridae. Monophyletic Silentes and Stridentes lineages are recovered within Palinuridae, and all sub-families within Scyllaridae are found to be monophyletic with the exception of Ibacinae. We demonstrate the feasibility of building larger supertrees of arthropods, with the ultimate objective of building a complete species-level phylogeny for the entire phylum using a divide and conquer strategy.	[Davis, Katie E.; Hesketh, Thomas W.; Delmer, Cyrille; Wills, Matthew A.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Davis, KE (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	k.davis2@bath.ac.uk	Wills, Matthew Albion/AAE-1790-2019	Wills, Matthew/0000-0002-7344-7749	BBSRC (Biotechnology and Biological Sciences Research Council) [BB/K006754/1]; SynTax (Systematics and Taxonomy research scheme) grant; BBSRC [BB/K006754/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K006754/1, BB/C006682/1] Funding Source: researchfish	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SynTax (Systematics and Taxonomy research scheme) grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC (Biotechnology and Biological Sciences Research Council) grant BB/K006754/1 awarded to MAW (PI) and KED (Researcher CoI) (URL: http://www.bbsrc.ac.uk/pa/grants/AwardDetails.aspx?FundingReference=BB%2FK006754%2F1), and by a SynTax (Systematics and Taxonomy research scheme) grant to MAW (URL: http://www.systass.org/awards/syntax.shtml#results10-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIS J, 1990, J TROP ECOL, V6, P115, DOI 10.1017/S0266467400004107; Akanni WA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-183; Altermatt F, 2011, AM NAT, V178, P372, DOI 10.1086/661248; BAUM BR, 2004, COMPU BIOL, V4, P17; Bernhard D, 2009, INSECT SYST EVOL, V40, P3, DOI 10.1163/187631209X416741; Beutel RG, 2007, ORG DIVERS EVOL, V7, P255, DOI 10.1016/j.ode.2006.05.003; Bininda-Emonds O.R., 2004, COMPU BIOL, P267; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bininda-Emonds Olaf R. P., 2010, Palaeodiversity, P99; Bininda-Emonds ORP, 2003, SYST BIOL, V52, P839, DOI 10.1080/10635150390252242; Bininda-Emonds ORP, 1998, SYST BIOL, V47, P497; Bracken HDB, ARTHROPOD SYSTEMATIC, V67, P99; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Cotton JA, 2006, SYST BIOL, V55, P345, DOI 10.1080/10635150500481556; Dabert J, 2001, MOL PHYLOGENET EVOL, V20, P124, DOI 10.1006/mpev.2001.0948; Davis KE, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.c1af68dda7c999ed9f1e4b2d2df7a08e; Davis Katie E, 2010, BMC Res Notes, V3, P95, DOI 10.1186/1756-0500-3-95; Davis KE, FIGSHARE; Davis RB, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-252; Davis RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-109; Martins LD, 2016, SYST BIOL, V65, P397, DOI 10.1093/sysbio/syu082; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gatesy J, 2004, SYST BIOL, V53, P342, DOI 10.1080/10635150490423971; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Higgins L, 2011, EVOL ECOL, V25, P1289, DOI 10.1007/s10682-011-9475-9; Higginson DM, 2012, P NATL ACAD SCI USA, V109, P4538, DOI 10.1073/pnas.1111474109; Hill J, SUPERTREE TOOLKIT DA; Hill Jon, 2014, Biodivers Data J, pe1053, DOI 10.3897/BDJ.2.e1053; Huang DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034459; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Lee MSY, 2007, SYST BIODIVERS, V5, P371, DOI 10.1017/S1477200007002290; Lind EM, 2010, ECOLOGY, V91, P3274, DOI 10.1890/09-1894.1; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; May Robert M., 2000, P30; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palero F, 2009, MOL PHYLOGENET EVOL, V50, P152, DOI 10.1016/j.ympev.2008.10.003; Pisani D, 2002, P ROY SOC B-BIOL SCI, V269, P915, DOI 10.1098/rspb.2001.1942; Poyry J, 2009, GLOBAL CHANGE BIOL, V15, P732, DOI 10.1111/j.1365-2486.2008.01789.x; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Rambaut A., FIGTREE; Redak RA, 2000, ENVIRON MANAGE, V26, pS97; Rudd MA, 2001, ENVIRON CONSERV, V28, P226, DOI 10.1017/S0376892901000236; Sanderson MJ, 1998, TRENDS ECOL EVOL, V13, P105, DOI 10.1016/S0169-5347(97)01242-1; Sekar S, 2012, J ANIM ECOL, V81, P174, DOI 10.1111/j.1365-2656.2011.01909.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; von Haeseler A, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-13; Wilkinson M, 2005, SYST BIOL, V54, P823, DOI 10.1080/10635150590950362; Wilson Edward O., 2000, P22; WoRMS Editorial Board, WORLD REGISTER MARIN; Yang CH, 2012, MOL PHYLOGENET EVOL, V62, P237, DOI 10.1016/j.ympev.2011.09.019; Yang CH, 2011, ZOOSYSTEMA, V33, P207, DOI 10.5252/z2011n2a4; Yang CH, 2008, RAFFLES B ZOOL, P71	54	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0140110	10.1371/journal.pone.0140110	http://dx.doi.org/10.1371/journal.pone.0140110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26461106	gold, Green Submitted, Green Published			2022-12-26	WOS:000362962300054
J	Radhapriya, P; Ramachandran, A; Anandham, R; Mahalingam, S				Radhapriya, Parthasarathy; Ramachandran, Andimuthu; Anandham, Rangasamy; Mahalingam, Sundararajan			Pseudomonas aeruginosa RRALC3 Enhances the Biomass, Nutrient and Carbon Contents of Pongamia pinnata Seedlings in Degraded Forest Soil	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; CAENORHABDITIS-ELEGANS; SONORAN DESERT; RHIZOSPHERE; MICROORGANISMS; IDENTIFICATION; BACTERIA; WHEAT; HOST; VIRULENCE	The study was aimed at assessing the effects of indigenous Plant Growth Promoting Bacterium (PGPB) on the legume Pongamia pinnata in the degraded soil of the Nanmangalam Reserve Forest (NRF) under nursery conditions. In total, 160 diazotrophs were isolated from three different nitrogen-free semi-solid media (LGI, Nfb, and JMV). Amongst these isolates, Pseudomonas aeruginosa RRALC3 exhibited the maximum ammonia production and hence was selected for further studies. RRALC3 was found to possess multiple plant growth promoting traits such as nitrogen accumulation (120.6ppm); it yielded a positive amplicon with nifH specific primers, tested positive for Indole Acetic Acid (IAA; 18.3 mu g/ml) and siderophore production, tested negative for HCN production and was observed to promote solubilization of phosphate, silicate and zinc in the plate assay. The 16S rDNA sequence of RRALC3 exhibited 99% sequence similarity to Pseudomonas aeruginosa JCM5962. Absence of virulence genes and non-hemolytic activity indicated that RRALC3 is unlikely to be a human pathogen. When the effects of RRALC3 on promotion of plant growth was tested in Pongamia pinnata, it was observed that in Pongamia seedlings treated with a combination of RRALC3 and chemical fertilizer, the dry matter increased by 30.75%. Nitrogen, phosphorus and potassium uptake increased by 34.1%, 27.08%, and 31.84%, respectively, when compared to control. Significant enhancement of total sugar, amino acids and organic acids content, by 23.4%, 29.39%, and 26.53% respectively, was seen in the root exudates of P. pinnata. The carbon content appreciated by 4-fold, when fertilized seedlings were treated with RRALC3. From the logistic equation, the rapid C accumulation time of Pongamia was computed as 43 days longer than the control when a combination of native PGPB and inorganic fertilizer was applied. The rapid accumulation time of N, P and K in Pongamia when treated with the same combination as above was 15, 40 and 33 days longer, respectively, as compared to the control.	[Radhapriya, Parthasarathy; Ramachandran, Andimuthu] Anna Univ, Ctr Climate Change & Adaptat Res, Madras 600025, Tamil Nadu, India; [Anandham, Rangasamy] Tamil Nadu Agr Univ, Coll Agr, Dept Agr Microbiol, Madurai 625104, Tamil Nadu, India; [Anandham, Rangasamy] Tamil Nadu Agr Univ, Res Inst, Madurai 625104, Tamil Nadu, India; [Mahalingam, Sundararajan] Anna Univ, Ctr Biotechnol, Madras 600025, Tamil Nadu, India	Anna University; Anna University Chennai; Tamil Nadu Agricultural University; Tamil Nadu Agricultural University; Anna University; Anna University Chennai	Radhapriya, P (corresponding author), Anna Univ, Ctr Climate Change & Adaptat Res, Madras 600025, Tamil Nadu, India.	radhapriya.cc@gmail.com	/AAP-2425-2020; /CAA-2711-2022	/0000-0002-8157-3219; /0000-0002-8157-3219; Radhapriya, Parthasarathy/0000-0001-7568-0176; Rangasamy, Anandham/0000-0002-3496-564X	University Grants Commission-Basic Science Research (UGC-BSR) [F.4-1/2006 (BSR)/5-7/2007 (BSR)]	University Grants Commission-Basic Science Research (UGC-BSR)	PR received University Grants Commission-Basic Science Research (UGC-BSR) UGC Sanction. No. F.4-1/2006 (BSR)/5-7/2007 (BSR), dated 16.11.2009, which provided financial support for this research work. The authors convey their heartfelt gratitude for the extensive support rendered by the Tamil Nadu Forest Department, Chennai.	Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; Abbasi MK, 2011, PLANT BIOSYST, V145, P159, DOI 10.1080/11263504.2010.542318; Adesemoye AO, 2008, BRAZ J MICROBIOL, V39, P423, DOI 10.1590/S1517-83822008000300003; Adesemoye AO, 2009, APPL MICROBIOL BIOT, V85, P1, DOI 10.1007/s00253-009-2196-0; Ahangar MA, 2012, ANN FOR RES, V55, P217; Ahemad M, 2010, ARCH ENVIRON CON TOX, V58, P361, DOI 10.1007/s00244-009-9382-z; Ambrosini A, 2012, PLANT SOIL, V356, P245, DOI 10.1007/s11104-011-1079-1; Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; Anuj SN, 2009, DIAGN MICR INFEC DIS, V63, P127, DOI 10.1016/j.diagmicrobio.2008.09.018; Aslantas R, 2007, SCI HORTIC-AMSTERDAM, V111, P371, DOI 10.1016/j.scienta.2006.12.016; Audenaert K, 2002, MOL PLANT MICROBE IN, V15, P1147, DOI 10.1094/MPMI.2002.15.11.1147; Balcht A, 1994, INFORM HLTH CARE, P83; Barua S, 2012, MICROBIOL RES, V167, P95, DOI 10.1016/j.micres.2011.04.001; Bashan Y, 2012, J ENVIRON MANAGE, V102, P26, DOI 10.1016/j.jenvman.2011.12.032; Bashan Y, 2009, BIOL FERT SOILS, V45, P655, DOI 10.1007/s00374-009-0368-9; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Berg G, 2014, MICROB BIOTECHNOL, V7, P487, DOI 10.1111/1751-7915.12159; BERGERSEN FJ, 1980, J GEN MICROBIOL, V118, P235; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNT JS, 1955, J SOIL SCI, V6, P119, DOI 10.1111/j.1365-2389.1955.tb00836.x; Cappuccino J. C., 1992, MICROBIOLOGY LAB MAN, Vthird, P125, DOI DOI 10.2307/1309615; Choi JY, 2002, J BACTERIOL, V184, P952, DOI 10.1128/jb.184.4.952-961.2002; Conn VM, 2004, APPL ENVIRON MICROB, V70, P6407, DOI 10.1128/AEM.70.11.6407-6413.2004; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Das SN, 2010, J PLANT GROWTH REGUL, V29, P409, DOI 10.1007/s00344-010-9152-1; de los Santos-Villalobos S, 2013, J PLANT GROWTH REGUL, V32, P615, DOI 10.1007/s00344-013-9329-5; Drezner TD, 2006, PLANT ECOL, V183, P171, DOI 10.1007/s11258-005-9015-1; Egamberdieva D, 2008, TURK J BIOL, V32, P9; Ewbank JJ, 2002, MICROBES INFECT, V4, P247, DOI 10.1016/S1286-4579(01)01531-3; FAO, 2009, 154 FAO FRA; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; Garcia JAL, 2004, ENVIRON EXP BOT, V52, P239, DOI 10.1016/j.envexpbot.2004.02.003; Gaur A.C., 1990, PHOSPHATE SOLUBILIZI; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Goswami D, 2015, PLANT GROWTH REGUL, V75, P253, DOI 10.1007/s10725-014-9949-1; Goswami D, 2013, J PLANT INTERACT, V8, P281, DOI 10.1080/17429145.2013.768360; GOVAN JRW, 1992, BRIT MED BULL, V48, P912, DOI 10.1093/oxfordjournals.bmb.a072585; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; HECK LW, 1990, J IMMUNOL, V144, P2253; Hooper E, 2002, ECOL APPL, V12, P1626, DOI 10.1890/1051-0761(2002)012[1626:RONTST]2.0.CO;2; Hussain A, 2011, WORLD J MICROB BIOT, V27, P2645, DOI 10.1007/s11274-011-0738-y; Islam R, 2010, BIOL FERT SOILS, V46, P261, DOI 10.1007/s00374-009-0425-4; Jha B, 2009, EUR J SOIL BIOL, V45, P62, DOI 10.1016/j.ejsobi.2008.06.007; Johnson CM, 1959, CALIFORNIA AGR EXP S, V766, P44; Karakurt H, 2011, TURK J BIOL, V35, P283, DOI 10.3906/biy-0908-35; Kasim WA, 2013, J PLANT GROWTH REGUL, V32, P122, DOI 10.1007/s00344-012-9283-7; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Kremer RJ, 2001, CURR MICROBIOL, V43, P182, DOI 10.1007/s002840010284; Kumar P, 2012, MICROBIOL RES, V167, P493, DOI 10.1016/j.micres.2012.05.002; LIFSHITZ R, 1987, CAN J MICROBIOL, V33, P390, DOI 10.1139/m87-068; Lindsey WL, 1969, AGR ABSTR, V61, P84; Liu FC, 2013, APPL MICROBIOL BIOT, V97, P4617, DOI 10.1007/s00253-012-4255-1; Hernandez YL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00038; Lu RK, 1999, J CHROMATOGR, V336, P93; Lugtenberg BJJ, 1999, ENVIRON MICROBIOL, V1, P9, DOI 10.1046/j.1462-2920.1999.00005.x; Lund HG, WHAT IS DEGRADED FOR; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Olsen SR, 1982, METHODS SOIL ANAL CH, P1159; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Pirlak L, 2007, J SUSTAIN AGR, V30, P145, DOI 10.1300/J064v30n04_11; Putz FE, 2009, GLOBAL ENVIRON CHANG, V19, P400, DOI 10.1016/j.gloenvcha.2009.07.005; PUZOVA H, 1994, FOLIA MICROBIOL, V39, P337, DOI 10.1007/BF02814324; Quinn JP, 1998, CLIN INFECT DIS, V27, pS117, DOI 10.1086/514912; Radhapriya P, 2014, J ENVIRON BIOL, V35, P1137; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Ramachandran A., 2007, Indian Forester, V133, P25; Rana A, 2011, ANN MICROBIOL, V61, P893, DOI 10.1007/s13213-011-0211-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sasirekha Bhakthavatchalu, 2013, Annals of Biological Research, V4, P214; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; Shishido M, 1998, SOIL BIOL BIOCHEM, V30, P939, DOI 10.1016/S0038-0717(97)00184-3; Shukla PS, 2012, J PLANT GROWTH REGUL, V31, P195, DOI 10.1007/s00344-011-9231-y; Singh G, 2010, J PLANT NUTR, V33, P1236, DOI 10.1080/01904161003765760; Suhardi, 2008, REHABILITATION DEGRA, P27; Sundara B, 2002, FIELD CROP RES, V77, P43, DOI 10.1016/S0378-4290(02)00048-5; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995; VAZQUEZ F, 1992, EUR J CLIN MICROBIOL, V11, P698, DOI 10.1007/BF01989973; Wahyudi A. T., 2011, American Journal of Agricultural and Biological Sciences, V6, P134, DOI 10.3844/ajabssp.2011.134.141; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Wang CY, 2011, PHYSICA A, V390, P1, DOI 10.1016/j.physa.2010.03.053; Wang DL, 1998, COMMUN SOIL SCI PLAN, V29, P15, DOI 10.1080/00103629809369925; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487	90	25	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2015	10	10							e0139881	10.1371/journal.pone.0139881	http://dx.doi.org/10.1371/journal.pone.0139881			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT6ZJ	26460867	Green Submitted, Green Published, gold			2022-12-26	WOS:000362962300030
J	Sellmer, A; Hjortdal, VE; Bjerre, JV; Schmidt, MR; McNamara, PJ; Bech, BH; Henriksen, TB				Sellmer, Anna; Hjortdal, Vibeke Elisabeth; Bjerre, Jesper Vandborg; Schmidt, Michael Rahbek; McNamara, Patrick J.; Bech, Bodil Hammer; Henriksen, Tine Brink			N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study	PLOS ONE			English	Article							PATENT DUCTUS-ARTERIOSUS; CONGENITAL CARDIAC-DISEASE; HEMODYNAMIC SIGNIFICANCE; HEART; INFANTS; CHILDREN; BNP; EXPRESSION; MANAGEMENT; DIAGNOSIS	Background Bronchopulmonary dysplasia (BPD) is a serious complication of preterm birth. Plasma N-terminal pro-B type natriuretic peptide (NT-proBNP) has been suggested as a marker that may predict BPD within a few days after birth. Objectives To investigate the association between NT-proBNP day three and bronchopulmonary dysplasia (BPD) or death and further to assess the impact of patent ductus arteriosus (PDA) on this association in neonates born before 32 gestational weeks. Methods A cohort study of 183 neonates born before 32 gestational weeks consecutively admitted to the Neonatal Intensive Care Unit, Aarhus University Hospital, Denmark. On day three plasma samples were collected and echocardiography carried out. NT-proBNP was measured by routine immunoassays. The combined outcome BPD or death was assessed at 36 weeks of postmenstrual age. Receiver operator characteristic (ROC) analysis was performed to determine the discrimination ability of NT-proBNP by the natural log continuous measure to recognize BPD or death. The association of BPD or death was assessed in relation to natural log NT-proBNP levels day three. Results The risk of BPD or death increased 1.7-fold with one unit increase of natural log NT-proBNP day three when adjusted for gestational age at birth (OR = 1.7, 95% CI 1.3; 2.3). The association was found both in neonates with and without a PDA. Adjusting for GA, PDA diameter, LA: Ao-ratio, or early onset sepsis did not change the estimate. Conclusion We found NT-proBNP to be associated with BPD or death in very preterm neonates. This association was not only explained by the PDA. We speculate that NT-proBNP may help the identification of neonates at risk of BPD as early as postnatal day three.	[Sellmer, Anna; Bjerre, Jesper Vandborg; Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus, Denmark; [Sellmer, Anna; Henriksen, Tine Brink] Aarhus Univ, Perinatal Epidemiol Res Unit, Aarhus, Denmark; [Sellmer, Anna] Herning Reg Hosp, Dept Pediat, Herning, Denmark; [Hjortdal, Vibeke Elisabeth] Aarhus Univ Hosp, Dept Cardiothorac Surg, DK-8000 Aarhus, Denmark; [Schmidt, Michael Rahbek] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [McNamara, Patrick J.] Hosp Sick Children, Div Neonatol, Toronto, ON M5G 1X8, Canada; [Bech, Bodil Hammer] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aarhus University	Sellmer, A (corresponding author), Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus, Denmark.	anna.sellmer@clin.au.dk	MCNAMARA, PATRICK J/M-6244-2018; Bech, Bodil Hammer/B-9646-2016	Bech, Bodil Hammer/0000-0002-0287-3687; Hjortdal, Vibeke/0000-0002-8047-0015; Henriksen, Tine Brink/0000-0001-6933-8294; McNamara, Patrick/0000-0001-7648-8872	Aarhus University Faculty of Health Science and Clinical Institute; Aarhus University Research Foundation; Aase og Ejnar Danielsen Foundation; Sophus Jacobsen and Astrid Jacobsen Foundation; Kurt Bonnelycke and Grethe Bonnelycke Foundation; Karl G. Andersson Foundation	Aarhus University Faculty of Health Science and Clinical Institute; Aarhus University Research Foundation; Aase og Ejnar Danielsen Foundation; Sophus Jacobsen and Astrid Jacobsen Foundation; Kurt Bonnelycke and Grethe Bonnelycke Foundation; Karl G. Andersson Foundation	Funding for the study was obtained from Aarhus University Faculty of Health Science and Clinical Institute (http://health.au.dk/en/), Aarhus University Research Foundation (http://auff.au.dk/en/), Aase og Ejnar Danielsen Foundation (www.danielsensfond.dk), Sophus Jacobsen and Astrid Jacobsen Foundation, Kurt Bonnelycke and Grethe Bonnelycke Foundation, and Karl G. Andersson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6; Cantinotti M, 2015, CARDIOL YOUNG, V25, P424, DOI 10.1017/S1047951114002133; Cantinotti M, 2014, HEART FAIL REV, V19, P727, DOI 10.1007/s10741-014-9422-2; Clerico A, 2011, AM J PHYSIOL-HEART C, V301, pH12, DOI 10.1152/ajpheart.00226.2011; Czernik C, 2011, PEDIATRICS, V128, pE545, DOI 10.1542/peds.2011-0603; da Graca RL, 2006, PEDIATRICS, V117, P2183, DOI 10.1542/peds.2005-1387; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Del Ry S, 2013, PHARMACOL RES, V76, P190, DOI 10.1016/j.phrs.2013.08.006; Doyle LW, 2009, SEMIN FETAL NEONAT M, V14, P391, DOI 10.1016/j.siny.2009.08.004; El Hajjar M, 2005, ARCH DIS CHILD-FETAL, V90, pF419, DOI 10.1136/adc.2003.027698; El-Khuffash A, 2008, ARCH DIS CHILD-FETAL, V93, P1407, DOI 10.1136/adc.2007.133140; El-Khuffash AF, 2008, J PEDIATR-US, V153, P350, DOI 10.1016/j.jpeds.2008.04.014; El-Khuffash AF, 2007, ARCH DIS CHILD-FETAL, V92, P421, DOI 10.1136/adc.2007.119701; El-Khuffash AF, 2011, ARCH DIS CHILD-FETAL, V96, pF133, DOI 10.1136/adc.2010.185967; EVANS N, 1994, J PEDIATR-US, V125, P778, DOI 10.1016/S0022-3476(94)70078-8; Farombi-Oghuvbu I, 2008, ARCH DIS CHILD-FETAL, V93, pF257, DOI 10.1136/adc.2007.120691; Gonzalez A, 1996, J PEDIATR-US, V128, P470, DOI 10.1016/S0022-3476(96)70356-6; Guo MMH, 2015, AM J PERINAT, V32, P155, DOI 10.1055/s-0034-1376393; IYER P, 1994, ARCH DIS CHILD-FETAL, V70, pF112, DOI 10.1136/fn.70.2.F112; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Joseph L, 2010, AM J PERINAT, V27, P381, DOI 10.1055/s-0029-1243312; Kalra VK, 2014, PEDIATR PULM, V49, P1106, DOI 10.1002/ppul.22942; Klersy C, 2012, CLIN CHIM ACTA, V413, P544, DOI 10.1016/j.cca.2011.11.012; KOJIMA T, 1990, PEDIATR RES, V27, P260, DOI 10.1203/00006450-199003000-00011; Korhonen P, 1999, EARLY HUM DEV, V54, P245, DOI 10.1016/S0378-3782(98)00101-7; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Landry JS, 2011, PAED CHILD HEALT-CAN, V16, P399, DOI 10.1093/pch/16.7.399; Levin ER, 1998, NEW ENGL J MED, V339, P321; Mata-Greenwood E, 2003, AM J PHYSIOL-LUNG C, V285, pL222, DOI 10.1152/ajplung.00388.2002; Merritt TA, 2009, SEMIN FETAL NEONAT M, V14, P345, DOI 10.1016/j.siny.2009.08.009; Nir A, 2009, PEDIATR CARDIOL, V30, P3, DOI 10.1007/s00246-008-9258-4; Nuntnarumit P, 2011, ACTA PAEDIATR, V100, P1217, DOI 10.1111/j.1651-2227.2011.02304.x; Ogawa T, 2014, ENDOCR CONNECT, V3, pR31, DOI 10.1530/EC-14-0012; Oh W, 2005, J PEDIATR-US, V147, P786, DOI 10.1016/j.jpeds.2005.06.039; Prontera C, 2009, CLIN CHIM ACTA, V400, P70, DOI 10.1016/j.cca.2008.10.011; Reynolds EW, 2004, PEDIATRICS, V114, P1297, DOI 10.1542/peds.2004-0525; Rudiger A, 2006, CRIT CARE MED, V34, P2140, DOI 10.1097/01.CCM.0000229144.97624.90; Sehgal A, 2009, EUR J PEDIATR, V168, P907, DOI 10.1007/s00431-009-0983-3; Sellmer A, 2013, ARCH DIS CHILD-FETAL, V98, pF505, DOI 10.1136/archdischild-2013-303816; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Stoll BJ, 1996, J PEDIATR-US, V129, P72, DOI 10.1016/S0022-3476(96)70192-0; Tanaka T, 2004, J INT MED RES, V32, P57, DOI 10.1177/147323000403200109; Vesely DL, 2009, J INVEST MED, V57, P29, DOI 10.2310/JIM.0b013e3181948b37; Weber M, 2006, HEART, V92, P843, DOI 10.1136/hrt.2005.071233; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2015	10	10							e0140079	10.1371/journal.pone.0140079	http://dx.doi.org/10.1371/journal.pone.0140079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TY	26452045	gold, Green Published, Green Submitted			2022-12-26	WOS:000362511200034
J	Kutzera, J; Smilde, AK; Wilderjans, TF; Hoefsloot, HCJ				Kutzera, Joachim; Smilde, Age K.; Wilderjans, Tom F.; Hoefsloot, Huub C. J.			Towards a Hierarchical Strategy to Explore Multi-Scale IP/MS Data for Protein Complexes	PLOS ONE			English	Article							MEDIATOR COMPLEX; IDENTIFICATION; MODEL	Protein interaction in cells can be described at different levels. At a low interaction level, proteins function together in small, stable complexes and at a higher level, in sets of interacting complexes. All interaction levels are crucial for the living organism, and one of the challenges in proteomics is to measure the proteins at their different interaction levels. One common method for such measurements is immunoprecipitation followed by mass spectrometry (IP/MS), which has the potential to probe the different protein interaction forms. However, IP/MS data are complex because proteins, in their diverse interaction forms, manifest themselves in different ways in the data. Numerous bioinformatic tools for finding protein complexes in IP/MS data are currently available, but most tools do not provide information about the interaction level of the discovered complexes, and no tool is geared specifically to unraveling and visualizing these different levels. We present a new bioinformatic tool to explore IP/MS datasets for protein complexes at different interaction levels and show its performance on several real-life datasets. Our tool creates clusters that represent protein complexes, but unlike previous methods, it arranges them in a tree-shaped structure, reporting why specific proteins are predicted to build a complex and where it can be divided into smaller complexes. In every data analysis method, parameters have to be chosen. Our method can suggest values for its parameters and comes with adapted visualization tools that display the effect of the parameters on the result. The tools provide fast graphical feedback and allow the user to interact with the data by changing the parameters and examining the result. The tools also allow for exploring the different organizational levels of the protein complexes in a given dataset. Our method is available as GNU-R source code and includes examples at www.bdagroup.nl.	[Kutzera, Joachim; Smilde, Age K.; Hoefsloot, Huub C. J.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Kutzera, Joachim; Smilde, Age K.; Hoefsloot, Huub C. J.] Univ Amsterdam, Netherlands Inst Syst Biol, Amsterdam, Netherlands; [Wilderjans, Tom F.] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Wilderjans, Tom F.] Leiden Univ, Fac Social & Behav Sci, Leiden, Netherlands	University of Amsterdam; University of Amsterdam; KU Leuven; Leiden University; Leiden University - Excl LUMC	Kutzera, J (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	j.kutzera@uva.nl	Wilderjans, Tom/AAC-5066-2019	Wilderjans, Tom/0000-0002-1677-4938; Smilde, Age/0000-0002-3052-4644; Kutzera, Joachim/0000-0003-2527-7893				Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Alberts B, 2008, MOL BIOL CELL E; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Cai BJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S4; Choi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.41; Clancy T, 2014, PROTEOMICS, V14, P24, DOI 10.1002/pmic.201300230; Clancy T, 2013, MOL CELL PROTEOMICS, V12, P1723, DOI 10.1074/mcp.O112.019828; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; DEBOECK P, 1988, PSYCHOMETRIKA, V53, P361; Drewes G, 2003, CURR OPIN CELL BIOL, V15, P199, DOI 10.1016/S0955-0674(03)00005-X; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gentleman R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-112; Geva G, 2011, BIOINFORMATICS, V27, P111, DOI 10.1093/bioinformatics/btq652; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Kim EDH, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-34; Kritikos GD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-239; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kutzera Joachim, 2013, BMC Res Notes, V6, P468, DOI 10.1186/1756-0500-6-468; Leenen I, 2008, PSYCHOMETRIKA, V73, P39, DOI 10.1007/s11336-007-9038-8; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Pizzuti C, 2014, BIOINFORMATICS, V30, P1343, DOI 10.1093/bioinformatics/btu034; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Scholtens D, 2005, BIOINFORMATICS, V21, P3548, DOI 10.1093/bioinformatics/bti567; Scholtens D., 2004, STAT APPL GENETICS M, V3, DOI [10.2202/1544-6115.1107, DOI 10.2202/1544-6115.1107]; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Wilderjans TF, 2012, PSYCHOMETRIKA, V77, P724, DOI 10.1007/s11336-012-9275-3; Wu M, 2011, J COMPUT BIOL, V18, P1; Xie ZP, 2011, BIOINFORMATICS, V27, pI159, DOI 10.1093/bioinformatics/btr212	36	0	0	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139704	10.1371/journal.pone.0139704	http://dx.doi.org/10.1371/journal.pone.0139704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448546	Green Published, Green Submitted, gold			2022-12-26	WOS:000362511000047
J	Yao, X; Carlson, D; Sun, YX; Ma, LS; Wolf, SE; Minei, JP; Zang, QS				Yao, Xiao; Carlson, Deborah; Sun, Yuxiao; Ma, Lisha; Wolf, Steven E.; Minei, Joseph P.; Zang, Qun S.			Mitochondrial ROS Induces Cardiac Inflammation via a Pathway through mtDNA Damage in a Pneumonia-Related Sepsis Model	PLOS ONE			English	Article							ANTIOXIDANT MITOQ PROTECTS; CYTOCHROME-C-OXIDASE; OXIDATIVE STRESS; TARGETED ANTIOXIDANTS; DNA DAMAGE; TRANSCRIPTION FACTOR; ORGAN FAILURE; BURN INJURY; DYSFUNCTION; RECEPTOR	We have previously shown that mitochondria-targeted vitamin E (Mito-Vit-E), a mtROS specific antioxidant, improves cardiac performance and attenuates inflammation in a pneumonia- related sepsis model. In this study, we applied the same approaches to decipher the signaling pathway(s) of mtROS-dependent cardiac inflammation after sepsis. Sepsis was induced in Sprague Dawley rats by intratracheal injection of S. pneumoniae. Mito-Vit-E, vitamin E or vehicle was administered 30 minutes later. In myocardium 24 hours post-inoculation, Mito-Vit-E, but not vitamin E, significantly protected mtDNA integrity and decreased mtDNA damage. Mito-Vit-E alleviated sepsis-induced reduction in mitochondria-localized DNA repair enzymes including DNA polymerase gamma, AP endonuclease, 8-oxoguanine glycosylase, and uracil-DNA glycosylase. Mito-Vit-E dramatically improved metabolism and membrane integrity in mitochondria, suppressed leakage of mtDNA into the cytoplasm, inhibited up-regulation of Toll-like receptor 9 (TLR9) pathway factors MYD88 and RAGE, and limited RAGE interaction with its ligand TFAM in septic hearts. Mito-Vit-E also deactivated NF-kappa B and caspase 1, reduced expression of the essential inflammasome component ASC, and decreased inflammatory cytokine IL-1 beta. In vitro, both Mito-Vit-E and TLR9 inhibitor OND-I suppressed LPS-induced up-regulation in MYD88, RAGE, ASC, active caspase 1, and IL-1 beta in cardiomyocytes. Since free mtDNA escaped from damaged mitochondria function as a type of DAMPs to stimulate inflammation through TLR9, these data together suggest that sepsis-induced cardiac inflammation is mediated, at least partially, through mtDNA-TLR9-RAGE. At last, Mito-Vit-E reduced the circulation of myocardial injury marker troponin-I, diminished apoptosis and amended morphology in septic hearts, suggesting that mitochondria-targeted antioxidants are a potential cardioprotective approach for sepsis.	[Yao, Xiao; Carlson, Deborah; Sun, Yuxiao; Ma, Lisha; Wolf, Steven E.; Minei, Joseph P.; Zang, Qun S.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zang, QS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	qun.zang@utsouthwestern.edu		Wolf, Steven/0000-0003-2972-3440; Zang, Qun (Sophia)/0000-0002-6397-8896	NIH [1R01GM111295-01]; UTSW Department of Surgery; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111295] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTSW Department of Surgery; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by NIH grant 1R01GM111295-01 and UTSW Department of Surgery internal funding to Q. S. Zang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Arbustini E, 1998, AM J PATHOL, V153, P1501, DOI 10.1016/S0002-9440(10)65738-0; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bjorkman L, 2008, J LEUKOCYTE BIOL, V83, P245, DOI 10.1189/jlb.0607-408; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Bucciarelli LG, 2008, DIABETES, V57, P1941, DOI 10.2337/db07-0326; Cairns CB, 1997, J TRAUMA, V42, P532, DOI 10.1097/00005373-199703000-00023; Cao Y, 2015, FEBS J, V282, P3799, DOI 10.1111/febs.13379; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Codina R, 2010, APOPTOSIS, V15, P139, DOI 10.1007/s10495-009-0412-0; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Court O, 2002, CRIT CARE, V6, P500, DOI 10.1186/cc1822; Czapiga M, 2005, EXP HEMATOL, V33, P73, DOI 10.1016/j.exphem.2004.09.010; Das S, 2014, BRIT J PHARMACOL, V171, P1260, DOI 10.1111/bph.12530; Deitch EA, 2006, AM J PHYSIOL-HEART C, V291, pH1456, DOI 10.1152/ajpheart.00694.2005; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Ehrentraut S, 2011, SHOCK, V36, P613, DOI 10.1097/SHK.0b013e318235805f; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Fromm RE, 2007, CRIT CARE MED, V35, P584, DOI 10.1097/01.CCM.0000254349.10953.BE; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Ha TZ, 2010, AM J PHYSIOL-HEART C, V298, pH984, DOI 10.1152/ajpheart.01109.2009; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; Hwaiz R, 2013, J SURG RES, V183, P798, DOI 10.1016/j.jss.2013.02.045; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Julian MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072354; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; KAYAR SR, 1987, RESP PHYSIOL, V70, P275, DOI 10.1016/0034-5687(87)90010-7; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Koenitzer JR, 2010, ANN NY ACAD SCI, V1203, P45, DOI 10.1111/j.1749-6632.2010.05559.x; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Li YY, 2001, CIRCULATION, V104, P2492, DOI 10.1161/hc4501.098944; Lohner R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/261049; Lowes DA, 2009, FREE RADICAL RES, V43, P323, DOI 10.1080/10715760902736275; Lowes DA, 2008, FREE RADICAL BIO MED, V45, P1559, DOI 10.1016/j.freeradbiomed.2008.09.003; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Musatov A, 2000, BIOCHEMISTRY-US, V39, P12996, DOI 10.1021/bi000884z; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Orange JS, 2003, J CLIN INVEST, V112, P983, DOI 10.1172/JCI200319960; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Powell TC, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-207; Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406; Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7; REVEL JP, 1960, J BIOPHYS BIOCHEM CY, V8, P575, DOI 10.1083/jcb.8.3.575; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Sheeran PW, 1998, J SURG RES, V76, P192, DOI 10.1006/jsre.1998.5352; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Simm A, 2004, EXP GERONTOL, V39, P407, DOI 10.1016/j.exger.2003.12.006; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Struck J, 2005, SHOCK, V23, P533, DOI 10.1097/01.shk.0000162236.75253.9e; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989; Supinski GS, 2009, AM J PHYSIOL-REG I, V297, pR1095, DOI 10.1152/ajpregu.90902.2008; Tao WK, 2005, SHOCK, V24, P495, DOI 10.1097/01.shk.0000183431.78973.cd; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Todorova J, 2012, ONCOL LETT, V3, P214, DOI 10.3892/ol.2011.459; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Tsutsui Hiroyuki, 2008, Circ J, V72 Suppl A, pA31, DOI 10.1253/circj.CJ-08-0014; Vasile VC, 2013, AM J MED, V126, P1114, DOI 10.1016/j.amjmed.2013.06.029; Wang L, 2010, BURNS, V36, P232, DOI 10.1016/j.burns.2009.02.019; Ware LB, 2013, CRIT CARE, V17, DOI 10.1186/cc13080; Wesche-Soldato DE, 2007, AM J PATHOL, V171, P87, DOI 10.2353/ajpath.2007.061099; White J, 2003, AM J PHYSIOL-HEART C, V285, pH47, DOI 10.1152/ajpheart.00833.2002; WOJTCZAK L, 1972, ACTA BIOCHIM POL, V19, P227; Yamanouchi S, 2013, J CRIT CARE, V28, P1027, DOI 10.1016/j.jcrc.2013.05.006; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016; Yao X, 2014, AM J PHYSIOL-HEART C, V306, pH882, DOI 10.1152/ajpheart.00475.2013; Zang Qun, 2007, Surg Infect (Larchmt), V8, P41, DOI 10.1089/sur.2006.033; Zang QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043424; Zang QS, 2012, AM J PHYSIOL-HEART C, V302, pH1847, DOI 10.1152/ajpheart.00203.2011; Zang QS, 2010, AM J PHYSIOL-HEART C, V298, pH1951, DOI 10.1152/ajpheart.00927.2009; Zanotti-Cavazzoni SL, 2009, CURR OPIN CRIT CARE, V15, P392, DOI 10.1097/MCC.0b013e3283307a4e; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	107	88	91	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139416	10.1371/journal.pone.0139416	http://dx.doi.org/10.1371/journal.pone.0139416			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TW	26448624	Green Submitted, Green Published, gold			2022-12-26	WOS:000362511000026
J	Jorgensen, MG; Andersen, S; Ryg, J; Masud, T				Jorgensen, Martin Gronbech; Andersen, Stig; Ryg, Jesper; Masud, Tahir			Novel Use of the Nintendo Wii Board for Measuring Isometric Lower Limb Strength: A Reproducible and Valid Method in Older Adults	PLOS ONE			English	Article							HAND-HELD DYNAMOMETRY; EXTREMITY MUSCLE STRENGTH; EXTENSION STRENGTH; SPORTS-MEDICINE; RELIABILITY; BALANCE; CHILDREN; PEOPLE; FORCE; HIP	Background Portable, low-cost, objective and reproducible assessment of muscle strength in the lower limbs is important as it allows clinicians to precisly track progression of patients undergoing rehabilitation. The Nintendo Wii Balance Board (WBB) is portable, inexpensive, durable, available worldwide, and may serve the above function. Objective The purpose of the study was to evaluate (1) reproducibility and (2) concurrent validity of the WBB for measuring isometric muscle strength in the lower limb. Methods A custom hardware and software was developed to utilize the WBB for assessment of isometric muscle strength. Thirty older adults (69.0 +/- 4.2 years of age) were studied on two separate occasions on both the WBB and a stationary isometric dynamometer (SID). On each occasion, three recordings were obtained from each device. For the first recording, means and maximum values were used for further analysis. The test-retest reproducibility was examined using intraclass correlation coefficients (ICC), Standard Error of Measurement (SEM), and limits of agreement (LOA). Bland-Altman plots (BAP) and ICC's were used to explore concurrent validity. Results No systematic difference between test-retest was detected for the WBB. ICC within-device were between 0.90 and 0.96 and between-devices were from 0.80 to 0.84. SEM ranged for the WBB from 9.7 to 13.9%, and for the SID from 11.9 to 13.1%. LOA ranged for the WBB from 20.3 to 28.7% and for the SID from 24.2 to 26.6%. The BAP showed no relationship between the difference and the mean. Conclusions A high relative and an acceptable absolute reproducibility combined with a good validity was found for the novel method using the WBB for measuring isometric lower limb strength in older adults. Further research using the WBB for assessing lower limb strength should be conducted in different study-populations.	[Jorgensen, Martin Gronbech; Andersen, Stig] Aalborg Univ Hosp, Dept Geriatr, Aalborg, Denmark; [Ryg, Jesper] Odense Univ Hosp, Dept Geriatr, DK-5000 Odense, Denmark; [Ryg, Jesper] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Masud, Tahir] Nottingham Univ Hosp NHS Trust, Hlth Care Older People, Nottingham, Notts, England; [Andersen, Stig] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aalborg University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Nottingham University Hospital NHS Trust; Aalborg University	Jorgensen, MG (corresponding author), Aalborg Univ Hosp, Dept Geriatr, Aalborg, Denmark.	mgj@rn.dk	Andersen, Stig/J-2636-2015	Ryg, Jesper/0000-0002-8641-3062; Jorgensen, Martin Gronbech/0000-0002-3189-644X				Arnold CM, 2010, J STRENGTH COND RES, V24, P815, DOI 10.1519/JSC.0b013e3181aa36b8; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bartlett HL, 2014, GAIT POSTURE, V39, P224, DOI 10.1016/j.gaitpost.2013.07.010; BEASLEY W C, 1956, Phys Ther Rev, V36, P21; Behm DG, 2008, APPL PHYSIOL NUTR ME, V33, P547, DOI 10.1139/H08-020; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bohannon RW, 2007, J REHABIL MED, V39, P14, DOI 10.2340/16501977-0018; Bohannon Richard W., 2012, Physiotherapy Theory and Practice, V28, P562, DOI 10.3109/09593985.2011.640385; Bohannon RW, 2011, J STRENGTH COND RES, V25, P1963, DOI 10.1519/JSC.0b013e3181e4f5ce; Cadore EL, 2014, AGING DIS, V5, P183, DOI 10.14336/AD.2014.0500183; Cuthbert Scott C, 2007, Chiropr Osteopat, V15, P4, DOI 10.1186/1746-1340-15-4; Domholdt E., 1993, PHYS THERAPY RES PRI; Fischer SL, 2010, J ELECTROMYOGR KINES, V20, P68, DOI 10.1016/j.jelekin.2009.01.007; Ford-Smith CD, 2001, ARCH PHYS MED REHAB, V82, P1128, DOI 10.1053/apmr.2001.24291; Hasegawa R, 2008, CLIN REHABIL, V22, P902, DOI 10.1177/0269215508094713; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jorgensen MG, 2013, J GERONTOL A-BIOL, V68, P845, DOI 10.1093/gerona/gls222; Keating JL, 1996, PHYS THER, V76, P866, DOI 10.1093/ptj/76.8.866a; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Lu YM, 2011, J STRENGTH COND RES, V25, P1065, DOI 10.1519/JSC.0b013e3181d650a6; Maffiuletti NA, 2010, J BONE JOINT SURG AM, V92A, P220, DOI 10.2106/JBJS.I.00305; Mahony K, 2009, PHYS OCCUP THER PEDI, V29, P44, DOI 10.1080/01942630802574858; Martin HJ, 2006, GERONTOLOGY, V52, P154, DOI 10.1159/000091824; Matsuzawa R, 2014, PHYS THER, V94, P947, DOI 10.2522/ptj.20130270; Neil SE, 2013, PHYSIOTHER THEOR PR, V29, P639, DOI 10.3109/09593985.2013.779337; Petterson SC, 2011, MED SCI SPORT EXER, V43, P225, DOI 10.1249/MSS.0b013e3181eb639a; Pijnappels M, 2008, EUR J APPL PHYSIOL, V102, P585, DOI 10.1007/s00421-007-0613-6; Pijnappels M, 2008, J ELECTROMYOGR KINES, V18, P188, DOI 10.1016/j.jelekin.2007.06.004; Rantanen T, SCAND J MED SCI SPOR, V13; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Thorborg K, 2013, KNEE SURG SPORT TR A, V21, P550, DOI 10.1007/s00167-012-2115-2; Whiteley R, 2012, J SCI MED SPORT, V15, P444, DOI 10.1016/j.jsams.2012.01.003	33	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0138660	10.1371/journal.pone.0138660	http://dx.doi.org/10.1371/journal.pone.0138660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444554	Green Published, gold, Green Submitted			2022-12-26	WOS:000362510600034
J	Pinto, RC; Engel, PM				Pinto, Rafael Coimbra; Engel, Paulo Martins			A Fast Incremental Gaussian Mixture Model	PLOS ONE			English	Article								This work builds upon previous efforts in online incremental learning, namely the Incremental Gaussian Mixture Network (IGMN). The IGMN is capable of learning from data streams in a single-pass by improving its model after analyzing each data point and discarding it thereafter. Nevertheless, it suffers from the scalability point-of-view, due to its asymptotic time complexity of O(NKD3) for N data points, K Gaussian components and D dimensions, rendering it inadequate for high-dimensional data. In this work, we manage to reduce this complexity to O(NKD2) by deriving formulas for working directly with precision matrices instead of covariance matrices. The final result is a much faster and scalable algorithm which can be applied to high dimensional tasks. This is confirmed by applying the modified algorithm to high-dimensional classification datasets.	[Pinto, Rafael Coimbra; Engel, Paulo Martins] Univ Fed Rio Grande do Sul, Inst Informat, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Pinto, RC (corresponding author), Univ Fed Rio Grande do Sul, Inst Informat, Porto Alegre, RS, Brazil.	rcpinto@inf.ufrgs.br	Pinto, Rafael/ABD-3100-2020	Pinto, Rafael/0000-0002-4512-5566				Damas B, 2012, IEEE INT C INT ROBOT, P1499, DOI 10.1109/IROS.2012.6386156; de Pontes Pereira R, 2012, NEUR NETW SBRN 2012, P131; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Engel P. M., 2009, INBC INCREMENTAL ALG; Engel PM, 2010, LECT NOTES ARTIF INT, V6404, P82, DOI 10.1007/978-3-642-16138-4_9; Flores JHF, 2012, NEUR NETW IJCNN 2012, P1; Gall FL, 2014, ARXIV140177142014; Ghahramani Z, 1994, ADV NEURAL INFORM PR, V6; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Harville D.A., 2008, MATRIX ALGEBRA STAT; Heinen M. R., 2011, CONNECTIONIST APPROA; Heinen M.R., 2011, P 8 ENC NAC INT ART; Heinen M. R., 2011, J APPL COMPUTING RES, V1, P2, DOI [10.4013/jacr.2011.11.01, DOI 10.4013/JACR.2011.11.01]; Heinen M.R., 2012, 2012 INT JOINT C NEU, P1; Heinen MR, 2011, IEEE INT C INTELL TR, P890, DOI 10.1109/ITSC.2011.6083107; Hinton G. E., 2012, ARXIV12070580, DOI DOI 10.9774/GLEAF.978-1-909493-38-42; Krizhevsky A., 2009, LEARNING MULTIPLE LA; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lefakis L, 2014, JMLR WORKSH CONF PRO, V33, P567; Olsen Peder A, 2001, T SPEECH AUDIO PROCE; Pinto R., 2011, P 9 ENIA BRAZ M ART; Pinto R. J. B., 2012, NEUR NETW IJCNN 2012, P1; Pinto RC, EXPT DATA FAST INCRE; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Salmen J, 2010, PATTERN RECOGN LETT, V31, P1903, DOI 10.1016/j.patrec.2010.03.001; Santos ADPd, 2012, ARXIV121040082012; SHERMAN J, 1950, ANN MATH STAT, V21, P124, DOI 10.1214/aoms/1177729893	29	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139931	10.1371/journal.pone.0139931	http://dx.doi.org/10.1371/journal.pone.0139931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TS	26444880	gold, Green Published, Green Submitted			2022-12-26	WOS:000362510600108
J	Zanolie, K; de Cremer, D; Guroglu, B; Crone, EA				Zanolie, Kiki; de Cremer, David; Gueroglu, Berna; Crone, Eveline A.			Rejection in Bargaining Situations: An Event-Related Potential Study in Adolescents and Adults	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; MEDIAL FRONTAL NEGATIVITY; ECONOMIC DECISION-MAKING; ERROR-RELATED NEGATIVITY; ULTIMATUM GAME; DEVELOPMENTAL TRAJECTORIES; SOCIAL EXCLUSION; PEER REJECTION; FAIRNESS; NEUROSCIENCE	The neural correlates of rejection in bargaining situations when proposing a fair or unfair offer are not yet well understood. We measured neural responses to rejection and acceptance of monetary offers with event-related potentials (ERPs) in mid-adolescents (14-17 years) and early adults (19-24 years). Participants played multiple rounds of the Ultimatum Game as proposers, dividing coins between themselves and a second player (responder) by making a choice between an unfair distribution (7 coins for proposer and 3 for responder; 7/3) and one of two alternatives: a fair distribution (5/5) or a hyperfair distribution (3/7). Participants mostly made fair offers (5/5) when the alternative was unfair (7/3), but made mostly unfair offers (7/3) when the alternative was hyperfair (3/7). When participants' fair offers (5/5; alternative was 7/3) were rejected this was associated with a larger Medial Frontal Negativity (MFN) compared to acceptance of fair offers and rejection of unfair offers (7/3; alternative was 3/7). Also, the MFN was smaller after acceptance of unfair offers (7/3) compared to rejection. These neural responses did not differ between adults and mid-adolescents, suggesting that the MFN reacts as a neural alarm system to social prediction errors which is already prevalent during adolescence.	[Zanolie, Kiki; Gueroglu, Berna; Crone, Eveline A.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Zanolie, Kiki; Gueroglu, Berna; Crone, Eveline A.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [de Cremer, David] Univ Cambridge, Judge Business Sch, Cambridge, England	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge	Zanolie, K (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	c.k.k.zanolie@fsw.leidenuniv.nl	Güroğlu, Berna/O-1639-2016; Guroglu, Berna/AAL-4664-2021	Güroğlu, Berna/0000-0002-5418-8737; Guroglu, Berna/0000-0002-5418-8737; Zanolie, Kiki/0000-0001-6101-1000; Crone, Eveline/0000-0002-7508-6078	De Jonge Akademie; AXA Research Fund; Netherlands Organization for Scientific Research, VENI grant [451-10-021]	De Jonge Akademie; AXA Research Fund(AXA Research Fund); Netherlands Organization for Scientific Research, VENI grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by De Jonge Akademie, www.dejongeakademie.nl; AXA Research Fund, www.axa-research.org; and Netherlands Organization for Scientific Research, VENI grant number 451-10-021, www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00059; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Boksem MAS, 2012, SOC COGN AFFECT NEUR, V7, P304, DOI 10.1093/scan/nsr010; Boksem MAS, 2011, PSYCHOPHYSIOLOGY, V48, P973, DOI 10.1111/j.1469-8986.2010.01163.x; Boksem MAS, 2010, SOC NEUROSCI-UK, V5, P118, DOI 10.1080/17470910903202666; Campanha C, 2011, J NEUROSCI, V31, P15569, DOI 10.1523/JNEUROSCI.1253-11.2011; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Crowley MJ, 2013, DEV NEUROPSYCHOL, V38, P595, DOI 10.1080/87565641.2012.694512; Eppinger B, 2008, NEUROPSYCHOLOGIA, V46, P521, DOI 10.1016/j.neuropsychologia.2007.09.001; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Feng CL, 2015, HUM BRAIN MAPP, V36, P591, DOI 10.1002/hbm.22649; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gratton G., 1983, CLIN NEUROPHYSIOL, V55, P468, DOI DOI 10.1016/0013-4694(83)90135-9; Groen Y, 2007, BIOL PSYCHOL, V76, P174, DOI 10.1016/j.biopsycho.2007.07.006; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Guroglu B, 2011, NEUROIMAGE, V57, P634, DOI 10.1016/j.neuroimage.2011.04.032; Guroglu B, 2010, SOC COGN AFFECT NEUR, V5, P414, DOI 10.1093/scan/nsq013; Guroglu B, 2009, J EXP CHILD PSYCHOL, V104, P398, DOI 10.1016/j.jecp.2009.07.002; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hammerer D, 2011, J COGNITIVE NEUROSCI, V23, P579, DOI 10.1162/jocn.2010.21475; Handgraaf M. J. J., 2003, SOCIAL JUSTICE RES, V16, P263, DOI DOI 10.1023/A:1025940829543; Hewig J, 2011, PSYCHOPHYSIOLOGY, V48, P507, DOI 10.1111/j.1469-8986.2010.01081.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Krigolson OE, 2009, J COGNITIVE NEUROSCI, V21, P1833, DOI 10.1162/jocn.2009.21128; Lieberman MD, 2009, SCIENCE, V323, P890, DOI 10.1126/science.1170008; Luque D, 2012, J COGNITIVE NEUROSCI, V24, P794, DOI 10.1162/jocn_a_00145; Masten CL, 2011, DEV PSYCHOPATHOL, V23, P283, DOI 10.1017/S0954579410000799; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; Moor BG, 2012, NEUROIMAGE, V59, P708, DOI 10.1016/j.neuroimage.2011.07.028; Moor BG, 2010, SOC NEUROSCI-UK, V5, P461, DOI 10.1080/17470910903526155; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Noordt SJR, 2012, FRONT HUM NEUROSCI, V6, P1; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Radke S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031491; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rotge JY, 2015, SOC COGN AFFECT NEUR, V10, P19, DOI 10.1093/scan/nsu110; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Santesso DL, 2011, PSYCHOPHYSIOLOGY, V48, P1481, DOI 10.1111/j.1469-8986.2011.01229.x; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Sebastian CL, 2011, NEUROIMAGE, V57, P686, DOI 10.1016/j.neuroimage.2010.09.063; Segalowitz SJ, 2012, SOC COGN AFFECT NEUR, V7, P115, DOI 10.1093/scan/nsq090; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Stouten J, 2005, EUR J SOC PSYCHOL, V35, P767, DOI 10.1002/ejsp.276; van den Bos W, 2010, COGNITIVE DEV, V25, P90, DOI 10.1016/j.cogdev.2009.07.004; Van der Veen FM, 2011, COGN AFFECT BEHAV NE, V11, P516, DOI 10.3758/s13415-011-0050-1; van Dijk E, 2004, J EXP SOC PSYCHOL, V40, P697, DOI 10.1016/j.jesp.2004.03.002; van Dijk E, 2000, J EXP SOC PSYCHOL, V36, P1, DOI 10.1006/jesp.1999.1392; Van Strien J. W., 1992, NEDERLANDS TIJDSCHRI, V47, P88; von Neumann J., 1953, THEORY GAMES EC BEHA; Walsh MM, 2012, NEUROSCI BIOBEHAV R, V36, P1870, DOI 10.1016/j.neubiorev.2012.05.008; Woolrich MW, 2009, NEUROMETHODS, V41, P179, DOI 10.1007/978-1-60327-919-2_7; Wu Y, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00131; Zottoli TM, 2012, PSYCHOPHYSIOLOGY, V49, P413, DOI 10.1111/j.1469-8986.2011.01312.x	57	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2015	10	10							e0139953	10.1371/journal.pone.0139953	http://dx.doi.org/10.1371/journal.pone.0139953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TS	26445134	Green Submitted, Green Published, gold			2022-12-26	WOS:000362510600110
